Citrus Sinensis ID: 002278
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 943 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGW6 | 966 | LRR receptor-like serine/ | yes | no | 0.988 | 0.964 | 0.799 | 0.0 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.988 | 0.963 | 0.796 | 0.0 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.996 | 0.963 | 0.642 | 0.0 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.889 | 0.746 | 0.388 | 1e-151 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.931 | 0.796 | 0.360 | 1e-151 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.908 | 0.854 | 0.357 | 1e-149 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.933 | 0.878 | 0.366 | 1e-149 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.904 | 0.681 | 0.366 | 1e-147 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.890 | 0.762 | 0.370 | 1e-144 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.889 | 0.703 | 0.35 | 1e-141 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1513 bits (3918), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 755/944 (79%), Positives = 841/944 (89%), Gaps = 12/944 (1%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
MAIK SFSNL N+LLDWDDVHNSD CSWRGVFCDN S SVVSLNLSSLNLGGEISP+IGD
Sbjct: 34 MAIKGSFSNLVNMLLDWDDVHNSDLCSWRGVFCDNVSYSVVSLNLSSLNLGGEISPAIGD 93
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
LRNLQSID QGNKL GQIPDEIGNC SLV+++LS+N LYGDIPFSISKLKQLE LNLKNN
Sbjct: 94 LRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGDIPFSISKLKQLETLNLKNN 153
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGP+P+TLTQIPNLK LDLA N LTGEI RL+YWNEVLQYLGLRGN LTG LS DMCQ
Sbjct: 154 QLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLGLRGNMLTGTLSSDMCQ 213
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTGTIP+SIGNCTSF+ILDISYNQITGEIPYNIGFLQVATLSLQGN+
Sbjct: 214 LTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFLQVATLSLQGNR 273
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTG+IPEVIGLMQALAVLDLS+NELVGPIPPILGNLS+TGKLYLHGN LTGPIP ELGNM
Sbjct: 274 LTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNMLTGPIPSELGNM 333
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
S+LSYLQL +N+LVGTIP ELGKLEQLFELNLA+N L GPIP NISSC ALNQFNVHGN
Sbjct: 334 SRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFNVHGNL 393
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSG+IP +FRNLGSLTYLNLS NNFKGK+P ELG IINLD LDLS NNFSGS+P ++GDL
Sbjct: 394 LSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDL 453
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLL LNLSRNHL+G LPAEFGNLRSIQ ID+SFN LSG IP ELGQLQN+ SLILNNN
Sbjct: 454 EHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNK 513
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
L G IPDQL+NCF+L NLNVS+NNLSGI+PP++NFSRF+ SF+GNP LCGNW+GSICGP
Sbjct: 514 LHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCGNWVGSICGP 573
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
+ K+RV FSR A++C+VLG ITLL M +AVYKS QQ+ +++ GS K G KLVILH
Sbjct: 574 -LPKSRV-FSRGALICIVLGVITLLCMIFLAVYKSMQQK-KILQGSSKQAEGLTKLVILH 630
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHTFDDIMR TENL+EK+I+GYGASSTVYKCALK+SRPIA+K+LYNQYPHNLREFE
Sbjct: 631 MDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREFE 690
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSIRHRNIVSLHGYALSP GNLLFYDYM NGSLWDLLHG KKVKLDWETRLKI
Sbjct: 691 TELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKI 750
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDC PRIIHRD+KSSNIL+DENF+AHLSDFGIA+ IP + HAST+VL
Sbjct: 751 AVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVL 810
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSR+NEKSD+YSFGIVLLE+LTGKKAVDNE+NLHQLI+SKADDNTVME
Sbjct: 811 GTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVDNEANLHQLILSKADDNTVME 870
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAP 900
AVDPEV+VTC+DL +RKTFQLALLCTKR P ERPTM EV+RVL+SL+P+ L +A
Sbjct: 871 AVDPEVTVTCMDLGHIRKTFQLALLCTKRNPLERPTMLEVSRVLLSLVPS----LQVAKK 926
Query: 901 KP-IDYYTKFVVNRERQQRVEHDDNSSDARWFVRFGEVISKNTL 943
P +D+ TK + +Q+ + ++ ++WFV+F EVISK+++
Sbjct: 927 LPSLDHSTK----KLQQENEVRNPDAEASQWFVQFREVISKSSI 966
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1510 bits (3910), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 751/943 (79%), Positives = 831/943 (88%), Gaps = 11/943 (1%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
MAIKASFSN+AN+LLDWDDVHN DFCSWRGVFCDN SL+VVSLNLS+LNLGGEIS ++GD
Sbjct: 36 MAIKASFSNVANMLLDWDDVHNHDFCSWRGVFCDNVSLNVVSLNLSNLNLGGEISSALGD 95
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
L NLQSID QGNKL GQIPDEIGNC SL +++ S N L+GDIPFSISKLKQLEFLNLKNN
Sbjct: 96 LMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFSTNLLFGDIPFSISKLKQLEFLNLKNN 155
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGPIP+TLTQIPNLKTLDLARNQLTGEIPRL+YWNEVLQYLGLRGN LTG LSPDMCQ
Sbjct: 156 QLTGPIPATLTQIPNLKTLDLARNQLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSPDMCQ 215
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTGTIP+SIGNCTSFEILD+SYNQITG IPYNIGFLQVATLSLQGNK
Sbjct: 216 LTGLWYFDVRGNNLTGTIPESIGNCTSFEILDVSYNQITGVIPYNIGFLQVATLSLQGNK 275
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTG+IPEVIGLMQALAVLDLS+NEL GPIPPILGNLS+TGKLYLHGNKLTG IPPELGNM
Sbjct: 276 LTGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNM 335
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
S+LSYLQL +N+LVG IP ELGKLEQLFELNLA+NNL G IP NISSC ALNQFNVHGN
Sbjct: 336 SRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNF 395
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSGA+P FRNLGSLTYLNLS N+FKGK+P ELG IINLDTLDLS NNFSGS+P ++GDL
Sbjct: 396 LSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDL 455
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLL LNLSRNHLNG LPAEFGNLRSIQ ID+SFN L+G IP ELGQLQNI SLILNNN
Sbjct: 456 EHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNK 515
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
+ G IPDQL+NCFSL+NLN+S+NNLSGIIPP++NF+RFS SF GNP LCGNW+GSICGP
Sbjct: 516 IHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSICGP 575
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
S+ K++V F+R AV+CMVLGFITL+ M IAVYKS QQ+ ++ GS K G KLVILH
Sbjct: 576 SLPKSQV-FTRVAVICMVLGFITLICMIFIAVYKSKQQK-PVLKGSSKQPEGSTKLVILH 633
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHTFDDIMR TENL EKYI+GYGASSTVYKC K SRPIA+K++YNQYP N REFE
Sbjct: 634 MDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNFREFE 693
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSIRHRNIVSLHGYALSP+GNLLFYDYM NGSLWDLLHGP KKVKLDWETRLKI
Sbjct: 694 TELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLKI 753
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDC PRIIHRD+KSSNIL+D NF+A LSDFGIA+ IP +AST+VL
Sbjct: 754 AVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYASTYVL 813
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSRLNEKSD+YSFGIVLLE+LTGKKAVDNE+NLHQ+I+SKADDNTVME
Sbjct: 814 GTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLTGKKAVDNEANLHQMILSKADDNTVME 873
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAP 900
AVD EVSVTC+D ++KTFQLALLCTKR P ERPTMQEV+RVL+SL+P+PP K +
Sbjct: 874 AVDAEVSVTCMDSGHIKKTFQLALLCTKRNPLERPTMQEVSRVLLSLVPSPPPKKLPSPA 933
Query: 901 KPIDYYTKFVVNRERQQRVEHDDNSSDARWFVRFGEVISKNTL 943
K V ++R H +++ +WFV+F E ISK++L
Sbjct: 934 K---------VQEGEERRESHSSDTTTPQWFVQFREDISKSSL 967
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1230 bits (3183), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 608/947 (64%), Positives = 746/947 (78%), Gaps = 7/947 (0%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
+ IK SF ++ NVL DW +SD+C WRGV C+N + +VV+LNLS LNL GEISP+IGD
Sbjct: 31 LEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSCENVTFNVVALNLSDLNLDGEISPAIGD 90
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
L++L SID +GN+L+GQIPDEIG+C SL +++LS N L GDIPFSISKLKQLE L LKNN
Sbjct: 91 LKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFNELSGDIPFSISKLKQLEQLILKNN 150
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QL GPIPSTL+QIPNLK LDLA+N+L+GEIPRLIYWNEVLQYLGLRGN L G +SPD+CQ
Sbjct: 151 QLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWNEVLQYLGLRGNNLVGNISPDLCQ 210
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVR N+LTG+IP++IGNCT+F++LD+SYNQ+TGEIP++IGFLQVATLSLQGN+
Sbjct: 211 LTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGEIPFDIGFLQVATLSLQGNQ 270
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
L+GKIP VIGLMQALAVLDLS N L G IPPILGNL++T KLYLH NKLTG IPPELGNM
Sbjct: 271 LSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNKLTGSIPPELGNM 330
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
SKL YL+L +N L G IP ELGKL LF+LN+A+N+LEGPIP ++SSCT LN NVHGN+
Sbjct: 331 SKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNSLNVHGNK 390
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
SG IP +F+ L S+TYLNLS NN KG +P EL RI NLDTLDLS N +G +P+S+GDL
Sbjct: 391 FSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDL 450
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLL +NLSRNH+ G++P +FGNLRSI ID+S N +SG IP EL QLQNII L L NNN
Sbjct: 451 EHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNN 510
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
L G + L+NC SL+ LNVS+NNL G IP NFSRFS +SFIGNP LCG+W+ S C
Sbjct: 511 LTGNV-GSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGSWLNSPCHD 569
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGS--RKSMLGPPKLVI 598
S RV SR A++ + +G + +L+M IA + + + GS + PKLVI
Sbjct: 570 SRRTVRVSISRAAILGIAIGGLVILLMVLIAACRPHNP-PPFLDGSLDKPVTYSTPKLVI 628
Query: 599 LHMDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLRE 658
LHM+MA+H ++DIMR TENLSEKYI+G+GASSTVYKC LKN +P+A+K+LY+ P ++++
Sbjct: 629 LHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYSHNPQSMKQ 688
Query: 659 FETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL 718
FETELE + SI+HRN+VSL Y+LS G+LLFYDY+ NGSLWDLLHGP+KK LDW+TRL
Sbjct: 689 FETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTLDWDTRL 748
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778
KIA GAAQGLAYLHHDC+PRIIHRDVKSSNIL+D++ +A L+DFGIA+ + + H ST+
Sbjct: 749 KIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVSKSHTSTY 808
Query: 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838
V+GTIGYIDPEYA TSRL EKSDVYS+GIVLLE+LT +KAVD+ESNLH LIMSK +N V
Sbjct: 809 VMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAVDDESNLHHLIMSKTGNNEV 868
Query: 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL--PAPPAKLS 896
ME DP+++ TC DL V+K FQLALLCTKR P++RPTM +V RVL S + PPA
Sbjct: 869 MEMADPDITSTCKDLGVVKKVFQLALLCTKRQPNDRPTMHQVTRVLGSFMLSEQPPAATD 928
Query: 897 LAAPKPIDYYTKFVVNRERQQRVEHDD-NSSDARWFVRFGEVISKNT 942
+A Y N + V ++SDA+ F+RFG+VIS+N+
Sbjct: 929 TSATLAGSCYVDEYANLKTPHSVNCSSMSASDAQLFLRFGQVISQNS 975
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 536 bits (1382), Expect = e-151, Method: Compositional matrix adjust.
Identities = 338/871 (38%), Positives = 485/871 (55%), Gaps = 32/871 (3%)
Query: 43 LNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDI 102
L L+ + GE+ IG L LQ + NK +G IP +IGN SL + L NSL G I
Sbjct: 234 LGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPI 293
Query: 103 PFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQY 162
P I +K L+ L L NQL G IP L ++ + +D + N L+GEIP + L+
Sbjct: 294 PSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRL 353
Query: 163 LGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEI 222
L L N LTG++ ++ +L L D+ N+LTG IP N TS L + +N ++G I
Sbjct: 354 LYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVI 413
Query: 223 PYNIG-FLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGK 281
P +G + + + N+L+GKIP I L +L+L N + G IPP + +
Sbjct: 414 PQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQ 473
Query: 282 LYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPI 341
L + GN+LTG P EL + LS ++L N+ G +P E+G ++L L+LA N +
Sbjct: 474 LRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNL 533
Query: 342 PHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDT 401
P+ IS + L FNV N L+G IPS N L L+LSRN+F G +P ELG + L+
Sbjct: 534 PNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEI 593
Query: 402 LDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQ-TIDMSFNQLSGS 460
L LS N FSG++P +IG+L HL L + N +G +P + G L S+Q +++S+N SG
Sbjct: 594 LRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGE 653
Query: 461 IPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSS 520
IP E+G L ++ L LNNN+L G IP N SL N SYNNL+G +P + F +
Sbjct: 654 IPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTL 713
Query: 521 NSFIGNPLLCGNWIGSICGP---------SVTKARVMFSRTAVVCMVLGFITLLVMAAIA 571
SF+GN LCG + S C P S+ R ++ + L++ AI
Sbjct: 714 TSFLGNKGLCGGHLRS-CDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIV 772
Query: 572 VY--KSNQQRQQLITGSRKSMLGPPKLVILHMDMAIHTFDDIMRSTENLSEKYIVGYGAS 629
V+ ++ + ++ + + + T DI+ +T+ + YIVG GA
Sbjct: 773 VHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKER--FTVKDILEATKGFHDSYIVGRGAC 830
Query: 630 STVYKCALKNSRPIAVKKL-------YNQYPHNLREFETELETIGSIRHRNIVSLHG--Y 680
TVYK + + + IAVKKL N + F E+ T+G IRHRNIV L+ Y
Sbjct: 831 GTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCY 890
Query: 681 ALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRII 740
NLL Y+YM GSL +LLHG K +DW TR IA+GAA+GLAYLHHDC PRII
Sbjct: 891 HQGSNSNLLLYEYMSRGSLGELLHG-GKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRII 949
Query: 741 HRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKS 800
HRD+KS+NILIDENF+AH+ DFG+A+ I + + + V G+ GYI PEYA+T ++ EK
Sbjct: 950 HRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKC 1009
Query: 801 DVYSFGIVLLEILTGKKAV---DNESNLHQLIMSKADDNTVM-EAVDPEVSVTCVD--LS 854
D+YSFG+VLLE+LTGK V + +L + D+++ E +DP ++ D L+
Sbjct: 1010 DIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILN 1069
Query: 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLV 885
+ ++A+LCTK PS+RPTM+EV +L+
Sbjct: 1070 HMITVTKIAVLCTKSSPSDRPTMREVVLMLI 1100
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 535 bits (1377), Expect = e-151, Method: Compositional matrix adjust.
Identities = 379/1052 (36%), Positives = 532/1052 (50%), Gaps = 174/1052 (16%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDN--SSLSVVSLNLSSLNLGGEISPSI 58
+ IK+ F + L +W+ ++S C W GV C N S V+SLNLSS+ L G++SPSI
Sbjct: 35 LEIKSKFVDAKQNLRNWNS-NDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPSI 93
Query: 59 GDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLK 118
G L +L+ +D N L+G+IP EIGNC SL ++L++N G+IP I KL LE L +
Sbjct: 94 GGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIY 153
Query: 119 NNQLTGPIPS------TLTQ---------------IPNLKTLDLAR---NQLTGEIPRLI 154
NN+++G +P +L+Q I NLK L R N ++G +P I
Sbjct: 154 NNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEI 213
Query: 155 YWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDIS 214
E L LGL N L+G L ++ L L + N +G IP I NCTS E L +
Sbjct: 214 GGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALY 273
Query: 215 YNQITGEIPYNIGFLQ-VATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPIL 273
NQ+ G IP +G LQ + L L N L G IP IG + +D SEN L G IP L
Sbjct: 274 KNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLEL 333
Query: 274 GNLSYTGKLYLHGNKLTGPIPPELGNMSKLS------------------------YLQLQ 309
GN+ LYL N+LTG IP EL + LS LQL
Sbjct: 334 GNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLF 393
Query: 310 NNQLVGTIPAELGKLEQLFELNLADN------------------------NLEGPIPHNI 345
N L GTIP +LG L+ L+++DN NL G IP I
Sbjct: 394 QNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGI 453
Query: 346 SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLS 405
++C L Q + N L G PS+ ++T + L +N F+G +P E+G L L L+
Sbjct: 454 TTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLA 513
Query: 406 VNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAEL 465
N F+G +P IG L L TLN+S N L G +P+E N + +Q +DM N SG++P+E+
Sbjct: 514 DNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEV 573
Query: 466 GQLQNIISLILNNNNLQGGIPDQLSNCFSLSN-------------------------LNV 500
G L + L L+NNNL G IP L N L+ LN+
Sbjct: 574 GSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNL 633
Query: 501 SYNNLSGIIPPI---------------------------------RNFS----------- 516
SYN L+G IPP NFS
Sbjct: 634 SYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLL 693
Query: 517 -RFSSNSFIGNPLLCGNWIGSIC-----GPSVTKARVMFSRT----AVVCMVLGFITLLV 566
S +SFIGN LCG + PS + + R+ A+ V+G ++L++
Sbjct: 694 RNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLML 753
Query: 567 MAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILHMDMAIHTFDDIMRSTENLSEKYIVGY 626
+A I VY + + + + ++ L I TF D++ +T+N E ++VG
Sbjct: 754 IALI-VYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGR 812
Query: 627 GASSTVYKCALKNSRPIAVKKLYNQYP----HNL-REFETELETIGSIRHRNIVSLHGYA 681
GA TVYK L +AVKKL + + +N+ F E+ T+G+IRHRNIV LHG+
Sbjct: 813 GACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFC 872
Query: 682 LSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIH 741
NLL Y+YM GSL ++LH PS LDW R KIA+GAAQGLAYLHHDC PRI H
Sbjct: 873 NHQGSNLLLYEYMPKGSLGEILHDPS--CNLDWSKRFKIALGAAQGLAYLHHDCKPRIFH 930
Query: 742 RDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF--VLGTIGYIDPEYAHTSRLNEK 799
RD+KS+NIL+D+ F+AH+ DFG+A+ I MPH+ + + G+ GYI PEYA+T ++ EK
Sbjct: 931 RDIKSNNILLDDKFEAHVGDFGLAKVI--DMPHSKSMSAIAGSYGYIAPEYAYTMKVTEK 988
Query: 800 SDVYSFGIVLLEILTGK---KAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD---L 853
SD+YS+G+VLLE+LTGK + +D ++ + S + + V + +T D +
Sbjct: 989 SDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGV-LDARLTLEDERIV 1047
Query: 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885
S + ++ALLCT P RP+M++V +L+
Sbjct: 1048 SHMLTVLKIALLCTSVSPVARPSMRQVVLMLI 1079
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 529 bits (1362), Expect = e-149, Method: Compositional matrix adjust.
Identities = 342/956 (35%), Positives = 515/956 (53%), Gaps = 99/956 (10%)
Query: 22 NSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDE 81
++ FC+W GV CD S V SL+LS LNL G +SP + LR LQ++ N ++G IP E
Sbjct: 53 STSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPE 112
Query: 82 IGNCGSLVHIELSDNSLYGDIPFSISK-LKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLD 140
I + L H+ LS+N G P IS L L L++ NN LTG +P ++T + L+ L
Sbjct: 113 ISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLH 172
Query: 141 LARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGL------WY-------- 186
L N G+IP V++YL + GN L G + P++ LT L +Y
Sbjct: 173 LGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLP 232
Query: 187 -----------FDVRGNNLTGTIPDSIGNC------------------------TSFEIL 211
FD LTG IP IG +S + +
Sbjct: 233 PEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSM 292
Query: 212 DISYNQITGEIPYNIGFLQVATL-SLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIP 270
D+S N TGEIP + L+ TL +L NKL G+IPE IG + L VL L EN G IP
Sbjct: 293 DLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIP 352
Query: 271 PILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFEL 330
LG + L NKLTG +PP + + +KL L N L G+IP LGK E L +
Sbjct: 353 QKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRI 412
Query: 331 NLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP 390
+ +N L G IP + L Q + N LSG +P + +L ++LS N G +P
Sbjct: 413 RMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLP 472
Query: 391 TELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTI 450
+G + L L N F G +P+ +G L+ L ++ S N +G + E + + +
Sbjct: 473 PAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFV 532
Query: 451 DMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIP 510
D+S N+LSG IP E+ ++ + L L+ N+L G IP +S+ SL++L+ SYNNLSG++P
Sbjct: 533 DLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVP 592
Query: 511 PIRNFSRFSSNSFIGNPLLCGNWIGSIC--------------GPSVTKARVMFSRTAVVC 556
FS F+ SF+GNP LCG ++G C GP +++ +VC
Sbjct: 593 GTGQFSYFNYTSFLGNPDLCGPYLGP-CKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVC 651
Query: 557 MVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILHMDMAIHTFDDIMRSTE 616
+ F + ++ A ++ K+++ R +T ++ +D T DD++ S
Sbjct: 652 SI-AFAVVAIIKARSLKKASESRAWRLTAFQR------------LDF---TCDDVLDS-- 693
Query: 617 NLSEKYIVGYGASSTVYKCALKNSRPIAVKKL--YNQYPHNLREFETELETIGSIRHRNI 674
L E I+G G + VYK + N +AVK+L ++ + F E++T+G IRHR+I
Sbjct: 694 -LKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHI 752
Query: 675 VSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD 734
V L G+ + NLL Y+YM NGSL ++LHG K L W+TR KIA+ AA+GL YLHHD
Sbjct: 753 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHG-KKGGHLHWDTRYKIALEAAKGLCYLHHD 811
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP-TAMPHASTFVLGTIGYIDPEYAHT 793
C+P I+HRDVKS+NIL+D NF+AH++DFG+A+ + + + + G+ GYI PEYA+T
Sbjct: 812 CSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 871
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLI-----MSKADDNTVMEAVDPEVSV 848
+++EKSDVYSFG+VLLE++TG+K V + ++ M+ ++ ++V++ +DP +S
Sbjct: 872 LKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDSNKDSVLKVLDPRLS- 930
Query: 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAK---LSLAAPK 901
+ + V F +A+LC + ERPTM+EV ++L + PP+K ++ +AP+
Sbjct: 931 -SIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKLPPSKDQPMTESAPE 985
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 529 bits (1362), Expect = e-149, Method: Compositional matrix adjust.
Identities = 353/962 (36%), Positives = 518/962 (53%), Gaps = 82/962 (8%)
Query: 1 MAIKASFS--NLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSI 58
+++K+SF+ + +L W+ ++ FCSW GV CD S V SL+LS LNL G +S +
Sbjct: 32 LSLKSSFTIDEHSPLLTSWN--LSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDV 89
Query: 59 GDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISK-LKQLEFLNL 117
L LQ++ N+++G IP +I N L H+ LS+N G P +S L L L+L
Sbjct: 90 AHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDL 149
Query: 118 KNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPD 177
NN LTG +P +LT + L+ L L N +G+IP VL+YL + GN LTG + P+
Sbjct: 150 YNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPE 209
Query: 178 MCQLTGL------WY-------------------FDVRGNNLTGTIPDSIGN-------- 204
+ LT L +Y FD LTG IP IG
Sbjct: 210 IGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLF 269
Query: 205 ----------------CTSFEILDISYNQITGEIPYNIGFLQVATL-SLQGNKLTGKIPE 247
+S + +D+S N TGEIP + L+ TL +L NKL G IPE
Sbjct: 270 LQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPE 329
Query: 248 VIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQ 307
IG M L VL L EN G IP LG L L NKLTG +PP + + ++L L
Sbjct: 330 FIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLI 389
Query: 308 LQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPS 367
N L G+IP LGK E L + + +N L G IP + L+Q + N L+G +P
Sbjct: 390 TLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPI 449
Query: 368 SFRNL-GSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTL 426
S + G L ++LS N G +P +G + + L L N FSGS+P IG L+ L L
Sbjct: 450 SGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKL 509
Query: 427 NLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIP 486
+ S N +G + E + + +D+S N+LSG IP EL ++ + L L+ N+L G IP
Sbjct: 510 DFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIP 569
Query: 487 DQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGPSVTKAR 546
+++ SL++++ SYNNLSG++P FS F+ SF+GN LCG ++G CG ++
Sbjct: 570 VTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGP-CGKGTHQSH 628
Query: 547 V--MFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILHMDMA 604
V + + T ++ ++ +V A +A+ K+ R + + +D
Sbjct: 629 VKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLT------AFQRLDF- 681
Query: 605 IHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLRE--FETE 662
T DD++ S L E I+G G + VYK + +AVK+L + + F E
Sbjct: 682 --TCDDVLDS---LKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAE 736
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722
++T+G IRHR+IV L G+ + NLL Y+YM NGSL ++LHG K L W TR KIA+
Sbjct: 737 IQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHG-KKGGHLHWNTRYKIAL 795
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP-TAMPHASTFVLG 781
AA+GL YLHHDC+P I+HRDVKS+NIL+D NF+AH++DFG+A+ + + + + G
Sbjct: 796 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAG 855
Query: 782 TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAV---DNESNLHQLIMSKADDN-- 836
+ GYI PEYA+T +++EKSDVYSFG+VLLE++TGKK V + ++ Q + S D N
Sbjct: 856 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWVRSMTDSNKD 915
Query: 837 TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLS 896
V++ +D + ++ V + V F +ALLC + ERPTM+EV ++L + P +K
Sbjct: 916 CVLKVID--LRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPKIPLSKQQ 973
Query: 897 LA 898
A
Sbjct: 974 AA 975
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 521 bits (1343), Expect = e-147, Method: Compositional matrix adjust.
Identities = 334/911 (36%), Positives = 499/911 (54%), Gaps = 58/911 (6%)
Query: 31 VFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVH 90
C N++ S+ L LS L GEI I + ++L+ +D N LTGQIPD + L +
Sbjct: 331 TICSNNT-SLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTN 389
Query: 91 IELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEI 150
+ L++NSL G + SIS L L+ L +N L G +P + + L+ + L N+ +GE+
Sbjct: 390 LYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEM 449
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEI 210
P I LQ + GN L+G + + +L L +R N L G IP S+GNC +
Sbjct: 450 PVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTV 509
Query: 211 LDISYNQITGEIPYNIGFLQVATL-SLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPI 269
+D++ NQ++G IP + GFL L + N L G +P+ + ++ L ++ S N+ G I
Sbjct: 510 IDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSI 569
Query: 270 PPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFE 329
P+ G+ SY + N G IP ELG + L L+L NQ G IP GK+ +L
Sbjct: 570 SPLCGSSSYL-SFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSL 628
Query: 330 LNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKV 389
L+++ N+L G IP + C L +++ N LSG IP+ L L L LS N F G +
Sbjct: 629 LDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSL 688
Query: 390 PTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQT 449
PTE+ + N+ TL L N+ +GS+P IG+L+ L LNL N L+G LP+ G L +
Sbjct: 689 PTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFE 748
Query: 450 IDMSFNQLSGSIPAELGQLQNII-------------------------SLILNNNNLQGG 484
+ +S N L+G IP E+GQLQ++ SL L++N L G
Sbjct: 749 LRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGE 808
Query: 485 IPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGPSVTK 544
+P Q+ + SL LN+SYNNL G + + FSR+ +++F+GN LCG+ + S C + +K
Sbjct: 809 VPGQIGDMKSLGYLNLSYNNLEGKLK--KQFSRWQADAFVGNAGLCGSPL-SHCNRAGSK 865
Query: 545 ARVMFSRTAVVCM----VLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
+ S VV + L I L+V+ I +K N + + G +
Sbjct: 866 NQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAP 925
Query: 601 M-----DMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKK-LYNQYPH 654
+ + +DDIM +T L+E++++G G S VYK LKN IAVKK L+
Sbjct: 926 LFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLM 985
Query: 655 NLREFETELETIGSIRHRNIVSLHGYALSPYG--NLLFYDYMVNGSLWDLLHG---PSKK 709
+ + F E++T+G+IRHR++V L GY S NLL Y+YM NGS+WD LH KK
Sbjct: 986 SNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKK 1045
Query: 710 VKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769
L WETRLKIA+G AQG+ YLH+DC P I+HRD+KSSN+L+D N +AHL DFG+A+ +
Sbjct: 1046 EVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILT 1105
Query: 770 ---TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK----KAVDNE 822
++T G+ GYI PEYA++ + EKSDVYS GIVL+EI+TGK D E
Sbjct: 1106 GNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEE 1165
Query: 823 SNLHQLIMSKADDNTVMEA----VDPEV-SVTCVDLSAVRKTFQLALLCTKRYPSERPTM 877
+++ + + + D EA +D E+ S+ + A + ++AL CTK YP ERP+
Sbjct: 1166 TDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSS 1225
Query: 878 QEVARVLVSLL 888
++ + L+++
Sbjct: 1226 RQASEYLLNVF 1236
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 513 bits (1321), Expect = e-144, Method: Compositional matrix adjust.
Identities = 340/917 (37%), Positives = 481/917 (52%), Gaps = 77/917 (8%)
Query: 39 SVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDN-- 96
S+ L + S NL G I PS+ LR L+ I N +G IP EI C SL + L++N
Sbjct: 164 SLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLL 223
Query: 97 ----------------------SLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIP 134
L G+IP S+ + +LE L L N TG IP + ++
Sbjct: 224 EGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLT 283
Query: 135 NLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNL 194
+K L L NQLTGEIPR I + N LTG + + + L + N L
Sbjct: 284 KMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENIL 343
Query: 195 TGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQ 253
G IP +G T E LD+S N++ G IP + FL + L L N+L GKIP +IG
Sbjct: 344 LGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYS 403
Query: 254 ALAVLDLSENELVGPIPP-----------ILGNLSYTG-------------KLYLHGNKL 289
+VLD+S N L GPIP LG+ +G KL L N+L
Sbjct: 404 NFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQL 463
Query: 290 TGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCT 349
TG +P EL N+ L+ L+L N L G I A+LGKL+ L L LA+NN G IP I + T
Sbjct: 464 TGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLT 523
Query: 350 ALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNF 409
+ FN+ N+L+G IP + ++ L+LS N F G + ELG+++ L+ L LS N
Sbjct: 524 KIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRL 583
Query: 410 SGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQ-TIDMSFNQLSGSIPAELGQL 468
+G +P S GDL L+ L L N L+ +P E G L S+Q ++++S N LSG+IP LG L
Sbjct: 584 TGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNL 643
Query: 469 QNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPL 528
Q + L LN+N L G IP + N SL N+S NNL G +P F R S++F GN
Sbjct: 644 QMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHG 703
Query: 529 LCGNWIGSICGPSV----TKARVMFSRT------AVVCMVLGFITLLVMAAIAVYKSNQQ 578
LC N S C P V +K + + + + C+V+G + L+ + +
Sbjct: 704 LC-NSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCW---TIK 759
Query: 579 RQQLITGSRKSMLGPPKLVILHMDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALK 638
R++ + + P + + T+ ++ +T N SE ++G GA TVYK +
Sbjct: 760 RREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMS 819
Query: 639 NSRPIAVKKL--YNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696
IAVKKL + + F E+ T+G IRHRNIV L+G+ NLL Y+YM
Sbjct: 820 GGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSK 879
Query: 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756
GSL + L K LDW R +IA+GAA+GL YLHHDC P+I+HRD+KS+NIL+DE F
Sbjct: 880 GSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQ 939
Query: 757 AHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
AH+ DFG+A+ I + + + V G+ GYI PEYA+T ++ EK D+YSFG+VLLE++TGK
Sbjct: 940 AHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK 999
Query: 817 KAVDNESNLHQLI--MSKADDNTV--MEAVDPEVSV----TCVDLSAVRKTFQLALLCTK 868
V L+ + ++ N + +E D + T ++S V K +AL CT
Sbjct: 1000 PPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLK---IALFCTS 1056
Query: 869 RYPSERPTMQEVARVLV 885
P+ RPTM+EV ++
Sbjct: 1057 NSPASRPTMREVVAMIT 1073
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 501 bits (1291), Expect = e-141, Method: Compositional matrix adjust.
Identities = 336/960 (35%), Positives = 486/960 (50%), Gaps = 121/960 (12%)
Query: 40 VVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLY 99
+ L+LS L I S G+L NL ++ +L G IP E+GNC SL + LS NSL
Sbjct: 236 LAKLDLSYNPLKCSIPKSFGELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLS 295
Query: 100 GDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEV 159
G +P +S++ L F + + NQL+G +PS + + L +L LA N+ +GEIP I +
Sbjct: 296 GPLPLELSEIPLLTF-SAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPM 354
Query: 160 LQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQIT 219
L++L L N L+G + ++C L D+ GN L+GTI + C+S L ++ NQI
Sbjct: 355 LKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQIN 414
Query: 220 GEIPYNIGFLQVATLSLQGNKLTGKIPEV------------------------IGLMQAL 255
G IP ++ L + L L N TG+IP+ IG +L
Sbjct: 415 GSIPEDLWKLPLMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASL 474
Query: 256 AVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVG 315
L LS+N+L G IP +G L+ L L+ N G IP ELG+ + L+ L L +N L G
Sbjct: 475 KRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQG 534
Query: 316 TIPAELGKLEQLFELNLADNNLEG------------------------------------ 339
IP ++ L QL L L+ NNL G
Sbjct: 535 QIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSG 594
Query: 340 PIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINL 399
PIP + C L + ++ N LSG IP+S L +LT L+LS N G +P E+G + L
Sbjct: 595 PIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKL 654
Query: 400 DTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459
L+L+ N +G +P S G L L+ LNL++N L+G +PA GNL+ + +D+SFN LSG
Sbjct: 655 QGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSG 714
Query: 460 SIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIP------PIR 513
+ +EL ++ ++ L + N G IP +L N L L+VS N LSG IP P
Sbjct: 715 ELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNL 774
Query: 514 NFSRFSSNS------------------FIGNPLLCGNWIGSICGPSVTKARVMFSRTAVV 555
F + N+ GN LCG +GS C TK R S +
Sbjct: 775 EFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLR---SAWGIA 831
Query: 556 CMVLGFITLLVMAAI------AVYKSNQQRQQ------------------LITGSRKSML 591
++LGF T++V + A+ K +QR ++GSR
Sbjct: 832 GLMLGF-TIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREP 890
Query: 592 GPPKLVILHMDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQ 651
+ + + DI+ +T++ S+K I+G G TVYK L + +AVKKL
Sbjct: 891 LSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEA 950
Query: 652 YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVK 711
REF E+ET+G ++H N+VSL GY LL Y+YMVNGSL L + ++
Sbjct: 951 KTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLE 1010
Query: 712 -LDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770
LDW RLKIAVGAA+GLA+LHH P IIHRD+K+SNIL+D +F+ ++DFG+AR I
Sbjct: 1011 VLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISA 1070
Query: 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNE------SN 824
H ST + GT GYI PEY ++R K DVYSFG++LLE++TGK+ + N
Sbjct: 1071 CESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGN 1130
Query: 825 LHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
L + K + ++ +DP + + S +R Q+A+LC P++RP M +V + L
Sbjct: 1131 LVGWAIQKINQGKAVDVIDPLLVSVALKNSQLR-LLQIAMLCLAETPAKRPNMLDVLKAL 1189
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 943 | ||||||
| 255539665 | 948 | erecta, putative [Ricinus communis] gi|2 | 0.997 | 0.992 | 0.835 | 0.0 | |
| 225455588 | 988 | PREDICTED: LRR receptor-like serine/thre | 0.996 | 0.951 | 0.843 | 0.0 | |
| 306411489 | 947 | leucine-rich repeat receptor-like kinase | 0.996 | 0.992 | 0.827 | 0.0 | |
| 224120186 | 949 | leucine-rich repeat protein kinase [Popu | 0.996 | 0.990 | 0.827 | 0.0 | |
| 449463818 | 950 | PREDICTED: LRR receptor-like serine/thre | 0.990 | 0.983 | 0.818 | 0.0 | |
| 296084110 | 930 | unnamed protein product [Vitis vinifera] | 0.976 | 0.990 | 0.828 | 0.0 | |
| 297793785 | 966 | hypothetical protein ARALYDRAFT_496399 [ | 0.989 | 0.965 | 0.797 | 0.0 | |
| 297810831 | 966 | hypothetical protein ARALYDRAFT_908657 [ | 0.988 | 0.964 | 0.795 | 0.0 | |
| 15241760 | 966 | LRR receptor-like serine/threonine-prote | 0.988 | 0.964 | 0.799 | 0.0 | |
| 79508007 | 967 | LRR receptor-like serine/threonine-prote | 0.988 | 0.963 | 0.796 | 0.0 |
| >gi|255539665|ref|XP_002510897.1| erecta, putative [Ricinus communis] gi|223550012|gb|EEF51499.1| erecta, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1630 bits (4220), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 794/950 (83%), Positives = 865/950 (91%), Gaps = 9/950 (0%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
M+IK SFSN+ANVLLDWDDVHN DFCSWRGVFCDN S SVVSLNLS+LNL GEIS +IGD
Sbjct: 1 MSIKESFSNVANVLLDWDDVHNGDFCSWRGVFCDNVSFSVVSLNLSNLNLDGEISTAIGD 60
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
LRNLQSIDFQGNKLTGQIPDEIGNC SL H++LSDN L GDIPFS+SKLKQLEFLNLKNN
Sbjct: 61 LRNLQSIDFQGNKLTGQIPDEIGNCASLYHLDLSDNLLDGDIPFSVSKLKQLEFLNLKNN 120
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGPIP+TLTQIPNLKTLDLARNQL GEIPRL+YWNEVLQYLGLRGN+LTG LS DMCQ
Sbjct: 121 QLTGPIPATLTQIPNLKTLDLARNQLIGEIPRLLYWNEVLQYLGLRGNSLTGTLSQDMCQ 180
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTGTIPDSIGNCTSF+ILD+SYNQI GEIPYNIGFLQVATLSLQGNK
Sbjct: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFQILDLSYNQINGEIPYNIGFLQVATLSLQGNK 240
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLS+TGKLYL+GNKLTGPIPPELGNM
Sbjct: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSFTGKLYLYGNKLTGPIPPELGNM 300
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
SKLSYLQL +NQLVG IP ELGKLEQLFELNL +N+LEGPIPHNISSCTALNQFNVHGNR
Sbjct: 301 SKLSYLQLNDNQLVGNIPPELGKLEQLFELNLGNNDLEGPIPHNISSCTALNQFNVHGNR 360
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
L+G IPS F+NL SLTYLNLS NNFKG++P ELG I+NLDTLDLS N+FSG VP SIG L
Sbjct: 361 LNGTIPSGFKNLESLTYLNLSSNNFKGRIPLELGHIVNLDTLDLSANSFSGPVPVSIGGL 420
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLLTLNLSRN L+G+LPAEFGNLRSIQ +D+SFN ++G IPAELGQLQNI+SLILNNN+
Sbjct: 421 EHLLTLNLSRNRLDGVLPAEFGNLRSIQILDISFNNVTGGIPAELGQLQNIVSLILNNNS 480
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
LQG IPDQL+NCFSL+NLN SYNNL+GIIPP+RNFSRF SFIGNPLLCGNW+GSICGP
Sbjct: 481 LQGEIPDQLTNCFSLANLNFSYNNLTGIIPPMRNFSRFPPESFIGNPLLCGNWLGSICGP 540
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
K+R +FSR AVVCM LGFITLL M +A+YKSNQQ+ QLI S K+ GPPKLV+LH
Sbjct: 541 YEPKSRAIFSRAAVVCMTLGFITLLSMVIVAIYKSNQQK-QLIKCSHKTTQGPPKLVVLH 599
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHTF+DIMRSTENLSEKY++GYGASSTVYKC LK SRPIA+K++YNQYP+NLREFE
Sbjct: 600 MDMAIHTFEDIMRSTENLSEKYVIGYGASSTVYKCVLKGSRPIAIKRIYNQYPYNLREFE 659
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSIRHRNIVSLHGYALSP GNLLFYDYM NGSLWDLLHGPSKKVKLDWETRLKI
Sbjct: 660 TELETIGSIRHRNIVSLHGYALSPCGNLLFYDYMDNGSLWDLLHGPSKKVKLDWETRLKI 719
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVG AQGLAYLHHDCNPRIIHRDVKSSNIL+D+NF+AHLSDFGIA+CI TA HAST+VL
Sbjct: 720 AVGTAQGLAYLHHDCNPRIIHRDVKSSNILLDDNFEAHLSDFGIAKCISTAKTHASTYVL 779
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSRLNEKSDVYSFGIVLLE+LTGKKAVDNESNLHQLI+SKADDNTVME
Sbjct: 780 GTIGYIDPEYARTSRLNEKSDVYSFGIVLLELLTGKKAVDNESNLHQLILSKADDNTVME 839
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAA- 899
VD EVSVTC+D++ VRKTFQLALLCTKR+PSERPTM EV RVLVS LPAPP K +A
Sbjct: 840 VVDQEVSVTCMDITHVRKTFQLALLCTKRHPSERPTMPEVVRVLVSFLPAPPTKKPCSAP 899
Query: 900 PKPIDYYTKFVVNRERQQR------VEHDDNSSDARWFVRFGEVISKNTL 943
PKPID Y KFV+++ +QQ + ++NSSDA+WF+RF EVISKNTL
Sbjct: 900 PKPID-YAKFVIDKGQQQPAPKNQLAQQENNSSDAQWFLRFREVISKNTL 948
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455588|ref|XP_002269540.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase ERL2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1614 bits (4180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 803/952 (84%), Positives = 878/952 (92%), Gaps = 12/952 (1%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
M+IKASFSN+AN LLDWDDVHN+DFCSWRGVFCDN SLSVVSLNLS+LNLGGEIS ++GD
Sbjct: 40 MSIKASFSNVANALLDWDDVHNADFCSWRGVFCDNVSLSVVSLNLSNLNLGGEISSAVGD 99
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
L+NLQSID QGN+LTGQ+PDEIGNC SL ++LSDN LYGDIPFSISKLK+LE LNLKNN
Sbjct: 100 LKNLQSIDLQGNRLTGQLPDEIGNCVSLSTLDLSDNLLYGDIPFSISKLKKLELLNLKNN 159
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGPIPSTLTQIPNLKT+DLARNQLTGEIPRLIYWNEVLQYLGLRGN+LTG LSPDMCQ
Sbjct: 160 QLTGPIPSTLTQIPNLKTIDLARNQLTGEIPRLIYWNEVLQYLGLRGNSLTGTLSPDMCQ 219
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK
Sbjct: 220 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 279
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTGKIPEVIGLMQALAVLDLSEN L+GPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM
Sbjct: 280 LTGKIPEVIGLMQALAVLDLSENNLIGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 339
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
SKLSYLQL +NQL+G+IPAELGKLEQLFELNLA+N+LEGPIPHNISSCTALNQFNVHGN
Sbjct: 340 SKLSYLQLNDNQLIGSIPAELGKLEQLFELNLANNDLEGPIPHNISSCTALNQFNVHGNH 399
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSG+IP F+NL SLTYLNLS NNFKG++P ELGRI+NLDTLDLS N F G+VPAS+GDL
Sbjct: 400 LSGSIPPGFQNLESLTYLNLSSNNFKGRIPLELGRIVNLDTLDLSSNGFLGTVPASVGDL 459
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLLTLNLSRN+L+G +PAEFGNLRSIQTIDMSFN+LSG IP ELGQLQNI+SLILNNNN
Sbjct: 460 EHLLTLNLSRNNLDGPVPAEFGNLRSIQTIDMSFNKLSGGIPRELGQLQNIVSLILNNNN 519
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
L G IPDQL+NCFSL+ LNVSYNN SG++PPIRNFSRFS +SFIGNPLLCGNW+GSICGP
Sbjct: 520 LDGEIPDQLTNCFSLTILNVSYNNFSGVVPPIRNFSRFSPDSFIGNPLLCGNWLGSICGP 579
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
V K+R +FSRTAV C+ LGF TLL+M +A+YKSNQ +QQ I GS + GP KLVILH
Sbjct: 580 YVPKSRAIFSRTAVACIALGFFTLLLMVVVAIYKSNQPKQQ-INGS-NIVQGPTKLVILH 637
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHT++DIMR TENLSEKYI+GYGASSTVYKC LKNSRPIA+K++Y+QY HNLREFE
Sbjct: 638 MDMAIHTYEDIMRITENLSEKYIIGYGASSTVYKCVLKNSRPIAIKRIYSQYAHNLREFE 697
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSI+HRN+VSLHGY+LSP GNLLFYDYM NGSLWDLLHGPSKKVKLDWETRLKI
Sbjct: 698 TELETIGSIKHRNLVSLHGYSLSPKGNLLFYDYMENGSLWDLLHGPSKKVKLDWETRLKI 757
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDCNPRIIHRDVKSSNIL+DENFDAHLSDFGIA+CIPTA HAST+VL
Sbjct: 758 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILLDENFDAHLSDFGIAKCIPTAKTHASTYVL 817
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSRLNEKSDVYSFGIVLLE+LTGKKAVDNESNLHQLI+SKADDNTVME
Sbjct: 818 GTIGYIDPEYARTSRLNEKSDVYSFGIVLLELLTGKKAVDNESNLHQLILSKADDNTVME 877
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAP 900
AVDPEVSVTC+DL+ VRKTFQLALLCTKR+PSERPTM EVARVLVSLLPAPPAK + P
Sbjct: 878 AVDPEVSVTCMDLAHVRKTFQLALLCTKRHPSERPTMHEVARVLVSLLPAPPAKPCSSPP 937
Query: 901 KPIDYYTKFVVNRERQQR-------VEHDDNSS--DARWFVRFGEVISKNTL 943
KPID Y FV+++ ++Q+ VE D+N+S DA+WFVRF EVISKN+L
Sbjct: 938 KPID-YAHFVMDKGQKQQNAQLPPHVEPDNNTSSNDAQWFVRFHEVISKNSL 988
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|306411489|gb|ADM86148.1| leucine-rich repeat receptor-like kinase [Populus nigra x Populus x canadensis] | Back alignment and taxonomy information |
|---|
Score = 1608 bits (4165), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 786/950 (82%), Positives = 865/950 (91%), Gaps = 10/950 (1%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
M+IK SFSN+ NVLLDWDDVHN DFCSWRGVFCDN SLSVVSLNLS+LNLGGEISP+IGD
Sbjct: 1 MSIKESFSNVVNVLLDWDDVHNEDFCSWRGVFCDNVSLSVVSLNLSNLNLGGEISPAIGD 60
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
LRNLQSIDF+GNKLTGQIP+EIGNC SL +++LSDN LYGDIPFSISKLKQL+ LNLKNN
Sbjct: 61 LRNLQSIDFKGNKLTGQIPEEIGNCASLFNLDLSDNLLYGDIPFSISKLKQLDTLNLKNN 120
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGPIPSTLTQIPNLKTL+LA+NQLTGEIPRLIYWNEVLQYLGLRGN LTG LS DMCQ
Sbjct: 121 QLTGPIPSTLTQIPNLKTLNLAKNQLTGEIPRLIYWNEVLQYLGLRGNLLTGTLSEDMCQ 180
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNL+GTIP SIGNCTSFEILDISYNQI+GEIPYNIGFLQVATLSLQGN
Sbjct: 181 LTGLWYFDVRGNNLSGTIPSSIGNCTSFEILDISYNQISGEIPYNIGFLQVATLSLQGNS 240
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTGKIPEVIGLMQALAVLDLS+NELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM
Sbjct: 241 LTGKIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
SKLSYLQL +NQLVG IP ELG LEQLFELNLA+N+LEGPIP+NISSC ALNQ NV+GN
Sbjct: 301 SKLSYLQLNDNQLVGRIPPELGMLEQLFELNLANNHLEGPIPNNISSCRALNQLNVYGNH 360
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSG I S F+ L SLTYLNLS N+FKG +P ELG IINLDTLDLS NNFSG +PASIGDL
Sbjct: 361 LSGIIASGFKGLESLTYLNLSSNDFKGSIPIELGHIINLDTLDLSSNNFSGPIPASIGDL 420
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLL LNLSRNHL+G LPAEFGNLRSIQ IDMSFN ++GSIP ELGQLQNI++LILNNN+
Sbjct: 421 EHLLILNLSRNHLHGRLPAEFGNLRSIQAIDMSFNNVTGSIPVELGQLQNIVTLILNNND 480
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
LQG IPDQL+NCFSL+NLN SYNNLSGI+PPIRN +RF +SFIGNPLLCGNW+GS+CGP
Sbjct: 481 LQGEIPDQLTNCFSLANLNFSYNNLSGIVPPIRNLTRFPPDSFIGNPLLCGNWLGSVCGP 540
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
V K++V+FSR AVVC+ LGF+TLL M + +YKSN QR+QLI GS K++ GPPKLV+LH
Sbjct: 541 YVLKSKVIFSRAAVVCITLGFVTLLSMVVVVIYKSN-QRKQLIMGSDKTLHGPPKLVVLH 599
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MD+AIHTFDDIMR+TENLSEKYI+GYGASSTVYKC LKNSRP+A+K+LYNQYP+NL EFE
Sbjct: 600 MDIAIHTFDDIMRNTENLSEKYIIGYGASSTVYKCVLKNSRPLAIKRLYNQYPYNLHEFE 659
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSIRHRNIVSLHGYALSP GNLLFYDYM NGSLWDLLHG SKKVKLDWETRLK+
Sbjct: 660 TELETIGSIRHRNIVSLHGYALSPRGNLLFYDYMKNGSLWDLLHGSSKKVKLDWETRLKV 719
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDCNPRIIHRDVKSSNIL+DE+F+AHLSDFGIA+CIPT HASTFVL
Sbjct: 720 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILLDEDFEAHLSDFGIAKCIPTTKSHASTFVL 779
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSRL EKSDVYSFGIVLLE+LTGKKAVDNESNL QLI+S+ADDNTVME
Sbjct: 780 GTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGKKAVDNESNLQQLILSRADDNTVME 839
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAP 900
AVDPEVSVTC+DL+ V+K+FQLALLCTKR+PSERPTMQ+V+RVLVS LPA P K SL P
Sbjct: 840 AVDPEVSVTCMDLTHVKKSFQLALLCTKRHPSERPTMQDVSRVLVSFLPALPTKASL-LP 898
Query: 901 KPIDYYTKFVVNRERQQRV-------EHDDNSSDARWFVRFGEVISKNTL 943
KPID Y KFV+++ +QQ+ ++NSSDA+WFVRF EV+SKNTL
Sbjct: 899 KPID-YAKFVIDKGQQQQPIVNQQQPSQENNSSDAQWFVRFKEVVSKNTL 947
|
Source: Populus nigra x Populus x canadensis Species: Populus nigra x Populus x canadensis Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120186|ref|XP_002318267.1| leucine-rich repeat protein kinase [Populus trichocarpa] gi|222858940|gb|EEE96487.1| leucine-rich repeat protein kinase [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1606 bits (4158), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 788/952 (82%), Positives = 864/952 (90%), Gaps = 12/952 (1%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
M+IK SFSN+ NVLLDWDDVHN DFCSWRGVFCDN SLSVVSLNLS+LNLGGEISP+IGD
Sbjct: 1 MSIKESFSNVVNVLLDWDDVHNEDFCSWRGVFCDNVSLSVVSLNLSNLNLGGEISPAIGD 60
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
LRNLQSIDFQGNKLTGQIP+EIGNC SL +++LSDN LYGDIPFSISKLKQL+ LNLKNN
Sbjct: 61 LRNLQSIDFQGNKLTGQIPEEIGNCASLFNLDLSDNLLYGDIPFSISKLKQLDTLNLKNN 120
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGPIPSTLTQIPNLKTLDLA+NQLTGEIPRLIYWNEVLQYLGLRGN LTG LS DMCQ
Sbjct: 121 QLTGPIPSTLTQIPNLKTLDLAKNQLTGEIPRLIYWNEVLQYLGLRGNLLTGTLSEDMCQ 180
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNL+GTIP SIGNCTSFEILDISYNQI+GEIPYNIGFLQVATLSLQGN
Sbjct: 181 LTGLWYFDVRGNNLSGTIPSSIGNCTSFEILDISYNQISGEIPYNIGFLQVATLSLQGNS 240
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTGKIPEVIGLMQALAVLDLS+NELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM
Sbjct: 241 LTGKIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
SKLSYLQL +NQLVG IP ELG LEQLFELNLA+N+LEGPIP+NISSC ALNQ NV+GN
Sbjct: 301 SKLSYLQLNDNQLVGRIPPELGMLEQLFELNLANNHLEGPIPNNISSCRALNQLNVYGNH 360
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSG I S F+ L SLTYLNLS N+FKG +P ELG IINLDTLDLS NNFSG +PASIGDL
Sbjct: 361 LSGIIASGFKGLESLTYLNLSSNDFKGSIPIELGHIINLDTLDLSSNNFSGPIPASIGDL 420
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLL LNLSRNHL+G LPAEFGNLRSIQ IDMSFN ++GSIP ELGQLQNI++LILNNN+
Sbjct: 421 EHLLILNLSRNHLHGRLPAEFGNLRSIQAIDMSFNNVTGSIPVELGQLQNIVTLILNNND 480
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
LQG IPDQL+NCFSL+NLN SYNNLSGI+PPIRN +RF +SFIGNPLLCGNW+GS+CGP
Sbjct: 481 LQGEIPDQLTNCFSLANLNFSYNNLSGIVPPIRNLTRFPPDSFIGNPLLCGNWLGSVCGP 540
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLG--PPKLVI 598
V K++V+FSR AVVC+ LGF+TLL M + +YKSN QR+QL GS K++ G PPKLV+
Sbjct: 541 YVLKSKVIFSRAAVVCITLGFVTLLSMIVVVIYKSN-QRKQLTMGSDKTLQGMCPPKLVV 599
Query: 599 LHMDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLRE 658
LHMDMAIHTFDDIMR+TENLSEKYI+GYGASSTVYKC LKNSRP+A+K+LYNQYP+NL E
Sbjct: 600 LHMDMAIHTFDDIMRNTENLSEKYIIGYGASSTVYKCVLKNSRPLAIKRLYNQYPYNLHE 659
Query: 659 FETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL 718
FETELETIGSIRHRNIVSLHGYALSP GNLLFYDYM NGSLWDLLHG SKKVKLDWETRL
Sbjct: 660 FETELETIGSIRHRNIVSLHGYALSPRGNLLFYDYMKNGSLWDLLHGSSKKVKLDWETRL 719
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778
K+AVGAAQGLAYLHHDCNPRIIHRDVKSSNIL+DE+F+AHLSDFGIA+CIPT HASTF
Sbjct: 720 KVAVGAAQGLAYLHHDCNPRIIHRDVKSSNILLDEDFEAHLSDFGIAKCIPTTKSHASTF 779
Query: 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838
VLGTIGYIDPEYA TSRL EKSDVYSFGIVLLE+LTGKKAVDNESNL QLI+S+ADDNTV
Sbjct: 780 VLGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGKKAVDNESNLQQLILSRADDNTV 839
Query: 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLA 898
MEAVDPEVSVTC+DL+ V+K+FQLALLCTKR+PSERPTMQ+V+RVLVS LPA P K SL
Sbjct: 840 MEAVDPEVSVTCMDLTHVKKSFQLALLCTKRHPSERPTMQDVSRVLVSFLPALPTKASL- 898
Query: 899 APKPIDYYTKFVVNRERQQRV-------EHDDNSSDARWFVRFGEVISKNTL 943
PKPID Y KFV+++ +QQ+ ++NSSDA+WFVRF EV+SKNTL
Sbjct: 899 LPKPID-YAKFVIDKGQQQQPIVNQQQPSQENNSSDAQWFVRFKEVVSKNTL 949
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463818|ref|XP_004149628.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase ERL1-like [Cucumis sativus] gi|449519276|ref|XP_004166661.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase ERL1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1588 bits (4112), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 778/950 (81%), Positives = 847/950 (89%), Gaps = 16/950 (1%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
M+IKASFSN+ANVLLDWDD HN DFCSWRGVFCDN SLSV +LNLS+LNLGGEISPSIGD
Sbjct: 1 MSIKASFSNVANVLLDWDDDHNHDFCSWRGVFCDNVSLSVAALNLSNLNLGGEISPSIGD 60
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
LRNLQSIDFQGNKLTGQIPDEIGNCG LVH++LSDN LYGDIPF++SKLKQLEFLN+KNN
Sbjct: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGLLVHLDLSDNLLYGDIPFTVSKLKQLEFLNMKNN 120
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGN LTG LS DMCQ
Sbjct: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNFLTGSLSSDMCQ 180
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTG+IPDSIGNCTSFEILDISYNQI+GEIPYNIGFLQVATLSLQGN+
Sbjct: 181 LTGLWYFDVRGNNLTGSIPDSIGNCTSFEILDISYNQISGEIPYNIGFLQVATLSLQGNR 240
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTGKIP+VIGLMQALAVLDLSENEL GPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM
Sbjct: 241 LTGKIPDVIGLMQALAVLDLSENELDGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
SKLSYLQL +NQLVGTIP+ELGKL+QLFELNLA+N LEGPIPHNISSCTALNQFNVHGN
Sbjct: 301 SKLSYLQLNDNQLVGTIPSELGKLDQLFELNLANNYLEGPIPHNISSCTALNQFNVHGNN 360
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
L+G+IP F+NL SLTYLNLS NNFKG++P ELGRI+NLDTLDLS N+F G VPASIGDL
Sbjct: 361 LNGSIPLGFQNLESLTYLNLSANNFKGRIPVELGRIVNLDTLDLSCNHFLGPVPASIGDL 420
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLL+LNLS N L G LPAEFGNLRS+Q IDMSFN LSGSIP ELG LQNIISLILNNN+
Sbjct: 421 EHLLSLNLSNNQLVGPLPAEFGNLRSVQMIDMSFNNLSGSIPMELGLLQNIISLILNNNH 480
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
QG IPD+L+NCFSL+NLN+SYNNLSGI+PP++NFSRF NSFIGNPLLCGNW+GSICGP
Sbjct: 481 FQGKIPDRLTNCFSLANLNLSYNNLSGILPPMKNFSRFEPNSFIGNPLLCGNWLGSICGP 540
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
+ K+R M SRT VVCM GFI LL M IAVYKS +QL+ GS K+ GPP LV+LH
Sbjct: 541 YMEKSRAMLSRTVVVCMSFGFIILLSMVMIAVYKS----KQLVKGSGKTGQGPPNLVVLH 596
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHTF+DIMRSTENLSEKYI+GYGASSTVYKC LKNSRPIA+K+LYN Y HN REFE
Sbjct: 597 MDMAIHTFEDIMRSTENLSEKYIIGYGASSTVYKCLLKNSRPIAIKRLYNHYAHNFREFE 656
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TEL TIGSIRHRN+VSLHGY+LSP GNLLFYDYM NGSLWDLLHG KKVKLDWE RLKI
Sbjct: 657 TELGTIGSIRHRNLVSLHGYSLSPCGNLLFYDYMENGSLWDLLHGTGKKVKLDWEARLKI 716
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDCNPRIIHRDVKSSNIL+DENF+AHLSDFGIA+CIPTA HAST+VL
Sbjct: 717 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILLDENFEAHLSDFGIAKCIPTAKTHASTYVL 776
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSRLNEKSDVYSFGIVLLE+LTGKKAVD+ESNLHQLI+SK + NTVME
Sbjct: 777 GTIGYIDPEYARTSRLNEKSDVYSFGIVLLELLTGKKAVDDESNLHQLILSKINSNTVME 836
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAP 900
AVDPEVSVTC+DL+ VRKTFQLALLCTK PSERPTM EV+RVL+SL P P + P
Sbjct: 837 AVDPEVSVTCIDLAHVRKTFQLALLCTKHNPSERPTMHEVSRVLISLQPPRPTVKQTSFP 896
Query: 901 KPIDYYTKFVVNR----------ERQQRVEHDDNSSDARWFVRFGEVISK 940
Y ++V+ + E QQ+ D N+SDARWFV+FGEV+S+
Sbjct: 897 TKTLDYAQYVIEKGQNRNAKGGQEEQQK--SDVNTSDARWFVQFGEVMSE 944
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084110|emb|CBI24498.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1576 bits (4082), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 789/952 (82%), Positives = 863/952 (90%), Gaps = 31/952 (3%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
M+IKASFSN+AN LLDWDDVHN+DFCSWRGVFCDN SLSVVSLNLS+LNLGGEIS ++GD
Sbjct: 1 MSIKASFSNVANALLDWDDVHNADFCSWRGVFCDNVSLSVVSLNLSNLNLGGEISSAVGD 60
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
L+NLQSID QGN+LTGQ+PDEIGNC SL ++LSDN LYGDIPFSISKLK+LE LNLKNN
Sbjct: 61 LKNLQSIDLQGNRLTGQLPDEIGNCVSLSTLDLSDNLLYGDIPFSISKLKKLELLNLKNN 120
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGPIPSTLTQIPNLKT+DLARNQLTGEIPRLIYWNEVLQYLGLRGN+LTG LSPDMCQ
Sbjct: 121 QLTGPIPSTLTQIPNLKTIDLARNQLTGEIPRLIYWNEVLQYLGLRGNSLTGTLSPDMCQ 180
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK
Sbjct: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTGKIPEVIGLMQALAVLDLSEN L+GPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM
Sbjct: 241 LTGKIPEVIGLMQALAVLDLSENNLIGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
SKLSYLQL +NQL+G+IPAELGKLEQLFELNLA+N+LEGPIPHNISSCTALNQFNVHGN
Sbjct: 301 SKLSYLQLNDNQLIGSIPAELGKLEQLFELNLANNDLEGPIPHNISSCTALNQFNVHGNH 360
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSG+IP F+NL SLTYLNLS NNFKG++P ELGRI+NLDTLDLS N F G+VPAS+GDL
Sbjct: 361 LSGSIPPGFQNLESLTYLNLSSNNFKGRIPLELGRIVNLDTLDLSSNGFLGTVPASVGDL 420
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLLTLNLSRN+L+G +PAEFGNLRSIQTIDMSFN+LSG IP ELGQLQNI+SLILNNNN
Sbjct: 421 EHLLTLNLSRNNLDGPVPAEFGNLRSIQTIDMSFNKLSGGIPRELGQLQNIVSLILNNNN 480
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
L G IPDQL+NCFSL+ LNVSYNN SG++PPIRNFSRFS +SFIGNPLLCGNW+GSICGP
Sbjct: 481 LDGEIPDQLTNCFSLTILNVSYNNFSGVVPPIRNFSRFSPDSFIGNPLLCGNWLGSICGP 540
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
V K+R +FSRTAV C+ LGF TLL+M +A+YKSNQ +QQ I GS + GP KLVILH
Sbjct: 541 YVPKSRAIFSRTAVACIALGFFTLLLMVVVAIYKSNQPKQQ-INGS-NIVQGPTKLVILH 598
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHT++DIMR TENLSEKYI+GYGASSTVYKC LKNSRPIA+K++Y+QY HNLREFE
Sbjct: 599 MDMAIHTYEDIMRITENLSEKYIIGYGASSTVYKCVLKNSRPIAIKRIYSQYAHNLREFE 658
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSI+HRN+VSLHGY+LSP GNLLFYDYM NGSLWDLLHGPSKKVKLDWETRLKI
Sbjct: 659 TELETIGSIKHRNLVSLHGYSLSPKGNLLFYDYMENGSLWDLLHGPSKKVKLDWETRLKI 718
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDCNPRIIHRDVKSSNIL+DENFDAHLSDFGIA+CIPTA HAST+VL
Sbjct: 719 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILLDENFDAHLSDFGIAKCIPTAKTHASTYVL 778
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSRLNEKSDVYSFGIVLLE+LTGKKAVDNESNLHQLI+SKADDNTVME
Sbjct: 779 GTIGYIDPEYARTSRLNEKSDVYSFGIVLLELLTGKKAVDNESNLHQLILSKADDNTVME 838
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAP 900
AVDPEVSVTC+DL+ VRKTFQLALLCTKR+PSERPTM EVAR
Sbjct: 839 AVDPEVSVTCMDLAHVRKTFQLALLCTKRHPSERPTMHEVAR------------------ 880
Query: 901 KPIDYYTKFVVNRERQQR-------VEHDDNSS--DARWFVRFGEVISKNTL 943
PID Y FV+++ ++Q+ VE D+N+S DA+WFVRF EVISKN+L
Sbjct: 881 -PID-YAHFVMDKGQKQQNAQLPPHVEPDNNTSSNDAQWFVRFHEVISKNSL 930
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793785|ref|XP_002864777.1| hypothetical protein ARALYDRAFT_496399 [Arabidopsis lyrata subsp. lyrata] gi|297310612|gb|EFH41036.1| hypothetical protein ARALYDRAFT_496399 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1534 bits (3971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 752/943 (79%), Positives = 835/943 (88%), Gaps = 10/943 (1%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
MAIK SFSNL N+LLDWDDVHNSDFCSWRGV+CD + SVVSLNLSSLNLGGEISP++GD
Sbjct: 34 MAIKGSFSNLVNMLLDWDDVHNSDFCSWRGVYCDIVTFSVVSLNLSSLNLGGEISPAMGD 93
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
LRNL+SID QGNKL GQIPDEIGNC SLV+++LSDN LYGDIPFSISKLKQLE LNLKNN
Sbjct: 94 LRNLESIDLQGNKLAGQIPDEIGNCASLVYLDLSDNLLYGDIPFSISKLKQLETLNLKNN 153
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGP+P+TLTQIPNLK LDLA N LTGEI RL+YWNEVLQYLGLRGN LTG LS DMCQ
Sbjct: 154 QLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLGLRGNMLTGTLSSDMCQ 213
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTGTIP+SIGNCTSF+ILDISYNQITGEIPYNIGFLQVATLSLQGN+
Sbjct: 214 LTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFLQVATLSLQGNR 273
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTG+IPEVIGLMQALAVLDLS+NELVGPIPPILGNLS+TGKLYLHGNKLTGPIP ELGNM
Sbjct: 274 LTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNKLTGPIPSELGNM 333
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
S+LSYLQL +N+LVGTIP ELGKLEQLFELNLA+N L GPIP NISSC ALNQFNVHGN
Sbjct: 334 SRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFNVHGNL 393
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSG+IP +FRNLGSLTYLNLS NNFKGK+P ELG IINLD LDLS NNFSGSVP ++GDL
Sbjct: 394 LSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSVPLTLGDL 453
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLL LNLSRNHL+G LPAEFGNLRSIQ ID+SFN +SG IP ELGQLQN+ SLILN N
Sbjct: 454 EHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLISGVIPTELGQLQNLNSLILNYNK 513
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
L G IPDQL+NCF+L NLNVS+NNLSGIIPP++NFSRF+ SF+GNP LCGNW+GSICGP
Sbjct: 514 LHGKIPDQLTNCFALVNLNVSFNNLSGIIPPMKNFSRFAPASFVGNPYLCGNWVGSICGP 573
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
+ K+RV FS+ AV+C+VLG ITLL M +AVYKS QQ+ +++ G K G KLVILH
Sbjct: 574 -LPKSRV-FSKGAVICIVLGVITLLCMIFLAVYKSKQQK-KILEGPSKQADGSTKLVILH 630
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHTFDDIMR TENLSEK+I+GYGASSTVYKCALK+SRPIA+K+LYNQYPHNLREFE
Sbjct: 631 MDMAIHTFDDIMRVTENLSEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREFE 690
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSIRHRNIVSLH YALSP GNLLFYDYM NGSLWDLLHG KKVKLDWETRLKI
Sbjct: 691 TELETIGSIRHRNIVSLHAYALSPVGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKI 750
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDC PRIIHRD+KSSNIL+DENF+AHLSDFGIA+ IP + HAST+VL
Sbjct: 751 AVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVL 810
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSRLNEKSD+YSFGIVLLE+LTGKKAVDNE+NLHQLI+SKADDNTVME
Sbjct: 811 GTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLTGKKAVDNEANLHQLILSKADDNTVME 870
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAP 900
AVDPEV+VTC+DL +RKTFQLALLCTKR P ERPTM EV+RVL+SLLP SL
Sbjct: 871 AVDPEVTVTCMDLGHIRKTFQLALLCTKRNPLERPTMLEVSRVLLSLLP------SLQVA 924
Query: 901 KPIDYYTKFVVNRERQQRVEHDDNSSDARWFVRFGEVISKNTL 943
K + + + +++ V + D + ++WFV+F EVISK+++
Sbjct: 925 KKLPSHDQSTKKPQQENEVRNHD-AEASQWFVQFREVISKSSI 966
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297810831|ref|XP_002873299.1| hypothetical protein ARALYDRAFT_908657 [Arabidopsis lyrata subsp. lyrata] gi|297319136|gb|EFH49558.1| hypothetical protein ARALYDRAFT_908657 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1523 bits (3943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 750/943 (79%), Positives = 834/943 (88%), Gaps = 11/943 (1%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
MAIKASFSN+AN+LLDW DVHN+DFCSWRGVFCDN SL+VVSLNLS+LNLGGEIS ++GD
Sbjct: 35 MAIKASFSNVANMLLDWGDVHNNDFCSWRGVFCDNVSLTVVSLNLSNLNLGGEISSALGD 94
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
LRNLQSID QGNKL GQIPDEIGNC SL +++ S NSL+GDIPFSISKLKQLEFLNLKNN
Sbjct: 95 LRNLQSIDLQGNKLGGQIPDEIGNCASLAYVDFSTNSLFGDIPFSISKLKQLEFLNLKNN 154
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGPIP+TLTQIPNLKTLDLARNQLTGEIPRL+YWNEVLQYLGLRGN LTG LSPDMCQ
Sbjct: 155 QLTGPIPATLTQIPNLKTLDLARNQLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSPDMCQ 214
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTG+IPD+IGNCTSFEILD+SYNQITG IPYNIGFLQVATLSLQGN+
Sbjct: 215 LTGLWYFDVRGNNLTGSIPDNIGNCTSFEILDVSYNQITGVIPYNIGFLQVATLSLQGNR 274
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTG+IPEVIGLMQALAVLDLS+NEL GPIPPILGNLS+TGKLYLHGNK TG IPPELGNM
Sbjct: 275 LTGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKFTGQIPPELGNM 334
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
S+LSYLQL +N+LVG IP ELGKLEQLFELNLA+N L GPIP NISSC ALNQFNVHGN
Sbjct: 335 SRLSYLQLNDNELVGNIPPELGKLEQLFELNLANNYLVGPIPSNISSCAALNQFNVHGNF 394
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSG+IP FRNLGSLTYLNLS N+FKGK+P ELG IINLDTLDLS NNFSGS+P ++GDL
Sbjct: 395 LSGSIPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDL 454
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLL LNLSRNHLNG LPAEFGNLRSIQ ID+SFN L+G IP ELGQLQNI S+ILNNN
Sbjct: 455 EHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSMILNNNK 514
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
+ G IPDQL+NCFSL+NLN+S+NNLSGIIPP++NFSRF+ SF GNP LCGNW+GSICGP
Sbjct: 515 IHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFSRFAPASFFGNPFLCGNWVGSICGP 574
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
S+ K+RV F+R AV+CMVLGFITL+ M IAVYKS QQ+ + GS K G KLVILH
Sbjct: 575 SLPKSRV-FTRVAVICMVLGFITLICMIFIAVYKSKQQK-PIAKGSSKQPEGSTKLVILH 632
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHTFDDIMR TENLSEKYI+GYGASSTVYKC K+SRPIA+K++YNQYP+N REFE
Sbjct: 633 MDMAIHTFDDIMRVTENLSEKYIIGYGASSTVYKCTSKSSRPIAIKRIYNQYPNNFREFE 692
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSIRHRNIVSLHGYALSP+GNLLFYDYM NGSLWDLLHGP KKVKLDWETRLKI
Sbjct: 693 TELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLKI 752
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDC PRIIHRD+KSSNIL+D NF+A LSDFGIA+ IP +AST+VL
Sbjct: 753 AVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYASTYVL 812
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSRLNEKSD+YSFGIVLLE+LTGKKAVDNE+NLHQ+I+SKADDNTVME
Sbjct: 813 GTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLTGKKAVDNEANLHQMILSKADDNTVME 872
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAP 900
AVD EVSVTC+D ++KTFQLALLCTKR P ERPTMQEV+RVL+SLLP+PP K +
Sbjct: 873 AVDAEVSVTCMDSGHIKKTFQLALLCTKRNPLERPTMQEVSRVLLSLLPSPPPKKLPSPA 932
Query: 901 KPIDYYTKFVVNRERQQRVEHDDNSSDARWFVRFGEVISKNTL 943
K + ++R H +++ +WFV+F E ISK++L
Sbjct: 933 K---------LQEGEERRECHSSDTTTPQWFVQFREDISKSSL 966
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15241760|ref|NP_201029.1| LRR receptor-like serine/threonine-protein kinase ERL1 [Arabidopsis thaliana] gi|263419056|sp|C0LGW6.1|ERL1_ARATH RecName: Full=LRR receptor-like serine/threonine-protein kinase ERL1; AltName: Full=Protein ERECTA-like kinase 1; Flags: Precursor gi|224589739|gb|ACN59401.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332010200|gb|AED97583.1| LRR receptor-like serine/threonine-protein kinase ERL1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1513 bits (3918), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 755/944 (79%), Positives = 841/944 (89%), Gaps = 12/944 (1%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
MAIK SFSNL N+LLDWDDVHNSD CSWRGVFCDN S SVVSLNLSSLNLGGEISP+IGD
Sbjct: 34 MAIKGSFSNLVNMLLDWDDVHNSDLCSWRGVFCDNVSYSVVSLNLSSLNLGGEISPAIGD 93
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
LRNLQSID QGNKL GQIPDEIGNC SLV+++LS+N LYGDIPFSISKLKQLE LNLKNN
Sbjct: 94 LRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGDIPFSISKLKQLETLNLKNN 153
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGP+P+TLTQIPNLK LDLA N LTGEI RL+YWNEVLQYLGLRGN LTG LS DMCQ
Sbjct: 154 QLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLGLRGNMLTGTLSSDMCQ 213
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTGTIP+SIGNCTSF+ILDISYNQITGEIPYNIGFLQVATLSLQGN+
Sbjct: 214 LTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFLQVATLSLQGNR 273
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTG+IPEVIGLMQALAVLDLS+NELVGPIPPILGNLS+TGKLYLHGN LTGPIP ELGNM
Sbjct: 274 LTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNMLTGPIPSELGNM 333
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
S+LSYLQL +N+LVGTIP ELGKLEQLFELNLA+N L GPIP NISSC ALNQFNVHGN
Sbjct: 334 SRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFNVHGNL 393
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSG+IP +FRNLGSLTYLNLS NNFKGK+P ELG IINLD LDLS NNFSGS+P ++GDL
Sbjct: 394 LSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDL 453
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLL LNLSRNHL+G LPAEFGNLRSIQ ID+SFN LSG IP ELGQLQN+ SLILNNN
Sbjct: 454 EHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNK 513
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
L G IPDQL+NCF+L NLNVS+NNLSGI+PP++NFSRF+ SF+GNP LCGNW+GSICGP
Sbjct: 514 LHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCGNWVGSICGP 573
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
+ K+RV FSR A++C+VLG ITLL M +AVYKS QQ+ +++ GS K G KLVILH
Sbjct: 574 -LPKSRV-FSRGALICIVLGVITLLCMIFLAVYKSMQQK-KILQGSSKQAEGLTKLVILH 630
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHTFDDIMR TENL+EK+I+GYGASSTVYKCALK+SRPIA+K+LYNQYPHNLREFE
Sbjct: 631 MDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREFE 690
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSIRHRNIVSLHGYALSP GNLLFYDYM NGSLWDLLHG KKVKLDWETRLKI
Sbjct: 691 TELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKI 750
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDC PRIIHRD+KSSNIL+DENF+AHLSDFGIA+ IP + HAST+VL
Sbjct: 751 AVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVL 810
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSR+NEKSD+YSFGIVLLE+LTGKKAVDNE+NLHQLI+SKADDNTVME
Sbjct: 811 GTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVDNEANLHQLILSKADDNTVME 870
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAP 900
AVDPEV+VTC+DL +RKTFQLALLCTKR P ERPTM EV+RVL+SL+P+ L +A
Sbjct: 871 AVDPEVTVTCMDLGHIRKTFQLALLCTKRNPLERPTMLEVSRVLLSLVPS----LQVAKK 926
Query: 901 KP-IDYYTKFVVNRERQQRVEHDDNSSDARWFVRFGEVISKNTL 943
P +D+ TK + +Q+ + ++ ++WFV+F EVISK+++
Sbjct: 927 LPSLDHSTK----KLQQENEVRNPDAEASQWFVQFREVISKSSI 966
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79508007|ref|NP_196335.2| LRR receptor-like serine/threonine-protein kinase ERL2 [Arabidopsis thaliana] gi|75324925|sp|Q6XAT2.1|ERL2_ARATH RecName: Full=LRR receptor-like serine/threonine-protein kinase ERL2; AltName: Full=Protein ERECTA-like kinase 2; Flags: Precursor gi|37954362|gb|AAP69764.1| ERECTA-like kinase 2 [Arabidopsis thaliana] gi|224589663|gb|ACN59363.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332003735|gb|AED91118.1| LRR receptor-like serine/threonine-protein kinase ERL2 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1510 bits (3910), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 751/943 (79%), Positives = 831/943 (88%), Gaps = 11/943 (1%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
MAIKASFSN+AN+LLDWDDVHN DFCSWRGVFCDN SL+VVSLNLS+LNLGGEIS ++GD
Sbjct: 36 MAIKASFSNVANMLLDWDDVHNHDFCSWRGVFCDNVSLNVVSLNLSNLNLGGEISSALGD 95
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
L NLQSID QGNKL GQIPDEIGNC SL +++ S N L+GDIPFSISKLKQLEFLNLKNN
Sbjct: 96 LMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFSTNLLFGDIPFSISKLKQLEFLNLKNN 155
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGPIP+TLTQIPNLKTLDLARNQLTGEIPRL+YWNEVLQYLGLRGN LTG LSPDMCQ
Sbjct: 156 QLTGPIPATLTQIPNLKTLDLARNQLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSPDMCQ 215
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTGTIP+SIGNCTSFEILD+SYNQITG IPYNIGFLQVATLSLQGNK
Sbjct: 216 LTGLWYFDVRGNNLTGTIPESIGNCTSFEILDVSYNQITGVIPYNIGFLQVATLSLQGNK 275
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTG+IPEVIGLMQALAVLDLS+NEL GPIPPILGNLS+TGKLYLHGNKLTG IPPELGNM
Sbjct: 276 LTGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNM 335
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
S+LSYLQL +N+LVG IP ELGKLEQLFELNLA+NNL G IP NISSC ALNQFNVHGN
Sbjct: 336 SRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNF 395
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSGA+P FRNLGSLTYLNLS N+FKGK+P ELG IINLDTLDLS NNFSGS+P ++GDL
Sbjct: 396 LSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDL 455
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480
EHLL LNLSRNHLNG LPAEFGNLRSIQ ID+SFN L+G IP ELGQLQNI SLILNNN
Sbjct: 456 EHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNK 515
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
+ G IPDQL+NCFSL+NLN+S+NNLSGIIPP++NF+RFS SF GNP LCGNW+GSICGP
Sbjct: 516 IHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSICGP 575
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
S+ K++V F+R AV+CMVLGFITL+ M IAVYKS QQ+ ++ GS K G KLVILH
Sbjct: 576 SLPKSQV-FTRVAVICMVLGFITLICMIFIAVYKSKQQK-PVLKGSSKQPEGSTKLVILH 633
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHTFDDIMR TENL EKYI+GYGASSTVYKC K SRPIA+K++YNQYP N REFE
Sbjct: 634 MDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNFREFE 693
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSIRHRNIVSLHGYALSP+GNLLFYDYM NGSLWDLLHGP KKVKLDWETRLKI
Sbjct: 694 TELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLKI 753
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDC PRIIHRD+KSSNIL+D NF+A LSDFGIA+ IP +AST+VL
Sbjct: 754 AVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYASTYVL 813
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSRLNEKSD+YSFGIVLLE+LTGKKAVDNE+NLHQ+I+SKADDNTVME
Sbjct: 814 GTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLTGKKAVDNEANLHQMILSKADDNTVME 873
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAP 900
AVD EVSVTC+D ++KTFQLALLCTKR P ERPTMQEV+RVL+SL+P+PP K +
Sbjct: 874 AVDAEVSVTCMDSGHIKKTFQLALLCTKRNPLERPTMQEVSRVLLSLVPSPPPKKLPSPA 933
Query: 901 KPIDYYTKFVVNRERQQRVEHDDNSSDARWFVRFGEVISKNTL 943
K V ++R H +++ +WFV+F E ISK++L
Sbjct: 934 K---------VQEGEERRESHSSDTTTPQWFVQFREDISKSSL 967
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 943 | ||||||
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.989 | 0.965 | 0.743 | 0.0 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.988 | 0.963 | 0.738 | 0.0 | |
| TAIR|locus:2005507 | 976 | ER "ERECTA" [Arabidopsis thali | 0.996 | 0.963 | 0.592 | 6.1e-300 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.433 | 0.327 | 0.398 | 1.2e-130 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.869 | 0.744 | 0.352 | 1.2e-127 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.477 | 0.405 | 0.357 | 1.7e-126 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.850 | 0.713 | 0.356 | 4.3e-125 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.871 | 0.746 | 0.352 | 3.9e-124 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.432 | 0.342 | 0.380 | 1.7e-122 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.869 | 0.718 | 0.339 | 1.4e-120 |
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3610 (1275.8 bits), Expect = 0., P = 0.
Identities = 701/943 (74%), Positives = 778/943 (82%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDXXXXXXXXXXXXXXXXGGEISPSIGD 60
MAIK SFSNL N+LLDWDDVHNSD CSWRGVFCD GGEISP+IGD
Sbjct: 34 MAIKGSFSNLVNMLLDWDDVHNSDLCSWRGVFCDNVSYSVVSLNLSSLNLGGEISPAIGD 93
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
LRNLQSID QGNKL GQIPDEIGNC SLV+++LS+N LYGDIPFSISKLKQLE LNLKNN
Sbjct: 94 LRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGDIPFSISKLKQLETLNLKNN 153
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGP+P+TLTQIPNLK LDLA N LTGEI RL+YWNEVLQYLGLRGN LTG LS DMCQ
Sbjct: 154 QLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLGLRGNMLTGTLSSDMCQ 213
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTGTIP+SIGNCTSF+ILDISYNQITGEIPYNIGFLQVATLSLQGN+
Sbjct: 214 LTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFLQVATLSLQGNR 273
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTG+IPEVIGLMQALAVLDLS+NELVGPIPPILGNLS+TGKLYLHGN LTGPIP ELGNM
Sbjct: 274 LTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNMLTGPIPSELGNM 333
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
S+LSYLQL +N+LVGTIP ELGKLEQLFELNLA+N L GPIP NISSC ALNQFNVHGN
Sbjct: 334 SRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFNVHGNL 393
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSG+IP +FRNLGSLTYLNLS NNFKGK+P ELG IINLD LDLS NNFSGS+P ++GDL
Sbjct: 394 LSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDL 453
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAEXXXXXXXXXXXXXXXX 480
EHLL LNLSRNHL+G LPAEFGNLRSIQ ID+SFN LSG IP E
Sbjct: 454 EHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNK 513
Query: 481 XXXXXPDQLSNCFXXXXXXXXXXXXXGIIPPIXXXXXXXXXXXIGNPLLCGNWIGSICGP 540
PDQL+NCF GI+PP+ +GNP LCGNW+GSICGP
Sbjct: 514 LHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCGNWVGSICGP 573
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
+ K+RV FSR A++C+VLG ITLL M +AVYKS QQ++ ++ GS K G KLVILH
Sbjct: 574 -LPKSRV-FSRGALICIVLGVITLLCMIFLAVYKSMQQKK-ILQGSSKQAEGLTKLVILH 630
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHTFDDIMR TENL+EK+I+GYGASSTVYKCALK+SRPIA+K+LYNQYPHNLREFE
Sbjct: 631 MDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREFE 690
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSIRHRNIVSLHGYALSP GNLLFYDYM NGSLWDLLHG KKVKLDWETRLKI
Sbjct: 691 TELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKI 750
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDC PRIIHRD+KSSNIL+DENF+AHLSDFGIA+ IP + HAST+VL
Sbjct: 751 AVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVL 810
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSR+NEKSD+YSFGIVLLE+LTGKKAVDNE+NLHQLI+SKADDNTVME
Sbjct: 811 GTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVDNEANLHQLILSKADDNTVME 870
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARXXXXXXXXXXXXXXXXXX 900
AVDPEV+VTC+DL +RKTFQLALLCTKR P ERPTM EV+R
Sbjct: 871 AVDPEVTVTCMDLGHIRKTFQLALLCTKRNPLERPTMLEVSRVLLSLVPSLQVAKKLPS- 929
Query: 901 XXIDYYTKFVVNRERQQRVEHDDNSSDARWFVRFGEVISKNTL 943
+D+ TK + +++ V + D + ++WFV+F EVISK+++
Sbjct: 930 --LDHSTKKL---QQENEVRNPDAEA-SQWFVQFREVISKSSI 966
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3586 (1267.4 bits), Expect = 0., P = 0.
Identities = 696/943 (73%), Positives = 764/943 (81%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDXXXXXXXXXXXXXXXXGGEISPSIGD 60
MAIKASFSN+AN+LLDWDDVHN DFCSWRGVFCD GGEIS ++GD
Sbjct: 36 MAIKASFSNVANMLLDWDDVHNHDFCSWRGVFCDNVSLNVVSLNLSNLNLGGEISSALGD 95
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
L NLQSID QGNKL GQIPDEIGNC SL +++ S N L+GDIPFSISKLKQLEFLNLKNN
Sbjct: 96 LMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFSTNLLFGDIPFSISKLKQLEFLNLKNN 155
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QLTGPIP+TLTQIPNLKTLDLARNQLTGEIPRL+YWNEVLQYLGLRGN LTG LSPDMCQ
Sbjct: 156 QLTGPIPATLTQIPNLKTLDLARNQLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSPDMCQ 215
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVRGNNLTGTIP+SIGNCTSFEILD+SYNQITG IPYNIGFLQVATLSLQGNK
Sbjct: 216 LTGLWYFDVRGNNLTGTIPESIGNCTSFEILDVSYNQITGVIPYNIGFLQVATLSLQGNK 275
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
LTG+IPEVIGLMQALAVLDLS+NEL GPIPPILGNLS+TGKLYLHGNKLTG IPPELGNM
Sbjct: 276 LTGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNM 335
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
S+LSYLQL +N+LVG IP ELGKLEQLFELNLA+NNL G IP NISSC ALNQFNVHGN
Sbjct: 336 SRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNF 395
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
LSGA+P FRNLGSLTYLNLS N+FKGK+P ELG IINLDTLDLS NNFSGS+P ++GDL
Sbjct: 396 LSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDL 455
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAEXXXXXXXXXXXXXXXX 480
EHLL LNLSRNHLNG LPAEFGNLRSIQ ID+SFN L+G IP E
Sbjct: 456 EHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNK 515
Query: 481 XXXXXPDQLSNCFXXXXXXXXXXXXXGIIPPIXXXXXXXXXXXIGNPLLCGNWIGSICGP 540
PDQL+NCF GIIPP+ GNP LCGNW+GSICGP
Sbjct: 516 IHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSICGP 575
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGSRKSMLGPPKLVILH 600
S+ K++V F+R AV+CMVLGFITL+ M IAVYKS QQ+ ++ GS K G KLVILH
Sbjct: 576 SLPKSQV-FTRVAVICMVLGFITLICMIFIAVYKSKQQKP-VLKGSSKQPEGSTKLVILH 633
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE 660
MDMAIHTFDDIMR TENL EKYI+GYGASSTVYKC K SRPIA+K++YNQYP N REFE
Sbjct: 634 MDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNFREFE 693
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TELETIGSIRHRNIVSLHGYALSP+GNLLFYDYM NGSLWDLLHGP KKVKLDWETRLKI
Sbjct: 694 TELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLKI 753
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AVGAAQGLAYLHHDC PRIIHRD+KSSNIL+D NF+A LSDFGIA+ IP +AST+VL
Sbjct: 754 AVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYASTYVL 813
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
GTIGYIDPEYA TSRLNEKSD+YSFGIVLLE+LTGKKAVDNE+NLHQ+I+SKADDNTVME
Sbjct: 814 GTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLTGKKAVDNEANLHQMILSKADDNTVME 873
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARXXXXXXXXXXXXXXXXXX 900
AVD EVSVTC+D ++KTFQLALLCTKR P ERPTMQEV+R
Sbjct: 874 AVDAEVSVTCMDSGHIKKTFQLALLCTKRNPLERPTMQEVSRVLLSLVPSPPPKKLPSPA 933
Query: 901 XXIDYYTKFVVNRERQQRVEHDDNSSDARWFVRFGEVISKNTL 943
V ++R H +++ +WFV+F E ISK++L
Sbjct: 934 K---------VQEGEERRESHSSDTTTPQWFVQFREDISKSSL 967
|
|
| TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2879 (1018.5 bits), Expect = 6.1e-300, P = 6.1e-300
Identities = 561/947 (59%), Positives = 689/947 (72%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDXXXXXXXXXXXXXXXXGGEISPSIGD 60
+ IK SF ++ NVL DW +SD+C WRGV C+ GEISP+IGD
Sbjct: 31 LEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSCENVTFNVVALNLSDLNLDGEISPAIGD 90
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120
L++L SID +GN+L+GQIPDEIG+C SL +++LS N L GDIPFSISKLKQLE L LKNN
Sbjct: 91 LKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFNELSGDIPFSISKLKQLEQLILKNN 150
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
QL GPIPSTL+QIPNLK LDLA+N+L+GEIPRLIYWNEVLQYLGLRGN L G +SPD+CQ
Sbjct: 151 QLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWNEVLQYLGLRGNNLVGNISPDLCQ 210
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240
LTGLWYFDVR N+LTG+IP++IGNCT+F++LD+SYNQ+TGEIP++IGFLQVATLSLQGN+
Sbjct: 211 LTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGEIPFDIGFLQVATLSLQGNQ 270
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300
L+GKIP VIGLMQALAVLDLS N L G IPPILGNL++T KLYLH NKLTG IPPELGNM
Sbjct: 271 LSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNKLTGSIPPELGNM 330
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
SKL YL+L +N L G IP ELGKL LF+LN+A+N+LEGPIP ++SSCT LN NVHGN+
Sbjct: 331 SKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNSLNVHGNK 390
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
SG IP +F+ L S+TYLNLS NN KG +P EL RI NLDTLDLS N +G +P+S+GDL
Sbjct: 391 FSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDL 450
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAEXXXXXXXXXXXXXXXX 480
EHLL +NLSRNH+ G++P +FGNLRSI ID+S N +SG IP E
Sbjct: 451 EHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNN 510
Query: 481 XXXXXPDQLSNCFXXXXXXXXXXXXXGIIPPIXXXXXXXXXXXIGNPLLCGNWIGSICGP 540
L+NC G IP IGNP LCG+W+ S C
Sbjct: 511 LTGNV-GSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGSWLNSPCHD 569
Query: 541 SVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGS--RKSMLGPPKLVI 598
S RV SR A++ + +G + +L+M IA + + + GS + PKLVI
Sbjct: 570 SRRTVRVSISRAAILGIAIGGLVILLMVLIAACRPHNP-PPFLDGSLDKPVTYSTPKLVI 628
Query: 599 LHMDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLRE 658
LHM+MA+H ++DIMR TENLSEKYI+G+GASSTVYKC LKN +P+A+K+LY+ P ++++
Sbjct: 629 LHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYSHNPQSMKQ 688
Query: 659 FETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL 718
FETELE + SI+HRN+VSL Y+LS G+LLFYDY+ NGSLWDLLHGP+KK LDW+TRL
Sbjct: 689 FETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTLDWDTRL 748
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778
KIA GAAQGLAYLHHDC+PRIIHRDVKSSNIL+D++ +A L+DFGIA+ + + H ST+
Sbjct: 749 KIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVSKSHTSTY 808
Query: 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838
V+GTIGYIDPEYA TSRL EKSDVYS+GIVLLE+LT +KAVD+ESNLH LIMSK +N V
Sbjct: 809 VMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAVDDESNLHHLIMSKTGNNEV 868
Query: 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARXXXXXXXXXXXXXXXX 898
ME DP+++ TC DL V+K FQLALLCTKR P++RPTM +V R
Sbjct: 869 MEMADPDITSTCKDLGVVKKVFQLALLCTKRQPNDRPTMHQVTRVLGSFMLSEQPPAATD 928
Query: 899 XXXXI--DYYTKFVVNRERQQRVEHDDNS-SDARWFVRFGEVISKNT 942
+ Y N + V S SDA+ F+RFG+VIS+N+
Sbjct: 929 TSATLAGSCYVDEYANLKTPHSVNCSSMSASDAQLFLRFGQVISQNS 975
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 731 (262.4 bits), Expect = 1.2e-130, Sum P(2) = 1.2e-130
Identities = 164/412 (39%), Positives = 244/412 (59%)
Query: 52 GEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQ 111
G++ I LR L+ + N+ +G+IP EIGNC SL I++ N G+IP SI +LK+
Sbjct: 422 GKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKE 481
Query: 112 LEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALT 171
L L+L+ N+L G +P++L L LDLA NQL+G IP + + L+ L L N+L
Sbjct: 482 LNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQ 541
Query: 172 GMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQ- 230
G L + L L ++ N L GTI G+ +S+ D++ N EIP +G Q
Sbjct: 542 GNLPDSLISLRNLTRINLSHNRLNGTIHPLCGS-SSYLSFDVTNNGFEDEIPLELGNSQN 600
Query: 231 VATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLT 290
+ L L N+LTGKIP +G ++ L++LD+S N L G IP L + L+ N L+
Sbjct: 601 LDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLS 660
Query: 291 GPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTA 350
GPIPP LG +S+L L+L +NQ V ++P EL +L L+L N+L G IP I + A
Sbjct: 661 GPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGA 720
Query: 351 LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDT-LDLSVNNF 409
LN N+ N+ SG++P + L L L LSRN+ G++P E+G++ +L + LDLS NNF
Sbjct: 721 LNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNF 780
Query: 410 SGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSI 461
+G +P++IG L L TL+LS N L G +P G+++S+ +++SFN L G +
Sbjct: 781 TGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL 832
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1253 (446.1 bits), Expect = 1.2e-127, P = 1.2e-127
Identities = 301/853 (35%), Positives = 443/853 (51%)
Query: 52 GEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQ 111
GE+ IG L+ L + N+ +G IP EI NC SL + L N L G IP + L+
Sbjct: 231 GELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQS 290
Query: 112 LEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALT 171
LEFL L N L G IP + + +D + N LTGEIP + E L+ L L N LT
Sbjct: 291 LEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLT 350
Query: 172 GMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIG-FLQ 230
G + ++ L L D+ N LTG IP +L + N ++G IP +G +
Sbjct: 351 GTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSD 410
Query: 231 VATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLT 290
+ L + N L+G+IP + L + +L+L N L G IP + +L L N L
Sbjct: 411 LWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLV 470
Query: 291 GPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTA 350
G P L ++ ++L N+ G+IP E+G L L LADN G +P I +
Sbjct: 471 GRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQ 530
Query: 351 LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFS 410
L N+ N+L+G +PS N L L++ NNF G +P+E+G + L+ L LS NN S
Sbjct: 531 LGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLS 590
Query: 411 GSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQ-TIDMSFNQLSGSIPAEXXXXX 469
G++P ++G+L L L + N NG +P E G+L +Q +++S+N+L+G IP E
Sbjct: 591 GTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLV 650
Query: 470 XXXXXXXXXXXXXXXXPDQLSNCFXXXXXXXXXXXXXGIIPPIXXXXXXXXXXXIGNPLL 529
P +N G IP + IGN L
Sbjct: 651 MLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSF---IGNEGL 707
Query: 530 CGNWIGSIC-----GPSVTKARVMFSRT----AVVCMVLGFITLLVMAAIAVYKSNQQRQ 580
CG + PS + + R+ A+ V+G ++L+++A I VY + +
Sbjct: 708 CGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALI-VYLMRRPVR 766
Query: 581 QLITGSRKSMLGPPKLVILHMDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNS 640
+ + ++ L I TF D++ +T+N E ++VG GA TVYK L
Sbjct: 767 TVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAG 826
Query: 641 RPIAVKKLYNQYP----HNL-REFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695
+AVKKL + + +N+ F E+ T+G+IRHRNIV LHG+ NLL Y+YM
Sbjct: 827 YTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMP 886
Query: 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF 755
GSL ++LH PS LDW R KIA+GAAQGLAYLHHDC PRI HRD+KS+NIL+D+ F
Sbjct: 887 KGSLGEILHDPS--CNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKF 944
Query: 756 DAHLSDFGIARCIPTAMPHASTF--VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
+AH+ DFG+A+ I MPH+ + + G+ GYI PEYA+T ++ EKSD+YS+G+VLLE+L
Sbjct: 945 EAHVGDFGLAKVID--MPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELL 1002
Query: 814 TGK---KAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD---LSAVRKTFQLALLCT 867
TGK + +D ++ + S + + V + +T D +S + ++ALLCT
Sbjct: 1003 TGKAPVQPIDQGGDVVNWVRSYIRRDALSSGV-LDARLTLEDERIVSHMLTVLKIALLCT 1061
Query: 868 KRYPSERPTMQEV 880
P RP+M++V
Sbjct: 1062 SVSPVARPSMRQV 1074
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 710 (255.0 bits), Expect = 1.7e-126, Sum P(2) = 1.7e-126
Identities = 162/453 (35%), Positives = 233/453 (51%)
Query: 11 ANVLLDWDDVHNSDFCSWRGVFCDXXXXXXXXXXXXXXXXGGEISPSIGDLRNLQSIDFQ 70
+++ W+ +S CSW GV CD G E P I L++L+ +
Sbjct: 43 SDITQSWN-ASDSTPCSWLGVECDRRQFVDTLNLSSYGISG-EFGPEISHLKHLKKVVLS 100
Query: 71 GNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTL 130
GN G IP ++GNC L HI+LS NS G+IP ++ L+ L L+L N L GP P +L
Sbjct: 101 GNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESL 160
Query: 131 TQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVR 190
IP+L+T+ N L G IP I L L L N +G + + +T L +
Sbjct: 161 LSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGPVPSSLGNITTLQELYLN 220
Query: 191 GNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYN-IGFLQVATLSLQGNKLTGKIPEVI 249
NNL GT+P ++ N + LD+ N + G IP + + Q+ T+SL N+ TG +P +
Sbjct: 221 DNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGL 280
Query: 250 GLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQ 309
G +L L GPIP G L+ LYL GN +G IPPELG + LQLQ
Sbjct: 281 GNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQ 340
Query: 310 NNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSF 369
NQL G IP ELG L QL L+L NNL G +P +I +L ++ N LSG +P
Sbjct: 341 QNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDM 400
Query: 370 RNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLS 429
L L L L N+F G +P +LG +L+ LDL+ N F+G +P ++ + L L L
Sbjct: 401 TELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLG 460
Query: 430 RNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIP 462
N+L G +P++ G +++ + + N L G +P
Sbjct: 461 YNYLEGSVPSDLGGCSTLERLILEENNLRGGLP 493
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1229 (437.7 bits), Expect = 4.3e-125, P = 4.3e-125
Identities = 305/856 (35%), Positives = 445/856 (51%)
Query: 52 GEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQ 111
G I IG+L +L+++ GN L G IP EIGN SL + L N L G IP + KL +
Sbjct: 267 GFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSK 326
Query: 112 LEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALT 171
+ ++ N L+G IP L++I L+ L L +N+LTG IP + L L L N+LT
Sbjct: 327 VMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLT 386
Query: 172 GMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIP-YNIGFLQ 230
G + P LT + + N+L+G IP +G + ++D S NQ++G+IP +
Sbjct: 387 GPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSN 446
Query: 231 VATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLT 290
+ L+L N++ G IP + ++L L + N L G P L L + L N+ +
Sbjct: 447 LILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFS 506
Query: 291 GPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTA 350
GP+PPE+G KL L L NQ +P E+ KL L N++ N+L GPIP I++C
Sbjct: 507 GPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKM 566
Query: 351 LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFS 410
L + ++ N G++P +L L L LS N F G +P +G + +L L + N FS
Sbjct: 567 LQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFS 626
Query: 411 GSVPASIGDLEHL-LTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAEXXXXX 469
GS+P +G L L + +NLS N +G +P E GNL + + ++ N LSG IP
Sbjct: 627 GSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLS 686
Query: 470 XXXXXXXXXXXXXXXXPDQLSNCFXXXXXXXXXXXXXGIIPPIXXXXXXXXXXXIGNPLL 529
L C G +P +GN L
Sbjct: 687 S------------------LLGC------NFSYNNLTGQLPHTQIFQNMTLTSFLGNKGL 722
Query: 530 CGNWIGSI-----CGPSVTKARVMFSRTA----VVCMVLGFITLLVMAAIAVYKSNQQRQ 580
CG + S P ++ + +R +V V+G I+LL++A + + N
Sbjct: 723 CGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEP 782
Query: 581 QL-ITGSRKSMLGPPKLVILHMDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKN 639
++ + + + T DI+ +T+ + YIVG GA TVYK + +
Sbjct: 783 TAPYVHDKEPFFQESDIYFVPKER--FTVKDILEATKGFHDSYIVGRGACGTVYKAVMPS 840
Query: 640 SRPIAVKKLY------NQYPHNL-REFETELETIGSIRHRNIVSLHG--YALSPYGNLLF 690
+ IAVKKL N +N F E+ T+G IRHRNIV L+ Y NLL
Sbjct: 841 GKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLL 900
Query: 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNIL 750
Y+YM GSL +LLHG K +DW TR IA+GAA+GLAYLHHDC PRIIHRD+KS+NIL
Sbjct: 901 YEYMSRGSLGELLHG-GKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNIL 959
Query: 751 IDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLL 810
IDENF+AH+ DFG+A+ I + + + V G+ GYI PEYA+T ++ EK D+YSFG+VLL
Sbjct: 960 IDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLL 1019
Query: 811 EILTGKKAV---DNESNLHQLIMSKADDNTVM-EAVDPEVSVTCVD--LSAVRKTFQLAL 864
E+LTGK V + +L + D+++ E +DP ++ D L+ + ++A+
Sbjct: 1020 ELLTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAV 1079
Query: 865 LCTKRYPSERPTMQEV 880
LCTK PS+RPTM+EV
Sbjct: 1080 LCTKSSPSDRPTMREV 1095
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1220 (434.5 bits), Expect = 3.9e-124, P = 3.9e-124
Identities = 300/851 (35%), Positives = 437/851 (51%)
Query: 52 GEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQ 111
G + + L+NL + N+L+G+IP +GN L + L +N G IP I KL +
Sbjct: 225 GSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTK 284
Query: 112 LEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALT 171
++ L L NQLTG IP + + + +D + NQLTG IP+ L+ L L N L
Sbjct: 285 MKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILL 344
Query: 172 GMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQ- 230
G + ++ +LT L D+ N L GTIP + L + NQ+ G+IP IGF
Sbjct: 345 GPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSN 404
Query: 231 VATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLT 290
+ L + N L+G IP Q L +L L N+L G IP L KL L N+LT
Sbjct: 405 FSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLT 464
Query: 291 GPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTA 350
G +P EL N+ L+ L+L N L G I A+LGKL+ L L LA+NN G IP I + T
Sbjct: 465 GSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTK 524
Query: 351 LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFS 410
+ FN+ N+L+G IP + ++ L+LS N F G + ELG+++ L+ L LS N +
Sbjct: 525 IVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLT 584
Query: 411 GSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQ-TIDMSFNQLSGSIPAEXXXXX 469
G +P S GDL L+ L L N L+ +P E G L S+Q ++++S N LSG+IP
Sbjct: 585 GEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQ 644
Query: 470 XXXXXXXXXXXXXXXXPDQLSNCFXXXXXXXXXXXXXGIIPPIXXXXXXXXXXXIGNPLL 529
P + N G +P GN L
Sbjct: 645 MLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGL 704
Query: 530 CGNWIGSICGPSV----TKARVMFSRT------AVVCMVLGFITLLVMAAIAVYKSNQQR 579
C N S C P V +K + + + + C+V+G + L+ + + ++R
Sbjct: 705 C-NSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCW--TIKRR 761
Query: 580 QQLITGSRKSMLGPPKLVILHMDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKN 639
+ + + P + + T+ ++ +T N SE ++G GA TVYK +
Sbjct: 762 EPAFV-ALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSG 820
Query: 640 SRPIAVKKLYN--QYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNG 697
IAVKKL + + + F E+ T+G IRHRNIV L+G+ NLL Y+YM G
Sbjct: 821 GEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKG 880
Query: 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDA 757
SL + L K LDW R +IA+GAA+GL YLHHDC P+I+HRD+KS+NIL+DE F A
Sbjct: 881 SLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQA 940
Query: 758 HLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK 817
H+ DFG+A+ I + + + V G+ GYI PEYA+T ++ EK D+YSFG+VLLE++TGK
Sbjct: 941 HVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKP 1000
Query: 818 AVDNESNLHQLI--MSKADDNTV--MEAVDPEVSV----TCVDLSAVRKTFQLALLCTKR 869
V L+ + ++ N + +E D + T ++S V K +AL CT
Sbjct: 1001 PVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLK---IALFCTSN 1057
Query: 870 YPSERPTMQEV 880
P+ RPTM+EV
Sbjct: 1058 SPASRPTMREV 1068
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 657 (236.3 bits), Expect = 1.7e-122, Sum P(2) = 1.7e-122
Identities = 160/421 (38%), Positives = 231/421 (54%)
Query: 54 ISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLE 113
I S G+L NL ++ +L G IP E+GNC SL + LS NSL G +P +S++ L
Sbjct: 250 IPKSFGELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLLT 309
Query: 114 FLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGM 173
F + + NQL+G +PS + + L +L LA N+ +GEIP I +L++L L N L+G
Sbjct: 310 F-SAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGS 368
Query: 174 LSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVAT 233
+ ++C L D+ GN L+GTI + C+S L ++ NQI G IP ++ L +
Sbjct: 369 IPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMA 428
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI 293
L L N TG+IP+ + L S N L G +P +GN + +L L N+LTG I
Sbjct: 429 LDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEI 488
Query: 294 PPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQ 353
P E+G ++ LS L L N G IP ELG L L+L NNL+G IP I++ L
Sbjct: 489 PREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQC 548
Query: 354 FNVHGNRLSGAIPSS----FRNLG--SLTYL------NLSRNNFKGKVPTELGRIINLDT 401
+ N LSG+IPS F + L++L +LS N G +P ELG + L
Sbjct: 549 LVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVE 608
Query: 402 LDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSI 461
+ LS N+ SG +PAS+ L +L L+LS N L G +P E GN +Q ++++ NQL+G I
Sbjct: 609 ISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHI 668
Query: 462 P 462
P
Sbjct: 669 P 669
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1167 (415.9 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
Identities = 290/855 (33%), Positives = 443/855 (51%)
Query: 52 GEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQ 111
G+I IGD NL + ++G +P +G L + + + G+IP + +
Sbjct: 216 GQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSE 275
Query: 112 LEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALT 171
L L L N L+G IP + Q+ L+ L L +N L G IP I L+ + L N L+
Sbjct: 276 LVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLS 335
Query: 172 GMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQV 231
G + + +L+ L F + N +G+IP +I NC+S L + NQI+G IP +G L
Sbjct: 336 GSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTK 395
Query: 232 ATLSLQ-GNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLT 290
TL N+L G IP + L LDLS N L G IP L L KL L N L+
Sbjct: 396 LTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLS 455
Query: 291 GPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTA 350
G IP E+GN S L L+L N++ G IP+ +G L+++ L+ + N L G +P I SC+
Sbjct: 456 GFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSE 515
Query: 351 LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFS 410
L ++ N L G++P+ +L L L++S N F GK+P LGR+++L+ L LS N FS
Sbjct: 516 LQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFS 575
Query: 411 GSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQ-TIDMSFNQLSGSIPAEXXXXX 469
GS+P S+G L L+L N L+G +P+E G++ +++ +++S N+L+G IP++
Sbjct: 576 GSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLN 635
Query: 470 XXXXXXXXXXXXXXXXPDQLSNCFXXXXXXXXXXXXXGIIPPIXXXXXXXXXXXIGNPLL 529
L+N G +P GN L
Sbjct: 636 KLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKL 694
Query: 530 CGN-----WI----GSICGPSVTKARVMFSRTAVVCMVLGFITLLVMAAIAVYKSNQQRQ 580
C + ++ G+ G +R R + ++ + L+++ A+AV ++ +
Sbjct: 695 CSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRN-- 752
Query: 581 QLITGSRKSMLGPP-KLVILHMDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKN 639
I R S LG K + D I+R L E ++G G S VY+ + N
Sbjct: 753 --IDNERDSELGETYKWQFTPFQKLNFSVDQIIRC---LVEPNVIGKGCSGVVYRADVDN 807
Query: 640 SRPIAVKKLY--------NQYPHNLRE-FETELETIGSIRHRNIVSLHGYALSPYGNLLF 690
IAVKKL+ ++ N+R+ F E++T+G+IRH+NIV G + LL
Sbjct: 808 GEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLM 867
Query: 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNIL 750
YDYM NGSL LLH + LDW+ R +I +GAAQGLAYLHHDC P I+HRD+K++NIL
Sbjct: 868 YDYMPNGSLGSLLH-ERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNIL 926
Query: 751 IDENFDAHLSDFGIARCIPTA-MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVL 809
I +F+ +++DFG+A+ + + S V G+ GYI PEY ++ ++ EKSDVYS+G+V+
Sbjct: 927 IGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVV 986
Query: 810 LEILTGKKAVDNE--SNLHQLIMSKADDNTVMEAVDPEV-SVTCVDLSAVRKTFQLALLC 866
LE+LTGK+ +D +H L+ + +E +D + S T + + + ALLC
Sbjct: 987 LEVLTGKQPIDPTVPEGIH-LVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLC 1045
Query: 867 TKRYPSERPTMQEVA 881
P ERPTM++VA
Sbjct: 1046 VNSSPDERPTMKDVA 1060
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGW6 | ERL1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7997 | 0.9883 | 0.9648 | yes | no |
| Q6XAT2 | ERL2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7963 | 0.9883 | 0.9638 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XII001240 | leucine-rich repeat protein kinase (949 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 943 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-126 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-05 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 6e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 406 bits (1045), Expect = e-126
Identities = 304/970 (31%), Positives = 463/970 (47%), Gaps = 134/970 (13%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSS------LS--------------- 39
++ K+S ++ L +W+ ++D C W+G+ C+NSS LS
Sbjct: 35 LSFKSSINDPLKYLSNWNS--SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRL 92
Query: 40 --VVSLNLSSLNLGGEISPSI-----------------------GDLRNLQSIDFQGNKL 74
+ ++NLS+ L G I I G + NL+++D N L
Sbjct: 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNML 152
Query: 75 TGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIP 134
+G+IP++IG+ SL ++L N L G IP S++ L LEFL L +NQL G IP L Q+
Sbjct: 153 SGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMK 212
Query: 135 NLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNL 194
+LK + L N L+GEIP I LT L + D+ NNL
Sbjct: 213 SLKWIYLGYNNLSGEIPYEI------------------------GGLTSLNHLDLVYNNL 248
Query: 195 TGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQ-VATLSLQGNKLTGKIPEVIGLMQ 253
TG IP S+GN + + L + N+++G IP +I LQ + +L L N L+G+IPE++ +Q
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308
Query: 254 ALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQL 313
L +L L N G IP L +L L L NK +G IP LG + L+ L L N L
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 314 VGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLG 373
G IP L LF+L L N+LEG IP ++ +C +L + + N SG +PS F L
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLP 428
Query: 374 ------------------------SLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNF 409
SL L+L+RN F G +P + L+ LDLS N F
Sbjct: 429 LVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQF 487
Query: 410 SGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQ 469
SG+VP +G L L+ L LS N L+G +P E + + + ++D+S NQLSG IPA ++
Sbjct: 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMP 547
Query: 470 NIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLL 529
+ L L+ N L G IP L N SL +N+S+N+L G +P F ++++ GN L
Sbjct: 548 VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDL 607
Query: 530 CGNWIGSICGPSVTKARVMFSRT---AVVCMVLGFITLLVMAAIAVYKSNQQRQQLITGS 586
CG S P RV + + + C + F+ L ++A V+ + +L
Sbjct: 608 CGGDTTSGLPPC---KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE 664
Query: 587 RKSMLGPPKLVILHMDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKC-ALKNSRPIAV 645
+ + + +I T +DI+ S L E+ ++ G YK ++KN V
Sbjct: 665 NEDGTWELQFFDSKVSKSI-TINDILSS---LKEENVISRGKKGASYKGKSIKNGMQFVV 720
Query: 646 KKL--YNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL 703
K++ N P +E+ +G ++H NIV L G S G L ++Y+ +L ++L
Sbjct: 721 KEINDVNSIP------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 704 HGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763
L WE R KIA+G A+ L +LH C+P ++ ++ I+ID + HL
Sbjct: 775 RN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL---- 824
Query: 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES 823
R + T + Y+ PE T + EKSD+Y FG++L+E+LTGK D E
Sbjct: 825 --RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882
Query: 824 NLHQLIMSKA----DDNTVMEAVDPEVSV-TCVDLSAVRKTFQLALLCTKRYPSERPTMQ 878
+H I+ A D + +DP + V+ + + + LAL CT P+ RP
Sbjct: 883 GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN 942
Query: 879 EVARVLVSLL 888
+V + L S
Sbjct: 943 DVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 72/261 (27%), Positives = 109/261 (41%), Gaps = 54/261 (20%)
Query: 624 VGYGASSTVYKC-ALKNSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYA 681
+G G TVY K + +A+K + + L E E+E + + H NIV L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 682 LSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIH 741
L +Y GSL DLL + KL + L+I + +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHS-NG--IIH 115
Query: 742 RDVKSSNILIDE-NFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE-YAHTSRLNEK 799
RD+K NIL+D N L+DFG+++ + + T V GT Y+ PE +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEK 174
Query: 800 SDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKT 859
SD++S G++L E+ L LI
Sbjct: 175 SDIWSLGVILYEL----------PELKDLIRK---------------------------- 196
Query: 860 FQLALLCTKRYPSERPTMQEV 880
++ P +RP+ +E+
Sbjct: 197 ------MLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 82/271 (30%), Positives = 124/271 (45%), Gaps = 35/271 (12%)
Query: 623 IVGYGASSTVYKCALKNSR-PIAVKKLYNQYPH--NLREFETELETIGSIRHRNIVSLHG 679
+G G+ TVYK K + +AVK L + + E+ + + H NIV L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 680 YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739
L +Y G L+D L S+ L + KIA+ +GL YLH + I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSN---GI 119
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE-----YAHTS 794
IHRD+K NIL+DEN ++DFG+A+ + + +TFV GT Y+ PE +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGP 178
Query: 795 RLNEKSDVYSFGIVLLEILTGK-----KAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849
K DV+S G++L E+LTGK + + ++ L + I+ E S
Sbjct: 179 ----KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGP--PLEFDEPKWSSGSEE 232
Query: 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
DL ++K L PS+RPT +E+
Sbjct: 233 AKDL--IKK-----CLNKD--PSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 7e-40
Identities = 78/272 (28%), Positives = 116/272 (42%), Gaps = 33/272 (12%)
Query: 625 GYGASSTVYKCALK-----NSRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLH 678
G GA VYK LK +AVK L EF E + + H NIV L
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR 738
G + +YM G L D L KL + L++A+ A+G+ YL +
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLE---SKN 122
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYID-----PEYAHT 793
+HRD+ + N L+ EN +SDFG++R + + G + PE
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSR----DIYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 794 SRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852
+ KSDV+SFG++L EI T G++ SN + ++ +D + PE C D
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN--EEVLELLEDGYRLPR--PE---NCPD 231
Query: 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+ ++L L C P +RPT E+ L
Sbjct: 232 -----ELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 72/260 (27%), Positives = 116/260 (44%), Gaps = 19/260 (7%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLRE-FETELETIGSIRHRNIVSLHGY 680
+G G+ VY K + + +A+K + + RE E++ + ++H NIV L+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 681 ALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRII 740
L +Y G L+DLL K+ +L + L YLH + I+
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLH---SKGIV 119
Query: 741 HRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKS 800
HRD+K NIL+DE+ L+DFG+AR + +TFV GT Y+ PE +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFV-GTPEYMAPEVLLGKGYGKAV 177
Query: 801 DVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTF 860
D++S G++L E+LTGK + L +L + ++S DL +RK
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDL--IRK-- 233
Query: 861 QLALLCTKRYPSERPTMQEV 880
+ P +R T +E
Sbjct: 234 -----LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 74/267 (27%), Positives = 111/267 (41%), Gaps = 24/267 (8%)
Query: 625 GYGASSTVYKCALK-----NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLH 678
G GA VYK LK +AVK L + EF E + + H N+V L
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR 738
G + +YM G L L + KL L A+ A+G+ YL
Sbjct: 68 GVCTEEEPLYIVMEYMEGGDLLSYLR--KNRPKLSLSDLLSFALQIARGMEYLESK---N 122
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE 798
IHRD+ + N L+ EN +SDFG++R + + I ++ PE +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 799 KSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVR 857
KSDV+SFG++L EI T G++ SN + ++ + + P C
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMSN--EEVLEYLKNGYRLPQ--PP---NCPP----- 230
Query: 858 KTFQLALLCTKRYPSERPTMQEVARVL 884
+ + L L C P +RPT E+ +L
Sbjct: 231 ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 77/266 (28%), Positives = 114/266 (42%), Gaps = 28/266 (10%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKK--LYNQYPHNLREFETELETIGSIRHRNIVSLHG 679
++G G+ +VY K++ +AVK L L E E+ + S++H NIV +G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 680 YALSPYGN--LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---GLAYLHHD 734
N +F +Y+ GSL LL K KL I Q GLAYLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLPEPV---IRKYTRQILEGLAYLH-- 118
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT-AMPHASTFVLGTIGYIDPEYAHT 793
+ I+HRD+K +NIL+D + L+DFG A+ + + V GT ++ PE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853
+D++S G ++E+ TGK N + PE+ L
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-----PEIP---EHL 229
Query: 854 SAVRKTFQLALLCTKRYPSERPTMQE 879
S K F C +R P +RPT E
Sbjct: 230 SEEAKDF--LRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 76/282 (26%), Positives = 117/282 (41%), Gaps = 42/282 (14%)
Query: 623 IVGYGASSTVYKCALK----NSRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSL 677
+G GA VYK LK + +AVK L ++F E + + H N+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLL------HGPSKKVKLDWETRLKIAVGAAQGLAYL 731
G L +YM G L D L +K L + L A+ A+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI----- 786
+ + +HRD+ + N L+ E+ +SDFG++R + + T G +
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR----DVYDDDYYRKKTGGKLPIRWM 174
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSKADDNTVMEAV 842
PE KSDV+SFG++L EI T G + NE + + + +
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-EVLEYLR----KGYRLPK- 228
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
PE C D + ++L L C + P +RPT E+ L
Sbjct: 229 -PE---YCPD-----ELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 76/271 (28%), Positives = 112/271 (41%), Gaps = 31/271 (11%)
Query: 625 GYGASSTVYKCALKN-----SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLH 678
G GA VYK LK +AVK L + EF E + + H NIV L
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR 738
G ++ +YM G L D L K L L A+ A+G+ YL
Sbjct: 68 GVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESK---N 123
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG----TIGYIDPEYAHTS 794
IHRD+ + N L+ EN +SDFG++R + + + I ++ PE
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 795 RLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853
+ KSDV+SFG++L EI T G++ SN ++ + P C
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN--AEVLEYLKKGYRLPK--PP---NCPP- 231
Query: 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+ ++L L C P +RPT E+ +L
Sbjct: 232 ----ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 81/279 (29%), Positives = 120/279 (43%), Gaps = 60/279 (21%)
Query: 625 GYGASSTVYKCALK-NSRPIAVKKLY-NQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
G G+S VYK K + A+KK++ + ++ EL+T+ S +V +G
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG--- 66
Query: 683 SPYGNLLFYD---------YMVNGSLWDLLHGPSKKVKLDWETRLK-IAVGAAQGLAYLH 732
FY YM GSL DLL KKV E L IA +GL YLH
Sbjct: 67 ------AFYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH 792
IIHRD+K SN+LI+ + ++DFGI++ + + +TFV GT+ Y+ PE
Sbjct: 117 TK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE--- 170
Query: 793 TSRLNEK-----SDVYSFGIVLLEILTGK---KAVDNES--NLHQLIMSKADDNTVMEAV 842
R+ + +D++S G+ LLE GK S L Q I + E
Sbjct: 171 --RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228
Query: 843 DPEVS--VTCVDLSAVRKTFQLALLCTKRYPSERPTMQE 879
PE ++ C ++ P +RP+ E
Sbjct: 229 SPEFRDFISA---------------CLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 22/268 (8%)
Query: 624 VGYGASSTVYK--CALKNSRPIAVKKL-YNQYPHNLREFETELETIGSIRHRNIVSLHGY 680
+G GA++ VY C L N+ +A+K++ + ++ E E++ + H N+V +
Sbjct: 9 IGVGATAVVYAAIC-LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 681 ALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRII 740
+ L Y+ GSL D++ + LD + +GL YLH + I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQI 124
Query: 741 HRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS----TFVLGTIGYIDPEYAHTSR- 795
HRD+K+ NIL+ E+ ++DFG++ + TFV GT ++ PE
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEVMEQVHG 183
Query: 796 LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855
+ K+D++SFGI +E+ TG + L+++ +D +E T D
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLE--------TGADYKK 235
Query: 856 VRKTF-QLALLCTKRYPSERPTMQEVAR 882
K+F ++ LC ++ PS+RPT +E+ +
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 624 VGYGASSTVYKC-ALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G G VYK + + +A+K + + + E++ + +H NIV +G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 683 SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV---GAAQGLAYLHHDCNPRI 739
+ ++ GSL DLL ++ + IA +GL YLH + I
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLH---SNGI 119
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEK 799
IHRD+K++NIL+ + + L DFG++ + +T V GT ++ PE + + K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMV-GTPYWMAPEVINGKPYDYK 177
Query: 800 SDVYSFGIVLLEILTGK 816
+D++S GI +E+ GK
Sbjct: 178 ADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 22/280 (7%)
Query: 621 KYI--VGYGASSTVYKCALKNSRP-----IAVKKL-YNQYPHNLREFETELETIGSIRHR 672
K+I +G G V C +AVK L ++ + +FE E+E + ++ H
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 673 NIVSLHGYALSPYGN--LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
NIV G P G L +Y+ +GSL D L + +++ + L + +G+ Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDY 124
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT--IGYIDP 788
L + R IHRD+ + NIL++ +SDFG+A+ +P + G I + P
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTV---MEAVDP 844
E TS+ + SDV+SFG+ L E+ T G + + ++I V +E +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+ S + + L LC + P +RP+ ++ ++
Sbjct: 242 GERLPRPP-SCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 56/193 (29%), Positives = 94/193 (48%), Gaps = 9/193 (4%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS 683
+G G V++ KN +A+K L + ++F+ E++ + +RH++++SL
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 684 PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRD 743
+ + M GSL L P +V L + + +A A+G+AYL IHRD
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ---NSIHRD 129
Query: 744 VKSSNILIDENFDAHLSDFGIARCI--PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSD 801
+ + NIL+ E+ ++DFG+AR I + + PE A + KSD
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAASHGTFSTKSD 186
Query: 802 VYSFGIVLLEILT 814
V+SFGI+L E+ T
Sbjct: 187 VWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 2e-25
Identities = 78/299 (26%), Positives = 117/299 (39%), Gaps = 24/299 (8%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKL---YNQYPHNLREFETELETIGSIRH-RNIVSLHG 679
+G G+ VY ++ + +A+K L + F E++ + S+ H NIV L+
Sbjct: 8 LGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 680 YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739
+ L +Y+ GSL DLL +K L L I L YLH I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GI 122
Query: 740 IHRDVKSSNILIDEN-FDAHLSDFGIARCIP-----TAMPHASTFVLGTIGYIDPEYAHT 793
IHRD+K NIL+D + L DFG+A+ +P +++P + +GT GY+ PE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 794 SRLNE---KSDVYSFGIVLLEILTGK---KAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847
L SD++S GI L E+LTG + N S Q + + T A S
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAPKPIDYY 906
+ A L + P R + + KP D
Sbjct: 243 NPELISKAASD---LLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSA 298
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 55/299 (18%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLRE-FETELETIGS 668
+ + K +G GA V+ + P +AVK L ++ R+ FE E E + +
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL--HGP---------SKKVKLDWETR 717
+H NIV +G ++ ++YM +G L L HGP S +L
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 718 LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777
L+IAV A G+ YL + +HRD+ + N L+ + + DFG++R + T +
Sbjct: 125 LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR-- 179
Query: 778 FVLGT----IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSK 832
V G I ++ PE + +SDV+SFG+VL EI T GK+ SN
Sbjct: 180 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-------- 230
Query: 833 ADDNTVMEAVD-------PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
V+E + P TC + + + L C KR P +R ++++ L
Sbjct: 231 ---EEVIECITQGRLLQRPR---TCPS-----EVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/263 (25%), Positives = 106/263 (40%), Gaps = 24/263 (9%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKK--LYNQYPHNLREFETELETIGSIRHRNIVSLHGY 680
+G G+ VY + + +K+ L N + E++ + + H NI+ +
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 681 ALSPYGNLLFY--DYMVNGSLWDLLH-GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
L +Y G L + + E L V L YLH
Sbjct: 68 FE--EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLN 797
+I+HRD+K NI + N L DFGI++ + + + A T V GT Y+ PE N
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181
Query: 798 EKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVR 857
KSD++S G VL E+ T K + E NL +L + + P S +L
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGE-NLLELAL-----KILKGQYPPIPSQYSSELR--- 232
Query: 858 KTFQLALLCTKRYPSERPTMQEV 880
L ++ P ERP++ ++
Sbjct: 233 ---NLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 67/262 (25%), Positives = 116/262 (44%), Gaps = 19/262 (7%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS 683
+G G V+ R +A+K + +F E + + + H +V L+G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 684 PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRD 743
L +++M +G L D L +++ K ET L + + +G+AYL +IHRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 744 VKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVY 803
+ + N L+ EN +SDFG+ R + +ST + + PE S+ + KSDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 804 SFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQL 862
SFG+++ E+ + GK +N SN + N P ++ V ++L
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSEVV----ETINAGFRLYKPRLASQSV--------YEL 233
Query: 863 ALLCTKRYPSERPTMQEVARVL 884
C K P +RP+ + L
Sbjct: 234 MQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 615 TENLSEKYIVGYGASSTVYKCALKNS-RPIAVKK--LYNQYPHNLREFETELETIGSIRH 671
E +G GAS VYK + + + +A+KK L Q + E+ + +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKH 74
Query: 672 RNIVSLHGYALSPYGNLLF--YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA-QGL 728
NIV + L G+ L+ +YM GSL D++ V+++ E ++ QGL
Sbjct: 75 PNIVDYYDSYL--VGDELWVVMEYMDGGSLTDIITQ--NFVRMN-EPQIAYVCREVLQGL 129
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDP 788
YLH + +IHRD+KS NIL+ ++ L+DFG A + ++ V GT ++ P
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILTG 815
E K D++S GI+ +E+ G
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 83/274 (30%), Positives = 121/274 (44%), Gaps = 32/274 (11%)
Query: 610 DIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI 669
+I R + L K +G G V+ + +AVK L + F E + + +
Sbjct: 2 EIPRESLKLERK--LGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKL 58
Query: 670 RHRNIVSLHGYALSPYGNLLFY--DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
RH +V L YA+ ++ +YM GSL D L K KL + +A A+G
Sbjct: 59 RHDKLVQL--YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEG 115
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYID 787
+AYL IHRD+ + NIL+ EN ++DFG+AR I A I +
Sbjct: 116 MAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA 172
Query: 788 PEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD---- 843
PE A+ R KSDV+SFGI+L EI+T V M+ + V+E V+
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVT-YGRVPYPG------MTNRE---VLEQVERGYR 222
Query: 844 -PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT 876
P C + + + L L C + P ERPT
Sbjct: 223 MPRPP-NCPE-----ELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 5e-22
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 624 VGYGASSTVYKCALKNSRPI-AVKKL-------YNQYPHNLREFETELETIGSIRHRNIV 675
+G G+ V K++ + A+K L + H L TE + I H IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL----TERNILSRINHPFIV 56
Query: 676 SLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLK-IAVGAAQGLAYLHH 733
LH YA L +Y G L+ L SK+ + E R + A L YLH
Sbjct: 57 KLH-YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALEYLH- 110
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
+ II+RD+K NIL+D + L+DFG+A+ + + +TF GT Y+ PE
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLG 167
Query: 794 SRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
+ D +S G++L E+LTGK ++ +++ I+
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 78/272 (28%), Positives = 125/272 (45%), Gaps = 24/272 (8%)
Query: 610 DIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI 669
+I R++ L K +G G V++ N+ P+AVK L + ++F E + + +
Sbjct: 2 EIDRTSIQLLRK--LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKL 58
Query: 670 RHRNIVSLHGYALSPYGN--LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
RH ++ L YA+ + + M GSL + L G L + +A A G
Sbjct: 59 RHPKLIQL--YAVCTLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASG 115
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYID 787
+AYL IHRD+ + N+L+ EN ++DFG+AR I + A I +
Sbjct: 116 MAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 788 PEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846
PE A +R + KSDV+SFGI+L EI+T G+ +N ++ + D M P
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQQVDQGYRMPC--PP- 227
Query: 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQ 878
C + + + L C K P +RPT +
Sbjct: 228 --GCPK-----ELYDIMLDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 623 IVGYGASSTVYKCA-LKNSRPIAVKK--LYNQYPHNLREFETELETIGSIRHRNIVSLHG 679
++G GA VYK L+ +A+K+ L L+ E++ + +++H NIV G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 680 YALSPYGNLLFYDYMVNGSLWDLL--HGPSKKVKLDWETRLKIAVGAA-QGLAYLHHDCN 736
+ + +Y NGSL ++ GP E+ + + V QGLAYLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFP------ESLVAVYVYQVLQGLAYLH---E 117
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL 796
+IHRD+K++NIL ++ L+DFG+A + + V+GT ++ PE S
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 797 NEKSDVYSFGIVLLEILTGK 816
+ SD++S G ++E+LTG
Sbjct: 177 STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 71/269 (26%), Positives = 113/269 (42%), Gaps = 26/269 (9%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLRE-FETELETIGSIRHRNIVSLHGYAL 682
+G G VYK LK + +AVK + P +L+ F E E + H NIV L G +
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 683 SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHR 742
+ + + GSL L ++ + + L++++ AA G+ YL IHR
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 743 DVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT----IGYIDPEYAHTSRLNE 798
D+ + N L+ EN +SDFG++R + S G I + PE + R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD---GLKQIPIKWTAPEALNYGRYTS 174
Query: 799 KSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVR 857
+SDV+S+GI+L E + G SN E ++ + L
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSN-----------QQTRERIESGYRMPAPQLCPE- 222
Query: 858 KTFQLALLCTKRYPSERPTMQEVARVLVS 886
+ ++L L C P RP+ E+ L
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 78/282 (27%), Positives = 120/282 (42%), Gaps = 33/282 (11%)
Query: 610 DIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI 669
++ R T L +K +G G V+ +A+K L Q + F E + +
Sbjct: 2 EVPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQL 58
Query: 670 RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLA 729
+H +V L+ ++ + +YM NGSL D L P KL + +A A+G+A
Sbjct: 59 QHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGI-KLTINKLIDMAAQIAEGMA 116
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
++ IHRD++++NIL+ E ++DFG+AR I A I + PE
Sbjct: 117 FIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
Query: 790 YAHTSRLNEKSDVYSFGIVLLEILT-------GKKAVDNESNLHQLIMSKADDNTVMEAV 842
+ KSDV+SFGI+L EI+T G + NL + DN E
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE-- 231
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
++L LC K P ERPT + + VL
Sbjct: 232 ----------------LYELMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 623 IVGYGASSTVYKCALK-NSRP---IAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSL 677
++G G V + LK + +A+K L R +F TE +G H NI+ L
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
G ++ +YM NGSL L K + + G A G+ YL
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG---TIGYIDPEYAHTS 794
+HRD+ + NIL++ N +SDFG++R + + +T G I + PE
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT--KGGKIPIRWTAPEAIAYR 183
Query: 795 RLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEA-VD-PEVSVTCV 851
+ SDV+SFGIV+ E+++ G++ + SN Q ++ +D + +D P
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKAVEDGYRLPPPMDCPSA----- 236
Query: 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+QL L C ++ +ERPT ++ L ++
Sbjct: 237 -------LYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 621 KYIVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN--LREFETELETIGSIRHRNIVSL 677
+G G+ +VYK + + +A+K + P L+E E+ + IV
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVV----PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV---GAAQGLAYLHHD 734
+G + +Y GS+ D++ +K + T +IA +GL YLH
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL-----TEEEIAAILYQTLKGLEYLH-- 116
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
+ + IHRD+K+ NIL++E A L+DFG++ + M +T V+GT ++ PE
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEI 174
Query: 795 RLNEKSDVYSFGIVLLEILTGK 816
N K+D++S GI +E+ GK
Sbjct: 175 GYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNL--REFETELETIGSIRHRN 673
E + E +G GA +V KC LKN+ I K P+ ++ ELE S +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 674 IVSLHGYALSPYGNLLF--YDYMVNGSLWDLLHGPSKKVK-----LDWETRLKIAVGAAQ 726
IV +G L + + +Y GSL + KKVK + + KIA +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY----KKVKKRGGRIGEKVLGKIAESVLK 116
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
GL+YLH + +IIHRD+K SNIL+ L DFG++ + ++ A TF GT Y+
Sbjct: 117 GLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFT-GTSFYM 170
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
PE + SDV+S G+ LLE+ +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETI-------GSIRHRNIV 675
+G G+ VYK + ++ +A+K + +L E E E+E I R I
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVI------DLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
+G L + +Y GS DLL K KLD I GL YLH +
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR 795
IHRD+K++NIL+ E D L+DFG++ + + M +TFV GT ++ PE S
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSG 174
Query: 796 LNEKSDVYSFGIVLLEILTGK 816
+EK+D++S GI +E+ G+
Sbjct: 175 YDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 71/264 (26%), Positives = 120/264 (45%), Gaps = 26/264 (9%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLRE---FETELETIGSIRHRNIVSLHG 679
+VG GA V+ C K + + + K E + E + + + H NI+ +
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 680 YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739
L ++ +Y G+L + + + LD +T L V Q L LHH I
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFV---QILLALHHVHTKLI 122
Query: 740 IHRDVKSSNILIDEN-FDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE 798
+HRD+K+ NIL+D++ + DFGI++ I ++ A T V+GT YI PE N+
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYT-VVGTPCYISPELCEGKPYNQ 180
Query: 799 KSDVYSFGIVLLEILTGKKAVDNESNLHQLIMS--KADDNTVMEAVDPEVSVTCVDLSAV 856
KSD+++ G VL E+ + K+A + NL L++ + + P++
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFAPISDRYSPDLR--------- 230
Query: 857 RKTFQLALLCTKRYPSERPTMQEV 880
QL L PS+RP + ++
Sbjct: 231 ----QLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 75/277 (27%), Positives = 121/277 (43%), Gaps = 41/277 (14%)
Query: 623 IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETI-------GSIRHRNI 674
+G GA S+ Y+ +K +AVK++ + E E +E + + H +I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQV-TYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 675 VSLHGYALSPYGNLLFYDYMVNGSLWDLLH--GPSKKVKLDWETRLKIAVGAAQGLAYLH 732
+ + G LF ++M GS+ LL G K+ + + +GL+YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLH 120
Query: 733 HDCNPRIIHRDVKSSNILIDEN-FDAHLSDFGIARCIPTAMPHASTF---VLGTIGYIDP 788
+ +IIHRDVK +N+LID ++DFG A + A F +LGTI ++ P
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILTGKKA--VDNESNLHQLIMSKADDNT---VMEAVD 843
E + DV+S G V++E+ T K + SN LI A T + E +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237
Query: 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
P +R + L C + P +RP +E+
Sbjct: 238 P----------GLR---DVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 70/206 (33%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPI-AVKKLY-NQYPHNLREFETELETIGSIRHRN 673
E L E +G G S V K + + I AVK + ++ EL+ +
Sbjct: 4 EYLGE---LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 674 IVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRL--KIAVGAAQGLAY 730
IV +G A G++ + +YM GSL +L K+V+ R+ KIAV +GL Y
Sbjct: 61 IVGFYG-AFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTY 115
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY 790
LH IIHRDVK SNIL++ L DFG++ + ++ A TFV GT Y+ PE
Sbjct: 116 LHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFV-GTSSYMAPER 170
Query: 791 AHTSRLNEKSDVYSFGIVLLEILTGK 816
+ + KSD++S G+ L+E+ TG+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 60/176 (34%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 643 IAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP-YGNL-LFYDYMVNGSLW 700
+AVKKL + +LR+FE E+E + S++H NIV G S NL L +Y+ GSL
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 701 DLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLS 760
D L + +LD L A +G+ YL + R +HRD+ + NIL++ +
Sbjct: 96 DYLQ--KHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIG 150
Query: 761 DFGIARCIPTAMPHASTFVLGT--IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
DFG+ + +P + G I + PE S+ + SDV+SFG+VL E+ T
Sbjct: 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 36/293 (12%)
Query: 624 VGYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLREFETELETIGSIRHRNIVSL 677
+G GA V+ N P +AVK L + ++F+ E E + +++H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLL--HGPSKKVKLDWETR-----------LKIAVGA 724
+G ++ ++YM +G L L HGP + +D + R L IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI-PTAMPHASTFVLGTI 783
A G+ YL + +HRD+ + N L+ N + DFG++R + T + I
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAV 842
++ PE + +SDV+SFG++L EI T GK+ SN ++ V+E
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--TEVIECITQGRVLER- 246
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKL 895
P V ++ + + L C +R P +R ++E+ ++L +L A P L
Sbjct: 247 -PRV--------CPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIYL 290
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 623 IVGYGASSTVYKC-ALKNSRPIAVKKLYNQYPHN------LREFETELETIGSIRHRNIV 675
+G G VYK K +A+KK+ + +RE ++ + +RH NIV
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPNIV 61
Query: 676 SLHGYALSPYGNLLF--YDYM---VNGSLWDLLHGPSKKVKLDWETRLK-IAVGAAQGLA 729
L S ++ ++YM + G LL S +VK E+++K +GL
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTG----LLD--SPEVKFT-ESQIKCYMKQLLEGLQ 114
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
YLH + I+HRD+K SNILI+ + L+DFG+AR T + T+ Y PE
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 790 -YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+R + D++S G +L E+ GK + L QL
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 624 VGYGASSTVYKC-ALKNSRPIAVKKLYNQ--YPHNLREFETELETIGSIRHRNIVSLHGY 680
+G G VY L +AVK++ Q P ++E E++ + ++H N+V +G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 681 ALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---GLAYLHHDCNP 737
+ +F +Y G+L +LL LD I V Q GLAYLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEH---GRILDEHV---IRVYTLQLLEGLAYLHSH--- 118
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCI---PTAMPHASTFVLGTIGYIDPEYAHTS 794
I+HRD+K +NI +D N L DFG A + T M + GT Y+ PE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 795 RLNEK---SDVYSFGIVLLEILTGKKAVDNESNLHQLIM 830
+ +D++S G V+LE+ TGK+ N Q IM
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 68/275 (24%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRN 673
+++ L +G G V + + +AVK L + + F E + ++RH N
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYRG-QKVAVKCLKDD-STAAQAFLAEASVMTTLRHPN 61
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
+V L G L + +YM GSL D L + V + +L A+ +G+ YL
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEE 120
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT----IGYIDPE 789
+HRD+ + N+L+ E+ A +SDFG+A+ ++ + + + PE
Sbjct: 121 K---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--------EASQGQDSGKLPVKWTAPE 169
Query: 790 YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849
+ + KSDV+SFGI+L EI + + L ++ + MEA PE
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PHVEKGYRMEA--PE---G 223
Query: 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
C + +++ C + P++RPT +++ L
Sbjct: 224 CPP-----EVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 8/206 (3%)
Query: 621 KYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFET---ELETIGSIRHRNIVSL 677
+G G+ V+K K + + K + N RE E E + + I+
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
+ L + +Y NG L LL + L + + + GLA+LH +
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLH---SK 120
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLN 797
+I+HRD+KS N+ +D + + D G+A+ + A+T ++GT Y+ PE N
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKPYN 179
Query: 798 EKSDVYSFGIVLLEILTGKKAVDNES 823
EKSDV++ G+VL E TGK D +
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANN 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-19
Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 21/227 (9%)
Query: 608 FDDIMRSTENLSEKYIVGYGASSTVYKCALKN---SRPIAVKKLYNQY--PHNLREFETE 662
F + T + VG GA V C+ ++ + +A+KK+ + P + E
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLV--CSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE 59
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLH-GPSKKVKLDWETRLKIA 721
L+ + +RH NI+SL +SP ++ F ++ L LL P +K + +
Sbjct: 60 LKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-----FL 114
Query: 722 VGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG 781
+GL Y+H + ++HRD+K SNILI+EN D + DFG+AR P + +V
Sbjct: 115 YQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYV-S 167
Query: 782 TIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQ 827
T Y PE T + + + D++S G + E+L GK + +++Q
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 75/271 (27%), Positives = 122/271 (45%), Gaps = 31/271 (11%)
Query: 623 IVGYGASSTVYKCA-LKNSRPIAVKKLY--NQYPHNLRE---FETELETIGSIRHRNIVS 676
++G GA VY C + R +AVK++ P +E E E++ + +++H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 677 LHGYALSPYGNLLFYDYMVNGSLWDLL--HGP-SKKVKLDWETRLKIAVGAAQGLAYLHH 733
+G +F +YM GS+ D L +G ++ V TR K +G+ YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV-----TR-KYTRQILEGVEYLHS 122
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF--VLGTIGYIDPEYA 791
+ I+HRD+K +NIL D + L DFG ++ + T + V GT ++ PE
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 792 HTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851
K+DV+S G ++E+LT K E I A T + + VS
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPW-AEFEAMAAIFKIATQPTNPQ-LPSHVSPDAR 237
Query: 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVAR 882
+ +R+TF +RP+ +E+ R
Sbjct: 238 NF--LRRTF-------VENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 65/262 (24%), Positives = 115/262 (43%), Gaps = 19/262 (7%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS 683
+G G V+ + +A+K + + + +F E + + + H N+V L+G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 684 PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRD 743
+ +YM NG L + L +K KL E L + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR--ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 744 VKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVY 803
+ + N L+ E+ +SDFG+AR + +S + + PE SR + KSDV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 804 SFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQL 862
SFG+++ E+ + GK + SN V+E+V + L A + + +
Sbjct: 186 SFGVLMWEVFSEGKMPYERFSNSE-----------VVESVSAGYRLYRPKL-APTEVYTI 233
Query: 863 ALLCTKRYPSERPTMQEVARVL 884
C P +RP +++ L
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 622 YIVGYGASSTVYKCALKNSRPIAVKKLYNQY----PHNLREFETELETIGSIRHRNIVSL 677
++G GA V ++++ + K N+ ++R E + + H +V+L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 678 HGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI-AVGAAQGLAYLHHDC 735
Y+ N+ L D ++ G DL + S+KVK E ++K L YLH
Sbjct: 66 W-YSFQDEENMYLVVDLLLGG---DLRYHLSQKVKFS-EEQVKFWICEIVLALEYLH--- 117
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR 795
+ IIHRD+K NIL+DE H++DF IA + +T GT GY+ PE
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPEVLCRQG 175
Query: 796 LNEKSDVYSFGIVLLEILTGKKAVDNESN 824
+ D +S G+ E L GK+ S
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 61/226 (26%), Positives = 94/226 (41%), Gaps = 46/226 (20%)
Query: 623 IVGYGASSTVYKCALK-NSRPIAVKKL-------YNQYPHNLREFETELETIGSIRHRNI 674
I+G G+ STV K ++ A+K L + + E E G H I
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG---HPGI 64
Query: 675 VSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---GLAY 730
+ L+ NL F +Y NG L + K LD + A A+ L Y
Sbjct: 65 IKLYYTFQDE-ENLYFVLEYAPNGELLQYIR---KYGSLDEKCTRFYA---AEILLALEY 117
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR--------------------CIPT 770
LH + IIHRD+K NIL+D++ ++DFG A+ I
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
++FV GT Y+ PE + + SD+++ G ++ ++LTGK
Sbjct: 175 NRRRFASFV-GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 33/297 (11%)
Query: 617 NLSEKYIVGYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLREFETELETIGSIR 670
N+ K +G GA V+ N P +AVK L + + ++F E E + +++
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL--HGP--------SKKVKLDWETRLKI 720
H +IV +G + ++ ++YM +G L L HGP ++ +L L I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI-PTAMPHASTFV 779
A A G+ YL + +HRD+ + N L+ EN + DFG++R + T
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTV 838
+ I ++ PE + +SDV+S G+VL EI T GK+ SN N V
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----------NEV 231
Query: 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKL 895
+E + + V + ++ + L L C +R P R ++E+ +L +L A P L
Sbjct: 232 IECIT-QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVYL 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 78/273 (28%), Positives = 121/273 (44%), Gaps = 25/273 (9%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNL--REFETELETIGSIRHRN 673
E+L +G G V+ + +A+K L P + F E + + +RH
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDK 62
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLL-HGPSKKVKLDWETRLKIAVGAAQGLAYLH 732
+V L+ +S + ++M GSL D L G K +KL + +A A G+AY+
Sbjct: 63 LVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIE 119
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH 792
IHRD++++NIL+ +N ++DFG+AR I A I + PE A
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 793 TSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851
R KSDV+SFGI+L E++T G+ N V+E V+ + C
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-----------REVLEQVERGYRMPCP 225
Query: 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+L LC K+ P ERPT + + L
Sbjct: 226 Q-GCPESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 76/265 (28%), Positives = 119/265 (44%), Gaps = 21/265 (7%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNL--REFETELETIGSIRHRN 673
E+L + +G G V+ + +A+K L P + F E + + +RH
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEK 62
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
+V L+ +S + +YM GSL D L G K L + +A A G+AY+
Sbjct: 63 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER 120
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
+HRD++++NIL+ EN ++DFG+AR I A I + PE A
Sbjct: 121 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853
R KSDV+SFGI+L E LT K V +++ ++ + + M PE + D
Sbjct: 178 GRFTIKSDVWSFGILLTE-LTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHD- 234
Query: 854 SAVRKTFQLALLCTKRYPSERPTMQ 878
L C ++ P ERPT +
Sbjct: 235 --------LMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 33/283 (11%)
Query: 618 LSEKYIVGYGASSTVYKCALKNS----RPIAVKKLYNQYPHNLR-EFETELETIGSIRHR 672
++++ ++G G V++ LK +A+K L Y R +F +E +G H
Sbjct: 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH 66
Query: 673 NIVSLHGYALSPYGNLLFYDYMVNGSLWDLLH---GPSKKVKLDWETRLKIAVGAAQGLA 729
NI+ L G ++ +YM NG+L L G +L R G A G+
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMK 121
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG---TIGYI 786
YL + +HRD+ + NIL++ N + +SDFG++R + P + G I +
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD-PEGTYTTSGGKIPIRWT 177
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845
PE + SDV+SFGIV+ E+++ G++ + SN +M +D + A
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGFRLPA---- 231
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ C SAV +QL L C ++ + RP ++ +L LL
Sbjct: 232 -PMDCP--SAV---YQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 78/276 (28%), Positives = 121/276 (43%), Gaps = 20/276 (7%)
Query: 610 DIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI 669
+I R + L +K +G G V+ NS +AVK L +++ F E + ++
Sbjct: 2 EIPRESIKLVKK--LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTL 58
Query: 670 RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLA 729
+H +V L+ + +YM GSL D L K+ + + A+G+A
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMA 117
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
Y+ IHRD++++N+L+ E+ ++DFG+AR I A I + PE
Sbjct: 118 YIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
Query: 790 YAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848
+ KSDV+SFGI+L EI+T GK SN +MS M P +
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGYRM----PRMEN 228
Query: 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+L + KT C K ERPT + VL
Sbjct: 229 CPDELYDIMKT------CWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 66/227 (29%), Positives = 100/227 (44%), Gaps = 24/227 (10%)
Query: 656 LREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL--HGPSKKVKLD 713
+++ E E+ + ++H NIV G +F + + GSL LL +G + +
Sbjct: 46 VKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIR 105
Query: 714 WETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773
TR + GL YLH + +HRD+K +NIL+D N L+DFG+A+ +
Sbjct: 106 LYTRQILL-----GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFS 156
Query: 774 HASTFVLGTIGYIDPEY-AHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSK 832
A +F G+ ++ PE A +D++S G +LE+ TGK QL
Sbjct: 157 FAKSFK-GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP------WSQLEGVA 209
Query: 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQE 879
A P + LS K F L C +R PS RPT E
Sbjct: 210 AVFKIGRSKELPPIP---DHLSDEAKDF--ILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-18
Identities = 78/302 (25%), Positives = 127/302 (42%), Gaps = 51/302 (16%)
Query: 623 IVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSLHGY 680
+G GA TVYK + R A+K +Y + +R + E+E + + H N+V H
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 681 ALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLK-IAVGAAQGLAYLHHDCNPR 738
G + + ++M GSL + + E L +A G+AYLH
Sbjct: 141 -FDHNGEIQVLLEFMDGGSL--------EGTHIADEQFLADVARQILSGIAYLHRR---H 188
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE 798
I+HRD+K SN+LI+ + ++DFG++R + M ++ V GTI Y+ PE +T LN
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTD-LNH 246
Query: 799 ------KSDVYSFGIVLLEILTGK------KAVDNESNLHQLIMSKADDNTVMEAVDPEV 846
D++S G+ +LE G+ + D S + + MS+ PE
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP----------PEA 296
Query: 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQE------VARVLVSLLPAPPAKLSLAAP 900
T A R+ C +R P++R + + + R P L P
Sbjct: 297 PAT-----ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPP 351
Query: 901 KP 902
Sbjct: 352 PR 353
|
Length = 353 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 66/240 (27%), Positives = 111/240 (46%), Gaps = 37/240 (15%)
Query: 653 PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHG------ 705
P E E+ + +++H NIV + + GNL + DY G L+ ++
Sbjct: 40 PKEREESRKEVAVLSNMKHPNIVQ-YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF 98
Query: 706 PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765
P ++ LDW ++ +A L H + +I+HRD+KS NI + ++ L DFGIA
Sbjct: 99 PEDQI-LDWFVQICLA---------LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIA 148
Query: 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL 825
R + + + A T +GT Y+ PE N KSD+++ G VL E+ T K A + N+
Sbjct: 149 RVLNSTVELART-CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE-AGNM 206
Query: 826 HQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCT---KRYPSERPTMQEVAR 882
L++ ++ P VS ++ L L + KR P +RP++ +
Sbjct: 207 KNLVLK------IIRGSYPPVS--------SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 25/272 (9%)
Query: 610 DIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNL--REFETELETIG 667
+I R + L +K +G G V+ + +AVK L P + F E + +
Sbjct: 2 EIPRESLQLIKK--LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMK 56
Query: 668 SIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLH-GPSKKVKLDWETRLKIAVGAAQ 726
+RH +V L+ +S + +YM GSL D L G + +KL + +A A
Sbjct: 57 KLRHDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAA 113
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
G+AY+ IHRD++S+NIL+ + ++DFG+AR I A I +
Sbjct: 114 GMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846
PE A R KSDV+SFGI+L E++T + + ++ V+E V+
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR----------VPYPGMNNREVLEQVERGY 220
Query: 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQ 878
+ C + +L L C K+ P ERPT +
Sbjct: 221 RMPCPQDCPI-SLHELMLQCWKKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 71/264 (26%), Positives = 120/264 (45%), Gaps = 26/264 (9%)
Query: 623 IVGYGA--SSTVYKCALKNSRPIAVKK--LYNQYPHNLREFETELETIGSIRHRNIVSLH 678
++G GA +T+Y+ +S + K+ L R+ E+ + ++H NI++ +
Sbjct: 7 VLGKGAFGEATLYRRTEDDSL-VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR 738
+ + L+ +Y G+L+D + K + E L ++Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE 798
I+HRD+K+ NI + + L DFGI++ + + A T V+GT Y+ PE + N
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNF 180
Query: 799 KSDVYSFGIVLLEILTGKKAVD--NESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856
KSD+++ G VL E+LT K+ D N NL I+ P VSV +L
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--------NYTPVVSVYSSELI-- 230
Query: 857 RKTFQLALLCTKRYPSERPTMQEV 880
L ++ P +RPT EV
Sbjct: 231 ----SLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSLHGYA 681
++G G V+K LK+ P+AVK P L+ +F +E + H NIV L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 682 LSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH-HDCNPRII 740
+ + + G L KK +L + +K A+ AA G+AYL +C I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR--KKKDELKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 741 HRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKS 800
HRD+ + N L+ EN +SDFG++R + +S I + PE + R + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 801 DVYSFGIVLLEILT 814
DV+S+GI+L E +
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 47/166 (28%), Positives = 88/166 (53%), Gaps = 13/166 (7%)
Query: 662 ELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL--HGPSKKVKLDWETRLK 719
E+ET+ + H NIV G+ + +F +Y+ GS+ L +G ++ + + T
Sbjct: 58 EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV 117
Query: 720 IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV 779
+ +GLAYLH + I+HRD+K+ N+L+D + +SDFGI++ +
Sbjct: 118 L-----EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169
Query: 780 L-GTIGYIDPEYAHTSR--LNEKSDVYSFGIVLLEILTGKKAVDNE 822
+ G++ ++ PE H+ + K D++S G V+LE+ G++ +E
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 20/197 (10%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYAL 682
+G G VYK + + K+ P + + E+ + RH NIV+ G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 683 SPYGNLLF--YDYMVNGSLWDLLH---GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
+ L+ +Y GSL D+ GP ++++ + R +GLAYLH
Sbjct: 71 R--RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHET--- 120
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYA---HTS 794
IHRD+K +NIL+ E+ D L+DFG++ + + +F+ GT ++ PE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKG 179
Query: 795 RLNEKSDVYSFGIVLLE 811
+ K D+++ GI +E
Sbjct: 180 GYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 35/280 (12%)
Query: 621 KYIVGYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLREFETELETIGSIRHRNI 674
K+ +G GA V+ N P +AVK L ++F+ E E + ++H++I
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 675 VSLHGYALSPYGNLLFYDYMVNGSLWDLL--HGPSKKV----------KLDWETRLKIAV 722
V +G L+ ++YM +G L L HGP K+ +L L IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI-PTAMPHASTFVLG 781
A G+ YL + +HRD+ + N L+ + + DFG++R I T +
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 782 TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVME 840
I ++ PE + +SD++SFG+VL EI T GK+ +QL ++A + + +
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP------WYQLSNTEAIE-CITQ 239
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ E TC + + + C +R P +R ++++
Sbjct: 240 GRELERPRTCPP-----EVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNL------REFETELETIGSIRHRNIV 675
++G GA TVY C L N + IAVK++ + L + + E++ + S++H NIV
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLH--GPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
G L +F +++ GS+ +L+ GP + T+ + G+AYLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS-----TFVLGTIGYIDP 788
+C ++HRD+K +N+++ N L DFG AR + H + + GT ++ P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848
E + S KSD++S G + E+ TGK + + L + +M + S
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-AAMFYIGAHRGLMPRLPDSFSA 236
Query: 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVAR 882
+D V C R ERP+ ++ R
Sbjct: 237 AAIDF--VT-------SCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 624 VGYGASSTVYKCAL------KNSRPIAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVS 676
+G GA VYK L ++ +A+K L ++ EF E E + ++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 677 LHGYALSPYGNLLFYDYMVNGSLWDLL--HGPSKKVK-----------LDWETRLKIAVG 723
L G + ++Y+ +G L + L + P V LD L IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 724 AAQGLAYL--HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA----MPHAST 777
A G+ YL HH +HRD+ + N L+ E +SDFG++R I +A + S
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS- 186
Query: 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEI 812
L + ++ PE + +SD++SFG+VL EI
Sbjct: 187 --LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 610 DIMRSTENLSEKYI--VGYGASSTVYKCALKNSRPIAVKKLYNQYP-HNLREFETELETI 666
DI+R + I VG G VYK ++ +A K+ P + + E+ +
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60
Query: 667 GSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLH--GPSKKVKLDWETRLKIAVGA 724
+H NIV+ G LS + +Y GSL D+ H GP ++++ + R +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---- 116
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIG 784
QGLAYLH +HRD+K +NIL+ +N D L+DFG+A I + +F+ GT
Sbjct: 117 -QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPY 171
Query: 785 YIDPEYAHTSR---LNEKSDVYSFGIVLLEI 812
++ PE A + N+ D+++ GI +E+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 668 SIRHRNIVSLHGYALSPYGNLLF--YDYMVNGSLWDLL-HGPSKKVKLDWETRLKIAVGA 724
++H NIV + + L+ +Y G L L+ ++ ++ E +I
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 725 AQGLAYLHH--DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT 782
L H+ D ++HRD+K +NI +D N + L DFG+A+ + A T+V GT
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
Query: 783 IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
Y+ PE + +EKSD++S G ++ E+
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 30/170 (17%)
Query: 399 LDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS 458
+D L L G +P I L HL ++NLS N + G +P G++ S++ +D+S+N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 459 GSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRF 518
GSIP LGQL ++ L LN N+L G +P L R R
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGG---------------------RLLHRA 518
Query: 519 SSNSFIGNPLLCGNWIGSI--CGPSVT---KARVMFSRT-AVVCMVLGFI 562
S N F N LCG I + CGP ++ K + F + A + +V+ +
Sbjct: 519 SFN-FTDNAGLCG--IPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAM 565
|
Length = 623 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCAL-----KNSRPIAVKKLYNQY-PHNLREFETELE 664
I++ TE L + ++G GA TVYK K P+A+K L + P +E E
Sbjct: 3 ILKETE-LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61
Query: 665 TIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ S+ H ++V L G LS L M G L D + K + + L V
Sbjct: 62 VMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQI 118
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT----------AMPH 774
A+G++YL R++HRD+ + N+L+ ++DFG+A+ + +P
Sbjct: 119 AKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP- 174
Query: 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDN 821
I ++ E KSDV+S+G+ + E++T G K +
Sbjct: 175 --------IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 11/171 (6%)
Query: 643 IAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL-LFYDYMVNGSLWD 701
+AVK + N + F E + +RH N+V L G + G L + +YM GSL D
Sbjct: 32 VAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 89
Query: 702 LLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSD 761
L + V L + LK ++ + + YL + +HRD+ + N+L+ E+ A +SD
Sbjct: 90 YLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSD 145
Query: 762 FGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEI 812
FG+ + + + + PE + + KSDV+SFGI+L EI
Sbjct: 146 FGLTKEASSTQDTGKL----PVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHG-- 679
++G G VYK K + + K+ + E + E + H NI + +G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 680 YALSPYGN----LLFYDYMVNGSLWDL---LHGPSKKVKLDWETRLKIAV---GAAQGLA 729
+P GN L + GS+ DL L K++K +W IA +GLA
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGLA 127
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
YLH ++IHRD+K NIL+ +N + L DFG++ + + + +TF+ GT ++ PE
Sbjct: 128 YLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPE 183
Query: 790 ---------YAHTSRLNEKSDVYSFGIVLLEILTGK 816
++ +R SDV+S GI +E+ GK
Sbjct: 184 VIACDEQPDASYDAR----SDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 75/270 (27%), Positives = 118/270 (43%), Gaps = 27/270 (10%)
Query: 624 VGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSLHGYA 681
+G G V+ L+ ++ P+AVK P +L+ +F E + H NIV L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 682 LSPYGNLLFYDYMVNGSLWDLLH--GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739
+ + + G L GP KVK +++ AA G+ YL
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVK----ELIQMVENAAAGMEYLESKH---C 115
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTI--GYIDPEYAHTSRLN 797
IHRD+ + N L+ E +SDFG++R + +AST + I + PE + R +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGV-YASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 798 EKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856
+SDV+SFGI+L E + G N SN EA++ V + C +L
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSN-----------QQTREAIEQGVRLPCPELCP- 222
Query: 857 RKTFQLALLCTKRYPSERPTMQEVARVLVS 886
++L C + P +RP+ V + L S
Sbjct: 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 59/243 (24%), Positives = 109/243 (44%), Gaps = 19/243 (7%)
Query: 643 IAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDL 702
+A+K + N+ + +F E + + + H +V L+G + ++M NG L +
Sbjct: 31 VAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY 89
Query: 703 LHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDF 762
L ++ KL + L + +G+ YL + IHRD+ + N L+ +SDF
Sbjct: 90 LR--QRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDF 144
Query: 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDN 821
G+ R + +S+ + + PE + S+ + KSDV+SFG+++ E+ T GK +
Sbjct: 145 GMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204
Query: 822 ESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVA 881
+SN V+E + + L A +++ C P RPT E+
Sbjct: 205 KSNYE-----------VVEMISRGFRLYRPKL-ASMTVYEVMYSCWHEKPEGRPTFAELL 252
Query: 882 RVL 884
R +
Sbjct: 253 RAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 70/236 (29%), Positives = 106/236 (44%), Gaps = 38/236 (16%)
Query: 662 ELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKV-KLDWETRLKI 720
EL+ + R IVS +G L+ + ++M GSL KK + E KI
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL----DRIYKKGGPIPVEILGKI 108
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AV +GL YL++ RI+HRD+K SNIL++ L DFG++ + ++ A TFV
Sbjct: 109 AVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFV- 163
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK-------KAVDNESN-------LH 826
GT Y+ PE + KSDV+S GI ++E+ GK D + + L
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ 223
Query: 827 QLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVAR 882
Q++ + + PE VD C + P+ERPT Q++
Sbjct: 224 QIVQEPPP--RLPSSDFPEDLRDFVD------------ACLLKDPTERPTPQQLCA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 18/272 (6%)
Query: 615 TENLSEKYIVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRN 673
+ E+ ++G G VY L IA+K++ + ++ E+ ++HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
IV G +F + + GSL LL +K + +T + +GL YLH
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 734 DCNPRIIHRDVKSSNILIDENFDA-HLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYA- 791
+ +I+HRD+K N+L++ +SDFG ++ + P TF GT+ Y+ PE
Sbjct: 127 N---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYMAPEVID 182
Query: 792 HTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850
R +D++S G ++E+ TGK E Q M K M + PE+ +
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPF-IELGEPQAAMFKVG----MFKIHPEIPES- 236
Query: 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVAR 882
LSA K F L C + P +R + ++ +
Sbjct: 237 --LSAEAKNFILR--CFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 29/259 (11%)
Query: 638 KNSRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696
K P+A+K L Y R+F +E +G H NI+ L G ++ +YM N
Sbjct: 30 KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMEN 89
Query: 697 GSLWDLLH---GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE 753
GSL L G ++L + + G A G+ YL + +HRD+ + NIL++
Sbjct: 90 GSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKYL---SDMGYVHRDLAARNILVNS 141
Query: 754 NFDAHLSDFGIARCIPTAMPHASTFVLGTIG--YIDPEYAHTSRLNEKSDVYSFGIVLLE 811
N +SDFG++R + A T G I + PE + SDV+S+GIV+ E
Sbjct: 142 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 201
Query: 812 ILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC-VDLSAVRKTFQLALLCTKR 869
+++ G++ SN V++A++ + +D A QL L C ++
Sbjct: 202 VMSYGERPYWEMSN-----------QDVIKAIEEGYRLPAPMDCPAA--LHQLMLDCWQK 248
Query: 870 YPSERPTMQEVARVLVSLL 888
+ERP +++ +L L+
Sbjct: 249 DRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-15
Identities = 38/82 (46%), Positives = 52/82 (63%)
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
L G IP+ L L +NLS N+ +G +P LG I +L+ LDLS N+F+GS+P S+G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 421 EHLLTLNLSRNHLNGLLPAEFG 442
L LNL+ N L+G +PA G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-15
Identities = 73/269 (27%), Positives = 122/269 (45%), Gaps = 35/269 (13%)
Query: 624 VGYGASSTVYKCALKNSRPI-AVKKLY---NQYPHNLREFETELETIGSIRHRNIVSLHG 679
+G+G+ VY ++ + AVKK+ Q ++ E++ + ++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 680 YALSPYGNLLFYDYMVNGSLWDLLH---GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCN 736
L + L +Y + GS DLL P ++V++ I GA QGLAYLH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYLHSHN- 141
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY---AHT 793
+IHRD+K+ NIL+ E L+DFG A + A++FV GT ++ PE
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSA----SKSSPANSFV-GTPYWMAPEVILAMDE 194
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853
+ + K DV+S GI +E+ K + N + + L +D+ +++ + S
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR---- 250
Query: 854 SAVRKTFQLALLCTKRYPSERPTMQEVAR 882
C ++ P ERP E+ R
Sbjct: 251 -------GFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 54/172 (31%), Positives = 78/172 (45%), Gaps = 30/172 (17%)
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778
KIAV + L YLH + +IHRDVK SN+LI+ N L DFGI+ + ++ A T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTI 162
Query: 779 VLGTIGY-----IDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKA 833
G Y I+PE + + KSDV+S GI ++E+ TG+ D+ Q +
Sbjct: 163 DAGCKPYMAPERINPE-LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL---- 217
Query: 834 DDNTVMEAVDPEV-----SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
V+E P++ S D C K+ ERP E+
Sbjct: 218 --KQVVEEPSPQLPAEKFSPEFQDFVNK---------CLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-15
Identities = 44/118 (37%), Positives = 58/118 (49%), Gaps = 9/118 (7%)
Query: 22 NSDFCS-----WRGVFC---DNSSLSVVS-LNLSSLNLGGEISPSIGDLRNLQSIDFQGN 72
N D C W G C + L L + L G I I LR+LQSI+ GN
Sbjct: 393 NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGN 452
Query: 73 KLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTL 130
+ G IP +G+ SL ++LS NS G IP S+ +L L LNL N L+G +P+ L
Sbjct: 453 SIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 23/268 (8%)
Query: 617 NLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIV 675
+++ K+ +G G VY+ K S +AVK L + + EF E + I+H N+V
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
L G + ++M G+L D L +++ +++ L +A + + YL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK- 123
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP--TAMPHA-STFVLGTIGYIDPEYAH 792
IHRD+ + N L+ EN ++DFG++R + T HA + F I + PE
Sbjct: 124 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKWTAPESLA 178
Query: 793 TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852
++ + KSDV++FG++L EI T + +L Q + + ME PE
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMER--PEGCPP--- 232
Query: 853 LSAVRKTFQLALLCTKRYPSERPTMQEV 880
K ++L C + PS+RP+ E+
Sbjct: 233 -----KVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 32/204 (15%)
Query: 625 GYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS 683
G GA VYK K A K + + L +F E++ + +H NIV L+
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE---- 69
Query: 684 PYGNLLFYDYMVNGSLWDLLH----GPSKKVKLDWETRLK---IAVGAAQ---GLAYLHH 733
Y LW L+ G + L+ E L I Q L +LH
Sbjct: 70 --------AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH- 120
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY--A 791
+ ++IHRD+K+ NIL+ + D L+DFG++ + + TF+ GT ++ PE
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVAC 177
Query: 792 HTSR---LNEKSDVYSFGIVLLEI 812
T + + K+D++S GI L+E+
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 44/272 (16%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLH----G 679
+G G+ V+K ++ + K+ + L E E E+E I + I L
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDI----QQEITVLSQCDSP 62
Query: 680 YALSPYGNLL-------FYDYMVNGSLWDLLH-GPSKKVKLDWETRLKIAVGAAQGLAYL 731
Y YG+ L +Y+ GS DLL GP + ++ T LK + +GL YL
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI--ATMLKEIL---KGLDYL 117
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYA 791
H + + IHRD+K++N+L+ E D L+DFG+A + +TFV GT ++ PE
Sbjct: 118 HSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 173
Query: 792 HTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851
S + K+D++S GI +E+ G+ S++H + V+ + T
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPP---NSDMHPM--------RVLFLIPKNNPPTLT 222
Query: 852 -DLSAVRKTFQLALLCTKRYPSERPTMQEVAR 882
+ S K F A C + PS RPT +E+ +
Sbjct: 223 GEFSKPFKEFIDA--CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 24/228 (10%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLY---NQYPHNLREFETELETIGSIRHRNIVSLHG 679
+G+G+ VY ++NS +A+KK+ Q ++ E+ + +RH N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 680 YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV---GAAQGLAYLHHDCN 736
L + L +Y + GS DLL K ++ ++IA GA QGLAYLH +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ-----EVEIAAVTHGALQGLAYLH---S 133
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY---AHT 793
+IHRDVK+ NIL+ E L DFG A + M A+ FV GT ++ PE
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANXFV-GTPYWMAPEVILAMDE 188
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA 841
+ + K DV+S GI +E+ K + N + + L +++ +++
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 81/317 (25%), Positives = 134/317 (42%), Gaps = 66/317 (20%)
Query: 616 ENLSEKYIVGYGASSTVYKCALK---NSRPIAVKKLYNQYPHN-LREFETELETIGSI-R 670
E++ + ++G G V + +K A+K L N R+F ELE + +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 671 HRNIVSL------HGY-----ALSPYGNLLFYDYMVNGSLWDL------LHGPSKKVKLD 713
H NI++L GY +PYGNLL D++ + + HG + L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLL--DFLRKSRVLETDPAFAKEHGTAST--LT 117
Query: 714 WETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773
+ L+ A A G+ YL + IHRD+ + N+L+ EN + ++DFG++R
Sbjct: 118 SQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR------- 167
Query: 774 HASTFVLGTIGYIDPEYAHTSRLN-----EKSDVYSFGIVLLEILT-------GKKAVDN 821
+V T+G + + LN KSDV+SFG++L EI++ G +
Sbjct: 168 GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL 227
Query: 822 ESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVA 881
L Q + N D EV ++L C + P ERP +++
Sbjct: 228 YEKLPQGYRMEKPRN-----CDDEV-------------YELMRQCWRDRPYERPPFAQIS 269
Query: 882 RVLVSLLPAPPAKLSLA 898
L +L A A +++A
Sbjct: 270 VQLSRMLEARKAYVNMA 286
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 614 STENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKL-YNQYPHNLREFETELETIGSIRH 671
+ E+L + +G GA TV K K S +AVK++ + +L+ + +R
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRS 59
Query: 672 RN---IVSLHGYALSPYGNLLFYDYMVNGSL---WDLLHGPSKKVKLDWETRLKIAVGAA 725
+ IV +G AL G+ +++ SL + ++ K + E KIAV
Sbjct: 60 SDCPYIVKFYG-ALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVATV 117
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY 785
+ L YL + IIHRDVK SNIL+D N + L DFGI+ + ++ A T G Y
Sbjct: 118 KALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--AKTRDAGCRPY 173
Query: 786 IDPEYAHTSRLNE---KSDVYSFGIVLLEILTGK 816
+ PE S + +SDV+S GI L E+ TGK
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-14
Identities = 41/103 (39%), Positives = 61/103 (59%), Gaps = 1/103 (0%)
Query: 330 LNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKV 389
L L + L G IP++IS L N+ GN + G IP S ++ SL L+LS N+F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 390 PTELGRIINLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRN 431
P LG++ +L L+L+ N+ SG VPA++G L H + N + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 616 ENLSEKYIVGYGASSTVYKC-ALKNSRPIAVKKL-----YNQYPHNLREFETELETIGSI 669
N ++G GA VY C R +AVK++ + + E E++ + ++
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 670 RHRNIVSLHGYALSPYGNLL--FYDYMVNGSLWDLL--HGP-SKKVKLDWETRLKIAVGA 724
RH IV +G P L F +YM GS+ D L +G ++ V + ++
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------ 115
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF--VLGT 782
QG++YLH + I+HRD+K +NIL D + L DFG ++ I T + V GT
Sbjct: 116 LQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 783 IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
++ PE K+DV+S ++E+LT K
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFET---ELETIGSIRHRNIVSLHG 679
+G G+ +Y K+ V K + ++E E E+ + ++H NIV+
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 680 YALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR 738
+ G L + +Y G L ++ + V + L V + GL ++H + +
Sbjct: 67 -SFQENGRLFIVMEYCDGGDLMKRIN-RQRGVLFSEDQILSWFVQISLGLKHIH---DRK 121
Query: 739 IIHRDVKSSNILIDEN-FDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLN 797
I+HRD+KS NI + +N A L DFGIAR + +M A T V GT Y+ PE N
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQNRPYN 180
Query: 798 EKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM 830
K+D++S G VL E+ T K + +NLHQL++
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEG-NNLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 78/307 (25%), Positives = 121/307 (39%), Gaps = 67/307 (21%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRH---R 672
++ + +G G V K + S I +KL LE +IR+ R
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKL------------IHLEIKPAIRNQIIR 48
Query: 673 NIVSLHG----YALSPYGNLLFYD---------YMVNGSLWDLLHGPSKKVKLDWETRL- 718
+ LH Y + YG FY +M GSL +L KK E L
Sbjct: 49 ELKVLHECNSPYIVGFYGA--FYSDGEISICMEHMDGGSLDQVL----KKAGRIPENILG 102
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778
KI++ +GL YL +I+HRDVK SNIL++ + L DFG++ + +M A++F
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSF 158
Query: 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838
V GT Y+ PE + +SD++S G+ L+E+ G+ + M +
Sbjct: 159 V-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSE- 216
Query: 839 MEAVDPEVSVTCVDLSAVRKTFQLALL--------------------------CTKRYPS 872
EA + V+ + R LL C K+ P
Sbjct: 217 GEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPK 276
Query: 873 ERPTMQE 879
ER ++E
Sbjct: 277 ERADLKE 283
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 55/226 (24%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 658 EFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETR 717
EF E + + + H +V L+G + +YM NG L + L K+ +
Sbjct: 45 EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQL 102
Query: 718 LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777
L++ +G+AYL + + IHRD+ + N L+D+ +SDFG++R + + T
Sbjct: 103 LEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV---LDDEYT 156
Query: 778 FVLGT---IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD 834
+G+ + + PE S+ + KSDV++FG+++ E+ + L ++ + +
Sbjct: 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS----------LGKMPYERFN 206
Query: 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
++ +E V + + L A K + + C ERPT Q++
Sbjct: 207 NSETVEKVSQGLRLYRPHL-ASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 61/203 (30%), Positives = 87/203 (42%), Gaps = 24/203 (11%)
Query: 624 VGYGASSTVYKCALKNS-RPIAVKKL-------YNQYPHNLREFETELETIGSIRHRNIV 675
+G G V +K+ R A+K + Q H E E E H IV
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE----CNHPFIV 56
Query: 676 SLH-GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLD-WETRLKIAVGAAQGLAYLHH 733
L+ + Y +L +Y + G LW +L + D + R IA YLH
Sbjct: 57 KLYRTFKDKKYIYMLM-EYCLGGELWTILR---DRGLFDEYTARFYIA-CVVLAFEYLH- 110
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
N II+RD+K N+L+D N L DFG A+ + + TF GT Y+ PE
Sbjct: 111 --NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-QKTWTFC-GTPEYVAPEIILN 166
Query: 794 SRLNEKSDVYSFGIVLLEILTGK 816
+ D +S GI+L E+LTG+
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 76/280 (27%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKL-YN--QYPHNLREFETELETIGSIRHRNIVSLHG 679
+G+G+ VY ++ + +A+KK+ Y+ Q ++ E+ + +RH N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 680 YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV---GAAQGLAYLHHDCN 736
L + L +Y + GS D+L K ++ ++IA GA QGLAYLH
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVHKKPLQ-----EVEIAAICHGALQGLAYLHSHER 136
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY---AHT 793
IHRD+K+ NIL+ E L+DFG A + + A++FV GT ++ PE
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSA----SLVSPANSFV-GTPYWMAPEVILAMDE 188
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD-PEVSVTCVD 852
+ + K DV+S GI +E+ K + N + + L +D+ + + D + VD
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVD 248
Query: 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892
C ++ P +RP+ +E+ + L PP
Sbjct: 249 ------------SCLQKIPQDRPSSEELLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 71/267 (26%), Positives = 116/267 (43%), Gaps = 34/267 (12%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS 683
+G G+ VYK ++ + K+ + L E E E+E I + +++ S
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDI-----QQEITVLSQCDS 61
Query: 684 PYGNLLFYDYMVNGSLW---DLLHGPS-----KKVKLDWETRLKIAVGAAQGLAYLHHDC 735
PY + Y+ LW + L G S K L+ I +GL YLH +
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR 795
R IHRD+K++N+L+ E D L+DFG+A + +TFV GT ++ PE S
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177
Query: 796 LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855
+ K+D++S GI +E+ G+ + + L + + +E S
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG----------QYSK 227
Query: 856 VRKTFQLALLCTKRYPSERPTMQEVAR 882
K F A C + P RPT +E+ +
Sbjct: 228 PFKEFVEA--CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 69/271 (25%), Positives = 125/271 (46%), Gaps = 19/271 (7%)
Query: 624 VGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G G++ V K++ + +AVKK+ + E+ + H N+V ++ L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 683 SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHR 742
+ +++ G+L D++ +++ E + + + L+YLH N +IHR
Sbjct: 90 VGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLH---NQGVIHR 142
Query: 743 DVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDV 802
D+KS +IL+ + LSDFG + +P + V GT ++ PE + D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDI 201
Query: 803 YSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQL 862
+S GI+++E++ G+ NE L M + DN + P V + S +R L
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQA--MRRIRDN-----LPPRVKDSHKVSSVLRGFLDL 254
Query: 863 ALLCTKRYPSERPTMQEVARVLVSLLPAPPA 893
L+ R PS+R T QE+ + L PP+
Sbjct: 255 MLV---REPSQRATAQELLQHPFLKLAGPPS 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (185), Expect = 2e-14
Identities = 62/219 (28%), Positives = 91/219 (41%), Gaps = 27/219 (12%)
Query: 623 IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN------LREFETELETIGSIRHRNIV 675
+G G VYK K +A+KK+ LRE E ++H NIV
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKE----LKHPNIV 61
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
L + L ++Y + L L + L I +GLAY H
Sbjct: 62 KLLDVIHTERKLYLVFEYC-DMDLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAYCHSH- 117
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR 795
RI+HRD+K NILI+ + L+DFG+AR + + V+ T+ Y PE
Sbjct: 118 --RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEIL---- 170
Query: 796 LNEKS-----DVYSFGIVLLEILTGKKAVDNESNLHQLI 829
L K D++S G + E++TGK +S + QL
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 31/280 (11%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLY---NQYPHNLREFETELETIGSIRHRNIVSLHG 679
+G+G+ VY ++ + +A+KK+ Q ++ E++ + I+H N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 680 YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLK-IAVGAAQGLAYLHHDCNPR 738
L + L +Y + GS DLL K ++ E + I GA QGLAYLH +
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ---EVEIAAITHGALQGLAYLH---SHN 145
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY---AHTSR 795
+IHRD+K+ NIL+ E L+DFG A + A++FV GT ++ PE +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSA----SIASPANSFV-GTPYWMAPEVILAMDEGQ 200
Query: 796 LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855
+ K DV+S GI +E+ K + N + + L +++ +++ + S
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS---------NEWSD 251
Query: 856 VRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKL 895
+ F + C ++ P +RPT +E+ + + L P L
Sbjct: 252 YFRNFVDS--CLQKIPQDRPTSEELLKHMFVLRERPETVL 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 15/195 (7%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYAL 682
+G G VYK N+ +A K+ P + + E+ + +H NIV+ G L
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 683 SPYGNLLFYDYMVNGSLWDLLH--GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRII 740
+ ++ GSL D+ H GP + ++ + +R + QGL YLH + +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH---SKGKM 128
Query: 741 HRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR---LN 797
HRD+K +NIL+ +N L+DFG++ I + +F+ GT ++ PE A R N
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187
Query: 798 EKSDVYSFGIVLLEI 812
+ D+++ GI +E+
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 68/276 (24%), Positives = 120/276 (43%), Gaps = 21/276 (7%)
Query: 610 DIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI 669
+I R + L +K +G G V+ +AVK + ++ F E + ++
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTL 58
Query: 670 RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLA 729
+H +V LH ++ + ++M GSL D L K + + A+G+A
Sbjct: 59 QHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMA 116
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
++ IHRD++++NIL+ + ++DFG+AR I A I + PE
Sbjct: 117 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 790 YAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848
+ KSDV+SFGI+L+EI+T G+ SN ++ + M +
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYRMPRPE----- 226
Query: 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+ + + + + C K P ERPT + + VL
Sbjct: 227 -----NCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 623 IVGYGASSTVYKC-ALKNSRPIAVKKLY--NQYPHNLRE---FETELETIGSIRHRNIVS 676
++G GA VY C + R +A K++ + P +E E E++ + +++H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 677 LHGYALSPYGN---LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
+G L +F +YM GS+ D L L K +G++YLH
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHS 124
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF--VLGTIGYIDPEYA 791
+ I+HRD+K +NIL D + L DFG ++ + T + V GT ++ PE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 792 HTSRLNEKSDVYSFGIVLLEILTGK 816
K+DV+S G ++E+LT K
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 69/266 (25%), Positives = 113/266 (42%), Gaps = 32/266 (12%)
Query: 632 VYKCALKNSRPIAVKKLYN-QYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690
+Y + +++ +A+K L + P EF+ E + + H NIV L G +
Sbjct: 26 LYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85
Query: 691 YDYMVNGSLWDLL--HGPSKKV------------KLDWETRLKIAVGAAQGLAYLHHDCN 736
++Y+ G L + L P V LD L IA+ A G+ YL +
Sbjct: 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SS 142
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA-MPHASTFVLGTIGYIDPEYAHTSR 795
+H+D+ + NILI E +SD G++R I +A L I ++ PE +
Sbjct: 143 HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK 202
Query: 796 LNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854
+ SD++SFG+VL EI + G + SN V+E V + C +
Sbjct: 203 FSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----------QEVIEMVRKRQLLPCSEDC 251
Query: 855 AVRKTFQLALLCTKRYPSERPTMQEV 880
R + L C + PS RP +++
Sbjct: 252 PPR-MYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 72/264 (27%), Positives = 119/264 (45%), Gaps = 37/264 (14%)
Query: 643 IAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWD 701
+AVK L + +++ +F+ E + H NIV L G L ++YM G L +
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 702 LL------------HGPSKKVK-------LDWETRLKIAVGAAQGLAYLHHDCNPRIIHR 742
L H S K L +L IA A G+AYL + +HR
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHR 154
Query: 743 DVKSSNILIDENFDAHLSDFGIARCIPTA-MPHASTFVLGTIGYIDPEYAHTSRLNEKSD 801
D+ + N L+ EN ++DFG++R I +A AS I ++ PE +R +SD
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESD 214
Query: 802 VYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTF 860
V+++G+VL EI + G + + H+ ++ D V+ +C D + + +
Sbjct: 215 VWAYGVVLWEIFSYGMQPYYGMA--HEEVIYYVRDGNVL---------SCPD-NCPLELY 262
Query: 861 QLALLCTKRYPSERPTMQEVARVL 884
L LC + PS+RP+ + R+L
Sbjct: 263 NLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 65/262 (24%), Positives = 117/262 (44%), Gaps = 24/262 (9%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYN--QYPHNLREFETELETIGSIRHRNIVSLHGYA 681
+G G+ V+K ++ + K+ + + + + + E+ + + +G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 682 LSPYGNLLFYDYMVNGSLWDLLH-GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRII 740
L + +Y+ GS DLL GP LD I +GL YLH + + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE---KKI 123
Query: 741 HRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKS 800
HRD+K++N+L+ E+ + L+DFG+A + +TFV GT ++ PE S + K+
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKA 182
Query: 801 DVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTF 860
D++S GI +E+ G+ + L + ++ +E + S K F
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG----------NYSKPLKEF 232
Query: 861 QLALLCTKRYPSERPTMQEVAR 882
A C + PS RPT +E+ +
Sbjct: 233 VEA--CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRP-IAVKKLY-NQYPHNLREFETELETIGSIRHR- 672
ENL E +G G VYK K + +AVK++ + +L+ + H
Sbjct: 18 ENLGE---IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHDC 73
Query: 673 -NIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL--KIAVGAAQGLA 729
IV +GY ++ + + M + D L K+++ + K+ V + L
Sbjct: 74 PYIVKCYGYFITDSDVFICMELM--STCLDKL---LKRIQGPIPEDILGKMTVAIVKALH 128
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
YL +IHRDVK SNIL+D + + L DFGI+ + + + G Y+ PE
Sbjct: 129 YLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAAYMAPE 184
Query: 790 YAHTSRLNEK----SDVYSFGIVLLEILTGK 816
N K +DV+S GI L+E+ TG+
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 69/265 (26%), Positives = 123/265 (46%), Gaps = 20/265 (7%)
Query: 618 LSEKYI-VGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIRHRNIV 675
L E YI +G G++ V K+S R +AVK + + E+ + +H+N+V
Sbjct: 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVV 81
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
++ L + +++ G+L D++ + +L+ E + Q L YLH
Sbjct: 82 EMYKSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLH--- 134
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR 795
+ +IHRD+KS +IL+ + LSDFG I +P + V GT ++ PE +
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTP 193
Query: 796 LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855
+ D++S GI+++E++ G+ ++S + M + D+ P +S
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKRLRDSP------PPKLKNAHKISP 245
Query: 856 VRKTFQLALLCTKRYPSERPTMQEV 880
V + F +L R P ER T QE+
Sbjct: 246 VLRDFLERMLT--REPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 64/272 (23%), Positives = 120/272 (44%), Gaps = 31/272 (11%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFE------TELETIGS 668
L +G G++ V K++ R +AVKK+ +LR+ + E+ +
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMRD 72
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
+H NIV ++ L + +++ G+L D++ +++ E + + + L
Sbjct: 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKAL 128
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDP 788
++LH +IHRD+KS +IL+ + LSDFG + +P + V GT ++ P
Sbjct: 129 SFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAP 184
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848
E + D++S GI+++E++ G+ NE L M + DN P
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA--MKRIRDN------LPPKLK 236
Query: 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+S ++F R P++R T E+
Sbjct: 237 NLHKVSPRLRSF--LDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 623 IVGYGASSTVYKCALKNSRPI----AVKKLYNQYP--HNLREFETELETIGSIRHRNIVS 676
++G G VY L +S AVK L N+ + +F E + H N++S
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 677 LHGYALSPYGN-LLFYDYMVNGSLWDLLHGPSKK--VKLDWETRLKIAVGAAQGLAYLHH 733
L G L G+ L+ YM +G L + + + VK + + A+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK----DLIGFGLQVAKGMEYL-- 114
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI---PTAMPHASTFVLGTIGYIDPEY 790
+ + +HRD+ + N ++DE+F ++DFG+AR I H T + ++ E
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 791 AHTSRLNEKSDVYSFGIVLLEILT 814
T + KSDV+SFG++L E++T
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 68/264 (25%), Positives = 110/264 (41%), Gaps = 30/264 (11%)
Query: 625 GYGASSTVYKCA-LKNSRPIAVKK--LYNQYPHNLREFETELETIGSIRHRNIVSLHGYA 681
G G+ +VYK L +++ A+K+ L + + E+ + S+ H NI+S
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 682 LSPYGNLLF--YDYMVNGSLWDLLHGPSKKVKL-DWETRLKIAVGAAQGLAYLHHDCNPR 738
L GN L +Y G L + KK KL + +I + +GL LH +
Sbjct: 69 LD--GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---K 123
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE 798
I+HRD+KS+NIL+ N + D GI++ + M A T +GT Y+ PE +
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--AKT-QIGTPHYMAPEVWKGRPYSY 180
Query: 799 KSDVYSFGIVLLEILTGKKAVDNES--NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856
KSD++S G +L E+ T + S +L + P + DL
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--------KYPPIPPIYSQDLQ-- 230
Query: 857 RKTFQLALLCTKRYPSERPTMQEV 880
+ P RP ++
Sbjct: 231 ----NFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 51/176 (28%), Positives = 78/176 (44%), Gaps = 8/176 (4%)
Query: 642 PIAVKKLYNQYPHN-LREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLW 700
P+AVK L + + + +F E + S+ H N++ L+G L+ ++ + GSL
Sbjct: 25 PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVT-ELAPLGSLL 83
Query: 701 DLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLS 760
D L T AV A G+ YL R IHRD+ + NIL+ + +
Sbjct: 84 DRLRKD-ALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIG 139
Query: 761 DFGIARCIPTAMPH-ASTFVLGT-IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
DFG+ R +P H L + PE T + SDV+ FG+ L E+ T
Sbjct: 140 DFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 35/280 (12%)
Query: 623 IVGYGASSTVYKCALK----NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSL 677
++G G V + LK +A+K L + Y R+F +E +G H NI+ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLH---GPSKKVKLDWETRLKIAVGAAQGLAYLHHD 734
G ++ ++M NG+L L G ++L R G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLS-E 124
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP--TAMPHASTFVLGTIG--YIDPEY 790
N +HRD+ + NIL++ N +SDFG++R + T+ P ++ + G I + PE
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 791 AHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849
+ SDV+S+GIV+ E+++ G++ + SN V+ A++ + +
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------QDVINAIEQDYRLP 231
Query: 850 C-VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+D QL L C ++ + RP ++ L ++
Sbjct: 232 PPMDCPTA--LHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQ-----YPHN-LREFETELETIGSIRHRNIVS 676
+G GA V+K + +A+KK+ + P+ LRE ++ + + +H +V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVK 63
Query: 677 LHGYALSPYGN--LLFYDYMVNGSLWDLLHG-----PSKKVKLDWETRLKIAVGAAQGLA 729
L + P+G+ +L +YM L ++L P +VK LK G+A
Sbjct: 64 L--LDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK-------GVA 113
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
Y+H I+HRD+K +N+LI + ++DFG+AR P + + T Y PE
Sbjct: 114 YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
Query: 790 YAHTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ +R + D+++ G + E+L G E+++ QL
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL 210
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 19/267 (7%)
Query: 616 ENLSEKYIVGYGASSTVYKC-ALKNSRPIAVKKL-YNQYPHNLREFETELETIGSIRHRN 673
+++ + I+G+G TVYK L R +AVK + + ++ +ELE +
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
I+ +G + ++M GSL D+ K+ +IAV +GL YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSL-DVYR------KIPEHVLGRIAVAVVKGLTYL-- 111
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
+ +I+HRDVK SN+L++ L DFG++ + ++ A T+V GT Y+ PE
Sbjct: 112 -WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYV-GTNAYMAPERISG 167
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853
+ SDV+S GI +E+ G+ +M +++ P + V
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE 227
Query: 854 SAVRKTFQLALLCTKRYPSERPTMQEV 880
V Q C ++ P ERP + +
Sbjct: 228 KFVHFITQ----CMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 31/89 (34%), Positives = 55/89 (61%)
Query: 378 LNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLL 437
L L +G +P ++ ++ +L +++LS N+ G++P S+G + L L+LS N NG +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 438 PAEFGNLRSIQTIDMSFNQLSGSIPAELG 466
P G L S++ ++++ N LSG +PA LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 623 IVGYGASSTVYKC-ALKNSRPIAVKKL-YN-QYPHNLRE---FETELETIGSIRHRNIVS 676
++G GA VY C R +AVK++ ++ + P +E E E++ + ++ H IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 677 LHGYALSPYGNLL--FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD 734
+G P L F ++M GS+ D L L K +G++YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHSN 125
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF--VLGTIGYIDPEYAH 792
I+HRD+K +NIL D + L DFG ++ + T + V GT ++ PE
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 793 TSRLNEKSDVYSFGIVLLEILTGK 816
K+D++S G ++E+LT K
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 27/174 (15%)
Query: 654 HNLREFETELETIGSIRHRNIVSL--------HGYALSPY---GNLLFYDYMVNGSLWDL 702
+ + E + ++H NIV+ H Y + Y G+L+ + G L+
Sbjct: 40 SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLF-- 97
Query: 703 LHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDF 762
+ L W ++ + V H R++HRD+KS NI + +N L DF
Sbjct: 98 ----PEDTILQWFVQMCLGV---------QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDF 144
Query: 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
G AR + + +A T+V GT Y+ PE N KSD++S G +L E+ T K
Sbjct: 145 GSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 36/89 (40%), Positives = 52/89 (58%)
Query: 306 LQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAI 365
L L N L G IP ++ KL L +NL+ N++ G IP ++ S T+L ++ N +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 366 PSSFRNLGSLTYLNLSRNNFKGKVPTELG 394
P S L SL LNL+ N+ G+VP LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 36/89 (40%), Positives = 55/89 (61%), Gaps = 1/89 (1%)
Query: 163 LGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEI 222
LGL L G + D+ +L L ++ GN++ G IP S+G+ TS E+LD+SYN G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 223 PYNIGFL-QVATLSLQGNKLTGKIPEVIG 250
P ++G L + L+L GN L+G++P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 65/223 (29%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 620 EKY----IVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHN------LREFETELETIGS 668
KY +VG GA V KC K +A+KK LRE ++ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALRE----VKVLRQ 56
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
+RH NIV+L L ++Y V +L +LL + L + Q +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEY-VERTLLELLE--ASPGGLPPDAVRSYIWQLLQAI 113
Query: 729 AYLH-HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP-TAMPHASTFVLGTIGYI 786
AY H H+ IIHRD+K NIL+ E+ L DFG AR + + +V T Y
Sbjct: 114 AYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYR 168
Query: 787 DPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDNESNLHQL 828
PE K DV++ G ++ E+L G+ +S++ QL
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 643 IAVKKLYNQYPHNLRE-FETELETIGSIRHRNIVSLHGYALSPYGN---LLFYDYMVNGS 698
+AVK L + ++ E+ + ++ H NIV G S G L +Y+ GS
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKG-CCSEQGGKGLQLIMEYVPLGS 94
Query: 699 LWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH 758
L D L P K+ L L A +G+AYLH + IHRD+ + N+L+D +
Sbjct: 95 LRDYL--PKHKLNL--AQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVK 147
Query: 759 LSDFGIARCIPTAMPHASTFVLGT--IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
+ DFG+A+ +P + G + + E ++ + SDV+SFG+ L E+LT
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 9/160 (5%)
Query: 659 FETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL 718
F E + + H+N+V L G L G + + M G+L + L + + + L
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLL 103
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778
+ ++ A+G+ YL + +++HRD+ + NIL+ E+ A +SDFG+AR + ++
Sbjct: 104 QFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160
Query: 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKA 818
V T PE + + KSDV+S+G++L E+ + +A
Sbjct: 161 VKWTA----PEALKHKKFSSKSDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 10/195 (5%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQ--YPHNLREFETELETIGSIRHRNIVSLHGYA 681
+G G V K K S I +KL + P + EL+ + IV +G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 682 LSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIH 741
S + ++M GSL +L + ++ E K+++ +GLAYL +I+H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMH 127
Query: 742 RDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSD 801
RDVK SNIL++ + L DFG++ + +M A++FV GT Y+ PE + + +SD
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFV-GTRSYMSPERLQGTHYSVQSD 184
Query: 802 VYSFGIVLLEILTGK 816
++S G+ L+E+ G+
Sbjct: 185 IWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 16/212 (7%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNS------RPIAVKKLYNQYPHN-LREFETELETIGS 668
NL E +G G V+ K + VK L N EF EL+
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVK------LDWETRLKIAV 722
+ H+N+V L G + + +Y G L L K + L + ++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT 782
A G+ +L N R +HRD+ + N L+ + +S +++ + + + L
Sbjct: 125 QIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 783 IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
+ ++ PE + KSDV+SFG+++ E+ T
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 54/169 (31%), Positives = 86/169 (50%), Gaps = 17/169 (10%)
Query: 656 LREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL--HGPSKKVKLD 713
L E+ + ++H NIV G +L +F +Y+ GS+ LL +G +
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE----- 104
Query: 714 WETRLKIAVGAA-QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI-----ARC 767
ET ++ V +GL YLH N IIHRD+K +NIL+D +SDFGI A
Sbjct: 105 -ETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160
Query: 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
+ T A + G++ ++ PE + K+D++S G +++E+LTGK
Sbjct: 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 624 VGYGASSTVYKCALKNS-RPIAVKKL----YNQ-YP-HNLREFETELETIGSIRHRNIVS 676
+G G VYK K + +A+KK+ ++ P LRE + E + H NI+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKE----LNHPNIIK 62
Query: 677 LHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLK-IAVGAAQGLAYLHHD 734
L G+L L +++M + L+ L+ + + E+ +K QGLA+ H
Sbjct: 63 LLD-VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLP---ESLIKSYLYQLLQGLAFCHSH 117
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
I+HRD+K N+LI+ L+DFG+AR + T + T Y PE
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP-VRPYTHYVVTRWYRAPELLLGD 173
Query: 795 RL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ + D++S G + E+L+ + +S + QL
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL 208
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQ--YPHNLREFETELETIGSIRHRN 673
E +SE +G G V+K + K S I +KL + P + EL+ +
Sbjct: 8 EKISE---LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
IV +G S + ++M GSL +L K ++ + K+++ +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
+I+HRDVK SNIL++ + L DFG++ + +M A++FV GT Y+ PE
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFV-GTRSYMSPERLQG 176
Query: 794 SRLNEKSDVYSFGIVLLEILTGK 816
+ + +SD++S G+ L+E+ G+
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 41/219 (18%)
Query: 623 IVGYGASSTVYKCALKNS--RPIAVKKLYNQYP--HNLREFETELETIGSI-RHRNIVSL 677
++G G V K +K R A K +Y + R+F ELE + + H NI++L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 678 ------HGY-----ALSPYGNLLFYDYMVNGSLWDL------LHGPSKKVKLDWETRLKI 720
GY +P+GNLL D++ + + + + L + L
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLL--DFLRKSRVLETDPAFAIANSTAST--LSSQQLLHF 117
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
A A+G+ YL + IHRD+ + NIL+ EN+ A ++DFG++R +V
Sbjct: 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVK 167
Query: 781 GTIGYIDPEYAHTSRLN-----EKSDVYSFGIVLLEILT 814
T+G + + LN SDV+S+G++L EI++
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYA 681
+VG G VYK + +A K+ + E + E+ + HRNI + +G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 682 L--SPYGN----LLFYDYMVNGSLWDLL-HGPSKKVKLDWETRLKIAVGAAQGLAYLHHD 734
+ SP G+ L ++ GS+ DL+ + +K DW I +GLA+LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT- 793
++IHRD+K N+L+ EN + L DFG++ + + +TF+ GT ++ PE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 196
Query: 794 ----SRLNEKSDVYSFGIVLLEILTG 815
+ + +SD++S GI +E+ G
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 40/225 (17%)
Query: 624 VGYGASSTVYK-CALKNSRPIAVKKLYNQYPHN---------LRE--FETELETIGSIRH 671
+G G + VYK + R +A+KK+ LRE EL +H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL------KH 61
Query: 672 RNIVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLK------IAVGA 724
NI+ L N+ L +++M DL +KV D L +
Sbjct: 62 PNIIGLLD-VFGHKSNINLVFEFM----ETDL-----EKVIKDKSIVLTPADIKSYMLMT 111
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIG 784
+GL YLH + I+HRD+K +N+LI + L+DFG+AR + + V+ T
Sbjct: 112 LRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 785 YIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
Y PE +R D++S G + E+L + +S++ QL
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 75/296 (25%), Positives = 118/296 (39%), Gaps = 63/296 (21%)
Query: 625 GYGASSTVYKC-ALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR----HRNIVSLHG 679
G G S V K + K + A+K + + +L + L I ++R H NI+ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQV-NNLREIQALRRLSPHPNILRLIE 65
Query: 680 YAL-SPYGNLLFYDYMVNGSLWDLLHG-----PSKKVKLDWETRLKIAVGAAQGLAYLHH 733
G L +++ +L++L+ G P K+VK LK L ++H
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLK-------SLDHMHR 118
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
+ I HRD+K NILI ++ L+DFG R I + P+ T + T Y PE T
Sbjct: 119 N---GIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLT 172
Query: 794 S-RLNEKSDVYSFGIVLLEILT------GKKAVDNESNLHQL-------IMSKADDNTVM 839
K D+++ G V EIL+ G +D + +H + ++ K + M
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232
Query: 840 ------------EAVDPEVSVTCVDLSAVRKTFQLALLCTKRY-PSERPTMQEVAR 882
+ P S +DL L L Y P ER T ++ R
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDL--------LKKLLA--YDPDERITAKQALR 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 66/227 (29%), Positives = 103/227 (45%), Gaps = 33/227 (14%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKC-----ALKNSRPIAVKKLYNQY-PHNLREFETELE 664
I++ TE L ++G GA TVYK P+A+K L P EF E
Sbjct: 3 ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61
Query: 665 TIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ S+ H ++V L G LSP L+ M +G L D +H K + + L V
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQLV-TQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQI 118
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP----------TAMPH 774
A+G+ YL R++HRD+ + N+L+ ++DFG+AR + MP
Sbjct: 119 AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP- 174
Query: 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVD 820
I ++ E H + +SDV+S+G+ + E++T G K D
Sbjct: 175 --------IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 36/88 (40%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY 785
+GL YLH RIIHRDVK+ NI I++ + D G A+ P P A + GT+
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAP-AFLGLAGTVET 222
Query: 786 IDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
PE + N K+D++S GIVL E+L
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 29/224 (12%)
Query: 620 EKY----IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIG------- 667
EKY +VG G+ V KC K + + +A+KK E + ++ I
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLE------SEDDKMVKKIAMREIRML 54
Query: 668 -SIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+RH N+V+L L ++++ + L DL P+ LD K +
Sbjct: 55 KQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILR 111
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP-HASTFVLGTIGY 785
G+ + H + IIHRD+K NIL+ ++ L DFG AR + A P T + T Y
Sbjct: 112 GIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDYVATRWY 166
Query: 786 IDPEY-AHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
PE ++ D+++ G ++ E+LTG+ +S++ QL
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 23/273 (8%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G GAS TVY + + +A+K++ Q E+ + ++ NIV+ L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 683 SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHR 742
+ +Y+ GSL D++ + +D + Q L +LH + ++IHR
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---QVIHR 139
Query: 743 DVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDV 802
D+KS NIL+ + L+DFG I ST V GT ++ PE K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 803 YSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTF-- 860
+S GI+ +E++ G+ NE+ L L + N E +PE LSAV + F
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NGTPELQNPE------RLSAVFRDFLN 250
Query: 861 QLALLCTKRYPSERPTMQ----EVARVLVSLLP 889
+ + R S + +Q ++A+ L SL P
Sbjct: 251 RCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 17/226 (7%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVS-LHGYA 681
+G GAS TV+ + + +A+K++ Q E+ + +++ NIV+ L +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 682 LSPYGNLLF--YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739
+ G+ LF +Y+ GSL D++ + +D + Q L +LH + ++
Sbjct: 87 V---GDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---QV 136
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEK 799
IHRD+KS N+L+ + L+DFG I ST V GT ++ PE K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 800 SDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845
D++S GI+ +E++ G+ NE+ L L + N E +PE
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NGTPELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 623 IVGYGASSTVYK-CALKNSRPIAVKKLYNQYPHN-LREFETELETIGSIRH---RNIVSL 677
++G GA VY+ + R +A+K + P + + + + E+ + +R NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLH-GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCN 736
+G L + +Y GS+ L+ GP + + R + L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-----VALKYIHKV-- 120
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL 796
+IHRD+K++NIL+ + L DFG+A + STFV GT ++ PE +
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 797 -NEKSDVYSFGIVLLEILTG 815
+ K+D++S GI + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 73/253 (28%), Positives = 112/253 (44%), Gaps = 31/253 (12%)
Query: 101 DIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVL 160
D ++ L L L+L N+L I S L ++ NL +LDL N +T +IP LI +
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLK-- 139
Query: 161 QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITG 220
+ L D+ N + ++P + N + + LD+S+N ++
Sbjct: 140 ---------------------SNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD 177
Query: 221 EIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTG 280
+ L L GNK++ +P I L+ AL LDLS N ++ + L NL
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340
L L NKL +GN+S L L L NNQ+ + + LG L L EL+L+ N+L
Sbjct: 236 GLELSNNKLEDLPES-IGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNA 292
Query: 341 IPHNISSCTALNQ 353
+P L
Sbjct: 293 LPLIALLLLLLEL 305
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-12
Identities = 35/86 (40%), Positives = 50/86 (58%), Gaps = 2/86 (2%)
Query: 66 SIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGP 125
+D QG L G IP++I L I LS NS+ G+IP S+ + LE L+L N G
Sbjct: 424 GLDNQG--LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 126 IPSTLTQIPNLKTLDLARNQLTGEIP 151
IP +L Q+ +L+ L+L N L+G +P
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 80/323 (24%), Positives = 126/323 (39%), Gaps = 41/323 (12%)
Query: 192 NNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGL 251
+N +P S+ S ++L S + L + +L L N+L I E++ L
Sbjct: 56 SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLEL 115
Query: 252 MQALAVLDLSENELVGPIPPILGNLSYT-GKLYLHGNKLTGPIPPELGNMSKLSYLQLQN 310
L LDL N + IPP++G L +L L NK+ +P L N+ L L L
Sbjct: 116 -TNLTSLDLDNN-NITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172
Query: 311 NQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFR 370
N L +P L L L L+L+ N + +P I +AL + ++ N + + SS
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLS 229
Query: 371 NLGSLTYLNLSRNNFKGKV---------------------PTELGRIINLDTLDLSVNNF 409
NL +L+ L LS N + + LG + NL LDLS N+
Sbjct: 230 NLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSL 289
Query: 410 SGSVPASIGDLE------------HLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457
S ++P L L L L+ LN + G S + + + +
Sbjct: 290 SNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNIL-SNGETSSPEALSILESLN 348
Query: 458 SGSIPAELGQLQNIISLILNNNN 480
+ N+ I+ N N
Sbjct: 349 NLWTLDNALDESNLNRYIVKNPN 371
|
Length = 394 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 65/271 (23%), Positives = 121/271 (44%), Gaps = 19/271 (7%)
Query: 624 VGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G G++ V +K+S + +AVKK+ + E+ + +H N+V ++ L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 683 SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHR 742
+ +++ G+L D++ +++ E + + + L+ LH +IHR
Sbjct: 88 VGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHR 140
Query: 743 DVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDV 802
D+KS +IL+ + LSDFG + +P + V GT ++ PE + D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDI 199
Query: 803 YSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQL 862
+S GI+++E++ G+ NE L + M + DN P +S K F
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--DNL------PPKLKNLHKVSPSLKGFLD 251
Query: 863 ALLCTKRYPSERPTMQEVARVLVSLLPAPPA 893
LL R P++R T E+ + PP+
Sbjct: 252 RLLV--RDPAQRATAAELLKHPFLAKAGPPS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 36/230 (15%)
Query: 625 GYGASSTVYKC-ALKNSRPIAVKKLYNQYPHNLRE-FET----ELETIGSIRHRNIVSLH 678
G G VYK +K R +A+KK+ HN ++ F E++ + ++H N+V L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 679 GYALSPYGNLL-----FY---DYMVNGSLWDLLHGPSKKVKLDWETRLK-IAVGAAQGLA 729
A+ Y YM + L LL PS VKL E+++K + +G+
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS--VKLT-ESQIKCYMLQLLEGIN 129
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR----CIPTAMP------HASTFV 779
YLH N I+HRD+K++NILID ++DFG+AR P T +
Sbjct: 130 YLH--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 780 LGTIGYIDPEY-AHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ T Y PE R D++ G V E+ T + + +S++ QL
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-12
Identities = 58/197 (29%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 643 IAVKKLYNQYPHNLRE---FETELETIGSIRHRNIVSLHGYALSPYGNLLF--YDYMVNG 697
+A+K L P + F E + H NIV+L +P G LLF ++Y+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPGR 64
Query: 698 SLWDLL--HGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---D 752
+L ++L G L ++ + LA H N I+HRD+K NI++
Sbjct: 65 TLREVLAADGA-----LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 753 ENFDAHLSDFGIARCIP------TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFG 806
A + DFGI +P A +T VLGT Y PE + SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 807 IVLLEILTGKKAVDNES 823
++ LE LTG++ V S
Sbjct: 177 LIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 4e-12
Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 24/236 (10%)
Query: 610 DIMRSTENLSEKYI----VGYGASSTVYKCALKNS-RPIAVKKLYN--QYPHNLREFETE 662
++ ++ + ++Y VG GA V + R +A+KKL Q + + E
Sbjct: 5 ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRE 64
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
L + + H N++ L F D Y+V + L+ K KL + +
Sbjct: 65 LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLV 124
Query: 722 VGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG 781
+GL Y+H + IIHRD+K SNI ++E+ + + DFG+AR M T +
Sbjct: 125 YQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM----TGYVA 177
Query: 782 TIGYIDPE----YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL--IMS 831
T Y PE + H N+ D++S G ++ E+LTGK ++ QL IM+
Sbjct: 178 TRWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVS-LHGYA 681
+G GAS TVY + + +A+K++ Q E+ + +H NIV+ L Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 682 LSPYGNLLF--YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA------QGLAYLHH 733
+ G+ L+ +Y+ GSL D++ ET + AA Q L +LH
Sbjct: 87 V---GDELWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQALEFLHS 133
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
+ ++IHRD+KS NIL+ + L+DFG I ST V GT ++ PE
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM 830
K D++S GI+ +E++ G+ NE+ L L +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKC-------ALKNSRPIAVKKLYNQYP-HNLREFETE 662
I++ TE L + ++G G TV+K ++K P+A+K + ++ +E
Sbjct: 3 ILKETE-LRKLKLLGSGVFGTVHKGIWIPEGDSIK--IPVAIKTIQDRSGRQTFQEITDH 59
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
+ +GS+ H IV L G + P +L L GSL D H + LD + L
Sbjct: 60 MLAMGSLDHAYIVRLLG--ICPGASLQLVTQLSPLGSLLD--HVRQHRDSLDPQRLLNWC 115
Query: 722 VGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG 781
V A+G+ YL ++HR++ + NIL+ + ++DFG+A + P +
Sbjct: 116 VQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY---PDDKKYFYS 169
Query: 782 ----TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
I ++ E R +SDV+S+G+ + E+++
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 34/213 (15%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYAL 682
+G G VYK K +A K+ + E E E + S+ H N+V +G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYG--- 86
Query: 683 SPYGNLLFY--DYMVNGSLW---DLLHGPS----------KKVKLDWETRLKIAVGAAQG 727
+FY D +V G LW +L +G S +LD I GA G
Sbjct: 87 ------MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYID 787
L +LH N RIIHRDVK +NIL+ L DFG++ + + +T V GT ++
Sbjct: 141 LQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 196
Query: 788 PEY-----AHTSRLNEKSDVYSFGIVLLEILTG 815
PE + + + DV+S GI +E+ G
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 10/177 (5%)
Query: 643 IAVKKLYNQYPHN-LREFETELETIGSIRHRNIVSLHGYALSPYGN--LLFYDYMVNGSL 699
+AVK L + N + + + E+E + ++ H NIV G GN L +++ +GSL
Sbjct: 36 VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95
Query: 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759
+ L P K K++ + +LK AV +G+ YL + + +HRD+ + N+L++ +
Sbjct: 96 KEYL--PRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKI 150
Query: 760 SDFGIARCIPTAMPHASTF--VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
DFG+ + I T + + + + + PE S+ SDV+SFG+ L E+LT
Sbjct: 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 624 VGYGASSTVYKCALKNS--RPIAVKKLYNQYPHNLREFETELETIGSI-----------R 670
+G GA VYK KN+ +A+K++ P ++ ++IG I R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL-KIAVGAAQGLA 729
H NIV + L + D + L + + +K + E R+ I V L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS-TFVLGTIGYIDP 788
YLH + RI+HRD+ +NI++ E+ ++DFG+A+ P + T V+GTI Y P
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILT 814
E EK+DV++FG +L ++ T
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 76/286 (26%), Positives = 114/286 (39%), Gaps = 44/286 (15%)
Query: 623 IVGYGASSTVYKCALKN-------SRPIAVKKLYN-QYPHNLREFETELETIGSIRHRNI 674
+G GA VY+ + +AVK L +EF E + + H NI
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 675 VSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVK----LDWETRLKIAVGAAQGLAY 730
V L G L + + M G L L + L + L I + A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 731 LHHDCNPRIIHRDVKSSNILIDE-NFDA----HLSDFGIARCIPTAMPHASTFV------ 779
L IHRD+ + N L+ E +DA + DFG+AR I + S +
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-----YKSDYYRKEGEG 173
Query: 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTV 838
L + ++ PE + +SDV+SFG+++ EILT G++ +N L V
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL-------QHV 226
Query: 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+ C D K +QL C + PSERPT + +L
Sbjct: 227 TAGGRLQKPENCPD-----KIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYN-QYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G GA VYK K + +A K+ + + L ++ E++ + S H NIV L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL---- 68
Query: 683 SPYGNLLFYDYMVNGSLWDLLH----GPSKKVKLDWE---TRLKIAVGAAQGLAYLHHDC 735
+ +Y+ +LW L+ G V L+ E T +I V Q L L++
Sbjct: 69 ----DAFYYE----NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE--YAHT 793
+IIHRD+K+ NIL + D L+DFG++ + +F+ GT ++ PE T
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCET 179
Query: 794 SR---LNEKSDVYSFGIVLLEI 812
S+ + K+DV+S GI L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 24/215 (11%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLRE----FETELETIGSIRHRNIVSLH 678
++G GA V LKN+ + K+ N++ R F E + + + ++ I +LH
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 679 GYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLD----WETRLKIAVGAAQGLAYLHH 733
YA NL L DY V G L LL ++ D + + IA+ + L Y
Sbjct: 68 -YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
+HRD+K NIL+D N L+DFG + S+ +GT YI PE
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 794 -----SRLNEKSDVYSFGIVLLEILTGKKAVDNES 823
+ + D +S G+ + E+L G+ ES
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 9/155 (5%)
Query: 662 ELETIGSIRHRNIVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
E + + + H IV LH YA G L L D++ G L+ L SK+V E
Sbjct: 48 ERDILAEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFY 103
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
A L +LH + II+RD+K NIL+DE L+DFG+++ A +F
Sbjct: 104 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC- 159
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
GT+ Y+ PE + + +D +SFG+++ E+LTG
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 616 ENLSEKYIVGYGASSTVYKCAL------KNSRPIAVKKLY-NQYPHNLREFETELETIGS 668
+ L+ +G GA V K + +AVK L + +L + +E+E +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 669 I-RHRNIVSLHGYALSPYGNL-LFYDYMVNGSLWDLLH-----GPSKKVKLDWETRLKI- 720
I +H+NI++L G + G L + +Y +G+L D L G +
Sbjct: 72 IGKHKNIINLLG-VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 721 -------AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773
A A+G+ +L + + IHRD+ + N+L+ E+ ++DFG+AR I
Sbjct: 131 QKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI----- 182
Query: 774 HASTFVLGT------IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
H + T + ++ PE +SDV+SFG++L EI T
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 17/238 (7%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G GAS TVY + + +A++++ Q E+ + ++ NIV+ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 683 SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHR 742
+ +Y+ GSL D++ + +D + Q L +LH + ++IHR
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 743 DVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDV 802
D+KS NIL+ + L+DFG I ST V GT ++ PE K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 803 YSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTF 860
+S GI+ +E++ G+ NE+ L L + N E +PE LSA+ + F
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIAT--NGTPELQNPE------KLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-11
Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 22/175 (12%)
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH--ASTFVLGTI 783
Q L +HH + +IHRD+KS+NIL+ N L DFG ++ + TF GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTP 209
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843
Y+ PE ++K+D++S G++L E+LT K+ D E N+ + +M K T+ D
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-NMEE-VMHK----TLAGRYD 263
Query: 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLA 898
P +S + ALL + P RP+ LL P KL ++
Sbjct: 264 PLPP----SISPEMQEIVTALLSSD--PKRRPSSS-------KLLNMPICKLFIS 305
|
Length = 496 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 71/292 (24%), Positives = 111/292 (38%), Gaps = 61/292 (20%)
Query: 624 VGYGASSTVYKCALKN------SRPIAVKKLY-NQYPHNLREFETELETIGSIRHRNIVS 676
+G G+ VY+ K +A+K + N EF E + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 677 LHGYALSPYGNLLFYDYMVNGSLWDLL--HGPSKKV--KLDWETRLKIAVGAAQ---GLA 729
L G + L+ + M G L L P + L T K AA+ G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI----------PTAMPHASTFV 779
YL + +HRD+ + N ++ E+ + DFG+ R I +P
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP------ 184
Query: 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-------GKKAVDNESNLHQLIMSK 832
+ ++ PE KSDV+SFG+VL E+ T G NE L + ++
Sbjct: 185 ---VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEVL-KFVI-- 235
Query: 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
D ++ PE C D K +L +C + P RPT E+ L
Sbjct: 236 --DGGHLDL--PE---NCPD-----KLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 80/296 (27%), Positives = 123/296 (41%), Gaps = 63/296 (21%)
Query: 623 IVGYGASSTVYKCALKNS--RPIAVKKLYNQYPH--NLREFETELETIGSI-RHRNIVSL 677
++G G V K +K R A K +Y + R+F ELE + + H NI++L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 678 HGYALSPYGNL-LFYDYMVNGSLWDLLH-------------GPSKKVKLDWETRLKIAVG 723
G A G L L +Y +G+L D L S L + L A
Sbjct: 74 LG-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 724 AAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTI 783
A+G+ YL + IHRD+ + NIL+ EN+ A ++DFG++R +V T+
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTM 182
Query: 784 GYIDPEYAHTSRLN-----EKSDVYSFGIVLLEILT-------GKKAVDNESNLHQLIMS 831
G + + LN SDV+S+G++L EI++ G + L Q
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---- 238
Query: 832 KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887
E + C D + + L C + P ERP+ A++LVSL
Sbjct: 239 ---------GYRLEKPLNCDD-----EVYDLMRQCWREKPYERPSF---AQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 26/202 (12%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYN-QYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G GA VYK K + +A K+ + L ++ E+E + + H IV L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG--- 76
Query: 683 SPYGNLLFYDYMVNGSLWDLLH----GPSKKVKLDWETRLK---IAVGAAQGLAYLHHDC 735
+ +G LW ++ G + L+ + L I V Q L L +
Sbjct: 77 ---------AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH 127
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR 795
+ +IIHRD+K+ N+L+ + D L+DFG++ + +F+ GT ++ PE
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCET 186
Query: 796 LNE-----KSDVYSFGIVLLEI 812
+ + K+D++S GI L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 9/236 (3%)
Query: 296 ELGNMSKLSYLQLQNNQLVG--TIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQ 353
++S+L L L + + L L L L+L N L I + T L
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTS 120
Query: 354 FNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSV 413
++ N ++ P +L L+LS N + +P+ L + NL LDLS N+ S +
Sbjct: 121 LDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DL 178
Query: 414 PASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIIS 473
P + +L +L L+LS N ++ LP E L +++ +D+S N + + + L L+N+
Sbjct: 179 PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSG 236
Query: 474 LILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLL 529
L L+NN L+ +P+ + N +L L++S N +S I + + + GN L
Sbjct: 237 LELSNNKLED-LPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLS 290
|
Length = 394 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 72/260 (27%), Positives = 110/260 (42%), Gaps = 22/260 (8%)
Query: 626 YGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPY 685
YG S V I L N + E E + + ++H NIV+ Y S
Sbjct: 13 YGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA---YRESWE 69
Query: 686 G-NLLFYDYMVNGSLWDLLHG-PSKKVKLDWETR-LKIAVGAAQGLAYLHHDCNPRIIHR 742
G + L Y M DL H +K KL E + ++ V A L YLH I+HR
Sbjct: 70 GEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHR 126
Query: 743 DVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDV 802
D+K+ N+ + + D GIAR + AST + GT Y+ PE N KSDV
Sbjct: 127 DLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYNYKSDV 185
Query: 803 YSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQL 862
++ G + E+ T K A N +++ L+ ++E P + D S
Sbjct: 186 WALGCCVYEMATLKHAF-NAKDMNSLVYR------IIEGKLPPMP---KDYSPELGELIA 235
Query: 863 ALLCTKRYPSERPTMQEVAR 882
+L + P +RP+++ + R
Sbjct: 236 TMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 59/257 (22%), Positives = 99/257 (38%), Gaps = 51/257 (19%)
Query: 642 PIAVKKLY-NQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLW 700
+AVK L +EF E + + H IV L G +L + G L
Sbjct: 25 EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-PLMLVMELAPLGPLL 83
Query: 701 DLL----HGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756
L P +K ++ A G+AYL + +HRD+ + N+L+
Sbjct: 84 KYLKKRREIPVSDLKE-LAHQV------AMGMAYLE---SKHFVHRDLAARNVLLVNRHQ 133
Query: 757 AHLSDFGIARCIPTAMPHASTFVLGTIG------YIDPEYAHTSRLNEKSDVYSFGIVLL 810
A +SDFG++R A+ S + T + PE + + + KSDV+S+G+ L
Sbjct: 134 AKISDFGMSR----ALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLW 189
Query: 811 EILT-------GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLA 863
E + K + +++ + + PE C + + +
Sbjct: 190 EAFSYGAKPYGEMKGAE--------VIAMLESGERLPR--PE---ECPQ-----EIYSIM 231
Query: 864 LLCTKRYPSERPTMQEV 880
L C K P +RPT E+
Sbjct: 232 LSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 624 VGYGASSTVYKCALKNSR---PIAVKKLYNQYPHNL---REFETELETIGSIRHRNIVSL 677
VG GA TV C+ + R +A+KKLY + L R + EL + ++H N++ L
Sbjct: 23 VGSGAYGTV--CSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGL 79
Query: 678 HGYALSPYGNL-LFYD-YMVNGSLWDLLHGPSKKVKLDWETRLKIAV-GAAQGLAYLHHD 734
+P +L F+D Y+V + L K KL E R++ V +GL Y+H
Sbjct: 80 LD-VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-EDRIQFLVYQMLKGLKYIH-- 135
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT- 793
IIHRD+K N+ ++E+ + + DFG+AR + M T + T Y PE
Sbjct: 136 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM----TGYVVTRWYRAPEVILNW 190
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ D++S G ++ E+LTGK +L QL
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-11
Identities = 36/85 (42%), Positives = 51/85 (60%), Gaps = 2/85 (2%)
Query: 216 NQ-ITGEIPYNIGFLQ-VATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPIL 273
NQ + G IP +I L+ + +++L GN + G IP +G + +L VLDLS N G IP L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 274 GNLSYTGKLYLHGNKLTGPIPPELG 298
G L+ L L+GN L+G +P LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-11
Identities = 34/85 (40%), Positives = 45/85 (52%)
Query: 258 LDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI 317
L L L G IP + L + + L GN + G IPP LG+++ L L L N G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 318 PAELGKLEQLFELNLADNNLEGPIP 342
P LG+L L LNL N+L G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-11
Identities = 56/182 (30%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 657 REFETELETIGSIRHRNIVSL-HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWE 715
+ E++ + +I HR I++L H Y ++ Y DL + L E
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-----CDLFTYVDRSGPLPLE 185
Query: 716 TRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775
+ I + LAYLH IIHRDVK+ NI +DE +A L DFG A C A P
Sbjct: 186 QAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA-CKLDAHPDT 241
Query: 776 STFV--LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEI------LTGKKAVDNESNLHQ 827
GT+ PE K+D++S G+VL E+ L GK+ + S L
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS 301
Query: 828 LI 829
+I
Sbjct: 302 II 303
|
Length = 392 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 29/204 (14%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFE-----------TELETIGSIRH 671
+G G S VYK L + R +A+KK+ + FE E++ + + H
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKV--------QIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 672 RNIVSLHGYALSPYGNLL--FYDYMVNGSLWDLL-HGPSKKVKLDWETRLKIAVGAAQGL 728
N++ A N L + G L ++ H +K + T K V L
Sbjct: 62 PNVIKY--LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDP 788
++H + RI+HRD+K +N+ I L D G+ R + A + V GT Y+ P
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEI 812
E H + N KSD++S G +L E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 11/182 (6%)
Query: 662 ELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
E+ + ++H NIV LH + +L ++YM + L + + LD T
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFT 106
Query: 722 VGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG 781
+G+A+ H + R++HRD+K N+LI++ + L+DFG+AR + S V+
Sbjct: 107 YQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV- 162
Query: 782 TIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGK---KAVDNESNLHQL--IMSKADD 835
T+ Y P+ SR S D++S G ++ E++TG+ +NE L ++ IM +
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE 222
Query: 836 NT 837
+T
Sbjct: 223 ST 224
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 9e-11
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYA 681
+VG G VYK + +A K+ + E + E+ + HRNI + +G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 682 L--SPYGN----LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
+ +P G L ++ GS+ DL+ +K L E I +GL++LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQH- 130
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT-- 793
++IHRD+K N+L+ EN + L DFG++ + + +TF+ GT ++ PE
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 187
Query: 794 ---SRLNEKSDVYSFGIVLLEILTG 815
+ + KSD++S GI +E+ G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 74/246 (30%), Positives = 113/246 (45%), Gaps = 32/246 (13%)
Query: 269 IPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLF 328
L NL L L+ N+L I L + L+ L L NN + P L
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNITDIPPLIGLLKSNLK 143
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK 388
EL+L+DN +E +P + + L ++ N LS +P NL +L L+LS N
Sbjct: 144 ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-D 200
Query: 389 VPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQ 448
+P E+ + L+ LDLS NN + +S+ +L++L L LS N L LP GNL +++
Sbjct: 201 LPPEIELLSALEELDLS-NNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLE 258
Query: 449 TIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508
T+D+S NQ+S IS + + NL+ L++S N+LS
Sbjct: 259 TLDLSNNQIS------------SISSLGSLTNLR--------------ELDLSGNSLSNA 292
Query: 509 IPPIRN 514
+P I
Sbjct: 293 LPLIAL 298
|
Length = 394 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 45/184 (24%), Positives = 90/184 (48%), Gaps = 19/184 (10%)
Query: 646 KKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS-----PYGNLLFYDYMVNGSLW 700
KK + + + E E++ + I NI+ ++G+ + P +L+ +Y G L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL-EYCTRGYLR 110
Query: 701 DLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH-HDCNPRIIHRDVKSSNILIDENFDAHL 759
++L K+ L ++T+L +A+ +GL L+ + P ++++ S + L+ EN+ +
Sbjct: 111 EVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKI 164
Query: 760 SDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKK 817
G+ + I ++ P + + + Y + + S K D+YS G+VL EI TGK
Sbjct: 165 ICHGLEK-ILSSPPFKN---VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220
Query: 818 AVDN 821
+N
Sbjct: 221 PFEN 224
|
Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDW-ETRLKIAVGAAQGLA 729
+ N + L+ + G++L DY+ +G L+DLL K+ KL E + KI + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVK-KIIRQLVEALN 123
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFD-AHLSDFGIARCIPTAMPHASTFVLGTIGYIDP 788
LH IIH D+K N+L D D +L D+G+ + I + GT+ Y P
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCYDGTLDYFSP 175
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILTG----KKAVDNESNLHQL 828
E + D ++ G++ E+LTG K+ D E +L L
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219
|
Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 41/219 (18%)
Query: 623 IVGYGASSTVYKCALK----NSRPIAVK--KLYNQYPHNLREFETELETIGSIRHRNIVS 676
I+G G +V + L + +AVK KL + EF +E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 677 LHGYAL------SPYGNLLFYDYMVNGSLWDLL-----HGPSKKVKLDWETRLKIAVGAA 725
L G ++ +M +G L L G +K+ L +T LK V A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIA 123
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA----------MPHA 775
G+ YL N IHRD+ + N ++ E+ ++DFG+++ I + MP
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP-- 178
Query: 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
+ +I E KSDV++FG+ + EI T
Sbjct: 179 -------VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 2e-10
Identities = 64/233 (27%), Positives = 95/233 (40%), Gaps = 46/233 (19%)
Query: 623 IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN------LREFETELETIGSIRHRNIV 675
+G GA V + R +A+KK+ N + LRE ++ + +RH NI+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE----IKLLRHLRHENII 62
Query: 676 SLHGYALSPYGNLLFYD-YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ-------- 726
L L P F D Y+V +L+ KV ++ + Q
Sbjct: 63 GLLD-ILRPPSPEDFNDVYIVT----ELMETDLHKV---IKSPQPLTDDHIQYFLYQILR 114
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR--CIPTAMPHASTFVLGTIG 784
GL YLH N +IHRD+K SNIL++ N D + DFG+AR T + T
Sbjct: 115 GLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 785 YIDPE-------YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM 830
Y PE Y + D++S G + E+LT K + QL +
Sbjct: 172 YRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 23/222 (10%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRP---IAVKKL---YNQYPHNLREFETELETIGSI 669
+NLS VG GA +V CA +++ +AVKKL + H R + EL + +
Sbjct: 20 QNLSP---VGSGAYGSV--CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHM 73
Query: 670 RHRNIVSLHGYALSPYGNLLFYD--YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
+H N++ L +P +L ++ Y+V + L+ K KL + + +G
Sbjct: 74 KHENVIGLLD-VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYID 787
L Y+H + IIHRD+K SN+ ++E+ + + DFG+AR M T + T Y
Sbjct: 133 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 185
Query: 788 PEYA-HTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
PE + N+ D++S G ++ E+LTG+ ++ QL
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 9/194 (4%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKK--LYNQYPHNLR-EFETELETIGSIRHRNIVSLHG 679
+G G S VY+ L + P+A+KK +++ R + E++ + + H N++ +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 680 YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWE-TRLKIAVGAAQGLAYLHHDCNPR 738
+ + + G L ++ K+ +L E T K V L ++H + R
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRR 126
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE 798
++HRD+K +N+ I L D G+ R + A + V GT Y+ PE H + N
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185
Query: 799 KSDVYSFGIVLLEI 812
KSD++S G +L E+
Sbjct: 186 KSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 43/130 (33%), Positives = 64/130 (49%), Gaps = 6/130 (4%)
Query: 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKS 746
+L F +NG DL+ + D A GL +LH II+RD+K
Sbjct: 70 HLFFVMEYLNGG--DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKL 124
Query: 747 SNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFG 806
N+L+D++ ++DFG+ + ASTF GT YI PE + NE D +SFG
Sbjct: 125 DNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNESVDWWSFG 183
Query: 807 IVLLEILTGK 816
++L E+L G+
Sbjct: 184 VLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 39/103 (37%), Positives = 51/103 (49%), Gaps = 1/103 (0%)
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI 293
L L L G IP I ++ L ++LS N + G IPP LG+++ L L N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 294 PPELGNMSKLSYLQLQNNQLVGTIPAELG-KLEQLFELNLADN 335
P LG ++ L L L N L G +PA LG +L N DN
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 30/204 (14%)
Query: 624 VGYGASSTVYKCALKNSRPI-AVKKLYNQYPHNLREFE---TELETIGSIRHRNIVSLHG 679
+G G+ V K S A+K L L++ E E + SIRH +V+L+G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 680 YALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVG---AAQ---GLAYLH 732
+ NL L +Y+ G L+ L +K R V AAQ L YLH
Sbjct: 69 -SFQDDSNLYLVMEYVPGGELFSHL----RKSG-----RFPEPVARFYAAQVVLALEYLH 118
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL-GTIGYIDPEYA 791
+ I++RD+K N+L+D + ++DFG A+ + T+ L GT Y+ PE
Sbjct: 119 S-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEII 170
Query: 792 HTSRLNEKSDVYSFGIVLLEILTG 815
+ + D ++ GI++ E+L G
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
H NIV+L G L+ +Y G L + L + L E L + A+G+A+
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAF 156
Query: 731 L-HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT----IGY 785
L +C IHRD+ + N+L+ + DFG+AR I M ++ V G + +
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI---MNDSNYVVKGNARLPVKW 209
Query: 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
+ PE +SDV+S+GI+L EI +
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 11/210 (5%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFET---ELETIGSIRHRNIVSLHG 679
+VG GA V KC K ++ I K + N ET EL+ + +++ NIV L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK- 66
Query: 680 YALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR 738
A G L L ++Y V ++ +LL V + K+ Q + +H
Sbjct: 67 EAFRRRGKLYLVFEY-VEKNMLELLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHKND 120
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE 798
I+HRD+K N+LI N L DFG AR + T + T Y PE + +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 799 KSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
D++S G +L E+ G+ ES + QL
Sbjct: 181 AVDMWSVGCILGELSDGQPLFPGESEIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 37/107 (34%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS--TFVLGTIG 784
GL Y+H N ++HRD+K SN+L++ N D + DFG+AR H T + T
Sbjct: 118 GLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 785 YIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDNESNLHQLIM 830
Y PE S+ K+ D++S G +L E+L+ + + LHQL +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL 221
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK 388
LNL+ N L +P ++S +L+ + S + NL L L+L+ N +
Sbjct: 51 ALNLSSNTLLL-LPSSLSRLLSLDLLS-PSGISSLDGSENLLNLLPLPSLDLNLNRLR-S 107
Query: 389 VPTELGRIINLDTLDLSVNNFSGSVPASIGDL-EHLLTLNLSRNHLNGLLPAEFGNLRSI 447
+EL + NL +LDL NN + +P IG L +L L+LS N + LP+ NL ++
Sbjct: 108 NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNL 165
Query: 448 QTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSG 507
+ +D+SFN LS +P L L N+ +L L+ N + +P ++ +L L++S N++
Sbjct: 166 KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSIIE 223
Query: 508 IIPPIRNFSRFSSNSFIGNPLLC 530
++ + N S N L
Sbjct: 224 LLSSLSNLKNLSGLELSNNKLED 246
|
Length = 394 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 620 EKY----IVGYGASSTVYKCALKNSRPI-AVKKLYNQY--PHNLREFETELETIGSIRHR 672
EKY +G G+ V+KC + + I A+KK P + E+ + ++H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 673 NIVSLHG-YALSPYGNLLFY--DYMVNGSLWDLLHG-PSKKVKLDWETRLKIAVGAAQGL 728
N+V+L + +L+F D+ V L G P +K KI Q +
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAV 113
Query: 729 AYLH-HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYID 787
+ H H+C IHRDVK NILI + L DFG AR I T T + T Y
Sbjct: 114 NFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDYTDYVATRWYRA 168
Query: 788 PEY-AHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
PE ++ DV++ G V E+LTG+ +S++ QL
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 8/89 (8%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
G+ LH IIHRD+K N+LID+ L+DFG++R + +GT Y+
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYL 160
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
PE ++ SD +S G V+ E L G
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 5e-10
Identities = 48/154 (31%), Positives = 70/154 (45%), Gaps = 20/154 (12%)
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL----GTI 783
L Y+H + +IHRD+K SNIL++ + L+DFG+AR + + VL T
Sbjct: 120 LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 784 GYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDNESNLHQL--IM------SKAD 834
Y PE S K D++S G +L E+L GK S L+QL I+ S D
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236
Query: 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTK 868
+E++ + T +D R L L K
Sbjct: 237 ----IESIKSPFAATMLDSLPSRPRKPLDELLPK 266
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 71/261 (27%), Positives = 111/261 (42%), Gaps = 42/261 (16%)
Query: 624 VGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFET----ELETIGSIRHRNIVSLH 678
+G G V C +K + + A KKL ++ R+ E E + + + R IVSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL-DKKRLKKRKGEQMALNEKKILEKVSSRFIVSL- 58
Query: 679 GYALSPYGNLLFYDYMVNGSLWDL-LHGPSKKVKLDWETRLKIAVGAAQ---GLAYLHHD 734
YA +L ++NG DL H + E R AAQ GL +LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGG--DLKYHIYNVGEPGFPEARAIFY--AAQIICGLEHLH-- 112
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM-PHASTFVLGTIGYIDPEYAHT 793
RI++RD+K N+L+D++ + +SD G+A + GT GY+ PE
Sbjct: 113 -QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQG 168
Query: 794 SRLNEKSDVYSFGIVLLEILTG-------KKAVDNESNLHQLIMSKA----DDNT----- 837
+ D ++ G L E++ G K+ V+ E L + + A D +
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-ELKRRTLEMAVEYPDKFSPEAKD 227
Query: 838 VMEAV---DPEVSVTCVDLSA 855
+ EA+ DPE + C SA
Sbjct: 228 LCEALLQKDPEKRLGCRGGSA 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
I+G G VY C ++ + K ++ +++ ET ++ R ++SL
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL-----ALNERIMLSLVSTGD 55
Query: 683 SPYGNLLFYDYMVNGSL---WDLLHGPSKKVKLDWE---TRLKIAVGAAQGLAYLHHDCN 736
P+ + Y + L DL++G L + ++ A + + L H N
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT-SR 795
+++RD+K +NIL+DE+ +SD G+A PHAS +GT GY+ PE +
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGTA 172
Query: 796 LNEKSDVYSFGIVLLEILTG 815
+ +D +S G +L ++L G
Sbjct: 173 YDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKK--LYNQYPHNLRE-FETELETIGSIRHRNIVS-LH 678
+G G S VY+ L + +P+A+KK ++ R+ E++ + + H N++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWE-TRLKIAVGAAQGLAYLHHDCNP 737
+ N++ + G L ++ K+ +L E T K V + ++H +
Sbjct: 70 SFIEDNELNIVL-ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SR 125
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLN 797
R++HRD+K +N+ I L D G+ R + A + V GT Y+ PE H + N
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 184
Query: 798 EKSDVYSFGIVLLEI 812
KSD++S G +L E+
Sbjct: 185 FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 70/259 (27%), Positives = 115/259 (44%), Gaps = 30/259 (11%)
Query: 643 IAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWD 701
+AVK L N R +F E++ + ++ NI+ L ++ + +YM NG L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 702 LL--HGP------SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE 753
L H P + V + + T + +A A G+ YL + +HRD+ + N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGK 165
Query: 754 NFDAHLSDFGIARCIPTAMPH--ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLE 811
N+ ++DFG++R + + + VL I ++ E + SDV++FG+ L E
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 812 ILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV------TCVDLSAVRKTFQLALL 865
ILT K E QL + +NT D V C D ++L L
Sbjct: 225 ILTLCK----EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDS-----LYKLMLS 275
Query: 866 CTKRYPSERPTMQEVARVL 884
C +R ERP+ QE+ L
Sbjct: 276 CWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 24/232 (10%)
Query: 658 EFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL-------HGPSKKV 710
EF E + ++V L G L+ + M G L L +
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 711 KLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI-P 769
+ +++A A G+AYL+ + + +HRD+ + N ++ E+F + DFG+ R I
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQL 828
T L + ++ PE SDV+SFG+VL EI T ++ SN L
Sbjct: 172 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231
Query: 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
VME + C D+ F+L +C + P RP+ E+
Sbjct: 232 -------RFVMEGGLLDKPDNCPDM-----LFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 36/235 (15%)
Query: 35 NSSLSVVSLNLSSLNLGG----EISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVH 90
+ ++ NL L+L + + +L NL+++D N L+ +P + N +L +
Sbjct: 132 PPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN 190
Query: 91 IELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEI 150
++LS N D+P I L LE L+L NN + + S+L+ + NL L+L+ N+L
Sbjct: 191 LDLSGN-KISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLP 248
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEI 210
+ + L+ L L N + + S+G+ T+
Sbjct: 249 ESIGNLSN-LETLDLSNNQI--------------------------SSISSLGSLTNLRE 281
Query: 211 LDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENEL 265
LD+S N ++ I L + L LT K E+ L L ++ N
Sbjct: 282 LDLSGNSLS-NALPLIALLLLLLELLLNLLLTLKALEL-KLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 15/176 (8%)
Query: 661 TELETIGSIRHRN-IVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRL 718
TE + + IR +V+LH YA L L DY+ G L+ L S++ + E +
Sbjct: 53 TERQVLEHIRQSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHL---SQRERFK-EQEV 107
Query: 719 KIAVGA-AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777
+I G L +LH II+RD+K NIL+D N L+DFG+++ +
Sbjct: 108 QIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY 164
Query: 778 FVLGTIGYIDPEYAH--TSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLI 829
GTI Y+ P+ ++ D +S G+++ E+LTG VD E N I
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 56/203 (27%), Positives = 84/203 (41%), Gaps = 23/203 (11%)
Query: 627 GASSTVYKCALKNSRPI-AVKKLYNQYPHNLREFE---TELETIGSIRHRNIVSLHGYAL 682
GA V+ K++ I A+K + + + TE + + + +V L+ Y+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 683 SPYGNL-LFYDYMVNGSLWDLLH--GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739
NL L +Y+ G L LL G LD + L YLH + I
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVG-----SLDEDVARIYIAEIVLALEYLH---SNGI 114
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIAR-------CIPTAMPHASTFVLGTIGYIDPEYAH 792
IHRD+K NILID N L+DFG+++ ++GT YI PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 793 TSRLNEKSDVYSFGIVLLEILTG 815
++ D +S G +L E L G
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 60/234 (25%), Positives = 106/234 (45%), Gaps = 37/234 (15%)
Query: 622 YIVGYGASSTVYKCALKNS--RPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHG 679
+G G++ V+ A+ + + +AVKK+ P +++ E++ I + H NIV ++
Sbjct: 11 RPLGCGSNGLVFS-AVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVY- 68
Query: 680 YALSPYGNLLFYD----------YMV----NGSLWDLL-HGP--SKKVKLDWETRLKIAV 722
L P G+ L D Y+V L ++L GP + +L L+
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR--- 125
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAMPHASTFVLG 781
GL Y+H + ++HRD+K +N+ I+ E+ + DFG+AR + H G
Sbjct: 126 ----GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 782 TIG--YIDPEYA-HTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIM 830
+ Y P + + D+++ G + E+LTGK A +E QLI+
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCAL----KNSR-PIAVKKLY-NQYPHNLREFETELE 664
I++ TE L + ++G GA TVYK +N + P+A+K L N P +E E
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 665 TIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ + + L G L+ L+ M G L D + K ++ + L V
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQLV-TQLMPYGCLLD--YVRENKDRIGSQDLLNWCVQI 118
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC--IPTAMPHASTFVLGT 782
A+G++YL R++HRD+ + N+L+ ++DFG+AR I HA +
Sbjct: 119 AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-P 174
Query: 783 IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVD 820
I ++ E R +SDV+S+G+ + E++T G K D
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 626 YGASSTVYKCALKNSRPIAVKKL---YNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
YG+ + Y L+ + +AVKKL + H R + EL + ++H N++ L
Sbjct: 28 YGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD-VF 83
Query: 683 SPYGNLLFYD--YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRII 740
+P ++ ++ Y+V + L+ K KL E + +GL Y+H + II
Sbjct: 84 TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SAGII 140
Query: 741 HRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE----YAHTSRL 796
HRD+K SN+ ++E+ + + DFG+AR M T + T Y PE + H
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYRAPEIMLNWMH---Y 193
Query: 797 NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
N+ D++S G ++ E+L GK + QL
Sbjct: 194 NQTVDIWSVGCIMAELLKGKALFPGNDYIDQL 225
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 29/232 (12%)
Query: 613 RSTENLSEKYIVGYGASSTVYKCALKNSRPI-AVKKLYNQYPHN------LREFETELET 665
RS + +G G VY+ S I A+KK+ + LRE +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITL 59
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLF--YDYMVN--GSLWDLLHGPSKKVKLDWETRLK-I 720
+ ++RH NIV L + + + +F +Y SL D + P E+++K +
Sbjct: 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFS------ESQVKCL 113
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS-TFV 779
+ +GL YLH + IIHRD+K SN+L+ + ++DFG+AR +P T
Sbjct: 114 MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPK 168
Query: 780 LGTIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDNESNLHQLIM 830
+ T+ Y PE + D+++ G +L E+L K + +S + QL +
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 37/229 (16%)
Query: 614 STENLSEKYIVGYGASSTVYKCALKNSR----PIAVKKLYNQYPHNLRE-FETELETIGS 668
E+++ +G G VY+ + +AVK N ++RE F E +
Sbjct: 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 669 IRHRNIVSLHG----------YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL 718
H +IV L G L+P G L Y L K LD + +
Sbjct: 64 FDHPHIVKLIGVITENPVWIVMELAPLGELRSY-----------LQ--VNKYSLDLASLI 110
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP-TAMPHAST 777
+ + LAYL + R +HRD+ + N+L+ L DFG++R + + AS
Sbjct: 111 LYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK 167
Query: 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNE 822
L I ++ PE + R SDV+ FG+ + EIL G K V N
Sbjct: 168 GKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN 215
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 30/87 (34%), Positives = 47/87 (54%)
Query: 282 LYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPI 341
L L L G IP ++ + L + L N + G IP LG + L L+L+ N+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 342 PHNISSCTALNQFNVHGNRLSGAIPSS 368
P ++ T+L N++GN LSG +P++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 20/196 (10%)
Query: 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI 751
+YM GSL L G + + +I +GL +L + N IIHRDVK +N+L+
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLV 136
Query: 752 DENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE------KSDVYSF 805
+ N L DFG++ + ++ + +G Y+ PE + N+ +SDV+S
Sbjct: 137 NGNGQVKLCDFGVSGNLVASLAKTN---IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSL 193
Query: 806 GIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALL 865
G+ +LE+ G+ E+ + A + + S D A
Sbjct: 194 GLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVA---------K 244
Query: 866 CTKRYPSERPTMQEVA 881
C + P+ RPT ++
Sbjct: 245 CLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 7/90 (7%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
GL ++H N +++RD+K +NIL+DE+ +SD G+A PHAS +GT GY+
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162
Query: 787 DPE-YAHTSRLNEKSDVYSFGIVLLEILTG 815
PE + +D +S G +L ++L G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 49/183 (26%), Positives = 77/183 (42%), Gaps = 46/183 (25%)
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIG 784
A+G+ +L + + IHRD+ + NIL+ EN + DFG+AR I
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI---------------- 223
Query: 785 YIDPEYAHT--SRL---------------NEKSDVYSFGIVLLEILTGKKAVDNESNLHQ 827
Y DP+Y +RL +SDV+SFG++L EI + + + +
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283
Query: 828 LIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887
+ + T M A PE A + + + L C P +RPT E+ +L L
Sbjct: 284 EFCRRLKEGTRMRA--PE--------YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333
Query: 888 LPA 890
L
Sbjct: 334 LQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 30/228 (13%)
Query: 661 TELETIGSIRHRNIVSLHG-YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLK 719
TE + +I H +I+ L G + + + L+ Y DL + K + L
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-----DLYCYLAAKRNIAICDILA 186
Query: 720 IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF- 778
I + + YLH RIIHRD+K+ NI I+ D L DFG A C P + +
Sbjct: 187 IERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYG 242
Query: 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAV----------DNESNLHQL 828
GTI PE D++S GIVL E+ T ++ D++ + +L
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI-KL 301
Query: 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT 876
I+ ++ + +D + + + + + + R P RP
Sbjct: 302 IIRRSGTHPNEFPIDAQ--------ANLDEIYIGLAKKSSRKPGSRPL 341
|
Length = 391 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
GL LH + RI++RD+K NIL+D++ +SD G+A +P +GT+GY+
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGYM 168
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
PE R D ++ G +L E++ G+
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 24/192 (12%)
Query: 706 PSKKVKLDWETRLKI------AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759
P ++ W++ L + + A+G+ +L + + IHRD+ + NIL+ EN +
Sbjct: 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKI 215
Query: 760 SDFGIARCI---PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
DFG+AR I P + S + + ++ PE +SDV+SFG++L EI +
Sbjct: 216 CDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 817 KAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT 876
+ +++ + D T M A PE A + +++ L C + P ERPT
Sbjct: 274 ASPYPGVQINEEFCQRLKDGTRMRA--PEN--------ATPEIYRIMLACWQGDPKERPT 323
Query: 877 MQEVARVLVSLL 888
+ +L LL
Sbjct: 324 FSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 61/258 (23%), Positives = 106/258 (41%), Gaps = 29/258 (11%)
Query: 638 KNSRPIAVKKLYNQYPHNLRE-FETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696
K P+A+ L R F E T+G H NIV L G ++ +YM N
Sbjct: 31 KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSN 90
Query: 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756
G+L L + +L + + G A G+ YL +H+ + + +L++ +
Sbjct: 91 GALDSFLR--KHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLV 145
Query: 757 AHLSDFG-----IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLE 811
+S F + I T M S + + PE + SDV+SFGIV+ E
Sbjct: 146 CKISGFRRLQEDKSEAIYTTMSGKSPVL-----WAAPEAIQYHHFSSASDVWSFGIVMWE 200
Query: 812 ILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRY 870
+++ G++ + S Q ++ +D + A C +L QL L C ++
Sbjct: 201 VMSYGERPYWDMS--GQDVIKAVEDGFRLPA-----PRNCPNL-----LHQLMLDCWQKE 248
Query: 871 PSERPTMQEVARVLVSLL 888
ERP ++ +L ++
Sbjct: 249 RGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 67/276 (24%), Positives = 117/276 (42%), Gaps = 47/276 (17%)
Query: 632 VYKCALKNSRP------IAVKKLYNQYPHNLRE-FETELETIGSIRHRNIVSLHGYALSP 684
VYK L + P +A+K L ++ LRE F+ E ++H NIV L G
Sbjct: 21 VYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80
Query: 685 YGNLLFYDYMVNGSLWDLL--HGP---------SKKVK--LDWETRLKIAVGAAQGLAYL 731
+ + Y + L + L P K VK L+ + I A G+ +L
Sbjct: 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL 140
Query: 732 --HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT----IGY 785
HH ++H+D+ + N+L+ + + +SD G+ R + A + ++G I +
Sbjct: 141 SSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK---LMGNSLLPIRW 192
Query: 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDP 844
+ PE + + SD++S+G+VL E+ + G + SN V+E +
Sbjct: 193 MSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----------QDVIEMIRN 241
Query: 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ C D + L L C +PS RP +++
Sbjct: 242 RQVLPCPD-DCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 5e-09
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 29/206 (14%)
Query: 624 VGYGASSTVYKCALKNSRPI-AVKKLYNQYPH-----NLREFETELETIGSIR----HRN 673
+G G +VY K + + A+KK+ ++ NLRE + S+R H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLRE-------VKSLRKLNEHPN 59
Query: 674 IVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLK-IAVGAAQGLAYL 731
IV L L F ++YM G+L+ L+ +K K E+ ++ I QGLA++
Sbjct: 60 IVKLKE-VFRENDELYFVFEYM-EGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE-Y 790
H HRD+K N+L+ ++DFG+AR I + P+ + +V T Y PE
Sbjct: 116 HKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEIL 170
Query: 791 AHTSRLNEKSDVYSFGIVLLEILTGK 816
++ + D+++ G ++ E+ T +
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLRE----FETELETIGSIRHRNIVSLH 678
++G GA V +K++ I K+ N++ R F E + + + I +LH
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 679 GYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA--VGAAQGLAYLHHDC 735
YA L L DY V G L LL ++ D R IA V A + LH+
Sbjct: 68 -YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYIAEMVLAIHSIHQLHY-- 123
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT-- 793
+HRD+K N+L+D N L+DFG + S+ +GT YI PE
Sbjct: 124 ----VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 794 ---SRLNEKSDVYSFGIVLLEILTGKKAVDNES 823
+ + D +S G+ + E+L G+ ES
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-09
Identities = 31/113 (27%), Positives = 57/113 (50%), Gaps = 24/113 (21%)
Query: 115 LNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGML 174
L L N L G IP+ ++++ +L++++L+ N + G IP
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP----------------------- 459
Query: 175 SPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIG 227
P + +T L D+ N+ G+IP+S+G TS IL+++ N ++G +P +G
Sbjct: 460 -PSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 29/193 (15%)
Query: 643 IAVKKLY-NQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMVNGSLW 700
+AVK L N +L + +E+E + I +H+NI++L G + +Y G+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 701 DLLH-----GP--------SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSS 747
+ L GP + +L ++ + A A+G+ YL + R IHRD+ +
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR 163
Query: 748 NILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT------IGYIDPEYAHTSRLNEKSD 801
N+L+ E+ ++DFG+AR + H + T + ++ PE +SD
Sbjct: 164 NVLVTEDNVMKIADFGLARGV-----HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSD 218
Query: 802 VYSFGIVLLEILT 814
V+SFGI++ EI T
Sbjct: 219 VWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 23/245 (9%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLRE----FETELETIGSIRHRNIVSLH 678
++G GA V +KN+ + K+ N++ R F E + + + R I +LH
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 679 GYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA--VGAAQGLAYLHHDC 735
YA NL L DY V G L LL ++ D R +A V A + L +
Sbjct: 68 -YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYLAEMVLAIDSVHQLGY-- 123
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH--- 792
+HRD+K N+L+D+N L+DFG + S +GT YI PE
Sbjct: 124 ----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 793 --TSRLNEKSDVYSFGIVLLEILTGKKAVDNES--NLHQLIMSKADDNTVMEAVDPEVSV 848
R + D +S G+ + E+L G+ ES + IM+ ++ +VS
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH-KEHFQFPPDVTDVSE 238
Query: 849 TCVDL 853
DL
Sbjct: 239 EAKDL 243
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 53/195 (27%), Positives = 95/195 (48%), Gaps = 23/195 (11%)
Query: 638 KNSRPIAVKKLY-NQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNL-LFYDYM 694
K + +AVK L + +L + +E+E + I +H+NI++L G A + G L + +Y
Sbjct: 45 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYA 103
Query: 695 VNGSLWDLLHG---PSKKVKLD----------WETRLKIAVGAAQGLAYLHHDCNPRIIH 741
G+L + L P + D ++ + A+G+ YL + + IH
Sbjct: 104 SKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIH 160
Query: 742 RDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG--TIGYIDPEYAHTSRLNEK 799
RD+ + N+L+ EN ++DFG+AR + + T G + ++ PE +
Sbjct: 161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT-TNGRLPVKWMAPEALFDRVYTHQ 219
Query: 800 SDVYSFGIVLLEILT 814
SDV+SFG+++ EI T
Sbjct: 220 SDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 64/266 (24%), Positives = 110/266 (41%), Gaps = 44/266 (16%)
Query: 643 IAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSLHGYALS--PYGNLLFYDYMVNGSL 699
+AVK L N R +F E++ + + NI L G P ++ +YM NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIM--EYMENGDL 106
Query: 700 WDLLH--------GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI 751
L L + T L +A A G+ YL + +HRD+ + N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV 163
Query: 752 DENFDAHLSDFGIARCIPTA----------MPHASTFVLGTIGYIDPEYAHTSRLNEKSD 801
+N+ ++DFG++R + ++ +P I ++ E + KSD
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP---------IRWMAWESVLLGKFTTKSD 214
Query: 802 VYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV--RK 858
V++FG+ L EILT ++ Q+I +N D + + +
Sbjct: 215 VWAFGVTLWEILTLCREQPYEHLTDQQVI-----ENAGHFFRDDGRQI-YLPRPPNCPKD 268
Query: 859 TFQLALLCTKRYPSERPTMQEVARVL 884
++L L C +R +RPT +E+ L
Sbjct: 269 IYELMLECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 53/159 (33%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 674 IVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA--VGAAQGLAY 730
+V+LH YA L L DY+ G L+ L+ + E R+ IA V A L +
Sbjct: 67 LVTLH-YAFQTDTKLHLILDYVNGGELFTHLY-QREHFTES-EVRVYIAEIVLA---LDH 120
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR-CIPTAMPHASTFVLGTIGYIDPE 789
LH II+RD+K NIL+D L+DFG+++ + A +F GTI Y+ PE
Sbjct: 121 LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPE 176
Query: 790 YAHT--SRLNEKSDVYSFGIVLLEILTGKK--AVDNESN 824
++ D +S G++ E+LTG VD E N
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 55/254 (21%)
Query: 616 ENLSEKYI-----VGYGASSTVYKCA-LKNSRPIAVKKLYN-QYPHNLRE---------- 658
++SE+YI +G G V K + +A+KK+ + +++ +
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 659 -FET--ELETIGSIRHRNIVSLHG-YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDW 714
F T EL+ + I+H NI+ L Y + NL+ D++ KKV +D
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVM----------DIMASDLKKV-VDR 112
Query: 715 ETRLK------IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768
+ RL I + GL LH +HRD+ +NI I+ ++DFG+AR
Sbjct: 113 KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRY 169
Query: 769 PTAMPHASTFVLG-------------TIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILT 814
+ T+ Y PE + + + D++S G + E+LT
Sbjct: 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
Query: 815 GKKAVDNESNLHQL 828
GK E+ + QL
Sbjct: 230 GKPLFPGENEIDQL 243
|
Length = 335 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 624 VGYGASSTVYKCALKNSR---PIAVKKL---YNQYPHNLREFETELETIGSIRHRNIVSL 677
+G GA V CA ++ +AVKKL + H R + EL + + H+NI+SL
Sbjct: 29 IGSGAQGIV--CAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 85
Query: 678 HGY-----ALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH 732
+L + ++ +++ +L ++H ++LD E + G+ +LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH 140
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH 792
+ IIHRD+K SNI++ + + DFG+AR T V T Y PE
Sbjct: 141 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVIL 195
Query: 793 TSRLNEKSDVYSFGIVLLEILTG 815
E D++S G ++ E++ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 56/190 (29%), Positives = 79/190 (41%), Gaps = 23/190 (12%)
Query: 674 IVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH 732
IV LH YA L + +YM G L +L+ + + W R A L +H
Sbjct: 105 IVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKW-ARFYTA-EVVLALDAIH 159
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI---PTAMPHASTFVLGTIGYIDPE 789
+ IHRDVK N+L+D++ L+DFG C+ M T V GT YI PE
Sbjct: 160 ---SMGFIHRDVKPDNMLLDKSGHLKLADFGT--CMKMDANGMVRCDTAV-GTPDYISPE 213
Query: 790 Y----AHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES--NLHQLIMSKADDNTVMEAVD 843
+ D +S G+ L E+L G +S + IM N++ D
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDD 271
Query: 844 PEVSVTCVDL 853
E+S DL
Sbjct: 272 IEISKQAKDL 281
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 66/244 (27%), Positives = 107/244 (43%), Gaps = 47/244 (19%)
Query: 609 DDIMRSTENLSEKYI----VGYGASSTVYKCA---LKNSRPIAVKKLYNQYPHNL---RE 658
+++ ++ L E+Y VG GA +V C+ + +A+KKL + + R
Sbjct: 4 EEVNKTVWELPERYTSLKQVGSGAYGSV--CSAIDKRTGEKVAIKKLSRPFQSEIFAKRA 61
Query: 659 FETELETIGSIRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLW-DL-----LHGPSKKVK 711
+ EL + ++H N++ L S F D Y+V + DL KV+
Sbjct: 62 YR-ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ 120
Query: 712 LDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771
L GL Y+H + IIHRD+K N+ ++E+ + + DFG+AR
Sbjct: 121 YLVYQMLC-------GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR----- 165
Query: 772 MPHASTFVLG---TIGYIDPE----YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN 824
HA + G T Y PE + H N+ D++S G ++ E+LTGK +
Sbjct: 166 --HADAEMTGYVVTRWYRAPEVILNWMH---YNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220
Query: 825 LHQL 828
L QL
Sbjct: 221 LDQL 224
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 724 AAQ---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
AA+ GL LH + RI++RD+K NIL+D+ +SD G+A IP +
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR--V 162
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
GT+GY+ PE R D + G ++ E++ GK
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 31/108 (28%), Positives = 57/108 (52%), Gaps = 7/108 (6%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV---LGTI 783
GL Y+H +IHRD+K SN+L++E+ + + DFG+AR + ++ F+ + T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 784 GYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM 830
Y PE + D++S G + E+L ++ ++ +HQL +
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL 223
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 40/224 (17%)
Query: 624 VGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGS--IR---------H 671
+G G VYK K + +A+KK+ +TE E + S IR H
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI---------RLDTETEGVPSTAIREISLLKELNH 58
Query: 672 RNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA------ 725
NIV L + L ++++ + L + + + + + +
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPL-------SGIPLPLIKSYLFQLL 110
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY 785
QGLA+ H + R++HRD+K N+LI+ L+DFG+AR + T + T+ Y
Sbjct: 111 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWY 166
Query: 786 IDPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDNESNLHQL 828
PE + + D++S G + E++T + +S + QL
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 8/109 (7%)
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL-GTI 783
A GL +LH + II+RD+K N+++D ++DFG+ C +T GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGM--CKENIFGGKTTRTFCGTP 165
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVD--NESNLHQLIM 830
YI PE + D ++FG++L E+L G+ D +E L Q IM
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNS---RPIAVKKL---YNQYPHNLREFETELE 664
+++ +NL +G GA V CA ++ R +A+KKL + H R + EL
Sbjct: 22 VLKRYQNLKP---IGSGAQGIV--CAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELV 75
Query: 665 TIGSIRHRNIVSLHGYALSPYGNLL-FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVG 723
+ + H+NI+ L +P +L F D + L D +++LD E +
Sbjct: 76 LMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 724 AAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTI 783
G+ +LH + IIHRD+K SNI++ + + DFG+AR T+ V T
Sbjct: 135 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TR 189
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
Y PE E D++S G ++ E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 55/193 (28%), Positives = 98/193 (50%), Gaps = 29/193 (15%)
Query: 643 IAVKKLYNQYPH-NLREFETELETIGSI-RHRNIVSLHGYALSPYGNL-LFYDYMVNGSL 699
+AVK L + +L + +E+E + I +H+NI++L G A + G L + +Y G+L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNL 111
Query: 700 WDLL-----------HGPSK--KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKS 746
+ L + P++ + +L ++ + A A+G+ YL + + IHRD+ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168
Query: 747 SNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIG-----YIDPEYAHTSRLNEKSD 801
N+L+ E+ ++DFG+AR I H + T G ++ PE +SD
Sbjct: 169 RNVLVTEDNVMKIADFGLARDI----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 802 VYSFGIVLLEILT 814
V+SFG++L EI T
Sbjct: 225 VWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 46/183 (25%)
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIG 784
A+G+ +L + + IHRD+ + NIL+ EN + DFG+AR I
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI---------------- 229
Query: 785 YIDPEYAHT--SRLNEK---------------SDVYSFGIVLLEILTGKKAVDNESNLHQ 827
Y DP+Y +RL K SDV+SFG++L EI + + + +
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289
Query: 828 LIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887
+ + T M A P+ + + +Q L C PS+RPT E+ L +L
Sbjct: 290 EFCRRLKEGTRMRA--PDYTTP--------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
Query: 888 LPA 890
L A
Sbjct: 340 LQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 49/275 (17%)
Query: 643 IAVKKLY-NQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWD 701
+AVK L N LR+ +E + + H +++ L+G LL +Y GSL
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 702 LLHGPSKKVK----------------------LDWETRLKIAVGAAQGLAYLHHDCNPRI 739
L S+KV L + A ++G+ YL ++
Sbjct: 93 FLR-ESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKL 148
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCI---PTAMPHASTFVLGTIGYIDPEYAHTSRL 796
+HRD+ + N+L+ E +SDFG++R + + + + + + ++ E
Sbjct: 149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI--PVKWMAIESLFDHIY 206
Query: 797 NEKSDVYSFGIVLLEILT-GKKAVDN--ESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853
+SDV+SFG++L EI+T G L L+ T PE C +
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL------KTGYRMERPE---NCSE- 256
Query: 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ + L L C K+ P +RPT ++++ L ++
Sbjct: 257 ----EMYNLMLTCWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 9/147 (6%)
Query: 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKS 746
NL F +NG DL+ K D A GL +LH + I++RD+K
Sbjct: 70 NLFFVMEYLNGG--DLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKL 124
Query: 747 SNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFG 806
NIL+D + ++DFG+ + TF GT YI PE + N D +SFG
Sbjct: 125 DNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNTSVDWWSFG 183
Query: 807 IVLLEILTGKK---AVDNESNLHQLIM 830
++L E+L G+ D E + M
Sbjct: 184 VLLYEMLIGQSPFHGHDEEELFQSIRM 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 61/238 (25%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 618 LSEKYI----VGYGASSTVYKCALKNS---RPIAVKKLYNQYPHNLREFET--ELETIGS 668
+ KY+ +G GA V C+ KNS +A+KK+ N + + + T E++ +
Sbjct: 3 VDTKYVPIKPIGRGAYGIV--CSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60
Query: 669 IRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ- 726
+ H N++++ + P F D Y+V ++L+ +T L + ++Q
Sbjct: 61 LDHENVIAIKD-IMPPPHREAFNDVYIV----YELM-----------DTDLHQIIRSSQT 104
Query: 727 ---------------GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771
GL Y+H + ++HRD+K SN+L++ N D + DFG+AR
Sbjct: 105 LSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161
Query: 772 MPHASTFVLGTIGYIDPE-YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ +V+ T Y PE + S DV+S G + E+L K + +HQL
Sbjct: 162 GDFMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL 218
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 46/150 (30%), Positives = 70/150 (46%), Gaps = 11/150 (7%)
Query: 668 SIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+++H +V LH ++ L F DY+ G L+ H ++ L+ R A A
Sbjct: 52 NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARF-YAAEIAS 107
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL-GTIGY 785
L YLH + I++RD+K NIL+D L+DFG+ C + +T GT Y
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGL--CKENIEHNGTTSTFCGTPEY 162
Query: 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
+ PE H + D + G VL E+L G
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 36/102 (35%), Positives = 49/102 (48%), Gaps = 5/102 (4%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
GL +LH +C I+HRD+K NIL+ L+DFG+AR M A T V+ T+ Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYR 174
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
PE S D++S G + E+ K S QL
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 10/157 (6%)
Query: 662 ELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
E+ + +++H NIV+LH + L ++Y+ + DL L +KI
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIF 108
Query: 722 V-GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
+ +GL+Y H +I+HRD+K N+LI+E + L+DFG+AR S V+
Sbjct: 109 MFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV 165
Query: 781 GTIGYIDPE-YAHTSRLNEKSDVYSFGIVLLEILTGK 816
T+ Y P+ ++ + D++ G +L E+ TG+
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 31/194 (15%)
Query: 643 IAVKKLYNQ-YPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNL-LFYDYMVNGSL 699
+AVK L + +L + +E+E + I +H+NI++L G A + G L + +Y G+L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVLVEYASKGNL 105
Query: 700 WDLLHG---PSKKVKLD----------WETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKS 746
+ L P D ++ + A A+G+ YL + + IHRD+ +
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAA 162
Query: 747 SNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT------IGYIDPEYAHTSRLNEKS 800
N+L+ E+ ++DFG+AR + H + T + ++ PE +S
Sbjct: 163 RNVLVTEDNVMKIADFGLARDV-----HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 217
Query: 801 DVYSFGIVLLEILT 814
DV+SFG++L EI T
Sbjct: 218 DVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 31/86 (36%), Positives = 49/86 (56%), Gaps = 5/86 (5%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
G+ Y+H RI+HRD+K+ NI + N + DFG++R + + A+TF GT Y+
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT-GTPYYM 172
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEI 812
PE + KSD++S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNS---RPIAVKKL---YNQYPHNLREFETELE 664
+++ +NL +G GA V CA ++ R +A+KKL + H R + EL
Sbjct: 15 VLKRYQNLKP---IGSGAQGIV--CAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELV 68
Query: 665 TIGSIRHRNIVSLHGYALSPYGNLL-FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVG 723
+ + H+NI+SL +P +L F D + L D +++LD E +
Sbjct: 69 LMKCVNHKNIISLLN-VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 127
Query: 724 AAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTI 783
G+ +LH + IIHRD+K SNI++ + + DFG+AR T+ V T
Sbjct: 128 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TR 182
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
Y PE E D++S G ++ E++ K
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 5/103 (4%)
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY 785
+GL +LH + R++HRD+K NIL+ + L+DFG+AR M A T V+ T+ Y
Sbjct: 121 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWY 175
Query: 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
PE S D++S G + E+ K S++ QL
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNL----REFETELETIGSIRHRNIVS-- 676
+GYGA V+ ++ + +A+KK+ N + NL R F EL+ + +H N++S
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFR-ELKMLCFFKHDNVLSAL 65
Query: 677 --LHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWE--TRLKIAVGAAQ---GLA 729
L + P+ + Y+V +L+ K+ + + + + V Q GL
Sbjct: 66 DILQPPHIDPFEEI----YVVT----ELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI-PTAMPHASTFVLGTIGYIDP 788
YLH + I+HRD+K N+L++ N + DFG+AR P H + V+ T Y P
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAP 173
Query: 789 EYAHTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM 830
E SR D++S G + E+L + +S + QL +
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 36/225 (16%)
Query: 614 STENLSEKYIVGYGASSTVYKCALKNSR------PIAVKKL-YNQYPHNLREFETELETI 666
++++ +G+GA VY+ + +AVK L + + +F E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 667 GSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLH----GPSKKVKLDWETRLKIAV 722
H+NIV L G + + + M G L L P + L + L A
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD---AHLSDFGIARCI----------P 769
A+G YL + IHRD+ + N L+ A ++DFG+AR I
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
+P I ++ PE K+DV+SFG++L EI +
Sbjct: 181 AMLP---------IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 63/235 (26%), Positives = 88/235 (37%), Gaps = 50/235 (21%)
Query: 623 IVGYGASSTVYK---------CALKNSR--------PI-AVKKLYNQYPHNLREFETELE 664
+G G VYK ALK R PI A++ E++
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---------------EIK 58
Query: 665 TIGSIRHRNIVSLHGYALSPYGNL----------LFYDYMVNGSLWDLLHGPSKKVKLDW 714
+ + HRNIV+L L L ++YM + L LL S V
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLE--SGLVHFSE 115
Query: 715 ETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774
+ +GL Y H +HRD+K SNIL++ L+DFG+AR +
Sbjct: 116 DHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 775 ASTFVLGTIGYIDPE-YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
T + T+ Y PE R DV+S G +L E+ T K L QL
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 52/207 (25%), Positives = 79/207 (38%), Gaps = 31/207 (14%)
Query: 627 GASSTVYKCALKNSRPIAVKK--LYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP 684
+ K + +AVKK L + +L+ + E+ T ++H NI+
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY--VTSFI 69
Query: 685 YGNLLF--YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV---GAAQGLAYLHHDCNPRI 739
+ L+ M GS DLL K + L IA L Y+H
Sbjct: 70 VDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALDYIHSK---GF 122
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCI---------PTAMPHASTFVLGTIGYIDPE- 789
IHR VK+S+IL+ + LS + + P +S L ++ PE
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEV 179
Query: 790 -YAHTSRLNEKSDVYSFGIVLLEILTG 815
+ NEKSD+YS GI E+ G
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 8/145 (5%)
Query: 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKS 746
+L F +NG DL+ K + D A GL +LH + II+RD+K
Sbjct: 70 HLFFVMEFLNGG--DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKL 124
Query: 747 SNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFG 806
N+++D + ++DFG+ + ASTF GT YI PE + D +SFG
Sbjct: 125 DNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSVDWWSFG 183
Query: 807 IVLLEILTGKKAV--DNESNLHQLI 829
++L E+L G+ D+E L + I
Sbjct: 184 VLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 31/220 (14%)
Query: 624 VGYGASSTVYKCALKNSRPI-AVKKLYNQYPHNLREFETELETIGS-----------IRH 671
+G G VYK K + I A+KK+ E+E E + S ++H
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI---------RLESEEEGVPSTAIREISLLKELQH 58
Query: 672 RNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYL 731
NIV L + L ++++ + L L K +D E QG+ +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC--IPTAMPHASTFVLGTIGYIDPE 789
H + R++HRD+K N+LID L+DFG+AR IP T + T+ Y PE
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---RVYTHEVVTLWYRAPE 171
Query: 790 YAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
S R + D++S G + E+ T K +S + QL
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 14/148 (9%)
Query: 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI-AVGAAQGLAYLH-HDCNPRIIHRDVK 745
L F VNG DL+ + K D E R + A L +LH H +I+RD+K
Sbjct: 71 LFFVMEYVNGG--DLMFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRHG----VIYRDLK 123
Query: 746 SSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL-GTIGYIDPEYAHTSRLNEKSDVYS 804
NIL+D L+DFG+ C + +T GT YI PE D ++
Sbjct: 124 LDNILLDAEGHCKLADFGM--CKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWA 181
Query: 805 FGIVLLEILTGKKA--VDNESNLHQLIM 830
G+++ E++ G+ DNE +L + I+
Sbjct: 182 LGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKI-AVG 723
+ +++H +V LH Y+ L F DY+ G L+ L ++ + E R + A
Sbjct: 50 LKNVKHPFLVGLH-YSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARFYAAE 104
Query: 724 AAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTI 783
A L YLH + II+RD+K NIL+D L+DFG+ + STF GT
Sbjct: 105 IASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTP 160
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
Y+ PE + D + G VL E+L G
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 44/149 (29%), Positives = 64/149 (42%), Gaps = 10/149 (6%)
Query: 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH-HDCNPRIIHRDVK 745
L F VNG DL+ + + D A GL +LH II+RD+K
Sbjct: 70 RLFFVMEYVNGG--DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG----IIYRDLK 123
Query: 746 SSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSF 805
N+L+D ++DFG+ + STF GT YI PE D ++
Sbjct: 124 LDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQPYGPAVDWWAL 182
Query: 806 GIVLLEILTGKKA--VDNESNLHQLIMSK 832
G++L E+L G+ D+E L Q I+
Sbjct: 183 GVLLYEMLAGQSPFEGDDEDELFQSILED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 47/149 (31%), Positives = 69/149 (46%), Gaps = 9/149 (6%)
Query: 668 SIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+++H +V LH Y+ L F DY+ G L+ H ++ L+ R A A
Sbjct: 52 NLKHPFLVGLH-YSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVAS 107
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
+ YLH + II+RD+K NIL+D L+DFG+ + STF GT Y+
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYL 163
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
PE + D + G VL E+L G
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 32/216 (14%)
Query: 623 IVGYGASST---VYKCALKNS---RPIAVKKL---YNQY----PHNLREFETELETIGSI 669
I G T VYK KN + A+KK QY RE E +
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE----L 59
Query: 670 RHRNIVSLHGYALSPYGNLLF--YDYMVNGSLWDLL--HGPSKKVKLDWETRLKIAVGAA 725
+H N+VSL L ++ +DY LW ++ H +K+V + +
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH----LSDFGIARCI--PTAMPHASTFV 779
G+ YLH + ++HRD+K +NIL+ + D G+AR P V
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 780 LGTIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILT 814
+ TI Y PE +R K+ D+++ G + E+LT
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 24/183 (13%)
Query: 712 LDWETRLKIAVGAAQGLAYL-HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770
LD + L+ + AQG+ +L +C IHRDV + N+L+ + A + DFG+AR I
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI-- 262
Query: 771 AMPHASTFVLGT----IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNL 825
M ++ V G + ++ PE +SDV+S+GI+L EI + GK
Sbjct: 263 -MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP----- 316
Query: 826 HQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885
++ + V ++ D A + + + +C P+ERPT ++++++
Sbjct: 317 -----GILVNSKFYKMVKRGYQMSRPDF-APPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
Query: 886 SLL 888
L
Sbjct: 371 RQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 9/172 (5%)
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
TE + + RH + SL Y+ L F VNG H ++V + TR
Sbjct: 44 TESRVLKNTRHPFLTSLK-YSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRF-Y 100
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
L YLH + +I++RD+K N+++D++ ++DFG+ + T TF
Sbjct: 101 GAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC- 156
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN--LHQLIM 830
GT Y+ PE + D + G+V+ E++ G+ N+ + L +LI+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 624 VGYGASSTVYKCALKNSRPI-AVKKLY-----NQYPHN-LREFETELETIGSIRHRNIVS 676
+G G TV+K + + I A+K++ P + LRE + + ++H+NIV
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELKHKNIVR 63
Query: 677 LHGYALSPYGNLLFYDYMVNG--SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD 734
L+ S L ++Y +D +G +D E +GLA+ H
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
++HRD+K N+LI++N + L+DFG+AR + S V+ T+ Y P+ +
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGA 174
Query: 795 RLNEKS-DVYSFGIVLLEI 812
+L S D++S G + E+
Sbjct: 175 KLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 63/226 (27%), Positives = 91/226 (40%), Gaps = 38/226 (16%)
Query: 620 EKYIVGYGASSTVYK-CALKNSRPIAVKKLYNQYPHNLREFETELETIGS---------- 668
EK +G G VYK +A+KK+ ETE E + S
Sbjct: 5 EK--IGEGTYGVVYKARDKLTGEIVALKKI---------RLETEDEGVPSTAIREISLLK 53
Query: 669 -IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLH--GPSKKVKLDWETRLKIAVGAA 725
+ H NIV L S L ++++ L DL S LD
Sbjct: 54 ELNHPNIVRLLDVVHSENKLYLVFEFL---DL-DLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC--IPTAMPHASTFVLGTI 783
QG+AY H R++HRD+K N+LID L+DFG+AR +P T + T+
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV---RTYTHEVVTL 163
Query: 784 GYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDNESNLHQL 828
Y PE SR D++S G + E++ + +S + QL
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 16/184 (8%)
Query: 643 IAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWD 701
+AVK L R +F E++ + +++ NI+ L G +S + +YM NG L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 702 LLHGPSKKVKL---------DWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID 752
L + L +AV A G+ YL + +HRD+ + N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 753 ENFDAHLSDFGIARCIPTAMPH--ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLL 810
++ ++DFG++R + + + VL I ++ E + SDV++FG+ L
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 811 EILT 814
E+ T
Sbjct: 223 EMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 64/277 (23%), Positives = 111/277 (40%), Gaps = 40/277 (14%)
Query: 637 LKNSRP--IAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693
++ RP +AVK L N R +F E++ + ++ NI+ L G + + +Y
Sbjct: 41 VRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEY 100
Query: 694 MVNGSLWDLLH--------GPSKKVK--------LDWETRLKIAVGAAQGLAYLHHDCNP 737
M NG L L + + + L +A+ A G+ YL +
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSL 157
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF-------VLGTIGYIDPEY 790
+HRD+ + N L+ EN ++DFG++R + +A + VL I ++ E
Sbjct: 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNL-----YAGDYYRIQGRAVL-PIRWMAWEC 211
Query: 791 AHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850
+ SDV++FG+ L EIL + E +L + +N D V
Sbjct: 212 ILMGKFTTASDVWAFGVTLWEILM----LCKEQPYGELTDEQVIENAGEFFRDQGRQVYL 267
Query: 851 VDLSAV-RKTFQLALLCTKRYPSERPTMQEVARVLVS 886
+ ++L L C R ERP+ ++ L
Sbjct: 268 FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 33/154 (21%)
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIAR--CIPTAMPHASTFVLGTIGYIDPEYAHTSR 795
+++HRD+KS+NI + L DFG ++ ++ AS+F GT Y+ PE R
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC-GTPYYLAPELWERKR 247
Query: 796 LNEKSDVYSFGIVLLEILTGKKAVDNESN---LHQLIMSKADD-----NTVMEAV-DPEV 846
++K+D++S G++L E+LT + S + Q++ K D ++ M+A+ DP +
Sbjct: 248 YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLL 307
Query: 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
S + P+ RPT Q++
Sbjct: 308 S---------------------KNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 9/87 (10%)
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL-GTIGYIDP 788
YLH + II+RD+K N+L+D ++DFG A+ +P TF L GT Y+ P
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAP 184
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILTG 815
E + + D ++ G++L E + G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
GL LH + ++RD+K NIL+D+ +SD G+A IP + +GT+GY+
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYM 168
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
PE + R D + G ++ E++ G+
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 45/215 (20%)
Query: 624 VGYGASSTVYKCALKNSRPI-AVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G G VY+ K++R I A+K L + +E + E +I RNI+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 683 SPY-----------GNLLFY-DYMVNGSL-WDLLHG---PSKKVKLDWETRLKIAVGAAQ 726
SP+ +L DYM G L W L + K + L +A
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKF-YIAELVLA----- 108
Query: 727 GLAYLH-HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY 785
L +LH +D I++RD+K NIL+D L DFG+++ T +TF GT Y
Sbjct: 109 -LEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEY 162
Query: 786 IDPEYAHTSRLNEKS-----DVYSFGIVLLEILTG 815
+ PE L+EK D +S G+++ E+ G
Sbjct: 163 LAPEVL----LDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 14/197 (7%)
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS--TFVLGTI 783
+ L Y+H + HRD+K NIL + + + DFG+AR P A T + T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 784 GYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL-IMSKADDNTVME 840
Y PE + S+ D++S G + E+LTGK ++ +HQL +++ E
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230
Query: 841 AVDPEVSVTCVD-LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAA 899
+ + LS++RK + + ++++P+ P R+L LL P A
Sbjct: 231 TISRVRNEKARRYLSSMRK--KQPVPFSQKFPNADPL---ALRLLERLLAFDPKDRPTAE 285
Query: 900 PKPIDYYTKFVVNRERQ 916
D Y K + ER+
Sbjct: 286 EALADPYFKGLAKVERE 302
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 46/243 (18%)
Query: 600 HMDMAIHTFDDIMRSTENL---SEKY----IVGYGASSTVYKCALKNSRPIAVKKLYNQY 652
++D ++ ++ I+R L +E Y ++G GA V K+S+ + KL +++
Sbjct: 20 NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF 79
Query: 653 PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF------------YDYMVNGSLW 700
E ++ R+I++ +A SP+ LF +YM G L
Sbjct: 80 -----EMIKRSDSAFFWEERDIMA---FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV 131
Query: 701 DLLHG---PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDA 757
+L+ P K K + + +A+ A + +IHRDVK N+L+D++
Sbjct: 132 NLMSNYDVPEKWAKF-YTAEVVLALDAIHSMG---------LIHRDVKPDNMLLDKHGHL 181
Query: 758 HLSDFGIA-RCIPTAMPHASTFVLGTIGYIDPEYAHTS----RLNEKSDVYSFGIVLLEI 812
L+DFG + T M T V GT YI PE + + D +S G+ L E+
Sbjct: 182 KLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240
Query: 813 LTG 815
L G
Sbjct: 241 LVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 50/242 (20%), Positives = 92/242 (38%), Gaps = 32/242 (13%)
Query: 659 FETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL 718
F E++ + H N++ G + LL ++ G L + L V + +
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101
Query: 719 --KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC------IPT 770
++A A GL +LH IH D+ N + + + D+G+A T
Sbjct: 102 LQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158
Query: 771 AMPHASTFVLGTIGYIDPEYAH-------TSRLNEKSDVYSFGIVLLEILT-GKKAVDNE 822
HA + ++ PE +KS+++S G+ + E+ T + +
Sbjct: 159 KDCHAVP-----LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213
Query: 823 SNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVAR 882
S+ L V E D ++ +DL + +++ C P RPT +EV
Sbjct: 214 SDEQVL------KQVVREQ-DIKLPKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHE 265
Query: 883 VL 884
+L
Sbjct: 266 LL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 59/231 (25%), Positives = 92/231 (39%), Gaps = 52/231 (22%)
Query: 625 GYGASSTVYKCALKNS-RPIAVK---KLYNQYPHNLREFETELETIGSIRHRNIVSLHGY 680
G G V+ LK + + A+K K + ++ TE E + ++ H + +L+
Sbjct: 10 GKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYAS 69
Query: 681 ALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA-VGAAQGLAYLHHDCNPRI 739
+ L DY G L+ LL K + R A V A L YLH I
Sbjct: 70 FQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA--LEYLH---LLGI 124
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIAR-------------------------------CI 768
++RD+K NIL+ E+ LSDF +++
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 769 PTAMPHASTFVLGTIGYIDPE----YAHTSRLNEKSDVYSFGIVLLEILTG 815
P+ +++FV GT YI PE H S + D ++ GI+L E+L G
Sbjct: 185 PSF--RSNSFV-GTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 10/158 (6%)
Query: 661 TELETIGSIRHRN-IVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRL 718
TE + +R +V+LH YA L L DY+ G ++ L+ + D +
Sbjct: 53 TERNVLEHVRQSPFLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLY------QRDNFSED 105
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778
++ + + + L H I++RD+K NIL+D L+DFG+++ + +
Sbjct: 106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 779 VLGTIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTG 815
GTI Y+ PE + K+ D +S GI++ E+LTG
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 10/107 (9%)
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDA-HLSDFGIARC--IPTAMPHASTFVLGT 782
+G+AY H + R++HRD+K N+LID +A L+DFG+AR IP T + T
Sbjct: 113 RGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV---RTFTHEVVT 166
Query: 783 IGYIDPEYAHTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ Y PE SR + D++S G + E++ K +S + +L
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL 213
|
Length = 294 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 18/215 (8%)
Query: 624 VGYGASSTVYKCALKNSRP-IAVKKLYNQYPHNLREFE---TELETIGSIRHRNIVSLHG 679
VG G V+ + S A+K + L++ + E + + H I+ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 680 YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739
+ +Y+ G L+ L + T L A L YLH + I
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLH---SKEI 122
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL-GTIGYIDPEYAHTSRLNE 798
++RD+K NIL+D+ L+DFG A+ + T+ L GT Y+ PE + N+
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEYLAPEVIQSKGHNK 177
Query: 799 KSDVYSFGIVLLEILTGKKAV--DNESNLHQLIMS 831
D ++ GI++ E+L G DN +++ I++
Sbjct: 178 AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 63/235 (26%), Positives = 90/235 (38%), Gaps = 58/235 (24%)
Query: 623 IVGYGASSTVYKCALKNSRPI-AVKKL-------YNQYPHNLREFETELETIGSIRHRNI 674
++G GA V+ K++ + A+K L NQ H E + + I
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILADADSPWI 63
Query: 675 VSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWET-RLKIA--VGAAQGLAY 730
V L+ Y+ +L L +YM G L +LL +K ET R IA V A L
Sbjct: 64 VKLY-YSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFYIAELVLA---LDS 116
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIA--------------RCIPTAMP- 773
+H IHRD+K NILID D H L+DFG+
Sbjct: 117 VH---KLGFIHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 774 -------------HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
+ +GT YI PE + + D +S G++L E+L G
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 20/177 (11%)
Query: 645 VKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLH 704
V K+ + F + + H+++V L+G + N++ +Y+ G L LH
Sbjct: 34 VLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLH 92
Query: 705 GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI-----DENF--DA 757
V L W +L +A A L YL + +++H +V NIL+ +E +
Sbjct: 93 REKNNVSLHW--KLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFI 147
Query: 758 HLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH--TSRLNEKSDVYSFGIVLLEI 812
LSD GI + + + I +I PE + L +D +SFG LLEI
Sbjct: 148 KLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 13/151 (8%)
Query: 668 SIRHRNIVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+++H IV L YA G L L +Y+ G L+ +H + + ++ ++ +
Sbjct: 56 AVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELF--MHLEREGIFMEDTACFYLS-EISL 111
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR--CIPTAMPHASTFVLGTIG 784
L +LH II+RD+K NIL+D L+DFG+ + + H TF GTI
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH--TFC-GTIE 165
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
Y+ PE S + D +S G ++ ++LTG
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 9e-07
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 32/172 (18%)
Query: 658 EFETELETIGSIRHRNIVSL--------HGYALSPYGNLLFYDYMVNGSL-WDLLHGPSK 708
+ E E+ +G + H NI+ + + Y ++ + Y +M + + W K
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-------K 261
Query: 709 KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768
L +TR I + Y+H + ++IHRD+K NI ++ + L DFG
Sbjct: 262 DRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFG----- 312
Query: 769 PTAMPHASTFV------LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
TAMP +GT+ PE E +D++S G++LL++L+
Sbjct: 313 -TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 54/236 (22%), Positives = 93/236 (39%), Gaps = 24/236 (10%)
Query: 658 EFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL-------HGPSKKV 710
EF E + ++V L G L+ + M +G L L +
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 711 KLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI-P 769
+ +++A A G+AYL+ + +HRD+ + N ++ +F + DFG+ R I
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQL 828
T L + ++ PE SD++SFG+VL EI + ++ SN L
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231
Query: 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
VM+ + C + + L +C + P RPT E+ +L
Sbjct: 232 -------KFVMDGGYLDQPDNCPE-----RVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 59/227 (25%), Positives = 92/227 (40%), Gaps = 25/227 (11%)
Query: 623 IVGYGASSTVYKCALKNSRPI----AVKKLYNQYPHNLREFETELETI-GSIRHRNIVSL 677
++G G+ + V LK + I VKK ++ +TE + H +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
H L F VNG DL+ ++ KL E + + L YLH
Sbjct: 62 HS-CFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEISLALNYLHER--- 115
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL-GTIGYIDPEYAHTSRL 796
II+RD+K N+L+D L+D+G+ C P +T GT YI PE
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGM--CKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 797 NEKSDVYSFGIVLLEILTGKKAVD-----------NESNLHQLIMSK 832
D ++ G+++ E++ G+ D E L Q+I+ K
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSS 747
L F VNG DL++ + K + A + GL +LH II+RD+K
Sbjct: 76 LYFVMEYVNGG--DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLD 130
Query: 748 NILIDENFDAHLSDFGIARCIPTAMPHASTFVL-GTIGYIDPEYAHTSRLNEKSDVYSFG 806
N+++D ++DFG+ C + +T GT YI PE + D +++G
Sbjct: 131 NVMLDSEGHIKIADFGM--CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYG 188
Query: 807 IVLLEILTGKKAVD--NESNLHQLIM 830
++L E+L G+ D +E L Q IM
Sbjct: 189 VLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 17/219 (7%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCAL----KNSR-PIAVKKLYN-QYPHNLREFETELE 664
I++ TE K ++G GA TVYK + + P+A+K+L P +E E
Sbjct: 3 ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 665 TIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ S+ + ++ L G L+ L+ M G L D + + + L V
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQI 118
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP--HASTFVLGT 782
A+G+ YL R++HRD+ + N+L+ ++DFG+A+ + HA +
Sbjct: 119 AKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV-P 174
Query: 783 IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVD 820
I ++ E +SDV+S+G+ + E++T G K D
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 9/92 (9%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF--VLGTIG 784
GL L + RI++RD+K NIL+D+ +SD G+A +P T +GT+G
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVG 166
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
Y+ PE + + D + G ++ E++ G+
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 46/147 (31%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI-AVGAAQGLAYLHHDCNPRIIHRDVKS 746
L F VNG DL+ K + D E R + A L +LH + II+RD+K
Sbjct: 71 LFFVMEFVNGG--DLMFHIQKSRRFD-EARARFYAAEITSALMFLH---DKGIIYRDLKL 124
Query: 747 SNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFG 806
N+L+D L+DFG+ + STF GT YI PE D ++ G
Sbjct: 125 DNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGPSVDWWAMG 183
Query: 807 IVLLEILTGKKA--VDNESNLHQLIMS 831
++L E+L G +NE +L + I++
Sbjct: 184 VLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-06
Identities = 57/245 (23%), Positives = 98/245 (40%), Gaps = 53/245 (21%)
Query: 623 IVGYGASSTVY-----KCALKNSRPIAVKKLYNQYPHNLR---EFETELETIGSIRHRNI 674
++G G VY C SR +A+KK+ N F E + + H I
Sbjct: 9 LIGKGGMGEVYLAYDPVC----SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 675 VSLHGYALSPYGNLLFYD--YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA-------- 724
V + Y++ G+ ++Y Y+ +L LL +K L E K +VGA
Sbjct: 65 VPV--YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI--------------PT 770
+ Y+H + ++HRD+K NIL+ + + D+G A
Sbjct: 123 CATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 771 AMPHASTF---VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT---------GKKA 818
+ T ++GT Y+ PE +E +D+Y+ G++L ++LT G+K
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239
Query: 819 VDNES 823
+
Sbjct: 240 SYRDV 244
|
Length = 932 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-06
Identities = 22/60 (36%), Positives = 34/60 (56%)
Query: 398 NLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457
NL +LDLS N + + L +L L+LS N+L + P F L S++++D+S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 9/149 (6%)
Query: 668 SIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+++H +V LH Y+ L F D++ G L+ H ++ + R A A
Sbjct: 52 NVKHPFLVGLH-YSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIAS 107
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
L YLH + I++RD+K NIL+D L+DFG+ + A +T GT Y+
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYL 163
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
PE + D + G VL E+L G
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 21/173 (12%)
Query: 656 LREFETELETIGSIRHRNIVSLHGYALSPYGN------LLFYDYMVNGSLWDLL---HGP 706
+ +F +E + H N++ L G L + ++ +M +G L L
Sbjct: 44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG 103
Query: 707 SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766
L + +K A G+ YL + IHRD+ + N +++EN + ++DFG+++
Sbjct: 104 DCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
Query: 767 CIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE-----KSDVYSFGIVLLEILT 814
I + + G I + ++ L + KSDV+SFG+ + EI T
Sbjct: 161 KI----YNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 16/168 (9%)
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
+V LH + L +Y VNG DL+ ++ KL E A L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEY-VNGG--DLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
II+RD+K N+L+D + L+D+G+ + STF GT YI PE
Sbjct: 115 R---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRG 170
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVD---------NESNLHQLIMSK 832
D ++ G+++ E++ G+ D E L Q+I+ K
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 624 VGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFET--ELETIGSIRHRNIVSLHGY 680
+G G+ +TVYK + N + +A+K + + + F E + ++H NIV LH
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 681 ALSPYGNLLFYDYMVNGSLWDLLHGP----SKKVKLDWETRLKIAVGAAQGLAYLHHDCN 736
+ ++YM ++ P V+L L+ GLAY+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQ-- 122
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARC--IPTAMPHASTFVLGTIGYIDPE-YAHT 793
I+HRD+K N+LI + L+DFG+AR IP+ ++S V T+ Y P+
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-YSSEVV--TLWYRPPDVLLGA 178
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESN-LHQL 828
+ + D++ G + +E+L G+ A S+ QL
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 624 VGYGASSTVYKCALKNSR-----PIAVKKLYNQYPHNL--REFETELETIGSIR-HRNIV 675
+G GA V C+ +N+ +A+KK+ N + + + EL+ + R H+NI
Sbjct: 8 LGQGAYGIV--CSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 676 SLHGYAL---SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---GLA 729
L+ + + L Y+ ++ L ++ L T Q GL
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIR---SGQPL---TDAHFQSFIYQILCGLK 119
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI---PTAMPHASTFVLGTIGYI 786
Y+H + ++HRD+K N+L++ + + + DFG+AR P T + T Y
Sbjct: 120 YIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176
Query: 787 DPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDNESNLHQL 828
PE + + K+ DV+S G +L E+L K + + QL
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQL 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 28/211 (13%)
Query: 620 EKYI----VGYGASSTVYKCALK-NSRPIAVKKLYNQYPHN-----LREFETELETIGSI 669
E YI +G G +TVYK K +A+K++ ++ +RE + + +
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 61
Query: 670 RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV-GAAQGL 728
+H NIV+LH + L ++Y+ + L L + + +K+ + +GL
Sbjct: 62 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH---NVKLFLFQLLRGL 117
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC--IPTAMPHASTFVLGTIGYI 786
Y H +++HRD+K N+LI+E + L+DFG+AR IPT +++ V T+ Y
Sbjct: 118 NYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YSNEVV--TLWYR 171
Query: 787 DPE-YAHTSRLNEKSDVYSFGIVLLEILTGK 816
P+ ++ + + D++ G + E+ TG+
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY 785
GL +LH RII+RD+K N+L+D + + +SD G+A + + GT G+
Sbjct: 108 SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGF 163
Query: 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
+ PE + D ++ G+ L E++ +
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 8/113 (7%)
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
A A GL +LH + II+RD+K N+++D ++DFG+ C +T
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGM--CKENMWDGVTTKTF 161
Query: 781 -GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVD--NESNLHQLIM 830
GT YI PE + D ++FG++L E+L G+ + +E L Q IM
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 21/46 (45%), Positives = 30/46 (65%), Gaps = 5/46 (10%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC--IPT 770
GLAY H R++HRD+K N+LI E + L+DFG+AR +P+
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 58/243 (23%), Positives = 111/243 (45%), Gaps = 46/243 (18%)
Query: 620 EKYI----VGYGASSTVYKCALK-NSRPIAVKKLYNQYPHN-----LREFETELETIGSI 669
E YI +G G +TV+K K +A+K++ ++ +RE + + +
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 61
Query: 670 RHRNIVSLHGYALSPYGNLLFYDYMVN---------GSLWDLLHGPSKKVKLDWETRLKI 720
+H NIV+LH + L ++Y+ G++ + VK+ L+
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM-----HNVKIFLYQILR- 115
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
GLAY H +++HRD+K N+LI+E + L+DFG+AR S V+
Sbjct: 116 ------GLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV 166
Query: 781 GTIGYIDPE-YAHTSRLNEKSDVYSFGIVLLEILTGK-----KAVDNESNL-HQLIMSKA 833
T+ Y P+ +S + + D++ G + E+ +G+ V++E +L +L+ +
Sbjct: 167 -TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT 225
Query: 834 DDN 836
++
Sbjct: 226 EET 228
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 63/237 (26%), Positives = 103/237 (43%), Gaps = 49/237 (20%)
Query: 623 IVGYGASSTVYKCALKNSRPI-AVKKLYNQYPHNLREFETELETIGSIR---------HR 672
+G G V+K K ++ I A+KK+ L E E E I ++R H
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKV-------LMENEKEGFPITALREIKILQLLKHE 71
Query: 673 NIVSL-----------HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
N+V+L + Y S Y F ++ + G L +K VK K+
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLL------SNKNVKFTLSEIKKVM 125
Query: 722 VGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM---PHASTF 778
GL Y+H + +I+HRD+K++NILI ++ L+DFG+AR + P+ T
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 779 VLGTIGYIDPEYAHTSRLNEKS-----DVYSFGIVLLEILTGKKAVDNESNLHQLIM 830
+ T+ Y PE L E+ D++ G ++ E+ T + + HQL +
Sbjct: 183 RVVTLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 23/201 (11%)
Query: 624 VGYGASSTVYKCALKNSR--PIAVKKLYNQYPHNLREFE---TELETIGSIRHRNIVSLH 678
+G G+ V KN P+A+K+ ++ + +E + + I H V+L+
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVG---AAQGLAYLHHDC 735
G L ++++ G + L R VG AAQ + +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRR---------NKRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL-GTIGYIDPEYAHTS 794
+ I++RD+K N+L+D++ ++DFG A+ + T T+ L GT YI PE
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNV 203
Query: 795 RLNEKSDVYSFGIVLLEILTG 815
+ +D ++ GI + EIL G
Sbjct: 204 GHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 31/230 (13%)
Query: 623 IVGYGASSTVYKCALKNSRPI----AVKKLYNQYPHNLREFETE---LETIGSIRHRNIV 675
++G G+ + V LK +R I +KK ++ +TE ET + H +V
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN--HPFLV 59
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
LH + L F V+G DL+ ++ KL E + + L +LH
Sbjct: 60 GLHSCFQTE-SRLFFVIEFVSGG--DLMFHMQRQRKLPEEHARFYSAEISLALNFLHER- 115
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP--HASTFVLGTIGYIDPEYAHT 793
II+RD+K N+L+D L+D+G+ C P STF GT YI PE
Sbjct: 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGM--CKEGIRPGDTTSTFC-GTPNYIAPEILRG 170
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVD-----------NESNLHQLIMSK 832
D ++ G+++ E++ G+ D E L Q+I+ K
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 14/109 (12%)
Query: 712 LDWETRLKIAVGAAQGLAYL-HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770
LD E L + A+G+++L +C IHRD+ + NIL+ + DFG+AR I
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 771 AMPHASTFVLG-----TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
S +V+ + ++ PE +SDV+S+GI+L EI +
Sbjct: 267 ----DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 7e-06
Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 623 IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN--------LREFETELETIGSIRHRN 673
+G GA TVYK L R +A+KK+ + P + LRE L+ + S H N
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIAL-LKQLESFEHPN 62
Query: 674 IVSL----HGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVK--LDWETRLKIAVGAAQ 726
IV L HG L L ++++ DL SK K L ET + +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
G+ +LH + RI+HRD+K NIL+ + ++DFG+AR M A T V+ T+ Y
Sbjct: 119 GVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVVTLWYR 173
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEI 812
PE S D++S G + E+
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI---PTAMPHASTFVLG 781
A G+ +L + +HRD+ + N+LI E + DFG+AR I + STF+
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL-- 303
Query: 782 TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
+ ++ PE + SDV+SFGI+L EI T
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 45/156 (28%), Positives = 65/156 (41%), Gaps = 28/156 (17%)
Query: 673 NIVSLHGYALSPYGNLLFYDYMVNGSLWD----LLHGPSKKVKLDWETRLKIAVGAAQGL 728
N+V LH Y +S L + G LW L+ P + VK W + +A+ A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-RWAAEMVVALDA---- 100
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR-----CIPTAMPHASTFVLGTI 783
LH + I+ RD+ +NIL+D+ L+ F C A+ +
Sbjct: 101 --LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-------- 147
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAV 819
Y PE S E D +S G +L E+LTGK V
Sbjct: 148 -YCAPEVGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 54/203 (26%), Positives = 85/203 (41%), Gaps = 14/203 (6%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHG-YA 681
+G G V+K K + A K+ + E E E + ++ H N+V +G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 682 LSPYGN----LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
N L + GS+ DL+ G K+ + IA + L L H
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG--ERMEEPIIAYILHEALMGLQHLHVN 143
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT---- 793
+ IHRDVK +NIL+ L DFG++ + T+ +GT ++ PE
Sbjct: 144 KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIACEQQL 202
Query: 794 -SRLNEKSDVYSFGIVLLEILTG 815
S + + DV+S GI +E+ G
Sbjct: 203 DSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 47/196 (23%), Positives = 89/196 (45%), Gaps = 23/196 (11%)
Query: 632 VYKCALKNSRPIAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690
VYK K +A+K L N+ ++R E E E + + + IV + G + L+
Sbjct: 15 VYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG--VCEAEALML 71
Query: 691 YDYMVNGSLWDLLHGP------SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDV 744
M +G GP KK ++ +++ + G+ YL +HRD+
Sbjct: 72 VMEMASG-------GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDL 121
Query: 745 KSSNILIDENFDAHLSDFGIARCIPTAMPH--ASTFVLGTIGYIDPEYAHTSRLNEKSDV 802
+ N+L+ A +SDFG+++ + + A + + + PE + + + +SDV
Sbjct: 122 AARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDV 181
Query: 803 YSFGIVLLEILT-GKK 817
+S+GI + E + G+K
Sbjct: 182 WSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
H+++V +G + +++ +Y+ GSL L + + W K+ V A+ LA+
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW----KLEV--AKQLAW 111
Query: 731 -LHHDCNPRIIHRDVKSSNILIDENFDAH--------LSDFGIARCIPTAMPHASTFVLG 781
LH + + H +V + N+L+ D LSD GI+ T +P +L
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS---ITVLP--KEILLE 166
Query: 782 TIGYIDPEYAHTSR-LNEKSDVYSFGIVLLEILTG 815
I ++ PE + L+ +D +SFG L EI +G
Sbjct: 167 RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-06
Identities = 50/224 (22%), Positives = 90/224 (40%), Gaps = 54/224 (24%)
Query: 695 VNGSLWDLLHGPSKKVKLDWETR----------------LKIAVGAAQGLAYLHHDCNPR 738
+ S +D S K D E + L A+G+ +L +
Sbjct: 203 IQRSNYD--RPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKN 257
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCI---PTAMPHASTFVLGTIGYIDPEYAHTSR 795
+HRD+ + N+L+ + + DFG+AR I + STF+ + ++ PE +
Sbjct: 258 CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWMAPESIFDNL 315
Query: 796 LNEKSDVYSFGIVLLEIL----TGKKAVDNESNLHQLI-----MSKADDNTVMEAVDPEV 846
SDV+S+GI+L EI T + +S + I M+K D
Sbjct: 316 YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPD------------ 363
Query: 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890
A ++ + + + C P +RP+ ++ ++ SLLP+
Sbjct: 364 -------HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLPS 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIG 784
G+ +LH + I++RD+K N+L+D+ + LSD G+A + T GT G
Sbjct: 105 TCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNG 159
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
Y+ PE + D ++ G + E++ G+
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 42/188 (22%), Positives = 81/188 (43%), Gaps = 19/188 (10%)
Query: 639 NSRPIAVKKLYNQ-YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGN-LLFYDYMVN 696
+ VK + + + E + + H+NI+ + + + Y YM
Sbjct: 34 KEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNW 93
Query: 697 GSLWDLL----HGPSKKVK-LDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI 751
G+L L G + + L + + +A+ A G++YLH +IH+D+ + N +I
Sbjct: 94 GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVI 150
Query: 752 DENFDAHLSDFGIARCIPTAMPHASTFVLGT-----IGYIDPEYAHTSRLNEKSDVYSFG 806
DE ++D ++R + H LG + ++ E + SDV+SFG
Sbjct: 151 DEELQVKITDNALSRDLFPMDYHC----LGDNENRPVKWMALESLVNKEYSSASDVWSFG 206
Query: 807 IVLLEILT 814
++L E++T
Sbjct: 207 VLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 623 IVGYGASSTVYKCALKNS----RPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVS 676
++G G +V + LK+ + +AVK L ++ EF E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 677 LHGYAL--SPYGNL----LFYDYMVNGSLWDLLHGP---SKKVKLDWETRLKIAVGAAQG 727
L G +L G L + +M +G L L + L +T ++ + A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH----ASTFVLGTI 783
+ YL + IHRD+ + N +++EN ++DFG+++ I + + AS +
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL---PV 179
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814
++ E + SDV++FG+ + EI+T
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 39/231 (16%)
Query: 605 IHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELE 664
I+ D+ E+ ++G GA V K++R + KL +++ E +
Sbjct: 32 INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF-----EMIKRSD 86
Query: 665 TIGSIRHRNIVSLHGYALSPYGNLLFY------------DYMVNGSLWDLLHG---PSKK 709
+ R+I++ +A SP+ LFY +YM G L +L+ P K
Sbjct: 87 SAFFWEERDIMA---FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW 143
Query: 710 VKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA-RCI 768
+ + + +A+ A + + IHRDVK N+L+D++ L+DFG +
Sbjct: 144 ARF-YTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193
Query: 769 PTAMPHASTFVLGTIGYIDPEYAHTS----RLNEKSDVYSFGIVLLEILTG 815
M T V GT YI PE + + D +S G+ L E+L G
Sbjct: 194 KEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 7/142 (4%)
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
IV L SP L +NG +L H ++ + D +R + A+ L L +
Sbjct: 55 IVPLKFSFQSP-EKLYLVLAFINGG--ELFHHLQREGRFD-LSRARFYT--AELLCALEN 108
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
+I+RD+K NIL+D L DFG+ + +TF GT Y+ PE
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLG 167
Query: 794 SRLNEKSDVYSFGIVLLEILTG 815
+ D ++ G++L E+LTG
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 44/178 (24%), Positives = 81/178 (45%), Gaps = 16/178 (8%)
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLK 719
TE + + RH + +L YA + L F +Y G L+ H ++V + R
Sbjct: 44 TESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARF- 99
Query: 720 IAVGA--AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777
GA L YLH + +++RD+K N+++D++ ++DFG+ + + T
Sbjct: 100 --YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154
Query: 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAV---DNESNLHQLIMSK 832
F GT Y+ PE + D + G+V+ E++ G+ D+E ++M +
Sbjct: 155 FC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCA---LKNSRPIAVKKL---YNQYPHNLREFETELE 664
+++ +NL +G GA V CA + +A+KKL + H R + EL
Sbjct: 14 VLKRYQNLK---PIGSGAQGIV--CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELV 67
Query: 665 TIGSIRHRNIVSLHGYALSPYGNL-LFYD-YMV----NGSLWDLLHGPSKKVKLDWETRL 718
+ + H+NI+ L +P +L F D Y+V + +L ++ + LD E
Sbjct: 68 LMKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHERMS 121
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778
+ G+ +LH + IIHRD+K SNI++ + + DFG+AR T+
Sbjct: 122 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 178
Query: 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
V T Y PE E D++S G ++ E++ G
Sbjct: 179 V--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 624 VGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFE-------TELETIGSIRHRNIV 675
+G G+ +TVYK K N + +A+K + L+E E E + ++H NIV
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI------RLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPS----KKVKLDWETRLKIAVGAAQGLAYL 731
LH + L ++Y+ + P + VKL L+ GL+Y+
Sbjct: 67 LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYI 119
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC--IPTAMPHASTFVLGTIGYIDPE 789
H I+HRD+K N+LI + + L+DFG+AR +P+ H + + T+ Y P+
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---HTYSNEVVTLWYRPPD 173
Query: 790 -YAHTSRLNEKSDVYSFGIVLLEILTGKKA 818
++ + D++ G + +E++ G A
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-05
Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 12/96 (12%)
Query: 674 IVSLHGYALSPYGNL-LFYDYMVNGSLWDLLH--GPSKKVKLDWETRLKIAVGAAQGLAY 730
IV L+ Y+L N+ L +Y++ G + LLH G D E +K A L Y
Sbjct: 66 IVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDY 119
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766
LH IIHRD+K N+LI L+DFG+++
Sbjct: 120 LHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE---------TELETIGSIRHRNI 674
VG G VYK K+ + + + L++ E E+ + ++H N+
Sbjct: 9 VGRGTYGHVYKAKRKDGK--------DDRDYALKQIEGTGISMSACREIALLRELKHPNV 60
Query: 675 VSLHGYALSPYGN--LLFYDYMVNGSLWDLL--HGPSKK----VKLDWETRLKIAVGAAQ 726
+SL LS L +DY LW ++ H SK V+L +
Sbjct: 61 ISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILI----DENFDAHLSDFGIARCIPTAMPHASTF--VL 780
G+ YLH + ++HRD+K +NIL+ E ++D G AR + + + V+
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 781 GTIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGK 816
T Y PE +R K+ D+++ G + E+LT +
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 32/103 (31%), Positives = 55/103 (53%), Gaps = 5/103 (4%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
G+A+LH + I+HRD+K+SN+L++ + DFG+AR + + + V+ T+ Y
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYR 173
Query: 787 DPE-YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
PE + D++S G + E+LT K +S + QL
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 5e-05
Identities = 19/55 (34%), Positives = 29/55 (52%)
Query: 355 NVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNF 409
++ NRL+ +F+ L +L L+LS NN P + +L +LDLS NN
Sbjct: 6 DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 4/77 (5%)
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE 798
IHRD+K N LID + L+DFG+++ I T +A++ V G+ Y+ PE +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVV-GSPDYMAPEVLRGKGYDF 177
Query: 799 KSDVYSFGIVLLEILTG 815
D +S G +L E L G
Sbjct: 178 TVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 6e-05
Identities = 14/35 (40%), Positives = 19/35 (54%), Gaps = 2/35 (5%)
Query: 1 MAIKASFSNLAN-VLLDWDDVHNSDFCSWRGVFCD 34
+A K+S + + L W+ SD CSW GV CD
Sbjct: 9 LAFKSSLNGDPSGALSSWNPSS-SDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (110), Expect = 6e-05
Identities = 36/128 (28%), Positives = 59/128 (46%), Gaps = 27/128 (21%)
Query: 726 QGLAYLHH----DCNPRIIHRDVKSSNILID-------------ENFD----AHLSDFGI 764
LAY H+ R++HRD+K NI + N + A + DFG+
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 765 ARCIPT-AMPHASTFVLGTIGYIDPEYA--HTSRLNEKSDVYSFGIVLLEILTGKKAVDN 821
++ I +M H+ +GT Y PE T ++KSD+++ G ++ E+ +GK
Sbjct: 189 SKNIGIESMAHS---CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 822 ESNLHQLI 829
+N QLI
Sbjct: 246 ANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 17/176 (9%)
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGS--LWDLLHGPSKKVKLDWETRL 718
TE + + RH + +L Y+ + L F NG + L ++V + R
Sbjct: 44 TESRVLQNTRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARF 99
Query: 719 KIAVGA--AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776
GA L YLH C+ +++RD+K N+++D++ ++DFG+ + +
Sbjct: 100 ---YGAEIVSALGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153
Query: 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN--LHQLIM 830
TF GT Y+ PE + D + G+V+ E++ G+ N+ + L +LI+
Sbjct: 154 TFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 14/175 (8%)
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLK 719
TE + + RH + +L Y+ + L F +Y G L+ H ++V + R
Sbjct: 44 TENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARF- 99
Query: 720 IAVGA--AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777
GA L YLH + N +++RD+K N+++D++ ++DFG+ + T
Sbjct: 100 --YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155
Query: 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN--LHQLIM 830
F GT Y+ PE + D + G+V+ E++ G+ N+ + L +LI+
Sbjct: 156 FC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 8e-05
Identities = 18/57 (31%), Positives = 26/57 (45%)
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNF 385
L+L++N L L ++ GN L+ P +F L SL L+LS NN
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFE---------TELETIGSIRHRNI 674
VG G VYK K+ + ++ + L++ E E+ + ++H N+
Sbjct: 9 VGRGTYGHVYKAKRKDGK--------DEKEYALKQIEGTGISMSACREIALLRELKHPNV 60
Query: 675 VSLHGYALSPYGN--LLFYDYMVNGSLWDLL--HGPSKK----VKLDWETRLKIAVGAAQ 726
++L LS L +DY LW ++ H SK ++L +
Sbjct: 61 IALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILI----DENFDAHLSDFGIARCIPTAMPHASTF--VL 780
G+ YLH + ++HRD+K +NIL+ E ++D G AR + + + V+
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 781 GTIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGK 816
T Y PE +R K+ D+++ G + E+LT +
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 659 FETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL 718
FET + + H++IV L+G + N++ +++ G L +H S + W +
Sbjct: 52 FETA-SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI-DENFDAH------LSDFGIARCIPTA 771
K+A A L+YL + ++H +V + NIL+ E D LSD GI + +
Sbjct: 109 KVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165
Query: 772 MPHASTFVLGTIGYIDPEYAHTSR-LNEKSDVYSFGIVLLEI 812
+ I +I PE S+ L+ +D +SFG L EI
Sbjct: 166 QE-----CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 63 NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQL 122
NL+S+D N+LT +L ++LS N+L P + S L L L+L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 51/204 (25%), Positives = 73/204 (35%), Gaps = 47/204 (23%)
Query: 87 SLVHIELSDNSLYGDI-PFSISKLKQ----LEFLNLKNNQLTG----PIPSTLTQIPNLK 137
SL ++L++N L LK LE L L N+L G + L +LK
Sbjct: 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLK 168
Query: 138 TLDLARNQLTGE-IPRL---IYWNEVLQYLGLRGNALT-------GMLSPDMCQLTGLWY 186
L+LA N + I L + N L+ L L N LT + L L
Sbjct: 169 ELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVL-- 226
Query: 187 FDVRGNNLTGTI-----PDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKL 241
++ NNLT + S L +S N IT + G +A
Sbjct: 227 -NLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDD-----GAKDLA--------- 271
Query: 242 TGKIPEVIGLMQALAVLDLSENEL 265
EV+ ++L LDL N+
Sbjct: 272 -----EVLAEKESLLELDLRGNKF 290
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 36/108 (33%), Positives = 49/108 (45%), Gaps = 17/108 (15%)
Query: 720 IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA-------- 771
I GA +GL YLH + IHR++K+S+ILI + LS +
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 772 -MPHASTFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGK 816
P ST VL ++ PE N KSD+YS GI E+ TG+
Sbjct: 163 DFPQFSTSVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 20/159 (12%)
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722
ET S RH +V+L + +Y G L ++H + D + +
Sbjct: 53 FETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMH-----IHTDVFSEPRAVF 105
Query: 723 GAAQ---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH---AS 776
AA GL YLH + +I++RD+K N+L+D ++DFG+ + M S
Sbjct: 106 YAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTS 159
Query: 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
TF GT ++ PE + D + G+++ E+L G
Sbjct: 160 TFC-GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 30/110 (27%), Positives = 45/110 (40%), Gaps = 34/110 (30%)
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIA------------RCIPTAMPHASTF--------- 778
IHRD+K N+L+D LSDFG+ R + ++P TF
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 779 -------------VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
+GT YI PE + N+ D +S G+++ E+L G
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 4e-04
Identities = 20/60 (33%), Positives = 33/60 (55%)
Query: 422 HLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNL 481
+L +L+LS N L + F L +++ +D+S N L+ P L ++ SL L+ NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 5e-04
Identities = 24/60 (40%), Positives = 30/60 (50%)
Query: 111 QLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNAL 170
L+ L+L NN+LT +PNLK LDL+ N LT P L+ L L GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 36/122 (29%), Positives = 54/122 (44%), Gaps = 10/122 (8%)
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEK 799
+HRD+K N+LID L+DFG A + S +GT YI PE T + K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 800 S------DVYSFGIVLLEILTGKK--AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851
D +S G++ E++ G+ + + IM+ E DP+VS +
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE--DPKVSSDFL 241
Query: 852 DL 853
DL
Sbjct: 242 DL 243
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 32/102 (31%), Positives = 45/102 (44%), Gaps = 17/102 (16%)
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP----------HAST 777
L YLH N I+HRD+K N+LI L+DFG+++ ++
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 778 F----VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
F V GT YI PE + D ++ GI+L E L G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 11/101 (10%)
Query: 717 RLKIAVGAAQGLA---YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773
++ A Q L+ Y+H + IIHRD+K+ N+L++ D L DFG A C
Sbjct: 259 LAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA-CFARG-S 313
Query: 774 HASTFVLGTIGYID---PEYAHTSRLNEKSDVYSFGIVLLE 811
++ F G G +D PE D++S G+V+ E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 59/248 (23%), Positives = 94/248 (37%), Gaps = 38/248 (15%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYA 681
+G G VYK KN+ + +A+KK E + E I R I L +
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKK---------TRLEMDEEGIPPTALREISLLQMLS 58
Query: 682 LSPY--------------GNLLFY---DYM-VNGSLWDLLHGPSKKVKLDWETRLKIAVG 723
S Y G Y +Y+ + + +G L +T
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 724 AAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDA-HLSDFGIARC--IPTAMPHASTFVL 780
+G+A+ H ++HRD+K N+L+D+ ++D G+ R IP + T +
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK---SYTHEI 172
Query: 781 GTIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM 839
T+ Y PE S D++S G + E+ + +S L QL+ T
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232
Query: 840 EAVDPEVS 847
E V P VS
Sbjct: 233 EQVWPGVS 240
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 29/115 (25%), Positives = 43/115 (37%), Gaps = 41/115 (35%)
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF--------------------- 778
IHRD+K N+L+D LSDFG+ C H + F
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGL--CTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 779 ------------------VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
+GT YI PE + N++ D +S G+++ E+L G
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 7e-04
Identities = 20/58 (34%), Positives = 24/58 (41%), Gaps = 2/58 (3%)
Query: 281 KLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNL 337
L L N+LT IP + L L L N L P L L L+L+ NNL
Sbjct: 4 SLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 8e-04
Identities = 20/60 (33%), Positives = 33/60 (55%)
Query: 87 SLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQL 146
+L ++LS+N L + L L+ L+L N LT P + +P+L++LDL+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 25/89 (28%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH--ASTFVLGT 782
+ G+ YL +HRD+ + N+L+ A +SDFG+++ + + A T
Sbjct: 105 SMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP 161
Query: 783 IGYIDPEYAHTSRLNEKSDVYSFGIVLLE 811
+ + PE + + + KSDV+SFG+++ E
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 30/233 (12%)
Query: 659 FETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL 718
FET + + H ++ +HG + N++ +++ +G L L +V + W ++
Sbjct: 64 FETA-SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778
+A A L+YL + ++H +V + NIL+ L++ G + I + P S
Sbjct: 121 TVAQQLASALSYLE---DKNLVHGNVCAKNILLARL---GLAE-GTSPFIKLSDPGVSFT 173
Query: 779 VLGT------IGYIDPE-YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMS 831
L I +I PE + L+ +D +SFG LLEI D E L + S
Sbjct: 174 ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-----CFDGEVPLKERTPS 228
Query: 832 KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+ + + PE S C +L+ L C P++RP+ + + R L
Sbjct: 229 EKERFYEKKHRLPEPS--CKELAT------LISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 29/112 (25%), Positives = 42/112 (37%), Gaps = 38/112 (33%)
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF--------------------- 778
IHRD+K N+L+D LSDFG+ C H + F
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGL--CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 779 ---------------VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
+GT YI PE + N+ D +S G+++ E+L G
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 69/292 (23%), Positives = 112/292 (38%), Gaps = 35/292 (11%)
Query: 156 WNEVLQYLGLRGNALTGMLS----PDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEIL 211
W+ V GLR L G + PD+ T L + + +P SI E L
Sbjct: 627 WDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDL 686
Query: 212 DISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPP 271
D+S + +P I + L+L G P++ + L + + + E +
Sbjct: 687 DMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNLR- 745
Query: 272 ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSY----LQLQNNQLVGTIPAELGKLEQL 327
L NL + KL + P M+ LS L L + + +P+ + L +L
Sbjct: 746 -LENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL 804
Query: 328 FELNLADN----------NLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTY 377
L + + NLE ++S C+ L F P N+ L
Sbjct: 805 EHLEIENCINLETLPTGINLESLESLDLSGCSRLRTF-----------PDISTNISDL-- 851
Query: 378 LNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLS 429
NLSR + +VP + + NL LD++ N V +I L+HL T++ S
Sbjct: 852 -NLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFS 901
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 22/61 (36%), Positives = 36/61 (59%), Gaps = 2/61 (3%)
Query: 446 SIQTIDMSFNQLSGSIPAE-LGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNN 504
+++++D+S N+L+ IP L N+ L L+ NNL P+ S SL +L++S NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 505 L 505
L
Sbjct: 60 L 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 943 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.53 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.52 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.16 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.16 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.0 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.9 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.82 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.72 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.7 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.56 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.47 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.42 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.39 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-108 Score=1039.97 Aligned_cols=862 Identities=34% Similarity=0.553 Sum_probs=612.5
Q ss_pred CcccccccCccccCCCCCCCCCCCCCCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCC
Q 002278 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPD 80 (943)
Q Consensus 1 ~~~~~~~~~~~~~~~~w~~~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~ 80 (943)
++||+++.||.+++++|+. +.|||.|.||.|++. .+|+.|||++|++++.+++++..+++|+.|+|++|++++.+|.
T Consensus 35 ~~~~~~~~~~~~~~~~w~~--~~~~c~w~gv~c~~~-~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~ 111 (968)
T PLN00113 35 LSFKSSINDPLKYLSNWNS--SADVCLWQGITCNNS-SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPD 111 (968)
T ss_pred HHHHHhCCCCcccCCCCCC--CCCCCcCcceecCCC-CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCCh
Confidence 4689999999899999974 579999999999864 5899999999999999998999999999999999999888887
Q ss_pred Ccc-CCCCCcEEeccCCCcCC----------------------ccchhccccccceEEEecCcccccCCCcccCCCCCCc
Q 002278 81 EIG-NCGSLVHIELSDNSLYG----------------------DIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLK 137 (943)
Q Consensus 81 ~~~-~l~~L~~L~Ls~N~l~~----------------------~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 137 (943)
.+. .+++|++|+|++|++++ .+|..|+.+++|++|+|++|.+.+.+|..|.++++|+
T Consensus 112 ~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 191 (968)
T PLN00113 112 DIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLE 191 (968)
T ss_pred HHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCC
Confidence 644 66677777666666654 4455555666666666666666656666666666666
Q ss_pred EEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeeccc
Q 002278 138 TLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQ 217 (943)
Q Consensus 138 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~ 217 (943)
+|+|++|++.+.+|..+..+++|++|+|++|.+.+..|..+..+++|++|++++|++++.+|..|+++++|++|++++|+
T Consensus 192 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 271 (968)
T PLN00113 192 FLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNK 271 (968)
T ss_pred eeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCe
Confidence 66666666665566666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred ccCcCCCCCC-cceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCC
Q 002278 218 ITGEIPYNIG-FLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPE 296 (943)
Q Consensus 218 l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 296 (943)
+++.+|..+. ..+|+.|++++|.+.+.+|..+..+++|+.|++++|.+.+..|..+..+++|+.|+|++|.+++.+|..
T Consensus 272 l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 351 (968)
T PLN00113 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351 (968)
T ss_pred eeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChH
Confidence 6655554443 335666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccc
Q 002278 297 LGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLT 376 (943)
Q Consensus 297 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 376 (943)
+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++++..|..|..+++|+
T Consensus 352 l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 431 (968)
T PLN00113 352 LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVY 431 (968)
T ss_pred HhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCC
Confidence 66666666666666666655555555555555555555555555555555555555555555555555555555555555
Q ss_pred eeeccCCcCCCCCCCCCC-----------------------CCCCccEEecCCCcCCCccCCCcccccccceeecccccc
Q 002278 377 YLNLSRNNFKGKVPTELG-----------------------RIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHL 433 (943)
Q Consensus 377 ~L~L~~N~l~~~~~~~~~-----------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 433 (943)
.|++++|.+++..|..+. ...+|+.|++++|++++.+|..+.++++|+.|+|++|++
T Consensus 432 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 511 (968)
T PLN00113 432 FLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL 511 (968)
T ss_pred EEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcc
Confidence 555555544444333222 235677777778888888888888999999999999999
Q ss_pred cccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCCc
Q 002278 434 NGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIR 513 (943)
Q Consensus 434 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~ 513 (943)
++.+|..|.++++|+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|..+.++++|+.|++++|+++|.+|...
T Consensus 512 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~ 591 (968)
T PLN00113 512 SGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG 591 (968)
T ss_pred eeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred ccCcCCCCccccCCCCCCCCCC---CccCCCccccccccceeeeeeeehhHHHHHHHH-HHHHhhhhccchhhh-cCCcc
Q 002278 514 NFSRFSSNSFIGNPLLCGNWIG---SICGPSVTKARVMFSRTAVVCMVLGFITLLVMA-AIAVYKSNQQRQQLI-TGSRK 588 (943)
Q Consensus 514 ~~~~~~~~~~~~Np~~c~~~~~---~~c~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~ 588 (943)
.+..+...++.|||.+||.... ..|.... +.. ...++++++++++++++++ +++++.+++++++.. ....
T Consensus 592 ~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 666 (968)
T PLN00113 592 AFLAINASAVAGNIDLCGGDTTSGLPPCKRVR---KTP-SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENE- 666 (968)
T ss_pred hhcccChhhhcCCccccCCccccCCCCCcccc---ccc-eeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccc-
Confidence 8889999999999999986542 3453221 111 1222333333333332222 222222222211111 0100
Q ss_pred ccCCCCceeeee-ccccccCHHHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHH
Q 002278 589 SMLGPPKLVILH-MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETI 666 (943)
Q Consensus 589 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l 666 (943)
.+........ ......+++++ ...|...++||+|+||.||+|+.+ ++..||||++..... ...+|++.+
T Consensus 667 --~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l 737 (968)
T PLN00113 667 --DGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADM 737 (968)
T ss_pred --cccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHH
Confidence 0000000000 00112233333 456778889999999999999974 688999999864432 223568889
Q ss_pred hcCCCCCcceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCC
Q 002278 667 GSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKS 746 (943)
Q Consensus 667 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 746 (943)
++++|||||+++++|.+++..++||||+++|+|.++++ .++|.++.+++.|+|+|++|||+.+.++|+||||||
T Consensus 738 ~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp 811 (968)
T PLN00113 738 GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811 (968)
T ss_pred hhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH
Confidence 99999999999999999999999999999999999995 278999999999999999999976667999999999
Q ss_pred ccEEECCCCceeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC----
Q 002278 747 SNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNE---- 822 (943)
Q Consensus 747 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~---- 822 (943)
+||+++.++.+++. ||.+...... ....|++.|+|||++.+..++.++|||||||++|||+||+.||+..
T Consensus 812 ~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~ 885 (968)
T PLN00113 812 EKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH 885 (968)
T ss_pred HhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC
Confidence 99999998888875 6655433221 1225789999999999999999999999999999999999998632
Q ss_pred ccHHHHHHHhccccccccccCcccccC-ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 823 SNLHQLIMSKADDNTVMEAVDPEVSVT-CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
.....|.............+++.+... .....+..++.+++.+||+.||++||||.|+++.|+.+....
T Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 886 GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 233444443333223333344444222 123455667889999999999999999999999999876543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-56 Score=567.06 Aligned_cols=467 Identities=36% Similarity=0.608 Sum_probs=385.4
Q ss_pred cEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEec
Q 002278 39 SVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLK 118 (943)
Q Consensus 39 ~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 118 (943)
+++.|+|++|.+++.+|..++.+++|++|+|++|.+++.+|..|+++++|++|+|++|++.+.+|..|+++++|++|+|+
T Consensus 141 ~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 220 (968)
T PLN00113 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220 (968)
T ss_pred CCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECc
Confidence 45667777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceeccccc
Q 002278 119 NNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTI 198 (943)
Q Consensus 119 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~ 198 (943)
+|++++.+|..|.++++|++|+|++|++++.+|..+..+++|++|+|++|++.+..|..+..+++|++|+|++|.+.+.+
T Consensus 221 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~ 300 (968)
T PLN00113 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300 (968)
T ss_pred CCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CCCCcCCCcccEEEeecccccCcCCCCCC-cceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCC
Q 002278 199 PDSIGNCTSFEILDISYNQITGEIPYNIG-FLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLS 277 (943)
Q Consensus 199 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 277 (943)
|..+.++++|++|++++|.+++.+|..+. ..+|+.|++++|.+.+.+|..++.+++|+.|++++|++.+..|..+..++
T Consensus 301 p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~ 380 (968)
T PLN00113 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSG 380 (968)
T ss_pred ChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcC
Confidence 77777777777777777777776665553 34677888888888777777777788888888888888777777777778
Q ss_pred CcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEee
Q 002278 278 YTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVH 357 (943)
Q Consensus 278 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 357 (943)
+|+.|++++|++.+.+|..+..+++|+.|++++|++++..|..|..+++|+.|++++|++.+.+|..+..+++|+.|+++
T Consensus 381 ~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 460 (968)
T PLN00113 381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA 460 (968)
T ss_pred CCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECc
Confidence 88888888888888888888888888888888888888888888888888888888888888888888888889999999
Q ss_pred CCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccC
Q 002278 358 GNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLL 437 (943)
Q Consensus 358 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 437 (943)
+|++.+.+|..+ ..++|+.|+|++|++++..|..+..+++|+.|+|++|++.+.+|..+..+++|++|+|++|.+++.+
T Consensus 461 ~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 539 (968)
T PLN00113 461 RNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539 (968)
T ss_pred CceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccC
Confidence 998888777765 4588999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCcc-ccc
Q 002278 438 PAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNN-LSG 507 (943)
Q Consensus 438 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~~ 507 (943)
|..|.++++|+.|+|++|++++.+|..+..+.+|+.|++++|++++.+|.. .....+....+.+|+ +.|
T Consensus 540 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~ 609 (968)
T PLN00113 540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLCG 609 (968)
T ss_pred ChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCccccC
Confidence 999999999999999999999999999999999999999999999999964 334455566677776 444
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=429.70 Aligned_cols=287 Identities=48% Similarity=0.777 Sum_probs=248.4
Q ss_pred cccccCHHHHHHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEE
Q 002278 602 DMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYA 681 (943)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 681 (943)
....++++++..+|++|...+.||+|+||.||+|...+++.||||++........++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 35668999999999999999999999999999999999999999988655432156699999999999999999999999
Q ss_pred ecCCc-ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeec
Q 002278 682 LSPYG-NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLS 760 (943)
Q Consensus 682 ~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 760 (943)
.+.+. .++||||+++|+|.++++..... .++|.++.+||.++|+||+|||+.+.+.||||||||+|||+|+++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99984 99999999999999999865443 89999999999999999999999988899999999999999999999999
Q ss_pred ccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCC-----CccHHHHHHHhccc
Q 002278 761 DFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDN-----ESNLHQLIMSKADD 835 (943)
Q Consensus 761 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~-----~~~~~~~~~~~~~~ 835 (943)
|||+|+..+.......+...||.+|+|||+...+..+.|+|||||||++.|++||+.|.+. ......|.......
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999976654111111111699999999999999999999999999999999999998873 23467777777777
Q ss_pred cccccccCccccc-CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 836 NTVMEAVDPEVSV-TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 836 ~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
....+.+||.+.. ......++.++..++..|++.+|.+||+|.+|++.|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 7889999999873 33323678889999999999999999999999999965443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=400.10 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=223.4
Q ss_pred hccccceEEeeeceEEEEEEEe-cCCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCAL-KNSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
..|...+.||+|||+.||.++. ..|..||+|++.+. .+...+.+.+|+++.+.|+|||||+++++|++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999998 67999999999663 3556778999999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
|+|..|+|..+++ ...++++.++..+.+||+.|+.|||+. +|+|||||-.|++++++.+|||+|||+|..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999997 456799999999999999999999999 9999999999999999999999999999998755
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
.... .+.+|||.|.|||++....++..+||||+||++|.|++|++||+...-.+.+..+...+..++..+.
T Consensus 172 ~Erk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls-------- 242 (592)
T KOG0575|consen 172 GERK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLS-------- 242 (592)
T ss_pred cccc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccC--------
Confidence 3333 4468999999999999999999999999999999999999999988777777777666665555332
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....++|..+|+++|.+|||+++|+.|-.-
T Consensus 243 -----~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 243 -----AEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred -----HHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 234589999999999999999999997654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=377.52 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=209.4
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc-ceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ-YPHNLREFETELETIGSIRHRNIVSLHGYALSPYG-NLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e 692 (943)
.+++....||+|..|+||++.++ +++.+|+|++... .+...+++.+|+++++..+||+||.+||.|..+.. ..|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34566778999999999999988 4677899998433 35566789999999999999999999999999984 999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||.+|+|.+++. ..+++++....+++.+|++||.|||+ + +||||||||+|||++..|+|||||||.++.+...
T Consensus 159 YMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999987 34679999999999999999999996 6 9999999999999999999999999999987655
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC----ccHHHHHHHhccccccccccCcccc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNE----SNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
.....+||..|||||.+.+..|+.++||||||++++|+++|+.||... .....+......+ ..|.++
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~------ppP~lP 303 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE------PPPRLP 303 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC------CCCCCC
Confidence 223456999999999999999999999999999999999999999764 2222322222221 122222
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.. ....++..++..|+++||.+||+++|+++|-+
T Consensus 304 ~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 304 EG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred cc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 21 12256778999999999999999999999865
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=395.55 Aligned_cols=259 Identities=34% Similarity=0.490 Sum_probs=214.5
Q ss_pred ccccceEEeeeceEEEEEEEecCCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-cceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPY-GNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 693 (943)
.+.....||+|+||+||+|.++....||||++..... ...++|.+|+.++++++|||||+++|+|.++. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 3344455999999999999999666699999976432 22568999999999999999999999999987 78999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCC-eEecCCCCccEEECCCC-ceeecccccccccCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR-IIHRDVKSSNILIDENF-DAHLSDFGIARCIPTA 771 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~kl~DFGla~~~~~~ 771 (943)
+++|+|.++++.. ....+++..++.++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999853 356899999999999999999999999 7 99999999999999997 9999999999876543
Q ss_pred CCceeeeEecccceeCccccc--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 772 MPHASTFVLGTIGYIDPEYAH--TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
. ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+... .+.+...... ..+|.++..
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~-----~~Rp~~p~~ 270 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVG-----GLRPPIPKE 270 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhc-----CCCCCCCcc
Confidence 2 2223356999999999999 56999999999999999999999999998776 3333332221 222333322
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
....+..++..||+.||++||++.+++..|+.+....
T Consensus 271 -----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 271 -----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred -----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 2357788999999999999999999999998776533
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=382.25 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=209.3
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc-------cHHHHHHHHHHHhcCCCCCcceeeeEEecCC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH-------NLREFETELETIGSIRHRNIVSLHGYALSPY 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 685 (943)
..+.|...+.+|+|+||.|-+|..+ +++.||||.+.+.... ....+++|+++|++++|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456778889999999999999865 6899999998654311 2234679999999999999999999999999
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC---Cceeeccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN---FDAHLSDF 762 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DF 762 (943)
..|+||||+.||+|.+.+- ..+.+.+.....+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999986 455688888899999999999999999 99999999999999755 78999999
Q ss_pred ccccccCCCCCceeeeEecccceeCccccccCC---CCCcchhhhHHHHHHHHHhCCCCCCCCccHH-HHHHHhcccccc
Q 002278 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR---LNEKSDVYSFGIVLLEILTGKKAVDNESNLH-QLIMSKADDNTV 838 (943)
Q Consensus 763 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~ 838 (943)
|+|+..+. .......+|||.|.|||++.++. +..++|+||+||+||-+++|.+||.+..... ....+......+
T Consensus 324 GlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 324 GLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred chhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 99998763 34455678999999999998765 3358899999999999999999998554322 222222222233
Q ss_pred ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
....|.++ .++..++|.+|+..||++|||+.|+++|-|-.
T Consensus 402 ~p~~w~~I---------seea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 402 GPLQWDRI---------SEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred cChhhhhh---------hHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 33333333 35667899999999999999999999998753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=376.56 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=206.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ--YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
...+|...+.||+|+||+||+|+++ ++..||||.+.+. ..+..+.+..|+.+|+.++|||||.+++++..++..++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3467888888999999999999987 5789999999766 455667788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC------Cceeeccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN------FDAHLSDFGI 764 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~------~~~kl~DFGl 764 (943)
||||.||+|.++++ ..+.+++.++..++.|+|.|+++||++ +||||||||+|||++.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999998 456899999999999999999999999 99999999999999754 5689999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
|+.+.... .....+|++-|||||++....|+.|+|+||+|+++|++++|+.||+.....+-..++......+ .....
T Consensus 162 AR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~-~~~~~ 238 (429)
T KOG0595|consen 162 ARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV-PVLPA 238 (429)
T ss_pred hhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc-Cchhh
Confidence 99987542 2345789999999999999999999999999999999999999999877666555443332221 11111
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
... ....+++...++.+|.+|-++.+...+
T Consensus 239 ~~s---------~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 239 ELS---------NPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hcc---------CchhhhhhHHHhcCccccCchHHhhhh
Confidence 111 122355666667777777766665544
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=402.00 Aligned_cols=474 Identities=29% Similarity=0.413 Sum_probs=349.7
Q ss_pred EEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecC
Q 002278 40 VVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKN 119 (943)
Q Consensus 40 v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 119 (943)
...++|++|.+. .+.+.+.++..|+.|++++|+++ .+|.+++.+..++.|+.++|+++ .+|++++.+.+|..|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 567999999999 78899999999999999999999 88999999999999999999999 8999999999999999999
Q ss_pred cccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccC
Q 002278 120 NQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIP 199 (943)
Q Consensus 120 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 199 (943)
|.+. .+|+.++.+..|..|+..+|+++ ..|..+..+.+|..|++.+|+++..++..+. ++.|++||+.+|.+. ++|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence 9999 78899999999999999999999 7888899999999999999999999887777 999999999999998 788
Q ss_pred CCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCc
Q 002278 200 DSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYT 279 (943)
Q Consensus 200 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 279 (943)
..++.|.+|+.|+|.+|+|. .+|.+-++..|+.|+++.|.|.....+..+.+.+|.+|||..|++. ..|+.++-+.+|
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL 277 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSL 277 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhh
Confidence 89999999999999999998 7787778888999999999999655555669999999999999999 789999999999
Q ss_pred ceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCccc--ceEEE-------ccccccC--------CcCc
Q 002278 280 GKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQ--LFELN-------LADNNLE--------GPIP 342 (943)
Q Consensus 280 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~-------L~~N~l~--------~~~p 342 (943)
++|++++|.|+ ..|..++++ +|+.|.+.+|.+..+-.+.+..-++ |++|. ++...=. ....
T Consensus 278 ~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~ 355 (565)
T KOG0472|consen 278 ERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESF 355 (565)
T ss_pred hhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcc
Confidence 99999999999 578899999 9999999999986322221111110 11110 0000000 0000
Q ss_pred ccccCCCcCcEEEeeCCcccCcccccccccC--ccceeeccCCcCCCCCCCCCCCCCCcc-EEecCCCcCCCccCCCccc
Q 002278 343 HNISSCTALNQFNVHGNRLSGAIPSSFRNLG--SLTYLNLSRNNFKGKVPTELGRIINLD-TLDLSVNNFSGSVPASIGD 419 (943)
Q Consensus 343 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~ 419 (943)
.....+.+.+.|++++-+++..+.+.|..-. -.+..+++.|++. .+|..+..++.+. .+++++|.++ .+|..+..
T Consensus 356 ~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~ 433 (565)
T KOG0472|consen 356 PDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQ 433 (565)
T ss_pred cchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHh
Confidence 1122234455566666666533333333222 1555666666665 4555555554443 3444444444 55555566
Q ss_pred ccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccc
Q 002278 420 LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLN 499 (943)
Q Consensus 420 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 499 (943)
+++|..|+|++|.+. .+|.+++.+..|++||+|+|++. .+|..+..+..|+.+-.++|++....|+.+.++.+|..||
T Consensus 434 l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLD 511 (565)
T KOG0472|consen 434 LQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLD 511 (565)
T ss_pred hhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceec
Confidence 666666666666555 45556666666666666666665 5566655555555555555666544444455666666666
Q ss_pred cCCccccccCCCCcccCcCCCCccccCCC
Q 002278 500 VSYNNLSGIIPPIRNFSRFSSNSFIGNPL 528 (943)
Q Consensus 500 ls~N~l~~~~~~~~~~~~~~~~~~~~Np~ 528 (943)
|.+|.|..+||.++....+..+.+.|||+
T Consensus 512 L~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 512 LQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred cCCCchhhCChhhccccceeEEEecCCcc
Confidence 66666666666555555555555666654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=386.61 Aligned_cols=260 Identities=28% Similarity=0.403 Sum_probs=220.6
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..+.++..+.||+|.||+||.|.++...+||+|.++.. ....++|.+|+++|++++|++||+++|+|..++..+|||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 34455667789999999999999998889999999765 34557889999999999999999999999998899999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
|+.|+|.++|+. .....+...+.+.++.|||+|++||+++ ++|||||.++||||+++..|||+|||+|+...++..
T Consensus 283 m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999999985 2456789999999999999999999999 999999999999999999999999999996665555
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......-+..|.|||.+....++.|||||||||+||||+| |+.||.+....+........ ..++. +
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-yRlp~----------P- 426 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-YRLPR----------P- 426 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-CcCCC----------C-
Confidence 55544445789999999999999999999999999999999 99999887765544333222 22111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
..++..++++|..||+.+|++|||+..+...++.+...
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 12346788999999999999999999999988876653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=365.94 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=210.1
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..+.|+..++||+|+||.||.++.++ ++.+|+|++.+.. ....+...+|..+++.++||.||+++-.|++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35678999999999999999999774 6788999987654 2345678899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
|+||+.||.|..+|+ +.+.+++..+.-++..|+.||.|||++ +||||||||+|||+|++|+++|+|||+++...
T Consensus 103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999997 567899999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
... ..+...+||+.|||||++.+.+|+.++|+||+|+++|||++|.+||.+.+.......+........... +
T Consensus 177 ~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~---l--- 249 (357)
T KOG0598|consen 177 KDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGY---L--- 249 (357)
T ss_pred cCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCcc---C---
Confidence 332 233447899999999999999999999999999999999999999998775554444433331111110 1
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERP----TMQEVARV 883 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RP----t~~el~~~ 883 (943)
.....++++..++.||++|- ++.++.+|
T Consensus 250 ------s~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 250 ------SEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred ------CHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 13456889999999999994 56666554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=359.94 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=209.6
Q ss_pred hhccccceEEeeeceEEEEEEEe-cCCceEEEEEecc--cCcccHHHHHHHHHHHhcCCCCCcceeee-EEecCCc-ceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCAL-KNSRPIAVKKLYN--QYPHNLREFETELETIGSIRHRNIVSLHG-YALSPYG-NLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l 689 (943)
...|++.++||+|+||+||++.. .+|..||.|++.= ......+....|+.+|++++|||||++++ .+.++.+ .+|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 45678888999999999999985 4789999999852 22344567889999999999999999999 4555555 799
Q ss_pred EEEEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCccEEECCCCceeeccccccc
Q 002278 690 FYDYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPR--IIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
|||||..|+|...++..+ .+..+++.++++++.|++.||.++|++ -++ |+||||||.||+++++|.||++|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999986433 345799999999999999999999994 225 8999999999999999999999999999
Q ss_pred ccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
.+........+ .+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.++. +..+........ . |.+
T Consensus 177 ~l~s~~tfA~S-~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-~~~L~~KI~qgd-~-----~~~ 248 (375)
T KOG0591|consen 177 FLSSKTTFAHS-LVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-LLSLCKKIEQGD-Y-----PPL 248 (375)
T ss_pred HhcchhHHHHh-hcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-HHHHHHHHHcCC-C-----CCC
Confidence 98776554444 569999999999999999999999999999999999999999884 444444333221 1 111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
++.-....+..++..|+..||+.||+...++..+..
T Consensus 249 ----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 ----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 122334678889999999999999986555555544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=353.54 Aligned_cols=261 Identities=23% Similarity=0.289 Sum_probs=213.4
Q ss_pred hccccceEEeeeceEEEEEEEecC-CceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
+.|+...++|+|+||+||+|++++ |+.||||++..... ...+-..+|++++++++|||+|.++.+|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 568888999999999999999885 78999999976543 233446799999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
||+..-|.+ ++. ....++.+.+.+++.|++.|+.|+|++ +++||||||+|||++.+|.+||||||+|+.+.. .
T Consensus 82 ~~dhTvL~e-Le~--~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LER--YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchHHHHH-HHh--ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 997655544 432 344588999999999999999999999 999999999999999999999999999998864 2
Q ss_pred CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc----------
Q 002278 773 PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA---------- 841 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 841 (943)
....+.++.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|.+.++.+++..+...-+.+...
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 344556779999999999887 689999999999999999999999999999999988776654443221
Q ss_pred ----cCcccccCccC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 842 ----VDPEVSVTCVD----LSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 842 ----~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.-|+.....+- ......+.++++.|++.||++|++-++++.|
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 01111100000 0122356799999999999999999998865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=370.14 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=222.1
Q ss_pred HHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCc
Q 002278 612 MRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYG 686 (943)
Q Consensus 612 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 686 (943)
++...+|..++.||+|+|++||+|+.+ .++.||||++.+.. ....+.+..|-.+|.+| .||.|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 455678889999999999999999976 57899999986543 23345567888999999 79999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.|+|+||+++|+|.++|+ ..+.+++.....++.+|+.||+|||++ |||||||||+|||+|+||++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999998 567899999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCc---------e---eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcc
Q 002278 767 CIPTAMPH---------A---STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD 834 (943)
Q Consensus 767 ~~~~~~~~---------~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 834 (943)
.+...... . ....+||..|.+||++.+...++.+|+|+|||++|+|+.|++||.+.+++..+.++...
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 87432111 1 13467999999999999999999999999999999999999999999988888888777
Q ss_pred ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
+..+++.+++ ...+++++.+..||.+|+|.+++.+|.
T Consensus 303 ~y~fp~~fp~-------------~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 303 DYEFPEGFPE-------------DARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred cccCCCCCCH-------------HHHHHHHHHHccCccccccHHHHhhCc
Confidence 7776666553 345899999999999999999998875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=364.53 Aligned_cols=264 Identities=24% Similarity=0.270 Sum_probs=224.3
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Ccce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 688 (943)
..+.|+.+.+||+|.||.||+|++. +|+.||+|++.-.. +.......+||.+|+++.||||+++.+...+. ...|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3456778888999999999999965 68899999996543 55567788999999999999999999998876 6799
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+|+|||+. +|..++.. ....+++.++..++.|++.||+|+|++ +|+|||||.+|||+|.+|.+||+|||+|+++
T Consensus 195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 99999965 78777763 345799999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
........+..+-|.+|+|||++.|. .|+.++|+||.|||+.||++|++.|.+...++++..+....+...+..|+...
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 77766656667789999999998874 69999999999999999999999999999999999888887777777776221
Q ss_pred cCc-------c----CH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 848 VTC-------V----DL-----SAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 848 ~~~-------~----~~-----~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
... . .. .......+++..+|..||.+|.||.+++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 110 0 00 112355689999999999999999999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=366.33 Aligned_cols=264 Identities=21% Similarity=0.245 Sum_probs=222.6
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHH-HHHHHHHHhcCC-CCCcceeeeEEecCC-cceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLRE-FETELETIGSIR-HRNIVSLHGYALSPY-GNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 689 (943)
..++|...+.||.|.||.||+|+.+ .+..||||++++......+. -.+|+..|+++. |||||++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4578999999999999999999965 57889999998765443333 358999999998 999999999999988 8999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||| ..+|+++++++ ...+++.++..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||...
T Consensus 88 VfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 99999 56999999864 56799999999999999999999999 99999999999999988899999999999886
Q ss_pred CCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc--
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV-- 846 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 846 (943)
...+. +.++.|.+|+|||++.+ +.|+.+.||||+|||++|+.+-++.|.+.++.+++.++...-+...+.-+++-
T Consensus 162 SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 65443 44678999999998765 67999999999999999999999999999999999888876665544433330
Q ss_pred ------------ccC---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 847 ------------SVT---CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 847 ------------~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
... ..-.....+..+++.+|+.+||++||||++++++-.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 000 000124467789999999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.84 Aligned_cols=263 Identities=22% Similarity=0.258 Sum_probs=224.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc--cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH--NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.+|...+++|+|.||.||+|++. .++.||||+++..... -.....+|+..++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46788889999999999999965 6899999999755322 24567899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|++ .+|+..++. ....++..++..++.++.+|++|+|++ .|+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 589888874 456799999999999999999999999 99999999999999999999999999999987654
Q ss_pred CceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc-
Q 002278 773 PHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC- 850 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 850 (943)
..... .+-|.+|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.+.++++++..+...-+...+..+|++....
T Consensus 156 ~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 43333 3579999999988874 69999999999999999999999999999999999988877777777776653111
Q ss_pred --------------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 851 --------------VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 851 --------------~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.-..+.....+++..++..+|.+|.|++|++++-.
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 00123345689999999999999999999998743
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=377.51 Aligned_cols=390 Identities=22% Similarity=0.236 Sum_probs=285.8
Q ss_pred EEEEEcCCCCCccccCCCcCCC--CCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEe
Q 002278 40 VVSLNLSSLNLGGEISPSIGDL--RNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNL 117 (943)
Q Consensus 40 v~~L~l~~~~~~~~~~~~l~~l--~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 117 (943)
-..||.+++.+...--..+.++ ...+.|||++|+|...-+..|.++++|+.++|.+|.++ .+|.-.+...+|+.|+|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL 132 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence 3467888877763222223332 23567999999998777778889999999999999998 78876667778999999
Q ss_pred cCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccc
Q 002278 118 KNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGT 197 (943)
Q Consensus 118 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 197 (943)
.+|.|+.+-.+.++.++.|+.||||.|.|+...-..|-.-.++++|+|++|+|+.+..+.|.++.+|..|.|+.|+|+..
T Consensus 133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL 212 (873)
T KOG4194|consen 133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL 212 (873)
T ss_pred eccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence 99999988888899999999999999999866666677777899999999999999888999999999999999999977
Q ss_pred cCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCC
Q 002278 198 IPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLS 277 (943)
Q Consensus 198 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 277 (943)
.+..|.++++|+.|+|..|+|.-. ---.|..+.+|+.|.|..|.|...-...|-.+.
T Consensus 213 p~r~Fk~L~~L~~LdLnrN~iriv-----------------------e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~ 269 (873)
T KOG4194|consen 213 PQRSFKRLPKLESLDLNRNRIRIV-----------------------EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLE 269 (873)
T ss_pred CHHHhhhcchhhhhhccccceeee-----------------------hhhhhcCchhhhhhhhhhcCcccccCcceeeec
Confidence 778888899999999999988621 112345555666666666666655555566666
Q ss_pred CcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEee
Q 002278 278 YTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVH 357 (943)
Q Consensus 278 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 357 (943)
++++|+|+.|+++.....++.++++|+.|+|++|.|..+.++.+...++|++|+|++|+|+...++.|..+..|++|+|+
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs 349 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS 349 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence 66666666666665555566666666666666666666666666666666666666666666666666666666666666
Q ss_pred CCcccCcccccccccCccceeeccCCcCCCCCC---CCCCCCCCccEEecCCCcCCCccCCCcccccccceeeccccccc
Q 002278 358 GNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP---TELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLN 434 (943)
Q Consensus 358 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 434 (943)
+|.|+.+-..+|..+.+|+.|||++|.++..+. ..|.+++.|+.|+|.+|+|..+...+|.+++.|++|||.+|.|.
T Consensus 350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Naia 429 (873)
T KOG4194|consen 350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIA 429 (873)
T ss_pred ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcce
Confidence 666666666667777777777777776654432 34666777777777777777555566777777888888888877
Q ss_pred ccCCccccCCCccceecccC
Q 002278 435 GLLPAEFGNLRSIQTIDMSF 454 (943)
Q Consensus 435 ~~~p~~~~~l~~L~~L~Ls~ 454 (943)
++-|..|..+ .|++|.+..
T Consensus 430 SIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 430 SIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred eecccccccc-hhhhhhhcc
Confidence 7777777777 777776543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=358.32 Aligned_cols=258 Identities=29% Similarity=0.413 Sum_probs=206.7
Q ss_pred hccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCC--cceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPY--GNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 692 (943)
.++...+.||+|+||+||++...+ |...|||.+........+.+.+|+++|++++|||||+++|...... ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778889999999999999764 8899999986553333677999999999999999999999855444 5889999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-CCceeecccccccccCC-
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-NFDAHLSDFGIARCIPT- 770 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFGla~~~~~- 770 (943)
|+++|+|.+++.... +.+++..+..++.||++||+|||++ |||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999997432 2799999999999999999999999 9999999999999999 79999999999987763
Q ss_pred -CCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCC-ccHHHHHHHhccccccccccCcccc
Q 002278 771 -AMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNE-SNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 771 -~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
..........||+.|||||++..+ ....++||||+||++.||+||++||... ........+.... ..+ .++..++
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ip~~ls 249 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-EIPDSLS 249 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-CCCcccC
Confidence 222233456799999999999953 3445999999999999999999999873 3333333332222 111 2222222
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
....+++..|+..||++||||.++++|......
T Consensus 250 ---------~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 250 ---------DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ---------HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 355689999999999999999999999765443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=373.22 Aligned_cols=389 Identities=22% Similarity=0.255 Sum_probs=298.7
Q ss_pred CEEEeeCCcccccCCCCccC-C-CCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEe
Q 002278 65 QSIDFQGNKLTGQIPDEIGN-C-GSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLA 142 (943)
Q Consensus 65 ~~L~Ls~n~l~~~~p~~~~~-l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 142 (943)
.-||.++++|...--..+.+ + +.-+.||||+|++...-+..|.++++|+.++|..|.++ .+|.......+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 46788888887321122222 1 23456777777777666667777777777777777777 566665556667777777
Q ss_pred ccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcC
Q 002278 143 RNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEI 222 (943)
Q Consensus 143 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 222 (943)
+|.|++.-...+..++.|+.|+|+.|.|+.+....|..-.++++|+|++|+|+..-...|..+.+|.+|.|++|+|+
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit--- 210 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT--- 210 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc---
Confidence 77777666666667777777777777777776666666666666666666666555566666666666666666665
Q ss_pred CCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCc
Q 002278 223 PYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSK 302 (943)
Q Consensus 223 ~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 302 (943)
...+..|+++++|+.|||..|+|.-..--.|.+|.+|+.|.|..|+|...-...|..|.+
T Consensus 211 --------------------tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~k 270 (873)
T KOG4194|consen 211 --------------------TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEK 270 (873)
T ss_pred --------------------ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecc
Confidence 345567888999999999999888444567888999999999999998877788888999
Q ss_pred CcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccC
Q 002278 303 LSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSR 382 (943)
Q Consensus 303 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 382 (943)
+++|+|+.|++...-.+++.+|+.|+.|+|++|.|..+-++....+++|+.|+|++|+|+...+.+|..|..|++|+|++
T Consensus 271 me~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~ 350 (873)
T KOG4194|consen 271 MEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSH 350 (873)
T ss_pred cceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccc
Confidence 99999999999878888888899999999999999888888888888999999999999888888888888899999999
Q ss_pred CcCCCCCCCCCCCCCCccEEecCCCcCCCccCC---CcccccccceeecccccccccCCccccCCCccceecccCccccc
Q 002278 383 NNFKGKVPTELGRIINLDTLDLSVNNFSGSVPA---SIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459 (943)
Q Consensus 383 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 459 (943)
|.++......|..+++|+.|||++|.|+..+.+ .|.+|+.|+.|+|.+|+|+.+....|.+|.+|+.|||.+|.|..
T Consensus 351 Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaS 430 (873)
T KOG4194|consen 351 NSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIAS 430 (873)
T ss_pred cchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCccee
Confidence 988877777788888888888888888765443 47778888888888888887666788888888888888888887
Q ss_pred cCChhhhcccccceecccC
Q 002278 460 SIPAELGQLQNIISLILNN 478 (943)
Q Consensus 460 ~~p~~~~~l~~L~~L~L~~ 478 (943)
+-|..|..+ .|+.|.++.
T Consensus 431 Iq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 431 IQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred ecccccccc-hhhhhhhcc
Confidence 778888887 787777654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=336.18 Aligned_cols=237 Identities=21% Similarity=0.279 Sum_probs=210.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||.|+||.|.+++.+ ++..+|+|.+.+... +..+...+|..+++.+.||+++++++.+.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356888899999999999999987 477889999866532 3345567899999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||++||.|..+++ ..++++++.+.-+|.||+.|++|||+. +|++||+||+|||+|.+|++||+|||+|+.+..
T Consensus 123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999997 556799999999999999999999999 999999999999999999999999999997754
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
. +.+.+|||.|+|||++..++|+.++|.|||||++|||+.|.+||.+...+..+..+......++..+.+.
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~----- 267 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSD----- 267 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHH-----
Confidence 3 4567899999999999999999999999999999999999999999988888877777777766665543
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCC
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSER 874 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~R 874 (943)
+.+++...++.|-.+|
T Consensus 268 --------~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 268 --------AKDLLKKLLQVDLTKR 283 (355)
T ss_pred --------HHHHHHHHHhhhhHhh
Confidence 3478888888888888
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=381.76 Aligned_cols=265 Identities=28% Similarity=0.416 Sum_probs=219.4
Q ss_pred hhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCcc-cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
..+....+.||+|+||+||+|+.. +...||||.++..... ..++|++|+++++.++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344555678999999999999853 2467999999877655 778999999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCC-----------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc
Q 002278 688 LLFYDYMVNGSLWDLLHGPS-----------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 756 (943)
++|+|||..|+|.++|.... .+.+++..+.+.||.|||.|++||-++ .+|||||.++|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 99999999999999986322 133488999999999999999999999 9999999999999999999
Q ss_pred eeecccccccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcc
Q 002278 757 AHLSDFGIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKAD 834 (943)
Q Consensus 757 ~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 834 (943)
|||+|||+++..-..+.+. .....-+.+|||||.+..++++++||||||||+|||+++ |+.||.+..+.+.+..+..+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 9999999998653333322 212234789999999999999999999999999999999 99999988776655444332
Q ss_pred ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCc
Q 002278 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAK 894 (943)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~~~ 894 (943)
.- .+. ...++.+++.+|..||+..|++||+++||-..|+......+..
T Consensus 722 ~l--L~~----------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~ 769 (774)
T KOG1026|consen 722 QL--LSC----------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY 769 (774)
T ss_pred Cc--ccC----------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence 22 111 1123468899999999999999999999999999877655443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=366.14 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=218.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
...|.....||+|+.|.||.|... .++.||||++........+-+.+|+.+|+..+|+|||++++.|...++.++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 456777778999999999999855 5788999999777666677889999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
++||+|.|.+. ...+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999985 44599999999999999999999999 999999999999999999999999999998866654
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
. +...+||+.|||||+.....|++|+||||||++++||+-|++||-.+.++..+..+.....+.... +..
T Consensus 425 K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~-~~k-------- 494 (550)
T KOG0578|consen 425 K-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN-PEK-------- 494 (550)
T ss_pred c-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC-ccc--------
Confidence 3 444669999999999999999999999999999999999999999888876666554433322111 111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+.+++.+|+..||++||++.|+++|-.
T Consensus 495 -lS~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 495 -LSPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred -cCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 2246778999999999999999999999854
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=376.31 Aligned_cols=465 Identities=26% Similarity=0.353 Sum_probs=368.1
Q ss_pred CCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcE
Q 002278 59 GDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKT 138 (943)
Q Consensus 59 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 138 (943)
+.-..|+.|+|++|.++ .+-+.+.++..|.+|++.+|++. .+|.+++.+..++.|+.++|+++ .+|..+..+.+|+.
T Consensus 42 W~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~ 118 (565)
T KOG0472|consen 42 WEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVK 118 (565)
T ss_pred hhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhh
Confidence 34467889999999999 66667899999999999999999 89999999999999999999999 89999999999999
Q ss_pred EEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccc
Q 002278 139 LDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQI 218 (943)
Q Consensus 139 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l 218 (943)
|++++|.+. .+|+.++.+..|+.|+..+|++.+. |+++..+.+|..+++.+|+++...|..+. ++.|++||+..|-+
T Consensus 119 l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~sl-p~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L 195 (565)
T KOG0472|consen 119 LDCSSNELK-ELPDSIGRLLDLEDLDATNNQISSL-PEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLL 195 (565)
T ss_pred hhcccccee-ecCchHHHHhhhhhhhccccccccC-chHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhh
Confidence 999999998 7888899999999999999999976 56788899999999999999965555444 99999999999999
Q ss_pred cCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcC
Q 002278 219 TGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELG 298 (943)
Q Consensus 219 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 298 (943)
+...|...+..+|..|+|..|+|. ..| .|..+..|..|+++.|+|.....+...++..+..|+|.+|+++ ..|..++
T Consensus 196 ~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c 272 (565)
T KOG0472|consen 196 ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC 272 (565)
T ss_pred hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHH
Confidence 844444444557888888888887 355 6777888888888888887433344558888888888888888 6788888
Q ss_pred CCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCC--cCcEEEe--eCCccc---------Cc-
Q 002278 299 NMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCT--ALNQFNV--HGNRLS---------GA- 364 (943)
Q Consensus 299 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L--~~N~l~---------~~- 364 (943)
.+++|.+||+++|.|+ ..|..++++ .|+.|-+.+|.+..+-.+.+..-+ -|++|.= ..-.++ ..
T Consensus 273 lLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~ 350 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTL 350 (565)
T ss_pred HhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCC
Confidence 8888888888888888 667778888 788888888887643222211111 1222210 000110 00
Q ss_pred ccc---cccccCccceeeccCCcCCCCCCCCCCCCCC---ccEEecCCCcCCCccCCCcccccccce-eecccccccccC
Q 002278 365 IPS---SFRNLGSLTYLNLSRNNFKGKVPTELGRIIN---LDTLDLSVNNFSGSVPASIGDLEHLLT-LNLSRNHLNGLL 437 (943)
Q Consensus 365 ~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~ 437 (943)
.+. ....+.+.+.|+++.-+++ .+|+....... .+..+++.|++. ++|..+..+..+++ +.+++|.+. .+
T Consensus 351 ~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv 427 (565)
T KOG0472|consen 351 PSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FV 427 (565)
T ss_pred CCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cc
Confidence 111 2234567899999999998 67776555444 789999999999 78998888887765 566666665 88
Q ss_pred CccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCC-CcccC
Q 002278 438 PAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP-IRNFS 516 (943)
Q Consensus 438 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~~ 516 (943)
|..+..+++|..|+|++|-+. .+|.+++.+..|+.|++++|++. .+|..+..+..|+.+-.++|++..+.|. +....
T Consensus 428 ~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~ 505 (565)
T KOG0472|consen 428 PLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMR 505 (565)
T ss_pred hHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhh
Confidence 999999999999999999998 89999999999999999999998 8898888888899999999999999887 56677
Q ss_pred cCCCCccccCCCCCCCCCCCccC
Q 002278 517 RFSSNSFIGNPLLCGNWIGSICG 539 (943)
Q Consensus 517 ~~~~~~~~~Np~~c~~~~~~~c~ 539 (943)
.+..+.+.+|...--+|.-..|.
T Consensus 506 nL~tLDL~nNdlq~IPp~Lgnmt 528 (565)
T KOG0472|consen 506 NLTTLDLQNNDLQQIPPILGNMT 528 (565)
T ss_pred hcceeccCCCchhhCChhhcccc
Confidence 78888888887655454434443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.60 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=218.8
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
..+.|+...+||.|..++||+|+.. .+..||||++.-.. ......+++|++.++.++||||++++..|..+...|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 4567889999999999999999954 57899999995433 334688999999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
.||.+|++.++++..-. ..+++..+..|.+++++||.|||.+ |.||||||+.|||++++|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999975432 3489999999999999999999999 9999999999999999999999999998877544
Q ss_pred CCce--e-eeEecccceeCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 772 MPHA--S-TFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 772 ~~~~--~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
.... + ....||+.|||||++.. ..|+.|+||||||++..||.+|..||....++..+........+.+.... .
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~--~ 257 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG--L 257 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc--C
Confidence 3222 1 34579999999999543 57999999999999999999999999988888777777666554333111 1
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
. ..........+.+++..|+.+||.+|||+++++++-
T Consensus 258 ~-~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 258 D-KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred C-hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 1 111122335778899999999999999999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=362.73 Aligned_cols=256 Identities=22% Similarity=0.283 Sum_probs=217.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc----Cc-ccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ----YP-HNLREFETELETIGSIR-HRNIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 686 (943)
..+.|...+.||+|+||+|+.|.+. .++.||+|.+.+. .. ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999865 5799999966543 11 23456778999999999 9999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC-Cceeecccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-FDAHLSDFGIA 765 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DFGla 765 (943)
.++||||+.||+|.+++. ..+++.+..+..+++|++.|++|+|++ ||+||||||+||+++.+ +.+||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999997 357799999999999999999999999 99999999999999999 99999999999
Q ss_pred cccCCCCCceeeeEecccceeCccccccCC-CC-CcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTSR-LN-EKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.........+......++..+.
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~ 247 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL 247 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC
Confidence 9874 2223344567999999999999977 76 7999999999999999999999987665555555554455555442
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...+..++.+|+..||.+|+|+.+++++-|-..
T Consensus 248 ------------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 248 ------------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ------------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 135568999999999999999999998776544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.52 Aligned_cols=247 Identities=27% Similarity=0.366 Sum_probs=211.4
Q ss_pred hccccceEEeeeceEEEEEEEecC-CceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++|.+.+.||+|+||.||||+.+. .+.||+|.+.+.. .+..+.+.+|+++++.++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 567788889999999999999774 5778999886543 3445678999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+.| +|..++. ..+.++++.+..++.+++.||.|||+. +|+|||+||+||+++.+|++|++|||+|+.+...
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9976 9999997 567899999999999999999999999 9999999999999999999999999999988654
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccc-ccccccCcccccCcc
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN-TVMEAVDPEVSVTCV 851 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 851 (943)
....+...|||-|||||+..+.+|+..+|+||+||++||+++|++||....-. +++.....+. .++.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-~Lv~~I~~d~v~~p~----------- 221 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-QLVKSILKDPVKPPS----------- 221 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-HHHHHHhcCCCCCcc-----------
Confidence 34445567999999999999999999999999999999999999999865433 3343333322 2222
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.....+..++...+.+||.+|.|..+++.|-
T Consensus 222 --~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 222 --TASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred --cccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 2234677899999999999999999998874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=351.78 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=214.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..+.|+...+||+||||.||.|+-+ .|..+|+|++++.. ....+.+..|..+|....+|.||++|-.|++.+..|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 5678999999999999999999977 47888999997764 3345667889999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||++||++..+|. ....+++..+..++.+++-|++.+|+. |||||||||+|+|||..|++||+|||+++-+.
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999997 567899999999999999999999999 99999999999999999999999999995431
Q ss_pred C-----------------------CCCc---ee--------------------eeEecccceeCccccccCCCCCcchhh
Q 002278 770 T-----------------------AMPH---AS--------------------TFVLGTIGYIDPEYAHTSRLNEKSDVY 803 (943)
Q Consensus 770 ~-----------------------~~~~---~~--------------------~~~~gt~~y~aPE~~~~~~~~~~~Dvw 803 (943)
. +... .. ...+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 00 114699999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCC---CHHHH
Q 002278 804 SFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP---TMQEV 880 (943)
Q Consensus 804 SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~el 880 (943)
|+|||+|||+.|.+||.++++.+.+..+..+...+......... .+..++|.+|+. ||++|- .++||
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s---------~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLS---------DEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCccc---------HHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 99999999999999999999998888777655432222111111 345688999888 999997 58888
Q ss_pred HHHHh
Q 002278 881 ARVLV 885 (943)
Q Consensus 881 ~~~L~ 885 (943)
.+|-+
T Consensus 443 K~HPf 447 (550)
T KOG0605|consen 443 KKHPF 447 (550)
T ss_pred hcCCc
Confidence 77653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=330.56 Aligned_cols=265 Identities=24% Similarity=0.248 Sum_probs=222.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc--cHHHHHHHHHHHhcCCCCCcceeeeEEec--CCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH--NLREFETELETIGSIRHRNIVSLHGYALS--PYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 688 (943)
..++|+..+.|++|.||.||+|+++ +++.||+|+++..... ..-...+|+.++.+.+|||||.+..+... -+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4567888999999999999999976 5788999999754322 22346789999999999999999988754 35789
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+|||||+. +|..+++.. ..++...++..+..|+++|++|||.. .|+||||||+|+|+...|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 99999965 788888743 35799999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
+.... ..+..+-|.+|+|||++.+. .|+++.|+||+|||+.||+++++.|.+...++++..+....+...+..+|.+.
T Consensus 228 gsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 228 GSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred cCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 76633 33445579999999998875 59999999999999999999999999999999999998888888888877764
Q ss_pred cCcc-------------------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 848 VTCV-------------------DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 848 ~~~~-------------------~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.... .......-++++...+..||.+|.||.|.++|=+
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 2210 0011245578999999999999999999999854
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.61 Aligned_cols=265 Identities=29% Similarity=0.422 Sum_probs=213.1
Q ss_pred HHHHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 610 DIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 610 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
+.....+++.....||+|+||+||+|+|.+ .||||++.... ++..+.|..|+.++++-+|.||+-+.|||..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 334455667788899999999999999873 59999986544 4567889999999999999999999999998876
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
.||..+|+|.+|+.+++.. ..+++..+.+.||+|||+|+.|||.+ +|||||||..||++.+++.|||+|||++..
T Consensus 463 AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 9999999999999999864 35799999999999999999999999 999999999999999999999999999965
Q ss_pred cCCC-CCceeeeEecccceeCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 768 IPTA-MPHASTFVLGTIGYIDPEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 768 ~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
...- .........|...|||||++.. .+|++++||||||+|+|||+||..||. ....++++.......-.++...
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSK 616 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchh
Confidence 3211 1111222347889999999875 368999999999999999999999998 4444443322222211111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
. ...+.+++.+++..||..+|++||.+.+++..|+.+.+.
T Consensus 617 ~-------~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 617 I-------RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred h-------hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1 113446788999999999999999999999999888774
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=366.86 Aligned_cols=271 Identities=26% Similarity=0.421 Sum_probs=226.1
Q ss_pred ccCHHHHHHHhhc---------cccceEEeeeceEEEEEEEecC----CceEEEEEecccCc-ccHHHHHHHHHHHhcCC
Q 002278 605 IHTFDDIMRSTEN---------LSEKYIVGYGASSTVYKCALKN----SRPIAVKKLYNQYP-HNLREFETELETIGSIR 670 (943)
Q Consensus 605 ~~~~~~~~~~~~~---------~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~ 670 (943)
.++|+|.-.+..+ ..+.++||.|.||.||+|+++- ...||||.++.... +...+|..|+.+|.++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 4556555544443 4456799999999999999863 35799999987764 45678999999999999
Q ss_pred CCCcceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEE
Q 002278 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNIL 750 (943)
Q Consensus 671 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 750 (943)
||||+++.|+.......+||.|||++|+|..+|+.. .+.+.+.+...|.++||.|++||-+. ++|||||.++|||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL 763 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL 763 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence 999999999999999999999999999999999854 46699999999999999999999998 9999999999999
Q ss_pred ECCCCceeecccccccccCCCCCceeeeE--ecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHH
Q 002278 751 IDENFDAHLSDFGIARCIPTAMPHASTFV--LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQ 827 (943)
Q Consensus 751 l~~~~~~kl~DFGla~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~ 827 (943)
++.+-.+|++|||+++.++++.....+.. .-+.+|.|||.+...+++.++||||||++|||.++ |.+||.+..+.+.
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 99999999999999998866553333322 23579999999999999999999999999999887 9999998877654
Q ss_pred HHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 828 LIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
+..+. +...++.. .+++..+.++|..||++|-.+||.+.+++.+|.++...+.
T Consensus 844 IkaIe-~gyRLPpP-----------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 844 IKAIE-QGYRLPPP-----------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHHHH-hccCCCCC-----------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 43332 22222221 1345688999999999999999999999999999887654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=348.39 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=212.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ-YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
...|+....||+|+||.||+|.+. .++.||+|.+.-. .....+++++|+.++..++++||.++|+.+..+...+++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 346777789999999999999976 5788999998543 34556789999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+.||++.+.++ ....+++..+.-+++++..|+.|||++ +.+|||||+.||++..+|.||++|||.+..+....
T Consensus 92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999996 344458888888999999999999999 99999999999999999999999999999886665
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
... ...+||+.|||||++.+..|+.|+||||||++.+||++|.+|+....++..+ .-+++..+|.+...
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-------flIpk~~PP~L~~~--- 234 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-------FLIPKSAPPRLDGD--- 234 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-------EeccCCCCCccccc---
Confidence 444 4567999999999999999999999999999999999999999876653211 12233334444432
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
....+.+++..|++++|+.||+|.++++|-
T Consensus 235 --~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 235 --FSPPFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred --cCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 224577899999999999999999999874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=354.75 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=213.9
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
+-|+.++.||.|+.|.|-.|++. .|+.+|||.+.+.. ......+++|+-+|+-+.||||+++|+++++..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45677888999999999999975 68999999986552 334567899999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|.|++++. .++++++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+|.....+
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999997 677899999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCceeeeEecccceeCccccccCCCC-CcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLN-EKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
. .-...||++.|.|||++.|.+|. .++||||.|||||.|+||+.||++++-...+.....+...++..+.
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is------- 236 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNIS------- 236 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCC-------
Confidence 2 23346799999999999998875 7999999999999999999999965544444444444444444433
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.+..+++.+|+..||++|.|++||.+|.+-.
T Consensus 237 ------~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 237 ------SEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred ------HHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 2445899999999999999999999997643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=313.76 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=217.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
+.++|++.+.||+|.||.||.|+.+ ++..||+|++.+.. .....++.+|+++-+.++||||.++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4567899999999999999999966 56789999987643 3345678999999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
++||.++|++...|++. ...++++.....++.|+|.|+.|+|.+ +|+||||||+|+|++..+..|++|||-+..-+
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999754 345689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
...+...+||..|.+||...+..++..+|+|++|++.||++.|.+||.+...-+.+.++...+-.+++.+.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is------ 246 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTIS------ 246 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccC------
Confidence 23445678999999999999999999999999999999999999999987755555555554444443222
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....++|..|+..+|.+|.+..|+++|-|-
T Consensus 247 -------~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 247 -------GGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred -------hhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 344589999999999999999999998763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=356.36 Aligned_cols=262 Identities=25% Similarity=0.386 Sum_probs=205.6
Q ss_pred HhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPY 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 685 (943)
..++|+..+.||+|+||.||+|.+. .++.||+|++.... ......+.+|+++++.+ +||||+++++++....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4568999999999999999999742 24679999986543 23345788999999999 8999999999987654
Q ss_pred -cceEEEEEccCCChhhhccCCCC--------------------------------------------------------
Q 002278 686 -GNLLFYDYMVNGSLWDLLHGPSK-------------------------------------------------------- 708 (943)
Q Consensus 686 -~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 708 (943)
..+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999998864211
Q ss_pred ---CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc-eeeeEecccc
Q 002278 709 ---KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIG 784 (943)
Q Consensus 709 ---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~ 784 (943)
...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 13478889999999999999999999 9999999999999999999999999999865332211 1122345678
Q ss_pred eeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHH
Q 002278 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLA 863 (943)
Q Consensus 785 y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 863 (943)
|+|||++.+..++.++|||||||++|||++ |+.||.+................. ..+. .....+.+++
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~------~~~~-----~~~~~l~~li 310 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM------RAPE-----NATPEIYRIM 310 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC------CCCC-----CCCHHHHHHH
Confidence 999999999999999999999999999997 999998654333322222211110 0110 1124677899
Q ss_pred HHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 864 LLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 864 ~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
..||+.||++|||+.++++.|+.+..
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=319.48 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=217.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecc--cCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYN--QYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.+++|+..+.||+|+|+.||++... .|+++|+|.+.. -.....+++.+|+++-+.++|||||++.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3567888889999999999999866 578899987742 2345678899999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---CCceeecccccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE---NFDAHLSDFGIARC 767 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DFGla~~ 767 (943)
+|+|.||+|..-+- .+-.+++..+-.+++||++||.|+|.+ +|||||+||+|+++.+ ..-+|++|||+|..
T Consensus 89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999976554 234578888889999999999999999 9999999999999953 34599999999998
Q ss_pred cCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
+... .......|||+|||||+....+|+..+|||+-||+||-++.|++||.+++.-..+..+......+....++.+.
T Consensus 163 l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 163 VNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred eCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 8733 33445679999999999999999999999999999999999999999877666666666666666665566555
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
+...+++++|+..||++|.|+.|.++|-|-.
T Consensus 241 ---------~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 241 ---------PEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred ---------HHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 2345789999999999999999999987643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=330.28 Aligned_cols=264 Identities=24% Similarity=0.294 Sum_probs=212.6
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEec-----CC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALS-----PY 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 685 (943)
....|...+.||+|+||.|++|.++ +++.||+|++.... ....++..+|++.++.++|+||+.+++++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666788999999999999976 58999999997443 3456778899999999999999999999865 24
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..|+|+|+| +.+|...++ ....++...+..+++|+++||.|+|+. +|+||||||+|++++.++.+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 579999999 678999886 445599999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC-CCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 766 RCIPTA-MPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 766 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+..... .....+..+.|.+|+|||++.. ..|+.+.||||.|||+.||++|++-|.+.+..+++..+....+...+...
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987542 1223355678999999998764 67999999999999999999999999999888887776655444332211
Q ss_pred cccc----------------cC--ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 844 PEVS----------------VT--CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 844 ~~~~----------------~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
..+. .. ..-........+++.+|+..||.+|+|++|+++|-
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 0000 00 00001224556899999999999999999999974
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=375.01 Aligned_cols=266 Identities=27% Similarity=0.427 Sum_probs=218.2
Q ss_pred hhccccceEEeeeceEEEEEEEecC--C----ceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN--S----RPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
..+.+..+.||+|+||.||.|...+ + ..||+|++.+.. .+...+|.+|..+|+.++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 5566777899999999999999763 3 248999987654 45677899999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCC----CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPS----KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
+|++|||++|+|..+|+..+ ....++..+.+.++.|||+|+.||+++ ++|||||.++|+|+++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998542 244688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceee-eEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccc
Q 002278 764 IARCIPTAMPHAST-FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEA 841 (943)
Q Consensus 764 la~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 841 (943)
+|+.+-........ ...=...|||||.+.++.++.|+|||||||++||++| |..||.+..+.+......... .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R---- 922 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R---- 922 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c----
Confidence 99954333222221 1123468999999999999999999999999999999 999999888776554333322 1
Q ss_pred cCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCcc
Q 002278 842 VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKL 895 (943)
Q Consensus 842 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~~~~ 895 (943)
++ .+.. ++..++++|..||+.+|++||++..+++.+..+........
T Consensus 923 L~--~P~~-----CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 923 LD--PPSY-----CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred cC--CCCC-----CChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 11 1111 23578899999999999999999999999888776654443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.41 Aligned_cols=244 Identities=18% Similarity=0.240 Sum_probs=200.4
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNG 697 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 697 (943)
+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999975 57899999986532 233456778999999999999999999999999999999999999
Q ss_pred ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceee
Q 002278 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777 (943)
Q Consensus 698 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 777 (943)
+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 9999986 345689999999999999999999999 99999999999999999999999999997543222 2223
Q ss_pred eEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHH
Q 002278 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVR 857 (943)
Q Consensus 778 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (943)
...||+.|+|||++.+..++.++||||+||++|||+||+.||..................++. .+ ..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~---------~~ 220 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TL---------SP 220 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CC---------CH
Confidence 456999999999999999999999999999999999999999865543332222222211111 11 24
Q ss_pred HHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 858 KTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 858 ~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
.+.+++..|++.||++|| ++.++++|-+
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 567899999999999999 8999988743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=350.78 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=210.8
Q ss_pred ccccceEEeeeceEEEEEEEecCC-----ceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 617 NLSEKYIVGYGASSTVYKCALKNS-----RPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
+....+.||+|+||.||+|+.+.. ..||||..+.. ......++.+|+++|+.++|||||++||++......+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 334457899999999999997642 22899988752 2456678999999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+|||+|.||+|.++|+.. ...++..+...++.++|.||+|||++ +++||||.++|+|++.++.+||+|||+++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999742 33699999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
....... ....-+.+|+|||.+....++.++|||||||++||+++ |..||.+.........+.......... +
T Consensus 313 ~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~--- 386 (474)
T KOG0194|consen 313 SQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--S--- 386 (474)
T ss_pred cceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--C---
Confidence 3111111 01124689999999999999999999999999999999 899999887665444442322221111 0
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPA 893 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~~ 893 (943)
..+..+..++..||..+|++||+|.++.+.++.+......
T Consensus 387 ------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 387 ------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 2235677889999999999999999999999887765443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=350.46 Aligned_cols=248 Identities=19% Similarity=0.242 Sum_probs=206.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||.||+|+++ +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357889999999999999999986 57889999986432 23345688999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999986 345688999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.................+.. +
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~----~---- 238 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW----F---- 238 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCC----C----
Confidence 22 23469999999999999999999999999999999999999998766544333332221111111 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPT-----MQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L~ 885 (943)
...+.+++..||+.||++||+ ++++++|-+
T Consensus 239 -----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 239 -----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred -----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 135678999999999999996 788888754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.40 Aligned_cols=241 Identities=26% Similarity=0.415 Sum_probs=199.7
Q ss_pred cceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 620 EKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 620 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
..+-+|.|+.|.||.|+++ ++.|||||+... -+.+++-|++++||||+.+.|+|.....++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 4456999999999999988 678999998543 24578889999999999999999999999999999999999
Q ss_pred hhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeE
Q 002278 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV 779 (943)
Q Consensus 700 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 779 (943)
..+|+ ...++.......+..+||.|+.|||.+ .|||||||.-|||+..+..|||+|||-++..... .. ...+
T Consensus 200 ~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-ST-kMSF 271 (904)
T KOG4721|consen 200 YEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-ST-KMSF 271 (904)
T ss_pred HHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hh-hhhh
Confidence 99997 455688888999999999999999999 9999999999999999999999999999876544 22 2335
Q ss_pred ecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHH
Q 002278 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKT 859 (943)
Q Consensus 780 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 859 (943)
+||..|||||++...+.++|+||||||||||||+||..||.+.+.... +...+. ..+.-.++. .++..+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGVGs--NsL~LpvPs-----tcP~Gf 340 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGVGS--NSLHLPVPS-----TCPDGF 340 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EEeccC--CcccccCcc-----cCchHH
Confidence 699999999999999999999999999999999999999986544321 111111 111111222 223456
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 860 FQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 860 ~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.-+++.||+..|..||++.+++.|+.-.
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 6789999999999999999999999743
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.64 Aligned_cols=249 Identities=18% Similarity=0.276 Sum_probs=208.2
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 688 (943)
..++|...++||+|.||+|++|..+ +++.+|||.+++.. .+..+....|.+++... +||.++.++..|+..++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578999999999999999999987 46788999998764 45567788888888777 5999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+.||++..+. ....+++..+.-+|..|+.||+|||++ +|||||||-+|||+|.+|++||+|||+++.-
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999955544 346799999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
-.. ...+++.+|||.|||||++.+..|+.++|.|||||+||||+.|+.||.+++.-+....+...+...+..+
T Consensus 519 m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~l------ 591 (694)
T KOG0694|consen 519 MGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL------ 591 (694)
T ss_pred CCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcc------
Confidence 322 2345567899999999999999999999999999999999999999998776555544444333322222
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPT-----MQEVARV 883 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~ 883 (943)
..+...++++++.++|++|-- +.+|.+|
T Consensus 592 -------s~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 592 -------SKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred -------cHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 245668999999999999984 4555543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=345.60 Aligned_cols=252 Identities=25% Similarity=0.317 Sum_probs=214.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc-ceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYG-NLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 690 (943)
.++|...+++|+|+||.++.++++ +++.||+|++.-.. ....+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 467888999999999999999977 57889999986443 3344567899999999999999999999999988 8999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|+|++||++.+.+...+ ...++++.+..++.|++.|+.|||+. +|+|||||+.||+++.++.|||+|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999997543 45799999999999999999999998 999999999999999999999999999999877
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
...... .++||+.||.||.+.+.+|+.|+||||+||++|||++-+++|...+...-...+...... .+..
T Consensus 159 ~~~~a~-tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~---Plp~------ 228 (426)
T KOG0589|consen 159 EDSLAS-TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS---PLPS------ 228 (426)
T ss_pred chhhhh-eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC---CCCc------
Confidence 653433 467999999999999999999999999999999999999999877665554444443311 1111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.....+..+++.|++.+|..||++.+++.+
T Consensus 229 ---~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 ---MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122467789999999999999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.65 Aligned_cols=247 Identities=21% Similarity=0.230 Sum_probs=205.7
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999976 57899999985432 233456889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999986 345689999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||.+................++.. +
T Consensus 155 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~----- 221 (291)
T cd05612 155 T----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH----L----- 221 (291)
T ss_pred c----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCcc----C-----
Confidence 1 23458999999999999999999999999999999999999998765544333322222111111 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPT-----MQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L~ 885 (943)
...+.+++++|++.||.+||+ +.++++|-+
T Consensus 222 ----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 222 ----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred ----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 135678999999999999995 999998865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=340.37 Aligned_cols=253 Identities=21% Similarity=0.262 Sum_probs=201.4
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
|+..+.||+|+||+||+|... +++.||+|++.... ......+.+|+++++.++|++|+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677889999999999999975 68899999886432 22334577899999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999998887532 233589999999999999999999999 999999999999999999999999999987643221
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
.....||..|+|||++.+..++.++||||+||++|||++|+.||..........................+
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 228 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKF------- 228 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccC-------
Confidence 22345899999999999999999999999999999999999999865432111111100000011111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPT-----MQEVARVLV 885 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L~ 885 (943)
...+.+++..||+.||++||+ ++++++|-+
T Consensus 229 --s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 229 --SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred --CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 245678999999999999997 888888743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.18 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=219.4
Q ss_pred HHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC----cc----cHHHHHHHHHHHhcC-CCCCcceee
Q 002278 609 DDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY----PH----NLREFETELETIGSI-RHRNIVSLH 678 (943)
Q Consensus 609 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~----~~~~~~~E~~~l~~l-~h~niv~l~ 678 (943)
++-......|...+.+|.|..++|.++.++ .|+++|+|++.... .+ ..++..+|+.+++++ .||+|+++.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 334455677888899999999999999876 57889999885332 11 234456899999998 599999999
Q ss_pred eEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCcee
Q 002278 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH 758 (943)
Q Consensus 679 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 758 (943)
++++.+...++|+|.|+.|.|.|++. ....+++....+|+.|+.+|++|||.+ +||||||||+|||++++.++|
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceE
Confidence 99999999999999999999999996 567899999999999999999999999 999999999999999999999
Q ss_pred ecccccccccCCCCCceeeeEecccceeCccccc------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHh
Q 002278 759 LSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH------TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSK 832 (943)
Q Consensus 759 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 832 (943)
|+|||+|+.++.+. .-...+|||+|.|||.+. ...|+..+|+||.||+||.++.|.+||.....+..+..+.
T Consensus 164 isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im 241 (411)
T KOG0599|consen 164 ISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM 241 (411)
T ss_pred EeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH
Confidence 99999999887653 234578999999999875 3468899999999999999999999999877766666666
Q ss_pred ccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.+...+...-+.+++ ...-+++.+|++.||.+|.|++|+++|-+-
T Consensus 242 eGkyqF~speWadis---------~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 242 EGKYQFRSPEWADIS---------ATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred hcccccCCcchhhcc---------ccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 666655555444444 234579999999999999999999998654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.19 Aligned_cols=247 Identities=19% Similarity=0.328 Sum_probs=200.1
Q ss_pred ceEEeeeceEEEEEEEecCCceEEEEEecccCccc---HHHHHHHHHHHhcCCCCCcceeeeEEec----CCcceEEEEE
Q 002278 621 KYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHN---LREFETELETIGSIRHRNIVSLHGYALS----PYGNLLFYDY 693 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 693 (943)
...||+|++|.||+|.. +++.||||++....... .+.+.+|++++++++|||||++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 48899999987654333 4677899999999999999999999876 3467899999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++.. ...+++.....++.+++.|++|||+.. +++||||||+||++++++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999973 356899999999999999999999732 78899999999999999999999999998654321
Q ss_pred ceeeeEecccceeCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 774 HASTFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+................ +.++.
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~------~~~~~--- 245 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS------LKLPL--- 245 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC------CCCCC---
Confidence 12358899999999876 67999999999999999999999999876543332222211111 11111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.....+.+++.+||+.||++|||++++++.|+.+.
T Consensus 246 --~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 246 --DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 12246778999999999999999999999987653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=326.03 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=211.4
Q ss_pred hhccccceEEeeeceEEEEEEEe-cCCceEEEEEecccCcccHH---HHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCAL-KNSRPIAVKKLYNQYPHNLR---EFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
..+|++.+.||+|.||.|-+|.. +.|+.||||.+.+..-.+.+ .+++|+++|+.++||||+.+|.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45778888899999999999985 67999999999766544433 578999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||..+|.|+|++. ..+.+++.++..+++||..|+.|+|.+ ++||||||.+|||+|.++.+||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999997 456799999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCceeeeEecccceeCccccccCCCC-CcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLN-EKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.. .-+.++|++-|.+||+..|.+|. +.+|.||+||+||.++.|..||++.+.......+... ...+ |.-+
T Consensus 206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G--aYrE---P~~P-- 276 (668)
T KOG0611|consen 206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG--AYRE---PETP-- 276 (668)
T ss_pred cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc--cccC---CCCC--
Confidence 43 33457899999999999998875 7899999999999999999999987643332222222 2222 2222
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....-+|++|+-.+|++|.|..++..|-|-
T Consensus 277 -------SdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 277 -------SDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred -------chHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 123468999999999999999999998763
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=342.00 Aligned_cols=262 Identities=23% Similarity=0.231 Sum_probs=206.4
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++|+..+.||+|+||+||+|+++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999987 46789999886542 3345678899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|++++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765543 234689999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc------------
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME------------ 840 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------------ 840 (943)
........|++.|+|||++.+..++.++||||+||++|||++|+.||................++...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 33333456899999999999988999999999999999999999999876554443332221111110
Q ss_pred --ccCcccccCcc-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 841 --AVDPEVSVTCV-----DLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 841 --~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
...+....... .......+.+++++|++.||++|||++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00010000000 00122467899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=342.67 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=223.4
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcc---cHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPH---NLREFETELETIGSIR-HRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 688 (943)
....|+..+.||+|.||.||+|+.+. |+.+|+|.+.+.... ....+.+|+++|+++. |||||.++++|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34578888999999999999999875 899999999766543 3468999999999998 999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC----CCceeeccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE----NFDAHLSDFGI 764 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~DFGl 764 (943)
+|||++.||.|.+.+... .+++.++..++.|++.|++|||+. ||+|||+||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998643 399999999999999999999998 9999999999999963 35799999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
|..... .......+||+.|+|||+..+..|+.++||||+||++|.|++|.+||.+.........+......+....++
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~ 263 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD 263 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc
Confidence 998876 445566789999999999999999999999999999999999999999988777777666666656666555
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.+. ...-++++.++..||.+|+|+.++++|.|
T Consensus 264 ~is---------~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 264 DIS---------ESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ccC---------HHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 554 34568999999999999999999999976
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=344.47 Aligned_cols=244 Identities=20% Similarity=0.260 Sum_probs=199.8
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNG 697 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 697 (943)
+.||+|+||.||+|..+ +++.||+|++.+.. ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999976 57899999986542 234456788999999999999999999999999999999999999
Q ss_pred ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceee
Q 002278 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777 (943)
Q Consensus 698 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 777 (943)
+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 9999886 345689999999999999999999999 999999999999999999999999999875432211 223
Q ss_pred eEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHH
Q 002278 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVR 857 (943)
Q Consensus 778 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (943)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..................++ +.+ ..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~---------~~ 220 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTL---------SA 220 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCC---------CH
Confidence 35699999999999999999999999999999999999999986554333222222111111 111 14
Q ss_pred HHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 858 KTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 858 ~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
.+.+++.+|+..||++|| ++.++++|-+
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 567899999999999997 8999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=349.12 Aligned_cols=248 Identities=21% Similarity=0.234 Sum_probs=206.1
Q ss_pred hhccccceEEeeeceEEEEEEEecC--CceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN--SRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.++|+..+.||+|+||.||+|.++. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4578899999999999999998653 3689999885432 2344568899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999996 345689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+................++ +.+
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~--- 251 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFL--- 251 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCC---
Confidence 32 2235699999999999998899999999999999999999999987665443333332221111 111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
...+.+++++|++.||++|+ +++++++|.+
T Consensus 252 ------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 252 ------DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred ------CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 13456899999999999995 8999998854
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=322.63 Aligned_cols=264 Identities=24% Similarity=0.282 Sum_probs=215.5
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc--cHHHHHHHHHHHhcCCCCC-cceeeeEEecCC-----
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH--NLREFETELETIGSIRHRN-IVSLHGYALSPY----- 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 685 (943)
...|...++||+|+||+||+|+.+ +|+.||+|++.-.... ......+|+.+++.++|+| ||++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456677778999999999999976 6789999999655332 3345689999999999999 999999998877
Q ss_pred -cceEEEEEccCCChhhhccCCCCC-ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 686 -GNLLFYDYMVNGSLWDLLHGPSKK-VKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 686 -~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
..++|+||+ .-+|.+++...... ..++...+..++.|++.||+|||++ +|+||||||+||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 678999998 56898888754322 3577789999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 842 (943)
+|+...-.... .+..++|.+|+|||++.+. .|+...||||+||+++||+++++-|.+..+..++..+...-+...+..
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99966533222 3344589999999999886 799999999999999999999999999999888888877666665555
Q ss_pred CcccccC------ccCH-------H----HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 843 DPEVSVT------CVDL-------S----AVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 843 ~~~~~~~------~~~~-------~----~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
+|.+... +... . ......+++..|++.+|++|.|++.++.|
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 5544211 0000 0 01356789999999999999999999987
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=344.54 Aligned_cols=244 Identities=19% Similarity=0.251 Sum_probs=199.6
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNG 697 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 697 (943)
+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999975 57899999986542 233456778999999999999999999999999999999999999
Q ss_pred ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceee
Q 002278 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777 (943)
Q Consensus 698 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 777 (943)
+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 9998886 344689999999999999999999999 999999999999999999999999999875422211 122
Q ss_pred eEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHH
Q 002278 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVR 857 (943)
Q Consensus 778 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (943)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+..............++. .+ ..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~---------~~ 220 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TL---------SP 220 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CC---------CH
Confidence 346899999999999999999999999999999999999999866544333332222221111 11 24
Q ss_pred HHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 858 KTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 858 ~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
.+.+++..|+..||++|| ++.++++|-+
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~ 253 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 253 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCC
Confidence 567899999999999998 8999988743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=310.84 Aligned_cols=265 Identities=23% Similarity=0.306 Sum_probs=210.1
Q ss_pred HHhhccccceEEeeeceEEEEEEE-ecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----c
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPY-----G 686 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 686 (943)
...++|.+.+.+|+|||+-||.++ ..+++.||+|++.....+..+...+|++..++++||||++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456789999999999999999998 4568899999998877778888999999999999999999999875433 4
Q ss_pred ceEEEEEccCCChhhhccCCCCCc-cCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKV-KLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
.|++++|...|+|.+.+.....++ .+++.+++.|+.++++||++||+. .|+++||||||.||++.+.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999987654444 799999999999999999999998 445999999999999999999999999999
Q ss_pred cccCCCCCc--------eeeeEecccceeCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcc
Q 002278 766 RCIPTAMPH--------ASTFVLGTIGYIDPEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD 834 (943)
Q Consensus 766 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 834 (943)
+...-.-.. ....-..|..|+|||.+.- ...++++|||||||++|+|+.|..||+.. ...
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQ 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhc
Confidence 765321100 0011236889999998863 45789999999999999999999999631 111
Q ss_pred ccc-cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 835 DNT-VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 835 ~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.+. ......+.+..+... ...+.+.++++.|++.||.+||++.+++.++..+.
T Consensus 248 GgSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 GGSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CCeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111 112222222211111 13467889999999999999999999999987653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=330.23 Aligned_cols=260 Identities=20% Similarity=0.250 Sum_probs=208.6
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--------------ccHHHHHHHHHHHhcCCCCCccee
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--------------HNLREFETELETIGSIRHRNIVSL 677 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l 677 (943)
...++|+....||+|.||.|-+|+.. +++.||+|++.+... ...+.+.+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45678999999999999999999965 688999999854311 123578899999999999999999
Q ss_pred eeEEecC--CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC
Q 002278 678 HGYALSP--YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF 755 (943)
Q Consensus 678 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 755 (943)
+.+..++ +..|+|+|||..|.+...- .....+++.++++++.+++.||+|||.+ +||||||||+|+|++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 9998764 5689999999998875433 1233399999999999999999999999 999999999999999999
Q ss_pred ceeecccccccccCCCCC----ceeeeEecccceeCccccccCC----CCCcchhhhHHHHHHHHHhCCCCCCCCccHHH
Q 002278 756 DAHLSDFGIARCIPTAMP----HASTFVLGTIGYIDPEYAHTSR----LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQ 827 (943)
Q Consensus 756 ~~kl~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~p~~~~~~~~~ 827 (943)
+|||+|||.+........ ..-....|||.|+|||...++. .+.+.||||+||+||-|+.|+.||-+...++.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 999999999987633211 1112356999999999887733 45789999999999999999999988777666
Q ss_pred HHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 828 LIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.-.+....-.+++. + +....+.+++++++.+||+.|.+..+|..|.|....
T Consensus 328 ~~KIvn~pL~fP~~-----p------e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 328 FDKIVNDPLEFPEN-----P------EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHhcCcccCCCc-----c------cccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 55554332222221 1 123466789999999999999999999999886554
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.30 Aligned_cols=262 Identities=21% Similarity=0.247 Sum_probs=203.3
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
++|+..+.||+|+||+||+|..+ +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999976 57889999886443 23345678999999999999999999999998899999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
++ |+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 97 589888853 233578999999999999999999999 999999999999999999999999999976543222
Q ss_pred ceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC---
Q 002278 774 HASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT--- 849 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 849 (943)
. .....|++.|+|||++.+ ..++.++||||+||++|||+||+.||.+..............+......++.+...
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 T-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred c-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 1 123458999999998865 56899999999999999999999999876554443333222221111111111000
Q ss_pred --------c--c----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 850 --------C--V----DLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 850 --------~--~----~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
. . .........+++.+|++.||.+|||++|+++|-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence 0 0 001124567899999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.45 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=206.1
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
++|+..+.||+|+||.||+|.++++..+|+|.+... ....+.+.+|+++++.++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 467888899999999999999988888999987643 3345678899999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||.++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999998632 24589999999999999999999999 99999999999999999999999999998654332222
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||.................. ..+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----~~~~~-------- 225 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----YRPKL-------- 225 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----CCCCC--------
Confidence 222235678999999998889999999999999999999 99999876554433333221111 01111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
....+.+++.+||+.+|++||++.++++.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 124678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=346.43 Aligned_cols=255 Identities=20% Similarity=0.235 Sum_probs=207.5
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||.||+|++. .++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999987 47899999986542 223456788999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999996 345689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
......||+.|+|||++.+..++.++||||+||++|||++|+.||........+............ |.... .
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~--~ 225 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR---PVYDD--P 225 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC---CCCCc--c
Confidence 122345899999999999999999999999999999999999999876554433332221111111 11100 0
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.......+.+++..|+..+|++||++.++++|.+
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 0112246778999999999999999999998854
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.27 Aligned_cols=271 Identities=25% Similarity=0.373 Sum_probs=210.5
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhc--CCCCCcceeeeEEecCC----cce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGS--IRHRNIVSLHGYALSPY----GNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~ 688 (943)
....+...+||+|+||.||+|.+. ++.||||++.. +..+.|..|-++++. |+|+||++++++-...+ +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 344556677999999999999987 48999999853 345778888888775 58999999999876655 789
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhC------CCCCeEecCCCCccEEECCCCceeeccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD------CNPRIIHRDVKSSNILIDENFDAHLSDF 762 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~Dlkp~Nill~~~~~~kl~DF 762 (943)
+|++|.+.|+|.++|. ...++|....+|+..+++||+|||+. .+|+|+|||||++|||+.+|+++.|+||
T Consensus 285 LVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999995 56799999999999999999999975 4789999999999999999999999999
Q ss_pred ccccccCCCCCce-eeeEecccceeCccccccCC-CC-----CcchhhhHHHHHHHHHhCCCCCC--CCccHHHHHHHhc
Q 002278 763 GIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSR-LN-----EKSDVYSFGIVLLEILTGKKAVD--NESNLHQLIMSKA 833 (943)
Q Consensus 763 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlGvil~elltG~~p~~--~~~~~~~~~~~~~ 833 (943)
|+|..+....+.. ....+||.+|||||++.+.- +. .+.||||+|.|+|||++....++ ...++..-.....
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999886544332 22357999999999988742 22 37899999999999998654442 1111110011111
Q ss_pred cc---------cccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCC
Q 002278 834 DD---------NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPA 893 (943)
Q Consensus 834 ~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~~ 893 (943)
+. ..+.+..+|.++..+.....+..+.+.+..||+.||+.|-|+.=+.+++..+....+.
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 11 1123345666666555556677888999999999999999999999998887765543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=338.37 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=200.9
Q ss_pred hhccccceEEeeeceEEEEEEEecC-----------------CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-----------------SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVS 676 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 676 (943)
.++|...+.||+|+||.||+|.+++ +..||+|.+.... .....++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999998542 2369999886543 223457889999999999999999
Q ss_pred eeeEEecCCcceEEEEEccCCChhhhccCCC----------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeE
Q 002278 677 LHGYALSPYGNLLFYDYMVNGSLWDLLHGPS----------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRII 740 (943)
Q Consensus 677 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 740 (943)
+++++.+.+..++||||+++|+|.+++.... ....+++.++.+++.|++.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999999999999999999999885321 113478889999999999999999999 999
Q ss_pred ecCCCCccEEECCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh--CCC
Q 002278 741 HRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT--GKK 817 (943)
Q Consensus 741 H~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~ 817 (943)
||||||+||++++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 1122335788999999998899999999999999999987 567
Q ss_pred CCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 818 AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 818 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
||............................. .....+.+++.+||+.||++|||+.++.+.|+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPP-----PCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCC-----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7775443222111110000000000000010 11246789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=330.35 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=204.8
Q ss_pred hhccccceEEeeeceEEEEEEEec----CCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.++|+..+.||+|+||.||+|.++ .+..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457888999999999999999864 356899999875432 334578899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998632 34689999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
...........++..|+|||++.+..++.++|||||||++||+++ |+.||.+.......... ...... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~------~~~~ 231 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRL------PAPR 231 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCC------CCCC
Confidence 222111112235678999999999999999999999999999775 99999866543322222 111110 1111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.....+.+++..||+.+|++||++.++.+.|..+
T Consensus 232 -----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 232 -----NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1224677899999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=343.48 Aligned_cols=242 Identities=21% Similarity=0.252 Sum_probs=197.4
Q ss_pred EeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 624 VGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 47889999986432 33445678899999999999999999999999999999999999999
Q ss_pred hhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeE
Q 002278 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV 779 (943)
Q Consensus 700 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 779 (943)
.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 99986 345689999999999999999999999 999999999999999999999999999986433222 22335
Q ss_pred ecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHH
Q 002278 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKT 859 (943)
Q Consensus 780 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 859 (943)
.||+.|+|||++.+..++.++||||+||++|||+||+.||.+.................+. .+ ...+
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~---------~~~~ 220 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GF---------DRDA 220 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC----cC---------CHHH
Confidence 6999999999999999999999999999999999999999876543333222221111111 11 1456
Q ss_pred HHHHHHccCCCCCCCC---CHHHHHHHHh
Q 002278 860 FQLALLCTKRYPSERP---TMQEVARVLV 885 (943)
Q Consensus 860 ~~l~~~cl~~dP~~RP---t~~el~~~L~ 885 (943)
.+++..||+.||++|| ++.+++.|-+
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 7899999999999997 4677777643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=348.35 Aligned_cols=254 Identities=19% Similarity=0.222 Sum_probs=200.5
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.|+..+.||+|+||+||+|+.+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999875 57889999986532 2334568899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999986 345688999999999999999999999 99999999999999999999999999976431100
Q ss_pred C----------------------------------------------ceeeeEecccceeCccccccCCCCCcchhhhHH
Q 002278 773 P----------------------------------------------HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFG 806 (943)
Q Consensus 773 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 806 (943)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001124699999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHHHH
Q 002278 807 IVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALL--CTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 807 vil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPt~~el~~~L 884 (943)
|++|||+||+.||..........................+ .....+++.+ |+..+|..||++.++++|-
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---------s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKL---------SPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCC---------CHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 9999999999999876654443333221111110000011 1345567766 5667777799999999985
Q ss_pred h
Q 002278 885 V 885 (943)
Q Consensus 885 ~ 885 (943)
+
T Consensus 307 ~ 307 (381)
T cd05626 307 F 307 (381)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.26 Aligned_cols=259 Identities=24% Similarity=0.309 Sum_probs=205.4
Q ss_pred hccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc-----ceE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYG-----NLL 689 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~l 689 (943)
-.|...+++|.|+||.||+|.... ++.||||++.... +.-.+|+++|+.+.|||||++.-+|....+ ..+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 357778899999999999999764 6899999986542 233579999999999999999998864332 357
Q ss_pred EEEEccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC-Cceeecccccccc
Q 002278 690 FYDYMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-FDAHLSDFGIARC 767 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DFGla~~ 767 (943)
||||++. +|.+.++.. ..+..++...+.-+..|+.+||+|||+. +|+||||||+|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999975 788887631 1245678888899999999999999998 99999999999999955 9999999999999
Q ss_pred cCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc------
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME------ 840 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------ 840 (943)
+....+..+ ...|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+++...+++.+...-+...+
T Consensus 176 L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 877665543 446999999999887 57999999999999999999999999999988888777654443221
Q ss_pred ------ccCcccccCc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 841 ------AVDPEVSVTC----VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 841 ------~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
...|.+.... .......+..+++.+++..+|.+|.++.|++.|-
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~ 307 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP 307 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence 1111111110 1112235678999999999999999999998763
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=345.95 Aligned_cols=256 Identities=20% Similarity=0.231 Sum_probs=203.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..++|+..+.||+|+||.||+|+.+ +++.||+|.+.+.. ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4578999999999999999999986 46789999885421 2234567889999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+...
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999999852 3578899999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeeEecccceeCccccccCC----CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSR----LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
...........||+.|+|||++.+.. ++.++||||+||++|||++|+.||...........+........ .+..
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~ 271 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN--FPED 271 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC--CCCc
Confidence 33222223456999999999987643 78899999999999999999999987665444433332211111 0000
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHh
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSE--RPTMQEVARVLV 885 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~el~~~L~ 885 (943)
. .....+.+++..|+..+|.+ ||++.|+++|-+
T Consensus 272 ~-------~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 272 V-------EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred c-------cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 0 11234567888888755544 899999999865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=346.73 Aligned_cols=256 Identities=21% Similarity=0.245 Sum_probs=206.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..++|+..+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4578999999999999999999976 57889999985421 2233457789999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999852 3578889999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeeEecccceeCccccccC----CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTS----RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||........+..+........ . |.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--~-~~ 270 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT--F-PD 270 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC--C-CC
Confidence 4322222345699999999988653 478999999999999999999999987665444333322211111 0 11
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHh
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSE--RPTMQEVARVLV 885 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~el~~~L~ 885 (943)
. ......+.+++..|+..+|++ ||++.++++|-+
T Consensus 271 ~------~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 271 D------IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred c------CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 0 011245678999999999998 999999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=340.96 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=205.7
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||.||+|.++ ++..||+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367889999999999999999977 46778888876442 2344678999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999863 346899999999999999999999852 69999999999999999999999999997654322
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccc-c----ccc-------
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN-T----VME------- 840 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-~----~~~------- 840 (943)
.....|++.|+|||++.+..++.++|||||||++|||+||+.||........ ........ . ...
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhcccccccccCCccccCcccc
Confidence 1234589999999999999999999999999999999999999975543221 11111000 0 000
Q ss_pred ----------------------------ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 841 ----------------------------AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 841 ----------------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+... .......+.+++.+||+.||++|||+.++++|.+-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP----NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCC----CccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0000000 00123567899999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=338.54 Aligned_cols=242 Identities=21% Similarity=0.288 Sum_probs=193.2
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||.||+|..+ +++.||+|.+.... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 46789999886532 22344556677776654 799999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 99999886 345689999999999999999999999 99999999999999999999999999998653322 222
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.................+ ..+ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~---------~ 220 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWI---------S 220 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCC---------C
Confidence 345699999999999999999999999999999999999999987655433322221111111 111 1
Q ss_pred HHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 002278 857 RKTFQLALLCTKRYPSERPTMQ-EVARV 883 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~-el~~~ 883 (943)
..+.+++..||+.||++||++. ++.++
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 3566899999999999999865 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=347.24 Aligned_cols=254 Identities=21% Similarity=0.244 Sum_probs=204.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999976 57889999986432 233456788999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999986 345689999999999999999999999 9999999999999999999999999999764321
Q ss_pred CCc-------------------------------------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh
Q 002278 772 MPH-------------------------------------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT 814 (943)
Q Consensus 772 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt 814 (943)
... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112359999999999999999999999999999999999
Q ss_pred CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHh
Q 002278 815 GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT---MQEVARVLV 885 (943)
Q Consensus 815 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~el~~~L~ 885 (943)
|+.||.+.................. ..... .....+.+++..|+. +|.+|++ +.++++|-+
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~-------~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETLQ--FPDEV-------PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCccC--CCCCC-------CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 9999987765544333322211111 01110 112355678888886 8999997 999988754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.51 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=208.8
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCccc-HHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHN-LREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
+......++.||+|.||.|..|....+.+||||+++...... ..+|.+|+++|.+++|||||+++|+|..++..++++|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 345566778899999999999999888999999998766444 4789999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|..++...... ........+|+.|||.|++||.+. ++||||+.++|+|++.++++||+|||+++.+-...
T Consensus 616 YmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999743211 245556678999999999999998 99999999999999999999999999999654443
Q ss_pred Cc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh--CCCCCCCCccHHHHHHHhc-cccccccccCccccc
Q 002278 773 PH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT--GKKAVDNESNLHQLIMSKA-DDNTVMEAVDPEVSV 848 (943)
Q Consensus 773 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 848 (943)
.+ .....+=+.+|||||.+.-+++++++|||+||+++||+++ .+.||....+.. .+.... -.......+-+..+.
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-VVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-HHHhhhhhcCCCCcceeccCCC
Confidence 33 2333445789999999999999999999999999999876 788887543321 111110 000000111111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.++..+++++..||..|-++||+++++..+|...
T Consensus 771 -----~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 771 -----ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2346788999999999999999999999998753
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=340.79 Aligned_cols=244 Identities=23% Similarity=0.278 Sum_probs=199.4
Q ss_pred eEEeeeceEEEEEEEec----CCceEEEEEecccC----cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 622 YIVGYGASSTVYKCALK----NSRPIAVKKLYNQY----PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+.||+|+||.||+|+.. .++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999853 46889999986432 22345677899999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++. ....+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999986 345688899999999999999999999 999999999999999999999999999875432222
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......||+.|+|||++.+..++.++|||||||++|||++|+.||................... ++.+
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~------- 223 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL----PPYL------- 223 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCC-------
Confidence 2223468999999999999899999999999999999999999998766544333332222111 1111
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 854 SAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
...+.+++.+|++.||++|| ++.+++++-+
T Consensus 224 --~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 224 --TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred --CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 14567899999999999999 8999988753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.39 Aligned_cols=244 Identities=21% Similarity=0.274 Sum_probs=197.5
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||+||+|+.+ +++.||+|++.+.. ....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 47889999986432 23445677888888876 699999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 99999886 345689999999999999999999999 99999999999999999999999999987543221 122
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...................+.. + .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----~---------~ 220 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW----L---------S 220 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCC----C---------C
Confidence 33569999999999999999999999999999999999999998766544333322221111111 1 1
Q ss_pred HHHHHHHHHccCCCCCCCCCH------HHHHHHHh
Q 002278 857 RKTFQLALLCTKRYPSERPTM------QEVARVLV 885 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~------~el~~~L~ 885 (943)
..+.+++..|++.||++||++ .++++|-+
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 456789999999999999998 77776643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=346.29 Aligned_cols=254 Identities=23% Similarity=0.261 Sum_probs=208.8
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|...+.||+|+||+||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999976 68899999986432 234567889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999873 35789999999999999999999998 9999999999999999999999999999876543
Q ss_pred C----------------------------CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 002278 772 M----------------------------PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES 823 (943)
Q Consensus 772 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~ 823 (943)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112233569999999999999999999999999999999999999998776
Q ss_pred cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHh
Q 002278 824 NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT-MQEVARVLV 885 (943)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~el~~~L~ 885 (943)
....+...............+. ....+.+++..|+. ||.+||+ +.++++|.+
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~---------~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPP---------VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCC---------CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 5444433333111111100111 12466789999997 9999999 999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.73 Aligned_cols=244 Identities=18% Similarity=0.246 Sum_probs=198.8
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNG 697 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 697 (943)
+.||+|+||.||+|..+ +++.||+|.+.... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999975 57899999986532 233456778999999999999999999999999999999999999
Q ss_pred ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 698 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 9999886 34468999999999999999999997 6 999999999999999999999999999875432221 22
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.+................++.. + .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~----~---------~ 220 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----L---------S 220 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCC----C---------C
Confidence 23469999999999999999999999999999999999999998655433322222222111111 1 1
Q ss_pred HHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 857 RKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
..+.+++.+|++.||++|+ ++.++++|-+
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 3567899999999999996 8999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.32 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=212.9
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
+-|.+...+|+|+||.||+|.++ .|+.+|+|++.. ....+++.+|+.++++++.|+||++||.+......+||||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 45667778999999999999987 578899999854 456789999999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
..|++.|+++. +..++.+.++..+++..++||+|||.. .-+|||||+.|||++-+|++|++|||.|-.+.+...
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 99999999974 456799999999999999999999998 889999999999999999999999999987755433
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.+..++||+.|||||++..-.|+.++||||+|++..||..|++||.+..++.....+ +...+|.+.. ...
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------PT~PPPTF~K---PE~ 254 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------PTKPPPTFKK---PEE 254 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------cCCCCCCCCC---hHh
Confidence 345578999999999999999999999999999999999999999876554322221 1222233321 122
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
....+.++++.|+-+.|++|.|+.++++|-
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 345778999999999999999999999985
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=340.43 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=200.2
Q ss_pred ccccceEEeeeceEEEEEEEec----CCceEEEEEecccC----cccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcc
Q 002278 617 NLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQY----PHNLREFETELETIGSIR-HRNIVSLHGYALSPYGN 687 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 687 (943)
+|+..+.||+|+||.||+|+.. .++.||+|++.+.. ....+.+.+|+++++.++ ||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999863 47889999986432 223456788999999995 89999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999986 345689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCc---cHHHHHHHhccccccccccC
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNES---NLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~---~~~~~~~~~~~~~~~~~~~~ 843 (943)
+............||+.|+|||++.+. .++.++|||||||++|||+||+.||.... ........... .+
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~~ 227 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-------CD 227 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-------CC
Confidence 544333333345699999999998865 47899999999999999999999996432 12222111111 11
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
+.++.. ....+.+++.+|++.||++|| +++++++|-+
T Consensus 228 ~~~~~~-----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 228 PPFPSF-----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCCCCC-----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 111111 114567899999999999999 7889988754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=344.57 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=204.6
Q ss_pred hhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPYG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 686 (943)
.++|+..+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 457889999999999999999742 35679999986433 23445788999999999 89999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCC----------------------------------------------------------
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSK---------------------------------------------------------- 708 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 708 (943)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998853211
Q ss_pred --------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 709 --------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 709 --------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
...+++..+.+++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478899999999999999999998 9999999999999999999999999999866433221
Q ss_pred e-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 775 A-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 775 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
. .....++..|+|||++.+..++.++|||||||++|||++ |..||................... ..+..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~------ 341 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM---LSPEC------ 341 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC---CCCCC------
Confidence 1 111234668999999999999999999999999999998 899997654333322222211110 01111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
....+.+++..||+.||++||++.++++.|+..
T Consensus 342 --~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 342 --APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 124678999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.32 Aligned_cols=256 Identities=28% Similarity=0.416 Sum_probs=209.3
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..++|+..+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346788899999999999999998878889999986543 3457789999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999986432 34689999999999999999999999 999999999999999999999999999987753322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......++..|+|||+..+..++.++||||||+++|||+| |+.||.+............ .... ...+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~--~~~~-------- 227 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-GYRM--PCPP-------- 227 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCC--CCCC--------
Confidence 22222223458999999999999999999999999999999 9999987654433322221 1111 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.....+.+++.+|++.+|++||++.++++.|+.
T Consensus 228 -~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 -GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 112567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=343.64 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=199.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+|..+ .++.||+|++.+.. ......+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999999999999876 47899999986532 223456788999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999986 345689999999999999999999999 9999999999999999999999999999765321
Q ss_pred CC----------------------------------ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCC
Q 002278 772 MP----------------------------------HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK 817 (943)
Q Consensus 772 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 817 (943)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123469999999999999999999999999999999999999
Q ss_pred CCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHcc--CCCCCCCCCHHHHHHHH
Q 002278 818 AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCT--KRYPSERPTMQEVARVL 884 (943)
Q Consensus 818 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl--~~dP~~RPt~~el~~~L 884 (943)
||.+................. ..++.... . ....+++.+++ ..++..||++.|+++|-
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~---s----~~~~~li~~l~~~~~~r~~r~~~~ei~~hp 294 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETL--IFPPEVPI---S----EKAKDLILRFCCEWEHRIGAPGVEEIKTNP 294 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcc--cCCCcCCC---C----HHHHHHHHHHcCChhhcCCCCCHHHHhCCC
Confidence 998776555444433221111 11111110 1 23344555433 23444679999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.68 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=208.5
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.++|+..+.||+|+||.||+|...++..||+|++... ....+.+.+|+.+++.++||||+++++++......+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4678899999999999999999888888999987643 234578899999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++|+|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998643 234688999999999999999999998 9999999999999999999999999999876543222
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......++..|+|||+..+..++.++|||||||++|||+| |+.||............. ..... +...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~-----~~~~------ 227 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRM-----PRME------ 227 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCC-----CCCC------
Confidence 2222335678999999998889999999999999999998 999997654433222221 11110 0000
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112467789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=335.67 Aligned_cols=264 Identities=23% Similarity=0.289 Sum_probs=201.6
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||.||+|..+ +++.||+|++..... .....+.+|+++++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999986 578899999865432 233467789999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+. ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 678777753 335688999999999999999999999 99999999999999999999999999997553322
Q ss_pred CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcc-cccccccc--------
Q 002278 773 PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD-DNTVMEAV-------- 842 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~~-------- 842 (943)
. ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||.+..+.......... .+......
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 H-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred c-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 1 1223458999999998875 45889999999999999999999999876543322221110 00000000
Q ss_pred --Ccc-cccC-ccCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 843 --DPE-VSVT-CVDL-------SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 843 --~~~-~~~~-~~~~-------~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.++ +... .... .....+.+++..|++.||++|||+.|+++|-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 000 0000 0000 01135668999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.46 Aligned_cols=242 Identities=24% Similarity=0.303 Sum_probs=197.1
Q ss_pred eEEeeeceEEEEEEEec----CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 622 YIVGYGASSTVYKCALK----NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
+.||+|+||.||++... .++.||+|++..... .....+..|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998752 478899999865432 233456789999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 999999986 345689999999999999999999999 999999999999999999999999999986543322 2
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHH
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (943)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..................++. .+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~--------- 221 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FL--------- 221 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CC---------
Confidence 23356899999999999988999999999999999999999999876554433333222221111 11
Q ss_pred HHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002278 856 VRKTFQLALLCTKRYPSERPTM-----QEVARV 883 (943)
Q Consensus 856 ~~~l~~l~~~cl~~dP~~RPt~-----~el~~~ 883 (943)
...+.+++..|++.||++||++ .+++++
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 1456789999999999999994 555544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=344.71 Aligned_cols=258 Identities=22% Similarity=0.213 Sum_probs=199.7
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..+|+..+.||+|+||.||+|.+. .++.||+|+... ..+.+|++++++++|||||++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999976 578899997532 4567899999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+. ++|.+++. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+.......
T Consensus 165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 84 78888875 334689999999999999999999999 999999999999999999999999999976433322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc-------HHHHHHHhcccccccccc----
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN-------LHQLIMSKADDNTVMEAV---- 842 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~-------~~~~~~~~~~~~~~~~~~---- 842 (943)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||..... ...+.......+..+...
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 233345699999999999999999999999999999999999988753221 111111111111100000
Q ss_pred -----------------CcccccCcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 843 -----------------DPEVSVTCV-DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 843 -----------------~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.+.....+. .......+.+++.+|++.||++|||+.|++++-+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 000000000 0122356788999999999999999999998765
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=344.30 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=205.1
Q ss_pred HhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPY 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 685 (943)
..++|+..+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+++++.+ +|||||++++++...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4568899999999999999999853 23579999986543 33345688999999999 8999999999999999
Q ss_pred cceEEEEEccCCChhhhccCCC----------------------------------------------------------
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPS---------------------------------------------------------- 707 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 707 (943)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999875311
Q ss_pred ---------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce-ee
Q 002278 708 ---------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA-ST 777 (943)
Q Consensus 708 ---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~ 777 (943)
...++++.++.+++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++......... ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 112478899999999999999999999 99999999999999999999999999998654332211 11
Q ss_pred eEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 778 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
...++..|+|||++.+..++.++|||||||++|||++ |+.||................. .+..+.. ..
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~------~~~~~~~-----~~ 341 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY------QMSRPDF-----AP 341 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc------CccCCCC-----CC
Confidence 1234568999999998899999999999999999997 9999976543222222221111 1111100 12
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 857 RKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 46778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=337.89 Aligned_cols=246 Identities=20% Similarity=0.267 Sum_probs=197.9
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHH---hcCCCCCcceeeeEEecCCcceEE
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETI---GSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
|++.+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999976 57899999986432 22344566666654 566899999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|..++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999998885 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||.+.................+ +.+
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~---- 224 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFL---- 224 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCC----
Confidence 21 122335699999999999999999999999999999999999999987654433322222211111 111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVL 884 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L 884 (943)
...+.+++.+|++.||++|| ++.+++++-
T Consensus 225 -----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 225 -----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred -----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 24567899999999999999 678887764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.22 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=204.4
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
++|+..+.||+|+||+||.|..+++..+|+|.+... ......+.+|+++++.++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 467888899999999999999887778999988643 3345678999999999999999999999999888999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+|+|.+++... ...+++.+++.++.|++.|++|||+. +++|+||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998642 23689999999999999999999999 99999999999999999999999999998664332211
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.....++..|+|||...+..++.++|||||||++|||++ |+.||................... .+..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~-------- 225 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY----RPHL-------- 225 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC----CCCC--------
Confidence 112235678999999998889999999999999999999 999997655433222222111110 0100
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+.+++..||+.+|++||++.++++.++
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1256789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=341.13 Aligned_cols=255 Identities=20% Similarity=0.219 Sum_probs=205.8
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+|+.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999976 57889999986542 234456888999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998632 34689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeeEecccceeCccccc------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAH------TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
.........||+.|+|||++. +..++.++|||||||++|||++|+.||........+...........-...+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence 333333446899999999986 45678999999999999999999999987655444333222111110000111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+.+++..|++ +|++||++.++++|-+
T Consensus 236 ---------~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 236 ---------VSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred ---------CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 12456788999998 9999999999998743
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=350.67 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=209.8
Q ss_pred hhccccceEEeeeceEEEEEEEecCC-ceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeE-Eec------CC
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGY-ALS------PY 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~ 685 (943)
..++++.++|.+|||+.||.|.+..+ .+||+|++........+.+.+|+++|+.|+ |+|||.+++. ... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45677889999999999999998766 999999998877778889999999999997 9999999993 321 13
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
+.++.||||.||.|.|++..+.. ..|.+.++++|++|+++|+++||.. .|+|||||||.+|||+..+|+.||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 56899999999999999975433 3499999999999999999999985 788999999999999999999999999999
Q ss_pred cccCCCCCc--e------eeeEecccceeCcccc---ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcc
Q 002278 766 RCIPTAMPH--A------STFVLGTIGYIDPEYA---HTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD 834 (943)
Q Consensus 766 ~~~~~~~~~--~------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 834 (943)
.-.-..... . .-....|+-|+|||.+ .+.+.++|+|||||||+||-|+....||+......
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------- 265 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------- 265 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--------
Confidence 753222111 0 0123469999999965 46789999999999999999999999998654321
Q ss_pred ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
.+...+.... .......+.+||+.||+++|.+||++-+|+..+..+...+
T Consensus 266 ------Ilng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 266 ------ILNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ------EEeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1111111111 1134467889999999999999999999999998776554
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=338.06 Aligned_cols=247 Identities=19% Similarity=0.261 Sum_probs=200.2
Q ss_pred ccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcCCC-CCcceeeeEEecCCcceEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSIRH-RNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 691 (943)
+|+..+.||+|+||.||+|..+. ++.||+|++.... ....+.+..|.++++.+.| ++|+.+++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999999764 6789999986532 2344567889999999976 46888999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999886 345689999999999999999999999 9999999999999999999999999998754222
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
. .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.................+. .+
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~----- 224 (324)
T cd05587 155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SL----- 224 (324)
T ss_pred C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CC-----
Confidence 2 2233456999999999999999999999999999999999999999876654433333222211111 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTM-----QEVARV 883 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~-----~el~~~ 883 (943)
...+.+++.+|++.||++|++. .++.+|
T Consensus 225 ----~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 225 ----SKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1456789999999999999976 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=345.56 Aligned_cols=253 Identities=19% Similarity=0.225 Sum_probs=200.4
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.|++.+.||+|+||.||+|+.+ .++.||+|.+.+.. ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999976 57889999986432 2234567899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999986 345688899999999999999999999 99999999999999999999999999985321000
Q ss_pred ------------------------------------------CceeeeEecccceeCccccccCCCCCcchhhhHHHHHH
Q 002278 773 ------------------------------------------PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLL 810 (943)
Q Consensus 773 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ 810 (943)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011246999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHh
Q 002278 811 EILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP---TMQEVARVLV 885 (943)
Q Consensus 811 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~el~~~L~ 885 (943)
||++|+.||.+........................+ ...+.+++.+|+ .+|.+|+ ++.++++|-+
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---------s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKL---------SREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCC---------CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 999999999877654443332221111110000011 134556777765 4999999 9999998854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=341.07 Aligned_cols=261 Identities=21% Similarity=0.234 Sum_probs=205.5
Q ss_pred HHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecC
Q 002278 609 DDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSP 684 (943)
Q Consensus 609 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 684 (943)
.++....++|+..+.||+|+||.||+|.++ +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 334445689999999999999999999987 46788999885421 22334577899999999999999999999999
Q ss_pred CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
...++||||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999999852 3578889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccC----CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTS----RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 840 (943)
++..............||+.|+|||++.+. .++.++||||+||++|||++|+.||...........+........-
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 268 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 268 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence 987654332233345699999999998754 3789999999999999999999999876654444333322111110
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHh
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSE--RPTMQEVARVLV 885 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~el~~~L~ 885 (943)
...+.+ ...+.+++..|+...|.+ ||++.++++|.+
T Consensus 269 ~~~~~~---------s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 269 PDDNDI---------SKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CCcCCC---------CHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 001111 245567899999844443 789999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=338.95 Aligned_cols=244 Identities=20% Similarity=0.271 Sum_probs=199.0
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||.||+|+.+ .++.||+|.+.... ....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35899999999999976 46889999986532 23345677888888866 799999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 99999886 345689999999999999999999999 999999999999999999999999999975432222 22
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...................+.. + .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~----~---------~ 220 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW----L---------S 220 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC----C---------C
Confidence 33568999999999999999999999999999999999999998776544443333222111111 1 1
Q ss_pred HHHHHHHHHccCCCCCCCC-------CHHHHHHHHh
Q 002278 857 RKTFQLALLCTKRYPSERP-------TMQEVARVLV 885 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RP-------t~~el~~~L~ 885 (943)
..+.+++..|++.||++|| ++.++++|-+
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 4567899999999999999 8888988743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.81 Aligned_cols=266 Identities=25% Similarity=0.361 Sum_probs=220.8
Q ss_pred HHHHHHhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 609 DDIMRSTENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 609 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
++......+....++||-|.||.||.|.|+. .-.||||.++.. ....++|.+|+.+|+.++|||+|+++|+|......
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3444455667788999999999999999874 678999998654 45678999999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
|||.|||..|+|.|+|++. .+..++.-..++||.||+.|++||..+ ++|||||.++|+|+.++..||++|||+++.
T Consensus 339 YIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999865 345677778899999999999999999 999999999999999999999999999999
Q ss_pred cCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
+..+.........-.+.|.|||-+....++.|+|||+|||+|||+.| |..||.+.+- .+.........
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-SqVY~LLEkgy---------- 483 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYGLLEKGY---------- 483 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHhccc----------
Confidence 97665554444445778999999999999999999999999999999 9999987543 22222222211
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
..+. ...++.+++++|+.||++.|.+||++.|+-+.++.+....
T Consensus 484 RM~~-PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 484 RMDG-PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred cccC-CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 1111 1134468889999999999999999999999988776543
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.99 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=212.7
Q ss_pred HHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++..+|+..+.||.|+||.||+|..++++.+|+|.+..........+.+|+++++.++||||+++++++.+....++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888999999999999999998889999999877655566789999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999997432 34689999999999999999999999 99999999999999999999999999998764432
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
... ....++..|+|||...+..++.++||||||+++|+|++ |+.||............... .. +....
T Consensus 159 ~~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~------~~~~~--- 227 (261)
T cd05148 159 YLS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YR------MPCPA--- 227 (261)
T ss_pred ccc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-Cc------CCCCC---
Confidence 221 12335778999999998899999999999999999998 89999765543333222211 11 11111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.....+.+++.+|++.||++|||+.++++.|+.
T Consensus 228 --~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 228 --KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 112467799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=331.63 Aligned_cols=242 Identities=21% Similarity=0.294 Sum_probs=194.2
Q ss_pred eEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhc-CCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGS-IRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||.||+|.++. ++.||+|.+.... ....+.+..|..+++. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999764 6789999986542 2334556678888876 4899999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 99999986 335689999999999999999999999 999999999999999999999999999875422222 22
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....||+.|+|||++.+..++.++||||+||++|||++|+.||................. .++.. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--------~~~~~-----~~ 220 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP--------CYPRW-----LT 220 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CCCcc-----CC
Confidence 345699999999999998999999999999999999999999987654332222211111 11110 11
Q ss_pred HHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 002278 857 RKTFQLALLCTKRYPSERPTMQ-EVARV 883 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~-el~~~ 883 (943)
..+.+++.+|++.||++||++. ++.++
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 3567899999999999999997 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.75 Aligned_cols=261 Identities=23% Similarity=0.239 Sum_probs=197.9
Q ss_pred hccccceEEeeeceEEEEEEEec--CCceEEEEEecccC--cccHHHHHHHHHHHhcC---CCCCcceeeeEEec-----
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK--NSRPIAVKKLYNQY--PHNLREFETELETIGSI---RHRNIVSLHGYALS----- 683 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 683 (943)
.+|+..+.||+|+||+||+|++. +++.||+|++.... ......+.+|+++++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999874 36789999886432 22334566777776665 69999999999853
Q ss_pred CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
....++||||+. ++|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 6898888643 234589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc-ccc
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM-EAV 842 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 842 (943)
+++..... .......|++.|+|||++.+..++.++|||||||++|||++|++||.+.........+........ +..
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99876443 222334589999999999988999999999999999999999999987766554443332111100 000
Q ss_pred Cccc-------cc-CccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 843 DPEV-------SV-TCVD-----LSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 843 ~~~~-------~~-~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
+... .. .... ......+.+++.+|++.||++|||+.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 00 0000 0112456689999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.20 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=198.4
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----cce
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY-----GNL 688 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 688 (943)
+|+..+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999976 57899999986432 233456889999999999999999999886432 369
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+ +++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~-~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELM-ESDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecC-CCCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999999 478988886 344689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC--ceeeeEecccceeCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc-----
Q 002278 769 PTAMP--HASTFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM----- 839 (943)
Q Consensus 769 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~----- 839 (943)
..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+..............+...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 11223468999999999876 6789999999999999999999999986654332211111000000
Q ss_pred -----------cccCcccccCc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 -----------EAVDPEVSVTC--VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 -----------~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+...... ........+.+++.+|++.||++|||+.|++++-+
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 00000000000 00011245678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=335.80 Aligned_cols=243 Identities=20% Similarity=0.261 Sum_probs=194.8
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||.||+|+++ +++.||+|.+.... ....+....|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999987 57889999986532 23345567788887754 899999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 99999886 345689999999999999999999999 99999999999999999999999999987532222 222
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....||+.|+|||++.+..++.++||||+||++|||++|+.||................. .++.. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~--------~~~~~-----~~ 220 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP--------HYPRW-----IT 220 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CCCCC-----CC
Confidence 345699999999999999999999999999999999999999986654333222221111 11111 11
Q ss_pred HHHHHHHHHccCCCCCCCCCHH-HHHHHH
Q 002278 857 RKTFQLALLCTKRYPSERPTMQ-EVARVL 884 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~-el~~~L 884 (943)
..+.+++..|++.||++||++. ++.+|-
T Consensus 221 ~~~~~li~~~l~~dP~~R~~~~~~~~~h~ 249 (316)
T cd05620 221 KESKDILEKLFERDPTRRLGVVGNIRGHP 249 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence 3567899999999999999974 666553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=344.77 Aligned_cols=254 Identities=21% Similarity=0.224 Sum_probs=201.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888999999999999999875 57899999986432 233456788999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999986 345688999999999999999999999 9999999999999999999999999999643211
Q ss_pred CCc----------------------------------------------eeeeEecccceeCccccccCCCCCcchhhhH
Q 002278 772 MPH----------------------------------------------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSF 805 (943)
Q Consensus 772 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 805 (943)
... .....+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012359999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 002278 806 GIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSER---PTMQEVAR 882 (943)
Q Consensus 806 Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~el~~ 882 (943)
||++|||+||+.||........+..+........ .|... .....+.+++..|+. +|.+| +++.+++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~p~~~------~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLY---FPDDI------HLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC---CCCCC------CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 9999999999999987665444333322111110 01100 011356688999997 66664 69999999
Q ss_pred HHh
Q 002278 883 VLV 885 (943)
Q Consensus 883 ~L~ 885 (943)
|-+
T Consensus 305 hp~ 307 (377)
T cd05629 305 HPF 307 (377)
T ss_pred CCC
Confidence 864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.79 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=195.3
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
++|+..+.||+|+||.||+|++. +++.||+|++..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45566788999999999999976 578999999865432 3346788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986532 356778889999999999999999 999999999999999999999999999987643321
Q ss_pred ceeeeEecccceeCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCc--cHHHHHHHhccccccccccCccc
Q 002278 774 HASTFVLGTIGYIDPEYAHT-----SRLNEKSDVYSFGIVLLEILTGKKAVDNES--NLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
......||..|+|||++.. ...+.++|||||||++|||++|+.||.... ............. .+..
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------~~~~ 296 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ------PPEA 296 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC------CCCC
Confidence 1223468999999998743 234568999999999999999999997322 1221111111100 1111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.. .....+.+++..||+.||++|||+.|+++|-+-
T Consensus 297 ~~-----~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~ 331 (353)
T PLN00034 297 PA-----TASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331 (353)
T ss_pred CC-----ccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 10 112467899999999999999999999998653
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.32 Aligned_cols=252 Identities=19% Similarity=0.230 Sum_probs=198.5
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++++.++|||||++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999976 57889999986532 2234568889999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999863 34688999999999999999999999 99999999999999999999999999975321000
Q ss_pred ----------------------------------------------CceeeeEecccceeCccccccCCCCCcchhhhHH
Q 002278 773 ----------------------------------------------PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFG 806 (943)
Q Consensus 773 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 806 (943)
........||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002278 807 IVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT---MQEVARV 883 (943)
Q Consensus 807 vil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~el~~~ 883 (943)
|++|||++|+.||..........................+ .....+++.+++ .+|++|++ +.++++|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~---------s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKL---------SPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccC---------CHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999999999877655444433322111111001111 133456666655 48999987 8888876
Q ss_pred H
Q 002278 884 L 884 (943)
Q Consensus 884 L 884 (943)
-
T Consensus 306 p 306 (382)
T cd05625 306 P 306 (382)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=351.35 Aligned_cols=252 Identities=19% Similarity=0.224 Sum_probs=204.8
Q ss_pred ccccceEEeeeceEEEEEEEecC--CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 617 NLSEKYIVGYGASSTVYKCALKN--SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.|...+.||+|+||.||+|.... ++.||+|++..........+.+|+++++.++|||||++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48889999999999999998653 5678888775544444566788999999999999999999999999999999999
Q ss_pred cCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 695 VNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 695 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
++|+|.+++... ....++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887532 2345688999999999999999999999 999999999999999999999999999987654322
Q ss_pred -ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 -HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.................. .....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---~~~~~------- 294 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---PFPCP------- 294 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCcc-------
Confidence 1223456999999999999999999999999999999999999999866543333222221111 00111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
....+.+++..||+.||++||++.+++.+
T Consensus 295 --~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 295 --VSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11457789999999999999999998754
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=325.85 Aligned_cols=249 Identities=33% Similarity=0.513 Sum_probs=194.6
Q ss_pred cceEEeeeceEEEEEEEec-----CCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 620 EKYIVGYGASSTVYKCALK-----NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 620 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..+.||.|+||.||+|.++ .+..|+||.+..... ...+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 246799999965432 3467899999999999999999999999988889999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++... ....+++.++..|+.||+.||+|||+. +++||||+++||++++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999743 235789999999999999999999999 999999999999999999999999999987632211
Q ss_pred -ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 774 -HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 774 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
.......+...|+|||.+.+..++.++||||||+++||+++ |+.||.+..... ........... . .....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-~~~~~~~~~~~-~-~~~~~----- 230 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-IIEKLKQGQRL-P-IPDNC----- 230 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-HHHHHHTTEET-T-SBTTS-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccc-e-eccch-----
Confidence 11222346789999999999999999999999999999999 789988764433 32222222111 1 11111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
...+.+++..||+.+|++|||+.++++.|
T Consensus 231 ----~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 231 ----PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 24678999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.10 Aligned_cols=243 Identities=21% Similarity=0.270 Sum_probs=198.1
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||+||+|.++ +++.||+|.+.+.. ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 46789999987542 23445677888888887 699999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTT 153 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccc
Confidence 99999886 344689999999999999999999999 99999999999999999999999999987532222 122
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....|++.|+|||++.+..++.++||||+||++|||++|+.||...................+ .. ..
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~---------~~ 220 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RW---------LS 220 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----Cc---------CC
Confidence 335699999999999999999999999999999999999999986654333322222211111 11 12
Q ss_pred HHHHHHHHHccCCCCCCCCCH-----HHHHHHH
Q 002278 857 RKTFQLALLCTKRYPSERPTM-----QEVARVL 884 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~-----~el~~~L 884 (943)
..+.+++.+||+.||++||++ .+++++-
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 456789999999999999999 8888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.78 Aligned_cols=254 Identities=22% Similarity=0.255 Sum_probs=202.7
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.|+..+.||+|+||+||++... +++.||+|++.... ......+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999975 57899999986432 1223456789999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887532 234689999999999999999999999 99999999999999999999999999998764332
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
. .....|++.|+|||++.+..++.++||||+||++|||++|+.||.+......................+.
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------- 227 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK------- 227 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc-------
Confidence 2 1234589999999999988999999999999999999999999986543222111111100111111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
....+.+++..|++.||++|| ++.+++++-+
T Consensus 228 --~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 228 --FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred --cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 124567899999999999999 8889988743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.85 Aligned_cols=249 Identities=19% Similarity=0.220 Sum_probs=196.4
Q ss_pred EeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 624 VGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
||+|+||+||+|.++ +++.||+|++..... ...+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999976 578999999864322 2235677899999999999999999999999999999999999999
Q ss_pred hhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeee
Q 002278 700 WDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778 (943)
Q Consensus 700 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 778 (943)
.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 8877432 2335689999999999999999999999 9999999999999999999999999999866443222 223
Q ss_pred EecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHH
Q 002278 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRK 858 (943)
Q Consensus 779 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (943)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........................+. ....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 227 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK---------FSPA 227 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCccc---------CCHH
Confidence 4689999999999999999999999999999999999999975432211111110000000011111 1246
Q ss_pred HHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 859 TFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 859 l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
+.+++..|++.||++|| +++++++|-+
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 77899999999999999 7888888743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.01 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=205.0
Q ss_pred ceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 621 KYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
.-++|+|.||+||.|++.+ ...+|||.+.....+..+.+..|+..-++++|.|||+++|.+.+++..-|.||-++||+|
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 3479999999999999875 467899999888777788899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCccC--CHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC-CCCceeecccccccccCCCCCcee
Q 002278 700 WDLLHGPSKKVKL--DWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 700 ~~~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
.++++. .-+++ .+.++-.+..||++||.|||+. .|||||||-.|||++ -.|.+||+|||-++++..-.+...
T Consensus 660 SsLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 660 SSLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred HHHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 999973 34455 7888999999999999999999 999999999999996 678999999999999876655443
Q ss_pred eeEecccceeCccccccC--CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 777 TFVLGTIGYIDPEYAHTS--RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
...||.-|||||++..+ .|+.++|||||||++.||.||++||..-...... ....+..+ +.|.++. +
T Consensus 735 -TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-MFkVGmyK----vHP~iPe-----e 803 (1226)
T KOG4279|consen 735 -TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-MFKVGMYK----VHPPIPE-----E 803 (1226)
T ss_pred -ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-hhhhccee----cCCCCcH-----H
Confidence 45599999999999865 5899999999999999999999999755443221 11222222 2333331 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
...+...++.+|..+||.+||+++++++.
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 23455679999999999999999999874
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=333.22 Aligned_cols=252 Identities=29% Similarity=0.374 Sum_probs=214.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
...|...+.||.|+||.||-|++. +.+.||||++.-. +.+...++.+|++++++++|||+|.+.|+|..+...|+|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 456777788999999999999975 5678999998533 234566889999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||| -|+-.|++.. .+.++.+..+..|..+.+.||+|||+. +.||||||+.|||+++.|.||++|||.|..+..
T Consensus 105 MEYC-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHH-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 9999 5677787753 345788999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeEecccceeCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
.. .++|||.|||||++.. +.|+-++||||+|++..|+.-.++|+.+.+.+..+..+...+.+....
T Consensus 179 An-----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs------ 247 (948)
T KOG0577|consen 179 AN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS------ 247 (948)
T ss_pred hh-----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC------
Confidence 42 3569999999998763 679999999999999999999999999988888888877766544431
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.+....+..++..|+++-|.+|||..++++|-.-..
T Consensus 248 -----~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 248 -----NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred -----chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 123356778999999999999999999998865433
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.10 Aligned_cols=254 Identities=24% Similarity=0.269 Sum_probs=213.3
Q ss_pred hccccceEEeeeceEEEEEEEecC-CceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
+.|+..+.||+|.-|+||+|+.++ +..+|+|++.+..- ....+.+.|.++|+.++||.++.+|+.|+.+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456777889999999999999886 47889999976542 33456778999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
|||+||+|..+.+.+ ....+++..+.-+|..++.||+|||-. |||+|||||+||||.++|++-|+||.++......
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999988754 456799999999999999999999999 9999999999999999999999999998543110
Q ss_pred ---------------------------------CC----------------------ceeeeEecccceeCccccccCCC
Q 002278 772 ---------------------------------MP----------------------HASTFVLGTIGYIDPEYAHTSRL 796 (943)
Q Consensus 772 ---------------------------------~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 796 (943)
.. ......+||-+|.|||++.|..+
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 00112469999999999999999
Q ss_pred CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCC
Q 002278 797 NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT 876 (943)
Q Consensus 797 ~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 876 (943)
+.++|+|+|||++|||+.|+.||.+.+.-+.+..+..+...+++.. . ......++|++.+.+||.+|-.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~---------vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--E---------VSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--c---------chhHHHHHHHHHhccChhhhhc
Confidence 9999999999999999999999999888888777766555544432 1 2245678999999999999997
Q ss_pred ----HHHHHHHH
Q 002278 877 ----MQEVARVL 884 (943)
Q Consensus 877 ----~~el~~~L 884 (943)
|.||-+|-
T Consensus 382 ~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 382 SKRGAAEIKRHP 393 (459)
T ss_pred cccchHHhhcCc
Confidence 88888764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=348.45 Aligned_cols=374 Identities=26% Similarity=0.414 Sum_probs=254.4
Q ss_pred CCCCCCCEEEeeCCccc-ccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCc
Q 002278 59 GDLRNLQSIDFQGNKLT-GQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLK 137 (943)
Q Consensus 59 ~~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 137 (943)
+-|+..+-.|+++|.++ +..|.....+++++.|.|...++. .+|..++.|.+|++|.+++|++. .+.+.++.||.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 34566777788888887 467777888888888888888887 78888888888888888888887 5667777777777
Q ss_pred EEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeeccc
Q 002278 138 TLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQ 217 (943)
Q Consensus 138 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~ 217 (943)
.+++..|++... -+|..+..+..|++||||+|+
T Consensus 82 sv~~R~N~LKns-----------------------------------------------GiP~diF~l~dLt~lDLShNq 114 (1255)
T KOG0444|consen 82 SVIVRDNNLKNS-----------------------------------------------GIPTDIFRLKDLTILDLSHNQ 114 (1255)
T ss_pred HHhhhccccccC-----------------------------------------------CCCchhcccccceeeecchhh
Confidence 777777776511 123333444445555555555
Q ss_pred ccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCc
Q 002278 218 ITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPEL 297 (943)
Q Consensus 218 l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 297 (943)
++ ..|..+..-+++-+|+||+|+|..+....|-+|+.|-.|+|++|++. .+|+..
T Consensus 115 L~------------------------EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~ 169 (1255)
T KOG0444|consen 115 LR------------------------EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQI 169 (1255)
T ss_pred hh------------------------hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHH
Confidence 44 22333333344444444444444333334444444444555555544 344455
Q ss_pred CCCCcCcEEEcccCccccccccccCCcccceEEEccccccC-CcCcccccCCCcCcEEEeeCCcccCcccccccccCccc
Q 002278 298 GNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLE-GPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLT 376 (943)
Q Consensus 298 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 376 (943)
..+.+|+.|+|++|.+...--..+..+++|++|.+++.+=+ .-+|..+..+.+|..++++.|.+. +.|+.+.++.+|+
T Consensus 170 RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~Lr 248 (1255)
T KOG0444|consen 170 RRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLR 248 (1255)
T ss_pred HHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhh
Confidence 55566666666666554333334445556666666655432 245666777777777777777776 6777778888888
Q ss_pred eeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccc-cCCccccCCCccceecccCc
Q 002278 377 YLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNG-LLPAEFGNLRSIQTIDMSFN 455 (943)
Q Consensus 377 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N 455 (943)
.|+||+|+|+ .+.-..+...+|+.|+||.|+++ .+|..+.+|+.|+.|++.+|+++- -+|..++.|.+|+.+..++|
T Consensus 249 rLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN 326 (1255)
T KOG0444|consen 249 RLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANN 326 (1255)
T ss_pred eeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcc
Confidence 8888888887 55556677778888888888887 678888888888888888888762 36778888888888888888
Q ss_pred cccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCC
Q 002278 456 QLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP 511 (943)
Q Consensus 456 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 511 (943)
.|. .+|..++++..|+.|.|++|+|- .+|+.+.-++.|+.|||..|+=--.||.
T Consensus 327 ~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 327 KLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred ccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 887 78888888888888888888887 6788888888888888888875555553
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=339.54 Aligned_cols=262 Identities=23% Similarity=0.324 Sum_probs=206.5
Q ss_pred HhhccccceEEeeeceEEEEEEEecC------CceEEEEEecccCc-ccHHHHHHHHHHHhcCC-CCCcceeeeEEecCC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQYP-HNLREFETELETIGSIR-HRNIVSLHGYALSPY 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 685 (943)
..++|.+.+.||+|+||.||+|.+.. +..||||++..... ...+.+.+|+++++++. |||||++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35688899999999999999998632 24699999865432 33467889999999996 999999999999999
Q ss_pred cceEEEEEccCCChhhhccCCC----------------------------------------------------------
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPS---------------------------------------------------------- 707 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 707 (943)
..++||||+++|+|.++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998875321
Q ss_pred -----------------------------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC
Q 002278 708 -----------------------------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID 752 (943)
Q Consensus 708 -----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 752 (943)
....+++.++..++.|++.||+|||+. +|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 012478888999999999999999998 999999999999999
Q ss_pred CCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHH
Q 002278 753 ENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIM 830 (943)
Q Consensus 753 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 830 (943)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 9999999999999865432221 1222346788999999999899999999999999999997 9999976433222222
Q ss_pred HhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 831 SKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
....... +.... .....+.+++..||+.||++||++.++.+.|+.+.+
T Consensus 352 ~~~~~~~------~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 KIKSGYR------MAKPD-----HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHhcCCC------CCCCc-----cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 2211111 11110 123567899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.65 Aligned_cols=247 Identities=18% Similarity=0.255 Sum_probs=199.0
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 691 (943)
+|+..+.||+|+||.||+|..+ +++.||+|.+.+.. ....+.+..|.+++..+ +|++|+.+++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999976 46789999986542 22334566788888777 5899999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999886 345689999999999999999999999 9999999999999999999999999999754322
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+.......+. .+
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~----- 224 (323)
T cd05616 155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SM----- 224 (323)
T ss_pred CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cC-----
Confidence 21 223346899999999999999999999999999999999999999876654433333322211111 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTM-----QEVARV 883 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~-----~el~~~ 883 (943)
...+.+++.+|++.||++|++. .++.+|
T Consensus 225 ----s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 225 ----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ----CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 2456789999999999999974 666655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=325.64 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=205.1
Q ss_pred hccccceEEeeeceEEEEEEEecCC------ceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNS------RPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
++|+..+.||+|+||.||+|..... ..||+|.+.... ......+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4678889999999999999986532 578999886443 233456889999999999999999999999988999
Q ss_pred EEEEEccCCChhhhccCCCC-------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC
Q 002278 689 LFYDYMVNGSLWDLLHGPSK-------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF 755 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 755 (943)
++|||+++|+|.+++..... ...+++.++..++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999864221 14588999999999999999999999 999999999999999999
Q ss_pred ceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhc
Q 002278 756 DAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKA 833 (943)
Q Consensus 756 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 833 (943)
.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...... .....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~-~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV-IEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHH
Confidence 999999999986533221 11223346789999999998899999999999999999998 9999986544322 22211
Q ss_pred cccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 834 DDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.. .. +..+. .....+.+++.+||+.||++||+++++.++|+.
T Consensus 241 ~~-~~-----~~~~~-----~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 SR-QL-----LPCPE-----DCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cC-Cc-----CCCcc-----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 11 11111 123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=320.51 Aligned_cols=256 Identities=27% Similarity=0.383 Sum_probs=207.2
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.++|+..+.||+|+||+||+|.+.++..||+|++.... ...+.+.+|++++++++||||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 45789999999999999999998877789999986532 345678999999999999999999998754 5689999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999642 234578999999999999999999999 9999999999999999999999999999876543322
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......++..|+|||+..+..++.++|||||||++|||+| |+.||.+............ .... ... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~--~~~---------~ 226 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRM--PCP---------P 226 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCC--CCc---------c
Confidence 2223346778999999998899999999999999999999 8889976554333222211 1110 001 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.....+.+++.+|++.+|++||++.++.+.|+...
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 22356789999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=320.40 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=203.4
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
.+|+..+.||+|+||.||+|.++.+..+|+|.+... ......+.+|+++++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 457788899999999999999887778999987643 2344678889999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999998632 33689999999999999999999999 99999999999999999999999999998664322211
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.....++..|+|||...+..++.++||||||+++|||++ |+.||............... . ....+. .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~------~~~~~~-----~ 225 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-Y------RLYRPK-----L 225 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-C------cCCCCC-----C
Confidence 111123457999999999899999999999999999999 89999765544333222111 1 111110 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
....+.+++.+||+.+|++|||+.++++.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 234678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=319.82 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=206.6
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.+|...+.||+|+||.||+|.++ .++.||+|.+... .....++.+|+++++.++||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778889999999999999976 4788999987643 334567889999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++++|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998643 234589999999999999999999999 9999999999999999999999999999876543222
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..... ......... .+..+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~------~~~~~~----- 228 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGY------RMERPE----- 228 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCC------CCCCCC-----
Confidence 2222234668999999999999999999999999999998 999997654332 222221111 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.....+.+++.+||..+|++||++.++++.|+.+
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1125677899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=329.45 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=211.0
Q ss_pred hhccccceEEeeeceEEEEEEEecC---C--ceEEEEEecc-cCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN---S--RPIAVKKLYN-QYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
.+..+..++||.|.||.||+|...+ | -.||||..+. ..++..+.|..|+.+|+.++|||||+++|+|.+. ..+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 3444556789999999999998543 3 3588998876 3466688899999999999999999999999874 689
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
||||.++.|.|..+++. ++..++..+...++.||+.||+|||+. ++|||||.++|||+.+.-.||++|||+++.+
T Consensus 467 ivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 99999999999999985 445688899999999999999999999 9999999999999999999999999999999
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
+++.....+...=+..|||||.+...+++.++|||.|||.+||++. |..||.+..+-+.+..+..++. ...+
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-------lP~P 614 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-------LPCP 614 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-------CCCC
Confidence 8776655554445678999999999999999999999999999988 9999987554332222211111 1111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
. .++..++.++.+||+.||.+||++.++...|..+..
T Consensus 615 ~-----nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 615 P-----NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred C-----CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1 233577899999999999999999999988865543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=332.28 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=203.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||.||+|.++ ++..+|+|.+.... ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367899999999999999999987 56778888776432 2334678899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++. ....+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999986 3346889999999999999999999741 79999999999999999999999999997653321
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHh-cccccccc-----------
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSK-ADDNTVME----------- 840 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~-~~~~~~~~----------- 840 (943)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||............. ........
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 122458999999999999899999999999999999999999997543221111000 00000000
Q ss_pred -------------------------ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 841 -------------------------AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 841 -------------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+... .....+.+++.+||+.||++|||+.|+++|-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSG----VFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCC----CcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000000000 11245778999999999999999999998755
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.30 Aligned_cols=242 Identities=22% Similarity=0.263 Sum_probs=193.1
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHH-HHhcCCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELE-TIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||+||+|..+ +++.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999976 57899999986432 122334455554 46789999999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 99999886 345689999999999999999999999 99999999999999999999999999987542221 222
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....||+.|+|||++.+..++.++|||||||++|||++|+.||................. ...+.+ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~---------~ 220 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL----RLKPNI---------S 220 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC----CCCCCC---------C
Confidence 345699999999999999999999999999999999999999987654333222222111 112222 2
Q ss_pred HHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 002278 857 RKTFQLALLCTKRYPSERPTM----QEVARV 883 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~----~el~~~ 883 (943)
..+.+++.+|++.||++||++ .+++++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 456789999999999999987 466654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=328.93 Aligned_cols=258 Identities=22% Similarity=0.359 Sum_probs=204.7
Q ss_pred hccccceEEeeeceEEEEEEEecC-Cc----eEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SR----PIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.+|+..+.||+|+||.||+|.+.. +. .||+|++.... ....+++.+|+.+++.++||||+++++++..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468899999999999999998653 33 48999986443 34456788999999999999999999999764 5789
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
++||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999874 234588999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 770 TAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 770 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
...... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.... .............. .+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~--~~~-- 235 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGERLPQ--PPI-- 235 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhCCCCCCC--CCC--
Confidence 432211 111224678999999999999999999999999999998 99999765432 22222221111110 111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
....+.+++..||..+|++||++.+++..+..+...+
T Consensus 236 -------~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 236 -------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1135678999999999999999999999998776544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=322.40 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=207.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999975 67899999875422 233456889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 692 DYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875322 234578999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc-HHHHHHHhccccccccccCcccccC
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN-LHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.... .....|++.|+|||.+.+..++.++|+||+|+++|||++|+.||..... ...+........ .+...
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~-- 229 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD------YPPLP-- 229 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC------CCCCC--
Confidence 3221 1223588899999999988899999999999999999999999965432 222222221111 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.......+.+++.+||+.+|++||++.++++.++.+
T Consensus 230 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 --TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111235678999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=324.53 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=205.7
Q ss_pred hhccccceEEeeeceEEEEEEEecC------CceEEEEEecccCcc-cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.++|...+.||+|+||.||+|...+ ++.||+|.+...... ..+.+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3567888899999999999998643 478999998765443 456889999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCC-----------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc
Q 002278 688 LLFYDYMVNGSLWDLLHGPS-----------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 756 (943)
++||||+++|+|.+++.... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999986421 234578999999999999999999999 9999999999999999999
Q ss_pred eeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcc
Q 002278 757 AHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKAD 834 (943)
Q Consensus 757 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 834 (943)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||..............
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~- 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ- 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-
Confidence 99999999976532221 11122335788999999999999999999999999999999 9999976544332222211
Q ss_pred ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.... ... .....+.+++.+||..||++||++.|+++.|.
T Consensus 240 -~~~~~-~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 -GRLLQ-RPR---------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -CCcCC-CCC---------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11100 011 11246779999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=365.33 Aligned_cols=445 Identities=30% Similarity=0.362 Sum_probs=310.9
Q ss_pred EEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecC
Q 002278 40 VVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKN 119 (943)
Q Consensus 40 v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 119 (943)
++.|+++.|-+...--+...+.-.|+.|||+.|++. ..|..+..+.+|+.|+++.|-|. ..|.+.+.+++|++|.|.+
T Consensus 23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~ 100 (1081)
T KOG0618|consen 23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKN 100 (1081)
T ss_pred HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheecc
Confidence 555666666554211122333444777777777666 56666677777777777777776 5666666777777777777
Q ss_pred cccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCC-------------------ccCCCCCccccc
Q 002278 120 NQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGN-------------------ALTGMLSPDMCQ 180 (943)
Q Consensus 120 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n-------------------~l~~~~~~~~~~ 180 (943)
|++. ..|..+..+.+|+.||+|.|++. .+|..+..+..++.+.+++| .+.+-...++..
T Consensus 101 n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~ 178 (1081)
T KOG0618|consen 101 NRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYN 178 (1081)
T ss_pred chhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhh
Confidence 7766 66777777777777777777766 56666666666666666666 333333333333
Q ss_pred ccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEec
Q 002278 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDL 260 (943)
Q Consensus 181 l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 260 (943)
+.. .|+|+.|.+. . -.+.++.+|+.|.+..|++.. ......+++.|+.++|.+....+ -....+|+++|+
T Consensus 179 l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~---l~~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~di 248 (1081)
T KOG0618|consen 179 LTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSE---LEISGPSLTALYADHNPLTTLDV--HPVPLNLQYLDI 248 (1081)
T ss_pred hhe--eeecccchhh-h--hhhhhccchhhhhhhhcccce---EEecCcchheeeeccCcceeecc--ccccccceeeec
Confidence 332 3555555544 1 134445555555555555431 11233467788888888874332 234567888999
Q ss_pred CCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCc
Q 002278 261 SENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340 (943)
Q Consensus 261 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 340 (943)
++|+++. +|++++.+.+|+.|...+|.++ .+|..+..+++|+.|++.+|.+. -+|....+++.|++|+|..|+|...
T Consensus 249 s~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~l 325 (1081)
T KOG0618|consen 249 SHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSL 325 (1081)
T ss_pred chhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccccc
Confidence 9998884 5688888889999999999886 67788888888999999999888 5666777888899999999988855
Q ss_pred CcccccCCCc-CcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCccc
Q 002278 341 IPHNISSCTA-LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGD 419 (943)
Q Consensus 341 ~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 419 (943)
++..+..+.. |+.|+.+.|++.......=..+..|+.|++.+|.++...-..+.+...|+.|+|++|++.......+.+
T Consensus 326 p~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~k 405 (1081)
T KOG0618|consen 326 PDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRK 405 (1081)
T ss_pred chHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhc
Confidence 4444454444 788888888887444222234567889999999998777777888889999999999998544455788
Q ss_pred ccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccc
Q 002278 420 LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLN 499 (943)
Q Consensus 420 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 499 (943)
++.|+.|+||+|+|+ .+|..+.+++.|++|...+|+|. ..| ++.+++.|+.+|++.|+|+...-......++|++||
T Consensus 406 le~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLd 482 (1081)
T KOG0618|consen 406 LEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLD 482 (1081)
T ss_pred hHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceee
Confidence 999999999999998 57788999999999999999998 677 889999999999999998853322233337899999
Q ss_pred cCCcc
Q 002278 500 VSYNN 504 (943)
Q Consensus 500 ls~N~ 504 (943)
|++|.
T Consensus 483 lSGN~ 487 (1081)
T KOG0618|consen 483 LSGNT 487 (1081)
T ss_pred ccCCc
Confidence 99997
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=319.38 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=206.3
Q ss_pred hhccccceEEeeeceEEEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN----SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.++|+..+.||+|+||+||+|.++. ...||+|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4578889999999999999998753 3578999886543 2334578899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
+|||+++++|.+++... ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.++++|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998642 34689999999999999999999998 99999999999999999999999999998875
Q ss_pred CCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 770 TAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 770 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||............ ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~------~~ 230 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLP------PP 230 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCC------CC
Confidence 22221 1112234678999999999899999999999999999998 99999765433322222 1111110 00
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
. .....+.+++.+|++.+|++||++.+++++|..+
T Consensus 231 ~-----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 231 M-----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 1124677999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=325.12 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=209.8
Q ss_pred hhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..+|...+.||+|+||.||+|... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 346778889999999999999853 24568888887665555677899999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC
Q 002278 689 LFYDYMVNGSLWDLLHGPS-------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF 755 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 755 (943)
+||||+++++|.+++.... ....+++..++.++.|++.|++|||++ +|+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 9999999999999986321 123589999999999999999999999 999999999999999999
Q ss_pred ceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhc
Q 002278 756 DAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKA 833 (943)
Q Consensus 756 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 833 (943)
.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||........+.....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 999999999976543221 11122346788999999999999999999999999999999 9999976554332221111
Q ss_pred cccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 834 DDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
..... ... ..+..+.+++.+||+.+|++||++.++++.|..+....
T Consensus 241 --~~~~~-----~~~-----~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 241 --GRVLE-----RPR-----VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred --CCCCC-----CCc-----cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 11111 110 11246779999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=337.97 Aligned_cols=254 Identities=22% Similarity=0.277 Sum_probs=201.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+|..+ .++.||+|++.... ......+.+|++++..++||+|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999976 57889999986432 234456788999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999986 345689999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC----------------------------------ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCC
Q 002278 772 MP----------------------------------HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK 817 (943)
Q Consensus 772 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 817 (943)
.. ......+||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00113469999999999999999999999999999999999999
Q ss_pred CCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHh
Q 002278 818 AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP---TMQEVARVLV 885 (943)
Q Consensus 818 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~el~~~L~ 885 (943)
||.+................. ..++... ......+++.+++. ||.+|+ ++.++.+|-+
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~-------~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETL--VFPPEVP-------ISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCce--ecCCCCC-------CCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 998776655443333211111 1111111 11345566776664 999998 4788888753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=365.25 Aligned_cols=445 Identities=27% Similarity=0.344 Sum_probs=372.4
Q ss_pred cEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEec
Q 002278 39 SVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLK 118 (943)
Q Consensus 39 ~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 118 (943)
++.+||++.|.++ .+|..+..+.+|+.|+++.|-|. ..|.+.+++.+|++|+|..|++. .+|.++..+++|+.|++|
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 4789999999988 89999999999999999999998 88899999999999999999999 899999999999999999
Q ss_pred CcccccCCCcccCCCCCCcEEEEecc-------------------ccccccchhccccccceeccccCCccCCCCCcccc
Q 002278 119 NNQLTGPIPSTLTQIPNLKTLDLARN-------------------QLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMC 179 (943)
Q Consensus 119 ~n~l~~~~~~~~~~l~~L~~L~Ls~N-------------------~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 179 (943)
.|++. .+|..+..++.+.+++.++| .+.+.++..+..+.. .|+|+.|.+. + .++.
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls 196 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLS 196 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhh
Confidence 99998 67777777766666666666 333344444444433 5999999998 2 4678
Q ss_pred cccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEe
Q 002278 180 QLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLD 259 (943)
Q Consensus 180 ~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 259 (943)
.+.+|+.+++..|++... .-..++|+.|+.++|.++ .....+...+++++++++|++++ +|++++.+.+|+.|+
T Consensus 197 ~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~-~~~~~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~ 270 (1081)
T KOG0618|consen 197 NLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLT-TLDVHPVPLNLQYLDISHNNLSN-LPEWIGACANLEALN 270 (1081)
T ss_pred hccchhhhhhhhcccceE----EecCcchheeeeccCcce-eeccccccccceeeecchhhhhc-chHHHHhcccceEec
Confidence 889999999999999843 234588999999999998 44444556689999999999996 569999999999999
Q ss_pred cCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCccc-ceEEEccccccC
Q 002278 260 LSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQ-LFELNLADNNLE 338 (943)
Q Consensus 260 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~ 338 (943)
..+|.++ .+|..+....+|+.|.+..|.+. -+|.....++.|++|+|..|+|....+..+.-+.. |..|+.+.|++.
T Consensus 271 ~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~ 348 (1081)
T KOG0618|consen 271 ANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS 348 (1081)
T ss_pred ccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc
Confidence 9999996 78888888999999999999999 67888889999999999999998444444444444 888999999998
Q ss_pred CcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcc
Q 002278 339 GPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIG 418 (943)
Q Consensus 339 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 418 (943)
...--.=.....|+.|++.+|.++...-..+.+...|+.|+|++|++.......+.++..|++|+||+|+++ .+|..+.
T Consensus 349 ~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva 427 (1081)
T KOG0618|consen 349 TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVA 427 (1081)
T ss_pred ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHH
Confidence 554333345678999999999999888888999999999999999999655667889999999999999999 7899999
Q ss_pred cccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCccc
Q 002278 419 DLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNL 498 (943)
Q Consensus 419 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 498 (943)
.+..|++|...+|+|. ..| .+..++.|+.+|+|.|+|+...-..-..-++|++|||+||.-.-..-..|..+..+..+
T Consensus 428 ~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~ 505 (1081)
T KOG0618|consen 428 NLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQM 505 (1081)
T ss_pred hhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhhe
Confidence 9999999999999998 567 89999999999999999985432222233899999999998543444556667777777
Q ss_pred ccCCc
Q 002278 499 NVSYN 503 (943)
Q Consensus 499 ~ls~N 503 (943)
++.-|
T Consensus 506 ~i~~~ 510 (1081)
T KOG0618|consen 506 DITLN 510 (1081)
T ss_pred ecccC
Confidence 77777
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.94 Aligned_cols=254 Identities=28% Similarity=0.381 Sum_probs=205.4
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.++|+..+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++||+++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457888999999999999999988888899999865432 4567899999999999999999999885 45689999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++++|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998642 234589999999999999999999999 9999999999999999999999999999876443222
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......++..|+|||+..+..++.++||||||+++|||++ |+.||.+............ ... +....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~------~~~~~----- 226 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYR------MPCPQ----- 226 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC------CCCCC-----
Confidence 2222335678999999988889999999999999999999 8999976554332222211 111 11111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.....+.+++.+|++++|++|||+.++.+.|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 122467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=333.55 Aligned_cols=246 Identities=20% Similarity=0.306 Sum_probs=194.7
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
++||+|+||.||+|..+ +++.||+|.+.... ......+.+|..+++.+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999976 57889999987532 23345678899999888 699999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 99999886 345699999999999999999999999 99999999999999999999999999987532211 122
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-------cHHHHHHHhccccccccccCcccccC
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES-------NLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
....||+.|+|||++.+..++.++||||+||++|||+||+.||+... ....+.......... .++..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~--- 228 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSL--- 228 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCC---
Confidence 33569999999999999999999999999999999999999996311 111111111111100 011111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPT------MQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~el~~~L~ 885 (943)
...+.+++..|++.||++||+ +.++++|-+
T Consensus 229 ------~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 229 ------SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred ------CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 135678999999999999997 678887744
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.53 Aligned_cols=267 Identities=26% Similarity=0.364 Sum_probs=214.5
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhc--CCCCCcceeeeEEecCC----cc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGS--IRHRNIVSLHGYALSPY----GN 687 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~ 687 (943)
..++....+.||+|.||.||+|.++ |+.||||++... +.+...+|.++++. ++|+||..+++.-..+. +.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4667888899999999999999998 788999999654 44667778888775 59999999999876543 46
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhC-----CCCCeEecCCCCccEEECCCCceeeccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD-----CNPRIIHRDVKSSNILIDENFDAHLSDF 762 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~kl~DF 762 (943)
++|.+|.+.|||+|+|. ...++....++++..+|.||+|||-. .+|.|+|||||+.|||+..++.+.|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 89999999999999995 46799999999999999999999953 5789999999999999999999999999
Q ss_pred ccccccCCCCC---ceeeeEecccceeCccccccCC----C--CCcchhhhHHHHHHHHHhC----------CCCCCCCc
Q 002278 763 GIARCIPTAMP---HASTFVLGTIGYIDPEYAHTSR----L--NEKSDVYSFGIVLLEILTG----------KKAVDNES 823 (943)
Q Consensus 763 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlGvil~elltG----------~~p~~~~~ 823 (943)
|+|........ ......+||.+|||||++...- + -..+||||||.|+||++-. +.||.+..
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 99987754422 2334567999999999987532 1 1479999999999999742 46776332
Q ss_pred cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 824 NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
+.+.-... ..+..-.+.++|.++..+...+....+.++|+.||..+|+.|-|+-.+.+.+.++..
T Consensus 441 p~DPs~ee-MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDPSFEE-MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCHHH-HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11100000 111223456678888888888899999999999999999999999999999887664
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=324.60 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=209.2
Q ss_pred hhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..+|...+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467888999999999999999852 23568999887665555667899999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCCC----------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCcee
Q 002278 689 LFYDYMVNGSLWDLLHGPS----------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH 758 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 758 (943)
+||||+++++|.+++.... ....+++.++..++.|++.||+|||++ +++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999986321 223589999999999999999999999 999999999999999999999
Q ss_pred ecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcccc
Q 002278 759 LSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDN 836 (943)
Q Consensus 759 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 836 (943)
|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.||................
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~- 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR- 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 9999999865332211 1112235778999999998899999999999999999998 999997665433222222211
Q ss_pred ccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 837 TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
... ... .....+.+++.+||+.+|.+|||+.++.+.|+.+...
T Consensus 240 -~~~-----~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 240 -VLQ-----RPR-----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -cCC-----CCC-----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111 000 0124678999999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.82 Aligned_cols=255 Identities=25% Similarity=0.339 Sum_probs=203.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|+..+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 457889999999999999999975 5788999988655445556788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++. ....+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++.......
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999886 345689999999999999999999998 999999999999999999999999999987643221
Q ss_pred ceeeeEecccceeCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 774 HASTFVLGTIGYIDPEYAH---TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
......|+..|+|||.+. ...++.++||||+||++|||++|+.||.................. .+....
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~-- 233 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-----PPKLKD-- 233 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC-----CCCCcc--
Confidence 122345889999999874 345788999999999999999999999754433221111111000 011110
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.......+.+++.+||+.+|++||+++++++++
T Consensus 234 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 -KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 011235678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.08 Aligned_cols=261 Identities=20% Similarity=0.231 Sum_probs=213.6
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC-C-----CCcceeeeEEecCCcceE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR-H-----RNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 689 (943)
+|.+.++||+|+||.|.+|.+. .++.||||.+++. .....+-..|+.+|..++ | -|+|+++++|....+.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8899999999999999999976 5899999999765 334455677999999986 4 389999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC--Cceeecccccccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN--FDAHLSDFGIARC 767 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~DFGla~~ 767 (943)
|+|.+ .-+|+++++... ...++...+..++.||+.||.+||+. +|||+||||+|||+.+. ..+||+|||.|++
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99988 679999998653 45699999999999999999999999 99999999999999743 4699999999997
Q ss_pred cCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc-----
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV----- 842 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 842 (943)
...... ..+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+++..+....+..+..+
T Consensus 341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 654322 45689999999999999999999999999999999999999999998888877665433221100
Q ss_pred ------Cc-------------------------------c--cccCc------cCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002278 843 ------DP-------------------------------E--VSVTC------VDLSAVRKTFQLALLCTKRYPSERPTM 877 (943)
Q Consensus 843 ------~~-------------------------------~--~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~ 877 (943)
+. . .+... ........+.+++++|+.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 00 0 00000 001234567899999999999999999
Q ss_pred HHHHHHHhhc
Q 002278 878 QEVARVLVSL 887 (943)
Q Consensus 878 ~el~~~L~~~ 887 (943)
.++++|-+--
T Consensus 497 ~qal~Hpfl~ 506 (586)
T KOG0667|consen 497 AQALNHPFLT 506 (586)
T ss_pred HHHhcCcccc
Confidence 9999987643
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.52 Aligned_cols=245 Identities=21% Similarity=0.302 Sum_probs=192.8
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||.||+|+.+ +++.||+|.+.+.. ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 46889999987542 23345577888888776 799999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 99998886 345689999999999999999999999 999999999999999999999999999975422211 22
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-------cHHHHHHHhccccccccccCcccccC
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES-------NLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+........ ...++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------~~~~p~~ 227 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------QIRIPRS 227 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC------CCCCCCC
Confidence 33569999999999999999999999999999999999999995211 1111111111000 0011111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHH
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPT------MQEVARVL 884 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~el~~~L 884 (943)
....+.+++.+|++.||++||+ +.++++|-
T Consensus 228 -----~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 228 -----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred -----CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 1245678999999999999998 56887763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=345.96 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=198.2
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecC--------
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP-------- 684 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 684 (943)
..++|+..+.||+|+||.||+|... .++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999975 57899999885432 3345799999999999999999987432
Q ss_pred CcceEEEEEccCCChhhhccC-CCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC-ceeeccc
Q 002278 685 YGNLLFYDYMVNGSLWDLLHG-PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-DAHLSDF 762 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DF 762 (943)
...++||||+++ ++.+++.. ......+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999975 67666542 12345689999999999999999999999 999999999999999654 6999999
Q ss_pred ccccccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc-
Q 002278 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME- 840 (943)
Q Consensus 763 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~- 840 (943)
|+|+.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|++||.+..............+....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99987643322 223468999999998876 46899999999999999999999999887666555444332211110
Q ss_pred ---ccC--------cccccCc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 841 ---AVD--------PEVSVTC----VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 841 ---~~~--------~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
... +.+.... ........+.+++.+||..||.+|||+.|+++|-+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 000 0000000 00011246779999999999999999999998765
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.26 Aligned_cols=255 Identities=28% Similarity=0.399 Sum_probs=206.9
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..+.|+..++||+|+||.||+|..++++.||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 346788899999999999999998888999999986543 34578899999999999999999999874 4578999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999988643 234689999999999999999999998 999999999999999999999999999987653322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......++..|+|||++.+..++.++||||||+++||+++ |+.||.+........... .... .....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~------~~~~~---- 226 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYR------MPRPD---- 226 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCC------CCCCC----
Confidence 22222345778999999998889999999999999999999 999998655433222211 1111 01111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....++.+++.+|+..+|++||+++++...|+.
T Consensus 227 -~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 -NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=337.71 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=202.4
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----cce
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY-----GNL 688 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 688 (943)
+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 68899999986532 233467889999999999999999999998776 679
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+. ++|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999986 57877775 345689999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccc-ccc-----
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV-MEA----- 841 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~----- 841 (943)
............+++.|+|||++.+. .++.++||||+||++|||++|+.||.+.........+....+.. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 44333333334578999999998874 47899999999999999999999998766544433322111100 000
Q ss_pred -----------c-CcccccC-ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 842 -----------V-DPEVSVT-CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 842 -----------~-~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
. .+..... .........+.+++.+|++.||++|||+.|+++|-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0 0000000 000011346778999999999999999999998865
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=322.13 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=203.2
Q ss_pred HhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
..++|+..+.||+|+||.||+|.++ .+..||+|++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999764 24679999885432 2334568899999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCC-------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSK-------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864221 23467889999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccc
Q 002278 760 SDFGIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNT 837 (943)
Q Consensus 760 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 837 (943)
+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+........... ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~- 238 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG- 238 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC-
Confidence 9999997653322111 112235778999999998899999999999999999999 788987654432222111 111
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.. .... .....+.+++.+|++.+|++|||+.|++++++
T Consensus 239 ~~-----~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 239 LL-----DKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cC-----CCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11 1111 11246778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=347.24 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=205.1
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC----
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY---- 685 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 685 (943)
...++|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+..+..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34579999999999999999999865 68899999986432 334456788999999999999999988775432
Q ss_pred ----cceEEEEEccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeec
Q 002278 686 ----GNLLFYDYMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLS 760 (943)
Q Consensus 686 ----~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 760 (943)
..++||||+++|+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 257999999999999988632 2234689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc
Q 002278 761 DFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM 839 (943)
Q Consensus 761 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 839 (943)
|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~--- 262 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY--- 262 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC---
Confidence 9999987643221 122345699999999999999999999999999999999999999987654332222221111
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
...++.+ ...+.+++..||+.||++||++.+++++
T Consensus 263 ~~~~~~~---------~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 DPLPPSI---------SPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCC---------CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111 2467789999999999999999999876
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.92 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=203.0
Q ss_pred hccccceEEeeeceEEEEEEEec-----CCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-----NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
+.|+..+.||+|+||.||+|... .+..||+|.+..... .....+.+|+++++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46778889999999999999852 457899999875432 334678899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCC--------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC
Q 002278 690 FYDYMVNGSLWDLLHGPS--------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF 755 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 755 (943)
||||+++|+|.+++.... ....+++.++..++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999885221 123578999999999999999999999 999999999999999999
Q ss_pred ceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhc
Q 002278 756 DAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKA 833 (943)
Q Consensus 756 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 833 (943)
.+||+|||+++....... .......++..|+|||+..+..++.++|||||||++|||++ |..||.+..... ......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-VIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHH
Confidence 999999999986533221 11222335678999999998889999999999999999999 999997654322 222221
Q ss_pred cccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 834 DDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
... ... .... ....+.+++..|++.||++||++.++.+++..
T Consensus 241 ~~~-~~~-~~~~---------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQ-LLP-CSED---------CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCC-cCC-CCCC---------CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 110 1111 12467789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.96 Aligned_cols=253 Identities=28% Similarity=0.387 Sum_probs=204.5
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
++|...+.||+|++|.||+|.+..+..+|+|++.... ...+.+.+|+++++.++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998877789999876432 34567889999999999999999999875 456899999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999998642 233578999999999999999999998 99999999999999999999999999998764332222
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.....++..|+|||+..+..++.++|||||||++|||+| |+.||.+............ .... .... .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~--~~~~---------~ 227 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRM--PCPQ---------G 227 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCC--CCCc---------c
Confidence 222335678999999998899999999999999999999 9999987654433322211 1110 0111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....+.+++.+||+++|++||+++++.+.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 22567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=324.56 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=208.2
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..+|+..+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 457888899999999999999965 5789999998766555567888999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999985 23578999999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||........+.......... ....+
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~--------- 240 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPE--------- 240 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCC-CCCcc---------
Confidence 1 222358899999999998889999999999999999999999998766544333222111110 00011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.....+.+++.+||..+|++||++.+++++-+
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 12245778999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.28 Aligned_cols=259 Identities=23% Similarity=0.348 Sum_probs=201.8
Q ss_pred hccccceEEeeeceEEEEEEEecC-Cc----eEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SR----PIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
++|+..+.||+|+||+||+|.+.. ++ ++++|++..... ....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 467788899999999999999753 43 477777753322 234567788889999999999999998754 56789
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
++||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999963 234689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 770 TAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 770 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
.... .......++..|+|||++.+..++.++|||||||++||++| |+.||.+...... ........... .+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~---~~~~- 235 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLA---QPQI- 235 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCC---CCCC-
Confidence 3321 11223446788999999998899999999999999999998 9999976543221 11111111111 0111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
....+..++..||..+|++|||+.|+++.+..+...++
T Consensus 236 -------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 236 -------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred -------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence 11356788999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.61 Aligned_cols=363 Identities=25% Similarity=0.421 Sum_probs=271.6
Q ss_pred EEEEEcCCCCCcc-ccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEec
Q 002278 40 VVSLNLSSLNLGG-EISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLK 118 (943)
Q Consensus 40 v~~L~l~~~~~~~-~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 118 (943)
|...|+++|.++| .+|.+...+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-..++.|+.|+.+.+.
T Consensus 9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R 86 (1255)
T KOG0444|consen 9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR 86 (1255)
T ss_pred eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence 6678999999995 79999999999999999999999 99999999999999999999998 677789999999999999
Q ss_pred Ccccc-cCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccc
Q 002278 119 NNQLT-GPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGT 197 (943)
Q Consensus 119 ~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 197 (943)
+|++. .-+|..+.++..|+.||||+|++. ..|..+...+++-.|+|++|+|..|+..-|-+|+.|-.||||+|++. .
T Consensus 87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~ 164 (1255)
T KOG0444|consen 87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-M 164 (1255)
T ss_pred ccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-h
Confidence 99986 357888999999999999999999 78999999999999999999999999999999999999999999998 6
Q ss_pred cCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCC-CCCCcccCCC
Q 002278 198 IPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELV-GPIPPILGNL 276 (943)
Q Consensus 198 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l 276 (943)
+|..+..+..|++|+|++|.+..- ++ ..+..|++|++|.+++.+-+ ..+|..+..+
T Consensus 165 LPPQ~RRL~~LqtL~Ls~NPL~hf------------------QL-----rQLPsmtsL~vLhms~TqRTl~N~Ptsld~l 221 (1255)
T KOG0444|consen 165 LPPQIRRLSMLQTLKLSNNPLNHF------------------QL-----RQLPSMTSLSVLHMSNTQRTLDNIPTSLDDL 221 (1255)
T ss_pred cCHHHHHHhhhhhhhcCCChhhHH------------------HH-----hcCccchhhhhhhcccccchhhcCCCchhhh
Confidence 777889999999999999987510 11 11234677888888876543 2456666666
Q ss_pred CCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEe
Q 002278 277 SYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNV 356 (943)
Q Consensus 277 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 356 (943)
.+|..++|+.|.+. ..|+.+.++.+|+.|+||+|+|+ .+....+...+|++|+||.|+++ ..|+.++.++.|+.|++
T Consensus 222 ~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~ 298 (1255)
T KOG0444|consen 222 HNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYA 298 (1255)
T ss_pred hhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHh
Confidence 66666666666666 56666666666666666666666 33344444555666666666665 44555555555555555
Q ss_pred eCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeeccccccccc
Q 002278 357 HGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGL 436 (943)
Q Consensus 357 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 436 (943)
.+|+++- . -+|..++.+.+|+++..++|.+. .+|+.++.+..|+.|.|++|++. .
T Consensus 299 n~NkL~F----------------------e-GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-T 353 (1255)
T KOG0444|consen 299 NNNKLTF----------------------E-GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-T 353 (1255)
T ss_pred ccCcccc----------------------c-CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-e
Confidence 5554431 1 14555666666666666666655 55666666666666666666665 4
Q ss_pred CCccccCCCccceecccCccc
Q 002278 437 LPAEFGNLRSIQTIDMSFNQL 457 (943)
Q Consensus 437 ~p~~~~~l~~L~~L~Ls~N~l 457 (943)
+|+.+.-|+.|+.|||..|.-
T Consensus 354 LPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 354 LPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred chhhhhhcCCcceeeccCCcC
Confidence 566666666666666666643
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=336.89 Aligned_cols=262 Identities=23% Similarity=0.256 Sum_probs=201.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY----- 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 685 (943)
..++|+..+.||+|+||.||+|.++ .++.||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999975 57899999986432 234566789999999999999999999986543
Q ss_pred -cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 686 -GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 686 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
..++||||+.+ ++.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999965 5666553 2478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc----
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME---- 840 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---- 840 (943)
++...... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+....+.......+....
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 97653321 122345899999999999999999999999999999999999999876654443322211111000
Q ss_pred ----------------------ccCcccccC---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 841 ----------------------AVDPEVSVT---CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 841 ----------------------~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+..... .........+.+++.+|+..||++|||+.|+++|-+-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 000000000 0000112456789999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.11 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=205.5
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-----ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-----HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
++|...+.||+|++|.||.|... ++++||+|.+..... .....+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888999999999999999865 578999998864321 123568889999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
|+||+++++|.+++. ....+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999886 344688999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCcee--eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 770 TAMPHAS--TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 770 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
....... ....|+..|+|||+..+..++.++||||+|+++|||++|+.||.................. ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~-- 231 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSH-- 231 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCcc--
Confidence 3221111 2234788999999999988999999999999999999999999876554443332221111 111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+.+++..||..+|++|||+.+++++.+
T Consensus 232 -------~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 232 -------VSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred -------CCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 1245678999999999999999999998743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=330.67 Aligned_cols=247 Identities=19% Similarity=0.261 Sum_probs=198.0
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 691 (943)
+|+..+.||+|+||+||+|..+ +++.||+|++.... ....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999976 57889999986432 233456778888888886 577888999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999986 345689999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.................+. .+
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~----- 224 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SL----- 224 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cC-----
Confidence 11 222345899999999999999999999999999999999999999876544333332222111111 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTM-----QEVARV 883 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~-----~el~~~ 883 (943)
...+.+++.+|++.+|++|++. .++.+|
T Consensus 225 ----~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 225 ----SKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ----CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 1356789999999999999974 556554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=331.42 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=203.7
Q ss_pred hhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCc-ccHHHHHHHHHHHhcC-CCCCcceeeeEEecC-C
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYP-HNLREFETELETIGSI-RHRNIVSLHGYALSP-Y 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 685 (943)
.++|++.+.||+|+||.||+|... .++.||+|++..... .....+.+|+++++++ +||||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457899999999999999999743 246899998864432 2345677899999999 799999999988654 4
Q ss_pred cceEEEEEccCCChhhhccCCCC---------------------------------------------------------
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSK--------------------------------------------------------- 708 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 708 (943)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 57889999999999998853211
Q ss_pred -CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc-eeeeEeccccee
Q 002278 709 -KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYI 786 (943)
Q Consensus 709 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~ 786 (943)
...+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||+++.+...... ......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 12688999999999999999999999 9999999999999999999999999999876433221 122234577899
Q ss_pred CccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHH
Q 002278 787 DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALL 865 (943)
Q Consensus 787 aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 865 (943)
|||++.+..++.++|||||||++|||++ |+.||.+................ +..+. .....+.+++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~-----~~~~~~~~l~~~ 311 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR------MRAPE-----YATPEIYSIMLD 311 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC------CCCCc-----cCCHHHHHHHHH
Confidence 9999999999999999999999999998 99999764332222222111111 00110 112467899999
Q ss_pred ccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 866 CTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 866 cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
||+.+|++||++.+++++|+.+..
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=332.65 Aligned_cols=238 Identities=22% Similarity=0.270 Sum_probs=189.8
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHH-HHhcCCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELE-TIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||+||+|+++ +++.||+|.+.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 46789999986432 122234444444 56788999999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 99999986 345678889999999999999999999 999999999999999999999999999975432221 22
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.+......+........ ...+.+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~--------- 220 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----QLKPNIT--------- 220 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc----CCCCCCC---------
Confidence 345699999999999999999999999999999999999999987655443332222111 1122221
Q ss_pred HHHHHHHHHccCCCCCCCCCHHH
Q 002278 857 RKTFQLALLCTKRYPSERPTMQE 879 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~e 879 (943)
..+.+++..|++.||.+||++.+
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCC
Confidence 35678999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=330.58 Aligned_cols=242 Identities=21% Similarity=0.231 Sum_probs=190.7
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHH-HHhcCCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELE-TIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
++||+|+||.||+|+.+ +++.||+|.+.+.. ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 57889999986432 122334555554 57889999999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+.+. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 99998886 345688999999999999999999998 99999999999999999999999999987532221 122
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+............. .+.+.. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~---------~ 220 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL----QLPGGK---------T 220 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC----CCCCCC---------C
Confidence 335689999999999998999999999999999999999999987654322222211111 111111 2
Q ss_pred HHHHHHHHHccCCCCCCCCCHH----HHHHH
Q 002278 857 RKTFQLALLCTKRYPSERPTMQ----EVARV 883 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~----el~~~ 883 (943)
..+.+++..|++.||++||++. ++.++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 4567899999999999999753 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.31 Aligned_cols=259 Identities=23% Similarity=0.305 Sum_probs=209.0
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|++|+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 78899999885322 233567889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 692 DYMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 692 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
||+++|+|.+++... .....+++.++..++.+++.|++|||+. +|+||||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988532 2234689999999999999999999999 999999999999999999999999999986644
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-cHHHHHHHhccccccccccCcccccC
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES-NLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||.... ........... . ..+..+
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~-----~~~~~~-- 229 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-C-----DYPPLP-- 229 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-C-----CCCCCC--
Confidence 3222 223458899999999998889999999999999999999999996443 22222111111 1 111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.......+.+++..||+.+|++|||+.++++.++.+.
T Consensus 230 --~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 --ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1122346778999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=319.57 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=207.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||.||+|..+ +++.+|||++.... .....++.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46778889999999999999964 68899999876432 223457889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 692 DYMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 692 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
||+++++|.+++... .....+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988632 1235689999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc-HHHHHHHhccccccccccCcccccC
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN-LHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.... .....|+..|+|||+..+..++.++||||||+++|||++|..||..... .......... ...+....
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~- 230 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ------CDYPPLPS- 230 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc------CCCCCCCc-
Confidence 3222 2234588999999999988899999999999999999999999975432 1121111111 01111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
......+.+++.+||+.+|++|||+.+|++.++++
T Consensus 231 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 231 ---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11235678899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=327.46 Aligned_cols=264 Identities=20% Similarity=0.250 Sum_probs=202.0
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
++|...+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57889999999999999999976 56789999886443 23344677899999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 974 88887753 234578999999999999999999999 999999999999999999999999999976533222
Q ss_pred ceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc-----
Q 002278 774 HASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS----- 847 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 847 (943)
. .....+++.|+|||++.+ ..++.++||||+||++|||+||+.||.+.+............+......++.+.
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 T-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred c-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1 222357899999998865 468899999999999999999999998665433322222111111110000000
Q ss_pred ------cCc------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 848 ------VTC------VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 848 ------~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
... ........+.+++.+|++.||.+|||+.|+++|-+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 000 000112456789999999999999999999987653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=333.69 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=211.3
Q ss_pred hccccceEEeeeceEEEEEEEecCCceE-EEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPI-AVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
+-|.++..||.|+||.||+|..++.... |.|++.....+..+++.-|+++|+.+.||+||++++.|..+...+|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4456677799999999999998865544 667776667777889999999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
.||-+..++-. -...+.+.++..+++|++.||.|||+. +|||||||+.|||++-+|.++++|||.+....... .
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-Q 185 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-h
Confidence 99999887753 345689999999999999999999999 99999999999999999999999999986543322 2
Q ss_pred eeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 775 ASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.+..++|||.|||||+.. ..+|+.++||||||++|.||..+.+|-....++-.+..+...+.+.... |.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq--PS---- 259 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ--PS---- 259 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC--cc----
Confidence 234467999999999754 5689999999999999999999999998877776666655444332211 11
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.....+.++++.|+.++|..||++.++++|-+
T Consensus 260 ----~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 260 ----HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred ----hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 22356778999999999999999999999865
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.67 Aligned_cols=257 Identities=20% Similarity=0.240 Sum_probs=202.5
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+++.+ .++.||+|.+.+.. ......+.+|..++..++|++|+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 56789999886421 223445788999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999632 34688999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeeEecccceeCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHT-----SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
.........||+.|+|||++.+ ..++.++||||+||++|||++|+.||................... .+++.+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~ 233 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF--QFPSHI 233 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc--cCCCcc
Confidence 3333334569999999998875 467889999999999999999999998766544443333222111 011111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHh
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSE--RPTMQEVARVLV 885 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~el~~~L~ 885 (943)
. .....+.+++.+|+..++++ |++++++.+|-+
T Consensus 234 ~------~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 234 T------DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred c------cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 1 11245667888888765554 568999988753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=332.38 Aligned_cols=242 Identities=21% Similarity=0.259 Sum_probs=192.8
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHH-HHhcCCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELE-TIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||.||+|..+ +++.||+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35899999999999976 57899999986432 223344555555 46789999999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT 153 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence 99998886 345689999999999999999999999 99999999999999999999999999987542221 122
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....||+.|+|||++.+..++.++||||+||++|||++|+.||................. ...+.. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~----~~~~~~---------~ 220 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL----VLRPGA---------S 220 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc----cCCCCC---------C
Confidence 345699999999999999999999999999999999999999987654433322222111 111221 1
Q ss_pred HHHHHHHHHccCCCCCCCCCHH----HHHHH
Q 002278 857 RKTFQLALLCTKRYPSERPTMQ----EVARV 883 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~----el~~~ 883 (943)
..+.+++..|++.+|.+||++. ++++|
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 3566899999999999999875 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.21 Aligned_cols=257 Identities=22% Similarity=0.258 Sum_probs=201.5
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+|+.+ +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888999999999999999976 5789999998642 1233456788999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999863 234689999999999999999999999 9999999999999999999999999999776544
Q ss_pred CCceeeeEecccceeCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHT-----SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
.........||+.|+|||++.. ..++.++||||+||++|||++|+.||.................... ..+..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~ 233 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ--FPPDV 233 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc--CCCcc
Confidence 3333334569999999999863 4578899999999999999999999987655444333322211111 11111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHHHh
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYP--SERPTMQEVARVLV 885 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP--~~RPt~~el~~~L~ 885 (943)
. .....+.+++++|+..++ ..||++.++++|-+
T Consensus 234 ~------~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 234 T------DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred C------CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 0 012345677777665433 34889999999854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=312.04 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=199.3
Q ss_pred EEeeeceEEEEEEEecCCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCChhh
Q 002278 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWD 701 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 701 (943)
+||+|+||.||+|..++++.||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6899999999999988888999998865543 234568899999999999999999999999999999999999999999
Q ss_pred hccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeEec
Q 002278 702 LLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG 781 (943)
Q Consensus 702 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 781 (943)
++... ...+++..+..++.|++.||.|+|+. +++||||||+||+++.++.+|++|||++...............+
T Consensus 82 ~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 82 FLRKK--KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 88632 34588999999999999999999998 99999999999999999999999999997654332222222234
Q ss_pred ccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHH
Q 002278 782 TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTF 860 (943)
Q Consensus 782 t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 860 (943)
+..|+|||+..+..++.++||||||+++||+++ |..||.............. ... ...... ....+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-~~~--~~~~~~---------~~~~~~ 224 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYR--MSCPQK---------CPDDVY 224 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCC--CCCCCC---------CCHHHH
Confidence 678999999998889999999999999999998 9999976544332222211 110 011111 125678
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 861 QLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 861 ~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+++.+|+..+|++||++.++++.|.
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHHhc
Confidence 8999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.13 Aligned_cols=244 Identities=21% Similarity=0.287 Sum_probs=193.2
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.++.++ +||+|+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 46889999987542 23345678899998888 599999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 99998886 335699999999999999999999999 99999999999999999999999999997532221 222
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc------cHHHHHHHhccccccccccCcccccCc
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES------NLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... .. ...+..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~--~~~p~~~---- 226 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KP--IRIPRFL---- 226 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CC--CCCCCCC----
Confidence 34569999999999999999999999999999999999999996321 11111111111 10 0011111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPT------MQEVARVL 884 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt------~~el~~~L 884 (943)
...+.+++.+|+..||++|++ +.++.+|-
T Consensus 227 -----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 227 -----SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred -----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 135668999999999999998 45777664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.69 Aligned_cols=252 Identities=20% Similarity=0.256 Sum_probs=200.5
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
|+..+.||+|+||+||+|.+. +++.||+|.+.... ......+.+|+++++.++|++|+++++++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999976 57889999886432 12234577899999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999888632 234689999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
.....|+..|+|||++.+..++.++|+||+||++|||++|+.||........................+.+
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 228 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF------- 228 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccC-------
Confidence 12345899999999999889999999999999999999999999865443222111111111111111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 002278 854 SAVRKTFQLALLCTKRYPSERPT-----MQEVARVL 884 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L 884 (943)
...+.+++..|++.||++||+ +.+++++-
T Consensus 229 --~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05632 229 --SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHP 262 (285)
T ss_pred --CHHHHHHHHHHccCCHhHcCCCcccChHHHHcCh
Confidence 235678999999999999999 77877763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=313.54 Aligned_cols=256 Identities=30% Similarity=0.418 Sum_probs=209.2
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..++|++.+.||+|+||.||+|..++++.||+|.+... ....+++.+|+.++++++||||+++++++......+++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 35688899999999999999999888888999988643 33457889999999999999999999999998899999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++... ....+++.++..++.+++.|++|||+. +++||||||+||++++++.+|++|||.++.......
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999643 224689999999999999999999999 999999999999999999999999999987653322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......++..|+|||.+.+..++.++||||+||++||++| |+.||.+............. .. ......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~------- 228 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YR--MPRPPN------- 228 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC--CCCCCC-------
Confidence 22222335678999999998889999999999999999999 99999765543333222111 10 000111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....+.+++.+|+..+|++||+++++.+.|+.
T Consensus 229 --~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 229 --CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 12467889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.89 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=205.8
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ--YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|++|.||+|..+ +++.||+|.+... ......++.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999976 5788999988543 234566788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998743 235689999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
.. ....|++.|+|||+..+..++.++|+|||||++|||++|+.||................ .+.+..
T Consensus 157 ~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~----- 223 (256)
T cd08529 157 FA-NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-------FPPVSQ----- 223 (256)
T ss_pred hh-hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------CCCCcc-----
Confidence 22 23458899999999999999999999999999999999999998665433222221111 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.....+.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 122567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.73 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=204.9
Q ss_pred hhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..+|...+.||+|+||.||+|... ++..+|+|.+..........+.+|+++++.++||||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356777889999999999999742 35678999887665566678999999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCC------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc
Q 002278 689 LFYDYMVNGSLWDLLHGPSK------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 756 (943)
++|||+++|+|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999864321 13588999999999999999999999 9999999999999999999
Q ss_pred eeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcc
Q 002278 757 AHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKAD 834 (943)
Q Consensus 757 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 834 (943)
+||+|||+++........ ......+++.|+|||+..+..++.++|||||||++|||++ |++||...............
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 999999999765332211 1122235678999999999999999999999999999998 99999765543332222111
Q ss_pred ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.. +..+. .....+.+++.+||+.||++||++.++.+.|+
T Consensus 241 ~~-------~~~~~-----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 241 RE-------LERPR-----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cc-------CCCCC-----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11 01110 11245679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=331.31 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=207.4
Q ss_pred HHHhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCc-ccHHHHHHHHHHHhcCC-CCCcceeeeEEec
Q 002278 612 MRSTENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYP-HNLREFETELETIGSIR-HRNIVSLHGYALS 683 (943)
Q Consensus 612 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 683 (943)
....++|...+.||+|+||.||+|+++ .++.||+|++..... ...+.+.+|+++++++. |||||++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 345567888899999999999999864 246799999975432 23456889999999997 9999999999999
Q ss_pred CCcceEEEEEccCCChhhhccCCCC-------------------------------------------------------
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGPSK------------------------------------------------------- 708 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 708 (943)
.+..++||||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999864211
Q ss_pred ----------------------------------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCcc
Q 002278 709 ----------------------------------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSN 748 (943)
Q Consensus 709 ----------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 748 (943)
...+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 12367788899999999999999998 99999999999
Q ss_pred EEECCCCceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHH
Q 002278 749 ILIDENFDAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLH 826 (943)
Q Consensus 749 ill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~ 826 (943)
|++++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986533211 11122346789999999998889999999999999999998 899997654433
Q ss_pred HHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 827 QLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
........... +..+.. ....+.+++..||..+|++||+++++++.|+.+.
T Consensus 350 ~~~~~~~~~~~------~~~p~~-----~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 QFYNAIKRGYR------MAKPAH-----ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHcCCC------CCCCCC-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 32222221111 111111 1246788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.90 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=202.8
Q ss_pred HhhccccceEEeeeceEEEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
.+++|...+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678999999999999999999764 4678888875433 2334568899999999999999999999999989
Q ss_pred ceEEEEEccCCChhhhccCCCC----CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC---ceee
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSK----KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF---DAHL 759 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl 759 (943)
.++||||+++|+|.+++..... ...+++.++..++.||+.|++|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999864321 23589999999999999999999999 999999999999998654 5999
Q ss_pred cccccccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccc
Q 002278 760 SDFGIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNT 837 (943)
Q Consensus 760 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 837 (943)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......... ........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~ 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-EFVTGGGR 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHcCCc
Confidence 9999998763322111 111223568999999998899999999999999999997 99999865543322 22111111
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
. ...+. ....+.+++.+|++.+|++||++.+++++|.
T Consensus 240 ~--~~~~~---------~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 L--DPPKG---------CPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred C--CCCCC---------CCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 01111 1246778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=349.85 Aligned_cols=261 Identities=21% Similarity=0.221 Sum_probs=204.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||.||+|.+. .++.||+|++..... ...+++.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999976 478999999865322 23457889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCC--------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 692 DYMVNGSLWDLLHGPS--------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
||++||+|.+++.... .....++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 123456778899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-----------------ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHH
Q 002278 764 IARCIPTAMP-----------------HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLH 826 (943)
Q Consensus 764 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~ 826 (943)
+++....... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 01112459999999999999999999999999999999999999997644322
Q ss_pred HHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcCC
Q 002278 827 QLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP-TMQEVARVLVSLLP 889 (943)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~el~~~L~~~~~ 889 (943)
......... +....+ ....+..+.+++.+|++.||++|| +++++.+.++....
T Consensus 239 i~~~~~i~~---P~~~~p-------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYRDVILS---PIEVAP-------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhhccC---hhhccc-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111110000 000000 001224567899999999999996 66777777776654
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.71 Aligned_cols=246 Identities=24% Similarity=0.329 Sum_probs=196.6
Q ss_pred EEeeeceEEEEEEEec---CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCC
Q 002278 623 IVGYGASSTVYKCALK---NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNG 697 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 697 (943)
.||+|+||.||+|.++ ++..+|+|++.... ....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 4899999999999753 46789999886443 223567889999999999999999999885 45678999999999
Q ss_pred ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee-
Q 002278 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS- 776 (943)
Q Consensus 698 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~- 776 (943)
+|.+++. ....+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.+........
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999986 334689999999999999999999999 999999999999999999999999999987654332211
Q ss_pred -eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 777 -TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 777 -~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
....++..|+|||.+....++.++|||||||++|||++ |+.||............. .... +..+. .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~------~~~~~-----~ 222 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGER------MECPQ-----R 222 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCC------CCCCC-----C
Confidence 11224578999999988889999999999999999998 999998655433322222 1111 11111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
....+.+++..||+.||++||++++|.+.|+.+
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 124677999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.91 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=202.5
Q ss_pred hccccceEEeeeceEEEEEEEecC------CceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..|...+.||+|+||.||+|...+ +..||+|++..... ...+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346677789999999999998643 46799999875432 23456889999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCC-------------CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC
Q 002278 689 LFYDYMVNGSLWDLLHGP-------------SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF 755 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 755 (943)
+++||+++++|.+++... .....+++..+..++.|++.||+|+|++ +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 999999999999987421 1123588899999999999999999999 999999999999999999
Q ss_pred ceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhc
Q 002278 756 DAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKA 833 (943)
Q Consensus 756 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 833 (943)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+............
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999886543321 11122345789999999988889999999999999999998 8889876554332222222
Q ss_pred cccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 834 DDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.... .+.. .....+.+++..||+.+|++||+++++++.|+.
T Consensus 242 ~~~~-------~~~~-----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 242 RQVL-------PCPD-----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCcC-------CCCC-----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111 0111 122457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=315.29 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=198.1
Q ss_pred ccceEEeeeceEEEEEEEecCCc---eEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC------Ccc
Q 002278 619 SEKYIVGYGASSTVYKCALKNSR---PIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP------YGN 687 (943)
Q Consensus 619 ~~~~~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 687 (943)
.+.+.||+|+||.||+|.+.... .||+|.+.... ....+.+.+|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999976432 58999876432 33456788999999999999999999987532 246
Q ss_pred eEEEEEccCCChhhhccCC---CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGP---SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
+++|||+++|+|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887321 1234589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcccccccccc
Q 002278 765 ARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAV 842 (943)
Q Consensus 765 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 842 (943)
++.+....... .....+++.|+|||...+..++.++|||||||++|||++ |+.||............... ... . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~-~-~ 235 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NRL-K-Q 235 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCC-C-C
Confidence 98764432211 122336778999999999999999999999999999999 89999765543322222211 110 0 1
Q ss_pred CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 843 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.+. ....+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 236 ~~~---------~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 PPD---------CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 124577999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=319.73 Aligned_cols=262 Identities=24% Similarity=0.270 Sum_probs=201.9
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|++|.||+|+.+ ++..||+|++.... ......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999976 57899999886432 22346788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
++ ++|.+++........+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68888886544446789999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc-------
Q 002278 774 HASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE------- 845 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 845 (943)
......+++.|+|||++.+. .++.++|||||||++|||+||+.||.+..................+..++.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 11223468899999988654 578999999999999999999999987655443333221111111110000
Q ss_pred ---cccCc------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 846 ---VSVTC------VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 846 ---~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
+.... .......++.+++.+|+..||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 000012456789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.12 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=196.4
Q ss_pred EEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCChh
Q 002278 623 IVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLW 700 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 700 (943)
.||+|+||.||+|.++ +++.||+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5899999999999976 67889999876443 234567899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee-eeE
Q 002278 701 DLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS-TFV 779 (943)
Q Consensus 701 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~-~~~ 779 (943)
+++.. ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||++........... ...
T Consensus 82 ~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 82 TFLRT--EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99863 234589999999999999999999999 999999999999999999999999999976543211110 111
Q ss_pred ecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHH
Q 002278 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRK 858 (943)
Q Consensus 780 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (943)
.++..|+|||.+.+..++.++|||||||++|||++ |..||............... . .+..+. .....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-~------~~~~~~-----~~~~~ 224 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-V------RLPCPE-----LCPDA 224 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-C------CCCCcc-----cCCHH
Confidence 23457999999999899999999999999999998 88998755433222211111 0 011110 11246
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 859 TFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 859 l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.+++.+|++.+|++|||+.++.+.|.
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.33 Aligned_cols=260 Identities=20% Similarity=0.315 Sum_probs=207.7
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-----CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEec-CCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-----SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALS-PYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 686 (943)
..++|+..+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45788899999999999999999875 6788999886443 3345668899999999999999999998776 467
Q ss_pred ceEEEEEccCCChhhhccCCCCC-----ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKK-----VKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSD 761 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 761 (943)
.++++||+++|+|.+++...... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998643222 4689999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccc
Q 002278 762 FGIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVM 839 (943)
Q Consensus 762 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 839 (943)
||+++.+....... .....++..|+|||++.+..++.++|||||||++||+++ |+.||....... +...........
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHHHcCCCCC
Confidence 99998664332211 112235678999999998889999999999999999999 999998654433 222222111111
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
... .....+.+++.+||..||++|||+.++++.|..+.
T Consensus 240 ------~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 240 ------QPI-----NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ------CCC-----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 110 11246789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=315.12 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=201.2
Q ss_pred cccceEEeeeceEEEEEEEecC----CceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc-----
Q 002278 618 LSEKYIVGYGASSTVYKCALKN----SRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYG----- 686 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 686 (943)
|...+.||+|+||.||+|.... +..||+|++.... ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998653 3679999986432 2334578899999999999999999999876554
Q ss_pred -ceEEEEEccCCChhhhccCCC---CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccc
Q 002278 687 -NLLFYDYMVNGSLWDLLHGPS---KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDF 762 (943)
Q Consensus 687 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DF 762 (943)
.+++|||+++|+|.+++.... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 689999999999999885321 234689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcccccccc
Q 002278 763 GIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVME 840 (943)
Q Consensus 763 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 840 (943)
|+++.+...... ......++..|+|||+..+..++.++|||||||++|||++ |..||.+....... ........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~-~~~~~~~~--- 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY-DYLRHGNR--- 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCC---
Confidence 999876433221 1112235678999999988899999999999999999999 89999765543322 22111111
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
+..+. .....+.+++.+||+.||++||++.+++++|..+
T Consensus 234 ---~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 ---LKQPE-----DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---CCCCc-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 1224678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=319.67 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=209.4
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..+|+..+.||.|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 456889999999999999999864 6889999998765555567888999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++. ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999885 23589999999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||..................... ...
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--------- 239 (296)
T cd06655 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-NPE--------- 239 (296)
T ss_pred c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccC-Ccc---------
Confidence 1 22235889999999999888999999999999999999999999877654443322221111100 001
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.....+.+++.+||..||++||++.+++.+-+-
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 112456789999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=312.13 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=203.5
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
.+|+..+.||+|+||.||+|.+..++.+|+|.+... ......+.+|++++++++||+++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467788899999999999999877888999988643 3345678999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+++|.+++.. ....++++.+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++.........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999863 234588999999999999999999999 99999999999999999999999999997654332221
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.....++.+|+|||+..+..++.++||||+|+++|||++ |+.||.............. ... ...+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~---~~~~~~-------- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFR---LYKPRL-------- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCC---CCCCCC--------
Confidence 222235678999999998889999999999999999998 9999976543322222111 110 011111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
....+.+++.+||+.+|++||++.++++.+
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 125678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=327.33 Aligned_cols=251 Identities=21% Similarity=0.343 Sum_probs=207.0
Q ss_pred ccccceEEeeeceEEEEEEEecC--C--ceEEEEEecccCcc-cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALKN--S--RPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
+....+.||+|.||.|++|.|+. | ..||||.+...... ...+|.+|+.+|.+|+|||++++||+..+ ....+|+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34455679999999999999873 3 45799999765533 56789999999999999999999999987 6789999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
|.++.|+|.+.|+. .....+-......++.|||.|++||.++ ++|||||.++|+++.....|||+|||+.+-+...
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999986 4566788899999999999999999999 9999999999999999999999999999988655
Q ss_pred CCceee--eEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 772 MPHAST--FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 772 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
..+... ...-...|+|||.+....++.++|||+|||++|||+| |+.||-+......+..+. ....+.. |
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpR---P---- 337 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPR---P---- 337 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCC---C----
Confidence 433211 1223568999999999999999999999999999999 999998877655443332 1111111 1
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
..+.+.++++++.||...|++|||+.++.+.+
T Consensus 338 ----k~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 338 ----KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ----CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 12357899999999999999999999998554
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.93 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=203.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|+..+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357788888999999999999875 5788999988655444456688899999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++. ..+.+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999986 345689999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeeEecccceeCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 774 HASTFVLGTIGYIDPEYAH---TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
......|+..|+|||++. ...++.++||||+||++|||++|+.||.................. ........
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~---- 235 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PPKLKDKM---- 235 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC-CCcccccC----
Confidence 223346899999999874 456889999999999999999999999755443332222111111 01000000
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.....+.+++.+|++.+|++||++.+++++
T Consensus 236 ---~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 236 ---KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ---CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 112356789999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=348.73 Aligned_cols=259 Identities=20% Similarity=0.277 Sum_probs=203.3
Q ss_pred HHhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Ccc
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGN 687 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 687 (943)
...++|.+.+.||+|+||+||+|.+.. +..||+|.+.... ......+..|+.+++.++|||||+++++|... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345789999999999999999999764 5678888875432 23456788999999999999999999988653 457
Q ss_pred eEEEEEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCC----CCeEecCCCCccEEECC---------
Q 002278 688 LLFYDYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCN----PRIIHRDVKSSNILIDE--------- 753 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~Dlkp~Nill~~--------- 753 (943)
++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999986321 23569999999999999999999998521 25999999999999964
Q ss_pred --------CCceeecccccccccCCCCCceeeeEecccceeCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 002278 754 --------NFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKKAVDNES 823 (943)
Q Consensus 754 --------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~p~~~~~ 823 (943)
.+.+||+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2358999999998664332 1223469999999999864 458899999999999999999999998776
Q ss_pred cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 824 NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+......... ++.. .....+.+++..||+.+|.+||++.+++.+-+
T Consensus 248 ~~~qli~~lk~~p~--------lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 248 NFSQLISELKRGPD--------LPIK----GKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred cHHHHHHHHhcCCC--------CCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 66655544332211 1100 11246778999999999999999999996543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=331.70 Aligned_cols=261 Identities=22% Similarity=0.254 Sum_probs=202.6
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY----- 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 685 (943)
..++|...+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999976 57889999986532 334467788999999999999999999876432
Q ss_pred -cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 686 -GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 686 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
..++||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 46899999964 6777664 2478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc---
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA--- 841 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 841 (943)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+.......+.....
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98654332 1223458999999999999999999999999999999999999998776655544333221111000
Q ss_pred -----------------------cCcccccCc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 842 -----------------------VDPEVSVTC---VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 842 -----------------------~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+...... ........+.+++.+|++.||++|||+.++++|-+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 000000000 00011245678999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.31 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=197.8
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ-YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
+|+..+.||+|+||.||+|.+. +++.||+|.+... ......++.+|++++++++||||+++++++..+...++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5778889999999999999865 5788999988644 2334567889999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999986542 367888999999999999999999 99999999999999999999999999997654321
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHH------HHHHHhccccccccccCccccc
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLH------QLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ........ ...+....
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 222 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD------EDPPVLPV 222 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc------cCCCCCCC
Confidence 223458999999999999999999999999999999999999996432111 11111000 01111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
. .....+.+++.+|++.+|++||++++++++.+
T Consensus 223 ~----~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 223 G----QFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred C----cCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 1 11245778999999999999999999998854
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.36 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=203.5
Q ss_pred hccccceEEeeeceEEEEEEEecC-C--ceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-S--RPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 690 (943)
++|+..+.||+|+||.||+|..++ + ..+|+|.+.... ....+.+.+|+++++++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998764 3 346888776432 33446788999999999 699999999999999999999
Q ss_pred EEEccCCChhhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCce
Q 002278 691 YDYMVNGSLWDLLHGPS-------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDA 757 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 757 (943)
|||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999986421 123588999999999999999999998 99999999999999999999
Q ss_pred eecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcccc
Q 002278 758 HLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDN 836 (943)
Q Consensus 758 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 836 (943)
||+|||++........ ......+..|+|||+..+..++.++|||||||++|||++ |..||...............
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-- 234 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 234 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--
Confidence 9999999864322111 111123567999999998889999999999999999998 99999765543322221111
Q ss_pred ccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 837 TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
..+..+. .....+.+++.+||..+|.+||++.++++.|..+....
T Consensus 235 -----~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 235 -----YRMEKPR-----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -----CCCCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111111 11246778999999999999999999999998777544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=319.02 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=203.9
Q ss_pred ccccceEEeeeceEEEEEEEecC------CceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 617 NLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
+|+..+.||+|+||.||+|.... ...+|+|.+..... .....+.+|+++++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 36778899999999999998642 24688887764432 334678899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCC---------------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCcc
Q 002278 690 FYDYMVNGSLWDLLHGPS---------------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSN 748 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 748 (943)
++||+.+|+|.+++.... ....+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999875321 123588999999999999999999998 99999999999
Q ss_pred EEECCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHH
Q 002278 749 ILIDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLH 826 (943)
Q Consensus 749 ill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~ 826 (943)
|++++++.+||+|||+++........ ......++..|+|||...+..++.++||||||+++|||+| |+.||.+.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999865332221 1122335678999999988889999999999999999999 999997654333
Q ss_pred HHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 827 QLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.+.. ..... .+.... .....+.+++..|++.+|++||++.++++.|+.+..
T Consensus 238 ~~~~-~~~~~------~~~~~~-----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNL-LKTGY------RMERPE-----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHH-HhCCC------CCCCCC-----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 2222 11111 111111 112467799999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.30 Aligned_cols=261 Identities=22% Similarity=0.244 Sum_probs=201.2
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY----- 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 685 (943)
..++|+..+.||+|+||.||+|.+. .++.||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999875 57889999986543 233456778999999999999999999986543
Q ss_pred -cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 686 -GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 686 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
..++||||+++ ++.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999965 6666664 2478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc-----
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM----- 839 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~----- 839 (943)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+.......+...
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654332 22234689999999999999999999999999999999999999987665444332221111000
Q ss_pred ----------------------cccCcc-cccCc-cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 ----------------------EAVDPE-VSVTC-VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 ----------------------~~~~~~-~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...... ..... ........+.+++.+|++.||++|||+.|+++|-+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 000000 00000 00011245678999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.74 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=206.4
Q ss_pred HhhccccceEEeeeceEEEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPY 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 685 (943)
..++|+..+.||+|+||.||+|..+. ...+|+|.+.... .....++.+|+++++++ +||||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 45678889999999999999998653 3578999886532 23345688999999999 7999999999999999
Q ss_pred cceEEEEEccCCChhhhccCC-------------CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC
Q 002278 686 GNLLFYDYMVNGSLWDLLHGP-------------SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID 752 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 752 (943)
..+++|||+++|+|.++++.. .....+++..++.++.|++.|++|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999999998632 1234689999999999999999999998 999999999999999
Q ss_pred CCCceeecccccccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHH
Q 002278 753 ENFDAHLSDFGIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIM 830 (943)
Q Consensus 753 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 830 (943)
+++.+||+|||+++.+....... .....++..|+|||+..+..++.++|||||||++||+++ |..||......... .
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-K 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH-H
Confidence 99999999999998764332111 111234678999999998899999999999999999998 99999765432222 2
Q ss_pred HhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 831 SKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
....... +..+. .....+.+++.+|++.+|++|||+.++++.|+.+.
T Consensus 246 ~~~~~~~------~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLKEGYR------MEKPQ-----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHcCCc------CCCCC-----CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111110 11111 11246778999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.27 Aligned_cols=253 Identities=22% Similarity=0.276 Sum_probs=199.9
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
|+..+.||+|+||+||+|... .++.||+|++..... .....+.+|+.+++.++|++|+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999976 578999998864322 2234567899999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988532 223589999999999999999999998 999999999999999999999999999976543321
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||..........................
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 227 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK-------- 227 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCcc--------
Confidence 1223589999999999999999999999999999999999999985432111100000000011111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPT-----MQEVARVLV 885 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L~ 885 (943)
....+.+++..||+.||++||| +.|+++|-+
T Consensus 228 -~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 228 -FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred -CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 1235678999999999999999 899988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=317.93 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=203.6
Q ss_pred ccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 617 NLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
.|+..+.||+|+||.||+|.... +..+|+|.+........+.+.+|+++++.++||||+++++++..+...++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36677889999999999999774 66778888865555556778899999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+|+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++........ .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 9999988753 234689999999999999999999999 999999999999999999999999999976533221 1
Q ss_pred eeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 776 STFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
.....|+..|+|||++. +..++.++||||+||++|||++|++||................... ...+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~----- 233 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSR----- 233 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccc-----
Confidence 22345899999999874 4457889999999999999999999998766544433332221110 011111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+.+++..||+.+|++||++.+++++-+
T Consensus 234 ----~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 234 ----WSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred ----cCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 1246778999999999999999999988765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.81 Aligned_cols=250 Identities=20% Similarity=0.257 Sum_probs=212.5
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
+-|...+.||+|.|+.|-+|++- .|.+||||++.+.. ......+.+|++.|+.++|||||++|.+.......|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45666778999999999999864 79999999997654 3345678899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC-CCCceeecccccccccCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DFGla~~~~~~ 771 (943)
.-.+|+|+|++-. ....+.+.-..+++.||+.|+.|+|+. .+|||||||+||.+- .-|-||+.|||++..+..+
T Consensus 98 LGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999863 344589999999999999999999998 999999999998875 5688999999999877654
Q ss_pred CCceeeeEecccceeCccccccCCCC-CcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLN-EKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
. .-+..+|+..|-|||++.|..|+ +++||||+|||||-+++|++||+..++-+.+-.++.-...++..+
T Consensus 173 ~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshv-------- 242 (864)
T KOG4717|consen 173 K--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHV-------- 242 (864)
T ss_pred c--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhh--------
Confidence 3 33456899999999999999887 589999999999999999999998777777666554444333332
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..++.++|..|+..||.+|.+..+++.+-|
T Consensus 243 -----S~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 243 -----SKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred -----hHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 356678999999999999999999998755
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=311.37 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=205.9
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.++|+..+.||+|+||.||+|...++..+|+|.+... ....+.+.+|+++++.++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678889999999999999999877888999987643 2345678899999999999999999999887 7789999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++|+|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998643 234678999999999999999999998 9999999999999999999999999999866443222
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......++..|+|||++.+..++.++|+|||||++|+++| |+.||............ ...... ...+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~--~~~~--------- 226 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRM--PRPE--------- 226 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCCC--CCcc---------
Confidence 2222345678999999998889999999999999999999 99999865443322211 111110 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.....+.+++.+|++.+|++||++.++.+.|..
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 122467799999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=319.97 Aligned_cols=263 Identities=23% Similarity=0.327 Sum_probs=204.0
Q ss_pred hhccccceEEeeeceEEEEEEEecC-----------------CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-----------------SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVS 676 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 676 (943)
.++|+..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678889999999999999998653 2458999886543 234567889999999999999999
Q ss_pred eeeEEecCCcceEEEEEccCCChhhhccCCC--------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCcc
Q 002278 677 LHGYALSPYGNLLFYDYMVNGSLWDLLHGPS--------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSN 748 (943)
Q Consensus 677 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 748 (943)
+++++..++..+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999986422 122689999999999999999999999 99999999999
Q ss_pred EEECCCCceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh--CCCCCCCCccH
Q 002278 749 ILIDENFDAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT--GKKAVDNESNL 825 (943)
Q Consensus 749 ill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~p~~~~~~~ 825 (943)
|+++.++.++|+|||+++....... .......+++.|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986533221 11223346778999999998889999999999999999998 77888755443
Q ss_pred HHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 826 HQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+............ ...... .......+.+++..|++.||++|||+.++++.|.
T Consensus 241 ~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGR--QIYLPR---PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccccccc--cccCCC---ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 332222111000000 000000 0011246889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=313.25 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=202.2
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc---------cHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH---------NLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
+|.....||+|+||.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677789999999999999875 5788999988654321 12467889999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.+++|||+++++|.+++. ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999996 335688999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCC-----ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc
Q 002278 767 CIPTAMP-----HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA 841 (943)
Q Consensus 767 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 841 (943)
....... .......|+..|+|||.+.+..++.++||||+||++|+|++|+.||.............. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-------N 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-------c
Confidence 7642211 111223478899999999988899999999999999999999999987654433322211 1
Q ss_pred cCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 842 VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 842 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
..+.+.. .....+.+++.+||+.||++||++.+++++
T Consensus 228 ~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 ASPEIPS-----NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCCcCCc-----ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1112211 112567789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=312.96 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=205.2
Q ss_pred hhccccceEEeeeceEEEEEEEecC-C---ceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-S---RPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..+|+..+.||+|+||.||+|..+. + ..+|+|++.... ....+.+..|+++++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578888999999999999999763 3 368999886542 3345678899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++++|.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999863 235689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceee--eEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 770 TAMPHAST--FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 770 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
........ ....+..|+|||++.+..++.++|||||||++|||++ |+.||............. .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~------ 231 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPA------ 231 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCC------
Confidence 33222111 1123457999999998889999999999999999998 999997655433222222 1111100
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.. .....+.+++.+||+.+|++||++.++++.|.++
T Consensus 232 ~~-----~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 PM-----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 1225678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=323.56 Aligned_cols=256 Identities=22% Similarity=0.248 Sum_probs=200.9
Q ss_pred hccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+++.+. ++.||+|.+.+.. ......+..|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368889999999999999999764 6778999885421 223345788999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++.. ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999963 234689999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCceeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 772 MPHASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||.................... .+...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~ 233 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--FPAQV 233 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc--CCCcc
Confidence 333333456999999999886 34688999999999999999999999987765554444332221110 11100
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSE--RPTMQEVARVL 884 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~el~~~L 884 (943)
......+.+++++|+..+|++ |+++.++++|-
T Consensus 234 ------~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~ 267 (332)
T cd05623 234 ------TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267 (332)
T ss_pred ------ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence 011245667888877554444 78999999884
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=313.66 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=203.8
Q ss_pred ccccceEEeeeceEEEEEEEecCCceEEEEEecccCc------ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYP------HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
+|+..+.||+|+||+||+|...+++.+|+|.+..... .....+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778889999999999999988889999998864321 1234688899999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++++|.+++. ....+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999986 334688999999999999999999998 999999999999999999999999999976532
Q ss_pred CC-----CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 771 AM-----PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 771 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
.. ........|+..|+|||++.+..++.++||||+||++|+|++|+.||................... ....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 233 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-PRLPDS 233 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-CCCCCC
Confidence 11 111123458899999999999889999999999999999999999998665544333222211111 111111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
....+.+++.+||+.+|++||++.+++++
T Consensus 234 ---------~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 234 ---------FSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ---------CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12467789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=313.41 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=205.2
Q ss_pred hccccceEEeeeceEEEEEEEecCC----ceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNS----RPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
++|...+.||+|+||.||+|.+.+. ..||+|...... ....+.+.+|+++++.++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4678889999999999999986532 468889886554 3445678999999999999999999998875 467899
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999632 33589999999999999999999998 999999999999999999999999999987644
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
..........++..|+|||.+....++.++|||||||++||+++ |+.||.................. ...+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~---- 232 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPN---- 232 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCC----
Confidence 32222222234568999999988889999999999999999986 99999876554433332221111 01111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
....+.+++.+|+..+|++|||+.++++.|..+..
T Consensus 233 -----~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 233 -----CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 12467789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=311.56 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=203.5
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ-YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
+|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999976 5788999988543 2344567888999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++|+|.+++... ....+++..+..++.|++.|++|||+. +|+|+||||+||++++++.++++|||.++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999988532 234578999999999999999999999 9999999999999999999999999999866443222
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||.................. .....
T Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~--------- 223 (255)
T cd08219 157 -ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK---PLPSH--------- 223 (255)
T ss_pred -cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC---CCCcc---------
Confidence 22345889999999999888999999999999999999999999865543332222211111 11111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
....+.+++.+||+.||++||++.+++..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 12356789999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.89 Aligned_cols=254 Identities=29% Similarity=0.383 Sum_probs=202.0
Q ss_pred cccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHH--HHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 618 LSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLR--EFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
|+..+.||+|+||+||+|.... ++.||+|.+......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999999875 568999999766433222 3356999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++++|.+++. ....+++..+..++.|+++||++||+. +|+||||||+||++++++.++|+|||.+...... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TS
T ss_pred cccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cc
Confidence 9999999996 456789999999999999999999999 9999999999999999999999999999864222 22
Q ss_pred eeeeEecccceeCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 775 ASTFVLGTIGYIDPEYAH-TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......++..|+|||++. +..++.++||||+|+++|+|++|..||............................
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 227 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR------ 227 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc------
Confidence 333455899999999998 8889999999999999999999999998762222111111111100000000000
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.....+.+++..|++.||++||++.+++++-
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence 0125788999999999999999999998864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=320.88 Aligned_cols=258 Identities=23% Similarity=0.320 Sum_probs=202.9
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
++|+..+.||+|+||.||+|.+. ++..+|+|.+.... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999976 46778888775432 23345688999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++. ....+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 99999999996 3356899999999999999999999732 89999999999999999999999999987653321
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc-ccc------------
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT-VME------------ 840 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~------------ 840 (943)
.....|+..|+|||+..+..++.++|||||||++|||++|+.||....... .......... ...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCCCC
Confidence 123458899999999988889999999999999999999999997544222 1111111000 000
Q ss_pred -----------------ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 841 -----------------AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 841 -----------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...|..+. ......+.+++.+|+..+|++|||+.+++++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPS----GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcC----cccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00011110 0122457899999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=319.66 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=203.8
Q ss_pred ccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCC
Q 002278 619 SEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNG 697 (943)
Q Consensus 619 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 697 (943)
.....||+|+||.||++... ++..||+|++........+.+.+|+.+++.++||||+++++.+..++..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33456999999999999875 57889999986555555667889999999999999999999999999999999999999
Q ss_pred ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceee
Q 002278 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777 (943)
Q Consensus 698 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 777 (943)
+|.+++. ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++......... ..
T Consensus 105 ~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~ 176 (292)
T cd06658 105 ALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RK 176 (292)
T ss_pred cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cc
Confidence 9999885 23588999999999999999999999 9999999999999999999999999999765433222 23
Q ss_pred eEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHH
Q 002278 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVR 857 (943)
Q Consensus 778 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (943)
...|+..|+|||...+..++.++|||||||++|||++|+.||............... ..+.+... .....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~---~~~~~ 246 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-------LPPRVKDS---HKVSS 246 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------CCCccccc---cccCH
Confidence 346899999999999888999999999999999999999999876554332221111 11111100 01123
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 858 KTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 858 ~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.+.+++..|+..||++|||+.+++++-+-..
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 5678999999999999999999999855433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=310.11 Aligned_cols=246 Identities=21% Similarity=0.326 Sum_probs=195.3
Q ss_pred EeeeceEEEEEEEec---CCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 624 VGYGASSTVYKCALK---NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
||+|+||.||+|.++ .+..||+|.+..... ...+.+.+|++++++++||||+++++++.. +..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999865 345689998865432 234568899999999999999999998854 578999999999999
Q ss_pred hhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee--e
Q 002278 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS--T 777 (943)
Q Consensus 700 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~--~ 777 (943)
.+++.. ....+++.++++++.|++.|++|||++ +++||||||+||+++.++.+||+|||+++.......... .
T Consensus 82 ~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 82 NKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999863 234689999999999999999999999 999999999999999999999999999986543322111 1
Q ss_pred eEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 778 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
...++..|+|||.+.+..++.++|||||||++||+++ |+.||.+............... +..+. ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~-----~~~ 224 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-------LDCPA-----ECP 224 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-------CCCCC-----CCC
Confidence 1123578999999988889999999999999999996 9999986654332222211111 11111 112
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 857 RKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
..+.+++..||..+|++||++.++.+.|+.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 5677899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=312.26 Aligned_cols=255 Identities=23% Similarity=0.344 Sum_probs=208.4
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|+..+.||+|+||.||+|... +++.+|+|.+........+.+.+|+++++.++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888999999999999999975 4678999998766555677899999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999998863 225689999999999999999999998 999999999999999999999999999986643221
Q ss_pred ceeeeEecccceeCccccccC---CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 774 HASTFVLGTIGYIDPEYAHTS---RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
......++..|+|||...+. .++.++|||||||++|||+||+.||................... +...
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~--- 227 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-----PKLK--- 227 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----cccc---
Confidence 12234588899999998876 78999999999999999999999998765444333222211110 0000
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
........+.+++.+||..+|++|||+.+++.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011233567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=317.88 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=206.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPY 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 685 (943)
..++|...+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467889999999999999999752 24579999886543 23345788999999999 7999999999999999
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..+++|||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.++++|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999986422 23489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccC
Q 002278 766 RCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 766 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+........ ......++..|+|||.+.+..++.++||||+||++|||++ |+.||................... ...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 266 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--AQP 266 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--CCC
Confidence 866433211 1112235678999999999899999999999999999998 999997655433332222111110 000
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
+ .....+.+++.+|+.++|++|||+.++++.|...
T Consensus 267 ~---------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 267 E---------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C---------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 1124678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=315.86 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=204.7
Q ss_pred HhhccccceEEeeeceEEEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
..++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999997542 4579999875433 2234467889999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCC-------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 687 NLLFYDYMVNGSLWDLLHGPS-------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
.++||||+++|+|.+++.... .....++..+..++.|++.||+|||++ +|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996321 123457788899999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccc
Q 002278 760 SDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNT 837 (943)
Q Consensus 760 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 837 (943)
+|||+++........ ......++..|+|||...+..++.++|||||||++|||++ |..||.+..... ..........
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~ 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-VLKFVMDGGY 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCC
Confidence 999999865332211 1112235678999999998899999999999999999999 788987644322 2222111111
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
. .... .....+.+++..|++.||++|||+.++++.++....
T Consensus 240 ~------~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 240 L------DQPD-----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred C------CCCC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 0 0110 112467899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=314.28 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=203.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCc----eEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSR----PIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..+|+..+.||+|+||+||+|.+. +++ +||+|.+.... ....+.+.+|+.+++.+.||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 457888899999999999999864 333 48999886543 33456788999999999999999999999754 578
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+++||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999863 234689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 769 PTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 769 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
....... .....++..|+|||...+..++.++|||||||++|||++ |..||......... .......... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~--~~~-- 234 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLP--QPP-- 234 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCC--CCc--
Confidence 4332211 111224678999999998899999999999999999998 99999765432211 1111111110 011
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
.....+.+++..||+.||++||++.++++.+..+...
T Consensus 235 -------~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 235 -------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred -------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1124677899999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=312.07 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=204.2
Q ss_pred hccccceEEeeeceEEEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN----SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.+|+..+.||+|+||.||+|.++. +..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578888999999999999998652 3368999886543 23456788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998632 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeee--EecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 771 AMPHASTF--VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 771 ~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
........ ..++..|+|||++.+..++.++|+|||||++||+++ |+.||............. ...... ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~------~~ 231 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLP------AP 231 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCC------CC
Confidence 32222111 123568999999998899999999999999999887 999997654433222221 111110 01
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
. .....+.+++.+|++.+|++||++.++++.|..+
T Consensus 232 ~-----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 232 M-----DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C-----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 1124667899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=315.36 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=204.9
Q ss_pred hhccccceEEeeeceEEEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.++|+..+.||+|+||.||+|..+. +..||+|.+.... ......+.+|+++++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678889999999999999998753 3679999986443 23345788999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCC-------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeec
Q 002278 688 LLFYDYMVNGSLWDLLHGPSK-------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLS 760 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 760 (943)
++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999864221 23478899999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcccccc
Q 002278 761 DFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTV 838 (943)
Q Consensus 761 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 838 (943)
|||+++....... .......++..|+|||.+.+..++.++|||||||++||++| |+.||............. ... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~-~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG-H 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC-C
Confidence 9999986543321 11222346789999999988889999999999999999998 999997654433222221 111 1
Q ss_pred ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+..+.. ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 240 -----~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 -----LDLPEN-----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -----CCCCCC-----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111 1356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=319.62 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=207.4
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
...+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 3468889999999999999999964 688999999876555556778899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++++|.+++. ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999985 24578999999999999999999999 99999999999999999999999999998654332
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.. .....|++.|+|||...+..++.++|||||||++|++++|+.||................ .+.... .
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-------~~~~~~---~ 238 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-------TPELQN---P 238 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-------CCCCCC---c
Confidence 21 223458899999999999889999999999999999999999997655432221111110 001000 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
......+.+++.+||+.+|++||++.+++++-+
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 011245678999999999999999999999744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=321.86 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=203.9
Q ss_pred hhccccceEEeeeceEEEEEEEecC-Cc--eEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SR--PIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 689 (943)
.++|+..+.||+|+||.||+|.++. +. .+|+|++.... ......+.+|++++.++ +||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 4678888999999999999999753 43 45777765432 23445788999999999 89999999999999999999
Q ss_pred EEEEccCCChhhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc
Q 002278 690 FYDYMVNGSLWDLLHGPS-------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 756 (943)
||||+++|+|.+++.... ....+++.+++.++.|++.|++|||+. +++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 999999999999986422 123588999999999999999999999 9999999999999999999
Q ss_pred eeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccc
Q 002278 757 AHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADD 835 (943)
Q Consensus 757 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 835 (943)
+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |..||........... ....
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQG 239 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH-HhcC
Confidence 9999999986432111 1111224668999999988889999999999999999998 9999976543322211 1111
Q ss_pred cccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 836 NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
..+.... .....+.+++.+||+.+|++||++.++++.++.+.....
T Consensus 240 ------~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 240 ------YRLEKPL-----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ------CcCCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 0111111 112456789999999999999999999999987665443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.39 Aligned_cols=256 Identities=22% Similarity=0.338 Sum_probs=202.0
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
++|+..+.||+|+||.||+|.++ .++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999976 68899999886432 33346788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|..++........+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||.+..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 999999998874333447899999999999999999999632 899999999999999999999999999976533221
Q ss_pred ceeeeEecccceeCccccccCC------CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 774 HASTFVLGTIGYIDPEYAHTSR------LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
....|++.|+|||.+.+.. ++.++||||+||++|||++|+.||......................+.+.
T Consensus 159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 233 (286)
T cd06622 159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG-- 233 (286)
T ss_pred ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc--
Confidence 2234788999999886543 57899999999999999999999975433221111110000111111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+.+++.+|+..+|++||++.+++.+-+
T Consensus 234 -------~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 234 -------YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred -------cCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 2256678999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=318.25 Aligned_cols=259 Identities=23% Similarity=0.350 Sum_probs=200.6
Q ss_pred hhccccceEEeeeceEEEEEEEecC---------------CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceee
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN---------------SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLH 678 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~ 678 (943)
.++|+..+.||+|+||.||+|.... ...||+|++.... ......+.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999987642 2348999886542 23345788999999999999999999
Q ss_pred eEEecCCcceEEEEEccCCChhhhccCCC---------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccE
Q 002278 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPS---------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNI 749 (943)
Q Consensus 679 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 749 (943)
+++......++||||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999885321 112478899999999999999999999 999999999999
Q ss_pred EECCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh--CCCCCCCCccHH
Q 002278 750 LIDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT--GKKAVDNESNLH 826 (943)
Q Consensus 750 ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~p~~~~~~~~ 826 (943)
++++++.+||+|||++......... ......++..|+|||+..+..++.++|||||||++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765432211 1122335678999999998889999999999999999998 667887544322
Q ss_pred HHHHHhc---cc-cccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 827 QLIMSKA---DD-NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 827 ~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....... .. ........+. ....+.+++.+|++.+|++||++.++++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPL---------CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCC---------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111110 00 0000001111 1247889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=322.67 Aligned_cols=195 Identities=26% Similarity=0.398 Sum_probs=159.6
Q ss_pred ceEEeeeceEEEEEEEec---CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEec--CCcceEEEEEcc
Q 002278 621 KYIVGYGASSTVYKCALK---NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS--PYGNLLFYDYMV 695 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 695 (943)
...||+|+||+||+|..+ .++.||+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999865 45789999886432 23567889999999999999999999864 345789999985
Q ss_pred CCChhhhccCCC------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE----CCCCceeecccccc
Q 002278 696 NGSLWDLLHGPS------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI----DENFDAHLSDFGIA 765 (943)
Q Consensus 696 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DFGla 765 (943)
++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58877764211 223588999999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCCCc--eeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 002278 766 RCIPTAMPH--ASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDN 821 (943)
Q Consensus 766 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~ 821 (943)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876443211 1233568999999999877 4589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=318.70 Aligned_cols=261 Identities=23% Similarity=0.380 Sum_probs=207.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec--------CCceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEec
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK--------NSRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALS 683 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 683 (943)
..++|...+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4567888999999999999999742 23478999886432 33456788999999999 79999999999999
Q ss_pred CCcceEEEEEccCCChhhhccCCCC-------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEE
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGPSK-------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNIL 750 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 750 (943)
....+++|||+++|+|.+++..... ...+++.++..++.|++.||+|||+. +++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999864321 23578899999999999999999999 9999999999999
Q ss_pred ECCCCceeecccccccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHH
Q 002278 751 IDENFDAHLSDFGIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQL 828 (943)
Q Consensus 751 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~ 828 (943)
+++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||..... ..+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~ 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EEL 248 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-HHH
Confidence 9999999999999998764332221 122235678999999998889999999999999999998 7888875543 233
Q ss_pred HHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.......... .... .....+.+++.+||+.+|++||++.++++.|..+..
T Consensus 249 ~~~~~~~~~~------~~~~-----~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 249 FKLLKEGHRM------DKPA-----NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHcCCcC------CCCC-----CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 2222211111 0110 122567789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=316.41 Aligned_cols=255 Identities=22% Similarity=0.282 Sum_probs=204.8
Q ss_pred hhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.+.|++.+.||+|+||.||+|.... ++.||+|.+........+.+.+|+++++.++||||+++++++..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3678899999999999999999764 788999998766555667788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|..++.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 999999887753 234589999999999999999999998 99999999999999999999999999987543322
Q ss_pred ceeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 774 HASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
.......+++.|+|||++. ...++.++|||||||++|||++|+.||................. +....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~ 237 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-------PTLSQ 237 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC-------ccCCC
Confidence 1223345889999999885 34568899999999999999999999976554332222211111 11100
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.......+.+++.+||+.+|++||++.+++++-+
T Consensus 238 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 238 ---PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred ---CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0011245778999999999999999999988643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=315.51 Aligned_cols=242 Identities=22% Similarity=0.267 Sum_probs=191.4
Q ss_pred EeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 624 VGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
||+|+||.||++..+ +++.||+|++.... ......+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999976 58899999986432 12234456799999999999999999999999999999999999999
Q ss_pred hhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeE
Q 002278 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV 779 (943)
Q Consensus 700 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 779 (943)
.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 9887532 233588999999999999999999999 99999999999999999999999999998764432 22234
Q ss_pred ecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccH---HHHHHHhccccccccccCcccccCccCHHHH
Q 002278 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL---HQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 780 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
.|+..|+|||++.+..++.++||||+||++|||++|+.||...... .......... ... ... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~--~~~----~~~~ 223 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-----EVK--FEH----QNFT 223 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-----ccc--ccc----ccCC
Confidence 5899999999999988999999999999999999999999754321 1111111110 000 000 0112
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHH
Q 002278 857 RKTFQLALLCTKRYPSERPTMQEVAR 882 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~el~~ 882 (943)
..+.+++..|++.||++||++.|+++
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchh
Confidence 45679999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=320.53 Aligned_cols=264 Identities=21% Similarity=0.261 Sum_probs=202.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|...+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|+++++.++||||+++++++..+...++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357889999999999999999976 57889999886433 3334567789999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 85 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 996 588888763 234588999999999999999999999 99999999999999999999999999997653322
Q ss_pred CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC--------
Q 002278 773 PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD-------- 843 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 843 (943)
.. .....+++.|+|||++.+ ..++.++|||||||++|||+||++||...+....+..............+
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 11 122347889999998865 45788999999999999999999999876544333222211111111110
Q ss_pred ------cccccCcc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 844 ------PEVSVTCV---DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 844 ------~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.....+. .......+.+++.+|++.||.+|||++|+++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 11100000 0011245678999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.41 Aligned_cols=261 Identities=24% Similarity=0.264 Sum_probs=200.1
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecC-----
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSP----- 684 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 684 (943)
...++|+..+.||+|+||+||+|... +++.||||++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 35678999999999999999999975 578899999865322 2345677899999999999999999987543
Q ss_pred -CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 685 -YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 685 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
...+++++++ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3458889987 889988874 34689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 842 (943)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..............+......
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99865432 123458999999999877 5689999999999999999999999986654433332221111110000
Q ss_pred C---------------cccccCcc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 843 D---------------PEVSVTCV---DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 843 ~---------------~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
. +....... .......+.+++.+|++.||++|||+.|+++|-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0 00000000 0001134678999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=315.27 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=202.0
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEecC------
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALSP------ 684 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 684 (943)
.+.+.|+..+.||+|+||.||+|... .++.||+|.+... ......+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888899999999999999976 4678899988543 34456788999999998 699999999998753
Q ss_pred CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
...+++|||+++|+|.+++... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 3478999999999999998742 234689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM 839 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 839 (943)
++....... ......|+..|+|||++. +..++.++||||+||++|||++|+.||............... ...
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~ 234 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--PAP 234 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC--CCC
Confidence 986543322 223345899999999886 345788999999999999999999999765544333322111 111
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
..... .....+.+++.+||..+|.+|||+.+++++
T Consensus 235 ~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 235 RLKSK---------KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCC---------CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11111 112467789999999999999999999886
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=317.65 Aligned_cols=262 Identities=24% Similarity=0.362 Sum_probs=201.2
Q ss_pred hhccccceEEeeeceEEEEEEEecC-----------------CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-----------------SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVS 676 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 676 (943)
.++|+..+.||+|+||.||+|...+ ...||+|++.... ......+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3578999999999999999986432 3468999886543 334467889999999999999999
Q ss_pred eeeEEecCCcceEEEEEccCCChhhhccCCC--------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCcc
Q 002278 677 LHGYALSPYGNLLFYDYMVNGSLWDLLHGPS--------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSN 748 (943)
Q Consensus 677 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 748 (943)
+++++..++..+++|||+++|+|.+++.... ....+++.++..++.|++.|++|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 9999999999999999999999999986422 113477889999999999999999999 99999999999
Q ss_pred EEECCCCceeecccccccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh--CCCCCCCCccH
Q 002278 749 ILIDENFDAHLSDFGIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT--GKKAVDNESNL 825 (943)
Q Consensus 749 ill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~p~~~~~~~ 825 (943)
|++++++.++|+|||+++.+....... .....++..|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999998654332111 112234678999999888889999999999999999998 77888754433
Q ss_pred HHHHHHhccc-cccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 826 HQLIMSKADD-NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 826 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.......... ........+. .. .....+.+++.+||+.||++||++.++.+.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPK-PA-----LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhhccccccCCC-CC-----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2221110000 0000000010 00 11256789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=341.69 Aligned_cols=264 Identities=19% Similarity=0.215 Sum_probs=198.6
Q ss_pred HHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCC------CCcceeeeEEe
Q 002278 610 DIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRH------RNIVSLHGYAL 682 (943)
Q Consensus 610 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~ 682 (943)
++....++|++.+.||+|+||+||+|.+. .++.||||++... .........|+++++.++| ++++.+++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445788999999999999999999976 4678999998643 2233455667777776654 45889999887
Q ss_pred cC-CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCC-----
Q 002278 683 SP-YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENF----- 755 (943)
Q Consensus 683 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~----- 755 (943)
.. ...++|||++ +++|.+++. ....+++..+..++.||+.||+|||+ . +||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccc
Confidence 65 4578888887 788988886 34568999999999999999999997 5 999999999999998665
Q ss_pred -----------ceeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc
Q 002278 756 -----------DAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN 824 (943)
Q Consensus 756 -----------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~ 824 (943)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998864322 22345699999999999999999999999999999999999999987766
Q ss_pred HHHHHHHhccccccccccC-------------------ccccc----------CccCHHHHHHHHHHHHHccCCCCCCCC
Q 002278 825 LHQLIMSKADDNTVMEAVD-------------------PEVSV----------TCVDLSAVRKTFQLALLCTKRYPSERP 875 (943)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~-------------------~~~~~----------~~~~~~~~~~l~~l~~~cl~~dP~~RP 875 (943)
...+.......+.++..+. +.... ..........+.+++..||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 5444333222221111100 00000 000001124567999999999999999
Q ss_pred CHHHHHHHHh
Q 002278 876 TMQEVARVLV 885 (943)
Q Consensus 876 t~~el~~~L~ 885 (943)
|+.|+++|-+
T Consensus 431 ta~e~L~Hp~ 440 (467)
T PTZ00284 431 NARQMTTHPY 440 (467)
T ss_pred CHHHHhcCcc
Confidence 9999999855
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=313.07 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=200.8
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
+++++.....||+|+||.||+|.+. ++..||+|.+........+.+.+|+++++.++|+||+++++++..++..++++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 4566666778999999999999966 467899998876655566789999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccC--CHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-CCceeecccccccccC
Q 002278 693 YMVNGSLWDLLHGPSKKVKL--DWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-NFDAHLSDFGIARCIP 769 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFGla~~~~ 769 (943)
|+++++|.+++... ...+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|||.+....
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 86 QVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred cCCCCCHHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999998632 1234 7888899999999999999999 9999999999999976 6799999999997654
Q ss_pred CCCCceeeeEecccceeCccccccCC--CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSR--LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
..... .....|++.|+|||++.+.. ++.++||||+|+++|+|++|+.||............... . ...+.++
T Consensus 161 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~-~----~~~~~~~ 234 (268)
T cd06624 161 GINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM-F----KIHPEIP 234 (268)
T ss_pred cCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh-h----ccCCCCC
Confidence 32221 22234789999999987643 788999999999999999999999754332211111100 0 0111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
. .....+.+++.+||+.+|++|||+.+++++
T Consensus 235 ~-----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 E-----SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred c-----ccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1 112457789999999999999999999887
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=317.99 Aligned_cols=260 Identities=24% Similarity=0.223 Sum_probs=195.1
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcC---CCCCcceeeeEEecC-----C
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSI---RHRNIVSLHGYALSP-----Y 685 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 685 (943)
+|+..+.||+|+||+||+|.++ +++.||+|.+.... ......+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999976 57889999886432 22234556677776655 699999999998643 3
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..+++|||++ ++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 4689999997 5888887643 234589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc-----ccc
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT-----VME 840 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-----~~~ 840 (943)
+....... .....|+..|+|||++.+..++.++||||+||++|||++|++||.................. ...
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 87643321 22345899999999999999999999999999999999999999766544333222211100 000
Q ss_pred c-------cCcccccCc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 841 A-------VDPEVSVTC--VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 841 ~-------~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
. ..+...... ........+.+++.+|++.||++|||+.+++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000000 000122456789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=321.01 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=205.8
Q ss_pred hhccccceEEeeeceEEEEEEEecC--------CceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecC
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN--------SRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSP 684 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 684 (943)
.++|.+.+.||+|+||.||+|.... ...+|+|.+.... .....++.+|+++++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4678999999999999999998532 2469999886542 23445688899999999 799999999999999
Q ss_pred CcceEEEEEccCCChhhhccCCCC-------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSK-------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI 751 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 751 (943)
+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999964321 23588999999999999999999998 99999999999999
Q ss_pred CCCCceeecccccccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHH
Q 002278 752 DENFDAHLSDFGIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLI 829 (943)
Q Consensus 752 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~ 829 (943)
+.++.+||+|||.++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.... .....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-HHHHH
Confidence 999999999999997654321111 111224568999999998889999999999999999998 888886543 33333
Q ss_pred HHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 830 MSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
........ ...+. .....+.+++..|++.+|++||++.++++.|..+.+.
T Consensus 253 ~~~~~~~~------~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 253 KLLKEGHR------MDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHcCCC------CCCCC-----cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 32222111 01110 1124677899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.99 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=204.0
Q ss_pred hccccceEEeeeceEEEEEEEecC------CceEEEEEecccCcc-cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
++|+....||+|+||.||+|+.+. .+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578889999999999999999652 456888887654333 3567899999999999999999999999988999
Q ss_pred EEEEEccCCChhhhccCCCCC------ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKK------VKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDF 762 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DF 762 (943)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643311 2689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccc
Q 002278 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEA 841 (943)
Q Consensus 763 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 841 (943)
|+++..............++..|+|||.+.+..++.++||||||+++|+|++ |..||.................. ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~--~~ 239 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE--LP 239 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC--CC
Confidence 9987553322222223346788999999988889999999999999999999 88898754433222221111111 10
Q ss_pred cCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 842 VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 842 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
... .....+.+++.+|++.+|++||++.++++.+.
T Consensus 240 ~~~---------~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 VPE---------GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCC---------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111 11246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.97 Aligned_cols=262 Identities=25% Similarity=0.395 Sum_probs=198.9
Q ss_pred cccceEEeeeceEEEEEEEe-----cCCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--CcceE
Q 002278 618 LSEKYIVGYGASSTVYKCAL-----KNSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGNLL 689 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 689 (943)
|+..+.||+|+||+||.+.. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 246789999886543 23456788999999999999999999988654 35789
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
+|||+++|+|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999852 3589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCce--eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccH-HHHHHHhccc---cccccccC
Q 002278 770 TAMPHA--STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL-HQLIMSKADD---NTVMEAVD 843 (943)
Q Consensus 770 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~-~~~~~~~~~~---~~~~~~~~ 843 (943)
...... .....++..|+|||...+..++.++||||||+++|||+||+.||...... .......... ....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 332111 11123566799999999888999999999999999999999998643321 1111000000 00000000
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
....... .......+.+++..||+.+|++|||++++++.|+.+
T Consensus 239 ~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPC-PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCC-CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 0000000 011235788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.61 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=197.5
Q ss_pred eEEeeeceEEEEEEEecC----CceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALKN----SRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||.||+|.... +..+|+|.+..... ...+++.+|+++++.+.||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 368999999999998542 26799998875543 34567889999999999999999999876 4567999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999973 33689999999999999999999998 999999999999999999999999999987644322211
Q ss_pred --eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 777 --TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 777 --~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
....++..|+|||...+..++.++|||||||++|||++ |+.||............. ..... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~--~~~~--------- 221 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERL--PRPE--------- 221 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcC--CCCC---------
Confidence 11223568999999998899999999999999999998 999998665433222221 11110 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.....+.+++.+|+..+|++||++.++++.|+.+.
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11246779999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.46 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=206.4
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|+||.||.++.. +++.+++|++.... .....++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999865 57889999875432 44456788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999987432 35689999999999999999999998 999999999999999999999999999987644432
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......|++.|+|||...+..++.++||||||+++|||++|+.||.................. . ..+
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~-~~~--------- 223 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT--P-VVS--------- 223 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--C-Ccc---------
Confidence 222345899999999999888999999999999999999999999865544333332221111 1 011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.....+.+++..|+..+|++||++.++++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1124677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.24 Aligned_cols=264 Identities=27% Similarity=0.425 Sum_probs=201.1
Q ss_pred hccccceEEeeeceEEEEEEEec-----CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Ccce
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-----NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP--YGNL 688 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 688 (943)
..|+..+.||+|+||+||+|..+ .++.||+|++........+.+.+|+++++.++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788899999999999999743 4788999998766555567889999999999999999999987543 4578
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998632 34589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcee--eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc-------cc
Q 002278 769 PTAMPHAS--TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT-------VM 839 (943)
Q Consensus 769 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-------~~ 839 (943)
........ ....++..|+|||+..+..++.++|||||||++|||++|..|+...... +......... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hhhhcccccccccchHHHH
Confidence 44322111 1112345699999999888999999999999999999988776533211 1111000000 00
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
+......... ........+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000000 0011224678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.89 Aligned_cols=250 Identities=25% Similarity=0.405 Sum_probs=205.4
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.++|+..+.||+|+||.||+|... ++.||+|++..... ..+++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888899999999999999876 78899999976543 4678899999999999999999999999988999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999986432 23689999999999999999999999 999999999999999999999999999987633221
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
...++..|+|||++.+..++.++||||||+++||+++ |+.||....... .......... +....
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~~~~------~~~~~----- 222 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPHVEKGYR------MEAPE----- 222 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHhcCCC------CCCcc-----
Confidence 2234678999999998889999999999999999997 999997654322 2222111111 11110
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
..+..+.+++.+|+..+|++||++.++++.|..
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 112567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.22 Aligned_cols=252 Identities=20% Similarity=0.319 Sum_probs=192.1
Q ss_pred EEeeeceEEEEEEEecC---CceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCC
Q 002278 623 IVGYGASSTVYKCALKN---SRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGS 698 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 698 (943)
.||+|+||.||+|...+ +..+|+|++..... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998653 35789998865432 234578889999999999999999999999999999999999999
Q ss_pred hhhhccCCC--CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce-
Q 002278 699 LWDLLHGPS--KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA- 775 (943)
Q Consensus 699 L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~- 775 (943)
|.+++.... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999986422 223467788889999999999999999 99999999999999999999999999997543322111
Q ss_pred eeeEecccceeCccccccC-------CCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 776 STFVLGTIGYIDPEYAHTS-------RLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
.....|+..|+|||++.+. .++.++|||||||++|||++ |+.||................ ......+.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ--QLKLPKPRLK 236 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc--cCCCCCCccC
Confidence 1223467889999988642 35789999999999999996 999997655443322211111 1111112221
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.. ....+.+++..|| .+|++|||+++|.+.|.
T Consensus 237 ~~-----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 237 LP-----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CC-----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 1235667899999 58999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=295.92 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=208.3
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc---cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH---NLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..++|...+++|+|.||.|-.++.+ .++.+|+|++++..-- ..+.-..|-++++..+||.+..+.-.|+..+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4567888999999999999999977 5788999998766432 23345578999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+.||.|.-++. ....+++....-+...|+.||.|||++ +||+||+|.+|.|+|.+|++||+|||+++.--
T Consensus 246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999987 345688888888999999999999999 99999999999999999999999999998532
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
. ........+|||.|.|||++....|+.++|.|.+||++|||++|+.||.+.+.-.....+...+-.++..+.|+
T Consensus 320 ~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~e---- 394 (516)
T KOG0690|consen 320 K-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPE---- 394 (516)
T ss_pred c-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHH----
Confidence 2 23345567899999999999999999999999999999999999999997765444444444444554444332
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARV 883 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~ 883 (943)
...++...+.+||.+|- .+.|+.++
T Consensus 395 ---------AktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 395 ---------AKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ---------HHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 23678888999999995 57777665
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.59 Aligned_cols=247 Identities=27% Similarity=0.419 Sum_probs=199.5
Q ss_pred EEeeeceEEEEEEEecC--C--ceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCC
Q 002278 623 IVGYGASSTVYKCALKN--S--RPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNG 697 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 697 (943)
.||+|++|.||+|.+.. + ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 58999999999998753 2 3689999876655 556788999999999999999999999988 8889999999999
Q ss_pred ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce--
Q 002278 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA-- 775 (943)
Q Consensus 698 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~-- 775 (943)
+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 81 SLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999874322 4689999999999999999999999 99999999999999999999999999998764432211
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||................... . .+. .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~--~~~--------~ 225 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL-E--RPE--------A 225 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC-C--CCc--------c
Confidence 112346789999999999899999999999999999999 999997654433222221111100 0 000 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.+..+.+++.+|++.+|++||++.++++.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 2256788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.89 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=202.8
Q ss_pred hccccceEEeeeceEEEEEEEecC-C---ceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-S---RPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
..|+..+.||+|+||.||+|..+. + ..||+|.+.... ....+++..|+++++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457788999999999999999763 2 359999886542 33456889999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998642 34689999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCcee--eeEe--cccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 771 AMPHAS--TFVL--GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 771 ~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
...... .... .+..|+|||++.+..++.++||||+||++||+++ |..||............ ......+. .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~--~~- 234 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPP--PM- 234 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCC--cc-
Confidence 322111 1111 2457999999999999999999999999999887 99999765543222221 11111100 01
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
..+..+.+++..||..+|++||++.+++..|+.+
T Consensus 235 --------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 235 --------DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1124567899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=315.66 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=206.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|++.+.||+|+||.||+|.++ ++..||+|.+........+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888999999999999999975 5788999998765555567788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++.. ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999999863 234689999999999999999999999 999999999999999999999999999876543322
Q ss_pred ceeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 774 HASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
. .....|++.|+|||++. +..++.++|||||||++|||++|+.||................. +.+..
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~ 230 (280)
T cd06611 159 K-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-------PTLDQ 230 (280)
T ss_pred c-cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC-------CCcCC
Confidence 2 23345899999999875 34577899999999999999999999987654433322221111 11100
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
. ......+.+++..||+.+|++||++.+++++-+
T Consensus 231 ~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 231 P---SKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred c---ccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 0 011245678999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.65 Aligned_cols=243 Identities=22% Similarity=0.230 Sum_probs=191.0
Q ss_pred EeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC---CCCCcceeeeEEecCCcceEEEEEccC
Q 002278 624 VGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI---RHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
||+|+||+||+|+.+ +++.||+|++.... ......+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999976 57899999985432 12223445566666655 699999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 99999886 345689999999999999999999999 999999999999999999999999999975432222 22
Q ss_pred eeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHH
Q 002278 777 TFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (943)
....||+.|+|||++.+. .++.++||||+||++|||+||+.||........+.........+... . .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~---------~ 221 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---V---------L 221 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc---c---------C
Confidence 335699999999998764 48999999999999999999999998765443332222221111110 0 1
Q ss_pred HHHHHHHHHHccCCCCCCCC----CHHHHHHHHh
Q 002278 856 VRKTFQLALLCTKRYPSERP----TMQEVARVLV 885 (943)
Q Consensus 856 ~~~l~~l~~~cl~~dP~~RP----t~~el~~~L~ 885 (943)
...+.+++.+|++.||++|| ++.++++|-+
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 23566899999999999998 6778777643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=313.42 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=205.6
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
+|+..+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 6778889999999999999976 57889999886443 344567889999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 99999999863 2789999999999999999999998 9999999999999999999999999999877544222
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.....|++.|+|||+..+..++.++|||||||++|||+||+.||............... ..+.+... .
T Consensus 155 -~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~----~ 222 (274)
T cd06609 155 -RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-------NPPSLEGN----K 222 (274)
T ss_pred -cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-------CCCCCccc----c
Confidence 22345888999999999988999999999999999999999999765543322221111 11111111 0
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+.+++..|+..+|++|||+++++++-+
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~ 253 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence 2245778999999999999999999998744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=311.51 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=206.3
Q ss_pred hhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|+..+.||+|+||.||+|..+. ++.||+|.+..... .+.+.+|+++++.++||||+++++++.++...++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578888999999999999999875 78899998865422 67899999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++.. ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999863 235689999999999999999999999 999999999999999999999999999987654322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||................ .+.... ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~---~~ 223 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP-------PPTLSD---PE 223 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC-------CCCCCc---hh
Confidence 2233458899999999998899999999999999999999999998655433222111100 011110 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.....+.+++.+|++.+|++|||+.+++++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 122467889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.79 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=200.3
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEe-cCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL-SPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~ 693 (943)
.++|+..+.||+|+||.||+|..+ +..||+|.+... ...+.+.+|+.++++++|+|++++++++. .+...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 457888999999999999999776 778999988543 33567889999999999999999999865 44568999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+|++|||+++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 9999999998643 223588999999999999999999999 999999999999999999999999999976533221
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
...++..|+|||+..+..++.++|||||||++|||++ |+.||..... ............ +....
T Consensus 158 ----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~~~~------~~~~~---- 222 (256)
T cd05082 158 ----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYK------MDAPD---- 222 (256)
T ss_pred ----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCCC------CCCCC----
Confidence 1234678999999998899999999999999999998 9999975433 222222211111 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.....+.+++.+|++.+|++|||+.++++.|+.
T Consensus 223 -~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 -GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112467789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=324.52 Aligned_cols=261 Identities=26% Similarity=0.346 Sum_probs=202.2
Q ss_pred hhccccceEEeeeceEEEEEEEe------cCCceEEEEEecccCc-ccHHHHHHHHHHHhcC-CCCCcceeeeEEecC-C
Q 002278 615 TENLSEKYIVGYGASSTVYKCAL------KNSRPIAVKKLYNQYP-HNLREFETELETIGSI-RHRNIVSLHGYALSP-Y 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 685 (943)
.++|+..+.||+|+||.||+|.+ ..++.||||++..... .....+.+|+.+++++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45789999999999999999974 2467899999865432 2345688999999999 689999999988654 4
Q ss_pred cceEEEEEccCCChhhhccCCCC---------------------------------------------------------
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSK--------------------------------------------------------- 708 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 708 (943)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 56899999999999998853210
Q ss_pred -------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc-eeeeEe
Q 002278 709 -------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH-ASTFVL 780 (943)
Q Consensus 709 -------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~ 780 (943)
...+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12468888999999999999999999 9999999999999999999999999999865322111 111223
Q ss_pred cccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHH
Q 002278 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKT 859 (943)
Q Consensus 781 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 859 (943)
++..|+|||.+.+..++.++||||||+++|||++ |..||.................. +..+.. ....+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~-----~~~~~ 311 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------MRAPDY-----TTPEM 311 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC------CCCCCC-----CCHHH
Confidence 5678999999998899999999999999999997 99999765432222222211111 011100 11357
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 860 FQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 860 ~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.+++..||+.+|++|||+.+++++|+.+..
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.79 Aligned_cols=249 Identities=29% Similarity=0.415 Sum_probs=202.8
Q ss_pred eEEeeeceEEEEEEEecC----CceEEEEEecccCcc-cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALKN----SRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|+++++.++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999999764 788999998755433 367889999999999999999999999999999999999999
Q ss_pred CChhhhccCCCC------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 697 GSLWDLLHGPSK------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 697 g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
++|.+++..... ...+++..+..++.|++.|++|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999975321 36789999999999999999999998 999999999999999999999999999987754
Q ss_pred CCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 771 AMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 771 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
... .......++..|+|||.+.+..++.++||||+||++|||++ |..||......... ........ ...+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~------~~~~~ 230 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL-EYLRKGYR------LPKPE 230 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHcCCC------CCCCc
Confidence 321 11223447889999999998889999999999999999999 69999876443322 22221110 11110
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.....+.+++..|++.+|++|||+.+++++|+
T Consensus 231 -----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 231 -----YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11356789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.93 Aligned_cols=257 Identities=29% Similarity=0.443 Sum_probs=203.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
..++|+..+.||+|+||.||+|... ++..||+|.+..... ....++.+|++++++++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999864 357899998865432 334678899999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCC-------------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPS-------------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSS 747 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~ 747 (943)
.+++|||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999986321 123478899999999999999999999 9999999999
Q ss_pred cEEECCCCceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccH
Q 002278 748 NILIDENFDAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNL 825 (943)
Q Consensus 748 Nill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~ 825 (943)
||++++++.++|+|||+++.+..... .......++..|+|||...+..++.++|||||||++|||++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876532211 11112234678999999998899999999999999999998 88898755433
Q ss_pred HHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 826 HQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+ ......... ... ..+ .....+.+++.+|++.+|++|||+.|+++.|+
T Consensus 240 ~-~~~~~~~~~-~~~-~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 E-VIYYVRDGN-VLS-CPD---------NCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H-HHHHHhcCC-CCC-CCC---------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 2 222221111 110 001 11256788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=332.14 Aligned_cols=259 Identities=21% Similarity=0.223 Sum_probs=199.7
Q ss_pred hhccccceEEeeeceEEEEEEEec---CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK---NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
..+|.+.+.||+|+||.||+|... .++.||+|.+... ....+|+++++.++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999754 3577899987543 34568999999999999999999999988999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
|++. ++|.+++. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++.....
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9985 68888884 345789999999999999999999999 9999999999999999999999999999866443
Q ss_pred CCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc---HHHHHHHhcccccccc-------
Q 002278 772 MPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN---LHQLIMSKADDNTVME------- 840 (943)
Q Consensus 772 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~---~~~~~~~~~~~~~~~~------- 840 (943)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+............
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 222 22245699999999999999999999999999999999999999975432 1111111110000000
Q ss_pred ------------ccCcccccC--ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 841 ------------AVDPEVSVT--CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 841 ------------~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+..... .........+.+++..|+..||++|||+.|++.+-+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 000100000 000011245678999999999999999999999854
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=317.24 Aligned_cols=257 Identities=26% Similarity=0.338 Sum_probs=205.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356788889999999999999976 57888999875443 3345678899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++++|.+++. ..+.+++..+..++.+++.|+.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 84 FMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred cCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999999886 3346899999999999999999999731 89999999999999999999999999987543221
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccH----------HHHHHHhcccccccccc
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL----------HQLIMSKADDNTVMEAV 842 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~----------~~~~~~~~~~~~~~~~~ 842 (943)
. ....|+..|+|||++.+..++.++|||||||++|+++||+.||...... ..+...... ..
T Consensus 159 ~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 229 (284)
T cd06620 159 A---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ------EP 229 (284)
T ss_pred c---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh------cc
Confidence 1 2245899999999998889999999999999999999999999854331 111111110 00
Q ss_pred CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 843 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.+.+. .......+.+++.+|++.||++|||+.|++++.+-+..
T Consensus 230 ~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 230 PPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 11111 01123467789999999999999999999998655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.33 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=195.4
Q ss_pred EEeeeceEEEEEEEecC-Cc--eEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEEccCC
Q 002278 623 IVGYGASSTVYKCALKN-SR--PIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMVNG 697 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 697 (943)
.||+|+||.||+|.+++ +. .+|+|.+.... ....+.+.+|+++++++ +||||+++++++......++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999999764 33 46888876433 33456788999999999 7999999999999999999999999999
Q ss_pred ChhhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 698 SLWDLLHGPS-------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 698 ~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
+|.+++.... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence 9999986422 123578999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccC
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.+.......... .... .
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~~~~------~ 229 (270)
T cd05047 159 SRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGY------R 229 (270)
T ss_pred ccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-hCCC------C
Confidence 86332111 1111224567999999988889999999999999999997 99999765433222111 1110 1
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
..... .....+.+++.+|++.+|.+|||+.++++.|..+.
T Consensus 230 ~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 LEKPL-----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCC-----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111 11246779999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.74 Aligned_cols=244 Identities=24% Similarity=0.382 Sum_probs=200.8
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEe--c--ccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc--ceEEEEEc
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKL--Y--NQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYG--NLLFYDYM 694 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~--~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~~ 694 (943)
.+||+|+|-+||+|.+. .|..||-=.+ . ...+...++|..|+++|+.|+|||||++|.++.+... ..+|+|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 46999999999999976 3556654222 1 2235556899999999999999999999999988766 67889999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-CCceeecccccccccCCCCC
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-NFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFGla~~~~~~~~ 773 (943)
..|+|..|.+ ...+.+...+..|++||++||.|||++ +|+|+|||||-.||+|+. .|.|||+|.|+|+.+.....
T Consensus 126 TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 126 TSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred cCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 9999999997 456788999999999999999999997 899999999999999984 58999999999998765533
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
. . ++|||.|||||+.. ..|++.+||||||++++||+|+..||..-.+..++.+......+ +..+. ...
T Consensus 202 k--s-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK-P~sl~-----kV~-- 269 (632)
T KOG0584|consen 202 K--S-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK-PAALS-----KVK-- 269 (632)
T ss_pred c--e-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC-HHHhh-----ccC--
Confidence 2 2 78999999999888 77999999999999999999999999988877777665543322 11111 111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
...+.++|.+|+.. .++|||+.|++++-
T Consensus 270 --dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 270 --DPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred --CHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 13556899999999 99999999999864
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.83 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=200.5
Q ss_pred hccccceEEeeeceEEEEEEEec-----CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Ccc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-----NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGN 687 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 687 (943)
..|++.+.||+|+||.||.|... .+..||+|.+.... ......+.+|+++++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45788899999999999999742 46789999986443 33456789999999999999999999998775 567
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998632 33589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccH--------------HHHHHH
Q 002278 768 IPTAMPH--ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL--------------HQLIMS 831 (943)
Q Consensus 768 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~--------------~~~~~~ 831 (943)
....... ......|+..|+|||+..+..++.++|||||||++|||+|++.|+...... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 112234677899999998888999999999999999999987765432111 111111
Q ss_pred hccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 832 KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
..... ...... .....+.+++.+|++.+|++|||+.++++.++.+
T Consensus 239 ~~~~~------~~~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK------RLPRPP-----NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc------cCCCCC-----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 10000 000010 1235788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.09 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=208.4
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
++|+..+.||.|+||+||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+..+...+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888999999999999999965 57789999886433 33567789999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++........+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999987433335689999999999999999999999 999999999999999999999999999987654322
Q ss_pred c---eeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 774 H---ASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 774 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
. ......|+..|+|||++... .++.++|+|||||++|||++|+.||.................. .+...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~ 230 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP-------SLETG 230 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC-------CcCCc
Confidence 2 22334589999999998876 7899999999999999999999999876554433332222111 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.........+.+++..|+..||++||++.++++|
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0001223567899999999999999999999886
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.38 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=206.8
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 57899999986544 33456788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+ +++|.+++... ...+++.++..++.|+++||+|||+. +++|+||||+||+++.++.++++|||.+........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999998632 25689999999999999999999999 999999999999999999999999999987654432
Q ss_pred ceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc-----
Q 002278 774 HASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS----- 847 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 847 (943)
.......|+..|+|||.+.+. .++.++||||+||++|||+||++||.+..+...+..............++.+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 223344689999999988754 46899999999999999999999887766554443332211111110001000
Q ss_pred ------cC----c--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 848 ------VT----C--VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 848 ------~~----~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.. . ........+.+++.+|++.+|++||++.++++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00 0 0001236778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.03 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=201.6
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCc----eEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSR----PIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+..... ....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356778889999999999999865 333 468887764432 2334688999999999999999999998764 467
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+++||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 89999999999999863 234588999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 769 PTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 769 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
...... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+..... ............. .+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~--~~-- 234 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQ--PP-- 234 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCC--CC--
Confidence 433221 1112335678999999998899999999999999999997 999997653221 1111111111100 00
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
.....+.+++..||..+|++||++.++++.++.+...+
T Consensus 235 -------~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 235 -------ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 01245678999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.61 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=208.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CC----ceEEEEEeccc-CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NS----RPIAVKKLYNQ-YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
......++||+|+||+||+|.+- .+ -+||+|++... .++...++.+|+-+|.+++|||+++++|+|..+. ..|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 34556789999999999999864 23 46899988644 3556678999999999999999999999998876 889
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
|++|++.|+|.|+++. .+..+..+..+.|..|||+||.|||++ ++|||||.++||||.+-.++||.|||+|+...
T Consensus 775 vtq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999999985 455688899999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCcee-eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 770 TAMPHAS-TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 770 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
....... ....-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+ +-.......++.. +|
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~geRLsq--Pp--- 923 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGERLSQ--PP--- 923 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhccccCCC--CC---
Confidence 5432221 11223578999999999999999999999999999999 999998754322 1111111111111 11
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPA 893 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~~ 893 (943)
-....++.++.+||..|++.||+++++...+.++...+..
T Consensus 924 ------iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 924 ------ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred ------CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 1234677899999999999999999999998877655443
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.78 Aligned_cols=261 Identities=24% Similarity=0.297 Sum_probs=203.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++|+....||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999987 57899999886442 2234567899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|++++.+..+.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998888765 334689999999999999999999998 99999999999999999999999999998765432
Q ss_pred CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc-----------
Q 002278 773 PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME----------- 840 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 840 (943)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+...................
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 2 1222347889999999876 45789999999999999999999999876654433322111100000
Q ss_pred ---ccCcccccCcc----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 841 ---AVDPEVSVTCV----DLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 841 ---~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
...+....... .......+.+++.+|++.+|++||++.|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000000 00113567799999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=315.53 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=206.1
Q ss_pred HHHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEe---
Q 002278 608 FDDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYAL--- 682 (943)
Q Consensus 608 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 682 (943)
++.+.++.++|+..+.||+|+||.||+|..+ .++.+|+|++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 4556678899999999999999999999876 4688999987543 22346678899999999 6999999999884
Q ss_pred --cCCcceEEEEEccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 683 --SPYGNLLFYDYMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 683 --~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
.++..++||||+++++|.+++... .....+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 334579999999999999987532 1334688999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCceeeeEecccceeCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcc
Q 002278 760 SDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT-----SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD 834 (943)
Q Consensus 760 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 834 (943)
+|||+++........ .....|++.|+|||++.. ..++.++||||+||++|||++|+.||...............
T Consensus 166 ~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 166 VDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred ccCCceeecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 999999876433222 223458999999998753 45788999999999999999999999876544433221111
Q ss_pred ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.......+.. ....+.+++.+||+.||++|||+.|++++.+
T Consensus 245 --~~~~~~~~~~--------~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 245 --PPPTLHQPEL--------WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred --CCCcccCCCC--------cCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 1011111111 1245778999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=307.99 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=193.1
Q ss_pred eEEeeeceEEEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEe-cCCcceEEEEEcc
Q 002278 622 YIVGYGASSTVYKCALKN----SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYAL-SPYGNLLFYDYMV 695 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 695 (943)
+.||+|+||.||+|.+.+ ...||+|++.... ....+.+.+|+.+++.++||||+++++++. .++..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 358999999999998642 3568999875432 334567888999999999999999999876 4556789999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC--
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP-- 773 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~-- 773 (943)
+|+|.+++... ....++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998632 33467888899999999999999998 999999999999999999999999999976533211
Q ss_pred -ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhC-CCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 774 -HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG-KKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 774 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
.......++..|+|||...+..++.++|||||||++|||++| .+||....... ........... ....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~--- 225 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-ITVYLLQGRRL------LQPE--- 225 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhcCCCC------CCCC---
Confidence 111123357789999999888999999999999999999995 56666544332 22222111111 0010
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
..+..+.+++..||+.+|++||++.++++.++.+.
T Consensus 226 --~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 --YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11246779999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=316.47 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=205.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec--------CCceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEec
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK--------NSRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALS 683 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 683 (943)
..++|...+.||+|+||.||+|... ....+|+|.+.... ......+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3468889999999999999999752 23568889876443 23456788999999999 59999999999999
Q ss_pred CCcceEEEEEccCCChhhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEE
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGPS-------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNIL 750 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 750 (943)
....+++|||+++|+|.+++.... ....+++.++..++.|++.||+|||++ +++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 888999999999999999986422 124588999999999999999999999 9999999999999
Q ss_pred ECCCCceeecccccccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHH
Q 002278 751 IDENFDAHLSDFGIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQL 828 (943)
Q Consensus 751 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~ 828 (943)
++.++.+||+|||.++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998664322111 111224467999999998889999999999999999999 89999765432222
Q ss_pred HHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
........ ..... .....+.+++.+|++.+|++|||+.++++.|+.+...
T Consensus 247 -~~~~~~~~------~~~~~-----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 247 -KLLREGHR------MDKPS-----NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred -HHHHcCCC------CCCCC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 22211110 01111 1124677899999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=329.75 Aligned_cols=259 Identities=17% Similarity=0.208 Sum_probs=196.2
Q ss_pred hhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
...|.+.+.||+|+||.||+|.+.. ++.||||... ...+.+|++++++++|||||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4478899999999999999999764 6889999642 23467899999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+ .++|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~-~~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 Y-RSDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred c-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9 4788888753 234699999999999999999999999 999999999999999999999999999987643221
Q ss_pred c-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc------c-HHHHHHHhccccccccccC--
Q 002278 774 H-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES------N-LHQLIMSKADDNTVMEAVD-- 843 (943)
Q Consensus 774 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~------~-~~~~~~~~~~~~~~~~~~~-- 843 (943)
. ......||+.|+|||++.+..++.++|||||||++|||++|..|+.... . ..+...+..........+.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 1223469999999999999999999999999999999999876553211 1 1112222111111000000
Q ss_pred ------------------cccccC-cc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 844 ------------------PEVSVT-CV-DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 844 ------------------~~~~~~-~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+..... +. .......+.+++.+|++.||++|||+.|+++|-+
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 000000 00 0011135678999999999999999999999843
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.29 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=203.2
Q ss_pred cceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCC
Q 002278 620 EKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGS 698 (943)
Q Consensus 620 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 698 (943)
....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..+++|||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3446999999999999975 578999999865544556678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeee
Q 002278 699 LWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778 (943)
Q Consensus 699 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 778 (943)
|.+++. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......... ...
T Consensus 105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~ 176 (297)
T cd06659 105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKS 176 (297)
T ss_pred HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccc
Confidence 999874 24589999999999999999999999 9999999999999999999999999999765433222 223
Q ss_pred EecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHH
Q 002278 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRK 858 (943)
Q Consensus 779 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (943)
..|+..|+|||++.+..++.++|||||||++|||++|+.||................... ....+ .....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~---------~~~~~ 246 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNAH---------KISPV 246 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-ccccC---------CCCHH
Confidence 568999999999998899999999999999999999999998665544333222111100 00011 11245
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 859 TFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 859 l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
+.+++..|++.+|++||++.+++++-+-
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~~~~ 274 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDHPFL 274 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhChhh
Confidence 6789999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.01 Aligned_cols=238 Identities=23% Similarity=0.322 Sum_probs=188.4
Q ss_pred EEeeeceEEEEEEEecC-------------CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 623 IVGYGASSTVYKCALKN-------------SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.||+|+||.||+|.... ...||+|.+..........+..|+.+++.++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 22578888765544455678889999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc-------eeeccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD-------AHLSDF 762 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------~kl~DF 762 (943)
||||+++|+|..++.. ....+++..+.+++.||++|++|||+. +|+||||||+||+++.++. ++++||
T Consensus 82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999988863 234689999999999999999999999 9999999999999986654 899999
Q ss_pred ccccccCCCCCceeeeEecccceeCccccc-cCCCCCcchhhhHHHHHHHHH-hCCCCCCCCccHHHHHHHhcccccccc
Q 002278 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAH-TSRLNEKSDVYSFGIVLLEIL-TGKKAVDNESNLHQLIMSKADDNTVME 840 (943)
Q Consensus 763 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~ 840 (943)
|++...... ....|+..|+|||.+. +..++.++|||||||++|||+ +|+.||......+. ........ .
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~---~ 227 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQC---M 227 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcCc---c
Confidence 998755322 2234788999999887 466899999999999999998 58888875432221 11111100 0
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
... .....+.+++.+||+.||++||++.++++++
T Consensus 228 ~~~----------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 228 LVT----------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCC----------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 0124577899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.09 Aligned_cols=262 Identities=23% Similarity=0.256 Sum_probs=203.5
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc-----cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH-----NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
+|+..+.||+|+||.||+|..+ +++.||+|++...... ....+..|+++++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999976 5789999998654322 344567899999999999999999999998899999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+ +|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999996422 3689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc-----
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP----- 844 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 844 (943)
..... ....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||........................+
T Consensus 155 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 155 PNRKM-THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CCccc-cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 32221 22346788999998865 467899999999999999999988888766554433322111110000000
Q ss_pred ----------ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 845 ----------EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 845 ----------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..............+.+++.+||+++|++|||+.|++++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~ 284 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence 00000000112356789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=307.38 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=203.6
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc--cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH--NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999865 6789999998655432 567889999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++. ....+++..+..++.+++.|++|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999986 334578999999999999999999999 999999999999999999999999999987654332
Q ss_pred ceee---eEecccceeCccccccCC---CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 774 HAST---FVLGTIGYIDPEYAHTSR---LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 774 ~~~~---~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
.... ...++..|+|||++.+.. ++.++||||||+++||+++|+.||................ ..+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~------~~~~~~ 228 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG------HKPPIP 228 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC------CCCCCC
Confidence 2211 245788999999988766 8899999999999999999999997653322222221111 111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.. ......+.+++..|++.+|++||++.+++.+
T Consensus 229 ~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 229 DS---LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred cc---cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 10 0112456789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=288.62 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=197.6
Q ss_pred cccceEEeeeceEEEEEEEecC-CceEEEEEecccC-cccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEEEEc
Q 002278 618 LSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY-PHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.+....||.|..|.||+++.+. +...|||.+.+.. .+..+++...++++.... +|+||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 3445569999999999999875 6788999997654 344566777777766654 899999999999999999999987
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
......++++ -.+++++.-+-++...++.||.||.+++ +|+|||+||+|||+|+.|.+|+||||++-++-+...+
T Consensus 174 -s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 174 -STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred -HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 3455555553 3456888888899999999999999875 9999999999999999999999999999888665444
Q ss_pred eeeeEecccceeCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 775 ASTFVLGTIGYIDPEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
.. ..|-+.|||||.+.- ..|+.++||||||++++|+.||+.||.+...-.........+.+ ..+++...
T Consensus 249 tr--sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP--P~L~~~~g---- 320 (391)
T KOG0983|consen 249 TR--SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP--PLLPGHMG---- 320 (391)
T ss_pred cc--ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--CCCCcccC----
Confidence 33 458899999998864 46899999999999999999999999865443333333333222 11221111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
....+.+++..|+++|+.+||.+.++++|-
T Consensus 321 ---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 321 ---FSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred ---cCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 224677899999999999999999999874
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.95 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=202.8
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-----cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-----PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
+|+..+.||+|+||.||+|..+ +++.||+|.+.... .+..+.+.+|+++++.++||||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999977 68899999885433 22456788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
+||+++++|.+++. ....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999986 334588999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeeEecccceeCccccccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.. ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||................ ......+.+
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~--- 227 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--ELPPIPDHL--- 227 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--cCCCcCCCc---
Confidence 32 122345889999999987766 8999999999999999999999997665433333222111 111111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
...+.+++.+||+.+|++||++.+++++
T Consensus 228 ------~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 228 ------SDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ------CHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 2456789999999999999999999876
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=318.46 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=206.4
Q ss_pred hccccceEEeeeceEEEEEEEecC--------CceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN--------SRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPY 685 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 685 (943)
.+|++.+.||+|+||.||+|.... ...||+|.+.... ....+++.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468889999999999999997531 2368999876433 33456788999999999 7999999999999999
Q ss_pred cceEEEEEccCCChhhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPS-------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID 752 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 752 (943)
..+++|||+++|+|.+++.... ....+++.++..++.|++.||+|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999986421 123588999999999999999999999 999999999999999
Q ss_pred CCCceeecccccccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHH
Q 002278 753 ENFDAHLSDFGIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIM 830 (943)
Q Consensus 753 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 830 (943)
+++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.... ....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-ELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Confidence 99999999999998664322111 111224568999999999999999999999999999998 88998765432 2222
Q ss_pred HhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 831 SKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
....... +.... .....+.+++.+|++.+|++||++.++++.|+.+.....
T Consensus 248 ~~~~~~~------~~~~~-----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 248 LLKEGHR------MDKPA-----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHcCCC------CCCCC-----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 2211111 11111 112467799999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.34 Aligned_cols=238 Identities=21% Similarity=0.323 Sum_probs=187.5
Q ss_pred EEeeeceEEEEEEEecC-------------------------CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCccee
Q 002278 623 IVGYGASSTVYKCALKN-------------------------SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSL 677 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 677 (943)
.||+|+||.||+|.... ...||+|.+.........++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 13578888865444445678889999999999999999
Q ss_pred eeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC--
Q 002278 678 HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-- 755 (943)
Q Consensus 678 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-- 755 (943)
++++..+...++||||+++|+|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998863 245688999999999999999999998 999999999999997543
Q ss_pred -----ceeecccccccccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHH-hCCCCCCCCccHHHH
Q 002278 756 -----DAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEIL-TGKKAVDNESNLHQL 828 (943)
Q Consensus 756 -----~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tG~~p~~~~~~~~~~ 828 (943)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||.........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 3899999998644222 11247888999998875 56899999999999999995 699999765433221
Q ss_pred HHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.. .......+. . ....+.+++.+||+.+|++|||+.++++.|
T Consensus 232 ~~-~~~~~~~~~--------~-----~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 RF-YEKKHRLPE--------P-----SCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HH-HHhccCCCC--------C-----CChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11 111111110 0 013577899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=313.73 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=202.5
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34566677999999999999875 46789999876433 33456788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++. ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++++|||++........
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999885 34689999999999999999999998 999999999999999999999999999987644322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......|+..|+|||++.+..++.++|||||||++|||+||+.||............. ....+.+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~~~~----- 223 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-------KNSPPTLEG----- 223 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-------cCCCCCCCc-----
Confidence 1222457889999999999899999999999999999999999997544332221111 111111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.....+.+++.+|++.+|++||++.+++++-+
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 12346778999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.32 Aligned_cols=247 Identities=20% Similarity=0.240 Sum_probs=204.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999976 57899999886432 234566889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999863 35689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...................+ +.+
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~----- 221 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFF----- 221 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccC-----
Confidence 2234588999999999888899999999999999999999999986653332222221111111 111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
...+.+++.+||..+|++|| +++|++++-+
T Consensus 222 ----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 222 ----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred ----CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 24667899999999999999 8888887643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=312.24 Aligned_cols=238 Identities=22% Similarity=0.332 Sum_probs=188.8
Q ss_pred EEeeeceEEEEEEEecC--------CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 623 IVGYGASSTVYKCALKN--------SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.||+|+||.||+|..+. ..+||+|.+........+.+..|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999998642 2347888775544445567888999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc--------eeeccccccc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD--------AHLSDFGIAR 766 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl~DFGla~ 766 (943)
++|+|.++++.. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++. ++++|||.+.
T Consensus 82 ~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999743 33689999999999999999999999 9999999999999987765 6999999987
Q ss_pred ccCCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCC-CCCCCCccHHHHHHHhccccccccccCc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGK-KAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
..... ....++..|+|||++.+. .++.++|||||||++|||++|. .||......... ........
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~------- 223 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQ------- 223 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHcccc-------
Confidence 54322 223578899999999874 5789999999999999999985 666544332221 11111111
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
++. ....++.+++..||+.+|++|||++++++.|
T Consensus 224 -~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 224 -LPA-----PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -CCC-----CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 110 0124577999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.00 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=199.0
Q ss_pred eEEeeeceEEEEEEEecCCceEEEEEecccCcc-cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCChh
Q 002278 622 YIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLW 700 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 700 (943)
+.||+|+||.||+|.+.+++.||+|++...... ....+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999877899999988765433 4567899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee-eeE
Q 002278 701 DLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS-TFV 779 (943)
Q Consensus 701 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~-~~~ 779 (943)
+++... ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||.++.......... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998632 34678999999999999999999999 999999999999999999999999999986542211111 112
Q ss_pred ecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHH
Q 002278 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRK 858 (943)
Q Consensus 780 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (943)
.++..|+|||.+.+..++.++|||||||++|||+| |..||............... ... ..+ ......
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~------~~~-----~~~~~~ 223 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRM------PAP-----QLCPEE 223 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCC------CCC-----ccCCHH
Confidence 23567999999998899999999999999999999 88998765433222211111 100 000 012246
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 859 TFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 859 l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.+++.+|+..+|++|||+.|+++.|.
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.13 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=205.8
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..|+..+.||+|+||.||+|.++ .+..||+|.+.... ......+.+|+++++++.||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777788999999999999976 47889999876432 33456788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++. ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999985 24588999999999999999999998 999999999999999999999999999976644322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......++..|+|||++.+..++.++|+|||||++|||+||+.||.............. ...+.+ ..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~-----~~ 223 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK-------NNPPTL-----TG 223 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-------CCCCCC-----ch
Confidence 22234578899999999988899999999999999999999999976544322211111 111111 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.....+.+++..||+.+|++||++.+++++-+-
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 234567899999999999999999999988653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.83 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=201.0
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC-CcceEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP-YGNLLFYD 692 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 692 (943)
+|+..+.||+|++|.||++..+ +++.||+|++.... ....+.+.+|++++++++|||++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999976 46889999986432 23445688999999999999999999987644 45789999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++++|.+++... ....+++.++..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998642 234589999999999999999999999 99999999999999999999999999998764332
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
. ......|++.|+|||+..+..++.++||||+|+++|||++|+.||...+.......... +.. +...
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--~~~-----~~~~----- 223 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--GKL-----PPMP----- 223 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cCC-----CCCc-----
Confidence 2 22234588999999999999999999999999999999999999986543322211111 111 1111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
......+.+++.+|++.+|++||++.+++++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1122467799999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.85 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=201.4
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc----------ccHHHHHHHHHHHhcCCCCCcceeeeEEecCC
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP----------HNLREFETELETIGSIRHRNIVSLHGYALSPY 685 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 685 (943)
+|...+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999865 578899998753211 11245778999999999999999999999999
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..++||||+++|+|.+++.. ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999863 35689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCc-eeeeEecccceeCccccccCC--CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccc--ccccc
Q 002278 766 RCIPTAMPH-ASTFVLGTIGYIDPEYAHTSR--LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADD--NTVME 840 (943)
Q Consensus 766 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~--~~~~~ 840 (943)
+........ ......|+..|+|||...... ++.++|+||+|+++||+++|..||................ .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 765432111 122345889999999987654 8899999999999999999999997655544333222111 11111
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
...+. ....+.+++..|++++|++||++.++++|-
T Consensus 236 ~~~~~---------~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 236 DVSMN---------LSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred ccccc---------CCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 11111 225677899999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.57 Aligned_cols=261 Identities=25% Similarity=0.317 Sum_probs=203.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++|+..+.||+|+||.||+|.++ .++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888899999999999999986 478899998764332 234568889999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|++++++.++.. ....+++.++..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988765 234589999999999999999999999 99999999999999999999999999998764432
Q ss_pred CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc----------
Q 002278 773 PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA---------- 841 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 841 (943)
. ......++..|+|||+..+ ..++.++|||||||++|||++|++||........+...........+.
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 E-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred c-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 2 2223457899999998875 457889999999999999999999998666544333322111111000
Q ss_pred ----cCcccccCc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 842 ----VDPEVSVTC----VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 842 ----~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
..+...... ........+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000 000123567889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=315.53 Aligned_cols=194 Identities=25% Similarity=0.395 Sum_probs=158.9
Q ss_pred eEEeeeceEEEEEEEecC---CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEec--CCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALKN---SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS--PYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 696 (943)
..||+|+||+||+|..++ +..||+|.+.... ....+.+|+++++.++||||+++++++.. +...++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 579999999999999753 4789999886542 23567889999999999999999999854 456789999986
Q ss_pred CChhhhccCC------CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE----CCCCceeeccccccc
Q 002278 697 GSLWDLLHGP------SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI----DENFDAHLSDFGIAR 766 (943)
Q Consensus 697 g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DFGla~ 766 (943)
++|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 5777766421 1223588999999999999999999999 99999999999999 566789999999998
Q ss_pred ccCCCCCc--eeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 002278 767 CIPTAMPH--ASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDN 821 (943)
Q Consensus 767 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~ 821 (943)
........ ......||+.|+|||++.+ ..++.++||||+||++|||+||++||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76443221 1233468999999999876 4589999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.33 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=196.3
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-----cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Ccce
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-----PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGNL 688 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 688 (943)
+|+..+.||+|+||.||+|... .++.||+|++.... ......+.+|+++++.++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6888899999999999999975 57899999875432 12335678899999999999999999998753 4578
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+++||+++++|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 83 l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 83 IFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999999986 334588999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCC--ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 769 PTAMP--HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 769 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
..... .......++..|+|||++.+..++.++||||+||++|||++|+.||................ ..+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~------~~~~~ 230 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP------TNPQL 230 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC------CCCCC
Confidence 32111 11122347889999999999889999999999999999999999998665444333221111 11222
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
+. .....+..++ .||..+|++||+++|+++|
T Consensus 231 ~~-----~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 231 PS-----HISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ch-----hcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11 1113444556 6888999999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.69 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=202.0
Q ss_pred HHhhccccceEEeeeceEEEEEEEecCCceEEEEEecc--cCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceE
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYN--QYPHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 689 (943)
.....|++.+.||+||.+.||++...+.+.||+|++.. .+......|..|+..|.+++ |.+||++++|-..++..|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 35567999999999999999999988888899998743 33556678999999999996 9999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||- ..+|..+|+... .....| .+..+..|++.|+.++|.+ ||||.||||.|+++-. |.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99974 669999997432 122334 7788999999999999999 9999999999999865 689999999999876
Q ss_pred CCCCc-eeeeEecccceeCccccccCC-----------CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc
Q 002278 770 TAMPH-ASTFVLGTIGYIDPEYAHTSR-----------LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT 837 (943)
Q Consensus 770 ~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 837 (943)
.+... .....+||+.||+||.+.... .++++||||+|||||+|+.|++||....+...-+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~------- 583 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLH------- 583 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHH-------
Confidence 54332 334567999999999875432 55799999999999999999999986543222111
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
...+|....++++.....+++++++.|++.||.+||+..++++|-
T Consensus 584 --aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 584 --AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred --hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 222332222222222223488999999999999999999999873
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=313.12 Aligned_cols=265 Identities=25% Similarity=0.320 Sum_probs=208.2
Q ss_pred cccCHHHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEE
Q 002278 604 AIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYA 681 (943)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 681 (943)
+.++.+++..++++|+..+.||+|+||.||+|..+ +++.+|+|.+... ......+.+|+.+++++ +|||++++++++
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 34555666677899999999999999999999975 5788999988543 23346778899999998 799999999998
Q ss_pred ecCC-----cceEEEEEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC
Q 002278 682 LSPY-----GNLLFYDYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF 755 (943)
Q Consensus 682 ~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 755 (943)
...+ ..++||||+++|+|.++++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 7543 4799999999999999885321 234689999999999999999999998 999999999999999999
Q ss_pred ceeecccccccccCCCCCceeeeEecccceeCccccccC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHH
Q 002278 756 DAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS-----RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM 830 (943)
Q Consensus 756 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~ 830 (943)
.+||+|||+++........ .....|+..|+|||++... .++.++|||||||++|||++|+.||...........
T Consensus 166 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~ 244 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244 (291)
T ss_pred CEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence 9999999999865433222 1223588999999987643 368899999999999999999999987655444333
Q ss_pred HhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 831 SKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
...... +.+... ......+.+++.+|++.+|++||++.++++|
T Consensus 245 ~~~~~~-------~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPRNPP-------PTLLHP---EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HhcCCC-------CCCCcc---cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 222111 111000 0112457789999999999999999999887
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.59 Aligned_cols=262 Identities=20% Similarity=0.257 Sum_probs=195.6
Q ss_pred cceEEeee--ceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 620 EKYIVGYG--ASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 620 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
...+||+| +||+||++..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34679999 78999999876 57889999986542 223456778999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999986321 23589999999999999999999999 9999999999999999999999999875443211100
Q ss_pred ------eeeeEecccceeCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccc-c------
Q 002278 775 ------ASTFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV-M------ 839 (943)
Q Consensus 775 ------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~------ 839 (943)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.................+. .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 0112246778999999876 468999999999999999999999997544322222211110000 0
Q ss_pred -cc---------cC-------------ccccc---CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 -EA---------VD-------------PEVSV---TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 -~~---------~~-------------~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+. .+ +.... ..........+.+++..|++.||++|||+++++++-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 00 00 00000 0001112346789999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=306.38 Aligned_cols=237 Identities=25% Similarity=0.364 Sum_probs=189.3
Q ss_pred eEEeeeceEEEEEEEecCCc-----------eEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 622 YIVGYGASSTVYKCALKNSR-----------PIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
+.||+|+||.||+|.++... .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 35899999999999987533 4677766543322 6788999999999999999999999988 788999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC-------ceeecccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-------DAHLSDFG 763 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~~kl~DFG 763 (943)
|||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+|++|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998632 22689999999999999999999998 999999999999999887 79999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccccC--CCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcccccccc
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTS--RLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVME 840 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 840 (943)
++..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||........ .........
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~~~~~~~~~--- 224 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERFYQDQHR--- 224 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-HHHHhcCCC---
Confidence 9986543 1223467889999998876 78999999999999999999 5777865532221 111111000
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.... . ...+.+++.+||..+|++|||+.++++.|
T Consensus 225 -----~~~~--~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 225 -----LPMP--D---CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -----CCCC--C---chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 0 15678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=315.02 Aligned_cols=254 Identities=24% Similarity=0.269 Sum_probs=206.4
Q ss_pred hccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcc---cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPH---NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+|...+ ++.||+|.+...... ..+.+..|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999764 889999998654322 4456889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+.+++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998632 235689999999999999999999999 9999999999999999999999999998765322
Q ss_pred CCc----------------------------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 002278 772 MPH----------------------------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES 823 (943)
Q Consensus 772 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~ 823 (943)
... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 111 0112357889999999999899999999999999999999999998766
Q ss_pred cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHHH
Q 002278 824 NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT----MQEVARVL 884 (943)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~el~~~L 884 (943)
....+............. ......+.+++.+|+..||++||+ +.+++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 237 RDETFSNILKKEVTFPGS-----------PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred hHHHHHHHhcCCccCCCc-----------cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 544443332221111110 012357789999999999999999 88888763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=308.22 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=204.4
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
.|...+.||+|++|.||+|... +++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3445578999999999999965 678899998865544455678899999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+++|.+++.. .++++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+........ .
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 9999999863 4689999999999999999999999 999999999999999999999999999876543322 2
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHH
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (943)
.....|++.|+|||...+..++.++|||||||++|||++|+.||................. +..... ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~---~~~ 241 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-------PKLKNL---HKV 241 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC-------CCCccc---ccC
Confidence 2234589999999999888899999999999999999999999987655443332222111 111100 012
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 856 VRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 856 ~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++.+||+.+|++||++.+++++-+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHccCcc
Confidence 246789999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.97 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=204.3
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ--YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|+||.||.+... +++.||+|++... ......++.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999865 5788999988643 233446788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++... ....+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988632 223578999999999999999999998 999999999999999999999999999986644322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
. .....|++.|+|||+..+..++.++|+|||||++|+|++|+.||................. +....
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-------~~~~~----- 223 (256)
T cd08218 157 L-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-------PPVSS----- 223 (256)
T ss_pred h-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-------CCCcc-----
Confidence 1 1224588899999999988899999999999999999999999986554333322222111 11111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.....+.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 112467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=307.51 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=204.6
Q ss_pred hhccccceEEeeeceEEEEEEEecC-C----ceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-S----RPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..+|+..+.||+|+||.||+|.++. + ..||+|....... .....+.+|+++++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3578888999999999999998653 3 2588888765432 344678899999999999999999999987 7889
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999998642 34589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCcee-eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 769 PTAMPHAS-TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 769 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
........ ....++..|+|||......++.++|+|||||++||+++ |+.||.+.... .+............ ++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~--~~~- 235 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-EIPDLLEKGERLPQ--PPI- 235 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHhCCCCCCC--CCC-
Confidence 53322111 11223568999999988889999999999999999999 99999865432 22222221111100 000
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
....+.+++.+||..+|++||++.++++.+..+...
T Consensus 236 --------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 236 --------CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred --------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 113567899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=306.98 Aligned_cols=251 Identities=19% Similarity=0.308 Sum_probs=189.4
Q ss_pred EEeeeceEEEEEEEecC---CceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCC
Q 002278 623 IVGYGASSTVYKCALKN---SRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGS 698 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 698 (943)
.||+|+||+||+|.... ...+|+|.+..... .....+.+|++.++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 48999999999997543 34678887754332 234567889999999999999999999999999999999999999
Q ss_pred hhhhccCCCC--CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc-e
Q 002278 699 LWDLLHGPSK--KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH-A 775 (943)
Q Consensus 699 L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~ 775 (943)
|.+++..... ....++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999864322 23356788899999999999999999 9999999999999999999999999998754322111 1
Q ss_pred eeeEecccceeCcccccc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 776 STFVLGTIGYIDPEYAHT-------SRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
.....++..|+|||+... ..++.++|||||||++|||++ |..||....+............. ....+.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI--KLPKPQLD 236 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc--cCCCCccc
Confidence 122335678999998643 356789999999999999999 78888766554433332222111 11111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
. .....+.+++..|| .||++|||+++|++.+
T Consensus 237 ~-----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 237 L-----KYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred c-----cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 1 11245567888898 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.11 Aligned_cols=262 Identities=24% Similarity=0.299 Sum_probs=205.0
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++|+..+.||+|+||.||+|.++ +++.||+|++.... ......+.+|+++++.++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 47889999886432 3345678999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|++++.+..+.. ....+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877766654 334589999999999999999999999 99999999999999999999999999998765543
Q ss_pred CceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc------cCcc
Q 002278 773 PHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA------VDPE 845 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 845 (943)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||.+..............+..... ..+.
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 3233335578999999999887 88999999999999999999999998665544333222111110000 0000
Q ss_pred ccc-----C--------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 846 VSV-----T--------CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 846 ~~~-----~--------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
... . .........+.+++++||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 0 0000113567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=305.54 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=198.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-----cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Ccc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-----PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGN 687 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 687 (943)
++|+..+.||+|+||.||.|..+ +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999976 47899999875321 12245678899999999999999999998764 356
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
+++|||+++++|.+++. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 78999999999999986 334578899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC--ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 768 IPTAMP--HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 768 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||............... . ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~-----~~~~ 229 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-P-----TNPV 229 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC-C-----CCCC
Confidence 532111 1122345889999999998888999999999999999999999999865444333222111 1 0111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.+ ......+.+++.+|+. +|++||++++++++-
T Consensus 230 ~~-----~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 230 LP-----PHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred Cc-----hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 11 1122456678888984 899999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=303.44 Aligned_cols=251 Identities=29% Similarity=0.435 Sum_probs=201.1
Q ss_pred cccceEEeeeceEEEEEEEecC-----CceEEEEEecccCcc-cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 618 LSEKYIVGYGASSTVYKCALKN-----SRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++..+.||+|+||.||+|.+.. +..||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566789999999999999764 378999998655433 5678899999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999863211 1289999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
.........+++.|+|||...+..++.++||||+|+++|+|++ |+.||........ ......... . ....
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~-~~~~~~~~~-~-~~~~------ 227 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV-LEYLKKGYR-L-PKPE------ 227 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhcCCC-C-CCCC------
Confidence 2222212236789999999988889999999999999999998 8888876443222 222211111 0 0011
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.....+.+++.+|+..+|++|||+.++++.|
T Consensus 228 ---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 ---NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1235678899999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=321.14 Aligned_cols=192 Identities=24% Similarity=0.333 Sum_probs=163.6
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
...+|+..+.||+|+||.||+|.... ++.||+|..... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 44579999999999999999999764 577888875332 23568999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
++ .++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 138 ~~-~~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 138 HY-SSDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cc-CCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 98 4688888753 345689999999999999999999999 99999999999999999999999999997543221
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAV 819 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~ 819 (943)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 122345899999999999999999999999999999999855444
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=311.50 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=206.6
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468888999999999999999865 5788999998655455567788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999985 23578999999999999999999999 999999999999999999999999999876543322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......|++.|+|||...+..++.++|||||||++|++++|+.||................. +... ...
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-------~~~~---~~~ 239 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-------PELQ---NPE 239 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-------CCCC---Ccc
Confidence 22234588999999999888899999999999999999999999986654332221111110 1111 011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.....+.+++..||..+|++||++.+++.|-+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 12245778999999999999999999998854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.90 Aligned_cols=256 Identities=23% Similarity=0.254 Sum_probs=202.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..+.|..-++||+|+||.||.+..+ .|+.||.|++.+.. .....-...|-++++++..+.||.+--.|+..+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456777889999999999999866 57889999885443 2223345689999999999999999989999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
|+..|.||+|.-+|..... ..+++..+.-+|.+|+.||++||.. +||+||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999975433 4699999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
...+.. ..+||.+|||||++....|+..+|.||+||++|||+.|+.||........+...........+.....+
T Consensus 339 ~g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kF--- 413 (591)
T KOG0986|consen 339 EGKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKF--- 413 (591)
T ss_pred CCCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccccc---
Confidence 665443 336999999999999999999999999999999999999999743322221111111001111111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVL 884 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L 884 (943)
.++.-.+.+..+++||++|- .+++|.+|-
T Consensus 414 ------S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 414 ------SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred ------CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 13445678888999999986 567777653
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.19 Aligned_cols=261 Identities=23% Similarity=0.274 Sum_probs=201.4
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||.|++|.||+|+.+ +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999976 57889999886432 22345788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+. ++|.+++... ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||+++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 6888887643 235689999999999999999999998 999999999999999999999999999976543322
Q ss_pred ceeeeEecccceeCccccccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc------
Q 002278 774 HASTFVLGTIGYIDPEYAHTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV------ 846 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 846 (943)
. .....++..|+|||+..+.. ++.++|||||||++|||+||+.||................+......++..
T Consensus 156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred c-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 1 12234688999999887644 688999999999999999999999876654444333322221111111100
Q ss_pred ----ccC-ccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 847 ----SVT-CVD-----LSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 847 ----~~~-~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
... ... ......+.+++.+|++.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 000 0012356689999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.21 Aligned_cols=261 Identities=20% Similarity=0.223 Sum_probs=196.5
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|+||.||+|..+ +|+.||+|++.... ......+.+|+++++.++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999976 57889999886432 22335677899999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+. ++|.+++.. ....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 578777653 235689999999999999999999999 999999999999999999999999999986543322
Q ss_pred ceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHH-Hhcccccccc-----------
Q 002278 774 HASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM-SKADDNTVME----------- 840 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~----------- 840 (943)
. .....++..|+|||++.+. .++.++||||+||++|||+||+.|+....+...... ..........
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 1 1223478899999988764 478999999999999999999888654333222211 1110000000
Q ss_pred -ccCcccccCc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 841 -AVDPEVSVTC----VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 841 -~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
...+...... ........+.+++.+|++.||++|||+.++++|.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 0000000000 0001224667899999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=337.52 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=195.0
Q ss_pred HHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCC----
Q 002278 612 MRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ-YPHNLREFETELETIGSIRHRNIVSLHGYALSPY---- 685 (943)
Q Consensus 612 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 685 (943)
.+...+|++...||+||||.||+++.+ ||+.|||||+.-. .......+.+|+..+++++|||||+++..+.+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 466778888999999999999999988 8999999999644 3445667889999999999999999977642110
Q ss_pred --------------------------------------------------------------------------------
Q 002278 686 -------------------------------------------------------------------------------- 685 (943)
Q Consensus 686 -------------------------------------------------------------------------------- 685 (943)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -----------------------------------cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHH
Q 002278 686 -----------------------------------GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730 (943)
Q Consensus 686 -----------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~ 730 (943)
..||-||||+...+.++++..... -.....++++++|++||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHH
Confidence 026678888888888887632111 1467789999999999999
Q ss_pred hhhCCCCCeEecCCCCccEEECCCCceeecccccccccC-----------------CCCCceeeeEecccceeCcccccc
Q 002278 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP-----------------TAMPHASTFVLGTIGYIDPEYAHT 793 (943)
Q Consensus 731 LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~ 793 (943)
+|+. |||||||||.||+++++..|||+|||+|+... .......+..+||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998721 011112345679999999999887
Q ss_pred CC---CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCC
Q 002278 794 SR---LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRY 870 (943)
Q Consensus 794 ~~---~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 870 (943)
.. |+.|+|+||+|||++||+. ||.............. .+.++.. +.+. ......-..+|++++++|
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~--~~f~-----~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEP--ADFF-----DPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCC--cccc-----cccchHHHHHHHHHhcCC
Confidence 54 9999999999999999984 5765544333333222 3333332 1111 112233457899999999
Q ss_pred CCCCCCHHHHHHH
Q 002278 871 PSERPTMQEVARV 883 (943)
Q Consensus 871 P~~RPt~~el~~~ 883 (943)
|++||||.|++..
T Consensus 859 P~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 859 PSKRPTATELLNS 871 (1351)
T ss_pred CccCCCHHHHhhc
Confidence 9999999999875
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=305.59 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=201.2
Q ss_pred ccccceEEeeeceEEEEEEEecC--CceEEEEEecccC----------cccHHHHHHHHHHHhc-CCCCCcceeeeEEec
Q 002278 617 NLSEKYIVGYGASSTVYKCALKN--SRPIAVKKLYNQY----------PHNLREFETELETIGS-IRHRNIVSLHGYALS 683 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 683 (943)
.|+..+.||+|+||.||+|.++. ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778889999999999999875 6789999875321 2233456778888765 789999999999999
Q ss_pred CCcceEEEEEccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCCceeecc
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSD 761 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~D 761 (943)
++..+++|||+++++|.+++... .....+++..++.++.|++.|+.|||+ . +++||||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999987431 234568999999999999999999996 5 899999999999999999999999
Q ss_pred cccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc
Q 002278 762 FGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA 841 (943)
Q Consensus 762 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 841 (943)
||.+....... ......|+..|+|||...+..++.++||||||+++|||++|+.||..................
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 231 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE---- 231 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC----
Confidence 99998765432 223445899999999999888999999999999999999999999765443322221111111
Q ss_pred cCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 842 VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 842 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+ .. .......+.+++.+||+.||++||++.|+.++++
T Consensus 232 --~-~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 --P-LP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --c-CC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 00 0011246778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=312.11 Aligned_cols=252 Identities=22% Similarity=0.253 Sum_probs=197.7
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
+|+..+.||+|+||.||++..+ .++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6788899999999999999976 46789999886543 2234567889999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 82 ~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 82 YVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999963 35689999999999999999999999 99999999999999999999999999987421110
Q ss_pred C--------------ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccc
Q 002278 773 P--------------HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838 (943)
Q Consensus 773 ~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 838 (943)
. .......|+..|+|||.+.+..++.++|+|||||++|||++|+.||.+.................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence 0 01112347889999999988889999999999999999999999998654432222221111111
Q ss_pred ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
+. ..+ .....+.+++.+||+.+|++||++.++.+.+
T Consensus 236 ~~-~~~---------~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 236 PE-GDE---------ALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred CC-ccc---------cCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 11 000 1124567999999999999999854444333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=310.16 Aligned_cols=263 Identities=22% Similarity=0.253 Sum_probs=198.6
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
+++.|...+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999875 57899999986543 233346778999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+. +++.+.+.. ....+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 677766642 234578888999999999999999999 9999999999999999999999999999764332
Q ss_pred CCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcc-cccc-----------
Q 002278 772 MPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD-DNTV----------- 838 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-~~~~----------- 838 (943)
... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||+.............. .+..
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 111 122347899999999876 45788999999999999999999999865443222111110 0000
Q ss_pred ---cccc-----CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 839 ---MEAV-----DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 839 ---~~~~-----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.... .+..............+.+++.+|+..||++|||+.|++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000 00000000001113466789999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=309.88 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=203.9
Q ss_pred CHHHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEec-
Q 002278 607 TFDDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALS- 683 (943)
Q Consensus 607 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 683 (943)
+..++..+.+.|+..+.||+|+||.||+|.+. .++.+|+|.+... .....++..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45556667789999999999999999999975 5678899987543 23446788899999998 69999999999853
Q ss_pred -----CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCcee
Q 002278 684 -----PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH 758 (943)
Q Consensus 684 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 758 (943)
....+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 346799999999999999886432 34578888999999999999999999 999999999999999999999
Q ss_pred ecccccccccCCCCCceeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhc
Q 002278 759 LSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKA 833 (943)
Q Consensus 759 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 833 (943)
|+|||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|+.||..............
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 240 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence 999999876543222 122345899999999875 34578899999999999999999999976544333222111
Q ss_pred cccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 834 DDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
. ..+.... ......+.+++..||+.||.+|||+.|++++
T Consensus 241 ~-------~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 241 N-------PPPKLKS----KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred C-------CCCCCcc----cccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 1 0111110 0123567899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.37 Aligned_cols=248 Identities=29% Similarity=0.416 Sum_probs=197.0
Q ss_pred EEeeeceEEEEEEEecC-------CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 623 IVGYGASSTVYKCALKN-------SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.||+|+||.||+|..++ +..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998653 2568999875443 244667889999999999999999999999999999999999
Q ss_pred cCCChhhhccCCC----CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC-----ceeecccccc
Q 002278 695 VNGSLWDLLHGPS----KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-----DAHLSDFGIA 765 (943)
Q Consensus 695 ~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~DFGla 765 (943)
++|+|.+++.... ....+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999986321 223478999999999999999999998 999999999999999877 8999999999
Q ss_pred cccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccC
Q 002278 766 RCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 766 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||.............. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~----- 232 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-GGRL----- 232 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-CCcc-----
Confidence 76533211 11112235678999999999999999999999999999998 9999976554433222211 1100
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
... ......+.+++.+||..+|++||+++++.+.|.
T Consensus 233 -~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 233 -QKP-----ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -CCc-----ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 011 012356779999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=303.66 Aligned_cols=250 Identities=27% Similarity=0.410 Sum_probs=207.5
Q ss_pred ccccceEEeeeceEEEEEEEecC-CceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 617 NLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
+|+..+.||+|++|.||+|..+. ++.||+|++..... .....+.+|++++++++||||+++++++..+...++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 57888999999999999999874 88999999866543 44678999999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
++++|.+++.. ...+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 82 DGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999963 3668999999999999999999999 8 999999999999999999999999999987654332
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc--cHHHHHHHhccccccccccCcccccCcc
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES--NLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
.. ....++..|+|||...+..++.++|+||||+++|+|+||+.||.... ............. .+.....
T Consensus 156 ~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~-- 226 (264)
T cd06623 156 QC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP------PPSLPAE-- 226 (264)
T ss_pred cc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC------CCCCCcc--
Confidence 22 23458899999999999899999999999999999999999998664 3333222222111 1111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.....+.+++..|++.+|++||++.+++++
T Consensus 227 --~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 --EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 022577899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=309.80 Aligned_cols=262 Identities=23% Similarity=0.285 Sum_probs=198.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367888999999999999999976 578999999864332 223456789999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|++ ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLD-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCC-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 997 5899888632 34688999999999999999999999 99999999999999999999999999987543221
Q ss_pred CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHH-HhccccccccccCcc-----
Q 002278 773 PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM-SKADDNTVMEAVDPE----- 845 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~----- 845 (943)
.. .....++..|+|||+..+ ..++.++||||+||++|||++|+.||........... .............+.
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 11 122246889999998875 4588999999999999999999999976542222111 111000000000000
Q ss_pred --------------cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 846 --------------VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 846 --------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
+..............+++..|++.+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000001111456789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=306.51 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=200.5
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc------ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP------HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
+|+..+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778889999999999999864 678999998864331 134578899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC-ceeeccccccccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-DAHLSDFGIARCI 768 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFGla~~~ 768 (943)
||||+++++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|||.+..+
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999986 344688999999999999999999999 999999999999998776 5999999999876
Q ss_pred CCCCCc---eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 769 PTAMPH---ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 769 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
...... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||................. ....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS---ATTAPS 231 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc---cCCCCC
Confidence 443211 12234588999999999888899999999999999999999999975432211111110000 000111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
++ ......+.+++..|+..+|++||++.+++++
T Consensus 232 ~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 232 IP-----EHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred Cc-----hhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11 1123567789999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=304.59 Aligned_cols=252 Identities=19% Similarity=0.303 Sum_probs=189.0
Q ss_pred EEeeeceEEEEEEEecCCc---eEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCC
Q 002278 623 IVGYGASSTVYKCALKNSR---PIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGS 698 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 698 (943)
.||+|+||+||+|...++. .+++|.+.... ....+.+.+|+..++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999865433 45566654432 2345678999999999999999999999999999999999999999
Q ss_pred hhhhccCCCC-CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC-Ccee
Q 002278 699 LWDLLHGPSK-KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM-PHAS 776 (943)
Q Consensus 699 L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~-~~~~ 776 (943)
|.+++..... ....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999864321 23467778889999999999999998 99999999999999999999999999986432211 1112
Q ss_pred eeEecccceeCcccccc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 777 TFVLGTIGYIDPEYAHT-------SRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
....|+..|+|||+... ..++.++|||||||++|||++ |..||................ .....+|.+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ--QVKLFKPQLEL 236 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhc--ccccCCCccCC
Confidence 23457889999998753 245789999999999999997 577887655443333222111 11122233221
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
. ....+.+++..|| .+|++||+++++++.|.
T Consensus 237 ~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 237 P-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred C-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1 1245667889999 57999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.04 Aligned_cols=247 Identities=24% Similarity=0.406 Sum_probs=198.8
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
+.|+..+.||+|+||.||++.. .++.||+|.+... .....+.+|+.+++.++|||++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688899999999999999875 4778999988543 2346788999999999999999999998764 5799999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+|+|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence 99999998643 234588999999999999999999998 999999999999999999999999999976432211
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
....+..|+|||.+.+..++.++|+|||||++|||++ |+.||........ ......... .+ ..+ .
T Consensus 156 --~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~-~~-~~~---------~ 221 (254)
T cd05083 156 --NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-KECVEKGYR-ME-PPE---------G 221 (254)
T ss_pred --CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-HHHHhCCCC-CC-CCC---------c
Confidence 1224568999999998899999999999999999998 9999976544322 222211111 00 011 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....+.+++.+||+.+|++||+++++++.++.
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 12467799999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.66 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=202.5
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999975 57889999886442 33456788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC-CceeecccccccccCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-FDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DFGla~~~~~~~ 772 (943)
+++++|.+++... ....+++..+.+++.+++.|++|||++ +++||||||+||+++++ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999642 234589999999999999999999999 99999999999999854 468999999998765432
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
. .....|+..|+|||...+..++.++||||||+++|+|++|+.||.................. .....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------- 224 (256)
T cd08220 157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDR------- 224 (256)
T ss_pred c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---CCCCC-------
Confidence 2 12245889999999999888999999999999999999999999876543332222211110 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
....+.+++..||+.+|++|||+.+++++
T Consensus 225 --~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 225 --YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 12457789999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=306.26 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=203.6
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
+|+..+.||+|+||.||+|.++ +++.||+|.+.... ....+++.+|+++++.++||||+++++++..+...++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677788999999999999987 57889999886553 344567889999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
++++|.+++... ...+++..+..++.|++.|++|||+ . +++||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999998742 2578999999999999999999999 7 999999999999999999999999999876533221
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc----cHHHHHHHhccccccccccCcccccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES----NLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.. ..|+..|+|||...+..++.++||||+|+++|+|++|+.||.... ............ ..+.....
T Consensus 157 ~~---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 227 (265)
T cd06605 157 KT---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE------PPPRLPSG 227 (265)
T ss_pred hc---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC------CCCCCChh
Confidence 11 558899999999999999999999999999999999999997542 222222211111 11111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.....+.+++..||..+|++|||+.+++.+-+
T Consensus 228 ----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 228 ----KFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred ----hcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 02346778999999999999999999988743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.30 Aligned_cols=267 Identities=23% Similarity=0.254 Sum_probs=204.8
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Ccce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSP--YGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 688 (943)
..++|+..+.||+|+||.||+|.++ +++.||+|++..... .....+.+|++++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4578999999999999999999976 588999998864332 2233566899999999999999999998765 4579
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+. ++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+...
T Consensus 85 lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999996 5788887632 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc-
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV- 846 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 846 (943)
...... .....++..|+|||.+.+ ..++.++||||+||++|||++|++||...+............+......++.+
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 543222 222346788999998875 45789999999999999999999999877665554433332211111111100
Q ss_pred --------cc---CccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 847 --------SV---TCVD-----LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 847 --------~~---~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.. .... ......+.+++..|++.||++|||+.++++|-+-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 00 0000 00134567899999999999999999999986643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.43 Aligned_cols=256 Identities=26% Similarity=0.408 Sum_probs=202.3
Q ss_pred hccccceEEeeeceEEEEEEEec-----CCceEEEEEecccCcc-cHHHHHHHHHHHhcCCCCCcceeeeEEec--CCcc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-----NSRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALS--PYGN 687 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 687 (943)
+.|+..+.||+|+||.||+|... .+..||+|.+...... ..+.+.+|+++++.+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677789999999999999854 3678999998755443 46789999999999999999999999877 5578
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
+++|||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999642 33589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce--eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHH--------------HHHHH
Q 002278 768 IPTAMPHA--STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLH--------------QLIMS 831 (943)
Q Consensus 768 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~--------------~~~~~ 831 (943)
........ .....++..|+|||...+..++.++||||||+++|||+||+.|+....... .+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65322211 111234567999999998899999999999999999999999986432211 01111
Q ss_pred hccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 832 KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
...... ... ......++.+++.+|++.+|++|||+.|+++.|..+
T Consensus 239 ~~~~~~--------~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGER--------LPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCc--------CCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 110000 000 011225688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.60 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=198.3
Q ss_pred cccceEEeeeceEEEEEEEec----CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc-----
Q 002278 618 LSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYG----- 686 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 686 (943)
|...+.||+|+||.||+|.++ .++.||+|.+.... ....+++.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999864 35789999886542 2345678899999999999999999999865432
Q ss_pred -ceEEEEEccCCChhhhccCCC---CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccc
Q 002278 687 -NLLFYDYMVNGSLWDLLHGPS---KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDF 762 (943)
Q Consensus 687 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DF 762 (943)
.++++||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 368899999999988764211 223578999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcccccccc
Q 002278 763 GIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVME 840 (943)
Q Consensus 763 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 840 (943)
|.++........ ......+++.|++||......++.++|||||||++|||++ |++||............... ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~- 235 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRLK- 235 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcCC-
Confidence 999866432211 1112235678999999998889999999999999999999 89998765543322222211 1110
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
..+ .....+.+++.+|++.+|++||++.++++.|+.+
T Consensus 236 -~~~---------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 -QPP---------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -CCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011 1124678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.76 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=202.8
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+-|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 35677888999999999999865 57889999875432 23446788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++. ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||++........
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999985 24589999999999999999999998 999999999999999999999999999876643321
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......|+..|+|||...+..++.++|+|||||++|+|++|..||............... . .+.+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~------~~~~~~----- 223 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-N------PPTLEG----- 223 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-C------CCCCCc-----
Confidence 122345788999999998888999999999999999999999999765433222221111 0 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.....+.+++..|++.+|++||++.+++++-+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 255 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 11245778999999999999999999999743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=344.32 Aligned_cols=253 Identities=26% Similarity=0.338 Sum_probs=203.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
+-++.....||.|.||.||.|... .|.-.|+|-+.-.. ........+|+.++..++|||+|++||+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 456777889999999999999965 57778999775332 334456789999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
|||.+|+|.+++.. ....++.....+..|++.|++|||++ |||||||||.||+++.+|.+|.+|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999962 33355555566888999999999999 9999999999999999999999999999887543
Q ss_pred C---CceeeeEecccceeCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 772 M---PHASTFVLGTIGYIDPEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 772 ~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
. +..-....||+.|||||++.+ ++...++||||+|||+.||+||+.||...++-.+++........ |.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~------Pq 1461 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK------PQ 1461 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC------CC
Confidence 2 122234569999999999976 35778999999999999999999999877665555554433221 11
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
++.. ...+-.+++..|+..||++|-++.|++++-
T Consensus 1462 ~P~~-----ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1462 IPER-----LSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred Cchh-----hhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 2111 123445899999999999999999998874
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=309.08 Aligned_cols=263 Identities=20% Similarity=0.225 Sum_probs=200.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCc-----
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIR-HRNIVSLHGYALSPYG----- 686 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 686 (943)
++|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999976 57899999875433 223457888999999995 6999999999987665
Q ss_pred ceEEEEEccCCChhhhccCCCC--CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-CCceeecccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSK--KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-NFDAHLSDFG 763 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFG 763 (943)
.++||||+++ +|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 78888753221 34689999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 842 (943)
+++.+...... .....+++.|+|||++.+ ..++.++||||||+++|||++|..||.+.....................
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99865432221 122346889999998765 4578999999999999999999999987766655443322111111111
Q ss_pred Cccc------------ccC---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 843 DPEV------------SVT---CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 843 ~~~~------------~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.+.. ... .........+.+++..|+.++|++||++.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1000 000 0000123567889999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.35 Aligned_cols=250 Identities=21% Similarity=0.349 Sum_probs=202.2
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCC---CCCcceeeeEEecCCcceEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIR---HRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 691 (943)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+++.+|+++++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677788999999999999974 67899999886442 344567889999999986 999999999999998999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++++|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999852 3689999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||............ .. ...+.+...
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-~~------~~~~~~~~~- 225 (277)
T cd06917 155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-PK------SKPPRLEDN- 225 (277)
T ss_pred ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-cc------CCCCCCCcc-
Confidence 322 223458999999998875 45789999999999999999999999865443222111 10 011112111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.....+.+++..||+.||++||++.+++++-+
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~ 257 (277)
T cd06917 226 ---GYSKLLREFVAACLDEEPKERLSAEELLKSKW 257 (277)
T ss_pred ---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence 12346778999999999999999999988644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=306.17 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=203.1
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC------
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPY------ 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 685 (943)
++++|+..+.||+|++|.||+|..+ +++.+|+|.+.... ...+.+.+|+++++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999986 56789999876443 3456789999999999 6999999999997644
Q ss_pred cceEEEEEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 3799999999999999886422 235789999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHT-----SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM 839 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 839 (943)
+......... .....|+..|+|||++.. ..++.++|||||||++|+|++|+.||................
T Consensus 160 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---- 234 (275)
T cd06608 160 SAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---- 234 (275)
T ss_pred ceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC----
Confidence 9765433222 223458899999998754 346789999999999999999999998654443333222111
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.+.+.. .......+.+++.+|+..||++|||+.+++++
T Consensus 235 ---~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 235 ---PPTLKS---PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ---CCCCCc---hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111110 11123567799999999999999999999876
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.36 Aligned_cols=261 Identities=21% Similarity=0.252 Sum_probs=202.1
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY----- 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 685 (943)
..++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999976 68899999986432 333456778999999999999999999986443
Q ss_pred -cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 686 -GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 686 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
..++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 4689999995 588887752 288899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc----
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME---- 840 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---- 840 (943)
++....... .....|+..|+|||.+.+..++.++||||+||++|+|++|+.||...+....+.......+....
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 987644322 22335789999999999999999999999999999999999999876554443332211111000
Q ss_pred ----------------------ccCcccccC----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 841 ----------------------AVDPEVSVT----CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 841 ----------------------~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+..... .........+.+++.+|++.||++|||+.|++++-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 000000000 000112345779999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=316.61 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=200.9
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC------cceE
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPY------GNLL 689 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 689 (943)
+...+.||+||||.||+|+.+ .|+.||||.+.... ....+...+|++++++++|||||+++++-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445567999999999999965 69999999997654 445567789999999999999999998865443 5689
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC--CCC--ceeecccccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID--ENF--DAHLSDFGIA 765 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~kl~DFGla 765 (943)
|||||.||||+..+..+.+...+++.+.+.+..+++.||.|||++ +||||||||.||++- ++| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999999888888899999999999999999999999 999999999999994 334 4899999999
Q ss_pred cccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcc----HHHHHHHhcccc-ccc
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESN----LHQLIMSKADDN-TVM 839 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~----~~~~~~~~~~~~-~~~ 839 (943)
+.+++.. .....+||..|.|||+... +.|+..+|.|||||++|+.+||..||-.... .+....+..... ...
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9887654 4455779999999999995 8899999999999999999999999963322 222222222211 111
Q ss_pred ccc----------CcccccCc-cCHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHhhc
Q 002278 840 EAV----------DPEVSVTC-VDLSAVRKTFQLALLCTKRYPSERP--TMQEVARVLVSL 887 (943)
Q Consensus 840 ~~~----------~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RP--t~~el~~~L~~~ 887 (943)
... ...++..+ ........+...+..++..+|++|- .+.+..+.+..+
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 100 01111111 1123334556677777888888887 555544444333
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=297.08 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=207.1
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
|+..+.||+|++|.||+|..+ +++.+++|++..........+.+|+++++.++||+|+++++++..+...++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 677889999999999999986 6788999998766555667899999999999999999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
++|.+++... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 82 ~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 82 GSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 9999998642 25689999999999999999999998 999999999999999999999999999987654432 2
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....|+..|+|||...+..++.++||||||+++|+|++|+.||............... .. +...... ...
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-----~~~~~~~---~~~ 224 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--GP-----PGLRNPE---KWS 224 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--CC-----CCcCccc---ccC
Confidence 3456889999999999888999999999999999999999999876544333322221 11 1111000 012
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 857 RKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
..+.+++..|++.||++|||+.+++++
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 567899999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.89 Aligned_cols=262 Identities=23% Similarity=0.295 Sum_probs=202.2
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
+|+..+.||+|++|.||+|+.+ +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999986 57889999886543 233566778999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
+ ++|.+++........+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 7 48888876443345689999999999999999999998 9999999999999999999999999999765432211
Q ss_pred eeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc----------ccC
Q 002278 775 ASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME----------AVD 843 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~ 843 (943)
.....++..|+|||++.+. .++.++||||+||++|+|++|+.||.+................... ...
T Consensus 157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1223478899999988664 5789999999999999999999999876554433322211100000 000
Q ss_pred cccccCc------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 844 PEVSVTC------VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 844 ~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
..++... ........+.+++..|++.||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 000123467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.68 Aligned_cols=251 Identities=21% Similarity=0.313 Sum_probs=201.2
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--CcceEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGNLLFY 691 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 691 (943)
+|+..+.||.|+||.||+|... +++.||+|.+.... ....+.+..|+++++.++||||+++++++... ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778889999999999999865 57889999886432 33445688899999999999999999988643 4568999
Q ss_pred EEccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhh-----hCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 692 DYMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLH-----HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 692 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
||+++++|.+++... .....+++..++.++.|++.||+||| +. +++||||||+||+++.++.+|++|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998642 12457899999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
.......... ....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......... ... +.
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~-~~~-----~~ 229 (265)
T cd08217 158 KILGHDSSFA-KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIKE-GKF-----RR 229 (265)
T ss_pred ccccCCcccc-cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-HHHHHHHhc-CCC-----CC
Confidence 8775443212 234589999999999988899999999999999999999999986652 222222111 111 11
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
++. .....+.+++..|++.+|++||++.+++++
T Consensus 230 ~~~-----~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 IPY-----RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred Ccc-----ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 122567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=309.27 Aligned_cols=262 Identities=22% Similarity=0.249 Sum_probs=201.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--CcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 689 (943)
.++|+..+.||+|+||.||+|.++ +++.+|+|++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357888899999999999999986 57889999886443 22234567899999999999999999999877 78999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+. ++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 84 VMEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999997 5898888632 23689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc------
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV------ 842 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 842 (943)
..... .....+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||................+......
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 43222 2223478899999988764 468999999999999999999999987655443322211111000000
Q ss_pred -------------CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 843 -------------DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 843 -------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
...+............+.+++..|++.+|++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000010013457789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=304.56 Aligned_cols=247 Identities=24% Similarity=0.291 Sum_probs=202.9
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
+|+..+.||+|+||.||+|.+. .++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 58889999986543 2345678899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+.+++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999863 35789999999999999999999998 99999999999999999999999999998664432
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc--HHHHHHHhccccccccccCcccccCc
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN--LHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... .......... ......+.
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~----- 224 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADVLYPAT----- 224 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccccCccc-----
Confidence 12234588899999999988899999999999999999999999986553 2222222111 11111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTM--QEVARV 883 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~--~el~~~ 883 (943)
....+.+++.+||+.||.+||++ +|++++
T Consensus 225 ----~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 225 ----WSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred ----CcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 12567789999999999999999 776654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.35 Aligned_cols=260 Identities=23% Similarity=0.272 Sum_probs=200.1
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
|+..+.||.|++|.||+|.++ ++..||+|++.... ....+.+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999975 68899999886443 223457888999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
+ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 4 68999886432 23689999999999999999999998 9999999999999999999999999999765433221
Q ss_pred eeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc------c--
Q 002278 775 ASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP------E-- 845 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~-- 845 (943)
. ....++..|+|||++.+. .++.++||||||+++|+|++|+.||.......................++ .
T Consensus 156 ~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 Y-THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred c-CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 1 222468899999987664 57899999999999999999999998766544433322211111110000 0
Q ss_pred --cc---cCc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 846 --VS---VTC---VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 846 --~~---~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
+. ... ........+.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000 000112467789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.43 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=208.9
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++.|+....||+|++|.||+|.++ ++..||+|++..... ..+.+.+|+++++.++|+||+++++++......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 5667888889999999999999987 678899999865443 46778899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999997422 3799999999999999999999998 99999999999999999999999999987654332
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
. ......++..|+|||++.+..++.++|||||||++|+|++|+.||.................. ....+
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~-------- 239 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP--PLKNP-------- 239 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCcch--------
Confidence 2 222335788999999998888999999999999999999999999876554433332211110 00000
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
......+.+++.+|++.+|.+||++.+++++.+
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 012246778999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=304.40 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=196.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHH-HhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELET-IGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++|+..+.||+|+||.||+|.++ +++.||+|++.... .....++..|+.. ++..+||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999976 58899999886543 2234455566665 666789999999999999999999999
Q ss_pred EccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 693 YMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 693 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
|++ |+|.+++... .....+++..++.++.|++.|++|||+++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6887776532 23356899999999999999999999843 8999999999999999999999999999865432
Q ss_pred CCceeeeEecccceeCcccccc----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcc-HHHHHHHhccccccccccCccc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHT----SRLNEKSDVYSFGIVLLEILTGKKAVDNESN-LHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
. ......|+..|+|||.+.+ ..++.++|+||+||++|||++|+.||..... .......... ..+.+
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~ 228 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-------PSPQL 228 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-------CCCCC
Confidence 1 1222458899999998865 4568899999999999999999999975332 2222221111 11111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
... .....+.+++..|+..+|++||++.+++++-+
T Consensus 229 ~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 263 (283)
T cd06617 229 PAE----KFSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263 (283)
T ss_pred Ccc----ccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 111 11246778999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.95 Aligned_cols=261 Identities=26% Similarity=0.290 Sum_probs=202.4
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--CcceEEEE
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGNLLFYD 692 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 692 (943)
|+..+.||+|+||.||+|... .++.+|+|++.... ......+.+|+++++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999977 47889999997653 34456788999999999999999999999888 78999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|++ ++|.+++... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 997 4888887632 24689999999999999999999998 99999999999999999999999999998775543
Q ss_pred CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc---
Q 002278 773 PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV--- 848 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 848 (943)
........++..|+|||.+.+ ..++.++||||||+++|||+||+.||.......................++....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 222333457889999997765 4578999999999999999999999987665433332221111111110110000
Q ss_pred ---------------CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 849 ---------------TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 849 ---------------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
..........+.++++.|+..+|++||++.+++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~ 285 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence 000000145778999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.75 Aligned_cols=256 Identities=21% Similarity=0.263 Sum_probs=210.0
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.....|.+...||+|.|+.|..|++. .+..||+|.+.+.. ....+.+.+|+++|..++|||||+++.+.......|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 35678889999999999999999976 58999999887654 2334568899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+.+|.+++++. ..++..+..+..++.|+..|++|+|++ .|||||||++||+++.+..+||+|||++.++.
T Consensus 133 V~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999997 455566788899999999999999999 99999999999999999999999999999887
Q ss_pred CCCCceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
.. ......+|++.|.|||++.+..| ++++|+||+|+++|.|+.|..||++..-..-.-+.......+ +-.+.
T Consensus 207 ~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI----p~~ms- 279 (596)
T KOG0586|consen 207 YG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI----PFYMS- 279 (596)
T ss_pred cc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc----cceee-
Confidence 44 33345679999999999999776 489999999999999999999998654221111111111111 11111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
..+.+++++++-.+|.+|++.+++.++-|.-..
T Consensus 280 --------~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 280 --------CDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred --------chhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 244578999999999999999999998775443
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=303.13 Aligned_cols=259 Identities=26% Similarity=0.332 Sum_probs=201.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecC--CcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSP--YGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 691 (943)
++|...+.||.|++|.||+|.+. .++.+|+|.+..... ....++.+|+++++.++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778899999999999999986 578889998864432 3456788999999999999999999998654 3579999
Q ss_pred EEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 692 DYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998875321 245688999999999999999999999 999999999999999999999999999875533
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc----HHHHHHHhccccccccccCccc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN----LHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
... ....++..|+|||...+..++.++||||+||++|+|++|+.||..... ............. .......
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 232 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--PELKDEP 232 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--hhhccCC
Confidence 221 123478899999999988999999999999999999999999985521 1111111111010 0000000
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
. ........+.+++.+||+.+|++|||+.|++++-+
T Consensus 233 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 233 G---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred C---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0 00112356789999999999999999999999755
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=298.89 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=201.9
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|+||.||+|..+ ++..||+|.+.... ....+.+.+|+++++.++|+||+++++.+..+...++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999976 47889999885432 23456788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC-ceeecccccccccCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-DAHLSDFGIARCIPTAM 772 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFGla~~~~~~~ 772 (943)
+++++|.+++... ....+++..+..++.|+++|++|||+. +++|+||||+||++++++ .+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999998642 223579999999999999999999999 999999999999999875 47999999998765432
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.. .....|++.|+|||+..+..++.++|+||||+++|||++|+.||............. ... . ....+.+
T Consensus 157 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~-~-~~~~~~~------ 226 (257)
T cd08225 157 EL-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGY-F-APISPNF------ 226 (257)
T ss_pred cc-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccc-C-CCCCCCC------
Confidence 22 223458899999999988889999999999999999999999997654333222211 111 1 1111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
...+.+++.+|+..+|++|||+.+++++
T Consensus 227 ---~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 227 ---SRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 2467789999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.79 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=200.1
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCChh
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLW 700 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 700 (943)
..||+|+||.||+|..+ +++.||+|++..........+.+|+.+++.++|+||+++++++...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999875 67899999986554455667889999999999999999999999999999999999999999
Q ss_pred hhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeEe
Q 002278 701 DLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780 (943)
Q Consensus 701 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 780 (943)
+++. ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++........ ......
T Consensus 106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 9874 23578999999999999999999999 999999999999999999999999999876643322 223345
Q ss_pred cccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHH
Q 002278 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTF 860 (943)
Q Consensus 781 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 860 (943)
|++.|+|||...+..++.++|+||+||++|||++|+.||............... .++.+... ......+.
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~---~~~~~~l~ 247 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-------LPPKLKNL---HKVSPSLK 247 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-------CCcccCCc---ccCCHHHH
Confidence 889999999998888999999999999999999999999865544332221111 11111100 01124567
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 861 QLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 861 ~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+++.+|++.+|.+||++.+++++-+
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhcChH
Confidence 8999999999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=313.29 Aligned_cols=266 Identities=23% Similarity=0.320 Sum_probs=203.4
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC----Ccc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP----YGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~ 687 (943)
.++|+..+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368889999999999999999976 58899999986542 23456778899999999999999999987643 457
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+. |+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 68988886 344589999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCCc---eeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc-
Q 002278 768 IPTAMPH---ASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV- 842 (943)
Q Consensus 768 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 842 (943)
....... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+..............+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 1123468899999998765 4688999999999999999999999987655443322221111110000
Q ss_pred ---------------CcccccCc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 843 ---------------DPEVSVTC--VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 843 ---------------~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
........ ........+.++++.|++.+|++||++.+++.+.+-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 00000000 0001235678999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=284.33 Aligned_cols=261 Identities=21% Similarity=0.319 Sum_probs=204.4
Q ss_pred cCHHHHHHHhhccccceEEeeeceEEEEEEE-ecCCceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEec
Q 002278 606 HTFDDIMRSTENLSEKYIVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALS 683 (943)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 683 (943)
.+|+|...-++. .||+|+||.|-.+. ..++..||||++.+.......++.+|++++.+.+ |+||+.++++|++
T Consensus 73 g~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 356777666664 59999999999988 5689999999998887778889999999999996 9999999999999
Q ss_pred CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC---ceeec
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF---DAHLS 760 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~ 760 (943)
++..|+|||-|.||+|..+++ ....+.+.++.+++.+|+.||.|||.+ ||+|||+||+|||..+.. -|||+
T Consensus 148 d~~FYLVfEKm~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred cceEEEEEecccCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence 999999999999999999997 456799999999999999999999999 999999999999997544 38999
Q ss_pred ccccccccCC--C----CCceeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc-----
Q 002278 761 DFGIARCIPT--A----MPHASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESN----- 824 (943)
Q Consensus 761 DFGla~~~~~--~----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~----- 824 (943)
||.++.-... . ....-...+|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+||.+.-.
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 9988754311 1 111122346899999999753 24589999999999999999999999963211
Q ss_pred ---------HHHHHH-HhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 825 ---------LHQLIM-SKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 825 ---------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.. +......+++.-|..++ .+--+++...+..|+.+|-++.+++.|-+-
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS---------~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHIS---------SEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCcCChhhhHHhh---------HHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 111222 22222233333222222 233467888888999999999999986653
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=312.73 Aligned_cols=262 Identities=24% Similarity=0.306 Sum_probs=198.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----cc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPY-----GN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 687 (943)
.++|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999875 57899999986432 234456788999999999999999999876543 46
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++++||+. +++.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 89999996 58887774 34689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc--eeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc-cccc--
Q 002278 768 IPTAMPH--ASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT-VMEA-- 841 (943)
Q Consensus 768 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~~-- 841 (943)
....... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+......+.......+. ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 5432211 1123458899999998754 56889999999999999999999999765543332221110000 0000
Q ss_pred -------------c--CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 842 -------------V--DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 842 -------------~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
. .+..............+.+++.+||+.+|++|||+.+++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0 000000000001134678999999999999999999999983
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=305.92 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=201.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.+.|...+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999976 578999998854322 2345688999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||++ |++.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99996 577776642 234689999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeeeEecccceeCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAH---TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
. ....|+..|+|||++. ...++.++||||||+++|||+||+.||.+............... +.+.
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-------~~~~ 235 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-------PTLS 235 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-------CCCC
Confidence 2 1235788999999874 35688999999999999999999999987655443332221111 1111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.......+.+++.+||..+|++||++.+++.+.+-
T Consensus 236 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 236 ----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred ----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 11123567899999999999999999999988653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=301.35 Aligned_cols=247 Identities=21% Similarity=0.240 Sum_probs=194.0
Q ss_pred EeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 624 VGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
||+|+||+||+|..+ +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 57899999886432 22344567899999999999999999999999999999999999999
Q ss_pred hhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeE
Q 002278 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV 779 (943)
Q Consensus 700 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 779 (943)
.+++.... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 99986432 23689999999999999999999999 99999999999999999999999999997654321 12223
Q ss_pred ecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHH
Q 002278 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKT 859 (943)
Q Consensus 780 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 859 (943)
.++..|+|||+..+..++.++||||+||++|+|++|+.||........................+.+ ...+
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 225 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF---------SPEA 225 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccC---------CHHH
Confidence 4788999999998888999999999999999999999999755431111111111000011111111 2466
Q ss_pred HHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 860 FQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 860 ~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
.+++.+||+.+|++|| ++.+++.|-+
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~ 256 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVREHPL 256 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHHhChh
Confidence 7899999999999999 7777877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=312.16 Aligned_cols=260 Identities=24% Similarity=0.292 Sum_probs=200.3
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC--cc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ--YPHNLREFETELETIGSI-RHRNIVSLHGYALSPY--GN 687 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~ 687 (943)
..++|+..+.||+|+||.||+|.+. +++.+|+|++... .......+.+|+.+++++ +||||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999976 5788999988543 233445677899999999 9999999999986543 57
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999996 589888852 2688999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCC----ceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc--
Q 002278 768 IPTAMP----HASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME-- 840 (943)
Q Consensus 768 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-- 840 (943)
...... .......|+..|+|||++.+ ..++.++||||||+++|+|+||+.||................+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643321 12233458999999998765 56789999999999999999999999866554433322221111100
Q ss_pred --------------ccC----cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 841 --------------AVD----PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 841 --------------~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
... ........ .....+.+++..|++.+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLP--KASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhcc--CCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 00000000 123567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=329.42 Aligned_cols=268 Identities=18% Similarity=0.194 Sum_probs=190.9
Q ss_pred HhhccccceEEeeeceEEEEEEEecC--CceEEEEE--------------ec---ccCcccHHHHHHHHHHHhcCCCCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN--SRPIAVKK--------------LY---NQYPHNLREFETELETIGSIRHRNI 674 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~ni 674 (943)
..++|++.+.||+|+||+||+|..+. +..++.|. +. .........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987643 22222221 10 1112234567899999999999999
Q ss_pred ceeeeEEecCCcceEEEEEccCCChhhhccCCCC--CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC
Q 002278 675 VSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSK--KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID 752 (943)
Q Consensus 675 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 752 (943)
|++++++...+..++++|++. +++.+++..... ........+..++.|++.||+|||++ +||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999984 577776643211 12234567788999999999999999 999999999999999
Q ss_pred CCCceeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCC-CCCC--ccHHHHH
Q 002278 753 ENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKA-VDNE--SNLHQLI 829 (943)
Q Consensus 753 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p-~~~~--~~~~~~~ 829 (943)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +... ....+..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987755433333345699999999999999999999999999999999998754 4322 1222222
Q ss_pred HHhccccccccccCc-------------------ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 830 MSKADDNTVMEAVDP-------------------EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 830 ~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..........+.+.. .+............+.+++.+|++.||++|||+.|++++-+
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 221111110110000 00000000001134567789999999999999999998754
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.63 Aligned_cols=265 Identities=26% Similarity=0.285 Sum_probs=202.9
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC----
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY---- 685 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 685 (943)
+..++|+..+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 47889999886432 233456788999999999999999999987654
Q ss_pred ------cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 686 ------GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 686 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
..++|+||+++ ++.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 67899999976 67666653 234689999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccc
Q 002278 760 SDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838 (943)
Q Consensus 760 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 838 (943)
+|||++...............++..|+|||.+.+ ..++.++||||+||++|||++|++||...................
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998765433222222346788999998765 457899999999999999999999998766554443332221111
Q ss_pred ccccCcccccC-----------------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 839 MEAVDPEVSVT-----------------CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 839 ~~~~~~~~~~~-----------------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.....+.+... .........+.+++..||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111110000 0000113567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=305.35 Aligned_cols=265 Identities=22% Similarity=0.265 Sum_probs=199.3
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc----
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYG---- 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 686 (943)
..++|+..+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467899999999999999999976 57899999885432 2223456789999999999999999999876543
Q ss_pred ----ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccc
Q 002278 687 ----NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDF 762 (943)
Q Consensus 687 ----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DF 762 (943)
.++||||+. +++.+.+.. ....+++.++..++.|++.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 499999985 578887753 234689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc---eeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccc
Q 002278 763 GIARCIPTAMPH---ASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838 (943)
Q Consensus 763 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 838 (943)
|++..+...... ......++..|+|||.+.+. .++.++||||||+++|||+||+.||................+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999866432211 11234578899999988764 47889999999999999999999998766544333222211111
Q ss_pred ccccCcccc-----------cC--------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 839 MEAVDPEVS-----------VT--------CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 839 ~~~~~~~~~-----------~~--------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.....|... .. .........+.+++..|+..||++|||++++++|-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~ 308 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD 308 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence 111111110 00 00000123556899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=295.80 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=199.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEeccc-----CcccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Ccc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ-----YPHNLREFETELETIGSIRHRNIVSLHGYALSP--YGN 687 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 687 (943)
.+|...+.||+|+||.||+|.++ +++.||+|.+... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999975 5789999987422 123345788999999999999999999998764 347
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++++||+++++|.+++. ....+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999886 334588999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC--ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 768 IPTAMP--HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 768 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
...... .......|+..|+|||+..+..++.++|+|||||++|||++|+.||............... +.....++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~p~~ 233 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTKPMLPDG 233 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC--CCCCCCCcc
Confidence 532111 1112345889999999999888999999999999999999999999876554443322211 111111111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
....+.+++..|+. +|.+||++.+++.|
T Consensus 234 ---------~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 234 ---------VSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---------cCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 12467789999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=298.47 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=197.5
Q ss_pred EeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 624 VGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
||.|+||.||+|.... ++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999764 7899999886432 23446788999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeE
Q 002278 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV 779 (943)
Q Consensus 700 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 779 (943)
.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.++...... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999963 34589999999999999999999998 99999999999999999999999999998765432 22234
Q ss_pred ecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc--cHHHHHHHhccccccccccCcccccCccCHHHHH
Q 002278 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES--NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVR 857 (943)
Q Consensus 780 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (943)
.|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||.... ............. .+.++.. ...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~-----~~~ 221 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG------KLEFPNY-----IDK 221 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC------CCCCCcc-----cCH
Confidence 58899999999988889999999999999999999999997655 2222221111010 1111111 124
Q ss_pred HHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 002278 858 KTFQLALLCTKRYPSERPT-----MQEVARVLV 885 (943)
Q Consensus 858 ~l~~l~~~cl~~dP~~RPt-----~~el~~~L~ 885 (943)
.+.+++..||+.+|++||+ +.|++++-+
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 6789999999999999999 888887644
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=302.43 Aligned_cols=263 Identities=22% Similarity=0.257 Sum_probs=198.9
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++|+..+.||+|++|+||+|..+ +++.||+|++..... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999976 578899998854322 234568889999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-CCceeecccccccccCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-NFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFGla~~~~~~ 771 (943)
|++ +++.+++... ....+++..+..++.|++.||+|||++ +++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 5787777532 223468888999999999999999999 9999999999999985 567999999999765432
Q ss_pred CCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC-------
Q 002278 772 MPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD------- 843 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 843 (943)
... .....+++.|+|||++.+ ..++.++||||+||++|+|+||+.||....................+..+
T Consensus 157 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 VRT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred ccc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 211 122347889999998866 45789999999999999999999999876554444332211111111000
Q ss_pred ------cccccCc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 844 ------PEVSVTC---VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 844 ------~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
+...... ........+.+++.+|++.+|++||++.+++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~ 285 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE 285 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0000000 0001124567899999999999999999999863
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=326.80 Aligned_cols=259 Identities=22% Similarity=0.243 Sum_probs=215.6
Q ss_pred HHHHHHhhccccceEEeeeceEEEEEEEecC-CceEEEEEecc---cCcccHHHHHHHHHHHhcCCCCCcceeeeEEecC
Q 002278 609 DDIMRSTENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYN---QYPHNLREFETELETIGSIRHRNIVSLHGYALSP 684 (943)
Q Consensus 609 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 684 (943)
.+++...+.|.+.++||+|+||.|..++.+. ++.||+|++.+ ......+.|..|.++|..-..+=||.++-.|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 4445567889999999999999999999875 57779998865 2234456788999999999999999999999999
Q ss_pred CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
...|+||||++||+|..++. ...++++..+..++..|+.||.-+|+. |+|||||||+|||+|..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999997 344799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccc--c
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHT-----SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN--T 837 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~--~ 837 (943)
+-.+..+........+|||.|++||++.. +.|++.+|.||+||++|||+.|..||+.+.-.+++-.+..... .
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS 301 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence 98887666666667789999999998762 5699999999999999999999999998887777777665522 2
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHh
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT---MQEVARVLV 885 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~el~~~L~ 885 (943)
+++..+ ++ ...-++|+..+. +|+.|-. +.++..|..
T Consensus 302 FP~~~~--VS---------eeakdLI~~ll~-~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 302 FPDETD--VS---------EEAKDLIEALLC-DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred CCcccc--cC---------HHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence 332221 22 344566766554 5888887 999988764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.51 Aligned_cols=242 Identities=24% Similarity=0.273 Sum_probs=186.8
Q ss_pred EEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHH---hcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 623 IVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETI---GSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
.||+|+||.||+|... +++.+|+|.+..... .....+.+|..++ ...+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999976 578899998864321 1122334444433 34479999999999999999999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++........
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 999999886 345699999999999999999999999 999999999999999999999999999975543221
Q ss_pred eeeEecccceeCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc--HHHHHHHhccccccccccCcccccCccC
Q 002278 776 STFVLGTIGYIDPEYAH-TSRLNEKSDVYSFGIVLLEILTGKKAVDNESN--LHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
....|+..|+|||... +..++.++||||+||++|||++|+.||..... ........ .. ....++.
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~----~~~~~~~---- 220 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT----VNVELPD---- 220 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hc----CCcCCcc----
Confidence 2235899999999886 45689999999999999999999999974322 11111111 00 1111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
.....+.+++..|++.||++|| +++++++|.+
T Consensus 221 -~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 221 -SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred -ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 1124677899999999999999 6999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=296.59 Aligned_cols=247 Identities=22% Similarity=0.273 Sum_probs=191.7
Q ss_pred HHHHHHHhhccccceEE--eeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEec
Q 002278 608 FDDIMRSTENLSEKYIV--GYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALS 683 (943)
Q Consensus 608 ~~~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 683 (943)
..++....++|+..+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34455556677776666 99999999999976 567788888754322111 22222222 69999999999999
Q ss_pred CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC-ceeeccc
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-DAHLSDF 762 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DF 762 (943)
++..++||||+++|+|.+++.. ...+++.++..++.|+++|++|||+. +++||||||+||+++.++ .++|+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 9999999999999999999863 33789999999999999999999999 999999999999999888 9999999
Q ss_pred ccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccH----HHHHHHhcccccc
Q 002278 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL----HQLIMSKADDNTV 838 (943)
Q Consensus 763 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~----~~~~~~~~~~~~~ 838 (943)
|+++...... ...|+..|+|||++.+..++.++||||+||++|||++|+.||...... ..+.... ..
T Consensus 155 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~- 225 (267)
T PHA03390 155 GLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QK- 225 (267)
T ss_pred ccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cc-
Confidence 9998664332 234789999999999989999999999999999999999999744321 1111111 00
Q ss_pred ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 002278 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT-MQEVARV 883 (943)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~el~~~ 883 (943)
.....+ .....+.+++..|++.+|.+||+ ++++++|
T Consensus 226 ~~~~~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 KLPFIK---------NVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cCCccc---------ccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000111 12246778999999999999996 6999876
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=307.90 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=196.0
Q ss_pred ccccceEEeeeceEEEEEEEecC---CceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Ccce
Q 002278 617 NLSEKYIVGYGASSTVYKCALKN---SRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGNL 688 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 688 (943)
+|+..+.||+|+||.||+|..+. ++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788899999999999999764 6899999987632 34456778899999999999999999999988 7789
Q ss_pred EEEEEccCCChhhhccCCC--CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC----CCceeeccc
Q 002278 689 LFYDYMVNGSLWDLLHGPS--KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE----NFDAHLSDF 762 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~DF 762 (943)
+||||+++ ++.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 6766654221 223689999999999999999999999 9999999999999999 899999999
Q ss_pred ccccccCCCCC--ceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHH---------HHHH
Q 002278 763 GIARCIPTAMP--HASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLH---------QLIM 830 (943)
Q Consensus 763 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~---------~~~~ 830 (943)
|+++....... .......++..|+|||++.+. .++.++|||||||++|||++|++||....... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 112234578999999987764 57899999999999999999999997543211 0000
Q ss_pred Hhccccc--------------ccc----ccCcccccCc----cCH--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 831 SKADDNT--------------VME----AVDPEVSVTC----VDL--SAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 831 ~~~~~~~--------------~~~----~~~~~~~~~~----~~~--~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
....... ... .......... ... .....+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 000 0000000000 000 122467889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=302.82 Aligned_cols=258 Identities=17% Similarity=0.193 Sum_probs=182.8
Q ss_pred hhccccceEEeeeceEEEEEEEecCC----ceEEEEEecccCcccH-----------HHHHHHHHHHhcCCCCCcceeee
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNS----RPIAVKKLYNQYPHNL-----------REFETELETIGSIRHRNIVSLHG 679 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 679 (943)
.++|.+.+.||+|+||+||+|...++ ..+|+|.......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999997654 3455554322211110 11123344556778999999999
Q ss_pred EEecCC----cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC
Q 002278 680 YALSPY----GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF 755 (943)
Q Consensus 680 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 755 (943)
++.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 775543 2366777663 466666542 23357888999999999999999999 999999999999999999
Q ss_pred ceeecccccccccCCCCC------ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHH
Q 002278 756 DAHLSDFGIARCIPTAMP------HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLI 829 (943)
Q Consensus 756 ~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~ 829 (943)
.++|+|||+|+.+..... .......||+.|+|||+..+..++.++|||||||++|||++|+.||.+.......+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643211 11122459999999999999999999999999999999999999998653322222
Q ss_pred HHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 830 MSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.....+ .......+..... .....+.+++..|++.+|++||++.++.+.+
T Consensus 244 ~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCD-FIKRLHEGKIKIK----NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHH-HHHHhhhhhhccC----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111100 0000000111000 1125678999999999999999999998865
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=302.79 Aligned_cols=254 Identities=27% Similarity=0.384 Sum_probs=202.8
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
+.|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777888999999999999975 57889999886432 233456888999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||++ |++.+++.. ....+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9996 577777652 234689999999999999999999999 9999999999999999999999999998755332
Q ss_pred CCceeeeEecccceeCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 772 MPHASTFVLGTIGYIDPEYAH---TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
....|++.|+|||++. ...++.++|||||||++|||++|+.||.................. ....
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~ 246 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-------TLQS 246 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC-------CCCC
Confidence 2235888999999874 456889999999999999999999999876544433332222111 0110
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
......+.+++.+|++.+|.+||++.+++++.+......
T Consensus 247 ----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 247 ----NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ----ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 012245778999999999999999999999887655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=293.37 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=206.1
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|++|.||+|... .++.||+|.+..... .....+.+|++++++++|||++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778889999999999999876 578899999876543 4556789999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++.. ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999863 35789999999999999999999999 999999999999999999999999999987754433
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
. .....|+..|+|||...+..++.++||||+|+++|+|++|+.||................. ....+.+
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~------- 223 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH---PPLPEGI------- 223 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC---CCCCCCC-------
Confidence 2 2234588999999999888889999999999999999999999987665444333221111 1111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
...+.+++.+|+..+|++||++.+++.+
T Consensus 224 --~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 224 --SPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred --CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 2466789999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=301.02 Aligned_cols=257 Identities=23% Similarity=0.252 Sum_probs=195.0
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCC-CCCcceeeeEEecC--CcceEEEE
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIR-HRNIVSLHGYALSP--YGNLLFYD 692 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 692 (943)
|+..+.||+|+||.||+|..+ +++.||+|++.... ........+|+.+++++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567788999999999999975 57889999886542 222334457888898885 99999999999887 78899999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|++ |++.+.+.. ....+++.++..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 578887753 234689999999999999999999999 9999999999999999 999999999998764332
Q ss_pred CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc----------c
Q 002278 773 PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME----------A 841 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------~ 841 (943)
.. ....++..|+|||+..+ ..++.++||||+||++|||++|+.||.+.+............+...+ .
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 22 22357899999997654 55789999999999999999999999876544332222111111000 0
Q ss_pred cCcccccCc------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 842 VDPEVSVTC------VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 842 ~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
....++... ........+.+++.+|++++|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 001124678899999999999999999999886
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.30 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=206.3
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecC--CcceEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSP--YGNLLFY 691 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 691 (943)
+|...+.||+|++|.||+|..+ +++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999987 688999998865542 4467889999999999999999999999988 7899999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++++|.+++.. ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999863 33789999999999999999999998 9999999999999999999999999999877554
Q ss_pred CCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 772 MPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 772 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
... ......++..|+|||...+...+.++||||||+++|+|++|+.||.................. . +.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~----~~~~~-- 227 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE-P----PEIPE-- 227 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCC-C----cCCCc--
Confidence 321 122345889999999999888999999999999999999999999876533322222211011 1 11111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.....+.+++.+|+..+|++||++.+++++-
T Consensus 228 ---~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 228 ---HLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred ---ccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 1135678899999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=281.51 Aligned_cols=267 Identities=23% Similarity=0.270 Sum_probs=205.9
Q ss_pred hhccccceEEeeeceEEEEEEEecC-----CceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEec-CCc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-----SRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALS-PYG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 686 (943)
...|+.+..||+|.||.||+|.-++ ...+|+|+++.... ......-+|+..++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4578899999999999999996442 23789999976532 223456789999999999999999999877 778
Q ss_pred ceEEEEEccCCChhhhccC--CCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC----Cceeec
Q 002278 687 NLLFYDYMVNGSLWDLLHG--PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN----FDAHLS 760 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~ 760 (943)
.++++||++. +|..+++. ......++...+..|+.||+.|+.|||+. =|+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999865 78888753 22335789999999999999999999998 79999999999999877 899999
Q ss_pred ccccccccCCCCCc--eeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCc---------cHHHH
Q 002278 761 DFGIARCIPTAMPH--ASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNES---------NLHQL 828 (943)
Q Consensus 761 DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~---------~~~~~ 828 (943)
|||+|+.+...... ....++-|.+|+|||++.|. -|+.+.||||.|||..||+|-++.|.+.. ...++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999988543221 23346679999999999886 48999999999999999999988886431 23344
Q ss_pred HHHhccccccccccCcccccCccC----------------HH--------HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 829 IMSKADDNTVMEAVDPEVSVTCVD----------------LS--------AVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~----------------~~--------~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.++....+...+..+|.+.....- .. ....-++++..++..||.+|.|+.+.+++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 444444444444444443211100 00 012256889999999999999999999875
Q ss_pred h
Q 002278 885 V 885 (943)
Q Consensus 885 ~ 885 (943)
-
T Consensus 339 y 339 (438)
T KOG0666|consen 339 Y 339 (438)
T ss_pred c
Confidence 3
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=307.86 Aligned_cols=262 Identities=25% Similarity=0.280 Sum_probs=205.1
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----cce
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY-----GNL 688 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 688 (943)
+|+..+.||+|+||.||+|... .++.||+|++.... ....+.+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999976 47899999987644 344567889999999999999999999998775 679
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
++|||++ ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 588888863 34799999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCC--ceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc-
Q 002278 769 PTAMP--HASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP- 844 (943)
Q Consensus 769 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 844 (943)
..... .......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||.+..............+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54421 112234578899999999887 78999999999999999999999998766544333322211111110000
Q ss_pred ---------------ccccCc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 845 ---------------EVSVTC--VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 845 ---------------~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...... ........+.+++.+||+.+|++||++.+++++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 000000 00012356778999999999999999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.07 Aligned_cols=257 Identities=27% Similarity=0.330 Sum_probs=195.4
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|+||.||++.+. .++.||+|++.... ......+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999976 57899999986543 234557889999999996 99999999999998899999999
Q ss_pred ccCCChhhhccC--CCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 694 MVNGSLWDLLHG--PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 694 ~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
+. +++.++... ......+++..+..++.+++.||+|||+.+ +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 455443221 112356899999999999999999999732 8999999999999999999999999999765433
Q ss_pred CCceeeeEecccceeCccccccC---CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTS---RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
... ....|+..|+|||++.+. .++.++||||+||++|||++|+.||................. .+.+..
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~ 233 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD------PPILSN 233 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC------CCcCCC
Confidence 221 223488999999998876 688999999999999999999999976543222111111111 111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.. .......+.+++.+|++.+|++|||+.+++++-+
T Consensus 234 ~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 234 SE-EREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred cC-CCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00 0112356789999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=301.64 Aligned_cols=249 Identities=21% Similarity=0.280 Sum_probs=196.6
Q ss_pred ccccceEEeeeceEEEEEEEec----CCceEEEEEecccC----cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcc
Q 002278 617 NLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQY----PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 687 (943)
+|+..+.||+|+||.||.|... +++.||+|.+.... ....+.+.+|+++++.+ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677889999999999999863 57889999986432 22345678899999999 589999999999998889
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999986 334688999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCceeeeEecccceeCccccccC--CCCCcchhhhHHHHHHHHHhCCCCCCCCcc---HHHHHHHhcccccccccc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTS--RLNEKSDVYSFGIVLLEILTGKKAVDNESN---LHQLIMSKADDNTVMEAV 842 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 842 (943)
.............|+..|+|||...+. .++.++||||||+++|+|++|+.||..... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------ 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------ 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC------
Confidence 644332333345589999999998753 467899999999999999999999964322 122221111111
Q ss_pred CcccccCccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002278 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARV 883 (943)
Q Consensus 843 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~ 883 (943)
+.++. .....+.+++.+|+..||++|| ++.++.++
T Consensus 229 -~~~~~-----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 -PPYPQ-----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -CCCCc-----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11110 1124567899999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=296.23 Aligned_cols=242 Identities=22% Similarity=0.205 Sum_probs=189.0
Q ss_pred eEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHH-hcCCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETI-GSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||.||+|... .++.||+|.+..... .....+..|..++ ...+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 45899999999999975 578999998865432 1223344555544 445899999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
++|.+++. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.....
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 99999986 334689999999999999999999998 9999999999999999999999999998754331
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
....|+..|+|||...+..++.++||||+|+++|||++|..||........+...............+ ...
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 221 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKE---------FCS 221 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccc---------cCC
Confidence 22347889999999988889999999999999999999999998665443332222211111111111 122
Q ss_pred HHHHHHHHHccCCCCCCCCCHH---HHHHH
Q 002278 857 RKTFQLALLCTKRYPSERPTMQ---EVARV 883 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~---el~~~ 883 (943)
..+.+++.+|++.+|++||++. |++.|
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 5678999999999999999664 55444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=301.29 Aligned_cols=259 Identities=23% Similarity=0.279 Sum_probs=203.7
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
|+..+.||+|++|.||+|... +++.+|+|++..... .....+.+|+++++.++||||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999975 678899998865432 24567889999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++ ++.+++... ...+++.++..++.|++.|++|||+. +|+|+||||+||++++++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 65 888877632 25789999999999999999999999 99999999999999999999999999998765443 1
Q ss_pred eeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc-----
Q 002278 775 ASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV----- 848 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 848 (943)
......++..|+|||...+. .++.++||||+|+++|+|+||+.||................+.......+.+..
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 12224578899999998776 789999999999999999999999987666554433322211111111111100
Q ss_pred ------------CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 849 ------------TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 849 ------------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
..........+.+++..||++||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00001234578899999999999999999999876
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=302.71 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=204.5
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 690 (943)
++|...+.||+|+||.||+|..+ +++.||+|.+.... ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999976 68899999886532 233466888999999998 99999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999963 34799999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-------------------ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHH
Q 002278 771 AMP-------------------HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMS 831 (943)
Q Consensus 771 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~ 831 (943)
... .......|+..|+|||...+..++.++||||+|++++++++|+.||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 321 1222345789999999999888999999999999999999999999876543332222
Q ss_pred hccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 002278 832 KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTM----QEVARV 883 (943)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~el~~~ 883 (943)
.......+. .+ ...+.+++..|++.+|++||++ .++++|
T Consensus 235 ~~~~~~~~~----~~---------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 235 LKLEYSFPP----NF---------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HhcCCCCCC----cc---------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 211111111 11 2467799999999999999999 888775
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=301.65 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=197.5
Q ss_pred ccccceEEeeeceEEEEEEEec----CCceEEEEEecccC----cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcc
Q 002278 617 NLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQY----PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 687 (943)
+|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999853 46789999886432 22345678899999999 599999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+++|+|.+++. ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999886 334688999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCceeeeEecccceeCccccccCC--CCCcchhhhHHHHHHHHHhCCCCCCCCccH---HHHHHHhcccccccccc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTSR--LNEKSDVYSFGIVLLEILTGKKAVDNESNL---HQLIMSKADDNTVMEAV 842 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 842 (943)
.............|+..|+|||...+.. .+.++||||||+++|||++|+.||...... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS------- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-------
Confidence 6443332233345899999999987655 788999999999999999999999643221 1111111111
Q ss_pred CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 843 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.+..+.. ....+.+++.+|++.+|++|||+.++.+.+..
T Consensus 228 ~~~~~~~-----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 KPPFPKT-----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCCcc-----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0111111 11356789999999999999998777665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=307.32 Aligned_cols=256 Identities=25% Similarity=0.282 Sum_probs=195.6
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY------ 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 685 (943)
..+|.....||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999975 58899999986532 223456789999999999999999999987543
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..++|+||+. +++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 3589999985 46766542 3588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc--
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV-- 842 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 842 (943)
+...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+..............+......
T Consensus 165 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 165 RHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred cCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 7653321 22357889999999876 4688999999999999999999999987654443332222111000000
Q ss_pred -------------CcccccCcc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 843 -------------DPEVSVTCV---DLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 843 -------------~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.+....... .......+.+++.+|++.||++||++.+++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00112457799999999999999999999987
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.89 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=196.7
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC-cccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY-PHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 690 (943)
..++|+..+.||+|+||.||+|.++. ++.||||.+.... ......+..|+.++.+.. ||||+++++++.++...+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999999875 8899999986543 223455667777776665 99999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
|||+. +++.++... ....+++..+..++.|++.|++|||+ . +|+||||+|+||++++++.+||+|||++..+.
T Consensus 93 ~e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99984 577776643 23468999999999999999999997 5 89999999999999999999999999998664
Q ss_pred CCCCceeeeEecccceeCccccccCC----CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSR----LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
..... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||................. .+.
T Consensus 167 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------~~~ 238 (296)
T cd06618 167 DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE------PPS 238 (296)
T ss_pred CCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC------CCC
Confidence 33222 2234788999999987654 78899999999999999999999975433222221111111 011
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..... .....+.+++.+||+.||++||++.+++++.+
T Consensus 239 ~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 239 LPPNE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 11000 11246788999999999999999999998855
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.54 Aligned_cols=265 Identities=23% Similarity=0.260 Sum_probs=201.6
Q ss_pred HHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC-
Q 002278 609 DDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP- 684 (943)
Q Consensus 609 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 684 (943)
.++...+++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 455667899999999999999999999864 68899999986532 22345678899999999999999999988643
Q ss_pred -----CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 685 -----YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 685 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
...+++++++ +++|.+++. ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence 2356777775 889988875 23589999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccc
Q 002278 760 SDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838 (943)
Q Consensus 760 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 838 (943)
+|||+++..... .....|+..|+|||+..+ ..++.++||||+||++|||++|+.||...................
T Consensus 162 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 162 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred eccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999865332 223457899999998866 568899999999999999999999997655433322221111111
Q ss_pred ccccCcccc---------------cCcc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 839 MEAVDPEVS---------------VTCV---DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 839 ~~~~~~~~~---------------~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.....+.+. .... .......+.+++..|++.||++||++.+++++-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 000000000 0000 0011245779999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=298.98 Aligned_cols=244 Identities=23% Similarity=0.280 Sum_probs=196.0
Q ss_pred EeeeceEEEEEEEecC-CceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 624 VGYGASSTVYKCALKN-SRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
||+|+||.||+|+... ++.+|+|.+..... ...+.+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999999874 88999998865433 3456788999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC------
Q 002278 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP------ 773 (943)
Q Consensus 700 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~------ 773 (943)
.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999863 34689999999999999999999999 999999999999999999999999999876533211
Q ss_pred -ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 -HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......++..|+|||...+..++.++||||||+++||+++|+.||.......................
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 224 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV---------- 224 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccc----------
Confidence 122334578899999999888899999999999999999999999986654333222222111111100
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.....+.+++.+|++.+|++|||+.++.+.+
T Consensus 225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 225 -EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0125677999999999999999994444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=291.24 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=205.9
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|...+.||+|+||.||++.+. ++..||+|++..... .....+.+|+++++.++|||++++++.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999976 578899999865433 4566788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 694 MVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 694 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
+++++|.+++.... ....+++.++..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986432 136799999999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
. ......|++.|+|||...+..++.++|+||+|+++|+|++|+.||................ . +.++.
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---~----~~~~~---- 225 (258)
T cd08215 158 D-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ---Y----PPIPS---- 225 (258)
T ss_pred c-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC---C----CCCCC----
Confidence 2 2233468899999999988889999999999999999999999997655322222111111 1 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.....+.+++..|+..+|++|||+.+++++
T Consensus 226 -~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 -QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 112467789999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=307.83 Aligned_cols=261 Identities=22% Similarity=0.278 Sum_probs=199.5
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----c
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY-----G 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 686 (943)
.++|...+.||+|+||+||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999975 57899999986532 233456778999999999999999999886542 4
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.++||||+. ++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 78888886 345689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc-c----
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM-E---- 840 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~---- 840 (943)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+..............+... +
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 7643321 1223457889999998765 4688999999999999999999999976543322221111100000 0
Q ss_pred ---------------ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 841 ---------------AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 841 ---------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..++..... .......+.+++.+|++.+|++|||+.++++|-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARL--FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHH--cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 000000000 0012356789999999999999999999999843
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=303.51 Aligned_cols=258 Identities=22% Similarity=0.263 Sum_probs=194.4
Q ss_pred EEeee--ceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCC
Q 002278 623 IVGYG--ASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNG 697 (943)
Q Consensus 623 ~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 697 (943)
.||+| +||+||.|.+. .++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 35555 99999999975 68999999886432 233467889999999999999999999999999999999999999
Q ss_pred ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce--
Q 002278 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA-- 775 (943)
Q Consensus 698 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~-- 775 (943)
++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+..........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999886432 23588999999999999999999998 99999999999999999999999998654332111110
Q ss_pred ----eeeEecccceeCccccccC--CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc---------
Q 002278 776 ----STFVLGTIGYIDPEYAHTS--RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME--------- 840 (943)
Q Consensus 776 ----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------- 840 (943)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||...................+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 1112356679999998763 4789999999999999999999999866543333322221110000
Q ss_pred --------------------------ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 841 --------------------------AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 841 --------------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....... ..........+.+++++||..||++|||+.+++++-+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0000000 0001123457889999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=281.02 Aligned_cols=251 Identities=24% Similarity=0.282 Sum_probs=195.7
Q ss_pred hhccccc-eEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhc-CCCCCcceeeeEEecC----Ccc
Q 002278 615 TENLSEK-YIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGS-IRHRNIVSLHGYALSP----YGN 687 (943)
Q Consensus 615 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~----~~~ 687 (943)
+++|++. .+||-|-.|.|..+..+ .++++|+|++... ...++|++.--. -.|||||.++++|... ...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4445443 46899999999999976 5789999998654 556778877443 3699999999998653 346
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC---CCCceeeccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID---ENFDAHLSDFGI 764 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DFGl 764 (943)
.+|||.++||.|+..++.. ....+.+.++..|+.||+.|++|||+. +|+||||||+|+|.+ .+..+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 7899999999999999754 345699999999999999999999999 999999999999996 455699999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHH----HHHHHhcccccccc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLH----QLIMSKADDNTVME 840 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~ 840 (943)
|+..... ......+-|+.|.|||++...+|+...|+||+||++|-|+.|.+||.+..... ...++......+++
T Consensus 211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 9965432 22233457999999999999999999999999999999999999998654311 11111122222222
Q ss_pred ccCcccccCccCHHHH-HHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 841 AVDPEVSVTCVDLSAV-RKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~-~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
+++.++ +..-++|+.+++.+|.+|.|..++++|-|-
T Consensus 289 ----------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi 325 (400)
T KOG0604|consen 289 ----------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI 325 (400)
T ss_pred ----------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence 222222 344579999999999999999999998764
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.59 Aligned_cols=242 Identities=23% Similarity=0.259 Sum_probs=187.8
Q ss_pred EEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHH---HHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 623 IVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETEL---ETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
+||+|+||.||+|... .++.||+|.+..... .....+..|. +.++...||+|+.+++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999875 578999998865321 1112233343 34445679999999999999999999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+|+|.+++. ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||+++.......
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 999999886 345699999999999999999999998 999999999999999999999999999976543322
Q ss_pred eeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccH--HHHHHHhccccccccccCcccccCccC
Q 002278 776 STFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNL--HQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
....|+..|+|||++.++ .++.++||||+||++|||++|+.||...... ........ ...+.++..
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~--- 221 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-------TMAVELPDS--- 221 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-------ccCCCCCCc---
Confidence 223589999999998754 6899999999999999999999999765221 11111110 011111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
....+.+++.+|+..+|++|| ++.+++++-+
T Consensus 222 --~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~ 257 (278)
T cd05606 222 --FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257 (278)
T ss_pred --CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence 124677899999999999999 9999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=281.33 Aligned_cols=273 Identities=22% Similarity=0.291 Sum_probs=216.2
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC------
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP------ 684 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 684 (943)
....|.....||+|.||.||+|+.+ .+++||+|++.-.. ........+|+++++.++|+|++.++..|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 4556777888999999999999976 47889999874322 23345678899999999999999998887432
Q ss_pred --CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccc
Q 002278 685 --YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDF 762 (943)
Q Consensus 685 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DF 762 (943)
...|+||.+|+. +|..++.. ...+++..++.++..++..||.|+|+. .|+|||+||.|++++.+|.+||+||
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence 236899999854 78888863 335799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCC---ceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccc
Q 002278 763 GIARCIPTAMP---HASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838 (943)
Q Consensus 763 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 838 (943)
|+|+.+..... ...+..+-|.+|++||.+.|. .|+++.|||+.||++.||+||.+-+.+.....++..+..-.+..
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99977643221 123334569999999988874 69999999999999999999999999998888887777777776
Q ss_pred ccccCcccccCc----------------------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 839 MEAVDPEVSVTC----------------------VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 839 ~~~~~~~~~~~~----------------------~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
...++|.+.... ..........+++..++..||.+|+++++++.|-+-...+.+
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 666666543110 000011245688999999999999999999998776555443
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=301.91 Aligned_cols=257 Identities=21% Similarity=0.214 Sum_probs=192.3
Q ss_pred EeeeceEEEEEEEecCCceEEEEEeccc--CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCChhh
Q 002278 624 VGYGASSTVYKCALKNSRPIAVKKLYNQ--YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWD 701 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 701 (943)
+|.|+++.||++.. +++.||+|++... .......+.+|+++++.++||||+++++++.+.+..+++|||+++|+|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44455555555444 5889999998654 34456789999999999999999999999999999999999999999999
Q ss_pred hccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC------ce
Q 002278 702 LLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP------HA 775 (943)
Q Consensus 702 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~------~~ 775 (943)
++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+..+..... ..
T Consensus 89 ~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 89 LLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 987432 24588999999999999999999999 999999999999999999999999999875532211 01
Q ss_pred eeeEecccceeCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc-------ccc------
Q 002278 776 STFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT-------VME------ 840 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-------~~~------ 840 (943)
.....++..|+|||++.+ ..++.++||||+||++|||++|+.||.................. ...
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 122346788999999876 35889999999999999999999999866544433222111100 000
Q ss_pred -----ccCcccc---cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 841 -----AVDPEVS---VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 841 -----~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+... ...........+.+++..||..||++|||+++++++-+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0000000 00001122346778999999999999999999999755
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=306.08 Aligned_cols=259 Identities=24% Similarity=0.288 Sum_probs=199.4
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY----- 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 685 (943)
..++|+..+.||+|+||.||+|... ++..||||++.... ......+.+|+++++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 5678999999999999999999865 68899999985432 223456789999999999999999999987654
Q ss_pred -cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 686 -GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 686 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
..++||||+ +++|.+++. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 348999998 789988875 24689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+....... ....+++.|+|||.+.+ ..++.++|+||+||++|++++|+.||......................+.
T Consensus 165 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 165 ARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98654321 22347889999998876 45889999999999999999999999876554433332221111110000
Q ss_pred c---------------ccccC-c--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 844 P---------------EVSVT-C--VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 844 ~---------------~~~~~-~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
. ..... . ........+.+++.+|++.||++|||+.+++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0 00000 0 0001123577899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=298.58 Aligned_cols=247 Identities=22% Similarity=0.297 Sum_probs=204.2
Q ss_pred ceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCC
Q 002278 621 KYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNG 697 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 697 (943)
.+++|+|.||+||-|.++ .|+.||||++.+.. ......+++|+++++.+.||.||.+.-.|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 468999999999999976 68999999996543 344578899999999999999999999999999999999999665
Q ss_pred ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC---CceeecccccccccCCCCCc
Q 002278 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN---FDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 698 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DFGla~~~~~~~~~ 774 (943)
-|.-++. ...+++++.....++.||+.||.|||.+ +|||.||||+|||+.+. .++||||||+|+..+.. .
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 5555554 2567899999999999999999999999 99999999999999643 46999999999998654 2
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.+..++||+.|.|||++..+.|+..-|+||.||++|--++|..||..+.++...+.... ..++..-|.++.
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa--FMyPp~PW~eis------- 792 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA--FMYPPNPWSEIS------- 792 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc--cccCCCchhhcC-------
Confidence 33446799999999999999999999999999999999999999988777665544322 122223333333
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+++|...++..-.+|.+.+..+.|.|
T Consensus 793 --~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 793 --PEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred --HHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 34568888889988999999988877765
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.33 Aligned_cols=249 Identities=22% Similarity=0.291 Sum_probs=203.6
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|+..+.||+|+||.||++..+ +++.+|+|++.... .....++.+|+++++.++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999865 57889999986532 33455678899999999999999999999999999999999
Q ss_pred ccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 694 MVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 694 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
+++++|.+++.... ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999885321 235689999999999999999999999 99999999999999999999999999998765441
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.....|++.|+|||...+..++.++|+||+|+++|||++|+.||...+.......... ... +...
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~-----~~~~----- 222 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR--GKY-----PPIP----- 222 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCC-----CCCc-----
Confidence 1224588999999999998899999999999999999999999986654322221111 111 1111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
......+.+++..|++.+|++||++.+++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1223567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=298.72 Aligned_cols=252 Identities=28% Similarity=0.388 Sum_probs=199.4
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.+.|+..+.||+|+||.||+|..+ ++..+|+|.+... ......++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344777788999999999999976 4678999988532 223345678899999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+. |++.+++.. ....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++++|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99996 678777642 234588999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeeEecccceeCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAH---TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
. ....|++.|+|||++. ...++.++|||||||++|||++|+.||................. +...
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~ 235 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------PALQ 235 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-------CCcC
Confidence 2 2235788999999875 34678899999999999999999999976544332222211111 1111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.......+.+++.+||+.+|++||++.+++++.+...
T Consensus 236 ----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 236 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ----cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0112245778999999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=287.69 Aligned_cols=242 Identities=20% Similarity=0.267 Sum_probs=201.0
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 688 (943)
....|....+||+|+||.|.+|..+. .+.+|||++++.. ....+--..|-++|+... -|.++.++..|+.-+..|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 44568888999999999999998774 5678999887653 223344456777777664 689999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+.||+|..+++ +.+++.++.+.-+|..||-||-+||++ ||++||||..|||+|.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999997 567788999999999999999999999 9999999999999999999999999999743
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
-.. ...+...+|||.|+|||++...+|+..+|.||+||+||||+.|++||++++..+....+.......+..+.
T Consensus 501 i~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslS----- 574 (683)
T KOG0696|consen 501 IFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLS----- 574 (683)
T ss_pred ccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccccc-----
Confidence 222 23344578999999999999999999999999999999999999999998876666555555444443322
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERP 875 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 875 (943)
.+...+.+..+.+.|.+|-
T Consensus 575 --------kEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 575 --------KEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --------HHHHHHHHHHhhcCCcccc
Confidence 3445788888999999985
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=295.30 Aligned_cols=259 Identities=25% Similarity=0.252 Sum_probs=197.2
Q ss_pred cccceEEeeeceEEEEEEEecC-CceEEEEEecccCc--ccHHHHHHHHHHHhcC---CCCCcceeeeEEecCCc-----
Q 002278 618 LSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYP--HNLREFETELETIGSI---RHRNIVSLHGYALSPYG----- 686 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 686 (943)
|+..+.||+|+||.||+|+++. ++.||+|++..... .....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999874 88999999864332 2234566777776655 59999999999988776
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.+++|||+. ++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||.+.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 58888876422 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc------
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME------ 840 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------ 840 (943)
.+...... ....++..|+|||++.+..++.++|||||||++|||++|++||.....................
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 156 IYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 76433221 2234788999999999999999999999999999999999999876654443332221110000
Q ss_pred ------ccCcccccCc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 841 ------AVDPEVSVTC--VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 841 ------~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.......... ........+.+++.+||+.||++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000000 001223566789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.03 Aligned_cols=261 Identities=24% Similarity=0.276 Sum_probs=197.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCC------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPY------ 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 685 (943)
.++|+..+.||+|+||.||+|.++ +++.||+|++..... .....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999976 578999998864432 22346778999999999999999999876544
Q ss_pred --cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 686 --GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 686 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
..++||||+.+ ++.+.+.. ....+++.++..++.|+++||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999864 67666653 234699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc----------eeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHh
Q 002278 764 IARCIPTAMPH----------ASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSK 832 (943)
Q Consensus 764 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 832 (943)
+++........ ..+...|++.|+|||.+.+. .++.++|||||||++|||++|++||.+...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865432211 11234578899999987654 58899999999999999999999998665544332221
Q ss_pred cccccccc-------------------ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 833 ADDNTVME-------------------AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 833 ~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.......+ ...+...... ......+.+++.+|++.||++|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF--GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHc--ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11110000 0000000000 0112467799999999999999999999876
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=306.14 Aligned_cols=262 Identities=22% Similarity=0.308 Sum_probs=197.8
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecC----------
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP---------- 684 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 684 (943)
.+|...+.||+|+||.||+|..+ .++.||+|++........+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67889999999999999999976 5789999998766666667788999999999999999999876554
Q ss_pred ----CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC-CCCceee
Q 002278 685 ----YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHL 759 (943)
Q Consensus 685 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl 759 (943)
...++||||++ ++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+|+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 24689999996 58888874 24588999999999999999999999 999999999999997 5567899
Q ss_pred cccccccccCCCCCce--eeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccc
Q 002278 760 SDFGIARCIPTAMPHA--STFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN 836 (943)
Q Consensus 760 ~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 836 (943)
+|||.++......... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.................
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998654321111 122347889999997654 5688899999999999999999999986655443332221110
Q ss_pred cccc------------cc-----CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 837 TVME------------AV-----DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 837 ~~~~------------~~-----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.... .. .+..+...........+.+++..|+..||++|||+.+++.+-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~ 302 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence 0000 00 0000000000011245678999999999999999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=304.56 Aligned_cols=264 Identities=24% Similarity=0.219 Sum_probs=200.7
Q ss_pred hcccc-ceEEeeeceEEEEEEEec-CCceEEEEEecccCccc--------------HHHHHHHHHHHhcCCCCCcceeee
Q 002278 616 ENLSE-KYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHN--------------LREFETELETIGSIRHRNIVSLHG 679 (943)
Q Consensus 616 ~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 679 (943)
++|.. .+.||+|+||+||+|.++ .++.||+|++....... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 44543 467999999999999976 58899999886432211 124678999999999999999999
Q ss_pred EEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 680 YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 680 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
++...+..++||||+. |+|.+++. ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999996 68988886 345689999999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCC-------------CceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccH
Q 002278 760 SDFGIARCIPTAM-------------PHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNL 825 (943)
Q Consensus 760 ~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~ 825 (943)
+|||.++...... ........++..|+|||.+.+. .++.++||||+||++|||+||+.||.+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998664110 1111223468889999998764 4689999999999999999999999877765
Q ss_pred HHHHHHhccccccccccCc-------------ccccCc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 826 HQLIMSKADDNTVMEAVDP-------------EVSVTC--VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~-------------~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
..........+.......+ ..+... ........+.+++..|++.+|++||++.+++.+-+-
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 5443332211111111000 000000 000112467789999999999999999999987654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=307.55 Aligned_cols=260 Identities=25% Similarity=0.286 Sum_probs=201.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc----
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYG---- 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 686 (943)
..++|+..+.||+|++|.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999976 57889999886432 2334567789999999999999999998876654
Q ss_pred --ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 687 --NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 687 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
.++|+||+ +++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 78999998 6799998852 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+...... .....++..|+|||...+ ..++.++||||+||++||+++|+.||.+..............+...+...
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 9866432 122357889999998765 46789999999999999999999999876654443332221111111100
Q ss_pred cccccC-------------ccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 844 PEVSVT-------------CVD-----LSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 844 ~~~~~~-------------~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+... ... ......+.+++.+|+..+|++|||+.+++++-+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~ 300 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence 000000 000 011356789999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=301.38 Aligned_cols=263 Identities=25% Similarity=0.311 Sum_probs=200.3
Q ss_pred HHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEec-CCc
Q 002278 611 IMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALS-PYG 686 (943)
Q Consensus 611 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 686 (943)
+...+++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446788999999999999999999866 68899999885432 2345678899999999999999999999876 456
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.++++||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||+|+||++++++.++|+|||.+.
T Consensus 85 ~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 78999998 678988875 34578888999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc----
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA---- 841 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 841 (943)
...... ....++..|+|||.+.+ ..++.++||||+||++|||+||+.||................+...+.
T Consensus 157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 553321 22347889999998766 568999999999999999999999997654322221111111100000
Q ss_pred ------------cCc--ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 842 ------------VDP--EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 842 ------------~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
... ..+...........+.+++.+|+..+|++||++.+++.+-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~ 290 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCc
Confidence 000 00000000011256788999999999999999999988743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=296.35 Aligned_cols=259 Identities=22% Similarity=0.282 Sum_probs=198.3
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEEEEc
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-HNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
|+..+.||+|++|+||+|... .++.||+|++..... .......+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567788999999999999986 478899999865432 22334567999999999 999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
+|+|.+++.... ...+++.++..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 889999886432 24689999999999999999999998 9999999999999999999999999999866443221
Q ss_pred eeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc-------------
Q 002278 775 ASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME------------- 840 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------------- 840 (943)
....|+..|+|||++.+ ..++.++|+||||+++|||++|++||................+....
T Consensus 156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 22357889999998754 45789999999999999999999999766544333222111111000
Q ss_pred --ccCcccccCccC--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 841 --AVDPEVSVTCVD--LSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 841 --~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
...........+ ......+.++++.|++.+|++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 0112567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=295.81 Aligned_cols=246 Identities=28% Similarity=0.381 Sum_probs=196.5
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
|...+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999975 578899998864322 2345678899999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+. |++.+++.. ....+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 95 577777753 234689999999999999999999999 9999999999999999999999999998643221
Q ss_pred ceeeeEecccceeCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 774 HASTFVLGTIGYIDPEYAH---TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
....|+..|+|||++. ...++.++|||||||++|||++|+.||................. .....+.
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~----- 244 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNE----- 244 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccc-----
Confidence 2245889999999974 35688899999999999999999999987655444333222111 1111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+.+++.+|++.+|++||++.+++.+-+
T Consensus 245 ----~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 245 ----WTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred ----cCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 1135678999999999999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.40 Aligned_cols=291 Identities=20% Similarity=0.271 Sum_probs=230.8
Q ss_pred hhccccceEEeeeceEEEEEEEecCCc-eEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSR-PIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
..+++.+..||-|+||.|=++..+... .+|+|.+++.. ....+.+..|-++|...+.|.||++|-.|.++...|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345566677999999999999876543 47888776543 34456688899999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
||-|-||.+...++ .++.++..+...++..+.+|++|||++ +||+|||||+|.+++.+|-+||.|||+|+.+..
T Consensus 499 mEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999997 567899999999999999999999999 999999999999999999999999999998866
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
.. .+-..+|||.|.|||++..+.++.++|.||+|+++||++||.+||.+.+++..+..+...-..+. ++..+.
T Consensus 573 g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~--~Pr~I~--- 645 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE--FPRRIT--- 645 (732)
T ss_pred CC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh--cccccc---
Confidence 53 34457899999999999999999999999999999999999999999998877766654433211 111121
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhcC----------CCCCCccCcCCCCCCCcccceeecccc
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPT-----MQEVARVLVSLL----------PAPPAKLSLAAPKPIDYYTKFVVNRER 915 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (943)
+...++++.....+|.+|-- ..++.+|-|-.- -.+|...+.+.|....+|.++. .
T Consensus 646 ------k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~p----~ 715 (732)
T KOG0614|consen 646 ------KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNFP----P 715 (732)
T ss_pred ------hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCCC----c
Confidence 33457888888999999974 788888876432 1234444566666666665443 2
Q ss_pred ccccccCCCCCcc
Q 002278 916 QQRVEHDDNSSDA 928 (943)
Q Consensus 916 ~~~~e~~~~~~~~ 928 (943)
....+++|+.|.|
T Consensus 716 dnd~pppde~SGW 728 (732)
T KOG0614|consen 716 DNDEPPPDELSGW 728 (732)
T ss_pred ccCCCCchhcccC
Confidence 3444554554433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.11 Aligned_cols=256 Identities=26% Similarity=0.325 Sum_probs=197.4
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHhc-CCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-HNLREFETELETIGS-IRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+++....||.|+||+|++-.++ .|+..|||++..... ...+++..|.++..+ -+.||||++||.+..++..++-||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3344556999999999999877 578899999976543 556778888887544 4699999999999999999999999
Q ss_pred ccCCChhhhccC--CCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 694 MVNGSLWDLLHG--PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 694 ~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
|. -|+..+-+. .-.+..+++.-.-.|+...+.||.||-+.. .|+|||+||+|||++..|.+|+||||++-.+..+
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 84 455443211 113456888888889999999999998764 8999999999999999999999999999776543
Q ss_pred CCceeeeEecccceeCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 772 MPHASTFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.. .+.-.|-..|||||.+.. ..|+.++||||+|++|||+.||+.||...+.....+.......+. .+..+
T Consensus 222 iA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp------~l~~~ 293 (361)
T KOG1006|consen 222 IA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP------ILLFD 293 (361)
T ss_pred HH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC------eecCc
Confidence 22 223358889999998864 458999999999999999999999999877655444433332221 11112
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
..+......+..++..|+.+|-..||.+.++.++
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2222334678899999999999999999998775
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=319.89 Aligned_cols=261 Identities=27% Similarity=0.365 Sum_probs=208.1
Q ss_pred HhhccccceEEeeeceEEEEEEEecC--------CceEEEEEecccCc-ccHHHHHHHHHHHhcCC-CCCcceeeeEEec
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN--------SRPIAVKKLYNQYP-HNLREFETELETIGSIR-HRNIVSLHGYALS 683 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 683 (943)
..++....+.+|+|+||.||+|.... ...||||.++.... ...+.+..|+++|+.+. ||||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 44555566699999999999998541 35689999876543 45678899999999995 9999999999999
Q ss_pred CCcceEEEEEccCCChhhhccCCC------C-----C--ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEE
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGPS------K-----K--VKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNIL 750 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~~------~-----~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 750 (943)
.+..++|+||+..|+|.++++..+ . . ..++..+.+.++.|||.|++||++. ++|||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEE
Confidence 999999999999999999997543 0 0 2388999999999999999999999 9999999999999
Q ss_pred ECCCCceeecccccccccCCCCCceeeeEec--ccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHH
Q 002278 751 IDENFDAHLSDFGIARCIPTAMPHASTFVLG--TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQ 827 (943)
Q Consensus 751 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~ 827 (943)
++++..+||+|||+|+..............| +..|||||.+....|+.++|||||||+|||++| |..||.+......
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 9999999999999999665443333221222 456999999999999999999999999999999 9999987543333
Q ss_pred HHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 828 LIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.......... .+.+. .+..+++++|+.||+.+|++||++.++.+.+....
T Consensus 531 l~~~l~~G~r------~~~P~-----~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 LLEFLKEGNR------MEQPE-----HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHhcCCC------CCCCC-----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 3322221111 11111 12357889999999999999999999999998753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=322.31 Aligned_cols=146 Identities=29% Similarity=0.369 Sum_probs=130.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|.+.+.||+|+||+||+|.+. .++.||+|++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367889999999999999999977 57899999986532 22346788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
|||+.+++|.+++. ....+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~---~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLH---IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999986 334688999999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=296.00 Aligned_cols=260 Identities=25% Similarity=0.276 Sum_probs=202.0
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
|+....||+|++|.||+|... +++.||+|.+.... ....+.+..|+++++.++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999976 48899999987653 334567788999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
+ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.++........
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 5899998732 14689999999999999999999999 9999999999999999999999999999876443221
Q ss_pred eeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc------------
Q 002278 775 ASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA------------ 841 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 841 (943)
.....++..|+|||.+.+. .++.++|||||||++||+++|+.||....................+.
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 1223467889999998776 78999999999999999999999998765544333222111100000
Q ss_pred -cCcccccCcc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 842 -VDPEVSVTCV---DLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 842 -~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
..+....... .......+.+++..|+..+|++||++.+++.+-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p 280 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence 0000000000 001135688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=299.13 Aligned_cols=262 Identities=21% Similarity=0.243 Sum_probs=194.7
Q ss_pred ccccceEEeeeceEEEEEEEecC---CceEEEEEecccC--cccHHHHHHHHHHHhcC-CCCCcceeeeEEecC----Cc
Q 002278 617 NLSEKYIVGYGASSTVYKCALKN---SRPIAVKKLYNQY--PHNLREFETELETIGSI-RHRNIVSLHGYALSP----YG 686 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 686 (943)
+|+..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47778899999999999999763 6789999886432 22345678899999999 599999999976432 34
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.++++||+. ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888875 68988885 345689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---eeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc-
Q 002278 767 CIPTAMPH---ASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA- 841 (943)
Q Consensus 767 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 841 (943)
........ ......|+..|+|||+..+ ..++.++||||+||++|+|++|++||................+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432111 1123458999999998765 468999999999999999999999998665433322211111100000
Q ss_pred -----------------cCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 842 -----------------VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 842 -----------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+..............+.+++.+|++.||++|||+.+++++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 00000000000011246789999999999999999999988754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=289.67 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=196.1
Q ss_pred ccccceEEeeeceEEEEEEEecC-CceEEEEEeccc-----CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQ-----YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
+|...+.||+|+||.||++.+.. +..+++|.++.. .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788899999999999998764 344555554321 122334577899999999999999999999998899999
Q ss_pred EEEccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 691 YDYMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
|||+++++|.+++... .....+++.+++.++.|++.|++|||+. +++|+||||+||++++ +.++++|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888532 2335689999999999999999999999 9999999999999975 569999999998764
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.... ......|++.|+|||...+..++.++|+||||+++|+|++|..||................ .+...
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~-- 226 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-------TPSLP-- 226 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC-------CCCCc--
Confidence 3322 1223447889999999988889999999999999999999999997655433332222111 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
......+.+++.+|++.+|++||++.+++++
T Consensus 227 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 227 ---ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1223467789999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=250.34 Aligned_cols=260 Identities=21% Similarity=0.246 Sum_probs=207.6
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|...+.||+|.||+||+|+.+ .++.||+|++.-.. +.......+|+-+++.++|.|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566778999999999999976 46789999886432 33345678999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
|. .+|..+... -.+.++.+.+..++.|+++|+.|+|++ ++.|||+||+|.+++.+|+.|++|||+|+.++-...
T Consensus 83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 94 467666642 356789999999999999999999999 999999999999999999999999999997765432
Q ss_pred ceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCc-
Q 002278 774 HASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC- 850 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 850 (943)
..+..+-|.+|.+|.++.+. -|++..|+||.||++.|+.. |++.|.+.+..+++.++...-+...+..+|.+..-.
T Consensus 157 -cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred -eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 22333468999999999885 58999999999999999987 888888888788888877766666666555442110
Q ss_pred -------cC----HHHH----HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 851 -------VD----LSAV----RKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 851 -------~~----~~~~----~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
+. ...+ ..-.++++..+.-+|.+|.++++.+++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 00 0111 122467777888889999999888776
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=286.38 Aligned_cols=240 Identities=25% Similarity=0.296 Sum_probs=194.9
Q ss_pred EeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 624 VGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
||+|+||.||++... +++.+|+|.+..... .....+..|+++++.++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 478999998865432 2455788999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeE
Q 002278 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV 779 (943)
Q Consensus 700 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 779 (943)
.+++.. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 999863 34689999999999999999999998 999999999999999999999999999987644321 22234
Q ss_pred ecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHH
Q 002278 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKT 859 (943)
Q Consensus 780 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 859 (943)
.++..|+|||...+...+.++|+||||+++||+++|+.||...... .......... ..++.. ....+
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~~~~~~~~~~-------~~~~~~-----~~~~l 220 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-EIYEKILKDP-------LRFPEF-----LSPEA 220 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHhcCC-------CCCCCC-----CCHHH
Confidence 5788999999999888999999999999999999999999766542 2222221111 111111 12466
Q ss_pred HHHHHHccCCCCCCCCCH---HHHHHH
Q 002278 860 FQLALLCTKRYPSERPTM---QEVARV 883 (943)
Q Consensus 860 ~~l~~~cl~~dP~~RPt~---~el~~~ 883 (943)
.++++.|+..||++||++ .++.++
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred HHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 789999999999999999 666554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=304.18 Aligned_cols=262 Identities=22% Similarity=0.336 Sum_probs=215.6
Q ss_pred CHHHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEec-
Q 002278 607 TFDDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALS- 683 (943)
Q Consensus 607 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 683 (943)
.++.+...++.|++..+||+|.+|.||+++.+ +++..|+|+.. ...+..++++.|.++++.. .|||++.++|+|..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~-~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMD-PTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeec-CCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34555567788999999999999999999966 56777777654 4455667888899999888 59999999999853
Q ss_pred ----CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 684 ----PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 684 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
+++.++|||||.+|+..|+++... ..++.|+.+..|++.++.|+.+||.. .++|||||-.|||++.++.||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 567899999999999999998765 67899999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCceeeeEecccceeCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcc
Q 002278 760 SDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT-----SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD 834 (943)
Q Consensus 760 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 834 (943)
+|||.+..+....... ...+||+.|||||++.- ..|+.++|+||+|++..||.-|.+|+.+..++-.++.+..
T Consensus 165 vDFGvSaQldsT~grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR- 242 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRR-NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR- 242 (953)
T ss_pred eeeeeeeeeecccccc-cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC-
Confidence 9999999886654443 34569999999999864 3477899999999999999999999988776655443322
Q ss_pred ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.-+|.+.. .....+++.++|..|+.+|.++||++.++++|-
T Consensus 243 ------NPPPkLkr---p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 243 ------NPPPKLKR---PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred ------CCCccccc---hhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 22222221 123457888999999999999999999998874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-33 Score=282.50 Aligned_cols=261 Identities=20% Similarity=0.243 Sum_probs=207.7
Q ss_pred hhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCC-C-C----CcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIR-H-R----NIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 687 (943)
+.+|.+...+|+|.||.|-.+.++. +..||+|+++.. ....+...-|+++++++. + | -+|.+.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 7789999999999999999998764 588999988643 344456677999999994 2 3 378888889999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC--------------
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-------------- 753 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-------------- 753 (943)
+||+|.+ |-|+.|++... +..+++...+..|+.|++++++|||+. +++|-||||+||++.+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999987 77999999754 456799999999999999999999999 9999999999999832
Q ss_pred ------CCceeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHH
Q 002278 754 ------NFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQ 827 (943)
Q Consensus 754 ------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~ 827 (943)
+..++++|||.|++..... +..+.|..|+|||++.+-+++.++||||+||||+|+.||...|+.-++.+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 2358999999998654332 456789999999999999999999999999999999999999987776665
Q ss_pred HHHHhcccccccccc---------------------------------CcccccCccCHHHHHHHHHHHHHccCCCCCCC
Q 002278 828 LIMSKADDNTVMEAV---------------------------------DPEVSVTCVDLSAVRKTFQLALLCTKRYPSER 874 (943)
Q Consensus 828 ~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 874 (943)
+.....-.++++... .|.-........+...++++++.|+..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 544333333322111 11111111223456789999999999999999
Q ss_pred CCHHHHHHHHh
Q 002278 875 PTMQEVARVLV 885 (943)
Q Consensus 875 Pt~~el~~~L~ 885 (943)
+|+.|++.|-.
T Consensus 398 iTl~EAL~HpF 408 (415)
T KOG0671|consen 398 ITLREALSHPF 408 (415)
T ss_pred ccHHHHhcCHH
Confidence 99999998743
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=274.17 Aligned_cols=264 Identities=19% Similarity=0.284 Sum_probs=209.2
Q ss_pred HHHHHHhhccccceEEeeeceEEEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEE
Q 002278 609 DDIMRSTENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYA 681 (943)
Q Consensus 609 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 681 (943)
.++.....+++..-.+-+|.||.||.|.+++ .+.|.+|.++... +-....+..|.-.+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3344455666667788999999999997653 3557777775432 33345677888888999999999999998
Q ss_pred ecC-CcceEEEEEccCCChhhhcc-----CCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC
Q 002278 682 LSP-YGNLLFYDYMVNGSLWDLLH-----GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF 755 (943)
Q Consensus 682 ~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 755 (943)
.++ ...+++|.++.-|+|..++. .......+...+...++.|++.|++|||.+ ++||.||.++|.++|+.-
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 765 45688899999999999997 444455678888899999999999999999 999999999999999999
Q ss_pred ceeecccccccccCCCCCceeee-EecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhc
Q 002278 756 DAHLSDFGIARCIPTAMPHASTF-VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKA 833 (943)
Q Consensus 756 ~~kl~DFGla~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 833 (943)
+|||+|=.+++.+-..+.+.-.. ...+..||+||.+....|+.++|||||||+||||+| |+.|+...++.+.......
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 99999999999775554433211 124678999999999999999999999999999999 9999998877665443322
Q ss_pred cccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 834 DDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
+. .+. -+. .++.+++.++.-||..+|++||++++++..|.++
T Consensus 514 Gy-Rla------QP~-----NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 514 GY-RLA------QPF-----NCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred cc-eec------CCC-----CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 21 111 112 2345789999999999999999999999988764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=295.70 Aligned_cols=243 Identities=21% Similarity=0.243 Sum_probs=193.4
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++.|.....+|.|+|+.|-.+... +++..+||.+.+. ..+..+|+.++... .||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 566777778999999999999876 4678899998655 23445677665555 69999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE-CCCCceeecccccccccCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI-DENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~DFGla~~~~~~ 771 (943)
.+.||-+.+.+. ... .....+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~---~~~-~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIR---SKP-EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHH---hcc-hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999998887775 222 23367778999999999999999 99999999999999 58999999999999877554
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
....+=|..|.|||+....+|++++|+||||++||+|++|+.||.....-..+.. ....+++.+.
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~-~i~~~~~s~~---------- 534 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT-RIQMPKFSEC---------- 534 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH-hhcCCccccc----------
Confidence 1112347899999999999999999999999999999999999975443322221 1111211111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
......+++.+|++.||.+||++.++..|-|.
T Consensus 535 ---vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 535 ---VSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---cCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11344589999999999999999999998776
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=275.69 Aligned_cols=225 Identities=23% Similarity=0.256 Sum_probs=178.1
Q ss_pred eceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCChhhhccC
Q 002278 627 GASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHG 705 (943)
Q Consensus 627 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 705 (943)
|.+|.||++.++ +++.||+|++.... .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999976 57889999986542 234455555566799999999999999999999999999999998863
Q ss_pred CCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeEecccce
Q 002278 706 PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY 785 (943)
Q Consensus 706 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y 785 (943)
...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 34589999999999999999999998 99999999999999999999999999886554321 122357789
Q ss_pred eCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHH
Q 002278 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALL 865 (943)
Q Consensus 786 ~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 865 (943)
+|||...+..++.++||||+|+++|||++|+.|+....... . ......++. .....+.+++.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~-----~~~~~~~~~-----~~~~~~~~li~~ 211 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------N-----THTTLNIPE-----WVSEEARSLLQQ 211 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------c-----cccccCCcc-----cCCHHHHHHHHH
Confidence 99999988889999999999999999999998875321100 0 000001110 112456789999
Q ss_pred ccCCCCCCCCCH-----HHHHHH
Q 002278 866 CTKRYPSERPTM-----QEVARV 883 (943)
Q Consensus 866 cl~~dP~~RPt~-----~el~~~ 883 (943)
|++.||++||++ .++++|
T Consensus 212 ~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 212 LLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred HccCCHHHhcCCCccchHHHHcC
Confidence 999999999986 555543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=277.37 Aligned_cols=259 Identities=21% Similarity=0.268 Sum_probs=197.3
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc-Ccc------cHHHHHHHHHHHhcCCCCCcceeeeEEec-C
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ-YPH------NLREFETELETIGSIRHRNIVSLHGYALS-P 684 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 684 (943)
-.++|-..+.||+|||+.||+|.+- ..+.||||+-.-. ... ..+...+|.++-+.+.||.||++|+||.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3567777889999999999999865 4677888865321 111 12235689999999999999999999964 4
Q ss_pred CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC---CCCceeecc
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID---ENFDAHLSD 761 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~D 761 (943)
+..+-|+|||+|.+|.-+|+ ....+++.++..|+.||+.||.||.+. +++|+|-||||.|||+- .-|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 56788999999999999997 455689999999999999999999987 78999999999999994 457899999
Q ss_pred cccccccCCCCCc------eeeeEecccceeCccccccC----CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHH
Q 002278 762 FGIARCIPTAMPH------ASTFVLGTIGYIDPEYAHTS----RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMS 831 (943)
Q Consensus 762 FGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~ 831 (943)
||+++.++++... .+....||.+|.+||.+.-+ ..+.|+||||+|||+|..+.|+.||........+...
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999998654332 23345699999999977533 4678999999999999999999999876544333221
Q ss_pred hccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 832 KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
..+...-.-.++... ....+.-.+|++|+++--++|....++..+
T Consensus 697 ----NTIlkAtEVqFP~KP---vVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 697 ----NTILKATEVQFPPKP---VVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ----hchhcceeccCCCCC---ccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 111111111111000 111344578999999999999999888764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=293.18 Aligned_cols=266 Identities=18% Similarity=0.207 Sum_probs=182.4
Q ss_pred HhhccccceEEeeeceEEEEEEEe-----------------cCCceEEEEEecccCcccHHH--------------HHHH
Q 002278 614 STENLSEKYIVGYGASSTVYKCAL-----------------KNSRPIAVKKLYNQYPHNLRE--------------FETE 662 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 662 (943)
..++|.+.++||+|+||+||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 567899999999999999999964 235679999986443222222 3346
Q ss_pred HHHHhcCCCCCc-----ceeeeEEec--------CCcceEEEEEccCCChhhhccCCC---------------------C
Q 002278 663 LETIGSIRHRNI-----VSLHGYALS--------PYGNLLFYDYMVNGSLWDLLHGPS---------------------K 708 (943)
Q Consensus 663 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------~ 708 (943)
+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766544 677777753 346799999999999999986421 0
Q ss_pred CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeEecccceeCc
Q 002278 709 KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDP 788 (943)
Q Consensus 709 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 788 (943)
...+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++.+............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356788899999999999999999 999999999999999999999999999976543322222223358899999
Q ss_pred cccccCC----------------------CCCcchhhhHHHHHHHHHhCCC-CCCCCccHHHHHHHhccccc-c--cccc
Q 002278 789 EYAHTSR----------------------LNEKSDVYSFGIVLLEILTGKK-AVDNESNLHQLIMSKADDNT-V--MEAV 842 (943)
Q Consensus 789 E~~~~~~----------------------~~~~~DvwSlGvil~elltG~~-p~~~~~~~~~~~~~~~~~~~-~--~~~~ 842 (943)
|.+.... ...+.||||+||++|+|++|.. ||.+................ + ....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1134799999999999999875 66532111111100000000 0 0000
Q ss_pred CcccccCccCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHHh
Q 002278 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYP---SERPTMQEVARVLV 885 (943)
Q Consensus 843 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~el~~~L~ 885 (943)
...+.. .........+++.+++..+| .+|+|++|+++|-+
T Consensus 460 ~~~~~~---~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 460 KYDFSL---LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred CCCccc---ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 111110 00112456688999998766 68999999999865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=269.00 Aligned_cols=239 Identities=27% Similarity=0.360 Sum_probs=196.2
Q ss_pred ceEEEEEEEecC-CceEEEEEecccCccc-HHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCChhhhccC
Q 002278 628 ASSTVYKCALKN-SRPIAVKKLYNQYPHN-LREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHG 705 (943)
Q Consensus 628 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 705 (943)
+||.||+|.... ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 8899999987655444 67899999999999999999999999999999999999999999999863
Q ss_pred CCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeEecccce
Q 002278 706 PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY 785 (943)
Q Consensus 706 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y 785 (943)
. ..+++..+..++.+++.+++|||+. +++|+||+|+||++++++.++++|||.+....... ......++..|
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 2 2388999999999999999999999 99999999999999999999999999998765432 22334578899
Q ss_pred eCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHH
Q 002278 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALL 865 (943)
Q Consensus 786 ~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 865 (943)
+|||...+..++.++||||+|+++|++++|..||.......................... ....+.+++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~i~~ 223 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWK---------ISPEAKDLIRK 223 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccccc---------CCHHHHHHHHH
Confidence 999999988899999999999999999999999987444444333322211111110000 22567889999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 002278 866 CTKRYPSERPTMQEVARV 883 (943)
Q Consensus 866 cl~~dP~~RPt~~el~~~ 883 (943)
|+..+|++||++.+++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 224 LLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HccCCchhccCHHHHhhC
Confidence 999999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=302.26 Aligned_cols=263 Identities=19% Similarity=0.170 Sum_probs=173.1
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-----CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeE------Ee
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-----SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGY------AL 682 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 682 (943)
..++|...+.||+|+||.||+|.+.. +..||+|++...... +....| .++...+.+++.+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999764 588999987543211 111111 1122222222222221 23
Q ss_pred cCCcceEEEEEccCCChhhhccCCCCC-----------------ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 002278 683 SPYGNLLFYDYMVNGSLWDLLHGPSKK-----------------VKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVK 745 (943)
Q Consensus 683 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 745 (943)
.+...++||||+.+++|.+++...... .......+..++.|++.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 456789999999999999988632110 0112344667999999999999999 99999999
Q ss_pred CccEEECC-CCceeecccccccccCCCCCceeeeEecccceeCccccccC----------------------CCCCcchh
Q 002278 746 SSNILIDE-NFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS----------------------RLNEKSDV 802 (943)
Q Consensus 746 p~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 802 (943)
|+|||+++ ++.+||+|||+|+.+............|++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 57999999999987654433334456789999999965422 23456799
Q ss_pred hhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc----cccccCcccccC----ccC-HHHHHHHHHHHHHccCCCCCC
Q 002278 803 YSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT----VMEAVDPEVSVT----CVD-LSAVRKTFQLALLCTKRYPSE 873 (943)
Q Consensus 803 wSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~----~~~-~~~~~~l~~l~~~cl~~dP~~ 873 (943)
||+||++|||+++..|++.. ...+.......+. +.....+..... ... ........+++..|++.||++
T Consensus 363 wSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 99999999999977665432 2222221111110 001111110000 000 001123458999999999999
Q ss_pred CCCHHHHHHHHh
Q 002278 874 RPTMQEVARVLV 885 (943)
Q Consensus 874 RPt~~el~~~L~ 885 (943)
|||+.++++|-+
T Consensus 441 R~ta~e~L~Hpf 452 (566)
T PLN03225 441 RISAKAALAHPY 452 (566)
T ss_pred CCCHHHHhCCcC
Confidence 999999999854
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=281.07 Aligned_cols=209 Identities=21% Similarity=0.272 Sum_probs=175.8
Q ss_pred hhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
..-|..++.||-|+||.|.++...+ ...||.|.+.+.+ ......+..|.++|.....+-||++|-.|.+.+..|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457788899999999999998554 4567999887654 23345677899999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|+|++||++..+|- +.+.|++.-+..++..+..|+++.|.. |+|||||||+|||+|.+|++||.|||+++-+..
T Consensus 708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999986 456788888888999999999999999 999999999999999999999999999864311
Q ss_pred --------CCCce---------------------------------eeeEecccceeCccccccCCCCCcchhhhHHHHH
Q 002278 771 --------AMPHA---------------------------------STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVL 809 (943)
Q Consensus 771 --------~~~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil 809 (943)
...+. ....+||+.|+|||++....|+.-+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00000 0114699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCccHHHHH
Q 002278 810 LEILTGKKAVDNESNLHQLI 829 (943)
Q Consensus 810 ~elltG~~p~~~~~~~~~~~ 829 (943)
|||+.|++||......+...
T Consensus 862 ~em~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQY 881 (1034)
T ss_pred HHHhhCCCCccCCCCCccee
Confidence 99999999998766554433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=262.10 Aligned_cols=258 Identities=24% Similarity=0.316 Sum_probs=198.8
Q ss_pred cceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----cceEEE
Q 002278 620 EKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPY-----GNLLFY 691 (943)
Q Consensus 620 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~ 691 (943)
..+.||.|+||.||.+++. +|+.||.|++..... .+.+.+.+|+.++..++|.||...++...... +.|++.
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 4567999999999999864 789999999865432 34567889999999999999999988875442 457788
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
|.+ ..+|..++- ....++...+.-+.+||++||.|||+. +|.||||||.|.+++++...||+|||+|+..+..
T Consensus 137 ELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 137 ELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 877 457777775 556789999999999999999999999 9999999999999999999999999999987665
Q ss_pred CCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccc-ccc--------
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV-MEA-------- 841 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~-------- 841 (943)
.....+..+-|..|+|||++.|. .|+.+.||||.||++.|++..+..|....+..++..+...-+.. .+.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 55555555578999999999885 58999999999999999999988888766666554433322211 100
Q ss_pred ---------cCccccc----CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 842 ---------VDPEVSV----TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 842 ---------~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..|.++. ...+ ..-..-..+...+++.||++|.+..+.+.++-
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~-~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPD-DKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCc-ccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111111 1111 11123446778899999999999999888753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=296.38 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=188.7
Q ss_pred cccceEEeeeceEE-EEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEEcc
Q 002278 618 LSEKYIVGYGASST-VYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 618 ~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
|...+++|.|+.|+ ||+|... ++.||||++... ...-..+|++.++.- +|||||++|+.-.++...||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44445789999988 7899876 789999998643 335667899999988 4999999999988899999999998
Q ss_pred CCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---C--CceeecccccccccC
Q 002278 696 NGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE---N--FDAHLSDFGIARCIP 769 (943)
Q Consensus 696 ~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~DFGla~~~~ 769 (943)
..+|.|+++.. ...........+.+..|++.|+++||+. +||||||||.|||++. + .+++|+|||+++.++
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999752 1111111144577889999999999998 9999999999999975 3 469999999999986
Q ss_pred CCCCce--eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 770 TAMPHA--STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 770 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
.+.... .....||-+|+|||++.....+.++||||+||++|+.++ |.+||++.- ++-..+......... +.+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~-L~~~~ 739 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVH-LEPLP 739 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceee-eccCc
Confidence 553321 334569999999999999988999999999999999999 599998643 222222222222111 11111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
++ ...++|.+|+++||..||+|.+|+.|
T Consensus 740 -------d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 740 -------DC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -------hH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11 45689999999999999999999887
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=257.60 Aligned_cols=243 Identities=20% Similarity=0.303 Sum_probs=192.5
Q ss_pred hhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 689 (943)
...|...++||+|+|+.|..++++. .+.||+|++++.. .+...-++.|-.+..+. +||.+|.++.+|+.....++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4578889999999999999999764 6778999887653 33444567777777665 69999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
|.||++||+|.-+++ +..+++++.+..+...|+-||.|||++ ||++||||..||++|+.|++|+.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999988887 456799999999999999999999999 99999999999999999999999999997432
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCC------CccHHHHHHHhccccccccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDN------ESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~------~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
. ....++..+|||.|.|||++.+..|...+|.|++||+++||+.|+.||+- +.+.+.+......+..+ .++
T Consensus 403 ~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--rip 479 (593)
T KOG0695|consen 403 G-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIP 479 (593)
T ss_pred C-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--ccc
Confidence 2 23345567899999999999999999999999999999999999999971 11222221111111110 011
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCC
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERP 875 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 875 (943)
..++ .+...+++.-+.+||.+|-
T Consensus 480 rsls---------vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 480 RSLS---------VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ceee---------hhhHHHHHHhhcCCcHHhc
Confidence 1111 2334678888999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=243.49 Aligned_cols=213 Identities=25% Similarity=0.307 Sum_probs=170.4
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHh-cCCCCCcceeeeEEecCCcceE
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-HNLREFETELETIG-SIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~l 689 (943)
...+.+.....||+|++|.|-+-++. +|...|+|++..... +..++..+|+.+.. ...+|.+|.+||........+|
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 34455556667999999999888866 578889999976543 34456778888754 4479999999999999999999
Q ss_pred EEEEccCCChhhhcc-CCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 690 FYDYMVNGSLWDLLH-GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 690 v~e~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
.||.|. -||..+-. .....+..++.-+-+||..+.+||.|||++. .++|||+||+|||++.+|+||+||||.+-.+
T Consensus 123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999984 46655432 1224567899999999999999999999974 8999999999999999999999999999877
Q ss_pred CCCCCceeeeEecccceeCcccccc----CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHH
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHT----SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM 830 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~ 830 (943)
.++... +.-.|-..|||||.+.. ..|+.|+||||+|+++.||.+++.||+......+...
T Consensus 200 ~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk 263 (282)
T KOG0984|consen 200 VDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK 263 (282)
T ss_pred hhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence 654332 22347789999998754 4689999999999999999999999997655444433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=252.35 Aligned_cols=258 Identities=24% Similarity=0.285 Sum_probs=204.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY------ 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 685 (943)
..+|.....+|.|+- .|..|.+. .+++||+|++.... ....++..+|...+..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777778899998 66666654 57899999985442 345677889999999999999999999986543
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
+.|+|||+| .++|...+. ..++-+++..+..|++.|++|||+. +|+||||||+||++..++.+||.|||+|
T Consensus 95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 469999998 568877764 3467788999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC--
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD-- 843 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 843 (943)
+..... ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+.+...+|.++....+...+.+.
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 865443 3456677899999999999988999999999999999999999999999888888877655443221110
Q ss_pred ------------cc--------------cccCcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 844 ------------PE--------------VSVTCV-DLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 844 ------------~~--------------~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
|. ++.... .........+++.+|+..+|++|.+++++++|-
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 00 000000 001223456789999999999999999999984
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=237.03 Aligned_cols=256 Identities=21% Similarity=0.227 Sum_probs=201.1
Q ss_pred hhccccceEEeeeceEEEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecCC--cceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCAL-KNSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALSPY--GNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv 690 (943)
.++|++.+.+|+|.++.||.|.. .+.++++||.++. ...+.+.+|+.+++.+. ||||+++++...++. ...++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45788889999999999999984 4678899998864 34578999999999997 999999999987754 45799
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-CCceeecccccccccC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-NFDAHLSDFGIARCIP 769 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFGla~~~~ 769 (943)
+||+.+.+...+- ..++..++..++.+++.||.|+|+. ||.|||+||.|+|+|. .-..+++|+|+|.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999888776654 3578888999999999999999999 9999999999999995 4569999999999886
Q ss_pred CCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCC-CCccHHHHHHHhccccc---------c
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVD-NESNLHQLIMSKADDNT---------V 838 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~-~~~~~~~~~~~~~~~~~---------~ 838 (943)
.... ....+.+..|--||.+.. ..|+..-|+|||||++..|+..+.||- +.++.++++++...-+. .
T Consensus 185 p~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 185 PGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred CCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 5433 233457788899998876 458899999999999999999888874 66777777776543322 1
Q ss_pred ccccCccccc---------------CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 839 MEAVDPEVSV---------------TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 839 ~~~~~~~~~~---------------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.-.++|.+.. .....-...+..+++...+..|-.+|+|++|.++|-
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 1112332211 000011124667899999999999999999998873
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-29 Score=271.63 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=213.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..++|.....+|.|.||.||+|+++ .++..|+|.++-......+..++|+-+++..+|||||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3457888899999999999999976 578889999987767778888999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
||.+|+|.|.-+ ..+++++.++..+.+...+|++|||+. +-+|||||-.||++++.|.+|++|||.+..+....
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999999876 456899999999999999999999999 88999999999999999999999999997765433
Q ss_pred CceeeeEecccceeCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 773 PHASTFVLGTIGYIDPEYAH---TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
. .+...+||+.|||||+.. .+.|..++|||+.|++..|+---++|..+..++.............+...++.-
T Consensus 167 ~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~k--- 242 (829)
T KOG0576|consen 167 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTK--- 242 (829)
T ss_pred h-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCcc---
Confidence 2 233467999999999764 467999999999999999998888887766665555544444433333333322
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
....+.++++.|+.++|++||++..++.|
T Consensus 243 -----ws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 243 -----WSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred -----chHHHHHHHHHHhcCCCccCCChhhheec
Confidence 22456789999999999999999887654
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-30 Score=264.44 Aligned_cols=422 Identities=20% Similarity=0.188 Sum_probs=273.9
Q ss_pred ccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecC-cccccCCCcccC
Q 002278 53 EISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKN-NQLTGPIPSTLT 131 (943)
Q Consensus 53 ~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-n~l~~~~~~~~~ 131 (943)
++|..+- ...+.|+|..|+|+...|++|+.+.+|+.||||+|.|+.+-|.+|.+|.+|-.|-+-+ |+|+....+.|.
T Consensus 60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~ 137 (498)
T KOG4237|consen 60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG 137 (498)
T ss_pred cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence 4555443 2567888999999977777899999999999999999988888999998887776666 888877777888
Q ss_pred CCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEE
Q 002278 132 QIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEIL 211 (943)
Q Consensus 132 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L 211 (943)
+|..|+.|.+.-|++.....+.|..+++|..|.+.+|.+..+..++|..+..++.+++..|.+- ...+++.+..
T Consensus 138 gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~- 211 (498)
T KOG4237|consen 138 GLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLAD- 211 (498)
T ss_pred hHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccccchhhh-
Confidence 8999999999999988888888888889999999999988888888888888888888888732 1122222221
Q ss_pred EeecccccCcCCCCCCcceEeEEEecCccccccCCcccccc-CCCcEEecCCCCCCCCCC-cccCCCCCcceEEecCCCC
Q 002278 212 DISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLM-QALAVLDLSENELVGPIP-PILGNLSYTGKLYLHGNKL 289 (943)
Q Consensus 212 ~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~l 289 (943)
++.-|.+. ..+..-..-..+.++++....+..|... .++..=-.+.+...++-| ..|..|++|+.|+|++|+|
T Consensus 212 ~~a~~~ie-----tsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i 286 (498)
T KOG4237|consen 212 DLAMNPIE-----TSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI 286 (498)
T ss_pred HHhhchhh-----cccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc
Confidence 11111111 0011112222333444443333333221 222221222333333444 4577777777777777777
Q ss_pred CCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCc-cccc
Q 002278 290 TGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGA-IPSS 368 (943)
Q Consensus 290 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~ 368 (943)
+++-+.+|.++.+++.|.|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+.-- --.+
T Consensus 287 ~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~w 366 (498)
T KOG4237|consen 287 TRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAW 366 (498)
T ss_pred chhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHH
Confidence 777777777777777777777777766666777777777777777777777777777777777777777766310 0011
Q ss_pred ccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCC---ccCCCc---------ccccccc-eeecccccccc
Q 002278 369 FRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG---SVPASI---------GDLEHLL-TLNLSRNHLNG 435 (943)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~---------~~l~~L~-~L~Ls~N~l~~ 435 (943)
+.. .|.++.-.|..| -+....++.+.++++.+.. ..|+.. ..++-+. ....|++.++
T Consensus 367 l~~-------Wlr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk- 436 (498)
T KOG4237|consen 367 LGE-------WLRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK- 436 (498)
T ss_pred HHH-------HHhhCCCCCCCC--CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-
Confidence 111 111222111111 1222345555555554431 122221 1223343 3455555565
Q ss_pred cCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCc
Q 002278 436 LLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYN 503 (943)
Q Consensus 436 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 503 (943)
.+|..+. ..-.+|++.+|.++ .+|.+ .+.+| .++|++|++...--..|.++++|.+|-||+|
T Consensus 437 ~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 437 LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 5665554 45678999999999 78887 67788 8999999999777778899999999999887
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=263.72 Aligned_cols=197 Identities=23% Similarity=0.352 Sum_probs=168.7
Q ss_pred hccccceEEeeeceEEEEEEEecC-CceEEEEEecccC--------cccHHHHHHHHHHHhcCC---CCCcceeeeEEec
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY--------PHNLREFETELETIGSIR---HRNIVSLHGYALS 683 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 683 (943)
..|+....+|.|+||.|+.|.++. ...|++|.+.+.. ......+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458888999999999999999875 4678888876543 112224557999999997 9999999999999
Q ss_pred CCcceEEEEEcc-CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccc
Q 002278 684 PYGNLLFYDYMV-NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDF 762 (943)
Q Consensus 684 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DF 762 (943)
++.+|++||-.. +-+|.+++. .+..+++..+..|+.||+.|+++||+. +|||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 999999999864 458999987 566799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCC
Q 002278 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDN 821 (943)
Q Consensus 763 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~ 821 (943)
|.|.....+. ....+||..|.|||++.|.+| +..-|||++|++||.++....||++
T Consensus 715 gsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9998664432 234579999999999999876 4678999999999999999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=250.73 Aligned_cols=132 Identities=23% Similarity=0.325 Sum_probs=110.6
Q ss_pred hhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCC-----C---CCcceeeeEEec--
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIR-----H---RNIVSLHGYALS-- 683 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 683 (943)
..+|.+.++||.|.|++||+|.+.. .+.||+|+.+. .....+....|+++|++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3688899999999999999999764 57788888753 3455567788999999883 3 369999999965
Q ss_pred --CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE
Q 002278 684 --PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI 751 (943)
Q Consensus 684 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 751 (943)
+.+.++|+|++ |.+|..++... ....++...+.+|++||+.||.|||++| +|+|-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 34679999998 77888888643 3445899999999999999999999998 99999999999997
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=234.02 Aligned_cols=251 Identities=18% Similarity=0.259 Sum_probs=185.8
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeE-EecCCcceEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGY-ALSPYGNLLF 690 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~~~~~lv 690 (943)
-.+.|++.+.+|+|.||.+-+|+++. .+.+|+|.+.+. ....++|.+|...--.+. |.||+.-|++ |+..+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 34678888899999999999999885 466788877554 345688999998765664 8999988776 5667778899
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC--CCCceeeccccccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID--ENFDAHLSDFGIARCI 768 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~DFGla~~~ 768 (943)
+||++.|+|..-+. ...+-+....+++.|++.|+.|+|++ ++||||||.+|||+- +..++|+||||+.+..
T Consensus 101 qE~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999999885 34577888899999999999999999 999999999999993 3347999999999865
Q ss_pred CCCCCceeeeEecccceeCccccccC-----CCCCcchhhhHHHHHHHHHhCCCCCCCC----ccHHHHHHHhccccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTS-----RLNEKSDVYSFGIVLLEILTGKKAVDNE----SNLHQLIMSKADDNTVM 839 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~p~~~~----~~~~~~~~~~~~~~~~~ 839 (943)
+..... ..-+..|.|||+.... ...+.+|||.||+++|..+||+.||+.. ..+..|........+
T Consensus 174 g~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 174 GTTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred Cceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 543222 2235679999976542 3567899999999999999999999732 233333333322221
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHh
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP---TMQEVARVLV 885 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~el~~~L~ 885 (943)
.++..+..- .....++.++-+.++|++|- +++.....+|
T Consensus 248 -~~P~~F~~f------s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 248 -ALPKKFNPF------SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred -cCchhhccc------CHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 222222211 13556788889999999994 4444444443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=254.93 Aligned_cols=263 Identities=21% Similarity=0.175 Sum_probs=210.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC------CCCcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR------HRNIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~ 686 (943)
-..+|.+....|+|-|++|..|.+. .+..||||++.+. ....+.=.+|+++|++|. .-|+++++-.|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 3467888888899999999999976 4789999999764 333445567999999994 3489999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC-Cceeecccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-FDAHLSDFGIA 765 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DFGla 765 (943)
.|+|+|-+ .-+|.++|+.......+....+..++.|+.-||..|-.. +|+|.||||.||||++. ..+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccc
Confidence 99999987 568999998766666788999999999999999999987 99999999999999965 45899999999
Q ss_pred cccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc----
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA---- 841 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 841 (943)
.+..... .+.+.-+..|.|||++.|-+|+...|+||+||+|||+.||+..|.+..+-+.+...+...++++..
T Consensus 585 ~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 585 SFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 8765432 233345678999999999999999999999999999999999999877766555444444433321
Q ss_pred ---------------------------------cCcc------cc----cCccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002278 842 ---------------------------------VDPE------VS----VTCVDLSAVRKTFQLALLCTKRYPSERPTMQ 878 (943)
Q Consensus 842 ---------------------------------~~~~------~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 878 (943)
+.|. +. ....+.....++.+++..|+..||++|.|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 1110 00 1112334567888999999999999999999
Q ss_pred HHHHHH
Q 002278 879 EVARVL 884 (943)
Q Consensus 879 el~~~L 884 (943)
++++|-
T Consensus 742 qAL~Hp 747 (752)
T KOG0670|consen 742 QALKHP 747 (752)
T ss_pred HHhcCC
Confidence 998874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=237.34 Aligned_cols=211 Identities=33% Similarity=0.498 Sum_probs=182.9
Q ss_pred EeeeceEEEEEEEecC-CceEEEEEecccCcc-cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCChhh
Q 002278 624 VGYGASSTVYKCALKN-SRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWD 701 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 701 (943)
||+|++|.||++.... ++++++|++...... ..+.+.+|++.++.++|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 889999998755432 35678999999999999999999999999999999999999999999
Q ss_pred hccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-CCceeecccccccccCCCCCceeeeEe
Q 002278 702 LLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-NFDAHLSDFGIARCIPTAMPHASTFVL 780 (943)
Q Consensus 702 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 780 (943)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 986321 4689999999999999999999999 9999999999999998 89999999999987654321 122244
Q ss_pred cccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHH
Q 002278 781 GTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKT 859 (943)
Q Consensus 781 gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 859 (943)
+...|++||..... .++.++|+|++|++++++ ..+
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~~ 190 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PEL 190 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HHH
Confidence 78899999999887 888999999999999999 245
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 860 FQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 860 ~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.+++..|++.+|++||++.++++++
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=238.66 Aligned_cols=198 Identities=31% Similarity=0.404 Sum_probs=173.4
Q ss_pred cccceEEeeeceEEEEEEEecC-CceEEEEEecccCcc-cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 618 LSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
|...+.||+|++|.||+|.... ++.+|+|.+...... ..+.+.+|++.++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999875 789999998765544 56788999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCcc-CCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 696 NGSLWDLLHGPSKKVK-LDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
+++|.+++... .. +++..+..++.+++.++.+||+. +++|+|++|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999998632 23 78999999999999999999999 9999999999999999999999999999877554311
Q ss_pred eeeeEecccceeCcccc-ccCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 002278 775 ASTFVLGTIGYIDPEYA-HTSRLNEKSDVYSFGIVLLEILTGKKAVDN 821 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG~~p~~~ 821 (943)
......++..|++||.. ....++.++|+|+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334578899999998 667788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=237.93 Aligned_cols=262 Identities=22% Similarity=0.272 Sum_probs=196.0
Q ss_pred HHHhhccccceEEeeeceEEEEEEEecC----CceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCc
Q 002278 612 MRSTENLSEKYIVGYGASSTVYKCALKN----SRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALSPYG 686 (943)
Q Consensus 612 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 686 (943)
....+.|..+++||+|.|++||+|.+.. ++.||+|.+...+ ....+..|++++..+. +.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3355678889999999999999998643 5789999997553 3467899999999995 8999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC-CCCceeecccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIA 765 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DFGla 765 (943)
..+|+||++.....++.. .++...+..+++.+..||+++|+. |||||||||+|++.+ ..+.-.|.|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 999999999999888875 366888999999999999999999 999999999999997 5677899999999
Q ss_pred cccCCC--------------C-----------------------------CceeeeEecccceeCcccccc-CCCCCcch
Q 002278 766 RCIPTA--------------M-----------------------------PHASTFVLGTIGYIDPEYAHT-SRLNEKSD 801 (943)
Q Consensus 766 ~~~~~~--------------~-----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 801 (943)
..++.. . ........||++|.|||++.. ...++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 732100 0 000112459999999999876 45889999
Q ss_pred hhhHHHHHHHHHhCCCCCCC-Ccc---HHHHHHHhc---------cccc--ccc---------------ccC-ccccc--
Q 002278 802 VYSFGIVLLEILTGKKAVDN-ESN---LHQLIMSKA---------DDNT--VME---------------AVD-PEVSV-- 848 (943)
Q Consensus 802 vwSlGvil~elltG~~p~~~-~~~---~~~~~~~~~---------~~~~--~~~---------------~~~-~~~~~-- 848 (943)
|||.||++.-+++++.||-. .++ +...+.+.. ..+. ..+ .++ ..+..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999852 222 111111110 0111 000 000 00000
Q ss_pred ----CccC-H-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 849 ----TCVD-L-SAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 849 ----~~~~-~-~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
...+ . ......++++.+|+..||.+|.|+++.++|-
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0000 0 1123678999999999999999999999884
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=272.36 Aligned_cols=347 Identities=20% Similarity=0.246 Sum_probs=216.4
Q ss_pred CCCcCCCCCCCEEEeeCCc------ccccCCCCccCCC-CCcEEeccCCCcCCccchhccccccceEEEecCcccccCCC
Q 002278 55 SPSIGDLRNLQSIDFQGNK------LTGQIPDEIGNCG-SLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIP 127 (943)
Q Consensus 55 ~~~l~~l~~L~~L~Ls~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~ 127 (943)
+.+|.++++|+.|.+..+. +...+|+.|..++ +|+.|++.+|.+. .+|..| .+.+|+.|+|++|++. .++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 3468889999999997654 3345777777764 5899999998887 778777 5788999999998887 677
Q ss_pred cccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCc
Q 002278 128 STLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTS 207 (943)
Q Consensus 128 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~ 207 (943)
..+..+++|+.|+|++|.....+|. +..+++|++|+|++|..-...|..+..+++|+.|++++|.....+|..+ ++++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 7888888999999987754435553 6667777777777765544556667777777777777754333555544 5677
Q ss_pred ccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCC
Q 002278 208 FEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGN 287 (943)
Q Consensus 208 L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n 287 (943)
|+.|++++|.....+|... .+|+.|++++|.+.. +|..+ .+++|+.|++.++.... +. +
T Consensus 706 L~~L~Lsgc~~L~~~p~~~--~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~-l~----------------~ 764 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDIS--TNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEK-LW----------------E 764 (1153)
T ss_pred CCEEeCCCCCCcccccccc--CCcCeeecCCCcccc-ccccc-cccccccccccccchhh-cc----------------c
Confidence 7777777765444444321 244555555555542 33322 34444544444432110 00 0
Q ss_pred CCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccc
Q 002278 288 KLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPS 367 (943)
Q Consensus 288 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 367 (943)
.+....+..+...++|+.|+|++|.....+|..++++++|+.|+|++|..-+.+|..+ ++++|+.|++++|.....+|.
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~ 843 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD 843 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc
Confidence 0111111122233566666776666555666666666677777776654333455544 566677777776544333443
Q ss_pred cccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeeccccc
Q 002278 368 SFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNH 432 (943)
Q Consensus 368 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 432 (943)
. .++|+.|+|++|.++ .+|..+..+++|+.|+|++|+--..+|..+..++.|+.|++++|.
T Consensus 844 ~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 844 I---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred c---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 2 356777777777776 566677777777777777743323566666777777777777764
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=270.03 Aligned_cols=345 Identities=23% Similarity=0.261 Sum_probs=185.6
Q ss_pred CcccCCCCCCcEEEEeccc------cccccchhcccc-ccceeccccCCccCCCCCcccccccccceeeccceecccccC
Q 002278 127 PSTLTQIPNLKTLDLARNQ------LTGEIPRLIYWN-EVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIP 199 (943)
Q Consensus 127 ~~~~~~l~~L~~L~Ls~N~------l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 199 (943)
+.+|.++++|+.|.+..+. +...+|..|..+ .+|+.|++.++.++.++. .| .+.+|+.|++++|++. .++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~-~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPS-NF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCC-cC-CccCCcEEECcCcccc-ccc
Confidence 4456667777777665543 222345555554 347777777777665543 33 4567777777777776 456
Q ss_pred CCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCc
Q 002278 200 DSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYT 279 (943)
Q Consensus 200 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 279 (943)
..+..+++|+.|+|++|.....+|......+|+.|+|++|.....+|..+..+++|+.|++++|...+.+|..+ ++++|
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 66677777777777776544455554444566666666665555666667777777777777664444455444 56667
Q ss_pred ceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCC
Q 002278 280 GKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGN 359 (943)
Q Consensus 280 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 359 (943)
+.|+|++|...+.+|.. ..+|++|++++|.+. .+|..+ .+++|+.|++.++..... ...
T Consensus 707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l-~~~--------------- 765 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKL-WER--------------- 765 (1153)
T ss_pred CEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhc-ccc---------------
Confidence 77777766544444432 345666666666665 444433 455666666655332110 000
Q ss_pred cccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCc
Q 002278 360 RLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPA 439 (943)
Q Consensus 360 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 439 (943)
+....+..+...++|+.|+|++|...+.+|..++.+++|+.|++++|...+.+|..+ .+++|+.|+|++|.....+|.
T Consensus 766 -~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~ 843 (1153)
T PLN03210 766 -VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD 843 (1153)
T ss_pred -ccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc
Confidence 000111112223445555555554444455555555555555555543333444433 445555555555433323332
Q ss_pred cccCCCccceecccCccccccCChhhhcccccceecccC-cccCCCCCCcCccccCCcccccCCc
Q 002278 440 EFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNN-NNLQGGIPDQLSNCFSLSNLNVSYN 503 (943)
Q Consensus 440 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N 503 (943)
. .++|+.|+|++|.|+ .+|..+..+++|+.|+|++ |+|+ .+|..+..+++|+.++++++
T Consensus 844 ~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 844 I---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred c---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 2 234555555555555 4555555555555555555 3333 34444555555555555554
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-27 Score=240.26 Aligned_cols=298 Identities=21% Similarity=0.201 Sum_probs=234.8
Q ss_pred ceeEecCCCCc---------EEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccC-CCc
Q 002278 29 RGVFCDNSSLS---------VVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSD-NSL 98 (943)
Q Consensus 29 ~gv~c~~~~~~---------v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l 98 (943)
.-|.|.+.++. .+.++|..|+|+..-+.+|+.+++|++||||+|+|+.+-|++|.++.+|..|-+.+ |+|
T Consensus 49 ~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 49 GIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred ceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 34899877653 67899999999965556899999999999999999999999999999987776665 999
Q ss_pred CCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCccc
Q 002278 99 YGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDM 178 (943)
Q Consensus 99 ~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 178 (943)
+......|++|..|+.|.+.-|++.-+..+.|..+++|..|.|-.|.+.......|..+..++.+.+..|.+.. .
T Consensus 129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----d 203 (498)
T KOG4237|consen 129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----D 203 (498)
T ss_pred hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----c
Confidence 96556789999999999999999998899999999999999999999996656699999999999999998542 2
Q ss_pred ccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcc--eE-eEEEecCccccccCCccccccCCC
Q 002278 179 CQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFL--QV-ATLSLQGNKLTGKIPEVIGLMQAL 255 (943)
Q Consensus 179 ~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~--~L-~~L~L~~n~l~~~~~~~l~~l~~L 255 (943)
++++.+... +. ..|..++...-..-..+.++++..+-+.-+... .+ ..+....+....-+...|..+++|
T Consensus 204 CnL~wla~~-~a------~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L 276 (498)
T KOG4237|consen 204 CNLPWLADD-LA------MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNL 276 (498)
T ss_pred cccchhhhH-Hh------hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccc
Confidence 333333221 11 223334444445555555555554433333221 11 112222223332333558899999
Q ss_pred cEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEcccc
Q 002278 256 AVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADN 335 (943)
Q Consensus 256 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 335 (943)
+.|+|++|+|+++.+.+|.++..+++|+|..|+|.......|.++..|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|
T Consensus 277 ~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~N 356 (498)
T KOG4237|consen 277 RKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSN 356 (498)
T ss_pred eEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccC
Confidence 99999999999999999999999999999999999877788999999999999999999999999999999999999888
Q ss_pred ccC
Q 002278 336 NLE 338 (943)
Q Consensus 336 ~l~ 338 (943)
.+.
T Consensus 357 p~~ 359 (498)
T KOG4237|consen 357 PFN 359 (498)
T ss_pred ccc
Confidence 653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-25 Score=270.41 Aligned_cols=198 Identities=20% Similarity=0.241 Sum_probs=142.9
Q ss_pred cCCC-CCcceeeeEE-------ecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 002278 668 SIRH-RNIVSLHGYA-------LSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739 (943)
Q Consensus 668 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 739 (943)
.++| +||++++++| .++...+.++||+ +++|.+++.. ....+++.+++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 3455 5788888877 2334566778876 6799999963 234689999999999999999999999 99
Q ss_pred EecCCCCccEEECC-------------------CCceeecccccccccCCCC---------------CceeeeEecccce
Q 002278 740 IHRDVKSSNILIDE-------------------NFDAHLSDFGIARCIPTAM---------------PHASTFVLGTIGY 785 (943)
Q Consensus 740 vH~Dlkp~Nill~~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~y 785 (943)
+||||||+|||++. ++.+|++|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4556777777776432100 0001123588999
Q ss_pred eCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHH
Q 002278 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALL 865 (943)
Q Consensus 786 ~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 865 (943)
||||++.+..++.++|||||||++|||++|.+|+............ . ..++... ........++..
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~----~----~~~~~~~------~~~~~~~~~~~~ 247 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH----R----VLPPQIL------LNWPKEASFCLW 247 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH----h----hcChhhh------hcCHHHHHHHHH
Confidence 9999999999999999999999999999999887643221111110 0 0111111 112234578889
Q ss_pred ccCCCCCCCCCHHHHHHHHh
Q 002278 866 CTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 866 cl~~dP~~RPt~~el~~~L~ 885 (943)
||+++|.+||++.|++++-+
T Consensus 248 ~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred hCCCChhhCcChHHHhhchh
Confidence 99999999999999998765
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=215.41 Aligned_cols=170 Identities=24% Similarity=0.267 Sum_probs=128.2
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|+|.+++.. ....+++.+++.++.|++.||+|||+. + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 688998863 244699999999999999999999998 5 999999999999999 99998764432
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
..||+.|+|||++.+..++.++|||||||++|||+||+.||.................. .. .+............
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~ 138 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP--AD-DPRDRSNLESVSAA 138 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc--cC-CccccccHHHHHhh
Confidence 14899999999999999999999999999999999999999765443322222211111 00 00000000011111
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 857 RKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
..+.+++..||..+|++||++.+++++++...
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 25889999999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=245.28 Aligned_cols=264 Identities=27% Similarity=0.357 Sum_probs=165.1
Q ss_pred EEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcc
Q 002278 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ 121 (943)
Q Consensus 42 ~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~ 121 (943)
.|||+.++++ .+|+.+. ++|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.
T Consensus 205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~ 273 (788)
T PRK15387 205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNP 273 (788)
T ss_pred EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCc
Confidence 4677777777 5777665 36777777777777 4554 2467777777777777 44532 3566777777777
Q ss_pred cccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCC
Q 002278 122 LTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDS 201 (943)
Q Consensus 122 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~ 201 (943)
++ .+|..+ ++|+.|+|++|+|+. +|.. .++|++|+|++|+|++++. ...+|+.|++++|+|++ +|..
T Consensus 274 L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~Lp~----lp~~L~~L~Ls~N~L~~-LP~l 340 (788)
T PRK15387 274 LT-HLPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLPA----LPSELCKLWAYNNQLTS-LPTL 340 (788)
T ss_pred hh-hhhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCccccCCC----CcccccccccccCcccc-cccc
Confidence 76 344322 456667777777663 3332 3456666666666665432 12335555555555552 3321
Q ss_pred CcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcce
Q 002278 202 IGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGK 281 (943)
Q Consensus 202 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 281 (943)
..+|++|+|++|+|+ + +|.. ..+|+.|++++|+|.. +|.. ..+|+.
T Consensus 341 ---p~~Lq~LdLS~N~Ls-----------------------~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~ 386 (788)
T PRK15387 341 ---PSGLQELSVSDNQLA-----------------------S-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKE 386 (788)
T ss_pred ---ccccceEecCCCccC-----------------------C-CCCC---Ccccceehhhcccccc-Cccc---ccccce
Confidence 134555555555554 2 2221 2355666677776663 4432 245777
Q ss_pred EEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcc
Q 002278 282 LYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRL 361 (943)
Q Consensus 282 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 361 (943)
|+|++|+|++ +|.. .++|+.|++++|++++ +|.. ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|
T Consensus 387 LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~L 457 (788)
T PRK15387 387 LIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 457 (788)
T ss_pred EEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCC
Confidence 7777777774 4432 3578888888888874 5543 246778888999988 5788888889999999999999
Q ss_pred cCccccccccc
Q 002278 362 SGAIPSSFRNL 372 (943)
Q Consensus 362 ~~~~~~~~~~l 372 (943)
++..+..+..+
T Consensus 458 s~~~~~~L~~l 468 (788)
T PRK15387 458 SERTLQALREI 468 (788)
T ss_pred CchHHHHHHHH
Confidence 87766665443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-23 Score=223.79 Aligned_cols=262 Identities=18% Similarity=0.205 Sum_probs=194.8
Q ss_pred ccccceEEeeeceEEEEEEEecCC--ceEEEEEecccCcccHHHHHHHHHHHhcCCC----CCcceeeeEE-ecCCcceE
Q 002278 617 NLSEKYIVGYGASSTVYKCALKNS--RPIAVKKLYNQYPHNLREFETELETIGSIRH----RNIVSLHGYA-LSPYGNLL 689 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 689 (943)
+|.+.+.||+|+||.||.|..... ..+|+|............+..|..++..+.. +++..+++.+ ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997654 4678877655433322367788888888862 6899999999 47778899
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC-----Cceeeccccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-----FDAHLSDFGI 764 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~DFGl 764 (943)
||+.+ |.+|.++..... ...++..++..++.|++.+|+++|+. |++||||||.|+++... ..+.+.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99986 899999875433 56799999999999999999999999 99999999999999754 4699999999
Q ss_pred cc--ccCCCCC------ce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccc
Q 002278 765 AR--CIPTAMP------HA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADD 835 (943)
Q Consensus 765 a~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 835 (943)
|+ .+..... .. .....||.+|+++....+.+.+++.|+||++.++.|+..|..||................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 3321111 11 233559999999999999999999999999999999999999997544322211111110
Q ss_pred cccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 836 NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
... ...+ . .. .....+.++...+-..+...+|.+..+...++......
T Consensus 254 ~~~--~~~~-~--~~---~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RKL--LTDR-F--GD---LKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhh--cccc-c--cC---CChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000 0000 0 00 11234445555555688999999999999887665544
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=243.16 Aligned_cols=265 Identities=29% Similarity=0.398 Sum_probs=174.9
Q ss_pred CCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEe
Q 002278 63 NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLA 142 (943)
Q Consensus 63 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 142 (943)
.-..|||+.|+|+ .+|..+. .+|+.|++++|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|+
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 3456677777776 5666554 36667777777666 3443 2455666666666666 33432 2455666666
Q ss_pred ccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcC
Q 002278 143 RNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEI 222 (943)
Q Consensus 143 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 222 (943)
+|.|+ .+|..+ .+|+.|+|++|+|+.+ |. .+++|+.|+|++|+|++ +
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~L-------------------------P~---~p~~L~~LdLS~N~L~~-L 317 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLTSL-------------------------PV---LPPGLQELSVSDNQLAS-L 317 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCccccc-------------------------cc---cccccceeECCCCcccc-C
Confidence 66655 233211 2344444444444433 22 12456666666666653 2
Q ss_pred CCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCc
Q 002278 223 PYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSK 302 (943)
Q Consensus 223 ~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 302 (943)
|.. ..+|+.|++++|++++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+. +|.. ..+
T Consensus 318 p~l--p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~ 383 (788)
T PRK15387 318 PAL--PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSG 383 (788)
T ss_pred CCC--cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccc
Confidence 321 1245566666666664 3431 2579999999999995 5543 3568889999999995 5543 367
Q ss_pred CcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccC
Q 002278 303 LSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSR 382 (943)
Q Consensus 303 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 382 (943)
|+.|++++|+|++ +|.. .++|+.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|..|..+++|+.|+|++
T Consensus 384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 9999999999994 5543 3579999999999985 5553 356889999999998 6788999999999999999
Q ss_pred CcCCCCCCCCCC
Q 002278 383 NNFKGKVPTELG 394 (943)
Q Consensus 383 N~l~~~~~~~~~ 394 (943)
|+|++..+..+.
T Consensus 455 N~Ls~~~~~~L~ 466 (788)
T PRK15387 455 NPLSERTLQALR 466 (788)
T ss_pred CCCCchHHHHHH
Confidence 999987666553
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-24 Score=206.36 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=193.7
Q ss_pred cccceEEeeeceEEEEEEEecCCceEEEEEeccc--CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 618 LSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQ--YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
+....+|.+...|..|+|+++ |..+++|++... .....++|..|.-.++.+.||||.+++|.|..+....++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344456888999999999998 445666766432 23445689999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeec--ccccccccCCCCC
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLS--DFGIARCIPTAMP 773 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~--DFGla~~~~~~~~ 773 (943)
.|+|+..+++.. .-..+..++.+++.++|+|++|||+. .|-|.---+.+..|++|++.+++|+ |--++. ....
T Consensus 271 ~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf---qe~g 345 (448)
T KOG0195|consen 271 FGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---QEVG 345 (448)
T ss_pred chHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee---eccc
Confidence 999999998653 34577889999999999999999996 4445556789999999999887764 322221 1111
Q ss_pred ceeeeEecccceeCccccccCCCC---CcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLN---EKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
..=.|.||+||.++.++-+ .++|+|||++++||+.|...||.+..+++.-+.+..+. ....++|.+.
T Consensus 346 -----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg--lrv~ippgis--- 415 (448)
T KOG0195|consen 346 -----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG--LRVHIPPGIS--- 415 (448)
T ss_pred -----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc--ccccCCCCcc---
Confidence 1236889999999876644 58999999999999999999999888877655543322 2223334443
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
..+.+++.-|+..||.+||.++.++-.|+++.
T Consensus 416 ------~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 416 ------RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ------HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 56788999999999999999999999888653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=223.68 Aligned_cols=176 Identities=16% Similarity=0.119 Sum_probs=134.2
Q ss_pred HHHhhccccceEEeeeceEEEEEEEec--CCceEEEEEecccC-----cccHHHHHHHHHHHhcCCCCCcceeeeEEecC
Q 002278 612 MRSTENLSEKYIVGYGASSTVYKCALK--NSRPIAVKKLYNQY-----PHNLREFETELETIGSIRHRNIVSLHGYALSP 684 (943)
Q Consensus 612 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 684 (943)
....++|...+.||+|+||+||+|.++ +++.||||++.... ....+.+.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999875 46778999875331 2234568999999999999999853322 2
Q ss_pred CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC-CCccEEECCCCceeecccc
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDV-KSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~DFG 763 (943)
+..++||||++|++|... . ... ...++.++++||+|||+. ||+|||| ||+||+++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~---~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R---PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C---ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 467999999999999632 1 111 146788999999999999 9999999 9999999999999999999
Q ss_pred cccccCCCCCcee-------eeEecccceeCccccccCC------CCCcchhh
Q 002278 764 IARCIPTAMPHAS-------TFVLGTIGYIDPEYAHTSR------LNEKSDVY 803 (943)
Q Consensus 764 la~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 803 (943)
+|+.+........ +...+++.|+|||++...+ .+..+|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9997644321111 2455788899999886533 33456766
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=201.20 Aligned_cols=259 Identities=18% Similarity=0.187 Sum_probs=197.8
Q ss_pred hhccccceEEeeeceEEEEEEE-ecCCceEEEEEecccCcccHHHHHHHHHHHhcCCC-CCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRH-RNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 692 (943)
...|..++.||.|+||.+|.|. ..+|..||+|.-..... ...+.-|..+++.+++ ..|..+..++.+.....+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4678999999999999999998 46799999998654332 2467778999999975 788888889999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---CCceeecccccccccC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE---NFDAHLSDFGIARCIP 769 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DFGla~~~~ 769 (943)
.+ |.+|.++.... ...++..+++-.|-|++.-++|+|.+ +++||||||+|+|+.- ...+.++|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 89999988643 23588999999999999999999999 9999999999999963 3459999999999875
Q ss_pred CCCCc------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHH---HHHHHhccc-cccc
Q 002278 770 TAMPH------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLH---QLIMSKADD-NTVM 839 (943)
Q Consensus 770 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~---~~~~~~~~~-~~~~ 839 (943)
+.... ......||.+|.+--...+.+.+.+.|+-|+|.++.++--|..||++-.... ....+.... ....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 43221 2234569999999999999999999999999999999999999998653321 111111111 1122
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
+.+-..+ +.++.-.+.-|-..--++-|...-+.+.+..+...
T Consensus 246 e~LC~G~---------P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 246 EVLCKGF---------PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred HHHhCCC---------cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 2222222 24556677777777788888887776666554443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-22 Score=197.65 Aligned_cols=254 Identities=18% Similarity=0.201 Sum_probs=193.1
Q ss_pred ccccceEEeeeceEEEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEEEEc
Q 002278 617 NLSEKYIVGYGASSTVYKCAL-KNSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.|.+.++||+|+||.++.|+. -++++||||.-... ....++..|.+.++.+. .++|..+|-+..++....+|+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 688999999999999999984 46899999975443 33467888999999885 699999998888888999999987
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC-----CceeecccccccccC
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-----FDAHLSDFGIARCIP 769 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~DFGla~~~~ 769 (943)
|.+|.|+.... ..+++..+++.+|.|++.-++|+|++ .+|.|||||+|+|+... ..+.++|||+|+.+.
T Consensus 107 -GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 88999987643 34699999999999999999999999 99999999999999643 348999999999886
Q ss_pred CCCCce------eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC---ccHHHHHHHhcccc-ccc
Q 002278 770 TAMPHA------STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNE---SNLHQLIMSKADDN-TVM 839 (943)
Q Consensus 770 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~---~~~~~~~~~~~~~~-~~~ 839 (943)
+..... .....||.+||+-....+.+.+.+.|+-|+|=++++++-|..||.+- ...+.+..+..... ...
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 554322 23356999999999999999999999999999999999999999853 22222222222111 111
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
+.+.. ..+.++...++-.=..+-.+-|.++-+...+..+
T Consensus 261 ~~Lc~---------g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 261 EVLCE---------GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV 299 (449)
T ss_pred HHHHh---------cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 11111 1223444444444456677888876665554433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-20 Score=205.95 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=199.0
Q ss_pred cccceEEeeeceEEEEEEEecCCceEEEEEecccCcc---cHHHHHHHHHHHhcCCCC-CcceeeeEEecCCcceEEEEE
Q 002278 618 LSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH---NLREFETELETIGSIRHR-NIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 693 (943)
|.....||.|+||.||++... ..+|+|.+...... ....+.+|+..++.+.|+ +++++++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567788999999999999987 77899988655433 367889999999999988 799999999777778999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC-ceeecccccccccCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-DAHLSDFGIARCIPTAM 772 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFGla~~~~~~~ 772 (943)
+.++++.+++........+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997775321113688999999999999999999999 999999999999999888 79999999998654433
Q ss_pred Cc-----eeeeEecccceeCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCcc---HHHHHHHhcccc-c-cc
Q 002278 773 PH-----ASTFVLGTIGYIDPEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNESN---LHQLIMSKADDN-T-VM 839 (943)
Q Consensus 773 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~p~~~~~~---~~~~~~~~~~~~-~-~~ 839 (943)
.. ......|+..|+|||...+ ..+....|+||+|++++++++|..||..... ............ . ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 22 2345679999999999988 5788999999999999999999999876653 222222222111 1 11
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
....+... ......+.+++..|+..+|..|.+..+....
T Consensus 237 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111110 1122456788999999999999999887765
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=230.33 Aligned_cols=222 Identities=28% Similarity=0.422 Sum_probs=96.4
Q ss_pred CcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccC
Q 002278 88 LVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRG 167 (943)
Q Consensus 88 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 167 (943)
...|+|+++.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 344444444444 3343332 24444455554444 2333322 24555555555544 2333221 2455555555
Q ss_pred CccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCc
Q 002278 168 NALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPE 247 (943)
Q Consensus 168 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 247 (943)
|.+..++. .+. .+|+.|++++|+|+ .+|..+. .+|+.|++++|++++ +|..+. .+|+.|++++|.++. +|.
T Consensus 251 N~L~~LP~-~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp-~sL~~L~Ls~N~Lt~-LP~ 321 (754)
T PRK15370 251 NRITELPE-RLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP-SGITHLNVQSNSLTA-LPE 321 (754)
T ss_pred CccCcCCh-hHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch-hhHHHHHhcCCcccc-CCc
Confidence 55554322 221 34566666666665 3444332 356666666666652 232211 133444444444442 222
Q ss_pred cccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccc
Q 002278 248 VIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQL 327 (943)
Q Consensus 248 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 327 (943)
.+ .++|+.|++++|.++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. ..|
T Consensus 322 ~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL 390 (754)
T PRK15370 322 TL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AAL 390 (754)
T ss_pred cc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHH
Confidence 21 1345555555555543 333221 34445555555444 2333221 34555555555554 2232221 134
Q ss_pred eEEEccccccC
Q 002278 328 FELNLADNNLE 338 (943)
Q Consensus 328 ~~L~L~~N~l~ 338 (943)
+.|++++|+|.
T Consensus 391 ~~LdLs~N~L~ 401 (754)
T PRK15370 391 QIMQASRNNLV 401 (754)
T ss_pred HHHhhccCCcc
Confidence 44444444444
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-21 Score=227.94 Aligned_cols=183 Identities=28% Similarity=0.457 Sum_probs=81.2
Q ss_pred CCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEcc
Q 002278 254 ALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLA 333 (943)
Q Consensus 254 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 333 (943)
+|+.|+|++|.+. .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|+++. +|..+. ++|+.|+++
T Consensus 242 ~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls 312 (754)
T PRK15370 242 TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQ 312 (754)
T ss_pred cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhc
Confidence 4555555555555 2333322 24555555555555 2333332 345555555555552 232221 234445555
Q ss_pred ccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCcc
Q 002278 334 DNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSV 413 (943)
Q Consensus 334 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 413 (943)
+|+++. +|..+ .+ +|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+
T Consensus 313 ~N~Lt~-LP~~l--~~------------------------sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~L 361 (754)
T PRK15370 313 SNSLTA-LPETL--PP------------------------GLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VL 361 (754)
T ss_pred CCcccc-CCccc--cc------------------------cceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cC
Confidence 555442 22211 13 34444444444442 333222 34555555555554 23
Q ss_pred CCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhh----cccccceecccCcccC
Q 002278 414 PASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELG----QLQNIISLILNNNNLQ 482 (943)
Q Consensus 414 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~L~~N~l~ 482 (943)
|..+. +.|+.|+|++|+|+. +|..+. .+|+.|++++|+|+ .+|..+. .++++..|+|.+|+++
T Consensus 362 P~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 362 PETLP--PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred Chhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 33331 345555555555552 333332 24555555555555 3343322 2345555666666554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.7e-22 Score=228.54 Aligned_cols=255 Identities=20% Similarity=0.227 Sum_probs=185.2
Q ss_pred cceEEeeeceEEEEEEEecC-CceEEEEEeccc--CcccHH----HHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 620 EKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQ--YPHNLR----EFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 620 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..+++|.|++|.|+.+.... ....+.|..... ...... .+..|+-+-..+.|||++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45679999999888776542 333444433210 111111 25567777778899999988888877777777799
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
||++ +|..++.. ...+...++-.++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+.......
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99999863 34688888999999999999999999 99999999999999999999999999998764432
Q ss_pred C---ceeeeEecccceeCccccccCCCCC-cchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 773 P---HASTFVLGTIGYIDPEYAHTSRLNE-KSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 773 ~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
. ......+|+..|+|||+..+.+|++ ..||||.|+++..|.+|+.||........................+
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~---- 550 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP---- 550 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh----
Confidence 2 3455677999999999999999886 6899999999999999999996332211110000000000000000
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.......+.+...++.+++++||.+|.|++++++.=|
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 0011123356667999999999999999999988644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9e-21 Score=191.08 Aligned_cols=171 Identities=14% Similarity=0.197 Sum_probs=134.5
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHH---------HHHHHHHHhcCCCCCcceeeeEEecC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLRE---------FETELETIGSIRHRNIVSLHGYALSP 684 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~ 684 (943)
-.++|...+++|.|+||.||.+.. +++.+|+|.+.......... +++|++.++++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999766 57789999997554333322 67899999999999999999886643
Q ss_pred --------CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc
Q 002278 685 --------YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756 (943)
Q Consensus 685 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 756 (943)
...+++|||++|.+|.++.. ++. ....+++.+++.+|+. |++|||+||+||+++.+|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 35789999999999988642 222 2456899999999999 999999999999999988
Q ss_pred eeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHH
Q 002278 757 AHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813 (943)
Q Consensus 757 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 813 (943)
++++|||..+........ ..+.....++.++|+||||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988755322111 11334445668999999999987664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-20 Score=185.44 Aligned_cols=139 Identities=15% Similarity=0.135 Sum_probs=108.9
Q ss_pred eEEeeeceEEEEEEEecCCceEEEEEecccCcc--c-------H-----------------HHHHHHHHHHhcCCCCCcc
Q 002278 622 YIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH--N-------L-----------------REFETELETIGSIRHRNIV 675 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~niv 675 (943)
..||+|+||.||+|...+|+.||||++...... . . .....|++.++++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 569999999999999888999999998654211 1 0 1223599999999888775
Q ss_pred eeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHh-hhCCCCCeEecCCCCccEEECCC
Q 002278 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYL-HHDCNPRIIHRDVKSSNILIDEN 754 (943)
Q Consensus 676 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlkp~Nill~~~ 754 (943)
....+.. ...++||||++++++..... ....++..++..++.|++.+|+|+ |+. +|+||||||+||+++ +
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 4433322 23489999999887755432 234688999999999999999999 687 999999999999998 4
Q ss_pred CceeecccccccccC
Q 002278 755 FDAHLSDFGIARCIP 769 (943)
Q Consensus 755 ~~~kl~DFGla~~~~ 769 (943)
+.++++|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.4e-22 Score=179.96 Aligned_cols=165 Identities=32% Similarity=0.553 Sum_probs=151.7
Q ss_pred CCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCC
Q 002278 56 PSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPN 135 (943)
Q Consensus 56 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 135 (943)
+.+-++.+++.|-||+|+++ .+|..|..+.+|+.|++++|+|+ ++|.+++.+++|+.|+++-|++. +.|..|+.+|.
T Consensus 27 ~gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~ 103 (264)
T KOG0617|consen 27 PGLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPA 103 (264)
T ss_pred ccccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCch
Confidence 35667888999999999999 78889999999999999999999 89999999999999999999998 89999999999
Q ss_pred CcEEEEeccccc-cccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEee
Q 002278 136 LKTLDLARNQLT-GEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDIS 214 (943)
Q Consensus 136 L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls 214 (943)
|+.|||+.|++. ..+|..|+.+..|+.|+|++|.+. +.|++++.+++|+.|.++.|.+- .+|..++.++.|++|++.
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence 999999999997 468999999999999999999998 56789999999999999999998 789999999999999999
Q ss_pred cccccCcCCCCC
Q 002278 215 YNQITGEIPYNI 226 (943)
Q Consensus 215 ~N~l~~~~~~~~ 226 (943)
+|+++ .+|..+
T Consensus 182 gnrl~-vlppel 192 (264)
T KOG0617|consen 182 GNRLT-VLPPEL 192 (264)
T ss_pred cceee-ecChhh
Confidence 99998 444443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-21 Score=178.66 Aligned_cols=155 Identities=30% Similarity=0.537 Sum_probs=88.3
Q ss_pred CcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEE
Q 002278 323 KLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTL 402 (943)
Q Consensus 323 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 402 (943)
++..++.|.|++|+++ .+|..++.+.+|+.|++++|+|. .+|..+..+++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3455556666666665 44555666666666666666665 45555666666666666666655 555666666666666
Q ss_pred ecCCCcCCC-ccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCccc
Q 002278 403 DLSVNNFSG-SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNL 481 (943)
Q Consensus 403 ~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 481 (943)
||++|++.. .+|..|-.++.|+.|+|+.|.+. .+|..+++|++|+.|.+..|.+- .+|.+++.|..|++|.+++|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 666655542 34555555555555555555554 45555555555555555555554 4555555555555555555555
Q ss_pred C
Q 002278 482 Q 482 (943)
Q Consensus 482 ~ 482 (943)
+
T Consensus 186 ~ 186 (264)
T KOG0617|consen 186 T 186 (264)
T ss_pred e
Confidence 4
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.9e-21 Score=209.51 Aligned_cols=223 Identities=22% Similarity=0.225 Sum_probs=174.8
Q ss_pred EeeeceEEEEEEEe----cCCceEEEEEecccCccc--HHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEEEEccC
Q 002278 624 VGYGASSTVYKCAL----KNSRPIAVKKLYNQYPHN--LREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 624 lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+|+|+||.|+.++- ..+.-+|+|..++..... ......|..++...+ ||.+|+++-.++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 69999999998753 236778888876554221 124556888888887 99999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCcee
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 776 (943)
|.+...+. ....+.+.....+...++-|++++|+. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 82 g~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 82 GDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred chhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99988886 455678888888888999999999999 9999999999999999999999999999865433222
Q ss_pred eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHH
Q 002278 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAV 856 (943)
Q Consensus 777 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (943)
+||..|||||++. .+..++|.||||++++||+||..||.. +....+...+..++...+
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~------------- 211 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELS------------- 211 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhh-------------
Confidence 7999999999998 678899999999999999999999987 222222222222222222
Q ss_pred HHHHHHHHHccCCCCCCCCC
Q 002278 857 RKTFQLALLCTKRYPSERPT 876 (943)
Q Consensus 857 ~~l~~l~~~cl~~dP~~RPt 876 (943)
.....++..+...+|..|--
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg 231 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLG 231 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhc
Confidence 23335666777777777753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=176.28 Aligned_cols=185 Identities=14% Similarity=0.077 Sum_probs=139.0
Q ss_pred cceEEeeeceEEEEEEEecCCceEEEEEecccCcc----cHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEEEEc
Q 002278 620 EKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH----NLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 620 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
....|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++++++. |++|++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997765 5778887776543221 1125789999999996 5889999886 4579999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC-CCccEEECCCCceeecccccccccCCCCC
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDV-KSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
.|.+|..... . ....++.|++.+++++|+. ||+|||| ||+||+++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999865432 1 1235778999999999999 9999999 79999999999999999999986543221
Q ss_pred c----e--------eeeEecccceeCccccccC-CCC-CcchhhhHHHHHHHHHhCCCCCCCC
Q 002278 774 H----A--------STFVLGTIGYIDPEYAHTS-RLN-EKSDVYSFGIVLLEILTGKKAVDNE 822 (943)
Q Consensus 774 ~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~elltG~~p~~~~ 822 (943)
. . ......++.|++|+....- ..+ .+.+.++.|+-+|.++|++.|..++
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 1 0 1112256777888754432 333 6789999999999999998887543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=178.58 Aligned_cols=141 Identities=16% Similarity=0.171 Sum_probs=111.8
Q ss_pred ceEEeeeceEEEEEEEecCCceEEEEEecccCcc--c------------------------HHHHHHHHHHHhcCCCCCc
Q 002278 621 KYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH--N------------------------LREFETELETIGSIRHRNI 674 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 674 (943)
...||+|+||.||+|...+|+.||||.+...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4579999999999999878999999998654211 0 1123578999999999988
Q ss_pred ceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECC
Q 002278 675 VSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDE 753 (943)
Q Consensus 675 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~ 753 (943)
.....+... ..++||||++|+++..... ....++..+...++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 655544433 3589999999885543321 23457788999999999999999999 8 999999999999999
Q ss_pred CCceeecccccccccCC
Q 002278 754 NFDAHLSDFGIARCIPT 770 (943)
Q Consensus 754 ~~~~kl~DFGla~~~~~ 770 (943)
++.++|+|||+|+....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.7e-20 Score=209.83 Aligned_cols=251 Identities=24% Similarity=0.290 Sum_probs=184.1
Q ss_pred ccccceEEeeeceEEEEEEEecCCceEEEEEecccCc-ccHHHHHHHHHH--HhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYP-HNLREFETELET--IGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+|...+.+|++.|=.|.+|+++.|. |+||++.+..+ -..+.+.++++- ...++|||++++.-+-..+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777788999999999999998776 89999876653 334444443333 5566899999998887777778888888
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc--cCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC--IPTA 771 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~--~~~~ 771 (943)
+ .-+|+|.+. .+..+...+.+-|+.|++.|+.-+|.. ||+|||||.+|||+++=.=+.|+||..-+. ++.+
T Consensus 103 v-khnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 V-KHNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred H-hhhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 7 458999886 445566777778999999999999999 999999999999999887899999977653 2344
Q ss_pred CCceeeeEecc----cceeCccccccC----------C-CCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccc
Q 002278 772 MPHASTFVLGT----IGYIDPEYAHTS----------R-LNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADD 835 (943)
Q Consensus 772 ~~~~~~~~~gt----~~y~aPE~~~~~----------~-~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 835 (943)
.+...+...-| ..|.|||.+... . .+++-||||+||+++|+++ |++||. +.++.......
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccC
Confidence 44333333222 469999976531 1 5678999999999999998 899986 33333322221
Q ss_pred cccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 836 NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
....+..-..+. ...+..++..|++.||++|-++++.++.-++.
T Consensus 252 ~~~~e~~Le~Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 252 ADDPEQLLEKIE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ccCHHHHHHhCc--------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111111111111 12456899999999999999999999875544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=180.30 Aligned_cols=234 Identities=21% Similarity=0.279 Sum_probs=148.3
Q ss_pred hccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcCC----------CCCcceeeeEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSIR----------HRNIVSLHGYA 681 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~ 681 (943)
..+.....||.|+++.||.+++.. ++++|||.+.-.. ....+++.+|.-....+. |-.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 355667889999999999999875 7899999875332 234566776665555532 22333333332
Q ss_pred ecC---------C--------cceEEEEEccCCChhhhccC----CCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeE
Q 002278 682 LSP---------Y--------GNLLFYDYMVNGSLWDLLHG----PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRII 740 (943)
Q Consensus 682 ~~~---------~--------~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 740 (943)
... . ..+++|+-+ .++|.+++.. ......+....+..+..|+++.+++||+. |+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence 211 1 125667766 5688777542 11122344555667889999999999999 999
Q ss_pred ecCCCCccEEECCCCceeecccccccccCCCCCceeeeEecccceeCcccccc--------CCCCCcchhhhHHHHHHHH
Q 002278 741 HRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT--------SRLNEKSDVYSFGIVLLEI 812 (943)
Q Consensus 741 H~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~el 812 (943)
|+||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999988755432111 224578999997643 2478899999999999999
Q ss_pred HhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCC
Q 002278 813 LTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSER 874 (943)
Q Consensus 813 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 874 (943)
++|+.||+...... .... .+. .|. ..++.+..+|..+++++|.+|
T Consensus 244 WC~~lPf~~~~~~~-------~~~~-------~f~-~C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEA-------DPEW-------DFS-RCR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGS-------TSGG-------GGT-TSS-----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccc-------cccc-------cch-hcC--CcCHHHHHHHHHHccCCcccC
Confidence 99999998543210 0000 111 122 445677889999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8e-19 Score=180.54 Aligned_cols=194 Identities=24% Similarity=0.273 Sum_probs=135.6
Q ss_pred CCCCcceeeeEEecC---------------------------CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHH
Q 002278 670 RHRNIVSLHGYALSP---------------------------YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722 (943)
Q Consensus 670 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 722 (943)
+|||||++.++|.+. ...|+||...+ .+|.+++.. ...+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 699999999987643 22478888763 588888863 3456677778899
Q ss_pred HHHHHHHHhhhCCCCCeEecCCCCccEEE--CCCC--ceeecccccccccCC---CCCcee--eeEecccceeCcccccc
Q 002278 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILI--DENF--DAHLSDFGIARCIPT---AMPHAS--TFVLGTIGYIDPEYAHT 793 (943)
Q Consensus 723 ~i~~~l~~LH~~~~~~ivH~Dlkp~Nill--~~~~--~~kl~DFGla~~~~~---~~~~~~--~~~~gt~~y~aPE~~~~ 793 (943)
|+++|+.|||.+ ||.|||+|++||++ |+|+ ...|+|||.+---+. ..+..+ -..-|....||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999999 3443 478999998743211 011111 11236778999998875
Q ss_pred CC------CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHH--hccccccccccCcccccCccCHHHHHHHHHHHHH
Q 002278 794 SR------LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMS--KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALL 865 (943)
Q Consensus 794 ~~------~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 865 (943)
.+ .-.|+|.|+.|.+.||+++...||++...+.--.+. ..+-..+++.+. ..+.+++..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vp-------------p~~rqlV~~ 492 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVP-------------PVARQLVFD 492 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCC-------------hHHHHHHHH
Confidence 33 125899999999999999999999875433221111 111122222222 345578999
Q ss_pred ccCCCCCCCCCHHHHHHHH
Q 002278 866 CTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 866 cl~~dP~~RPt~~el~~~L 884 (943)
.++.||++|++..-....+
T Consensus 493 lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HhcCCccccCCccHHHhHH
Confidence 9999999999876655544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-18 Score=192.43 Aligned_cols=216 Identities=26% Similarity=0.461 Sum_probs=165.2
Q ss_pred HhcCCCCCcceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCe-EecCC
Q 002278 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI-IHRDV 744 (943)
Q Consensus 666 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~Dl 744 (943)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.. ....+++.-...++++|+.||+|+|.. .| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 3567899999999999999999999999999999999974 345688999999999999999999987 55 99999
Q ss_pred CCccEEECCCCceeecccccccccCC-CCCceeeeEecccceeCccccccCC-------CCCcchhhhHHHHHHHHHhCC
Q 002278 745 KSSNILIDENFDAHLSDFGIARCIPT-AMPHASTFVLGTIGYIDPEYAHTSR-------LNEKSDVYSFGIVLLEILTGK 816 (943)
Q Consensus 745 kp~Nill~~~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGvil~elltG~ 816 (943)
++.|.++|....+|++|||+...... ..........-..-|.|||.+.+.. .+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999987642 1111111122345799999887631 467899999999999999999
Q ss_pred CCCCCCccH---HHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 817 KAVDNESNL---HQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 817 ~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
.||+..... .+.+..... .......|.+.... +....+..+++.||..+|++||+++++...++.+....
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred CccccccccCChHHHHHHHHh--cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 999843221 223333222 12223344443221 22236788999999999999999999999888766543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-20 Score=208.59 Aligned_cols=260 Identities=25% Similarity=0.309 Sum_probs=139.1
Q ss_pred CccccccCCCcEEecCCCCCCCC----CCcccCCCCCcceEEecCCCCCC------CCCCCcCCCCcCcEEEcccCcccc
Q 002278 246 PEVIGLMQALAVLDLSENELVGP----IPPILGNLSYTGKLYLHGNKLTG------PIPPELGNMSKLSYLQLQNNQLVG 315 (943)
Q Consensus 246 ~~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~~L~~L~L~~N~l~~ 315 (943)
...+..+.+|+.|++++|.++.. ++..+...++++.|+++++.+.+ .++..+..+++|+.|++++|.+.+
T Consensus 16 ~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~ 95 (319)
T cd00116 16 TELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGP 95 (319)
T ss_pred HHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCCh
Confidence 34445555566666666665431 23344455556666666655542 122344556666667776666654
Q ss_pred ccccccCCccc---ceEEEccccccCC----cCcccccCC-CcCcEEEeeCCcccCc----ccccccccCccceeeccCC
Q 002278 316 TIPAELGKLEQ---LFELNLADNNLEG----PIPHNISSC-TALNQFNVHGNRLSGA----IPSSFRNLGSLTYLNLSRN 383 (943)
Q Consensus 316 ~~~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N 383 (943)
..+..+..+.+ |++|++++|++.+ .+...+..+ ++|+.|++++|.+++. ++..+..+++|++|+|++|
T Consensus 96 ~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n 175 (319)
T cd00116 96 DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANN 175 (319)
T ss_pred hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCC
Confidence 44444444444 6666666666652 222334444 6666666666666522 2334445556666676666
Q ss_pred cCCCC----CCCCCCCCCCccEEecCCCcCCCc----cCCCcccccccceeecccccccccCCcccc-----CCCcccee
Q 002278 384 NFKGK----VPTELGRIINLDTLDLSVNNFSGS----VPASIGDLEHLLTLNLSRNHLNGLLPAEFG-----NLRSIQTI 450 (943)
Q Consensus 384 ~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L 450 (943)
.+++. ++..+...++|+.|++++|.+.+. ++..+..+++|++|++++|.+++.....+. ..+.|+.|
T Consensus 176 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L 255 (319)
T cd00116 176 GIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL 255 (319)
T ss_pred CCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEE
Confidence 66532 222233445666666666666532 223344556666777776666542222221 13566777
Q ss_pred cccCccccc----cCChhhhcccccceecccCcccCCC----CCCcCccc-cCCcccccCCccc
Q 002278 451 DMSFNQLSG----SIPAELGQLQNIISLILNNNNLQGG----IPDQLSNC-FSLSNLNVSYNNL 505 (943)
Q Consensus 451 ~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~ls~N~l 505 (943)
++++|.++. .+...+..+++|+.+++++|+++.. ....+... +.|+.+++.+|++
T Consensus 256 ~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 256 SLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred EccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 777776651 2334455556666667777666633 22222233 4666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-18 Score=198.19 Aligned_cols=208 Identities=24% Similarity=0.291 Sum_probs=149.1
Q ss_pred hhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
...|+.++.|..|+||.||.++++. .+.+|+ ++.+..- +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccch-----hhhc--cccccCCccee------------------
Confidence 4578899999999999999999885 456777 4433211 1110 33333445444
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC-
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM- 772 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~- 772 (943)
|+=.+.++ ..++++.. ++.+++|+|+. +|+|||+||+|.+++.-|++|+.|||+++..-...
T Consensus 136 ---gDc~tllk---~~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc---cCCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 33344443 22333322 27889999999 99999999999999999999999999997532111
Q ss_pred -------------CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc
Q 002278 773 -------------PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM 839 (943)
Q Consensus 773 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 839 (943)
......++||+.|+|||++....|+..+|+|++|+++||++-|+.||.++.+-+.+-........++
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 1112346899999999999999999999999999999999999999998876554444443333344
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCC
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP 875 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 875 (943)
+. +..+. .+..+++...++.+|..|-
T Consensus 279 E~-dea~p---------~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 279 EE-DEALP---------PEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cc-CcCCC---------HHHHHHHHHHHHhChHhhc
Confidence 43 33222 3556788899999999995
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9e-18 Score=169.44 Aligned_cols=137 Identities=18% Similarity=0.203 Sum_probs=106.6
Q ss_pred cccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcC-----CCCCcceeeeEEecCC---cce-
Q 002278 618 LSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI-----RHRNIVSLHGYALSPY---GNL- 688 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 688 (943)
++....||+|+||.||. +......+||++........+.+.+|+++++.+ .||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999995 444344479988665444567899999999999 5799999999998874 223
Q ss_pred EEEEE--ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHH-HHhhhCCCCCeEecCCCCccEEECC----CCceeecc
Q 002278 689 LFYDY--MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL-AYLHHDCNPRIIHRDVKSSNILIDE----NFDAHLSD 761 (943)
Q Consensus 689 lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~D 761 (943)
+|+|| +.+|+|.+++.. ..+++. ..++.+++.++ +|||++ +||||||||+||+++. ++.++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 68999 557999999963 235555 35677777777 999999 9999999999999974 34799999
Q ss_pred cccc
Q 002278 762 FGIA 765 (943)
Q Consensus 762 FGla 765 (943)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.7e-20 Score=202.73 Aligned_cols=83 Identities=22% Similarity=0.245 Sum_probs=45.7
Q ss_pred EEEeeCCccc-ccCCCCccCCCCCcEEeccCCCcCCc----cchhccccccceEEEecCccccc------CCCcccCCCC
Q 002278 66 SIDFQGNKLT-GQIPDEIGNCGSLVHIELSDNSLYGD----IPFSISKLKQLEFLNLKNNQLTG------PIPSTLTQIP 134 (943)
Q Consensus 66 ~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~------~~~~~~~~l~ 134 (943)
.|+|+.+.++ ...+..|..+.+|+.|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4666666666 23444455666677777777776432 34445555666677776666542 1123344445
Q ss_pred CCcEEEEecccccc
Q 002278 135 NLKTLDLARNQLTG 148 (943)
Q Consensus 135 ~L~~L~Ls~N~l~~ 148 (943)
+|+.|+|++|.+..
T Consensus 82 ~L~~L~l~~~~~~~ 95 (319)
T cd00116 82 GLQELDLSDNALGP 95 (319)
T ss_pred ceeEEEccCCCCCh
Confidence 55555555555543
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=194.49 Aligned_cols=199 Identities=20% Similarity=0.214 Sum_probs=160.7
Q ss_pred HHHHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCC---CCCcceeeeEEecCCc
Q 002278 610 DIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR---HRNIVSLHGYALSPYG 686 (943)
Q Consensus 610 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~ 686 (943)
++....+.|.+.+.||+|+||+||.|...+++.||+|+-+.... -+|.=-.+++.+|+ -+-|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 34445677888999999999999999988899999998765432 22322234444554 3556666666677778
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC-------CCCceee
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-------ENFDAHL 759 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-------~~~~~kl 759 (943)
-++|+||.+.|+|.|++. .....+|.-+..++.|++..+++||.. +||||||||+|+|+. +...++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999997 455689999999999999999999999 999999999999994 2345999
Q ss_pred cccccccccCCC-CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCC
Q 002278 760 SDFGIARCIPTA-MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK 817 (943)
Q Consensus 760 ~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 817 (943)
+|||.+-.+.-- ........++|-.+-.+|...|.+++.++|.|.++.+++-|+.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999765321 1234456778999999999999999999999999999999999854
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.2e-17 Score=167.36 Aligned_cols=142 Identities=15% Similarity=0.130 Sum_probs=111.0
Q ss_pred ccccceEEeeeceEEEEEEE--ecCCceEEEEEecccCcc------------------------cHHHHHHHHHHHhcCC
Q 002278 617 NLSEKYIVGYGASSTVYKCA--LKNSRPIAVKKLYNQYPH------------------------NLREFETELETIGSIR 670 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 670 (943)
-|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+.+|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 457899999988643210 0123568999999997
Q ss_pred CCC--cceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCC-eEecCCCCc
Q 002278 671 HRN--IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR-IIHRDVKSS 747 (943)
Q Consensus 671 h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~ 747 (943)
+.. +.+++++ ...++||||++++++..... ........++..++.|++.++++||+. + |+||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 533 3444443 24589999999988876542 223456667789999999999999999 9 999999999
Q ss_pred cEEECCCCceeecccccccccC
Q 002278 748 NILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 748 Nill~~~~~~kl~DFGla~~~~ 769 (943)
||+++ ++.++++|||.|....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.6e-18 Score=184.23 Aligned_cols=177 Identities=24% Similarity=0.343 Sum_probs=135.4
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..||.|++|..++|.+++.+.+.....++...+.++.|++.|++| + +.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999877777778899999999999999999 6 8999999999999999999999999999
Q ss_pred cccCCCC-----CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccc
Q 002278 766 RCIPTAM-----PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVM 839 (943)
Q Consensus 766 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 839 (943)
....... ....+...||..||+||.+.+..|+.++||||||++++|+++ -..+++..... .....+.++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~-----~d~r~g~ip 478 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL-----TDIRDGIIP 478 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh-----hhhhcCCCC
Confidence 8775544 233455679999999999999999999999999999999997 22322211100 011122222
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
+ .+..+. ..-..++.+++++.|.+||++.++..+
T Consensus 479 ~----~~~~d~------p~e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 479 P----EFLQDY------PEEYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred h----HHhhcC------cHHHHHHHHhcCCCcccCchHHHHhhh
Confidence 1 221111 223478999999999999966555443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=162.24 Aligned_cols=134 Identities=19% Similarity=0.283 Sum_probs=112.9
Q ss_pred eEEeeeceEEEEEEEecCCceEEEEEecccCcc--------cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 622 YIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH--------NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
+.||+|++|.||+|.. .+..|++|+....... ....+.+|++++..+.|++|.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 5778999976543221 123577899999999999998888887777888999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++|++|.+++... .+ .+..++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988521 12 7889999999999999999 999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-16 Score=158.53 Aligned_cols=144 Identities=15% Similarity=0.147 Sum_probs=111.9
Q ss_pred HHHHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcc----------------------cHHHHHHHHHHHh
Q 002278 610 DIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH----------------------NLREFETELETIG 667 (943)
Q Consensus 610 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 667 (943)
++......|...+.||+|+||.||+|..++++.||||++...... .......|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444457778899999999999999888999999986532210 1123567888888
Q ss_pred cCCCCC--cceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 002278 668 SIRHRN--IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVK 745 (943)
Q Consensus 668 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 745 (943)
.+.|++ +...++ ....++||||+++++|.++... .....++.+++.++.++|+. +|+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 888774 444443 2456899999999998765420 33567889999999999998 99999999
Q ss_pred CccEEECCCCceeecccccccccC
Q 002278 746 SSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 746 p~Nill~~~~~~kl~DFGla~~~~ 769 (943)
|+||++++++.++|+|||.+....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=3e-16 Score=160.07 Aligned_cols=130 Identities=18% Similarity=0.298 Sum_probs=106.6
Q ss_pred EeeeceEEEEEEEecCCceEEEEEecccCc-c-------cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYP-H-------NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
||+|+||.||+|.+ ++..|++|+...... . ...++.+|+++++.++|+++.....++......+++|||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 79999999999985 467899998654321 1 12456789999999998887666666666777899999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
|++|.+++... .. .++.+++.+|+++|+. +++|||++|.||+++ ++.++++|||+++..
T Consensus 81 g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEG---ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhc---HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999887521 10 7899999999999999 999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.5e-16 Score=179.81 Aligned_cols=137 Identities=19% Similarity=0.296 Sum_probs=112.2
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEe-cccCc-------ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKL-YNQYP-------HNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
...|...+.||+|+||+||+|.+.... +++|+. .+... ...+.+.+|+++++.++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 445567789999999999999876443 444433 22111 113467899999999999999988888888778
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.++||||+++++|.+++. ....++.+++++++|||+. +++|||+||+||++ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998874 3567899999999999999 99999999999999 67899999999997
Q ss_pred c
Q 002278 767 C 767 (943)
Q Consensus 767 ~ 767 (943)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.5e-14 Score=138.88 Aligned_cols=135 Identities=19% Similarity=0.154 Sum_probs=114.1
Q ss_pred cceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCC--CCcceeeeEEecCCcceEEEEEccCC
Q 002278 620 EKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRH--RNIVSLHGYALSPYGNLLFYDYMVNG 697 (943)
Q Consensus 620 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 697 (943)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999864 7899998765433 5678899999999976 58999999888888899999999887
Q ss_pred ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 698 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
.+..+ +......++.+++++++++|.....+++|||++|+||+++..+.++++|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 5567788899999999999986445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.5e-16 Score=171.36 Aligned_cols=195 Identities=30% Similarity=0.491 Sum_probs=165.0
Q ss_pred CCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceee
Q 002278 300 MSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLN 379 (943)
Q Consensus 300 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 379 (943)
+.--...||+.|++. .+|..++.+..|+.+.|..|.|. .+|..++++..|++|+|+.|+++ ..|..++.|+ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 444567888888888 78888888888888889999887 78888899999999999999998 6777788776 89999
Q ss_pred ccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccc
Q 002278 380 LSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459 (943)
Q Consensus 380 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 459 (943)
+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++..|+.|++..|++. .+|.++..| .|..||+|.|+++
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis- 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS- 224 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-
Confidence 9999998 78889998899999999999998 68888999999999999999998 567777766 4899999999998
Q ss_pred cCChhhhcccccceecccCcccCCCCCCcCccc---cCCcccccCCcc
Q 002278 460 SIPAELGQLQNIISLILNNNNLQGGIPDQLSNC---FSLSNLNVSYNN 504 (943)
Q Consensus 460 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~ls~N~ 504 (943)
.+|.+|.+|+.|++|-|.+|.|+ .+|..++.. .=.++|+....+
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 89999999999999999999998 677776533 334667766664
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2e-14 Score=145.05 Aligned_cols=136 Identities=18% Similarity=0.183 Sum_probs=97.9
Q ss_pred ceEEeeeceEEEEEEEecCCceEEEEEecccCccc--HHH----------------------HHHHHHHHhcCCCCC--c
Q 002278 621 KYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHN--LRE----------------------FETELETIGSIRHRN--I 674 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--i 674 (943)
.+.||+|+||+||+|...+++.||||++....... ... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999998889999999876432111 111 134555666654433 4
Q ss_pred ceeeeEEecCCcceEEEEEccCCChhhh-ccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEEC
Q 002278 675 VSLHGYALSPYGNLLFYDYMVNGSLWDL-LHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILID 752 (943)
Q Consensus 675 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~ 752 (943)
.+.+++ ...++||||++++.+... +... ... .+...++.+++.++.++|+ . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444433 246899999998654321 2110 011 5678899999999999999 7 999999999999999
Q ss_pred CCCceeecccccccccC
Q 002278 753 ENFDAHLSDFGIARCIP 769 (943)
Q Consensus 753 ~~~~~kl~DFGla~~~~ 769 (943)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.6e-16 Score=178.75 Aligned_cols=261 Identities=23% Similarity=0.253 Sum_probs=190.6
Q ss_pred hhccccceEEeeeceEEEEEEEecCC--ceEEEEEecccC--cccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNS--RPIAVKKLYNQY--PHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 689 (943)
...|...+.||+|+|+.|-.+..... ..+|+|.+.... .........|..+-..+. |+|++.+++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 44677777899999999988876433 445666554332 233344555777766776 9999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhh-hCCCCCeEecCCCCccEEECCCC-ceeecccccccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH-HDCNPRIIHRDVKSSNILIDENF-DAHLSDFGIARC 767 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFGla~~ 767 (943)
..+|..+|++.+.+... .....+......++.|+..++.|+| .. +++|||+||+|.+++..+ ..+++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999999988311 1114566777889999999999999 77 999999999999999999 999999999998
Q ss_pred cCC--CCCceeeeEec-ccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhc-ccccccccc
Q 002278 768 IPT--AMPHASTFVLG-TIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKA-DDNTVMEAV 842 (943)
Q Consensus 768 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 842 (943)
+.. +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+............. .........
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 765 33333445568 9999999999884 456889999999999999999999975432221100000 000111111
Q ss_pred CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 843 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
+..+. ....++...++..+|..|.+..++...-+...
T Consensus 255 ~~~~~---------~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSIS---------DQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCC---------hhhhhcccccccCCchhccccccccccccccc
Confidence 11111 23456788888899999999999877655443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.1e-14 Score=172.56 Aligned_cols=141 Identities=32% Similarity=0.542 Sum_probs=119.2
Q ss_pred cccccccCccccCCCCCCCCCCCCC----CcceeEecCC--C--CcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCc
Q 002278 2 AIKASFSNLANVLLDWDDVHNSDFC----SWRGVFCDNS--S--LSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNK 73 (943)
Q Consensus 2 ~~~~~~~~~~~~~~~w~~~~~~~~c----~w~gv~c~~~--~--~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~ 73 (943)
+||+++.++.. .+|.+ ..|| .|.||.|... . ..|+.|+|++|++.|.+|+.++.+++|+.|+|++|+
T Consensus 379 ~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~ 453 (623)
T PLN03150 379 TLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNS 453 (623)
T ss_pred HHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCc
Confidence 46777776542 48963 3443 7999999532 2 358999999999999999999999999999999999
Q ss_pred ccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCC-CCCcEEEEeccccc
Q 002278 74 LTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQI-PNLKTLDLARNQLT 147 (943)
Q Consensus 74 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~ 147 (943)
|+|.+|..++.+++|+.|+|++|++++.+|..+++|++|+.|+|++|++++.+|..+..+ .++..+++++|...
T Consensus 454 l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 454 IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred ccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccc
Confidence 999999999999999999999999999999999999999999999999999999888764 46778888888643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.9e-14 Score=146.57 Aligned_cols=135 Identities=16% Similarity=0.144 Sum_probs=105.0
Q ss_pred ceEEe-eeceEEEEEEEecCCceEEEEEecccC-------------cccHHHHHHHHHHHhcCCCCCc--ceeeeEEecC
Q 002278 621 KYIVG-YGASSTVYKCALKNSRPIAVKKLYNQY-------------PHNLREFETELETIGSIRHRNI--VSLHGYALSP 684 (943)
Q Consensus 621 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 684 (943)
.+.|| .|+.|+||.+... +..+|||.+.... ......+.+|+++++.++|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 9999999999875 6788998774311 1223467889999999998875 6677765433
Q ss_pred Cc----ceEEEEEccC-CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 685 YG----NLLFYDYMVN-GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 685 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
.. .++|||+++| .+|.+++.. ..++.. .+.+++.++++||+. ||+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 689888752 234443 356899999999999 9999999999999999889999
Q ss_pred cccccccc
Q 002278 760 SDFGIARC 767 (943)
Q Consensus 760 ~DFGla~~ 767 (943)
+|||.++.
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-14 Score=172.33 Aligned_cols=119 Identities=34% Similarity=0.553 Sum_probs=96.2
Q ss_pred ccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccC
Q 002278 422 HLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVS 501 (943)
Q Consensus 422 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 501 (943)
.++.|+|++|.+++.+|..+..+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|+.++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 46778888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CccccccCCCCcc--cCcCCCCccccCCCCCCCCCCCccCC
Q 002278 502 YNNLSGIIPPIRN--FSRFSSNSFIGNPLLCGNWIGSICGP 540 (943)
Q Consensus 502 ~N~l~~~~~~~~~--~~~~~~~~~~~Np~~c~~~~~~~c~~ 540 (943)
+|+|+|.+|.... ...+....+.+|+.+||.+.-..|..
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~ 539 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGP 539 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCcc
Confidence 8888888775311 22344567899999999876667853
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.3e-16 Score=167.17 Aligned_cols=180 Identities=28% Similarity=0.450 Sum_probs=164.9
Q ss_pred CcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEE
Q 002278 323 KLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTL 402 (943)
Q Consensus 323 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 402 (943)
.+.--...+|+.|++. .+|..++.+..|+.+.|+.|.|. .+|.+++++..|++|+|+.|+++ .+|..++.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3445567899999998 88999999999999999999998 78999999999999999999999 7888888875 8999
Q ss_pred ecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccC
Q 002278 403 DLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 403 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 482 (943)
-+++|+++ .+|..++.+..|..||.|.|.+. .+|..+++|.+|+.|++..|++. .+|.+++.|+ |..||++.|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee
Confidence 99999999 78999999999999999999998 68889999999999999999998 7899999776 999999999999
Q ss_pred CCCCCcCccccCCcccccCCccccccCCC
Q 002278 483 GGIPDQLSNCFSLSNLNVSYNNLSGIIPP 511 (943)
Q Consensus 483 ~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 511 (943)
.+|-.|.+|..|++|-|.+|+|+..+..
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLqSPPAq 252 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQSPPAQ 252 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCCCChHH
Confidence 8899999999999999999999976654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.7e-13 Score=155.55 Aligned_cols=180 Identities=34% Similarity=0.584 Sum_probs=102.8
Q ss_pred CCCcceEEecCCCCCCCCCCCcCCCC-cCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEE
Q 002278 276 LSYTGKLYLHGNKLTGPIPPELGNMS-KLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQF 354 (943)
Q Consensus 276 l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 354 (943)
++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|++. .+|.....+++|+.|
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L 191 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence 344555555555555 3333444442 5666666666665 44445555666666666666665 333333355666666
Q ss_pred EeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeeccccccc
Q 002278 355 NVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLN 434 (943)
Q Consensus 355 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 434 (943)
++++|+++ .+|.....+..|++|.+++|.+. ..+..+..+.++..|.+++|++. ..+..++.+++|+.|++++|+++
T Consensus 192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 192 DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc
Confidence 66666665 34443334444666666666433 34555666666666666666665 33556666666777777777776
Q ss_pred ccCCccccCCCccceecccCccccccCCh
Q 002278 435 GLLPAEFGNLRSIQTIDMSFNQLSGSIPA 463 (943)
Q Consensus 435 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 463 (943)
...+ ++.+.+|+.|++++|.+....|.
T Consensus 269 ~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 269 SISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cccc--ccccCccCEEeccCccccccchh
Confidence 4322 66667777777777776644443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.8e-13 Score=152.75 Aligned_cols=201 Identities=36% Similarity=0.555 Sum_probs=154.6
Q ss_pred eEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcc-cceEEEccccccCCcCcccccCCCcCcEEEeeCC
Q 002278 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLE-QLFELNLADNNLEGPIPHNISSCTALNQFNVHGN 359 (943)
Q Consensus 281 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 359 (943)
.+.+..|.+.. ....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 56667776642 2334555678888999999888 5666666674 8889999999887 55567888888999999999
Q ss_pred cccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCc
Q 002278 360 RLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPA 439 (943)
Q Consensus 360 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 439 (943)
+++ .+|.....+++|+.|++++|++. .+|.....+..|++|++++|.+. ..+..+.++.++..|.+++|++.. .+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence 988 45555557888888999999888 66766666667888899988654 467778888888888888888873 477
Q ss_pred cccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCc
Q 002278 440 EFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLS 490 (943)
Q Consensus 440 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 490 (943)
.++++++|++|++++|+++ .++. ++.+.+|+.|++++|.+...+|....
T Consensus 250 ~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 250 SIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred hhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhhc
Confidence 7888888999999999888 4555 88888899999999988866665443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.7e-13 Score=136.18 Aligned_cols=206 Identities=21% Similarity=0.310 Sum_probs=143.9
Q ss_pred HHHHhcCCCCCcceeeeEEecCC-----cceEEEEEccCCChhhhccCCCC-CccCCHHHHHHHHHHHHHHHHHhhhCCC
Q 002278 663 LETIGSIRHRNIVSLHGYALSPY-----GNLLFYDYMVNGSLWDLLHGPSK-KVKLDWETRLKIAVGAAQGLAYLHHDCN 736 (943)
Q Consensus 663 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 736 (943)
..-+-++.|.|||+++.|+.+.. ...++.||+..|++..+|++.+. ...+......+++.||..||.|||+ |+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 34455567999999999986543 45788999999999999975432 3457788888999999999999999 59
Q ss_pred CCeEecCCCCccEEECCCCceeeccccccccc---CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHH
Q 002278 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCI---PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813 (943)
Q Consensus 737 ~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 813 (943)
|.|+|+++..+-|++..+|-+|+.--.-.... ..........-.|-++|.|||.-.....+.++|||+||+...||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999998887532111111 001111122234678999999988888889999999999999998
Q ss_pred hCCCCC-CCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 814 TGKKAV-DNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 814 tG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.|..-- .+......-..+. ...-...... -..++..|+...|..||+|.+++.|.-
T Consensus 277 ilEiq~tnseS~~~~ee~ia----~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIA----NVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HheeccCCCcceeehhhhhh----hheeeccCcc------------ccCcCcccccCCCCCCcchhhhhcCce
Confidence 876432 2222111000000 0000000001 124688899999999999999987653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.5e-12 Score=147.32 Aligned_cols=141 Identities=18% Similarity=0.191 Sum_probs=99.4
Q ss_pred ceEEeeeceEEEEEEEecCCceEEEEEecccCcccH----------------------------------------HHHH
Q 002278 621 KYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNL----------------------------------------REFE 660 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 660 (943)
.+.||.|++|.||+|+.++|+.||||+......+.. -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 357999999999999999999999999754311100 0234
Q ss_pred HHHHHHhcC----CCCCcceeeeEE-ecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHH-HHHHhhhC
Q 002278 661 TELETIGSI----RHRNIVSLHGYA-LSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ-GLAYLHHD 734 (943)
Q Consensus 661 ~E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~ 734 (943)
+|++.+.++ +|..-+.+-.++ ......++||||++|+++.++.... .... ...+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 455555544 233333333333 2345679999999999998876421 1112 23456666665 47788988
Q ss_pred CCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 735 ~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
|++|+|++|.||++++++.++++|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.9e-12 Score=140.99 Aligned_cols=247 Identities=21% Similarity=0.178 Sum_probs=179.2
Q ss_pred hccccceEEee--eceEEEEEEEe--c-CCceEEEEEecccC--cccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcc
Q 002278 616 ENLSEKYIVGY--GASSTVYKCAL--K-NSRPIAVKKLYNQY--PHNLREFETELETIGSIR-HRNIVSLHGYALSPYGN 687 (943)
Q Consensus 616 ~~~~~~~~lG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 687 (943)
..|.....+|. |.+|.||.+.. + ++..+|+|+-+... +.....-.+|+.....++ |++.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34556677899 99999999986 3 57889999854332 233334456676666665 99999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHH----HHHHhhhCCCCCeEecCCCCccEEECCC-Cceeeccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ----GLAYLHHDCNPRIIHRDVKSSNILIDEN-FDAHLSDF 762 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DF 762 (943)
++-.|++ +.++..+.+.. ...++....+.+..+..+ |+.++|+. +++|-|+||.||+...+ ...+++||
T Consensus 194 fiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9989987 57888877642 233677778888888888 99999999 99999999999999999 88999999
Q ss_pred ccccccCCCCCceee----eEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC--ccHHHHHHHhcccc
Q 002278 763 GIARCIPTAMPHAST----FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNE--SNLHQLIMSKADDN 836 (943)
Q Consensus 763 Gla~~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~--~~~~~~~~~~~~~~ 836 (943)
|+...+....-.... ...|...|++||...+ .++..+|+|++|.+..+..+|..+.... ..+.+ .....
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~---~r~~~- 342 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ---LRQGY- 342 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc---ccccc-
Confidence 999887655322111 1247888999998774 5788999999999999999887666433 21111 10000
Q ss_pred ccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 837 TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
.+. ++- .....++...+..+++.+|-.|++++.+..+
T Consensus 343 -ip~----e~~-----~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 343 -IPL----EFC-----EGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred -Cch----hhh-----cCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 111 110 0111344458888999999999999888764
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.2e-13 Score=132.10 Aligned_cols=138 Identities=25% Similarity=0.281 Sum_probs=105.0
Q ss_pred ccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCc
Q 002278 367 SSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRS 446 (943)
Q Consensus 367 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 446 (943)
..+.....|++||||+|.|+ .+.+...-++.++.|++|+|.|.. + ..+..+++|+.||||+|.++ .+..+-..|-+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 34444567888888888887 566777778888888888888873 2 33778888888888888887 44455556778
Q ss_pred cceecccCccccccCChhhhcccccceecccCcccCCCC-CCcCccccCCcccccCCccccccCC
Q 002278 447 IQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGI-PDQLSNCFSLSNLNVSYNNLSGIIP 510 (943)
Q Consensus 447 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~~ 510 (943)
+++|.|++|.|. .-..++.|-+|..||+++|+|.... -..++++|.|+.+.|.+|+|++++.
T Consensus 354 IKtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 354 IKTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred EeeeehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 888889988886 2346777888888999999887422 2347889999999999999988765
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.5e-12 Score=129.79 Aligned_cols=131 Identities=27% Similarity=0.358 Sum_probs=103.1
Q ss_pred CCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceee
Q 002278 348 CTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLN 427 (943)
Q Consensus 348 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 427 (943)
...|+++||++|.|+ .+.++..-+|.++.|++|+|.+... +.+..+++|+.||||+|.++ .+-..-.++-++++|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 356777777777777 5566677778888888888888732 34788888999999999887 4555556788899999
Q ss_pred cccccccccCCccccCCCccceecccCccccccC-ChhhhcccccceecccCcccCCC
Q 002278 428 LSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSI-PAELGQLQNIISLILNNNNLQGG 484 (943)
Q Consensus 428 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~ 484 (943)
|++|.|.+. ..++.|-+|..||+++|+|.... -..+++||-|+.|.|.+|+|.+.
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 999998743 56778889999999999997422 35789999999999999999843
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.3e-11 Score=119.39 Aligned_cols=130 Identities=19% Similarity=0.134 Sum_probs=95.7
Q ss_pred ceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcc-eeeeEEecCCcceEEEEEccCCCh
Q 002278 621 KYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIV-SLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
.+.++.|.++.||++... ++.|++|....... ....+.+|+++++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356899999999999876 77899998754321 234567899999988665544 444443 3346899999999877
Q ss_pred hhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCC--CCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC--NPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 700 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.+.- .....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5430 111345678999999999872 12359999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.7e-12 Score=145.74 Aligned_cols=203 Identities=26% Similarity=0.315 Sum_probs=102.5
Q ss_pred ccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccce
Q 002278 249 IGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLF 328 (943)
Q Consensus 249 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 328 (943)
+..+.+|++|++++|.|+.+. .+..++.|+.|++.+|.|+.. ..+..+..|+.+++++|++..+.+.....+.+++
T Consensus 114 l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~ 189 (414)
T KOG0531|consen 114 LSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLE 189 (414)
T ss_pred hhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchH
Confidence 445666666666666666432 233444455566666665532 3344455666666666666533321024444455
Q ss_pred EEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCC--ccEEecCC
Q 002278 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIIN--LDTLDLSV 406 (943)
Q Consensus 329 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~Ls~ 406 (943)
.+.+.+|.+.. ...+..+. .+..+++..|.++..- .+..+.. |+.+++++
T Consensus 190 ~l~l~~n~i~~--i~~~~~~~------------------------~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~ 241 (414)
T KOG0531|consen 190 ELDLGGNSIRE--IEGLDLLK------------------------KLVLLSLLDNKISKLE--GLNELVMLHLRELYLSG 241 (414)
T ss_pred HHhccCCchhc--ccchHHHH------------------------HHHHhhcccccceecc--CcccchhHHHHHHhccc
Confidence 55555555431 12222333 3333344444444221 1122222 55666666
Q ss_pred CcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccc---cCChh-hhcccccceecccCcccC
Q 002278 407 NNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG---SIPAE-LGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 407 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~-~~~l~~L~~L~L~~N~l~ 482 (943)
|.+. ..+..+..+.++..|++++|++... ..+.....+..+.++.|.+.. ..... ....+.++.+.+.+|.+.
T Consensus 242 n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (414)
T KOG0531|consen 242 NRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIR 318 (414)
T ss_pred Cccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccc
Confidence 6655 2334555566666666666666533 334445566666666666552 11111 455666777777777776
Q ss_pred CCCC
Q 002278 483 GGIP 486 (943)
Q Consensus 483 ~~~p 486 (943)
...+
T Consensus 319 ~~~~ 322 (414)
T KOG0531|consen 319 KISS 322 (414)
T ss_pred cccc
Confidence 5444
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.9e-11 Score=136.24 Aligned_cols=143 Identities=14% Similarity=0.136 Sum_probs=94.6
Q ss_pred ccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcc----------------------------------cHH----
Q 002278 617 NLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPH----------------------------------NLR---- 657 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~---- 657 (943)
.|+. +.||+|++|.||+|++++ |+.||||+....... ..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 689999999999999987 999999998643110 011
Q ss_pred --HHHHHHHHHhcC----CCCCcceeeeEEec-CCcceEEEEEccCCChhhhc--cCCC-CCccCCHHHHHHHHHHHHHH
Q 002278 658 --EFETELETIGSI----RHRNIVSLHGYALS-PYGNLLFYDYMVNGSLWDLL--HGPS-KKVKLDWETRLKIAVGAAQG 727 (943)
Q Consensus 658 --~~~~E~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~-~~~~l~~~~~~~i~~~i~~~ 727 (943)
++.+|+..+.++ .+...+.+-.++.+ ....++||||+.|+.+.++- .... ....+....+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 133444444444 24444444444433 45678999999999998742 2110 01123333333344444
Q ss_pred HHHhhhCCCCCeEecCCCCccEEECCCC----ceeecccccccccCC
Q 002278 728 LAYLHHDCNPRIIHRDVKSSNILIDENF----DAHLSDFGIARCIPT 770 (943)
Q Consensus 728 l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DFGla~~~~~ 770 (943)
... |++|+|+||.||+++.++ +++++|||++..+..
T Consensus 277 ----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999888 999999999987644
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.7e-12 Score=144.69 Aligned_cols=216 Identities=28% Similarity=0.337 Sum_probs=117.2
Q ss_pred CCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEe
Q 002278 277 SYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNV 356 (943)
Q Consensus 277 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 356 (943)
..++.+.+..|.+.. +-..+..+++|..|++.+|+|.. +...+..+++|++|+|++|.|+.+. .+..++.|+.|++
T Consensus 72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l 147 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNL 147 (414)
T ss_pred HhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhhee
Confidence 334444444454442 22234455555566666665552 2222455556666666666665432 2444455666666
Q ss_pred eCCcccCcccccccccCccceeeccCCcCCCCCC-CCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccc
Q 002278 357 HGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP-TELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNG 435 (943)
Q Consensus 357 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 435 (943)
++|.|+.+ ..+..+.+|+.+++++|++....+ . ...+.+++.+++++|.+. ....+..+..+..+++..|+++.
T Consensus 148 ~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 148 SGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISK 222 (414)
T ss_pred ccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhccccccee
Confidence 66666522 234446666666666666663332 1 355666666777777665 23334445555555667777663
Q ss_pred cCCccccCCCc--cceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCcccc
Q 002278 436 LLPAEFGNLRS--IQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLS 506 (943)
Q Consensus 436 ~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 506 (943)
.- .+..+.. |+.+++++|++. .++..+..+..+..|++.+|++...- .+.....+..+....|.+.
T Consensus 223 ~~--~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 223 LE--GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLA 290 (414)
T ss_pred cc--CcccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhc
Confidence 32 1222233 677777777776 44455666667777777777765321 2334455666666666665
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.5e-11 Score=134.62 Aligned_cols=250 Identities=18% Similarity=0.165 Sum_probs=181.3
Q ss_pred HHHHhhccccceEEeeeceEEEEEEEec--CCceEEEEEecccCcccHHHH--HHHHHHHhcCC-CCCcceeeeEEecCC
Q 002278 611 IMRSTENLSEKYIVGYGASSTVYKCALK--NSRPIAVKKLYNQYPHNLREF--ETELETIGSIR-HRNIVSLHGYALSPY 685 (943)
Q Consensus 611 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~l~~~~~~~~ 685 (943)
......+|..+..||.|.|+.||....+ ++..|++|.+.+.......+. ..|+.+...+. |.++++.+..+...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445678888999999999999998744 578899998876554433332 35666666664 899999888888888
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC-Cceeeccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-FDAHLSDFGI 764 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DFGl 764 (943)
..|+--||+.++++..... -...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 8889999999998877652 345688888999999999999999998 99999999999999875 8899999999
Q ss_pred ccccCCCCCceeeeEeccccee--CccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYI--DPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 842 (943)
++.+.-. .....+.-+++ +|+......+..++|++|||..+.|..+|..--...... ..+. ...
T Consensus 414 ~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~-------~~~ 479 (524)
T KOG0601|consen 414 WTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIR-------SGD 479 (524)
T ss_pred cccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeee-------ccc
Confidence 8753211 11112233444 566666778899999999999999999986544332221 1111 111
Q ss_pred CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 843 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
-+... . ....+..+.+.+..+++..||.+.++..+.+.
T Consensus 480 ~p~~~----~--~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 480 TPNLP----G--LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccCCC----c--hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11111 1 11345567788889999999999888776543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.3e-12 Score=133.93 Aligned_cols=234 Identities=22% Similarity=0.315 Sum_probs=144.6
Q ss_pred CCcEEEEEcCCCCCccc----cCCCcCCCCCCCEEEeeCC---cccccCCC-------CccCCCCCcEEeccCCCcCCcc
Q 002278 37 SLSVVSLNLSSLNLGGE----ISPSIGDLRNLQSIDFQGN---KLTGQIPD-------EIGNCGSLVHIELSDNSLYGDI 102 (943)
Q Consensus 37 ~~~v~~L~l~~~~~~~~----~~~~l~~l~~L~~L~Ls~n---~l~~~~p~-------~~~~l~~L~~L~Ls~N~l~~~~ 102 (943)
...++.++||+|.+... +.+.|...++|+..++|+- ++...+|. .+...++|++||||+|-+.-..
T Consensus 29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g 108 (382)
T KOG1909|consen 29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG 108 (382)
T ss_pred cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence 34688999999998864 5567888889999999973 23334444 3445679999999999987555
Q ss_pred chh----ccccccceEEEecCcccccCCCc-------------ccCCCCCCcEEEEeccccccc----cchhccccccce
Q 002278 103 PFS----ISKLKQLEFLNLKNNQLTGPIPS-------------TLTQIPNLKTLDLARNQLTGE----IPRLIYWNEVLQ 161 (943)
Q Consensus 103 p~~----~~~l~~L~~L~Ls~n~l~~~~~~-------------~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~ 161 (943)
+.. ++.+..|++|+|.+|.+.-.... -...-++|++++..+|++... +...|...+.|+
T Consensus 109 ~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~le 188 (382)
T KOG1909|consen 109 IRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLE 188 (382)
T ss_pred hHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccc
Confidence 544 45678999999999988732222 233457889999999988732 344555666777
Q ss_pred eccccCCccCCC----CCcccccccccceeeccceeccc----ccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeE
Q 002278 162 YLGLRGNALTGM----LSPDMCQLTGLWYFDVRGNNLTG----TIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVAT 233 (943)
Q Consensus 162 ~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~i~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~ 233 (943)
.+.++.|.|..- ....|..+++|++|||+.|-++. .+...++.+++|++|++++|.+...-...
T Consensus 189 evr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a-------- 260 (382)
T KOG1909|consen 189 EVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIA-------- 260 (382)
T ss_pred eEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHH--------
Confidence 777777776522 12234555666666666665542 12234444555555555555554221111
Q ss_pred EEecCccccccCCccc-cccCCCcEEecCCCCCCC----CCCcccCCCCCcceEEecCCCC
Q 002278 234 LSLQGNKLTGKIPEVI-GLMQALAVLDLSENELVG----PIPPILGNLSYTGKLYLHGNKL 289 (943)
Q Consensus 234 L~L~~n~l~~~~~~~l-~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~n~l 289 (943)
+.+.+ ...++|++|.|.+|.|+. .+.......+.|..|+|++|.+
T Consensus 261 -----------~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 261 -----------FVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred -----------HHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 11111 124566677777776653 1222344466677777777776
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.9e-10 Score=128.50 Aligned_cols=165 Identities=17% Similarity=0.218 Sum_probs=125.5
Q ss_pred cCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHH
Q 002278 638 KNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETR 717 (943)
Q Consensus 638 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~ 717 (943)
.++.+|.|...............+.++.++.+|||+|+++++.+..++..|+|+|.+. .|..++.. +....+
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 3578888888776655445567788889999999999999999999999999999874 45556642 335667
Q ss_pred HHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeEecccceeCccccccCCCC
Q 002278 718 LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLN 797 (943)
Q Consensus 718 ~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 797 (943)
...+.||+.||.|||..| +++|++|.-.-|++++.|+.||++|-++......... .....--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-AKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-cccchhhhcccChhhcCccc--
Confidence 778899999999999765 9999999999999999999999999888654332210 11111122455666544322
Q ss_pred CcchhhhHHHHHHHHHhC
Q 002278 798 EKSDVYSFGIVLLEILTG 815 (943)
Q Consensus 798 ~~~DvwSlGvil~elltG 815 (943)
...|.|.|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 356999999999999998
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.8e-11 Score=118.74 Aligned_cols=123 Identities=28% Similarity=0.340 Sum_probs=34.2
Q ss_pred CCCCcEEeccCCCcCCccchhcc-ccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhc-ccccccee
Q 002278 85 CGSLVHIELSDNSLYGDIPFSIS-KLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLI-YWNEVLQY 162 (943)
Q Consensus 85 l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~ 162 (943)
..++++|+|++|+|+. + +.++ .+.+|+.|+|++|.|+.. +.+..+++|++|+|++|+|+.. ...+ ..+++|++
T Consensus 18 ~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred cccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCCE
Confidence 3344445555554442 1 1232 344555555555555422 2344455555555555555522 2222 23455555
Q ss_pred ccccCCccCCCCC-cccccccccceeeccceecccccC---CCCcCCCcccEEE
Q 002278 163 LGLRGNALTGMLS-PDMCQLTGLWYFDVRGNNLTGTIP---DSIGNCTSFEILD 212 (943)
Q Consensus 163 L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~---~~l~~l~~L~~L~ 212 (943)
|+|++|+|..+.. ..+..+++|++|+|.+|.++...- ..+..+++|+.||
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 5555555544321 345556677777777777663211 1345677777777
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.8e-10 Score=111.03 Aligned_cols=136 Identities=13% Similarity=0.111 Sum_probs=98.0
Q ss_pred eEEeeeceEEEEEEEecC-------CceEEEEEecccC------------c----------ccHHHH----HHHHHHHhc
Q 002278 622 YIVGYGASSTVYKCALKN-------SRPIAVKKLYNQY------------P----------HNLREF----ETELETIGS 668 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~~ 668 (943)
..||.|.-+.||.|...+ +..+|||..+... + .....+ ++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998553 4789999764211 0 001222 379999998
Q ss_pred CCC--CCcceeeeEEecCCcceEEEEEccCCChhh-hccCCCCCccCCHHHHHHHHHHHHHHHHHh-hhCCCCCeEecCC
Q 002278 669 IRH--RNIVSLHGYALSPYGNLLFYDYMVNGSLWD-LLHGPSKKVKLDWETRLKIAVGAAQGLAYL-HHDCNPRIIHRDV 744 (943)
Q Consensus 669 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dl 744 (943)
+.. -++..++++ ...++||||+.++.+.. .++ ...++..+...+..+++.++..+ |.. ++|||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 864 355566554 56799999997654322 222 12345566777889999999999 777 9999999
Q ss_pred CCccEEECCCCceeecccccccccC
Q 002278 745 KSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 745 kp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
++.||+++ ++.++++|||.|....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8e-12 Score=131.53 Aligned_cols=137 Identities=27% Similarity=0.247 Sum_probs=65.3
Q ss_pred cCCCCcCcEEEcccCccccccc--cccCCcccceEEEccccccCCcCcccc-cCCCcCcEEEeeCCcccCc-cccccccc
Q 002278 297 LGNMSKLSYLQLQNNQLVGTIP--AELGKLEQLFELNLADNNLEGPIPHNI-SSCTALNQFNVHGNRLSGA-IPSSFRNL 372 (943)
Q Consensus 297 ~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~-~~~~~~~l 372 (943)
...+++++.|||+.|-+....+ .....|++|+.|+|+.|++.-...... ..++.|+.|.|+.|.++-. +......+
T Consensus 142 ~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~f 221 (505)
T KOG3207|consen 142 SKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTF 221 (505)
T ss_pred hhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhC
Confidence 3445566666666665542211 223456666666666666652221111 1344555666666655421 11223345
Q ss_pred CccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccC--CCcccccccceeeccccccc
Q 002278 373 GSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVP--ASIGDLEHLLTLNLSRNHLN 434 (943)
Q Consensus 373 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~ 434 (943)
|+|+.|+|..|..-........-+..|+.|||++|++.. .+ ...+.++.|+.|+++.+.+.
T Consensus 222 Psl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 222 PSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIA 284 (505)
T ss_pred CcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhhccccCcc
Confidence 566666666663222333333344455555555555542 22 22344555555555555554
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-11 Score=129.88 Aligned_cols=208 Identities=20% Similarity=0.158 Sum_probs=94.3
Q ss_pred CCCCCcEEeccCCCcCCccc--hhccccccceEEEecCcccccCC--CcccCCCCCCcEEEEeccccccccchhc-cccc
Q 002278 84 NCGSLVHIELSDNSLYGDIP--FSISKLKQLEFLNLKNNQLTGPI--PSTLTQIPNLKTLDLARNQLTGEIPRLI-YWNE 158 (943)
Q Consensus 84 ~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~ 158 (943)
++.+|+...|.+..+. ..+ .....|++++.||||+|-+.... ......||+|+.|+|+.|++........ ..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 3455555555555544 222 13344555555555555444221 1233445555555555555542111111 1234
Q ss_pred cceeccccCCccCCCC-CcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEec
Q 002278 159 VLQYLGLRGNALTGML-SPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQ 237 (943)
Q Consensus 159 ~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~ 237 (943)
.|+.|.|+.|.++.-. ......+++|+.|+|..|.....-......+..|++|||++|++-... .
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~-~------------- 263 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFD-Q------------- 263 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccc-c-------------
Confidence 4555555555554211 011233456666666666432233334445566666666666654211 0
Q ss_pred CccccccCCccccccCCCcEEecCCCCCCCC-CCcc-----cCCCCCcceEEecCCCCCCC-CCCCcCCCCcCcEEEccc
Q 002278 238 GNKLTGKIPEVIGLMQALAVLDLSENELVGP-IPPI-----LGNLSYTGKLYLHGNKLTGP-IPPELGNMSKLSYLQLQN 310 (943)
Q Consensus 238 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~~~~-----~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~ 310 (943)
-...+.++.|+.|+++.+.+..+ .|+. ...+++|+.|++..|+|... .-..+..+.+|+.|.+..
T Consensus 264 --------~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~ 335 (505)
T KOG3207|consen 264 --------GYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITL 335 (505)
T ss_pred --------ccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccc
Confidence 01122333444444444443321 1111 23345555555555555321 112344456677777777
Q ss_pred Cccc
Q 002278 311 NQLV 314 (943)
Q Consensus 311 N~l~ 314 (943)
|.+.
T Consensus 336 n~ln 339 (505)
T KOG3207|consen 336 NYLN 339 (505)
T ss_pred cccc
Confidence 7776
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.5e-11 Score=116.65 Aligned_cols=16 Identities=19% Similarity=0.106 Sum_probs=4.6
Q ss_pred cccCCcccccCCcccc
Q 002278 491 NCFSLSNLNVSYNNLS 506 (943)
Q Consensus 491 ~l~~L~~L~ls~N~l~ 506 (943)
.+++|+.|++.+|+++
T Consensus 111 ~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 111 SLPKLRVLSLEGNPVC 126 (175)
T ss_dssp G-TT--EEE-TT-GGG
T ss_pred cCCCcceeeccCCccc
Confidence 3444444444444443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.7e-10 Score=105.39 Aligned_cols=130 Identities=22% Similarity=0.349 Sum_probs=100.6
Q ss_pred EEeeeceEEEEEEEecCCceEEEEEe-cccCc--c-----cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 623 IVGYGASSTVYKCALKNSRPIAVKKL-YNQYP--H-----NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~--~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.+++|+-+.+|.+.+. |.++++|.= .+... . ...+..+|++++.+++--.|....-+..+++...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775 444555533 22221 1 1234567999999988777766667778888889999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
+|..|.+.+... ...++..+-.-+.-||.. +|||+||.++||++..+. +.++|||++.+
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888632 245667777778899999 999999999999998764 99999999874
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.6e-12 Score=129.37 Aligned_cols=98 Identities=24% Similarity=0.319 Sum_probs=47.7
Q ss_pred CcCCCCCCCEEEeeCCcccc----cCCCCccCCCCCcEEeccCC---CcCCccchhccccccceEEEecCcccccCCCcc
Q 002278 57 SIGDLRNLQSIDFQGNKLTG----QIPDEIGNCGSLVHIELSDN---SLYGDIPFSISKLKQLEFLNLKNNQLTGPIPST 129 (943)
Q Consensus 57 ~l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N---~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~ 129 (943)
-+..+..+++|+||+|.|.. .+...+.+.++|+..++|+= ++...+|.++.- +...
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~-----------------l~~a 87 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKM-----------------LSKA 87 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHH-----------------HHHH
Confidence 34455666666777666642 23334455556666666542 222333333211 1123
Q ss_pred cCCCCCCcEEEEeccccccccchh----ccccccceeccccCCccC
Q 002278 130 LTQIPNLKTLDLARNQLTGEIPRL----IYWNEVLQYLGLRGNALT 171 (943)
Q Consensus 130 ~~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~L~~n~l~ 171 (943)
+...++|++||||.|-+....+.. +..+..|++|+|.+|.+.
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg 133 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLG 133 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCC
Confidence 334455555555555554222222 233455666666666665
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-09 Score=111.99 Aligned_cols=141 Identities=18% Similarity=0.195 Sum_probs=109.7
Q ss_pred eEEeeeceEEEEEEEecCCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCC--CcceeeeEEecCC---cceEEEEEcc
Q 002278 622 YIVGYGASSTVYKCALKNSRPIAVKKLYNQYP-HNLREFETELETIGSIRHR--NIVSLHGYALSPY---GNLLFYDYMV 695 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~~ 695 (943)
+.+|.|.++.||++...+|+.+++|....... .....+.+|+++++.+++. .+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887668899998754322 1346788999999999764 4566777766542 5689999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCC----------------------------------------
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC---------------------------------------- 735 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 735 (943)
|+++.+.+.. ..++..+...++.++++++++||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888776531 34677788888889999999998531
Q ss_pred -------------CCCeEecCCCCccEEECC--CCceeeccccccc
Q 002278 736 -------------NPRIIHRDVKSSNILIDE--NFDAHLSDFGIAR 766 (943)
Q Consensus 736 -------------~~~ivH~Dlkp~Nill~~--~~~~kl~DFGla~ 766 (943)
...++|+|+.|.||+++. ++.+.++||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 246799999999999998 6678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.7e-10 Score=139.55 Aligned_cols=151 Identities=21% Similarity=0.270 Sum_probs=99.4
Q ss_pred CCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCC--cCCccchhccccccceEEEecCcccccCCCcccCCCCCCc
Q 002278 60 DLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNS--LYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLK 137 (943)
Q Consensus 60 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 137 (943)
+....+++.+.+|++. .++....+ ++|+.|-+..|. +.......|..++.|+.|||++|.=.+.+|..++.|-+||
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred chhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 3356777777777776 45544433 367777777775 4423333466778888888887766567788888888888
Q ss_pred EEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecc--cccCCCCcCCCcccEEEe
Q 002278 138 TLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLT--GTIPDSIGNCTSFEILDI 213 (943)
Q Consensus 138 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~~~l~~l~~L~~L~L 213 (943)
+|+|+...+. .+|..+..++.|.+|++..+.-....++....|.+|++|.+..-... ...-..+.++.+|+.|..
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 8888888777 67777788888888888777655555666667788888777665422 122233344555555554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-09 Score=100.92 Aligned_cols=142 Identities=20% Similarity=0.320 Sum_probs=105.0
Q ss_pred cceEEeeeceEEEEEEEecCCceEEEEEe-cccCcc-------cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 620 EKYIVGYGASSTVYKCALKNSRPIAVKKL-YNQYPH-------NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 620 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
....+-||+-+.|+++.+. |+...||.- .+.... ..++..+|++.+.+++--.|.-..-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567899999999999887 666666643 222211 2345678999999887666665556777777889999
Q ss_pred EEccC-CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC---ceeeccccccc
Q 002278 692 DYMVN-GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF---DAHLSDFGIAR 766 (943)
Q Consensus 692 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~DFGla~ 766 (943)
||++| .++.+++....... ...+.....+..|-+.+.-||.. +|+||||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 47788775332222 22233367889999999999999 999999999999997554 35899999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.8e-11 Score=136.92 Aligned_cols=249 Identities=20% Similarity=0.178 Sum_probs=166.6
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.-+.+.+.+-+-+|+++.++.+.-.. +...+.|..... .....+....+-.+.-..++|-+++....+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 34456666678899999999876442 333344433211 11122233333333333456777766555555667899
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
+++|+.+++|...++. .+..+.+........+..+.+|||.. .+.|||++|.|.+...+++.+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999873 33455555666777888999999997 79999999999999999999999998443221
Q ss_pred CC------------------------------CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCC
Q 002278 770 TA------------------------------MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAV 819 (943)
Q Consensus 770 ~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~ 819 (943)
.- .........||+.|.|||...+......+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 001122356899999999999999999999999999999999999999
Q ss_pred CCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002278 820 DNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQ 878 (943)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 878 (943)
...........+..... -+|..... ......+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f~ni~~~~~-----~~p~g~~~-----~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDI-----PWPEGPEE-----GSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCC-----CCCCCccc-----cChhhhhhhhhhhccCchhccCcc
Confidence 87665433322211111 12222111 112334567777788899987665
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-09 Score=132.38 Aligned_cols=272 Identities=23% Similarity=0.267 Sum_probs=147.3
Q ss_pred CcccEEEeecccccCcCCCCCCcceEeEEEecCcc--ccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEE
Q 002278 206 TSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK--LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLY 283 (943)
Q Consensus 206 ~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~--l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 283 (943)
...+...+-+|++. .++......++++|-+.+|. +.....+.|..++.|++|||++|.=-+.+|..+++|-+|+.|+
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred hheeEEEEeccchh-hccCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 55677777777765 45555555577777777775 5555556677788888888888766567788888888888888
Q ss_pred ecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccC--CcCcccccCCCcCcEEEeeCCcc
Q 002278 284 LHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLE--GPIPHNISSCTALNQFNVHGNRL 361 (943)
Q Consensus 284 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l 361 (943)
|++..++ .+|..+.++++|.+|++..+.-...+|.....+++|++|.+..-... ...-..+..+.+|+.|.......
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~ 680 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV 680 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence 8888877 67777888888888888777655555666666777777777654421 12222334444444444432222
Q ss_pred cCcccccccccCccc----eeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCccc------ccccceeecccc
Q 002278 362 SGAIPSSFRNLGSLT----YLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGD------LEHLLTLNLSRN 431 (943)
Q Consensus 362 ~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~Ls~N 431 (943)
.+-..+..++.|. .+.+.++... ..+..+..+.+|+.|.+.++.+.......... ++++..+...++
T Consensus 681 --~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~ 757 (889)
T KOG4658|consen 681 --LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC 757 (889)
T ss_pred --HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence 0111122222222 2222222222 33445556666666666666654322211111 112222222222
Q ss_pred cccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCC
Q 002278 432 HLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG 483 (943)
Q Consensus 432 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 483 (943)
..- ..+....-.++|+.|++.++.....+.+....+..+..+.+..+.+.+
T Consensus 758 ~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 758 HML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred ccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEeccccccc
Confidence 211 112222233556666666555544444444444444444444444443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.6e-09 Score=85.17 Aligned_cols=59 Identities=41% Similarity=0.579 Sum_probs=25.5
Q ss_pred CCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcc
Q 002278 63 NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ 121 (943)
Q Consensus 63 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~ 121 (943)
+|++|+|++|+|+...++.|.++++|++|+|++|+++...|.+|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333344444444444444444443333344444444444444443
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.4e-11 Score=131.52 Aligned_cols=130 Identities=31% Similarity=0.434 Sum_probs=90.0
Q ss_pred CccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCCh-hhhcccccceecc
Q 002278 398 NLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPA-ELGQLQNIISLIL 476 (943)
Q Consensus 398 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L 476 (943)
.|...+.+.|.+. .+-.++.-++.|+.||||+|+++.. ..+..|+.|++|||++|.|. .+|. ....++ |+.|+|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 5667777888777 5566677778888888888888754 36777788888888888887 4553 223333 788888
Q ss_pred cCcccCCCCCCcCccccCCcccccCCcccccc--CCCCcccCcCCCCccccCCCCCCCCC
Q 002278 477 NNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI--IPPIRNFSRFSSNSFIGNPLLCGNWI 534 (943)
Q Consensus 477 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--~~~~~~~~~~~~~~~~~Np~~c~~~~ 534 (943)
+||.++... .+.++.+|+.||||+|-|++. ..++..+..+..+.++|||.-|.+|-
T Consensus 240 rnN~l~tL~--gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~h 297 (1096)
T KOG1859|consen 240 RNNALTTLR--GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPWH 297 (1096)
T ss_pred cccHHHhhh--hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHHH
Confidence 888877432 356788888888888888763 22334455556667888887776553
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.4e-08 Score=96.87 Aligned_cols=126 Identities=21% Similarity=0.233 Sum_probs=82.6
Q ss_pred EEEEEEecCCceEEEEEecccC-------------cc-------------cHHHHHHHHHHHhcCCCC--CcceeeeEEe
Q 002278 631 TVYKCALKNSRPIAVKKLYNQY-------------PH-------------NLREFETELETIGSIRHR--NIVSLHGYAL 682 (943)
Q Consensus 631 ~Vy~~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 682 (943)
.||.|...++..+|||..+... .. ......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999764211 00 122456899999999866 455565442
Q ss_pred cCCcceEEEEEcc--CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHH-hhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 683 SPYGNLLFYDYMV--NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY-LHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 683 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
..++||||++ |..+..+... .++......++.+++..+.. +|.. ||+|||+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 5689999998 5455443321 11234456677777775555 4677 99999999999999987 8999
Q ss_pred cccccccccC
Q 002278 760 SDFGIARCIP 769 (943)
Q Consensus 760 ~DFGla~~~~ 769 (943)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.9e-09 Score=84.11 Aligned_cols=61 Identities=43% Similarity=0.588 Sum_probs=51.9
Q ss_pred CCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEecccc
Q 002278 86 GSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQL 146 (943)
Q Consensus 86 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 146 (943)
++|++|+|++|+|+...+..|.++++|++|++++|+++...+..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5788899999998855557888899999999999999888888889999999999998875
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=9.3e-08 Score=103.78 Aligned_cols=170 Identities=21% Similarity=0.313 Sum_probs=129.2
Q ss_pred ceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEe----cCCcceEEEEEccC-CChhh
Q 002278 628 ASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL----SPYGNLLFYDYMVN-GSLWD 701 (943)
Q Consensus 628 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~ 701 (943)
-..+.|++... +|..|++|++..........-..-+++++++.|+|||++.++|. .+...++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44578999854 78999999994433333333345678899999999999999986 34457899999986 57777
Q ss_pred hccCC------------CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 702 LLHGP------------SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 702 ~l~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
+--.. ......++...|.++.|+..||.++|+. |+.-+-|.+.+|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 53211 1233577899999999999999999999 99999999999999999999999999876654
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKA 818 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p 818 (943)
.+.. |.+. --.+-|.=.||.+++.|.||..-
T Consensus 445 ~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 4320 1111 12367889999999999999553
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2e-07 Score=98.57 Aligned_cols=263 Identities=12% Similarity=0.085 Sum_probs=153.4
Q ss_pred ccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeE----Ee--cCCc-ceEE
Q 002278 619 SEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGY----AL--SPYG-NLLF 690 (943)
Q Consensus 619 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~~--~~~~-~~lv 690 (943)
...+.+|+|+-+.+|..-.-. ..+.|+..+..+....+. ++.|... .||-+-.=+.+ .. +... .-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~--d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR--DQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhh--chhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 345679999999999653221 224566655444322222 2333333 46644331111 11 1111 3456
Q ss_pred EEEccCC-Chhhhcc---CCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 691 YDYMVNG-SLWDLLH---GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 691 ~e~~~~g-~L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
|..+.+. -..++.. ++.......|.-.+++++.+|.+.+.||.. |.+-||+.++|+|+.+++.|.+.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 7666554 2222222 122344588999999999999999999999 99999999999999999999999854332
Q ss_pred ccCCCCCceeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhC-CCCCCCC-------ccHHHHHHHhc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTG-KKAVDNE-------SNLHQLIMSKA 833 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG-~~p~~~~-------~~~~~~~~~~~ 833 (943)
... ........+|...|.+||.-. +-.-+...|-|.+||++++++.| ++||.+. ...+..+....
T Consensus 166 i~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 INA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 221 122233345899999999643 44567889999999999999885 9999742 22221111100
Q ss_pred cccccccccCccc--ccCccCHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHHhhcCCCCC
Q 002278 834 DDNTVMEAVDPEV--SVTCVDLSAVRKTFQLALLCTKR--YPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 834 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
-... .+.-.+.. +...+-.-....+..+..+|... .|.-|||++..+..|........
T Consensus 244 f~ya-~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 244 FAYA-SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeec-hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 0000 00000000 00111111123444556666543 26689999988887765554433
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.9e-08 Score=97.43 Aligned_cols=135 Identities=21% Similarity=0.193 Sum_probs=96.5
Q ss_pred cccceEEeeeceEEEEEEEecCCceEEEEEecccC-----------------c-----ccHHHHHHHHHHHhcCCCC--C
Q 002278 618 LSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY-----------------P-----HNLREFETELETIGSIRHR--N 673 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~-----~~~~~~~~E~~~l~~l~h~--n 673 (943)
..+...||-|.-|.||.|....|.++|||.-.... . ......++|.++|+.+.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 44567899999999999999999999999542110 0 1123457899999998754 5
Q ss_pred cceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC
Q 002278 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE 753 (943)
Q Consensus 674 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 753 (943)
|.+.+++ +.+.+|||+++|-.|...- ++.+..-.++..|.+-+..+-.. ||||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 6666553 4678999999886664422 12333344444455444444455 9999999999999999
Q ss_pred CCceeecccccccc
Q 002278 754 NFDAHLSDFGIARC 767 (943)
Q Consensus 754 ~~~~kl~DFGla~~ 767 (943)
+|.++++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-07 Score=99.67 Aligned_cols=140 Identities=12% Similarity=0.065 Sum_probs=98.2
Q ss_pred EEeeeceEEEEEEEecCCceEEEEEecccCcc-----------cHHHHHHHHHHHhcCCCCCc--ceeeeEEec-----C
Q 002278 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPH-----------NLREFETELETIGSIRHRNI--VSLHGYALS-----P 684 (943)
Q Consensus 623 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~ 684 (943)
.+-......|+++.. +|+.|.||+....... ....+.+|.+.+.++...+| .++++++.. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445667655 4678999976433211 11247788888888754333 344455543 2
Q ss_pred CcceEEEEEccCC-ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-------CCc
Q 002278 685 YGNLLFYDYMVNG-SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-------NFD 756 (943)
Q Consensus 685 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~ 756 (943)
...++|+|++++. +|.+++.... ....+......++.+++..++-||.. ||+|+|++++|||++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 2468999999886 8988874211 23455667788999999999999999 9999999999999975 467
Q ss_pred eeecccccccc
Q 002278 757 AHLSDFGIARC 767 (943)
Q Consensus 757 ~kl~DFGla~~ 767 (943)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.1e-09 Score=121.87 Aligned_cols=180 Identities=32% Similarity=0.371 Sum_probs=122.8
Q ss_pred CCCcCCCCcCcEEEcccCccccccccccCCc-ccceEEEccccccCC---cCc---ccccCC---CcCcEEEeeCCcccC
Q 002278 294 PPELGNMSKLSYLQLQNNQLVGTIPAELGKL-EQLFELNLADNNLEG---PIP---HNISSC---TALNQFNVHGNRLSG 363 (943)
Q Consensus 294 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~---~~p---~~~~~l---~~L~~L~L~~N~l~~ 363 (943)
|-.+..+.+|+.|.|.++.|.. ...+..+ .+|+.|.- .|.+.. ++. +.|++- ..|...+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 5567778889999999998873 1122222 23444432 222220 111 112221 25777788888887
Q ss_pred cccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccC
Q 002278 364 AIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGN 443 (943)
Q Consensus 364 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 443 (943)
....++.-++.|+.|+|++|+++.. +.+..++.|++|||++|.+..+.--...++. |+.|.|++|.+++. ..+.+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~ 252 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIEN 252 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHh
Confidence 6677788888899999999998743 3778888899999999988843333344444 88899999988854 45778
Q ss_pred CCccceecccCccccccCC-hhhhcccccceecccCcccC
Q 002278 444 LRSIQTIDMSFNQLSGSIP-AELGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 444 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 482 (943)
|++|+.||+++|-|.+.-. .-++.|..|+.|+|.||.+-
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 8889999999998875322 34677888888899998875
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.2e-08 Score=111.54 Aligned_cols=151 Identities=19% Similarity=0.287 Sum_probs=102.4
Q ss_pred HHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce--------eeeEecccceeCccccc
Q 002278 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA--------STFVLGTIGYIDPEYAH 792 (943)
Q Consensus 721 ~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~ 792 (943)
+.+++.|+.|+|.. +++||++|.|++|.+++.+..||+.|+.+.......... .....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34555999999976 599999999999999999999999999886543311110 01112346799999999
Q ss_pred cCCCCCcchhhhHHHHHHHHH-hCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCC
Q 002278 793 TSRLNEKSDVYSFGIVLLEIL-TGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYP 871 (943)
Q Consensus 793 ~~~~~~~~DvwSlGvil~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 871 (943)
+...+.++|+||+||++|.+. .|+.-+................+....... ...+.++.+-+.+++..++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s---------~~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS---------NNLPSELRESLKKLLNGDS 253 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc---------ccCcHHHHHHHHHHhcCCc
Confidence 988899999999999999999 566655543222211111111111011111 1223566677888999999
Q ss_pred CCCCCHHHHHH
Q 002278 872 SERPTMQEVAR 882 (943)
Q Consensus 872 ~~RPt~~el~~ 882 (943)
..||++.++..
T Consensus 254 ~~rp~~~~l~~ 264 (700)
T KOG2137|consen 254 AVRPTLDLLLS 264 (700)
T ss_pred ccCcchhhhhc
Confidence 99998777654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.3e-09 Score=94.39 Aligned_cols=131 Identities=21% Similarity=0.304 Sum_probs=78.9
Q ss_pred ccceeeccCCcCCCCCCCC---CCCCCCccEEecCCCcCCCccCCCc-ccccccceeecccccccccCCccccCCCccce
Q 002278 374 SLTYLNLSRNNFKGKVPTE---LGRIINLDTLDLSVNNFSGSVPASI-GDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQT 449 (943)
Q Consensus 374 ~L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 449 (943)
.+..++|+++++. .+++. +.....|+..+|++|.+.. .|..| ...+.++.|+|++|+|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3455666666654 23332 3334455666777777773 44444 33456777777777777 46666777777777
Q ss_pred ecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccC
Q 002278 450 IDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGII 509 (943)
Q Consensus 450 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 509 (943)
|++++|.|. ..|..+..|.+|-.|+..+|.+. .+|..+.--..+...++.+|++.+--
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~ 162 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDET 162 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccC
Confidence 777777777 56666777777777777777776 44444322233333445555555443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.9e-08 Score=101.14 Aligned_cols=77 Identities=22% Similarity=0.242 Sum_probs=38.3
Q ss_pred cceEEecCCCCCCCCCCCcCCCCcCcEEEcccCcccccc-ccccCCcccceEEEccccccCCcC-cccccCCCcCcEEEe
Q 002278 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI-PAELGKLEQLFELNLADNNLEGPI-PHNISSCTALNQFNV 356 (943)
Q Consensus 279 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L 356 (943)
+..++++-|++... ++++..+.+..|.+.... ...+..++.+--|+|+.|+|.... -+++..++.|..|.+
T Consensus 184 ~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv 256 (418)
T KOG2982|consen 184 LEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRV 256 (418)
T ss_pred HHHHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeec
Confidence 33444455555432 245555666666554221 123444555556666666664321 133445555555555
Q ss_pred eCCccc
Q 002278 357 HGNRLS 362 (943)
Q Consensus 357 ~~N~l~ 362 (943)
++|.+.
T Consensus 257 ~~~Pl~ 262 (418)
T KOG2982|consen 257 SENPLS 262 (418)
T ss_pred cCCccc
Confidence 655554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=8.7e-07 Score=90.27 Aligned_cols=107 Identities=24% Similarity=0.244 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHhcCCCCC--cceeeeEEecCC----cceEEEEEccCC-ChhhhccCCCCCccCCHHHHHHHHHHHHHHH
Q 002278 656 LREFETELETIGSIRHRN--IVSLHGYALSPY----GNLLFYDYMVNG-SLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728 (943)
Q Consensus 656 ~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l 728 (943)
.....+|.+.+..+...+ +.+.+++..... ..++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 346778888877775333 445566655432 348999999884 799988631 2256677888999999999
Q ss_pred HHhhhCCCCCeEecCCCCccEEECCCC---ceeeccccccccc
Q 002278 729 AYLHHDCNPRIIHRDVKSSNILIDENF---DAHLSDFGIARCI 768 (943)
Q Consensus 729 ~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~DFGla~~~ 768 (943)
+-||+. ||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999999876 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.9e-08 Score=89.64 Aligned_cols=113 Identities=29% Similarity=0.345 Sum_probs=81.8
Q ss_pred CccceeeccCCcCCCCCCCCCC-CCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceec
Q 002278 373 GSLTYLNLSRNNFKGKVPTELG-RIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTID 451 (943)
Q Consensus 373 ~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 451 (943)
..|+..+|++|.++ .+|..|. ..+.++.|+|++|.|+ .+|..+..++.|+.|+++.|.+. ..|..|..|.+|-.||
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 45666677888777 4444443 3447788888888888 57777888888888888888887 5677777788888888
Q ss_pred ccCccccccCChhhhcccccceecccCcccCCCCCCcC
Q 002278 452 MSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQL 489 (943)
Q Consensus 452 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 489 (943)
..+|.+. .+|..+-.-...-..++.++.+.+.-+..+
T Consensus 130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~kl 166 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKL 166 (177)
T ss_pred CCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccc
Confidence 8888887 666655444445556677888877655443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.6e-08 Score=97.80 Aligned_cols=87 Identities=25% Similarity=0.308 Sum_probs=47.6
Q ss_pred CCCCCEEEeeCCcccccCC-CCcc-CCCCCcEEeccCCCcCCc--cchhccccccceEEEecCcccccCCCcccCCCCCC
Q 002278 61 LRNLQSIDFQGNKLTGQIP-DEIG-NCGSLVHIELSDNSLYGD--IPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNL 136 (943)
Q Consensus 61 l~~L~~L~Ls~n~l~~~~p-~~~~-~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 136 (943)
+..++-|-+.++.|..+.- ..|+ ..+.++.|||.+|.|+.. +..-+.+|+.|+.|+|++|++...+...-..+.+|
T Consensus 44 ~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl 123 (418)
T KOG2982|consen 44 LRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNL 123 (418)
T ss_pred ccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccce
Confidence 3344455555555542111 1122 356677777777777632 22334567777777777777763332222455677
Q ss_pred cEEEEeccccc
Q 002278 137 KTLDLARNQLT 147 (943)
Q Consensus 137 ~~L~Ls~N~l~ 147 (943)
++|-|.+..+.
T Consensus 124 ~~lVLNgT~L~ 134 (418)
T KOG2982|consen 124 RVLVLNGTGLS 134 (418)
T ss_pred EEEEEcCCCCC
Confidence 77777766655
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 943 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-52 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-52 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-52 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-27 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-13 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-13 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 6e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-12 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-12 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 4e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-12 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 5e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-10 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 6e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-08 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 7e-08 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 7e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-06 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 3e-06 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 3e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-06 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 5e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-06 | ||
| 2z81_A | 549 | Crystal Structure Of The Tlr1-tlr2 Heterodimer Indu | 8e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-05 | ||
| 3a79_A | 580 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 1e-05 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 1e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 2e-05 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 4e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-05 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 4e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-05 | ||
| 3ulu_A | 694 | Structure Of Quaternary Complex Of Human Tlr3ecd Wi | 9e-05 | ||
| 3ulu_A | 694 | Structure Of Quaternary Complex Of Human Tlr3ecd Wi | 1e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 2a0z_A | 705 | The Molecular Structure Of Toll-like Receptor 3 Lig | 1e-04 | ||
| 2a0z_A | 705 | The Molecular Structure Of Toll-like Receptor 3 Lig | 1e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 1ziw_A | 680 | Human Toll-Like Receptor 3 Extracellular Domain Str | 1e-04 | ||
| 1ziw_A | 680 | Human Toll-Like Receptor 3 Extracellular Domain Str | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 4fho_A | 231 | Crystal Structure Of An Internalin C2 (Inlc2) From | 2e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-04 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 5e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-04 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 5e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2Z81|A Chain A, Crystal Structure Of The Tlr1-tlr2 Heterodimer Induced By Binding Of A Tri-acylated Lipopeptide Length = 549 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3A79|A Chain A, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 580 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694 | Back alignment and structure |
|
| >pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705 | Back alignment and structure |
|
| >pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 | Back alignment and structure |
|
| >pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 499 bits (1288), Expect = e-165
Identities = 165/499 (33%), Positives = 258/499 (51%), Gaps = 14/499 (2%)
Query: 41 VSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEI-GNCGSLVHIELSDNSLY 99
LN+SS G I P L++LQ + NK TG+IPD + G C +L ++LS N Y
Sbjct: 250 KLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307
Query: 100 GDIPFSISKLKQLEFLNLKNNQLTGPIP-STLTQIPNLKTLDLARNQLTGEIPR-LIYWN 157
G +P LE L L +N +G +P TL ++ LK LDL+ N+ +GE+P L +
Sbjct: 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLS 367
Query: 158 EVLQYLGLRGNALTGMLSPDMCQ--LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISY 215
L L L N +G + P++CQ L ++ N TG IP ++ NC+ L +S+
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 216 NQITGEIPYNIGFLQ-VATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILG 274
N ++G IP ++G L + L L N L G+IP+ + ++ L L L N+L G IP L
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 275 NLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLAD 334
N + + L N+LTG IP +G + L+ L+L NN G IPAELG L L+L
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 335 NNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN--NFKGKVPTE 392
N G IP + + + N ++G +N G + + N F+G +
Sbjct: 548 NLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603
Query: 393 LGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDM 452
L R+ + +++ + G + + ++ L++S N L+G +P E G++ + +++
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 663
Query: 453 SFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPI 512
N +SGSIP E+G L+ + L L++N L G IP +S L+ +++S NNLSG IP +
Sbjct: 664 GHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
Query: 513 RNFSRFSSNSFIGNPLLCG 531
F F F+ NP LCG
Sbjct: 724 GQFETFPPAKFLNNPGLCG 742
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 485 bits (1250), Expect = e-159
Identities = 164/547 (29%), Positives = 273/547 (49%), Gaps = 32/547 (5%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNL---GGEISPS 57
++ K + N+L DW N + C++ GV C + V S++LSS L +S S
Sbjct: 18 ISFKDVLPD-KNLLPDWS--SNKNPCTFDGVTCRDD--KVTSIDLSSKPLNVGFSAVSSS 72
Query: 58 IGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIP--FSISKLKQLEFL 115
+ L L+S+ + + G + SL ++LS NSL G + S+ L+FL
Sbjct: 73 LLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFL 131
Query: 116 NLKNNQLTGPIP-STLTQIPNLKTLDLARNQLTGEIPRLIYWNEV---LQYLGLRGNALT 171
N+ +N L P S ++ +L+ LDL+ N ++G ++ L++L + GN ++
Sbjct: 132 NVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS 191
Query: 172 GMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFL-Q 230
G + + + L + DV NN + IP +G+C++ + LDIS N+++G+ I +
Sbjct: 192 GDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTE 248
Query: 231 VATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPP-ILGNLSYTGKLYLHGNKL 289
+ L++ N+ G IP +++L L L+EN+ G IP + G L L GN
Sbjct: 249 LKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHF 306
Query: 290 TGPIPPELGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLADNNLEGPIPHNISSC 348
G +PP G+ S L L L +N G +P + L K+ L L+L+ N G +P ++++
Sbjct: 307 YGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNL 366
Query: 349 TA-LNQFNVHGNRLSGAIPSSFRN--LGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLS 405
+A L ++ N SG I + +L L L N F GK+P L L +L LS
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 406 VNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAEL 465
N SG++P+S+G L L L L N L G +P E +++++T+ + FN L+G IP+ L
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486
Query: 466 GQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP-IRNFS-----RFS 519
N+ + L+NN L G IP + +L+ L +S N+ SG IP + + +
Sbjct: 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN 546
Query: 520 SNSFIGN 526
+N F G
Sbjct: 547 TNLFNGT 553
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-147
Identities = 155/505 (30%), Positives = 238/505 (47%), Gaps = 26/505 (5%)
Query: 39 SVVSLNLSSLNLGGEISPSI---GDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSD 95
S+ L+LS+ ++ G L+ + GNK++G + + C +L +++S
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSS 209
Query: 96 NSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIY 155
N+ IP + L+ L++ N+L+G ++ LK L+++ NQ G IP L
Sbjct: 210 NNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPL 268
Query: 156 WNEVLQYLGLRGNALTGMLSPDMC-QLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDIS 214
+ LQYL L N TG + + L D+ GN+ G +P G+C+ E L +S
Sbjct: 269 KS--LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326
Query: 215 YNQITGEIPYN-IGFL-QVATLSLQGNKLTGKIPEVIG-LMQALAVLDLSENELVGPIPP 271
N +GE+P + + + + L L N+ +G++PE + L +L LDLS N GPI P
Sbjct: 327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386
Query: 272 ILGNLSYTG--KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFE 329
L +LYL N TG IPP L N S+L L L N L GTIP+ LG L +L +
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 330 LNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKV 389
L L N LEG IP + L + N L+G IPS N +L +++LS N G++
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506
Query: 390 PTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQT 449
P +GR+ NL L LS N+FSG++PA +GD L+ L+L+ N NG +PA
Sbjct: 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG--- 563
Query: 450 IDMSFNQLSGSIPAELGQLQN--IISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSG 507
++ N ++G + N QG +QL+ + + N++ G
Sbjct: 564 -KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 622
Query: 508 IIPP-IRNFSR-----FSSNSFIGN 526
P N S N G
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGY 647
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-35
Identities = 43/170 (25%), Positives = 64/170 (37%), Gaps = 24/170 (14%)
Query: 32 FCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHI 91
++ + L G S + L + G N GS++ +
Sbjct: 578 IKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637
Query: 92 ELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIP 151
++S N L G IP I + L LNL +N ++G IP + + L LDL+ N+L G IP
Sbjct: 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIP 697
Query: 152 RLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDS 201
M LT L D+ NNL+G IP+
Sbjct: 698 ------------------------QAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-108
Identities = 111/287 (38%), Positives = 171/287 (59%), Gaps = 10/287 (3%)
Query: 607 TFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKL-YNQYPHNLREFETELET 665
+ ++ +++N S K I+G G VYK L + +AVK+L + +F+TE+E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHG-PSKKVKLDWETRLKIAVGA 724
I HRN++ L G+ ++P LL Y YM NGS+ L P + LDW R +IA+G+
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIG 784
A+GLAYLH C+P+IIHRDVK++NIL+DE F+A + DFG+A+ + H +T V GTIG
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQ---LIMSKA----DDNT 837
+I PEY T + +EK+DV+ +G++LLE++TG++A D + +++ +
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260
Query: 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+ VD ++ V + Q+ALLCT+ P ERP M EV R+L
Sbjct: 261 LEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 342 bits (879), Expect = e-106
Identities = 82/547 (14%), Positives = 171/547 (31%), Gaps = 80/547 (14%)
Query: 22 NSDFCSWR---GVFCDNSSLSVVSLNLSSLNLGGEISPSI-------------------- 58
N + W GV +++ V L+L G + +I
Sbjct: 63 NKELDMWGAQPGVSLNSNG-RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE 121
Query: 59 --------GDLRNLQSIDFQGNKLTGQIPDEIG--NCGSLVHIELSDNSLYGDIPFSISK 108
+ + D + L+ ++ + I S
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181
Query: 109 LKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGN 168
+ + +N +T + + ++ L+ + + E + NE +Y
Sbjct: 182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240
Query: 169 ALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGF 228
L L +V +P + ++++++ N+
Sbjct: 241 -----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI--------- 286
Query: 229 LQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENEL-VGPIPPILGNLSYTGKLYLHGN 287
S + K + + + + ++ + N L P+ L + G L N
Sbjct: 287 ------SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYN 340
Query: 288 KLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEG-PIPHNIS 346
+L G P G+ KL+ L L NQ+ G EQ+ L+ A N L+ P +
Sbjct: 341 QLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 347 SCTALNQFNVHGNRLSG-------AIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINL 399
S + ++ + N + + + +++ +NLS N L
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459
Query: 400 DTLDLSVNNFSG-------SVPASIGDLEHLLTLNLSRNHLNGLLPA-EFGNLRSIQTID 451
+++L N + + + L +++L N L L L + ID
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGID 519
Query: 452 MSFNQLSGSIPAELGQLQNIISLILNN------NNLQGGIPDQLSNCFSLSNLNVSYNNL 505
+S+N S P + + + N N P+ ++ C SL+ L + N++
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 506 SGIIPPI 512
+ I
Sbjct: 579 RKVNEKI 585
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-104
Identities = 94/551 (17%), Positives = 181/551 (32%), Gaps = 52/551 (9%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGD 60
++ A + L + D N S +G + + N G + S+
Sbjct: 22 LSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANW--NFNKELDMWGAQPGVSLNS 79
Query: 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGD----IPFSISKLKQLEFLN 116
+ + +G +G++PD IG L + L + + P IS E
Sbjct: 80 NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQ 139
Query: 117 LKNNQLTGPIPSTLT--QIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGML 174
+L + + I + +G N +T +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-V 198
Query: 175 SPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQ-VAT 233
S + +LT L F + + + E Y Q L+ +
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLKDLTD 253
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELV--------GPIPPILGNLSYTGKLYLH 285
+ + K+P + + + +++++ N + +Y+
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313
Query: 286 GNKL-TGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHN 344
N L T P+ L M KL L+ NQL G +P G +L LNLA N + +
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANF 372
Query: 345 ISSCTALNQFNVHGNRLSGAIPSSF--RNLGSLTYLNLSRNNFKG-------KVPTELGR 395
+ + N+L IP+ F +++ ++ ++ S N + +
Sbjct: 373 CGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 396 IINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGL-------LPAEFGNLRSIQ 448
IN+ +++LS N S L ++NL N L + F N +
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491
Query: 449 TIDMSFNQLSGSIPAEL--GQLQNIISLILNNNNLQGGIPDQLSNCFSL------SNLNV 500
+ID+ FN+L+ + + L ++ + L+ N+ P Q N +L + +
Sbjct: 492 SIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDA 549
Query: 501 SYNNLSGIIPP 511
N P
Sbjct: 550 QGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = 2e-96
Identities = 74/530 (13%), Positives = 162/530 (30%), Gaps = 46/530 (8%)
Query: 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGD 101
+LN + + G + + + +D G Q + + G + + L G
Sbjct: 41 ALNGKNWSQQGFGTQPGANWNFNKELDMWGA----QPGVSLNSNGRVTGLSLEGFGASGR 96
Query: 102 IPFSISKLKQLEFLNLKNNQLTGP----IPSTLTQIPNLKTLDLARNQLTGEIPRLIYWN 157
+P +I +L +LE L L ++ P ++ + + R
Sbjct: 97 VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRE 156
Query: 158 EV--LQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISY 215
+ L + + + NN+T + ++ T +
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGN 215
Query: 216 NQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGN 275
+ E + + + ++ L +++ + +P L
Sbjct: 216 SPFVAENICEAWEN----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
Query: 276 LSYTGKLYLHGNKLT--------GPIPPELGNMSKLSYLQLQNNQL-VGTIPAELGKLEQ 326
L + + N+ + K+ + + N L + L K+++
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331
Query: 327 LFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFK 386
L L N LEG +P S L N+ N+++ + + L+ + N K
Sbjct: 332 LGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK 390
Query: 387 GKVP--TELGRIINLDTLDLSVNNFSG-------SVPASIGDLEHLLTLNLSRNHLNGLL 437
+P + + + +D S N + + ++ ++NLS N ++
Sbjct: 391 Y-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFP 449
Query: 438 PAEFGNLRSIQTIDMSFNQLSG-------SIPAELGQLQNIISLILNNNNLQGGIPD--Q 488
F + +I++ N L+ + S+ L N L + D +
Sbjct: 450 KELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFR 508
Query: 489 LSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWI-GSI 537
+ L +++SYN+ S N S GN
Sbjct: 509 ATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREW 558
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 6e-91
Identities = 82/498 (16%), Positives = 158/498 (31%), Gaps = 75/498 (15%)
Query: 35 NSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELS 94
+L + S N+ +S ++ L L+ + + E +
Sbjct: 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----E 233
Query: 95 DNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLI 154
Y LK L + + N +P+ L +P ++ +++A N+
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS------ 287
Query: 155 YWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNL-TGTIPDSIGNCTSFEILDI 213
+ L AL D + + NNL T + S+ +L+
Sbjct: 288 -----GEQLKDDWQALA-----DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337
Query: 214 SYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPIL 273
YNQ+ G++P G LA L+L+ N++
Sbjct: 338 LYNQLEGKLP------------------------AFGSEIKLASLNLAYNQITEIPANFC 373
Query: 274 GNLSYTGKLYLHGNKLTG-PIPPELGNMSKLSYLQLQNNQLVG-------TIPAELGKLE 325
G L NKL P + ++S +S + N++ + K
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433
Query: 326 QLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSG-------AIPSSFRNLGSLTYL 378
+ +NL++N + S+ + L+ N+ GN L+ +F+N LT +
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493
Query: 379 NLSRNNFKGKVPTEL--GRIINLDTLDLSVNNFSGSVPASIGDLEHLLTL------NLSR 430
+L N + + + L +DLS N+FS P + L +
Sbjct: 494 DLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG 551
Query: 431 NHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLS 490
N P S+ + + N + + ++ NI L + +N +
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVC 608
Query: 491 NCFSLSNLNVSYNNLSGI 508
+ Y+ I
Sbjct: 609 PYIEAGMYMLFYDKTQDI 626
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-61
Identities = 57/366 (15%), Positives = 121/366 (33%), Gaps = 41/366 (11%)
Query: 43 LNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLT-GQIPDEIGNCGSLVHIELSDNSLYGD 101
++ L + +Q I N L + + L +E N L G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGK 345
Query: 102 IPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWN--EV 159
+P + +L LNL NQ+T + ++ L A N+L IP + V
Sbjct: 346 LP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSV 403
Query: 160 LQYLGLRGNALTGM-------LSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILD 212
+ + N + + L P + + ++ N ++ + + ++
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN 463
Query: 213 ISYNQITG-------EIPYNIGFLQ-VATLSLQGNKLTGKIPEVIGL--MQALAVLDLSE 262
+ N +T + N + ++ L+ NKLT + + + L +DLS
Sbjct: 464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSY 522
Query: 263 NELVGPIPPILGNLSY------TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT 316
N P N S + GN+ P + L+ LQ+ +N +
Sbjct: 523 NSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-K 580
Query: 317 IPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLT 376
+ ++ + L++ DN + + + ++ +++
Sbjct: 581 VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT--------QDIRGCD 630
Query: 377 YLNLSR 382
L++ R
Sbjct: 631 ALDIKR 636
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-42
Identities = 37/301 (12%), Positives = 94/301 (31%), Gaps = 16/301 (5%)
Query: 232 ATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTG 291
A + ++ ++ I + + L + L+ G N ++ +L + G +
Sbjct: 16 AIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQ--- 72
Query: 292 PIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP----IPHNISS 347
L + +++ L L+ G +P +G+L +L L L + + P IS+
Sbjct: 73 -PGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISA 131
Query: 348 CTALNQFNVHGNRLSGAIPSS--FRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLS 405
+ Q + L ++ + + + + +
Sbjct: 132 NMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQL 191
Query: 406 VNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAEL 465
NN + V ++ L L + + E + + + Q + +
Sbjct: 192 SNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKW 245
Query: 466 GQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIG 525
L+++ + + N +P L + +NV+ N ++ +
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 526 N 526
Sbjct: 306 K 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 324 bits (834), Expect = e-104
Identities = 109/285 (38%), Positives = 158/285 (55%), Gaps = 11/285 (3%)
Query: 607 TFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETI 666
D+ +T N K+++G+G VYK L++ +A+K+ + + EFETE+ET+
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 667 GSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVK-LDWETRLKIAVGAA 725
RH ++VSL G+ +L Y YM NG+L L+G + WE RL+I +GAA
Sbjct: 90 SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA-MPHASTFVLGTIG 784
+GL YLH IIHRDVKS NIL+DENF ++DFGI++ H ST V GT+G
Sbjct: 150 RGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVD-----NESNLHQLIMSKADDNTVM 839
YIDPEY RL EKSDVYSFG+VL E+L + A+ NL + + ++ +
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+ VDP + + ++RK A+ C +RP+M +V L
Sbjct: 267 QIVDPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-101
Identities = 104/501 (20%), Positives = 185/501 (36%), Gaps = 24/501 (4%)
Query: 34 DNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIEL 93
D+ ++ LNL+ L + + L S+D N ++ P+ L + L
Sbjct: 21 DDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNL 80
Query: 94 SDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRL 153
N L + + L L+L +N + + + NL TLDL+ N L+
Sbjct: 81 QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT 140
Query: 154 IYWNEVLQYLGLRGNALTGMLSPDM--CQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEIL 211
E LQ L L N + + S ++ + L ++ N + P L
Sbjct: 141 QVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGL 200
Query: 212 DISYNQITGEIPYNIGF----LQVATLSLQGNKLTGKIPEVIGLMQ--ALAVLDLSENEL 265
++ Q+ + + + LSL ++L+ ++ L +LDLS N L
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260
Query: 266 VGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNN---------QLVGT 316
L +L N + L + + YL L+ + L
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320
Query: 317 IPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGA--IPSSFRNLG- 373
L+ L LN+ DN++ G + + L ++ + S +F +L
Sbjct: 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH 380
Query: 374 -SLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPAS-IGDLEHLLTLNLSRN 431
L LNL++N + +L+ LDL +N + LE++ + LS N
Sbjct: 381 SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYN 440
Query: 432 HLNGLLPAEFGNLRSIQTIDMSFNQLSG--SIPAELGQLQNIISLILNNNNLQGGIPDQL 489
L F + S+Q + + L S P+ L+N+ L L+NNN+ D L
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 490 SNCFSLSNLNVSYNNLSGIIP 510
L L++ +NNL+ +
Sbjct: 501 EGLEKLEILDLQHNNLARLWK 521
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = 7e-97
Identities = 117/536 (21%), Positives = 203/536 (37%), Gaps = 35/536 (6%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCG--S 87
F +L +L+LS L + L NLQ + NK+ +E+ S
Sbjct: 115 NPFVKQKNLI--TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172
Query: 88 LVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLT---QIPNLKTLDLARN 144
L +ELS N + P + +L L L N QL + L +++ L L+ +
Sbjct: 173 LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS 232
Query: 145 QLTGEIPRLIYWNEV--LQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSI 202
QL+ + L L L N L + + L L YF + NN+ S+
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
Query: 203 GNCTSFEILD---------ISYNQITGEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLM 252
+ L+ IS + ++ +L + L+++ N + G + +
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352
Query: 253 QALAVLDLSEN--ELVGPIPPILGNLSYTG--KLYLHGNKLTGPIPPELGNMSKLSYLQL 308
L L LS + L +L+++ L L NK++ + L L L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412
Query: 309 QNNQLVGTIPA-ELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSG--AI 365
N++ + E LE +FE+ L+ N ++ + +L + + L +
Sbjct: 413 GLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSS 472
Query: 366 PSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFS--------GSVPASI 417
PS F+ L +LT L+LS NN L + L+ LDL NN + G +
Sbjct: 473 PSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFL 532
Query: 418 GDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILN 477
L HL LNL N + + F +L ++ ID+ N L+ + ++ SL L
Sbjct: 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592
Query: 478 NNNLQGGIPDQLSNCF-SLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGN 532
N + F +L+ L++ +N I F + + + P L +
Sbjct: 593 KNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSH 648
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = 6e-94
Identities = 96/480 (20%), Positives = 180/480 (37%), Gaps = 25/480 (5%)
Query: 63 NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQL 122
+ + D KLT Q+PD++ ++ + L+ N L + ++ QL L++ N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 123 TGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLT 182
+ P ++P LK L+L N+L+ + + L L L N++ + + +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 183 GLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVA---TLSLQGN 239
L D+ N L+ T + + + L +S N+I + + L L N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 240 KLTGKIPEVIGLMQALAVLDLSENELVGPIPPILG---NLSYTGKLYLHGNKLTGPIPPE 296
++ P + L L L+ +L + L + L L ++L+
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 297 LGNM--SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQF 354
+ + L+ L L N L L QL L NN++ H++ +
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 355 NVHGN---------RLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLS 405
N+ + L SF+ L L +LN+ N+ G +INL L LS
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 406 VNNFSGSVPASIG----DLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSI 461
+ S + L LNL++N ++ + F L ++ +D+ N++ +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 462 PA-ELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSS 520
E L+NI + L+ N + + SL L + L + F +
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 1e-67
Identities = 82/463 (17%), Positives = 169/463 (36%), Gaps = 33/463 (7%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSIGD---LRNLQSIDFQGNKLTGQIPDEIGNCG 86
G F L L L+++ LG ++ + +++++ ++L+
Sbjct: 189 GCFHAIGRLFG--LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246
Query: 87 --SLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKT------ 138
+L ++LS N+L S + L QLE+ L+ N + +L + N++
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 139 ---LDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLT 195
++ L W + L++L + N + G+ S L L Y + + +
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 196 GTIPDSIG----NCTSFEILDISYNQITGEIPYNIGFL-QVATLSLQGNKLTGKIP-EVI 249
+ + IL+++ N+I+ +L + L L N++ ++ +
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW 426
Query: 250 GLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTG--PIPPELGNMSKLSYLQ 307
++ + + LS N+ + + +L L L P + L+ L
Sbjct: 427 RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486
Query: 308 LQNNQLVGTIPAELGKLEQLFELNLADNNLE--------GPIPHNISSCTALNQFNVHGN 359
L NN + L LE+L L+L NNL G + + + L+ N+ N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 360 RLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGD 419
F++L L ++L NN + ++L +L+L N + G
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
Query: 420 -LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSI 461
+L L++ N + + + I + +LS
Sbjct: 607 AFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-25
Identities = 40/181 (22%), Positives = 61/181 (33%), Gaps = 11/181 (6%)
Query: 29 RGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSL 88
R F SL + L +L LRNL +D N + D + L
Sbjct: 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL 506
Query: 89 VHIELSDNSL--------YGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLD 140
++L N+L G + + L L LNL++N + LK +D
Sbjct: 507 EILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566
Query: 141 LARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ--LTGLWYFDVRGNNLTGTI 198
L N L + L+ L L+ N +T + + L D+R N T
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDMRFNPFDCTC 625
Query: 199 P 199
Sbjct: 626 E 626
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = 1e-97
Identities = 96/308 (31%), Positives = 147/308 (47%), Gaps = 30/308 (9%)
Query: 233 TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVG--PIPPILGNLSYTGKLYLHG-NKL 289
T G + + + LDLS L PIP L NL Y LY+ G N L
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 290 TGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCT 349
GPIPP + +++L YL + + + G IP L +++ L L+ + N L G +P +ISS
Sbjct: 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149
Query: 350 ALNQFNVHGNRLSGAIPSSFRNLGSL-TYLNLSRNNFKGKVPTELGRIINLDTLDLSVNN 408
L GNR+SGAIP S+ + L T + +SRN GK+P +NL +DLS N
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN-LNLAFVDLSRNM 208
Query: 409 FSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQL 468
G G ++ ++L++N L L + G +++ +D+ N++ G++P L QL
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 469 QNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPL 528
+ L +LNVS+NNL G IP N RF +++ N
Sbjct: 268 KF------------------------LHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 529 LCGNWIGS 536
LCG+ + +
Sbjct: 304 LCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 6e-87
Identities = 85/325 (26%), Positives = 138/325 (42%), Gaps = 35/325 (10%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDN--SSLSVVSLNLSSLNLGGE--ISP 56
+ IK N L W + +W GV CD + V +L+LS LNL I
Sbjct: 12 LQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS 70
Query: 57 SIGDLRNLQSIDFQG-NKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFL 115
S+ +L L + G N L G IP I L ++ ++ ++ G IP +S++K L L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 116 NLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLS 175
+ N L+G +P +++ +PNL + N+++G IP
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP------------------------ 166
Query: 176 PDMCQLTGLW-YFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQV-AT 233
+ L+ + N LTG IP + N + +D+S N + G+ G +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI 293
+ L N L + + +GL + L LDL N + G +P L L + L + N L G I
Sbjct: 226 IHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 294 PPELGNMSKLSYLQLQNNQLVGTIP 318
P+ GN+ + NN+ + P
Sbjct: 285 -PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 38/135 (28%), Positives = 59/135 (43%), Gaps = 9/135 (6%)
Query: 400 DTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNG--LLPAEFGNLRSIQTIDMS-FNQ 456
T D + G + + + L+LS +L +P+ NL + + + N
Sbjct: 29 PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88
Query: 457 LSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP-IRNF 515
L G IP + +L + L + + N+ G IPD LS +L L+ SYN LSG +PP I +
Sbjct: 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148
Query: 516 SR-----FSSNSFIG 525
F N G
Sbjct: 149 PNLVGITFDGNRISG 163
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 5e-95
Identities = 100/301 (33%), Positives = 154/301 (51%), Gaps = 30/301 (9%)
Query: 607 TFDDIMRSTENLSEKYIV---------GYGASSTVYKCALKNSRPIAVKKLYNQYPHN-- 655
+F ++ T N E+ I G+G VYK + N +AVKKL
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFG---VVYKGYVNN-TTVAVKKLAAMVDITTE 71
Query: 656 --LREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLD 713
++F+ E++ + +H N+V L G++ L Y YM NGSL D L L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 714 WETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT-AM 772
W R KIA GAA G+ +LH + IHRD+KS+NIL+DE F A +SDFG+AR A
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSK 832
++ ++GT Y+ PE + KSD+YSFG+VLLEI+TG AVD E QL++
Sbjct: 189 TVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLLLDI 246
Query: 833 A-----DDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887
++ T+ + +D + D ++V + +A C ++RP +++V ++L +
Sbjct: 247 KEEIEDEEKTIEDYIDK--KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 888 L 888
Sbjct: 305 T 305
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 307 bits (787), Expect = 8e-91
Identities = 87/562 (15%), Positives = 176/562 (31%), Gaps = 80/562 (14%)
Query: 3 IKASFSNLANVLLDWDDVHNSDFCSWR---GVFCDNSSLSVVSLNLSSLNLGGEISPSIG 59
+ N L+W+ N + W GV DN+ V L+L+ G + +IG
Sbjct: 288 YYSGTINNTIHSLNWNF--NKELDMWGDQPGVDLDNNG-RVTGLSLAGFGAKGRVPDAIG 344
Query: 60 DLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIP---------------- 103
L L+ + F + T + E + +
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404
Query: 104 -------FSISKLKQLEFLNLKNNQLTG------PIPSTLTQIPNLKTLDLARNQLTGEI 150
+ +K+ ++LK+ Q+ I + ++ L+ + A + T +
Sbjct: 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDN 464
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEI 210
+ + L L ++ +PD + + +
Sbjct: 465 IAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519
Query: 211 LDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVG-PI 269
L+I+ N+ + ++ + + + + N L P
Sbjct: 520 LNIACNRGISAAQLKADW--------------TRLADDEDTGPKIQIFYMGYNNLEEFPA 565
Query: 270 PPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGK-LEQLF 328
L + G L NK+ G KL+ L+L NQ+ IP + +Q+
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622
Query: 329 ELNLADNNLEG-PIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLG-----SLTYLNLSR 382
L + N L+ P N S + + N++ + ++ + + + LS
Sbjct: 623 GLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682
Query: 383 NNFKGKVPTELGRIINLDTLDLSVNNFS-------GSVPASIGDLEHLLTLNLSRNHLNG 435
N + + T+ LS N + + + L T++L N L
Sbjct: 683 NEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
Query: 436 LLPA-EFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISL------ILNNNNLQGGIPDQ 488
L L + +D+S+N S S P + + + N + P
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801
Query: 489 LSNCFSLSNLNVSYNNLSGIIP 510
++ C SL L + N++ +
Sbjct: 802 ITTCPSLIQLQIGSNDIRKVDE 823
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 277 bits (709), Expect = 5e-80
Identities = 78/496 (15%), Positives = 157/496 (31%), Gaps = 43/496 (8%)
Query: 72 NKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLT 131
+ Q ++ N G + + L+ G +P +I +L +L+ L+ + T
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 132 QIPNLKTLDLARNQLTGEIPRL-IYWNEVLQYLGLRGNALT-----GMLSPDMCQLTGLW 185
+ + ++++ ++ + +++ L L +A+ + D
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 186 YFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKI 245
N +T I +I T +I+ + + T + + + K
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENE 483
Query: 246 PEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGP---------IPPE 296
++ L ++L + +P L +L L + N+ + +
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
Query: 297 LGNMSKLSYLQLQNNQLVGTIPAE--LGKLEQLFELNLADNNLEGPIPHNISSCTALNQF 354
K+ + N L PA L K+ +L L+ N + + L
Sbjct: 544 EDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDL 600
Query: 355 NVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP--TELGRIINLDTLDLSVNNFSG- 411
+ N++ + L S N K +P + + ++D S N
Sbjct: 601 KLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSE 659
Query: 412 ----SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS-------GS 460
S + T+ LS N + F I TI +S N ++
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719
Query: 461 IPAELGQLQNIISLILNNNNLQGGIPDQL--SNCFSLSNLNVSYNNLSGIIPPIRNFSRF 518
+ ++ L N L + D + LSN++VSYN S N S+
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQL 778
Query: 519 SSNSFIGNPLLCGNWI 534
+ GN I
Sbjct: 779 KAFGIRHQRDAEGNRI 794
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 1e-67
Identities = 70/471 (14%), Positives = 136/471 (28%), Gaps = 83/471 (17%)
Query: 35 NSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELS 94
N ++ N S +L++L ++ Q+PD + + L + ++
Sbjct: 464 NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523
Query: 95 DNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLI 154
N + + + P ++ + N L E P
Sbjct: 524 CNRGIS-AAQLKADWTR--------------LADDEDTGPKIQIFYMGYNNLE-EFPA-- 565
Query: 155 YWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDIS 214
S + ++ L D N + ++ G L +
Sbjct: 566 --------------------SASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLD 603
Query: 215 YNQITGEIPYNIGFL--QVATLSLQGNKLTGKIPEVIGL--MQALAVLDLSENELVGPIP 270
YNQI EIP + QV L NKL IP + + + +D S N++
Sbjct: 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGR 661
Query: 271 PILGNLSYTG-----KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQL-------VGTIP 318
I ++ + L N++ S +S + L NN + +
Sbjct: 662 NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKD 721
Query: 319 AELGKLEQLFELNLADNNLEG-PIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTY 377
L ++L N L ++ L+ +V N S P+ N L
Sbjct: 722 GNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKA 780
Query: 378 LNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLL 437
+ D N P I L+ L + N + +
Sbjct: 781 FGIRHQ------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-V 821
Query: 438 PAEFGNLRSIQTIDMSFNQL-SGSIPAELGQLQ-NIISLILNNNNLQGGIP 486
+ + +D++ N S + + ++ + L+ + G
Sbjct: 822 DEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCD 870
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-49
Identities = 65/415 (15%), Positives = 129/415 (31%), Gaps = 56/415 (13%)
Query: 3 IKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGG---------E 53
+ S+SNL + L D + + + D L SLN++
Sbjct: 483 EELSWSNLKD-LTDVELYNCPNMTQLPDFLYDLPEL--QSLNIACNRGISAAQLKADWTR 539
Query: 54 ISPSIGDLRNLQSIDFQGNKLTGQIPDE--IGNCGSLVHIELSDNSLYGDIPFSISKLKQ 111
++ +Q N L P + L ++ N + + + +
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKV-RHLE-AFGTNVK 596
Query: 112 LEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWN--EVLQYLGLRGNA 169
L L L NQ+ ++ L + N+L IP + V+ + N
Sbjct: 597 LTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNK 655
Query: 170 LTGM-----LSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQIT----- 219
+ S D + + N + + + + +S N +T
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 220 --GEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGL--MQALAVLDLSENELVGPIPPILG 274
N + T+ L+ NKLT + + + L+ +D+S N P
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773
Query: 275 NLSYTGKLYL------HGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLF 328
N S + GN++ P + L LQ+ +N + + +L QL+
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLY 830
Query: 329 ELNLADNNL-EGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSR 382
L++ADN + + + ++ ++ L + R
Sbjct: 831 ILDIADNPNISIDVTSVCPYIE-AGMYVLLYDKTQ--------DIRGCDALGIER 876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-44
Identities = 46/351 (13%), Positives = 102/351 (29%), Gaps = 23/351 (6%)
Query: 180 QLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGN 239
+LT ++ I D +E LD + N + + +
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELD 309
Query: 240 KLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGN 299
+ + + L L+ G +P +G L+ L + T
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 300 MSKLSYLQLQNNQLVGTIPAELGKLEQ------LFELNLADNNLEGPIPHNISSCTALNQ 353
+ + +++ +Q L + + N PI + Q
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ 429
Query: 354 FNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSV 413
NR++ I + + L L + + + F T ++ + + +
Sbjct: 430 IGNLTNRITF-ISKAIQRLTKLQIIYFANSPF-----TYDNIAVDWEDANSDYAKQYENE 483
Query: 414 PASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG---------SIPAE 464
S +L+ L + L LP +L +Q+++++ N+ + +
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
Query: 465 LGQLQNIISLILNNNNLQG-GIPDQLSNCFSLSNLNVSYNNLSGIIPPIRN 514
I + NNL+ L L L+ +N + +
Sbjct: 544 EDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGT 593
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 4e-21
Identities = 27/204 (13%), Positives = 61/204 (29%), Gaps = 6/204 (2%)
Query: 330 LNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKV 389
L+ + +N N FN + N G +T L+L+ KG+V
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339
Query: 390 PTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFG-NLRSIQ 448
P +G++ L L ++ + S + ++ + F + +
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399
Query: 449 TIDMSFNQLSG---SIPAELGQLQNIISL-ILNNNNLQGGIPDQLSNCFSLSNLNVSYNN 504
D+ + ++ P + ++ I N N I + L + + +
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSP 459
Query: 505 LSGIIPPIRNFSRFSSNSFIGNPL 528
+ + S +
Sbjct: 460 FTYDNIAVDWEDANSDYAKQYENE 483
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 3e-88
Identities = 100/502 (19%), Positives = 180/502 (35%), Gaps = 32/502 (6%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLV 89
G + S LS L L+ + + L +LQ + L IG+ +L
Sbjct: 70 GAYQSLSHLST--LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 90 HIELSDNSL-YGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLK----TLDLARN 144
+ ++ N + +P S L LE L+L +N++ + L + + +LDL+ N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 145 QLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ-LTGLWYFDVRGN------NLTGT 197
+ P L L LR N + + Q L GL + NL
Sbjct: 188 PMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 198 IPDSIGNCTSFEILDISYNQI---TGEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQ 253
++ + I + + +I L V++ SL +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNF 304
Query: 254 ALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQL 313
L+L + L +L L G ++ L +L L N L
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSL-----KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL 359
Query: 314 --VGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSS-FR 370
G L L+L+ N + + N L + + L S F
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 371 NLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSV-PASIGDLEHLLTLNLS 429
+L +L YL++S + + + +L+ L ++ N+F + P +L +L L+LS
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 430 RNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQL 489
+ L L P F +L S+Q ++MS N L ++ L + N++ +L
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538
Query: 490 SNCF-SLSNLNVSYNNLSGIIP 510
+ SL+ LN++ N+ +
Sbjct: 539 QHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 1e-87
Identities = 97/497 (19%), Positives = 175/497 (35%), Gaps = 29/497 (5%)
Query: 34 DNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIEL 93
DN S +L+LS L S S LQ +D ++ + L + L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 94 SDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTG-EIPR 152
+ N + + S L L+ L L + + LK L++A N + ++P
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 153 LIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYF----DVRGNNLTGTIPDSIGNCTSF 208
L++L L N + + D+ L + D+ N + I
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRL 202
Query: 209 EILDISYNQITGEIP----YNIGFLQVATLSLQGNKLTGKIPEV-IGLMQALAVLDLSEN 263
L + N + + + L+V L L + G + + ++ L L + E
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 264 EL------VGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI 317
L + I + L+ L + +L+L N +
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFP 320
Query: 318 PAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLS--GAIPSSFRNLGSL 375
+L L L + +G + +L ++ N LS G S SL
Sbjct: 321 TLKLKSL-----KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 376 TYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASI-GDLEHLLTLNLSRNHLN 434
YL+LS N + + + L+ LD +N S+ L +L+ L++S H
Sbjct: 376 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 435 GLLPAEFGNLRSIQTIDMSFNQLSGSIPAE-LGQLQNIISLILNNNNLQGGIPDQLSNCF 493
F L S++ + M+ N + + +L+N+ L L+ L+ P ++
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 494 SLSNLNVSYNNLSGIIP 510
SL LN+S+NN +
Sbjct: 495 SLQVLNMSHNNFFSLDT 511
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 3e-82
Identities = 97/513 (18%), Positives = 173/513 (33%), Gaps = 47/513 (9%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTG-QIPDEIGNCGSL 88
G F SSL L NL + IG L+ L+ ++ N + ++P+ N +L
Sbjct: 94 GAFSGLSSLQK--LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151
Query: 89 VHIELSDNSLYGDIPFSISKLKQLEF----LNLKNNQLTGPIPSTLTQIPNLKTLDLARN 144
H++LS N + + L Q+ L+L N + P +I L L L N
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNN 210
Query: 145 QLTGEIPRLIYWN-EVLQYLGLRGNALTG---MLSPDMCQLTGLWYFDVRGNNLT----- 195
+ + + L+ L + D L GL + L
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 196 -GTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLT------------ 242
I D T+ + I + L L K
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR 329
Query: 243 -------GKIPEVIGLMQALAVLDLSENEL--VGPIPPILGNLSYTGKLYLHGNKLTGPI 293
G + +L LDLS N L G + L L N + +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388
Query: 294 PPELGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLADNNLEGPIPHNISSCTALN 352
+ +L +L Q++ L L L L+++ + + ++L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 353 QFNVHGNRLSGAI-PSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG 411
+ GN P F L +LT+L+LS+ + PT + +L L++S NNF
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 412 SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNL-RSIQTIDMSFNQLSGSIPAE--LGQL 468
L L L+ S NH+ E + S+ ++++ N + + + L +
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWI 568
Query: 469 QNIISLILNNNNLQGGIPDQLSNCFSLSNLNVS 501
++ L++ ++ P + +LN++
Sbjct: 569 KDQRQLLVEVERMECATPSDKQG-MPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-33
Identities = 42/205 (20%), Positives = 76/205 (37%), Gaps = 8/205 (3%)
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK 388
+ N IP N+ + ++ N L SF + L L+LSR +
Sbjct: 11 TYQCMELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 389 VPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQ 448
+ +L TL L+ N + L L L +L L G+L++++
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 449 TIDMSFNQL-SGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSN----LNVSYN 503
++++ N + S +P L N+ L L++N +Q L + L++S N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 504 NLSGIIPPIRNFSRFSSNSFIGNPL 528
++ I P R + N
Sbjct: 188 PMNFIQPGAFKEIRLHKLTLRNNFD 212
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 4e-86
Identities = 92/508 (18%), Positives = 176/508 (34%), Gaps = 25/508 (4%)
Query: 26 CSWRGVFCDNSSLSVV---------SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTG 76
+ C+N L+ + L S L + + L NL +D ++
Sbjct: 12 EVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 77 QIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNL 136
D + L + L+ N L ++S K L+ L ++ L L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 137 KTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGL--WYFDVRGNNL 194
++L L N ++ + E L+ L + NA+ + DM L ++ GN++
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 195 TGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVA---TLSLQGNKLTGKIPEVIGL 251
I + F+ L+ Q I + + + + P V
Sbjct: 192 A-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 252 MQALAV--LDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQ 309
+ ++V ++L ++ S +L L L+ +P L +S L L L
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLS 309
Query: 310 NNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHN-ISSCTALNQFNVHGNRL--SGAIP 366
N+ L L++ N + + + L + ++ + + S
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 367 SSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASI-GDLEHLLT 425
RNL L LNLS N L+ LDL+ S +L L
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 426 LNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIIS---LILNNNNLQ 482
LNLS + L+ F L ++Q +++ N + LQ + L+L+ +L
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 483 GGIPDQLSNCFSLSNLNVSYNNLSGIIP 510
++ ++++++S+N L+
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 6e-83
Identities = 93/497 (18%), Positives = 182/497 (36%), Gaps = 20/497 (4%)
Query: 27 SWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCG 86
S + + + N +L L EI ++ + + ++F N L
Sbjct: 4 SDQKCIEKEVNKTY---NCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLI 57
Query: 87 SLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQL 146
+L ++L+ +Y + +L+ L L N L + L+ LK L + +
Sbjct: 58 NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117
Query: 147 TGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCT 206
+ ++ + L+ L L N ++ + P L D + N + + + +
Sbjct: 118 SSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177
Query: 207 S--FEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGL--MQALAVLDLSE 262
L+++ N I G P +L+ G + I + + +Q+L + +
Sbjct: 178 QATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED 237
Query: 263 NELVGPIPPILGNLSYTG--KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAE 320
+ P + L + L + S L L L L +P+
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSG 296
Query: 321 LGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPS-SFRNLGSLTYLN 379
L L L +L L+ N E + S+ +L ++ GN + + NL +L L+
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 380 LSRNNFK--GKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLL 437
LS ++ + +L + +L +L+LS N + + L L+L+ L
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416
Query: 438 P-AEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGI---PDQLSNCF 493
+ F NL ++ +++S + L S L + L L N+ G + L
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476
Query: 494 SLSNLNVSYNNLSGIIP 510
L L +S+ +LS I
Sbjct: 477 RLEILVLSFCDLSSIDQ 493
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 4e-80
Identities = 96/493 (19%), Positives = 171/493 (34%), Gaps = 19/493 (3%)
Query: 29 RGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSL 88
F L L L++ L ++ + L+ + F ++ + N +L
Sbjct: 74 EDTFQSQHRLDT--LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 89 VHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLK--TLDLARNQL 146
+ L N + ++L+ L+ +NN + ++ + +L+L N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 147 TGEIPRLIYWNEVLQYLGLRGNALTGMLSPDM--CQLTGLWYFDVRGNNLTGTIPDSIGN 204
I + + V Q L G ++ + + LW + P
Sbjct: 192 A-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 205 C--TSFEILDISYNQITGEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQALAVLDLS 261
S E +++ + + L L L+ ++P + + L L LS
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 262 ENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQL--VGTIP 318
N+ N L + GN + L N+ L L L ++ +
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 319 AELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIP-SSFRNLGSLTY 377
+L L L LNL+ N C L ++ RL S F+NL L
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 378 LNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG---SVPASIGDLEHLLTLNLSRNHLN 434
LNLS + + L L+L N+F S+ L L L LS L+
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 435 GLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFS 494
+ F +L+ + +D+S N+L+ S L L+ I L L +N++ +P L
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQ 548
Query: 495 LSNLNVSYNNLSG 507
+N+ N L
Sbjct: 549 QRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 3e-67
Identities = 95/491 (19%), Positives = 176/491 (35%), Gaps = 23/491 (4%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLV 89
+ +L SL L S ++ P L+ +DFQ N + +++ +
Sbjct: 123 IPLHNQKTL--ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQAT 180
Query: 90 HIEL--SDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTL--TQIPNLKTLDLARNQ 145
++ L + N + I + LN Q I L + I +L
Sbjct: 181 NLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239
Query: 146 LTGEIPRLIYW--NEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIG 203
P + ++ + L+ + + S +GL D+ +L+ +P +
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLV 298
Query: 204 NCTSFEILDISYNQITGEIPYNIGFL-QVATLSLQGNKLTGKI-PEVIGLMQALAVLDLS 261
++ + L +S N+ + + LS++GN ++ + ++ L LDLS
Sbjct: 299 GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS 358
Query: 262 ENEL--VGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIP- 318
+++ L NLS+ L L N+ +L L L +L
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418
Query: 319 AELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAI---PSSFRNLGSL 375
+ L L LNL+ + L+ AL N+ GN +S + LG L
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478
Query: 376 TYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNG 435
L LS + + ++ +DLS N + S ++ L+ + LNL+ NH++
Sbjct: 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK-GIYLNLASNHISI 537
Query: 436 LLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSL 495
+LP+ L +TI++ N L + N L+ N L
Sbjct: 538 ILPSLLPILSQQRTINLRQNPLDCTC--SNIYFLEW--YKENMQKLEDTEDTLCENPPLL 593
Query: 496 SNLNVSYNNLS 506
+ +S LS
Sbjct: 594 RGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-59
Identities = 70/398 (17%), Positives = 131/398 (32%), Gaps = 15/398 (3%)
Query: 123 TGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLT 182
T + KT + L EIP + + + L N L + + +L
Sbjct: 1 TTSSDQKCIEKEVNKTYNCENLGLN-EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLI 57
Query: 183 GLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQ-VATLSLQGNKL 241
L + D+ + D+ + + L ++ N + + + + L +
Sbjct: 58 NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117
Query: 242 TGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMS 301
+ + + L L L N + P L N + ++ ++
Sbjct: 118 SSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177
Query: 302 KLS--YLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCT--ALNQFNVH 357
+ + L L N + I LN I + + T +L
Sbjct: 178 QATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFE 236
Query: 358 GNRLSGAIPSSFRNLG--SLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPA 415
P+ F L S+ +NL ++ F L LDL+ + S +P+
Sbjct: 237 DMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPS 295
Query: 416 SIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAE-LGQLQNIISL 474
+ L L L LS N L N S+ + + N + L L+N+ L
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLREL 355
Query: 475 ILNNNNLQ--GGIPDQLSNCFSLSNLNVSYNNLSGIIP 510
L++++++ QL N L +LN+SYN +
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-44
Identities = 48/301 (15%), Positives = 89/301 (29%), Gaps = 13/301 (4%)
Query: 233 TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGP 292
T + + L +IP L + L+ S N L L L L ++
Sbjct: 16 TYNCENLGLN-EIPG--TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 293 IPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALN 352
+ +L L L N L+ L + L L + + + L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 353 QFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVN-NFSG 411
+ N +S L L+ N ++ + L L++N N
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 412 SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGN--LRSIQTIDMSFNQLSGSIPAELGQLQ 469
+ D +LN ++ N ++S+ PA L
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 470 --NIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSR-----FSSNS 522
++ S+ L + + L L+++ +LS + + S S+N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANK 312
Query: 523 F 523
F
Sbjct: 313 F 313
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 5e-76
Identities = 90/511 (17%), Positives = 175/511 (34%), Gaps = 33/511 (6%)
Query: 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGD 101
L+LS + + L +L ++ GN + P SL ++ + L
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 102 IPFSISKLKQLEFLNLKNNQLTG-PIPSTLTQIPNLKTLDLARNQLTGEIPRLIYW---- 156
F I +L L+ LN+ +N + +P+ + + NL +DL+ N + + +
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 157 NEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIP-DSIGNCTSFEILDISY 215
+V L + N + + Q L +RGN + I + N + +
Sbjct: 180 PQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLIL 238
Query: 216 NQITG---------EIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELV 266
+ I + + + L + ++ + L+ +
Sbjct: 239 GEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298
Query: 267 GPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQ 326
+ L + +L P ++ L L L N+ +I + L
Sbjct: 299 YL--EDVPKHFKWQSLSIIRCQLKQ-FPT--LDLPFLKSLTLTMNKG--SISFKKVALPS 351
Query: 327 LFELNLADNNLE--GPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNN 384
L L+L+ N L G ++ +L ++ N + ++F L L +L+ +
Sbjct: 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHST 410
Query: 385 FKGKVPTE-LGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAE-FG 442
K + L LD+S N L L TL ++ N + F
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 443 NLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSY 502
N ++ +D+S QL L + L +++NNL + +SLS L+ S+
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530
Query: 503 NNLSGIIPPIRNFSRFSSNSFI---GNPLLC 530
N + + S +F N + C
Sbjct: 531 NRIETSKGIL--QHFPKSLAFFNLTNNSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-74
Identities = 100/496 (20%), Positives = 171/496 (34%), Gaps = 28/496 (5%)
Query: 34 DNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIEL 93
D+ S +++LS L S S + LQ +D ++ L ++ L
Sbjct: 28 DDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLIL 87
Query: 94 SDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTG-EIPR 152
+ N + P S S L LE L +L + Q+ LK L++A N + ++P
Sbjct: 88 TGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA 147
Query: 153 LIYWNEVLQYLGLRGNALTGMLSPDMCQLTGL----WYFDVRGNNLTGTIPDSIGNCTSF 208
L ++ L N + + D+ L D+ N + I D
Sbjct: 148 YFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKL 206
Query: 209 EILDISYNQITGEIP----YNIGFLQVATLS----LQGNKLTGKIPEVIGLMQALAV--L 258
L + N + I N+ L V L L P ++ + + +
Sbjct: 207 HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266
Query: 259 DLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIP 318
L+ L+ + L G + ++ K L + QL
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPT 324
Query: 319 AELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLG--SLT 376
+L L+ L L N I + +L+ ++ N LS + S+ +LG SL
Sbjct: 325 LDLPFLK---SLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379
Query: 377 YLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPAS-IGDLEHLLTLNLSRNHLNG 435
+L+LS N + + L LD + S LE LL L++S +
Sbjct: 380 HLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 436 LLPAEFGNLRSIQTIDMSFNQLSGSIPAE-LGQLQNIISLILNNNNLQGGIPDQLSNCFS 494
F L S+ T+ M+ N + + N+ L L+ L+
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 495 LSNLNVSYNNLSGIIP 510
L LN+S+NNL +
Sbjct: 499 LQLLNMSHNNLLFLDS 514
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 3e-69
Identities = 101/497 (20%), Positives = 183/497 (36%), Gaps = 30/497 (6%)
Query: 29 RGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSL 88
+ LS L L+ + S L +L+++ KL IG +L
Sbjct: 73 DKAWHGLHHLSN--LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 89 VHIELSDNSLYG-DIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLK----TLDLAR 143
+ ++ N ++ +P S L L ++L N + + L + +LD++
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 144 NQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ-LTGLWYFDVRGNNLTGTIPDSI 202
N + I + L L LRGN + + Q L GL + I
Sbjct: 191 NPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 203 GNCTSFE--------ILDISYNQITGEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQ 253
+ E ++Y + L V+ +SL G + + +V +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFK 308
Query: 254 ALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQL 313
L + +L L L L L NK + I + + LSYL L N L
Sbjct: 309 -WQSLSIIRCQLKQFPTLDLPFLKS---LTLTMNKGS--ISFKKVALPSLSYLDLSRNAL 362
Query: 314 --VGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIP-SSFR 370
G L L+L+ N + N L + + L S+F
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421
Query: 371 NLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASI-GDLEHLLTLNLS 429
+L L YL++S N K + +L+TL ++ N+F + +++ + +L L+LS
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481
Query: 430 RNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQL 489
+ L + F L +Q ++MS N L + QL ++ +L + N ++
Sbjct: 482 KCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQ 541
Query: 490 SNCFSLSNLNVSYNNLS 506
SL+ N++ N+++
Sbjct: 542 HFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-35
Identities = 54/287 (18%), Positives = 99/287 (34%), Gaps = 19/287 (6%)
Query: 257 VLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT 316
+ +L +P + S T + L N L N S+L +L L ++
Sbjct: 15 TYQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 317 IPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLT 376
L L L L N ++ P + S T+L +L+ L +L
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 377 YLNLSRNNFKG-KVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHL----LTLNLSRN 431
LN++ N K+P + NL +DLS N + L L+L++S N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 432 HLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQ-------LQNIISLILNNNNLQGG 484
++ + F + + + + N S +I Q + I+ + NL+
Sbjct: 192 PIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250
Query: 485 IPDQLSNCFSLS--NLNVSYNNLSGIIPP-IRNFSRFSSNSFIGNPL 528
P + ++ ++Y N + S+ S G +
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-23
Identities = 27/149 (18%), Positives = 55/149 (36%), Gaps = 4/149 (2%)
Query: 363 GAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEH 422
G++ + ++T KVP ++ + +DLS N S +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 423 LLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQ 482
L L+LSR + + + L + + ++ N + P L ++ +L+ L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 483 GGIPDQLSNCFSLSNLNVSYNNLSGIIPP 511
+ +L LNV++N + P
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLP 146
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-17
Identities = 20/128 (15%), Positives = 45/128 (35%), Gaps = 3/128 (2%)
Query: 21 HNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSI-GDLRNLQSIDFQGNKLTGQIP 79
+ + + G+F +SL+ L ++ + ++ + NL +D +L
Sbjct: 433 YTNTKIDFDGIFLGLTSLNT--LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490
Query: 80 DEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTL 139
L + +S N+L ++L L L+ N++ +L
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550
Query: 140 DLARNQLT 147
+L N +
Sbjct: 551 NLTNNSVA 558
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 5e-73
Identities = 67/309 (21%), Positives = 113/309 (36%), Gaps = 33/309 (10%)
Query: 606 HTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELET 665
+++ + L + G V+K L N +AVK Q + + E E+ +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 666 IGSIRHRNIVSLHGYALSPYGN----LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
+ ++H NI+ G L + GSL D L + W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIA 127
Query: 722 VGAAQGLAYLHHD-------CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774
A+GLAYLH D P I HRD+KS N+L+ N A ++DFG+A
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 775 A-STFVLGTIGYIDPEYAHTS-----RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ +GT Y+ PE + + D+Y+ G+VL E+ + A D + + L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 829 I----------MSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQ 878
+ + V + P + + + + C R +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 879 EVARVLVSL 887
V + +
Sbjct: 308 CVGERITQM 316
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-66
Identities = 105/471 (22%), Positives = 187/471 (39%), Gaps = 37/471 (7%)
Query: 39 SVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSL 98
+ S ++ +I L +T + + + ++ +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 99 YGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNE 158
I + L L +N NNQLT P L + L + + NQ+ P +
Sbjct: 59 -KSID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLT 112
Query: 159 VLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQI 218
L L L N +T + + LT L ++ N ++ ++ TS + L NQ+
Sbjct: 113 NLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQV 167
Query: 219 TGEIP-YNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLS 277
T P N+ L+ L + NK++ V+ + L L + N++ P LG L+
Sbjct: 168 TDLKPLANLTTLE--RLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILT 221
Query: 278 YTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNL 337
+L L+GN+L L +++ L+ L L NNQ+ P L L +L EL L N +
Sbjct: 222 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 277
Query: 338 EGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRII 397
P ++ TAL ++ N+L S NL +LTYL L NN + + +
Sbjct: 278 SNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD--ISPVSSLT 331
Query: 398 NLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457
L L N S +S+ +L ++ L+ N ++ L P NL I + ++
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 458 SGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508
+ + P +I + + N P +S+ S + ++++N S
Sbjct: 388 T-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 5e-57
Identities = 100/448 (22%), Positives = 178/448 (39%), Gaps = 61/448 (13%)
Query: 86 GSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQ 145
G L ++ ++ I F+ + L + L +T + T + + TL R
Sbjct: 1 GPLGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 146 LTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNC 205
+ I + Y N L + N LT + + LT L + N + P + N
Sbjct: 58 IK-SIDGVEYLNN-LTQINFSNNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANL 111
Query: 206 TSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENEL 265
T+ L + NQIT P + + L L+LS N +
Sbjct: 112 TNLTGLTLFNNQITDIDP-------------------------LKNLTNLNRLELSSNTI 146
Query: 266 VGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLE 325
L L+ +L GN++T P L N++ L L + +N++ + + L KL
Sbjct: 147 SDISA--LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKV--SDISVLAKLT 199
Query: 326 QLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNF 385
L L +N + P + T L++ +++GN+L + +L +LT L+L+ N
Sbjct: 200 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 255
Query: 386 KGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLR 445
P L + L L L N S P + L L L L+ N L + P NL+
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLK 309
Query: 446 SIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNL 505
++ + + FN +S P + L + L NN + L+N +++ L+ +N +
Sbjct: 310 NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQI 365
Query: 506 SGIIPPIRNFSR-----FSSNSFIGNPL 528
S + P+ N +R + ++ P+
Sbjct: 366 SD-LTPLANLTRITQLGLNDQAWTNAPV 392
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 8e-42
Identities = 80/351 (22%), Positives = 138/351 (39%), Gaps = 28/351 (7%)
Query: 44 NLSSLNLGG-EIS--PSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYG 100
NL+ L L IS ++ L +LQ + F GN++T P + N +L +++S N +
Sbjct: 135 NLNRLELSSNTISDISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKV-S 190
Query: 101 DIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVL 160
DI ++KL LE L NNQ++ P L + NL L L NQL + L
Sbjct: 191 DIS-VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNL 245
Query: 161 QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITG 220
L L N ++ + + LT L + N ++ P + T+ L+++ NQ+
Sbjct: 246 TDLDLANNQISNL--APLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED 301
Query: 221 EIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYT 279
P I L + L+L N ++ P + + L L N++ L NL+
Sbjct: 302 ISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNI 355
Query: 280 GKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEG 339
L N+++ P L N+++++ L L + + + L
Sbjct: 356 NWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIA 413
Query: 340 PIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP 390
P IS + + ++ N S S+ + F G V
Sbjct: 414 PA--TISDGGSYTEPDITWNLPSYTNEVSY-TFSQPVTIGKGTTTFSGTVT 461
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-65
Identities = 109/468 (23%), Positives = 179/468 (38%), Gaps = 72/468 (15%)
Query: 54 ISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKL---- 109
I+P LQ + LT ++P E N S + + + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 110 ---------KQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVL 160
+Q L L N L+ +P P+L++L + N LT E+P L + L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSL 116
Query: 161 QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITG 220
AL+ + L Y V N L +P+ + N + +I+D+ N +
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK- 166
Query: 221 EIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTG 280
++P L+ ++ N+L ++PE + + L + N L +P + +L
Sbjct: 167 KLPDLPPSLE--FIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKK-LPDLPLSLE--- 218
Query: 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340
+ N L PEL N+ L+ + NN L T+P LE LN+ DN L
Sbjct: 219 SIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE---ALNVRDNYLTD- 271
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
+P S T L+ + LS +L YLN S N + + +L+
Sbjct: 272 LPELPQSLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIR-SLCDLPP---SLE 320
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460
L++S N +PA LE L S NHL +P NL+ + + +N L
Sbjct: 321 ELNVSNNKLI-ELPALPPRLER---LIASFNHLAE-VPELPQNLKQ---LHVEYNPLR-E 371
Query: 461 IPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508
P +++ L N+ +P+ N L L+V N L
Sbjct: 372 FPDIPESVED-----LRMNSHLAEVPELPQN---LKQLHVETNPLREF 411
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-49
Identities = 81/440 (18%), Positives = 147/440 (33%), Gaps = 68/440 (15%)
Query: 34 DNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIEL 93
D L L++L L + +L+S+ N LT ++P+ + SL+
Sbjct: 67 DCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 94 SDNSLYGDIPF---------------SISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKT 138
+ +L P + L+ +++ NN L +P P+L+
Sbjct: 122 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPD---LPPSLEF 177
Query: 139 LDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTI 198
+ NQL E+P L L + N+L L L + N L
Sbjct: 178 IAAGNNQLE-ELPELQNLPF-LTAIYADNNSLKK-LPDLPLSLESI---VAGNNILE--E 229
Query: 199 PDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVL 258
+ N + N + +P L+ L+++ N LT +PE+ + L V
Sbjct: 230 LPELQNLPFLTTIYADNNLLK-TLPDLPPSLE--ALNVRDNYLT-DLPELPQSLTFLDVS 285
Query: 259 DLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIP 318
+ + L + NL L N++ + + L L + NN+L+ +P
Sbjct: 286 ENIFSGL----SELPPNL---YYLNASSNEIRS-LCDLPPS---LEELNVSNNKLI-ELP 333
Query: 319 AELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYL 378
A +LE L + N+L +P + L+ V N L P ++ L
Sbjct: 334 ALPPRLE---RLIASFNHLAE-VPELPQNLKQLH---VEYNPLR-EFPDIPESVEDLRM- 384
Query: 379 NLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLP 438
N+ +VP NL L + N P +E L ++ +
Sbjct: 385 ----NSHLAEVPELPQ---NLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYE 433
Query: 439 AEFGNLRSIQTIDMSFNQLS 458
++ +
Sbjct: 434 FAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 25/145 (17%), Positives = 51/145 (35%), Gaps = 18/145 (12%)
Query: 366 PSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLT 425
P + N L +N ++P E + + + + + + P G+ +
Sbjct: 5 PRNVSNT-FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 426 LNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGI 485
L ++++ LS S+P L+ SL+ + N+L +
Sbjct: 63 SRLRDCLDRQA-----------HELELNNLGLS-SLPELPPHLE---SLVASCNSLT-EL 106
Query: 486 PDQLSNCFSLSNLNVSYNNLSGIIP 510
P+ + SL N + LS + P
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 20/114 (17%), Positives = 43/114 (37%), Gaps = 19/114 (16%)
Query: 414 PASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQL----- 468
P ++ L ++L + P E N++S ++++ + P G+
Sbjct: 5 PRNVS-NTFLQEPLRHSSNLTEM-PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 469 --------QNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRN 514
+ L LNN L +P+ + L +L S N+L+ + ++
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLTELPELPQS 112
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-63
Identities = 83/309 (26%), Positives = 142/309 (45%), Gaps = 31/309 (10%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIV 675
+ + + +VG GA V K A ++ +A+K++ ++ + F EL + + H NIV
Sbjct: 8 KEIEVEEVVGRGAFGVVCK-AKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIV 64
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
L+G L+P L +Y GSL+++LHG + + +QG+AYLH
Sbjct: 65 KLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 736 NPRIIHRDVKSSNILIDENFD-AHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
+IHRD+K N+L+ + DFG A I T M T G+ ++ PE S
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----TNNKGSAAWMAPEVFEGS 178
Query: 795 RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN---TVMEAVDPEVSVTCV 851
+EK DV+S+GI+L E++T +K D IM + +++ + +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE---- 234
Query: 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAPKPIDYYTKFVV 911
L C + PS+RP+M+E+ +++ L+ P A +P+ Y + +
Sbjct: 235 ---------SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP-----GADEPLQYPCQHSL 280
Query: 912 NRERQQRVE 920
RVE
Sbjct: 281 PPGEDGRVE 289
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-59
Identities = 81/286 (28%), Positives = 139/286 (48%), Gaps = 22/286 (7%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH--NLREFETELETIGSIRHRN 673
+L+ K +G G+ TV++ S +AVK L Q H + EF E+ + +RH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
IV G P + +Y+ GSL+ LLH + +LD RL +A A+G+ YLH+
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
NP I+HR++KS N+L+D+ + + DFG++R + + + GT ++ PE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRD 213
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN---TVMEAVDPEVSVTC 850
NEKSDVYSFG++L E+ T ++ N + Q++ + + ++P+V+
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKCKRLEIPRNLNPQVA--- 269
Query: 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLS 896
+ C P +RP+ + +L L+ + +
Sbjct: 270 ----------AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-57
Identities = 69/287 (24%), Positives = 125/287 (43%), Gaps = 33/287 (11%)
Query: 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHN-------LREFETELETIG 667
+ + +G G V+K L + +A+K L +EF+ E+ +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 668 SIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
++ H NIV L+G +P + +++ G L+ L K + W +L++ + A G
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALG 134
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDE-----NFDAHLSDFGIARCIPTAMPHASTFVLGT 782
+ Y+ + NP I+HRD++S NI + A ++DFG+++ ++ + +LG
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV----SGLLGN 189
Query: 783 IGYIDPE--YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840
++ PE A EK+D YSF ++L ILTG+ D S ++ E
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM----IREE 245
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887
+ P + C +R + LC P +RP + + L L
Sbjct: 246 GLRPTIPEDC--PPRLRN---VIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-56
Identities = 60/282 (21%), Positives = 115/282 (40%), Gaps = 33/282 (11%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH--NLREFETELETIGSIRHRN 673
+ L+ + S ++K + + I VK L + R+F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 674 IVSLHGYALSPYGNLLFY--DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYL 731
++ + G SP +M GSL+++LH +D +K A+ A+G+A+L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFL 127
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE-- 789
H P I + S +++IDE+ A +S + S + ++ PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEAL 180
Query: 790 -YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN---TVMEAVDPE 845
+D++SF ++L E++T + + SN+ ++ M A + T+ + P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-EIGMKVALEGLRPTIPPGISPH 239
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887
VS +L +C P++RP + +L +
Sbjct: 240 VS-------------KLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 196 bits (502), Expect = 3e-56
Identities = 77/395 (19%), Positives = 148/395 (37%), Gaps = 50/395 (12%)
Query: 88 LVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLT 147
+ + I F + L + L+ +T + ++ ++ L +A ++
Sbjct: 2 AATLATLPAPI-NQI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 148 GEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTS 207
I + Y L+YL L GN +T + + L L + N +T ++ N T+
Sbjct: 58 -SIQGIEYLTN-LEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 208 FEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVG 267
L ++ + I+ P + + + L+L N +
Sbjct: 112 LRELYLNEDNISDISP-------------------------LANLTKMYSLNLGANHNLS 146
Query: 268 PIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQL 327
+ P L N++ L + +K+ P + N++ L L L NQ+ P L L L
Sbjct: 147 DLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 328 FELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKG 387
N + P +++ T LN + N+++ P NL LT+L + N
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257
Query: 388 KVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSI 447
+ + L L++ N S + + +L L +L L+ N L G L ++
Sbjct: 258 --INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313
Query: 448 QTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQ 482
T+ +S N ++ P L L + S N ++
Sbjct: 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-53
Identities = 86/393 (21%), Positives = 154/393 (39%), Gaps = 52/393 (13%)
Query: 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGD 101
+L + +I P DL Q +T + S+ + ++ +
Sbjct: 4 TLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV-AS 58
Query: 102 IPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQ 161
I I L LE+LNL NQ+T P L+ + L L + N++T +I L
Sbjct: 59 IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISAL-------- 106
Query: 162 YLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGE 221
LT L + +N++ P + N T L++ N +
Sbjct: 107 -----------------QNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD 147
Query: 222 IPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTG 280
+ + + + L++ +K+ P I + L L L+ N++ P L +L+
Sbjct: 148 LS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLH 202
Query: 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340
+ N++T P + NM++L+ L++ NN++ P L L QL L + N +
Sbjct: 203 YFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI 258
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
+ T L NV N++S S NL L L L+ N + +G + NL
Sbjct: 259 NA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHL 433
TL LS N+ + P + L + + + + +
Sbjct: 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-51
Identities = 78/347 (22%), Positives = 140/347 (40%), Gaps = 26/347 (7%)
Query: 39 SVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSL 98
+ L ++ ++ +L ++ + G K+ I +L ++ L+ N +
Sbjct: 23 EGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQI 78
Query: 99 YGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNE 158
P S L +L L + N++T S L + NL+ L L + ++ I L +
Sbjct: 79 TDISPL--SNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTK 133
Query: 159 VLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQI 218
+ L L N LSP + +TGL Y V + + P I N T L ++YNQI
Sbjct: 134 -MYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189
Query: 219 TGEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLS 277
P + L + + N++T P + M L L + N++ P L NLS
Sbjct: 190 EDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLS 243
Query: 278 YTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNL 337
L + N+++ + +++KL L + +NQ+ + + L L QL L L +N L
Sbjct: 244 QLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQL 299
Query: 338 EGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNN 384
I T L + N ++ P +L + + +
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 181 bits (463), Expect = 7e-51
Identities = 75/352 (21%), Positives = 150/352 (42%), Gaps = 26/352 (7%)
Query: 160 LQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQIT 219
L + + PD L ++ ++T + S L ++ ++
Sbjct: 2 AATLATLPAPINQ-IFPD-ADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 220 GEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSY 278
I I +L + L+L GN++T P + + L L + N++ L NL+
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLE 338
+LYL+ + ++ P L N++K+ L L N + + + L + L L + ++ ++
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168
Query: 339 GPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIIN 398
P I++ T L +++ N++ P +L SL Y N T + +
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTR 222
Query: 399 LDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS 458
L++L + N + P + +L L L + N ++ + +L ++ +++ NQ+S
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQIS 278
Query: 459 GSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIP 510
I L L + SL LNNN L + + +L+ L +S N+++ I P
Sbjct: 279 -DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-46
Identities = 69/323 (21%), Positives = 141/323 (43%), Gaps = 25/323 (7%)
Query: 44 NLSSLNLGG-EIS--PSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYG 100
+++ L + G +++ I L NL+ ++ GN++T P + N L ++ + N +
Sbjct: 45 SITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI-T 101
Query: 101 DIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVL 160
DI ++ L L L L + ++ P L + + +L+L N ++ L L
Sbjct: 102 DIS-ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTG-L 157
Query: 161 QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITG 220
YL + + + + + LT L+ + N + P + + TS NQIT
Sbjct: 158 NYLTVTESKVKDV--TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213
Query: 221 EIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYT 279
P + + ++ +L + NK+T P + + L L++ N++ + +L+
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKL 267
Query: 280 GKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEG 339
L + N+++ L N+S+L+ L L NNQL +G L L L L+ N++
Sbjct: 268 KMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
Query: 340 PIPHNISSCTALNQFNVHGNRLS 362
P ++S + ++ + +
Sbjct: 326 IRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-18
Identities = 31/151 (20%), Positives = 63/151 (41%), Gaps = 10/151 (6%)
Query: 367 SSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTL 426
+L L + + V + ++ L ++ + S+ I L +L L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYL 71
Query: 427 NLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIP 486
NL+ N + + P NL + + + N+++ + L L N+ L LN +N+ P
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP 127
Query: 487 DQLSNCFSLSNLNVSYNNLSGIIPPIRNFSR 517
L+N + +LN+ N+ + P+ N +
Sbjct: 128 --LANLTKMYSLNLGANHNLSDLSPLSNMTG 156
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-55
Identities = 96/492 (19%), Positives = 172/492 (34%), Gaps = 43/492 (8%)
Query: 56 PSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFL 115
P + + N+ + +IPD + S +++LS N L +S +L+ L
Sbjct: 2 PCVEVVPNI-TYQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 116 NLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLS 175
+L ++ + +L TL L N + LQ L L + +
Sbjct: 58 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117
Query: 176 PDMCQLTGLWYFDVRGNNLT-GTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQ---- 230
+ L L +V N + +P+ N T+ E LD+S N+I ++ L
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177
Query: 231 -VATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPP-ILGNLSYTGKLYL---- 284
+L L N + P ++ L L L N + + L+ L
Sbjct: 178 LNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236
Query: 285 --HGNKLTGPIPPELGNMSKLSYLQLQNNQL---VGTIPAELGKLEQLFELNLADNNLEG 339
+ L L + L+ + + L + I L + +L +E
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296
Query: 340 -PIPHNISSCTALNQFNVHGNRLSGAIPSS----------------FRNLGSLTYLNLSR 382
L N + S +L SL +L+LSR
Sbjct: 297 VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSR 356
Query: 383 N--NFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAE 440
N +FKG +L LDLS N ++ ++ LE L L+ ++L +
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS 415
Query: 441 -FGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGI-PDQLSNCFSLSNL 498
F +LR++ +D+S + L ++ L + N+ Q PD + +L+ L
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 499 NVSYNNLSGIIP 510
++S L + P
Sbjct: 476 DLSQCQLEQLSP 487
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 2e-54
Identities = 98/481 (20%), Positives = 178/481 (37%), Gaps = 33/481 (6%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLV 89
G + S LS L L+ + + L +LQ + L IG+ +L
Sbjct: 70 GAYQSLSHLST--LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 90 HIELSDNSL-YGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLK----TLDLARN 144
+ ++ N + +P S L LE L+L +N++ + L + + +LDL+ N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 145 QLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ-LTGLWYFD------VRGNNLTGT 197
+ I + L L LR N + + Q L GL NL
Sbjct: 188 PMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 198 IPDSIGNCTS--FEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPEVIGLMQ 253
++ + E ++Y + ++ V++ SL + ++ +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFG 305
Query: 254 ALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQL 313
L+L + L +L L NK ++ L +L L N L
Sbjct: 306 -WQHLELVNCKFGQFPTLKLKSLKR---LTFTSNKGGNA--FSEVDLPSLEFLDLSRNGL 359
Query: 314 --VGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSS-FR 370
G L L+L+ N + + N L + + L S F
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 371 NLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASI-GDLEHLLTLNLS 429
+L +L YL++S + + + +L+ L ++ N+F + I +L +L L+LS
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 430 RNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAE-LGQLQNIISLILNNNNLQGGIPDQ 488
+ L L P F +L S+Q ++M+ NQL S+P +L ++ + L+ N P
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537
Query: 489 L 489
Sbjct: 538 D 538
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-30
Identities = 58/294 (19%), Positives = 100/294 (34%), Gaps = 20/294 (6%)
Query: 257 VLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT 316
E IP L T L L N L + +L L L ++
Sbjct: 11 TYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 317 IPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLT 376
L L L L N ++ S ++L + L+ +L +L
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 377 YLNLSRNNFK-GKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHL----LTLNLSRN 431
LN++ N + K+P + NL+ LDLS N + L + L+L+LS N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 432 HLNGLLPAEFGNLRSIQTIDMSFNQLSGSIP-------AELGQLQNIISLILNNNNLQGG 484
+N + P F + + + + N S ++ A L + ++ N NL+
Sbjct: 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 485 IPDQLSNCFSLSNLNVSYNNLSGI-IPPIRNFSRFSSNSFIGNPLLCGNWIGSI 537
L L NL + L+ + F+ + + + L I +
Sbjct: 247 DKSALEG---LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-12
Identities = 28/127 (22%), Positives = 52/127 (40%), Gaps = 3/127 (2%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEI-GNCGSL 88
VF +L + L++S + + L +L+ + GN +I +L
Sbjct: 415 SVFLSLRNL--IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 89 VHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTG 148
++LS L P + + L L+ LN+ +NQL ++ +L+ + L N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532
Query: 149 EIPRLIY 155
PR+ Y
Sbjct: 533 SCPRIDY 539
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-55
Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 48/322 (14%)
Query: 607 TFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELE-- 664
+ +NL ++G G VYK +L RP+AVK N + F E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFA---NRQNFINEKNIY 59
Query: 665 TIGSIRHRNIVSLHGYALSPYGN-----LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLK 719
+ + H NI + LL +Y NGSL L + DW + +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCR 115
Query: 720 IAVGAAQGLAYLHHD------CNPRIIHRDVKSSNILIDENFDAHLSDFGIAR------- 766
+A +GLAYLH + P I HRD+ S N+L+ + +SDFG++
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 767 CIPTAMPHASTFVLGTIGYIDPEYA-------HTSRLNEKSDVYSFGIVLLEILTGKKAV 819
P +A+ +GTI Y+ PE ++ D+Y+ G++ EI +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 820 DNESNLHQLIMSKAD----DNTVMEAVD--------PEVSVTCVDLSAVRKTF-QLALLC 866
++ + M+ T + P+ + S ++ + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 867 TKRYPSERPTMQEVARVLVSLL 888
+ R T Q + L+
Sbjct: 296 WDQDAEARLTAQXAEERMAELM 317
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-54
Identities = 68/287 (23%), Positives = 118/287 (41%), Gaps = 37/287 (12%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHN----LREFETELETIGSIRH 671
L+ + I+G G VY+ A +AVK + + + E + ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYR-AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 672 RNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYL 731
NI++L G L L ++ G L +L G ++ + + AV A+G+ YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYL 121
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAH--------LSDFGIARCIPTAMPHASTFVLGTI 783
H + IIHRD+KSSNILI + + ++DFG+AR ++ G
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAY 178
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN---TVME 840
++ PE S ++ SDV+S+G++L E+LTG+ L + A + +
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-AVAYGVAMNKLALPIPS 237
Query: 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887
+ +L C P RP+ + L ++
Sbjct: 238 TCPEPFA-------------KLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-53
Identities = 69/297 (23%), Positives = 111/297 (37%), Gaps = 37/297 (12%)
Query: 624 VGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G G K + + + +K+L R F E++ + + H N++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 683 SPYGNLLFY-DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIH 741
L F +Y+ G+L ++ S + W R+ A A G+AYLH N IIH
Sbjct: 78 KD-KRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLH-SMN--IIH 131
Query: 742 RDVKSSNILIDENFDAHLSDFGIARCIP-------------TAMPHASTFVLGTIGYIDP 788
RD+ S N L+ EN + ++DFG+AR + V+G ++ P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA---VDPE 845
E + +EK DV+SFGIVL EI+ A + P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPS 251
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAPKP 902
F + + C P +RP+ ++ L +L L L
Sbjct: 252 F-------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLE 295
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-53
Identities = 77/282 (27%), Positives = 130/282 (46%), Gaps = 27/282 (9%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH--NLREFETELETIGSIRHRN 673
++ +G G+ TVYK +AVK L P L+ F+ E+ + RH N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 674 IVSLHGYALSPYGNLLFY---DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
I+ GY+ +P + SL+ LH + + K + + + IA A+G+ Y
Sbjct: 82 ILLFMGYSTAP----QLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDY 135
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI-PTAMPHASTFVLGTIGYIDPE 789
LH IIHRD+KS+NI + E+ + DFG+A + H + G+I ++ PE
Sbjct: 136 LH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 790 ---YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846
++ + +SDVY+FGIVL E++TG+ N +N Q I+ ++ + +V
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMVGRGSLSPDL-SKV 250
Query: 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
C +++ L C K+ ERP+ + + L
Sbjct: 251 RSNC--PKRMKR---LMAECLKKKRDERPSFPRILAEIEELA 287
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 5e-53
Identities = 55/321 (17%), Positives = 106/321 (33%), Gaps = 21/321 (6%)
Query: 180 QLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGN 239
+G +G+ D + D + N Q+ + G
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-NSNNPQI--ETRTGR 66
Query: 240 KLTGKIPEVIGL--MQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPEL 297
L +++ L+L L P LS+ + + L +P +
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLME-LPDTM 123
Query: 298 GNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTA------- 350
+ L L L N L +PA + L +L EL++ +P ++S A
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 351 --LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNN 408
L + + ++P+S NL +L L + + + + + L+ LDL
Sbjct: 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCT 240
Query: 409 FSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQL 468
+ P G L L L LP + L ++ +D+ +P+ + QL
Sbjct: 241 ALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300
Query: 469 QNIISLILNNNNLQGGIPDQL 489
+++ +LQ +
Sbjct: 301 PANCIILV-PPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-51
Identities = 60/366 (16%), Positives = 104/366 (28%), Gaps = 50/366 (13%)
Query: 105 SISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLG 164
E L + + P L+Q D R Q
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIET 62
Query: 165 LRGNALTGML-SPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIP 223
G AL + G ++R L PD + + + I + E+P
Sbjct: 63 RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP 120
Query: 224 YNIGFLQ-VATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKL 282
+ + TL+L N L +P I + L L + + +P L +
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD----- 174
Query: 283 YLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIP 342
E + L L+L+ + ++PA + L+ L L + ++ L
Sbjct: 175 ----------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS---- 219
Query: 343 HNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTL 402
A+ + +L L L+L P G L L
Sbjct: 220 ---------------------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 403 DLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIP 462
L + ++P I L L L+L LP+ L + I + + +
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
Query: 463 AELGQL 468
Sbjct: 319 HRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-49
Identities = 55/340 (16%), Positives = 104/340 (30%), Gaps = 27/340 (7%)
Query: 56 PSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFL 115
+++ FQG+ D + + + + + + +
Sbjct: 6 HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIE 61
Query: 116 NLKNNQLTGPIPSTLTQI--PNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGM 173
L L P L+L L + P + LQ++ + L
Sbjct: 62 TRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME- 118
Query: 174 LSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVAT 233
L M Q GL + N L +P SI + L I E+P +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD--- 174
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI 293
+ L L L + +P + NL L + + L+ +
Sbjct: 175 -----------ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-L 221
Query: 294 PPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQ 353
P + ++ KL L L+ + P G L L L D + +P +I T L +
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281
Query: 354 FNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTEL 393
++ G +PS L + + + + + ++
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 1e-46
Identities = 54/290 (18%), Positives = 100/290 (34%), Gaps = 21/290 (7%)
Query: 233 TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGP 292
L QG+ +V+ Q D + N + G L
Sbjct: 16 NLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALKA- 70
Query: 293 IPPELGN--MSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTA 350
L + L+L++ L P + +L L + + L +P +
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAG 128
Query: 351 LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRII---------NLDT 401
L + N L A+P+S +L L L++ ++P L NL +
Sbjct: 129 LETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
Query: 402 LDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSI 461
L L S+PASI +L++L +L + + L+ L +L ++ +D+ +
Sbjct: 188 LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNY 245
Query: 462 PAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP 511
P G + LIL + + +P + L L++ +P
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 9e-43
Identities = 48/333 (14%), Positives = 112/333 (33%), Gaps = 50/333 (15%)
Query: 22 NSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLR--NLQSIDFQGNKLTGQIP 79
+ + ++++ + + +L + + D +++ + L Q P
Sbjct: 42 DRNRWHSAWRQANSNNPQIETRTGRALK---ATADLLEDATQPGRVALELRSVPLP-QFP 97
Query: 80 DEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTL 139
D+ L H+ + L ++P ++ + LE L L N L +P+++ + L+ L
Sbjct: 98 DQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLREL 155
Query: 140 DLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIP 199
+ E+P + + L L + + ++P
Sbjct: 156 SIRACPELTELPEPLASTDASGEHQ---------------GLVNLQSLRLEWTGIR-SLP 199
Query: 200 DSIGNCTSFEILDISYNQITGEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQALAVL 258
SI N + + L I + ++ + I L ++ L L+G P + G L L
Sbjct: 200 ASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 259 DLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIP 318
L + L +P ++ +++L L L+ + +P
Sbjct: 259 ILK-----------------------DCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 319 AELGKLEQLFELNLADNNLEGPIPHNISSCTAL 351
+ + +L + + + H + A
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 42/276 (15%), Positives = 77/276 (27%), Gaps = 35/276 (12%)
Query: 266 VGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVG---------- 315
+G + S LY G+ P L +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60
Query: 316 ---------TIPAELGKL--EQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGA 364
L L L L P + L + L
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 365 IPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIG------ 418
+P + + L L L+RN + +P + + L L + +P +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 419 ---DLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLI 475
L +L +L L + LPA NL++++++ + + LS ++ + L + L
Sbjct: 178 EHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD 235
Query: 476 LNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP 511
L P L L + + +P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 9e-53
Identities = 87/518 (16%), Positives = 162/518 (31%), Gaps = 59/518 (11%)
Query: 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNC 85
CS+ G NL+ + P L + + N +
Sbjct: 2 CSFDGRIAFYRFC-----NLTQV-------PQ--VLNTTERLLLSFNYIRTVTASSFPFL 47
Query: 86 GSLVHIELSDNSLYGDIPF-SISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARN 144
L +EL I + L L L+L ++++ P + +L L L
Sbjct: 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107
Query: 145 QLTGEI--PRLIYWNEVLQYLGLRGNALTGM-LSPDMCQLTGLWYFDVRGNNLTGTIPDS 201
L+ + + L L L N + + L P +L L D N +
Sbjct: 108 GLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHE 167
Query: 202 IGNCT--SFEILDISYNQITGEIPYNIG-------FLQVATLSLQGNKLTGKIPEV---- 248
+ + ++ N + + + G + + L + GN T I
Sbjct: 168 LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNA 227
Query: 249 --------IGLMQALAVLDLSENELVGPIPPILGNLSYTG--KLYLHGNKLTGPIPPE-L 297
+ L + + + P L+ + L L + +
Sbjct: 228 ISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRVF 286
Query: 298 GNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVH 357
+ L L L N++ L+ L LNL+ N L N + ++
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346
Query: 358 GNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASI 417
N ++ +F+ L L L+L N T + I ++ + LS N ++
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINL 401
Query: 418 GDLEHLLTLNLSRNHLNGLLPAEF-GNLRSIQTIDMSFNQLSG-SIPAELGQLQNIISLI 475
++LS N L L F + +Q + ++ N+ S S + ++ L
Sbjct: 402 T----ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF 457
Query: 476 LNNNNLQGGI-----PDQLSNCFSLSNLNVSYNNLSGI 508
L N LQ D L L +++N L+ +
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSL 495
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-48
Identities = 101/520 (19%), Positives = 188/520 (36%), Gaps = 49/520 (9%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTG-QIPDEIGNCGSL 88
F L + L L+ +L+ L +D N++ + G SL
Sbjct: 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSL 150
Query: 89 VHIELSDNSLYGDIPFSISKLKQ--LEFLNLKNNQLTGPIPSTLTQIPN------LKTLD 140
I+ S N ++ + L+ L F +L N L + + N L+ LD
Sbjct: 151 KSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILD 210
Query: 141 LARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPD 200
++ N T +I G NA++ + + + +N+ +
Sbjct: 211 VSGNGWTVDIT------------GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 201 SIGN--CTSFEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPEVIGLMQALA 256
+ +S LD+S+ + + + + L+L NK+ E + L
Sbjct: 259 TFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317
Query: 257 VLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT 316
VL+LS N L L + L N + + KL L L++N L
Sbjct: 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-- 375
Query: 317 IPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSG-AIPSSFRNLGSL 375
+ + + ++ L+ N L N++ N ++ NRL I + L
Sbjct: 376 ---TIHFIPSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHL 428
Query: 376 TYLNLSRNNFKGKVPTEL-GRIINLDTLDLSVNNFSGSVPASI-----GDLEHLLTLNLS 429
L L++N F + +L+ L L N + + L HL L L+
Sbjct: 429 QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLN 488
Query: 430 RNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQL 489
N+LN L P F +L +++ + ++ N+L+ + N+ L ++ N L PD
Sbjct: 489 HNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDVF 546
Query: 490 SNCFSLSNLNVSYNNLSGIIP--PIRNFSRFSSNSFIGNP 527
+ LS L++++N N+ ++ + G P
Sbjct: 547 VS---LSVLDITHNKFICECELSTFINWLNHTNVTIAGPP 583
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-39
Identities = 81/445 (18%), Positives = 145/445 (32%), Gaps = 59/445 (13%)
Query: 115 LNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGML 174
+ LT +P L + L L+ N + + E LQ L L +
Sbjct: 9 AFYRFCNLTQ-VPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 175 SPDMCQ-LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVAT 233
+ + L L D+ + + PD+ L + + ++
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS-------------D 111
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVG-PIPPILGNLSYTGKLYLHGNKLTGP 292
L+ ++AL LDLS+N++ + P G L+ + N++
Sbjct: 112 AVLKDGYFRN--------LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
Query: 293 IPPELGN--MSKLSYLQLQNNQLVGTIPAELGKLEQLF------ELNLADNNLEGPIPHN 344
EL LS+ L N L + + GK F L+++ N I N
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGN 223
Query: 345 ISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRI--INLDTL 402
S N +S + S + +N K + ++ L
Sbjct: 224 FS------------NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHL 271
Query: 403 DLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIP 462
DLS L+ L LNL+ N +N + F L ++Q +++S+N L
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331
Query: 463 AELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI--IPPIR------- 513
+ L + + L N++ L L++ N L+ I IP I
Sbjct: 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGN 391
Query: 514 NFSRFSSNSFIGNPL-LCGNWIGSI 537
+ N + L N + ++
Sbjct: 392 KLVTLPKINLTANLIHLSENRLENL 416
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-27
Identities = 71/362 (19%), Positives = 131/362 (36%), Gaps = 43/362 (11%)
Query: 29 RGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSL 88
+ F + SV L+LS + S L++L+ ++ NK+ + +L
Sbjct: 257 QNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNL 316
Query: 89 VHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTG 148
+ LS N L + L ++ +++L+ N + T + L+TLDL N LT
Sbjct: 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376
Query: 149 EIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTG-TIPDSIGNCTS 207
I++ + + L GN L + ++ + N L I +
Sbjct: 377 -----IHFIPSIPDIFLSGNKLVTLPKINLTAN----LIHLSENRLENLDILYFLLRVPH 427
Query: 208 FEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVG 267
+IL ++ N+ + + +L L L EN L
Sbjct: 428 LQILILNQNRFS-SCSGDQTP---------------------SENPSLEQLFLGENMLQL 465
Query: 268 PIPP-----ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELG 322
+ LS+ LYL+ N L P +++ L L L +N+L +
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND- 523
Query: 323 KLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIP-SSFRNLGSLTYLNLS 381
L L+++ N L P P S L+ ++ N+ S+F N + T + ++
Sbjct: 524 LPANLEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECELSTFINWLNHTNVTIA 580
Query: 382 RN 383
Sbjct: 581 GP 582
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-50
Identities = 65/463 (14%), Positives = 144/463 (31%), Gaps = 43/463 (9%)
Query: 58 IGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNL 117
+ + + L + + ++ ++LS N L ++ +LE LNL
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 118 KNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPD 177
+N L + L + L+TLDL N + E+ ++ L N ++ +S
Sbjct: 66 SSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVGPS----IETLHAANNNIS-RVSCS 117
Query: 178 MCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQ 237
G + N +T G + + LD+ N+I + +
Sbjct: 118 R--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNF------------- 161
Query: 238 GNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPEL 297
E+ L L+L N + + + + L L NKL + PE
Sbjct: 162 --------AELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEF 210
Query: 298 GNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVH 357
+ + ++++ L+NN+LV I L + L +L N + S V
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVA 268
Query: 358 GNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSV----NNFSGSV 413
+ + T + + R+I L + ++ + + +
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERL 328
Query: 414 PASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIIS 473
+ ++ + ++ ++ T++ L + +
Sbjct: 329 ECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG 388
Query: 474 LILNNNNLQG--GIPDQLSNCFSLSNLNVSYNNLSGIIPPIRN 514
+ ++ S L + Y + ++N
Sbjct: 389 TLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQN 431
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-49
Identities = 70/482 (14%), Positives = 153/482 (31%), Gaps = 47/482 (9%)
Query: 31 VFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVH 90
+ + + + ++ +L ++ N++ +D GN L+ ++ L
Sbjct: 5 IKQNGNRYKI--EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 91 IELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEI 150
+ LS N LY + + L L L+L NN + L P+++TL A N ++ +
Sbjct: 63 LNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RV 114
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTG-TIPDSIGNCTSFE 209
+ + L N +T + D + + Y D++ N + + + + E
Sbjct: 115 SCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 210 ILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPI 269
L++ YN I + + L LDLS N+L +
Sbjct: 173 HLNLQYNFIY------------------------DVKGQVVF-AKLKTLDLSSNKLAF-M 206
Query: 270 PPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLV-GTIPAELGKLEQLF 328
P + + + L NKL I L L + L+ N GT+ K +++
Sbjct: 207 GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV- 264
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLS----RNN 384
+A ++ N CT + L +L + + +
Sbjct: 265 -QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323
Query: 385 FKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNL 444
++ E +D + + + +TL + L+ +
Sbjct: 324 ETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383
Query: 445 RSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNN 504
+ A Q + + + + Q ++ + ++ +
Sbjct: 384 AELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHK 443
Query: 505 LS 506
+
Sbjct: 444 ET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-43
Identities = 59/394 (14%), Positives = 123/394 (31%), Gaps = 19/394 (4%)
Query: 126 IPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLW 185
I K + + L + L ++ L L GN L+ + + D+ T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 186 YFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKI 245
++ N L D + + ++ LD++ N + E+ + TL N ++ ++
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLVGP---SIETLHAANNNIS-RV 114
Query: 246 PEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTG-PIPPELGNMSKLS 304
Q + L+ N++ G S L L N++ + L
Sbjct: 115 SC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 305 YLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGA 364
+L LQ N + + ++ +L L+L+ N L + S + ++ N+L
Sbjct: 173 HLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-L 228
Query: 365 IPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLL 424
I + R +L + +L N F + N ++ + +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 425 TLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS----IPAELGQLQNIISLILNNNN 480
+ L L +++ + + GS + E +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRN 514
+ I + L L + R
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-37
Identities = 46/289 (15%), Positives = 102/289 (35%), Gaps = 38/289 (13%)
Query: 245 IPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLS 304
I E+ + ++++ L + + + +L L GN L+ +L +KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 305 YLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGA 364
L L +N L +L L L L+L +N +
Sbjct: 62 LLNLSSNVL--YETLDLESLSTLRTLDLNNNYV--------------------------- 92
Query: 365 IPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLL 424
S+ L+ + NN +V G+ + L+ N + G +
Sbjct: 93 --QELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQ 147
Query: 425 TLNLSRNHLNGL-LPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG 483
L+L N ++ + + +++ +++ +N + + ++ + +L L++N L
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF 205
Query: 484 GIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGN 532
+ + + ++ +++ N L I +R GN CG
Sbjct: 206 -MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT 253
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-25
Identities = 49/365 (13%), Positives = 116/365 (31%), Gaps = 13/365 (3%)
Query: 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTG-QIPDEIGNCGSLVHIELSDNSLYG 100
++ L++ + G +Q +D + N++ + + +L H+ L N +Y
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 101 DIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVL 160
D+ + +L+ L+L +N+L + + + L N+L I + + +++ L
Sbjct: 183 DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 161 QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQIT- 219
++ LRGN D V + + CT +
Sbjct: 240 EHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED 298
Query: 220 --GEIPYNIGFLQV---ATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILG 274
+ L+ A LS QG++ ++ +D + + I +
Sbjct: 299 LPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQVTL 357
Query: 275 NLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLAD 334
L L + ++L Q + A + +
Sbjct: 358 RKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVK 417
Query: 335 NNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELG 394
E + A+ ++++ ++ + + R +L+ + + +
Sbjct: 418 RYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVV 477
Query: 395 RIINL 399
R NL
Sbjct: 478 REQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-20
Identities = 33/147 (22%), Positives = 60/147 (40%), Gaps = 10/147 (6%)
Query: 364 AIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHL 423
AI +N ++ ++ K + + N+ LDLS N S A + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 424 LTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG 483
LNLS N L L +L +++T+D++ N + EL +I +L NNN+
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 484 GIPDQLSNCFSLSNLNVSYNNLSGIIP 510
+ N+ ++ N ++ +
Sbjct: 114 VSCSRGQG---KKNIYLANNKITMLRD 137
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-50
Identities = 65/302 (21%), Positives = 121/302 (40%), Gaps = 37/302 (12%)
Query: 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREF--ETELETIGSIRHR 672
+++ VG G V++ + + +AVK ++ + + + ETEL +RH
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQG-ENVAVKIFSSR---DEKSWFRETELYNTVMLRHE 62
Query: 673 NIVSLHGYALSPYGNLLFY----DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
NI+ ++ + Y GSL+D L LD + L+I + A GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGL 118
Query: 729 AYLHHD-----CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI---PTAMPHASTFVL 780
A+LH + P I HRD+KS NIL+ +N ++D G+A + + +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 781 GTIGYIDPE------YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL----HQLIM 830
GT Y+ PE ++ D+++FG+VL E+ + + + ++
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 831 SKADDNTVMEAVD-----PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885
+ + + V P + + +L C + PS R T + + L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 886 SL 887
+
Sbjct: 299 KI 300
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-50
Identities = 95/500 (19%), Positives = 191/500 (38%), Gaps = 40/500 (8%)
Query: 34 DNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEI-GNCGSLVHIE 92
+ ++ SL+LS + + NLQ + + +++ I + + GSL H++
Sbjct: 22 SGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLD 80
Query: 93 LSDNSLYGDIPFSISKLKQLEFLNLKNNQLTG-PIPSTLTQIPNLKTLDLARNQLTGEIP 151
LSDN L L L++LNL N + S + NL+TL + + EI
Sbjct: 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140
Query: 152 RLIYWN-EVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEI 210
R+ + L L ++ +L S + + + + + + + +S
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 211 LDISYNQITGEIPYNIGFLQVAT----LSLQGNKLTG-------KIPEVIGLMQALAVLD 259
L++ + + +V++ L+ +G+ LT K+ I + + D
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 260 LSENELVGPIPPILGNLSYTGK--------LYLHGNKLTGPIPPELGNMSKLSYLQLQNN 311
+ N L P +S GK L++ L + + K+ + ++N+
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 312 QLVGTIPAELGK-LEQLFELNLADNNLEGPIPHN---ISSCTALNQFNVHGNRLS--GAI 365
++ +P + L+ L L+L++N + N + +L + N L
Sbjct: 321 KV-FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT 379
Query: 366 PSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLT 425
L +LT L++SRN F +P + L+LS V I + L
Sbjct: 380 GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEV 435
Query: 426 LNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGI 485
L++S N+L+ L +Q + +S N+L ++P ++ + ++ N L+
Sbjct: 436 LDVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVP 489
Query: 486 PDQLSNCFSLSNLNVSYNNL 505
SL + + N
Sbjct: 490 DGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 8e-47
Identities = 84/456 (18%), Positives = 159/456 (34%), Gaps = 43/456 (9%)
Query: 84 NCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLAR 143
+C + + S IP ++ ++ L+L N++T L NL+ L L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 144 NQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ-LTGLWYFDVRGNNLTG-TIPDS 201
+++ Y L++L L N L+ LS L+ L Y ++ GN +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 202 IGNCTSFEILDISYNQITGEIP----YNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAV 257
N T+ + L I + EI + L L ++ L + + ++ +
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLN--ELEIKALSLRNYQSQSLKSIRDIHH 176
Query: 258 LDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI 317
L L +E + LS L L L L S ++ +
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 318 PAELGKLEQLFELNLADNNLE---------GPIPHNISS---------CTALNQFNVHGN 359
+L +L L + +E G + S + + ++
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 360 RLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSV---PAS 416
L + + + L + + + + + + +L+ LDLS N A
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356
Query: 417 IGDLEHLLTLNLSRNHLNGL--LPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISL 474
G L TL LS+NHL + L+++ ++D+S N +P + + L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415
Query: 475 ILNNNNLQGGIPDQLSNCF--SLSNLNVSYNNLSGI 508
L++ ++ + C +L L+VS NNL
Sbjct: 416 NLSSTGIR-----VVKTCIPQTLEVLDVSNNNLDSF 446
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-42
Identities = 79/451 (17%), Positives = 159/451 (35%), Gaps = 51/451 (11%)
Query: 44 NLSSLNLGG------EISPSIGDLRNLQSIDFQGNKLTGQIPDE-IGNCGSLVHIELSDN 96
+L LNL G ++ +L NLQ++ + +I SL +E+
Sbjct: 99 SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158
Query: 97 SLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYW 156
SL S+ ++ + L L ++ + + +++ L+L L +
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218
Query: 157 NEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYN 216
+EV + + + +L L + + + + +CT + D + +
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPS 272
Query: 217 QITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNL 276
+ ++ +G ++ T+ L + + L + + L
Sbjct: 273 ES--DVVSELGKVETVTIR---------------------RLHIPQFYLFYDLSTVYSLL 309
Query: 277 SYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI---PAELGKLEQLFELNLA 333
++ + +K+ ++ L +L L N +V A G L L L+
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 334 DNNLE--GPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPT 391
N+L + + L ++ N +P S + + +LNLS + V T
Sbjct: 370 QNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT 427
Query: 392 ELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTID 451
+ + L+ LD+S NN S L L L +SRN L L A + +
Sbjct: 428 CIPQ--TLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLKTLPDASL--FPVLLVMK 479
Query: 452 MSFNQLSGSIPAELGQLQNIISLILNNNNLQ 482
+S NQL +L ++ + L+ N
Sbjct: 480 ISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-35
Identities = 65/394 (16%), Positives = 125/394 (31%), Gaps = 17/394 (4%)
Query: 134 PNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNN 193
D T IP + ++ L L N +T + D+ L ++ +
Sbjct: 5 DASGVCDGRSRSFT-SIPSGLTAA--MKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 194 LTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFL-QVATLSLQGNKLTG-KIPEVIGL 251
+ D+ + S E LD+S N ++ G L + L+L GN + +
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
Query: 252 MQALAVLDLSENELVGPIPP-ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQN 310
+ L L + E I L+ +L + L L ++ + +L L
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181
Query: 311 NQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFR 370
++ + L + L L D NL + + R S SF
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 371 NLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSR 430
L L L + E D + + + + L++ +
Sbjct: 242 ELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 431 NHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQ-LQNIISLILNNNNLQGGIPDQ- 488
+L L + L ++ I + +++ +P Q L+++ L L+ N +
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
Query: 489 --LSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSS 520
SL L +S N+L + +
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 55/342 (16%), Positives = 98/342 (28%), Gaps = 48/342 (14%)
Query: 204 NCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSEN 263
+C + + D T IP + + +L L NK+T + L VL L +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL-TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 264 ELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVG-TIPAEL 321
+ +L L L N L+ + G +S L YL L N + +
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 322 GKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLS 381
L L L + + I F L SL L +
Sbjct: 120 PNLTNLQTLRIGNVETFSEIR-----------------------RIDFAGLTSLNELEIK 156
Query: 382 RNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEF 441
+ + L I ++ L L ++ + + L + L L +L +
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216
Query: 442 G-----------NLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNL---QGGIPD 487
R D SFN+L + + +L + N L D
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESD 275
Query: 488 QLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLL 529
+S + + + ++ S + +
Sbjct: 276 VVSELGKVETVTIRRLHIPQF-----YLFYDLSTVYSLLEKV 312
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-27
Identities = 64/341 (18%), Positives = 112/341 (32%), Gaps = 48/341 (14%)
Query: 3 IKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLR 62
+ S + V + F + L L LS + +GD
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270
Query: 63 NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQL 122
+S ++ + + L+ D+ S L++++ + ++N+++
Sbjct: 271 PSESDVVSELGKV--------ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 123 TGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEV---LQYLGLRGNALTGM--LSPD 177
S + +L+ LDL+ N + E + LQ L L N L M
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382
Query: 178 MCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQ 237
+ L L D+ N +PDS L++S I +
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT------------- 427
Query: 238 GNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPEL 297
+ Q L VLD+S N L L L +LY+ NKL P+
Sbjct: 428 ------------CIPQTLEVLDVSNNNLDS-FSLFLPRLQ---ELYISRNKLK--TLPDA 469
Query: 298 GNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLADNNL 337
L +++ NQL ++P +L L ++ L N
Sbjct: 470 SLFPVLLVMKISRNQL-KSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 32/156 (20%), Positives = 53/156 (33%), Gaps = 13/156 (8%)
Query: 6 SFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQ 65
L N L D+ + F + LNLSS + + I + L+
Sbjct: 382 ILLTLKN--LTSLDISRNTFHPMPDSCQWPEKMRF--LNLSSTGIR-VVKTCI--PQTLE 434
Query: 66 SIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGP 125
+D N L + L + +S N L +P S L + + NQL
Sbjct: 435 VLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSV 488
Query: 126 IPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQ 161
++ +L+ + L N PR+ Y + L
Sbjct: 489 PDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 524
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-50
Identities = 73/307 (23%), Positives = 117/307 (38%), Gaps = 33/307 (10%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIV 675
+ + +G G V+ + +AVK + ETE+ +RH NI+
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWRG-EKVAVKVFFTTE-EASWFRETEIYQTVLMRHENIL 94
Query: 676 SLHGYALSPYGNLLFY----DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYL 731
+ G+ DY NGSL+D L LD ++ LK+A + GL +L
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHL 150
Query: 732 H-----HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH---ASTFVLGTI 783
H P I HRD+KS NIL+ +N ++D G+A + +GT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 784 GYIDPE------YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL----HQLIMSKA 833
Y+ PE + + +D+YSFG++L E+ + H L+ S
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270
Query: 834 DDNTVMEAVD-----PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ E V P +R+ +L C P+ R T V + L +
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
Query: 889 PAPPAKL 895
+ KL
Sbjct: 331 ESQDIKL 337
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 60/305 (19%), Positives = 110/305 (36%), Gaps = 47/305 (15%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH--NLREFETELETIGSIRHRN 673
E L ++G G VY +A++ + + + L+ F+ E+ RH N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 674 IVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH 732
+V G +SP +L + +L+ ++ K+ LD +IA +G+ YLH
Sbjct: 91 VVLFMGACMSP-PHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR----CIPTAMPHASTFVLGTIGYIDP 788
I+H+D+KS N+ D ++DFG+ G + ++ P
Sbjct: 148 ---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 789 E---------YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM 839
E ++ SDV++ G + E+ + + I+ +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--IIWQMGTGMKP 261
Query: 840 E----AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKL 895
+ E+S + L C ERPT ++ +L L P
Sbjct: 262 NLSQIGMGKEIS-------------DILLFCWAFEQEERPTFTKLMDMLEKL---PKRNR 305
Query: 896 SLAAP 900
L+ P
Sbjct: 306 RLSHP 310
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 3e-48
Identities = 84/376 (22%), Positives = 129/376 (34%), Gaps = 47/376 (12%)
Query: 33 CDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIE 92
C N+ +V LN+ L + + ++ ++ N LT +P L +E
Sbjct: 37 CLNNGNAV--LNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPE---LRTLE 87
Query: 93 LSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPR 152
+S N L +P L +L + L L L + NQLT +P
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPV 138
Query: 153 LIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILD 212
L LQ L + N L L +L LW N LT ++P L
Sbjct: 139 LP---PGLQELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSGLQE---LS 187
Query: 213 ISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPI 272
+S NQ+ +P L L N+LT +P + L L +S N L +P +
Sbjct: 188 VSDNQLA-SLPTLPSELY--KLWAYNNRLT-SLPALPS---GLKELIVSGNRLTS-LPVL 239
Query: 273 LGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNL 332
L +L + GN+LT +P L L + NQL +P L L +NL
Sbjct: 240 PSELK---ELMVSGNRLTS-LPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNL 291
Query: 333 ADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTE 392
N L + T+ ++ R A S+ R +L + + E
Sbjct: 292 EGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH--LAAADWLVPAREGE 349
Query: 393 LGRIINLDTLDLSVNN 408
N
Sbjct: 350 PAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 6e-46
Identities = 78/327 (23%), Positives = 130/327 (39%), Gaps = 46/327 (14%)
Query: 179 CQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQG 238
C G +V + LT T+PD + L I N +T +P L+ TL + G
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELR--TLEVSG 90
Query: 239 NKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELG 298
N+LT +P + + L++ L P + L KL++ GN+LT +P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLC---KLWIFGNQLTS-LPVLPP 141
Query: 299 NMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHG 358
L L + +NQL ++PA +L +L +N L +P S L + +V
Sbjct: 142 G---LQELSVSDNQL-ASLPALPSELC---KLWAYNNQLTS-LPMLPSG---LQELSVSD 190
Query: 359 NRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIG 418
N+L+ ++P+ L L N +P L L +S N + S+P
Sbjct: 191 NQLA-SLPTL---PSELYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLT-SLPVLPS 241
Query: 419 DLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNN 478
+L+ L +S N L L P L S+ + NQL+ +P L L + ++ L
Sbjct: 242 ELKEL---MVSGNRLTSL-PMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 479 NNLQGGIPDQLSNCFSLSNLNVSYNNL 505
N L +++ +
Sbjct: 294 NPLSERTL---QALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-43
Identities = 75/364 (20%), Positives = 132/364 (36%), Gaps = 45/364 (12%)
Query: 135 NLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNL 194
L++ + LT +P + + + L + N LT L +L L +V GN L
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLTS-LPALPPELRTL---EVSGNQL 93
Query: 195 TGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQA 254
T ++P I + + L + GN+LT +P +
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALPS------GLCKLWIFGNQLT-SLPVLPP---G 142
Query: 255 LAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLV 314
L L +S+N+L +P + L KL+ + N+LT +P L L + +NQL
Sbjct: 143 LQELSVSDNQLAS-LPALPSELC---KLWAYNNQLTS-LPMLPSG---LQELSVSDNQLA 194
Query: 315 GTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGS 374
++P +L +L+ N N L +P S L V GNRL+ ++P
Sbjct: 195 -SLPTLPSELYKLWAYN---NRLT-SLPALPSGLKELI---VSGNRLT-SLPVL---PSE 242
Query: 375 LTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLN 434
L L +S N +P L +L + N + +P S+ L T+NL N L+
Sbjct: 243 LKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 435 GLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFS 494
+ S + + + + + + + L + +
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHL--AAADWLVPAREGEPAPADR 355
Query: 495 LSNL 498
Sbjct: 356 WHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-32
Identities = 60/254 (23%), Positives = 90/254 (35%), Gaps = 37/254 (14%)
Query: 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340
L + + LT +P L ++ L + +N L ++PA +L L ++ N L
Sbjct: 44 VLNVGESGLTT-LPDCLPA--HITTLVIPDNNLT-SLPALPPELR---TLEVSGNQLTS- 95
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
+P L+ F+ L L L + N +P L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPVLPP---GLQ 144
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460
L +S N + S+PA +L L N L L P L Q + +S NQL+ S
Sbjct: 145 ELSVSDNQLA-SLPALPSELCKL---WAYNNQLTSL-PMLPSGL---QELSVSDNQLA-S 195
Query: 461 IPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSR--F 518
+P +L L NN L +P S L L VS N L+ +
Sbjct: 196 LPTLPSELYK---LWAYNNRLTS-LPALPSG---LKELIVSGNRLTSLPVLPSELKELMV 248
Query: 519 SSNSFIGNPLLCGN 532
S N P+L
Sbjct: 249 SGNRLTSLPMLPSG 262
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 23/113 (20%), Positives = 39/113 (34%), Gaps = 9/113 (7%)
Query: 420 LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNN 479
LN+ + L L P I T+ + N L+ S+PA +L+ L ++ N
Sbjct: 39 NNGNAVLNVGESGLTTL-PDCLPA--HITTLVIPDNNLT-SLPALPPELRT---LEVSGN 91
Query: 480 NLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGN 532
L +P LS + +L + + N P+L
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLW-IFGNQLTSLPVLPPG 142
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-48
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 37/295 (12%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELE--TIGSIRHRNIVSLHGY 680
+G G V++ + +AVK ++ R + E E +RH NI+
Sbjct: 49 SIGKGRFGEVWRGKWRG-EEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 681 ALSPYGNLLFY----DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD-- 734
G DY +GSL+D L+ + + E +K+A+ A GLA+LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 735 ---CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH---ASTFVLGTIGYIDP 788
P I HRD+KS NIL+ +N ++D G+A +A A +GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 789 E------YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQ----LIMSKADDNTV 838
E +++D+Y+ G+V EI + L+ S +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 839 MEAVD-----PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ V P + A+R ++ C + R T + + L L
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-42
Identities = 80/449 (17%), Positives = 151/449 (33%), Gaps = 75/449 (16%)
Query: 25 FCSWRGVFCDNSSLSVV----SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPD 80
C +S+L +++ L N + + F+ + + ++P
Sbjct: 4 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPA 62
Query: 81 EI-GNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTL 139
+ + + + L+D + ++ + ++ L + N + P +P L L
Sbjct: 63 ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122
Query: 140 DLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIP 199
L RN L+ +PR I+ N L + NNL
Sbjct: 123 VLERNDLS-SLPRGIFHN-----------------------TPKLTTLSMSNNNLERIED 158
Query: 200 DSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLD 259
D+ TS + L +S N++T + + + ++ N L+ + + A+ LD
Sbjct: 159 DTFQATTSLQNLQLSSNRLT-HVDLS-LIPSLFHANVSYNLLS-----TLAIPIAVEELD 211
Query: 260 LSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPA 319
S N + P+ L+ L L N LT L N L + L N+L I
Sbjct: 212 ASHNSINVVRGPVNVELTI---LKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMY 265
Query: 320 E-LGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYL 378
K+++L L +++N L A+ + + +L L
Sbjct: 266 HPFVKMQRLERLYISNNRLV-------------------------ALNLYGQPIPTLKVL 300
Query: 379 NLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLP 438
+LS N+ V + L+ L L N+ ++ S L L LS N +
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSL 356
Query: 439 AEFGNLRSIQTIDMSFNQLSGSIPAELGQ 467
R++ + I +L
Sbjct: 357 RAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-42
Identities = 74/384 (19%), Positives = 135/384 (35%), Gaps = 24/384 (6%)
Query: 150 IPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFE 209
I + ++ V + + + L + + + + + E
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 210 ILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVG 267
+L+++ QI EI + L + N + P V + L VL L N+L
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 268 PIPPILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAELGKLEQ 326
I N L + N L I + + L LQL +N+L + L +
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPS 187
Query: 327 LFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFK 386
LF N++ N L ++ A+ + + N ++ L T L L NN
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVEL---TILKLQHNNLT 239
Query: 387 GKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRS 446
L L +DLS N + ++ L L +S N L L + +
Sbjct: 240 D--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPT 296
Query: 447 IQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLS 506
++ +D+S N L + Q + +L L++N++ + LS +L NL +S+N+
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
Query: 507 GIIPPIRNFSRFSSNSFIGNPLLC 530
F + + C
Sbjct: 353 C-NSLRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 54/299 (18%), Positives = 104/299 (34%), Gaps = 24/299 (8%)
Query: 214 SYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPP-I 272
Y I + Y+ F V + +Q + ++ + ++ + + +P +
Sbjct: 9 EYKCIDSNLQYDCVFYDV-HIDMQTQDVYFGFEDIT--LNNQKIVTFKNSTMRK-LPAAL 64
Query: 273 LGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFEL 330
L + L L+ ++ I + L + N + +P + L L
Sbjct: 65 LDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL 122
Query: 331 NLADNNLEGPIPHNI-SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKV 389
L N+L +P I + L ++ N L +F+ SL L LS N V
Sbjct: 123 VLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HV 180
Query: 390 PTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQT 449
L I +L ++S N S ++ + L+ S N +N + L
Sbjct: 181 D--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVEL---TI 230
Query: 450 IDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508
+ + N L+ L ++ + L+ N L+ + L L +S N L +
Sbjct: 231 LKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL 287
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-21
Identities = 39/210 (18%), Positives = 71/210 (33%), Gaps = 5/210 (2%)
Query: 305 YLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGA 364
Y I + L +++++ + + + +
Sbjct: 1 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 60
Query: 365 IPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLL 424
+ + + LNL+ + + L + N P ++ L
Sbjct: 61 PAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 120
Query: 425 TLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQ-LQNIISLILNNNNLQG 483
L L RN L+ L F N + T+ MS N L I + Q ++ +L L++N L
Sbjct: 121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH 179
Query: 484 GIPDQLSNCFSLSNLNVSYNNLSGIIPPIR 513
+ + L + NVSYN LS + PI
Sbjct: 180 VDLSLIPS---LFHANVSYNLLSTLAIPIA 206
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 51/305 (16%), Positives = 106/305 (34%), Gaps = 17/305 (5%)
Query: 198 IPDSIGNCTSFEILDISYNQITGEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQALA 256
I + N ++I ++ + + + V L L GN L+ + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 257 VLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT 316
+L+LS N L + +LS L L+ N + EL + L NN +
Sbjct: 62 LLNLSSNVLYE-TLDL-ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SR 113
Query: 317 IPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSG-AIPSSFRNLGSL 375
+ + + LA+N + + + + ++ N + + +L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 376 TYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNG 435
+LNL N V ++ L TLDLS N + + + ++L N L
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228
Query: 436 LLPAEFGNLRSIQTIDMSFNQLS-GSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFS 494
+ ++++ D+ N G++ + Q + ++ G ++ +
Sbjct: 229 I-EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 495 LSNLN 499
L +
Sbjct: 288 LGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 50/269 (18%), Positives = 97/269 (36%), Gaps = 15/269 (5%)
Query: 245 IPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLS 304
I E+ + ++++ L + + + +L L GN L+ +L +KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 305 YLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGA 364
L L +N L +L L L L+L +N ++ + ++ + N +S
Sbjct: 62 LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV 114
Query: 365 IPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG-SVPASIGDLEHL 423
S + + L+ N + G + LDL +N + + L
Sbjct: 115 SCSRGQGK---KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 424 LTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG 483
LNL N + + ++T+D+S N+L+ + E + + L NN L
Sbjct: 172 EHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228
Query: 484 GIPDQLSNCFSLSNLNVSYNNLSGIIPPI 512
I L +L + ++ N
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGFHCGTLRD 256
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 61/360 (16%), Positives = 117/360 (32%), Gaps = 48/360 (13%)
Query: 54 ISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLE 113
I + + + L + + ++ ++LS N L ++ +LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 114 FLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGM 173
LNL +N L + L + L+TLDL N + E+ ++ L N ++
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVGPS----IETLHAANNNIS-R 113
Query: 174 LSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVAT 233
+S G + N +T G + + LD+ N+I + +
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNF--------- 161
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI 293
E+ L L+L N + + + + L L NKL +
Sbjct: 162 ------------AELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAF-M 206
Query: 294 PPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQ 353
PE + + ++++ L+NN+LV I L + L +L N C L
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF---------HCGTLRD 256
Query: 354 FNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNF---KGKVPTELGRIINLDTLDLSVNNFS 410
F R+ + + L + +L + L ++
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-41
Identities = 56/303 (18%), Positives = 112/303 (36%), Gaps = 17/303 (5%)
Query: 31 VFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVH 90
+ + + + ++ +L ++ N++ +D GN L+ ++ L
Sbjct: 5 IKQNGNRYKI--EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 91 IELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEI 150
+ LS N LY + + L L L+L NN + L P+++TL A N ++ +
Sbjct: 63 LNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RV 114
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTG-TIPDSIGNCTSFE 209
+ + L N +T + D + + Y D++ N + + + + E
Sbjct: 115 SCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 210 ILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPI 269
L++ YN I ++ + F ++ TL L NKL + + + L N+LV I
Sbjct: 173 HLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-I 229
Query: 270 PPILGNLSYTGKLYLHGNKLT-GPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLF 328
L L GN G + ++ + Q + + E + L
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
Query: 329 ELN 331
Sbjct: 290 HYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 43/226 (19%), Positives = 87/226 (38%), Gaps = 13/226 (5%)
Query: 293 IPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALN 352
I N ++ ++ ++ L + + + EL+L+ N L +++ T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 353 QFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGS 412
N+ N L +L +L L+L+ N EL +++TL + NN S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 413 VPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG-SIPAELGQLQNI 471
V S + + L+ N + L + G +Q +D+ N++ + +
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 472 ISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSR 517
L L N + + L L++S N L+ + P ++ +
Sbjct: 172 EHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAG 215
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 33/147 (22%), Positives = 60/147 (40%), Gaps = 10/147 (6%)
Query: 364 AIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHL 423
AI +N ++ ++ K + + N+ LDLS N S A + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 424 LTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG 483
LNLS N L L +L +++T+D++ N + EL +I +L NNN+
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 484 GIPDQLSNCFSLSNLNVSYNNLSGIIP 510
+ N+ ++ N ++ +
Sbjct: 114 VSCSRGQG---KKNIYLANNKITMLRD 137
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 90/489 (18%), Positives = 162/489 (33%), Gaps = 67/489 (13%)
Query: 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGD 101
S ++ + + S L L S+D + +T I L + + N++
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI-TT 78
Query: 102 IPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQ 161
+ S+ L +L +N+LT + +T + L L+ N+LT ++ + N +L
Sbjct: 79 LDL--SQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLT 130
Query: 162 YLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGE 221
YL N LT D+ T L D N + + T LD S+N+IT
Sbjct: 131 YLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL 185
Query: 222 IPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGK 281
L L+ N +T K+ + L LD S N+L I + L+
Sbjct: 186 DVSQNKLLN--RLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTY 237
Query: 282 LYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPI 341
N LT + + +SKL+ L L+ I L QL +
Sbjct: 238 FDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL 291
Query: 342 PHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDT 401
+++ T L + ++ L YL L+ L
Sbjct: 292 --DVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNT--------------ELTE 332
Query: 402 LDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSI 461
LD+S L +L+ H+ + G + ++ + Q
Sbjct: 333 LDVS-------------HNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMP 377
Query: 462 PAELGQLQNIISLILNNNNLQG---GIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRF 518
L I++ + + G I + + +++ NLS P +
Sbjct: 378 KETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTS 437
Query: 519 SSNSFIGNP 527
+ + +G
Sbjct: 438 ENGAIVGTV 446
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-39
Identities = 66/406 (16%), Positives = 131/406 (32%), Gaps = 43/406 (10%)
Query: 107 SKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLR 166
+ + Q+ L +LD + +T ++ + L L
Sbjct: 18 DNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTGIEKLTG-LTKLICT 72
Query: 167 GNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI 226
N +T + D+ Q T L Y N LT + + T L+ N++T
Sbjct: 73 SNNIT---TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQN 126
Query: 227 GFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHG 286
L L+ N LT +I + L LD N+ + + + + L
Sbjct: 127 PLLT--YLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 287 NKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNIS 346
NK+T ++ L+ L N + + L + QL L+ + N L +++
Sbjct: 180 NKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---IDVT 230
Query: 347 SCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSV 406
T L F+ N L+ + S L LT L+ + + E+ N +
Sbjct: 231 PLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDL-----LEIDLTHNTQLIYFQA 282
Query: 407 NNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELG 466
+ L L+ + L + + + ++ +L+ + +
Sbjct: 283 EGCRKIKELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VS 336
Query: 467 QLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPI 512
+ SL N ++Q + +L+N + +
Sbjct: 337 HNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKET 380
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 157 bits (397), Expect = 3e-40
Identities = 85/487 (17%), Positives = 164/487 (33%), Gaps = 34/487 (6%)
Query: 21 HNSDFCSWRGVFCDNSSLSVV----SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTG 76
+ C +S+L +++ L N + + F+ + +
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR- 64
Query: 77 QIPDEI-GNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPN 135
++P + + + + L+D + ++ + ++ L + N + P +P
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124
Query: 136 LKTLDLARNQLTGEIPRLIYWN-EVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNL 194
L L L RN L+ +PR I+ N L L + N L + T L + N L
Sbjct: 125 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 183
Query: 195 TGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQA 254
T + S ++SYN ++ + I ++ L N + + +
Sbjct: 184 T-HVDL--SLIPSLFHANVSYNLLS-TLAIPI-AVE--ELDASHNSIN-VVRG--PVNVE 233
Query: 255 LAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQL 313
L +L L N L L N ++ L N+L I M +L L + NN+L
Sbjct: 234 LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRL 290
Query: 314 VGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLG 373
V + + L L+L+ N+L + N L + N + +
Sbjct: 291 V-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHH 345
Query: 374 SLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHL 433
+L L LS N++ L R N+ + + + LEH L S
Sbjct: 346 TLKNLTLSHNDWDCNSLRALFR--NVARPAVDDADQHCKIDYQ---LEHGLCCKESDKPY 400
Query: 434 NGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCF 493
L ++ + + + S + +Q++ I + +QL
Sbjct: 401 LDRLLQYIALTSVVEKVQRAQGRCSA--TDTINSVQSLSHYITQQGGVPLQGNEQLEAEV 458
Query: 494 SLSNLNV 500
+ V
Sbjct: 459 NELRAEV 465
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-33
Identities = 65/315 (20%), Positives = 135/315 (42%), Gaps = 25/315 (7%)
Query: 210 ILDISYNQITGEIPYNIGFLQVA---TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELV 266
D+ + T ++ + + + ++ + + + ++ + + +L+L++ ++
Sbjct: 29 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 88
Query: 267 GPIPPILGNLSYTGKLYLHGNKLTGPIPPEL-GNMSKLSYLQLQNNQLVGTIPAEL-GKL 324
KLY+ N + +PP + N+ L+ L L+ N L ++P +
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 146
Query: 325 EQLFELNLADNNLEGPIPHNI-SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383
+L L++++NNLE I + + T+L + NRL+ + + SL + N+S N
Sbjct: 147 PKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 202
Query: 384 NFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGN 443
+ L I ++ LD S N+ + V + L L L N+L A N
Sbjct: 203 LL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLN 252
Query: 444 LRSIQTIDMSFNQLSGSIPAE-LGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSY 502
+ +D+S+N+L I ++Q + L ++NN L + +L L++S+
Sbjct: 253 YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSH 310
Query: 503 NNLSGIIPPIRNFSR 517
N+L + F R
Sbjct: 311 NHLLHVERNQPQFDR 325
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 52/303 (17%), Positives = 103/303 (33%), Gaps = 22/303 (7%)
Query: 218 ITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLS 277
I + Y+ F V + +Q + ++ + ++ + + +L +
Sbjct: 19 IDSNLQYDCVFYDV-HIDMQTQDVYFGFEDIT--LNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 278 YTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADN 335
L L+ ++ I + L + N + +P + + L L L N
Sbjct: 76 QVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN 133
Query: 336 NLEGPIPHNI-SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELG 394
+L +P I + L ++ N L +F+ SL L LS N V L
Sbjct: 134 DLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LS 189
Query: 395 RIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSF 454
I +L ++S N S ++ + L+ S N +N + L + +
Sbjct: 190 LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVEL---TILKLQH 241
Query: 455 NQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRN 514
N L+ L ++ + L+ N L+ + L L +S N L + +
Sbjct: 242 NNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQP 299
Query: 515 FSR 517
Sbjct: 300 IPT 302
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 4e-21
Identities = 39/214 (18%), Positives = 72/214 (33%), Gaps = 5/214 (2%)
Query: 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360
+ Y I + L +++++ + + +
Sbjct: 3 GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62
Query: 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420
+ + + + LNL+ + + L + N P ++
Sbjct: 63 MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQ-LQNIISLILNNN 479
L L L RN L+ L F N + T+ MS N L I + Q ++ +L L++N
Sbjct: 123 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSN 181
Query: 480 NLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIR 513
L + + L + NVSYN LS + PI
Sbjct: 182 RLTHVDLSLIPS---LFHANVSYNLLSTLAIPIA 212
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 3e-17
Identities = 35/191 (18%), Positives = 68/191 (35%), Gaps = 8/191 (4%)
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFR--NLGSLTYLNLSRNNFKGKVPTELGRIIN 398
I N+ +VH + + + F L + + + + L
Sbjct: 19 IDSNLQYDCVFY--DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 399 LDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS 458
++ L+L+ + + L + N + L P F N+ + + + N LS
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 459 GSIPAEL-GQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSR 517
S+P + + +L ++NNNL+ D SL NL +S N L+ + +
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV--DLSLIPS 193
Query: 518 FSSNSFIGNPL 528
+ N L
Sbjct: 194 LFHANVSYNLL 204
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 2e-39
Identities = 84/495 (16%), Positives = 161/495 (32%), Gaps = 39/495 (7%)
Query: 31 VFCDNSSLSVV---------SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDE 81
V + L V LN+S + + I L L+ + N++
Sbjct: 5 VDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64
Query: 82 IGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTG-PIPSTLTQIPNLKTLD 140
L +++LS N L I L+ L+L N PI + LK L
Sbjct: 65 FKFNQELEYLDLSHNKL-VKISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121
Query: 141 LARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPD 200
L+ L I + + L + G P+ L + T
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE--GLQDFNTESLHIVFPTNKEFH 179
Query: 201 SIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDL 260
I + + + ++ + I + N + + L L ++
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFL-------SILAKLQTNPKLSNLTLNNIET 232
Query: 261 SENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMS-----KLSYLQLQNNQLVG 315
+ N + + + + + KL G + + S LS Q+ ++
Sbjct: 233 TWNSFIRILQLV--WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 316 TIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSL 375
+ N + S + + N L+ + + +L L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 376 TYLNLSRNNFKGKVPTELG---RIINLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRN 431
L L N K ++ ++ +L LD+S N+ S + LL+LN+S N
Sbjct: 351 ETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN 409
Query: 432 HLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQ-LS 490
L + I+ +D+ N++ SIP ++ +L+ + L + +N L+ +PD
Sbjct: 410 ILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFD 465
Query: 491 NCFSLSNLNVSYNNL 505
SL + + N
Sbjct: 466 RLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-39
Identities = 93/492 (18%), Positives = 176/492 (35%), Gaps = 40/492 (8%)
Query: 66 SIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGP 125
+D N L +P ++ + +S N + I L +L L + +N++
Sbjct: 4 LVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 126 IPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGM-LSPDMCQLTGL 184
S L+ LDL+ N+L +I + L++L L NA + + + ++ L
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 185 WYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGK 244
+ + +L + I + ++L + + G T SL T K
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE-GLQDFNTESLHIVFPTNK 176
Query: 245 IPEVIGLMQALAVLDLSENELVG-----------PIPPILGNLSYTGKLYLHGNKLTGPI 293
I + V +L + + I L L L+ + T
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 294 PPELGNM---SKLSYLQLQNNQLVGTIPAELG-----KLEQLFELNLADNNLEGPIPHNI 345
+ + + + Y + N +L G + L+ L + + P +
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 346 SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLS 405
+ +N N + + +L+ S N V G + L+TL L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 406 VNNFSGSVPASIG---DLEHLLTLNLSRNHLNGLLPAE-FGNLRSIQTIDMSFNQLSGSI 461
+N + ++ L L++S+N ++ +S+ +++MS N L+ +I
Sbjct: 357 MNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415
Query: 462 PAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSN 521
L I L L++N ++ IP Q+ +L LNV+ N L + P F R +S
Sbjct: 416 FRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSV--PDGIFDRLTSL 470
Query: 522 SFI---GNPLLC 530
I NP C
Sbjct: 471 QKIWLHTNPWDC 482
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-35
Identities = 88/433 (20%), Positives = 139/433 (32%), Gaps = 20/433 (4%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPD--EIGNCGS 87
VF N L L+LS L S NL+ +D N +P E GN
Sbjct: 63 SVFKFNQELEY--LDLSHNKLV---KISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQ 116
Query: 88 LVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLT 147
L + LS L I+ L + L + + + T L T
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPT 174
Query: 148 GEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTS 207
+ I V L + + +L + C ++ N + + T
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234
Query: 208 FEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVG 267
+ I + Y ++ + LQG ++AL++ + +
Sbjct: 235 NSFIRILQLVWHTTVWY----FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 268 PIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQL 327
P I S + +S +L NN L T+ G L +L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 328 FELNLADNNLE--GPIPHNISSCTALNQFNVHGNRLSGAIPS-SFRNLGSLTYLNLSRNN 384
L L N L+ I + +L Q ++ N +S SL LN+S N
Sbjct: 351 ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410
Query: 385 FKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNL 444
+ L + LDL N S+P + LE L LN++ N L + F L
Sbjct: 411 LTDTIFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467
Query: 445 RSIQTIDMSFNQL 457
S+Q I + N
Sbjct: 468 TSLQKIWLHTNPW 480
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-38
Identities = 68/328 (20%), Positives = 124/328 (37%), Gaps = 15/328 (4%)
Query: 210 ILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPI 269
+ + +P I + L L N++ + L L+L+EN + +
Sbjct: 15 AVLCHRKRFV-AVPEGI-PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA-V 71
Query: 270 PP-ILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQ 326
P NL L L N+L IP +S L+ L + N++V + + L
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYN 129
Query: 327 LFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFK 386
L L + DN+L S +L Q + L+ + +L L L L N
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189
Query: 387 GKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRS 446
R+ L L++S + ++ + +L +L+++ +L + +L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249
Query: 447 IQTIDMSFNQLSGSIPAE-LGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNL 505
++ +++S+N +S +I L +L + + L L P L LNVS N L
Sbjct: 250 LRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL 308
Query: 506 SGIIPPIRNFSRFSSNSFI---GNPLLC 530
+ + F + + NPL C
Sbjct: 309 TTL--EESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-34
Identities = 75/367 (20%), Positives = 127/367 (34%), Gaps = 50/367 (13%)
Query: 26 CSWRG--VFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIG 83
CS + V C V + + + +D N++ DE
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPT---------------ETRLLDLGKNRIKTLNQDEFA 53
Query: 84 NCGSLVHIELSDNSLYGDI-PFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLA 142
+ L +EL++N + + P + + L L L L++N+L T + NL LD++
Sbjct: 54 SFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS 112
Query: 143 RNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSI 202
N++ L L L +V N+L +
Sbjct: 113 ENKIV----------------ILLDYMFQD--------LYNLKSLEVGDNDLVYISHRAF 148
Query: 203 GNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDL 260
S E L + +T IP + L L+ + + L VL++
Sbjct: 149 SGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEI 207
Query: 261 SENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPA 319
S + + P L + LT +P + ++ L +L L N + TI
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPIS-TIEG 265
Query: 320 E-LGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYL 378
L +L +L E+ L L P+ L NV GN+L+ S F ++G+L L
Sbjct: 266 SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETL 325
Query: 379 NLSRNNF 385
L N
Sbjct: 326 ILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 66/374 (17%), Positives = 119/374 (31%), Gaps = 60/374 (16%)
Query: 90 HIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGE 149
+ +P I + L+L N++ P+L+ L+L N ++
Sbjct: 15 AVLCHRKRF-VAVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-A 70
Query: 150 IPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFE 209
+ A L L +R N L ++
Sbjct: 71 VEP---------------GAFNN--------LFNLRTLGLRSNRLKLIPLGVFTGLSNLT 107
Query: 210 ILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPE-VIGLMQALAVLDLSENELV 266
LDIS N+I + + + +L + N L I + +L L L + L
Sbjct: 108 KLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT 165
Query: 267 GPIPP-ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLE 325
IP L +L L L + + +L L++ + + T+
Sbjct: 166 S-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224
Query: 326 QLFELNLADNNLEGPIPHN-ISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNN 384
L L++ NL +P+ + L N+ N +S S L L + L
Sbjct: 225 NLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283
Query: 385 FKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNL 444
+ F G L +L LN+S N L L + F ++
Sbjct: 284 LA----------------VVEPYAFRG--------LNYLRVLNVSGNQLTTLEESVFHSV 319
Query: 445 RSIQTIDMSFNQLS 458
+++T+ + N L+
Sbjct: 320 GNLETLILDSNPLA 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 61/268 (22%), Positives = 107/268 (39%), Gaps = 32/268 (11%)
Query: 623 IVGYGASSTVYKCA-LKNSRPIAVK--KLYNQYPHNLREFETELETIGSIRHRNIVSLHG 679
+G G+ TVYK + + +A + + F+ E E + ++H NIV +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 680 YALSPY---GNLLFY-DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
S ++ + M +G+L L + + + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 736 NPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
P IIHRD+K NI I + D G+A + A V+GT ++ PE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMY-EE 204
Query: 795 RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL---IMSKADDNTVMEAVDPEVSVTCV 851
+ +E DVY+FG+ +LE+ T + N Q+ + S + + PEV
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV----- 259
Query: 852 DLSAVRKTFQLALLCTKRYPSERPTMQE 879
K C ++ ER ++++
Sbjct: 260 ------KEI--IEGCIRQNKDERYSIKD 279
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-36
Identities = 73/409 (17%), Positives = 133/409 (32%), Gaps = 81/409 (19%)
Query: 35 NSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELS 94
N SLS S + + + N+ + +
Sbjct: 10 NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE-------------- 55
Query: 95 DNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLI 154
+ Q L L L+ +P L P + L++ +N L +P L
Sbjct: 56 ------------CLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLPELP 99
Query: 155 YWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDIS 214
L L D N L+ T+P+ + LD+
Sbjct: 100 ------------------------ASLEYL---DACDNRLS-TLPELPASLKH---LDVD 128
Query: 215 YNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILG 274
NQ+T +P L+ ++ N+LT +PE L +L VL + N+L +P +
Sbjct: 129 NNQLT-MLPELPALLE--YINADNNQLT-MLPE---LPTSLEVLSVRNNQLTF-LPELPE 180
Query: 275 NLSYTGKLYLHGNKLTGPIPPELGNMSKLS----YLQLQNNQLVGTIPAELGKLEQLFEL 330
+L L + N L +P + + + N++ IP + L+ +
Sbjct: 181 SLE---ALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTI 235
Query: 331 NLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP 390
L DN L I ++S T Q + HG R+ ++ +N + F
Sbjct: 236 ILEDNPLSSRIRESLSQQT--AQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQ 293
Query: 391 TELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPA 439
+++ +I + + N FS + + D + R + L
Sbjct: 294 SDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQVAAWLEK 341
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-34
Identities = 73/393 (18%), Positives = 126/393 (32%), Gaps = 52/393 (13%)
Query: 42 SLNLSSLNLGGEIS-PSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYG 100
L N +S + + L+ +PD + + +E++ N+L
Sbjct: 38 KQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNAL-I 93
Query: 101 DIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVL 160
+P + LE+L+ +N+L+ +P +LK LD+ NQLT +P L +L
Sbjct: 94 SLPELPA---SLEYLDACDNRLST-LPE---LPASLKHLDVDNNQLT-MLPELP---ALL 142
Query: 161 QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITG 220
+Y+ N LT ML L L VR N LT +P+ + E LD+S N +
Sbjct: 143 EYINADNNQLT-MLPELPTSLEVL---SVRNNQLT-FLPELPESL---EALDVSTNLLE- 193
Query: 221 EIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTG 280
+P + EN + IP + +L T
Sbjct: 194 SLPAVPVRNH-------------------HSEETEIFFRCRENRITH-IPENILSLDPTC 233
Query: 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340
+ L N L+ I L + ++ +
Sbjct: 234 TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFPEN 291
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
++S + H N S + L + + F+ +V L ++
Sbjct: 292 KQSDVSQIWHAFEHEEHANTFS----AFLDRLSDTVSAR-NTSGFREQVAAWLEKLSASA 346
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHL 433
L + S D L NL + L
Sbjct: 347 ELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 60/287 (20%), Positives = 105/287 (36%), Gaps = 36/287 (12%)
Query: 239 NKLTGKIPEVIGLMQALAVLDLSE---NELVGPIPPI-LGNLSYTGKLYLHGNKLTGPIP 294
N ++G + L NE V + + S +L L+ L+ +P
Sbjct: 20 NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFS---ELQLNRLNLSS-LP 75
Query: 295 PELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQF 354
L +++ L++ N L+ ++P LE L+ DN L +P +S L+
Sbjct: 76 DNLP--PQITVLEITQNALI-SLPELPASLE---YLDACDNRLST-LPELPASLKHLD-- 126
Query: 355 NVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVP 414
V N+L+ +P L Y+N N +P +L+ L + N + +P
Sbjct: 127 -VDNNQLT-MLPEL---PALLEYINADNNQLT-MLPELPT---SLEVLSVRNNQLT-FLP 176
Query: 415 ASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQT----IDMSFNQLSGSIPAELGQLQN 470
LE L ++S N L L PA + N+++ IP + L
Sbjct: 177 ELPESLEAL---DVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDP 231
Query: 471 IISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSR 517
++IL +N L I + LS + + + S R
Sbjct: 232 TCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHR 278
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-32
Identities = 64/327 (19%), Positives = 107/327 (32%), Gaps = 42/327 (12%)
Query: 197 TIPDSIGNCTSFEILDISYNQITGEIPYNIGFL-----QVATLSLQGNKLTGKIPEVIGL 251
+I I N S + YN I+ + + A N+ + E L
Sbjct: 2 SIMLPINNNFS-LSQNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CL 57
Query: 252 MQALAVLDLSENELVGPIPPILG-NLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQN 310
+ + L L+ L +P L ++ L + N L +P + L YL +
Sbjct: 58 INQFSELQLNRLNLSS-LPDNLPPQIT---VLEITQNALI-SLPELPAS---LEYLDACD 109
Query: 311 NQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFR 370
N+L T+P L+ L++ +N L +P + L N N+L+ +P
Sbjct: 110 NRLS-TLPELPASLK---HLDVDNNQLTM-LPELPAL---LEYINADNNQLT-MLPEL-- 158
Query: 371 NLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLT----L 426
SL L++ N +P +L+ LD+S N S+PA H
Sbjct: 159 -PTSLEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFF 212
Query: 427 NLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIP 486
N + + P +L TI + N LS I L Q + + +
Sbjct: 213 RCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTA--QPDYHGPRIYFSMS 269
Query: 487 DQLSNCFSLSNLNVSYNNLSGIIPPIR 513
D N +
Sbjct: 270 DGQQNTLHRPLADAVTAWFPENKQSDV 296
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 35/229 (15%), Positives = 65/229 (28%), Gaps = 16/229 (6%)
Query: 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSL----VHIELSDNS 97
L++ + L + L L D N L +P + +N
Sbjct: 164 VLSVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENR 218
Query: 98 LYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWN 157
+ IP +I L + L++N L+ I +L+Q R + + +
Sbjct: 219 I-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
Query: 158 EVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQ 217
L D+ Q+ + + N + D + + S Q
Sbjct: 278 RPLADAVTAW--FPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQ 334
Query: 218 ITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELV 266
+ + L Q + E AL +L + LV
Sbjct: 335 VA-AWLEKLSASA--ELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-35
Identities = 79/481 (16%), Positives = 152/481 (31%), Gaps = 65/481 (13%)
Query: 31 VFCDNSSLSVV---------SLNLSSLNLGGEISPS-IGDLRNLQSIDFQGNKLTGQIPD 80
V N +L+ V +L+LS N E+ I L L+ + N++ +
Sbjct: 36 VDYSNRNLTHVPKDLPPRTKALSLSQ-NSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93
Query: 81 EI-GNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTG-PIPSTLTQIPNLKT 138
+ L ++++S N L +I + L L+L N P+ + L
Sbjct: 94 HVFLFNQDLEYLDVSHNRL-QNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTF 150
Query: 139 LDLARNQLT-GEIPRLIYWNEVLQYLGLRGNALTGMLSPDMC--QLTGLWYFDVRGNNLT 195
L L+ + ++ + + + L L + G + + T L + +
Sbjct: 151 LGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFS 210
Query: 196 GTIPDSIGNCTSFEILDISYNQITG--------------------------------EIP 223
+ S+ ++ +I N ++
Sbjct: 211 VQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF 270
Query: 224 YNIGFLQVATLSLQGNKLTGKIPEVIG-----LMQALAVLDLSENELVGPIPPILGNLSY 278
V L++ +T +I +++L + + + + +
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLE 338
L + + S ++L N ++ L++L L L N L+
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 339 GPIPHNISSCTALNQFNVHGNRL----SGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELG 394
++ L S A + S+ LNLS N G V L
Sbjct: 391 N-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449
Query: 395 RIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSF 454
+ LDL N S+P + L+ L LN++ N L + F L S+Q I +
Sbjct: 450 P--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD 506
Query: 455 N 455
N
Sbjct: 507 N 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-30
Identities = 82/447 (18%), Positives = 165/447 (36%), Gaps = 34/447 (7%)
Query: 85 CGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARN 144
++ S+ +L +P + + + L+L N ++ ++ + L+ L L+ N
Sbjct: 30 NELESMVDYSNRNLT-HVPKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLRLSHN 86
Query: 145 QLTGEIPRLIYWNEV-LQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDS-- 201
++ + ++ L+YL + N L +S + L + D+ N+ +P
Sbjct: 87 RIR-SLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFD-VLPVCKE 141
Query: 202 IGNCTSFEILDISYNQITGEIPYNIGFLQVAT--LSLQGNKLTGKIPEVIGLMQALAVLD 259
GN T L +S + + L ++ L L + G E + + VL
Sbjct: 142 FGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTVLH 200
Query: 260 LSENELVGPIPPILGNLSYTGKLYLHGNKLTG-------PIPPELGNMSKLSYLQLQNNQ 312
L + + +++ G L L KL EL L + LQ+ +
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260
Query: 313 LVGTIPAELGKL---EQLFELNLADNNLEGPIPHNI-----SSCTALNQFNVHGNRLSGA 364
+L + + LN+ + + I ++ +L +V +
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFS 320
Query: 365 IPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLL 424
+ + + LS ++ + L+ + N F+ SV L+ L
Sbjct: 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380
Query: 425 TLNLSRNHLNGL--LPAEFGNLRSIQTIDMSFNQL-SGSIPAELGQLQNIISLILNNNNL 481
TL L RN L + N+ S++T+D+S N L S + ++I+ L L++N L
Sbjct: 381 TLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML 440
Query: 482 QGGIPDQLSNCFSLSNLNVSYNNLSGI 508
G + L + L++ N + I
Sbjct: 441 TGSVFRCLPP--KVKVLDLHNNRIMSI 465
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 6e-22
Identities = 73/369 (19%), Positives = 126/369 (34%), Gaps = 51/369 (13%)
Query: 38 LSVVSLNLSSLNLGGEISPSIGDL-RNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDN 96
LS + L+L S ++ G + S+ + + F N L + N +L H++LS+
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN--ALGHLQLSNI 228
Query: 97 SLYGDIPFSISKLKQLEFLNLKNNQLTGPIPST----------LTQIPNLKTLDLARNQL 146
L + + +T T ++ L++ +
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 147 TGEIPRLIYWN-----EVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDS 201
T I R + + L ++ + + ++
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348
Query: 202 IGNCTSFEILDISYNQITGEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGL---MQALAV 257
+ +SF L+ + N T + L ++ TL LQ N L +V + M +L
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLET 407
Query: 258 LDLSENEL-VGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT 316
LD+S N L L L N LTG + L K+ L L NN++ +
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRI-MS 464
Query: 317 IPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLT 376
IP ++ L+ L ELN+A N L+ +P F L SL
Sbjct: 465 IPKDVTHLQALQELNVASNQLKS-VPD-----------------------GVFDRLTSLQ 500
Query: 377 YLNLSRNNF 385
Y+ L N +
Sbjct: 501 YIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-18
Identities = 64/341 (18%), Positives = 119/341 (34%), Gaps = 25/341 (7%)
Query: 188 DVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFL-QVATLSLQGNKLTGKIP 246
D NLT +P + + L +S N I+ +I FL ++ L L N++
Sbjct: 37 DYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDF 93
Query: 247 EVIGLMQALAVLDLSENELVGPIPP-ILGNLSYTGKLYLHGNKLTG-PIPPELGNMSKLS 304
V Q L LD+S N L I + +L + L L N P+ E GN++KL+
Sbjct: 94 HVFLFNQDLEYLDVSHNRLQN-ISCCPMASLRH---LDLSFNDFDVLPVCKEFGNLTKLT 149
Query: 305 YLQLQNNQLVGTIPAELGKLE-QLFELNLADNNLE-GPIPHNISSCTALNQFNVHGNRLS 362
+L L + + L L+L +++ G T + H N L
Sbjct: 150 FLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLF 209
Query: 363 GAIPS-SFRNLGSLTYLNLSRNNFKGKVPTEL--GRIINLDTLDLSVNNFSGSVPASIGD 419
+ S LG L N+ N+ + L++++ + + S+
Sbjct: 210 SVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL 269
Query: 420 LE-----HLLTLNLSRNHLNGLLPAEFGN-----LRSIQTIDMSFNQLSGSIPAELGQLQ 469
+ + LN+ + + E L+S+ + S A
Sbjct: 270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFA 329
Query: 470 NIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIP 510
+ +L+ ++ + S + LN + N + +
Sbjct: 330 EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 84/315 (26%), Positives = 140/315 (44%), Gaps = 42/315 (13%)
Query: 612 MRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN---LREFETEL 663
M + +LS++Y I+G+G S V+ L++ R +AVK L + F E
Sbjct: 4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 664 ETIGSIRHRNIVSLH--GYALSPYGNLLF----YDYMVNG-SLWDLLHGPSKKVKLDWET 716
+ ++ H IV+++ G A +P G L + Y V+G +L D++H + + +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY---VDGVTLRDIVH---TEGPMTPKR 117
Query: 717 RLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI---PTAMP 773
+++ A Q L + H + IIHRDVK +NI+I + DFGIAR I ++
Sbjct: 118 AIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKA 833
+ V+GT Y+ PE A ++ +SDVYS G VL E+LTG+ +S +
Sbjct: 175 QTAA-VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233
Query: 834 DDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT-----MQEVARVLVSLL 888
+D A +S + + + L + P R ++ RV
Sbjct: 234 EDPIPPSARHEGLS------ADLD---AVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284
Query: 889 PAPPAKLSLAAPKPI 903
P P L+ A +
Sbjct: 285 PEAPKVLTDAERTSL 299
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 78/314 (24%), Positives = 128/314 (40%), Gaps = 56/314 (17%)
Query: 618 LSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN---LREFETELETIGSI 669
++E+Y +G G STVY + +A+K ++ L+ FE E+ +
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 670 RHRNIVSLHGYALSPYGNLLFYDY----------M--VNG-SLWDLLHGPSKKVKLDWET 716
H+NIVS+ D M + G +L + + L +T
Sbjct: 69 SHQNIVSM-------------IDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDT 112
Query: 717 RLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776
+ G+ + H RI+HRD+K NILID N + DFGIA+ + +
Sbjct: 113 AINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169
Query: 777 TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN 836
VLGT+ Y PE A +E +D+YS GIVL E+L G+ + E+ + I D
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV 229
Query: 837 -TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP-TMQEVARVLVSLL-----P 889
V V ++ + + + L T++ + R T+QE+ L S+L
Sbjct: 230 PNVTTDVRKDIPQS-LS--------NVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280
Query: 890 APPAKLSLAAPKPI 903
+L +
Sbjct: 281 EDVYELDKMKTIAV 294
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-34
Identities = 95/457 (20%), Positives = 167/457 (36%), Gaps = 80/457 (17%)
Query: 66 SIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGP 125
+ L Q+P+ + + +++LS NS+ S S+L+ L+FL ++
Sbjct: 14 NAICINRGLH-QVPELPAH---VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69
Query: 126 IPS-TLTQIPNLKTLDLARNQLTGEIPRLIYWNEV-LQYLGLRGNALTGMLSPDMC--QL 181
I + T + +L L L NQ ++ + L+ L L L G + L
Sbjct: 70 IRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128
Query: 182 TGLWYFDVRGNNLTGTIPDSI-GNCTSFEILDISYNQIT---GEIPYNIGFLQVATLSLQ 237
T L +R NN+ P S N F +LD+++N++ E N L L
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS 188
Query: 238 GNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPP-- 295
L D++E L + L L GN +
Sbjct: 189 SITL----------------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232
Query: 296 -ELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNIS--SCTALN 352
+ +K+ L L N+ +G+ + N + P + +
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGS--------------SFGHTNFKDPDNFTFKGLEASGVK 278
Query: 353 QFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGS 412
++ +++ + S F + L L L++N + N F G
Sbjct: 279 TCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN----------------KIDDNAFWG- 321
Query: 413 VPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAEL-GQLQNI 471
L HLL LNLS+N L + F NL ++ +D+S+N + ++ + L N+
Sbjct: 322 -------LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNL 373
Query: 472 ISLILNNNNLQ---GGIPDQLSNCFSLSNLNVSYNNL 505
L L+ N L+ GI D+L+ SL + + N
Sbjct: 374 KELALDTNQLKSVPDGIFDRLT---SLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 6e-20
Identities = 48/265 (18%), Positives = 78/265 (29%), Gaps = 26/265 (9%)
Query: 269 IPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQL 327
+P + + + L N + + L +L+++ I L L
Sbjct: 25 VPELPAH---VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 328 FELNLADNNLEGPIPHNI-SSCTALNQFNVHGNRL-SGAIPS-SFRNLGSLTYLNLSRNN 384
L L N + + L + L + F+ L SL L L NN
Sbjct: 82 IILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 385 FKGKVPTEL-GRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGN 443
K P + LDL+ N S+ N H L
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLL-------NFQGKHFTLL------R 186
Query: 444 LRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG---GIPDQLSNCFSLSNLNV 500
L SI DM+ L + +I +L L+ N + + +L +
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 501 SYNNLSGIIPPIRNFSRFSSNSFIG 525
S + G NF + +F G
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 23/112 (20%), Positives = 42/112 (37%), Gaps = 6/112 (5%)
Query: 63 NLQSIDFQGNKLTGQIPDEI-GNCGSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLKNN 120
+++ D +K+ + + + L + L+ N + I + L L LNL N
Sbjct: 276 GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQN 333
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWN-EVLQYLGLRGNALT 171
L + L+ LDL+ N + + + L+ L L N L
Sbjct: 334 FLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK 384
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-33
Identities = 53/289 (18%), Positives = 97/289 (33%), Gaps = 46/289 (15%)
Query: 624 VGYGASSTVYKC---ALKNSRPIAVKKLYNQYPHNLRE-FETELETIGSIRHRNIVSLH- 678
+ +G +Y + N RP+ +K L + + E + + + H +IV +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 679 -GYALSPYGNLLFYDYM--VNG-SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD 734
+G+ + Y M V G SL L + + L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHSI 201
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
+++ D+K NI++ E L D G + + GT G+ PE +
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGY-LYGTPGFQAPEIV-RT 251
Query: 795 RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854
+D+Y+ G L + + ++ + + V S
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPTRNGRY---------------VDGLPEDDPVLKTYDS 296
Query: 855 AVRKTFQLALLCTKRYPSERP-TMQEVARVLVSLLPAPPAKLSLAAPKP 902
R L P +R T +E++ L +L A P+P
Sbjct: 297 YGR----LLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVA-QDTGVPRP 340
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 55/202 (27%), Positives = 81/202 (40%), Gaps = 20/202 (9%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN---LREFETELETIGSIRHRNIVSLHG 679
VG G VY+ R +A+K + + + E T G ++ ++V +H
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 680 YALSPYGNLLFYDYM--VNG-SLWDLL--HGPSKKVKLDWETRLKIAVGAAQGLAYLHHD 734
+ L+ D M +NG L +L GP L + I L H
Sbjct: 102 F--GEIDGQLYVD-MRLINGVDLAAMLRRQGP-----LAPPRAVAIVRQIGSALDAAHAA 153
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
HRDVK NIL+ + A+L DFGIA +GT+ Y+ PE S
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 795 RLNEKSDVYSFGIVLLEILTGK 816
++D+Y+ VL E LTG
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 23/290 (7%)
Query: 233 TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGP 292
+ L K+P+ L A+LDL N++ NL L L NK++
Sbjct: 35 VVQCSDLGLE-KVPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK- 90
Query: 293 IPPE-LGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNI-SSCTA 350
I P + KL L L NQL +P ++ + L EL + +N + + ++ +
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITK-VRKSVFNGLNQ 146
Query: 351 LNQFNVHGNRL-SGAIPS-SFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNN 408
+ + N L S I + +F+ + L+Y+ ++ N +P L +L L L N
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNK 203
Query: 409 FSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQL 468
+ AS+ L +L L LS N ++ + N ++ + ++ N+L +P L
Sbjct: 204 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262
Query: 469 QNIISLILNNNNLQG------GIPDQLSNCFSLSNLNVSYNNLSGI-IPP 511
+ I + L+NNN+ P + S S +++ N + I P
Sbjct: 263 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 59/331 (17%), Positives = 125/331 (37%), Gaps = 43/331 (12%)
Query: 135 NLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNL 194
+L+ + + L ++P+ + + L L+ N +T + D L L + N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 195 TGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPE-VIGLMQ 253
+ P + E L +S NQ+ E+P + + L + N++T K+ + V +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM-PKTLQELRVHENEIT-KVRKSVFNGLN 145
Query: 254 ALAVLDLSENEL-VGPIPPI----LGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQL 308
+ V++L N L I + LSY + + +T IP L L+ L L
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSY---IRIADTNITT-IPQGL--PPSLTELHL 199
Query: 309 QNNQLVGTIPAE-LGKLEQLFELNLADNNLEGPIPHNI-SSCTALNQFNVHGNRLSGAIP 366
N++ + A L L L +L L+ N++ + + ++ L + +++ N+L +P
Sbjct: 200 DGNKI-TKVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVP 256
Query: 367 SSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTL 426
+ + + L NN ++ + P +
Sbjct: 257 GGLADHKYIQVVYLHNNNIS------------------AIGSNDFCPPGYNTKKASYSGV 298
Query: 427 NLSRNHLN--GLLPAEFGNLRSIQTIDMSFN 455
+L N + + P+ F + + +
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 78/369 (21%), Positives = 128/369 (34%), Gaps = 81/369 (21%)
Query: 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNC 85
C R V C + L V +L + +D Q NK+T
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPP---------------DTALLDLQNNKIT---------- 65
Query: 86 GSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQ 145
E+ D LK L L L NN+++ P + L+ L L++NQ
Sbjct: 66 ------EIKDGDF--------KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 146 LTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDM-CQLTGLWYFDVRGNNLTGTI--PDSI 202
L E+P + LQ L + N +T + + L + ++ N L + +
Sbjct: 112 LK-ELPEKMPKT--LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 203 GNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPE-VIGLMQALAVLDLS 261
+ I+ IT IP + + L L GNK+T K+ + + LA L LS
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQGL-PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224
Query: 262 ENELVGPIPP-ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQL------V 314
N + + L N + +L+L+ NKL +P L + + + L NN +
Sbjct: 225 FNSISA-VDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 315 GTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGS 374
P K ++L N ++ I PS+FR +
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQ---YWEIQ-------------------PSTFRCVYV 320
Query: 375 LTYLNLSRN 383
+ L
Sbjct: 321 RAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 28/133 (21%), Positives = 55/133 (41%), Gaps = 6/133 (4%)
Query: 374 SLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHL 433
L + S + KVP +L + LDL N + +L++L TL L N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 434 NGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCF 493
+ + P F L ++ + +S NQL +P ++ + + L ++ N + +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 494 SLSNLNVSYNNLS 506
+ + + N L
Sbjct: 146 QMIVVELGTNPLK 158
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 64/258 (24%), Positives = 117/258 (45%), Gaps = 14/258 (5%)
Query: 230 QVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKL 289
Q + + L+ ++P+ G+ L+L EN + +L + L L N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 290 TGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLADNNLEGPIPHNI-S 346
I ++ L+ L+L +N L IP+ L +L EL L +N +E IP +
Sbjct: 112 RQ-IEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFN 168
Query: 347 SCTALNQFNV-HGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLS 405
+L + ++ +L +F L +L YLNL N K +P L ++ L+ L++S
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMS 226
Query: 406 VNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAE- 464
N+F P S L L L + + ++ + F L S+ ++++ N LS S+P +
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
Query: 465 LGQLQNIISLILNNNNLQ 482
L+ ++ L L++N
Sbjct: 286 FTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 53/254 (20%), Positives = 89/254 (35%), Gaps = 13/254 (5%)
Query: 282 LYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPI 341
+ L+ +P + S YL L N + L L L L N++
Sbjct: 59 VVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE 115
Query: 342 PHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDT 401
+ +LN + N L+ +F L L L L N + R+ +L
Sbjct: 116 VGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMR 175
Query: 402 LDLSVNNFSGSVPASI-GDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460
LDL + L +L LNL ++ + L ++ ++MS N
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFP-E 232
Query: 461 IPAE-LGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFS 519
I L ++ L + N+ + + SL LN+++NNLS + P F+
Sbjct: 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSL--PHDLFTPLR 290
Query: 520 SNSFI---GNPLLC 530
+ NP C
Sbjct: 291 YLVELHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 58/282 (20%), Positives = 101/282 (35%), Gaps = 39/282 (13%)
Query: 62 RNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ 121
+ L+ ++P I + + ++ L +N++ + L LE L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 122 LTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQL 181
+ + +L TL+L N LT IP A L
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLT-VIPS---------------GAFEY--------L 146
Query: 182 TGLWYFDVRGNNLTGTIPDSI-GNCTSFEILDIS-YNQITGEIPYNI--GFLQVATLSLQ 237
+ L +R N + +IP S LD+ ++ I G + L+L
Sbjct: 147 SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLG 204
Query: 238 GNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPE- 296
+ +P + L L L++S N P LS KL++ ++++ I
Sbjct: 205 MCNIK-DMPNLTPL-VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL-IERNA 261
Query: 297 LGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLADNNL 337
++ L L L +N L ++P + L L EL+L N
Sbjct: 262 FDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 52/258 (20%), Positives = 90/258 (34%), Gaps = 15/258 (5%)
Query: 134 PNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNN 193
+ R L+ E+P+ I +YL L N + + + L L + N+
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 194 LTGTIPDSIGNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPEVI-- 249
+ + S L++ N +T IP ++ L L+ N + IP
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
Query: 250 GLMQALAVLDLSENELVGPIPP-ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQL 308
+ +L LDL E + + I L L L + P L + L L++
Sbjct: 169 RV-PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEM 225
Query: 309 QNNQLVGTIPAE-LGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPS 367
N I L L +L + ++ + + +L + N+ N LS
Sbjct: 226 SGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHD 284
Query: 368 SFRNLGSLTYLNLSRNNF 385
F L L L+L N +
Sbjct: 285 LFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 66/255 (25%), Positives = 100/255 (39%), Gaps = 23/255 (9%)
Query: 26 CSWRG--VFCDNSSLSVV----SLNLSSLNLGG----EISPSI-GDLRNLQSIDFQGNKL 74
CS + V C LS V N LNL I L +L+ + N +
Sbjct: 52 CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 75 TGQIPDEI-GNCGSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPSTLTQ 132
QI SL +EL DN L IP L +L L L+NN + +
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 133 IPNLKTLDLAR-NQLTGEIPRLIYWN-EVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVR 190
+P+L LDL +L I + L+YL L + M P++ L GL ++
Sbjct: 170 VPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMS 226
Query: 191 GNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPEV 248
GN+ P S +S + L + +Q++ I N G + L+L N L+ ++
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDL 285
Query: 249 IGLMQALAVLDLSEN 263
++ L L L N
Sbjct: 286 FTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 34/143 (23%), Positives = 58/143 (40%), Gaps = 7/143 (4%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSI-GDLRNLQSIDFQGNKLTGQIPDEIGNCGSL 88
F SL + L+L L IS L NL+ ++ + +P+ + L
Sbjct: 165 YAFNRVPSL--MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGL 220
Query: 89 VHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTG 148
+E+S N P S L L+ L + N+Q++ + + +L L+LA N L+
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS- 279
Query: 149 EIPRLIYWN-EVLQYLGLRGNAL 170
+P ++ L L L N
Sbjct: 280 SLPHDLFTPLRYLVELHLHHNPW 302
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 69/271 (25%), Positives = 114/271 (42%), Gaps = 30/271 (11%)
Query: 620 EKYIV----GYGASSTVYKC-ALKNSRPIAVKK--LYNQYPHNLREFETELETIGSIRHR 672
EKY+ G G+ + ++ R +K+ + E E+ + +++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 673 NIVSLHGYALSPYGNLLFY-DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYL 731
NIV G+L DY G L+ ++ K V + L V L ++
Sbjct: 84 NIVQYRESFEEN-GSLYIVMDYCEGGDLFKRIN-AQKGVLFQEDQILDWFVQICLALKHV 141
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYA 791
H + +I+HRD+KS NI + ++ L DFGIAR + + + A + GT Y+ PE
Sbjct: 142 H---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEIC 197
Query: 792 HTSRLNEKSDVYSFGIVLLEILTGKKA--VDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849
N KSD+++ G VL E+ T K A + NL I+ + V S
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-----SGSFPPVSLHYSYD 252
Query: 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
L V + F+ R P +RP++ +
Sbjct: 253 LRSL--VSQLFK-------RNPRDRPSVNSI 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 65/297 (21%), Positives = 110/297 (37%), Gaps = 41/297 (13%)
Query: 620 EKYIVGYGASSTVYKC-ALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLH 678
+ + G G S V L + A+K++ + E + E + H NI+ L
Sbjct: 34 IQKL-GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 679 GYALSPYGN-----LLFYDYMVNGSLWDLL-HGPSKKVKLDWETRLKIAVGAAQGLAYLH 732
Y L G LL + G+LW+ + K L + L + +G +GL +H
Sbjct: 93 AYCLRERGAKHEAWLLL-PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL--------GTIG 784
HRD+K +NIL+ + L D G + + + TI
Sbjct: 152 A---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 785 YIDPE----YAHTSRLNEKSDVYSFGIVLLEILTGK---KAVDNESNLHQLIMSKADDNT 837
Y PE +H ++E++DV+S G VL ++ G+ V + + L + N
Sbjct: 209 YRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ----NQ 263
Query: 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAK 894
+ P S L + P +RP + + L +L P P +
Sbjct: 264 LSIPQSPRHSSALWQL--LNSMMT-------VDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 62/275 (22%), Positives = 108/275 (39%), Gaps = 29/275 (10%)
Query: 620 EKYIV----GYGASSTVYKCALKNSRPI-AVKK--LYNQYPHNLREFETELETIGSIRHR 672
E Y V G G+ K K+ I K+ + + +E+ + ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 673 NIVSLHGYALSPYGNLLFY--DYMVNGSLWDLL-HGPSKKVKLDWETRLKIAVGAAQGLA 729
NIV + + L+ +Y G L ++ G ++ LD E L++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 730 YLH--HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYID 787
H D ++HRD+K +N+ +D + L DFG+AR + A TFV GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 788 PEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVD--NESNLHQLIMSKADDNTVMEAVDPE 845
PE + NEKSD++S G +L E+ ++ L I +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-----EGKFRRIPYR 239
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
S ++ + + RP+++E+
Sbjct: 240 YSDELNEI--ITR-------MLNLKDYHRPSVEEI 265
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 72/289 (24%), Positives = 115/289 (39%), Gaps = 31/289 (10%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGS 668
+ L E+ +G G V+ L+ ++ +AVK P +F E +
Sbjct: 111 LNHEDLVLGEQ--IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQ 168
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
H NIV L G + + + G L ++ +L +T L++ AA G+
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGM 226
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI-- 786
YL IHRD+ + N L+ E +SDFG++R + AS G + +
Sbjct: 227 EYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS----GGLRQVPV 279
Query: 787 ---DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAV 842
PE + R + +SDV+SFGI+L E + G N SN Q + +
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKGGRLPC- 336
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
PE C D F+L C P +RP+ + + L S+
Sbjct: 337 -PE---LCPD-----AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 39/290 (13%)
Query: 625 GYGASSTVYKCALK-----NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHG 679
G G +V C +AVK+L + P R+F+ E++ + ++ IV G
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRG 91
Query: 680 YALSPYGNLLFY--DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
+ P L +Y+ +G L D L + +LD L + +G+ YL +
Sbjct: 92 VSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG---SR 146
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI-----DPEYAH 792
R +HRD+ + NIL++ ++DFG+A+ +P +V+ G PE
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPL---DKDYYVVREPGQSPIFWYAPESLS 203
Query: 793 TSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVD-------- 843
+ + +SDV+SFG+VL E+ T K+ + +++ + D + ++
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL 263
Query: 844 --PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
P C + +L LC P +RP+ + L L
Sbjct: 264 PAPP---ACPA-----EVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 63/274 (22%), Positives = 112/274 (40%), Gaps = 30/274 (10%)
Query: 620 EKYIV----GYGASSTVYKCALKNS-RPIAVKK--LYNQYPHNLREF-ETELETIGSIRH 671
+ + G G S VY+ A P+A+KK +++ R E++ + + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 672 RNIVSLHGYALSPYGNLLFY-DYMVNGSLWDLL-HGPSKKVKLDWETRLKIAVGAAQGLA 729
N++ + + L + G L ++ H +K + T K V L
Sbjct: 92 PNVIKYYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
++H + R++HRD+K +N+ I L D G+ R + A + V GT Y+ PE
Sbjct: 151 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 206
Query: 790 YAHTSRLNEKSDVYSFGIVLLEILTGKKA-VDNESNLHQLIMSKADDNTVMEAVDPEVSV 848
H + N KSD++S G +L E+ + ++ NL+ L + + P +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK------IEQCDYPPLPS 260
Query: 849 TCV--DLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+L QL +C P +RP + V
Sbjct: 261 DHYSEELR------QLVNMCINPDPEKRPDVTYV 288
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 66/370 (17%), Positives = 121/370 (32%), Gaps = 82/370 (22%)
Query: 25 FCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGN 84
C R V C + L V +S + +D Q N ++
Sbjct: 32 HCHLRVVQCSDLGLKAVPKEISP---------------DTTLLDLQNNDIS--------- 67
Query: 85 CGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARN 144
EL + L+ L L L NN+++ + + L+ L +++N
Sbjct: 68 -------ELRKDDF--------KGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 145 QLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ-LTGLWYFDVRGNNLTGT-IPDSI 202
L EIP + + L L + N + + + L + ++ GN L +
Sbjct: 113 HLV-EIPPNLPSS--LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168
Query: 203 GNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPE-VIGLMQALAVLDLS 261
+ L IS ++T IP ++ + L L NK+ I + L L L
Sbjct: 169 FDGLKLNYLRISEAKLT-GIPKDL-PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225
Query: 262 ENELVGPIPP-ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAE 320
N++ I L L +L+L NKL+ +P L ++ L + L N + +
Sbjct: 226 HNQIRM-IENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVN 282
Query: 321 -------LGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLG 373
K ++L +N + + P++FR +
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVP---YWEVQ-------------------PATFRCVT 320
Query: 374 SLTYLNLSRN 383
+
Sbjct: 321 DRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 66/328 (20%), Positives = 123/328 (37%), Gaps = 36/328 (10%)
Query: 135 NLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNL 194
+L+ + + L +P+ I + L L+ N ++ + D L L+ + N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPD--TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 195 TGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQA 254
+ + + L IS N + EIP N+ + L + N++ V ++
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL-PSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 255 LAVLDLSENEL-VGPIPP-ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQ 312
+ +++ N L P L L + KLTG IP +L L+ L L +N+
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLN-YLRISEAKLTG-IPKDL--PETLNELHLDHNK 204
Query: 313 LVGTIPAE-LGKLEQLFELNLADNNLEGPIPHNI-SSCTALNQFNVHGNRLSGAIPSSFR 370
+ I E L + +L+ L L N + I + S L + ++ N+LS +P+
Sbjct: 205 IQ-AIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261
Query: 371 NLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSR 430
+L L + L NN + VN+F + ++L
Sbjct: 262 DLKLLQVVYLHTNNIT----------------KVGVNDFCPVGFGV--KRAYYNGISLFN 303
Query: 431 NHL--NGLLPAEFGNLRSIQTIDMSFNQ 456
N + + PA F + I +
Sbjct: 304 NPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 62/320 (19%), Positives = 109/320 (34%), Gaps = 48/320 (15%)
Query: 204 NCT-SFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSE 262
C ++ S + +P I L LQ N ++ + +Q L L L
Sbjct: 30 GCHCHLRVVQCSDLGLK-AVPKEI-SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87
Query: 263 NELVGPIPP-ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAE- 320
N++ I L KLY+ N L IPP L S L L++ +N++ +P
Sbjct: 88 NKISK-IHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIR-KVPKGV 142
Query: 321 LGKLEQLFELNLADNNL-EGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLN 379
L + + + N L P +F L L YL
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFE-----------------------PGAFDGL-KLNYLR 178
Query: 380 LSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPA 439
+S +P +L L+ L L N + L L L N + +
Sbjct: 179 ISEAKLT-GIPKDLPE--TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENG 235
Query: 440 EFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQ-------LSNC 492
L +++ + + N+LS +PA L L+ + + L+ NN+ +
Sbjct: 236 SLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKR 293
Query: 493 FSLSNLNVSYNNLSGI-IPP 511
+ +++ N + + P
Sbjct: 294 AYYNGISLFNNPVPYWEVQP 313
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 20/116 (17%), Positives = 40/116 (34%), Gaps = 16/116 (13%)
Query: 44 NLSSLNLGG----EISPSI-GDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSL 98
L L LG I L L+ + NKL+ ++P + + L + L N++
Sbjct: 218 KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276
Query: 99 YGDIPFSI-------SKLKQLEFLNLKNNQLTGPI--PSTLTQIPNLKTLDLARNQ 145
+ + K ++L NN + P+T + + + +
Sbjct: 277 -TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 58/255 (22%), Positives = 108/255 (42%), Gaps = 11/255 (4%)
Query: 258 LDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQL--VG 315
+ + L +P + S +L L NKL +++L+ L L +N L G
Sbjct: 12 IRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 316 TIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSS-FRNLGS 374
L L+L+ N + + N L + + L S F +L +
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 375 LTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASI-GDLEHLLTLNLSRNHL 433
L YL++S + + + +L+ L ++ N+F + I +L +L L+LS+ L
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
Query: 434 NGLLPAEFGNLRSIQTIDMSFNQLSGSIPAE-LGQLQNIISLILNNNNLQGGIPDQLSNC 492
L P F +L S+Q ++MS N S+ L ++ L + N++ +L +
Sbjct: 188 EQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246
Query: 493 F-SLSNLNVSYNNLS 506
SL+ LN++ N+ +
Sbjct: 247 PSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 49/275 (17%), Positives = 92/275 (33%), Gaps = 32/275 (11%)
Query: 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNC 85
CS + C++ L+ V + S + ++ + NKL
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPS---------------SATRLELESNKLQSLPHGVFDKL 51
Query: 86 GSLVHIELSDNSLY--GDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLAR 143
L + LS N L G S L++L+L N + + S + L+ LD
Sbjct: 52 TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 110
Query: 144 NQLTGEIPRLIYWN-EVLQYLGLRGNALTGMLSPDMCQ-LTGLWYFDVRGNNLTGTIPDS 201
+ L ++ + L YL + + + L+ L + GN+
Sbjct: 111 SNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
Query: 202 I-GNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPEVIGLMQALAVL 258
I + LD+S Q+ ++ + L++ N + +L VL
Sbjct: 170 IFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228
Query: 259 DLSENELV----GPIPPILGNLSYTGKLYLHGNKL 289
D S N ++ + +L++ L L N
Sbjct: 229 DYSLNHIMTSKKQELQHFPSSLAF---LNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 54/257 (21%), Positives = 91/257 (35%), Gaps = 16/257 (6%)
Query: 90 HIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLT-G 148
I + L +P I L L++N+L ++ L L L+ N L+
Sbjct: 11 EIRCNSKGL-TSVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 149 EIPRLIYWN-EVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSI-GNCT 206
+ L+YL L N + +S + L L + D + +NL S+ +
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 207 SFEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPE-VIGLMQALAVLDLSEN 263
+ LDIS+ I G + L + GN + ++ L LDLS+
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 264 ELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAEL- 321
+L P +LS L + N + ++ L L N ++ T +
Sbjct: 186 QLEQLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIM-TSKKQEL 243
Query: 322 -GKLEQLFELNLADNNL 337
L LNL N+
Sbjct: 244 QHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 41/185 (22%), Positives = 73/185 (39%), Gaps = 10/185 (5%)
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNN--FK 386
E+ L +P I ++ + + N+L F L LT L+LS N FK
Sbjct: 11 EIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 387 GKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAE-FGNLR 445
G +L LDLS N ++ ++ LE L L+ ++L + F +LR
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 446 SIQTIDMSFNQLSGSIPAE-LGQLQNIISLILNNNNLQGGIPDQ-LSNCFSLSNLNVSYN 503
++ +D+S L ++ L + N+ Q + +L+ L++S
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 504 NLSGI 508
L +
Sbjct: 186 QLEQL 190
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 54/275 (19%), Positives = 107/275 (38%), Gaps = 44/275 (16%)
Query: 623 IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGY- 680
++G G V+K + + +K++ +N + E E++ + + H NIV +G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 681 ------------ALSPYGNLLFY---DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA 725
S + ++ G+L + + KLD L++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQIT 132
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY 785
+G+ Y+H + ++I+RD+K SNI + + + DFG+ + + GT+ Y
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRSK-GTLRY 187
Query: 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845
+ PE + ++ D+Y+ G++L E+L S + +
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG--------IISDI 239
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
L ++K LL K P +RP E+
Sbjct: 240 FDKKEKTL--LQK-----LLSKK--PEDRPNTSEI 265
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 68/300 (22%), Positives = 119/300 (39%), Gaps = 43/300 (14%)
Query: 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKL--YNQYPHNLREFETELETIGSIRH 671
++ + +G G V+K + K S + +KL P + EL+ +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 90
Query: 672 RNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL-KIAVGAAQGLAY 730
IV +G S + ++M GSL +L KK E L K+++ +GL Y
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTY 146
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY 790
L I+HRDVK SNIL++ + L DFG++ + +M A++FV GT Y+ PE
Sbjct: 147 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFV-GTRSYMSPER 201
Query: 791 AHTSRLNEKSDVYSFGIVLLEILTGK-------KAVDNESNLHQLIMSKADDNTVMEAVD 843
+ + +SD++S G+ L+E+ G+ Q+ A+
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 844 PEVSVTCVDLSAVRKTFQLALL------------------------CTKRYPSERPTMQE 879
++ +D F+L C + P+ER +++
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 71/297 (23%), Positives = 121/297 (40%), Gaps = 40/297 (13%)
Query: 616 ENLSEKYIVGYGASSTVYKCALK-----NSRPIAVKKL-YNQYPHNLREFETELETIGSI 669
L +G G V C +AVK L +++ + + E+E + ++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 670 RHRNIVSLHGYALSPYGNLLF--YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
H NIV G GN + +++ +GSL + L P K K++ + +LK AV +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI- 786
+ YL + + +HRD+ + N+L++ + DFG+ + I T + +
Sbjct: 139 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET---DKEYYTVKDDRDSP 192
Query: 787 ----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEA 841
PE S+ SDV+SFG+ L E+LT + ++I TV
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 842 VD----------PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
V+ P C D + +QL C + PS R + Q + +LL
Sbjct: 253 VNTLKEGKRLPCPP---NCPD-----EVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 65/278 (23%), Positives = 109/278 (39%), Gaps = 44/278 (15%)
Query: 624 VGYGASSTVYKCALKNSRPIAVK--KLYNQYPHNLREFETELETIGSIRH--RNIVSLHG 679
+G G SS V++ + + A+K L L + E+ + ++ I+ L+
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 680 YALSPYGNLLFYDYMV----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
Y ++ + YMV N L L KK +D R + + +H
Sbjct: 77 YEITD-QYI----YMVMECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH- 127
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP--TAMPHASTFVLGTIGYIDPE---- 789
I+H D+K +N LI + L DFGIA + T + V GT+ Y+ PE
Sbjct: 128 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKD 183
Query: 790 -------YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842
S+++ KSDV+S G +L + GK N + + D N +E
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-F 242
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
D+ ++ C KR P +R ++ E+
Sbjct: 243 PDIPEKDLQDV--LKC-------CLKRDPKQRISIPEL 271
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 25/280 (8%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIV 675
L+ +G G V+ N +A+K + + +F E E + + H +V
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLV 66
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
L+G L L ++M +G L D L ET L + + +G+AYL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYL---E 121
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT---IGYIDPEYAH 792
+IHRD+ + N L+ EN +SDFG+ R + +ST GT + + PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST---GTKFPVKWASPEVFS 178
Query: 793 TSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851
SR + KSDV+SFG+++ E+ + GK +N SN ++ + P
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFRLYK--PR---LAS 231
Query: 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
+Q+ C + P +RP + R L + +
Sbjct: 232 T-----HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 65/278 (23%), Positives = 110/278 (39%), Gaps = 44/278 (15%)
Query: 624 VGYGASSTVYKCALKNSRPIAVK--KLYNQYPHNLREFETELETIGSIRHRN--IVSLHG 679
+G G SS V++ + + A+K L L + E+ + ++ + I+ L+
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 680 YALSPYGNLLFYDYMV----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
Y ++ + YMV N L L KK +D R + + +H
Sbjct: 96 YEITD-QYI----YMVMECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIH--- 144
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP--TAMPHASTFVLGTIGYIDPE---- 789
I+H D+K +N LI + L DFGIA + T + V GT+ Y+ PE
Sbjct: 145 QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKD 202
Query: 790 -------YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842
S+++ KSDV+S G +L + GK N + + D N +E
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-F 261
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
D+ ++ C KR P +R ++ E+
Sbjct: 262 PDIPEKDLQDV--LKC-------CLKRDPKQRISIPEL 290
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 625 GYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS 683
G G VY+ K S +AVK L + + EF E + I+H N+V L G
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 684 PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRD 743
+ ++M G+L D L +++ ++ L +A + + YL IHR+
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 744 VKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVY 803
+ + N L+ EN ++DFG++R + A I + PE ++ + KSDV+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 804 SFGIVLLEILT-GKK---AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKT 859
+FG++L EI T G +D L + + ME PE C + K
Sbjct: 404 AFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKDYRMER--PE---GCPE-----KV 448
Query: 860 FQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
++L C + PS+RP+ E+ + ++
Sbjct: 449 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 480
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 65/264 (24%), Positives = 108/264 (40%), Gaps = 24/264 (9%)
Query: 623 IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYA 681
++G G VY L N IA+K++ + + E+ ++H+NIV G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 682 LSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---GLAYLHHDCNPR 738
+F + + GSL LL +K + +T I Q GL YLH + +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IGFYTKQILEGLKYLHDN---Q 142
Query: 739 IIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL- 796
I+HRD+K N+LI+ + +SDFG ++ + P TF GT+ Y+ PE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRG 201
Query: 797 -NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855
+ +D++S G ++E+ TGK M K V + +S
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMFKVHPEIPESMSAEAKAF-- 258
Query: 856 VRKTFQLALLCTKRYPSERPTMQE 879
+ K F+ P +R +
Sbjct: 259 ILKCFE-------PDPDKRACAND 275
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 71/299 (23%), Positives = 119/299 (39%), Gaps = 38/299 (12%)
Query: 616 ENLSEKYIVGYGASSTVYKCALK-----NSRPIAVKKLYNQYPHNLREFETELETIGSIR 670
+L +G G +V C +AVKKL + +LR+FE E+E + S++
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 671 HRNIVSLHGYALSPYGNLLFY--DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
H NIV G S L +Y+ GSL D L K ++D L+ +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT--IGYI 786
YL R IHRD+ + NIL++ + DFG+ + +P G I +
Sbjct: 128 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846
PE S+ + SDV+SFG+VL E+ T + S + M D +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMRMIGNDKQG 234
Query: 847 SVTCVDL-SAVRK-------------TFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
+ L ++ + + C ++RP+ +++A + +
Sbjct: 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 21/282 (7%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR 670
I R + L +K +G G V+ +AVK + + F E + +++
Sbjct: 185 IPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQ 241
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
H +V LH ++ + ++M GSL D L K + + A+G+A+
Sbjct: 242 HDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAF 299
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY 790
+ IHRD++++NIL+ + ++DFG+AR I A I + PE
Sbjct: 300 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356
Query: 791 AHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849
+ KSDV+SFGI+L+EI+T G+ SN ++ + M PE
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRMPR--PE---N 409
Query: 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
C + + + + + C K P ERPT + + VL A
Sbjct: 410 CPE-----ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 47/290 (16%), Positives = 90/290 (31%), Gaps = 46/290 (15%)
Query: 620 EKYIV----GYGASSTVYKCALKNS-RPIAVKKL-YNQYPHNLREFETELETIGSIRHRN 673
+ G G V++ K A+K++ + E++ + + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 674 IVSLHGY---------ALSPYGNLLFY---DYMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
IV + Y +L D ++G + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 722 VGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL- 780
+ A+ + +LH + ++HRD+K SNI + + DFG+ + +
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 781 ----------GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM 830
GT Y+ PE H + + K D++S G++L E+L +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVR 241
Query: 831 SKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ P + + P ERP +
Sbjct: 242 N--------LKFPPLFTQKYPCEY------VMVQDMLSPSPMERPEAINI 277
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 40/348 (11%), Positives = 77/348 (22%), Gaps = 53/348 (15%)
Query: 577 QQRQQLITGSRKSMLGPPKLVILHMDMAIHTFDDIMRSTENLSEKY-------IVGYGAS 629
++ ++LI R+ L P ++ + + + LS+ + G
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 630 STVYKCALKNS-RPIAVKKLY---NQYPHNLREFETELETIGSIRHRNIVSL-------- 677
S V+ A+K L + +
Sbjct: 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 678 -----------------HGYALSPYGNLLFYDYMVNGSLWDLL----HGPSKKVKLDWET 716
G N L + L L +
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 717 RLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776
+ + A L ++H N+ I + L D + T P
Sbjct: 196 LHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP--- 249
Query: 777 TFVLGTIGYIDPEY--AHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD 834
+ Y E+ A T+ + + G+ + + + + +
Sbjct: 250 ASS-VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVAR 882
D +C L KT L R E
Sbjct: 309 LRVPGT--DSLAFGSCTPLPDFVKTLIGRFLNFD--RRRRLLPLEAME 352
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 21/282 (7%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR 670
I R + L K +G G V+ + +A+K L F E + + +R
Sbjct: 181 IPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLR 237
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
H +V L+ +S + +YM GSL D L G + K L + +A A G+AY
Sbjct: 238 HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAY 295
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY 790
+ +HRD++++NIL+ EN ++DFG+AR I A I + PE
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 791 AHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849
A R KSDV+SFGI+L E+ T G+ N + ++ + + M P
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMPC--PP---E 405
Query: 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
C + L C ++ P ERPT + + L +
Sbjct: 406 CPE-----SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 65/308 (21%), Positives = 118/308 (38%), Gaps = 48/308 (15%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSR-----PIAVKKL-YNQYPHNLREFETELETIGSI 669
L + +G G V + +AVK L + P + ++ E++ + ++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 670 RHRNIVSLHGYALSPYGN--LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
H +I+ G L +Y+ GSL D L + + L A +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI- 786
+AYLH IHRD+ + N+L+D + + DFG+A+ +P + + G
Sbjct: 147 MAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRVREDGDSP 200
Query: 787 ----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLI------MSKADD 835
PE + SDV+SFG+ L E+LT + + +LI M+
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR- 259
Query: 836 NTVMEAVD-------PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ E ++ P+ C + + L C + S RPT + + +L ++
Sbjct: 260 --LTELLERGERLPRPD---KCPA-----EVYHLMKNCWETEASFRPTFENLIPILKTVH 309
Query: 889 PAPPAKLS 896
+
Sbjct: 310 EKYQGQAP 317
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 71/296 (23%), Positives = 123/296 (41%), Gaps = 34/296 (11%)
Query: 616 ENLSEKYIVGYGASSTVYKCAL-----KNSRPIAVKKLYNQYPHNLREFETELETIGSIR 670
+L +G G +V C +AVKKL + +LR+FE E+E + S++
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 671 HRNIVSLHGYALSPYGNLLF--YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
H NIV G S L +Y+ GSL D L K ++D L+ +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT--IGYI 786
YL R IHRD+ + NIL++ + DFG+ + +P + G I +
Sbjct: 159 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKA-----DDNTVMEA 841
PE S+ + SDV+SFG+VL E+ T + + ++ ++E
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 842 VD-------PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890
+ P+ C D + + + C ++RP+ +++A + +
Sbjct: 276 LKNNGRLPRPD---GCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 69/293 (23%), Positives = 117/293 (39%), Gaps = 33/293 (11%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQYPHN-LREFETELET 665
I ++G G VY N A+K L + F E
Sbjct: 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL 75
Query: 666 IGSIRHRNIVSLHGYALSPYG-NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ + H N+++L G L P G + YM +G L + P + + + + +
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQV 133
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT-- 782
A+G+ YL + +HRD+ + N ++DE+F ++DFG+AR I ++
Sbjct: 134 ARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 783 -IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSKADDNT 837
+ + E T R KSDV+SFG++L E+LT G +D H L
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-----AQGR 245
Query: 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890
+ PE C D +Q+ C + P+ RPT + + + ++ A
Sbjct: 246 RLPQ--PE---YCPD-----SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 74/307 (24%), Positives = 121/307 (39%), Gaps = 45/307 (14%)
Query: 609 DDIMRSTENLSEKYIVGYGASSTVYKCALKN----SRPIAVK--KLYNQYPHNLREFETE 662
+D++ L I+G G +V + LK S +AVK KL N + EF +E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 663 LETIGSIRHRNIVSLHG--YALSPYGNLLFY---DYMVNGSLWDLL---HGPSKKVKLDW 714
+ H N++ L G +S G +M G L L + +
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 715 ETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774
+T LK V A G+ YL N +HRD+ + N ++ ++ ++DFG+++ I
Sbjct: 147 QTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI----YS 199
Query: 775 ASTFVLGTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNL 825
+ G I + E KSDV++FG+ + EI T G V N
Sbjct: 200 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 826 HQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885
L ++ PE C+D + +++ C + P +RPT + L
Sbjct: 260 DYL-----LHGHRLKQ--PE---DCLD-----ELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
Query: 886 SLLPAPP 892
LL + P
Sbjct: 305 KLLESLP 311
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 8e-28
Identities = 64/278 (23%), Positives = 108/278 (38%), Gaps = 44/278 (15%)
Query: 624 VGYGASSTVYKCALKNSRPIAVK--KLYNQYPHNLREFETELETIGSIRH--RNIVSLHG 679
+G G SS V++ + + A+K L L + E+ + ++ I+ L+
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 680 YALSPYGNLLFYDYMV----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
Y ++ + YMV N L L KK +D R + + +H
Sbjct: 124 YEITD-QYI----YMVMECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH- 174
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP--TAMPHASTFVLGTIGYIDPE---- 789
I+H D+K +N LI + L DFGIA + T + V G + Y+ PE
Sbjct: 175 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKD 230
Query: 790 -------YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842
S+++ KSDV+S G +L + GK N + + D N +E
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-F 289
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
D+ ++ C KR P +R ++ E+
Sbjct: 290 PDIPEKDLQDV--LKC-------CLKRDPKQRISIPEL 318
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 61/267 (22%), Positives = 100/267 (37%), Gaps = 37/267 (13%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFET-ELETIGSIRHRNIVSLHGYA 681
VG G+ V++ + AVKK+ L F EL + IV L+G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLYGAV 119
Query: 682 LSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---GLAYLHHDCNPR 738
+F + + GSL L+ + L E R Q GL YLH R
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI---KQMGCLP-EDR--ALYYLGQALEGLEYLHTR---R 170
Query: 739 IIHRDVKSSNILIDEN-FDAHLSDFGIARCI-----PTAMPHASTFVLGTIGYIDPEYAH 792
I+H DVK+ N+L+ + A L DFG A C+ ++ GT ++ PE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP-GTETHMAPEVVM 229
Query: 793 TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852
+ K D++S ++L +L G L + A + + + P +
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-PLCLKIASEPPPIREIPPSCAPLTAQ 288
Query: 853 LSAVRKTFQLALLCTKRYPSERPTMQE 879
+++ + + P R + E
Sbjct: 289 A--IQEGLR-------KEPVHRASAME 306
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 60/276 (21%), Positives = 106/276 (38%), Gaps = 35/276 (12%)
Query: 211 LDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIP 270
+ + E+P I L+L N++ ++ L +L LS N +
Sbjct: 48 VICVRKNLR-EVPDGI-STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI 105
Query: 271 PILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLF 328
L+ L L N+LT IP +SKL L L+NN + +IP+ ++ L
Sbjct: 106 GAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLR 163
Query: 329 ELNLADNNLEGPIPHNI-SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKG 387
L+L + I + L N+ L IP+ L L L+LS N+
Sbjct: 164 RLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSA 221
Query: 388 KVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSI 447
+ +F G L HL L + ++ + + F NL+S+
Sbjct: 222 ----------------IRPGSFQG--------LMHLQKLWMIQSQIQVIERNAFDNLQSL 257
Query: 448 QTIDMSFNQLSGSIPAE-LGQLQNIISLILNNNNLQ 482
I+++ N L+ +P + L ++ + L++N
Sbjct: 258 VEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 63/282 (22%), Positives = 100/282 (35%), Gaps = 39/282 (13%)
Query: 62 RNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ 121
+ L ++PD I + + L +N + S L+ LE L L N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 122 LTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQL 181
+ + NL TL+L N+LT IP A L
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPN---------------GAFVY--------L 135
Query: 182 TGLWYFDVRGNNLTGTIPDSI-GNCTSFEILDIS-YNQITGEIPYNI--GFLQVATLSLQ 237
+ L +R N + +IP S LD+ +++ I G + L+L
Sbjct: 136 SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLA 193
Query: 238 GNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPE- 296
L +IP + L L LDLS N L P L + KL++ +++ I
Sbjct: 194 MCNLR-EIPNLTPL-IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNA 250
Query: 297 LGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLADNNL 337
N+ L + L +N L +P + L L ++L N
Sbjct: 251 FDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 58/255 (22%), Positives = 96/255 (37%), Gaps = 15/255 (5%)
Query: 282 LYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPI 341
+ L +P + + L L NQ+ L L L L+ N++
Sbjct: 48 VICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE 104
Query: 342 PHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTEL-GRIINLD 400
+ LN + NRL+ +F L L L L N + +P+ RI +L
Sbjct: 105 IGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLR 163
Query: 401 TLDLSVNNFSGSVPASI-GDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459
LDL + L +L LNL+ +L + L + +D+S N LS
Sbjct: 164 RLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLS- 220
Query: 460 SIPAE-LGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRF 518
+I L ++ L + + +Q + N SL +N+++NNL+ + P F+
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL--PHDLFTPL 278
Query: 519 SSNSFI---GNPLLC 530
I NP C
Sbjct: 279 HHLERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 65/255 (25%), Positives = 101/255 (39%), Gaps = 23/255 (9%)
Query: 26 CSWRG--VFCDNSSLSVV----SLNLSSLNLGG----EISPSI-GDLRNLQSIDFQGNKL 74
CS + V C +L V S N LNL I + LR+L+ + N +
Sbjct: 41 CSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 75 TGQIPDEI-GNCGSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPSTLTQ 132
I +L +EL DN L IP L +L+ L L+NN + +
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158
Query: 133 IPNLKTLDLAR-NQLTGEIPRLIYWN-EVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVR 190
IP+L+ LDL +L+ I + L+YL L L + P++ L L D+
Sbjct: 159 IPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLS 215
Query: 191 GNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPEV 248
GN+L+ P S + L + +QI I N + ++L N LT ++
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDL 274
Query: 249 IGLMQALAVLDLSEN 263
+ L + L N
Sbjct: 275 FTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-16
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 9/168 (5%)
Query: 346 SSCTALNQFNV---HGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTL 402
S C+ NQF+ L +P + LNL N + + +L+ L
Sbjct: 37 SVCSCSNQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEIL 93
Query: 403 DLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIP 462
LS N+ + L +L TL L N L + F L ++ + + N + SIP
Sbjct: 94 QLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIP 152
Query: 463 AEL-GQLQNIISLILNNNNLQGGIPDQ-LSNCFSLSNLNVSYNNLSGI 508
+ ++ ++ L L I + +L LN++ NL I
Sbjct: 153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 35/143 (24%), Positives = 58/143 (40%), Gaps = 7/143 (4%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSI-GDLRNLQSIDFQGNKLTGQIPDEIGNCGSL 88
F SL L+L L IS L NL+ ++ L +IP+ + L
Sbjct: 154 YAFNRIPSL--RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKL 209
Query: 89 VHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTG 148
++LS N L P S L L+ L + +Q+ + + +L ++LA N LT
Sbjct: 210 DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT- 268
Query: 149 EIPRLIYWN-EVLQYLGLRGNAL 170
+P ++ L+ + L N
Sbjct: 269 LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 608 FDDIMRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETE 662
+ + E + +G G+ V+K + + +A+K + +L E E E
Sbjct: 10 LPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII------DLEEAEDE 63
Query: 663 LETI-------GSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWE 715
+E I + +G L + +Y+ GS DLL + LD E
Sbjct: 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLD-E 118
Query: 716 TRLKIAV---GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772
T +IA +GL YLH + + IHRD+K++N+L+ E+ + L+DFG+A +
Sbjct: 119 T--QIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173
Query: 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
+TFV GT ++ PE S + K+D++S GI +E+ G+
Sbjct: 174 IKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 68/291 (23%), Positives = 120/291 (41%), Gaps = 33/291 (11%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNSR----PIAVKKLYNQY-PHNLREFETELET 665
I S+ + ++G G VY L ++ AVK L + +F TE
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ H N++SL G L G+ L YM +G L + + ++ + + +
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQV 137
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA---MPHASTFVLG 781
A+G+ YL + + +HRD+ + N ++DE F ++DFG+AR + H T
Sbjct: 138 AKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194
Query: 782 TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSKADDNT 837
+ ++ E T + KSDV+SFG++L E++T G V+ L
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-----LQGR 249
Query: 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ PE C D +++ L C RP+ E+ + ++
Sbjct: 250 RLLQ--PE---YCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 21/282 (7%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR 670
I R + L K +G G V+ + +A+K L F E + + +R
Sbjct: 264 IPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLR 320
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
H +V L+ +S + +YM GSL D L G + K L + +A A G+AY
Sbjct: 321 HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAY 378
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY 790
+ +HRD++++NIL+ EN ++DFG+AR I A I + PE
Sbjct: 379 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 791 AHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849
A R KSDV+SFGI+L E+ T G+ N + ++ + + M P
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMPC--PP---E 488
Query: 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
C + L C ++ P ERPT + + L +
Sbjct: 489 CPE-----SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 54/282 (19%), Positives = 115/282 (40%), Gaps = 27/282 (9%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR 670
I ++ +G G V + +A+K + + EF E + + ++
Sbjct: 21 IDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLS 77
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
H +V L+G + +YM NG L + L + + + L++ + + Y
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEY 135
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT---IGYID 787
L + + +HRD+ + N L+++ +SDFG++R + +S G+ + +
Sbjct: 136 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSP 189
Query: 788 PEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846
PE S+ + KSD+++FG+++ EI + GK + +N + P
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQGLRLYR--PH- 244
Query: 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ K + + C ERPT + + ++ ++
Sbjct: 245 --LASE-----KVYTIMYSCWHEKADERPTFKILLSNILDVM 279
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 81/289 (28%), Positives = 124/289 (42%), Gaps = 35/289 (12%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR 670
+ R T L E+ +G G V+ +AVK L + F E + ++
Sbjct: 10 VPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQ 66
Query: 671 HRNIVSLHGYAL-SPYGNLLFY---DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
H+ +V L+ P Y +YM NGSL D L P +KL L +A A+
Sbjct: 67 HQRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 120
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
G+A++ IHRD++++NIL+ + ++DFG+AR I A I +
Sbjct: 121 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSKADDNTVMEAV 842
PE + KSDV+SFGI+L EI+T G+ + N + L + M
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----ERGYRMVR- 231
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
P+ C + + +QL LC K P +RPT + VL A
Sbjct: 232 -PD---NCPE-----ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 7/210 (3%)
Query: 277 SYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLADN 335
+ + +++LHGN+++ L+ L L +N L I A L L +L+L+DN
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDN 90
Query: 336 NLEGPIPHNI-SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTE-L 393
+ L+ ++ L P FR L +L YL L N + +P +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 394 GRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMS 453
+ NL L L N S + L L L L +N + + P F +L + T+ +
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 454 FNQLSGSIPAE-LGQLQNIISLILNNNNLQ 482
N LS ++P E L L+ + L LN+N
Sbjct: 210 ANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 51/255 (20%), Positives = 84/255 (32%), Gaps = 37/255 (14%)
Query: 282 LYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPI 341
L +P + + + L N++ A L L L N L
Sbjct: 16 TSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA--- 69
Query: 342 PHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTE-LGRIINLD 400
I ++F L L L+LS N V + L
Sbjct: 70 --RID-------------------AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH 108
Query: 401 TLDLSVNNFSGSVPASI-GDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459
TL L + + L L L L N L L F +L ++ + + N++S
Sbjct: 109 TLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS- 166
Query: 460 SIPAE-LGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRF 518
S+P L ++ L+L+ N + P + L L + NNLS + P +
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL--PTEALAPL 224
Query: 519 SSNSFI---GNPLLC 530
+ ++ NP +C
Sbjct: 225 RALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 56/260 (21%), Positives = 89/260 (34%), Gaps = 35/260 (13%)
Query: 60 DLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKN 119
+ L +P I + I L N + S + L L L +
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 120 NQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWN-EVLQYLGLRGNALTGMLSPDM 178
N L + T + L+ LDL+ N + + L L L L L P +
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL 124
Query: 179 -CQLTGLWYFDVRGNNLTGTIPDSI-GNCTSFEILDISYNQITGEIPYNIGFLQVATLSL 236
L L Y ++ N L +PD + + L + N+I+ S+
Sbjct: 125 FRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS---------------SV 168
Query: 237 QGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPP-ILGNLSYTGKLYLHGNKLTGPIPP 295
G + +L L L +N + + P +L LYL N L+ +P
Sbjct: 169 PERAFRG--------LHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSA-LPT 218
Query: 296 E-LGNMSKLSYLQLQNNQLV 314
E L + L YL+L +N V
Sbjct: 219 EALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 32/161 (19%), Positives = 60/161 (37%), Gaps = 14/161 (8%)
Query: 44 NLSSLNLGG-----EISPSI-GDLRNLQSIDFQGNKLTGQIPDEI-GNCGSLVHIELSDN 96
L L+L + P+ L L ++ L ++ + +L ++ L DN
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139
Query: 97 SLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIY 155
+L +P L L L L N+++ + +L L L +N++ + +
Sbjct: 140 AL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAF 197
Query: 156 WN-EVLQYLGLRGNALTGMLSPD-MCQLTGLWYFDVRGNNL 194
+ L L L N L+ L + + L L Y + N
Sbjct: 198 RDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 20/110 (18%), Positives = 37/110 (33%), Gaps = 6/110 (5%)
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460
T +VP I + L N ++ + A F R++ + + N L+
Sbjct: 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-R 70
Query: 461 IPAE-LGQLQNIISLILNNNNLQGGIPDQ-LSNCFSLSNLNVSYNNLSGI 508
I A L + L L++N + L L++ L +
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 68/277 (24%), Positives = 119/277 (42%), Gaps = 25/277 (9%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIV 675
E ++ +G G V K +AVK + + EF E +T+ + H +V
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLV 66
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
+G Y + +Y+ NG L + L S L+ L++ +G+A+L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFLE--- 121
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT---IGYIDPEYAH 792
+ + IHRD+ + N L+D + +SDFG+ R + +S GT + + PE H
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV---GTKFPVKWSAPEVFH 178
Query: 793 TSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851
+ + KSDV++FGI++ E+ + GK D +N ++ K + P
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEVVLKVSQGHRLYR--PH---LAS 231
Query: 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
D +Q+ C P +RPT Q++ + L
Sbjct: 232 D-----TIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 63/298 (21%), Positives = 118/298 (39%), Gaps = 47/298 (15%)
Query: 612 MRSTENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIR 670
+R + E ++G GA V K R A+KK+ L +E+ + S+
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 671 HRNIVSLHG--------YALSPYGNLLFYDYMV-----NGSLWDLLHGPSKKVKLDWETR 717
H+ +V + ++ NG+L+DL+H S+ + +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH--SENLNQQRDEY 118
Query: 718 LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP---- 773
++ + L+Y+H + IIHRD+K NI IDE+ + + DFG+A+ + ++
Sbjct: 119 WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 774 ----------HASTFVLGTIGYIDPE-YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNE 822
+ ++ + GT Y+ E T NEK D+YS GI+ E++
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER 234
Query: 823 SNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
N+ + + S D + +R L+ P++RP + +
Sbjct: 235 VNILKKLRSV--SIEFPPDFDDNKMKVEKKI--IRL-----LIDHD--PNKRPGARTL 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 52/266 (19%), Positives = 87/266 (32%), Gaps = 37/266 (13%)
Query: 624 VGYGASSTVYKCALKNSRPI-AVKKLYNQYPHNLREFETELETIGSI----RHRNIVSLH 678
+G+G+ V+K K + AVK+ ++ +L +GS +H V L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 679 GYALSPYGNLLFYDYMVN----GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD 734
G L Y+ SL + L LA+LH
Sbjct: 124 QAWEEG-GIL----YLQTELCGPSLQQHCE--AWGASLPEAQVWGYLRDTLLALAHLH-- 174
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
+ ++H DVK +NI + L DFG+ + TA G Y+ PE
Sbjct: 175 -SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AGEVQE-GDPRYMAPE-LLQG 230
Query: 795 RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854
+DV+S G+ +LE+ + QL + +S +
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY-----LPPEFTAGLSSELRSV- 284
Query: 855 AVRKTFQLALLCTKRYPSERPTMQEV 880
+ + P R T + +
Sbjct: 285 -LVM-------MLEPDPKLRATAEAL 302
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 614 STENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKL-YNQYPHNLREFETELETI-GSIR 670
+ E+L + +G GA +V K K S + +AVK++ ++ +L+ + S
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD 79
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL------KIAVGA 724
IV +G + + M + S K V + + KI +
Sbjct: 80 CPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLAT 134
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIG 784
+ L +L + IIHRD+K SNIL+D + + L DFGI+ + ++ A T G
Sbjct: 135 VKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI--AKTRDAGCRP 190
Query: 785 YIDPEYAHTSRLNE----KSDVYSFGIVLLEILTGK 816
Y+ PE S + +SDV+S GI L E+ TG+
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 64/297 (21%), Positives = 113/297 (38%), Gaps = 36/297 (12%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSR-----PIAVKKLYNQY-PHNLREFETELETIGSI 669
+ ++G GA TVYK P+A+K+L P +E E + S+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 670 RHRNIVSLHGYALS--PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
+ ++ L G L+ L M G L D + K + + L V A+G
Sbjct: 75 DNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKG 129
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT---IG 784
+ YL + R++HRD+ + N+L+ ++DFG+A+ + G I
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIK 184
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVD 843
++ E +SDV+S+G+ + E++T G K D I S + +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQ-- 240
Query: 844 PEVSVTC-VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAA 899
P C +D+ + + C RP +E+ + P L +
Sbjct: 241 PP---ICTIDV------YMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 65/290 (22%), Positives = 116/290 (40%), Gaps = 47/290 (16%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR 670
+ L + +G G V + +AVK + N + F E + +R
Sbjct: 190 LNMKELKLLQT--IGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLR 244
Query: 671 HRNIVSLHGYALSPYGNLLFY---DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
H N+V L G + G Y +YM GSL D L + L + LK ++ +
Sbjct: 245 HSNLVQLLGVIVEEKGG--LYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEA 301
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA-----MPHASTFVLGT 782
+ YL +HRD+ + N+L+ E+ A +SDFG+ + + +P
Sbjct: 302 MEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--------- 349
Query: 783 IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSKADDNTV 838
+ + PE + + KSDV+SFGI+L EI + G+ + + + ++ +
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYK 404
Query: 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
M+A P+ C + + C + RPT ++ L +
Sbjct: 405 MDA--PD---GCPP-----AVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 55/291 (18%), Positives = 116/291 (39%), Gaps = 26/291 (8%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNSR---PIAVKKLYNQY-PHNLREFETELETI 666
+ R +++ + G G +V + + + +A+K L + E E + +
Sbjct: 6 LKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 64
Query: 667 GSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+ + IV L G + +L + G L L G K+ ++ ++ +
Sbjct: 65 HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSM 121
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT--IG 784
G+ YL +HRD+ + N+L+ A +SDFG+++ + + + G +
Sbjct: 122 GMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVD 843
+ PE + + + +SDV+S+G+ + E L+ G+K +M+ + ME
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRMEC-- 234
Query: 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAK 894
P C + + L C +RP V + + + + +K
Sbjct: 235 PP---ECPP-----ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 71/277 (25%), Positives = 119/277 (42%), Gaps = 31/277 (11%)
Query: 623 IVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYA 681
+G G VY+ K S +AVK L + EF E + I+H N+V L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 682 LSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIH 741
+ ++M G+L D L +++ ++ L +A + + YL IH
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 742 RDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT---IGYIDPEYAHTSRLNE 798
RD+ + N L+ EN ++DFG++R + A G I + PE ++ +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA---GAKFPIKWTAPESLAYNKFSI 191
Query: 799 KSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854
KSDV++FG++L EI T G +D L + + ME PE C +
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKDYRMER--PE---GCPE-- 239
Query: 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
K ++L C + PS+RP+ E+ + ++
Sbjct: 240 ---KVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 61/313 (19%), Positives = 117/313 (37%), Gaps = 46/313 (14%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKN----SRPIAVK--KLYNQYPHNLREFETELETIGSI 669
+ + ++G G +V + LK +AVK K ++ EF E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 670 RHRNIVSLHG------YALSPYGNLLFYDYMVNGSLWDLL---HGPSKKVKLDWETRLKI 720
H ++ L G ++ +M +G L L L +T ++
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 721 AVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
V A G+ YL + IHRD+ + N ++ E+ ++DFG++R I + +
Sbjct: 143 MVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS----GDYYRQ 195
Query: 781 GTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMS 831
G + E + SDV++FG+ + EI+T G+ ++N + L
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL--- 252
Query: 832 KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
++ P C++ + + L C P +RP+ + L ++L
Sbjct: 253 --IGGNRLKQ--PP---ECME-----EVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300
Query: 892 PAKLSLAAPKPID 904
+ P I+
Sbjct: 301 SVLSTSQDPLYIN 313
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 87/344 (25%), Positives = 142/344 (41%), Gaps = 33/344 (9%)
Query: 570 IAVYKSNQQRQQLITGSRKSMLGPPKLVILHMDMAIHTFD-DIMRSTENLSEKYIVGYGA 628
++ Y + I + + A+ F +I S + +G G
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGS--DPNQAVLKFTTEIHPSCVTRQKV--IGAGE 56
Query: 629 SSTVYKCALKNSR-----PIAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSLHGYAL 682
VYK LK S P+A+K L Y R +F E +G H NI+ L G
Sbjct: 57 FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116
Query: 683 SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHR 742
++ +YM NG+L L K + + + G A G+ YL + +HR
Sbjct: 117 KYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHR 171
Query: 743 DVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT---IGYIDPEYAHTSRLNEK 799
D+ + NIL++ N +SDFG++R + P A+ G I + PE +
Sbjct: 172 DLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 230
Query: 800 SDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRK 858
SDV+SFGIV+ E++T G++ SN +M +D + P C
Sbjct: 231 SDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDGFRLPT--PM---DCPS-----A 278
Query: 859 TFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAPKP 902
+QL + C ++ + RP ++ +L L+ AP + +LA P
Sbjct: 279 IYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDP 322
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 16/218 (7%)
Query: 607 TFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPI-AVKKL-YNQYPHNLREFETELE 664
+ + E + E +G GA V K S I AVK++ + +L+
Sbjct: 1 SMEVKADDLEPIME---LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD 57
Query: 665 TI-GSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRL-KIAV 722
++ V+ +G + + M + SL K + E L KIAV
Sbjct: 58 ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT 782
+ L +LH +IHRDVK SN+LI+ + DFGI+ + + G
Sbjct: 117 SIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-AKDIDA-GC 172
Query: 783 IGYIDPE----YAHTSRLNEKSDVYSFGIVLLEILTGK 816
Y+ PE + + KSD++S GI ++E+ +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 615 TENLSEKYIVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRN 673
E +G G+ +VYK + + +A+K++ +L+E E+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV---GAAQGLAY 730
+V +G + +Y GS+ D++ +K + D IA +GL Y
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IATILQSTLKGLEY 140
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY 790
LH R IHRD+K+ NIL++ A L+DFG+A + M +T + GT ++ PE
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196
Query: 791 AHTSRLNEKSDVYSFGIVLLEILTGK 816
N +D++S GI +E+ GK
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 50/210 (23%), Positives = 84/210 (40%), Gaps = 33/210 (15%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKL--YNQYPHNLREFETELETI-GSIRHRNIVSLHGY 680
+G G V+K + + + K + + +L+ + S IV G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 681 ALSPYGNLLFYDYMVNGSLW---DLLHGPSKKVKLDWETRL------KIAVGAAQGLAYL 731
++ N ++ +L+ ++K+K + + K+ V + L YL
Sbjct: 93 ------------FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY-----I 786
+IHRDVK SNIL+DE L DFGI+ + G Y I
Sbjct: 141 KEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA-KDRSA-GCAAYMAPERI 196
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
DP + ++DV+S GI L+E+ TG+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 55/283 (19%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G G V + +AVK + N + F E + +RH N+V L G +
Sbjct: 28 TIGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 683 SPYGNLLFY---DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739
G L Y +YM GSL D L + L + LK ++ + + YL
Sbjct: 85 EEKGGL--YIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCIPTA----------MPHASTFVLGTIGYIDPE 789
+HRD+ + N+L+ E+ A +SDFG+ + + PE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA--------------PE 184
Query: 790 YAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSKADDNTVMEAVDPE 845
+ + KSDV+SFGI+L EI + G+ + + + ++ + M+A P+
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKMDA--PD 237
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
C +++ C + RP+ ++ L +
Sbjct: 238 ---GCPP-----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 76/315 (24%), Positives = 131/315 (41%), Gaps = 70/315 (22%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLREFETELETIGSI 669
++ K +G GA V+ N P +AVK L + ++F+ E E + ++
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 670 RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL--HGPSKKVKLDWETR---------- 717
+H +IV +G ++ ++YM +G L L HGP + +D + R
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 718 -LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA----- 771
L IA A G+ YL + +HRD+ + N L+ N + DFG++R + +
Sbjct: 135 MLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 772 ----------MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK--- 817
MP PE + +SDV+SFG++L EI T GK+
Sbjct: 192 GGHTMLPIRWMP--------------PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 818 AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTM 877
+ N + + V+E P C + + + L C +R P +R +
Sbjct: 238 QLSNTEVIECI-----TQGRVLER--PR---VCPK-----EVYDVMLGCWQREPQQRLNI 282
Query: 878 QEVARVLVSLLPAPP 892
+E+ ++L +L A P
Sbjct: 283 KEIYKILHALGKATP 297
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 66/293 (22%), Positives = 116/293 (39%), Gaps = 37/293 (12%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQYPHN-LREFETELET 665
I S+ + ++G G VY L AVK L + +F TE
Sbjct: 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 143
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ H N++SL G L G+ L YM +G L + + ++ + + +
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQV 201
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIG 784
A+G+ +L + + +HRD+ + N ++DE F ++DFG+AR + + T
Sbjct: 202 AKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS--VHNKTGA 256
Query: 785 YI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSKADD 835
+ E T + KSDV+SFG++L E++T G V+ L
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-----LQ 311
Query: 836 NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ PE C D +++ L C RP+ E+ + ++
Sbjct: 312 GRRLLQ--PE---YCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 38/329 (11%), Positives = 82/329 (24%), Gaps = 69/329 (20%)
Query: 623 IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYP------HNLREFETELETIGSIRHRNIV 675
++G + + V Y ++E L + I+++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 676 SLHGYALSPY-----------------------GNLLFYDYMVNGSLWD----LLHGPSK 708
+H + P+ + F + +L LL S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 709 KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768
L RL++ + + LA LHH ++H ++ +I++D+ L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 769 PTAMPHASTFVLGTIGYIDPE-----YAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDN 821
+ H + + D ++ G+ + I D
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 822 ESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV- 880
+ I + L + +R +
Sbjct: 322 ALGGSEWIFRS----------CKNIPQPVRAL--LEG------FLRYP-KEDRLLPLQAM 362
Query: 881 -----ARVLVSLLPAPPAKLSLAAPKPID 904
++ L A P + P
Sbjct: 363 ETPEYEQLRTELSAALPLYQTDGEPTREG 391
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 62/308 (20%), Positives = 107/308 (34%), Gaps = 46/308 (14%)
Query: 620 EKYIVGYGASSTVYKC-ALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSL 677
+ + G + VY+ + + R A+K+L + R E+ + + H NIV
Sbjct: 33 RRVL-AEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 678 HGYALSPYGNLL--FYDYMV-----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
A ++++ G L + L + L +T LKI + + +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL---------- 780
+H P IIHRD+K N+L+ L DFG A + P S
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT-TISHYPDYSWSAQRRALVEEEIT 209
Query: 781 --GTIGYIDPEYAHTSR---LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADD 835
T Y PE + EK D+++ G +L + + ++ + L I++
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--IVNG--- 264
Query: 836 NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKL 895
L +R Q+ P ER ++ EV L + A
Sbjct: 265 -KYSIPPHDTQYTVFHSL--IRAMLQV-------NPEERLSIAEVVHQLQEIAAARN--- 311
Query: 896 SLAAPKPI 903
+ PI
Sbjct: 312 -VNPKSPI 318
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 39/305 (12%), Positives = 83/305 (27%), Gaps = 74/305 (24%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKLYNQYP------HNLREFETELETIGSIRHRNIV 675
++G + + + V Y ++E L + I+++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 676 SLHGYALSPYG-----------------------NLLFYDYMVNGSLWD----LLHGPSK 708
+H + P+ + F + +L LL S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 709 KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768
L RL++ + + LA LHH ++H ++ +I++D+ L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 769 PTAMPHASTFVLGTIGYIDPEY-----------AHTSRLNEKSDVYSFGIVLLEILTGKK 817
A + G+ PE + + D ++ G+V+ I
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 818 --AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP 875
D + I + + L + L +R
Sbjct: 312 PITKDAALGGSEWIFRSCKN----------IPQPVRAL--LEG-----FLRYP--KEDRL 352
Query: 876 TMQEV 880
+
Sbjct: 353 LPLQA 357
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 27/289 (9%)
Query: 623 IVGYGASSTVYKCALK----NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSL 677
+VG G V LK +A+K L Y R+F E +G H NI+ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
G ++ +YM NGSL L + + + G A G+ YL +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLS---DM 166
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT---IGYIDPEYAHTS 794
+HRD+ + NILI+ N +SDFG+ R + P A+ G I + PE
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 795 RLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853
+ SDV+S+GIVL E+++ G++ SN Q ++ D+ + P C
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAVDEGYRLPP--PM---DCPA- 277
Query: 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAPKP 902
+QL L C ++ + RP +++ +L L+ P + + +
Sbjct: 278 ----ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 52/229 (22%), Positives = 81/229 (35%), Gaps = 35/229 (15%)
Query: 612 MRSTENLSEKY----IVGYGASS--TVYK--CALKNSRPIAVKK--LYNQYPHNLREFET 661
M S Y ++G G TV + V++ L + +
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARY-KPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 662 ELETIGSIRHRNIVSLHGYALSPYGNLLF--YDYMVNGSLWDLLHGPSKKVKLDWETRLK 719
EL H NIV ++ N L+ +M GS DL+ ++ E
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIA--DNELWVVTSFMAYGSAKDLIC-THFMDGMN-EL--A 129
Query: 720 IAV---GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI-------P 769
IA G + L Y+HH +HR VK+S+ILI + +LS +
Sbjct: 130 IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186
Query: 770 TAMPHASTFVLGTIGYIDPEYAHTSRL--NEKSDVYSFGIVLLEILTGK 816
V + ++ PE + + KSD+YS GI E+ G
Sbjct: 187 VVHDFPKYSV-KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 74/280 (26%), Positives = 121/280 (43%), Gaps = 31/280 (11%)
Query: 623 IVGYGASSTVYKCALK----NSRPIAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSL 677
I+G G S V L+ P+A+K L Y R +F +E +G H NI+ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
G ++ +YM NGSL L + + + + G G+ YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYLSDL--- 170
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI-----DPEYAH 792
+HRD+ + N+L+D N +SDFG++R + T G I PE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 793 TSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851
+ SDV+SFG+V+ E+L G++ N +N + ++S ++ + A P C
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSVEEGYRLPA--PM---GCP 280
Query: 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
QL L C + ++RP ++ VL +L+ +P
Sbjct: 281 H-----ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 53/267 (19%), Positives = 99/267 (37%), Gaps = 20/267 (7%)
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNL 337
L L N++T +L L L L +N + TI + L L L+L+ N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 338 EGPIPHNI-SSCTALNQFNVHGNRLSGAIPSS-FRNLGSLTYLNLSRNNFKGKVPTE-LG 394
+ + ++L N+ GN +S F +L L L + + K+ +
Sbjct: 113 SN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 395 RIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSF 454
+ L+ L++ ++ P S+ ++++ L L LL S++ +++
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 455 NQLSG----SIPA----ELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLS 506
L + L + ++ + + +L + L+ L L S N L
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK 290
Query: 507 GIIPPIRNFSRFSSNSFI---GNPLLC 530
+ P F R +S I NP C
Sbjct: 291 SV--PDGIFDRLTSLQKIWLHTNPWDC 315
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 59/344 (17%), Positives = 111/344 (32%), Gaps = 42/344 (12%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRG-VFCDNSSLSVVSLNLSSLNLGGEISPSIG 59
+ + + ++ + S C G + SL+ + L+
Sbjct: 5 LWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTE------------ 52
Query: 60 DLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLK 118
++S+D N++T ++ C +L + L+ N + I S L LE L+L
Sbjct: 53 ---AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLS 108
Query: 119 NNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWN-EVLQYLGLRGNALTGMLSPD 177
N L+ S + +L L+L N ++ + LQ L + +
Sbjct: 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 178 M-CQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI--GFLQVATL 234
LT L ++ ++L P S+ + + L + Q + V L
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227
Query: 235 SLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIP 294
L+ L +EL L + + L +
Sbjct: 228 ELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270
Query: 295 PELGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLADNNL 337
L +S L L+ NQL ++P +L L ++ L N
Sbjct: 271 KLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 63/375 (16%), Positives = 117/375 (31%), Gaps = 97/375 (25%)
Query: 85 CGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARN 144
C + S SL IP +++ ++ L+L NN++T S L + NL+ L L N
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 145 QLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSI-G 203
+ I ++ + L L + D+ N L+ + S
Sbjct: 87 GIN-TIE---------------EDSFSS--------LGSLEHLDLSYNYLS-NLSSSWFK 121
Query: 204 NCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSEN 263
+S L++ N + F + L +L +
Sbjct: 122 PLSSLTFLNLLGNPYK-TLGETSLF---------------------SHLTKLQILRVGNM 159
Query: 264 ELVGPIPP-ILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAEL 321
+ I L++ +L + + L P+ L ++ +S+L L Q + +
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQS-YEPKSLKSIQNVSHLILHMKQHI-LLLEIF 217
Query: 322 -GKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNL 380
+ L L D +L+ H + LS +S + + +
Sbjct: 218 VDVTSSVECLELRDTDLD----------------TFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 381 SRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAE 440
+ + V + + LL L SRN L +
Sbjct: 262 TDESLF-------------------------QVMKLLNQISGLLELEFSRNQLKSVPDGI 296
Query: 441 FGNLRSIQTIDMSFN 455
F L S+Q I + N
Sbjct: 297 FDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 27/117 (23%), Positives = 52/117 (44%), Gaps = 5/117 (4%)
Query: 398 NLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457
+ +LDLS N + + + +L L L+ N +N + F +L S++ +D+S+N L
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 458 SGSIPAEL-GQLQNIISLILNNNNLQGGIPDQ--LSNCFSLSNLNVSYNNLSGIIPP 511
S ++ + L ++ L L N + + + S+ L L V + I
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 66/285 (23%), Positives = 111/285 (38%), Gaps = 43/285 (15%)
Query: 623 IVGYGASSTVYKCALK----NSRPIAVKKL---YNQYPHNLREFETELETIGSIRHRNIV 675
+G G+ V + + +AVK L P + +F E+ + S+ HRN++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
L+G L+P + + GSL D L L T + AV A+G+ YL
Sbjct: 85 RLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLE--- 138
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT--IGYIDPEYAHT 793
+ R IHRD+ + N+L+ + DFG+ R +P H + PE T
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 794 SRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVD--------P 844
+ SD + FG+ L E+ T G++ + + ++ +D P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----------SQILHKIDKEGERLPRP 247
Query: 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889
E C + + + C P +RPT + L+ P
Sbjct: 248 E---DCPQ-----DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 76/309 (24%), Positives = 128/309 (41%), Gaps = 49/309 (15%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLREFETELETIGSI 669
++ K+ +G GA V+ N P +AVK L ++F+ E E + +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 670 RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL--HGPSKKVKLDWETR---------- 717
+H++IV G L+ ++YM +G L L HGP K+ E
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 718 LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777
L +A A G+ YL +HRD+ + N L+ + + DFG++R I
Sbjct: 161 LAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI----YSTDY 213
Query: 778 FVLGTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQL 828
+ +G + PE + +SDV+SFG+VL EI T GK+ + N + +
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273
Query: 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+E P C + + + C +R P +R ++++V L +L
Sbjct: 274 -----TQGRELER--PR---ACPP-----EVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
Query: 889 PAPPAKLSL 897
APP L +
Sbjct: 319 QAPPVYLDV 327
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 33/214 (15%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETI-------GSIRHRNIV 675
+G GA++ V +A+K++ NL + +T ++ + H NIV
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRI------NLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 676 SLHGYALSPYGNLLFY--DYMVNGSLWDLLHGPSKKVKLDWE--TRLKIAV---GAAQGL 728
S + + + L+ + GS+ D++ K + IA +GL
Sbjct: 77 SYYTSFVV--KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI-----PTAMPHASTFVLGTI 783
YLH + IHRDVK+ NIL+ E+ ++DFG++ + T TFV GT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTP 190
Query: 784 GYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGK 816
++ PE R + K+D++SFGI +E+ TG
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 5e-25
Identities = 53/291 (18%), Positives = 115/291 (39%), Gaps = 26/291 (8%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNSR---PIAVKKLYNQY-PHNLREFETELETI 666
+ R +++ + G G +V + + + +A+K L + E E + +
Sbjct: 332 LKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 390
Query: 667 GSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+ + IV L G + +L + G L L K+ ++ ++ +
Sbjct: 391 HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSM 447
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT--IG 784
G+ YL +HR++ + N+L+ A +SDFG+++ + + + G +
Sbjct: 448 GMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVD 843
+ PE + + + +SDV+S+G+ + E L+ G+K +M+ + ME
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRMEC-- 560
Query: 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAK 894
P C + + L C +RP V + + + + +K
Sbjct: 561 PP---ECPP-----ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 72/313 (23%), Positives = 114/313 (36%), Gaps = 48/313 (15%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRP------IAVKKLYNQY-PHNLREFETELETIGS 668
+N++ +G+GA VY+ + +AVK L + +F E I
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL----HGPSKKVKLDWETRLKIAVGA 724
H+NIV G +L + + M G L L PS+ L L +A
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILID---ENFDAHLSDFGIARCIPTAMPHASTFVLG 781
A G YL IHRD+ + N L+ A + DFG+AR I A S + G
Sbjct: 150 ACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKG 202
Query: 782 TIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSK 832
+ PE K+D +SFG++L EI + G + N+ L +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV---- 258
Query: 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892
M+ P+ C +++ C + P +RP + + P
Sbjct: 259 -TSGGRMDP--PK---NCPG-----PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307
Query: 893 AKLSLAAPKPIDY 905
+ PI+Y
Sbjct: 308 ---VINTALPIEY 317
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 64/281 (22%), Positives = 107/281 (38%), Gaps = 36/281 (12%)
Query: 623 IVGYGASSTVYKCALKN----SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSL 677
+G G V++ + + +A+K N +F E T+ H +IV L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 678 HGYAL-SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCN 736
G +P + + G L L + L + + A + LAYL +
Sbjct: 82 IGVITENPV--WIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLE---S 134
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI-----DPEYA 791
R +HRD+ + N+L+ N L DFG++R + ST+ + G + PE
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESI 189
Query: 792 HTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850
+ R SDV+ FG+ + EIL G K N ++ + ++ + P C
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGERLPM--PP---NC 242
Query: 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
+ L C PS RP E+ L ++L
Sbjct: 243 PP-----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 63/298 (21%), Positives = 113/298 (37%), Gaps = 30/298 (10%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSR-----PIAVKKLYNQY-PHNLREFETELETIGSI 669
+ ++G GA TVYK P+A+K+L P +E E + S+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 670 RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLA 729
+ ++ L G L+ L M G L D + K + + L V A+G+
Sbjct: 75 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT---IGYI 786
YL + R++HRD+ + N+L+ ++DFG+A+ + G I ++
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWM 186
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845
E +SDV+S+G+ + E++T G K D I S + + P
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQ--PP 242
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAPKPI 903
C + + + C RP +E+ + P L + + +
Sbjct: 243 ---ICTI-----DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 292
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 59/310 (19%), Positives = 108/310 (34%), Gaps = 80/310 (25%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSR--------PIAVKKLYNQYPHNLREFETELETIG 667
E+L +G G + ++K + + +K L + + F +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 668 SIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
+ H+++V +G + N+L +++ GSL L + + W+ L++A A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAA 125
Query: 728 LAYL--HHDCNPRIIHRDVKSSNILIDENFDAH--------LSDFGIARCI--------- 768
+ +L + +IH +V + NIL+ D LSD GI+ +
Sbjct: 126 MHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 769 -----PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AV 819
P + + +D +SFG L EI + G K A+
Sbjct: 181 IPWVPPECIENPKNL--------------NL----ATDKWSFGTTLWEICSGGDKPLSAL 222
Query: 820 DNESNLHQLIMSKADDNTVMEA-VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQ 878
D++ L +D + A E+ L C P RP+ +
Sbjct: 223 DSQRKLQFY-----EDRHQLPAPKAAEL-------------ANLINNCMDYEPDHRPSFR 264
Query: 879 EVARVLVSLL 888
+ R L SL
Sbjct: 265 AIIRDLNSLF 274
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 55/279 (19%), Positives = 89/279 (31%), Gaps = 29/279 (10%)
Query: 83 GNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQI---PNLKTL 139
G ++ D I K L+ L ++ ++ I ++ L+ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 140 DLARNQLTGEIPRLI--YWNEVLQYLGLRGNALTGMLSPD----MCQLTGLWYFDVRGNN 193
L ++TG P + L L LR + + GL + +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 194 LTGTIPDSIGNCTSFEILDISYNQITGEIP-----YNIGFLQVATLSLQGNKLT---GKI 245
+ + + LD+S N GE + F + L+L+ + G
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 246 PEVIGLMQALAVLDLSENELVGPIPPI----LGNLSYTGKLYLHGNKLTGPIPPELGNMS 301
+ L LDLS N L L+ L L L +P L +
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS---LNLSFTGLKQ-VPKGLP--A 274
Query: 302 KLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340
KLS L L N+L P+ L Q+ L+L N
Sbjct: 275 KLSVLDLSYNRL-DRNPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 59/307 (19%), Positives = 105/307 (34%), Gaps = 30/307 (9%)
Query: 7 FSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQS 66
N ++ DW N + ++ SL + + + G+ + I L L+
Sbjct: 14 SCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLS-LKR 72
Query: 67 IDFQGNKLTGQIPD---EIGNCGSLVHIELSDNSLYGDIPFSISKL--KQLEFLNLKNNQ 121
+ + ++ +I + L + L + + G P + + L LNL+N
Sbjct: 73 LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132
Query: 122 LTGPIPSTLTQI-----PNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTG---- 172
+ L ++ P LK L +A+ + L L L N G
Sbjct: 133 WAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191
Query: 173 MLSPDMCQLTGLWYFDVRGNNLT---GTIPDSIGNCTSFEILDISYNQITGEIPYNIGFL 229
+ + + L +R + G + LD+S+N +
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD-AAGAPSCD 250
Query: 230 QVA---TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVG-PIPPILGNLSYTGKLYLH 285
+ +L+L L ++P+ GL L+VLDLS N L P P L + L L
Sbjct: 251 WPSQLNSLNLSFTGLK-QVPK--GLPAKLSVLDLSYNRLDRNPSPDELPQVGN---LSLK 304
Query: 286 GNKLTGP 292
GN
Sbjct: 305 GNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 5e-23
Identities = 58/290 (20%), Positives = 95/290 (32%), Gaps = 39/290 (13%)
Query: 251 LMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPP---ELGNMSKLSYLQ 307
L L +D + I+ +LS +L + ++ I + +S L L
Sbjct: 45 LEYLLKRVDTEADLG--QFTDIIKSLSLK-RLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 308 LQNNQLVGTIPAELGKL--EQLFELNLADNNLEGPIPHNIS----SCTALNQFNVHGNRL 361
L+N ++ GT P L + L LNL + + L ++
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 362 SGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLE 421
R +L+ L+LS N G+ S P L+
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERG-----------------LISALCPLKFPTLQ 204
Query: 422 HLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQ-LQNIISLILNNNN 480
L N +G+ A +Q +D+S N L + A + SL L+
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 481 LQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSR-----FSSNSFIG 525
L+ +P L LS L++SYN L P + N F+
Sbjct: 265 LK-QVPKGLPA--KLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 6e-22
Identities = 58/310 (18%), Positives = 92/310 (29%), Gaps = 56/310 (18%)
Query: 135 NLKTLDLARNQLTGEIPRLIYWNEV-LQYLGLRGNALTGMLSPDMCQL---TGLWYFDVR 190
+L+ L + + L+ L +R + + ++ +GL +
Sbjct: 44 SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103
Query: 191 GNNLTGTIPDSIGNCT--SFEILDISYNQITGEIP-----YNIGFLQVATLSLQGNKLTG 243
+TGT P + T IL++ + LS+
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163
Query: 244 KIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKL 303
E + + AL+ LDLS+N +G I + P + + L
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLI-----------------SALCPLKFPTLQVL 206
Query: 304 SYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSG 363
+ G A QL L+L+ N+L
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG--------------------- 245
Query: 364 AIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHL 423
S L LNLS K +VP L L LDLS N P S +L +
Sbjct: 246 --APSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNP-SPDELPQV 298
Query: 424 LTLNLSRNHL 433
L+L N
Sbjct: 299 GNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 40/220 (18%), Positives = 71/220 (32%), Gaps = 18/220 (8%)
Query: 312 QLVGTIPAEL--GKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSS- 368
+G EL G + L D + +I +L + V R+ I
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 369 --FRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGS-VPASIGDL----- 420
+ L L L G P L D L++ N S + A + +L
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148
Query: 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIP----AELGQLQNIISLIL 476
L L++++ H + ++ T+D+S N G + + L L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 477 NNNNLQ---GGIPDQLSNCFSLSNLNVSYNNLSGIIPPIR 513
N ++ G + L L++S+N+L
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 33/200 (16%), Positives = 68/200 (34%), Gaps = 13/200 (6%)
Query: 5 ASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNL 64
+ +L+ +V + +W + L+++ + + L
Sbjct: 116 LEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175
Query: 65 QSIDFQGNKLTGQIPDEIGNC----GSLVHIELSDN---SLYGDIPFSISKLKQLEFLNL 117
++D N G+ C +L + L + + G + QL+ L+L
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235
Query: 118 KNNQLTGPIPSTLTQIP-NLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSP 176
+N L + P L +L+L+ L ++P+ + L L L N L P
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAK--LSVLDLSYNRLDRN--P 290
Query: 177 DMCQLTGLWYFDVRGNNLTG 196
+L + ++GN
Sbjct: 291 SPDELPQVGNLSLKGNPFLD 310
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 75/321 (23%), Positives = 128/321 (39%), Gaps = 56/321 (17%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKN---SRPIAVKKLYNQYPHN-LREFETELETIGSI-R 670
++ + ++G G V K +K A+K++ + R+F ELE + +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 671 HRNIVSLHG-------------YALSPYGNLLFY--DYMVNGSLWDLLHGPSKKVKLDWE 715
H NI++L G YA P+GNLL + V + S L +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYA--PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 716 TRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775
L A A+G+ YL + IHRD+ + NIL+ EN+ A ++DFG++R
Sbjct: 143 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQ 192
Query: 776 STFVLGTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLH 826
+V T+G + E + S SDV+S+G++L EI++ G +
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252
Query: 827 QLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886
+L +E P C D + + L C + P ERP+ ++ L
Sbjct: 253 KL-----PQGYRLEK--PL---NCDD-----EVYDLMRQCWREKPYERPSFAQILVSLNR 297
Query: 887 LLPAPPAKLSLAAPKPIDYYT 907
+L ++ + Y
Sbjct: 298 MLEERKTYVNTTLYEKFTYAG 318
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 50/293 (17%), Positives = 113/293 (38%), Gaps = 21/293 (7%)
Query: 216 NQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGN 275
I P ++ + +T + + + L + I +
Sbjct: 7 TAINVIFPDP-ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEG-VQY 61
Query: 276 LSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADN 335
L+ L L N++T + P L N++K++ L+L N L + + L+ + L+L
Sbjct: 62 LNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTST 117
Query: 336 NLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGR 395
+ P ++ + L + N+++ S L +L YL++ T L
Sbjct: 118 QITDVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD--LTPLAN 171
Query: 396 IINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFN 455
+ L TL N S P + L +L+ ++L N ++ + P N ++ + ++
Sbjct: 172 LSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQ 227
Query: 456 QLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508
++ L ++ ++ + P +S+ + ++ N+++N S I
Sbjct: 228 TITNQPVFYNNNL--VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 52/242 (21%), Positives = 96/242 (39%), Gaps = 18/242 (7%)
Query: 273 LGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNL 332
L+ K+ + +T + ++ ++ L + T + L L L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLEL 70
Query: 333 ADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTE 392
DN + P + + T + + + GN L S+ L S+ L+L+ P
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP-- 124
Query: 393 LGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDM 452
L + NL L L +N + P + L +L L++ ++ L P NL + T+
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 453 SFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPI 512
N++S I L L N+I + L NN + P L+N +L + ++ ++
Sbjct: 181 DDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFY 236
Query: 513 RN 514
N
Sbjct: 237 NN 238
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 54/294 (18%), Positives = 100/294 (34%), Gaps = 44/294 (14%)
Query: 53 EISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQL 112
I P L N I + +T + + + + + I + L L
Sbjct: 11 VIFP-DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-TTIEG-VQYLNNL 65
Query: 113 EFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTG 172
L LK+NQ+T P L + + L+L+ N L + + ++ L L +T
Sbjct: 66 IGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQS-IKTLDLTSTQITD 121
Query: 173 MLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVA 232
+ + L+ L + N +T P + T+ + L I Q++
Sbjct: 122 V--TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS------------- 164
Query: 233 TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGP 292
L + + L L +N++ I P L +L +++L N+++
Sbjct: 165 --DLTP----------LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV 210
Query: 293 IPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNIS 346
P L N S L + L N + L + + + P IS
Sbjct: 211 SP--LANTSNLFIVTLTNQTITNQPVFYNNNL--VVPNVVKGPSGAPIAPATIS 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 41/232 (17%), Positives = 92/232 (39%), Gaps = 17/232 (7%)
Query: 297 LGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNV 356
++ + + + T+ L+ + L+ + I + L +
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLEL 70
Query: 357 HGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPAS 416
N+++ + +NL +T L LS N K + + + ++ TLDL+ + P
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP-- 124
Query: 417 IGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLIL 476
+ L +L L L N + + P L ++Q + + Q+S + L L + +L
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKA 180
Query: 477 NNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPL 528
++N + I L++ +L +++ N +S + P+ N S + +
Sbjct: 181 DDNKISD-ISP-LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 40/209 (19%), Positives = 79/209 (37%), Gaps = 17/209 (8%)
Query: 308 LQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPS 367
Q + P L ++ +N+ + + + + G ++
Sbjct: 4 TQPTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--E 57
Query: 368 SFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLN 427
+ L +L L L N L + + L+LS N ++I L+ + TL+
Sbjct: 58 GVQYLNNLIGLELKDNQIT--DLAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLD 113
Query: 428 LSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPD 487
L+ + + P L ++Q + + NQ++ +I L L N+ L + N + P
Sbjct: 114 LTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP- 168
Query: 488 QLSNCFSLSNLNVSYNNLSGIIPPIRNFS 516
L+N L+ L N +S I P+ +
Sbjct: 169 -LANLSKLTTLKADDNKISD-ISPLASLP 195
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 56/277 (20%), Positives = 100/277 (36%), Gaps = 45/277 (16%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELET-----IGSIRHRNIVSL 677
++G+GA T+ + ++R +AVK++ L E + + S H N++
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRI-------LPECFSFADREVQLLRESDEHPNVIRY 83
Query: 678 HGYALSPYGNLLFYDYMV----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
+ F Y+ +L + + K + + GLA+LH
Sbjct: 84 FCT----EKDRQFQ-YIAIELCAATLQEYVE--QKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 734 DCNPRIIHRDVKSSNILIDENFD-----AHLSDFGIARCIPTAMP--HASTFVLGTIGYI 786
I+HRD+K NILI A +SDFG+ + + + V GT G+I
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 787 DPEY---AHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843
PE D++S G V +++ +S Q + + +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
V +L + K P +RP+ + V
Sbjct: 254 KHEDVIAREL--IEK-------MIAMDPQKRPSAKHV 281
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 614 STENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGS 668
S + +KY +G GAS TVY + + +A++++ Q E+ +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 669 IRHRNIVSLHGYALSPYGNLLFY--DYMVNGSLWDLLHGPSKKVKLDWETRLK---IAV- 722
++ NIV+ L G+ L+ +Y+ GSL D++ ET + IA
Sbjct: 74 NKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAV 121
Query: 723 --GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
Q L +LH + ++IHRD+KS NIL+ + L+DFG I ST V
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 177
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
GT ++ PE K D++S GI+ +E++ G+
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 59/297 (19%), Positives = 112/297 (37%), Gaps = 44/297 (14%)
Query: 623 IVGYGASSTVYKCALKNSR-----PIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVS 676
++G G TV+K P+ +K + ++ + + + IGS+ H +IV
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 677 LHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCN 736
L G L Y+ GSL D + + + L V A+G+ YL
Sbjct: 80 LLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLE---E 133
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIP----------TAMPHASTFVLGTIGYI 786
++HR++ + N+L+ ++DFG+A +P P I ++
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP---------IKWM 184
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845
E H + +SDV+S+G+ + E++T G + + + + P+
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKGERLAQ--PQ 240
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAPKP 902
C + + + C + RPT +E+A + PP L +
Sbjct: 241 ---ICTI-----DVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESG 289
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 59/292 (20%), Positives = 110/292 (37%), Gaps = 28/292 (9%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNSR---PIAVKKLYNQY--PHNLREFETELET 665
+ R L +K + G G TV K + + +AVK L N+ P E E
Sbjct: 13 LDRKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 71
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA 725
+ + + IV + G + +L + G L L + + + +++ +
Sbjct: 72 MQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVS 127
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT--I 783
G+ YL +HRD+ + N+L+ A +SDFG+++ + + G +
Sbjct: 128 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAV 842
+ PE + + + KSDV+SFG+++ E + G+K + + + M
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGC- 241
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAK 894
P C + + L LC RP V L + +
Sbjct: 242 -PA---GCPR-----EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G GA VYK + A K + + L ++ E+E + + H IV L G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 683 SPYGNLLFY--DYMVNGSLWDLLHGPSKKVKLDWETRLKIAV---GAAQGLAYLHHDCNP 737
+ L+ ++ G++ ++ + + I V + L +LH
Sbjct: 87 --HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNFLHSK--- 136
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY------IDPEYA 791
RIIHRD+K+ N+L+ D L+DFG++ + +F+ GT Y + E
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GT-PYWMAPEVVMCETM 194
Query: 792 HTSRLNEKSDVYSFGIVLLEILTGK 816
+ + K+D++S GI L+E+ +
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 63/300 (21%), Positives = 106/300 (35%), Gaps = 58/300 (19%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSR----PIAVKKLYNQY-PHNLREFETELETIGSIR 670
E++ I+G G VY+ N + +AVK N +F +E + ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 671 HRNIVSLHGYAL-SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLA 729
H +IV L G P + + G L L +K+ T + ++ + +A
Sbjct: 72 HPHIVKLIGIIEEEPT--WIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMA 127
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI-------------P---TAMP 773
YL +HRD+ NIL+ L DFG++R I P +
Sbjct: 128 YLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS-- 182
Query: 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSK 832
PE + R SDV+ F + + EIL+ GK+ N + ++
Sbjct: 183 --------------PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGV 226
Query: 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892
+ + P+ C + L C PS+RP E+ L +
Sbjct: 227 LEKGDRLPK--PD---LCPP-----VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 71/313 (22%), Positives = 113/313 (36%), Gaps = 48/313 (15%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRP------IAVKKLYNQY-PHNLREFETELETIGS 668
+N++ +G+GA VY+ + +AVK L + +F E I
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL----HGPSKKVKLDWETRLKIAVGA 724
H+NIV G +L + + M G L L PS+ L L +A
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILID---ENFDAHLSDFGIARCIPTAMPHASTFVLG 781
A G YL IHRD+ + N L+ A + DFG+AR I A + G
Sbjct: 191 ACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY----RAGYYRKG 243
Query: 782 TIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSK 832
+ PE K+D +SFG++L EI + G + N+ L +
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV---- 299
Query: 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892
M+ P+ C +++ C + P +RP + + P
Sbjct: 300 -TSGGRMDP--PK---NCPG-----PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348
Query: 893 AKLSLAAPKPIDY 905
+ PI+Y
Sbjct: 349 ---VINTALPIEY 358
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 614 STENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGS 668
+ +G G++ V + R +AVK + + E+ +
Sbjct: 39 DQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 98
Query: 669 IRHRNIVSLHGYALSPYGNLLFY--DYMVNGSLWDLLHGPSKKVKLDWETRLK---IAV- 722
+H N+V ++ L G L+ +++ G+L D++ + RL IA
Sbjct: 99 YQHFNVVEMYKSYL--VGEELWVLMEFLQGGALTDIVS----------QVRLNEEQIATV 146
Query: 723 --GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL 780
Q LAYLH +IHRD+KS +IL+ + LSDFG I +P + V
Sbjct: 147 CEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV- 202
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
GT ++ PE S + D++S GI+++E++ G+
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-24
Identities = 72/334 (21%), Positives = 121/334 (36%), Gaps = 39/334 (11%)
Query: 573 YKSNQQRQQLITGSRKSMLGPPKLVILHMDMAIHTF---DDIMRSTENLSEKYIVGYGAS 629
K +Q + S+ + + +T D E + +G G
Sbjct: 344 PKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQF 403
Query: 630 STVYKCALKNSR----PIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYAL-S 683
V++ + +A+K N +F E T+ H +IV L G +
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463
Query: 684 PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRD 743
P + + G L L +K LD + + A + LAYL + R +HRD
Sbjct: 464 PV--WIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRD 516
Query: 744 VKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI-----DPEYAHTSRLNE 798
+ + N+L+ N L DFG++R + ST+ + G + PE + R
Sbjct: 517 IAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 799 KSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVR 857
SDV+ FG+ + EIL G K N ++ + ++ + P C
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGERLPM--PP---NCPP----- 619
Query: 858 KTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891
+ L C PS RP E+ L ++L
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 71/314 (22%), Positives = 117/314 (37%), Gaps = 64/314 (20%)
Query: 605 IHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELE 664
I F+ +++ + I+GYG+S TV RP+AVK++ L +F
Sbjct: 6 IPNFEQSLKNLVVSEK--ILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIAL 56
Query: 665 T-----IGSIRHRNIVSLHGYALSPYGNLLFYDYMV----NGSLWDLLHGPSKKVKLDWE 715
S H N++ + F Y+ N +L DL+ + +
Sbjct: 57 MEIKLLTESDDHPNVIRYYCS----ETTDRFL-YIALELCNLNLQDLVESKNVSDENLKL 111
Query: 716 TRLKIAVGA----AQGLAYLHHDCNPRIIHRDVKSSNILID-------------ENFDAH 758
+ + A G+A+LH + +IIHRD+K NIL+ EN
Sbjct: 112 QKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 759 LSDFGIARCIPTAMPHASTF---VLGTIGYIDPE-------YAHTSRLNEKSDVYSFGIV 808
+SDFG+ + + + T GT G+ PE RL D++S G V
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 809 LLEILTGKKA--VDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLC 866
IL+ K D S +I + + D + DL + + ++
Sbjct: 229 FYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDL--ISQ-----MID 281
Query: 867 TKRYPSERPTMQEV 880
P +RPT +V
Sbjct: 282 HD--PLKRPTAMKV 293
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 55/291 (18%)
Query: 625 GYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLR-EFETELETIGSIRHRNIVSL 677
G VYK L P +A+K L ++ LR EF E ++H N+V L
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 77
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLH-------------GPSKKVKLDWETRLKIAVGA 724
G + + Y +G L + L + K L+ + +
Sbjct: 78 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137
Query: 725 AQGLAYL--HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT 782
A G+ YL HH ++H+D+ + N+L+ + + +SD G+ R + A + L
Sbjct: 138 AAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV----YAADYYKLLG 188
Query: 783 IGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSKA 833
+ PE + + SD++S+G+VL E+ + G + N+ + +
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI----- 243
Query: 834 DDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+ V+ P+ C + L + C +PS RP +++ L
Sbjct: 244 RNRQVLPC--PD---DCPA-----WVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 66/305 (21%), Positives = 115/305 (37%), Gaps = 45/305 (14%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLR-EFETELETIGS 668
E ++ +G G+ VY+ K +A+K + R EF E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL-------HGPSKKVKLDWETRLKIA 721
++V L G L+ + M G L L +++A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 722 VGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG 781
A G+AYL+ + +HRD+ + N ++ E+F + DFG+ R I + G
Sbjct: 145 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDYYRKG 197
Query: 782 TIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIMSK 832
G + PE SDV+SFG+VL EI T ++ + NE L +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---- 253
Query: 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892
+ +++ P+ C D F+L +C + P RP+ E+ + +
Sbjct: 254 -MEGGLLDK--PD---NCPD-----MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302
Query: 893 AKLSL 897
++S
Sbjct: 303 REVSF 307
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-22
Identities = 36/199 (18%), Positives = 68/199 (34%), Gaps = 28/199 (14%)
Query: 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID 752
+L D ++ + L I + A+ + +LH + ++HRD+K SNI
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFT 198
Query: 753 ENFDAHLSDFGIAR-----------CIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSD 801
+ + DFG+ P T +GT Y+ PE H + + K D
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 802 VYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQ 861
++S G++L E+L + + + +
Sbjct: 259 IFSLGLILFELLYSFSTQMERVRIITDVRNL--------KFPLLFTQKYPQEH------M 304
Query: 862 LALLCTKRYPSERPTMQEV 880
+ P+ERP ++
Sbjct: 305 MVQDMLSPSPTERPEATDI 323
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 47/271 (17%), Positives = 88/271 (32%), Gaps = 17/271 (6%)
Query: 279 TGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLADNN 336
+L KL I L +++ N ++ I A+ L +L E+ + N
Sbjct: 32 AIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 337 LEGPIPHNI-SSCTALNQFNVHGNRLSGAIPS-SFRNLGSLTYLNLSRNNFKGKVPTEL- 393
I + L + + +P + L++ N +
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 394 -GRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSR-NHLNGLLPAEFGNLRSIQTID 451
G L L+ N + S + L LNLS N+L L F +D
Sbjct: 150 VGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 208
Query: 452 MSFNQLSGSIPAELGQLQNIISL-ILNNNNLQGGIPDQLSNCFSLSNLNVSYN-NLSGII 509
+S ++ S+P+ L+N+ L + NL+ +P L +L +++Y +
Sbjct: 209 ISRTRIH-SLPS--YGLENLKKLRARSTYNLK-KLPT-LEKLVALMEASLTYPSHCCAFA 263
Query: 510 PPIRNFSRFSSNSFIGNPLLCGNWIGSICGP 540
R S +++ G
Sbjct: 264 NWRRQISELHPICNKSILRQEVDYMTQARGQ 294
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 60/313 (19%), Positives = 94/313 (30%), Gaps = 74/313 (23%)
Query: 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNC 85
CS R C S ++ + +L RN + F KL
Sbjct: 9 CSNRVFLCQESKVTEIPSDLP---------------RNAIELRFVLTKLRVIQKGAFSGF 53
Query: 86 GSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNL-KNNQLTGPIPSTLTQIPNLKTLDLAR 143
G L IE+S N + I + S L +L + + K N L P +PNL+ L ++
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113
Query: 144 NQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSI- 202
+ +P + D++ N TI +
Sbjct: 114 TGIK-HLPDVH-----------------------KIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 203 -GNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLS 261
G IL ++ N I EI Q +
Sbjct: 150 VGLSFESVILWLNKNGIQ-EIH----------------------NSAFNGTQLDELNLSD 186
Query: 262 ENELVGPIPP-ILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPA 319
N L +P + S L + ++ +P L N+ KL N + +P
Sbjct: 187 NNNLEE-LPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT 241
Query: 320 ELGKLEQLFELNL 332
L KL L E +L
Sbjct: 242 -LEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 21/115 (18%), Positives = 42/115 (36%), Gaps = 9/115 (7%)
Query: 398 NLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457
+ + + +P+ + + + L L + F ++ I++S N +
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 458 SGSIPAE----LGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508
I A+ L +L I I NNL P+ N +L L +S + +
Sbjct: 67 LEVIEADVFSNLPKLHEI--RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL 119
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 29/228 (12%)
Query: 609 DDIMRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETEL 663
+ + + + + + +VG G VYK +K + A+K + + E + E+
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEI 71
Query: 664 ETIGSI-RHRNIVSLHGYALSPYGNLLFYD------YMVNGSLWDLLHGPSKKVKLDWET 716
+ HRNI + +G + + + GS+ DL+ +K L E
Sbjct: 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK-NTKGNTLK-EE 129
Query: 717 RLKIAV---GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773
IA +GL++LH ++IHRD+K N+L+ EN + L DFG++ + +
Sbjct: 130 --WIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 774 HASTFVLGTIGYIDPEYAHTSRL-----NEKSDVYSFGIVLLEILTGK 816
+TF+ GT ++ PE + KSD++S GI +E+ G
Sbjct: 185 RRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 4e-22
Identities = 44/264 (16%), Positives = 93/264 (35%), Gaps = 26/264 (9%)
Query: 575 SNQQRQQLITGSRKSMLGPPKLVILHMDM-AIHTFDDIMRSTENLSEKYIVGYGASSTVY 633
++ +L++G K + P + AI + ++ + +++G GA + VY
Sbjct: 23 DDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVY 82
Query: 634 KCALKNSRPIAVKKLY---NQYPHNLREFE---TELETIGSIRHRNIVSLHGYALSPYGN 687
+ + K+ + Q P N EF +E + + + L G+
Sbjct: 83 EATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142
Query: 688 LLFYDYMVNGSLWDLL--HGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVK 745
+L + G+L + + + + + + + A+ + +H + IIH D+K
Sbjct: 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIK 199
Query: 746 SSNILIDENFDAH-----------LSDFGIARCIPTAMPHASTF--VLGTIGYIDPEYAH 792
N ++ F L D G + + P + F T G+ E
Sbjct: 200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM-KLFPKGTIFTAKCETSGFQCVEMLS 258
Query: 793 TSRLNEKSDVYSFGIVLLEILTGK 816
N + D + + +L G
Sbjct: 259 NKPWNYQIDYFGVAATVYCMLFGT 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 25/225 (11%)
Query: 612 MRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLY-NQYPHNLREFETELET 665
M S + +++ G GA++ V++ K + A+K + + E E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFY--DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVG 723
+ + H+NIV L ++ GSL+ +L PS L L +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 724 AAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH----LSDFGIARCIPTAMPHASTFV 779
G+ +L + I+HR++K NI+ D L+DFG AR + +
Sbjct: 121 VVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY 176
Query: 780 LGTIGYIDPE--------YAHTSRLNEKSDVYSFGIVLLEILTGK 816
GT Y+ P+ H + D++S G+ TG
Sbjct: 177 -GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 1e-21
Identities = 54/280 (19%), Positives = 102/280 (36%), Gaps = 17/280 (6%)
Query: 104 FSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYL 163
F + NLK +T + ++ ++ + + + + + Y + L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQYLPN-VTKL 70
Query: 164 GLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIP 223
L GN LT + + L L + + N + + S+ + + L + +N I+ +I
Sbjct: 71 FLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DIN 125
Query: 224 YNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLY 283
+ Q+ +L L NK+T V+ + L L L +N++ I P L L+ LY
Sbjct: 126 GLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLY 181
Query: 284 LHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPH 343
L N ++ L + L L+L + + + L + D +L P
Sbjct: 182 LSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPE 237
Query: 344 NISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383
IS + NV + SF +T
Sbjct: 238 IISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 1e-20
Identities = 59/301 (19%), Positives = 106/301 (35%), Gaps = 28/301 (9%)
Query: 191 GNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIG 250
+ PD ++ +T + + + + + + + I
Sbjct: 8 STPIKQIFPDD--AFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SV-QGIQ 62
Query: 251 LMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQN 310
+ + L L+ N+L I P L NL G L+L NK+ + L ++ KL L L++
Sbjct: 63 YLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIKD-LSS-LKDLKKLKSLSLEH 118
Query: 311 NQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFR 370
N + I L L QL L L +N + +S T L+ ++ N++S
Sbjct: 119 NGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDI--VPLA 172
Query: 371 NLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSR 430
L L L LS+N+ L + NLD L+L +L T+ +
Sbjct: 173 GLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT- 229
Query: 431 NHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLS 490
G+L + + I + ++ L + N +S I G +
Sbjct: 230 ----------DGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFH 279
Query: 491 N 491
Sbjct: 280 G 280
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 1e-18
Identities = 53/321 (16%), Positives = 118/321 (36%), Gaps = 19/321 (5%)
Query: 31 VFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVH 90
+F D++ + NL ++ ++ +L ++ I + + + I ++
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTK 69
Query: 91 IELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEI 150
+ L+ N L DI ++ LK L +L L N++ S+L + LK+L L N ++ +I
Sbjct: 70 LFLNGNKL-TDI-KPLTNLKNLGWLFLDENKIK--DLSSLKDLKKLKSLSLEHNGIS-DI 124
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEI 210
L++ + L+ L L N +T + + +LT L + N ++ I + T +
Sbjct: 125 NGLVHLPQ-LESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQN 179
Query: 211 LDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGP-- 268
L +S N I+ ++ G + L L + K + + ++ LV P
Sbjct: 180 LYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238
Query: 269 --IPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQ 326
+ L N+++ + + + Q + + ++
Sbjct: 239 ISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDG 298
Query: 327 LFELNLADNNLEGPIPHNISS 347
+ P +
Sbjct: 299 TVIKTKVEAGTRITAPKPPTK 319
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 1e-18
Identities = 40/230 (17%), Positives = 83/230 (36%), Gaps = 18/230 (7%)
Query: 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340
+ + I P ++ L+ + + +L + ++ +++++
Sbjct: 3 ETITVSTPIKQ-IFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-- 56
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
I + + ++GN+L+ NL +L +L L N K L + L
Sbjct: 57 SVQGIQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLK 112
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460
+L L N S + + L L +L L N + + L + T+ + NQ+S
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-D 167
Query: 461 IPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIP 510
I L L + +L L+ N++ L+ +L L +
Sbjct: 168 IVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPI 214
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 4e-14
Identities = 38/184 (20%), Positives = 76/184 (41%), Gaps = 14/184 (7%)
Query: 327 LFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFK 386
+ E ++ P + + N+ ++ A+ L S+ + + ++ K
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 387 GKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRS 446
V + + N+ L L+ N + P + +L++L L L N + L +L+
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS--LKDLKK 110
Query: 447 IQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLS 506
++++ + N +S I L L + SL L NN + LS L L++ N +S
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166
Query: 507 GIIP 510
I+P
Sbjct: 167 DIVP 170
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 39/209 (18%)
Query: 625 GYGASSTVYKC-ALKNSRPIAVKKL-------YNQYPHNLREFETELETIGSIRHRNIVS 676
G G VY ++ +A+K L RE +E +RH NI+
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE----VEIQSHLRHPNILR 73
Query: 677 LHGYALSPYGNLLFYD----YMV-----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
L+GY F+D Y++ G+++ L K K D + A
Sbjct: 74 LYGY---------FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANA 121
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYID 787
L+Y H R+IHRD+K N+L+ + ++DFG + P++ GT+ Y+
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--DLC-GTLDYLP 175
Query: 788 PEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
PE +EK D++S G++ E L GK
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 76/466 (16%), Positives = 144/466 (30%), Gaps = 104/466 (22%)
Query: 87 SLVHIELSDNSLYGDIPFS--ISKLKQLEFLNLKNNQLT----GPIPSTLTQIPNLKTLD 140
+ +++ L D ++ + L+Q + + L + LT I S L P L L+
Sbjct: 4 DIQSLDIQCEEL-SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 141 LARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGT--- 197
L N+L G+ + L C++ L ++ LTG
Sbjct: 63 LRSNELGDV--------------GVH--CVLQGLQTPSCKIQKL---SLQNCCLTGAGCG 103
Query: 198 -IPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALA 256
+ ++ + + L +S N + G + L L
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDA-----GLQLLCEGLLDPQC-------------RLE 145
Query: 257 VLDLSENEL----VGPIPPILGNLSYTGKLYLHGNKLTGPIPPELG-----NMSKLSYLQ 307
L L L P+ +L +L + N + L + +L L+
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 308 LQNNQL----VGTIPAELGKLEQLFELNLADNNLEGP-----IPHNISSCTALNQFNVHG 358
L++ + + + L EL L N L P + + L +
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265
Query: 359 NRLS----GAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRII-----NLDTLDLSVNNF 409
++ G + R SL L+L+ N + L + L++L + +F
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
Query: 410 SGSVPASIGDL----EHLLTLNLSRNHL-----NGLLPAEFGNLRSIQTIDMSFNQLSGS 460
+ + + + LL L +S N L L ++ + ++ +S S
Sbjct: 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385
Query: 461 IPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLS 506
+ L L SL L++S N L
Sbjct: 386 SCSSLAAT--------------------LLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-20
Identities = 95/497 (19%), Positives = 164/497 (32%), Gaps = 114/497 (22%)
Query: 41 VSLNLSSLNLGGEISPSIGD---------LRNLQSIDFQGNKLTGQ----IPDEIGNCGS 87
+SL++ SL++ E + D L+ Q + LT I + +
Sbjct: 1 MSLDIQSLDIQCE---ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPA 57
Query: 88 LVHIELSDNSLYGDIPFSI--SKLK----QLEFLNLKNNQLT----GPIPSTLTQIPNLK 137
L + L N L GD+ L+ +++ L+L+N LT G + STL +P L+
Sbjct: 58 LAELNLRSNEL-GDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 116
Query: 138 TLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGT 197
L L+ N L GL+ L L C+L L + +L+
Sbjct: 117 ELHLSDNLLGDA--------------GLQ--LLCEGLLDPQCRLEKL---QLEYCSLSAA 157
Query: 198 ----IPDSIGNCTSFEILDISYNQITGE--------IPYNIGFLQVATLSLQGNKLTGK- 244
+ + F+ L +S N I + + L+ L L+ +T
Sbjct: 158 SCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE--ALKLESCGVTSDN 215
Query: 245 ---IPEVIGLMQALAVLDLSENELVGPIPPILGN--LSYTGKLYLHGNKLTGPIPPELGN 299
+ ++ +L L L N+ LG+ ++ LH +
Sbjct: 216 CRDLCGIVASKASLRELALGSNK--------LGDVGMAELCPGLLHPSS----------- 256
Query: 300 MSKLSYLQLQNNQL----VGTIPAELGKLEQLFELNLADNNLEGPIPHNIS-----SCTA 350
+L L + + G + L E L EL+LA N L +
Sbjct: 257 --RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ 314
Query: 351 LNQFNVHGNRLSG----AIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRII-----NLDT 401
L V + S L L +S N + EL + + L
Sbjct: 315 LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV 374
Query: 402 LDLSVNNFSGSVPASIGDL----EHLLTLNLSRNHL-----NGLLPAEFGNLRSIQTIDM 452
L L+ + S S +S+ L L+LS N L L+ + ++ + +
Sbjct: 375 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 434
Query: 453 SFNQLSGSIPAELGQLQ 469
S + L L+
Sbjct: 435 YDIYWSEEMEDRLQALE 451
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 614 STENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKK--LYNQYPH-NLREFETELET 665
++ + + +G+G+ VY ++NS +A+KK + + ++ E+
Sbjct: 48 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 107
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV--- 722
+ +RH N + G L + L +Y GS DLL K ++ IA
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVE-----IAAVTH 161
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT 782
GA QGLAYLH +IHRDVK+ NIL+ E L DFG A + M A++FV GT
Sbjct: 162 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFV-GT 213
Query: 783 IGYIDPEYAHTSRL---NEKSDVYSFGIVLLEILTGK 816
++ PE + K DV+S GI +E+ K
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 47/223 (21%), Positives = 81/223 (36%), Gaps = 33/223 (14%)
Query: 258 LDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI 317
++ + L +PP T L+L N L L ++L+ L L +L +
Sbjct: 15 VNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKL 70
Query: 318 PAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTY 377
+ G L L L+L+ N L+ ++P + L +LT
Sbjct: 71 QVD-GTLPVLGTLDLSHNQLQ-------------------------SLPLLGQTLPALTV 104
Query: 378 LNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRNHLNGL 436
L++S N L + L L L N ++P + L L+L+ N+L L
Sbjct: 105 LDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTEL 163
Query: 437 LPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNN 479
L ++ T+ + N L +IP + L+ N
Sbjct: 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 50/229 (21%), Positives = 77/229 (33%), Gaps = 32/229 (13%)
Query: 204 NCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSEN 263
S ++ +T +P ++ L L N L + L L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL-PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 264 ELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAEL-G 322
EL + G L G L L N+L +P + L+ L + N+L ++P
Sbjct: 66 ELT--KLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121
Query: 323 KLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSR 382
L +L EL L N L+ +P + L L+L+
Sbjct: 122 GLGELQELYLKGNELKT-LPPGL-----------------------LTPTPKLEKLSLAN 157
Query: 383 NNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRN 431
NN L + NLDTL L N+ ++P L L N
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 51/187 (27%), Positives = 77/187 (41%), Gaps = 20/187 (10%)
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK 388
E+N NL +P ++ ++ N L ++ LT LNL R K
Sbjct: 14 EVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-K 69
Query: 389 VPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQ 448
+ + G + L TLDLS N S+P L L L++S N L L L +Q
Sbjct: 70 LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ 127
Query: 449 TIDMSFNQLSGSIPA----ELGQLQNIISLILNNNNLQ---GGIPDQLSNCFSLSNLNVS 501
+ + N+L ++P +L+ L L NNNL G+ + L N L L +
Sbjct: 128 ELYLKGNELK-TLPPGLLTPTPKLEK---LSLANNNLTELPAGLLNGLEN---LDTLLLQ 180
Query: 502 YNNLSGI 508
N+L I
Sbjct: 181 ENSLYTI 187
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 50/201 (24%), Positives = 77/201 (38%), Gaps = 14/201 (6%)
Query: 115 LNLKNNQLTGPIPSTLTQIP-NLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGM 173
+N LT +P +P + L L+ N L + L L L LT +
Sbjct: 15 VNCDKRNLTA-LPPD---LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL 70
Query: 174 LSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI--GFLQV 231
L L D+ N L ++P + +LD+S+N++T +P G ++
Sbjct: 71 --QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGEL 126
Query: 232 ATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPP-ILGNLSYTGKLYLHGNKLT 290
L L+GN+L P ++ L L L+ N L +P +L L L L N L
Sbjct: 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY 185
Query: 291 GPIPPELGNMSKLSYLQLQNN 311
IP L + L N
Sbjct: 186 T-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 49/207 (23%), Positives = 75/207 (36%), Gaps = 27/207 (13%)
Query: 26 CSWRGVFCDNSSLSVV---------SLNLSSLNLGGEISPSIGD-LRNLQSIDFQGNKLT 75
S V CD +L+ + L+LS NL S + L ++ +LT
Sbjct: 10 ASHLEVNCDKRNLTALPPDLPKDTTILHLSE-NLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 76 GQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPN 135
++ G L ++LS N L +P L L L++ N+LT L +
Sbjct: 69 -KLQ-VDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 136 LKTLDLARNQLTGEIP-----RLIYWNEVLQYLGLRGNALTGMLSPDMCQ-LTGLWYFDV 189
L+ L L N+L +P L+ L L N LT L + L L +
Sbjct: 126 LQELYLKGNELK-TLPPGLLTPTPK----LEKLSLANNNLT-ELPAGLLNGLENLDTLLL 179
Query: 190 RGNNLTGTIPDSIGNCTSFEILDISYN 216
+ N+L TIP + N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 60/239 (25%), Positives = 87/239 (36%), Gaps = 29/239 (12%)
Query: 221 EIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPP-ILGNLSYT 279
+IP N+ L L N L L VLDLS E+ I +LS+
Sbjct: 21 KIPDNL-PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHL 78
Query: 280 GKLYLHGNKLTGPIPPEL-GNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNL 337
L L GN + + +S L L L ++ G L+ L ELN+A N +
Sbjct: 79 STLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136
Query: 338 -EGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRI 396
+P S+ T L ++ N++ + R L + LNLS
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS--------------- 181
Query: 397 INLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFN 455
LDLS+N + + L L L N L + F L S+Q I + N
Sbjct: 182 -----LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 44/211 (20%), Positives = 78/211 (36%), Gaps = 13/211 (6%)
Query: 182 TGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQGN 239
D+ N L S + ++LD+S +I I ++TL L GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 240 KLTGKIPEVIGLMQALAVLDLSENELVGPIPP-ILGNLSYTGKLYLHGNKLTG-PIPPEL 297
+ + +L L E L + +G+L +L + N + +P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 298 GNMSKLSYLQLQNNQLVGTIPAE----LGKLEQL-FELNLADNNLEGPIPHNISSCTALN 352
N++ L +L L +N++ +I L ++ L L+L+ N + I L
Sbjct: 146 SNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLK 203
Query: 353 QFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383
+ + N+L F L SL + L N
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 25/225 (11%)
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSS-FRNLGSLTYLNLSRNNFKG 387
L+L+ N L ++ S L ++ + I +++L L+ L L+ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 388 KVPTELGRIINLDTLDLSVNNFSGSVPASI-GDLEHLLTLNLSRNHLNGL-LPAEFGNLR 445
+ +L L N + S+ G L+ L LN++ N + LP F NL
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 446 SIQTIDMSFNQLSGSIPAE----LGQLQNI-ISLILNNNNLQGGIPDQLSNCFSLSNLNV 500
+++ +D+S N++ SI L Q+ + +SL L+ N + I L L +
Sbjct: 150 NLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELAL 207
Query: 501 SYNNLSGIIPPIRNFSRFSSNSFI---GNPLLCG--------NWI 534
N L + P F R +S I NP C W+
Sbjct: 208 DTNQLKSV--PDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 250
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 41/248 (16%), Positives = 80/248 (32%), Gaps = 30/248 (12%)
Query: 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNC 85
C + + NL + +++D N L +
Sbjct: 7 VPNITYQCMELNFYKIPDNLPF---------------STKNLDLSFNPLRHLGSYSFFSF 51
Query: 86 GSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARN 144
L ++LS + I L L L L N + + + +L+ L
Sbjct: 52 PELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 145 QLTGEIPRLIYWN-EVLQYLGLRGNALTGMLSPDMC-QLTGLWYFDVRGNNLTGTIP--- 199
L + + + L+ L + N + P+ LT L + D+ N + +I
Sbjct: 111 NLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTD 168
Query: 200 -DSIGNCTSFEI-LDISYNQITGEIPYNIGF--LQVATLSLQGNKLTGKIPEVIGLMQAL 255
+ + LD+S N + I F +++ L+L N+L + + +L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMN-FIQPGA-FKEIRLKELALDTNQLKSVPDGIFDRLTSL 226
Query: 256 AVLDLSEN 263
+ L N
Sbjct: 227 QKIWLHTN 234
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 25/225 (11%)
Query: 612 MRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLY-NQYPHNLREFETELET 665
M S + +++ G GA++ V++ K + A+K + + E E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFY--DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVG 723
+ + H+NIV L ++ GSL+ +L PS L L +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 724 AAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH----LSDFGIARCIPTAMPHASTFV 779
G+ +L + I+HR++K NI+ D L+DFG AR + +
Sbjct: 121 VVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY 176
Query: 780 LGTIGYIDPE--------YAHTSRLNEKSDVYSFGIVLLEILTGK 816
GT Y+ P+ H + D++S G+ TG
Sbjct: 177 -GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 72/312 (23%), Positives = 123/312 (39%), Gaps = 63/312 (20%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLY-NQYPHNLREFETELETIGS 668
+NL +G G V K + +AVK L N P LR+ +E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 669 IRHRNIVSLHG-------------YALSPYGNLLFY----------DYMVNGSLWDLLHG 705
+ H +++ L+G YA YG+L + GS
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYA--KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 706 PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765
+ L + A +QG+ YL +++HRD+ + NIL+ E +SDFG++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 766 RCIPTAMPHASTFVLGTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK-- 817
R + ++V + G I E +SDV+SFG++L EI+T G
Sbjct: 198 RDV----YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 818 -AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT 876
+ E + L ME P+ C + + ++L L C K+ P +RP
Sbjct: 254 PGIPPERLFNLLK-----TGHRMER--PD---NCSE-----EMYRLMLQCWKQEPDKRPV 298
Query: 877 MQEVARVLVSLL 888
++++ L ++
Sbjct: 299 FADISKDLEKMM 310
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 75/307 (24%), Positives = 119/307 (38%), Gaps = 54/307 (17%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLY-NQYPHNLREFETELETIGS 668
+ L +G GA V + R +AVK L R +EL+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 669 I-RHRNIVSLHGYALSPYGN--LLFYDYMVNGSLWDLL-------------HGPSKKVKL 712
I H N+V+L G A + G ++ ++ G+L L K L
Sbjct: 87 IGHHLNVVNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 713 DWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772
E + + A+G+ +L + + IHRD+ + NIL+ E + DFG+AR I
Sbjct: 146 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-- 200
Query: 773 PHASTFVLGTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNES 823
+V + PE +SDV+SFG++L EI + G V +
Sbjct: 201 --DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 824 NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883
+ + + T M A P+ + +Q L C PS+RPT E+
Sbjct: 259 EFCRRLK----EGTRMRA--PD---YTTP-----EMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 884 LVSLLPA 890
L +LL A
Sbjct: 305 LGNLLQA 311
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 47/302 (15%), Positives = 98/302 (32%), Gaps = 60/302 (19%)
Query: 612 MRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKK--LYNQYPHNLREFETELE 664
M + ++ +G G +V+KC + A+K+ + + E+
Sbjct: 3 MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62
Query: 665 TIGSI-RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLK-IAV 722
+ +H ++V L+ +Y GSL D + + + E LK + +
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH-------------------LSDFG 763
+GL Y+H ++H D+K SNI I + + D G
Sbjct: 123 QVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 764 IARCIPTAMPHASTFVLGTIGYIDPE-----YAHTSRLNEKSDVYSFGIVLLEILTGKKA 818
T + G ++ E Y H K+D+++ + ++ +
Sbjct: 180 HV----TRISSPQVEE-GDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPL 230
Query: 819 VDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQ 878
N H++ + + + +S +L + P RP+
Sbjct: 231 PRNGDQWHEIRQGR------LPRIPQVLSQEFTELLK---------VMIHPDPERRPSAM 275
Query: 879 EV 880
+
Sbjct: 276 AL 277
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 69/323 (21%), Positives = 122/323 (37%), Gaps = 67/323 (20%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLR-EFETELETIGS 668
N+ +G GA V++ P +AVK L + +++ +F+ E +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 669 IRHRNIVSLHG-------------YALSPYGNLLFY----------DYMVNGSLWDLLHG 705
+ NIV L G Y YG+L + +
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYM--AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 706 PSKKVKLDWETRLKIAVGAAQGLAYL--HHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763
L +L IA A G+AYL +HRD+ + N L+ EN ++DFG
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFG 219
Query: 764 IARCIPTAMPHASTFVLGTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK 817
++R I A + I PE +R +SDV+++G+VL EI + G +
Sbjct: 220 LSRNI----YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 818 ---AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSER 874
+ +E ++ + D ++ PE C + + L LC + P++R
Sbjct: 276 PYYGMAHEEVIYYVR-----DGNILAC--PE---NCPL-----ELYNLMRLCWSKLPADR 320
Query: 875 PTMQEVARVLVSLLPAPPAKLSL 897
P+ + R+L + + +
Sbjct: 321 PSFCSIHRILQRMCERAEGTVGV 343
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 73/323 (22%), Positives = 130/323 (40%), Gaps = 58/323 (17%)
Query: 616 ENLSEKYIVGYGASSTVYKCAL--------KNSRPIAVKKLY-NQYPHNLREFETELETI 666
+ L+ +G GA V K + +AVK L + +L + +E+E +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 667 GSI-RHRNIVSLHG-------------YALSPYGNLLFY--DYMVNGSLWDLLHGPSKKV 710
I +H+NI++L G YA GNL Y G + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYA--SKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 711 KLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770
++ ++ + A+G+ YL + + IHRD+ + N+L+ EN ++DFG+AR I
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-- 207
Query: 771 AMPHASTFVLGTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDN 821
+ + T G + PE +SDV+SFG+++ EI T G +
Sbjct: 208 --NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265
Query: 822 ESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVA 881
E L + M+ P C + + + + C PS+RPT +++
Sbjct: 266 EELFKLLK-----EGHRMDK--PA---NCTN-----ELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 882 RVLVSLLPAPPAKLSLAAPKPID 904
L +L + L +P++
Sbjct: 311 EDLDRILTLTTNEEYLDLSQPLE 333
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 34/293 (11%), Positives = 67/293 (22%), Gaps = 66/293 (22%)
Query: 624 VGYGASSTVYKC---ALKNSRPIAVKKLYNQYPHN---LREFETELETIGSIRHRNIVSL 677
G ++ AL R +A+ + Q L+E + + I + +
Sbjct: 39 HGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 678 HGYALSPYGNLLFYDYM--VNG-SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD 734
+ G SL ++ ++ A H
Sbjct: 97 LDVV--HTRAGGLVV-AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA 148
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
+ S + + + D L+ +P+
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPATMP------------------DANPQ----- 182
Query: 795 RLNEKSDVYSFGIVLLEILTGK---KAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851
D+ G L +L + S L A +D ++
Sbjct: 183 -----DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP---F 234
Query: 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAPKPID 904
+SAV A + R + ++ PID
Sbjct: 235 QISAV------AARSVQGDGGIRSAS-TLLNLMQQATAVADR---TEVLGPID 277
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-20
Identities = 70/309 (22%), Positives = 123/309 (39%), Gaps = 58/309 (18%)
Query: 616 ENLSEKYIVGYGASSTVYKCAL--------KNSRPIAVKKLY-NQYPHNLREFETELETI 666
+ L+ +G G V K + +AVK L + +L + +E+E +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 667 GSI-RHRNIVSLHG-------------YALSPYGNLLFY--DYMVNGSLWDLLHGPSKKV 710
I +H+NI++L G YA GNL Y G + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYA--SKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 711 KLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770
++ ++ + A+G+ YL + + IHRD+ + N+L+ EN ++DFG+AR I
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-- 253
Query: 771 AMPHASTFVLGTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDN 821
+ + T G + PE +SDV+SFG+++ EI T G +
Sbjct: 254 --NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311
Query: 822 ESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVA 881
E L + M+ P C + + + + C PS+RPT +++
Sbjct: 312 EELFKLLK-----EGHRMDK--PA---NCTN-----ELYMMMRDCWHAVPSQRPTFKQLV 356
Query: 882 RVLVSLLPA 890
L +L
Sbjct: 357 EDLDRILTL 365
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 7e-20
Identities = 58/325 (17%), Positives = 93/325 (28%), Gaps = 72/325 (22%)
Query: 613 RSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVK-----KLYNQYPHNLREFETE 662
S L +KY + G G+ V + A+K K+ P ++ +TE
Sbjct: 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722
+ + + H NI L+ L + G L D L+ +
Sbjct: 79 VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 723 GAA-------------------------------------QGLAYLHHDCNPRIIHRDVK 745
L YLH N I HRD+K
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIK 195
Query: 746 SSNILIDENFDAHL--SDFGIARCIPTAMPHASTF---VLGTIGYIDPE--YAHTSRLNE 798
N L N + DFG+++ GT ++ PE
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255
Query: 799 KSDVYSFGIVLLEILTGK---KAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855
K D +S G++L +L G N+++ +++K +S DL
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPG-VNDADTISQVLNKKLC--FENPNYNVLSPLARDL-- 310
Query: 856 VRKTFQLALLCTKRYPSERPTMQEV 880
+ LL ER
Sbjct: 311 LSN-----LLNRN--VDERFDAMRA 328
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 57/273 (20%), Positives = 96/273 (35%), Gaps = 38/273 (13%)
Query: 632 VYKCALKNSRPIAVKKLYNQYPHNLRE-FETELETIGSIRHRNIVSLHGYALSPYGNLLF 690
K L+ R + + F+ EL+ I I++ ++ G + +
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYII 121
Query: 691 YDYMVNGSLWDLL--HGPSKKVKLDWETRLKIAVGAAQ---GLAYLHHDCNPRIIHRDVK 745
Y+YM N S+ K + I +Y+H++ N I HRDVK
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVK 179
Query: 746 SSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE--YAHTSRLNEKSDVY 803
SNIL+D+N LSDFG + + GT ++ PE +S K D++
Sbjct: 180 PSNILMDKNGRVKLSDFGESEYMVDKKIK--GSR-GTYEFMPPEFFSNESSYNGAKVDIW 236
Query: 804 SFGIVLLEILTGKKAVDNESNLHQL----------------IMSKADDNTVMEAVDPEVS 847
S GI L + + +L +L N + +S
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLS 296
Query: 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+D ++ L P+ER T ++
Sbjct: 297 NEDIDF--LKL-----FLRKN--PAERITSEDA 320
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 65/311 (20%), Positives = 121/311 (38%), Gaps = 61/311 (19%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLY-NQYPHNLREFETELETIGS 668
LS +G GA V + + +AVK L + + +EL+ +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 669 I-RHRNIVSLHG-------------YALSPYGNLLFY------DYMVNGSLWDLLHGPSK 708
+ H NIV+L G Y YG+LL + ++ + + ++
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYC--CYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 709 KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768
+ L E L + A+G+A+L + IHRD+ + NIL+ + DFG+AR I
Sbjct: 141 ALDL--EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 769 PTAMPHASTFVLGTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AV 819
+V+ + PE +SDV+S+GI L E+ + G +
Sbjct: 196 KNDS----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 820 DNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQE 879
+S +++I + M + PE + + + C P +RPT ++
Sbjct: 252 PVDSKFYKMIK----EGFRMLS--PE---HAPA-----EMYDIMKTCWDADPLKRPTFKQ 297
Query: 880 VARVLVSLLPA 890
+ +++ +
Sbjct: 298 IVQLIEKQISE 308
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-19
Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 19/225 (8%)
Query: 625 GYGASSTVYKCALKNS-RPIAVKKLYNQ-YPHNLREFETELETIGSIRHRNIVSLH---- 678
G G V + +++ +A+K+ + P N + E++ + + H N+VS
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 679 --GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCN 736
LL +Y G L L+ L + + L YLH +
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN-- 140
Query: 737 PRIIHRDVKSSNILIDENFDAH---LSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
RIIHRD+K NI++ + D G A+ + + FV GT+ Y+ PE
Sbjct: 141 -RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEFV-GTLQYLAPELLEQ 197
Query: 794 SRLNEKSDVYSFGIVLLEILTGK---KAVDNESNLHQLIMSKADD 835
+ D +SFG + E +TG H + K+++
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 75/361 (20%), Positives = 127/361 (35%), Gaps = 67/361 (18%)
Query: 573 YKSNQQRQQLITGSRKSMLGPPKLVILHMDMAIHTFDD---IMRSTENLSEKYIVGYGAS 629
+K +Q + + G ++D + +D R ENL ++G GA
Sbjct: 1 HKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPR--ENLEFGKVLGSGAF 58
Query: 630 STVYKCALKN------SRPIAVKKLY-NQYPHNLREFETELETIGSI-RHRNIVSLHG-- 679
V S +AVK L +EL+ + + H NIV+L G
Sbjct: 59 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118
Query: 680 -----------YALSPYGNLLFY---------DYMVNGSLWDLLHGPSKKVKLDWETRLK 719
Y YG+LL Y + + L L +E L
Sbjct: 119 TLSGPIYLIFEYC--CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176
Query: 720 IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV 779
A A+G+ +L +HRD+ + N+L+ + DFG+AR I + +V
Sbjct: 177 FAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS----NYV 229
Query: 780 LGTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDNESNLHQLIM 830
+ + PE KSDV+S+GI+L EI + G + ++N ++LI
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 289
Query: 831 SKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890
+ M+ P + + + + C +RP+ + L L
Sbjct: 290 ----NGFKMDQ--PF---YATE-----EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335
Query: 891 P 891
Sbjct: 336 A 336
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 47/265 (17%), Positives = 98/265 (36%), Gaps = 20/265 (7%)
Query: 244 KIPEVIGL--MQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMS 301
I ++ +L + + + L+ ++ + + + + + +
Sbjct: 13 PIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQG-IQYLP 68
Query: 302 KLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRL 361
++ L L N+L P L L+ L L L +N ++ ++ L ++ N +
Sbjct: 69 NVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGI 124
Query: 362 SGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLE 421
S + +L L L L N T L R+ LDTL L N S + + L
Sbjct: 125 S--DINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLT 178
Query: 422 HLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNL 481
L L LS+NH++ L L+++ +++ + L ++ + +L
Sbjct: 179 KLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
Query: 482 QGGIPDQLSNCFSLSNLNVSYNNLS 506
P+ +S+ NV ++
Sbjct: 237 VT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 50/237 (21%), Positives = 95/237 (40%), Gaps = 15/237 (6%)
Query: 104 FSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYL 163
FS + NLK +T T ++ ++ + + + + + Y + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQGIQYLPN-VTKL 73
Query: 164 GLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIP 223
L GN LT + + L L + + N + + S+ + + L + +N I+ +I
Sbjct: 74 FLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DIN 128
Query: 224 YNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLY 283
+ Q+ +L L NK+T I V+ + L L L +N++ I P L L+ LY
Sbjct: 129 GLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLY 184
Query: 284 LHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340
L N ++ + L + L L+L + + + L + D +L P
Sbjct: 185 LSKNHISD-LRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 38/228 (16%), Positives = 81/228 (35%), Gaps = 18/228 (7%)
Query: 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340
+ + ++ L+ + + +L + ++ +++++
Sbjct: 6 ETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS- 60
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
+ I + + ++GN+L+ NL +L +L L N K L + L
Sbjct: 61 VQ-GIQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLK 115
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460
+L L N S + L L +L L N + + L + T+ + NQ+S
Sbjct: 116 SLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-D 170
Query: 461 IPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508
I L L + +L L+ N++ L+ +L L +
Sbjct: 171 IVP-LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNK 215
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 49/238 (20%), Positives = 98/238 (41%), Gaps = 15/238 (6%)
Query: 31 VFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVH 90
+F D++ + NL + +L ++ I + + + I ++
Sbjct: 17 IFSDDAFAETIKDNLKK-KSVTDAVT-QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTK 72
Query: 91 IELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEI 150
+ L+ N L DI ++ LK L +L L N++ S+L + LK+L L N ++ +I
Sbjct: 73 LFLNGNKL-TDI-KPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGIS-DI 127
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEI 210
L++ + L+ L L N +T + + +LT L + N ++ I + T +
Sbjct: 128 NGLVHLPQ-LESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQN 182
Query: 211 LDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGP 268
L +S N I+ ++ G + L L + K + + ++ LV P
Sbjct: 183 LYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 34/167 (20%), Positives = 70/167 (41%), Gaps = 12/167 (7%)
Query: 344 NISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLD 403
+ + + N+ ++ + L S+ + + ++ K + + N+ L
Sbjct: 19 SDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLF 74
Query: 404 LSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPA 463
L+ N + P + +L++L L L N + L +L+ ++++ + N +S I
Sbjct: 75 LNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DING 129
Query: 464 ELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIP 510
L L + SL L NN + LS L L++ N +S I+P
Sbjct: 130 -LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP 173
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 71/316 (22%), Positives = 111/316 (35%), Gaps = 79/316 (25%)
Query: 616 ENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYPHN--LREFETELETIG 667
NL +G GA V + +AVK L H +EL+ +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMS 104
Query: 668 SI-RHRNIVSLHGYALS--PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETR------- 717
+ +H NIV+L G P L+ +Y G L + L S+ ++ D
Sbjct: 105 HLGQHENIVNLLGACTHGGPV--LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 718 ----LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773
L + AQG+A+L + IHRDV + N+L+ A + DFG+AR I
Sbjct: 163 TRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----- 214
Query: 774 HASTFVLGTIGYIDPEYAHTSR------------LNE-----KSDVYSFGIVLLEILT-G 815
D Y + + +SDV+S+GI+L EI + G
Sbjct: 215 -----------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 263
Query: 816 KK---AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPS 872
+ S ++L+ D M P + + C P+
Sbjct: 264 LNPYPGILVNSKFYKLVK----DGYQMAQ--PA---FAPK-----NIYSIMQACWALEPT 309
Query: 873 ERPTMQEVARVLVSLL 888
RPT Q++ L
Sbjct: 310 HRPTFQQICSFLQEQA 325
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 73/310 (23%), Positives = 122/310 (39%), Gaps = 58/310 (18%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKN--------SRPIAVKKLY-NQYPHNLREFETELETI 666
+ L +G GA V +AVK L + +L + +E+E +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 667 GSI-RHRNIVSLHG-------------YALSPYGNLLFY--DYMVNGSLWDLLHGPSKKV 710
I +H+NI++L G YA GNL Y G + + +
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYA--SKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 711 KLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770
+L + + A A+G+ YL + + IHRD+ + N+L+ E+ ++DFG+AR I
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 241
Query: 771 AMPHASTFVLGTIGYI-----DPEYAHTSRLNEKSDVYSFGIVLLEILT-GKK---AVDN 821
H + T G + PE +SDV+SFG++L EI T G V
Sbjct: 242 --HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299
Query: 822 ESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVA 881
E L + M+ P C + + + + C PS+RPT +++
Sbjct: 300 EELFKLLK-----EGHRMDK--PS---NCTN-----ELYMMMRDCWHAVPSQRPTFKQLV 344
Query: 882 RVLVSLLPAP 891
L ++
Sbjct: 345 EDLDRIVALT 354
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 7e-19
Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 39/201 (19%)
Query: 630 STVYKCALKNSRPIAVKKLYNQYPHNLRE-FETELETIGSIRHRNIVSLHGYALSPYGNL 688
T + A+K + KK + + + + E++ ++H +I+ L+ Y
Sbjct: 34 HTGLEVAIK----MIDKKAMYK--AGMVQRVQNEVKIHCQLKHPSILELYNY-------- 79
Query: 689 LFYD----YMV-----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739
F D Y+V NG + L K + E R + G+ YLH I
Sbjct: 80 -FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEARHFMH-QIITGMLYLHSH---GI 133
Query: 740 IHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL----GTIGYIDPEYAHTSR 795
+HRD+ SN+L+ N + ++DFG+A GT YI PE A S
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 796 LNEKSDVYSFGIVLLEILTGK 816
+SDV+S G + +L G+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGR 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-19
Identities = 74/325 (22%), Positives = 128/325 (39%), Gaps = 45/325 (13%)
Query: 578 QRQQLITGSRKSMLGPPKLVILHMDMAIHTFDDIMRSTENLSEKYIV----GYGASSTVY 633
+R+ L S ++ V + D+ T DD + L ++YI+ G GA V
Sbjct: 96 KRRPLNNNSEIALSLSRNKVFVFFDL---TVDDQSVYPKALRDEYIMSKTLGSGACGEVK 152
Query: 634 KCALKNS-RPIAVKKL--------YNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP 684
+ + + +A++ + + ETE+E + + H I+ + + +
Sbjct: 153 LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212
Query: 685 YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDV 744
++ + M G L+D + +L T + YLH IIHRD+
Sbjct: 213 DYYIVL-ELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDL 265
Query: 745 KSSNILI---DENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE---YAHTSRLNE 798
K N+L+ +E+ ++DFG ++ + T GT Y+ PE T+ N
Sbjct: 266 KPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPTYLAPEVLVSVGTAGYNR 323
Query: 799 KSDVYSFGIVLLEILTGKK---AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855
D +S G++L L+G + +L I S + V EVS +DL
Sbjct: 324 AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG--KYNFIPEVWAEVSEKALDL-- 379
Query: 856 VRKTFQLALLCTKRYPSERPTMQEV 880
V+K LL P R T +E
Sbjct: 380 VKK-----LLVVD--PKARFTTEEA 397
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 44/229 (19%)
Query: 610 DIMRSTENLSEKYIV----GYGASSTVYKCA-LKNSRPIAVK---KLYNQYPHNLREFET 661
+++ + +Y+ G G + ++ + A K K PH +
Sbjct: 6 EVLVDPRSR-RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM 64
Query: 662 ELETIGSIRHRNIVSLHGYALSPYGNLLFYD----YMV-----NGSLWDLLHGPSKKVKL 712
E+ S+ H+++V HG+ F D ++V SL +L ++ L
Sbjct: 65 EISIHRSLAHQHVVGFHGF---------FEDNDFVFVVLELCRRRSLLELH---KRRKAL 112
Query: 713 D-WETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771
E R G YLH + R+IHRD+K N+ ++E+ + + DFG+A
Sbjct: 113 TEPEAR-YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----T 163
Query: 772 MPHASTFVL----GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
GT YI PE + + DV+S G ++ +L GK
Sbjct: 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 25/185 (13%), Positives = 62/185 (33%), Gaps = 10/185 (5%)
Query: 299 NMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHG 358
L + A++ L + LA+ N+ + I + ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLT---YITLANINVTD-LT-GIEYAHNIKDLTINN 75
Query: 359 NRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIG 418
+ + L +L L + + L + +L LD+S + S+ I
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 419 DLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNN 478
L + +++LS N + L ++++++ F+ + + + L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 479 NNLQG 483
+ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 29/194 (14%), Positives = 62/194 (31%), Gaps = 32/194 (16%)
Query: 191 GNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIG 250
G + T I + S + ++ +T LTG I
Sbjct: 31 GQSSTANI--TEAQMNSLTYITLANINVT--------------------DLTG-----IE 63
Query: 251 LMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQN 310
+ L ++ P + LS +L + G +T P L ++ L+ L + +
Sbjct: 64 YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121
Query: 311 NQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFR 370
+ +I ++ L ++ ++L+ N I + + L N+ + +
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY--RGIE 178
Query: 371 NLGSLTYLNLSRNN 384
+ L L
Sbjct: 179 DFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 26/182 (14%), Positives = 60/182 (32%), Gaps = 34/182 (18%)
Query: 44 NLSSLNLGG----EISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLY 99
+L+ + L +++ I N++ + T P I +L + + +
Sbjct: 45 SLTYITLANINVTDLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVT 101
Query: 100 GDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEV 159
D ++S L L L++ ++ I + + +P + ++DL+ N +I L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPL------ 155
Query: 160 LQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQIT 219
L L +++ + + I + L I
Sbjct: 156 -------------------KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIG 194
Query: 220 GE 221
G+
Sbjct: 195 GK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 29/143 (20%), Positives = 56/143 (39%), Gaps = 5/143 (3%)
Query: 368 SFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLN 427
+ + SLTY+ L+ N T + N+ L ++ + + P I L +L L
Sbjct: 39 TEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 428 LSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPD 487
+ + L S+ +D+S + SI ++ L + S+ L+ N I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M 153
Query: 488 QLSNCFSLSNLNVSYNNLSGIIP 510
L L +LN+ ++ +
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 35/188 (18%), Positives = 70/188 (37%), Gaps = 11/188 (5%)
Query: 78 IPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLK 137
IPD + ++ L +S + +++ L ++ L N +T + N+K
Sbjct: 17 IPDS--TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVTDLTG--IEYAHNIK 69
Query: 138 TLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGT 197
L + T P I L+ L + G +T P++ LT L D+ + +
Sbjct: 70 DLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 198 IPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAV 257
I I +D+SYN +I ++ +L++Q + + + + L
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH-DYRGIEDFPK-LNQ 185
Query: 258 LDLSENEL 265
L +
Sbjct: 186 LYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 36/186 (19%), Positives = 72/186 (38%), Gaps = 11/186 (5%)
Query: 107 SKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLR 166
S K L + T Q+ +L + LA +T ++ + Y + ++ L +
Sbjct: 20 STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTGIEYAHN-IKDLTIN 74
Query: 167 GNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI 226
T +P + L+ L + G ++T ++ TS +LDIS++ I I
Sbjct: 75 NIHATN-YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 227 GFL-QVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLH 285
L +V ++ L N I + L + L L++ + + + + +LY
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMPLKTLPE-LKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 286 GNKLTG 291
+ G
Sbjct: 190 SQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 17/146 (11%), Positives = 58/146 (39%), Gaps = 7/146 (4%)
Query: 371 NLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSR 430
+ L +++ ++ + + +++V + +G I ++ L ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 431 NHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLS 490
H P L +++ + + ++ L L ++ L ++++ I +++
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 491 NCFSLSNLNVSYNNLSGIIPPIRNFS 516
++++++SYN I P++
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTLP 159
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-18
Identities = 61/283 (21%), Positives = 110/283 (38%), Gaps = 34/283 (12%)
Query: 611 IMRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVK--KLYNQYPHNLREFETEL 663
I +LSE Y G GA V C K + A+K + + + + E+
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 664 ETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVG 723
+ + H NI+ L+ + L + G L+D + ++K + I
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVIIKQ 144
Query: 724 AAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIPTAMPHASTFVL 780
G+ YLH I+HRD+K N+L+ +++ + DFG++ L
Sbjct: 145 VLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RL 199
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSKADDNTV 838
GT YI PE + +EK DV+S G++L +L G + + + +
Sbjct: 200 GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT--- 255
Query: 839 MEAVD-PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
++ + VS DL +++ +L R + Q+
Sbjct: 256 FDSPEWKNVSEGAKDL--IKQ-----MLQ--FDSQRRISAQQA 289
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 47/193 (24%), Positives = 81/193 (41%), Gaps = 32/193 (16%)
Query: 637 LKNSRPIAVKKLYNQ--YPHNLRE-FETELETIGSIRHRNIVSLHGYALSPYGNLLFYD- 692
+N +A+K L+ + E+E +RH NI+ ++ Y F+D
Sbjct: 36 KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY---------FHDR 86
Query: 693 ---YMV-----NGSLWDLLHGPSKKVKLD-WETRLKIAVGAAQGLAYLHHDCNPRIIHRD 743
Y++ G L+ L K + D + + A L Y H ++IHRD
Sbjct: 87 KRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFME-ELADALHYCHER---KVIHRD 139
Query: 744 VKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVY 803
+K N+L+ + ++DFG + P+ T GT+ Y+ PE +EK D++
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHAPSLRRR--TMC-GTLDYLPPEMIEGKTHDEKVDLW 196
Query: 804 SFGIVLLEILTGK 816
G++ E L G
Sbjct: 197 CAGVLCYEFLVGM 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 65/284 (22%), Positives = 119/284 (41%), Gaps = 35/284 (12%)
Query: 611 IMRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVK---KLYNQYPHNLREFETE 662
+ ST S++Y G G+ V C K + + AVK K + + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722
++ + + H NI+ L+ + L + G L+D + + + +I
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIR 133
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIPTAMPHASTFV 779
G+ Y+H + +I+HRD+K N+L+ ++ + + DFG++ +
Sbjct: 134 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--K 188
Query: 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSKADDNT 837
+GT YI PE H +EK DV+S G++L +L+G NE ++ + +
Sbjct: 189 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT-- 245
Query: 838 VMEAVD-PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
E +VS + DL +RK +L PS R + ++
Sbjct: 246 -FELPQWKKVSESAKDL--IRK-----MLTYV--PSMRISARDA 279
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 43/219 (19%)
Query: 620 EKYIV----GYGASSTVYKCA-LKNSRPIAVK---KLYNQYPHNLREFETELETIGSIRH 671
+Y+ G G + ++ + A K K PH + E+ S+ H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 672 RNIVSLHGYALSPYGNLLFYD----YMV-----NGSLWDLLHGPSKKVKLD-WETRLKIA 721
+++V HG+ F D ++V SL +L ++ L E R
Sbjct: 101 QHVVGFHGF---------FEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEAR-YYL 147
Query: 722 VGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVL- 780
G YLH + R+IHRD+K N+ ++E+ + + DFG+A
Sbjct: 148 RQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKK 199
Query: 781 ---GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
GT YI PE + + DV+S G ++ +L GK
Sbjct: 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 34/206 (16%)
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNL 337
T KL L NKL+ ++KL L L +N+L T+PA + +L+ L L + DN L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 338 EGPIPHNI-SSCTALNQFNVHGNRLSGAIPSS-FRNLGSLTYLNLSRNNFKGKVPTELGR 395
+ +P + L + + N+L ++P F +L LTYL+L N +
Sbjct: 98 QA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ--------- 146
Query: 396 IINLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSF 454
S+P + D L L L L N L + F L ++T+ +
Sbjct: 147 ----------------SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 455 NQLSGSIPAEL-GQLQNIISLILNNN 479
NQL +P L+ + L L N
Sbjct: 191 NQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 12/206 (5%)
Query: 63 NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQL 122
N S+D KLT IP I ++L N L + +L +L L L +N+L
Sbjct: 17 NKNSVDCSSKKLT-AIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73
Query: 123 TGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEV-LQYLGLRGNALTGMLSPDMC-Q 180
++ NL+TL + N+L +P ++ V L L L N L L P +
Sbjct: 74 QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDS 131
Query: 181 LTGLWYFDVRGNNLTGTIPDSI-GNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQ 237
LT L Y + N L ++P + TS + L + NQ+ +P ++ TL L
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLD 189
Query: 238 GNKLTGKIPEVIGLMQALAVLDLSEN 263
N+L ++ L +L L EN
Sbjct: 190 NNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 50/192 (26%), Positives = 77/192 (40%), Gaps = 14/192 (7%)
Query: 130 LTQIP-----NLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMC-QLTG 183
LT IP + K LDL N+L+ + + L+ L L N L L + +L
Sbjct: 28 LTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 184 LWYFDVRGNNLTGTIPDSI-GNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQGNK 240
L V N L +P + + L + NQ+ +P + ++ LSL N+
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 241 LTGKIPE-VIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGN 299
L +P+ V + +L L L N+L L+ L L N+L +
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDS 203
Query: 300 MSKLSYLQLQNN 311
+ KL LQLQ N
Sbjct: 204 LEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 46/203 (22%), Positives = 74/203 (36%), Gaps = 25/203 (12%)
Query: 31 VFCDNSSLSVV---------SLNLSSLNLGGEISPSIGD-LRNLQSIDFQGNKLTGQIPD 80
V C + L+ + L+L S N + L L+ + NKL +P
Sbjct: 21 VDCSSKKLTAIPSNIPADTKKLDLQS-NKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPA 78
Query: 81 EI-GNCGSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKT 138
I +L + ++DN L +P + +L L L L NQL P + L
Sbjct: 79 GIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY 137
Query: 139 LDLARNQLTGEIP-----RLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNN 193
L L N+L +P +L L+ L L N L + +LT L + N
Sbjct: 138 LSLGYNELQ-SLPKGVFDKLT----SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
Query: 194 LTGTIPDSIGNCTSFEILDISYN 216
L + + ++L + N
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 8/115 (6%)
Query: 398 NLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457
+ LDL N S + L L L L+ N L L F L++++T+ ++ N+L
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97
Query: 458 SGSIPAEL-GQLQNIISLILNNNNLQ---GGIPDQLSNCFSLSNLNVSYNNLSGI 508
++P + QL N+ L L+ N L+ + D L+ L+ L++ YN L +
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK---LTYLSLGYNELQSL 148
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 65/305 (21%), Positives = 112/305 (36%), Gaps = 67/305 (21%)
Query: 611 IMRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKL-------------YNQY 652
+ + + E Y G GA V C KN A+K +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 653 PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV-----NGSLWDLLHGPS 707
E E+ + S+ H NI+ L + + ++ Y+V G L++ +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDV----FEDKKYF-YLVTEFYEGGELFEQI---I 138
Query: 708 KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGI 764
+ K D I G+ YLH I+HRD+K NIL+ + + + DFG+
Sbjct: 139 NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGL 195
Query: 765 ARCIPTAMPHASTFVLGTIGYIDPE-----YAHTSRLNEKSDVYSFGIVLLEILTGK--- 816
+ + LGT YI PE Y NEK DV+S G+++ +L G
Sbjct: 196 SSFFSK--DYKLRDRLGTAYYIAPEVLKKKY------NEKCDVWSCGVIMYILLCGYPPF 247
Query: 817 KAVDNESNLHQLIMSKADDNTVMEAVD-PEVSVTCVDLSAVRKTFQLALLCTKRYPSERP 875
N+ ++ + + + D +S +L ++ +L ++R
Sbjct: 248 GG-QNDQDIIKKVEKGKYY---FDFNDWKNISDEAKEL--IKL-----MLT--YDYNKRC 294
Query: 876 TMQEV 880
T +E
Sbjct: 295 TAEEA 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 9e-17
Identities = 69/309 (22%), Positives = 123/309 (39%), Gaps = 62/309 (20%)
Query: 599 LHMDMAIHTFDDIMRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVK-----KL 648
+H + + + +E+Y + G G+ V KC + + + AVK
Sbjct: 1 MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60
Query: 649 YNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV-----NGSLWDLL 703
N+ + E+E + + H NI+ L + + Y+V G L+D +
Sbjct: 61 KNKDTSTIL---REVELLKKLDHPNIMKLFEI----LEDSSSF-YIVGELYTGGELFDEI 112
Query: 704 HGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLS 760
K+ + +I G+ Y+H I+HRD+K NIL+ +++ D +
Sbjct: 113 ---IKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166
Query: 761 DFGIARCIPTAMPHASTFVLGTIGYIDPE-----YAHTSRLNEKSDVYSFGIVLLEILTG 815
DFG++ C +GT YI PE Y +EK DV+S G++L +L+G
Sbjct: 167 DFGLSTCFQQN--TKMKDRIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSG 218
Query: 816 K---KAVDNESNLHQLIMSKADDNTVMEAVD-PEVSVTCVDLSAVRKTFQLALLCTKRYP 871
NE ++ + + + + +S DL +RK +L +P
Sbjct: 219 TPPFYG-KNEYDILKRVETGKYA---FDLPQWRTISDDAKDL--IRK-----MLT--FHP 265
Query: 872 SERPTMQEV 880
S R T +
Sbjct: 266 SLRITATQC 274
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 43/236 (18%), Positives = 79/236 (33%), Gaps = 17/236 (7%)
Query: 273 LGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNL 332
L+ K L +T + +S + N+ + A + L EL+L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHL 70
Query: 333 ADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTE 392
+ N + + + T L + +V+ NRL L + L L N +
Sbjct: 71 SHNQISD-LS-PLKDLTKLEELSVNRNRLKNLNGIPSACL---SRLFLDNNELRD--TDS 123
Query: 393 LGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDM 452
L + NL+ L + N V +G L L L+L N + L+ + ID+
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDL 179
Query: 453 SFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508
+ + +L ++ + P +SN S + V +
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 38/232 (16%), Positives = 83/232 (35%), Gaps = 20/232 (8%)
Query: 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340
+ + P ++ L + T +L + N ++N++
Sbjct: 1 ESIQRPTPINQVFP--DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-- 54
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
+ T L + ++ N++S S ++L L L+++RN K L
Sbjct: 55 SLAGMQFFTNLKELHLSHNQISD--LSPLKDLTKLEELSVNRNRLKNLNGIPS---ACLS 109
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460
L L N S+ L++L L++ N L ++ G L ++ +D+ N+++ +
Sbjct: 110 RLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-N 164
Query: 461 IPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPI 512
L +L+ + + L + + + L N + I P
Sbjct: 165 TG-GLTRLKKVNWIDLTGQKC---VNEPVKYQPELYITNTVKDPDGRWISPY 212
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 42/253 (16%), Positives = 86/253 (33%), Gaps = 40/253 (15%)
Query: 104 FSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYL 163
F L NL +T + ++ ++ + + + + +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SLAGM---------- 59
Query: 164 GLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIP 223
T L + N ++ + + + T E L ++ N++ +
Sbjct: 60 ---------------QFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLN 101
Query: 224 YNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLY 283
I ++ L L N+L + + ++ L +L + N+L I LG LS L
Sbjct: 102 -GIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKS-IVM-LGFLSKLEVLD 156
Query: 284 LHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPH 343
LHGN++T L + K++++ L + V +L + D P
Sbjct: 157 LHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY-- 212
Query: 344 NISSCTALNQFNV 356
IS+ + V
Sbjct: 213 YISNGGSYVDGCV 225
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 39/217 (17%), Positives = 80/217 (36%), Gaps = 15/217 (6%)
Query: 53 EISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQL 112
++ P L N + +T + + + ++++ + + L
Sbjct: 11 QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-QSLA-GMQFFTNL 65
Query: 113 EFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTG 172
+ L+L +NQ++ S L + L+ L + RN+L + + + L L L N L
Sbjct: 66 KELHLSHNQISD--LSPLKDLTKLEELSVNRNRLK-NLNGIP--SACLSRLFLDNNELRD 120
Query: 173 MLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVA 232
+ L L +R N L +I +G + E+LD+ N+IT +V
Sbjct: 121 T--DSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVN 175
Query: 233 TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPI 269
+ L G K + + + + + + P
Sbjct: 176 WIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY 212
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 37/221 (16%), Positives = 70/221 (31%), Gaps = 40/221 (18%)
Query: 308 LQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPS 367
+ + P L + NL ++ + + + FN + + +
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ--SLA 57
Query: 368 SFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLN 427
+ +L L+LS N I +L L DL L L+
Sbjct: 58 GMQFFTNLKELHLSHNQ-----------ISDLSPLK---------------DLTKLEELS 91
Query: 428 LSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPD 487
++RN L L L + + N+L + L L+N+ L + NN L+
Sbjct: 92 VNRNRLKNLNGIPSACLS---RLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLKS--IV 144
Query: 488 QLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPL 528
L L L++ N ++ + + + G
Sbjct: 145 MLGFLSKLEVLDLHGNEITN-TGGLTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 42/207 (20%), Positives = 79/207 (38%), Gaps = 18/207 (8%)
Query: 44 NLSSLNLGG----EISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLY 99
NL L+L ++SP + DL L+ + N+L + L + L +N L
Sbjct: 64 NLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELR 119
Query: 100 GDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEV 159
D S+ LK LE L+++NN+L L + L+ LDL N++T + +
Sbjct: 120 -DTD-SLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGG--LTRLKK 173
Query: 160 LQYLGLRGNALTGMLSPDMCQLTGLWYFD-VRGNNLTGTIPDSIGNCTSFEILDISYNQI 218
+ ++ L G + + L+ + V+ + P I N S+ + +
Sbjct: 174 VNWIDLTGQKCV---NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELP 230
Query: 219 TGEIPYNIGFLQVATLSLQGNKLTGKI 245
+ F + + G +
Sbjct: 231 VYTDEVSYKFSEYINVGETEAIFDGTV 257
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 38/265 (14%), Positives = 88/265 (33%), Gaps = 45/265 (16%)
Query: 176 PDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLS 235
C+ F V ++ IP S + L + + +
Sbjct: 5 SPPCECHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR---------------T 45
Query: 236 LQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPI----LGNLSYTGKLYLHGNKLTG 291
+ + + + ++ + +S + + + L +++ + + +
Sbjct: 46 IPSHAFSN--------LPNISRIYVSIDVTLQQLESHSFYNLSKVTH---IEIRNTRNLT 94
Query: 292 PIPPE-LGNMSKLSYLQLQNNQLVGTIPAE--LGKLEQLFELNLADNNLEGPIPHNISS- 347
I P+ L + L +L + N L P + + F L + DN IP N
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
Query: 348 -CTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTEL--GRIINLDTLDL 404
C ++ N + ++ N L + L++N + + + G LD+
Sbjct: 154 LCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDV 212
Query: 405 SVNNFSGSVPASI-GDLEHLLTLNL 428
S + + ++P+ L+ L+ N
Sbjct: 213 SQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 40/272 (14%), Positives = 80/272 (29%), Gaps = 55/272 (20%)
Query: 26 CS-WRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGN 84
C + + PS+ + Q++ L N
Sbjct: 10 CHQEEDFRVTCKDIQRI--------------PSL--PPSTQTLKLIETHLRTIPSHAFSN 53
Query: 85 CGSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPS-TLTQIPNLKTLDLA 142
++ I +S + + L ++ + ++N + I L ++P LK L +
Sbjct: 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113
Query: 143 RNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSI 202
L P L + ++ N +IP +
Sbjct: 114 NTGLK-MFPDLTKVY----------------------STDIFFILEITDNPYMTSIPVNA 150
Query: 203 --GNCTSFEILDISYNQITGEIPYNIGF--LQVATLSLQGNKLTGKIPEVI--GLMQALA 256
G C L + N T + F ++ + L NK I + G+ +
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYA-FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 257 VLDLSENELVGPIPP-ILGNLSYTGKLYLHGN 287
+LD+S+ + +P L +L +L
Sbjct: 209 LLDVSQTSVTA-LPSKGLEHLK---ELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 34/251 (13%), Positives = 72/251 (28%), Gaps = 67/251 (26%)
Query: 269 IPPILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQ 326
IP + + L L L IP N+ +S + + + + + + L +
Sbjct: 26 IPSLPPSTQT---LKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81
Query: 327 LFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFK 386
+ + + + I P + + L L +L + K
Sbjct: 82 VTHIEIRNTRNLTYID-----------------------PDALKELPLLKFLGIFNTGLK 118
Query: 387 GKVPTELGRIINLDTLDLSVNNFSGSVPA--SIGDLEHLLTLNLSRNHLNGLLPAE-FGN 443
P + + L ++ N +P F
Sbjct: 119 -------------------------MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
Query: 444 LRS-IQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFS-----LSN 497
L + T+ + N + S+ + ++ LN N I + F S
Sbjct: 154 LCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK---DAFGGVYSGPSL 209
Query: 498 LNVSYNNLSGI 508
L+VS +++ +
Sbjct: 210 LDVSQTSVTAL 220
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 22/168 (13%), Positives = 54/168 (32%), Gaps = 6/168 (3%)
Query: 349 TALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTEL-GRIINLDTLDLSVN 407
+ + L +F NL +++ + +S + ++ + + + +++
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 408 NFSGSVPASI-GDLEHLLTLNLSRNHLNGLLPAEF-GNLRSIQTIDMSFNQLSGSIPAEL 465
+ +L L L + L + ++++ N SIP
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 466 --GQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP 511
G ++L L NN + N L + ++ N +I
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 43/168 (25%), Positives = 67/168 (39%), Gaps = 14/168 (8%)
Query: 277 SYTGKLYLHGNKLTGPIPPE--LGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLA 333
SYT L L N L+ + E ++ L L L +N L I +E + L L+L+
Sbjct: 39 SYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLS 96
Query: 334 DNNLEGPIPHNI-SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTE 392
N+L + + S AL ++ N + ++F ++ L L LS+N + P E
Sbjct: 97 SNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154
Query: 393 ----LGRIINLDTLDLSVNNFSGSVPASIGDLEHL--LTLNLSRNHLN 434
++ L LDLS N + L L L N L
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 5e-16
Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPS--SFRNLGSLTYLNLSRNNFKGKVPTE-LGRII 397
+P ++ S TA ++ N LS + + + L +L L LS N+ + +E +
Sbjct: 33 VPQSLPSYTA--LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 398 NLDTLDLSVNNFSGSVPASI-GDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQ 456
NL LDLS N+ ++ + DL+ L L L NH+ + F ++ +Q + +S NQ
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 457 LSGSIPAE----LGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNN 504
+S P E +L ++ L L++N L+ L + + +N
Sbjct: 148 IS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 36/201 (17%), Positives = 64/201 (31%), Gaps = 35/201 (17%)
Query: 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNC 85
C+ + C L V +L S +D N L+ ++ E
Sbjct: 18 CASNILSCSKQQLPNVPQSLPS---------------YTALLDLSHNNLS-RLRAEWTPT 61
Query: 86 G--SLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLA 142
+L + LS N L I + L +L+L +N L + + L+ L L
Sbjct: 62 RLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120
Query: 143 RNQLTGEIPR-----LIYWNEVLQYLGLRGNALTGMLSPD----MCQLTGLWYFDVRGNN 193
N + + R + LQ L L N ++ + +L L D+ N
Sbjct: 121 NNHIV-VVDRNAFEDMAQ----LQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNK 174
Query: 194 LTGTIPDSIGNCTSFEILDIS 214
L + ++ +
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 41/190 (21%), Positives = 63/190 (33%), Gaps = 18/190 (9%)
Query: 135 NLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDM--CQLTGLWYFDVRGN 192
L ++ QL +P+ + L L N L+ L + +LT L + N
Sbjct: 19 ASNILSCSKQQLP-NVPQSLPSY--TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHN 74
Query: 193 NLTGTIPDSI-GNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPEVI 249
+L I + LD+S N + + + + L L N +
Sbjct: 75 HLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAF 132
Query: 250 GLMQALAVLDLSENELVGPIPP----ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLS- 304
M L L LS+N++ P L L L NKL +L +
Sbjct: 133 EDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
Query: 305 -YLQLQNNQL 313
L L NN L
Sbjct: 192 NGLYLHNNPL 201
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 61/287 (21%), Positives = 110/287 (38%), Gaps = 48/287 (16%)
Query: 613 RSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIG 667
T N+ + +I G GA S V+ + + + A+K + E E+ +
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 668 SIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
I+H NIV+L S L + G L+D + ++ + +
Sbjct: 62 KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSA 118
Query: 728 LAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIPTAMPHASTFVLGTIG 784
+ YLH I+HRD+K N+L +EN ++DFG+++ + GT G
Sbjct: 119 VKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTACGTPG 172
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAV-----DNESNLHQLIMSKADDNTVM 839
Y+ PE ++ D +S G++ +L G + ES L + I +
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCG---YPPFYEETESKLFEKIK-EGY----- 223
Query: 840 EAVD------PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ ++S + D + LL P+ER T ++
Sbjct: 224 --YEFESPFWDDISESAKDF--ICH-----LLEKD--PNERYTCEKA 259
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 60/299 (20%), Positives = 108/299 (36%), Gaps = 44/299 (14%)
Query: 604 AIHTFDDIMRSTENLSEKYIV----GYGASSTVYKCALKNSRP------IAVKKLYNQYP 653
D+ + Y + G G S V +C + + + V K +
Sbjct: 8 GGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPG 67
Query: 654 HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLD 713
+ + + E ++H +IV L S + +++M L + + +
Sbjct: 68 LSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 127
Query: 714 WETRLKIAVGAA-------QGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFG 763
E A+ + L Y H + IIHRDVK +L+ + + L FG
Sbjct: 128 SEAV------ASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178
Query: 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKA-VDNE 822
+A + + A V GT ++ PE + DV+ G++L +L+G +
Sbjct: 179 VAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237
Query: 823 SNLHQLIMSKADDNTVMEAVD-PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
L + I+ M +S + DL VR+ +L P+ER T+ E
Sbjct: 238 ERLFEGIIKGKYK---MNPRQWSHISESAKDL--VRR-----MLMLD--PAERITVYEA 284
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 6e-16
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 623 IVGYGASSTVYKCALKNSRPI-AVKKLY-------NQYPHNLREFETELETIGSIRHRNI 674
I+G G VY C ++ + A+K L L E L + + I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFI 254
Query: 675 VSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---GLAY 730
V + YA L F D M G DL + S+ E ++ AA+ GL +
Sbjct: 255 VCMS-YAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFS-EADMRFY--AAEIILGLEH 307
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE- 789
+H N +++RD+K +NIL+DE+ +SD G+A PH V GT GY+ PE
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEV 361
Query: 790 YAHTSRLNEKSDVYSFGIVLLEILTGK 816
+ +D +S G +L ++L G
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 25/223 (11%)
Query: 623 IVGYGASSTVYKCALKNSRPI-AVKKLYNQYPHNLREFE---TELETIGSIRHRNIVSLH 678
I+G G+ STV + A+K L ++ + E + + + H V L+
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 679 GYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---GLAYLHHD 734
+ L F Y NG L + K D ET + A+ L YLH
Sbjct: 97 -FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFD-ETCTRFY--TAEIVSALEYLH-G 148
Query: 735 CNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH--ASTFVLGTIGYIDPEYAH 792
IIHRD+K NIL++E+ ++DFG A+ + A++FV GT Y+ PE
Sbjct: 149 KG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLT 205
Query: 793 TSRLNEKSDVYSFGIVLLEILTGK---KAVDNESNLHQLIMSK 832
+ SD+++ G ++ +++ G +A NE + Q I+
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKL 247
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 613 RSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVK-----KLYNQYPHNLREFETE 662
ST E Y G G SS V +C K + + AVK + ++E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 663 LETIGSI-----RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLD-WET 716
I H NI+ L + L +D M G L+D L ++KV L ET
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKET 126
Query: 717 RLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776
R KI + + LH I+HRD+K NIL+D++ + L+DFG + +
Sbjct: 127 R-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKL 180
Query: 777 TFVLGTIGYIDPE------YAHTSRLNEKSDVYSFGIVLLEIL 813
V GT Y+ PE + ++ D++S G V++ L
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTL 222
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 61/275 (22%), Positives = 103/275 (37%), Gaps = 49/275 (17%)
Query: 623 IVGYGASSTVYKCALKNSRPI-AVKKL-------YNQYPHNLREFETELETIGSIRHRNI 674
++G GA S V +K + + A+K + + F E + + + R I
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC----FREERDVLVNGDRRWI 123
Query: 675 VSLHGYALSPYGNLLFY-DYMVNGSLWDLLHGPSKKVKLDWETRLKIA--VGAAQGLAYL 731
LH +A L +Y V G L LL +++ + R +A V A + +
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAEIVMA---IDSV 178
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIA-RCIPTAMPHASTFVLGTIGYIDP 788
H +HRD+K NIL+D H L+DFG + + V GT Y+ P
Sbjct: 179 H---RLGYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSP 232
Query: 789 EYAHTSRLNEKSDVY-------SFGIVLLEILTGKK--AVDNESNLHQLIMSKADDNTVM 839
E + Y + G+ E+ G+ D+ + + I+ ++ +
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY-KEHLSL 291
Query: 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSER 874
VD V D +++ LLC P R
Sbjct: 292 PLVDEGVPEEARDF--IQR-----LLCP---PETR 316
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 23/241 (9%)
Query: 600 HMDMAIHTFDDIMRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPH 654
+D ++ + + ST + ++Y +G GA V R +A+KKL + +
Sbjct: 43 KVDNQFYSVE-VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 101
Query: 655 N------LREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDLLHGPS 707
RE L + + H+NI+SL F D Y+V + L
Sbjct: 102 QTHAKRAYRE----LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI 157
Query: 708 KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767
+ +LD E + G+ +LH IIHRD+K SNI++ + + DFG+AR
Sbjct: 158 QM-ELDHERMSYLLYQMLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQ 827
T+ T + T Y PE E D++S G ++ E++ K + Q
Sbjct: 214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271
Query: 828 L 828
Sbjct: 272 W 272
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 23/235 (9%)
Query: 606 HTFDDIMRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN----- 655
++ + I ST + ++Y +G GA V R +A+KKL + +
Sbjct: 12 YSVE-IGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR 70
Query: 656 -LREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDLLHGPSKKVKLD 713
RE L + + H+NI+ L F D Y+V + L + +LD
Sbjct: 71 AYRE----LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-ELD 125
Query: 714 WETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773
E + G+ +LH + IIHRD+K SNI++ + + DFG+AR T+
Sbjct: 126 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 180
Query: 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
T + T Y PE E D++S G ++ E++ G ++ Q
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 235
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 43/214 (20%), Positives = 89/214 (41%), Gaps = 21/214 (9%)
Query: 610 DIMRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELE 664
+ ++ + Y + G GA V++C K + R K + YP + + E+
Sbjct: 41 PVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS 100
Query: 665 TIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ + H +++LH Y +L +++ G L+D + ++ K+ + ++
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKM---SEAEVINYM 155
Query: 725 AQ---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL--SDFGIARCIPTAMPHASTFV 779
Q GL ++H I+H D+K NI+ + + + DFG+A +
Sbjct: 156 RQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVT 210
Query: 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
T + PE + +D+++ G VL +L
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVL 243
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.8 bits (196), Expect = 2e-15
Identities = 52/326 (15%), Positives = 103/326 (31%), Gaps = 26/326 (7%)
Query: 87 SLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKT----LDLA 142
VH+ + L ++ ++ L L ++ + N + DL
Sbjct: 246 CCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLP 305
Query: 143 RNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSI 202
L ++P+ + + L + W D + S+
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVL-------LKDRPECWCRDSATDEQLFRCELSV 358
Query: 203 GNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLD--- 259
T + S ++ P N L L ++ E + L +D
Sbjct: 359 EKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR 418
Query: 260 -----LSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLV 314
++ + + + L+L LT + L + +++L L +N+L
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR 476
Query: 315 GTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSG-AIPSSFRNLG 373
+P L L L L +DN LE + +++ L + + NRL A +
Sbjct: 477 -ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCP 533
Query: 374 SLTYLNLSRNNFKGKVPTELGRIINL 399
L LNL N+ + R+ +
Sbjct: 534 RLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 1e-14
Identities = 53/311 (17%), Positives = 101/311 (32%), Gaps = 27/311 (8%)
Query: 186 YFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIG-----FLQVATLSLQGNK 240
+ L+ + + L + ++ + + V L
Sbjct: 249 HVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAAS 308
Query: 241 LTGKIPEVIGLMQALAVLDLSENELVGPI----PPILGNLSYTGKLYLHGNKLTGPIPPE 296
L ++P+ + E L+ + L K T + E
Sbjct: 309 LNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSE 367
Query: 297 LGNMSKLSYLQLQNNQLVGTIPAELGKLEQLF---ELNLADNNLEGPIPHNISSCTALNQ 353
L + +L L+ +N + TI + L+ L E + L+ P + L
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS 427
Query: 354 FNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSV 413
+ N + + R L+L+ + V L +++ + LDLS N ++
Sbjct: 428 KFLLENSVLKMEYADVR------VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-AL 478
Query: 414 PASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPA--ELGQLQNI 471
P ++ L L L S N L + NL +Q + + N+L A L +
Sbjct: 479 PPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRL 535
Query: 472 ISLILNNNNLQ 482
+ L L N+L
Sbjct: 536 VLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 75.6 bits (185), Expect = 3e-14
Identities = 43/213 (20%), Positives = 74/213 (34%), Gaps = 11/213 (5%)
Query: 318 PAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTY 377
+ EQLF L+ + + SC L + I R L L Y
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 378 LNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLL 437
+ F + + LD + F + + L+L+ L L
Sbjct: 401 EKETLQYFSTL---KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL- 456
Query: 438 PAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSN 497
L + +D+S N+L ++P L L+ + L ++N L+ + ++N L
Sbjct: 457 -CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQE 512
Query: 498 LNVSYNNLSGI--IPPIRNFSRFSSNSFIGNPL 528
L + N L I P+ + R + GN L
Sbjct: 513 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 1e-12
Identities = 40/264 (15%), Positives = 78/264 (29%), Gaps = 33/264 (12%)
Query: 22 NSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDE 81
N S S L L + K T + E
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPECWC-RDSATDEQLFRCELSVEKST-VLQSE 367
Query: 82 IGNCGSLVHIELSDN----------------SLYGDIPFSISKLKQLEFLNLKN-----N 120
+ +C L +E + + S LK ++ + +
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS 427
Query: 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
+ + +++ L LA LT + L + +L L N L L P +
Sbjct: 428 KFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLL-VTHLDLSHNRLRA-LPPALAA 484
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITG--EIPYNIGFLQVATLSLQG 238
L L N L + + N + L + N++ I + ++ L+LQG
Sbjct: 485 LRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542
Query: 239 NKLTGK---IPEVIGLMQALAVLD 259
N L + + ++ +++ +
Sbjct: 543 NSLCQEEGIQERLAEMLPSVSSIL 566
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 64/250 (25%), Positives = 100/250 (40%), Gaps = 33/250 (13%)
Query: 623 IVGYGASSTVYKCALKNSRPI-AVKKL-------YNQYPHNLREFETELETIGSIRHRNI 674
++G GA V LKN+ + A+K L + F E + + + + I
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC----FREERDVLVNGDSKWI 136
Query: 675 VSLHGYALSPYGNLLFY-DYMVNGSLWDLLHGPSKKVKLDWETRLKIA--VGAAQGLAYL 731
+LH YA NL DY V G L LL ++ + R +A V A + +
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLAEMVIA---IDSV 191
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA-RCIPTAMPHASTFVLGTIGYIDPEY 790
H +HRD+K NIL+D N L+DFG + + +S V GT YI PE
Sbjct: 192 H---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEI 247
Query: 791 AHTSRLNEKS-----DVYSFGIVLLEILTGKK--AVDNESNLHQLIMSKADDNTVMEAVD 843
+ D +S G+ + E+L G+ ++ + IM+ +
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH-KERFQFPTQV 306
Query: 844 PEVSVTCVDL 853
+VS DL
Sbjct: 307 TDVSENAKDL 316
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 59/288 (20%), Positives = 107/288 (37%), Gaps = 50/288 (17%)
Query: 613 RSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIG 667
+ ++++ Y + G G+ V K + A KK+ + ++ F+ E+E +
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 668 SIRHRNIVSLHGYALSPYGNLLFYDYMV-----NGSLWDLLHGPSKKVKLDWETRLKIAV 722
S+ H NI+ L+ + + Y+V G L++ + K +I
Sbjct: 62 SLDHPNIIRLYET----FEDNTDI-YLVMELCTGGELFERV---VHKRVFRESDAARIMK 113
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIPTAMPHASTFV 779
+AY H + HRD+K N L + L DFG+A +
Sbjct: 114 DVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--K 168
Query: 780 LGTIGYIDPE-----YAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
+GT Y+ P+ Y + D +S G+++ +L G + +S + I +
Sbjct: 169 VGTPYYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--R 220
Query: 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
T E VS L +R+ LL P +R T +
Sbjct: 221 EGTFTFPEKDWLNVSPQAESL--IRR-----LLTKS--PKQRITSLQA 259
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 66/286 (23%), Positives = 106/286 (37%), Gaps = 39/286 (13%)
Query: 611 IMRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELET 665
+ R++ ++ Y V G G+ S +C K + AVK + E E L
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRY 72
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLD-WETRLKIAVGA 724
H NI++L + + M G L D + ++ E +
Sbjct: 73 GQ---HPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREAS-AVLFTI 125
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNIL-IDENFDAH---LSDFGIARCIPTAMPHASTFVL 780
+ + YLH ++HRD+K SNIL +DE+ + + DFG A+ + T
Sbjct: 126 TKTVEYLH-AQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC- 181
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG-----KKAVDNESNLHQLIMSKADD 835
T ++ PE + D++S G++L +LTG D + I S
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241
Query: 836 NTVMEAVD-PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ VS T DL V K +L P +R T V
Sbjct: 242 ---LSGGYWNSVSDTAKDL--VSK-----MLHVD--PHQRLTAALV 275
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 44/237 (18%), Positives = 96/237 (40%), Gaps = 36/237 (15%)
Query: 615 TENLSEKY----IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSI 669
+ +++ + G G TV K++ +A+KK+ RE + ++ + +
Sbjct: 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVL 76
Query: 670 RHRNIVSLHGYALSP--------YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
H NIV L Y + Y N++ +Y+ + L + + + ++
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVM-EYVPD----TL----HRCCRNYYRRQVAPP 127
Query: 722 VGAAQ--------GLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAM 772
+ + LH + HRD+K N+L++ + L DFG A+ + +
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 773 PHASTFVLGTIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDNESNLHQL 828
P+ + + Y PE ++ + D++S G + E++ G+ +++ QL
Sbjct: 187 PNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 614 STENLSEKYIV----GYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLRE-FETE 662
+ + + Y + G G + V KC K++ I ++ RE E E
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722
+ + + H NI++LH + +L + + G L+D L + + + +
Sbjct: 66 VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATS 119
Query: 723 GAAQ---GLAYLHHDCNPRIIHRDVKSSNILI----DENFDAHLSDFGIARCIPTAMPHA 775
Q G+ YLH +I H D+K NI++ L DFG+A I +
Sbjct: 120 FIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
+ F GT ++ PE + L ++D++S G V+ IL
Sbjct: 177 NIF--GTPEFVAPEIVNYEPLGLEADMWSIG-VITYIL 211
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 6e-15
Identities = 44/213 (20%), Positives = 87/213 (40%), Gaps = 21/213 (9%)
Query: 611 IMRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELET 665
+ +++ + Y + G GA V++ + + A K + + + E++T
Sbjct: 148 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 207
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA 725
+ +RH +V+LH ++ Y++M G L++ + + K+ + +
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKM---SEDEAVEYMR 262
Query: 726 Q---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL--SDFGIARCIPTAMPHASTFVL 780
Q GL ++H +H D+K NI+ L DFG+ + +
Sbjct: 263 QVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTT 317
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
GT + PE A + +D++S G VL IL
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYIL 349
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 55/245 (22%), Positives = 97/245 (39%), Gaps = 55/245 (22%)
Query: 613 RSTENLSEKY----IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGS 668
++ E Y ++G G+ V++ L S +A+KK+ RE L+ +
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRI 88
Query: 669 IRHRNIVSLHGYALSP-------YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
++H N+V L + S + NL+ +Y+ + + +LK
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVL-EYVPE----TV-----YRA-SRHYAKLKQT 137
Query: 722 VGAA----------QGLAYLHHDCNPRIIHRDVKSSNILIDENFDA-HLSDFGIARCIPT 770
+ + LAY+H + I HRD+K N+L+D L DFG A+ +
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 771 AMPHASTFVLGTIGYI------DPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNES 823
P+ + YI PE + D++S G V+ E++ G+ ES
Sbjct: 195 GEPN--------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246
Query: 824 NLHQL 828
+ QL
Sbjct: 247 GIDQL 251
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 67/303 (22%), Positives = 120/303 (39%), Gaps = 50/303 (16%)
Query: 599 LHMDMAIHTFDDIMRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVK-----KL 648
+H + + + +E+Y + G G+ V KC + + + AVK
Sbjct: 1 MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60
Query: 649 YNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSK 708
N+ + E+E + + H NI+ L + + G L+D + K
Sbjct: 61 KNKDTSTIL---REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IK 114
Query: 709 KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIA 765
+ + +I G+ Y+H I+HRD+K NIL+ +++ D + DFG++
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 766 RCIPTAMPHASTFVLGTIGYIDPE-----YAHTSRLNEKSDVYSFGIVLLEILTGKK--A 818
C +GT YI PE Y +EK DV+S G++L +L+G
Sbjct: 172 TCFQQNTKMKD--RIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPPFY 223
Query: 819 VDNESNLHQLIMSKADDNTVMEAVD-PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTM 877
NE ++ + + + + +S DL +RK +L +PS R T
Sbjct: 224 GKNEYDILKRVETGKYA---FDLPQWRTISDDAKDL--IRK-----MLT--FHPSLRITA 271
Query: 878 QEV 880
+
Sbjct: 272 TQC 274
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 614 STENLSEKYIV----GYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLRE-FETE 662
+ + + Y + G G + V KC K++ I ++ RE E E
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722
+ + + H N+++LH + +L + + G L+D L + + + +
Sbjct: 66 VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATS 119
Query: 723 GAAQ---GLAYLHHDCNPRIIHRDVKSSNILI-DENFDAH---LSDFGIARCIPTAMPHA 775
Q G+ YLH +I H D+K NI++ D+N L DFG+A I +
Sbjct: 120 FIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
+ F GT ++ PE + L ++D++S G++ +L+G
Sbjct: 177 NIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 56/301 (18%), Positives = 116/301 (38%), Gaps = 44/301 (14%)
Query: 599 LHMDMAIHTFDDIMRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLY-NQY 652
+H + + + + + +I G GA V+ ++S +K + ++
Sbjct: 1 MHHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60
Query: 653 PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY----DYMVNGSLWD-LLHGPS 707
+ + E E+E + S+ H NI+ + + + + G L + ++ +
Sbjct: 61 QVPMEQIEAEIEVLKSLDHPNIIKIFEV----FEDYHNMYIVMETCEGGELLERIVSAQA 116
Query: 708 KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGI 764
+ L ++ LAY H + ++H+D+K NIL + + DFG+
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173
Query: 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNE 822
A + + GT Y+ PE + K D++S G+V+ +LTG +
Sbjct: 174 AELFKSDEHSTN--AAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230
Query: 823 SNLHQLIMSKADDNTVMEAVDPE---VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQE 879
+ Q K + E ++ VDL +++ +L + P RP+ +
Sbjct: 231 EEVQQKATYKEPN------YAVECRPLTPQAVDL--LKQ-----MLT--KDPERRPSAAQ 275
Query: 880 V 880
V
Sbjct: 276 V 276
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 25/236 (10%)
Query: 606 HTFDDIMRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN----- 655
+ + + ++ + Y VG GA V + +A+KKLY +
Sbjct: 12 YRQE-VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 70
Query: 656 -LREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDLLHGPSKKVKLD 713
RE L + +RH N++ L F D Y+V + L K KL
Sbjct: 71 AYRE----LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG 126
Query: 714 WETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773
+ + +GL Y+H IIHRD+K N+ ++E+ + + DFG+AR + M
Sbjct: 127 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM- 182
Query: 774 HASTFVLGTIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDNESNLHQL 828
T + T Y PE ++ D++S G ++ E++TGK +L QL
Sbjct: 183 ---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 235
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 61/251 (24%), Positives = 97/251 (38%), Gaps = 39/251 (15%)
Query: 623 IVGYGASSTVYKCALKNSRPI-AVKKL-------YNQYPHNLREFETELETIGSIRHRNI 674
++G GA V K++R + A+K L + F E + + +
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAFANSPWV 131
Query: 675 VSLHGYALSPYGNLLFY-DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---GLAY 730
V L YA L +YM G L +L+ + E + A+ L
Sbjct: 132 VQLF-YAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVP-EKWARFY--TAEVVLALDA 183
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA-RCIPTAMPHASTFVLGTIGYIDPE 789
+H + IHRDVK N+L+D++ L+DFG + M T V GT YI PE
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPE 239
Query: 790 ----YAHTSRLNEKSDVYSFGIVLLEILTGK---KAVDNESNLHQLIMSKADDNTVMEAV 842
+ D +S G+ L E+L G A D+ + IM+ + +
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNS--LTFPD 296
Query: 843 DPEVSVTCVDL 853
D ++S +L
Sbjct: 297 DNDISKEAKNL 307
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 25/207 (12%)
Query: 623 IVGYGASSTVYKCALKNSRPI-AVKKL-------YNQYPHNLREFETELETIGSIRHRNI 674
++G G V+ C +K + + A KKL Y + E + + + R I
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKVHSRFI 247
Query: 675 VSLHGYALSPYGNLLF-YDYMVNGSL-WDLLHGPSKKVKLDWETRLKIAVGAAQ---GLA 729
VSL YA +L M G + + + + E R AQ GL
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFY--TAQIVSGLE 303
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
+LH II+RD+K N+L+D++ + +SD G+A + + GT G++ PE
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 790 YAHTSRLNEKSDVYSFGIVLLEILTGK 816
+ D ++ G+ L E++ +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 68/308 (22%), Positives = 117/308 (37%), Gaps = 63/308 (20%)
Query: 615 TENLSEKYIV-----GYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGS 668
+ + Y + G GA + V C + + AVK + Q H E+E +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 669 IR-HRNIVSLHG-YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA-- 724
+ HRN++ L + L+F + M GS+ +H K+ + E A
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVF-EKMRGGSILSHIH---KRRHFN-E---LEASVVVQ 118
Query: 725 --AQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIAR-------CIPTAM 772
A L +LH N I HRD+K NIL ++ + DF + C P +
Sbjct: 119 DVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 773 PHASTFVLGTIGYIDPE-----YAHTSRLNEKSDVYSFGIVLLEILTGK----KAVDNES 823
P T G+ Y+ PE S +++ D++S G++L +L+G ++
Sbjct: 176 PELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234
Query: 824 NLHQLIMSKADDNTVMEAV--------DPE---VSVTCVDLSAVRKTFQLALLCTKRYPS 872
+ A N + E++ D + +S DL + K LL
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDL--ISK-----LLVRD--AK 285
Query: 873 ERPTMQEV 880
+R + +V
Sbjct: 286 QRLSAAQV 293
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 58/236 (24%), Positives = 100/236 (42%), Gaps = 26/236 (11%)
Query: 606 HTFDDIMRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN----- 655
+ D + ++ L + Y VG GA +V ++ +A+KKL +
Sbjct: 11 YKQD-VNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR 69
Query: 656 -LREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDLLHGPSKKVKLD 713
RE L + ++H N++ L FYD Y+V + L K
Sbjct: 70 AYRE----LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL-KFS 124
Query: 714 WETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773
E + +GL Y+H + ++HRD+K N+ ++E+ + + DFG+AR M
Sbjct: 125 EEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM- 180
Query: 774 HASTFVLGTIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDNESNLHQL 828
T + T Y PE + ++ D++S G ++ E+LTGK + L QL
Sbjct: 181 ---TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 233
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 24/184 (13%)
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLK 719
EL+ + + H +V+L Y+ ++ D ++ G L L + V E +K
Sbjct: 64 KELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFK-EETVK 118
Query: 720 IAVGAAQ---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776
+ + L YL + RIIHRD+K NIL+DE+ H++DF IA +P +
Sbjct: 119 LF--ICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-IT 172
Query: 777 TFVLGTIGYIDPEYAHTSRLNEKS---DVYSFGIVLLEILTGK-----KAVDNESNLHQL 828
T GT Y+ PE + + S D +S G+ E+L G+ ++ + +
Sbjct: 173 TMA-GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
Query: 829 IMSK 832
+
Sbjct: 232 FETT 235
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 65/303 (21%), Positives = 109/303 (35%), Gaps = 74/303 (24%)
Query: 615 TENLSEKY-------IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETI 666
+ Y +G G+ S KC K S + AVK + + N ++ E+ +
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITAL 59
Query: 667 GSIR-HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVG-- 723
H NIV LH L + + G L++ R+
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE---------------RI-KKKKHF 103
Query: 724 ----AAQ-------GLAYLHHDCNPRIIHRDVKSSNIL-IDENFDAHL--SDFGIARCIP 769
A+ ++++H D ++HRD+K N+L DEN + + DFG AR P
Sbjct: 104 SETEASYIMRKLVSAVSHMH-DVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160
Query: 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK-----KAVDNESN 824
T T+ Y PE + + +E D++S G++L +L+G+
Sbjct: 161 PDNQPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT 219
Query: 825 LHQLIMSKADDNTVMEA-VD------PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTM 877
IM K + + VS DL ++ LL P++R M
Sbjct: 220 SAVEIMKK-----IKKGDFSFEGEAWKNVSQEAKDL--IQG-----LLTVD--PNKRLKM 265
Query: 878 QEV 880
+
Sbjct: 266 SGL 268
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 33/141 (23%), Positives = 60/141 (42%), Gaps = 6/141 (4%)
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
IP N+ + + N + P +F L ++LS N P + +L+
Sbjct: 26 IPTNLPETI--TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83
Query: 401 TLDLSVNNFSGSVPASIGD-LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459
+L L N + +P S+ + L L L L+ N +N L F +L ++ + + N+L
Sbjct: 84 SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ- 141
Query: 460 SIPAE-LGQLQNIISLILNNN 479
+I L+ I ++ L N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 29/134 (21%), Positives = 56/134 (41%), Gaps = 6/134 (4%)
Query: 279 TGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNN 336
++ L N + IPP KL + L NNQ+ + + L L L L N
Sbjct: 34 ITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 337 LEGPIPHNI-SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGR 395
+ +P ++ +L ++ N+++ +F++L +L L+L N +
Sbjct: 92 ITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 396 IINLDTLDLSVNNF 409
+ + T+ L+ N F
Sbjct: 151 LRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 41/213 (19%), Positives = 80/213 (37%), Gaps = 22/213 (10%)
Query: 188 DVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKI 245
D RG LT IP ++ + + N I IP + ++ + L N+++ ++
Sbjct: 17 DCRGKGLT-EIPTNLPETI--TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-EL 71
Query: 246 PE-VIGLMQALAVLDLSENELVGPIPP-ILGNLSYTGKLYLHGNKLTGPIPPEL-GNMSK 302
+++L L L N++ +P + L L L+ NK+ + + ++
Sbjct: 72 APDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHN 129
Query: 303 LSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTAL---NQFNVHGN 359
L+ L L +N+L L + ++LA N I C + + +
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF-------ICDCHLKWLADYLHTNPI 182
Query: 360 RLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTE 392
SGA +S R L + + F+
Sbjct: 183 ETSGARCTSPRRLANKRIGQIKSKKFRCSAAAH 215
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 38/142 (26%), Positives = 64/142 (45%), Gaps = 8/142 (5%)
Query: 63 NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQL 122
+ +D +G LT +IP + ++ I L N++ P + S K+L ++L NNQ+
Sbjct: 12 SNNIVDCRGKGLT-EIPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI 68
Query: 123 TGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWN-EVLQYLGLRGNALTGMLSPDM-CQ 180
+ P + +L +L L N++T E+P+ ++ LQ L L N + L D
Sbjct: 69 SELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQD 126
Query: 181 LTGLWYFDVRGNNLTGTIPDSI 202
L L + N L TI
Sbjct: 127 LHNLNLLSLYDNKLQ-TIAKGT 147
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 33/157 (21%), Positives = 57/157 (36%), Gaps = 19/157 (12%)
Query: 26 CSWRGVFCDNSSLSVVSLNLSS----LNLGG----EISPSIGD-LRNLQSIDFQGNKLTG 76
CS V C L+ + NL + L I P + L+ ID N+++
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS- 69
Query: 77 QIP----DEIGNCGSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPSTLT 131
++ + + L + L N + ++P S+ L L+ L L N++
Sbjct: 70 ELAPDAFQGLRS---LNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQ 125
Query: 132 QIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGN 168
+ NL L L N+L +Q + L N
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 48/215 (22%), Positives = 88/215 (40%), Gaps = 23/215 (10%)
Query: 611 IMRSTENLSEKYIV------GYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETEL 663
+ ++ Y V G G V+KC + +A K + + + E + E+
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 664 ETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVG 723
+ + H N++ L+ S +L +Y+ G L+D + + L T L +
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDESYNL---TELDTILF 192
Query: 724 AAQ---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL--SDFGIARCIPTAMPHASTF 778
Q G+ ++H I+H D+K NIL + DFG+AR F
Sbjct: 193 MKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249
Query: 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
GT ++ PE + ++ +D++S G V+ +L
Sbjct: 250 --GTPEFLAPEVVNYDFVSFPTDMWSVG-VIAYML 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 8e-14
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 25/212 (11%)
Query: 615 TENLSEKYIV----GYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLREFETELE 664
+ S+ Y V G GA S V +C K + I KKL + L E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REAR 57
Query: 665 TIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
++H NIV LH + L +D + G L++ + +
Sbjct: 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQI 114
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIPTAMPHASTFVLG 781
+ +AY H + I+HR++K N+L+ + L+DFG+A + + F G
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFA-G 169
Query: 782 TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
T GY+ PE ++ D+++ G V+L IL
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACG-VILYIL 200
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 54/182 (29%), Positives = 78/182 (42%), Gaps = 32/182 (17%)
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNL 337
T KL L L ++KL++L L NQL T+ A + L +L L LA+N L
Sbjct: 37 TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL 95
Query: 338 EGPIPHNI-SSCTALNQFNVHGNRLSGAIPSS-FRNLGSLTYLNLSRNNFKGKVPTELGR 395
+P + T L++ + GN+L ++PS F L L L L+ N +
Sbjct: 96 AS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ--------- 144
Query: 396 IINLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSF 454
S+PA D L +L TL+LS N L + F L +QTI +
Sbjct: 145 ----------------SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188
Query: 455 NQ 456
NQ
Sbjct: 189 NQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 6/155 (3%)
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI 293
L LQ L + L L+L N+L + +L+ G L L N+L +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-L 98
Query: 294 PPEL-GNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNLEGPIPHNI-SSCTA 350
P + ++++L L L NQL ++P+ + +L +L EL L N L+ IP T
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTN 156
Query: 351 LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNF 385
L ++ N+L +F LG L + L N F
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 46/157 (29%), Positives = 66/157 (42%), Gaps = 12/157 (7%)
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK 388
+L+L L T L N+ N+L F +L L L L+ N
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 389 VPTEL-GRIINLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRNHLNGLLPAEFGNLRS 446
+P + + LD L L N S+P+ + D L L L L+ N L + F L +
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156
Query: 447 IQTIDMSFNQLSGSIPAE----LGQLQNIISLILNNN 479
+QT+ +S NQL S+P LG+LQ I L N
Sbjct: 157 LQTLSLSTNQLQ-SVPHGAFDRLGKLQTI---TLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 38/131 (29%), Positives = 55/131 (41%), Gaps = 6/131 (4%)
Query: 92 ELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIP 151
+L L + L +L +LNL NQL + L TL LA NQL +P
Sbjct: 41 DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLP 99
Query: 152 RLIYWNEV-LQYLGLRGNALTGMLSPDMC-QLTGLWYFDVRGNNLTGTIPDSI-GNCTSF 208
++ + L L L GN L L + +LT L + N L +IP T+
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157
Query: 209 EILDISYNQIT 219
+ L +S NQ+
Sbjct: 158 QTLSLSTNQLQ 168
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 46/178 (25%), Positives = 65/178 (36%), Gaps = 51/178 (28%)
Query: 400 DTLDLSVNNFSG-----------------------SVPASIGD-LEHLLTLNLSRNHLNG 435
+ LDL + ++ A + D L L TL L+ N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 436 LLPAEFGNLRSIQTIDMSFNQLSGSIPA----ELGQLQNIISLILNNNNLQ---GGIPDQ 488
L F +L + + + NQL S+P+ L +L+ L LN N LQ G D+
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKE---LRLNTNQLQSIPAGAFDK 153
Query: 489 LSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFI---GNPLLCG--------NWIG 535
L+N L L++S N L + P F R I GN C WI
Sbjct: 154 LTN---LQTLSLSTNQLQSV--PHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQWIR 206
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 60/295 (20%), Positives = 107/295 (36%), Gaps = 55/295 (18%)
Query: 612 MRSTENLSEKYIV-----GYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELET 665
+++ Y + G G + V +C + + + A+K L P +E + +
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-YDSPKARQEVDHHWQA 78
Query: 666 IGSIRHRNIVSLHG-YALSPYGNLLFY---DYMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
G +IV + Y +G + M G L+ + + + E + A
Sbjct: 79 SG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAFTE---REA 130
Query: 722 VGA----AQGLAYLHHDCNPRIIHRDVKSSNIL-IDENFDAHL--SDFGIARCIPTAMPH 774
+ +LH N I HRDVK N+L + DA L +DFG A+
Sbjct: 131 AEIMRDIGTAIQFLH-SHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NA 185
Query: 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
T T Y+ PE + ++ D++S G+++ +L G + + + +
Sbjct: 186 LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244
Query: 833 ADDNTVMEA-VD------PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ EVS L +R LL T P+ER T+ +
Sbjct: 245 -----IRLGQYGFPNPEWSEVSEDAKQL--IRL-----LLKTD--PTERLTITQF 285
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 67/292 (22%), Positives = 115/292 (39%), Gaps = 42/292 (14%)
Query: 611 IMRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVK-----KLYNQYPHNLRE-- 658
+ + L ++YI+ G GA V + + + +A+K K
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 659 -FETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETR 717
ETE+E + + H I+ + + + ++ + M G L+D + +L T
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV---VGNKRLKEATC 116
Query: 718 LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIPTAMPH 774
+ YLH + IIHRD+K N+L+ +E+ ++DFG ++ +
Sbjct: 117 KLYFYQMLLAVQYLH-ENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSL 172
Query: 775 ASTFVLGTIGYIDPE---YAHTSRLNEKSDVYSFGIVLLEILTGK---KAVDNESNLHQL 828
T GT Y+ PE T+ N D +S G++L L+G + +L
Sbjct: 173 MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
I + + V EVS +DL V+K LL P R T +E
Sbjct: 232 I--TSGKYNFIPEVWAEVSEKALDL--VKK-----LLVVD--PKARFTTEEA 272
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 78/328 (23%), Positives = 128/328 (39%), Gaps = 57/328 (17%)
Query: 574 KSNQQRQQLITGSRKSMLGPPKLVILHMDMAIHTFDDIMRSTENLSEKYIV----GYGAS 629
+ + S + P L D I + + LS+ + V G GA+
Sbjct: 12 DLGTENLYFQSMSSVTASAAPGTASLVPDYWI-----DGSNRDALSDFFEVESELGRGAT 66
Query: 630 STVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688
S VY+C K + +P A+K L + + TE+ + + H NI+ L +P
Sbjct: 67 SIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124
Query: 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA----AQGLAYLHHDCNPRIIHRDV 744
L + + G L+D + +K E + A A + +AYLH + I+HRD+
Sbjct: 125 LVLELVTGGELFDRI---VEKGYYS-E---RDAADAVKQILEAVAYLH-ENG--IVHRDL 174
Query: 745 KSSNIL-IDENFDAHL--SDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSD 801
K N+L DA L +DFG+++ + V GT GY PE + D
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 802 VYSFGIVLLEILTGK---KAVDNESNLHQLIMSKADDNTVMEAVD------PEVSVTCVD 852
++S GI+ +L G + + + I++ EVS+ D
Sbjct: 233 MWSVGIITYILLCGFEPFYDERGDQFMFRRILNC--------EYYFISPWWDEVSLNAKD 284
Query: 853 LSAVRKTFQLALLCTKRYPSERPTMQEV 880
L VRK L+ P +R T +
Sbjct: 285 L--VRK-----LIVLD--PKKRLTTFQA 303
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 24/232 (10%)
Query: 610 DIMRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN------LRE 658
++ ++ + E+Y VG GA +V K +AVKKL + RE
Sbjct: 19 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 659 FETELETIGSIRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDLLHGPSKKVKLDWETR 717
L + ++H N++ L F D Y+V + L+ K KL +
Sbjct: 79 ----LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 134
Query: 718 LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777
+ +GL Y+H + IIHRD+K SN+ ++E+ + + DFG+AR M T
Sbjct: 135 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----T 187
Query: 778 FVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ T Y PE N+ D++S G ++ E+LTG+ ++ QL
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 47/247 (19%), Positives = 85/247 (34%), Gaps = 35/247 (14%)
Query: 606 HTFDDIMRSTENLSEKY----IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNL--REF 659
D++ + Y + G+ V P+A+K+++N
Sbjct: 8 AAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNIL 67
Query: 660 ET---------ELETIGSIRHRNIVSLHGYALSPYGNLLFYD-YMV----NGSLWDLLHG 705
E+ + H NI+ L + + Y+V L ++H
Sbjct: 68 SDSFLCKRVLREIRLLNHFHHPNILGLRD-IFVHFEEPAMHKLYLVTELMRTDLAQVIH- 125
Query: 706 PSKKVKLDWETRLKIAVGAAQ---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDF 762
+++ + + I GL LH ++HRD+ NIL+ +N D + DF
Sbjct: 126 -DQRIVI---SPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDF 178
Query: 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAVDN 821
+AR T + Y PE + K D++S G V+ E+ K
Sbjct: 179 NLAREDTA--DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 822 ESNLHQL 828
+ +QL
Sbjct: 237 STFYNQL 243
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 47/224 (20%), Positives = 87/224 (38%), Gaps = 44/224 (19%)
Query: 613 RSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLY--NQYPHNLREFETELET 665
+ +E+Y + G GA S V +C + + A + + ++ E E
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVG-- 723
++H NIV LH + L +D + G L++ + +A
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE---------------DI-VAREYY 107
Query: 724 ----AA-------QGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIP 769
A+ + + + H ++HR++K N+L+ + L+DFG+A +
Sbjct: 108 SEADASHCIQQILEAVLHCH-QMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164
Query: 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
F GT GY+ PE + D+++ G V+L IL
Sbjct: 165 GEQQAWFGFA-GTPGYLSPEVLRKDPYGKPVDLWACG-VILYIL 206
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 20/208 (9%)
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLE 338
T K L +T ++ + + N+ + ++ + L + L L N L
Sbjct: 21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH 76
Query: 339 G-PIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTEL-GRI 396
+++ T L + GN+L F L +L L L N + +P + ++
Sbjct: 77 DISALKELTNLTYLI---LTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKL 132
Query: 397 INLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFN 455
NL L+L+ N S+P + D L +L L+LS N L L F L ++ + + N
Sbjct: 133 TNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191
Query: 456 QLSGSIP----AELGQLQNIISLILNNN 479
QL S+P L LQ I L++N
Sbjct: 192 QLK-SVPDGVFDRLTSLQYI---WLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 49/225 (21%), Positives = 83/225 (36%), Gaps = 33/225 (14%)
Query: 161 QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITG 220
L+ ++T +L + +++ ++ I + L + N++
Sbjct: 22 IKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLH- 76
Query: 221 EIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTG 280
+I + L L GN+L V + L L L EN+L + L+
Sbjct: 77 DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT 136
Query: 281 KLYLHGNKLTGPIPPEL-GNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNLE 338
L L N+L +P + ++ L+ L L NQL ++P + KL QL +L L N L+
Sbjct: 137 YLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLK 194
Query: 339 GPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383
+P G F L SL Y+ L N
Sbjct: 195 S-VPD-------------------GV----FDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 54/257 (21%), Positives = 97/257 (37%), Gaps = 50/257 (19%)
Query: 65 QSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLT- 123
++I PD+ + L S+ + + +L ++ + N+ +
Sbjct: 1 ETITVSTPIKQI-FPDDAFAETIKAN--LKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 55
Query: 124 -GPIPSTLTQIPNLKTLDLARNQLT--GEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQ 180
I PN++ L L N+L + L L YL L GN L + + +
Sbjct: 56 VQGIQYL----PNVRYLALGGNKLHDISALKELTN----LTYLILTGNQLQSLPNGVFDK 107
Query: 181 LTGLWYFDVRGNNLTGTIPDSIGNC-TSFEILDISYNQITGEIPYNIGF---LQVATLSL 236
LT L + N L ++PD + + T+ L++++NQ+ +P + F + L L
Sbjct: 108 LTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGV-FDKLTNLTELDL 164
Query: 237 QGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPE 296
N+L +PE V D L L L L+ N+L +P
Sbjct: 165 SYNQLQ-SLPE--------GVFD------------KLTQLKD---LRLYQNQLKS-VPDG 199
Query: 297 -LGNMSKLSYLQLQNNQ 312
++ L Y+ L +N
Sbjct: 200 VFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 38/164 (23%), Positives = 58/164 (35%), Gaps = 28/164 (17%)
Query: 25 FCSWRGVFCDNSSLSVVS-----LNLSSLNLGGEI---SPSIGDLRNLQSIDFQGNKLTG 76
F S++ ++ + I L N++ + GNKL
Sbjct: 18 FAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH- 76
Query: 77 QIPDEIGNCGSLV---HIELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPSTLTQ 132
+I L ++ L+ N L +P + KL L+ L L NQL +
Sbjct: 77 ----DISALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDK 131
Query: 133 IPNLKTLDLARNQLTGEIP-----RLIYWNEVLQYLGLRGNALT 171
+ NL L+LA NQL +P +L L L L N L
Sbjct: 132 LTNLTYLNLAHNQLQ-SLPKGVFDKLTN----LTELDLSYNQLQ 170
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 22/149 (14%)
Query: 30 GVFCDNSSLSVVSLNLSSLNLGGEISPSIGD-LRNLQSIDFQGNKLT---GQIPDEIGNC 85
+ ++L+ + L + L + + D L NL+ + N+L + D++ N
Sbjct: 79 SALKELTNLTYLILTGNQLQ---SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTN- 134
Query: 86 GSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPS----TLTQIPNLKTLD 140
L ++ L+ N L +P + KL L L+L NQL +P LTQ LK L
Sbjct: 135 --LTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQ---LKDLR 187
Query: 141 LARNQLTGEIPRLIYWN-EVLQYLGLRGN 168
L +NQL +P ++ LQY+ L N
Sbjct: 188 LYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 614 STENLSEKYIV----GYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLRE-FETE 662
EN+ + Y G G + V KC K++ I ++ + RE E E
Sbjct: 5 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722
+ + I+H N+++LH + +L + + G L+D L + + T +
Sbjct: 65 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL------AEKESLTEEEATE 118
Query: 723 GAAQ---GLAYLHHDCNPRIIHRDVKSSNIL-IDENFDAH---LSDFGIARCIPTAMPHA 775
Q G+ YLH +I H D+K NI+ +D N + DFG+A I
Sbjct: 119 FLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
+ GT ++ PE + L ++D++S G V+ IL
Sbjct: 175 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYIL 210
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 51/224 (22%), Positives = 86/224 (38%), Gaps = 42/224 (18%)
Query: 620 EKYIVGYGASSTVYKC---ALKNSRPIAVKKL--YNQYPHNLREFETELETIGSIRHRNI 674
E VG G VYK K+ + A+K++ RE E ++H N+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRE----LKHPNV 80
Query: 675 VSLHGYALSPYGNLLF--YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA------Q 726
+SL LS ++ +DY LW ++ +L + +
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAH----LSDFGIARC--IPT-AMPHASTFV 779
G+ YLH + ++HRD+K +NIL+ ++D G AR P + V
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 780 LGTIGYIDPE-------YAHTSRLNEKSDVYSFGIVLLEILTGK 816
+ T Y PE Y + D+++ G + E+LT +
Sbjct: 197 V-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 59/261 (22%), Positives = 101/261 (38%), Gaps = 33/261 (12%)
Query: 637 LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696
L++ R V Y R+ + + I R + S+ + S + + ++
Sbjct: 118 LRSKRNEFVP--YKTKGARFRQGKDYVGAIPVDLKRRLDSI-TSSQSSASSGFVEEKSLS 174
Query: 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756
+ K L E + + A+G+ +L + + IHRD+ + NIL+ E
Sbjct: 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 231
Query: 757 AHLSDFGIARCIPTAMPHASTFVLGTIGYID-----PEYAHTSRLNEKSDVYSFGIVLLE 811
+ DFG+AR I +V + PE +SDV+SFG++L E
Sbjct: 232 VKICDFGLARDIYK----DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287
Query: 812 ILT-GKK---AVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCT 867
I + G V + + + + T M A P+ + +Q L C
Sbjct: 288 IFSLGASPYPGVKIDEEFCRRLK----EGTRMRA--PD--------YTTPEMYQTMLDCW 333
Query: 868 KRYPSERPTMQEVARVLVSLL 888
PS+RPT E+ L +LL
Sbjct: 334 HGEPSQRPTFSELVEHLGNLL 354
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 48/230 (20%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYA 681
++G G+ VY+ L +S +A+KK+ RE L+ + + H NIV L +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFF 116
Query: 682 LSP-------YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ-------- 726
S Y NL+ DY+ + + + + + V +
Sbjct: 117 YSSGEKKDEVYLNLVL-DYVPE----TV----YRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDA-HLSDFGIARCIPTAMPHASTFVLGTIGY 785
LAY+H + I HRD+K N+L+D + L DFG A+ + P+ + Y
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--------VSY 216
Query: 786 I------DPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
I PE + DV+S G VL E+L G+ +S + QL
Sbjct: 217 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 51/229 (22%)
Query: 611 IMRSTENLSEKYIV----GYGASSTVYKCALKNSRP------IAVKKLYNQYPHNLREFE 660
+M ++ S+ Y V G GA S V +C K + I KKL + L
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--- 76
Query: 661 TELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI 720
E ++H NIV LH + L +D + G L++ + +
Sbjct: 77 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----------------V 120
Query: 721 AVG------AA-------QGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGI 764
A A+ + +AY H + I+HR++K N+L+ + L+DFG+
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
A + + F GT GY+ PE ++ D+++ G V+L IL
Sbjct: 178 AIEVNDSEAW-HGFA-GTPGYLSPEVLKKDPYSKPVDIWACG-VILYIL 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 613 RSTENLSEKY----IVGYGASSTVYKCALKNS-RPIAVK-------KLYNQYPHNLRE-F 659
+ + +KY ++G G SS V +C + + AVK +L + +RE
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 660 ETELETIGSIR-HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLD-WETR 717
E + + H +I++L S L +D M G L+D L ++KV L ETR
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETR 203
Query: 718 LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777
I + +++LH I+HRD+K NIL+D+N LSDFG + +
Sbjct: 204 -SIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL-RE 258
Query: 778 FVLGTIGYIDPE------YAHTSRLNEKSDVYSFGIVL 809
GT GY+ PE ++ D+++ G++L
Sbjct: 259 LC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 54/360 (15%), Positives = 108/360 (30%), Gaps = 79/360 (21%)
Query: 36 SSLSVVSLNLSSLNLGGE----ISPSIGDLRNLQSIDFQGNKLTGQ----IPDEIGNCGS 87
+ S+ +L + E + + + +++ I GN + + + + I +
Sbjct: 2 ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 61
Query: 88 LVHIELSDNSLYGDIPF-----------SISKLKQLEFLNLKNNQLTG----PIPSTLTQ 132
L E SD G + ++ K +L + L +N P+ L++
Sbjct: 62 LEIAEFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 133 IPNLKTLDLARNQLTGE-------------IPRLIYWNEVLQYLGLRGNALT--GM--LS 175
L+ L L N L + + + L+ + N L M +
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180
Query: 176 PDMCQLTGLWYFDVRGNNLT-----GTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQ 230
L + N + + + + C ++LD+ N T G
Sbjct: 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL-----GSSA 235
Query: 231 VATLSLQGNKLTGKIPEVIGLMQALAVLDLSENEL-------VGPIPPILGNLSYTGKLY 283
+A + L L L++ L V L N+ L
Sbjct: 236 LA--------------IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQ-TLR 280
Query: 284 LHGNKLTGPIPPELG-----NMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLE 338
L N++ L M L +L+L N+ + ++ ++F E
Sbjct: 281 LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGELDE 339
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 63/373 (16%), Positives = 116/373 (31%), Gaps = 69/373 (18%)
Query: 112 LEFLNLKNNQLTG----PIPSTLTQIPNLKTLDLARNQLTGE----IPRLIYWNEVLQYL 163
+E +LK + +T + + L + ++K + L+ N + E + I + L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 164 GLRGNAL--TGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGE 221
P+ + + ++ C + +S N
Sbjct: 66 EFSDIFTGRVKDEIPEALR----------------LLLQALLKCPKLHTVRLSDNAFGPT 109
Query: 222 IPYNIG-FLQVAT----LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNL 276
+ FL T L L N L + +AL L +++ P L
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLG--PQAGAKIARALQELAVNKKAKNAP------PL 161
Query: 277 SYTGKLYLHGNKLTGP----IPPELGNMSKLSYLQLQNNQL----VGTIPAE-LGKLEQL 327
+ N+L + L +++ N + + + E L ++L
Sbjct: 162 R---SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218
Query: 328 FELNLADNNL--EG--PIPHNISSCTALNQFNVHGNRLSG----AIPSSFRNLG--SLTY 377
L+L DN G + + S L + ++ LS A+ +F L L
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT 278
Query: 378 LNLSRNNFKGKVPTELGRII-----NLDTLDLSVNNFS--GSVPASIGD-LEHLLTLNLS 429
L L N + L +I +L L+L+ N FS V I + L
Sbjct: 279 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELD 338
Query: 430 RNHLNGLLPAEFG 442
L E
Sbjct: 339 ELDDMEELTDEEE 351
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 41/272 (15%), Positives = 73/272 (26%), Gaps = 53/272 (19%)
Query: 273 LGNLSYTGKLYLHGNKLTG----PIPPELGNMSKLSYLQLQNNQL----VGTIPAELGKL 324
+ S G L + +T + L + + L N + + +
Sbjct: 1 MARFSIEG-KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 325 EQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNN 384
+ L +D + L + L + LS N
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLL--------------QALLKCPKLHTVRLSDNA 105
Query: 385 FKGKVPTELGRII----NLDTLDLSVNNFS-------------GSVPASIGDLEHLLTLN 427
F L + L+ L L N +V + L ++
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165
Query: 428 LSRNHLNG----LLPAEFGNLRSIQTIDMSFNQL-----SGSIPAELGQLQNIISLILNN 478
RN L F + R + T+ M N + + L Q + L L +
Sbjct: 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225
Query: 479 NNL--QGG--IPDQLSNCFSLSNLNVSYNNLS 506
N G + L + +L L ++ LS
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 55/345 (15%), Positives = 111/345 (32%), Gaps = 78/345 (22%)
Query: 207 SFEILDISYNQITGEIPYNIGFL-----QVATLSLQGNKLTGK----IPEVIGLMQALAV 257
S E + + IT E ++ + V + L GN + + + E I + L +
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 258 LDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQL---- 313
+ S+ +TG++ + + L KL ++L +N
Sbjct: 65 AEFSDI--------------FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 110
Query: 314 VGTIPAELGKLEQLFELNLADNNL-------------EGPIPHNISSCTALNQFNVHGNR 360
+ L K L L L +N L E + + L NR
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170
Query: 361 LSG----AIPSSFRNLGSLTYLNLSRNNFKGK-VPTELGRII----NLDTLDLSVNNFSG 411
L +F++ L + + +N + + + L + L LDL N F+
Sbjct: 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230
Query: 412 SVPASIGD----LEHLLTLNLSRNHL-----NGLLPA-EFGNLRSIQTIDMSFNQLSGSI 461
+++ +L L L+ L ++ A +QT+ + +N++
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD- 289
Query: 462 PAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLS 506
++ + ++I L L ++ N S
Sbjct: 290 -----AVRTLKTVIDEKMP-------------DLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 56/361 (15%), Positives = 117/361 (32%), Gaps = 83/361 (22%)
Query: 181 LTGLWYFDVRGNNLTG----TIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSL 236
+ G ++ + +T ++ + S + + +S N I E ++
Sbjct: 6 IEGK---SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTE-----AARWLS---- 53
Query: 237 QGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPE 296
E I + L + + S+ +TG++ + +
Sbjct: 54 ----------ENIASKKDLEIAEFSDI--------------FTGRVKDEIPEALRLLLQA 89
Query: 297 LGNMSKLSYLQLQNNQL----VGTIPAELGKLEQLFELNLADNNL-------------EG 339
L KL ++L +N + L K L L L +N L E
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 340 PIPHNISSCTALNQFNVHGNRLSG----AIPSSFRNLGSLTYLNLSRNNFKGK-VPTELG 394
+ + L NRL +F++ L + + +N + + + L
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 395 RII----NLDTLDLSVNNFSGSVPASIGD----LEHLLTLNLSRNHL-----NGLLPA-E 440
+ L LDL N F+ +++ +L L L+ L ++ A
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 269
Query: 441 FGNLRSIQTIDMSFNQLSGSIPAELGQ-----LQNIISLILNNNNL--QGGIPDQLSNCF 493
+QT+ + +N++ L + +++ L LN N + + D++ F
Sbjct: 270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVF 329
Query: 494 S 494
S
Sbjct: 330 S 330
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 623 IVGYGASSTVYKCALKNSRPI-AVKKLY-------NQYPHNLREFETELETIGSIRHRNI 674
++G G V C ++ + + A KKL L E + + + R +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL----NEKQILEKVNSRFV 246
Query: 675 VSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDW-ETRLKIAVGAAQ---GLA 729
VSL YA L M NG DL + + E R AA+ GL
Sbjct: 247 VSLA-YAYETKDALCLVLTLM-NGG--DLKFHIYHMGQAGFPEARAVFY--AAEICCGLE 300
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
LH RI++RD+K NIL+D++ +SD G+A +P V GT+GY+ PE
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPE 355
Query: 790 YAHTSRLNEKSDVYSFGIVLLEILTGK 816
R D ++ G +L E++ G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 30/215 (13%)
Query: 617 NLSEKYIV----GYGASSTVYKCALKNS-RPIAVK-----KLYNQYPHNLRE-FETELET 665
+ + Y + G G + V KC K + + A K +L + RE E E+
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA 725
+ IRH NI++LH + +L + + G L+D L + + T +
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL------AEKESLTEDEATQFLK 115
Query: 726 Q---GLAYLHHDCNPRIIHRDVKSSNILI----DENFDAHLSDFGIARCIPTAMPHASTF 778
Q G+ YLH + RI H D+K NI++ N L DFGIA I + F
Sbjct: 116 QILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172
Query: 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
GT ++ PE + L ++D++S G V+ IL
Sbjct: 173 --GTPEFVAPEIVNYEPLGLEADMWSIG-VITYIL 204
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 49/264 (18%), Positives = 87/264 (32%), Gaps = 66/264 (25%)
Query: 616 ENLSEKY----IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIR 670
E S+KY +G G+ V + S + A+KK+ + RE L+ + +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLD 58
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETR------------- 717
H NI+ L Y + +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 718 ---------LKIAVGAAQ----------------GLAYLHHDCNPRIIHRDVKSSNILID 752
LK + + + + ++H + I HRD+K N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVN 175
Query: 753 ENFDA-HLSDFGIARCIPTAMPHASTFVLGTIGYI------DPEYAHTSRL-NEKSDVYS 804
+ L DFG A+ + + P + YI PE + D++S
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPS--------VAYICSRFYRAPELMLGATEYTPSIDLWS 227
Query: 805 FGIVLLEILTGKKAVDNESNLHQL 828
G V E++ GK E+++ QL
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQL 251
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 34/108 (31%), Positives = 56/108 (51%), Gaps = 7/108 (6%)
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNL 337
+LYL GN+ T +P EL N L+ + L NN++ T+ + + QL L L+ N L
Sbjct: 33 VTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL 90
Query: 338 EGPIPHNI-SSCTALNQFNVHGNRLSGAIP-SSFRNLGSLTYLNLSRN 383
IP +L ++HGN +S +P +F +L +L++L + N
Sbjct: 91 RC-IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 30/108 (27%), Positives = 55/108 (50%), Gaps = 12/108 (11%)
Query: 402 LDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSI 461
L L N F+ VP + + +HL ++LS N ++ L F N+ + T+ +S+N+L I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 462 PA----ELGQLQNIISLILNNNNLQGGIPDQL-SNCFSLSNLNVSYNN 504
P L L+ L L+ N++ +P+ ++ +LS+L + N
Sbjct: 94 PPRTFDGLKSLR---LLSLHGNDIS-VVPEGAFNDLSALSHLAI-GAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 22/80 (27%), Positives = 37/80 (46%), Gaps = 3/80 (3%)
Query: 92 ELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIP 151
L N +P +S K L ++L NN+++ + + + L TL L+ N+L IP
Sbjct: 37 YLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIP 94
Query: 152 RLIYWNEV-LQYLGLRGNAL 170
+ L+ L L GN +
Sbjct: 95 PRTFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 30/113 (26%), Positives = 46/113 (40%), Gaps = 10/113 (8%)
Query: 206 TSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENEL 265
L + NQ T + + + L N+++ + M L L LS N L
Sbjct: 31 RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90
Query: 266 VGPIPP----ILGNLSYTGKLYLHGNKLTGPIPPEL-GNMSKLSYLQLQNNQL 313
IPP L +L L LHGN ++ +P ++S LS+L + N L
Sbjct: 91 -RCIPPRTFDGLKSLRL---LSLHGNDISV-VPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 30/104 (28%), Positives = 43/104 (41%), Gaps = 3/104 (2%)
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK 388
EL L N +P +S+ L ++ NR+S SF N+ L L LS N +
Sbjct: 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 389 VPTELGRIINLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRN 431
P + +L L L N+ S VP + L L L + N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 64/316 (20%), Positives = 111/316 (35%), Gaps = 54/316 (17%)
Query: 613 RSTENLSEKYIV----GYGASSTVYKCA-LKNSRPIAVK----------KLYNQYPHNLR 657
+ E +Y + G G TV+ L + +A+K +
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 658 EFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGS-LWDLLHGPSKKVKLDWET 716
E + H ++ L + + G +L + + L+D + ++K L
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGP 140
Query: 717 RLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAMPHA 775
+ + H ++HRD+K NILID A L DFG +
Sbjct: 141 SRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT- 196
Query: 776 STFVLGTIGYIDPEYAHTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD 834
F GT Y PE+ + + V+S GI+L +++ G +
Sbjct: 197 -DFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE-------------R 241
Query: 835 DNTVMEA---VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV--LVSLLP 889
D ++EA VS C L +R+ L K PS RP+++E+ + +
Sbjct: 242 DQEILEAELHFPAHVSPDCCAL--IRR-----CLAPK--PSSRPSLEEILLDPWMQTPAE 292
Query: 890 APPAKLSLAAPKPIDY 905
P S P P+ +
Sbjct: 293 DVPLNPSKGGPAPLAW 308
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 12/154 (7%)
Query: 237 QGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPP--ILGNLSYTGKLYLHGNKLTGPIP 294
KL KIPE + Q A L L+ NE + I L K+ NK+T I
Sbjct: 19 SNQKLN-KIPE--HIPQYTAELRLNNNEFTV-LEATGIFKKLPQLRKINFSNNKITD-IE 73
Query: 295 PE-LGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNLEGPIPHNI-SSCTAL 351
S ++ + L +N+L + ++ LE L L L N + + ++ +++
Sbjct: 74 EGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSV 131
Query: 352 NQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNF 385
+++ N+++ P +F L SL+ LNL N F
Sbjct: 132 RLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 34/185 (18%), Positives = 56/185 (30%), Gaps = 55/185 (29%)
Query: 277 SYTGKLYLHGNKLTGPIPPE--LGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLA 333
YT +L L+ N+ T + + +L + NN++ I + E+ L
Sbjct: 32 QYTAELRLNNNEFTV-LEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLT 89
Query: 334 DNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTEL 393
N LE + H + F+ L SL L L N
Sbjct: 90 SNRLEN-VQHKM-----------------------FKGLESLKTLMLRSNRIT------- 118
Query: 394 GRIINLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDM 452
V L + L+L N + + P F L S+ T+++
Sbjct: 119 ------------------CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNL 160
Query: 453 SFNQL 457
N
Sbjct: 161 LANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 34/169 (20%), Positives = 61/169 (36%), Gaps = 36/169 (21%)
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPS-SFRNLGSLTYLNLSRNNFKGKVPTELGRIINL 399
IP +I TA + ++ N + + F+ L L +N S N
Sbjct: 26 IPEHIPQYTA--ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT------------- 70
Query: 400 DTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459
D+ F G + + L+ N L + F L S++T+ + N+++
Sbjct: 71 ---DIEEGAFEG--------ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT- 118
Query: 460 SIPAE----LGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNN 504
+ + L ++ L L +N + P SLS LN+ N
Sbjct: 119 CVGNDSFIGLSSVR---LLSLYDNQITTVAPGAFDTLHSLSTLNL-LAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 31/143 (21%), Positives = 55/143 (38%), Gaps = 9/143 (6%)
Query: 63 NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQ 121
++D KL +IP+ I + L++N I KL QL +N NN+
Sbjct: 12 EGTTVDCSNQKLN-KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK 68
Query: 122 LTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEV-LQYLGLRGNALTGMLSPDM-C 179
+T + + L N+L + ++ L+ L LR N +T + D
Sbjct: 69 ITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFI 126
Query: 180 QLTGLWYFDVRGNNLTGTIPDSI 202
L+ + + N +T T+
Sbjct: 127 GLSSVRLLSLYDNQIT-TVAPGA 148
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 18/159 (11%)
Query: 26 CSWRGVFCDNSSLSVV---------SLNLSSLNLGGEISPSIG--DLRNLQSIDFQGNKL 74
C V C N L+ + L L++ N + + L L+ I+F NK+
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNN-NEFTVLEATGIFKKLPQLRKINFSNNKI 69
Query: 75 TGQIPDEI-GNCGSLVHIELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPSTLTQ 132
T I + + I L+ N L ++ + L+ L+ L L++N++T +
Sbjct: 70 T-DIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIG 127
Query: 133 IPNLKTLDLARNQLTGEIPRLIYWN-EVLQYLGLRGNAL 170
+ +++ L L NQ+T + + L L L N
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 62/294 (21%), Positives = 115/294 (39%), Gaps = 51/294 (17%)
Query: 611 IMRSTENLSEKYIV-----GYGASSTVYKCALKNS-RPIAVK--KLYNQYPHNLREFETE 662
+S EN + YI+ G G + V +C K++ + A K K + E E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 663 LETIGSIRHR-NIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
+ + + +++LH + +L +Y G ++ L + ++ E
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC--LPELAEMVSE---NDV 133
Query: 722 VGAAQ----GLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIPTAMPH 774
+ + G+ YLH + I+H D+K NIL+ D + DFG++R I A
Sbjct: 134 IRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190
Query: 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
++GT Y+ PE + + +D+++ GI+ +LT ++ + I +
Sbjct: 191 --REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS-Q 247
Query: 833 ADDNTVMEAVD------PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ VD VS D ++ LL P +RPT +
Sbjct: 248 VN-------VDYSEETFSSVSQLATDF--IQS-----LLVKN--PEKRPTAEIC 285
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 42/208 (20%), Positives = 84/208 (40%), Gaps = 22/208 (10%)
Query: 616 ENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIR 670
+ L EKY++ G G V++C +S + K + + + E+ + R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIAR 59
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---G 727
HRNI+ LH S ++ ++++ +++ + + +L +I Q
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFEL---NEREIVSYVHQVCEA 114
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHL--SDFGIARCIPTAMPHASTFVLGTIGY 785
L +LH I H D++ NI+ + + +FG AR + + Y
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEY 169
Query: 786 IDPEYAHTSRLNEKSDVYSFGIVLLEIL 813
PE ++ +D++S G L+ +L
Sbjct: 170 YAPEVHQHDVVSTATDMWSLG-TLVYVL 196
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 41/163 (25%), Positives = 65/163 (39%), Gaps = 31/163 (19%)
Query: 620 EKY----IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIR---- 670
EKY +G G+ V+KC +++ + +A+KK L + + ++R
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRM 55
Query: 671 -----HRNIVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHG-PSKKVKLDWETRLKIAVG 723
H N+V+L L L ++Y +LH + + I
Sbjct: 56 LKQLKHPNLVNLLE-VFRRKRRLHLVFEYC----DHTVLHELDRYQRGVPEHLVKSITWQ 110
Query: 724 AAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766
Q + + H IHRDVK NILI ++ L DFG AR
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-11
Identities = 56/243 (23%), Positives = 89/243 (36%), Gaps = 43/243 (17%)
Query: 613 RSTENLSEKYIVGYGASSTVYKC-ALKNSRPIAVKKL--------YNQYPHN-LREFETE 662
+T +G GA TVYK + +A+K + P + +RE
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL- 64
Query: 663 LETIGSIRHRNIVSL----HGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETR 717
L + + H N+V L + L ++++ DL + LD
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----DQDL-----RTY-LDKAPP 114
Query: 718 LKIAVGAA--------QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC-- 767
+ +GL +LH + I+HRD+K NIL+ L+DFG+AR
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
Query: 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQ 827
A+ V+ T+ Y PE S D++S G + E+ K S Q
Sbjct: 172 YQMALTPV---VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227
Query: 828 LIM 830
L
Sbjct: 228 LGK 230
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 63/302 (20%), Positives = 108/302 (35%), Gaps = 52/302 (17%)
Query: 604 AIHTFDDIMRSTENLSEKY-----IVGYGASSTVYKCALKNSR-PIAVKKLYNQYPHNLR 657
H + + + Y ++G G + V + K ++ A+K L P R
Sbjct: 45 QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARR 103
Query: 658 EFETELETIGSIRHRNIVSLHG-YALSPYGNLLFY---DYMVNGSLWDLLHGPSKKVKLD 713
E E +IV + Y G + + G L+ + + +
Sbjct: 104 EVELHWRASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF 158
Query: 714 WETRLKIAVGA----AQGLAYLHHDCNPRIIHRDVKSSNIL-IDENFDAHL--SDFGIAR 766
E + A + + YLH N I HRDVK N+L + +A L +DFG A+
Sbjct: 159 TE---REASEIMKSIGEAIQYLH-SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 767 CIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL-------TGKKAV 819
+ +T T Y+ PE + ++ D++S G V++ IL +
Sbjct: 213 ETTSHNSL-TTPC-YTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGL 269
Query: 820 DNESNLHQLIMSKADDNTVMEAVD-PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQ 878
+ I + + EVS L +R LL T+ P++R T+
Sbjct: 270 AISPGMKTRIRMGQYE---FPNPEWSEVSEEVKML--IRN-----LLKTE--PTQRMTIT 317
Query: 879 EV 880
E
Sbjct: 318 EF 319
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 28/219 (12%)
Query: 669 IRHRNIVSLHGYALSPYGNLLF--YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+ H N+V L P + L+ ++ + G + ++ L + +
Sbjct: 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIK 148
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
G+ YLH+ +IIHRD+K SN+L+ E+ ++DFG++ + S V GT ++
Sbjct: 149 GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFM 204
Query: 787 DPEYAHTSRLN---EKSDVYSFGIVLLEILTGKKAVDNES--NLHQLIMSKADDNTVMEA 841
PE +R + DV++ G+ L + G+ +E LH I S
Sbjct: 205 APESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS---QALEFPD 261
Query: 842 VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
P+++ DL + + +L P R + E+
Sbjct: 262 -QPDIAEDLKDL--ITR-----MLDKN--PESRIVVPEI 290
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 22/200 (11%)
Query: 624 VGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFE---TELETIGSIRHRNIVSLHG 679
+G G+ V K + A+K L Q L++ E E + ++ +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 680 YALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---GLAYLHHDC 735
++ NL +Y+ G ++ L + + E + AAQ YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFS-EPHARFY--AAQIVLTFEYLH-SL 160
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR 795
+ +I+RD+K N+LID+ ++DFG A+ + T GT + PE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLC-GTPEALAPEIILSKG 214
Query: 796 LNEKSDVYSFGIVLLEILTG 815
N+ D ++ G+++ E+ G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 29/162 (17%)
Query: 620 EKY----IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIR---- 670
EKY +VG G+ V KC K++ R +A+KK L + ++ ++R
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKL 77
Query: 671 -----HRNIVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
H N+V+L L ++++ + ++ D L LD++ K
Sbjct: 78 LKQLRHENLVNLLE-VCKKKKRWYLVFEFV-DHTILDDLE--LFPNGLDYQVVQKYLFQI 133
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766
G+ + H IIHRD+K NIL+ ++ L DFG AR
Sbjct: 134 INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 59/244 (24%), Positives = 97/244 (39%), Gaps = 44/244 (18%)
Query: 610 DIMRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFET--- 661
+ ++ +Y +G GA V N +A+KK+ FE
Sbjct: 17 MVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTY 68
Query: 662 ------ELETIGSIRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDL----LHGPSKKV 710
E++ + RH NI+ ++ + D Y+V DL L+ K
Sbjct: 69 CQRTLREIKILLRFRHENIIGIND-IIRAPTIEQMKDVYIVQ----DLMETDLYKLLKTQ 123
Query: 711 KLDWETRLKIAVGAAQ---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767
L + I Q GL Y+H + ++HRD+K SN+L++ D + DFG+AR
Sbjct: 124 HL---SNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 768 IPTAMPHAS--TFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESN 824
H T + T Y PE S+ + D++S G +L E+L+ + +
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 825 LHQL 828
L QL
Sbjct: 238 LDQL 241
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 7/111 (6%)
Query: 277 SYTGKLYLHGNKLTGPIPPE--LGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLA 333
+T +L L+ N+L I + G + L L+L+ NQL I + EL L
Sbjct: 29 LHTTELLLNDNELGR-ISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLG 86
Query: 334 DNNLEGPIPHNI-SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383
+N ++ I + + L N++ N++S +P SF +L SLT LNL+ N
Sbjct: 87 ENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 30/114 (26%), Positives = 48/114 (42%), Gaps = 18/114 (15%)
Query: 400 DTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS 458
L L+ N + L HL+ L L RN L G+ P F IQ + + N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 459 GSIPA----ELGQLQNIISLILNNNNLQGGIP----DQLSNCFSLSNLNVSYNN 504
I L QL+ L L +N + + + L+ SL++LN+ +N
Sbjct: 92 -EISNKMFLGLHQLKT---LNLYDNQIS-CVMPGSFEHLN---SLTSLNL-ASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 13/88 (14%)
Query: 91 IELSDNSLYGDIPFSI-SKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGE 149
+ L+DN L + +L L L LK NQLTG P+ +++ L L N++ E
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92
Query: 150 IPRLIYWNEV------LQYLGLRGNALT 171
I N++ L+ L L N ++
Sbjct: 93 IS-----NKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 28/129 (21%), Positives = 49/129 (37%), Gaps = 27/129 (20%)
Query: 329 ELNLADNNLEGPIPHNI-SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKG 387
EL L DN L + L + + N+L+G P++F + L L N K
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 388 KVPTELGRIINLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRNHLNGLLPAEFGNLRS 446
+ + L L TLNL N ++ ++P F +L S
Sbjct: 92 ------------------------EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 447 IQTIDMSFN 455
+ +++++ N
Sbjct: 128 LTSLNLASN 136
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 35/237 (14%)
Query: 617 NLSEKY----IVGYGASSTVYKCALKNSR---PIAVKKLYNQYP----HNLREFETELET 665
+L +Y +G G + V + ++ +A+KK+ P H LRE ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLV--FSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKI 61
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDL----------LHGPSKKVKLDWE 715
I + H NIV + L P G+ L D L + L ++ L E
Sbjct: 62 IRRLDHDNIVKVFE-ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 716 TRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAMPH 774
+GL Y+H + ++HRD+K +N+ I+ E+ + DFG+AR + H
Sbjct: 121 HARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 775 AS--TFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ L T Y P + + D+++ G + E+LTGK L Q+
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 50/223 (22%), Positives = 80/223 (35%), Gaps = 33/223 (14%)
Query: 613 RSTENLSEKYIV----GYGASSTVY---------KCALKNSRPIAVKKLYNQYPHNLREF 659
S+KY G GA V+ + +K + V + L +
Sbjct: 17 ACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 660 ETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGS-LWDLLHGPSKKVKLDWETRL 718
E+ + + H NI+ + + L + +G L+ + + +LD
Sbjct: 77 TLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLAS 133
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF 778
I + YL IIHRD+K NI+I E+F L DFG A TF
Sbjct: 134 YIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA-YLERGKLFYTF 189
Query: 779 VLGTIGYIDPE------YAHTSRLNEKSDVYSFGIVLLEILTG 815
GTI Y PE Y + +++S G+ L ++
Sbjct: 190 C-GTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFE 226
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 44/252 (17%), Positives = 91/252 (36%), Gaps = 73/252 (28%)
Query: 617 NLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN------LREFETELET 665
++ + Y ++G G+ VY + +A+KK+ + LRE +
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE----ITI 78
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ ++ I+ L+ + P L F + Y+V ++ ++ LK
Sbjct: 79 LNRLKSDYIIRLYD-LIIPDDLLKFDELYIVL----EIA-----------DSDLKKLFKT 122
Query: 725 AQ----------------GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768
G ++H + IIHRD+K +N L++++ + DFG+AR I
Sbjct: 123 PIFLTEEHIKTILYNLLLGENFIH-ESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179
Query: 769 PTAMPHASTFVLGTIGYIDPEYAHTSR-----------------LNEKS-----DVYSFG 806
+ L P + + L +++ D++S G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
Query: 807 IVLLEILTGKKA 818
+ E+L ++
Sbjct: 240 CIFAELLNMLQS 251
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 57/239 (23%), Positives = 92/239 (38%), Gaps = 37/239 (15%)
Query: 613 RSTENLSEKYIVGYGASSTVYKC--ALKNSRPIAVKKLYNQYPHN------LREFETELE 664
R+ + +G GA V+K R +A+K++ Q +RE L
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LR 66
Query: 665 TIGSIRHRNIVSL----HGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLK 719
+ + H N+V L L L ++++ DL LD
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV----DQDL-----TTY-LDKVPEPG 116
Query: 720 IAVGAA--------QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771
+ +GL +LH R++HRD+K NIL+ + L+DFG+AR +
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--S 171
Query: 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM 830
A T V+ T+ Y PE S D++S G + E+ K S++ QL
Sbjct: 172 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 16/171 (9%)
Query: 668 SIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKI-AVGAA 725
+ RH + +L Y+ + L F +Y NG +L S++ E R +
Sbjct: 204 NSRHPFLTALK-YSFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFS-EDRARFYGAEIV 258
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLGTI 783
L YLH + N +++RD+K N+++D+ D H ++DFG+ + TF GT
Sbjct: 259 SALDYLHSEKN--VVYRDLKLENLMLDK--DGHIKITDFGLCKEGIKDGATMKTF-CGTP 313
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
Y+ PE + D + G+V+ E++ G+ + L +LI+ +
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 41/151 (27%), Positives = 59/151 (39%), Gaps = 27/151 (17%)
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI 293
L L N++T P V + L L L N+L + +L+ L L N+LT +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV-L 103
Query: 294 PPEL-GNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALN 352
P + + L L + N+L +P + +L L L L N L+ IPH
Sbjct: 104 PSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKS-IPH--------- 152
Query: 353 QFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383
GA F L SLT+ L N
Sbjct: 153 ----------GA----FDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 40/174 (22%), Positives = 55/174 (31%), Gaps = 53/174 (30%)
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNL 337
LYLH N++T P ++ L L L +NQL +P + L QL L+L N L
Sbjct: 42 AQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL 100
Query: 338 EGPIPHNISSCTALNQFNVHGNRLSGAIPSS-FRNLGSLTYLNLSRNNFKGKVPTELGRI 396
+PS+ F L L L + N
Sbjct: 101 T-------------------------VLPSAVFDRLVHLKELFMCCNKLT---------- 125
Query: 397 INLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTI 450
+P I L HL L L +N L + F L S+
Sbjct: 126 ---------------ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 40/151 (26%), Positives = 58/151 (38%), Gaps = 22/151 (14%)
Query: 400 DTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459
L L N + P L +L L L N L L F +L + +D+ NQL+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 460 SIPA----ELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNF 515
+P+ L L+ L + N L +P + L++L + N L I P F
Sbjct: 102 VLPSAVFDRLVHLKE---LFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSI--PHGAF 155
Query: 516 SRFSSNSFI---GNPLLCG--------NWIG 535
R SS + GNP C NW+
Sbjct: 156 DRLSSLTHAYLFGNPWDCECRDIMYLRNWVA 186
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 35/114 (30%), Positives = 49/114 (42%), Gaps = 12/114 (10%)
Query: 92 ELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIP 151
L DN + P L L+ L L +NQL + L LDL NQLT +P
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLP 104
Query: 152 -----RLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPD 200
RL++ L+ L + N LT L + +LT L + + N L +IP
Sbjct: 105 SAVFDRLVH----LKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPH 152
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 34/109 (31%), Positives = 46/109 (42%), Gaps = 9/109 (8%)
Query: 113 EFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEV-LQYLGLRGNALT 171
+ L L +NQ+T P + NLK L L NQL +P ++ + L L L N LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 172 GMLSP---DMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQ 217
L D +L L + N LT +P I T L + NQ
Sbjct: 102 V-LPSAVFD--RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 32/152 (21%), Positives = 53/152 (34%), Gaps = 24/152 (15%)
Query: 161 QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITG 220
Q L L N +T + L L + N L +P + ++ +T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGV------------FDSLT- 88
Query: 221 EIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTG 280
Q+ L L N+LT V + L L + N+L +P + L++
Sbjct: 89 ---------QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLT 138
Query: 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQ 312
L L N+L +S L++ L N
Sbjct: 139 HLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 37/221 (16%), Positives = 74/221 (33%), Gaps = 57/221 (25%)
Query: 610 DIMRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELE 664
S + ++Y ++G G+ V + R +A+KK+ FE ++
Sbjct: 43 PRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLID 95
Query: 665 TIGSIR---------HRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDLLHGPSKKVKLDW 714
+R H ++V + + P F + Y+V ++
Sbjct: 96 CKRILREIAILNRLNHDHVVKVLD-IVIPKDVEKFDELYVVL----EIA----------- 139
Query: 715 ETRLKIAVGAAQ----------------GLAYLHHDCNPRIIHRDVKSSNILIDENFDAH 758
++ K G+ Y+H + I+HRD+K +N L++++
Sbjct: 140 DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVK 196
Query: 759 LSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEK 799
+ DFG+AR + S + N K
Sbjct: 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 50/239 (20%), Positives = 96/239 (40%), Gaps = 38/239 (15%)
Query: 653 PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKL 712
P +L++ E+ + + H NIV L + L +Y G ++D L ++
Sbjct: 55 PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL---VAHGRM 111
Query: 713 DWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772
+ + Y H I+HRD+K+ N+L+D + + ++DFG + T
Sbjct: 112 KEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSN-EFTVG 167
Query: 773 PHASTFVLGTIGYIDPE------YAHTSRLNEKSDVYSFGIVLLEILTGKKAVD--NESN 824
F G Y PE Y + DV+S G++L +++G D N
Sbjct: 168 GKLDAFC-GAPPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221
Query: 825 LHQLIMSKADDNTVMEAVDPE-VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVAR 882
L + ++ + P +S C +L +++ L P +R T++++ +
Sbjct: 222 LRERVLRG-------KYRIPFYMSTDCENL--LKR-----FLVLN--PIKRGTLEQIMK 264
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 50/271 (18%), Positives = 96/271 (35%), Gaps = 46/271 (16%)
Query: 282 LYLHGNKLTGPIPPELG-----NMSKLSYLQLQNNQL----VGTIPAELGKL-EQLFELN 331
L L N L EL + ++ L L N L + L + + LN
Sbjct: 27 LDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLN 86
Query: 332 LADNNLEGPIPHNISS-----CTALNQFNVHGNRLSG----AIPSSFRNL-GSLTYLNLS 381
L+ N L + + ++ N S +F NL S+T LNL
Sbjct: 87 LSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLR 146
Query: 382 RNNFKGKVPTELGRII-----NLDTLDLSVNNFSGSVPASIGDL-----EHLLTLNLSRN 431
N+ K EL +I+ N+++L+L NN + A + + +L+LS N
Sbjct: 147 GNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSAN 206
Query: 432 HLN-----GLLPAEFGNLRSIQTIDMSFNQLSGS----IPAELGQLQNIISLILNNNNLQ 482
L L + ++++ N L G + L+++ ++ L+ + ++
Sbjct: 207 LLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266
Query: 483 GGIPDQ-------LSNCFSLSNLNVSYNNLS 506
+Q N + ++ + +
Sbjct: 267 NMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 50/277 (18%), Positives = 93/277 (33%), Gaps = 53/277 (19%)
Query: 39 SVVSLNLSSLNLGGEISPSIGDL-----RNLQSIDFQGNKLTGQIPDEIG-----NCGSL 88
V SL+LS NL + + ++ S++ GN L + DE+ ++
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82
Query: 89 VHIELSDNSLYGDIPFSISKL-----KQLEFLNLKNNQLTG----PIPSTLTQIP-NLKT 138
+ LS N L + K + L+L N + + +P ++ +
Sbjct: 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS 142
Query: 139 LDLARNQLTGE-----IPRLIYWNEVLQYLGLRGN--------ALTGMLSPDMCQLTGLW 185
L+L N L + I L + L LRGN L L+ +T L
Sbjct: 143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSL- 201
Query: 186 YFDVRGNNLTGTIPDSIG-----NCTSFEILDISYNQITGEIPYNIGFL-----QVATLS 235
D+ N L + L++ N + G N+ L + T+
Sbjct: 202 --DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259
Query: 236 LQGNKLTGK-------IPEVIGLMQALAVLDLSENEL 265
L + + + +Q + ++D + E+
Sbjct: 260 LDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 72/356 (20%), Positives = 117/356 (32%), Gaps = 75/356 (21%)
Query: 204 NCTSFEILDISYNQITGEIPYNIGFL------QVATLSLQGNKLTGKIPEVIGLMQALAV 257
LD+S N + + V +L+L GN L K L+Q LA
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK--NSDELVQILAA 77
Query: 258 -------LDLSENEL----VGPIPPILGNLSYT-GKLYLHGNKLTGPIPPELGNM----- 300
L+LS N L + L + +T L L N + E
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 301 SKLSYLQLQNNQLVGTIPAELGKL-----EQLFELNLADNNLEGPIPHNISSCTALNQFN 355
+ ++ L L+ N L EL ++ + LNL NNL +C L +F
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS------KNCAELAKFL 191
Query: 356 VHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRII-----NLDTLDLSVNNFS 410
S+T L+LS N K EL I ++ +L+L +N
Sbjct: 192 ASIPA-------------SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238
Query: 411 GSVPASIGDLE----HLLTLNLSRNHLNGLLPAE-------FGNLRSIQTIDMSFNQLSG 459
G ++ L+ HL T+ L + + + + F N++ I +D + ++
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298
Query: 460 SIPAELGQL-----QNIISLILNNNNL-----QGGIPDQLSNCFSLSNLNVSYNNL 505
S + L L N L + L+ L + L
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 62/376 (16%), Positives = 113/376 (30%), Gaps = 81/376 (21%)
Query: 117 LKNNQLTGP----IPSTLTQIPNLKTLDLARNQLTGE-----IPRLIYWNEVLQYLGLRG 167
+ P + + + +LDL+ N L I + L L G
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 168 N--------ALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIG-----NCTSFEILDIS 214
N L +L+ +T L ++ GN L+ D + + +LD+
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSL---NLSGNFLSYKSSDELVKTLAAIPFTITVLDLG 117
Query: 215 YNQITGEIPYNIG------FLQVATLSLQGNKLTGKIPEVIGLMQALA-------VLDLS 261
+N + + + +L+L+GN L K L+Q LA L+L
Sbjct: 118 WNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK--SSDELIQILAAIPANVNSLNLR 175
Query: 262 ENEL----VGPIPPILGNLSYT-GKLYLHGNKLTGPIPPELG-----NMSKLSYLQLQNN 311
N L + L ++ + L L N L EL + + L L N
Sbjct: 176 GNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLN 235
Query: 312 QL----VGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPS 367
L + + L+ L + L + A+ +
Sbjct: 236 CLHGPSLENLKLLKDSLKHLQTVYLDYD-----------------IVKNMSKEQCKALGA 278
Query: 368 SFRNLGSLTYLNLSRNNFKGKVPTELGRII-----NLDTLDLSVNN--FSGSVPASIGDL 420
+F N+ + ++ + + +I D L F+ +I DL
Sbjct: 279 AFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDL 338
Query: 421 ---EHLLTLNLSRNHL 433
+ L + L
Sbjct: 339 NIPDELRESIQTCKPL 354
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 61/287 (21%), Positives = 111/287 (38%), Gaps = 50/287 (17%)
Query: 613 RSTENLSEKYIV----GYGASSTVYKCA-LKNSRPIAVK-----KLYN-QYPHNLREFET 661
+ E L +Y V G G +VY + ++ P+A+K ++ + N
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 662 ELETIGSIRHR--NIVSLHGYALSPYGNLLFYDYMVN-GSLWDLLHGPSKKVKLDWETRL 718
E+ + + ++ L + P +L + L+D + +++ L E
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELAR 152
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-FDAHLSDFGIARCIPTAMPHAST 777
+ + + H+ ++HRD+K NILID N + L DFG + +
Sbjct: 153 SFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--D 207
Query: 778 FVLGTIGYIDPEYAHTSRLN-EKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN 836
F GT Y PE+ R + + V+S GI+L +++ G + D
Sbjct: 208 FD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-------------HDE 253
Query: 837 TVMEA---VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
++ VS C L +R L + PS+RPT +E+
Sbjct: 254 EIIRGQVFFRQRVSSECQHL--IRW-----CLALR--PSDRPTFEEI 291
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 7e-10
Identities = 58/248 (23%), Positives = 93/248 (37%), Gaps = 51/248 (20%)
Query: 613 RSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFET------ 661
R N+S + ++G GA V +A+KK+ F+
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFALR 55
Query: 662 ---ELETIGSIRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDL----LHGPSKKVKLD 713
E++ + +H NI+++ P F + Y++ +L LH L
Sbjct: 56 TLREIKILKHFKHENIITIF-NIQRPDSFENFNEVYIIQ----ELMQTDLHRVISTQML- 109
Query: 714 WETRLKIAVGAAQ---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770
+ I Q + LH N +IHRD+K SN+LI+ N D + DFG+AR I
Sbjct: 110 --SDDHIQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 771 AMPHASTFVLGTI---GYID------PEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVD 820
+ S ++ PE TS + DV+S G +L E+ +
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224
Query: 821 NESNLHQL 828
HQL
Sbjct: 225 GRDYRHQL 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 53/233 (22%), Positives = 95/233 (40%), Gaps = 45/233 (19%)
Query: 617 NLSEKYI----VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIR- 670
+ Y +G G S V++ + N+ + VK L P ++ + E++ + ++R
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRG 89
Query: 671 HRNIVSLHGYALSPYGN---LLFYDYMVNGSLWDLLHGPSKKV--KL-DWETR------L 718
NI++L P L+F D K++ L D++ R L
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVN----NTDF-----KQLYQTLTDYDIRFYMYEIL 140
Query: 719 KIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAMPHAST 777
K L Y H + I+HRDVK N++ID E+ L D+G+A +
Sbjct: 141 K-------ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--N 188
Query: 778 FVLGTIGYIDPEYAHTSRLNEKS-DVYSFGIVLLEILTGKKAV-DNESNLHQL 828
+ + + PE ++ + S D++S G +L ++ K+ N QL
Sbjct: 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 8e-10
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHN------LREFETELETIGSIRHRNIVSL 677
VG G VYK R +A+K++ +RE E + H NIVSL
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE----LHHPNIVSL 84
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
S L +++M L +L K L +G+A+ H
Sbjct: 85 IDVIHSERCLTLVFEFM-EKDLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQH--- 138
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL- 796
RI+HRD+K N+LI+ + L+DFG+AR + + V+ T+ Y P+ S+
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKY 197
Query: 797 NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ D++S G + E++TGK ++ QL
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 9e-10
Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 36/183 (19%)
Query: 662 ELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLD-WETRLK- 719
E+ + H N+V +G+ LF +Y G L+D + + + + +
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFF 111
Query: 720 ---IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776
+A G+ YLH I HRD+K N+L+DE + +SDFG+A T + +
Sbjct: 112 HQLMA-----GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA----TVFRYNN 159
Query: 777 TFVL-----GTIGYIDPE------YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL 825
L GT+ Y+ PE + E DV+S GIVL +L G+ D S+
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
Query: 826 HQL 828
Q
Sbjct: 215 CQE 217
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 1e-09
Identities = 104/599 (17%), Positives = 188/599 (31%), Gaps = 166/599 (27%)
Query: 292 PIPPELGNMSKLSYL-QLQN-NQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCT 349
P + + +L N NQ+ + +L+ +L A L P N+
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVF--AKYNVSRLQPYLKLRQALLELR-PAK-NVL--- 154
Query: 350 ALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFK------GKVPTELGRIINLDTL- 402
+ G + G+ + L+Y + +FK + + L L
Sbjct: 155 ------IDG--VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL 206
Query: 403 ------DLSVNNFSGSVPASIGDL-EHLLTLNLSRNHLNGLL------PAE----FGNLR 445
S ++ S ++ I + L L S+ + N LL A+ F NL
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF-NLS 265
Query: 446 S---IQTIDMS-FNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVS 501
+ T + LS + ISL ++ L PD++ + L+
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTH-------ISLDHHSMTLT---PDEVKSLLL-KYLDCR 314
Query: 502 YNNLSGIIPP-IRNFSRFSSNSFIGNPLLCGNWIGSICGPSVTKARVMFSRT----AVVC 556
+L P + NP SI S+ R + V C
Sbjct: 315 PQDL----PREVLT----------TNPRRL-----SIIAESI---RDGLATWDNWKHVNC 352
Query: 557 MVLGFITLLVMAAIAVYKSNQQRQQLITGS--RKSMLGPPK-LVILHMDMAIHTFDDIMR 613
L T ++ +++ V + + R+ S S P L ++ D+ D+M
Sbjct: 353 DKL---TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV---IKSDVMV 406
Query: 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRN 673
L + +L +P K+ P E + +LE ++ HR+
Sbjct: 407 VVNKLHKY--------------SLVEKQP---KESTISIPSIYLELKVKLENEYAL-HRS 448
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLD--WETRLKIAVGAAQGLAYL 731
IV Y +D DL+ LD + +++
Sbjct: 449 IVD-------HYNIPKTFDS------DDLI-----PPYLDQYF-------------YSHI 477
Query: 732 -HHDCNPRIIHRDVKSSNILIDENF-DAHLSDFGIARCIPTAMPHASTFVLGTI----GY 785
HH N R + +D F + + A ++ + L + Y
Sbjct: 478 GHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN----TLQQLKFYKPY 533
Query: 786 I---DPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA 841
I DP+Y RL + + F + E L K ++L ++ + D+ EA
Sbjct: 534 ICDNDPKY---ERL--VNAILDFLPKIEENLICSK----YTDLLRIALMAEDEAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 1e-04
Identities = 74/447 (16%), Positives = 135/447 (30%), Gaps = 131/447 (29%)
Query: 2 AIKASFSNL------ANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEIS 55
+I+A L N LL +V N+ +W F + S ++ +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAK--AWN-AF-NLSCKILL------------TT 272
Query: 56 PSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQL--E 113
R Q DF T I SL H + + ++K L +
Sbjct: 273 ------RFKQVTDFLSAATTTHI--------SLDHHSM---------TLTPDEVKSLLLK 309
Query: 114 FLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGM 173
+L+ + L P + N + L + + + W V + LT +
Sbjct: 310 YLDCRPQDL----PREVLTT-NPRRLSIIAESIRDGLATWDNWKHVNC------DKLTTI 358
Query: 174 LSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNC-TSFEILDISYNQITGEIPYNIGFLQVA 232
+ + L N L P + S + IP + L +
Sbjct: 359 I--ESS-L----------NVLE---PAEYRKMFDRLSVFPPSAH-----IPTIL--LSL- 394
Query: 233 TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKL----YLHGNK 288
+ + + + V+ + ++++ E IP I L KL LH
Sbjct: 395 ---IWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY--LELKVKLENEYALH-RS 448
Query: 289 L------------TGPIPPELGN--MSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLAD 334
+ IPP L S + + L+N E + LF + D
Sbjct: 449 IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-HLKN--------IEHPERMTLFRMVFLD 499
Query: 335 NN-LEGPIPHNISSCTA-------LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFK 386
LE I H+ ++ A L Q + + P R + ++ +F
Sbjct: 500 FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAIL-------DFL 552
Query: 387 GKVPTELGRIINLDTLDLSVNNFSGSV 413
K+ L D L +++ ++
Sbjct: 553 PKIEENLICSKYTDLLRIALMAEDEAI 579
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 51/160 (31%), Positives = 76/160 (47%), Gaps = 34/160 (21%)
Query: 624 VGYGASSTVYKCALKNS-RPIAVKK--LYNQYPHN-------LREFETELETIGSIRHRN 673
+G G +TVYK KN+ + +A+KK L ++ LRE + E + H N
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE----LSHPN 73
Query: 674 IVSLHGYALSPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA------Q 726
I+ L A N+ L +D+M DL + + D L + A Q
Sbjct: 74 IIGLLD-AFGHKSNISLVFDFM----ETDL-----EVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766
GL YLH I+HRD+K +N+L+DEN L+DFG+A+
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 26/202 (12%)
Query: 624 VGYGASSTVYKCALKNSRPI-AVKKLYNQYPHNLREFE---TELETIGSIRHRNIVSLHG 679
+G G+ V+ +++ A+K L + L++ E E + + H I+ +
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72
Query: 680 YALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ---GLAYLHHDC 735
+ DY+ G L+ LL K + K AA+ L YLH
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP-NPVAKFY--AAEVCLALEYLH-SK 125
Query: 736 NPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
+ II+RD+K NIL+D+ + H ++DFG A+ +P T GT YI PE T
Sbjct: 126 D--IIYRDLKPENILLDK--NGHIKITDFGFAKYVPD---VTYTLC-GTPDYIAPEVVST 177
Query: 794 SRLNEKSDVYSFGIVLLEILTG 815
N+ D +SFGI++ E+L G
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAG 199
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 624 VGYGASSTVYKC-ALKNSRPIAVKKLYNQY----PHN-LREFETELETIGSIRHRNIVSL 677
+G G +TVYK + +A+K++ ++ P +RE + ++H NIV+L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD----LKHANIVTL 65
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
H + L ++Y+ + L L ++ +GLAY H
Sbjct: 66 HDIIHTEKSLTLVFEYL-DKDLKQYLD--DCGNIINMHNVKLFLFQLLRGLAYCHR---Q 119
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL- 796
+++HRD+K N+LI+E + L+DFG+AR V+ T+ Y P+ S
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDY 178
Query: 797 NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ + D++ G + E+ TG+ + QL
Sbjct: 179 STQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 40/152 (26%), Positives = 59/152 (38%), Gaps = 28/152 (18%)
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI 293
L L+ N L V + +L L L N+L + L+ L L N+L +
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS-L 91
Query: 294 PPEL-GNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNLEGPIPHNISSCTAL 351
P + +++L L L NQL ++P + KL QL +L L N L+ +P
Sbjct: 92 PNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKS-VPD-------- 141
Query: 352 NQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383
G F L SL Y+ L N
Sbjct: 142 -----------GV----FDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 32/111 (28%), Positives = 51/111 (45%), Gaps = 6/111 (5%)
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNL 337
T L L N L ++ L+ L L N+L ++P + KL L LNL+ N L
Sbjct: 30 TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL 88
Query: 338 EGPIPHNI-SSCTALNQFNVHGNRLSGAIPS-SFRNLGSLTYLNLSRNNFK 386
+ +P+ + T L + ++ N+L ++P F L L L L +N K
Sbjct: 89 QS-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK 137
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 46/154 (29%), Positives = 63/154 (40%), Gaps = 27/154 (17%)
Query: 400 DTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459
LDL N+ +L L L L N L L F L S+ +++S NQL
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 460 SIPA----ELGQLQNIISLILNNNNLQ---GGIPDQLSNCFSLSNLNVSYNNLSGIIPPI 512
S+P +L QL+ L LN N LQ G+ D+L+ L +L + N L + P
Sbjct: 90 SLPNGVFDKLTQLKE---LALNTNQLQSLPDGVFDKLTQ---LKDLRLYQNQLKSV--PD 141
Query: 513 RNFSRFSSNSFI---GNPLLCG--------NWIG 535
F R +S +I NP C WI
Sbjct: 142 GVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWIN 175
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 13/114 (11%)
Query: 63 NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQL 122
+ +++ T +P I +++L NSL +L L L L N+L
Sbjct: 8 SGTTVECYSQGRTS-VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL 64
Query: 123 TGPIPSTLTQIPNLKTLDLARNQLTGEIP-----RLIYWNEVLQYLGLRGNALT 171
++ +L L+L+ NQL +P +L L+ L L N L
Sbjct: 65 QSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQ----LKELALNTNQLQ 113
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 22/220 (10%)
Query: 620 EKYI----VGYGASSTVYKCALKNSRPIAVKKLYNQYPHN------LREFETELETIGSI 669
EKY +G G VYK A+KK+ + +RE E +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE----L 57
Query: 670 RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLA 729
+H NIV L+ + +L ++++ + L LL + L+ T + G+A
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIA 114
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
Y H R++HRD+K N+LI+ + ++DFG+AR + + ++ T+ Y P+
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170
Query: 790 YAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
S+ + D++S G + E++ G S QL
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 42/206 (20%), Positives = 71/206 (34%), Gaps = 48/206 (23%)
Query: 584 TGSRKSMLGPPKLVILHMDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCA-LKNSRP 642
L M ++ + + K +G G VYK +
Sbjct: 5 HHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRI-TK--LGEGTYGEVYKAIDTVTNET 61
Query: 643 IAVKKLYNQYPHNLREFETELE--TIGSIR---------HRNIVSLHGYALSPYGNLLFY 691
+A+K++ E E E +IR HRNI+ L + L +
Sbjct: 62 VAIKRI---------RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112
Query: 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA------QGLAYLHHDCNPRIIHRDVK 745
+Y DL KK +D + + V + G+ + H R +HRD+K
Sbjct: 113 EYA----ENDL-----KKY-MDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLK 159
Query: 746 SSNILIDENFDAH-----LSDFGIAR 766
N+L+ + + + DFG+AR
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 49/221 (22%), Positives = 85/221 (38%), Gaps = 41/221 (18%)
Query: 621 KYIV----GYGASSTVY---------KCALKNSRPIAVKKLYNQYPHNLREFETELETIG 667
KY++ G G+ V + A+K I KK + P+ + E++ +
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVK----ILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 668 SIRHRNIVSLHGYALSPYGNLLFYDYMV----NGSLWDLLHGPSKKVKLDWETRLK---- 719
+RH+N++ L + + YMV + ++L +K +
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKM---YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 720 IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP--HAST 777
I GL YLH I+H+D+K N+L+ +S G+A + T
Sbjct: 119 ID-----GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 778 FVLGTIGYIDPEYAHTSRLNE--KSDVYSFGIVLLEILTGK 816
G+ + PE A+ K D++S G+ L I TG
Sbjct: 171 SQ-GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 53/173 (30%), Positives = 83/173 (47%), Gaps = 21/173 (12%)
Query: 668 SIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+ H IV LH YA G L D+ + G DL SK+V E +K A+
Sbjct: 82 EVNHPFIVKLH-YAFQTEGKLYLILDF-LRGG--DLFTRLSKEVMFT-EEDVKFY--LAE 134
Query: 727 ---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLG 781
L +LH + II+RD+K NIL+DE + H L+DFG+++ A +F G
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHEKKAYSF-CG 188
Query: 782 TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
T+ Y+ PE + + +D +SFG+++ E+LTG + +I+
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 31/178 (17%)
Query: 668 SIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+ RH + +L YA + L F +Y NG +L S++ E R + A+
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEY-ANGG--ELFFHLSRERVFT-EERARFY--GAE 113
Query: 727 ---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLG 781
L YLH + +++RD+K N+++D+ D H ++DFG+ + + TF G
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGATMKTFC-G 167
Query: 782 TIGYIDPEYAHTSRLNEKS-----DVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
T Y+ PE L + D + G+V+ E++ G+ + L +LI+ +
Sbjct: 168 TPEYLAPEV-----LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 50/187 (26%), Positives = 79/187 (42%), Gaps = 36/187 (19%)
Query: 662 ELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLD-WETRLK- 719
E+ + H N+V +G+ LF +Y G L+D + + + + +
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFF 111
Query: 720 ---IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAS 776
+A G+ YLH I HRD+K N+L+DE + +SDFG+A T + +
Sbjct: 112 HQLMA-----GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA----TVFRYNN 159
Query: 777 TFVL-----GTIGYIDPE------YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL 825
L GT+ Y+ PE + E DV+S GIVL +L G+ D S+
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
Query: 826 HQLIMSK 832
Q
Sbjct: 215 CQEYSDW 221
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-09
Identities = 30/111 (27%), Positives = 48/111 (43%), Gaps = 4/111 (3%)
Query: 299 NMSKLSYLQLQNNQL-VGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVH 357
S + L L N++ G + + E+L L+ + L I N+ L + +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IA-NLPKLNKLKKLELS 72
Query: 358 GNRLSGAIPSSFRNLGSLTYLNLSRNNFKG-KVPTELGRIINLDTLDLSVN 407
NR+SG + +LT+LNLS N K L ++ NL +LDL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 7/129 (5%)
Query: 36 SSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSD 95
S + + L+ S N G ++ + L+ + LT I + + L +ELSD
Sbjct: 17 SDVKELVLDNSRSNEG-KLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73
Query: 96 NSLYGDIPFSISKLKQLEFLNLKNNQLTGP-IPSTLTQIPNLKTLDLARNQLTGEIPRLI 154
N + G + K L LNL N++ L ++ NLK+LDL ++T +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT-NLND-- 130
Query: 155 YWNEVLQYL 163
Y V + L
Sbjct: 131 YRENVFKLL 139
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 24/115 (20%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 60 DLRNLQSIDFQGNKLT-GQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLK 118
+++ + ++ G++ L + + L I ++ KL +L+ L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIA-NLPKLNKLKKLELS 72
Query: 119 NNQLTGPIPSTLTQIPNLKTLDLARNQLT--GEIPRLIYWNEVLQYLGLRGNALT 171
+N+++G + + PNL L+L+ N++ I L E L+ L L +T
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKK-LENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 27/115 (23%), Positives = 45/115 (39%), Gaps = 10/115 (8%)
Query: 370 RNLGSLTYLNLSRNNFK-GKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEH---LLT 425
R + L L + GK+ L+ L + SI +L L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKK 68
Query: 426 LNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG-SIPAELGQLQNIISLILNNN 479
L LS N ++G L ++ +++S N++ S L +L+N+ SL L N
Sbjct: 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 28/131 (21%), Positives = 54/131 (41%), Gaps = 8/131 (6%)
Query: 135 NLKTLDLARNQLT-GEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNN 193
++K L L ++ G++ L E L++L LT + ++ +L L ++ N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNR 75
Query: 194 LTGTIPDSIGNCTSFEILDISYNQIT--GEIPYNIGFLQVATLSLQGNKLTGKI---PEV 248
++G + C + L++S N+I I + +L L ++T V
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENV 135
Query: 249 IGLMQALAVLD 259
L+ L LD
Sbjct: 136 FKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 25/113 (22%), Positives = 46/113 (40%), Gaps = 5/113 (4%)
Query: 419 DLEHLLTLNLSRNHLN-GLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILN 477
+ L L + N G L ++ + L+ SI A L +L + L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 478 NNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI--IPPIRNFSRFSSNSFIGNPL 528
+N + GG+ C +L++LN+S N + + I P++ S +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 8e-06
Identities = 28/112 (25%), Positives = 45/112 (40%), Gaps = 12/112 (10%)
Query: 230 QVATLSLQGNKLT-GKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKL---YLH 285
V L L ++ GK+ + + L L L + NL KL L
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELS 72
Query: 286 GNKLTGPIPPELGNMSKLSYLQLQNNQL--VGTIPAELGKLEQLFELNLADN 335
N+++G + L++L L N++ + TI L KLE L L+L +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNC 123
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 62/273 (22%), Positives = 94/273 (34%), Gaps = 91/273 (33%)
Query: 613 RSTENLSEKY----IVGYGASSTVYKCALKNSR---PIAVKKLYNQYPHN------LRE- 658
R ++ KY +G GA V + R +AVKK+++ + ++ RE
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIV--WKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREI 59
Query: 659 -FETELETIGSIRHRNIVSLHGYALSP-----YGNLLFYDYMVNGSLWDLLHGPSKKVKL 712
TEL H NIV+L + Y L +DYM
Sbjct: 60 MILTELSG-----HENIVNLLNVLRADNDRDVY---LVFDYM------------------ 93
Query: 713 DWETRLKIAVGAAQ----------------GLAYLHHDCNPRIIHRDVKSSNILIDENFD 756
ET L AV A + YLH ++HRD+K SNIL++
Sbjct: 94 --ETDLH-AVIRANILEPVHKQYVVYQLIKVIKYLH-SGG--LLHRDMKPSNILLNAECH 147
Query: 757 AHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL-------------------- 796
++DFG++R + L + L
Sbjct: 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK 207
Query: 797 -NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
+ D++S G +L EIL GK S ++QL
Sbjct: 208 YTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 33/117 (28%), Positives = 55/117 (47%), Gaps = 26/117 (22%)
Query: 727 GLAYLH-HDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIA-RCIPTAMPHASTFVLGT 782
L +LH II+RD+K NIL+D + H L+DFG++ + A F GT
Sbjct: 171 ALEHLHKLG----IIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDF-CGT 223
Query: 783 IGYIDPE------YAHTSRLNEKS-DVYSFGIVLLEILTGK---KAVDNESNLHQLI 829
I Y+ P+ H K+ D +S G+++ E+LTG +++ ++
Sbjct: 224 IEYMAPDIVRGGDSGHD-----KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 38/182 (20%), Positives = 71/182 (39%), Gaps = 34/182 (18%)
Query: 300 MSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGN 359
M+K + ++ + E++ EL+ +E + +S+ A + N
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKV-ELHGMIPPIEK-MDATLSTLKACKHLALSTN 58
Query: 360 RLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGD 419
+ I SS + +L L+L RN K +I NLD +
Sbjct: 59 NIE-KI-SSLSGMENLRILSLGRNLIK--------KIENLDAV----------------- 91
Query: 420 LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS--GSIPAELGQLQNIISLILN 477
+ L L +S N + L + L +++ + MS N+++ G I +L L + L+L
Sbjct: 92 ADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLA 148
Query: 478 NN 479
N
Sbjct: 149 GN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 40/171 (23%), Positives = 65/171 (38%), Gaps = 41/171 (23%)
Query: 101 DIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVL 160
+ ++S LK + L L N + I S+L+ + NL+ L L RN + +I L + L
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 161 QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQIT- 219
+ L + N + L+G+ + +L +S N+IT
Sbjct: 96 EELWISYNQIA--------SLSGI------------------EKLVNLRVLYMSNNKITN 129
Query: 220 -GEIPYNIGFLQVATLSLQGNKLTGKIPE----------VIGLMQALAVLD 259
GEI ++ L L GN L E V+ + L LD
Sbjct: 130 WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 29/151 (19%), Positives = 55/151 (36%), Gaps = 29/151 (19%)
Query: 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP 340
+L+ + + L + +L L N + I + L +E L L+L N ++
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK- 84
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
I + + L + + N+++ S L +L L +S N +I N
Sbjct: 85 IENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNN-----------KITNWG 131
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRN 431
+D + L+ L L L+ N
Sbjct: 132 EID------------KLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 30/147 (20%), Positives = 61/147 (41%), Gaps = 9/147 (6%)
Query: 33 CDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIE 92
+ V L+ + ++ ++ L+ + + N + +I + +L +
Sbjct: 20 VVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILS 76
Query: 93 LSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLT--GEI 150
L N + I + LE L + NQ+ S + ++ NL+ L ++ N++T GEI
Sbjct: 77 LGRNLIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEI 133
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPD 177
+L + L+ L L GN L +
Sbjct: 134 DKLAA-LDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 31/127 (24%), Positives = 53/127 (41%), Gaps = 11/127 (8%)
Query: 198 IPDSIGNCTSFEILDISYNQITGEIPYNIGFL-QVATLSLQGNKLTGKIPEVIGLMQALA 256
+ ++ + + L +S N I +I ++ + + LSL N + KI + + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 257 VLDLSENELVGPIPPI--LGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQL 313
L +S N++ + I L NL LY+ NK+T + L + KL L L N L
Sbjct: 97 ELWISYNQIAS-LSGIEKLVNLR---VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152
Query: 314 VGTIPAE 320
Sbjct: 153 YNDYKEN 159
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 22/138 (15%), Positives = 44/138 (31%), Gaps = 25/138 (18%)
Query: 346 SSCTALNQFNVH-GNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDL 404
+C + + +LT L + +L L+
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQ-------------HLQHLE- 48
Query: 405 SVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAE 464
+ L L L + ++ L + P F + +++SFN L S+ +
Sbjct: 49 ---------LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWK 98
Query: 465 LGQLQNIISLILNNNNLQ 482
Q ++ L+L+ N L
Sbjct: 99 TVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 1e-08
Identities = 20/126 (15%), Positives = 41/126 (32%), Gaps = 6/126 (4%)
Query: 412 SVPASIGDLEHLLTLNLSRN-HLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAE-LGQLQ 469
+ E+L L + HL L + L ++ + + + L + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 470 NIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYN--NLSGIIPPIRNFSRFSSNSFIGNP 527
+ L L+ N L+ + SL L +S N + S + ++ +
Sbjct: 81 RLSRLNLSFNALESLSWKTVQG-LSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQK 139
Query: 528 LLCGNW 533
L C
Sbjct: 140 LQCHGQ 145
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 22/94 (23%), Positives = 35/94 (37%), Gaps = 2/94 (2%)
Query: 293 IPPELGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQLFELNLADNNLEGPIPHNISSCTAL 351
L L+ L ++N Q + + L L +L L + + L P L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 352 NQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNF 385
++ N+ N L + + L SL L LS N
Sbjct: 83 SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 6e-07
Identities = 18/95 (18%), Positives = 34/95 (35%), Gaps = 4/95 (4%)
Query: 269 IPPILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLVGTIPAE-LGKLEQ 326
L +LY+ + + L + +L L + + L + + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 327 LFELNLADNNLEGPIPHNISSCTALNQFNVHGNRL 361
L LNL+ N LE + +L + + GN L
Sbjct: 82 LSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 7e-07
Identities = 19/101 (18%), Positives = 32/101 (31%), Gaps = 2/101 (1%)
Query: 72 NKLTGQIPDEIGNCGSLVHIELSDNSLYGDIP-FSISKLKQLEFLNLKNNQLTGPIPSTL 130
+ +L + + + + + L +L L + + L P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 131 TQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALT 171
P L L+L+ N L + LQ L L GN L
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 18/93 (19%), Positives = 34/93 (36%), Gaps = 2/93 (2%)
Query: 56 PSIGDLRNLQSIDFQGNKLTGQIPDE-IGNCGSLVHIELSDNSLYGDIPFSISKLKQLEF 114
+ NL + + + + + G L ++ + + L P + +L
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84
Query: 115 LNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLT 147
LNL N L + Q +L+ L L+ N L
Sbjct: 85 LNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 4e-06
Identities = 20/101 (19%), Positives = 34/101 (33%), Gaps = 2/101 (1%)
Query: 310 NNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHN-ISSCTALNQFNVHGNRLSGAIPSS 368
L E L EL + + + + L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 369 FRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNF 409
F L+ LNLS N + + + + ++L L LS N
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 25/119 (21%), Positives = 38/119 (31%), Gaps = 8/119 (6%)
Query: 176 PDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIP----YNIGFLQV 231
PD C G + + + L I Q + +G L+
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELR- 59
Query: 232 ATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLT 290
L++ + L P+ L+ L+LS N L + LS L L GN L
Sbjct: 60 -NLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 21/173 (12%)
Query: 668 SIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+++H +V LH ++ L F DY +NG +L + ++ E R + AA+
Sbjct: 95 NVKHPFLVGLH-FSFQTADKLYFVLDY-INGG--ELFYHLQRERCFL-EPRARFY--AAE 147
Query: 727 ---GLAYLHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLG 781
L YLH + I++RD+K NIL+D H L+DFG+ + STF G
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNSTTSTFC-G 201
Query: 782 TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
T Y+ PE H + D + G VL E+L G N + ++ I++K
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 9e-09
Identities = 56/248 (22%), Positives = 97/248 (39%), Gaps = 53/248 (21%)
Query: 612 MRSTENLSEKYIVGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELET--IGS 668
+ +G G V+K K + +A+KK+ E E E I +
Sbjct: 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---------LMENEKEGFPITA 63
Query: 669 IR---------HRNIVSLHG------YALSPYGNLLF--YDYMVNGSLWDL---LHGPSK 708
+R H N+V+L + ++ +D+ + DL L +
Sbjct: 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLS--NV 117
Query: 709 KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768
VK ++ GL Y+H + +I+HRD+K++N+LI + L+DFG+AR
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 769 PTAMPHAS---TFVLGTIGYIDPEYAHTSRLNEKS-----DVYSFGIVLLEILTGKKAVD 820
A T + T+ Y PE L E+ D++ G ++ E+ T +
Sbjct: 175 SLAKNSQPNRYTNRVVTLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230
Query: 821 NESNLHQL 828
+ HQL
Sbjct: 231 GNTEQHQL 238
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-08
Identities = 46/174 (26%), Positives = 72/174 (41%), Gaps = 23/174 (13%)
Query: 668 SIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
++H IV L YA G L +Y ++G +L ++ E A+
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEY-LSGG--ELFMQLEREGIFM-EDTACFY--LAE 129
Query: 727 ---GLAYLH-HDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVL 780
L +LH II+RD+K NI+++ H L+DFG+ + TF
Sbjct: 130 ISMALGHLHQKG----IIYRDLKPENIMLNH--QGHVKLTDFGLCKESIHDGTVTHTF-C 182
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
GTI Y+ PE S N D +S G ++ ++LTG +N I+
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 4/107 (3%)
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNL 337
+L L NKL +++L+ L L NQ+ ++P + KL +L L L +N L
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKL 88
Query: 338 EGPIPHNI-SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383
+ +P+ + T L + + N+L F L SL + L N
Sbjct: 89 QS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 32/109 (29%), Positives = 43/109 (39%), Gaps = 10/109 (9%)
Query: 376 TYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRNHLN 434
T L L N + ++ L L LS N S+P + D L L L L N L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89
Query: 435 GLLPAEFGNLRSIQTIDMSFNQLSGSIP----AELGQLQNIISLILNNN 479
L F L ++ + + NQL S+P L LQ I L+ N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKI---WLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 28/85 (32%), Positives = 40/85 (47%), Gaps = 10/85 (11%)
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPP----ILGNLSYTGKLYLHGNKL 289
L L+ NKL V + L L LS+N++ +P L L+ LYLH NKL
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTI---LYLHENKL 88
Query: 290 TGPIPPEL-GNMSKLSYLQLQNNQL 313
+P + +++L L L NQL
Sbjct: 89 QS-LPNGVFDKLTQLKELALDTNQL 112
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 25/84 (29%), Positives = 41/84 (48%), Gaps = 4/84 (4%)
Query: 305 YLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNI-SSCTALNQFNVHGNRLSG 363
L+L++N+L KL QL +L+L+ N ++ +P + T L +H N+L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ- 89
Query: 364 AIPSS-FRNLGSLTYLNLSRNNFK 386
++P+ F L L L L N K
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLK 113
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 23/80 (28%), Positives = 32/80 (40%), Gaps = 2/80 (2%)
Query: 92 ELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIP 151
EL N L KL QL L+L NQ+ ++ L L L N+L +P
Sbjct: 34 ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLP 92
Query: 152 RLIYWNEV-LQYLGLRGNAL 170
++ L+ L L N L
Sbjct: 93 NGVFDKLTQLKELALDTNQL 112
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 5e-04
Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 15/112 (13%)
Query: 400 DTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459
L+L N L L L+LS+N + L F L + + + N+L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 460 SIPA----ELGQLQNIISLILNNNNLQG---GIPDQLSNCFSLSNLNVSYNN 504
S+P +L QL+ L L+ N L+ GI D+L+ SL + + + N
Sbjct: 90 SLPNGVFDKLTQLK---ELALDTNQLKSVPDGIFDRLT---SLQKIWL-HTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 25/110 (22%), Positives = 47/110 (42%), Gaps = 5/110 (4%)
Query: 206 TSFEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSEN 263
+S L++ N++ +P+ + Q+ LSL N++ V + L +L L EN
Sbjct: 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86
Query: 264 ELVGPIPP-ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQ 312
+L +P + L+ +L L N+L ++ L + L N
Sbjct: 87 KLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 15/163 (9%)
Query: 612 MRSTENLSEKYIVGYGASSTVYKC-ALKNSRPIAVKKLYNQ----YPHN-LREFETELET 665
M S+ + +G G +TVYK +A+K++ P +RE E
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE- 59
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVN--GSLWDLLHGPSKKVKLDWETRLKIAVG 723
++H NIV L+ + L +++M N D + L+
Sbjct: 60 ---LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 724 AAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766
QGLA+ H + +I+HRD+K N+LI++ L DFG+AR
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 27/155 (17%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGS-----------IRH 671
+G G TV+K + +A+K++ + + E + S ++H
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV---------RLDDDDEGVPSSALREICLLKELKH 60
Query: 672 RNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYL 731
+NIV LH S L +++ + L S LD E +GL +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766
H ++HRD+K N+LI+ N + L++FG+AR
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 25/175 (14%)
Query: 668 SIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKI-AVGAAQ 726
+ + LH L F VNG DL++ + + E A A
Sbjct: 398 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGG--DLMYHIQQVGRFK-EPHAVFYAAEIAI 453
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLGTIG 784
GL +L + II+RD+K N+++D + H ++DFG+ + TF GT
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKTFC-GTPD 507
Query: 785 YIDPEYAHTSRLNEKS-----DVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
YI PE + + D ++FG++L E+L G+ ++E L Q IM
Sbjct: 508 YIAPEI-----IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 26/130 (20%), Positives = 50/130 (38%), Gaps = 11/130 (8%)
Query: 210 ILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPI 269
++ ++ I + ++ L L+G K+ I + + +D S+NE I
Sbjct: 1 MVKLTAELIE-QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----I 54
Query: 270 PPI--LGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQL--VGTIPAELGKLE 325
+ L L ++ N++ + L+ L L NN L +G + L L+
Sbjct: 55 RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLK 113
Query: 326 QLFELNLADN 335
L L + N
Sbjct: 114 SLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 22/114 (19%), Positives = 41/114 (35%), Gaps = 4/114 (3%)
Query: 295 PELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQF 354
+ N + L L+ ++ I L+Q ++ +DN + + L
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTL 69
Query: 355 NVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKG-KVPTELGRIINLDTLDLSVN 407
V+ NR+ + L LT L L+ N+ L + +L L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 26/119 (21%), Positives = 48/119 (40%), Gaps = 6/119 (5%)
Query: 55 SPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEF 114
+ + + +D +G K+ I + I+ SDN + + L++L+
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-RKLDG-FPLLRRLKT 68
Query: 115 LNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLT--GEIPRLIYWNEVLQYLGLRGNALT 171
L + NN++ +P+L L L N L G++ L L YL + N +T
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS-LTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 18/117 (15%), Positives = 37/117 (31%), Gaps = 10/117 (8%)
Query: 367 SSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLL-- 424
+ + N L+L + + D +D S N + L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRL 66
Query: 425 -TLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG-SIPAELGQLQNIISLILNNN 479
TL ++ N + + L + + ++ N L L L+++ L + N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 23/131 (17%), Positives = 49/131 (37%), Gaps = 11/131 (8%)
Query: 402 LDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGL--LPAEFGNLRSIQTIDMSFNQLSG 459
+ L+ + A + L+L + + L A ID S N++
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIPVIENLGATLDQFD---AIDFSDNEIR- 55
Query: 460 SIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLS--GIIPPIRNFSR 517
+ L+ + +L++NNN + L+ L ++ N+L G + P+ +
Sbjct: 56 KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
Query: 518 FSSNSFIGNPL 528
+ + NP+
Sbjct: 115 LTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 23/135 (17%), Positives = 41/135 (30%), Gaps = 8/135 (5%)
Query: 130 LTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDV 189
T + LDL ++ I L + + N + + L L V
Sbjct: 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLV 71
Query: 190 RGNNLTGTIPDSIGNCTSFEILDISYNQIT--GEIPYNIGFLQVATLSLQGNKLTGKI-- 245
N + L ++ N + G++ + L + N +T K
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 131
Query: 246 -PEVIGLMQALAVLD 259
VI + + VLD
Sbjct: 132 RLYVIYKVPQVRVLD 146
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 52/268 (19%), Positives = 83/268 (30%), Gaps = 77/268 (28%)
Query: 616 ENLSEKYIV----GYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIR 670
+ + +Y V G+G STV+ ++ + +A+K + H E+ + S+R
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVR 91
Query: 671 --------HRNIVSLHGY--ALSPYGN--LLFYDYMVNG-SLWDLLHGPSKKVKLDWETR 717
+V L G + ++ + G L + S L
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIK-SNYQGLPLPCV 148
Query: 718 LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI-------------------------- 751
KI QGL YLH C IIH D+K NIL+
Sbjct: 149 KKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 752 -----------------------DENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDP 788
E ++D G A + T + T Y
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC----WVHKHFTEDIQTRQYRSL 262
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILTGK 816
E S N +D++S + E+ TG
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 6e-08
Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 10/110 (9%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLGTIG 784
GL +L + II+RD+K N+++D + H ++DFG+ + TF GT
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKTFC-GTPD 186
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
YI PE + D ++FG++L E+L G+ ++E L Q IM
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 6e-08
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 20/115 (17%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLGTIG 784
L +LH + II+RD+K N+L+D + H L+DFG+ + +TF GT
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGICNGVTTATFC-GTPD 189
Query: 785 YIDPEYAHTSRLNEKS-----DVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
YI PE L E D ++ G++L E+L G +NE +L + I++
Sbjct: 190 YIAPEI-----LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 29/115 (25%), Positives = 47/115 (40%), Gaps = 10/115 (8%)
Query: 370 RNLGSLTYLNLS-RNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLL---T 425
R ++ L L + GK+ +NL+ L L S+ +L L
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKK 75
Query: 426 LNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG-SIPAELGQLQNIISLILNNN 479
L LS N + G L L ++ +++S N+L S L +L+ + SL L N
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 28/163 (17%), Positives = 61/163 (37%), Gaps = 12/163 (7%)
Query: 107 SKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLR 166
S ++ + +L P+ + ++ LD ++ G+I L L++L L
Sbjct: 3 SGSSGMDMKRRIHLELRNRTPAAVREL----VLDNCKSND-GKIEGLTAEFVNLEFLSLI 57
Query: 167 GNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQIT--GEIPY 224
L + ++ +L L ++ N + G + + L++S N++ +
Sbjct: 58 NVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP 115
Query: 225 NIGFLQVATLSLQGNKLTGKI---PEVIGLMQALAVLDLSENE 264
+ +L L ++T V L+ L LD + E
Sbjct: 116 LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 26/115 (22%), Positives = 51/115 (44%), Gaps = 6/115 (5%)
Query: 60 DLRNLQSIDFQGNKLT-GQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLK 118
++ + K G+I +L + L + L + ++ KL +L+ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISVS-NLPKLPKLKKLELS 79
Query: 119 NNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEV--LQYLGLRGNALT 171
N++ G + ++PNL L+L+ N+L +I L ++ L+ L L +T
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 21/113 (18%), Positives = 42/113 (37%), Gaps = 5/113 (4%)
Query: 419 DLEHLLTLNLSRNHLNGLLPAEFG-NLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILN 477
+ L L N +++ + + L S+ + L +L + L L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 478 NNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI--IPPIRNFSRFSSNSFIGNPL 528
N + GG+ +L++LN+S N L I + P++ S +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 21/104 (20%), Positives = 44/104 (42%), Gaps = 4/104 (3%)
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460
LD +N G + + +L L+L L + + L ++ +++S N++ G
Sbjct: 30 VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG 86
Query: 461 IPAELGQLQNIISLILNNNNLQG-GIPDQLSNCFSLSNLNVSYN 503
+ +L N+ L L+ N L+ + L L +L++
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 27/110 (24%), Positives = 42/110 (38%), Gaps = 4/110 (3%)
Query: 324 LEQLFELNLADN-NLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSR 382
+ EL L + + +G I + L ++ L S+ L L L LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80
Query: 383 NNFKGKVPTELGRIINLDTLDLSVNNFSG-SVPASIGDLEHLLTLNLSRN 431
N G + ++ NL L+LS N S + LE L +L+L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 27/106 (25%), Positives = 41/106 (38%), Gaps = 3/106 (2%)
Query: 210 ILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPI 269
+LD + F+ + LSL L + + + L L+LSEN + G +
Sbjct: 30 VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGL 87
Query: 270 PPILGNLSYTGKLYLHGNKLTGPIPPE-LGNMSKLSYLQLQNNQLV 314
+ L L L GNKL E L + L L L N ++
Sbjct: 88 DMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 32/131 (24%), Positives = 49/131 (37%), Gaps = 7/131 (5%)
Query: 257 VLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT 316
VLD ++ G I + L L L + L + KL L+L N++ G
Sbjct: 30 VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELSENRIFGG 86
Query: 317 IPAELGKLEQLFELNLADNNLEGP-IPHNISSCTALNQFNVHGN---RLSGAIPSSFRNL 372
+ KL L LNL+ N L+ + L ++ L+ S F+ L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLL 146
Query: 373 GSLTYLNLSRN 383
LTYL+
Sbjct: 147 PQLTYLDGYDR 157
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 37/163 (22%), Positives = 76/163 (46%), Gaps = 19/163 (11%)
Query: 660 ETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLK 719
+ E++ + RH +I+ L+ +P + +Y+ G L+D + K +++ +
Sbjct: 59 KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARR 115
Query: 720 IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV 779
+ + Y H ++HRD+K N+L+D + +A ++DFG++ + + T
Sbjct: 116 LFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSC 171
Query: 780 LGTIGYIDPE------YAHTSRLNEKSDVYSFGIVLLEILTGK 816
G+ Y PE YA + D++S G++L +L G
Sbjct: 172 -GSPNYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCGT 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 8e-08
Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 10/110 (9%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLGTIG 784
GL +LH + I++RD+K NIL+D+ D H ++DFG+ + +TF GT
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNTFC-GTPD 183
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIMSK 832
YI PE + N D +SFG++L E+L G+ +E L I
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 19/119 (15%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLGTIG 784
L YLH II+RD+K N+L+D + H L+D+G+ + STF GT
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFC-GTPN 175
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK-----------KAVDNESNLHQLIMSK 832
YI PE D ++ G+++ E++ G+ + E L Q+I+ K
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 49/256 (19%), Positives = 88/256 (34%), Gaps = 69/256 (26%)
Query: 621 KYIV----GYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIR----- 670
+YI+ G+G STV+ + N+ +A+K + E E++ + +
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNT 78
Query: 671 ------HRNIVSLHGYALSPYGNLLFYDYMVNG------------SLWDLL-----HG-P 706
+I+ L + F NG +L L+ G P
Sbjct: 79 KEDSMGANHILKLLDH---------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 707 SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH------LS 760
VK +I+ GL Y+H C IIH D+K N+L++ ++
Sbjct: 130 LIYVK-------QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIA 180
Query: 761 DFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK---- 816
D G A T + T Y PE + +D++S ++ E++TG
Sbjct: 181 DLGNACWY----DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
Query: 817 --KAVDNESNLHQLIM 830
+ + +
Sbjct: 237 PDEGHSYTKDDDHIAQ 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 61/298 (20%), Positives = 96/298 (32%), Gaps = 69/298 (23%)
Query: 606 HTFDDIMRSTENLSEKY-----IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREF 659
H + + + Y ++G G + V + K + A+K L P RE
Sbjct: 3 HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREV 61
Query: 660 ETELETIGSIRHRNIVSLHG-YALSPYGNLLFY---DYMVNGSLWD--LLHGPSKKVKLD 713
E +IV + Y G + + G L+ G + +
Sbjct: 62 ELHWRASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118
Query: 714 WETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIPT 770
+K A + YLH N I HRDVK N+L N L+DFG A
Sbjct: 119 ASEIMKSIGEA---IQYLH-SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 167
Query: 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL-------TGKKAVDNES 823
G Y ++ D++S G V++ IL +
Sbjct: 168 --KE----TTGE-KY-----------DKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISP 208
Query: 824 NLHQLIMSKADDNTVMEAVD-PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ I + + EVS L +R LL T+ P++R T+ E
Sbjct: 209 GMKTRIRMGQYE---FPNPEWSEVSEEVKML--IRN-----LLKTE--PTQRMTITEF 254
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 57/247 (23%), Positives = 91/247 (36%), Gaps = 56/247 (22%)
Query: 620 EKYIV----GYGASSTVYKCA-LKNSRPIAVK--KLYNQYPHNLREFETELETIGSIRHR 672
+Y + G G+ +Y + +A+K + ++P E + + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG- 66
Query: 673 NIVSLHGYALSPYGNLLFYDYMV----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
I ++ G Y+ MV SL DL + S+K L +T L +A +
Sbjct: 67 -IPTIRWC-----GAEGDYNVMVMELLGPSLEDLFNFCSRKFSL--KTVLLLADQMISRI 118
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAH---LSDFGIAR---------CIPTAMPHAS 776
Y+H IHRDVK N L+ + + DFG+A+ IP
Sbjct: 119 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175
Query: 777 TFVLGTIGYIDPEYA--HTSRLNEKS---DVYSFGIVLLEILTGK------KAVDNESNL 825
T GT YA +T E+S D+ S G VL+ G KA +
Sbjct: 176 T---GT-----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA-ATKRQK 226
Query: 826 HQLIMSK 832
++ I K
Sbjct: 227 YERISEK 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 660 ETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLK 719
E E+ + +RH +I+ L+ +P ++ +Y G L+D + +K ++ + +
Sbjct: 57 EREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYI---VEKKRMTEDEGRR 112
Query: 720 IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV 779
+ Y H +I+HRD+K N+L+D+N + ++DFG++ I T T
Sbjct: 113 FFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSC 168
Query: 780 LGTIGYIDPE------YAHTSRLNEKSDVYSFGIVLLEILTGK 816
G+ Y PE YA + DV+S GIVL +L G+
Sbjct: 169 -GSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGR 205
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 19/119 (15%)
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLGTIG 784
L YLH II+RD+K N+L+D + H L+D+G+ + STF GT
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFC-GTPN 218
Query: 785 YIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK-----------KAVDNESNLHQLIMSK 832
YI PE D ++ G+++ E++ G+ + E L Q+I+ K
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 40/171 (23%), Positives = 74/171 (43%), Gaps = 35/171 (20%)
Query: 660 ETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLL--HGPSKKVKLDWETR 717
E++ + RH +I+ L+ +P + +Y+ G L+D + +G R
Sbjct: 64 RREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-----------R 112
Query: 718 LKIAVGAA------QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771
L G+ Y H ++HRD+K N+L+D + +A ++DFG++ + +
Sbjct: 113 LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSD 168
Query: 772 MPHASTFVLGTIGYIDPE------YAHTSRLNEKSDVYSFGIVLLEILTGK 816
T G+ Y PE YA + D++S G++L +L G
Sbjct: 169 GEFLRTSC-GSPNYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGT 213
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 38/162 (23%), Positives = 63/162 (38%), Gaps = 29/162 (17%)
Query: 621 KYIV----GYGASSTVYKCA-LKNSRPIAVK--KLYNQYPHNLREFETELETIGSIRHRN 673
+ V G G + L + +A+K + ++ P E+ +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD---G 66
Query: 674 IVSLHGYALSPYGNLLFYDYMV----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLA 729
I ++ + P G Y+ MV SL DL + L +T L IA+ +
Sbjct: 67 IPQVYYF--GPCGK---YNAMVLELLGPSLEDLFDLCDRTFSL--KTVLMIAIQLISRME 119
Query: 730 YLHHDCNPRIIHRDVKSSNILI--DENFDA---HLSDFGIAR 766
Y+H + +I+RDVK N LI N H+ DF +A+
Sbjct: 120 YVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 6e-07
Identities = 38/213 (17%), Positives = 60/213 (28%), Gaps = 53/213 (24%)
Query: 605 IHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLY--------NQYPHNL 656
F + TE L +G G V++ + P+A+K + +
Sbjct: 10 PVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADH-TPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 657 REFETE---------LETIGSIRHRNIVSLHGYAL----SPYGNLLFYDYM--VNGS--- 698
E E L R + L+ P L +D+ GS
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 699 ---------LW----------DLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739
L+ DL +K T I LA + R
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEA--SLRF 183
Query: 740 IHRDVKSSNILIDENFDAHLSDF--GIARCIPT 770
HRD+ N+L+ + L G + IP+
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPS 216
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 74/505 (14%), Positives = 151/505 (29%), Gaps = 84/505 (16%)
Query: 38 LSVVSLNLSSLNLGGEISPSIGDL----RNLQSIDFQGNKLTGQIPDEIGNCGSLVHIEL 93
+ S + + + + L NL+S+ +G N G V +
Sbjct: 45 FKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWV 104
Query: 94 SDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQI--PNLKTLDLAR-NQLTGEI 150
++ S + L+QL+ ++ + ++ L + +L+TL L + + T
Sbjct: 105 TEIS---------NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT--- 152
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEI 210
+ L + + L + + + G L + + TS E+
Sbjct: 153 ------TDGLLSIVTHCRKIKT-LLMEESSFS-----EKDGKWLH-ELAQ---HNTSLEV 196
Query: 211 LDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGP-- 268
L+ + I + T++ L + + + E++
Sbjct: 197 LNFYMTEFA-----KISPKDLETIARNCRSLV--------------SVKVGDFEILELVG 237
Query: 269 IPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLF 328
NL L+ + L KL L L +P Q+
Sbjct: 238 FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIR 296
Query: 329 ELNLADNNLEGP-IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKG 387
+L+L LE I C L + + L L + R +
Sbjct: 297 KLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQ 356
Query: 388 KVPTELGRI------------INLDTLDLSVNNFSGSVPASIG----DLEHLLTLNLSRN 431
+ E G + L+ + + V++ + SIG +L + L R
Sbjct: 357 GMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDRE 416
Query: 432 HLNGLLPAEFG------NLRSIQTIDMSFN--QLSGSIPAELGQL-QNIISLILNNNNLQ 482
LP + G + ++ L+ + +GQ N+ ++L
Sbjct: 417 ERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGES 476
Query: 483 -GGIPDQLSNCFSLSNLNVSYNNLS 506
G+ + C +L L + S
Sbjct: 477 DEGLMEFSRGCPNLQKLEMRGCCFS 501
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 59/391 (15%), Positives = 105/391 (26%), Gaps = 56/391 (14%)
Query: 33 CDNSSLSVVSL--------NLSSLNLGGEISPSIGD---------LRNLQSIDFQGNKLT 75
S L +L LN I R+L S+ ++
Sbjct: 174 SSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL 233
Query: 76 GQ--IPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQI 133
N L+++ + ++ ++L L L +P
Sbjct: 234 ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFA 292
Query: 134 PNLKTLDLAR-NQLTGEIPRLIYWNEVLQYLGLR---GNALTGMLSPDMCQLTGLWYFDV 189
++ LDL T + LI L+ L R G+ +L+ QL L +
Sbjct: 293 AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRL---RI 349
Query: 190 RGNNLTGTIPDSIG------------NCTSFEILDISYNQITGEIPYNIGFLQVATLSLQ 237
+ D G C E + + + IT N + T
Sbjct: 350 ERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT-----NESLESIGTYLKN 404
Query: 238 GNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPEL 297
++ L + + DL + V + L YL LT +
Sbjct: 405 LCDF-----RLVLLDREERITDLPLDNGVRSLLIGCKKLRRF-AFYLRQGGLTDLGLSYI 458
Query: 298 G-NMSKLSYLQLQNNQL-VGTIPAELGKLEQLFELNLADNNL-EGPIPHNISSCTALNQF 354
G + ++ L + L +L + E I ++ +L
Sbjct: 459 GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYL 518
Query: 355 NVHGNRLSGAIPSSF---RNLGSLTYLNLSR 382
V G R S R ++ + R
Sbjct: 519 WVQGYRASMTGQDLMQMARPYWNIELIPSRR 549
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 39/234 (16%)
Query: 601 MDMAIHTFDDIMRSTENLSEKYIV----GYGASSTVYKCA-LKNSRPIAVKKLYNQYPHN 655
MD A T + + S++Y G G +AVK + +
Sbjct: 1 MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAI 59
Query: 656 LREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLD-W 714
+ E+ S+RH NIV L+P + +Y G L++ + +
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI---CNAGRFSED 116
Query: 715 ETRLK----IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL--SDFGIARCI 768
E R ++ G++Y H +I HRD+K N L+D + L DFG ++
Sbjct: 117 EARFFFQQLLS-----GVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
Query: 769 -PTAMPHASTFVLGTIGYIDPE------YAHTSRLNEKSDVYSFGIVLLEILTG 815
+ P + V GT YI PE Y + +DV+S G+ L +L G
Sbjct: 169 VLHSQPK--STV-GTPAYIAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVG 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 35/172 (20%), Positives = 66/172 (38%), Gaps = 30/172 (17%)
Query: 612 MRSTENL-SEKYIV----GYGASSTVYKCA-LKNSRPIAVK--KLYNQYPHNLREFETEL 663
M N+ Y V G G+ +++ L N++ +A+K + P E+ T
Sbjct: 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYK 60
Query: 664 ETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV----NGSLWDLLHGPSKKVKLDWETRLK 719
G I +++ + G ++ +V SL DLL +K + +T
Sbjct: 61 LLAGCT---GIPNVYYF--GQEGL---HNVLVIDLLGPSLEDLLDLCGRKFSV--KTVAM 110
Query: 720 IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDA-----HLSDFGIAR 766
A + +H +++RD+K N LI ++ DFG+ +
Sbjct: 111 AAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 27/161 (16%), Positives = 56/161 (34%), Gaps = 19/161 (11%)
Query: 8 SNLANVLLDWDDVHNSDFCSWRGV-FCDNSSLSVVSLNLSSLNLGGEISPSIG--DLRNL 64
+L+ VL ++N + ++ SL + S L + I DL NL
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 65 QSIDF---QGNKLTGQIPDEI------GNCGSLVHIELSDNSLYGDIPFSISK---LKQL 112
+ + + + +L + + D + + L QL
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 113 EFLNLKNNQLTG----PIPSTLTQIPNLKTLDLARNQLTGE 149
E +++ LT + + +I +LK +++ N L+ E
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 2e-06
Identities = 30/175 (17%), Positives = 64/175 (36%), Gaps = 20/175 (11%)
Query: 17 WDDVHNSDFC-SWRGVFCDNSSLSV-VSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKL 74
W D+ + SW + L LN + +S NL+S++ L
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGL 205
Query: 75 TGQIPDEIGNCG--SLVHIELS--DNSLYGDIP-------FSISKLKQLEFLNLKNNQLT 123
+ ++I +L + L D FS + L++L + + +
Sbjct: 206 PDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQ 265
Query: 124 GPIPSTL---TQIPNLKTLDLARNQLTGE----IPRLIYWNEVLQYLGLRGNALT 171
+ +P L+T+D++ LT E + + + L+++ ++ N L+
Sbjct: 266 NVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 6e-05
Identities = 24/158 (15%), Positives = 55/158 (34%), Gaps = 15/158 (9%)
Query: 291 GPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQL--FELNLADNNLEGPIPHNISSC 348
+ P L M L+ L+++ + L+ L L D+ +E + ++ +
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 349 TALNQFNVHGNRLSGAIPSSF------RNLGSLTYLNLSRNNFKGKVPTELGRII---NL 399
L + + + F +L +L + + V L
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 400 DTLDLSVNNFSGS----VPASIGDLEHLLTLNLSRNHL 433
+T+D+S + + + ++HL +N+ N+L
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 6e-05
Identities = 23/167 (13%), Positives = 56/167 (33%), Gaps = 27/167 (16%)
Query: 76 GQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLT--QI 133
+ + L ++++ + ++ L+ L + + L + + +
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 134 PNLKTLDL--------ARNQLTGEIPRLIYWN-EVLQYLGLRGNALTGML------SPDM 178
PNL+ L L + P L++LG+ ++ S +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 179 CQLTGLWYFDVRGNNLTGT----IPDSIGNCTSFEILDISYNQITGE 221
QL + D+ LT + D + + +++ YN ++ E
Sbjct: 279 PQLETM---DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 50/224 (22%), Positives = 90/224 (40%), Gaps = 47/224 (20%)
Query: 620 EKYIV----GYGASSTVYKCA-LKNSRPIAVK--KLYNQYPHNLREFETELETIGSIRHR 672
K+ + G G+ +Y ++ + +A+K + ++P L E + +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI-YRILQGGTG- 64
Query: 673 NIVSLHGYALSPYGNLLFYDYMV----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
I ++ + G Y+ +V SL DL + S+K+ L +T L +A +
Sbjct: 65 -IPNVRWF-----GVEGDYNVLVMDLLGPSLEDLFNFCSRKLSL--KTVLMLADQMINRV 116
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAH---LSDFGIAR---------CIPTAMPHAS 776
++H + +HRD+K N L+ A+ + DFG+A+ IP +
Sbjct: 117 EFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP---YREN 170
Query: 777 TFVLGTIGYIDPEYAHT----SRLNEKSDVYSFGIVLLEILTGK 816
+ GT Y H SR + D+ S G VL+ L G
Sbjct: 171 KNLTGTARYA-SVNTHLGIEQSR---RDDLESLGYVLMYFLRGS 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 40/230 (17%), Positives = 75/230 (32%), Gaps = 40/230 (17%)
Query: 608 FDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY-PHNLREFETELETI 666
+ + + G K K+ R + + + +L +
Sbjct: 55 QGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYST 114
Query: 667 GSIRHRNIVSLHGYALSPYGNLLFYDYMV----NGSLWDLLHGPSKKVKLDWETRLKIAV 722
I + G+ + Y ++V SL L K L + L++A
Sbjct: 115 P---LLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQSALDVSPKH-VLSERSVLQVAC 166
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARC-------IPTAM 772
L +LH + +H +V + NI + D++ L+ +G A +
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQS-QVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 773 PHASTFVLGTIGY--IDPEYAHT----SRLNEKSDVYSFGIVLLEILTGK 816
S G + + +D H SR +SD+ S G +L+ L G
Sbjct: 223 GSRSPHE-GDLEFISMD---LHKGCGPSR---RSDLQSLGYCMLKWLYGF 265
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 43/240 (17%), Positives = 85/240 (35%), Gaps = 50/240 (20%)
Query: 637 LKNSRPIAVKKLYNQYPHNLREFE-----------TELETIGSIRHRNIVSLHGYALSPY 685
+ + P VK + E + + +++ + G L
Sbjct: 62 VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDK 121
Query: 686 GNLLFYDYMV----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIH 741
Y +M+ L + +K+ +T L++++ L Y+H +H
Sbjct: 122 NGKS-YRFMIMDRFGSDLQKIYEANAKRFSR--KTVLQLSLRILDILEYIHEHE---YVH 175
Query: 742 RDVKSSNILI---DENFDAHLSDFGIAR--CIPTAMPH-----ASTFVLGTIGY--IDPE 789
D+K+SN+L+ + + +L D+G+A C GTI + ID
Sbjct: 176 GDIKASNLLLNYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHD-GTIEFTSID-- 231
Query: 790 YAHT----SRLNEKSDVYSFGIVLLEILTGK-----KAVDNESNLHQLIMSKADDNTVME 840
AH SR + D+ G +++ LTG D + I + + ++M+
Sbjct: 232 -AHNGVAPSR---RGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMD 287
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 58/263 (22%), Positives = 95/263 (36%), Gaps = 72/263 (27%)
Query: 608 FDD-----IMRSTENLSEKYIV----GYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLR 657
+DD + ++++ +Y V G G+ V K K + +A+K + N+ R
Sbjct: 80 YDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHR 138
Query: 658 EFETELETIGSIRHR------NIVSLHGY------------ALSPYGNLLFYDYMVNGSL 699
+ E+ + +R + N++ + LS NL Y+ +
Sbjct: 139 QAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM--NL--YELIKKNKF 194
Query: 700 WDLLHG-PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH 758
G V+ K A Q L LH RIIH D+K NIL+ + +
Sbjct: 195 ----QGFSLPLVR-------KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSG 240
Query: 759 --LSDFGIARCIPTAMPHA---STF------VLGTIGYIDPEYAHTSRLNEKSDVYSFGI 807
+ DFG + C + S F +LG Y D++S G
Sbjct: 241 IKVIDFGSS-CYEHQRVYTYIQSRFYRAPEVILG-ARY-----------GMPIDMWSLGC 287
Query: 808 VLLEILTGKKAVDNESNLHQLIM 830
+L E+LTG + E QL
Sbjct: 288 ILAELLTGYPLLPGEDEGDQLAC 310
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 38/108 (35%), Positives = 51/108 (47%), Gaps = 30/108 (27%)
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELG---KLEQLFELNLADN 335
T LYL+ N++T P +++L+ L L NNQL +PA G KL QL +L+L DN
Sbjct: 32 TQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPA--GVFDKLTQLTQLSLNDN 88
Query: 336 NLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383
L+ IP GA F NL SLT++ L N
Sbjct: 89 QLKS-IPR-------------------GA----FDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 33/108 (30%), Positives = 48/108 (44%), Gaps = 30/108 (27%)
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELG---KLEQLFELNLADN 335
+L+L+ N++T P ++ L L +N+L IP G KL QL +L+L DN
Sbjct: 35 KQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPT--GVFDKLTQLTQLDLNDN 91
Query: 336 NLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383
+L+ IP GA F NL SLT++ L N
Sbjct: 92 HLKS-IPR-------------------GA----FDNLKSLTHIYLYNN 115
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 50/255 (19%), Positives = 92/255 (36%), Gaps = 54/255 (21%)
Query: 608 FDD-----IMRSTENLSEKYIV----GYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLR 657
+DD I+++ E ++Y + G G+ V K +A+K + N+ L
Sbjct: 37 YDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLN 95
Query: 658 EFETELETIGSIRHR------NIVSLHGYALSPYGNLLFYDY--------MVNGSLWDLL 703
+ + E+ + + IV L + F M++ +L+DLL
Sbjct: 96 QAQIEVRLLELMNKHDTEMKYYIVHLKRH---------FMFRNHLCLVFEMLSYNLYDLL 146
Query: 704 -----HG-PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDA 757
G + K A L +L IIH D+K NIL+ +
Sbjct: 147 RNTNFRGVSLNLTR-------KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS 198
Query: 758 H--LSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG 815
+ DFG + + + + Y PE + D++S G +L+E+ TG
Sbjct: 199 AIKIVDFGSS----CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254
Query: 816 KKAVDNESNLHQLIM 830
+ + + Q+
Sbjct: 255 EPLFSGANEVDQMNK 269
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 35/145 (24%), Positives = 60/145 (41%), Gaps = 32/145 (22%)
Query: 691 YDYMV----NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKS 746
Y +MV L + + T L++ + L Y+H + +H D+K+
Sbjct: 126 YRFMVMERLGIDLQKIS---GQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKA 179
Query: 747 SNILI---DENFDAHLSDFGIA-RCIPT----AMPHASTFVL-GTIGY--IDPEYAHT-- 793
+N+L+ + + +L+D+G++ R P GTI + +D AH
Sbjct: 180 ANLLLGYKNPD-QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLD---AHKGV 235
Query: 794 --SRLNEKSDVYSFGIVLLEILTGK 816
SR +SDV G +L L GK
Sbjct: 236 ALSR---RSDVEILGYCMLRWLCGK 257
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 35/206 (16%), Positives = 67/206 (32%), Gaps = 32/206 (15%)
Query: 42 SLNL-SSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIG-----NCGSLVHIELSD 95
L+ S L +L+ ++ G ++T + +L + L+
Sbjct: 51 LLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLAS 110
Query: 96 NSLYGDIPFSISK-LKQLEFLNLKNNQLTGP----IPSTLT-QIPNLKTLDLARNQLTGE 149
L ++ + L L+ N L + L + TL L+ N LT
Sbjct: 111 CQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAA 170
Query: 150 ----IPRLIYWNEVLQYLGLRGN--------ALTGMLSPDMCQLTGLWYFDVRGNNLTGT 197
+ + N + +L L L L + QL L +V N T
Sbjct: 171 GVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN-RQLQEL---NVAYNGAGDT 226
Query: 198 ----IPDSIGNCTSFEILDISYNQIT 219
+ + S E+L + +N+++
Sbjct: 227 AALALARAAREHPSLELLHLYFNELS 252
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 49/290 (16%), Positives = 105/290 (36%), Gaps = 25/290 (8%)
Query: 27 SWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCG 86
W + D S + L +L+ + + Q E +
Sbjct: 38 RWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFR----CPRSFMDQPLAEHFSPF 93
Query: 87 SLVHIELSDNSL-YGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLAR-N 144
+ H++LS++ + + +S+ +L+ L+L+ +L+ PI +TL + NL L+L+ +
Sbjct: 94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153
Query: 145 QLTGEIPRLIYWN-EVLQYLGLRG------NALTGMLSPDMCQLTGLWYFDVRG--NNLT 195
+ + + + L L L + ++ +T L ++ G NL
Sbjct: 154 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQL---NLSGYRKNLQ 210
Query: 196 GTIPDSIG-NCTSFEILDISY-NQITGEIPYNIGFL-QVATLSLQG-NKLTGKIPEVIGL 251
+ ++ C + LD+S + + L + LSL + + +G
Sbjct: 211 KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 270
Query: 252 MQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMS 301
+ L L + G + + L L ++ + T P +GN
Sbjct: 271 IPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCSHFTTIARPTIGNKK 317
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 48/355 (13%), Positives = 109/355 (30%), Gaps = 46/355 (12%)
Query: 191 GNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQG-NKLTGK-IP 246
G + I + T E + + +T + I F L L + +
Sbjct: 90 GGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLA 149
Query: 247 EVIGLMQALAVLDLSENELVGPIPPILGNLSYTGK------LYLHGNKLTGP-IPPELGN 299
+ + L LDL E+++ L + T + ++++ + +
Sbjct: 150 AIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTR 209
Query: 300 MSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLA------DNNLEGPIPHNISSCTALNQ 353
L L+L + + L + QL EL ++ + +S C L
Sbjct: 210 CPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRC 269
Query: 354 FNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRII----NLDTLDLSVNNF 409
+ + + +P+ + LT LNLS +L +++ L L +
Sbjct: 270 LSGFWDAVPAYLPAVYSVCSRLTTLNLSYAT---VQSYDLVKLLCQCPKLQRLWVLDYIE 326
Query: 410 SGSVPASIGDLEHLLTLNLSRNHLNGL----------LPAEFGNLRSIQTIDMSFNQLSG 459
+ + L L + + + L + ++++ Q++
Sbjct: 327 DAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTN 386
Query: 460 SIPAELGQ------------LQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSY 502
+ + + ++ L L G + +C L L++S
Sbjct: 387 AALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG 441
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 943 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.66 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.44 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.44 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.38 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.17 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.87 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.75 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.62 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.38 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.15 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.93 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.84 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.68 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.64 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.62 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.42 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.29 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.17 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.94 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.79 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.66 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.59 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.49 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.26 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.25 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.09 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.04 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.56 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-75 Score=713.72 Aligned_cols=537 Identities=35% Similarity=0.573 Sum_probs=433.2
Q ss_pred CcccccccCccccCCCCCCCCCCCCCCcceeEecCCCCcEEEEEcCCCCCccc---cC----------------------
Q 002278 1 MAIKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGE---IS---------------------- 55 (943)
Q Consensus 1 ~~~~~~~~~~~~~~~~w~~~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~---~~---------------------- 55 (943)
++||+++.||. .+++|.. ++|||+|.||.|+ +++|+.|||+++++.|. +|
T Consensus 18 l~~k~~~~~~~-~l~~W~~--~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~~l 92 (768)
T 3rgz_A 18 ISFKDVLPDKN-LLPDWSS--NKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGS 92 (768)
T ss_dssp HHHHTTCSCTT-SSTTCCT--TSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEEEC
T ss_pred HHHHhhCCCcc-cccCCCC--CCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcCCC
Confidence 47999999998 9999974 6899999999998 68999999999999886 43
Q ss_pred -CCcCCCCCCCEEEeeCCcccccCCC--CccCCCCCcEEeccCCCcCCccchhc--------------------------
Q 002278 56 -PSIGDLRNLQSIDFQGNKLTGQIPD--EIGNCGSLVHIELSDNSLYGDIPFSI-------------------------- 106 (943)
Q Consensus 56 -~~l~~l~~L~~L~Ls~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-------------------------- 106 (943)
+.++.+++|++|||++|.++|.+|. .|+++++|++|+|++|.+.+..|..+
T Consensus 93 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 172 (768)
T 3rgz_A 93 VSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWV 172 (768)
T ss_dssp CCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHH
T ss_pred chhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhh
Confidence 5778888899999999998887777 77777777777777777665544332
Q ss_pred ------------------------cccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhcccccccee
Q 002278 107 ------------------------SKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQY 162 (943)
Q Consensus 107 ------------------------~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 162 (943)
+.+++|++|+|++|++++.+|. +.++++|++|+|++|++++.+|..+..+++|++
T Consensus 173 ~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~ 251 (768)
T 3rgz_A 173 LSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKL 251 (768)
T ss_dssp HTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCE
T ss_pred hhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCE
Confidence 2344455555555555544444 777777777777777777777777776666666
Q ss_pred ccccCCccCC----------------------CCCcccccc-cccceeeccceecccccCCCCcCCCcccEEEeeccccc
Q 002278 163 LGLRGNALTG----------------------MLSPDMCQL-TGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQIT 219 (943)
Q Consensus 163 L~L~~n~l~~----------------------~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~ 219 (943)
|+|++|.+++ ..|..+..+ ++|++|+|++|++++.+|..|+++++|++|+|++|+++
T Consensus 252 L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 331 (768)
T 3rgz_A 252 LNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331 (768)
T ss_dssp EECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred EECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCccc
Confidence 6666665542 233344443 77888888888887777777777777777777777777
Q ss_pred CcCCCC-C-CcceEeEEEecCccccccCCccccc---------------------------cCCCcEEecCCCCCCCCCC
Q 002278 220 GEIPYN-I-GFLQVATLSLQGNKLTGKIPEVIGL---------------------------MQALAVLDLSENELVGPIP 270 (943)
Q Consensus 220 ~~~~~~-~-~~~~L~~L~L~~n~l~~~~~~~l~~---------------------------l~~L~~L~Ls~N~l~~~~~ 270 (943)
+.+|.. + ...+|++|++++|.+++.+|..+.. +++|+.|++++|.+.+.+|
T Consensus 332 ~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p 411 (768)
T 3rgz_A 332 GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411 (768)
T ss_dssp EECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECC
T ss_pred CcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccC
Confidence 666642 2 3345666666666665555555444 4456666666666666777
Q ss_pred cccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCc
Q 002278 271 PILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTA 350 (943)
Q Consensus 271 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 350 (943)
..|.++++|+.|+|++|++++.+|..|..+++|++|++++|++.+.+|..+..+++|++|+|++|++++.+|..+..+++
T Consensus 412 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 491 (768)
T 3rgz_A 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN 491 (768)
T ss_dssp GGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred HHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCC
Confidence 77888888888888888888888888888888888888888888888888888889999999999998888888999999
Q ss_pred CcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCC--------------
Q 002278 351 LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPAS-------------- 416 (943)
Q Consensus 351 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------- 416 (943)
|++|+|++|++++.+|.+|..+++|++|+|++|++++.+|..++.+++|+.|++++|.++|.+|..
T Consensus 492 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~ 571 (768)
T 3rgz_A 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIA 571 (768)
T ss_dssp CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTC
T ss_pred CCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccc
Confidence 999999999999888999999999999999999998888999999999999999999888766643
Q ss_pred --------------------------------------------------------cccccccceeecccccccccCCcc
Q 002278 417 --------------------------------------------------------IGDLEHLLTLNLSRNHLNGLLPAE 440 (943)
Q Consensus 417 --------------------------------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~ 440 (943)
++.+++|+.|||++|+++|.+|..
T Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~ 651 (768)
T 3rgz_A 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651 (768)
T ss_dssp SCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGG
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHH
Confidence 344678899999999999999999
Q ss_pred ccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCCcccCcCCC
Q 002278 441 FGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSS 520 (943)
Q Consensus 441 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~ 520 (943)
|+++++|+.|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..+.++++|++|||++|+|+|.||...++.++..
T Consensus 652 l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~ 731 (768)
T 3rgz_A 652 IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPP 731 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCG
T ss_pred HhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCCCCCccCCCccc
Q 002278 521 NSFIGNPLLCGNWIGSICGPSVTK 544 (943)
Q Consensus 521 ~~~~~Np~~c~~~~~~~c~~~~~~ 544 (943)
.+|.|||++||.|+. .|+.....
T Consensus 732 ~~~~gN~~Lcg~~l~-~C~~~~~~ 754 (768)
T 3rgz_A 732 AKFLNNPGLCGYPLP-RCDPSNAD 754 (768)
T ss_dssp GGGCSCTEEESTTSC-CCCSCC--
T ss_pred HHhcCCchhcCCCCc-CCCCCccC
Confidence 999999999999987 89765433
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-60 Score=583.12 Aligned_cols=466 Identities=35% Similarity=0.541 Sum_probs=412.8
Q ss_pred cEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEec
Q 002278 39 SVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLK 118 (943)
Q Consensus 39 ~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 118 (943)
+++.|+|++|++++.+|. ++.+++|++|+|++|++++.+|..|+++++|++|+|++|++++.+|.. .+++|++|+|+
T Consensus 201 ~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~ 277 (768)
T 3rgz_A 201 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLA 277 (768)
T ss_dssp TCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECC
T ss_pred cCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECc
Confidence 466777777777766665 777777778888777777777777777777888888877777666654 67778888888
Q ss_pred CcccccCCCcccCCC-CCCcEEEEeccccccccchhccccccceeccccCCccCCCCCc-ccccccccceeeccceeccc
Q 002278 119 NNQLTGPIPSTLTQI-PNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSP-DMCQLTGLWYFDVRGNNLTG 196 (943)
Q Consensus 119 ~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~i~~ 196 (943)
+|++++.+|..+..+ ++|++|+|++|++++.+|..|..+++|++|+|++|++++..|. .+..+++|++|++++|++++
T Consensus 278 ~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~ 357 (768)
T 3rgz_A 278 ENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357 (768)
T ss_dssp SSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEE
T ss_pred CCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCc
Confidence 888887888887775 8899999999998888888888889999999999988844444 48888999999999999988
Q ss_pred ccCCCCcCCC-cccEEEeecccccCcCCCCCC---cceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcc
Q 002278 197 TIPDSIGNCT-SFEILDISYNQITGEIPYNIG---FLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPI 272 (943)
Q Consensus 197 ~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~---~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~ 272 (943)
.+|..+.+++ +|++|++++|++++.+|..+. ..+|+.|++++|.+++.+|..+..+++|++|+|++|.+.+.+|..
T Consensus 358 ~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 437 (768)
T 3rgz_A 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437 (768)
T ss_dssp CCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGG
T ss_pred cccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHH
Confidence 8888888887 899999999999887776665 357999999999999999999999999999999999999999999
Q ss_pred cCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCc
Q 002278 273 LGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALN 352 (943)
Q Consensus 273 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 352 (943)
|..+++|+.|+|++|.+++.+|..+..+++|++|++++|++++.+|..+.++++|++|+|++|++++.+|..+..+++|+
T Consensus 438 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 517 (768)
T 3rgz_A 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 517 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred HhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCC----------------------------------------
Q 002278 353 QFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTE---------------------------------------- 392 (943)
Q Consensus 353 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~---------------------------------------- 392 (943)
+|+|++|++++.+|..+..+++|+.|+|++|+++|.+|..
T Consensus 518 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (768)
T 3rgz_A 518 ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597 (768)
T ss_dssp EEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECT
T ss_pred EEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999998776653
Q ss_pred ------------------------------CCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCcccc
Q 002278 393 ------------------------------LGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFG 442 (943)
Q Consensus 393 ------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 442 (943)
+..+++|+.|||++|+++|.+|..|+.++.|+.|+|++|+++|.+|..|+
T Consensus 598 ~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~ 677 (768)
T 3rgz_A 598 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG 677 (768)
T ss_dssp TCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred cccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHh
Confidence 34467899999999999999999999999999999999999999999999
Q ss_pred CCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCcc-cccc
Q 002278 443 NLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNN-LSGI 508 (943)
Q Consensus 443 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~~~ 508 (943)
++++|+.|||++|+++|.+|..+..+++|++|+|++|+|+|.+|.. ..+..+....+.+|+ |+|.
T Consensus 678 ~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 678 DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp GCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence 9999999999999999999999999999999999999999999964 456677777788886 6764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-59 Score=559.70 Aligned_cols=503 Identities=22% Similarity=0.229 Sum_probs=450.9
Q ss_pred cceeEecCCC---------CcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCc
Q 002278 28 WRGVFCDNSS---------LSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSL 98 (943)
Q Consensus 28 w~gv~c~~~~---------~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 98 (943)
+..|.|.+.+ ..++.|+|++|++++..|.+|+++++|++|+|++|+|++..|+.|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 5568887553 3588999999999988788999999999999999999988899999999999999999999
Q ss_pred CCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCccc
Q 002278 99 YGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDM 178 (943)
Q Consensus 99 ~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 178 (943)
++..|.+|+++++|++|+|++|++++..+..|.++++|++|+|++|++++.....+..+++|++|++++|.++++.+..+
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 98889999999999999999999998778899999999999999999997554555569999999999999999989999
Q ss_pred ccccccc--eeeccceecccccCCCCcCCCcccEEEeeccccc-----------------------------CcCCCCCC
Q 002278 179 CQLTGLW--YFDVRGNNLTGTIPDSIGNCTSFEILDISYNQIT-----------------------------GEIPYNIG 227 (943)
Q Consensus 179 ~~l~~L~--~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~-----------------------------~~~~~~~~ 227 (943)
..+++|+ .|++++|.+++..|..+.. .+|+.|++++|... ........
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~ 252 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGG
T ss_pred hhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhh
Confidence 9999999 8999999999887777654 68999999887510 00011112
Q ss_pred cceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEE
Q 002278 228 FLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQ 307 (943)
Q Consensus 228 ~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 307 (943)
..+++.|++++|.+++..+..|..+++|++|++++|.++ .+|..+..+++|++|++++|.+++..|..+..+++|++|+
T Consensus 253 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 331 (606)
T 3t6q_A 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331 (606)
T ss_dssp GSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEE
T ss_pred cCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEE
Confidence 237999999999999999999999999999999999999 6788899999999999999999988888999999999999
Q ss_pred cccCcccccccc-ccCCcccceEEEccccccCCcC--cccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCc
Q 002278 308 LQNNQLVGTIPA-ELGKLEQLFELNLADNNLEGPI--PHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNN 384 (943)
Q Consensus 308 L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 384 (943)
+++|.+.+.+|. .+..+++|++|++++|.+++.. +..+..+++|++|++++|++.+..|..|..+++|+.|++++|+
T Consensus 332 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 411 (606)
T 3t6q_A 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411 (606)
T ss_dssp CCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCC
T ss_pred CCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCc
Confidence 999999865554 5999999999999999999776 7889999999999999999999999999999999999999999
Q ss_pred CCCCCCC-CCCCCCCccEEecCCCcCCCccCCCcccccccceeeccccccccc---CCccccCCCccceecccCcccccc
Q 002278 385 FKGKVPT-ELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGL---LPAEFGNLRSIQTIDMSFNQLSGS 460 (943)
Q Consensus 385 l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~ 460 (943)
+++..+. .+..+++|+.|++++|.+.+..|..+..+++|++|+|++|++++. .+..|..+++|++|+|++|++++.
T Consensus 412 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 491 (606)
T 3t6q_A 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491 (606)
T ss_dssp EECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEE
T ss_pred CCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCcc
Confidence 9877654 489999999999999999988999999999999999999999873 346799999999999999999998
Q ss_pred CChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCC-cccCcCCCCccccCCCCCCCC
Q 002278 461 IPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPI-RNFSRFSSNSFIGNPLLCGNW 533 (943)
Q Consensus 461 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~~~~~~~~~~Np~~c~~~ 533 (943)
.|..|..+++|+.|+|++|++++..|..+.+++.| .|++++|++++.+|.. ..+..+..+.+.||||.|+++
T Consensus 492 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 89999999999999999999999999999999999 9999999999988863 556788888999999999864
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=562.12 Aligned_cols=508 Identities=21% Similarity=0.203 Sum_probs=384.4
Q ss_pred CCcceeEecCC---------CCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCC
Q 002278 26 CSWRGVFCDNS---------SLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDN 96 (943)
Q Consensus 26 c~w~gv~c~~~---------~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N 96 (943)
|.+..|.|... ..+++.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 34455666543 236888999999999766677999999999999999999888888999999999999999
Q ss_pred CcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCc
Q 002278 97 SLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSP 176 (943)
Q Consensus 97 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 176 (943)
++++..+.+|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..+..+++|++|++++|.++++.+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99855555799999999999999999877778899999999999999999888888888888999999999988888776
Q ss_pred ccc--cccccceeeccceecccccCCCCcCC---------------------------CcccEEEeecccccCcCCCCCC
Q 002278 177 DMC--QLTGLWYFDVRGNNLTGTIPDSIGNC---------------------------TSFEILDISYNQITGEIPYNIG 227 (943)
Q Consensus 177 ~~~--~l~~L~~L~L~~N~i~~~~~~~l~~l---------------------------~~L~~L~Ls~N~l~~~~~~~~~ 227 (943)
.+. .+++|++|++++|++++..|..|..+ ++|+.|++++|.+++..|..+.
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~ 243 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence 654 34778888888888877766655543 3445555666666555555443
Q ss_pred cc---eEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCc---------------------------------
Q 002278 228 FL---QVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPP--------------------------------- 271 (943)
Q Consensus 228 ~~---~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~--------------------------------- 271 (943)
.. +|+.|++++|.+++..|..|..+++|++|++++|.+.+..|.
T Consensus 244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~ 323 (680)
T 1ziw_A 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323 (680)
T ss_dssp GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTT
T ss_pred ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChh
Confidence 32 366666666666666666666666666666666666554443
Q ss_pred ccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccC----------------------------ccccccccccCC
Q 002278 272 ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNN----------------------------QLVGTIPAELGK 323 (943)
Q Consensus 272 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N----------------------------~l~~~~~~~~~~ 323 (943)
.|..+++|++|++++|.+++..+..|.++++|++|++++| ++++..|..|..
T Consensus 324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 3445566666666667777666666666665555555444 444444555666
Q ss_pred cccceEEEccccccCCcCc-ccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCC--CCCCCCCCCCCCcc
Q 002278 324 LEQLFELNLADNNLEGPIP-HNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFK--GKVPTELGRIINLD 400 (943)
Q Consensus 324 l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~ 400 (943)
+++|+.|+|++|++.+.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++ +..|..+..+++|+
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 6666666666666654333 45666666666666666666666666666777777777777665 45778888999999
Q ss_pred EEecCCCcCCCccCCCcccccccceeecccccccccCC--------ccccCCCccceecccCccccccCChhhhcccccc
Q 002278 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLP--------AEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNII 472 (943)
Q Consensus 401 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 472 (943)
.|++++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|+.|+|++|+|+...+..|..+++|+
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 563 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence 99999999998778889999999999999999986532 2378899999999999999944445689999999
Q ss_pred eecccCcccCCCCCCcCccccCCcccccCCccccccCCCCc--ccCcCCCCccccCCCCCCCC
Q 002278 473 SLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIR--NFSRFSSNSFIGNPLLCGNW 533 (943)
Q Consensus 473 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~--~~~~~~~~~~~~Np~~c~~~ 533 (943)
.|+|++|+|++..+..|..+++|+.|+|++|+|++++|... .+..+..+.+.||||.|+|.
T Consensus 564 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999998777778899999999999999999887532 46778888899999999975
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-57 Score=543.21 Aligned_cols=496 Identities=19% Similarity=0.158 Sum_probs=442.5
Q ss_pred ceeEecCC---------CCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcC
Q 002278 29 RGVFCDNS---------SLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLY 99 (943)
Q Consensus 29 ~gv~c~~~---------~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 99 (943)
..|.|.+. ..+++.|+|++|++++..+.+|+++++|++|+|++|+|++..|..|.++++|++|+|++|+++
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~ 93 (606)
T 3vq2_A 14 ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93 (606)
T ss_dssp TEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccc
Confidence 35778653 246889999999999877779999999999999999999888999999999999999999999
Q ss_pred CccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEecccccc-ccchhccccccceeccccCCccCCCCCccc
Q 002278 100 GDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTG-EIPRLIYWNEVLQYLGLRGNALTGMLSPDM 178 (943)
Q Consensus 100 ~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 178 (943)
+..|.+|+++++|++|+|++|++++..+..|+++++|++|+|++|++++ .+|..|..+++|++|+|++|+++++.+..+
T Consensus 94 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 173 (606)
T 3vq2_A 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173 (606)
T ss_dssp CCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTT
T ss_pred ccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhh
Confidence 8889999999999999999999998887899999999999999999986 579999999999999999999999999889
Q ss_pred ccccccc----eeeccceecccccCCCCcCCCcccEEEeecccccCc---------------------------------
Q 002278 179 CQLTGLW----YFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGE--------------------------------- 221 (943)
Q Consensus 179 ~~l~~L~----~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~--------------------------------- 221 (943)
..+.+|+ +|++++|.+++..+..+... +|++|++++|.+++.
T Consensus 174 ~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~ 252 (606)
T 3vq2_A 174 QFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP 252 (606)
T ss_dssp HHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCG
T ss_pred hhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccCh
Confidence 8888776 79999999997766666655 899999999987521
Q ss_pred -CCCCCCcceEeEEEe-cCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCC
Q 002278 222 -IPYNIGFLQVATLSL-QGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGN 299 (943)
Q Consensus 222 -~~~~~~~~~L~~L~L-~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 299 (943)
.+.......++.+++ ..|.+.+..|. +..+++|+.|++++|.+.. +| .+..+++|++|++++|.+ +.+| .+ .
T Consensus 253 ~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~ 326 (606)
T 3vq2_A 253 SIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-D 326 (606)
T ss_dssp GGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-C
T ss_pred HHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC-C
Confidence 111223335777777 77888888887 9999999999999999974 55 889999999999999999 4677 55 9
Q ss_pred CCcCcEEEcccCccccccccccCCcccceEEEccccccCCc--CcccccCCCcCcEEEeeCCcccCcccccccccCccce
Q 002278 300 MSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGP--IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTY 377 (943)
Q Consensus 300 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 377 (943)
+++|++|++++|+..+.. .+..+++|++|++++|++++. .|..+..+++|++|++++|.+++ +|..|..+++|+.
T Consensus 327 l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~ 403 (606)
T 3vq2_A 327 LPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQH 403 (606)
T ss_dssp CSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCE
T ss_pred CCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCe
Confidence 999999999999665333 678999999999999999876 38889999999999999999985 6688999999999
Q ss_pred eeccCCcCCCCCC-CCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccc-cCCccccCCCccceecccCc
Q 002278 378 LNLSRNNFKGKVP-TELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNG-LLPAEFGNLRSIQTIDMSFN 455 (943)
Q Consensus 378 L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N 455 (943)
|++++|++.+..| ..+..+++|+.|++++|.+.+..|..+..+++|++|+|++|++++ .+|..|..+++|++|+|++|
T Consensus 404 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n 483 (606)
T 3vq2_A 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483 (606)
T ss_dssp EECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred eECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCC
Confidence 9999999998877 689999999999999999998899999999999999999999997 47999999999999999999
Q ss_pred cccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCCcccC-cCCCCccccCCCCCCCCC
Q 002278 456 QLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFS-RFSSNSFIGNPLLCGNWI 534 (943)
Q Consensus 456 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~-~~~~~~~~~Np~~c~~~~ 534 (943)
++++..|..|..+++|+.|+|++|++++.+|..+..+++|+.|++++|+|+.+++.+..+. .+..+.+.+|||.|++++
T Consensus 484 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred cCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 9999899999999999999999999999999999999999999999999998887766665 488889999999999764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-57 Score=558.68 Aligned_cols=494 Identities=23% Similarity=0.240 Sum_probs=407.5
Q ss_pred CCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccC-CCCccCCCCCcEEeccCCCcCCccch
Q 002278 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQI-PDEIGNCGSLVHIELSDNSLYGDIPF 104 (943)
Q Consensus 26 c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~ 104 (943)
|.|..|.+ ...+++.|||++|.+++..+.+|.++++|++|||++|.+.+.+ |..|.++++|++|+|++|++++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 45777766 4457889999999999888999999999999999999766566 78899999999999999999988899
Q ss_pred hccccccceEEEecCcccccCCCcc--cCCCCCCcEEEEeccccccccc-hhccccccceeccccCCccCCCCCcccccc
Q 002278 105 SISKLKQLEFLNLKNNQLTGPIPST--LTQIPNLKTLDLARNQLTGEIP-RLIYWNEVLQYLGLRGNALTGMLSPDMCQL 181 (943)
Q Consensus 105 ~~~~l~~L~~L~Ls~n~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 181 (943)
+|+++++|++|+|++|.+++..|.. |.++++|++|+|++|.+++..+ ..|..+++|++|+|++|.++++.+..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 9999999999999999999866665 9999999999999999987655 689999999999999999999999999988
Q ss_pred --cccceeeccceecccccCCCCcCCCc------ccEEEeecccccCcCCCCCC--------------------------
Q 002278 182 --TGLWYFDVRGNNLTGTIPDSIGNCTS------FEILDISYNQITGEIPYNIG-------------------------- 227 (943)
Q Consensus 182 --~~L~~L~L~~N~i~~~~~~~l~~l~~------L~~L~Ls~N~l~~~~~~~~~-------------------------- 227 (943)
++|+.|++++|.+.+..|..+..+++ |++|++++|.+++..+..+.
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 89999999999999988888877776 99999999988765553321
Q ss_pred -------------cceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCC
Q 002278 228 -------------FLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIP 294 (943)
Q Consensus 228 -------------~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 294 (943)
..+++.|++++|.+.+..+..|..+++|+.|+|++|.+.+..|..|.++++|++|+|++|.+++..|
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 331 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCS
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCH
Confidence 1357777777777777777777777777777777777777767777777777777777777777667
Q ss_pred CCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCc
Q 002278 295 PELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGS 374 (943)
Q Consensus 295 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 374 (943)
..|..+++|++|++++|.+.+..+..|..+++|+.|+|++|.+++. ..+++|+.|++++|+++. +|.. ..+
T Consensus 332 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~~-l~~~---~~~ 402 (844)
T 3j0a_A 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLVT-LPKI---NLT 402 (844)
T ss_dssp CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCCC-CCCC---CTT
T ss_pred HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCccc-cccc---ccc
Confidence 7777777777777777777766666777777777777777777642 226677777777777763 3332 356
Q ss_pred cceeeccCCcCCCCCC-CCCCCCCCccEEecCCCcCCCccCC-Ccccccccceeeccccccc-----ccCCccccCCCcc
Q 002278 375 LTYLNLSRNNFKGKVP-TELGRIINLDTLDLSVNNFSGSVPA-SIGDLEHLLTLNLSRNHLN-----GLLPAEFGNLRSI 447 (943)
Q Consensus 375 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L 447 (943)
++.|++++|++++... ..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|.++++|
T Consensus 403 l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L 482 (844)
T 3j0a_A 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHL 482 (844)
T ss_dssp CCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCE
T ss_pred cceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccc
Confidence 7778888888774321 2245788999999999999865443 4667899999999999997 4455779999999
Q ss_pred ceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCCcccCcCCCCccccCC
Q 002278 448 QTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNP 527 (943)
Q Consensus 448 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~~~~~Np 527 (943)
+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|.. +..+..+.+.|||
T Consensus 483 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np 558 (844)
T 3j0a_A 483 QVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNK 558 (844)
T ss_dssp ECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEEC
T ss_pred cEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCC
Confidence 9999999999988888999999999999999999987777766 89999999999999998853 5678888899999
Q ss_pred CCCCCCC
Q 002278 528 LLCGNWI 534 (943)
Q Consensus 528 ~~c~~~~ 534 (943)
|.|+|.+
T Consensus 559 ~~C~c~~ 565 (844)
T 3j0a_A 559 FICECEL 565 (844)
T ss_dssp CCCSSSC
T ss_pred ccccccc
Confidence 9998764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=546.35 Aligned_cols=471 Identities=18% Similarity=0.290 Sum_probs=328.2
Q ss_pred CCCCCCCCCCCCCCc---ceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCccc------c------cC
Q 002278 14 LLDWDDVHNSDFCSW---RGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLT------G------QI 78 (943)
Q Consensus 14 ~~~w~~~~~~~~c~w---~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~------~------~~ 78 (943)
..+|+. ++|||.| .||.|+.. ++|+.|+|++++++|.+|++|+.|++|++|||++|.+. + .+
T Consensus 57 ~~~W~~--~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~ 133 (636)
T 4eco_A 57 GANWNF--NKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANM 133 (636)
T ss_dssp -CCCCC--SSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTC
T ss_pred CCCCCC--CCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCc
Confidence 458985 6899999 99999876 79999999999999999999999999999999999873 2 23
Q ss_pred CCCccCCCCCcEEeccCCCcCCccchhccc-cccceEEEec--------------------CcccccCCCcccCCCCCCc
Q 002278 79 PDEIGNCGSLVHIELSDNSLYGDIPFSISK-LKQLEFLNLK--------------------NNQLTGPIPSTLTQIPNLK 137 (943)
Q Consensus 79 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls--------------------~n~l~~~~~~~~~~l~~L~ 137 (943)
|... +..|+ +++++|.+.+..|..+.. +.++..+++. +|++++ +|..|+++++|+
T Consensus 134 ~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~ 209 (636)
T 4eco_A 134 SDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209 (636)
T ss_dssp CHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCC
T ss_pred hHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCC
Confidence 3222 45667 888888888777776663 2333333333 455555 566666666666
Q ss_pred EEEEeccccccc-cchhccccccceeccccCCccCCCCCcccc--cccccceeeccceecccccCCCCcCCCcccEEEee
Q 002278 138 TLDLARNQLTGE-IPRLIYWNEVLQYLGLRGNALTGMLSPDMC--QLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDIS 214 (943)
Q Consensus 138 ~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls 214 (943)
+|+|++|++++. ++.. +. .-+.+...+..|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|+
T Consensus 210 ~L~Ls~n~l~~~~~~~~--~~------~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 281 (636)
T 4eco_A 210 QFYMGNSPFVAENICEA--WE------NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281 (636)
T ss_dssp EEEEESCCCCGGGBSSS--CS------CTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECT
T ss_pred EEECcCCcccccccccc--cc------ccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECc
Confidence 666666666543 0000 00 0000000000333444 45555555555555555555555555555555555
Q ss_pred ccc-ccC-cCCCCCCc-------ceEeEEEecCccccccCCc--cccccCCCcEEecCCCCCCCCCCcccCCCCCcceEE
Q 002278 215 YNQ-ITG-EIPYNIGF-------LQVATLSLQGNKLTGKIPE--VIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLY 283 (943)
Q Consensus 215 ~N~-l~~-~~~~~~~~-------~~L~~L~L~~n~l~~~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 283 (943)
+|+ +++ .+|..++. .+|+.|++++|+++ .+|. .++.+++|++|++++|.+.+.+| .|..+++|+.|+
T Consensus 282 ~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~ 359 (636)
T 4eco_A 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359 (636)
T ss_dssp TCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEE
T ss_pred CCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEE
Confidence 554 444 44433322 34555555555555 4566 67777778888888887776667 777777788888
Q ss_pred ecCCCCCCCCCCCcCCCCc-CcEEEcccCccccccccccCCcc--cceEEEccccccCCcCccccc-------CCCcCcE
Q 002278 284 LHGNKLTGPIPPELGNMSK-LSYLQLQNNQLVGTIPAELGKLE--QLFELNLADNNLEGPIPHNIS-------SCTALNQ 353 (943)
Q Consensus 284 L~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~ 353 (943)
|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++ +|+.|++++|++.+.+|..|. .+++|++
T Consensus 360 L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~ 437 (636)
T 4eco_A 360 LAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437 (636)
T ss_dssp CCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEE
T ss_pred CCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCE
Confidence 8888777 66777777777 888888888877 6676666654 788888888888877777777 6778888
Q ss_pred EEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCC-CCCC-------CccEEecCCCcCCCccCCCcc--ccccc
Q 002278 354 FNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTEL-GRII-------NLDTLDLSVNNFSGSVPASIG--DLEHL 423 (943)
Q Consensus 354 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~-------~L~~L~Ls~N~l~~~~~~~~~--~l~~L 423 (943)
|+|++|+++.+.+..+..+++|+.|+|++|+++ .+|..+ .... +|+.|+|++|+++ .+|..+. .+++|
T Consensus 438 L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L 515 (636)
T 4eco_A 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYL 515 (636)
T ss_dssp EECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTC
T ss_pred EECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCc
Confidence 888888887555555666788888888888887 444433 3222 7888888888888 6777776 88888
Q ss_pred ceeecccccccccCCccccCCCccceecc------cCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcc
Q 002278 424 LTLNLSRNHLNGLLPAEFGNLRSIQTIDM------SFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSN 497 (943)
Q Consensus 424 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 497 (943)
+.|+|++|++++ +|..+.++++|+.|+| ++|++.+.+|..+..+++|+.|+|++|++ +.+|..+. ++|+.
T Consensus 516 ~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~ 591 (636)
T 4eco_A 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISV 591 (636)
T ss_dssp CEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCE
T ss_pred CEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCE
Confidence 888888888886 7788888888888888 56888889999999999999999999999 57787766 79999
Q ss_pred cccCCccccccC
Q 002278 498 LNVSYNNLSGII 509 (943)
Q Consensus 498 L~ls~N~l~~~~ 509 (943)
|||++|++..+.
T Consensus 592 L~Ls~N~l~~~~ 603 (636)
T 4eco_A 592 LDIKDNPNISID 603 (636)
T ss_dssp EECCSCTTCEEE
T ss_pred EECcCCCCcccc
Confidence 999999887654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=520.81 Aligned_cols=483 Identities=18% Similarity=0.192 Sum_probs=436.0
Q ss_pred EEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcc
Q 002278 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ 121 (943)
Q Consensus 42 ~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~ 121 (943)
.++.++.+++ .+|..+.. .+++|||++|+|++..|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|+
T Consensus 16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 5889999998 78887764 79999999999998889999999999999999999998889999999999999999999
Q ss_pred cccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCC
Q 002278 122 LTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDS 201 (943)
Q Consensus 122 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~ 201 (943)
+++..|..|.++++|++|+|++|++++..+..+..+++|++|+|++|+++++..+.+..+++|++|++++|++++..+..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 99899999999999999999999999877889999999999999999999987777777999999999999999888889
Q ss_pred CcCCCccc--EEEeecccccCcCCCCCCcceEeEEEecCcccc--------------------------ccCCccccccC
Q 002278 202 IGNCTSFE--ILDISYNQITGEIPYNIGFLQVATLSLQGNKLT--------------------------GKIPEVIGLMQ 253 (943)
Q Consensus 202 l~~l~~L~--~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~--------------------------~~~~~~l~~l~ 253 (943)
|+.+++|+ .|++++|++++..|..+...+++.|++++|... ...+..+..+.
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~ 252 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhh
Confidence 99999999 999999999999998888889999999988511 11122233332
Q ss_pred --CCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEE
Q 002278 254 --ALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELN 331 (943)
Q Consensus 254 --~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 331 (943)
+|+.|++++|.+.+..+..|..+++|++|++++|.++ .+|..+..+++|++|++++|++.+..|..+..+++|++|+
T Consensus 253 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 331 (606)
T 3t6q_A 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331 (606)
T ss_dssp GSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEE
T ss_pred cCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEE
Confidence 7899999999999988889999999999999999999 6788999999999999999999988899999999999999
Q ss_pred ccccccCCcCcc-cccCCCcCcEEEeeCCcccCcc--cccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCc
Q 002278 332 LADNNLEGPIPH-NISSCTALNQFNVHGNRLSGAI--PSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNN 408 (943)
Q Consensus 332 L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 408 (943)
+++|.+.+.+|. .+..+++|++|++++|.+++.. +..+..+++|++|++++|++.+..|..+..+++|+.|++++|+
T Consensus 332 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 411 (606)
T 3t6q_A 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411 (606)
T ss_dssp CCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCC
T ss_pred CCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCc
Confidence 999999866554 5999999999999999999776 7889999999999999999998899999999999999999999
Q ss_pred CCCccCCC-cccccccceeecccccccccCCccccCCCccceecccCcccccc---CChhhhcccccceecccCcccCCC
Q 002278 409 FSGSVPAS-IGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS---IPAELGQLQNIISLILNNNNLQGG 484 (943)
Q Consensus 409 l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~ 484 (943)
+.+..+.. +..+++|+.|++++|.+++..|..|..+++|++|+|++|++++. .+..+..+++|+.|+|++|++++.
T Consensus 412 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 491 (606)
T 3t6q_A 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491 (606)
T ss_dssp EECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEE
T ss_pred CCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCcc
Confidence 98776654 89999999999999999999999999999999999999999872 346799999999999999999999
Q ss_pred CCCcCccccCCcccccCCccccccCCC-CcccCcCCCCccccCCCC
Q 002278 485 IPDQLSNCFSLSNLNVSYNNLSGIIPP-IRNFSRFSSNSFIGNPLL 529 (943)
Q Consensus 485 ~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~~~~~~~~~~~Np~~ 529 (943)
.|..+..+++|+.|+|++|++++.+|. +..+..+ .+.+.+|...
T Consensus 492 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~ 536 (606)
T 3t6q_A 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS 536 (606)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCC
T ss_pred ChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCccc
Confidence 999999999999999999999998774 3445555 5667777643
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-55 Score=534.26 Aligned_cols=450 Identities=20% Similarity=0.276 Sum_probs=289.3
Q ss_pred CcccccccCccccCCCCCCCC---CCCC--CCc------------ceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCC
Q 002278 1 MAIKASFSNLANVLLDWDDVH---NSDF--CSW------------RGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRN 63 (943)
Q Consensus 1 ~~~~~~~~~~~~~~~~w~~~~---~~~~--c~w------------~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~ 63 (943)
++||+++.|| +|.... ..+| |+| .||.|+. .++|+.|+|+++++.|.+|++|++|++
T Consensus 275 l~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~~l~~L~~ 348 (876)
T 4ecn_A 275 KAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPDAIGQLTE 348 (876)
T ss_dssp HHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECGGGGGCTT
T ss_pred HHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCchHHhcccc
Confidence 3689999886 897532 2356 999 9999987 589999999999999999999999999
Q ss_pred CCEEEe-eCCcccccCCCCc---------------------------------------------------cCCCCCcEE
Q 002278 64 LQSIDF-QGNKLTGQIPDEI---------------------------------------------------GNCGSLVHI 91 (943)
Q Consensus 64 L~~L~L-s~n~l~~~~p~~~---------------------------------------------------~~l~~L~~L 91 (943)
|++||| ++|.++|..|-.. .....++.+
T Consensus 349 L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l 428 (876)
T 4ecn_A 349 LKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428 (876)
T ss_dssp CCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTT
T ss_pred ceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchhhc
Confidence 999999 8898887644221 112233444
Q ss_pred eccC--CCcCCccchhccccccceEEEecCccccc-----------------CCCcccC--CCCCCcEEEEecccccccc
Q 002278 92 ELSD--NSLYGDIPFSISKLKQLEFLNLKNNQLTG-----------------PIPSTLT--QIPNLKTLDLARNQLTGEI 150 (943)
Q Consensus 92 ~Ls~--N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~-----------------~~~~~~~--~l~~L~~L~Ls~N~l~~~~ 150 (943)
.+.. |++++ +|..|+++++|++|+|++|++++ .+|..++ ++++|++|+|++|++.+.+
T Consensus 429 ~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~i 507 (876)
T 4ecn_A 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507 (876)
T ss_dssp TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSC
T ss_pred eeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccC
Confidence 4443 77775 77778888888888888888876 2677766 7777777777777777777
Q ss_pred chhccccccceeccccCCc-cCC-CCCccccccc-------ccceeeccceecccccCC--CCcCCCcccEEEeeccccc
Q 002278 151 PRLIYWNEVLQYLGLRGNA-LTG-MLSPDMCQLT-------GLWYFDVRGNNLTGTIPD--SIGNCTSFEILDISYNQIT 219 (943)
Q Consensus 151 ~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l~-------~L~~L~L~~N~i~~~~~~--~l~~l~~L~~L~Ls~N~l~ 219 (943)
|..|..+++|++|+|++|+ +++ ..|..+..++ +|++|+|++|+++ .+|. .|+++++|++|+|++|+++
T Consensus 508 P~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~ 586 (876)
T 4ecn_A 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR 586 (876)
T ss_dssp CGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC
T ss_pred hHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc
Confidence 7777777777777777776 665 4455555544 7777777777777 5666 6777777777777777766
Q ss_pred CcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCC-cceEEecCCCCCCCCCCCcC
Q 002278 220 GEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSY-TGKLYLHGNKLTGPIPPELG 298 (943)
Q Consensus 220 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~ 298 (943)
.+| .|+.+++|+.|+|++|.+. .+|..+..+++ |+.|+|++|+++ .+|..+.
T Consensus 587 -~lp------------------------~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~ 639 (876)
T 4ecn_A 587 -HLE------------------------AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFN 639 (876)
T ss_dssp -BCC------------------------CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCC
T ss_pred -cch------------------------hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhh
Confidence 444 3444445555555555554 44444555555 555555555555 3444444
Q ss_pred CCCc--CcEEEcccCcccccccccc---C--CcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCccccccc-
Q 002278 299 NMSK--LSYLQLQNNQLVGTIPAEL---G--KLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFR- 370 (943)
Q Consensus 299 ~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~- 370 (943)
.++. |+.|+|++|++.+.+|... . .+++|+.|+|++|+++.+.+..+..+++|+.|+|++|+|+.+.+..+.
T Consensus 640 ~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~ 719 (876)
T 4ecn_A 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719 (876)
T ss_dssp TTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSC
T ss_pred ccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhcc
Confidence 4432 5555555555554433221 1 223566666666666643333344566666666666666633332332
Q ss_pred ------ccCccceeeccCCcCCCCCCCCCC--CCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCcccc
Q 002278 371 ------NLGSLTYLNLSRNNFKGKVPTELG--RIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFG 442 (943)
Q Consensus 371 ------~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 442 (943)
++++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+
T Consensus 720 ~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~---------- 787 (876)
T 4ecn_A 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR---------- 787 (876)
T ss_dssp TTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB----------
T ss_pred ccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC----------
Confidence 2237777777777777 5666665 77777777777777775 67777777777777777654
Q ss_pred CCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCcccccc
Q 002278 443 NLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508 (943)
Q Consensus 443 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 508 (943)
++++|++.+.+|..|..+++|+.|+|++|+| +.+|..+. ++|+.|||++|++..+
T Consensus 788 --------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i 842 (876)
T 4ecn_A 788 --------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISI 842 (876)
T ss_dssp --------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEE
T ss_pred --------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCcc
Confidence 4445555555555555555555555555555 34444433 3555555555555443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-54 Score=522.55 Aligned_cols=482 Identities=22% Similarity=0.257 Sum_probs=339.5
Q ss_pred EEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcc
Q 002278 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ 121 (943)
Q Consensus 42 ~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~ 121 (943)
.+|.++++++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|++++..|.+|+++++|++|+|++|+
T Consensus 8 ~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 84 (680)
T 1ziw_A 8 VADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84 (680)
T ss_dssp EEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred eeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence 5899999998 7887775 799999999999998777789999999999999999998889999999999999999999
Q ss_pred cccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCC
Q 002278 122 LTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDS 201 (943)
Q Consensus 122 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~ 201 (943)
+++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|.++++.+..+..+++|++|++++|++++..+..
T Consensus 85 l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 164 (680)
T 1ziw_A 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164 (680)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHH
T ss_pred cCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHH
Confidence 99766678999999999999999999888899999999999999999999999999999999999999999999877765
Q ss_pred Cc--CCCcccEEEeecccccCcCCCCCCc----------------------------ceEeEEEecCccccccCCccccc
Q 002278 202 IG--NCTSFEILDISYNQITGEIPYNIGF----------------------------LQVATLSLQGNKLTGKIPEVIGL 251 (943)
Q Consensus 202 l~--~l~~L~~L~Ls~N~l~~~~~~~~~~----------------------------~~L~~L~L~~n~l~~~~~~~l~~ 251 (943)
+. .+++|++|++++|++++..|..+.. .+++.|++++|.+.+..|..|..
T Consensus 165 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~ 244 (680)
T 1ziw_A 165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG 244 (680)
T ss_dssp HGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGG
T ss_pred hhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhc
Confidence 54 5689999999999999877754431 45788999999999999999988
Q ss_pred cCC--CcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCcccc-----ccc----cc
Q 002278 252 MQA--LAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVG-----TIP----AE 320 (943)
Q Consensus 252 l~~--L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-----~~~----~~ 320 (943)
++. |+.|+|++|.+.+..|..|..+++|++|+|++|++++..|..|.++++|++|++++|...+ .+| ..
T Consensus 245 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~ 324 (680)
T 1ziw_A 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324 (680)
T ss_dssp GGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTT
T ss_pred cCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhh
Confidence 765 9999999999999888999999999999999999998777666665555555555443221 111 13
Q ss_pred cCCcccceEEEccccccCCcCcccccCCCcCcEE----------------------------EeeCCcccCccccccccc
Q 002278 321 LGKLEQLFELNLADNNLEGPIPHNISSCTALNQF----------------------------NVHGNRLSGAIPSSFRNL 372 (943)
Q Consensus 321 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L----------------------------~L~~N~l~~~~~~~~~~l 372 (943)
|..+++|++|++++|++.+..+..|.++++|++| ++++|++++..|.+|..+
T Consensus 325 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l 404 (680)
T 1ziw_A 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL 404 (680)
T ss_dssp TTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTC
T ss_pred cccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCC
Confidence 3344444444444444444433333333333333 333344444445555555
Q ss_pred CccceeeccCCcCCCCCC-CCCCCCCCccEEecCCCcCCCc--------------------------cCCCcccccccce
Q 002278 373 GSLTYLNLSRNNFKGKVP-TELGRIINLDTLDLSVNNFSGS--------------------------VPASIGDLEHLLT 425 (943)
Q Consensus 373 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~--------------------------~~~~~~~l~~L~~ 425 (943)
++|+.|+|++|.+++.+| ..+..+++|+.|++++|++.+. .|..|..+++|+.
T Consensus 405 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~ 484 (680)
T 1ziw_A 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484 (680)
T ss_dssp TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCE
T ss_pred CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCE
Confidence 666666666666554333 4455555555555555555444 4444555555555
Q ss_pred eecccccccccCCccccCCCccceecccCccccccCC--------hhhhcccccceecccCcccCCCCCCcCccccCCcc
Q 002278 426 LNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIP--------AELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSN 497 (943)
Q Consensus 426 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 497 (943)
|+|++|+++++.+..|.++++|+.|+|++|++++..+ ..|..+++|+.|+|++|+++...+..|.++++|+.
T Consensus 485 L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~ 564 (680)
T 1ziw_A 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcce
Confidence 5555555555444455555555555555555543211 12455555555555555555333334555555555
Q ss_pred cccCCccccccCCCC-cccCcCCCCccccC
Q 002278 498 LNVSYNNLSGIIPPI-RNFSRFSSNSFIGN 526 (943)
Q Consensus 498 L~ls~N~l~~~~~~~-~~~~~~~~~~~~~N 526 (943)
|+|++|+|+++++.. ..+..+..+.+.+|
T Consensus 565 L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N 594 (680)
T 1ziw_A 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred eECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence 555555555544432 23344444444444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=507.32 Aligned_cols=476 Identities=20% Similarity=0.159 Sum_probs=430.4
Q ss_pred EEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcc
Q 002278 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ 121 (943)
Q Consensus 42 ~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~ 121 (943)
.++.++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|++++..|.+|+++++|++|+|++|+
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 5899999999 7888765 789999999999998888899999999999999999998778899999999999999999
Q ss_pred cccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCC-CcccccccccceeeccceecccccCC
Q 002278 122 LTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGML-SPDMCQLTGLWYFDVRGNNLTGTIPD 200 (943)
Q Consensus 122 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~i~~~~~~ 200 (943)
+++..|..|.++++|++|+|++|++++..+..+..+++|++|++++|.++++. |..+.++++|++|++++|++++..+.
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 99888999999999999999999999888889999999999999999999854 88999999999999999999998888
Q ss_pred CCcCCCccc----EEEeecccccCcCCCCCCcceEeEEEecCcccc-ccCCccccccCCCcEEec---------------
Q 002278 201 SIGNCTSFE----ILDISYNQITGEIPYNIGFLQVATLSLQGNKLT-GKIPEVIGLMQALAVLDL--------------- 260 (943)
Q Consensus 201 ~l~~l~~L~----~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L--------------- 260 (943)
.|+.+++|+ +|++++|++++..+..+...+|+.|++++|.+. +..|..+..+++|+.+++
T Consensus 172 ~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~ 251 (606)
T 3vq2_A 172 DLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251 (606)
T ss_dssp TTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred hhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccC
Confidence 898888776 899999999988777787789999999999986 456677777888777766
Q ss_pred ------------------CCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccC
Q 002278 261 ------------------SENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELG 322 (943)
Q Consensus 261 ------------------s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 322 (943)
..|.+.+..|. +..+++|+.|++++|.++. +| .+..+++|++|++++|.+ +.+| .+
T Consensus 252 ~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~- 325 (606)
T 3vq2_A 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL- 325 (606)
T ss_dssp GGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-
T ss_pred hHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC-
Confidence 66677776666 8899999999999999985 55 899999999999999999 4777 45
Q ss_pred CcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCc--ccccccccCccceeeccCCcCCCCCCCCCCCCCCcc
Q 002278 323 KLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGA--IPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400 (943)
Q Consensus 323 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 400 (943)
.+++|++|++++|+..+.. .+..+++|++|++++|++++. .+..+..+++|++|++++|.+++ +|..+..+++|+
T Consensus 326 ~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~ 402 (606)
T 3vq2_A 326 DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQ 402 (606)
T ss_dssp CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCC
T ss_pred CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCC
Confidence 9999999999999665433 678999999999999999876 38889999999999999999984 678899999999
Q ss_pred EEecCCCcCCCccC-CCcccccccceeecccccccccCCccccCCCccceecccCccccc-cCChhhhcccccceecccC
Q 002278 401 TLDLSVNNFSGSVP-ASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG-SIPAELGQLQNIISLILNN 478 (943)
Q Consensus 401 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~ 478 (943)
.|++++|++.+..| ..+..+++|+.|++++|++++..|..|.++++|++|+|++|++++ .+|..|+.+++|+.|+|++
T Consensus 403 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~ 482 (606)
T 3vq2_A 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482 (606)
T ss_dssp EEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred eeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCC
Confidence 99999999998777 689999999999999999999999999999999999999999997 4799999999999999999
Q ss_pred cccCCCCCCcCccccCCcccccCCccccccCCC-CcccCcCCCCccccCCCC
Q 002278 479 NNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP-IRNFSRFSSNSFIGNPLL 529 (943)
Q Consensus 479 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~~~~~~~~~~~Np~~ 529 (943)
|++++..|..+..+++|+.|++++|++++.+|. +..+..+..+.+.+|...
T Consensus 483 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence 999999999999999999999999999998664 456777888888898743
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=500.43 Aligned_cols=467 Identities=19% Similarity=0.186 Sum_probs=417.1
Q ss_pred CcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEe
Q 002278 38 LSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNL 117 (943)
Q Consensus 38 ~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 117 (943)
.+++.|+|++|++++..+.+|.++++|++|||++|+|++..|+.|.++++|++|+|++|++++..|.+|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 35889999999999877889999999999999999999888889999999999999999999777789999999999999
Q ss_pred cCcccccCCCcccCCCCCCcEEEEecccccc-ccchhccccccceeccccCCccCCCCCccccccccc----ceeeccce
Q 002278 118 KNNQLTGPIPSTLTQIPNLKTLDLARNQLTG-EIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGL----WYFDVRGN 192 (943)
Q Consensus 118 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~N 192 (943)
++|++++..+..|+++++|++|+|++|.+++ .+|..|..+++|++|++++|+++++.+..+..+.+| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999997766689999999999999999986 469999999999999999999999999999999999 89999999
Q ss_pred ecccccCCCCcCCCcccEEEeecccccC------------------------------cCC-C---CCCcceEeEEEecC
Q 002278 193 NLTGTIPDSIGNCTSFEILDISYNQITG------------------------------EIP-Y---NIGFLQVATLSLQG 238 (943)
Q Consensus 193 ~i~~~~~~~l~~l~~L~~L~Ls~N~l~~------------------------------~~~-~---~~~~~~L~~L~L~~ 238 (943)
.+++..|..+..+ +|+.|++++|.... .++ . ......++.+++.+
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 9998888888776 89999999984221 011 1 11233678888888
Q ss_pred c-cccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCcccccc
Q 002278 239 N-KLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI 317 (943)
Q Consensus 239 n-~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 317 (943)
+ .+.+..|+.+..+++|+.|++++|.+. .+|..+..+ +|+.|++++|.++ .+|. ..+++|+.|++++|.+.+..
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~ 341 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAF 341 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBC
T ss_pred chhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccc
Confidence 8 788888999999999999999999998 578888888 9999999999999 4554 57899999999999998666
Q ss_pred ccccCCcccceEEEccccccCCcC--cccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCC-CCCC
Q 002278 318 PAELGKLEQLFELNLADNNLEGPI--PHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP-TELG 394 (943)
Q Consensus 318 ~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~ 394 (943)
+. ..+++|++|++++|++++.. |..+..+++|++|++++|.+.+..+. |..+++|+.|++++|.+++..+ ..+.
T Consensus 342 ~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~ 418 (570)
T 2z63_A 342 SE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFL 418 (570)
T ss_dssp CC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTT
T ss_pred cc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhh
Confidence 55 78899999999999998664 77889999999999999999966555 9999999999999999987766 5789
Q ss_pred CCCCccEEecCCCcCCCccCCCcccccccceeeccccccc-ccCCccccCCCccceecccCccccccCChhhhcccccce
Q 002278 395 RIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLN-GLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIIS 473 (943)
Q Consensus 395 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 473 (943)
.+++|+.|++++|.+.+..|..|.++++|+.|+|++|+++ +.+|..|..+++|++|+|++|++++..|..|..+++|+.
T Consensus 419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 498 (570)
T 2z63_A 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498 (570)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence 9999999999999999889999999999999999999998 578999999999999999999999888999999999999
Q ss_pred ecccCcccCCCCCCcCccccCCcccccCCccccccCCCCc
Q 002278 474 LILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIR 513 (943)
Q Consensus 474 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~ 513 (943)
|+|++|++++.+|..+.++++|+.|++++|++++..|...
T Consensus 499 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred EeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 9999999999888889999999999999999999888643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=510.40 Aligned_cols=474 Identities=18% Similarity=0.158 Sum_probs=410.5
Q ss_pred EEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCcc-chhccccccceEEEecCc
Q 002278 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDI-PFSISKLKQLEFLNLKNN 120 (943)
Q Consensus 42 ~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~n 120 (943)
..|.++++++ .+|. -.++|++|||++|+|++..|..|.++++|++|+|++|.+.+.+ |.+|+++++|++|+|++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 3556677788 6776 4579999999999999888999999999999999999766566 788999999999999999
Q ss_pred ccccCCCcccCCCCCCcEEEEeccccccccchh--ccccccceeccccCCccCCCCC-cccccccccceeeccceecccc
Q 002278 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRL--IYWNEVLQYLGLRGNALTGMLS-PDMCQLTGLWYFDVRGNNLTGT 197 (943)
Q Consensus 121 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~ 197 (943)
.+++..|..|.++++|++|+|++|.+++..|.. |..+++|++|+|++|.++++.+ ..|+++++|++|+|++|.+++.
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999999999999999999999999999766655 8999999999999999998865 5799999999999999999999
Q ss_pred cCCCCcCC--CcccEEEeecccccCcCCCCCC-------cceEeEEEecCccccccCCccccc-----------------
Q 002278 198 IPDSIGNC--TSFEILDISYNQITGEIPYNIG-------FLQVATLSLQGNKLTGKIPEVIGL----------------- 251 (943)
Q Consensus 198 ~~~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~-------~~~L~~L~L~~n~l~~~~~~~l~~----------------- 251 (943)
.+..+..+ ++|+.|++++|.+.+..|..++ ...|+.|++++|.+++..+..+..
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 89999888 8999999999999987775443 234999999999887766655432
Q ss_pred ---------------------cCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEccc
Q 002278 252 ---------------------MQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQN 310 (943)
Q Consensus 252 ---------------------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 310 (943)
.++|+.|+|++|.+.+..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++
T Consensus 244 ~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~ 323 (844)
T 3j0a_A 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323 (844)
T ss_dssp BCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEES
T ss_pred cccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCC
Confidence 26799999999999988888999999999999999999988888999999999999999
Q ss_pred CccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCC
Q 002278 311 NQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP 390 (943)
Q Consensus 311 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 390 (943)
|++++..|..|..+++|+.|+|++|++.++.+..|..+++|+.|+|++|.+++. ..+++|+.|++++|+++ .+|
T Consensus 324 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~ 397 (844)
T 3j0a_A 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLP 397 (844)
T ss_dssp CCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCC
T ss_pred CCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccc
Confidence 999988889999999999999999999988888899999999999999999843 23788999999999998 555
Q ss_pred CCCCCCCCccEEecCCCcCCCccC-CCcccccccceeecccccccccCCc-cccCCCccceecccCcccc-----ccCCh
Q 002278 391 TELGRIINLDTLDLSVNNFSGSVP-ASIGDLEHLLTLNLSRNHLNGLLPA-EFGNLRSIQTIDMSFNQLS-----GSIPA 463 (943)
Q Consensus 391 ~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~ 463 (943)
.. ..+++.|++++|++++... ..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|.
T Consensus 398 ~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~ 474 (844)
T 3j0a_A 398 KI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474 (844)
T ss_dssp CC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSS
T ss_pred cc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchh
Confidence 43 4578999999999985322 2356899999999999999976544 4667899999999999997 44567
Q ss_pred hhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCCcccCcCCCCccccCCCC
Q 002278 464 ELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLL 529 (943)
Q Consensus 464 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~~~~~Np~~ 529 (943)
.|..+++|+.|+|++|+|++.+|..+..+++|+.|+|++|+|++++|.... ..+..+.+.+|...
T Consensus 475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~ 539 (844)
T 3j0a_A 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLL 539 (844)
T ss_dssp CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCC
T ss_pred hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCC
Confidence 789999999999999999999999999999999999999999998876543 66777777777643
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-52 Score=493.18 Aligned_cols=480 Identities=19% Similarity=0.178 Sum_probs=421.6
Q ss_pred EEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCccc
Q 002278 43 LNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQL 122 (943)
Q Consensus 43 L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l 122 (943)
++-++.+++ .+|..+. +++++|||++|+|++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 344444555 6777654 5799999999999988888999999999999999999977788899999999999999999
Q ss_pred ccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCC-CCcccccccccceeeccceecccccCCC
Q 002278 123 TGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGM-LSPDMCQLTGLWYFDVRGNNLTGTIPDS 201 (943)
Q Consensus 123 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~ 201 (943)
++..|..|.++++|++|+|++|++++..+..+..+++|++|++++|.++++ .|..|+.+++|++|++++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~ 168 (570)
T 2z63_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (570)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGG
T ss_pred CccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHH
Confidence 988889999999999999999999977766799999999999999999986 4889999999999999999999888888
Q ss_pred CcCCCcc----cEEEeecccccCcCCCCCCcceEeEEEecCccccc-cCCcc----------------------------
Q 002278 202 IGNCTSF----EILDISYNQITGEIPYNIGFLQVATLSLQGNKLTG-KIPEV---------------------------- 248 (943)
Q Consensus 202 l~~l~~L----~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~---------------------------- 248 (943)
++.+++| +.|++++|.+++..|..+...+|+.|++++|.... .++..
T Consensus 169 ~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~ 248 (570)
T 2z63_A 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248 (570)
T ss_dssp GHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCT
T ss_pred ccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcch
Confidence 9999998 89999999999888888888899999999984321 11112
Q ss_pred --ccccC--CCcEEecCCC-CCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCC
Q 002278 249 --IGLMQ--ALAVLDLSEN-ELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGK 323 (943)
Q Consensus 249 --l~~l~--~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 323 (943)
+..+. .++.+++++| .+.+..|..|..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+. .+|. ..
T Consensus 249 ~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~ 323 (570)
T 2z63_A 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LK 323 (570)
T ss_dssp TTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CB
T ss_pred hhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--cc
Confidence 22222 2456666666 677778889999999999999999999 578888888 9999999999998 5554 57
Q ss_pred cccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcc--cccccccCccceeeccCCcCCCCCCCCCCCCCCccE
Q 002278 324 LEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAI--PSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDT 401 (943)
Q Consensus 324 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 401 (943)
+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. +..+..+++|++|++++|.+++..+. +..+++|+.
T Consensus 324 l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~ 400 (570)
T 2z63_A 324 LKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEH 400 (570)
T ss_dssp CSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCE
T ss_pred ccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCE
Confidence 88999999999999876665 78999999999999998654 77899999999999999999965444 999999999
Q ss_pred EecCCCcCCCccC-CCcccccccceeecccccccccCCccccCCCccceecccCcccc-ccCChhhhcccccceecccCc
Q 002278 402 LDLSVNNFSGSVP-ASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS-GSIPAELGQLQNIISLILNNN 479 (943)
Q Consensus 402 L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N 479 (943)
|++++|.+.+..| ..+..+++|++|++++|++++..|..|.++++|++|+|++|+++ +.+|..+..+++|+.|+|++|
T Consensus 401 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n 480 (570)
T 2z63_A 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480 (570)
T ss_dssp EECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred EEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCC
Confidence 9999999987666 57899999999999999999999999999999999999999998 579999999999999999999
Q ss_pred ccCCCCCCcCccccCCcccccCCccccccCCC-CcccCcCCCCccccCCCCCCCC
Q 002278 480 NLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP-IRNFSRFSSNSFIGNPLLCGNW 533 (943)
Q Consensus 480 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~~~~~~~~~~~Np~~c~~~ 533 (943)
++++..|..+..+++|++|++++|++++.+|. +..+..+..+.+.+||+.|+++
T Consensus 481 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 481 QLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 99998899999999999999999999999876 4667888888999999999864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=493.40 Aligned_cols=474 Identities=19% Similarity=0.229 Sum_probs=378.1
Q ss_pred CCCcceeEecCCC-----------CcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEec
Q 002278 25 FCSWRGVFCDNSS-----------LSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIEL 93 (943)
Q Consensus 25 ~c~w~gv~c~~~~-----------~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 93 (943)
.|.|.|| |+... .+++.|+|++|++++..|.+|+++++|++|+|++|+|++..|+.|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4899998 87432 36889999999999877888999999999999999999888888999999999999
Q ss_pred cCCCcCCccchhccccccceEEEecCcccccC-CCcccCCCCCCcEEEEeccc-cccccchhccccccceeccccCCccC
Q 002278 94 SDNSLYGDIPFSISKLKQLEFLNLKNNQLTGP-IPSTLTQIPNLKTLDLARNQ-LTGEIPRLIYWNEVLQYLGLRGNALT 171 (943)
Q Consensus 94 s~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~n~l~ 171 (943)
++|++++..|..|+++++|++|+|++|++++. .|..|.++++|++|+|++|+ +....+..|..+++|++|++++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 99999977777799999999999999999863 56789999999999999998 44444568889999999999999999
Q ss_pred CCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcC--C--CCCCcceEeEEEecCccccccCCc
Q 002278 172 GMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEI--P--YNIGFLQVATLSLQGNKLTGKIPE 247 (943)
Q Consensus 172 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--~--~~~~~~~L~~L~L~~n~l~~~~~~ 247 (943)
+..+..+..+++|++|++++|.+.......+..+++|++|++++|++++.. | ..-...+++.|++++|.+++..+.
T Consensus 162 ~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 241 (549)
T 2z81_A 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241 (549)
T ss_dssp EECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHH
T ss_pred ccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHH
Confidence 988889999999999999999887443334467899999999999998642 1 112345788999999988764443
Q ss_pred ----cccccCCCcEEecCCCCCCCCC------CcccCCCCCcceEEecCCCCCCCC-----CCCcCCCCcCcEEEcccCc
Q 002278 248 ----VIGLMQALAVLDLSENELVGPI------PPILGNLSYTGKLYLHGNKLTGPI-----PPELGNMSKLSYLQLQNNQ 312 (943)
Q Consensus 248 ----~l~~l~~L~~L~Ls~N~l~~~~------~~~~~~l~~L~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~ 312 (943)
.+..+++|+.|++++|.+.+.. ...+..+.+|+.|.+.++.+.... +..+..+.+|+.|++++|.
T Consensus 242 ~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~ 321 (549)
T 2z81_A 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321 (549)
T ss_dssp HHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSC
T ss_pred HHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCc
Confidence 3466788999999999876531 234567788888998888776321 1112334678999999999
Q ss_pred ccccccccc-CCcccceEEEccccccCCcCc---ccccCCCcCcEEEeeCCcccCccc--ccccccCccceeeccCCcCC
Q 002278 313 LVGTIPAEL-GKLEQLFELNLADNNLEGPIP---HNISSCTALNQFNVHGNRLSGAIP--SSFRNLGSLTYLNLSRNNFK 386 (943)
Q Consensus 313 l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~ 386 (943)
+. .+|..+ ..+++|++|+|++|++.+.+| ..+..+++|++|++++|++++..+ ..+..+++|++|+|++|+++
T Consensus 322 l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 400 (549)
T 2z81_A 322 VF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400 (549)
T ss_dssp CC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred cc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc
Confidence 87 555554 578889999999999887664 347788899999999999886543 45888889999999999888
Q ss_pred CCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhh
Q 002278 387 GKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELG 466 (943)
Q Consensus 387 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 466 (943)
.+|..+..+++|+.|++++|++++ +|..+ .++|++|+|++|++++.+ ..+++|++|+|++|+|+ .+|. ..
T Consensus 401 -~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~ 470 (549)
T 2z81_A 401 -PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-AS 470 (549)
T ss_dssp -CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GG
T ss_pred -cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cc
Confidence 678888888889999999998873 45443 257888999999888643 57788899999999888 6776 46
Q ss_pred cccccceecccCcccCCCCCCcCccccCCcccccCCccccccCC
Q 002278 467 QLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIP 510 (943)
Q Consensus 467 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 510 (943)
.+++|+.|+|++|++++.+|..+..+++|+.|++++|++++..|
T Consensus 471 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 471 LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp GCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 78888999999999888888888888888888888888877665
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=448.00 Aligned_cols=263 Identities=26% Similarity=0.415 Sum_probs=212.2
Q ss_pred hhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
.++|...+.||+|+||+||+|+++ +++.||||++........++|.+|++++++++|||||+++|+|.+++..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356778889999999999999865 36789999998766666788999999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc
Q 002278 689 LFYDYMVNGSLWDLLHGPS------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 756 (943)
+|||||++|+|.++++... ...+++|.+++.|+.|||.||+|||++ +||||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 9999999999999986432 134699999999999999999999999 9999999999999999999
Q ss_pred eeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcc
Q 002278 757 AHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKAD 834 (943)
Q Consensus 757 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 834 (943)
+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+........
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999987644322 22334569999999999999999999999999999999999 99999877655443333222
Q ss_pred ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
. .+..+..+ ...+.+++..||+.||++|||++||+++|+.+...++
T Consensus 277 ~-------~~~~p~~~-----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 277 R-------ELERPRAC-----PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp C-------CCCCCTTC-----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred C-------CCCCcccc-----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 1 11111111 2467899999999999999999999999998766543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=443.80 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=216.3
Q ss_pred hhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
.++|...+.||+|+||+||+|++. ++..||||++........++|.+|++++++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357888899999999999999864 36789999998766666788999999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCCC----------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCcee
Q 002278 689 LFYDYMVNGSLWDLLHGPS----------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAH 758 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 758 (943)
+|||||++|+|.++++... ....++|.++..++.|||.||+|||++ +||||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999996321 234699999999999999999999999 999999999999999999999
Q ss_pred ecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcccc
Q 002278 759 LSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDN 836 (943)
Q Consensus 759 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 836 (943)
|+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+..........
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999876443322 2233569999999999999999999999999999999999 9999987765543333322211
Q ss_pred ccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 837 TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
+..+..+ +..+.+++..||+.||++|||++++.+.|+.+...
T Consensus 249 -------~~~p~~~-----~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 249 -------LQRPRTC-----PQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -------CCCCTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCccc-----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111111 24678999999999999999999999999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=442.69 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=215.8
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
+.|+..+.||+|+||+||+|+++ +++.||||++........+.+.+|+++++.++|||||+++++|.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56899999999999999999986 58999999997665556677899999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
+||+|.+++. ...+++.++..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+.+......
T Consensus 154 ~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 9999999995 34699999999999999999999999 9999999999999999999999999999987554332
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
....+||+.|||||++.+..|+.++||||+||++|||++|++||.+......+..+........ ...+.+
T Consensus 227 -~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~~~~~~-------- 296 (346)
T 4fih_A 227 -RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-KNLHKV-------- 296 (346)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-SCGGGS--------
T ss_pred -ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-CccccC--------
Confidence 3345799999999999999999999999999999999999999998776655444332211111 111111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++.+||..||++|||+.|+++|-+-
T Consensus 297 -s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 297 -SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp -CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred -CHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 2456789999999999999999999998653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=438.32 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=211.9
Q ss_pred hccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..++..+.||+|+||+||+|++. +++.||||++.... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 44566788999999999999863 35789999996543 345678999999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC
Q 002278 689 LFYDYMVNGSLWDLLHGPS-------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF 755 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 755 (943)
+|||||++|+|.++|.... ....++|.++..|+.|||.||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999996432 134689999999999999999999999 999999999999999999
Q ss_pred ceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhc
Q 002278 756 DAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKA 833 (943)
Q Consensus 756 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 833 (943)
.+||+|||+|+....... .......||++|||||++.++.|+.++|||||||++|||+| |+.||.+............
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~ 262 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999987643322 22334569999999999999999999999999999999999 8999987765443332222
Q ss_pred cccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 834 DDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
. .. +..+.. .+..+.+++..||+.||++||||.||+++|+.+.
T Consensus 263 ~-~~------~~~p~~-----~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 263 R-QV------LPCPDD-----CPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp T-CC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred C-CC------CCCccc-----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1 11 111111 1246789999999999999999999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=435.37 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=207.4
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.+++...+.||+|+||+||+|++++ .||||+++... ....+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4577888999999999999998763 59999886433 3445689999999999999999999998865 56899999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
||++|+|.++++. ....+++.++..|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999974 345699999999999999999999999 99999999999999999999999999998764332
Q ss_pred -CceeeeEecccceeCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 773 -PHASTFVLGTIGYIDPEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 773 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
.......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.................+.. +....
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~--~~~~~ 264 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL--SKLYK 264 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS--TTSCT
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc--ccccc
Confidence 222344579999999999864 458999999999999999999999998776655544443332211110 11111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
. .+..+.+++..||+.||++|||+.|++++|+.+..
T Consensus 265 ~-----~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 265 N-----CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp T-----SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred c-----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 12567889999999999999999999999987654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=436.36 Aligned_cols=249 Identities=22% Similarity=0.257 Sum_probs=213.4
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+|+++ +++.||||++.+. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 5889999999643 2345678999999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||++||+|.+++. ..+.+++.++..++.||+.||+|||++ +||||||||+|||+++++++||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999997 456799999999999999999999999 9999999999999999999999999999987543
Q ss_pred CC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 772 MP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 772 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.......+......+++. ++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~----~s--- 258 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEK----FF--- 258 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----CC---
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc----cC---
Confidence 22 23345679999999999999999999999999999999999999998876655554444433332222 11
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
..+.+++.+|+..||++|||++|+..+
T Consensus 259 ------~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 259 ------PKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ------HHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ------HHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 356689999999999999999986443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=443.31 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=208.2
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
.++|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999976 58999999996543 334567899999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
|||+||+|.+++... ....+++.+++.++.||+.||+|||++ +||||||||+|||++++|.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999632 234578999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.......+.....+ ..++.+
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~----- 249 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHY----- 249 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTS-----
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccC-----
Confidence 1 1223356999999999999999999999999999999999999999987765555444433221 111112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++.+||+.||++|||+.|+++|-+
T Consensus 250 ----s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 250 ----SYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 145778999999999999999999998643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=483.66 Aligned_cols=483 Identities=19% Similarity=0.207 Sum_probs=409.2
Q ss_pred EecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhcccccc
Q 002278 32 FCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQ 111 (943)
Q Consensus 32 ~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 111 (943)
.|.... + .|.++++++ .+|..+. ++|++|||++|+|++..|..|.++++|++|+|++|++++..|.+|+++++
T Consensus 3 ~C~~~~--~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 75 (549)
T 2z81_A 3 SCDASG--V--CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75 (549)
T ss_dssp EECTTS--E--EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCCCc--e--EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence 476543 3 689999999 7888765 79999999999999888899999999999999999999888889999999
Q ss_pred ceEEEecCcccccCCCcccCCCCCCcEEEEecccccc-ccchhccccccceeccccCCc-cCCCCCcccccccccceeec
Q 002278 112 LEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTG-EIPRLIYWNEVLQYLGLRGNA-LTGMLSPDMCQLTGLWYFDV 189 (943)
Q Consensus 112 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L 189 (943)
|++|+|++|++++..|..|+++++|++|+|++|++++ ..|..+..+++|++|++++|. +..+++..+..+++|++|++
T Consensus 76 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L 155 (549)
T 2z81_A 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI 155 (549)
T ss_dssp CCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEE
T ss_pred CCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeec
Confidence 9999999999998888889999999999999999986 357789999999999999998 67777788999999999999
Q ss_pred cceecccccCCCCcCCCcccEEEeecccccCcCCCCC--CcceEeEEEecCccccccC---CccccccCCCcEEecCCCC
Q 002278 190 RGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGKI---PEVIGLMQALAVLDLSENE 264 (943)
Q Consensus 190 ~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~--~~~~L~~L~L~~n~l~~~~---~~~l~~l~~L~~L~Ls~N~ 264 (943)
++|++++..|..+..+++|++|++++|.+.. +|..+ ...+|+.|++++|++++.. ......+++|+.|++++|.
T Consensus 156 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~ 234 (549)
T 2z81_A 156 KALSLRNYQSQSLKSIRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234 (549)
T ss_dssp EETTCCEECTTTTTTCSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCE
T ss_pred cCCcccccChhhhhccccCceEecccCcccc-cchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccc
Confidence 9999999999999999999999999999863 33322 2468999999999998742 2233567899999999999
Q ss_pred CCCCCC----cccCCCCCcceEEecCCCCCCCC------CCCcCCCCcCcEEEcccCcccccc-----ccccCCcccceE
Q 002278 265 LVGPIP----PILGNLSYTGKLYLHGNKLTGPI------PPELGNMSKLSYLQLQNNQLVGTI-----PAELGKLEQLFE 329 (943)
Q Consensus 265 l~~~~~----~~~~~l~~L~~L~L~~n~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~ 329 (943)
+.+..+ ..+..+++|+.|++++|.+.+.. ...+..+.+|+.|++.++.+.... +..+....+|+.
T Consensus 235 l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~ 314 (549)
T 2z81_A 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR 314 (549)
T ss_dssp EEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCE
T ss_pred cchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceE
Confidence 876433 34567889999999999987632 234577889999999999876321 122334568999
Q ss_pred EEccccccCCcCcccc-cCCCcCcEEEeeCCcccCccc---ccccccCccceeeccCCcCCCCCC--CCCCCCCCccEEe
Q 002278 330 LNLADNNLEGPIPHNI-SSCTALNQFNVHGNRLSGAIP---SSFRNLGSLTYLNLSRNNFKGKVP--TELGRIINLDTLD 403 (943)
Q Consensus 330 L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~ 403 (943)
|++++|++. .+|..+ ..+++|++|++++|++++..| ..+..+++|+.|+|++|++++..+ ..+..+++|++|+
T Consensus 315 L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~ 393 (549)
T 2z81_A 315 ITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLD 393 (549)
T ss_dssp EEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEE
T ss_pred EEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEE
Confidence 999999998 455554 689999999999999997664 347889999999999999985432 4588999999999
Q ss_pred cCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCC
Q 002278 404 LSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG 483 (943)
Q Consensus 404 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 483 (943)
+++|+++ .+|..+..+++|++|+|++|++++ +|..+. ++|++|+|++|+|++.+ ..+++|++|+|++|+|+
T Consensus 394 Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~- 464 (549)
T 2z81_A 394 ISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK- 464 (549)
T ss_dssp CTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-
T ss_pred CCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-
Confidence 9999999 688899999999999999999985 444442 68999999999999643 57899999999999999
Q ss_pred CCCCcCccccCCcccccCCccccccCCC-CcccCcCCCCccccCCCCCCCC
Q 002278 484 GIPDQLSNCFSLSNLNVSYNNLSGIIPP-IRNFSRFSSNSFIGNPLLCGNW 533 (943)
Q Consensus 484 ~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~~~~~~~~~~~Np~~c~~~ 533 (943)
.+|. ...+++|++|+|++|+|++.+|. +..+..+..+.+.+|||.|+++
T Consensus 465 ~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 465 TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 6776 56899999999999999999886 5677888889999999999853
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=436.07 Aligned_cols=254 Identities=24% Similarity=0.264 Sum_probs=208.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.+.|+..+.||+|+||+||+|+++ +++.||||++..... ..+|+++++.++|||||++++++.+++..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888889999999999999986 588999999965422 24699999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC-ceeecccccccccCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-DAHLSDFGIARCIPTAM 772 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFGla~~~~~~~ 772 (943)
|+||+|.++++ ..+.+++.++..++.||+.||+|||++ +||||||||+|||++.+| ++||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999997 456799999999999999999999999 999999999999999887 69999999999875432
Q ss_pred Cc----eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 773 PH----ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 773 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
.. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.........+..... ....+++.++
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~s- 283 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP-PIREIPPSCA- 283 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-GGGGSCTTSC-
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-CchhcCccCC-
Confidence 21 12235699999999999999999999999999999999999999986554333333322222 1122233332
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
..+.+++.+||+.||++|||+.|+++++.....
T Consensus 284 --------~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 284 --------PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp --------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 456789999999999999999999999876553
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=444.53 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=217.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.+.|+..+.||+|+||+||+|+++ +++.||||++........+.+.+|+++|+.++|||||+++++|.+++..|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999986 5899999999766666667789999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
|+||+|.+++. ...+++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999985 34699999999999999999999999 999999999999999999999999999998755433
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
. ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+......+..+........ ...+.+
T Consensus 303 ~-~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~~~~~~------- 373 (423)
T 4fie_A 303 R-RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-KNLHKV------- 373 (423)
T ss_dssp C-BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SCTTSS-------
T ss_pred c-ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-cccccC-------
Confidence 3 3345799999999999999999999999999999999999999998776655544433211111 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++.+||..||++|||+.|+++|-+-
T Consensus 374 --s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 374 --SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp --CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred --CHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 1456789999999999999999999998653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=422.94 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=197.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+|+++ +++.||+|++.+.. ....+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999976 58999999986542 334567899999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+ +|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 789999986 456799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.........+......++.. +
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~----~---- 235 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF----L---- 235 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----S----
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCC----C----
Confidence 2 2234579999999999998876 589999999999999999999998765544333333222222211 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++.+|++.||++|||++|+++|-|-
T Consensus 236 -----s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 236 -----SPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp -----CHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred -----CHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 1356789999999999999999999998653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=424.27 Aligned_cols=249 Identities=23% Similarity=0.334 Sum_probs=203.0
Q ss_pred ccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEec----CCcceEEE
Q 002278 619 SEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALS----PYGNLLFY 691 (943)
Q Consensus 619 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 691 (943)
...+.||+|+||+||+|.++ .++.||+|++.... ....+.|.+|++++++++|||||+++++|.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55668999999999999976 57899999986442 3345678999999999999999999999865 23479999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-CCceeecccccccccCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-NFDAHLSDFGIARCIPT 770 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFGla~~~~~ 770 (943)
|||++|+|.+++. ....+++..+..++.||+.||+|||++ .++||||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999997 456799999999999999999999998 123999999999999984 79999999999986543
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+................ +...++..
T Consensus 185 ~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~~---- 255 (290)
T 3fpq_A 185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKVA---- 255 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGCC----
T ss_pred C---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC-CCCCCccC----
Confidence 2 2334579999999998865 6999999999999999999999999876666555544433221 11111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++.+||+.||++|||++|+++|-+
T Consensus 256 -----~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 256 -----IPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp -----CHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred -----CHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 135678999999999999999999998754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=472.13 Aligned_cols=449 Identities=17% Similarity=0.151 Sum_probs=255.8
Q ss_pred EEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcc
Q 002278 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ 121 (943)
Q Consensus 42 ~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~ 121 (943)
.||+++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 5788888888 5777665 788888888888886666778888888888888888887667788888888888888888
Q ss_pred cccCCCcccCCCCCCcEEEEecccccc-ccchhccccccceeccccCCccCCCCCccccccccc--ceeeccceec--cc
Q 002278 122 LTGPIPSTLTQIPNLKTLDLARNQLTG-EIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGL--WYFDVRGNNL--TG 196 (943)
Q Consensus 122 l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~i--~~ 196 (943)
++ .+|.. .+++|++|+|++|++++ .+|..|+.+++|++|+|++|++++ ..+..+++| +.|++++|.+ .+
T Consensus 81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccc
Confidence 87 45554 77888888888888875 356777777778888877777765 355666666 7777777777 56
Q ss_pred ccCCCCcCCC-cccEEEeecccccCcCCCCC--CcceEeEEEecCcc-------ccccCCccccccCCCcEEecCCCCCC
Q 002278 197 TIPDSIGNCT-SFEILDISYNQITGEIPYNI--GFLQVATLSLQGNK-------LTGKIPEVIGLMQALAVLDLSENELV 266 (943)
Q Consensus 197 ~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~--~~~~L~~L~L~~n~-------l~~~~~~~l~~l~~L~~L~Ls~N~l~ 266 (943)
..|..+..+. +...+++++|++.+.++... ...+|+.|++++|. +.+.+| .+..+++|+.|++++|.+.
T Consensus 155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~ 233 (520)
T 2z7x_B 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETT 233 (520)
T ss_dssp CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEE
T ss_pred cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccC
Confidence 6666666655 33445666666655444321 23456666666655 444443 4555556666666555544
Q ss_pred CCCCcccC---CCCCcceEEecCCCCCCCCCCCc-----CCCCcCcEEEcccCccccccc-cccCCc---ccceEEEccc
Q 002278 267 GPIPPILG---NLSYTGKLYLHGNKLTGPIPPEL-----GNMSKLSYLQLQNNQLVGTIP-AELGKL---EQLFELNLAD 334 (943)
Q Consensus 267 ~~~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~L~~ 334 (943)
+..+..+. ..++|++|++++|++++.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~ 311 (520)
T 2z7x_B 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSG 311 (520)
T ss_dssp HHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEES
T ss_pred HHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCC
Confidence 32111100 12345555555555555555554 5555555555555555 222 233332 3455555555
Q ss_pred cccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCC--CCCCCCCCCCCccEEecCCCcCCCc
Q 002278 335 NNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKG--KVPTELGRIINLDTLDLSVNNFSGS 412 (943)
Q Consensus 335 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~ 412 (943)
|.+.... .+..+++|++|++++|++++..|..|..+++|++|+|++|++++ .+|..+..+++|+.|++++|.+++.
T Consensus 312 n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~ 389 (520)
T 2z7x_B 312 TRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD 389 (520)
T ss_dssp SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCC
T ss_pred Ccccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcc
Confidence 5544221 11344555555555555554445555555555555555555543 2233444455555555555555442
Q ss_pred cCC-CcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCcc
Q 002278 413 VPA-SIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSN 491 (943)
Q Consensus 413 ~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 491 (943)
+|. .+..+++|+.|+|++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..
T Consensus 390 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~ 466 (520)
T 2z7x_B 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDR 466 (520)
T ss_dssp GGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred cccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhcc
Confidence 222 244445555555555555444444332 44555555555554 44444445555555555555554222222444
Q ss_pred ccCCcccccCCccccc
Q 002278 492 CFSLSNLNVSYNNLSG 507 (943)
Q Consensus 492 l~~L~~L~ls~N~l~~ 507 (943)
+++|+.|++++|++++
T Consensus 467 l~~L~~L~l~~N~~~c 482 (520)
T 2z7x_B 467 LTSLQKIWLHTNPWDC 482 (520)
T ss_dssp CTTCCEEECCSSCBCC
T ss_pred CCcccEEECcCCCCcc
Confidence 4555555555544443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=468.19 Aligned_cols=453 Identities=19% Similarity=0.215 Sum_probs=392.6
Q ss_pred CEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEecc
Q 002278 65 QSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARN 144 (943)
Q Consensus 65 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 144 (943)
++||+++|+|+ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 58999999999 6888776 89999999999999888889999999999999999999888999999999999999999
Q ss_pred ccccccchhccccccceeccccCCccCCC-CCcccccccccceeeccceecccccCCCCcCCCcc--cEEEeecccc--c
Q 002278 145 QLTGEIPRLIYWNEVLQYLGLRGNALTGM-LSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSF--EILDISYNQI--T 219 (943)
Q Consensus 145 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L--~~L~Ls~N~l--~ 219 (943)
+|+ .+|.. .+++|++|+|++|+++++ .|..|+.+++|++|++++|++++ ..+..+++| ++|++++|++ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 999 56665 799999999999999986 57899999999999999999986 457778888 9999999999 7
Q ss_pred CcCCCCCCcce--EeEEEecCccccccCCc-cccccCCCcEEecCCCC-------CCCCCCcccCCCCCcceEEecCCCC
Q 002278 220 GEIPYNIGFLQ--VATLSLQGNKLTGKIPE-VIGLMQALAVLDLSENE-------LVGPIPPILGNLSYTGKLYLHGNKL 289 (943)
Q Consensus 220 ~~~~~~~~~~~--L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~Ls~N~-------l~~~~~~~~~~l~~L~~L~L~~n~l 289 (943)
+..|..+.... ...+++++|.+.+.+++ .+..+++|+.|++++|. +.+.+| .+..+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 78887776643 66788999998775554 56789999999999997 555555 788999999999999988
Q ss_pred CCCCCCCcC---CCCcCcEEEcccCcccccccccc-----CCcccceEEEccccccCCcCcccccCC---CcCcEEEeeC
Q 002278 290 TGPIPPELG---NMSKLSYLQLQNNQLVGTIPAEL-----GKLEQLFELNLADNNLEGPIPHNISSC---TALNQFNVHG 358 (943)
Q Consensus 290 ~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~ 358 (943)
++..+..+. ..++|++|++++|++++.+|..+ ..+++|+.+++++|.+ ...+..+..+ ++|+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~ 311 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSG 311 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEES
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCC
Confidence 753222111 13589999999999999999988 9999999999999999 3333555555 6799999999
Q ss_pred CcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCC--ccCCCcccccccceeeccccccccc
Q 002278 359 NRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG--SVPASIGDLEHLLTLNLSRNHLNGL 436 (943)
Q Consensus 359 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~ 436 (943)
|.+.... .+..+++|++|++++|++++..|..+..+++|+.|++++|++++ .+|..+..+++|++|+|++|++++.
T Consensus 312 n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~ 389 (520)
T 2z7x_B 312 TRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD 389 (520)
T ss_dssp SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCC
T ss_pred Ccccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcc
Confidence 9987432 23688999999999999998899999999999999999999996 4567799999999999999999984
Q ss_pred CCc-cccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCC-Ccc
Q 002278 437 LPA-EFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP-IRN 514 (943)
Q Consensus 437 ~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~ 514 (943)
+|. .|..+++|++|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|++++|+|+++++. +..
T Consensus 390 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~ 466 (520)
T 2z7x_B 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDR 466 (520)
T ss_dssp GGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred cccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhcc
Confidence 554 589999999999999999988887765 79999999999999 7888888999999999999999987775 566
Q ss_pred cCcCCCCccccCCCCCCCC
Q 002278 515 FSRFSSNSFIGNPLLCGNW 533 (943)
Q Consensus 515 ~~~~~~~~~~~Np~~c~~~ 533 (943)
+..+..+.+.+||+.|+|+
T Consensus 467 l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 467 LTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CTTCCEEECCSSCBCCCHH
T ss_pred CCcccEEECcCCCCcccCC
Confidence 7788888999999999853
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=468.86 Aligned_cols=516 Identities=18% Similarity=0.146 Sum_probs=398.6
Q ss_pred CccccCCCCCCCCC--CCCCCc----ceeEecCCC---------CcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCc
Q 002278 9 NLANVLLDWDDVHN--SDFCSW----RGVFCDNSS---------LSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNK 73 (943)
Q Consensus 9 ~~~~~~~~w~~~~~--~~~c~w----~gv~c~~~~---------~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~ 73 (943)
|+...+++|...-. -+.|.+ ..|.|.+.+ ..++.|||++|+|++..+.+|.++++|++|||++|+
T Consensus 8 ~~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~ 87 (635)
T 4g8a_A 8 DDDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 87 (635)
T ss_dssp -----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CCcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCc
Confidence 55567788863211 123433 347787553 357889999999996666789999999999999999
Q ss_pred ccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEecccccc-ccch
Q 002278 74 LTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTG-EIPR 152 (943)
Q Consensus 74 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~ 152 (943)
|++..|++|.++++|++|+|++|+|++..+..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++ ..|.
T Consensus 88 i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~ 167 (635)
T 4g8a_A 88 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 167 (635)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred CCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCch
Confidence 997777889999999999999999986666788999999999999999997777789999999999999999875 3678
Q ss_pred hccccccceeccccCCccCCCCCcccccccccc----eeeccceecccccCCCCcCCCcccEEEeecccccCcCC----C
Q 002278 153 LIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLW----YFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIP----Y 224 (943)
Q Consensus 153 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~----~ 224 (943)
.+..+++|++|+|++|+|+++.+..+..+.+++ .++++.|.++.+.+..+ ....++.|++++|.....++ .
T Consensus 168 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~ 246 (635)
T 4g8a_A 168 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQ 246 (635)
T ss_dssp GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHH
T ss_pred hhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhc
Confidence 888899999999999999998888888776654 57888898886555444 44567778888775432110 0
Q ss_pred CCCcc----------------------------eEeEEEecCccc---cccCCccccccCCCcEEecCCCCCCCCCCccc
Q 002278 225 NIGFL----------------------------QVATLSLQGNKL---TGKIPEVIGLMQALAVLDLSENELVGPIPPIL 273 (943)
Q Consensus 225 ~~~~~----------------------------~L~~L~L~~n~l---~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 273 (943)
..... .+..+.+..+.. ....+..+..+.+++.+++.+|.+... ..+
T Consensus 247 ~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~ 324 (635)
T 4g8a_A 247 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDF 324 (635)
T ss_dssp TTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGG
T ss_pred CCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--ccc
Confidence 00111 122222222111 112334456677888888888877643 235
Q ss_pred CCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCC--cCcccccCCCcC
Q 002278 274 GNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEG--PIPHNISSCTAL 351 (943)
Q Consensus 274 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L 351 (943)
.....++.|++.+|.+....+ ..+..|+.+++.+|.+... .....+++|+.|++++|.+.. ..+..+..+.+|
T Consensus 325 ~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L 399 (635)
T 4g8a_A 325 SYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISL 399 (635)
T ss_dssp GSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCC
T ss_pred ccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhh
Confidence 566788999999999886544 3467788999999987633 345678999999999999863 456677788999
Q ss_pred cEEEeeCCcccCcccccccccCccceeeccCCcCCCCCC-CCCCCCCCccEEecCCCcCCCccCCCcccccccceeeccc
Q 002278 352 NQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP-TELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSR 430 (943)
Q Consensus 352 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 430 (943)
+.|++..|.+.. .+..+..+++|+.++++.|+.....+ ..+..+.+++.++++.|.+.+..+..+..++.|+.|+|++
T Consensus 400 ~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~ 478 (635)
T 4g8a_A 400 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 478 (635)
T ss_dssp CEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTT
T ss_pred hhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 999999999884 56678899999999999988765544 5688899999999999999988899999999999999999
Q ss_pred ccc-cccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccC
Q 002278 431 NHL-NGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGII 509 (943)
Q Consensus 431 N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 509 (943)
|++ .+..|..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|++|||++|+|++++
T Consensus 479 N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~ 558 (635)
T 4g8a_A 479 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 558 (635)
T ss_dssp CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCC
T ss_pred cccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCC
Confidence 985 4568899999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred CCC-ccc-CcCCCCccccCCCCCCCC
Q 002278 510 PPI-RNF-SRFSSNSFIGNPLLCGNW 533 (943)
Q Consensus 510 ~~~-~~~-~~~~~~~~~~Np~~c~~~ 533 (943)
|.. ..+ ..+..+.+.+|||.|+|.
T Consensus 559 ~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 559 KQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp SSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred HHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 864 334 567788899999999964
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=430.28 Aligned_cols=250 Identities=24% Similarity=0.300 Sum_probs=203.7
Q ss_pred hccccceEEeeeceEEEEEEEec----CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
++|+..+.||+|+||+||+|+.. .++.||+|++.+.. ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 36789999986432 2233468889999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||++||+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+|||++++|++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999997 456799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
..... ....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.......+......+++. ++
T Consensus 178 ~~~~~-~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~----~s-- 250 (304)
T 3ubd_A 178 DHEKK-AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF----LS-- 250 (304)
T ss_dssp ---CC-CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----SC--
T ss_pred CCCcc-ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCc----CC--
Confidence 43222 234579999999999999999999999999999999999999999877665555444433322222 11
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPT-----MQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L~ 885 (943)
..+.+++.+||+.||++||| ++|+++|-+
T Consensus 251 -------~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 251 -------PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp -------HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred -------HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 35678999999999999998 478887654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=431.67 Aligned_cols=269 Identities=25% Similarity=0.307 Sum_probs=217.6
Q ss_pred CHHHHHHHhhccccceEEeeeceEEEEEEEecC------CceEEEEEecccCc-ccHHHHHHHHHHHhcCCC-CCcceee
Q 002278 607 TFDDIMRSTENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQYP-HNLREFETELETIGSIRH-RNIVSLH 678 (943)
Q Consensus 607 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~ 678 (943)
+.++.....++|+..+.||+|+||+||+|.+.. ++.||||++..... ...+.+.+|++++++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 334444566889999999999999999998753 25799999976543 345679999999999975 8999999
Q ss_pred eEEecC-CcceEEEEEccCCChhhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC
Q 002278 679 GYALSP-YGNLLFYDYMVNGSLWDLLHGPS-------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDV 744 (943)
Q Consensus 679 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 744 (943)
|+|.++ ...++|||||++|+|.++|+... ....+++.++..++.|||.||+|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999765 46899999999999999996322 134589999999999999999999999 9999999
Q ss_pred CCccEEECCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCC
Q 002278 745 KSSNILIDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNE 822 (943)
Q Consensus 745 kp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~ 822 (943)
||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999977544332 3345679999999999999999999999999999999998 99999876
Q ss_pred ccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 823 SNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.....+........ .+..+..+ ...+.+++..||+.||++|||+.|++++|+.++.
T Consensus 292 ~~~~~~~~~i~~g~------~~~~p~~~-----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 292 KIDEEFCRRLKEGT------RMRAPDYT-----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCSHHHHHHHHHTC------CCCCCTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCC------CCCCCccC-----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 54443333322211 11111111 2467789999999999999999999999987653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=429.42 Aligned_cols=264 Identities=25% Similarity=0.334 Sum_probs=204.3
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCC----cceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPY----GNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 691 (943)
++|...+.||+|+||+||+|+++ |+.||||++.... .....++.|+..+.+++|||||++++++.+++ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 46778889999999999999985 8899999986432 11223345566667889999999999998654 468999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhC-----CCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD-----CNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
||+++|+|.++++ ...++|+.+.+++.|+|.||+|||++ +.++||||||||+|||+++++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999996 34689999999999999999999975 24589999999999999999999999999998
Q ss_pred ccCCCCCc---eeeeEecccceeCccccccC------CCCCcchhhhHHHHHHHHHhCCCCCCCCc--------------
Q 002278 767 CIPTAMPH---ASTFVLGTIGYIDPEYAHTS------RLNEKSDVYSFGIVLLEILTGKKAVDNES-------------- 823 (943)
Q Consensus 767 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~p~~~~~-------------- 823 (943)
........ .....+||+.|||||++.+. .++.++|||||||++|||+||++||....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 77544322 22345799999999998764 36789999999999999999988764221
Q ss_pred cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 824 NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
.......... ....+|.++......+....+.+++.+||+.||++||||.||++.|+.+...
T Consensus 237 ~~~~~~~~~~-----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHT-----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHh-----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1111111111 1223444444333445667888999999999999999999999999876543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=475.37 Aligned_cols=442 Identities=17% Similarity=0.235 Sum_probs=259.3
Q ss_pred CCCCEEEeeCCcccccCCCCccCCCCCcEEec-cCCCcCCccchhcccc---------ccceEEEe-------cCcccc-
Q 002278 62 RNLQSIDFQGNKLTGQIPDEIGNCGSLVHIEL-SDNSLYGDIPFSISKL---------KQLEFLNL-------KNNQLT- 123 (943)
Q Consensus 62 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~~~~l---------~~L~~L~L-------s~n~l~- 123 (943)
..++.|+|++|+++|.+|.+|++|++|++|+| ++|.+.|..|...... ..++..++ ....+.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57999999999999999999999999999999 8998876533221100 00000000 000000
Q ss_pred ----------cCCCcccCCCCCCcEEEEec--cccccccchhccccccceeccccCCccCC-----------------CC
Q 002278 124 ----------GPIPSTLTQIPNLKTLDLAR--NQLTGEIPRLIYWNEVLQYLGLRGNALTG-----------------ML 174 (943)
Q Consensus 124 ----------~~~~~~~~~l~~L~~L~Ls~--N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~~ 174 (943)
...+........++.+.+.. |++++ +|..|..+++|++|+|++|++++ ..
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 00000011112222222222 44444 44445555555555555555554 24
Q ss_pred Ccccc--cccccceeeccceecccccCCCCcCCCcccEEEeeccc-ccC-cCCCCCCc--------ceEeEEEecCcccc
Q 002278 175 SPDMC--QLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQ-ITG-EIPYNIGF--------LQVATLSLQGNKLT 242 (943)
Q Consensus 175 ~~~~~--~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~-l~~-~~~~~~~~--------~~L~~L~L~~n~l~ 242 (943)
|..++ .+++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++. .+|+.|+|++|.++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 55655 77788888888887777777778888888888888887 765 45543321 24555555555555
Q ss_pred ccCCc--cccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCc-CcEEEcccCcccccccc
Q 002278 243 GKIPE--VIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSK-LSYLQLQNNQLVGTIPA 319 (943)
Q Consensus 243 ~~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~ 319 (943)
.+|. .+..+++|+.|+|++|.+. .+| .|..+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 4555 5666666666666666666 455 6666666666666666666 55666666666 666666666666 5555
Q ss_pred ccCCccc--ceEEEccccccCCcCcccc---c--CCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCC
Q 002278 320 ELGKLEQ--LFELNLADNNLEGPIPHNI---S--SCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTE 392 (943)
Q Consensus 320 ~~~~l~~--L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 392 (943)
.+..++. |+.|+|++|++.+.+|... . .+++|+.|+|++|+|+.+.+..+..+++|+.|+|++|+++ .+|..
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~ 715 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPEN 715 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTT
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChH
Confidence 5555443 6666666666665444322 1 2235555555555555333333335555555555555555 33332
Q ss_pred CCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCcccc--CCCccceecccCccccccCChhhhcccc
Q 002278 393 LGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFG--NLRSIQTIDMSFNQLSGSIPAELGQLQN 470 (943)
Q Consensus 393 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 470 (943)
+.... +..+.++++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..+++
T Consensus 716 ~~~~~----------------~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~ 777 (876)
T 4ecn_A 716 SLKPK----------------DGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQ 777 (876)
T ss_dssp SSSCT----------------TSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTT
T ss_pred Hhccc----------------cccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCC
Confidence 22211 000112235555555555555 3445544 55555555555555554 4555555555
Q ss_pred cceecc------cCcccCCCCCCcCccccCCcccccCCccccccCCCCcccCcCCCCccccCCCCC
Q 002278 471 IISLIL------NNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLC 530 (943)
Q Consensus 471 L~~L~L------~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~~~~~Np~~c 530 (943)
|+.|+| ++|++.+.+|..+.++++|+.|+|++|+| +.+|.. ....+..+.+.+||+..
T Consensus 778 L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 778 LKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPNIS 841 (876)
T ss_dssp CCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTTCE
T ss_pred CCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCCCc
Confidence 555555 45899999999999999999999999999 555543 23577888899998654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=471.03 Aligned_cols=452 Identities=18% Similarity=0.287 Sum_probs=382.3
Q ss_pred CCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCc------CC------ccchhccccccceEEEecCcccccCCCcc
Q 002278 62 RNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSL------YG------DIPFSISKLKQLEFLNLKNNQLTGPIPST 129 (943)
Q Consensus 62 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l------~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~ 129 (943)
..++.|+|++|+++|.+|.+|++|++|++|+|++|.+ .+ .+|... +.+|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4789999999999999999999999999999999976 22 344443 66777 888888888777776
Q ss_pred cCCC-CCCcEEEEeccccccccchhccccccceecccc--CCccCCCCCcccccccccceeeccceecccc---------
Q 002278 130 LTQI-PNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLR--GNALTGMLSPDMCQLTGLWYFDVRGNNLTGT--------- 197 (943)
Q Consensus 130 ~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~--------- 197 (943)
+..+ ..+..+++....+.. .....++.+.+. +|++++ .|..++++++|++|+|++|++++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 230 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred HHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence 6632 233333333322221 112234444443 588888 677899999999999999999985
Q ss_pred --------cCCCCc--CCCcccEEEeecccccCcCCCCCCc-ceEeEEEecCcc-ccc-cCCcccccc------CCCcEE
Q 002278 198 --------IPDSIG--NCTSFEILDISYNQITGEIPYNIGF-LQVATLSLQGNK-LTG-KIPEVIGLM------QALAVL 258 (943)
Q Consensus 198 --------~~~~l~--~l~~L~~L~Ls~N~l~~~~~~~~~~-~~L~~L~L~~n~-l~~-~~~~~l~~l------~~L~~L 258 (943)
+|..++ ++++|++|+|++|++.+.+|..++. .+|++|++++|+ +++ .+|..++.+ ++|++|
T Consensus 231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L 310 (636)
T 4eco_A 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310 (636)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEE
T ss_pred ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEE
Confidence 899999 9999999999999999999987764 589999999998 998 899988887 999999
Q ss_pred ecCCCCCCCCCCc--ccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCccc-ceEEEcccc
Q 002278 259 DLSENELVGPIPP--ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQ-LFELNLADN 335 (943)
Q Consensus 259 ~Ls~N~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N 335 (943)
++++|+++ .+|. .++++++|+.|+|++|+++|.+| .|..+++|++|++++|+++ .+|..+..+++ |++|++++|
T Consensus 311 ~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N 387 (636)
T 4eco_A 311 YIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHN 387 (636)
T ss_dssp ECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSS
T ss_pred ECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCC
Confidence 99999999 7888 89999999999999999998888 9999999999999999999 88889999999 999999999
Q ss_pred ccCCcCcccccCCC--cCcEEEeeCCcccCccccccc-------ccCccceeeccCCcCCCCCCCCCCCCCCccEEecCC
Q 002278 336 NLEGPIPHNISSCT--ALNQFNVHGNRLSGAIPSSFR-------NLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSV 406 (943)
Q Consensus 336 ~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 406 (943)
+++ .+|..+..++ +|+.|++++|++++..|..|. .+++|+.|+|++|+++...+..+..+++|+.|+|++
T Consensus 388 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~ 466 (636)
T 4eco_A 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466 (636)
T ss_dssp CCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCS
T ss_pred cCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCC
Confidence 999 7788887765 999999999999999999998 888999999999999954444456789999999999
Q ss_pred CcCCCccCCC-cccc-------cccceeecccccccccCCcccc--CCCccceecccCccccccCChhhhcccccceecc
Q 002278 407 NNFSGSVPAS-IGDL-------EHLLTLNLSRNHLNGLLPAEFG--NLRSIQTIDMSFNQLSGSIPAELGQLQNIISLIL 476 (943)
Q Consensus 407 N~l~~~~~~~-~~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 476 (943)
|+++ .+|.. +..+ ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|
T Consensus 467 N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~L 543 (636)
T 4eco_A 467 NMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543 (636)
T ss_dssp SCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEEC
T ss_pred CCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEEC
Confidence 9999 55654 3333 39999999999999 6788887 99999999999999997 9999999999999999
Q ss_pred ------cCcccCCCCCCcCccccCCcccccCCccccccCCCCcccCcCCCCccccCCCCCCC
Q 002278 477 ------NNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGN 532 (943)
Q Consensus 477 ------~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~~~~~Np~~c~~ 532 (943)
++|++.+.+|..+..+++|+.|+|++|+|+.++..+ ...+..+.+.+||+.|-.
T Consensus 544 s~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ip~~~--~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISVLDIKDNPNISID 603 (636)
T ss_dssp CSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBCCSCC--CTTCCEEECCSCTTCEEE
T ss_pred CCCcccccCcccccChHHHhcCCCCCEEECCCCcCCccCHhH--hCcCCEEECcCCCCcccc
Confidence 568899999999999999999999999995544432 267888889999988743
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=413.57 Aligned_cols=254 Identities=19% Similarity=0.289 Sum_probs=194.2
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYG------ 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 686 (943)
.++|+..+.||+|+||+||+|+++ +++.||||++..... ...+.+.+|++++++++|||||++++++.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 356899999999999999999976 588999999865443 344678999999999999999999999875442
Q ss_pred ------ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeec
Q 002278 687 ------NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLS 760 (943)
Q Consensus 687 ------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 760 (943)
.|+||||+++|+|.+++.........++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 589999999999999998655445667788999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCc-----------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHH
Q 002278 761 DFGIARCIPTAMPH-----------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLI 829 (943)
Q Consensus 761 DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~ 829 (943)
|||+|+.+...... ..+..+||+.|||||++.+..|+.++||||+||++|||++ ||.+........
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 99999877543221 1234579999999999999999999999999999999996 776543322222
Q ss_pred HHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 830 MSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..... ... ++... .......+++.+||+.||++|||+.|+++|-+
T Consensus 238 ~~~~~-~~~----p~~~~------~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 238 TDVRN-LKF----PPLFT------QKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp HHHHT-TCC----CHHHH------HHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHhc-CCC----CCCCc------ccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 21111 111 11111 12234567999999999999999999998743
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=449.06 Aligned_cols=461 Identities=20% Similarity=0.212 Sum_probs=383.0
Q ss_pred cEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEec
Q 002278 39 SVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLK 118 (943)
Q Consensus 39 ~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 118 (943)
+++.|||++|+|++..+.+|+++++|++|+|++|+|++..++.|.++++|++|+|++|++++..+..|+++++|++|+|+
T Consensus 77 ~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls 156 (635)
T 4g8a_A 77 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 156 (635)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccc
Confidence 57899999999997667789999999999999999997667789999999999999999997777789999999999999
Q ss_pred CcccccC-CCcccCCCCCCcEEEEeccccccccchhccccccce----eccccCCccCCCCCcccccccccceeecccee
Q 002278 119 NNQLTGP-IPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQ----YLGLRGNALTGMLSPDMCQLTGLWYFDVRGNN 193 (943)
Q Consensus 119 ~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 193 (943)
+|++++. .|..+..+++|++|+|++|+|++..+..|..+.+++ .++++.|.++.+.+..+.. ..+..+++++|.
T Consensus 157 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~n~ 235 (635)
T 4g8a_A 157 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNF 235 (635)
T ss_dssp SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCC
T ss_pred cCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccc-hhhhhhhhhccc
Confidence 9999864 578899999999999999999988888888776654 6789999999887766554 356677887775
Q ss_pred ccc-ccCCCCcCCCcccEEEe------------------------------ecccccC----cCCCCCCcceEeEEEecC
Q 002278 194 LTG-TIPDSIGNCTSFEILDI------------------------------SYNQITG----EIPYNIGFLQVATLSLQG 238 (943)
Q Consensus 194 i~~-~~~~~l~~l~~L~~L~L------------------------------s~N~l~~----~~~~~~~~~~L~~L~L~~ 238 (943)
... ..+..+..+..++...+ ..+.... .........++..+.+.+
T Consensus 236 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~ 315 (635)
T 4g8a_A 236 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVS 315 (635)
T ss_dssp SSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEES
T ss_pred ccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccc
Confidence 432 12223344444444433 3332211 111112234688899999
Q ss_pred ccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCcccc--c
Q 002278 239 NKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVG--T 316 (943)
Q Consensus 239 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~ 316 (943)
+.+... ..+....+|+.|++++|.+....+. .+..|+.+++.+|.+... ..+..+++|+.|++++|.+.. .
T Consensus 316 ~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~ 388 (635)
T 4g8a_A 316 VTIERV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGC 388 (635)
T ss_dssp CEEEEC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEE
T ss_pred cccccc--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccc
Confidence 988754 3466778999999999998865543 456788999999988743 345678999999999999863 3
Q ss_pred cccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCccc-ccccccCccceeeccCCcCCCCCCCCCCC
Q 002278 317 IPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIP-SSFRNLGSLTYLNLSRNNFKGKVPTELGR 395 (943)
Q Consensus 317 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 395 (943)
.+..+..+.+|+.|++..|.+. ..+..+..+++|+.+++..|.+....+ ..|..+.+++.++++.|.+.+..+..+..
T Consensus 389 ~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~ 467 (635)
T 4g8a_A 389 CSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 467 (635)
T ss_dssp CCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred cccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccccccccccccccccccccccccccccccccc
Confidence 4566778889999999999987 456678899999999999988875544 57889999999999999999999999999
Q ss_pred CCCccEEecCCCcC-CCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhccccccee
Q 002278 396 IINLDTLDLSVNNF-SGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISL 474 (943)
Q Consensus 396 l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 474 (943)
++.|+.|++++|.+ .+..|..|..+++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..|..|..+++|+.|
T Consensus 468 ~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 547 (635)
T 4g8a_A 468 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 547 (635)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence 99999999999985 44678899999999999999999999999999999999999999999998888999999999999
Q ss_pred cccCcccCCCCCCcCccc-cCCcccccCCcccccc
Q 002278 475 ILNNNNLQGGIPDQLSNC-FSLSNLNVSYNNLSGI 508 (943)
Q Consensus 475 ~L~~N~l~~~~p~~~~~l-~~L~~L~ls~N~l~~~ 508 (943)
+|++|+|++..|..+..+ ++|+.|+|++|+++..
T Consensus 548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 999999999999999988 6899999999999863
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=449.11 Aligned_cols=450 Identities=18% Similarity=0.173 Sum_probs=287.3
Q ss_pred EEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCc
Q 002278 41 VSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120 (943)
Q Consensus 41 ~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n 120 (943)
..+|+++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|.+|+++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 57999999999 5887665 78999999999999777788999999999999999999777888999999999999999
Q ss_pred ccccCCCcccCCCCCCcEEEEeccccccc-cchhccccccceeccccCCccCCCCCccccccccc--ceeeccceec--c
Q 002278 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGE-IPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGL--WYFDVRGNNL--T 195 (943)
Q Consensus 121 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~i--~ 195 (943)
+++ .+|.. .+++|++|+|++|++++. .|..|..+++|++|+|++|++++. .+..+++| +.|++++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 998 55655 799999999999999863 468888899999999999988864 34445555 8888888888 7
Q ss_pred cccCCCCcCCC-cccEEEeecccccCcCCCCC--CcceEeEEEecCcc-----ccccCCccccccCCCcEEecCCCCCCC
Q 002278 196 GTIPDSIGNCT-SFEILDISYNQITGEIPYNI--GFLQVATLSLQGNK-----LTGKIPEVIGLMQALAVLDLSENELVG 267 (943)
Q Consensus 196 ~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~--~~~~L~~L~L~~n~-----l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 267 (943)
+..|..+..+. ..-.+++++|.+.+.++... ...+|+.|++++|+ +.+ ....+..+++|+.|+++++.+.+
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECH
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcH
Confidence 77777777655 12255777777766544321 23457777777764 221 12345556666666666665543
Q ss_pred CC----CcccCCCCCcceEEecCCCCCCCCCCCc-----CCCCcCcEEEcccCccccccc-cccCCc---ccceEEEccc
Q 002278 268 PI----PPILGNLSYTGKLYLHGNKLTGPIPPEL-----GNMSKLSYLQLQNNQLVGTIP-AELGKL---EQLFELNLAD 334 (943)
Q Consensus 268 ~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~L~~ 334 (943)
.. +..+ ..++|++|++++|.+++.+|..+ ..++.|+.++++.|.+ .+| ..+..+ .+|++|++++
T Consensus 264 ~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~ 340 (562)
T 3a79_B 264 KCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISD 340 (562)
T ss_dssp HHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEES
T ss_pred HHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccC
Confidence 11 1111 12356666666666666566555 5555555555555555 122 222222 3466666666
Q ss_pred cccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCC--CCCCCCCCCCccEEecCCCcCCCc
Q 002278 335 NNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK--VPTELGRIINLDTLDLSVNNFSGS 412 (943)
Q Consensus 335 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~ 412 (943)
|.+.... .+..+++|++|++++|++++..|..|..+++|+.|+|++|++++. .|..+..+++|+.|++++|++++.
T Consensus 341 n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 418 (562)
T 3a79_B 341 TPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSH 418 (562)
T ss_dssp SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSC
T ss_pred CCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCc
Confidence 6654221 114555666666666666655555666666666666666666542 124455566666666666666552
Q ss_pred cC-CCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCcc
Q 002278 413 VP-ASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSN 491 (943)
Q Consensus 413 ~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 491 (943)
+| ..+..+++|+.|+|++|++++..|..+. ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..
T Consensus 419 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~ 495 (562)
T 3a79_B 419 AYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDR 495 (562)
T ss_dssp CSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTT
T ss_pred cChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhc
Confidence 33 2355556666666666666554444433 45666666666665 45555556666666666666665322222555
Q ss_pred ccCCcccccCCcccccc
Q 002278 492 CFSLSNLNVSYNNLSGI 508 (943)
Q Consensus 492 l~~L~~L~ls~N~l~~~ 508 (943)
+++|+.|++++|++++.
T Consensus 496 l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 496 LTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp CTTCCCEECCSCCBCCC
T ss_pred CCCCCEEEecCCCcCCC
Confidence 55666666665555543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=444.41 Aligned_cols=457 Identities=19% Similarity=0.189 Sum_probs=381.0
Q ss_pred CCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEE
Q 002278 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLD 140 (943)
Q Consensus 61 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 140 (943)
+...+++|+++|+++ .+|..+. ++|++|+|++|+|++..|.+|+++++|++|+|++|++++..|+.|.++++|++|+
T Consensus 30 ~~~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 106 (562)
T 3a79_B 30 NELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLD 106 (562)
T ss_dssp ---CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEE
Confidence 334589999999999 5887664 8999999999999988888999999999999999999988899999999999999
Q ss_pred EeccccccccchhccccccceeccccCCccCCCC-CcccccccccceeeccceecccccCCCCcCCCcc--cEEEeeccc
Q 002278 141 LARNQLTGEIPRLIYWNEVLQYLGLRGNALTGML-SPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSF--EILDISYNQ 217 (943)
Q Consensus 141 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L--~~L~Ls~N~ 217 (943)
|++|+|+ .+|.. .+++|++|+|++|+++++. |..|.++++|++|++++|++++. .+..+++| ++|++++|+
T Consensus 107 Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~ 180 (562)
T 3a79_B 107 VSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVS 180 (562)
T ss_dssp CTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESS
T ss_pred CCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccc
Confidence 9999999 56655 7999999999999999976 57999999999999999999863 45666666 999999999
Q ss_pred c--cCcCCCCCCcce--EeEEEecCccccccCCc-cccccCCCcEEecCCCCCC----CCCCcccCCCCCcceEEecCCC
Q 002278 218 I--TGEIPYNIGFLQ--VATLSLQGNKLTGKIPE-VIGLMQALAVLDLSENELV----GPIPPILGNLSYTGKLYLHGNK 288 (943)
Q Consensus 218 l--~~~~~~~~~~~~--L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~L~~n~ 288 (943)
+ ++..|..+.... ...+++++|.+.+.+++ .+..+++|+.|++++|... ......|..+++|+.|+|.++.
T Consensus 181 l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~ 260 (562)
T 3a79_B 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260 (562)
T ss_dssp CCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEE
T ss_pred ccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCc
Confidence 9 877777765543 44678899998875554 4567899999999999621 0112356778899999999888
Q ss_pred CCCCC----CCCcCCCCcCcEEEcccCcccccccccc-----CCcccceEEEccccccCCcCc-ccccCC---CcCcEEE
Q 002278 289 LTGPI----PPELGNMSKLSYLQLQNNQLVGTIPAEL-----GKLEQLFELNLADNNLEGPIP-HNISSC---TALNQFN 355 (943)
Q Consensus 289 l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~ 355 (943)
+++.. +.. ...++|++|++++|.+++.+|..+ ..++.|+.++++.|.+ .+| ..+..+ .+|+.|+
T Consensus 261 l~~~~~~~~~~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~ 337 (562)
T 3a79_B 261 TTWKCSVKLFQF-FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLS 337 (562)
T ss_dssp ECHHHHHHHHHH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEE
T ss_pred CcHHHHHHHHHh-hhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEE
Confidence 76421 111 123589999999999998899887 7888888888888888 334 333322 6799999
Q ss_pred eeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCC--ccCCCcccccccceeecccccc
Q 002278 356 VHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG--SVPASIGDLEHLLTLNLSRNHL 433 (943)
Q Consensus 356 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l 433 (943)
+++|.+.... .+..+++|++|++++|++++..|..+..+++|+.|++++|++++ .+|..+..+++|+.|+|++|++
T Consensus 338 l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l 415 (562)
T 3a79_B 338 ISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL 415 (562)
T ss_dssp EESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCC
T ss_pred ccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcC
Confidence 9999986332 22688999999999999999899999999999999999999996 3356789999999999999999
Q ss_pred cccCC-ccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCC-
Q 002278 434 NGLLP-AEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP- 511 (943)
Q Consensus 434 ~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~- 511 (943)
++.+| ..|..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+++++.
T Consensus 416 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~ 492 (562)
T 3a79_B 416 NSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGV 492 (562)
T ss_dssp BSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTS
T ss_pred CCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHH
Confidence 98444 5689999999999999999987776654 78999999999999 6777777999999999999999988776
Q ss_pred CcccCcCCCCccccCCCCCCCCC
Q 002278 512 IRNFSRFSSNSFIGNPLLCGNWI 534 (943)
Q Consensus 512 ~~~~~~~~~~~~~~Np~~c~~~~ 534 (943)
+..+..+..+.+.+|||.|+|+.
T Consensus 493 ~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 493 FDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp TTTCTTCCCEECCSCCBCCCHHH
T ss_pred HhcCCCCCEEEecCCCcCCCcch
Confidence 67778888889999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=414.48 Aligned_cols=264 Identities=25% Similarity=0.320 Sum_probs=210.3
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecC------Cc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSP------YG 686 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 686 (943)
++|+..+.||+|+||+||+|+++ +++.||||++..... ...+.+.+|+++|+.++|||||++++++... ..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999976 689999999965432 3345788999999999999999999997643 56
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.|+|||||. |+|.+++. ....+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 799999995 67999986 456799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC---CceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc
Q 002278 767 CIPTAM---PHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842 (943)
Q Consensus 767 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 842 (943)
.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|++||.+.+..+.+..+....+......
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 764321 1223345799999999998875 569999999999999999999999998887776666544333322221
Q ss_pred Cccccc------------C-ccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 843 DPEVSV------------T-CVDL-----SAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 843 ~~~~~~------------~-~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...... . .... .....+.+++.+||..||++|||+.|+++|-+-
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence 111000 0 0000 012456789999999999999999999998653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=401.66 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=201.3
Q ss_pred HhhccccceEEeeeceEEEEEEEec----CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 688 (943)
..++|++.+.||+|+||+||+|+.+ .++.||+|++... ....++.+|+++++.+ +|||||++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999864 3578999998654 3456788999999988 6999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC-Cceeecccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-FDAHLSDFGIARC 767 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DFGla~~ 767 (943)
+||||+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999984 389999999999999999999999 99999999999999876 7999999999986
Q ss_pred cCCCCC---------------------------ceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCC
Q 002278 768 IPTAMP---------------------------HASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAV 819 (943)
Q Consensus 768 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~ 819 (943)
...... ...+..+||+.|+|||++.+. .|+.++||||+||++|||+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 543211 112234699999999999875 5899999999999999999999999
Q ss_pred CCC-ccHHHHHHHhcccccc-------------------c--------------cccCcccccCc--------cCHHHHH
Q 002278 820 DNE-SNLHQLIMSKADDNTV-------------------M--------------EAVDPEVSVTC--------VDLSAVR 857 (943)
Q Consensus 820 ~~~-~~~~~~~~~~~~~~~~-------------------~--------------~~~~~~~~~~~--------~~~~~~~ 857 (943)
... ++..++..+....+.. + ....|...... .......
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 644 3333333222110000 0 00000000000 0000123
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 858 KTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 858 ~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+++.+|++.||++|||++|+++|-+
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 5678999999999999999999998854
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=423.75 Aligned_cols=255 Identities=19% Similarity=0.295 Sum_probs=220.6
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|++.+.||+|+||+||+|.++ +++.||+|++........+.+.+|+++|+.++|||||+++++|.++...++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999986 5889999999776655667889999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC--CceeecccccccccCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN--FDAHLSDFGIARCIPTA 771 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~DFGla~~~~~~ 771 (943)
|+||+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999863 345699999999999999999999999 99999999999999854 89999999999987544
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+......+..+......+.....+.++
T Consensus 311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s---- 384 (573)
T 3uto_A 311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS---- 384 (573)
T ss_dssp --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSC----
T ss_pred --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCC----
Confidence 23345679999999999999999999999999999999999999999887766665555544444333333333
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+.+++.+||+.||++|||+.|+++|-|
T Consensus 385 -----~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 385 -----EDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp -----HHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred -----HHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 35678999999999999999999999865
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=406.05 Aligned_cols=389 Identities=20% Similarity=0.236 Sum_probs=277.8
Q ss_pred CCCCCCcce--eEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcC
Q 002278 22 NSDFCSWRG--VFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLY 99 (943)
Q Consensus 22 ~~~~c~w~g--v~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 99 (943)
..+.|.|.+ |.|++. +++ .+|. + .++|++|||++|+|++..|..|+++++|++|+|++|.+.
T Consensus 4 ~~~~c~~~~~~~~c~~~------------~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~ 67 (455)
T 3v47_A 4 GTSECSVIGYNAICINR------------GLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPG 67 (455)
T ss_dssp ---CCEEETTEEECCSS------------CCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTT
T ss_pred ccceeEEEccccCcCCC------------Ccc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCccc
Confidence 346677766 666654 344 4555 3 278999999999999888999999999999999999997
Q ss_pred Ccc-chhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchh--ccccccceeccccCCccCCCCCc
Q 002278 100 GDI-PFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRL--IYWNEVLQYLGLRGNALTGMLSP 176 (943)
Q Consensus 100 ~~~-p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~ 176 (943)
+.+ |..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..+.. |..+++|++|+|++|+++++.+.
T Consensus 68 ~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 147 (455)
T 3v47_A 68 LVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147 (455)
T ss_dssp CEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCC
T ss_pred ceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcc
Confidence 555 567999999999999999999888999999999999999999998755554 88899999999999999988776
Q ss_pred c-cccccccceeeccceecccccCCCCcCC--CcccEEEeecccccCcCCCCC---------CcceEeEEEecCcccccc
Q 002278 177 D-MCQLTGLWYFDVRGNNLTGTIPDSIGNC--TSFEILDISYNQITGEIPYNI---------GFLQVATLSLQGNKLTGK 244 (943)
Q Consensus 177 ~-~~~l~~L~~L~L~~N~i~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~~~~~---------~~~~L~~L~L~~n~l~~~ 244 (943)
. +..+++|++|++++|++++..+..+..+ .+|+.|++++|.+.+..+..+ ...+|+.|++++|.+++.
T Consensus 148 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~ 227 (455)
T 3v47_A 148 SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES 227 (455)
T ss_dssp GGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHH
T ss_pred cccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCccccc
Confidence 6 8889999999999999998888888776 688999999998886544332 234677777777777666
Q ss_pred CCcccccc---CCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCcccccccccc
Q 002278 245 IPEVIGLM---QALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAEL 321 (943)
Q Consensus 245 ~~~~l~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 321 (943)
.|..+... .+|+.|++++|.+.+.. +..+.+....+..+..+
T Consensus 228 ~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~--------------------- 272 (455)
T 3v47_A 228 MAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGL--------------------- 272 (455)
T ss_dssp HHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGG---------------------
T ss_pred chhhhhccccccceeeEeeccccccccc--------------cchhhhccCcccccccc---------------------
Confidence 66655443 56666666666544321 11112222222222222
Q ss_pred CCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccE
Q 002278 322 GKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDT 401 (943)
Q Consensus 322 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 401 (943)
..++|+.|++++|++.+..|..|..+++|++|++++|++++..|..|.++++|++|+|++|++++..|..+..+++|+.
T Consensus 273 -~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 351 (455)
T 3v47_A 273 -EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEV 351 (455)
T ss_dssp -TTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCE
T ss_pred -cccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCE
Confidence 1134555555555555555555555555555555555555555556666666666666666666555666666777777
Q ss_pred EecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCC
Q 002278 402 LDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIP 462 (943)
Q Consensus 402 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 462 (943)
|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..|
T Consensus 352 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 352 LDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 7777777776667777777788888888888877666677888888888888888887666
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=412.81 Aligned_cols=249 Identities=22% Similarity=0.257 Sum_probs=202.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHH---HHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREF---ETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.++|+..++||+|+||+||+|+.+ +++.||+|++.+.. ......+ ..++++++.++|||||+++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999987 58899999986432 1222333 3446777888999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
|+||||++||+|.+++. ..+.+++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999997 456799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCc--cHHHHHHH-hccccccccccC
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNES--NLHQLIMS-KADDNTVMEAVD 843 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~--~~~~~~~~-~~~~~~~~~~~~ 843 (943)
+..... ...+||+.|||||++.+ ..|+.++||||+||++|||++|++||.+.. ........ ......++
T Consensus 342 ~~~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p---- 414 (689)
T 3v5w_A 342 FSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---- 414 (689)
T ss_dssp CSSCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----
T ss_pred cCCCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----
Confidence 754432 23579999999999964 579999999999999999999999997533 22222221 11111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT-----MQEVARVLV 885 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L~ 885 (943)
+.++ ..+.+++..|++.||++|++ +.|+.+|-+
T Consensus 415 ~~~S---------~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 415 DSFS---------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp TTSC---------HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred ccCC---------HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 1121 35678999999999999998 799988764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=401.30 Aligned_cols=415 Identities=24% Similarity=0.299 Sum_probs=246.9
Q ss_pred cEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEec
Q 002278 39 SVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLK 118 (943)
Q Consensus 39 ~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 118 (943)
+++.|++++|++ |.+|++++++++|++|++++|+++|.+|..++++.+|+.+++++|. ..+|++|+++
T Consensus 12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~-----------~~~l~~L~l~ 79 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL-----------DRQAHELELN 79 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHH-----------HHTCSEEECT
T ss_pred cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhh-----------ccCCCEEEec
Confidence 344455555555 3455555555555555555555555555555554444333322221 0234778888
Q ss_pred CcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceeccccc
Q 002278 119 NNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTI 198 (943)
Q Consensus 119 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~ 198 (943)
+|.+++ +|.. .++|++|++++|++++ +|.. ..+|++|++++|+++++... .++|++|++++|++++ +
T Consensus 80 ~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~----~~~L~~L~L~~n~l~~-l 146 (454)
T 1jl5_A 80 NLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDL----PPLLEYLGVSNNQLEK-L 146 (454)
T ss_dssp TSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSC----CTTCCEEECCSSCCSS-C
T ss_pred CCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCC----CCCCCEEECcCCCCCC-C
Confidence 887774 3432 3677888888888775 4543 36788888888888765421 2678888888888885 5
Q ss_pred CCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCC
Q 002278 199 PDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSY 278 (943)
Q Consensus 199 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 278 (943)
| .|+++++|++|++++|++++ +|... .+|++|++++|++++ +| .++.+++|+.|++++|.+++ +|... ++
T Consensus 147 p-~~~~l~~L~~L~l~~N~l~~-lp~~~--~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~ 216 (454)
T 1jl5_A 147 P-ELQNSSFLKIIDVDNNSLKK-LPDLP--PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LS 216 (454)
T ss_dssp C-CCTTCTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TT
T ss_pred c-ccCCCCCCCEEECCCCcCcc-cCCCc--ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---Cc
Confidence 6 58888888888888888875 55433 378888888888886 45 57888899999999998885 44332 57
Q ss_pred cceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeC
Q 002278 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHG 358 (943)
Q Consensus 279 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 358 (943)
|++|++++|.++ .+| .+..+++|++|++++|++++ +|.. +++|+.|++++|++++ +|.. .++|+.|++++
T Consensus 217 L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~ 286 (454)
T 1jl5_A 217 LESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSE 286 (454)
T ss_dssp CCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCS
T ss_pred ccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcC
Confidence 888999999888 556 48888999999999998884 4432 3788899999999886 4443 37888999999
Q ss_pred CcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCC
Q 002278 359 NRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLP 438 (943)
Q Consensus 359 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 438 (943)
|++++. |.. .++|+.|++++|++++. +.. ..+|+.|++++|++++ +|.. +++|+.|++++|++++ +|
T Consensus 287 N~l~~l-~~~---~~~L~~L~l~~N~l~~i-~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp 353 (454)
T 1jl5_A 287 NIFSGL-SEL---PPNLYYLNASSNEIRSL-CDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VP 353 (454)
T ss_dssp SCCSEE-SCC---CTTCCEEECCSSCCSEE-CCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CC
T ss_pred CccCcc-cCc---CCcCCEEECcCCcCCcc-cCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-cc
Confidence 988853 211 26788999999988752 221 2478899999999885 5554 5788899999999884 55
Q ss_pred ccccCCCccceecccCccccc--cCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccc--cCCCCcc
Q 002278 439 AEFGNLRSIQTIDMSFNQLSG--SIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSG--IIPPIRN 514 (943)
Q Consensus 439 ~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~~~~~~ 514 (943)
. .+++|++|++++|++++ .+|..+..+ +.|++.+.+|.. +++|+.||+++|++++ .+|.
T Consensus 354 ~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~--- 416 (454)
T 1jl5_A 354 E---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE--- 416 (454)
T ss_dssp C---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC------------------------------------
T ss_pred c---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcCCEEECCCCcCCccccchh---
Confidence 5 46889999999999987 677766543 346666677753 4788899999999987 4442
Q ss_pred cCcCCCCccccCCCCC
Q 002278 515 FSRFSSNSFIGNPLLC 530 (943)
Q Consensus 515 ~~~~~~~~~~~Np~~c 530 (943)
.+..+.+.+|...|
T Consensus 417 --sl~~L~~~~~~~~~ 430 (454)
T 1jl5_A 417 --SVEDLRMNSERVVD 430 (454)
T ss_dssp ----------------
T ss_pred --hHhheeCcCcccCC
Confidence 23344455655444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=401.84 Aligned_cols=385 Identities=22% Similarity=0.209 Sum_probs=272.9
Q ss_pred CEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccC-CCcccCCCCCCcEEEEec
Q 002278 65 QSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGP-IPSTLTQIPNLKTLDLAR 143 (943)
Q Consensus 65 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~ 143 (943)
+.++.++++++ .+|. + .++|++|+|++|++++..|..|+++++|++|+|++|.+.+. .+..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 46777888887 6665 3 36788888888888866677788888888888888877633 356677788888888888
Q ss_pred cccccccchhccccccceeccccCCccCCCCCc--ccccccccceeeccceecccccCCC-CcCCCcccEEEeecccccC
Q 002278 144 NQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSP--DMCQLTGLWYFDVRGNNLTGTIPDS-IGNCTSFEILDISYNQITG 220 (943)
Q Consensus 144 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~N~i~~~~~~~-l~~l~~L~~L~Ls~N~l~~ 220 (943)
|++++..|..|..+++|++|+|++|++++..+. .+..+++|++|+|++|++++..|.. +.+++
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~-------------- 154 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMR-------------- 154 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCT--------------
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCC--------------
Confidence 777766666666666666666666665542221 1444444444444444444333332 34444
Q ss_pred cCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCC--CCcceEEecCCCCCCCCCCC--
Q 002278 221 EIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNL--SYTGKLYLHGNKLTGPIPPE-- 296 (943)
Q Consensus 221 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~-- 296 (943)
+|++|++++|.+.+..+..+..+ .+|+.|++++|.+.+..+..
T Consensus 155 ---------------------------------~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~ 201 (455)
T 3v47_A 155 ---------------------------------RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG 201 (455)
T ss_dssp ---------------------------------TCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTT
T ss_pred ---------------------------------cccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcc
Confidence 44444444444444444433333 34444444444444333222
Q ss_pred ------cCCCCcCcEEEcccCccccccccccCCc---ccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccc
Q 002278 297 ------LGNMSKLSYLQLQNNQLVGTIPAELGKL---EQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPS 367 (943)
Q Consensus 297 ------~~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 367 (943)
+..+++|++|++++|++++..|..+... ++|+.|++++|.+.+... ..+.+....+.
T Consensus 202 ~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~ 267 (455)
T 3v47_A 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNF 267 (455)
T ss_dssp HHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTT
T ss_pred ccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc--------------chhhhccCccc
Confidence 3356778888888888887777766554 778888888887654311 12233333333
Q ss_pred ccccc--CccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCC
Q 002278 368 SFRNL--GSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLR 445 (943)
Q Consensus 368 ~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 445 (943)
.|..+ ++|+.|++++|++++..|..+..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|.+++
T Consensus 268 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 347 (455)
T 3v47_A 268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD 347 (455)
T ss_dssp TTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCT
T ss_pred ccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcc
Confidence 44443 6899999999999988888999999999999999999988888999999999999999999988889999999
Q ss_pred ccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCCcc
Q 002278 446 SIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRN 514 (943)
Q Consensus 446 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 514 (943)
+|++|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+++|+.|++++|++++.+|....
T Consensus 348 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 416 (455)
T 3v47_A 348 KLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 416 (455)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHH
T ss_pred cCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcchH
Confidence 999999999999988899999999999999999999987777788999999999999999998886543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=381.79 Aligned_cols=283 Identities=39% Similarity=0.666 Sum_probs=234.5
Q ss_pred cccCHHHHHHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEe
Q 002278 604 AIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYAL 682 (943)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 682 (943)
..++++++....++|+..+.||+|+||.||+|..++++.||||++..... .....+.+|+++++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 45788999999999999999999999999999988899999999865432 22346899999999999999999999999
Q ss_pred cCCcceEEEEEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecc
Q 002278 683 SPYGNLLFYDYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSD 761 (943)
Q Consensus 683 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 761 (943)
.+...++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999997543 234599999999999999999999998777999999999999999999999999
Q ss_pred cccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCC-------CccHHHHHHHhcc
Q 002278 762 FGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDN-------ESNLHQLIMSKAD 834 (943)
Q Consensus 762 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~-------~~~~~~~~~~~~~ 834 (943)
||+++..............||+.|+|||++.+..++.++||||+||++|||+||+.||+. ......+......
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 999998765555555556699999999999988999999999999999999999999961 1223333333333
Q ss_pred ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 835 DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
........++..... ........+.+++..||+.||++|||+.+++++|+..
T Consensus 258 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 258 EKKLEALVDVDLQGN-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SCCSTTSSCTTCTTS-CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhhhhhcChhhccc-cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 333333333333322 2446678899999999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=377.87 Aligned_cols=278 Identities=39% Similarity=0.635 Sum_probs=228.9
Q ss_pred HHHHHHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 608 FDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 608 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
+.++...+++|+..+.||+|+||+||+|.+++++.||+|++........+.+.+|+++++.++||||+++++++.+.+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33445577899999999999999999999888999999998777666778899999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCC-CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSK-KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999974322 23689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc-----HHHHHHHhcccccccc
Q 002278 767 CIPTAM-PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN-----LHQLIMSKADDNTVME 840 (943)
Q Consensus 767 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~-----~~~~~~~~~~~~~~~~ 840 (943)
...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..... ...+............
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 654322 2223344589999999999999999999999999999999999999975332 2222222222333333
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.+++..... ........+.+++..||+.||++|||+.|++++|+.+..
T Consensus 268 ~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 268 IVDPNLADK-IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSSCTTC-SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcChhhccc-cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 344433322 234667789999999999999999999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=369.90 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=215.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..++|+..+.||+|+||+||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 3568999999999999999999964 688999999976666667889999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 98 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999986 23589999999999999999999999 99999999999999999999999999998775443
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.. .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+................... ..+.+
T Consensus 171 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~------ 242 (297)
T 3fxz_A 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKL------ 242 (297)
T ss_dssp CC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-CGGGS------
T ss_pred cc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-Ccccc------
Confidence 32 23356999999999999999999999999999999999999999877665544433322211110 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++..||+.||++|||+.|+++|-+-
T Consensus 243 ---~~~~~~li~~~l~~dp~~Rps~~ell~h~~~ 273 (297)
T 3fxz_A 243 ---SAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273 (297)
T ss_dssp ---CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 2457789999999999999999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=375.55 Aligned_cols=265 Identities=28% Similarity=0.433 Sum_probs=208.4
Q ss_pred HHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 612 MRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 612 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
....++|+..+.||+|+||+||+|++. ++.||||++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 345678999999999999999999874 7889999986553 2334578899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCccEEECCCCceeecccccccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR--IIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
||||+++|+|.+++........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999997543334599999999999999999999998 8 99999999999999999999999999986
Q ss_pred cCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.................. ....+.+
T Consensus 189 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~- 264 (309)
T 3p86_A 189 KASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR--LEIPRNL- 264 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC--CCCCTTS-
T ss_pred cccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCccC-
Confidence 543322 223456999999999999999999999999999999999999999876654433332211111 0111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
...+.+++..||+.||++|||+.++++.|+.+.....
T Consensus 265 --------~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 265 --------NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred --------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 1467789999999999999999999999998876543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=389.51 Aligned_cols=382 Identities=23% Similarity=0.308 Sum_probs=226.9
Q ss_pred cEEEEEcCCCCCccccCCCcCCCCCC-------------CEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchh
Q 002278 39 SVVSLNLSSLNLGGEISPSIGDLRNL-------------QSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFS 105 (943)
Q Consensus 39 ~v~~L~l~~~~~~~~~~~~l~~l~~L-------------~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 105 (943)
+++.|++++|+++|.+|.+++.+.+| ++|++++|++++ +|.. .++|++|++++|++++ +|..
T Consensus 35 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~ 109 (454)
T 1jl5_A 35 SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL 109 (454)
T ss_dssp CHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC
T ss_pred chhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc
Confidence 45678999999999999999999876 888888888874 4542 3678888888888885 5643
Q ss_pred ccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccc
Q 002278 106 ISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLW 185 (943)
Q Consensus 106 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 185 (943)
+++|++|++++|++++ +|.. .++|++|+|++|++++ +| .|..+++|++|++++|++++++. . ..+|+
T Consensus 110 ---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~-~---~~~L~ 176 (454)
T 1jl5_A 110 ---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPD-L---PPSLE 176 (454)
T ss_dssp ---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCC-C---CTTCC
T ss_pred ---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCC-C---ccccc
Confidence 4778888888888874 3322 1678888888888875 55 47777888888888888877532 2 34777
Q ss_pred eeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCC
Q 002278 186 YFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENEL 265 (943)
Q Consensus 186 ~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l 265 (943)
+|++++|++++ +| .++++++|++|++++|++++ +|.. ..+|+.|++++|.+
T Consensus 177 ~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~--------------------------~~~L~~L~l~~n~l 227 (454)
T 1jl5_A 177 FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL--------------------------PLSLESIVAGNNIL 227 (454)
T ss_dssp EEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC--------------------------CTTCCEEECCSSCC
T ss_pred EEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC--------------------------cCcccEEECcCCcC
Confidence 77888887775 44 57777777777777777763 3321 12566666666666
Q ss_pred CCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccc
Q 002278 266 VGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNI 345 (943)
Q Consensus 266 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 345 (943)
. .+| .+..+++|++|++++|++++ +|.. +++|++|++++|++++ +|.. +++|+.|++++|++++. |..
T Consensus 228 ~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~- 295 (454)
T 1jl5_A 228 E-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL- 295 (454)
T ss_dssp S-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC-
T ss_pred C-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc-
Confidence 5 344 25566666666666666664 3322 3566667777776664 3332 25667777777776642 111
Q ss_pred cCCCcCcEEEeeCCcccCccccccccc-CccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccc
Q 002278 346 SSCTALNQFNVHGNRLSGAIPSSFRNL-GSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLL 424 (943)
Q Consensus 346 ~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 424 (943)
.++|+.|++++|++++. + .+ ++|+.|++++|++++ +|.. +++|+.|++++|+++ .+|. .+++|+
T Consensus 296 --~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~ 360 (454)
T 1jl5_A 296 --PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLK 360 (454)
T ss_dssp --CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCC
T ss_pred --CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhcc
Confidence 15677777777777642 1 23 478888888888875 4543 467888888888888 4555 467888
Q ss_pred eeecccccccc--cCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCC--CCCCcCccccCCccccc
Q 002278 425 TLNLSRNHLNG--LLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG--GIPDQLSNCFSLSNLNV 500 (943)
Q Consensus 425 ~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l 500 (943)
+|++++|++++ .+|..+.. |+.|.+.+.+|.. +++|+.|++++|++++ .+|. .|+.|.+
T Consensus 361 ~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~ 423 (454)
T 1jl5_A 361 QLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE------SVEDLRM 423 (454)
T ss_dssp EEECCSSCCSSCCCCCTTCCE--------EECCC----------------------------------------------
T ss_pred EEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchh------hHhheeC
Confidence 88888888887 55665543 2346677777763 5778888899988886 5554 3566778
Q ss_pred CCccccccCCC
Q 002278 501 SYNNLSGIIPP 511 (943)
Q Consensus 501 s~N~l~~~~~~ 511 (943)
.+|.+.+.++.
T Consensus 424 ~~~~~~~~~~~ 434 (454)
T 1jl5_A 424 NSERVVDPYEF 434 (454)
T ss_dssp -----------
T ss_pred cCcccCCcccc
Confidence 88888876653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=374.76 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=214.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc------ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP------HNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.+.|+..+.||+|+||+||+|..+ +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999987 588999999865432 2357899999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC----ceeecccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF----DAHLSDFG 763 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DFG 763 (943)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999996 345799999999999999999999999 999999999999998776 79999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+......+....+
T Consensus 165 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp SCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred CceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 9987754322 23346999999999999999999999999999999999999999887665555444433332222222
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.++ ..+.+++..|+..||++|||+.|+++|-+
T Consensus 243 ~~~s---------~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 243 SQTS---------ELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp TTSC---------HHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred cCCC---------HHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 2222 45678999999999999999999998755
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=365.30 Aligned_cols=263 Identities=29% Similarity=0.408 Sum_probs=213.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||.||+|++. .++.||+|++..... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999976 578999999854432 3346788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999996 345699999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc-cccccCcccccC
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT-VMEAVDPEVSVT 849 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 849 (943)
..........||+.|+|||++.+..++.++||||+||++|||+||+.||.+...............+ ......+.++
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 241 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP-- 241 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC--
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC--
Confidence 4434444566999999999999999999999999999999999999999887765554443332221 1122222222
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcCCCCC
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERP-TMQEVARVLVSLLPAPP 892 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~el~~~L~~~~~~~~ 892 (943)
..+.+++.+|++.||++|| +++++.+.|+.+.....
T Consensus 242 -------~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 242 -------QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp -------HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred -------HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 4677899999999999998 99999999988766544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=369.75 Aligned_cols=251 Identities=19% Similarity=0.244 Sum_probs=211.4
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||+||+|+.+ +++.||+|++.+. .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999976 5889999998653 234567788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++++||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999986 345689999999999999999999999 999999999999999999999999999986433
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+......++.. +
T Consensus 158 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~----~---- 228 (337)
T 1o6l_A 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----L---- 228 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----S----
T ss_pred CCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC----C----
Confidence 222 2234569999999999999999999999999999999999999998766544333333222222111 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
...+.+++..||+.||++|| ++.|+++|-+
T Consensus 229 -----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 229 -----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp -----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred -----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 14567899999999999999 9999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=367.53 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=220.8
Q ss_pred cccCHHHHHHHhhc----------cccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCC
Q 002278 604 AIHTFDDIMRSTEN----------LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHR 672 (943)
Q Consensus 604 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 672 (943)
..++++++..+++. |...+.||+|+||.||+|+.+ +++.||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45677888777664 777789999999999999987 6899999999776666778899999999999999
Q ss_pred CcceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC
Q 002278 673 NIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID 752 (943)
Q Consensus 673 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 752 (943)
||+++++++...+..++||||+++|+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 99999999999999999999999999999985 34689999999999999999999999 999999999999999
Q ss_pred CCCceeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHh
Q 002278 753 ENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSK 832 (943)
Q Consensus 753 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 832 (943)
.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~ 254 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 254 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 9999999999999876544322 233469999999999999999999999999999999999999998766544433322
Q ss_pred ccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.... +..... ......+.+++..||+.||++|||+.+++++.+-.
T Consensus 255 ~~~~-------~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 255 DSPP-------PKLKNS---HKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp HSSC-------CCCTTG---GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred cCCC-------CCcCcc---ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 2111 111100 01124577899999999999999999999986643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=373.16 Aligned_cols=252 Identities=19% Similarity=0.279 Sum_probs=211.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
..++|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4568999999999999999999974 68999999986542 33456788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999986 345699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeEecccceeCccccccCCCC-CcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLN-EKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
... ....+||+.|+|||++.+..+. .++||||+||++|||++|+.||.+.................+.. +
T Consensus 167 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~----~--- 237 (328)
T 3fe3_A 167 GGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY----M--- 237 (328)
T ss_dssp SCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----S---
T ss_pred CCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC----C---
Confidence 322 2334699999999999988765 79999999999999999999998776544433333322222111 1
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++.+|+..||++|||+.|+++|-+-
T Consensus 238 ------s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 238 ------STDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp ------CHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred ------CHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 1456789999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=358.03 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=217.5
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..++|+..+.||+|+||.||+|.++++..||+|++.... ...+++.+|++++++++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 356899999999999999999999988899999987543 3457799999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999863 234599999999999999999999999 999999999999999999999999999987755433
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......+|+.|+|||++.+..++.++||||+|+++|||+| |+.||.................... +..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~------ 229 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR----PHL------ 229 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----CTT------
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC----CCc------
Confidence 33333456778999999999899999999999999999999 9999987665544433332221111 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
....+.+++..||+.||++|||+.+++++|+.+....
T Consensus 230 --~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 230 --ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1146778999999999999999999999999887643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=366.16 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=212.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc------ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP------HNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.+.|...+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999986 578999999865432 2467899999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC----ceeecccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF----DAHLSDFG 763 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DFG 763 (943)
++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999996 345699999999999999999999999 999999999999999877 79999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+......................
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 9987754322 22346999999999999999999999999999999999999999877655544443332222222111
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.+ ...+.+++..||+.||++|||+.++++|-+
T Consensus 242 ~~~---------~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 242 SNT---------SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp TTS---------CHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred ccC---------CHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 111 145678999999999999999999999855
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=358.65 Aligned_cols=257 Identities=27% Similarity=0.395 Sum_probs=214.5
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.++|+..+.||+|+||+||+|.+.+++.||+|++... ....+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 4678999999999999999999988899999998754 334578999999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999964 334689999999999999999999999 9999999999999999999999999999876443222
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......||+.|+|||++.+..++.++||||+|+++|||++ |+.||................... .+..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~------- 231 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----KPRL------- 231 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC----CCTT-------
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC----CCCc-------
Confidence 2223346788999999999999999999999999999999 999998766544333322221111 1110
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
....+.+++..||+.||++|||+.+++++|+.+..
T Consensus 232 -~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 232 -ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 12467789999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=375.34 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=201.5
Q ss_pred hhccccceEEeeeceEEEEEEEec----CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.++|+..+.||+|+||.||+|+++ .+..||||++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999875 46789999987543 3345678999999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999974 234689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCce--eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 770 TAMPHA--STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 770 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||............... .... ...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~-~~~~--~~~-- 273 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP--PPM-- 273 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT-EECC--CCT--
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCC--CCc--
Confidence 432211 122235778999999999999999999999999999998 99999876544332222111 1100 011
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
.....+.+++..||+.||++||++.++++.|+.+....
T Consensus 274 -------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 274 -------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 11256789999999999999999999999998876543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=364.22 Aligned_cols=256 Identities=18% Similarity=0.236 Sum_probs=214.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|+..+.||+|+||+||+|.++ +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999987 4788999988643 34456788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC--CCceeecccccccccCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE--NFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~DFGla~~~~~~ 771 (943)
+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999963 234689999999999999999999999 9999999999999987 789999999999877543
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+......................+.++
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s---- 231 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS---- 231 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSC----
T ss_pred --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCC----
Confidence 23345679999999999999889999999999999999999999998776554444433333322222222222
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
..+.+++..|+..||++|||+.|+++|-+-.
T Consensus 232 -----~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 232 -----IEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp -----HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred -----HHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 4677899999999999999999999987643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=378.68 Aligned_cols=262 Identities=21% Similarity=0.235 Sum_probs=214.6
Q ss_pred HHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecC
Q 002278 609 DDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSP 684 (943)
Q Consensus 609 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 684 (943)
.++....++|+..+.||+|+||+||+|+.+ +++.||+|++.+.. ....+.+.+|+++++.++|||||++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 444456789999999999999999999987 47889999986421 22234578899999999999999999999999
Q ss_pred CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
...++||||+++|+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999986 23589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCC----CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSR----LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 840 (943)
|+.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+........-
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 294 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 294 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC
Confidence 9877554333333567999999999998765 789999999999999999999999987665554444332211111
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhh
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSE--RPTMQEVARVLVS 886 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~el~~~L~~ 886 (943)
...+.++ ..+.+++..|+..+|.+ ||++.|+++|-+-
T Consensus 295 p~~~~~s---------~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 295 PDDNDIS---------KEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp CTTCCCC---------HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred CCccccc---------HHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 1111121 45678999999999998 9999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=379.81 Aligned_cols=256 Identities=21% Similarity=0.241 Sum_probs=213.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
..++|+..+.||+|+||+||+|..+ +++.||+|++.... ....+.+.+|+++++.++|||||++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4678999999999999999999976 57889999986543 23345788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC---CCCceeecccccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID---ENFDAHLSDFGIARC 767 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DFGla~~ 767 (943)
|||+++|+|.+.+. ....+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999886 345699999999999999999999999 999999999999998 467899999999987
Q ss_pred cCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
....... .....||+.|+|||++.+..++.++||||+||++|+|++|++||.+.....................++.++
T Consensus 163 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 241 (444)
T 3soa_A 163 VEGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241 (444)
T ss_dssp CCTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred ecCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence 6544322 233569999999999999999999999999999999999999998876655544444433333322222222
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+.+++..|++.||++|||+.|+++|-+
T Consensus 242 ---------~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 242 ---------PEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp ---------HHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred ---------HHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 45778999999999999999999999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=370.45 Aligned_cols=255 Identities=20% Similarity=0.313 Sum_probs=214.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|+..+.||+|+||+||+|..+ +++.||+|++..........+.+|+++++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999986 5788999998766555566789999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC--CCceeecccccccccCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE--NFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~DFGla~~~~~~ 771 (943)
+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999863 234689999999999999999999999 9999999999999974 577999999999877544
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+......................+.+
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~----- 277 (387)
T 1kob_A 205 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV----- 277 (387)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTS-----
T ss_pred c--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccC-----
Confidence 2 233456999999999999999999999999999999999999999987665544443333222222211122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++..||+.||++|||+.|++++-+
T Consensus 278 ----s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 278 ----SPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp ----CHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 246779999999999999999999999855
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=373.59 Aligned_cols=252 Identities=20% Similarity=0.245 Sum_probs=207.8
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 688 (943)
..++|+..+.||+|+||+||+|+.+ +++.||+|++.+. .....+.+.+|.++++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999976 5789999998653 233456788899999988 6999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999996 345699999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+......++..+
T Consensus 175 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~------ 247 (353)
T 3txo_A 175 ICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL------ 247 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS------
T ss_pred ccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC------
Confidence 3322 223345799999999999999999999999999999999999999988776555544443332222211
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTM------QEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~el~~~L~ 885 (943)
...+.++++.|++.||++||++ .++++|-+
T Consensus 248 -------~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 248 -------HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp -------CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred -------CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 1356789999999999999998 88888654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=370.57 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=212.4
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
..++|+..+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999976 57899999986543 23456788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC---Cceeecccccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN---FDAHLSDFGIARC 767 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DFGla~~ 767 (943)
|||+++|+|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+||+++.+ +.+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999886 345689999999999999999999999 99999999999999864 4599999999987
Q ss_pred cCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+......+..............++.+
T Consensus 181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 257 (362)
T 2bdw_A 181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV- 257 (362)
T ss_dssp CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGS-
T ss_pred ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC-
Confidence 654322 22346999999999999999999999999999999999999999877655444443333322222211222
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++..||+.||++|||+.++++|-+
T Consensus 258 --------~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 258 --------TPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp --------CHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred --------CHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 245678999999999999999999998865
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=365.37 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=212.7
Q ss_pred hhccccceEEeeeceEEEEEEEec----CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.++|+..+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|+++++.++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467888999999999999999985 34469999997543 3345678999999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999963 235699999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCc--eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 770 TAMPH--ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 770 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+................ . ....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~- 278 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-P--APMG- 278 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-C--CCTT-
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-C--CCCC-
Confidence 43222 2223346788999999999999999999999999999999 99999876654433332222110 0 1111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
....+.+++..||+.||++|||+.++++.|+.+...+.
T Consensus 279 --------~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 279 --------CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp --------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred --------cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 12467889999999999999999999999998875543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=364.48 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=210.6
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|...+.||+|+||+||+|.+. +++.||+|++........+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467899999999999999999976 5789999998776666778899999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999973 245689999999999999999999999 999999999999999999999999999987644322
Q ss_pred ce-------------eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc
Q 002278 774 HA-------------STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840 (943)
Q Consensus 774 ~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 840 (943)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||............ ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-~~~~~~~~ 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-NVRGFLDR 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-CHHHHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-hhhccccc
Confidence 11 11346999999999999999999999999999999999999998743211000000 00000000
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
...+.++ ..+.+++..||+.||++|||+.++++.|+.+..
T Consensus 243 ~~~~~~~---------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 243 YCPPNCP---------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp TCCTTCC---------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCC---------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111111 356789999999999999999999999987754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=365.13 Aligned_cols=248 Identities=17% Similarity=0.186 Sum_probs=211.7
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+.+|+++++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999976 58899999986432 34557788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999996 345689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+......++.. +
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~----~---- 261 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----F---- 261 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----C----
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCC----C----
Confidence 3 223469999999999999999999999999999999999999998776555444443332222211 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPT-----MQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L~ 885 (943)
...+.+++..||+.||++||+ +.++++|-+
T Consensus 262 -----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 262 -----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp -----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 145678999999999999998 999988765
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=357.70 Aligned_cols=281 Identities=34% Similarity=0.562 Sum_probs=226.8
Q ss_pred cccccCHHHHHHHhhccccc------eEEeeeceEEEEEEEecCCceEEEEEecccC----cccHHHHHHHHHHHhcCCC
Q 002278 602 DMAIHTFDDIMRSTENLSEK------YIVGYGASSTVYKCALKNSRPIAVKKLYNQY----PHNLREFETELETIGSIRH 671 (943)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 671 (943)
+...++++++..++++|... +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+++++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34568899999999999888 8999999999999987 47899999986532 2345778999999999999
Q ss_pred CCcceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE
Q 002278 672 RNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI 751 (943)
Q Consensus 672 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 751 (943)
|||+++++++.+.+..++||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999987544455699999999999999999999999 99999999999999
Q ss_pred CCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccH---HH
Q 002278 752 DENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL---HQ 827 (943)
Q Consensus 752 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~---~~ 827 (943)
++++.+||+|||+++........ ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... ..
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 99999999999999876543222 2223468999999998865 5889999999999999999999999754321 12
Q ss_pred HHHHhcc-ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 828 LIMSKAD-DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 828 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
+...... ...+.+.+++... .........+.+++..||+.||++|||+.+++++|+.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2221111 1122222222222 1234556788899999999999999999999999988653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=370.02 Aligned_cols=283 Identities=29% Similarity=0.514 Sum_probs=247.1
Q ss_pred CcccccccCccccCCCCCCCCCCCCCC--cceeEecCCC--CcEEEEEcCCCCCcc--ccCCCcCCCCCCCEEEeeC-Cc
Q 002278 1 MAIKASFSNLANVLLDWDDVHNSDFCS--WRGVFCDNSS--LSVVSLNLSSLNLGG--EISPSIGDLRNLQSIDFQG-NK 73 (943)
Q Consensus 1 ~~~~~~~~~~~~~~~~w~~~~~~~~c~--w~gv~c~~~~--~~v~~L~l~~~~~~~--~~~~~l~~l~~L~~L~Ls~-n~ 73 (943)
++||+++.||. .+++|.. ++|||. |.||.|+..+ ++|+.|+|++|++++ .+|+.++.+++|++|+|++ |+
T Consensus 12 ~~~k~~~~~~~-~l~~W~~--~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~ 88 (313)
T 1ogq_A 12 LQIKKDLGNPT-TLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88 (313)
T ss_dssp HHHHHHTTCCG-GGTTCCT--TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETT
T ss_pred HHHHHhcCCcc-cccCCCC--CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCc
Confidence 37899999887 8999975 579998 9999998765 799999999999999 8999999999999999995 99
Q ss_pred ccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchh
Q 002278 74 LTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRL 153 (943)
Q Consensus 74 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 153 (943)
+++.+|..|+++++|++|+|++|++++.+|..|+++++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..
T Consensus 89 l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 168 (313)
T 1ogq_A 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168 (313)
T ss_dssp EESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGG
T ss_pred ccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999899999
Q ss_pred ccccc-cceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEe
Q 002278 154 IYWNE-VLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVA 232 (943)
Q Consensus 154 ~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~ 232 (943)
+..+. +|++|+|++|++++..|..+..+. |+.|++++|++++..|..|..+++|++|+|++|++++.+|.
T Consensus 169 l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------- 239 (313)
T 1ogq_A 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-------- 239 (313)
T ss_dssp GGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG--------
T ss_pred HhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc--------
Confidence 99998 899999999999988888999887 99999999999988899999999999999999998754443
Q ss_pred EEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCc
Q 002278 233 TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQ 312 (943)
Q Consensus 233 ~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 312 (943)
+..+++|++|+|++|++++.+|..|..+++|+.|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 240 ----------------~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 240 ----------------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp ----------------CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred ----------------ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 344566666777777666666666666777777777777776666654 667777777777776
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=377.94 Aligned_cols=360 Identities=21% Similarity=0.271 Sum_probs=258.7
Q ss_pred ccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCC
Q 002278 53 EISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQ 132 (943)
Q Consensus 53 ~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 132 (943)
..+.+++.+++|++|+|++|+|++ +| .|+.+++|++|+|++|++++ +| ++.+++|++|+|++|++++. + ++.
T Consensus 33 ~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~ 104 (457)
T 3bz5_A 33 TDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTP 104 (457)
T ss_dssp TSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred ccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCC
Confidence 444567788888888888888885 45 68888888888888888885 34 78888888888888888864 3 788
Q ss_pred CCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEE
Q 002278 133 IPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILD 212 (943)
Q Consensus 133 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~ 212 (943)
+++|++|+|++|++++. + +..+++|++|++++|+++++ .++.+++|++|++++|+..+.+ .+..+++|++|+
T Consensus 105 l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 176 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD 176 (457)
T ss_dssp CTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence 88888888888888753 3 67777788888888887775 2667777777777777444333 366677777777
Q ss_pred eecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCC
Q 002278 213 ISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGP 292 (943)
Q Consensus 213 Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 292 (943)
+++|++++ +| +..+++|+.|++++|.+++. .+..+++|+.|++++|++++
T Consensus 177 ls~n~l~~------------------------l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~- 226 (457)
T 3bz5_A 177 CSFNKITE------------------------LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE- 226 (457)
T ss_dssp CCSSCCCC------------------------CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-
T ss_pred CCCCccce------------------------ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-
Confidence 77777663 12 44566677777777777654 26667777777777777775
Q ss_pred CCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCccccccccc
Q 002278 293 IPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNL 372 (943)
Q Consensus 293 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 372 (943)
+| +..+++|++|++++|++++.. +..+++|+.|++++|+ |+.|++++|.+.+.+| +..+
T Consensus 227 ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l 285 (457)
T 3bz5_A 227 ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGC 285 (457)
T ss_dssp CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTC
T ss_pred cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--cccc
Confidence 34 667777777777777777543 3455667777766653 4456677777666655 4567
Q ss_pred CccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecc
Q 002278 373 GSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDM 452 (943)
Q Consensus 373 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 452 (943)
++|+.|++++|.+.+.+|. ...+|+.|++++| ++|+.|+|++|++++. .++++++|+.|++
T Consensus 286 ~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l 346 (457)
T 3bz5_A 286 RKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLSC 346 (457)
T ss_dssp TTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEEC
T ss_pred ccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc---ccccCCcCcEEEC
Confidence 7788888888876666553 2344555555544 5788888888888874 2888888888888
Q ss_pred cCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCC
Q 002278 453 SFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP 511 (943)
Q Consensus 453 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 511 (943)
++|+|++ ++.|..|++++|+++|. ..+..|..+++++|+|+|.+|.
T Consensus 347 ~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 347 VNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp CSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred CCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence 8888885 24677778888888865 3567788889999999998875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=361.95 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=211.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999976 58899999986532 24456788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999997 345689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
. ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+......++. .+
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~---- 226 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FF---- 226 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TS----
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CC----
Confidence 2 22346999999999999999999999999999999999999999877665554444433222221 11
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
...+.+++.+|+..||++|| ++.++++|-+
T Consensus 227 -----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 227 -----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp -----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 14567899999999999999 8999998755
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=370.14 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=210.2
Q ss_pred hhccccceEEeeeceEEEEEEEec--------CCceEEEEEecccCc-ccHHHHHHHHHHHhcC-CCCCcceeeeEEecC
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK--------NSRPIAVKKLYNQYP-HNLREFETELETIGSI-RHRNIVSLHGYALSP 684 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 684 (943)
.++|+..+.||+|+||.||+|++. .+..||||++..... ...+.+.+|+++++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999863 245799999875432 3456789999999999 899999999999999
Q ss_pred CcceEEEEEccCCChhhhccCCCC-------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSK-------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI 751 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 751 (943)
+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++ +|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999864321 23589999999999999999999999 99999999999999
Q ss_pred CCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHH
Q 002278 752 DENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLI 829 (943)
Q Consensus 752 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~ 829 (943)
+.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999999876543221 1222346889999999999999999999999999999999 999998654433222
Q ss_pred HHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 830 MSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...... .+..+.. ....+.+++..||+.||++|||+.|++++|+.+.
T Consensus 317 ~~~~~~-------~~~~~~~-----~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 317 LLKEGH-------RMDKPAN-----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHTTC-------CCCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCC-------CCCCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 211111 1111111 1246788999999999999999999999998765
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=363.13 Aligned_cols=256 Identities=24% Similarity=0.311 Sum_probs=205.7
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||+||+|.++ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999977 68899999986443 2334668899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999997 345699999999999999999999999 99999999999999999999999999998663221
Q ss_pred C-ceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 773 P-HASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 773 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
. .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...................... ...+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~---- 234 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP-WKKI---- 234 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTT-GGGS----
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCc-cccC----
Confidence 1 11233569999999999987765 789999999999999999999998654432222221111111110 0111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++.+||+.||++|||+.|++++-+-
T Consensus 235 -----~~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 235 -----DSAPLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp -----CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred -----CHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 2456789999999999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=361.48 Aligned_cols=264 Identities=23% Similarity=0.248 Sum_probs=205.9
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||+||+|.+++++.||+|++.... ......+.+|++++++++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 47899999999999999999999889999999986443 2234678899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9975 78887763 334589999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc---
Q 002278 773 PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV--- 848 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 848 (943)
.. .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..............+.......+....
T Consensus 174 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 RS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 22 233458999999999876 5689999999999999999999999986554443333222111111110010000
Q ss_pred ---------CccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 ---------TCVDL-----SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ---------~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..... .....+.+++..|++.||++|||+.|+++|-+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 00000 11246778999999999999999999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=356.66 Aligned_cols=257 Identities=21% Similarity=0.348 Sum_probs=212.1
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..++|+..+.||+|+||+||+|.++++..||+|++... ....+++.+|+++++.++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 45789999999999999999999998889999998754 33457899999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999973 245699999999999999999999999 999999999999999999999999999987644322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......+|+.|+|||++.+..++.++||||+|+++|||+| |+.||.................... +..
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~------ 245 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR----PHL------ 245 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----CTT------
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC----CCc------
Confidence 22222346788999999999999999999999999999998 9999987665444333332211111 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
....+.+++..||+.||++|||+.+++++|+.+.
T Consensus 246 --~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 246 --ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp --CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 1146778999999999999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=369.14 Aligned_cols=254 Identities=20% Similarity=0.290 Sum_probs=210.0
Q ss_pred HHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCc
Q 002278 612 MRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYG 686 (943)
Q Consensus 612 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 686 (943)
....++|...+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+..|.++++.+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999986 57889999986532 34456788899998876 89999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999996 345699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
....... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+......+..+......++.. +
T Consensus 167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~----~ 241 (345)
T 1xjd_A 167 ENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----L 241 (345)
T ss_dssp CCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----S
T ss_pred hcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc----c
Confidence 6533222 2334569999999999999999999999999999999999999998776554444333322222111 1
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHh
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQ-EVARVLV 885 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-el~~~L~ 885 (943)
...+.+++.+|++.||++||++. ++.+|-+
T Consensus 242 ---------s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 242 ---------EKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp ---------CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred ---------CHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 14567899999999999999997 7776543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=358.78 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=207.7
Q ss_pred hhccccceEEeeeceEEEEEEEecC-C-------ceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-S-------RPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
.++|...+.||+|+||+||+|.++. + ..||+|++........+.+.+|+++++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4688999999999999999998763 2 4699999977666677889999999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc--------ee
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD--------AH 758 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~k 758 (943)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999973 233489999999999999999999999 9999999999999998887 99
Q ss_pred ecccccccccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc
Q 002278 759 LSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT 837 (943)
Q Consensus 759 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 837 (943)
|+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+..................
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 9999999755322 22348899999999987 67999999999999999999965555443333333333222222
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCccCc
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSL 897 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~~~~~~ 897 (943)
...... ..+.+++..||+.||++|||+.+++++|+.+..+...+...
T Consensus 237 ~~~~~~-------------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~ 283 (289)
T 4fvq_A 237 LPAPKA-------------AELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283 (289)
T ss_dssp CCCCSS-------------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---------
T ss_pred CCCCCC-------------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCc
Confidence 222211 23568999999999999999999999999998765554433
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=357.18 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=206.0
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
++|+..+.||+|+||+||+|....++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999999889999999986443 22346788999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 89888863 235689999999999999999999999 999999999999999999999999999987653322
Q ss_pred ceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc----------c
Q 002278 774 HASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA----------V 842 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------~ 842 (943)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..............+..... .
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 2233468999999999876 458999999999999999999999998776655544433211111100 0
Q ss_pred CcccccC------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 843 DPEVSVT------CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 843 ~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
++.+... .........+.+++.+|++.||++|||+.|+++|-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 1111000 000012246779999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=355.01 Aligned_cols=252 Identities=19% Similarity=0.262 Sum_probs=200.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--------------------------ccHHHHHHHHHHHh
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--------------------------HNLREFETELETIG 667 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 667 (943)
.++|+..+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999976 578899999864421 11346889999999
Q ss_pred cCCCCCcceeeeEEec--CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 002278 668 SIRHRNIVSLHGYALS--PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVK 745 (943)
Q Consensus 668 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 745 (943)
.++||||+++++++.+ ....++||||+++|+|.+++. ...+++.++..++.|++.||+|||+. +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999987 457899999999999988763 35699999999999999999999999 99999999
Q ss_pred CccEEECCCCceeecccccccccCCCCCceeeeEecccceeCccccccCC---CCCcchhhhHHHHHHHHHhCCCCCCCC
Q 002278 746 SSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR---LNEKSDVYSFGIVLLEILTGKKAVDNE 822 (943)
Q Consensus 746 p~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~p~~~~ 822 (943)
|+||+++.++.+||+|||+++........ .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999877544322 23346999999999998765 378899999999999999999999876
Q ss_pred ccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 823 SNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.................. .+.+ ...+.+++.+||+.||++|||+.|+++|-+
T Consensus 244 ~~~~~~~~~~~~~~~~~~--~~~~---------~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPD--QPDI---------AEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp SHHHHHHHHHHCCCCCCS--SSCC---------CHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred cHHHHHHHHhcccCCCCC--cccc---------CHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 543332222221111110 1111 246778999999999999999999988754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=365.50 Aligned_cols=264 Identities=25% Similarity=0.325 Sum_probs=208.4
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc----ceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYG----NLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~l 689 (943)
..++|+..+.||+|+||+||+|++. ++.||||++... ........+|+.++++++||||+++++++..... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4568999999999999999999876 789999998654 2334456678999999999999999999987554 599
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhC-------CCCCeEecCCCCccEEECCCCceeeccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD-------CNPRIIHRDVKSSNILIDENFDAHLSDF 762 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~~ivH~Dlkp~Nill~~~~~~kl~DF 762 (943)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +.++|+||||||+||+++.++.+||+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999962 4589999999999999999999975 1348999999999999999999999999
Q ss_pred ccccccCCCCCc-eeeeEecccceeCccccccC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCcc------------
Q 002278 763 GIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTS-----RLNEKSDVYSFGIVLLEILTGKKAVDNESN------------ 824 (943)
Q Consensus 763 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~p~~~~~~------------ 824 (943)
|+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+...
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999876543322 22234699999999998873 456789999999999999999999975321
Q ss_pred ---HHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 825 ---LHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 825 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...+..... .....+.+............+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 256 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 256 HPSLEDMQEVVV-----HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SCCHHHHHHHHT-----TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCchhhhhhhhh-----cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111111 11122222222223345667899999999999999999999999998764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=374.73 Aligned_cols=345 Identities=28% Similarity=0.413 Sum_probs=190.0
Q ss_pred CCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEE
Q 002278 61 LRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLD 140 (943)
Q Consensus 61 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 140 (943)
+++|+.|++++|+++ .+|. +..+++|++|+|++|.+++..| ++++++|++|++++|++++..+ +.++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 445555555555555 3332 5555556666666555553322 5555555555555555553332 55555555555
Q ss_pred EeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccC
Q 002278 141 LARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITG 220 (943)
Q Consensus 141 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~ 220 (943)
|++|++++..+ +..+++|++|++++|.++++. .+..+++|++|+++ |.+.+.. .+.++++|++|++++|++++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC
Confidence 55555553322 455555555555555555442 35555666666664 3443322 25666666666666666542
Q ss_pred cCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCC
Q 002278 221 EIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300 (943)
Q Consensus 221 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 300 (943)
. ..+..+++|+.|++++|.+.+..| ++.+++|+.|++++|.+++. ..+..+
T Consensus 192 ~-------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l 242 (466)
T 1o6v_A 192 I-------------------------SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASL 242 (466)
T ss_dssp C-------------------------GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGC
T ss_pred C-------------------------hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcC
Confidence 1 123445555555555555554333 44455555555555555532 245555
Q ss_pred CcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeec
Q 002278 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNL 380 (943)
Q Consensus 301 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 380 (943)
++|++|++++|.+.+..+ +..+++|++|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 556666666666554333 5555666666666666654433 5556666666666666654433 555666666666
Q ss_pred cCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccc
Q 002278 381 SRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459 (943)
Q Consensus 381 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 459 (943)
++|++++..| +..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 6666664433 55566666666666666643 245666666666666666665554 5666666666666666664
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=350.95 Aligned_cols=254 Identities=20% Similarity=0.235 Sum_probs=213.6
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..++|+..+.||+|+||.||+|.++. +..||+|++........+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35689999999999999999999774 67899999987666677889999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE---CCCCceeecccccccccC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIP 769 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DFGla~~~~ 769 (943)
|+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999886 345689999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.... .....||+.|+|||++.+. ++.++||||+|+++|||++|+.||........................+.+
T Consensus 161 ~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 234 (277)
T 3f3z_A 161 PGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNV--- 234 (277)
T ss_dssp TTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS---
T ss_pred Cccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcC---
Confidence 4332 2234599999999998764 899999999999999999999999877665554444333332222211111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++..|++.||++|||+.+++++-+
T Consensus 235 ------~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 235 ------SPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp ------CHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ------CHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 246778999999999999999999988644
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=364.83 Aligned_cols=252 Identities=18% Similarity=0.237 Sum_probs=210.2
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 688 (943)
..++|+..+.||+|+||.||+|+.+. ++.||+|++.+.. ....+.+..|.++++.+ +||+|+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45789999999999999999999874 6889999986532 34556788999999988 7999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999996 345699999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+......++. .+
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~-- 244 (353)
T 2i0e_A 172 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SM-- 244 (353)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TS--
T ss_pred ccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CC--
Confidence 33222 233456999999999999999999999999999999999999999877655444443333222221 11
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPT-----MQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L~ 885 (943)
...+.+++..|++.||++||+ +.++.+|-+
T Consensus 245 -------s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 245 -------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp -------CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred -------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 145678999999999999994 688888754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=377.14 Aligned_cols=264 Identities=22% Similarity=0.239 Sum_probs=216.2
Q ss_pred HHHHHHHhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEec
Q 002278 608 FDDIMRSTENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALS 683 (943)
Q Consensus 608 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 683 (943)
+.++....++|+..++||+|+||+||+|+++. ++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34455567899999999999999999999875 6789999986421 1222347889999999999999999999999
Q ss_pred CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
++..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999974 235699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccc--
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN-- 836 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-- 836 (943)
+|+.............+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.........+.....
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence 99877555444444467999999999987 56789999999999999999999999998776555444432211
Q ss_pred ccccccCcccccCccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhh
Q 002278 837 TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSE--RPTMQEVARVLVS 886 (943)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~el~~~L~~ 886 (943)
.++.. .+.+ ...+.+++++|+..+|++ ||++.|+++|-+-
T Consensus 301 ~~p~~-~~~~---------s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 301 QFPTQ-VTDV---------SENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp CCCSS-CCCS---------CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred cCCcc-cccC---------CHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 11111 0111 145678999999888888 9999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=365.99 Aligned_cols=257 Identities=18% Similarity=0.192 Sum_probs=207.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc-----CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ-----YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
.++|+..+.||+|+||+||+|.++ +++.||||++... .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999976 5789999998532 1234678999999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc---eeeccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD---AHLSDFGI 764 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DFGl 764 (943)
+||||+++|+|.+.+.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775221 223589999999999999999999999 9999999999999986654 99999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... .................++
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHT
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCccccc
Confidence 987754322 22334699999999999999999999999999999999999999987532 1111221111111111111
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.+ ...+.+++..||+.||++|||+.++++|-+
T Consensus 258 ~~---------s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 258 HI---------SESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp TS---------CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cC---------CHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 11 246778999999999999999999998765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=367.69 Aligned_cols=252 Identities=19% Similarity=0.250 Sum_probs=205.7
Q ss_pred cccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 618 LSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 618 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 344678999999999999975 5889999999766555667899999999999999999999999999999999999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE--CCCCceeecccccccccCCCCCc
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI--DENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill--~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.+.....
T Consensus 171 ~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 171 GELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp CEEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 999998853 334689999999999999999999999 99999999999999 5678999999999987754322
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+............+.+
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-------- 315 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI-------- 315 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTS--------
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccC--------
Confidence 22345999999999999999999999999999999999999999887766555444433222222211222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++..|++.||++|||+.|+++|-+
T Consensus 316 -~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 316 -SEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp -CHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -CHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 246778999999999999999999999755
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=370.75 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=210.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
..++|...+.||+|+||.||+|.++ +++.||||++..... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4568899999999999999999987 688999999875432 23456889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999962 234689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcee-eeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 772 MPHAS-TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 772 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
..... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||.+............. ... ..+..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~------~~~~~ 339 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRL------PCPEL 339 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-CCC------CCCTT
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC------CCCCC
Confidence 11111 11235778999999999999999999999999999998 99999876554332222111 111 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
....+.+++..||+.||++|||+.++++.|+.+.
T Consensus 340 -----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 340 -----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp -----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1246778999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=361.13 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=202.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc---
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGN--- 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 687 (943)
.++|+..+.||+|+||.||+|++. +++.||||++..... .....+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468999999999999999999974 678999999976432 2345788999999999999999999998776554
Q ss_pred -eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 688 -LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 688 -~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
++||||+++|+|.+++. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999996 345689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC--ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 767 CIPTAMP--HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 767 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+......................+
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 7644322 12233568999999999999999999999999999999999999998776655444433333222222222
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-HHhhc
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVAR-VLVSL 887 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~-~L~~~ 887 (943)
.+ ...+.+++.+||+.||++||++.++++ .+...
T Consensus 245 ~~---------~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 245 GL---------SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TC---------CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CC---------CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 22 246778999999999999997666554 44443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=378.17 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=215.1
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..++|+..+.||+|+||.||+|.++.+..||||++... ....+.+.+|+++++.++|||||++++++. ....++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 46789999999999999999999988899999999754 345788999999999999999999999986 5678999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999999632 123688999999999999999999999 999999999999999999999999999987643221
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......+++.|+|||++.+..++.++|||||||++|||+| |+.||.+............. ... ..+.
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~------~~~~---- 408 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRM------PRPE---- 408 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CCC------CCCT----
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC------CCCC----
Confidence 22222346789999999999999999999999999999999 99999876554433222211 111 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
.....+.+++..||+.||++|||+.++++.|+.+.....
T Consensus 409 -~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 409 -NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred -CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 112467899999999999999999999999998876543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=372.78 Aligned_cols=347 Identities=27% Similarity=0.404 Sum_probs=224.0
Q ss_pred cCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhcccccccee
Q 002278 83 GNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQY 162 (943)
Q Consensus 83 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 162 (943)
..+++|+.|++++|.+. .+| .+..+++|++|+|++|.+++..+ +.++++|++|+|++|++++..+ +..+++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 34678888888888887 455 37788888888888888885543 8888888888888888885544 777788888
Q ss_pred ccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCcccc
Q 002278 163 LGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLT 242 (943)
Q Consensus 163 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~ 242 (943)
|++++|.++++.+ +..+++|++|++++|.+++. + .+..+++|++|+++ |.+.
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~----------------------- 168 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVT----------------------- 168 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCC-----------------------
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-Cccc-----------------------
Confidence 8888888877643 77777777777777777743 2 36777777777775 3332
Q ss_pred ccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccC
Q 002278 243 GKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELG 322 (943)
Q Consensus 243 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 322 (943)
+. ..+..+++|+.|++++|.+.+. ..+..+++|+.|++++|.+++..| +..+++|+.|++++|++++. ..+.
T Consensus 169 ~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~ 240 (466)
T 1o6v_A 169 DL--KPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 240 (466)
T ss_dssp CC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGG
T ss_pred Cc--hhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhh
Confidence 11 1266777888888888887753 346677777777777777775544 56667777777777776643 3456
Q ss_pred CcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEE
Q 002278 323 KLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTL 402 (943)
Q Consensus 323 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 402 (943)
.+++|+.|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|
T Consensus 241 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 314 (466)
T 1o6v_A 241 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314 (466)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEE
T ss_pred cCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEE
Confidence 66666666666666665443 5666666666666666664433 5556666666666666654322 4555555555
Q ss_pred ecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccC
Q 002278 403 DLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 403 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 482 (943)
++++|++++..| +..+++|+.|++++|++++. ..+.++++|+.|++++|++++..| +..+++|+.|++++|+++
T Consensus 315 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred ECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 555555554433 45555555555555555543 345555555555555555554443 555555555555555555
Q ss_pred C
Q 002278 483 G 483 (943)
Q Consensus 483 ~ 483 (943)
+
T Consensus 389 ~ 389 (466)
T 1o6v_A 389 N 389 (466)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=364.45 Aligned_cols=265 Identities=24% Similarity=0.324 Sum_probs=211.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPY 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 685 (943)
..++|+..+.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 5678999999999999999999962 34679999986542 33456789999999999 8999999999999999
Q ss_pred cceEEEEEccCCChhhhccCCCCC--------------------ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKK--------------------VKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVK 745 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 745 (943)
..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999753221 3479999999999999999999999 99999999
Q ss_pred CccEEECCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCc
Q 002278 746 SSNILIDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNES 823 (943)
Q Consensus 746 p~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~ 823 (943)
|+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876443322 2334557889999999999999999999999999999998 999998765
Q ss_pred cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 824 NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
.............. +..+.. ....+.+++..||+.||++|||+.+++++|+.+....+
T Consensus 280 ~~~~~~~~~~~~~~------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 280 VDANFYKLIQNGFK------MDQPFY-----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CSHHHHHHHHTTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cHHHHHHHHhcCCC------CCCCCC-----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 43333332222111 111111 12467889999999999999999999999998876544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=359.78 Aligned_cols=258 Identities=21% Similarity=0.340 Sum_probs=205.5
Q ss_pred hhccccceEEeeeceEEEEEEEecC-Cce----EEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRP----IAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
.++|+..+.||+|+||+||+|.+.. ++. ||+|.+.... ......+.+|+.+++.++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 4578899999999999999999753 443 7788775433 233456788999999999999999999986 45689
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999973 245789999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcccc-ccccccCcc
Q 002278 769 PTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDN-TVMEAVDPE 845 (943)
Q Consensus 769 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 845 (943)
...... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+............... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT-- 243 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBC--
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCc--
Confidence 544322 2344568889999999999999999999999999999999 9999986554332222222111 1111111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
..+.+++..||+.||++|||+.+++++|+.+...+
T Consensus 244 -----------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 244 -----------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -----------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -----------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 23458999999999999999999999999876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=356.67 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=212.6
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc------ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP------HNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.++|+..+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999976 578999999865432 2467899999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC----ceeecccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF----DAHLSDFG 763 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DFG 763 (943)
++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997 345689999999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+......................
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 9987654322 22345999999999999999999999999999999999999999877655544443332222221111
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.+ ...+.+++..|++.||++|||+.|+++|-+
T Consensus 243 ~~~---------~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 243 SHT---------SELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp TTC---------CHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred ccc---------CHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 111 145778999999999999999999999754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=368.09 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=203.3
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 688 (943)
..++|+..++||+|+||+||+|+.+ +++.||+|++.+.. ....+.+.+|..+++++ +|||||++++++.+....+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3568999999999999999999987 46789999987543 22234578899998876 8999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 130 lV~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999986 345799999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc--------HHHHHHH-hccccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN--------LHQLIMS-KADDNTVM 839 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~--------~~~~~~~-~~~~~~~~ 839 (943)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....... ......++
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 282 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC
Confidence 3222 223345799999999999999999999999999999999999999964321 1111111 11111111
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHh
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTM------QEVARVLV 885 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~el~~~L~ 885 (943)
+.+ ...+.+++..||+.||++||++ .|+++|-+
T Consensus 283 ----~~~---------s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 283 ----RSL---------SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp ----TTS---------CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred ----CcC---------CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 111 1456789999999999999985 78887654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=361.55 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=200.7
Q ss_pred hhccccceEEeeeceEEEEEEEe----cCCceEEEEEecccC----cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 615 TENLSEKYIVGYGASSTVYKCAL----KNSRPIAVKKLYNQY----PHNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
.++|+..+.||+|+||.||+|+. .+++.||+|++.+.. ......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999997 368899999987542 2334567889999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999986 345689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.................+ +.+
T Consensus 170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~ 244 (327)
T 3a62_A 170 ESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYL 244 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTS
T ss_pred ccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCC
Confidence 6433221 12234589999999999999999999999999999999999999987765544433333222211 111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
...+.+++.+||+.||++|| ++.++++|-+
T Consensus 245 ---------~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 245 ---------TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp ---------CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred ---------CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 14567899999999999999 8889998865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=361.94 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=194.8
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..++|+..+.||+|+||+||+|+++ +++.||||++.... ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3567999999999999999999987 47889999987543 34678899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---CCceeecccccccccC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE---NFDAHLSDFGIARCIP 769 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DFGla~~~~ 769 (943)
|+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999986 345689999999999999999999999 9999999999999975 8899999999998764
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcc-ccccccccCccccc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD-DNTVMEAVDPEVSV 848 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 848 (943)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............... .........+.+
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 278 (349)
T 2w4o_A 203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV-- 278 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS--
T ss_pred ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC--
Confidence 332 223456999999999999999999999999999999999999999866554433322222 111111111122
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++.+|++.||++|||+.+++++-+
T Consensus 279 -------~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 279 -------SLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp -------CHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred -------CHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 246778999999999999999999999854
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.46 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=198.5
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccC----cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY----PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||.||+|.+. ++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467899999999999999999976 7889999986543 23356789999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC--------CCceeeccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE--------NFDAHLSDF 762 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--------~~~~kl~DF 762 (943)
|||+++++|.+++. ...+++..++.++.|++.||+|||++...+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999985 346899999999999999999999981112999999999999986 778999999
Q ss_pred ccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc
Q 002278 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842 (943)
Q Consensus 763 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 842 (943)
|+++....... ....||+.|+|||++.+..++.++||||+|+++|||++|+.||.+................ ...
T Consensus 161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 235 (271)
T 3dtc_A 161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--LPI 235 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC--CCC
T ss_pred Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC--CCC
Confidence 99986644322 2346999999999999999999999999999999999999999876654443333222111 111
Q ss_pred CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 843 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.... ...+.+++..||+.||++|||+.|++++|+.
T Consensus 236 ~~~~---------~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 236 PSTC---------PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred Cccc---------CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111 2467899999999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=366.97 Aligned_cols=269 Identities=25% Similarity=0.327 Sum_probs=215.3
Q ss_pred cCHHHHHHHhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCc-ccHHHHHHHHHHHhcC-CCCCccee
Q 002278 606 HTFDDIMRSTENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYP-HNLREFETELETIGSI-RHRNIVSL 677 (943)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l 677 (943)
+...+.....++|+..+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344555567789999999999999999999843 357899999975432 3346789999999999 78999999
Q ss_pred eeEEecCCc-ceEEEEEccCCChhhhccCCCC------------------------------------------------
Q 002278 678 HGYALSPYG-NLLFYDYMVNGSLWDLLHGPSK------------------------------------------------ 708 (943)
Q Consensus 678 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------ 708 (943)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987655 8999999999999999975322
Q ss_pred ---------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 709 ---------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 709 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12289999999999999999999999 999999999999999999999999999987643322
Q ss_pred -ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 774 -HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 774 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+................. ..+..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~-- 320 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------RAPDY-- 320 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------CCCTT--
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------CCCCC--
Confidence 23344568999999999999999999999999999999998 999998765433333322221111 11111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
....+.+++..||+.||++|||+.+++++|+.+.
T Consensus 321 ---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 321 ---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1146778999999999999999999999998765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=361.59 Aligned_cols=263 Identities=20% Similarity=0.182 Sum_probs=209.0
Q ss_pred HHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc-----CcccHHHHHHHHHHHhcCCCCCcceeeeEEecC
Q 002278 611 IMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ-----YPHNLREFETELETIGSIRHRNIVSLHGYALSP 684 (943)
Q Consensus 611 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 684 (943)
+....++|+..+.||+|+||+||+|.++ +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4456789999999999999999999975 5788999988543 244567899999999999999999999999999
Q ss_pred CcceEEEEEccCCChhhhccCCC-------------------------------------CCccCCHHHHHHHHHHHHHH
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPS-------------------------------------KKVKLDWETRLKIAVGAAQG 727 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~ 727 (943)
+..++||||+++|+|.+++.... ....+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985100 01234677888999999999
Q ss_pred HHHhhhCCCCCeEecCCCCccEEECCCC--ceeecccccccccCCCC---CceeeeEecccceeCcccccc--CCCCCcc
Q 002278 728 LAYLHHDCNPRIIHRDVKSSNILIDENF--DAHLSDFGIARCIPTAM---PHASTFVLGTIGYIDPEYAHT--SRLNEKS 800 (943)
Q Consensus 728 l~~LH~~~~~~ivH~Dlkp~Nill~~~~--~~kl~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 800 (943)
|+|||+. +|+||||||+||+++.++ .+||+|||+++.+.... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998766 89999999998653321 122344569999999999875 6789999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002278 801 DVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880 (943)
Q Consensus 801 DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el 880 (943)
|||||||++|||++|+.||.+......................+.+ ...+.+++..|++.||++|||+.++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL---------SPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGS---------CHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccC---------CHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999999999999877665555444433322222111111 2467789999999999999999999
Q ss_pred HHHHh
Q 002278 881 ARVLV 885 (943)
Q Consensus 881 ~~~L~ 885 (943)
+++-+
T Consensus 329 l~hp~ 333 (345)
T 3hko_A 329 LQHPW 333 (345)
T ss_dssp HHSHH
T ss_pred hcChh
Confidence 99765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=361.43 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=204.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 689 (943)
.++|+..+.||+|+||.||+|+.+ +++.||+|++.+... ...+.+.+|.++++++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999986 478899999975432 2345678899999887 89999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999986 345699999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc--------HHHHHH-Hhcccccccc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN--------LHQLIM-SKADDNTVME 840 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~--------~~~~~~-~~~~~~~~~~ 840 (943)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... +......+
T Consensus 162 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~-- 238 (345)
T 3a8x_A 162 RPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI-- 238 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC--
T ss_pred CCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC--
Confidence 2222 23345699999999999999999999999999999999999999964211 111111 11111111
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHh
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTM------QEVARVLV 885 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~el~~~L~ 885 (943)
++.+ ...+.+++.+||+.||++||++ .++++|-+
T Consensus 239 --p~~~---------s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 239 --PRSL---------SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp --CTTS---------CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred --CCCC---------CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 1111 1456789999999999999985 78887754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=353.59 Aligned_cols=270 Identities=19% Similarity=0.245 Sum_probs=212.5
Q ss_pred hhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC--cceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPY--GNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 690 (943)
.++|...+.||+|+||+||+|.+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4679999999999999999999874 8899999987543 345677889999999999999999999998765 66899
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE----CCCCceeeccccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI----DENFDAHLSDFGIAR 766 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DFGla~ 766 (943)
|||+++|+|.+++........+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999997544444599999999999999999999999 99999999999999 788889999999998
Q ss_pred ccCCCCCceeeeEecccceeCccccc--------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc----HHHHHHHhcc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAH--------TSRLNEKSDVYSFGIVLLEILTGKKAVDNESN----LHQLIMSKAD 834 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltG~~p~~~~~~----~~~~~~~~~~ 834 (943)
........ ....||+.|+|||++. +..++.++|||||||++|||+||+.||..... ..........
T Consensus 165 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 77544322 2345999999999876 56789999999999999999999999963221 2222222111
Q ss_pred ccc-ccc----------ccCccccc-CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 835 DNT-VME----------AVDPEVSV-TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 835 ~~~-~~~----------~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
... ... ...+.++. ..........+.+++..||+.||++|||++|++++......
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 110 000 00001111 11233556678899999999999999999999999876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=364.99 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=205.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|...+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.++||||+++++++..+...++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999974 67899999986431 23346789999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+ +|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 789999886 345699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
... ....+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||.+....... ... ......++..
T Consensus 161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------~~i-~~~~~~~p~~ 230 (336)
T 3h4j_B 161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------KKV-NSCVYVMPDF 230 (336)
T ss_dssp SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------CCC-CSSCCCCCTT
T ss_pred Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------HHH-HcCCCCCccc
Confidence 322 223469999999999998776 78999999999999999999999764321100 000 0000111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
....+.+++..|++.||++|||+.|++++-+-.
T Consensus 231 -----~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 231 -----LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp -----SCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred -----CCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 124567899999999999999999999987754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=374.47 Aligned_cols=261 Identities=28% Similarity=0.396 Sum_probs=209.7
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..++|+..+.||+|+||.||+|.++.+..||||++.... ...+.+.+|++++++++||||+++++++.+ ...++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456889999999999999999999888889999987543 346789999999999999999999999876 678999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++... ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999621 123589999999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......+++.|+|||++.+..++.++|||||||++|||+| |+.||.+............. ... ..++.
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~--~~~~~------- 405 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRM--PCPPE------- 405 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCC--CCCTT-------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC--CCCCC-------
Confidence 33334457889999999999999999999999999999999 99999876654433222211 110 01111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
....+.+++..||+.||++|||+.++++.|+.+.....
T Consensus 406 --~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 406 --CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred --CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 12467789999999999999999999999998876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=363.75 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=205.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++++.++|||||++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999976 47889999986432 34557788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+.+|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999997 345699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeEecccceeCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCc--cHHHHHHHh-ccccccccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNES--NLHQLIMSK-ADDNTVMEAVDP 844 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~p~~~~~--~~~~~~~~~-~~~~~~~~~~~~ 844 (943)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ......... ......+ +
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~ 241 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----S 241 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----T
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----C
Confidence 32 2234569999999999874 458999999999999999999999997432 222222221 1111111 1
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHH
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPT-MQEVARVL 884 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~el~~~L 884 (943)
.+ ...+.+++..||+.||++||+ +.++.+|-
T Consensus 242 ~~---------s~~~~~li~~lL~~dP~~R~s~~~~l~~hp 273 (384)
T 4fr4_A 242 AW---------SQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273 (384)
T ss_dssp TS---------CHHHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred cC---------CHHHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence 11 146778999999999999998 88887654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.32 Aligned_cols=257 Identities=26% Similarity=0.360 Sum_probs=212.9
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.++|+..+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 46789999999999999999999888899999987543 34578999999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999863 234689999999999999999999999 9999999999999999999999999999876432211
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......|++.|+|||++.+..++.++||||+|+++|||++ |+.||.................. .....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~-------- 229 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---YKPRL-------- 229 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTT--------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC---CCCcc--------
Confidence 1222346789999999999999999999999999999999 89999876544333222221111 00111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
....+.+++..||+.||++|||+.+++++|+.+..
T Consensus 230 -~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 230 -ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12467789999999999999999999999987643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.54 Aligned_cols=267 Identities=22% Similarity=0.258 Sum_probs=195.6
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
..++|+..+.||+|+||+||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3468899999999999999999976 57899999986543 334467889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCC---CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 692 DYMVNGSLWDLLHGP---SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 692 e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
||++ |+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 6999887521 1224589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc-
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV- 846 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 846 (943)
...... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..............+...+..++..
T Consensus 159 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 533222 223458999999999876 46899999999999999999999999877665544433222111111111110
Q ss_pred ---------ccC-----------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 847 ---------SVT-----------CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 847 ---------~~~-----------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
... .........+.+++..||+.||++|||+.|++++-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 000 000011246789999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.51 Aligned_cols=263 Identities=21% Similarity=0.240 Sum_probs=202.8
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++|+..+.||+|+||+||+|.++ +++.||+|++.... ......+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999986 57889999986543 2334678899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++ ++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9976 55554432 345699999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeeEecccceeCccccccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCccH-HHHHHHhccccccccccCccccc--
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNL-HQLIMSKADDNTVMEAVDPEVSV-- 848 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-- 848 (943)
. ......||+.|+|||++.+.. ++.++||||+||++|||++|..||...... ..........+......++....
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred c-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 2 223346899999999998765 899999999999999999988886433333 32222222111111111100000
Q ss_pred --------------CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 --------------TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 --------------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..........+.+++..|++.||++|||+.|+++|-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 0000012246678999999999999999999999754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=360.67 Aligned_cols=264 Identities=26% Similarity=0.393 Sum_probs=213.7
Q ss_pred HhhccccceEEeeeceEEEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
..++|+..+.||+|+||.||+|.+.. ++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 56789999999999999999999863 3789999987543 3345678999999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCC---------------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSK---------------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVK 745 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 745 (943)
.++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 9999999999999999864221 25689999999999999999999999 99999999
Q ss_pred CccEEECCCCceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCc
Q 002278 746 SSNILIDENFDAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNES 823 (943)
Q Consensus 746 p~Nill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~ 823 (943)
|+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999986643221 12233457899999999999999999999999999999999 999998765
Q ss_pred cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 824 NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
.............. ...+. ....+.+++..||+.||++|||+.+++++|+.+.....
T Consensus 282 ~~~~~~~~~~~~~~---~~~~~---------~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 282 HEEVIYYVRDGNIL---ACPEN---------CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HHHHHHHHHTTCCC---CCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred hHHHHHHHhCCCcC---CCCCC---------CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 54333222221110 11111 12467889999999999999999999999998876543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.58 Aligned_cols=257 Identities=25% Similarity=0.342 Sum_probs=198.1
Q ss_pred HhhccccceEEeeeceEEEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN----SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..++|+..+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.+++.++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 35689999999999999999999753 3568999886543 334567889999999999999999999984 46789
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999963 234689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
............+++.|+|||++.+..++.++|||||||++|||++ |+.||.+................ ...+.+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~- 242 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNC- 242 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTC-
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCCCCC-
Confidence 5543333334457889999999999999999999999999999997 99999866544333222221110 111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...+.+++..||+.||++|||+.+++++|+.+.
T Consensus 243 --------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 243 --------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 246778999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.76 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=207.7
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
+.++|+..+.||+|+||+||+|.++. +..||+|++.... ......+.+|+++++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45789999999999999999999764 6789999985432 2335678899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999986 345689999999999999999999999 99999999999999999999999999997554
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
... .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||...................+...
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 230 (279)
T 3fdn_A 161 SSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV------- 230 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTS-------
T ss_pred ccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcC-------
Confidence 322 2334689999999999999999999999999999999999999987665544433333222222111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++..||+.||++|||+.|+++|-+
T Consensus 231 ------~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 231 ------TEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp ------CHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred ------CHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 145678999999999999999999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=353.25 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=202.1
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhc--CCCCCcceeeeEEecC----Ccce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGS--IRHRNIVSLHGYALSP----YGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 688 (943)
.++|+..+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 56899999999999999999988 5889999998643 34556666666665 7999999999997543 3478
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeEecCCCCccEEECCCCceeec
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH--------HDCNPRIIHRDVKSSNILIDENFDAHLS 760 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 760 (943)
+||||+++|+|.++++ ...+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999995 346999999999999999999999 77 99999999999999999999999
Q ss_pred ccccccccCCCCCce---eeeEecccceeCccccccC------CCCCcchhhhHHHHHHHHHhC----------CCCCCC
Q 002278 761 DFGIARCIPTAMPHA---STFVLGTIGYIDPEYAHTS------RLNEKSDVYSFGIVLLEILTG----------KKAVDN 821 (943)
Q Consensus 761 DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG----------~~p~~~ 821 (943)
|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998765443322 1223699999999999876 455799999999999999999 888864
Q ss_pred Cc----cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 822 ES----NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 822 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.. ............. ..+..+...........+.+++..||+.||++|||+.++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 21 2222222211111 1222222222234567889999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.13 Aligned_cols=254 Identities=19% Similarity=0.273 Sum_probs=203.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc-----
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYG----- 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 686 (943)
..++|+..+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4578999999999999999999987 68999999986443 3456789999999999999999999999865432
Q ss_pred ----------------------------------------------------ceEEEEEccCCChhhhccCCCCCccCCH
Q 002278 687 ----------------------------------------------------NLLFYDYMVNGSLWDLLHGPSKKVKLDW 714 (943)
Q Consensus 687 ----------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~ 714 (943)
.++||||+++|+|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 6899999999999999987655666788
Q ss_pred HHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC-----------ceeeeEeccc
Q 002278 715 ETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP-----------HASTFVLGTI 783 (943)
Q Consensus 715 ~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~ 783 (943)
..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999999 999999999999999999999999999987754421 1122346999
Q ss_pred ceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHH
Q 002278 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLA 863 (943)
Q Consensus 784 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 863 (943)
.|+|||++.+..++.++||||+||++|||++|..|+..... ...... .... +.. .......+.+++
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~---~~~~~~-~~~~-----~~~-----~~~~~~~~~~li 306 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR---IITDVR-NLKF-----PLL-----FTQKYPQEHMMV 306 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH---HHHHHH-TTCC-----CHH-----HHHHCHHHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH---HHHHhh-ccCC-----Ccc-----cccCChhHHHHH
Confidence 99999999999999999999999999999999877642211 111111 1110 000 112234567899
Q ss_pred HHccCCCCCCCCCHHHHHHHH
Q 002278 864 LLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 864 ~~cl~~dP~~RPt~~el~~~L 884 (943)
..||+.||++|||+.|++++-
T Consensus 307 ~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHHST
T ss_pred HHHccCCCCcCCCHHHHhhch
Confidence 999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=359.73 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=203.4
Q ss_pred hhccccceEEeeeceEEEEEEEecC-Cc----eEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SR----PIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
.++|+..+.||+|+||+||+|++.. ++ +||+|.+.... ....+.+.+|++++++++||||+++++++.++ ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 4679999999999999999999653 33 46888775432 35567899999999999999999999999875 478
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+|+||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999863 245689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 769 PTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 769 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+............. .... ..+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~- 243 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP--QPPI- 243 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCC--CCTT-
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-CCCC--CCcc-
Confidence 543322 2233457889999999999999999999999999999999 99999865443222111111 1100 1111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
....+.+++..||+.||++||++.+++++|+.+...
T Consensus 244 --------~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 244 --------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 124677899999999999999999999999877553
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=371.13 Aligned_cols=263 Identities=20% Similarity=0.220 Sum_probs=213.0
Q ss_pred HHHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEec
Q 002278 608 FDDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALS 683 (943)
Q Consensus 608 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 683 (943)
+.+.....++|+..+.||+|+||+||+|+.+ +++.||+|++.+.. ....+.+.+|++++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444456789999999999999999999986 58899999986432 1223457889999999999999999999999
Q ss_pred CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
.+..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999963 124689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccc-------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccc
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAH-------TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN 836 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 836 (943)
+++.............+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.........+.....
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 287 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 99877554433333457999999999987 35689999999999999999999999988766554444332111
Q ss_pred cc-ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHHh
Q 002278 837 TV-MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSER---PTMQEVARVLV 885 (943)
Q Consensus 837 ~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~el~~~L~ 885 (943)
.. ....++.+ ...+.+++++|+. +|++| |++.|+++|-+
T Consensus 288 ~~~~p~~~~~~---------s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 288 HLSLPLVDEGV---------PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HCCCC----CC---------CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred CcCCCccccCC---------CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 10 00011112 1466789999999 99998 69999999865
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=346.94 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=211.5
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
.++|+..+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999976 57899999986543 334567889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc---eeeccccccccc
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD---AHLSDFGIARCI 768 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DFGla~~~ 768 (943)
||+++|+|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999998886 345689999999999999999999999 9999999999999986655 999999999876
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
..... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+......................+.+
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (284)
T 3kk8_A 159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV-- 234 (284)
T ss_dssp CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS--
T ss_pred ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhccc--
Confidence 54322 22345899999999999999999999999999999999999999877655444443333222222111112
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++..|++.||++|||+.|++++-+-
T Consensus 235 -------~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 235 -------TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp -------CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred -------CHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 2467789999999999999999999997653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=371.95 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=210.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|...+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+++++.++||||+++++++......++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367899999999999999999986 68999999986432 23456789999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999996 345799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
... ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.................+.. +
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~----~--- 239 (476)
T 2y94_A 169 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY----L--- 239 (476)
T ss_dssp TCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTT----C---
T ss_pred ccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCcc----C---
Confidence 322 233469999999999988765 689999999999999999999998766544433333222111111 1
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++..||+.||++|||+.++++|-+-
T Consensus 240 ------s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 240 ------NPSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp ------CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred ------CHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 1356789999999999999999999997653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=358.65 Aligned_cols=267 Identities=22% Similarity=0.358 Sum_probs=198.8
Q ss_pred HHhhccccceEEeeeceEEEEEEEecCCc----eEEEEEeccc--CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALKNSR----PIAVKKLYNQ--YPHNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
...++|+..+.||+|+||+||+|.++... .||||++... .....+.+.+|+++++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 34578999999999999999999976432 7999998654 23456789999999999999999999999988766
Q ss_pred c------eEEEEEccCCChhhhccCCC---CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCce
Q 002278 687 N------LLFYDYMVNGSLWDLLHGPS---KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDA 757 (943)
Q Consensus 687 ~------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 757 (943)
. ++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 99999999999999985211 222589999999999999999999999 99999999999999999999
Q ss_pred eecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccc
Q 002278 758 HLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADD 835 (943)
Q Consensus 758 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 835 (943)
||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+..............
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999999987644322 12223457889999999999999999999999999999999 999998765544333322221
Q ss_pred cccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCc
Q 002278 836 NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAK 894 (943)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~~~ 894 (943)
.. ...+.+ ...+.+++..||+.||++|||+.++++.++.+...+...
T Consensus 257 ~~---~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 257 RL---KQPPEC---------MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp CC---CCCTTC---------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred CC---CCCCcc---------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 11 111111 246789999999999999999999999999887665443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=354.49 Aligned_cols=263 Identities=25% Similarity=0.401 Sum_probs=205.1
Q ss_pred hhccccceEEeeeceEEEEEEEe-----cCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Ccc
Q 002278 615 TENLSEKYIVGYGASSTVYKCAL-----KNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP--YGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 687 (943)
.++|+..+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 47899999999999999999984 25789999999876666667899999999999999999999998654 457
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHH--CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHh--cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999963 234599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc--------
Q 002278 768 IPTAMPH--ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT-------- 837 (943)
Q Consensus 768 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-------- 837 (943)
....... ......|+..|+|||++.+..++.++||||||+++|||+||..||...... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHHHCTTCCTHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHhhhcCccccchhHHHH
Confidence 6443221 122234677899999999999999999999999999999999998643211 1110000000
Q ss_pred ---cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 838 ---VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 838 ---~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.........+. .....+.+++..||+.||++|||+.|+++.|+.+..
T Consensus 242 ~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 242 IELLKNNGRLPRPD-----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHTTCCCCCCT-----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhccCcCCCCc-----CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 00000111111 112567899999999999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=348.61 Aligned_cols=253 Identities=25% Similarity=0.440 Sum_probs=202.2
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCccc-------HHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHN-------LREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
.++|+..+.||+|+||+||+|.+. +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 468999999999999999999975 67899999986543221 167889999999999999999999986654
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCccEEECCCCc-----eee
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR--IIHRDVKSSNILIDENFD-----AHL 759 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~-----~kl 759 (943)
++||||+++|+|.+.+.. ....+++..++.++.|++.||+|||++ + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 799999999999998863 345699999999999999999999998 8 999999999999988776 999
Q ss_pred cccccccccCCCCCceeeeEecccceeCccccc--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc
Q 002278 760 SDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH--TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT 837 (943)
Q Consensus 760 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 837 (943)
+|||+++.... ......||+.|+|||++. ...++.++||||+||++|||++|+.||..................
T Consensus 171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 99999985432 233456999999999984 456789999999999999999999999865432221111111111
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
......+.+ ...+.+++..||+.||++|||+.++++.|+.+
T Consensus 247 ~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LRPTIPEDC---------PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCCTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCCccc---------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111111 24678999999999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=376.98 Aligned_cols=252 Identities=18% Similarity=0.233 Sum_probs=201.9
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..++|+..+.||+|+||.||+|..+ +++.||+|++... .......+.+|+++++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3578999999999999999999976 5789999998653 23344567889999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
||||+++|+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+|+..
T Consensus 226 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999986 34578999999999999999999998 7 9999999999999999999999999999864
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+................++.. +
T Consensus 300 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~----~-- 372 (446)
T 4ejn_A 300 IKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----L-- 372 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----S--
T ss_pred cCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCcc----C--
Confidence 33322 2233569999999999999999999999999999999999999998776544444333333222221 1
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
...+.+++..||+.||++|| ++.|+++|-+
T Consensus 373 -------~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 373 -------GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp -------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred -------CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 14567899999999999999 9999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=360.07 Aligned_cols=264 Identities=21% Similarity=0.245 Sum_probs=202.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc-cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH-NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
++|...+.||+|+||+||+|..+ +++.||+|++...... ....+.+|+++++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999986 6789999998644321 112345799999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
++ |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 588888863 234689999999999999999999999 999999999999999999999999999986643322
Q ss_pred ceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC---
Q 002278 774 HASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT--- 849 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 849 (943)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..............+.......+.....
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 2233468999999999876 56899999999999999999999999887765554444332222222222211100
Q ss_pred ---------ccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 850 ---------CVD-----LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 850 ---------~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
... ......+.+++..|++.||++|||+.|+++|-+-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 285 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence 000 0112466799999999999999999999998654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=351.93 Aligned_cols=263 Identities=21% Similarity=0.232 Sum_probs=203.6
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..++|+..+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4578999999999999999999976 578899999865432 234678899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++++|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999996 345689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
...........|++.|+|||++.+..++.++||||||+++|||++|+.||...... .................+.++
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~-- 262 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIP-- 262 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCC--
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCC--
Confidence 44333334456999999999999999999999999999999999999999876543 222222222222222222222
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcCCCCC
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERP-TMQEVARVLVSLLPAPP 892 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~el~~~L~~~~~~~~ 892 (943)
..+.+++..||+.||++|| +++++++.|+.......
T Consensus 263 -------~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 263 -------VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp -------THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred -------HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 3577899999999999999 99999999998776543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=368.62 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=211.0
Q ss_pred hhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.++|+..+.||+|+||+||+|.+. .++.||||++.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 468899999999999999999853 35689999986543 33455788999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCC----CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC---ceeec
Q 002278 688 LLFYDYMVNGSLWDLLHGPS----KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF---DAHLS 760 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~ 760 (943)
++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986321 224589999999999999999999999 999999999999999554 59999
Q ss_pred ccccccccCCCC-CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcccccc
Q 002278 761 DFGIARCIPTAM-PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTV 838 (943)
Q Consensus 761 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 838 (943)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...................
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~ 306 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 306 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999998642211 112223457899999999999999999999999999999998 999998766544333322221110
Q ss_pred ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
.... ....+.+++..||+.||++|||+.+++++|+.+....
T Consensus 307 ---~~~~---------~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 307 ---PPKN---------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp ---CCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---CCcc---------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 0111 1245778999999999999999999999998876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=363.17 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=213.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec--------CCceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEec
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK--------NSRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALS 683 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 683 (943)
..++|...+.||+|+||+||+|++. .+..||||++.... ....+.+.+|+++++.+ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4578999999999999999999863 23579999987543 33446788999999999 89999999999999
Q ss_pred CCcceEEEEEccCCChhhhccCCCC-------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEE
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGPSK-------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNIL 750 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 750 (943)
++..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999864321 24589999999999999999999999 9999999999999
Q ss_pred ECCCCceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHH
Q 002278 751 IDENFDAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQL 828 (943)
Q Consensus 751 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~ 828 (943)
+++++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987654322 12223457899999999999999999999999999999999 99999876543322
Q ss_pred HHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
........ +..+.. ....+.+++..||+.||++|||+.+++++|+.+...
T Consensus 304 -~~~~~~~~------~~~~~~-----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 304 -KLLKEGHR------MDKPSN-----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp -HHHHTTCC------CCCCSS-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHcCCC------CCCCcc-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 22221111 111111 124678899999999999999999999999887643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=357.17 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=182.9
Q ss_pred ceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEEEEccCCC
Q 002278 621 KYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFYDYMVNGS 698 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~ 698 (943)
.+.||+|+||+||+|.++ +++.||||++... ....+.+|+++++.+. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999986 5789999998643 4567889999999997 9999999999999999999999999999
Q ss_pred hhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC---ceeecccccccccCCCCCce
Q 002278 699 LWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF---DAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 699 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~DFGla~~~~~~~~~~ 775 (943)
|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++........
T Consensus 93 L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 93 LFERIK---KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence 999997 345799999999999999999999999 999999999999997665 8999999999876543322
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc------HHHHHHHhc-cccccccccCccccc
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN------LHQLIMSKA-DDNTVMEAVDPEVSV 848 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~~ 848 (943)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......... .........++.
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~--- 242 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN--- 242 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT---
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC---
Confidence 2334689999999999999999999999999999999999999975432 112222111 111111111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....+.+++..|++.||++|||+.++++|-+-
T Consensus 243 ------~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~ 274 (325)
T 3kn6_A 243 ------VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274 (325)
T ss_dssp ------SCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred ------CCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence 12467789999999999999999999988664
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=345.50 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=208.4
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc------ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP------HNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.++|+..+.||+|+||.||+|..+ +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999987 588999998865421 2467899999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC----ceeecccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF----DAHLSDFG 763 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DFG 763 (943)
++||||+++++|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999986 345689999999999999999999999 999999999999998877 89999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+++....... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||.+......................
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 235 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhc
Confidence 9987644322 23345899999999999999999999999999999999999999877655444433332222211111
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
+.. ...+.+++..|++.||++|||+.+++++-
T Consensus 236 ~~~---------~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 236 SNT---------SELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp TTC---------CHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred ccC---------CHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 111 24677899999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=374.00 Aligned_cols=260 Identities=22% Similarity=0.229 Sum_probs=203.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCC------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ--YPHNLREFETELETIGSIRHRNIVSLHGYALSPY------ 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 685 (943)
.++|+..+.||+|+||+||+|.+. .++.||||++... .....+.+.+|+++++.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999976 5788999999654 2334567889999999999999999999997654
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..++||||+.++ +.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 459999999764 666664 2389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc----
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA---- 841 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 841 (943)
+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...++..+....+.....
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 212 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp -----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8765432 2344579999999999999999999999999999999999999999887776665554332211110
Q ss_pred -----------------------cCcccccCcc--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 842 -----------------------VDPEVSVTCV--DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 842 -----------------------~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.+........ .......+.+++.+||+.||++|||+.|+++|-+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 0000000000 0112456789999999999999999999999865
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=346.66 Aligned_cols=259 Identities=28% Similarity=0.409 Sum_probs=212.3
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..++|+..+.||+|+||.||+|..++++.||+|++... ....+.+.+|+++++.++||||+++++++.. +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 35689999999999999999999988889999998654 3456789999999999999999999999864 568999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++++|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999999631 122689999999999999999999999 999999999999999999999999999987754432
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......+++.|+|||++.+..++.++||||||+++|||++ |+.||.+............... ......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~------- 234 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---MVRPDN------- 234 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTT-------
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---CCCccc-------
Confidence 22233446789999999998899999999999999999999 9999987654433222221111 001111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
....+.+++..|++.||++|||+.++++.|+.+...
T Consensus 235 --~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 235 --CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 124678999999999999999999999999877643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=350.12 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=209.3
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..++|...+.||+|+||.||+|+.+ +++.||+|++........+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3468999999999999999999976 688999999976554455678999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE---CCCCceeecccccccccC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIP 769 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DFGla~~~~ 769 (943)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999886 345689999999999999999999999 99999999999999 788999999999997654
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||........................+.+
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--- 234 (304)
T 2jam_A 161 NGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI--- 234 (304)
T ss_dssp CBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTS---
T ss_pred CCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccC---
Confidence 321 12235899999999999999999999999999999999999999876654433333332222222211222
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++..|++.||++|||+.+++++-+-
T Consensus 235 ------~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 235 ------SESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp ------CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred ------CHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 2467789999999999999999999997653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=376.50 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=214.3
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..++|+..+.||+|+||.||+|.++. +..||||++... ....+.+.+|++++++++|||||++++++......++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 35678899999999999999999875 788999998654 3456889999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999642 234589999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
........+++.|+|||++.+..++.++|||||||++|||+| |+.||.+.......... .... ....+.
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~------~~~~~~--- 442 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDY------RMERPE--- 442 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTC------CCCCCT---
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCC------CCCCCC---
Confidence 222223346789999999999999999999999999999999 99999865543222211 1111 111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
.....+.+++..||+.||++|||+.++++.|+.+...
T Consensus 443 --~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 443 --GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred --CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1124678899999999999999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=351.42 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=201.0
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.++|+..+.||+|+||+||+|.+. ++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 467889999999999999999886 788999998643 345788999999999999999999998864 589999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc-eeecccccccccCCCCC
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD-AHLSDFGIARCIPTAMP 773 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~DFGla~~~~~~~~ 773 (943)
++|+|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999985544446889999999999999999999932229999999999999998886 799999999765432
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHH-HHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLH-QLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ........ .. .+.....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~-----~~~~~~~--- 228 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GT-----RPPLIKN--- 228 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TC-----CCCCBTT---
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CC-----CCCcccc---
Confidence 123458999999999999999999999999999999999999998543221 11111111 11 1111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
....+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 229 --~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 229 --LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred --cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 1245778999999999999999999999998876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=363.13 Aligned_cols=251 Identities=21% Similarity=0.254 Sum_probs=199.1
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHH-HhcCCCCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELET-IGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..++|+..+.||+|+||.||+|+.+ +++.||+|++.+.. ......+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3568999999999999999999987 47889999986543 2233456677776 56789999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.+|++||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999986 345689999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......+ .+.++
T Consensus 190 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~- 263 (373)
T 2r5t_A 190 IEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNIT- 263 (373)
T ss_dssp BCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC----CSSSC-
T ss_pred ccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC----CCCCC-
Confidence 33222 2234569999999999999999999999999999999999999998776655444443322221 12221
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHH
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTM----QEVARVL 884 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~el~~~L 884 (943)
..+.+++..|++.||++||++ .++.+|-
T Consensus 264 --------~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~ 295 (373)
T 2r5t_A 264 --------NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295 (373)
T ss_dssp --------HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred --------HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence 456789999999999999987 4565553
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=348.94 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=211.7
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..++|...+.||+|+||.||+|.++. ++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34689999999999999999999874 6789999886542 2345678899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++++|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999886 345689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
..... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||...................... +
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~--- 238 (294)
T 2rku_A 167 YDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----I--- 238 (294)
T ss_dssp STTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT----S---
T ss_pred cCccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccc----c---
Confidence 33222 233458999999999999889999999999999999999999998766554444333322221111 1
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++..||+.||++|||+.+++++-+-
T Consensus 239 ------~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 239 ------NPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ------CHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 1456789999999999999999999997654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=359.79 Aligned_cols=257 Identities=16% Similarity=0.172 Sum_probs=207.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||+||+|... +++.||||.+..... .+.+.+|+++++.+ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 367899999999999999999974 688999999865432 24688999999999 89999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc-----eeecccccccc
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD-----AHLSDFGIARC 767 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~DFGla~~ 767 (943)
|+ +|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998732 35799999999999999999999999 9999999999999998887 99999999987
Q ss_pred cCCCCCc------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc--HHHHHHHh-cccccc
Q 002278 768 IPTAMPH------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN--LHQLIMSK-ADDNTV 838 (943)
Q Consensus 768 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~--~~~~~~~~-~~~~~~ 838 (943)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ........ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 6443221 12345699999999999999999999999999999999999999986422 21111111 110000
Q ss_pred c-cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 839 M-EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 839 ~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
. +.... .. ..+.+++..||+.||.+||++.++.+.|+.+..
T Consensus 240 ~~~~~~~---------~~-p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 240 PIEVLCE---------NF-PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp CHHHHTT---------TC-HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHHhc---------cC-hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 0 00000 01 267899999999999999999999999876643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=353.93 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=212.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
..++|...+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4578999999999999999999863 34789999986543 3345678899999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCC---------------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSK---------------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVK 745 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 745 (943)
.++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999864322 23489999999999999999999999 99999999
Q ss_pred CccEEECCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCc
Q 002278 746 SSNILIDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNES 823 (943)
Q Consensus 746 p~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~ 823 (943)
|+||++++++.+||+|||+++........ ......+++.|+|||++.+..++.++||||+||++|||+| |+.||.+..
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876543222 1223347889999999999999999999999999999999 999998655
Q ss_pred cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 824 NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
............. ....+. ....+.+++..||+.||++|||+.+++++|+.+..
T Consensus 258 ~~~~~~~~~~~~~---~~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 258 PERLFNLLKTGHR---MERPDN---------CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGGHHHHHHTTCC---CCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCc---CCCCcc---------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4332222211111 011111 12467899999999999999999999999987653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=361.95 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=196.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..++|+..+.||+|+||+||+|+.+ +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3568999999999999999999987 67899999986543 234678899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc--eeecccccccccCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD--AHLSDFGIARCIPT 770 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~DFGla~~~~~ 770 (943)
|+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999986 345699999999999999999999999 9999999999999987765 99999999975432
Q ss_pred CCCceeeeEecccceeCccccccCCCCCc-chhhhHHHHHHHHHhCCCCCCCCcc---HHHHHHHhc-cccccccccCcc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEK-SDVYSFGIVLLEILTGKKAVDNESN---LHQLIMSKA-DDNTVMEAVDPE 845 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltG~~p~~~~~~---~~~~~~~~~-~~~~~~~~~~~~ 845 (943)
.. ......||+.|+|||++.+..++.+ +||||+||++|||++|+.||.+... ......... .....+. ...
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 246 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIR 246 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSC
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCC
Confidence 21 2233469999999999988887655 8999999999999999999985432 122221111 1111111 001
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
+ ...+.+++.+||+.||++|||+.|+++|-+-
T Consensus 247 ~---------s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 247 I---------SPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp C---------CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred C---------CHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 1 1466789999999999999999999998664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=350.20 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=204.0
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++|+..+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999986 488999999865432 234567899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999886 345689999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc-----------
Q 002278 773 PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME----------- 840 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 840 (943)
.. .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+...................
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 DY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred cc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 22 233468999999999876 56899999999999999999999999877665544332221111000
Q ss_pred --cc-CcccccCccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 841 --AV-DPEVSVTCVD-----LSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 841 --~~-~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.. .+... .... ......+.+++..||+.||++|||+.|+++|-+
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 236 FSGVKIPDPE-DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp GTTCCCCCCS-SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred cccCcCCCcc-ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 00 00000 0000 011245778999999999999999999998854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.08 Aligned_cols=263 Identities=21% Similarity=0.282 Sum_probs=213.5
Q ss_pred HHHHHHHhhccccc-eEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCC-CCCcceeeeEEe
Q 002278 608 FDDIMRSTENLSEK-YIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIR-HRNIVSLHGYAL 682 (943)
Q Consensus 608 ~~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 682 (943)
+.......+.|... +.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.+++.++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33444556777777 88999999999999976 58899999986532 344678999999999995 699999999999
Q ss_pred cCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---CCceee
Q 002278 683 SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE---NFDAHL 759 (943)
Q Consensus 683 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl 759 (943)
+....++||||+++|+|.+++... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999998632 235699999999999999999999999 9999999999999987 789999
Q ss_pred cccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc
Q 002278 760 SDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM 839 (943)
Q Consensus 760 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 839 (943)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....................
T Consensus 176 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 253 (327)
T 3lm5_A 176 VDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS 253 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred eeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC
Confidence 99999987654322 2335699999999999999999999999999999999999999988776655544443333332
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+.++ ..+.+++..||+.||++|||+.+++++-+
T Consensus 254 ~~~~~~~~---------~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 254 EETFSSVS---------QLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp TTTTTTSC---------HHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred chhhcccC---------HHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 22222222 45778999999999999999999999865
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=356.76 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=203.9
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 691 (943)
..++|+..+.||+|+||.||+|.++ +++.||+|.+...... ..+|++++.++ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4578999999999999999999986 5788999998655332 35678888777 7999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC----Cceeecccccccc
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN----FDAHLSDFGIARC 767 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~DFGla~~ 767 (943)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999987 345699999999999999999999999 99999999999998533 3599999999987
Q ss_pred cCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC--ccHHHHHH-HhccccccccccCc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNE--SNLHQLIM-SKADDNTVMEAVDP 844 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~--~~~~~~~~-~~~~~~~~~~~~~~ 844 (943)
....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+. ........ ............++
T Consensus 170 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 170 LRAENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp CBCTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred CcCCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 6544322 22346899999999999888999999999999999999999999753 22222222 22222222222222
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.++ ..+.+++..|++.||++|||+.++++|-+-
T Consensus 249 ~~s---------~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 249 SVS---------DTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp TSC---------HHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred cCC---------HHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 222 467789999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=345.95 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=199.9
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
..++|+..+.||+|+||+||+|++.. .||+|++.... ....+.+.+|+++++.++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 45689999999999999999998653 59999986543 33456789999999999999999999965 456789999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999963 345699999999999999999999999 9999999999999999999999999999865432
Q ss_pred C-CceeeeEecccceeCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc--cccCcc
Q 002278 772 M-PHASTFVLGTIGYIDPEYAH---TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM--EAVDPE 845 (943)
Q Consensus 772 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 845 (943)
. ........||+.|+|||++. +..++.++|||||||++|||++|+.||.+.................. ......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 1 22223456999999999986 56788899999999999999999999987666555444333221111 111111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
....+.+++..||+.||++|||+.++++.|+.+..
T Consensus 254 ---------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 254 ---------CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---------CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 12567899999999999999999999999987653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=366.46 Aligned_cols=264 Identities=21% Similarity=0.274 Sum_probs=198.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCC-CCCcceeeeEEecCC--cc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIR-HRNIVSLHGYALSPY--GN 687 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 687 (943)
..++|+..+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|+.+++.+. ||||+++++++..++ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999976 58899999986542 334566789999999997 999999999997654 57
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||++ |+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 68988885 24689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC--------------------CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHH
Q 002278 768 IPTAM--------------------PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLH 826 (943)
Q Consensus 768 ~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~ 826 (943)
+.... ....+..+||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 53211 111234569999999999886 678999999999999999999999999887766
Q ss_pred HHHHHhccccccccccCc-----------------------ccccCcc-----------CHHHHHHHHHHHHHccCCCCC
Q 002278 827 QLIMSKADDNTVMEAVDP-----------------------EVSVTCV-----------DLSAVRKTFQLALLCTKRYPS 872 (943)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~-----------~~~~~~~l~~l~~~cl~~dP~ 872 (943)
++..+....+........ ....... .......+.+++.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 655543222111100000 0000000 001124677999999999999
Q ss_pred CCCCHHHHHHHHh
Q 002278 873 ERPTMQEVARVLV 885 (943)
Q Consensus 873 ~RPt~~el~~~L~ 885 (943)
+|||+.|+++|-+
T Consensus 319 ~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 319 KRISANDALKHPF 331 (388)
T ss_dssp GSCCHHHHTTSTT
T ss_pred cCCCHHHHhCCHH
Confidence 9999999999854
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=355.50 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=211.9
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..++|...+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35789999999999999999999874 6789999886542 2345678899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999886 345689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........+............. +
T Consensus 193 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~--- 264 (335)
T 2owb_A 193 YDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----I--- 264 (335)
T ss_dssp STTCC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT----S---
T ss_pred cCccc-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCcc----C---
Confidence 33222 233468999999999999899999999999999999999999998766544444333322222111 1
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++..||+.||++|||+.|++++-+-
T Consensus 265 ------~~~~~~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 265 ------NPVAASLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ------CHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1356789999999999999999999987653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.72 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=208.0
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--CcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 690 (943)
.++|+..+.||+|+||+||+|+++ ++.||+|++.... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467899999999999999999986 8889999987543 33456789999999999999999999999887 678999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCccEEECCCCceeeccccccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR--IIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.++++|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999743 223589999999999999999999998 7 999999999999999999999999887643
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCC---cchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNE---KSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
... ...||+.|+|||++.+..++. ++|||||||++|||++|+.||.+................ ....+.
T Consensus 164 ~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 235 (271)
T 3kmu_A 164 QSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR--PTIPPG 235 (271)
T ss_dssp SCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC--CCCCTT
T ss_pred ccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC--CCCCCC
Confidence 322 235899999999998765554 899999999999999999999877655443333222111 111111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
+ ...+.+++..||+.||++|||+.++++.|+.+..
T Consensus 236 ~---------~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 236 I---------SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp C---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred C---------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1 2467899999999999999999999999987653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=361.03 Aligned_cols=253 Identities=20% Similarity=0.237 Sum_probs=194.2
Q ss_pred hccccc-eEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHH-hcCCCCCcceeeeEEec----CCcce
Q 002278 616 ENLSEK-YIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETI-GSIRHRNIVSLHGYALS----PYGNL 688 (943)
Q Consensus 616 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 688 (943)
++|... +.||+|+||+||+|.++ +++.||||++... ..+.+|++++ +..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999976 5788999998532 5677888886 45589999999999865 45679
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---CCceeecccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE---NFDAHLSDFGIA 765 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DFGla 765 (943)
+||||+++|+|.+++... ....+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999743 234689999999999999999999999 9999999999999997 789999999999
Q ss_pred cccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHH----HHHHHhccccccccc
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLH----QLIMSKADDNTVMEA 841 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~~ 841 (943)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ...............
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 8764332 2234568999999999999999999999999999999999999997543211 111111111111111
Q ss_pred cCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 842 VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 842 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.++.+ ...+.+++..||+.||++|||+.|+++|.+-..
T Consensus 290 ~~~~~---------s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 290 EWSEV---------SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TTTTS---------CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ccccC---------CHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 11111 246778999999999999999999999877543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=346.22 Aligned_cols=253 Identities=22% Similarity=0.334 Sum_probs=186.8
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..++|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3568999999999999999999975 68899999985432 2345778999999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999873 235689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
..... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||................. ..+..
T Consensus 164 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 234 (278)
T 3cok_A 164 MPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY--------EMPSF 234 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC--------CCCTT
T ss_pred CCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc--------CCccc
Confidence 33222 2234689999999999999999999999999999999999999986543322211111110 11110
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+.+++.+|++.||++|||+.+++++-+
T Consensus 235 -----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 235 -----LSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp -----SCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred -----cCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 1246778999999999999999999988744
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=355.20 Aligned_cols=262 Identities=24% Similarity=0.368 Sum_probs=211.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec--------CCceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEec
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK--------NSRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALS 683 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 683 (943)
..++|+..+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+++++.+ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999863 45789999987543 23456788999999999 89999999999999
Q ss_pred CCcceEEEEEccCCChhhhccCCCC-------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEE
Q 002278 684 PYGNLLFYDYMVNGSLWDLLHGPSK-------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNIL 750 (943)
Q Consensus 684 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 750 (943)
.+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999975321 23489999999999999999999999 9999999999999
Q ss_pred ECCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHH
Q 002278 751 IDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQL 828 (943)
Q Consensus 751 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~ 828 (943)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 999999999999999876543221 1223347889999999998899999999999999999999 99999866543322
Q ss_pred HHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
........ +..... ....+.+++..||+.||++|||+.+++++|+.+...
T Consensus 270 ~~~~~~~~-------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 270 KLLKEGHR-------MDKPAN-----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHHTCC-------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCC-------CCCCcc-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 22111110 111111 124678899999999999999999999999987653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=371.71 Aligned_cols=328 Identities=20% Similarity=0.177 Sum_probs=205.6
Q ss_pred ccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCC
Q 002278 183 GLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSE 262 (943)
Q Consensus 183 ~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 262 (943)
+++.|+|++|+|++..+..|.++++|++|+|++|.++ +..|..|..+++|++|+|++
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~-----------------------~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-----------------------AVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC-----------------------EECTTTTTTCTTCCEEECCS
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccC-----------------------EeChhhhhCCccCCEEECCC
Confidence 3444444444444444444444444444444444443 23344455555555555555
Q ss_pred CCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCc
Q 002278 263 NELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIP 342 (943)
Q Consensus 263 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 342 (943)
|.+.+..+..|.++++|++|+|++|++++..+..|..+++|++|++++|.+.+..+..|..+++|++|+|++|++++..+
T Consensus 90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp SCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred CcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence 55555444555566666666666666665555666666666666666666666666666666666666666666666555
Q ss_pred ccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccc
Q 002278 343 HNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEH 422 (943)
Q Consensus 343 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 422 (943)
..|..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|+.|+|++|++++..+..|..+++
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 249 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTT
T ss_pred hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccc
Confidence 56666666666666666666666666666667777777766665555555555557777777777777444455677777
Q ss_pred cceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCC
Q 002278 423 LLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSY 502 (943)
Q Consensus 423 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 502 (943)
|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 329 (477)
T 2id5_A 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329 (477)
T ss_dssp CCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCS
T ss_pred cCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccC
Confidence 77777777777766666777777777777777777776677777777777777777777766666667777777777777
Q ss_pred ccccccCCCCcccCcCCCCccccCCCCCCCC
Q 002278 503 NNLSGIIPPIRNFSRFSSNSFIGNPLLCGNW 533 (943)
Q Consensus 503 N~l~~~~~~~~~~~~~~~~~~~~Np~~c~~~ 533 (943)
|++++..+....+.......+.++...|..|
T Consensus 330 N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 330 NPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp SCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred CCccCccchHhHHhhhhccccCccCceeCCc
Confidence 7776543322222223334566777777654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=350.72 Aligned_cols=248 Identities=20% Similarity=0.217 Sum_probs=196.2
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||+||+|.++ +++.||||++..... ........|+..+..+ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 368999999999999999999987 689999999865432 2233445555555544 899999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+ +++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 7799888863 234699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+........+. . ........+.+
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~---~--~~~~~~~~~~~---- 277 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR---Q--GYLPPEFTAGL---- 277 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHT---T--TCCCHHHHTTS----
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHh---c--cCCCcccccCC----
Confidence 32 2233459999999999876 78999999999999999999987776543322211 1 11111111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++..|++.||++|||+.|++++-+
T Consensus 278 -----~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 278 -----SSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp -----CHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred -----CHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 256789999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=374.01 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=208.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||.||+|..+ +++.||+|++.+.. ......+.+|+++++.++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999986 68899999986432 33456788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||++||+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++++||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999998743 233589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc---HHHHHHHhccccccccccCcccc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN---LHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............ ......+
T Consensus 339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~---~~~p~~~- 412 (576)
T 2acx_A 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP---EEYSERF- 412 (576)
T ss_dssp TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC---CCCCTTS-
T ss_pred Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc---ccCCccC-
Confidence 422 2334799999999999999999999999999999999999999986532 222222111110 1111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
...+.+++..|++.||++|| ++.|+++|-+
T Consensus 413 --------s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 413 --------SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred --------CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 14667899999999999999 7899998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=366.10 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=207.0
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCC-cceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPY-GNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 692 (943)
..++|+..+.||+|+||.||+|.++ ++.||||++.... ..+.+.+|++++++++|||||++++++.... ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3568889999999999999999986 7799999997543 4578999999999999999999999987765 6899999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999999999732 123478999999999999999999999 99999999999999999999999999998553221
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
....+++.|+|||++.+..++.++|||||||++|||+| |+.||............... . ....+..
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~------~~~~p~~-- 410 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-Y------KMDAPDG-- 410 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-C------CCCCCTT--
T ss_pred ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C------CCCCCCc--
Confidence 12347889999999999999999999999999999998 99999865443322222111 1 1111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
....+.+++..||+.||++|||+.++++.|+.+..
T Consensus 411 ---~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 411 ---CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 12567899999999999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=347.72 Aligned_cols=259 Identities=15% Similarity=0.181 Sum_probs=208.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||.||+|.+. +++.||+|++.... ..+.+.+|+++++.+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 467999999999999999999964 68899999886443 234678899999999 79999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc-----eeecccccccc
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD-----AHLSDFGIARC 767 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~DFGla~~ 767 (943)
|+ +++|.+++... ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999732 34589999999999999999999999 9999999999999987766 99999999987
Q ss_pred cCCCCCc------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc---HHHHHHHhccc-cc
Q 002278 768 IPTAMPH------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN---LHQLIMSKADD-NT 837 (943)
Q Consensus 768 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~---~~~~~~~~~~~-~~ 837 (943)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ........... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7543221 22345699999999999999999999999999999999999999986432 11111111110 01
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
......+.+ ...+.+++..||+.||++||+++++++.|+.+...
T Consensus 241 ~~~~~~~~~---------~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 241 PLRELCAGF---------PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp CHHHHTTTS---------CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cHHHHHhhC---------cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 111111111 25678999999999999999999999999887643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=355.13 Aligned_cols=267 Identities=24% Similarity=0.259 Sum_probs=205.7
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc-----cHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH-----NLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
...++|+..+.||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+++++.++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999976 5789999998643221 12467899999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.++||||+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999976 88888863 334688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
........ .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+..............+......++.
T Consensus 161 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 161 SFGSPNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTTSCCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eccCCccc-CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 76543222 2334689999999998764 589999999999999999999999998776665554443222221111111
Q ss_pred cccC----------ccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 846 VSVT----------CVD-----LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 846 ~~~~----------~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.... ... ......+.+++..|++.||++|||+.|+++|-+-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 1000 000 0112567899999999999999999999998764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=361.78 Aligned_cols=355 Identities=24% Similarity=0.261 Sum_probs=290.0
Q ss_pred CcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEe
Q 002278 38 LSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNL 117 (943)
Q Consensus 38 ~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 117 (943)
.+++.|+|++|++++ +| .++.+++|++|+|++|+|++ +| ++.+++|++|+|++|++++. | |+.+++|++|++
T Consensus 42 ~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 357899999999996 44 79999999999999999996 45 89999999999999999964 4 899999999999
Q ss_pred cCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccc
Q 002278 118 KNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGT 197 (943)
Q Consensus 118 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 197 (943)
++|++++. | +..+++|++|++++|++++. + +..+++|++|++++|+..+.. .+..+++|++|++++|++++.
T Consensus 114 ~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l 185 (457)
T 3bz5_A 114 DTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL 185 (457)
T ss_dssp CSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC
T ss_pred CCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee
Confidence 99999964 4 89999999999999999974 3 888999999999999543332 588899999999999999974
Q ss_pred cCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCC
Q 002278 198 IPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLS 277 (943)
Q Consensus 198 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 277 (943)
| +..+++|+.|++++|++++. .++.+++|+.|++++|++++ +| +..++
T Consensus 186 -~--l~~l~~L~~L~l~~N~l~~~--------------------------~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~ 233 (457)
T 3bz5_A 186 -D--VSQNKLLNRLNCDTNNITKL--------------------------DLNQNIQLTFLDCSSNKLTE-ID--VTPLT 233 (457)
T ss_dssp -C--CTTCTTCCEEECCSSCCSCC--------------------------CCTTCTTCSEEECCSSCCSC-CC--CTTCT
T ss_pred -c--cccCCCCCEEECcCCcCCee--------------------------ccccCCCCCEEECcCCcccc-cC--ccccC
Confidence 4 88999999999999998732 14556788888888888886 44 77788
Q ss_pred CcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEee
Q 002278 278 YTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVH 357 (943)
Q Consensus 278 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 357 (943)
+|+.|++++|++++.. +..+++|+.|++++|. |+.|++++|.+.+.+| +..+++|+.|+++
T Consensus 234 ~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls 294 (457)
T 3bz5_A 234 QLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVT 294 (457)
T ss_dssp TCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCT
T ss_pred CCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECC
Confidence 8888888888888653 4566778888887764 4566778888776666 5678888888888
Q ss_pred CCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccC
Q 002278 358 GNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLL 437 (943)
Q Consensus 358 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 437 (943)
+|...+.+|. ..++|+.|++++| ++|+.|++++|++++. + ++.+++|+.|++++|++++
T Consensus 295 ~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-- 353 (457)
T 3bz5_A 295 HNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD-- 353 (457)
T ss_dssp TCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--
T ss_pred CCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--
Confidence 8887776664 3456666666655 5788999999999874 3 8889999999999999985
Q ss_pred CccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCcc
Q 002278 438 PAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSN 491 (943)
Q Consensus 438 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 491 (943)
++.|..|++++|.++|. +++..|..++|++|+++|.+|..+..
T Consensus 354 ------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 354 ------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp ------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred ------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhc
Confidence 35678888999999875 46778888999999999988876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=356.11 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=202.0
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCCC--CCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIRH--RNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||.||+|...+++.||||++.... ....+.+.+|+++++.++| |||+++++++..+...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 46799999999999999999999889999999986443 2334678899999999986 9999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|| +.+|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 56889999997 345789999999999999999999999 999999999999997 57899999999987654
Q ss_pred CCCc-eeeeEecccceeCcccccc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccc
Q 002278 771 AMPH-ASTFVLGTIGYIDPEYAHT-----------SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838 (943)
Q Consensus 771 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 838 (943)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~- 238 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH- 238 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS-
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc-
Confidence 3222 2234569999999999865 67889999999999999999999999865443222222211111
Q ss_pred ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
...++... ...+.+++..||+.||++|||+.|+++|.+-...
T Consensus 239 ----~~~~~~~~-----~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 239 ----EIEFPDIP-----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ----CCCCCCCS-----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----ccCCcccC-----CHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 01111111 1457789999999999999999999998775443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.30 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=202.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|...+.||+|+||+||+|..+ ++..||+|++.... ....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 468999999999999999999976 57899999986543 4456889999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE---CCCCceeeccccccccc
Q 002278 693 YMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCI 768 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DFGla~~~ 768 (943)
|+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999885211 235689999999999999999999999 99999999999999 45678999999999876
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
.... ......||+.|+|||++. ..++.++||||+||++|||++|+.||.+...................... .+
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~-- 251 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR-PL-- 251 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--C-CC--
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccC-cC--
Confidence 4432 223456999999999876 56899999999999999999999999876544333222222221111111 01
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++..|++.||++|||+.|++++-+
T Consensus 252 -------~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 252 -------TPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp -------CHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred -------CHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 146678999999999999999999998744
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=354.88 Aligned_cols=252 Identities=28% Similarity=0.376 Sum_probs=207.5
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.+.|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 456899999999999999999974 688999999865432 2345688999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+. |++.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 678887752 235689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeeEecccceeCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAH---TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
. ....||+.|+|||++. +..++.++|||||||++|||++|+.||.+...............+.. ....+
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~- 278 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHW- 278 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTS-
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCC-
Confidence 2 2245999999999884 56789999999999999999999999987766555444333221111 11111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...+.+++..||+.||++|||+.+++++.+-..
T Consensus 279 --------~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 279 --------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------CHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 245778999999999999999999999877544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=350.25 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=213.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCc-ccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYP-HNLREFETELETIGSI-RHRNIVSLHGYALSPY 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 685 (943)
..++|+..+.||+|+||.||+|.+. .++.||+|++..... ...+.+.+|+++++++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 3568999999999999999999852 357899999875443 3456789999999999 8999999999999999
Q ss_pred cceEEEEEccCCChhhhccCCCC---------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEE
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSK---------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNIL 750 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 750 (943)
..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 99999999999999999864321 12589999999999999999999999 9999999999999
Q ss_pred ECCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHH
Q 002278 751 IDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQL 828 (943)
Q Consensus 751 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~ 828 (943)
++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999999877544332 1223457889999999999999999999999999999999 99999865543333
Q ss_pred HHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.......... ...+. ....+.+++..|++.||++|||+.+++++|+.+..
T Consensus 258 ~~~~~~~~~~--~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 258 YKMIKEGFRM--LSPEH---------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHHTCCC--CCCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhccCCCC--CCccc---------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 3222211110 01111 12467899999999999999999999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=356.30 Aligned_cols=265 Identities=20% Similarity=0.248 Sum_probs=201.6
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
...++|+..+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.++...++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 45678999999999999999999976 678999999865432 234567799999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE-----CCCCceeeccccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI-----DENFDAHLSDFGI 764 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill-----~~~~~~kl~DFGl 764 (943)
||||++ |+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 59999986 344689999999999999999999999 99999999999999 4555699999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..............+.......
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 987654322 22334689999999999875 4899999999999999999999999987766655544332221111111
Q ss_pred ccccc------C-----ccCHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 844 PEVSV------T-----CVDLS------AVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 844 ~~~~~------~-----~~~~~------~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.... . ..... ....+.+++..||+.||++|||+.|+++|-+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 11000 0 00000 1246779999999999999999999998755
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=362.38 Aligned_cols=269 Identities=16% Similarity=0.207 Sum_probs=204.4
Q ss_pred HhhccccceEEeeeceEEEEEEEecC------CceEEEEEecccCcccH-----------HHHHHHHHHHhcCCCCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQYPHNL-----------REFETELETIGSIRHRNIVS 676 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~ 676 (943)
..++|+..+.||+|+||+||+|.++. ++.||||++........ ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999865 37899999865432111 12334566677889999999
Q ss_pred eeeEEecC----CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC
Q 002278 677 LHGYALSP----YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID 752 (943)
Q Consensus 677 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 752 (943)
+++++... ...++||||+ +|+|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99998765 3479999999 9999999863 235699999999999999999999999 999999999999999
Q ss_pred --CCCceeecccccccccCCCCCc------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc
Q 002278 753 --ENFDAHLSDFGIARCIPTAMPH------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN 824 (943)
Q Consensus 753 --~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~ 824 (943)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876432111 11234599999999999999999999999999999999999999985332
Q ss_pred HHHHHHHhcc--ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 825 LHQLIMSKAD--DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 825 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
.......... .....+..++.+... .....+.+++..||+.||++||++.++++.|+.+.....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAA----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTT----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccc----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 2222211111 111111111111100 112567899999999999999999999999987765433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=346.61 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=215.6
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..++|+..+.||+|+||+||+|.++. +..||+|++... ....+.+.+|+++++.++||||+++++++.++...++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 56789999999999999999999874 788999998653 3456788999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999643 234689999999999999999999999 99999999999999999999999999998876554
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
........+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||............... .. ....+.+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~----- 237 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR--MERPEGC----- 237 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CC--CCCCTTC-----
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-CC--CCCCCCC-----
Confidence 444445567889999999999999999999999999999999 99999865433222211111 10 0111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
...+.+++..|++.||++|||+.++++.|+.+..
T Consensus 238 ----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 238 ----PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 2467899999999999999999999999987543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=370.60 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=206.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
.++|+..+.||+|+||+||+|+++ ++..||+|++.... ......+.+|+++++.++|||||++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999986 57889999986543 334577899999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---CCceeeccccccccc
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE---NFDAHLSDFGIARCI 768 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DFGla~~~ 768 (943)
||+++|+|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999999886 345689999999999999999999999 9999999999999975 455999999999877
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
.... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.....................++.++
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s- 265 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS- 265 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC-
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC-
Confidence 5432 223356999999999886 468999999999999999999999998876655444443333322222222222
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+.+++..||+.||++|||+.++++|-+
T Consensus 266 --------~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 266 --------EGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp --------HHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred --------HHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 45678999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=353.16 Aligned_cols=269 Identities=24% Similarity=0.373 Sum_probs=209.4
Q ss_pred hhccccceEEeeeceEEEEEEEe-----cCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEec--CCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCAL-----KNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS--PYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 687 (943)
.++|+..+.||+|+||.||+|++ ..++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999984 3578899999987666666789999999999999999999999874 4557
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 899999999999999963 234699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc--------
Q 002278 768 IPTAMPH--ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT-------- 837 (943)
Q Consensus 768 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-------- 837 (943)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..................
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 7544322 122345788899999999999999999999999999999999999753321100000000000
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCC
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPA 893 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~~ 893 (943)
......+.... .....+.+++..||+.||++|||+.+++++|+.+......
T Consensus 257 ~~~~~~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 257 LEEGQRLPAPP-----ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHTTCCCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred hhcccCCCCCC-----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 00000111111 1125678999999999999999999999999988765443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=354.03 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=212.3
Q ss_pred HHHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--------ccHHHHHHHHHHHhcC-CCCCccee
Q 002278 608 FDDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--------HNLREFETELETIGSI-RHRNIVSL 677 (943)
Q Consensus 608 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l 677 (943)
........++|...+.||+|+||.||+|.++ +|+.||||++..... ...+.+.+|+++++.+ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556778999999999999999999986 689999999865431 1135678899999998 79999999
Q ss_pred eeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCce
Q 002278 678 HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDA 757 (943)
Q Consensus 678 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 757 (943)
++++......++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999986 345699999999999999999999999 99999999999999999999
Q ss_pred eecccccccccCCCCCceeeeEecccceeCcccccc------CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHH
Q 002278 758 HLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT------SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMS 831 (943)
Q Consensus 758 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~ 831 (943)
||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999987754322 233569999999998863 35889999999999999999999999876654443333
Q ss_pred hccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 832 KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...........++.. ...+.+++..|++.||++|||+.++++|-+
T Consensus 318 ~~~~~~~~~~~~~~~---------~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 318 MEGQYQFSSPEWDDR---------SSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp HHTCCCCCHHHHSSS---------CHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HhCCCCCCCcccccC---------CHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 322221111111111 245778999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=344.66 Aligned_cols=257 Identities=24% Similarity=0.310 Sum_probs=204.6
Q ss_pred HhhccccceEEeeeceEEEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN----SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..++|...+.||+|+||+||+|.+.. +..||+|.+.... ....+.+.+|+++++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998653 2359999987543 3456778999999999999999999999865 4678
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999963 234589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
............+++.|+|||++.+..++.++||||||+++|||+| |+.||................... ....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~-- 238 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---KPDL-- 238 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---CCTT--
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---CCCC--
Confidence 5443333334457889999999999999999999999999999998 999997544333222221111100 0111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
....+.+++..||+.||++|||+.+++++|+.+.
T Consensus 239 -------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 239 -------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 1245778999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=371.69 Aligned_cols=254 Identities=21% Similarity=0.311 Sum_probs=213.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||+||+|..+ +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999987 68899999986442 34567899999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE---CCCCceeecccccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARC 767 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DFGla~~ 767 (943)
|||+.+|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999886 345699999999999999999999999 99999999999999 4678999999999987
Q ss_pred cCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
+..... .....||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.....................++.+
T Consensus 179 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 254 (484)
T 3nyv_A 179 FEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV- 254 (484)
T ss_dssp BCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS-
T ss_pred cccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC-
Confidence 754432 223459999999999876 6999999999999999999999999987766554444333322221111222
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++..||+.||++|||+.++++|-+-
T Consensus 255 --------s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 255 --------SESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred --------CHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 2457789999999999999999999997663
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=344.65 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=209.7
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999976 46789999985432 23456789999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999986 345689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
.. .....|++.|+|||++.+..++.++||||||+++|||++|+.||...................+ +.+
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~---- 235 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFL---- 235 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTS----
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcC----
Confidence 22 2234589999999999999999999999999999999999999987665444333322221111 111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++..|++.||++|||+.++++|-+-
T Consensus 236 -----~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 236 -----SDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp -----CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred -----CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 1456789999999999999999999987553
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=350.04 Aligned_cols=267 Identities=22% Similarity=0.298 Sum_probs=201.6
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
..++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3468999999999999999999975 68899999986532 3345678899999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 690 FYDYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999885311 234689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-cHHHHHHHhccccccccccCcccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNES-NLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
...... .....|++.|+|||++.+..++.++||||||+++|||++|+.||.+.. ........... ..........
T Consensus 187 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~-- 262 (310)
T 2wqm_A 187 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPLPSDH-- 262 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSCCCCTTT--
T ss_pred cCCCcc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCCCCcccc--
Confidence 443222 223458999999999999999999999999999999999999997543 22222222211 1111111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCc
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAK 894 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~~~ 894 (943)
....+.+++..||+.||++|||+.++++.++.+.+....+
T Consensus 263 -------~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 263 -------YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp -------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -------cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 1246778999999999999999999999999887655443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=370.31 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=210.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ--YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
..++|+..+.||+|+||+||+|.++ +++.||||++... .......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3568999999999999999999986 6889999998543 234567889999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC---CCCceeecccccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID---ENFDAHLSDFGIARC 767 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DFGla~~ 767 (943)
|||+.+|+|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999886 345699999999999999999999999 999999999999995 456799999999987
Q ss_pred cCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
...... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.....................++.+
T Consensus 174 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 249 (486)
T 3mwu_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI- 249 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGS-
T ss_pred CCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCC-
Confidence 654322 233469999999999876 5999999999999999999999999887665554444333222221111222
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++..||+.||++|||+.++++|-+-
T Consensus 250 --------s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 250 --------SDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp --------CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred --------CHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 1456789999999999999999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=361.15 Aligned_cols=268 Identities=19% Similarity=0.240 Sum_probs=207.1
Q ss_pred HhhccccceEEeee--ceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYG--ASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..++|+..+.||+| +||+||+|+++ +++.||||++.... ....+.+.+|+++++.++|||||++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45789999999999 99999999987 68899999986543 233467888999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998642 224589999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCC------CceeeeEecccceeCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc-
Q 002278 769 PTAM------PHASTFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM- 839 (943)
Q Consensus 769 ~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~- 839 (943)
.... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 2211 011122358999999999987 5799999999999999999999999986554443332221110000
Q ss_pred c-------cc-------------C------------cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 E-------AV-------------D------------PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 ~-------~~-------------~------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+ .. . ...............+.+++.+||+.||++|||+.|+++|-+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 0 00 0 000000000112246788999999999999999999998744
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=351.25 Aligned_cols=256 Identities=21% Similarity=0.265 Sum_probs=200.0
Q ss_pred hhccccc-eEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEE
Q 002278 615 TENLSEK-YIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 615 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 691 (943)
.+.|.+. +.||+|+||+||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567764 67999999999999965 6889999999776666678899999999885 7999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc---eeeccccccccc
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD---AHLSDFGIARCI 768 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DFGla~~~ 768 (943)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999996 345689999999999999999999999 9999999999999998766 999999999765
Q ss_pred CCCCC------ceeeeEecccceeCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCccH------------
Q 002278 769 PTAMP------HASTFVLGTIGYIDPEYAHT-----SRLNEKSDVYSFGIVLLEILTGKKAVDNESNL------------ 825 (943)
Q Consensus 769 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~p~~~~~~~------------ 825 (943)
..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 11223459999999999875 45889999999999999999999999754321
Q ss_pred --HHHHHH-hccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 826 --HQLIMS-KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 826 --~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...... .......+....+. ....+.+++.+|++.||++|||+.|+++|-+
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~---------~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAH---------ISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTT---------SCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHHHHhccCcccCchhccc---------CCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 111111 11111111110011 1246779999999999999999999999855
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=352.16 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=202.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCce----EEEEEeccc-CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRP----IAVKKLYNQ-YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
.++|+..+.||+|+||+||+|.+. +++. ||+|.+... .....+.+.+|+++++.++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999975 3443 577776543 3456788999999999999999999999998754 78
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+|+||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999863 234689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 769 PTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 769 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+............... .. ..+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 244 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LP--QPPIC 244 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CC--CCTTB
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CC--CCccC
Confidence 43322 12233447889999999999999999999999999999999 9999986544332222211111 00 11111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
...+.+++..||+.||++||++.|+++.|+.+...+
T Consensus 245 ---------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 245 ---------TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 245778999999999999999999999999877543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=349.37 Aligned_cols=265 Identities=23% Similarity=0.200 Sum_probs=204.9
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-----cccHHHHHHHHHHHhcC---CCCCcceeeeEEecC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-----PHNLREFETELETIGSI---RHRNIVSLHGYALSP 684 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~ 684 (943)
..++|+..+.||+|+||+||+|++. +++.||+|++.... ......+.+|+++++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999975 67899999986432 12235667788777766 499999999999876
Q ss_pred C-----cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 685 Y-----GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 685 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
. ..++||||+. |+|.+++.... ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 5 3689999996 69999987432 23489999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc
Q 002278 760 SDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM 839 (943)
Q Consensus 760 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 839 (943)
+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+..............+...
T Consensus 162 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 162 ADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp CSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999987654322 2334689999999999999999999999999999999999999988776655544433222111
Q ss_pred cccCcccc--------cC-ccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 EAVDPEVS--------VT-CVD-----LSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 ~~~~~~~~--------~~-~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...++... .. ... ......+.+++.+|++.||++|||+.|+++|-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 11111000 00 000 011256778999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.40 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=205.0
Q ss_pred hhccccceEEeeeceEEEEEEEe-----cCCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Cc
Q 002278 615 TENLSEKYIVGYGASSTVYKCAL-----KNSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSP--YG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 686 (943)
.+.|+..+.||+|+||.||+|++ ..++.||+|++.... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45688999999999999999983 357899999987443 44567899999999999999999999999876 56
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 7999999999999999853 335689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccH--------------HHHHH
Q 002278 767 CIPTAMPH--ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL--------------HQLIM 830 (943)
Q Consensus 767 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~--------------~~~~~ 830 (943)
........ ......||..|+|||++.+..++.++||||+|+++|||+||+.|+...... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 77544321 122334788899999999999999999999999999999999987532211 11111
Q ss_pred HhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 831 SKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...... ....+. .....+.+++..||+.||++|||+.++++.|+.+.
T Consensus 255 ~~~~~~------~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGK------RLPCPP-----NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTC------CCCCCT-----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC------CCCCCC-----CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111100 111111 11256789999999999999999999999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.58 Aligned_cols=269 Identities=25% Similarity=0.318 Sum_probs=214.9
Q ss_pred CHHHHHHHhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccCc-ccHHHHHHHHHHHhcC-CCCCcceee
Q 002278 607 TFDDIMRSTENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQYP-HNLREFETELETIGSI-RHRNIVSLH 678 (943)
Q Consensus 607 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~ 678 (943)
.........++|+..+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34444456789999999999999999999852 457899999875433 3345788999999999 699999999
Q ss_pred eEEecCC-cceEEEEEccCCChhhhccCCCC-------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC
Q 002278 679 GYALSPY-GNLLFYDYMVNGSLWDLLHGPSK-------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDV 744 (943)
Q Consensus 679 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 744 (943)
+++...+ ..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9998765 48999999999999999975332 12388999999999999999999999 9999999
Q ss_pred CCccEEECCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCC
Q 002278 745 KSSNILIDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNE 822 (943)
Q Consensus 745 kp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~ 822 (943)
||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999999999999999876543322 2334568899999999999999999999999999999998 99999865
Q ss_pred ccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 823 SNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
................ ..... ....+.+++..||+.||++|||+.+++++|+.+..
T Consensus 255 ~~~~~~~~~~~~~~~~--~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 255 KIDEEFCRRLKEGTRM--RAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CCSHHHHHHHHHTCCC--CCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhHHHHHHhccCccC--CCCCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 5433333222211110 01111 12467789999999999999999999999987653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=354.74 Aligned_cols=267 Identities=23% Similarity=0.338 Sum_probs=214.8
Q ss_pred HHHHHHhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEE
Q 002278 609 DDIMRSTENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYA 681 (943)
Q Consensus 609 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 681 (943)
++.....++|+..+.||+|+||.||+|.++ .++.||+|++.... ......+.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344456789999999999999999999865 36789999986543 23445688999999999999999999999
Q ss_pred ecCCcceEEEEEccCCChhhhccCCC-------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC
Q 002278 682 LSPYGNLLFYDYMVNGSLWDLLHGPS-------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN 754 (943)
Q Consensus 682 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 754 (943)
.+....++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 99999999999999999999986321 124578999999999999999999999 99999999999999999
Q ss_pred CceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHh
Q 002278 755 FDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSK 832 (943)
Q Consensus 755 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~ 832 (943)
+.+||+|||+++........ ......||+.|+|||++.+..++.++||||+||++|||+| |+.||.+...........
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999999999865433211 1122347889999999999999999999999999999999 899998765433322222
Q ss_pred ccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
.... . ...+. ....+.+++..||+.||++|||+.+++++|+.....
T Consensus 255 ~~~~--~-~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 255 EGGL--L-DKPDN---------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp TTCC--C-CCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred cCCc--C-CCCCC---------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 2111 0 01111 124677899999999999999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=360.62 Aligned_cols=271 Identities=21% Similarity=0.262 Sum_probs=212.6
Q ss_pred ccCHHHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC-----CCCcceee
Q 002278 605 IHTFDDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR-----HRNIVSLH 678 (943)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~ 678 (943)
.+++.+.....++|...+.||+|+||+||+|++. +++.||||++... ......+..|+++++.++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3444444456789999999999999999999985 5788999998642 334566788999999886 99999999
Q ss_pred eEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-----
Q 002278 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE----- 753 (943)
Q Consensus 679 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----- 753 (943)
+++...+..++||||+ +++|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 9999999999999999 99999998643 223589999999999999999999999 9999999999999975
Q ss_pred --------------------CCceeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHH
Q 002278 754 --------------------NFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEIL 813 (943)
Q Consensus 754 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 813 (943)
++.+||+|||+|+...... ....||+.|+|||++.+..++.++||||+||++|||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 7899999999998654332 2346899999999999999999999999999999999
Q ss_pred hCCCCCCCCccHHHHHHHhcccccccccc------------------CcccccCccCHHH---------------HHHHH
Q 002278 814 TGKKAVDNESNLHQLIMSKADDNTVMEAV------------------DPEVSVTCVDLSA---------------VRKTF 860 (943)
Q Consensus 814 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~---------------~~~l~ 860 (943)
||+.||...................+... ....+........ ...+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 99999987665544433322222111100 0000000000000 14567
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 861 QLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 861 ~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+++..||+.||++|||+.|+++|-+
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHhcCChhhCCCHHHHhcCcc
Confidence 9999999999999999999988743
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=349.85 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=204.4
Q ss_pred hhccccceEEeeeceEEEEEEEecCC-----ceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNS-----RPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
.++|+..+.||+|+||.||+|..+.. ..||+|++.... ......+.+|+++++.++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 45677889999999999999987632 359999987543 234457889999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999863 235689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 769 PTAMPH--ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 769 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||............... .... ....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~--~~~~ 274 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLP--TPMD 274 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCC--CCTT
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCC--Cccc
Confidence 543221 1222346789999999999999999999999999999999 99999866544332222211 1110 0111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
....+.+++..||+.||++||++.+++++|+.+....
T Consensus 275 ---------~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 275 ---------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ---------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1246788999999999999999999999998876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=354.60 Aligned_cols=264 Identities=16% Similarity=0.163 Sum_probs=198.6
Q ss_pred hhccccceEEeeeceEEEEEEEec----CCceEEEEEecccCcc-----------cHHHHHHHHHHHhcCCCCCcceeee
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQYPH-----------NLREFETELETIGSIRHRNIVSLHG 679 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 679 (943)
.++|...+.||+|+||+||+|.+. .+..||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999986 4678999998654321 1123567888999999999999999
Q ss_pred EEec----CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC
Q 002278 680 YALS----PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF 755 (943)
Q Consensus 680 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 755 (943)
++.. ....++||||+ +++|.+++. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISG---QNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCB---GGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9987 67789999999 999999997 334799999999999999999999999 999999999999999877
Q ss_pred --ceeecccccccccCCCCC------ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc-HH
Q 002278 756 --DAHLSDFGIARCIPTAMP------HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN-LH 826 (943)
Q Consensus 756 --~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~-~~ 826 (943)
.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999987643211 111334699999999999999999999999999999999999999964221 11
Q ss_pred HHHHHh-ccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 827 QLIMSK-ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 827 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
...... ............... .......+.+++..||+.||++|||+.++++.|+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHhhcccccHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111 101111111100000 00112467899999999999999999999999987554
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=368.98 Aligned_cols=255 Identities=23% Similarity=0.285 Sum_probs=208.4
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-------------ccHHHHHHHHHHHhcCCCCCcceeee
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-------------HNLREFETELETIGSIRHRNIVSLHG 679 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 679 (943)
..++|...+.||+|+||+||+|..+ +++.||+|++..... ...+.+.+|+++++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999986 478899999865321 33567899999999999999999999
Q ss_pred EEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC---c
Q 002278 680 YALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF---D 756 (943)
Q Consensus 680 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~ 756 (943)
++.+....++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999886 345699999999999999999999999 999999999999998775 6
Q ss_pred eeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccc
Q 002278 757 AHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN 836 (943)
Q Consensus 757 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 836 (943)
+||+|||+++....... .....||+.|+|||++. ..++.++||||+||++|+|++|+.||.+...............
T Consensus 188 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp EEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999999987754422 23346999999999987 4689999999999999999999999988766554444333322
Q ss_pred ccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 837 TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
......++.+ ...+.+++..|++.||++|||+.|+++|-+-
T Consensus 265 ~~~~~~~~~~---------s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 265 YFDFNDWKNI---------SDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp CCCHHHHTTS---------CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCCccccCCC---------CHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 2221111122 1467789999999999999999999997653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=356.16 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=198.0
Q ss_pred hccccceEEeeeceEEEEEEEecC--C--ceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEec-CCcceE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN--S--RPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALS-PYGNLL 689 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 689 (943)
..|...+.||+|+||+||+|.+.+ + ..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 356777899999999999998652 2 358999886533 3456789999999999999999999999765 457799
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999974 334588999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCC---ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 770 TAMP---HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 770 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
.... .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||................... .|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~----~p~ 319 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL----QPE 319 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC----CCT
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC----CCC
Confidence 3321 12233457889999999999999999999999999999999 778887554433222222111110 011
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
. ....+.+++..||+.||++|||+.+++++|+.+.....
T Consensus 320 ---~-----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 320 ---Y-----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ---T-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---C-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1 12467899999999999999999999999998765443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=358.67 Aligned_cols=256 Identities=23% Similarity=0.290 Sum_probs=201.8
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCC--CCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIR--HRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 690 (943)
.+.|+..+.||+|+||.||+|....++.||||++.... ....+.+.+|+++++.++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35699999999999999999998889999999986543 334567899999999996 59999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|| +.+++|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 67889999997 344689999999999999999999999 999999999999996 57999999999987654
Q ss_pred CCCc-eeeeEecccceeCcccccc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccc
Q 002278 771 AMPH-ASTFVLGTIGYIDPEYAHT-----------SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838 (943)
Q Consensus 771 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 838 (943)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~- 285 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH- 285 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS-
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc-
Confidence 3221 1233469999999999865 36889999999999999999999999865443222222211110
Q ss_pred ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...++... ...+.+++..||+.||++|||+.|++++.+-..
T Consensus 286 ----~~~~~~~~-----~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 286 ----EIEFPDIP-----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp ----CCCCCCCS-----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ----cCCCCccc-----hHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 00111100 145778999999999999999999999876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=375.86 Aligned_cols=261 Identities=28% Similarity=0.396 Sum_probs=213.7
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..++|+..+.||+|+||.||+|.++.+..||||++.... ...+.+.+|++++++++||||+++++++.+ ...++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 457889999999999999999999888889999987543 346789999999999999999999999876 678999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++... ....+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999631 123589999999999999999999999 999999999999999999999999999987643211
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.......++..|+|||++.+..++.++|||||||++|||+| |+.||.+............. ... ...+.
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~--~~~~~------- 488 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRM--PCPPE------- 488 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-CCC--CCCTT-------
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC--CCCCC-------
Confidence 11222346789999999999999999999999999999999 99999876554333222211 110 01111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
....+.+++..||+.||++|||+.++++.|+.+.....
T Consensus 489 --~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 489 --CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred --CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 12467889999999999999999999999998776443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.23 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=209.8
Q ss_pred hhccccce-EEeeeceEEEEEEEec---CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKY-IVGYGASSTVYKCALK---NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.++|.... .||+|+||.||+|.++ .+..||+|++.... ....+.+.+|+++++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566666 8999999999999864 56789999997643 33456789999999999999999999999 4556899
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999863 345689999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCce--eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 770 TAMPHA--STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 770 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||................. ...++.+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~ 238 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPEC 238 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---CCCCTTC
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc---CCCCCCc
Confidence 433221 122346889999999998899999999999999999999 9999987655433322222111 1111111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
...+.+++..||+.||++||++.+++++|+.+....
T Consensus 239 ---------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 239 ---------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp ---------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 246789999999999999999999999999876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=348.35 Aligned_cols=267 Identities=25% Similarity=0.360 Sum_probs=205.6
Q ss_pred HHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcC--CCCCcceeeeEEecC----Cc
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI--RHRNIVSLHGYALSP----YG 686 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~ 686 (943)
...++|+..+.||+|+||.||+|+++ ++.||||++... ....+.+|.+++... +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 45678999999999999999999986 889999998543 334555666666655 899999999999877 67
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeEecCCCCccEEECCCCceeecc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC-----NPRIIHRDVKSSNILIDENFDAHLSD 761 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~D 761 (943)
.++||||+++|+|.++++ ...+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 899999999999999995 336899999999999999999999752 34899999999999999999999999
Q ss_pred cccccccCCCCCce---eeeEecccceeCccccccCCCCCc------chhhhHHHHHHHHHhC----------CCCCCCC
Q 002278 762 FGIARCIPTAMPHA---STFVLGTIGYIDPEYAHTSRLNEK------SDVYSFGIVLLEILTG----------KKAVDNE 822 (943)
Q Consensus 762 FGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltG----------~~p~~~~ 822 (943)
||+++.+....... .....||+.|+|||++.+..++.+ +|||||||++|||+|| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998764432221 123469999999999988776665 9999999999999999 6666532
Q ss_pred c----cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 823 S----NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 823 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
. ......... .. ....+..+...........+.+++..||+.||++|||+.+++++|+.+.....
T Consensus 266 ~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 266 VPSDPSYEDMREIV-CI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp SCSSCCHHHHHHHH-TT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cCCCCchhhhHHHH-hh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 1 111111111 11 11122222222223556788999999999999999999999999998766543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.88 Aligned_cols=256 Identities=24% Similarity=0.307 Sum_probs=207.3
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
..++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4578999999999999999999986 68899999986443 344578899999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 85 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999986 345689999999999999999999999 9999999999999999999999999999865332
Q ss_pred CC-ceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 772 MP-HASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 772 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
.. .......|++.|+|||++.+..+ +.++||||||+++|||++|+.||..................... ..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 234 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKKI--- 234 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTST-TGGGS---
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccC-chhhc---
Confidence 11 11233468999999999987665 78999999999999999999999865432221111111111000 00111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++..|++.||++|||+.|++++.+
T Consensus 235 ------~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 235 ------DSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp ------CHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred ------CHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 245678999999999999999999988744
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=343.73 Aligned_cols=259 Identities=23% Similarity=0.370 Sum_probs=204.8
Q ss_pred hhccccceEEeeeceEEEEEEEecCC----ceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEe-cCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNS----RPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYAL-SPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 688 (943)
..+|+..+.||+|+||+||+|.+.++ ..||+|.+.... ....+.+.+|++++++++||||+++++++. .+...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 45688889999999999999986532 358999886543 334567889999999999999999999965 455779
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++.. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999974 345689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC---ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 769 PTAMP---HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 769 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
..... .......||+.|+|||.+.+..++.++||||+|+++|||++ |.+||.................... ..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 255 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PE 255 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC---CT
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC---Cc
Confidence 43321 12233457889999999999999999999999999999999 6667765544333322222211111 11
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
.. ...+.+++..||+.||++|||+.++++.|+.+...
T Consensus 256 ~~---------~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 256 YC---------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp TC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cC---------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 14678899999999999999999999999887654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=342.52 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=211.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
..+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467899999999999999999975 57899999986543 445678999999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999985 34689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.||................. +.+....
T Consensus 173 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~- 243 (303)
T 3a7i_A 173 QIK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------PTLEGNY- 243 (303)
T ss_dssp BCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-------CCCCSSC-
T ss_pred ccc-cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC-------CCCcccc-
Confidence 222 2334689999999999999999999999999999999999999987655443332222111 1111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++..||+.||++|||+.+++++.+-
T Consensus 244 ----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 244 ----SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp ----CHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 1457789999999999999999999998664
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.32 Aligned_cols=245 Identities=21% Similarity=0.286 Sum_probs=204.4
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--------ccHHHHHHHHHHHhcCCCCCcceeeeEEecC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--------HNLREFETELETIGSIRHRNIVSLHGYALSP 684 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 684 (943)
..++|+..+.||+|+||+||+|.++ +++.||||++..... .....+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4678999999999999999999975 578899999865431 1234577899999999999999999999999
Q ss_pred CcceEEEEEccCC-ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 685 YGNLLFYDYMVNG-SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 685 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
+..++||||+.+| +|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999987 345699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 842 (943)
+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... . ...
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~------~~~ 241 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------E------AAI 241 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------T------TCC
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------h------hcc
Confidence 9987754432 234569999999999988776 789999999999999999999997532210 0 000
Q ss_pred CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 843 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.+... ....+.+++..||+.||++|||+.+++++-+
T Consensus 242 ~~~~~-------~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 242 HPPYL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp CCSSC-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred CCCcc-------cCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00000 1246779999999999999999999999865
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.93 Aligned_cols=250 Identities=20% Similarity=0.314 Sum_probs=200.7
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|...+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467899999999999999999986 68899999986432 33456889999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYIC---KHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999986 345689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
... .....|++.|+|||++.+..+ +.++||||||+++|+|++|+.||...................+. .+
T Consensus 164 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~--- 234 (276)
T 2h6d_A 164 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YL--- 234 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TS---
T ss_pred Ccc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch----hc---
Confidence 321 223458999999999988765 68999999999999999999999876543332222221111111 11
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++..|++.||++|||+.+++++-+
T Consensus 235 ------~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 235 ------NRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ------CHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 145778999999999999999999999755
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=354.55 Aligned_cols=267 Identities=21% Similarity=0.272 Sum_probs=210.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC-------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP------- 684 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 684 (943)
.++|+..+.||+|+||+||+|+++ +++.||+|++.... ......+.+|+++++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 478999999999999999999985 68899999985443 23345788999999999999999999999774
Q ss_pred -CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 685 -YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 685 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
+..++||||+++ ++.+.+.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999975 77777653 234699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC---CceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc
Q 002278 764 IARCIPTAM---PHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM 839 (943)
Q Consensus 764 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 839 (943)
+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+..............+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998764321 122233468999999998876 4589999999999999999999999998776655554444333333
Q ss_pred cccCcccccC------------ccCH-H------HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 840 EAVDPEVSVT------------CVDL-S------AVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 840 ~~~~~~~~~~------------~~~~-~------~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
....+..... .... . ....+.+++.+|++.||++|||+.|+++|-+-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 3222222100 0000 0 123577899999999999999999999987643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=354.96 Aligned_cols=257 Identities=24% Similarity=0.275 Sum_probs=202.2
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCC------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPY------ 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 685 (943)
.++|+..+.||+|+||.||+|.++ +++.||||++..... ...+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999975 688999999865432 23467889999999999999999999998763
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 359999999 8899999862 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC-
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD- 843 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 843 (943)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+....+..+....+.......
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 876432 223468999999999887 67999999999999999999999999987766655544332222111110
Q ss_pred -------------------cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 844 -------------------PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 844 -------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+.... ......+.+++.+|++.||++|||+.++++|-+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASIL--TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTC--TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHC--CCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 0000000 011246779999999999999999999999855
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=367.84 Aligned_cols=254 Identities=19% Similarity=0.259 Sum_probs=208.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|...+.||+|+||.||+|+.+ +++.||+|++.+.. ......+.+|+++++.++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999986 58999999986432 23456788999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 691 YDYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
|||++||+|.+++.... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.+|++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999986432 234699999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc---HHHHHHHh-ccccccccccCcc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN---LHQLIMSK-ADDNTVMEAVDPE 845 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~---~~~~~~~~-~~~~~~~~~~~~~ 845 (943)
..... ....+||+.|+|||++.+..++.++|||||||++|||+||+.||..... ...+.... ......+ +.
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~ 415 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DK 415 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TT
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cc
Confidence 44322 2334699999999999999999999999999999999999999986432 22222221 1111111 11
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHh
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTM-----QEVARVLV 885 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~el~~~L~ 885 (943)
+ ...+.+++..||+.||++||++ .++.+|-+
T Consensus 416 ~---------s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf 451 (543)
T 3c4z_A 416 F---------SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451 (543)
T ss_dssp S---------CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred c---------CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence 1 1456789999999999999964 78877643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=361.40 Aligned_cols=254 Identities=22% Similarity=0.276 Sum_probs=204.1
Q ss_pred hhccccceEEeeeceEEEEEEEec----CCceEEEEEecccC----cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQY----PHNLREFETELETIGSI-RHRNIVSLHGYALSPY 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 685 (943)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999973 68899999986432 23345677899999999 6999999999999999
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999996 345689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCc---cHHHHHHHhcccccccc
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKKAVDNES---NLHQLIMSKADDNTVME 840 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~p~~~~~---~~~~~~~~~~~~~~~~~ 840 (943)
+.+............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ....+........ .
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---~ 283 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---P 283 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC---C
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC---C
Confidence 8764333333334569999999999986 347899999999999999999999997432 2222222111111 0
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhh
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLVS 886 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~~ 886 (943)
...+.+ ...+.+++.+||..||++|| ++.+++++.+-
T Consensus 284 ~~~~~~---------~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 284 PYPQEM---------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp CCCTTS---------CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred CCCccc---------CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 111111 14567899999999999999 99999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=339.51 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=204.0
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEec----CCcce
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALS----PYGNL 688 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 688 (943)
..|...+.||+|+||+||+|.+. ++..||+|++.... ....+.+.+|+++++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45778889999999999999976 56789999886542 3345678899999999999999999999865 34578
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCccEEEC-CCCceeecccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR--IIHRDVKSSNILID-ENFDAHLSDFGIA 765 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~DFGla 765 (943)
+||||+++|+|.+++. ....+++..+..++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999996 345689999999999999999999998 7 99999999999998 7899999999999
Q ss_pred cccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||................... ...+..
T Consensus 180 ~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 254 (290)
T 1t4h_A 180 TLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFDKV 254 (290)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-GGGGGC
T ss_pred cccccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-cccCCC
Confidence 765433 2233469999999998874 58999999999999999999999998766655554443332211 111111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
. ...+.+++..||+.||++|||+.++++|-+
T Consensus 255 ~---------~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 255 A---------IPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp C---------CHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred C---------CHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 1 145779999999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=360.79 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=194.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--------cccHHHHHHHHHHHhcCCCCCcceeeeEEecC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--------PHNLREFETELETIGSIRHRNIVSLHGYALSP 684 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 684 (943)
..++|...+.||+|+||+||+|.++ +++.||+|++.... ......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4678999999999999999999976 47899999986432 1122357899999999999999999999865
Q ss_pred CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC---Cceeecc
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN---FDAHLSD 761 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~D 761 (943)
...++||||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.+ +.+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 45799999999999999886 345799999999999999999999999 99999999999999754 4599999
Q ss_pred cccccccCCCCCceeeeEecccceeCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHh-ccccc
Q 002278 762 FGIARCIPTAMPHASTFVLGTIGYIDPEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSK-ADDNT 837 (943)
Q Consensus 762 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~-~~~~~ 837 (943)
||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||............. .....
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~ 363 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence 9999876543 22234569999999999864 568889999999999999999999997543321111111 11111
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
......+.+ ...+.+++.+||+.||++|||+.|+++|-+
T Consensus 364 ~~~~~~~~~---------~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 364 FIPEVWAEV---------SEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp CCHHHHTTS---------CHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCchhhccc---------CHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 111111111 246778999999999999999999999855
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=355.47 Aligned_cols=261 Identities=22% Similarity=0.256 Sum_probs=200.4
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY------ 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 685 (943)
.++|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999976 57889999986543 234467889999999999999999999997765
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..++||||++ |+|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 5799999996 47888775 2488999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc---
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV--- 842 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 842 (943)
+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+....+.......+......
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 8664332 22345699999999999999999999999999999999999999998877666555443322111100
Q ss_pred -----------C------------cccccCcc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 843 -----------D------------PEVSVTCV---DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 843 -----------~------------~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
. +....... .......+.+++.+|+..||++|||+.|+++|-+-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 0 00000000 01224578899999999999999999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=342.32 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=203.3
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
++|....+||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34566679999999999999975 57889999997766666788999999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-CCceeecccccccccCCCCC
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-NFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFGla~~~~~~~~ 773 (943)
++++|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999997543444678999999999999999999999 9999999999999987 89999999999987654322
Q ss_pred ceeeeEecccceeCccccccCC--CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 774 HASTFVLGTIGYIDPEYAHTSR--LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
. .....|++.|+|||++.+.. ++.++||||||+++|||++|+.||................ ...+.++..
T Consensus 179 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~-- 250 (295)
T 2clq_A 179 C-TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-----KVHPEIPES-- 250 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-----CCCCCCCTT--
T ss_pred c-ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-----ccccccccc--
Confidence 1 22345899999999987653 8899999999999999999999997544332211111000 111111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+.+++..||+.||++||++.+++++-+
T Consensus 251 ---~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 251 ---MSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp ---SCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred ---CCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 1246778999999999999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=342.08 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=207.1
Q ss_pred Hhhccccce-EEeeeceEEEEEEEec---CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 614 STENLSEKY-IVGYGASSTVYKCALK---NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 614 ~~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
..++|.... .||+|+||+||+|.+. .++.||||++.... ....+.+.+|+++++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788877 9999999999999653 35789999986543 23356789999999999999999999999 55678
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHH---hCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999997 345689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce--eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 768 IPTAMPHA--STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 768 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
........ .....|++.|+|||++.+..++.++||||||+++|||+| |+.||.+............... ....+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 243 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPA 243 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCC
Confidence 75443322 122346789999999998889999999999999999999 9999987655433222221111 01111
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
. ....+.+++..||+.||++||++.++++.|+.+...
T Consensus 244 ~---------~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 244 G---------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp T---------CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred C---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 124678999999999999999999999999877543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.50 Aligned_cols=266 Identities=23% Similarity=0.347 Sum_probs=202.1
Q ss_pred HHHHHHhhccccceEEeeeceEEEEEEEecC----CceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEe
Q 002278 609 DDIMRSTENLSEKYIVGYGASSTVYKCALKN----SRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYAL 682 (943)
Q Consensus 609 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 682 (943)
+++....++|...+.||+|+||.||+|.... +..||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3344456789999999999999999998653 3479999986543 334567889999999999999999999998
Q ss_pred cCCc-----ceEEEEEccCCChhhhccCC---CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC
Q 002278 683 SPYG-----NLLFYDYMVNGSLWDLLHGP---SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN 754 (943)
Q Consensus 683 ~~~~-----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 754 (943)
+... .++||||+++|+|.+++... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 7654 49999999999999998421 1345699999999999999999999999 99999999999999999
Q ss_pred CceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHh
Q 002278 755 FDAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSK 832 (943)
Q Consensus 755 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~ 832 (943)
+.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.............
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 263 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence 9999999999987643322 12233457889999999999999999999999999999999 899998665443332222
Q ss_pred ccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.... +..... ....+.+++..||+.||++|||+.+++++|+.+..
T Consensus 264 ~~~~-------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 264 HGHR-------LKQPED-----CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TTCC-------CCCBTT-----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCC-------CCCCcc-----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2111 111111 12467899999999999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=353.82 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=210.2
Q ss_pred HhhccccceEEeeeceEEEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPY 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 685 (943)
..++|+..+.||+|+||.||+|.+.. ...||+|.+.... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999999753 2479999986543 23456788999999999 8999999999999999
Q ss_pred cceEEEEEccCCChhhhccCCC-----------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPS-----------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN 754 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 754 (943)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 9999999999999999986321 123579999999999999999999999 99999999999999999
Q ss_pred CceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHh
Q 002278 755 FDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSK 832 (943)
Q Consensus 755 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~ 832 (943)
+.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+...........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 99999999999866433222 2223457889999999999999999999999999999999 999998654433332222
Q ss_pred ccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...... ..... ....+.+++..||+.||++|||+.+++++|+.+.
T Consensus 281 ~~~~~~--~~~~~---------~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 281 KDGYQM--AQPAF---------APKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHTCCC--CCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCC--CCCCC---------CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 211110 00111 1246778999999999999999999999998653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=350.73 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=206.4
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEec----CCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS----PYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 688 (943)
..++|+..+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 3568999999999999999999974 688999999876656667789999999999999999999999873 34678
Q ss_pred EEEEEccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
+||||+++|+|.+++... .....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999988631 1235689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCc--------eeeeEecccceeCccccccCC---CCCcchhhhHHHHHHHHHhCCCCCCCC----ccHHHHHHHh
Q 002278 768 IPTAMPH--------ASTFVLGTIGYIDPEYAHTSR---LNEKSDVYSFGIVLLEILTGKKAVDNE----SNLHQLIMSK 832 (943)
Q Consensus 768 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~p~~~~----~~~~~~~~~~ 832 (943)
....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||... ........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-- 261 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-- 261 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--
Confidence 5321100 001234699999999987654 689999999999999999999999531 11111111
Q ss_pred ccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCC
Q 002278 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPA 893 (943)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~~ 893 (943)
...... ..+. ....+.+++..||+.||++|||+.+++++|+.+.+..+.
T Consensus 262 -~~~~~~--~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 262 -NQLSIP--QSPR---------HSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp -CC--CC--CCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred -ccCCCC--cccc---------CCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 100000 0111 124678999999999999999999999999988765443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=357.81 Aligned_cols=272 Identities=19% Similarity=0.243 Sum_probs=213.7
Q ss_pred hhccccceEEeeeceEEEEEEEecC-CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC--cceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPY--GNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 690 (943)
.++|...+.||+|+||+||+|+++. ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4679999999999999999999874 8899999987543 345677889999999999999999999998765 56999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE----CCCCceeeccccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI----DENFDAHLSDFGIAR 766 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DFGla~ 766 (943)
|||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997544444599999999999999999999999 99999999999999 778889999999998
Q ss_pred ccCCCCCceeeeEecccceeCcccccc--------CCCCCcchhhhHHHHHHHHHhCCCCCCCC----ccHHHHHHHhcc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHT--------SRLNEKSDVYSFGIVLLEILTGKKAVDNE----SNLHQLIMSKAD 834 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltG~~p~~~~----~~~~~~~~~~~~ 834 (943)
....... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||... ............
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 7654322 223459999999998865 56788999999999999999999999632 222222222221
Q ss_pred ccc-cccc----------cCcccccC-ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 835 DNT-VMEA----------VDPEVSVT-CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 835 ~~~-~~~~----------~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
... .... ..+.++.. .........+.+++..||+.||++||+++++++.++.++...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 110 0000 00011111 112455667889999999999999999999999998887653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=342.12 Aligned_cols=258 Identities=23% Similarity=0.369 Sum_probs=203.8
Q ss_pred ccccceEEeeeceEEEEEEEecCC----ceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc-eEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALKNS----RPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGN-LLF 690 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 690 (943)
.|...+.||+|+||+||+|.+.++ ..||+|++..... ...+.+.+|+++++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 566678999999999999986532 2689999875433 3456788999999999999999999999877665 999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+.+|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999974 345689999999999999999999999 999999999999999999999999999986533
Q ss_pred CC---CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCC-CCCCccHHHHHHHhccccccccccCccc
Q 002278 771 AM---PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKA-VDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 771 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
.. ........|++.|+|||.+.+..++.++|||||||++|||++|..| |....... ............ ....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~- 252 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRLP--QPEY- 252 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHTTCCCC--CCTT-
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhcCCCCC--CCcc-
Confidence 21 1112234578999999999999999999999999999999995555 44433322 222221111110 0111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
....+.+++..||+.||++|||+.++++.|+.+....
T Consensus 253 --------~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 253 --------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp --------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 1246779999999999999999999999998876544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=341.01 Aligned_cols=256 Identities=18% Similarity=0.233 Sum_probs=203.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC----cccHHHHHHHHHHHhcCCCCCcceeeeEEe--cCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY----PHNLREFETELETIGSIRHRNIVSLHGYAL--SPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 687 (943)
.++|...+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999975 57899999986532 344577899999999999999999999984 44578
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||++++ +.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 66666532 245689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC-CceeeeEecccceeCccccccCC--CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 768 IPTAM-PHASTFVLGTIGYIDPEYAHTSR--LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 768 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
..... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||.+.................. +
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----~ 234 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----G 234 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----S
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----C
Confidence 64322 12223345899999999988654 47899999999999999999999987654443333222211111 1
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.. ...+.+++.+||+.||++|||+.+++++-+-..
T Consensus 235 ~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 235 DC---------GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp SS---------CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred cc---------CHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 11 145678999999999999999999999866433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=358.12 Aligned_cols=262 Identities=23% Similarity=0.253 Sum_probs=201.6
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc------ce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYG------NL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 688 (943)
..+|+..+.||+|+||+||+|++..+..||+|++..... ...+|+++++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999998888899999865432 22369999999999999999999965433 68
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC-CCCceeecccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIARC 767 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DFGla~~ 767 (943)
+||||++++.+............+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999998765443332112345689999999999999999999999 999999999999999 799999999999987
Q ss_pred cCCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc-------
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM------- 839 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~------- 839 (943)
....... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.........+....+...
T Consensus 192 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6443322 234589999999998765 589999999999999999999999998876665554433211110
Q ss_pred -----cccCcccccCc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 -----EAVDPEVSVTC----VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 -----~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+...+...... ........+.+++.+||+.||++|||+.|+++|-+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 00000000000 00012246789999999999999999999999854
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=346.45 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=208.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCce--EEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRP--IAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 689 (943)
.++|+..+.||+|+||.||+|+++ ++.. +|+|++.... ....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 468999999999999999999976 4554 4899886432 33456789999999999 89999999999999999999
Q ss_pred EEEEccCCChhhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc
Q 002278 690 FYDYMVNGSLWDLLHGPS-------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 756 (943)
||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997432 234689999999999999999999999 9999999999999999999
Q ss_pred eeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccc
Q 002278 757 AHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADD 835 (943)
Q Consensus 757 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 835 (943)
+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||.+.............
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~- 257 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 257 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-
Confidence 9999999997543221 1223347889999999998889999999999999999998 99999876544332222111
Q ss_pred cccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 836 NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
. .+..... ....+.+++..||+.||++|||+.+++++|..+.....
T Consensus 258 ~------~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 258 Y------RLEKPLN-----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp C------CCCCCTT-----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred C------CCCCCCC-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1 1111111 12467899999999999999999999999998776543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=345.37 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=204.3
Q ss_pred ccccceEEeeeceEEEEEEEec-----CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecC--Ccce
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-----NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSP--YGNL 688 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 688 (943)
.|+..+.||+|+||+||+|.++ +++.||||++.... ....+.+.+|+++++.++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3488999999999999988653 57889999997553 23456789999999999999999999999874 4578
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 112 lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999963 3489999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCc--eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhc--------ccccc
Q 002278 769 PTAMPH--ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKA--------DDNTV 838 (943)
Q Consensus 769 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~--------~~~~~ 838 (943)
...... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.............. .....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 554322 12234578889999999999999999999999999999999999975322110000000 00000
Q ss_pred ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.......... .....+.+++..||+.||++|||+.++++.|+.+..
T Consensus 265 ~~~~~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 265 ERGERLPRPD-----KCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HTTCCCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcccCCCCCc-----cccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 0000111111 112567899999999999999999999999987653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=373.34 Aligned_cols=256 Identities=20% Similarity=0.301 Sum_probs=204.2
Q ss_pred ccccce-EEeeeceEEEEEEEec---CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 617 NLSEKY-IVGYGASSTVYKCALK---NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 617 ~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++.... .||+|+||.||+|.++ .+..||||++.... ....+.+.+|+++++.++|||||++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999875 35679999997643 3457889999999999999999999999976 5689999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999964 345699999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCc--eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 772 MPH--ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 772 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||.+............... ...+.
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-------~~~p~ 562 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------MECPP 562 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-------CCCCT
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------CCCCC
Confidence 221 1222335689999999999999999999999999999998 9999987665543333222111 11111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
. ....+.+++..||+.||++||++.++++.|+.+...
T Consensus 563 ~-----~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 563 E-----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp T-----CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred c-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1 125678999999999999999999999999876543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=350.83 Aligned_cols=265 Identities=24% Similarity=0.314 Sum_probs=205.9
Q ss_pred HhhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcc--cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPH--NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
..++|+..+.||+|+||.||+|.+.. ++.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 35789999999999999999999864 789999998654332 345678999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++++|.++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999988875 345689999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc----------
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM---------- 839 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---------- 839 (943)
... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||................+...
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 322 22334589999999998875 789999999999999999999999988776554443322111110
Q ss_pred ----cccCcccccCccC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 ----EAVDPEVSVTCVD----LSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 ----~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+........ ......+.+++..||+.||++|||+.|+++|-+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0001111100000 012356889999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=354.45 Aligned_cols=260 Identities=23% Similarity=0.270 Sum_probs=191.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC------C
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP------Y 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 685 (943)
.++|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999965 57899999986543 23456788999999999999999999999764 4
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..++|+|++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999998 7899988852 4699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+....+..+....+.......+
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865432 233569999999999887 679999999999999999999999999877665554443322211111000
Q ss_pred cccc-------------CccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 845 EVSV-------------TCVDL-----SAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 845 ~~~~-------------~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.+.. ..... .....+.+++.+||+.||++|||+.++++|-+-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~ 315 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence 0000 00000 112457799999999999999999999998653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=362.98 Aligned_cols=263 Identities=19% Similarity=0.247 Sum_probs=188.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC-----Cc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP-----YG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 686 (943)
.++|+..+.||+|+||+||+|.++ +++.||||++.... ....+.+.+|+++++.++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999976 57899999996543 23456788999999999999999999998543 46
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.|+||||+ +|+|.+++. ....+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 79999987 679999886 345699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC--------------------------ceeeeEecccceeCcccc-ccCCCCCcchhhhHHHHHHHHHh-----
Q 002278 767 CIPTAMP--------------------------HASTFVLGTIGYIDPEYA-HTSRLNEKSDVYSFGIVLLEILT----- 814 (943)
Q Consensus 767 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ellt----- 814 (943)
....... ...+..+||+.|+|||++ .+..++.++|||||||++|||+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 7643211 122345689999999976 55679999999999999999999
Q ss_pred ------CCCCCCCCcc--------------------HHHHHHHhcccccccc--------------------ccCccccc
Q 002278 815 ------GKKAVDNESN--------------------LHQLIMSKADDNTVME--------------------AVDPEVSV 848 (943)
Q Consensus 815 ------G~~p~~~~~~--------------------~~~~~~~~~~~~~~~~--------------------~~~~~~~~ 848 (943)
|+++|.+... ..++..+....+...+ .....+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 6777755431 1111111110000000 00000000
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.. ......+.+++.+||..||++|||+.|+++|-+-
T Consensus 365 ~~--~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f 400 (458)
T 3rp9_A 365 RF--PASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400 (458)
T ss_dssp GS--TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HC--CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence 00 0112467799999999999999999999998653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=347.35 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=211.7
Q ss_pred HHHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhc--CCCCCcceeeeEEecCC---
Q 002278 611 IMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGS--IRHRNIVSLHGYALSPY--- 685 (943)
Q Consensus 611 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~--- 685 (943)
.....++|+..+.||+|+||.||+|.+. ++.||||++... ....+.+|+++++. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 3445678999999999999999999985 889999998543 34677888888887 78999999999998876
Q ss_pred -cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeEecCCCCccEEECCCCc
Q 002278 686 -GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH--------HDCNPRIIHRDVKSSNILIDENFD 756 (943)
Q Consensus 686 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlkp~Nill~~~~~ 756 (943)
..++||||+++|+|.+++. ...+++.+++.++.|++.||+||| +. +|+||||||+||+++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 6899999999999999996 246899999999999999999999 77 9999999999999999999
Q ss_pred eeecccccccccCCCCCc---eeeeEecccceeCccccccCC------CCCcchhhhHHHHHHHHHhC----------CC
Q 002278 757 AHLSDFGIARCIPTAMPH---ASTFVLGTIGYIDPEYAHTSR------LNEKSDVYSFGIVLLEILTG----------KK 817 (943)
Q Consensus 757 ~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG----------~~ 817 (943)
+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||+|| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876544322 122346899999999988752 33689999999999999999 77
Q ss_pred CCCCCc----cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 818 AVDNES----NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 818 p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
||.... ....+...... . ...+.++...........+.+++..||+.||++|||+.+++++|+.+....
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCE-Q----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTT-S----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CccccCcCcccHHHHHHHHHH-H----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 886432 22222222211 1 122222222223356678899999999999999999999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=380.66 Aligned_cols=252 Identities=18% Similarity=0.239 Sum_probs=212.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 688 (943)
..++|+..+.||+|+||.||+|+.+ +++.||||++.+. .....+.+..|.++++.+ +||+|+.+++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4678999999999999999999976 4678999998643 233456788899999988 6999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +||||||||+|||++.++++||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999997 345799999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+......++.. +
T Consensus 493 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~----~-- 565 (674)
T 3pfq_A 493 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----M-- 565 (674)
T ss_dssp CCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTT----S--
T ss_pred ccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCcc----C--
Confidence 33322 2334569999999999999999999999999999999999999999877665555554433332221 1
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHh
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTM-----QEVARVLV 885 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~el~~~L~ 885 (943)
...+.+++..||+.||++||++ .|+.+|-+
T Consensus 566 -------s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 566 -------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600 (674)
T ss_dssp -------CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred -------CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence 1456789999999999999987 88887643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.91 Aligned_cols=257 Identities=21% Similarity=0.287 Sum_probs=205.2
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEec--CCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALS--PYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 689 (943)
.++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999986 57889999986543 3345678899999999999999999998854 567899
Q ss_pred EEEEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCCCCC-----eEecCCCCccEEECCCCceeecccc
Q 002278 690 FYDYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDCNPR-----IIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999986321 123489999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+++........ .....|++.|+|||++.+..++.++||||||+++|||++|+.||................. ....
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---~~~~ 237 (279)
T 2w5a_A 162 LARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIP 237 (279)
T ss_dssp HHHHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---CCCC
T ss_pred hheeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc---ccCC
Confidence 99876543221 1224589999999999999999999999999999999999999987654332222221111 0111
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
..+ ...+.+++..||+.||++|||+.|++++++..
T Consensus 238 ~~~---------~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 238 YRY---------SDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp TTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ccc---------CHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 111 24677899999999999999999999987643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=339.98 Aligned_cols=255 Identities=25% Similarity=0.317 Sum_probs=208.8
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---------ccHHHHHHHHHHHhcCC-CCCcceeeeEEe
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---------HNLREFETELETIGSIR-HRNIVSLHGYAL 682 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 682 (943)
..++|+..+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999986 578999999864431 22356789999999996 999999999999
Q ss_pred cCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccc
Q 002278 683 SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDF 762 (943)
Q Consensus 683 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DF 762 (943)
.....++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999996 345689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeeEecccceeCccccc------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccc
Q 002278 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAH------TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN 836 (943)
Q Consensus 763 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 836 (943)
|++........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||.................
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 169 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 99987654322 22345899999999875 45688999999999999999999999987665444333332222
Q ss_pred ccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 837 TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.......+.+ ...+.+++..||+.||++|||+.+++++-+
T Consensus 247 ~~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 247 QFGSPEWDDY---------SDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp CCCTTTGGGS---------CHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred ccCccccccc---------CHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 2111111111 246789999999999999999999988644
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=361.39 Aligned_cols=320 Identities=19% Similarity=0.204 Sum_probs=168.1
Q ss_pred CEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEecc
Q 002278 65 QSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARN 144 (943)
Q Consensus 65 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 144 (943)
+.++.++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 46777777777 5665543 46777777777777655666777777777777777777666666777777777766666
Q ss_pred ccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCC
Q 002278 145 QLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPY 224 (943)
Q Consensus 145 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~ 224 (943)
+++...+..|.. +++|++|+|++|++++..+..|.++++|++|+|++|++++
T Consensus 91 ~l~~~~~~~~~~------------------------l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~---- 142 (477)
T 2id5_A 91 RLKLIPLGVFTG------------------------LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY---- 142 (477)
T ss_dssp CCCSCCTTSSTT------------------------CTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCE----
T ss_pred cCCccCcccccC------------------------CCCCCEEECCCCccccCChhHccccccCCEEECCCCccce----
Confidence 666433333444 4444444444444444444445555555555555444432
Q ss_pred CCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCc
Q 002278 225 NIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLS 304 (943)
Q Consensus 225 ~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 304 (943)
..+..|..+++|+.|+|++|.+++..+..|.++++|+.|+|++|.+++..+..|..+++|+
T Consensus 143 -------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~ 203 (477)
T 2id5_A 143 -------------------ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203 (477)
T ss_dssp -------------------ECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCC
T ss_pred -------------------eChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccc
Confidence 1222333344444444444444433333344444444444444444444444444445555
Q ss_pred EEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCc
Q 002278 305 YLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNN 384 (943)
Q Consensus 305 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 384 (943)
.|++++|...+.+|..+.... +|+.|++++|++++..+..|..+++|+.|+|++|+
T Consensus 204 ~L~l~~~~~~~~~~~~~~~~~------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 259 (477)
T 2id5_A 204 VLEISHWPYLDTMTPNCLYGL------------------------NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259 (477)
T ss_dssp EEEEECCTTCCEECTTTTTTC------------------------CCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSC
T ss_pred eeeCCCCccccccCcccccCc------------------------cccEEECcCCcccccCHHHhcCccccCeeECCCCc
Confidence 555555444333333333333 44444444444443333344444444444444444
Q ss_pred CCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCcccc
Q 002278 385 FKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS 458 (943)
Q Consensus 385 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 458 (943)
+++..+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+++
T Consensus 260 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 260 ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp CCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred CCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 44444444555555555555555555444555555555555555555555554555555555666666666555
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=337.92 Aligned_cols=249 Identities=17% Similarity=0.252 Sum_probs=202.4
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 689 (943)
..++|+..+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+..+..+ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999986 68999999987543 33456788899999998 89999999999999999999
Q ss_pred EEEEccCCChhhhccCCCC-CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC--------------
Q 002278 690 FYDYMVNGSLWDLLHGPSK-KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-------------- 754 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-------------- 754 (943)
||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999863211 25689999999999999999999999 99999999999999844
Q ss_pred -----CceeecccccccccCCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHH
Q 002278 755 -----FDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828 (943)
Q Consensus 755 -----~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~ 828 (943)
..+||+|||.++....... ..||+.|+|||++.+. .++.++|||||||++|||++|.+|+.........
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~ 240 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHH
T ss_pred ccCCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHH
Confidence 4799999999987654322 2489999999999876 5678999999999999999999887655433222
Q ss_pred HHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
. .... ....+.+ ...+.+++..||+.||++|||+.++++|-+
T Consensus 241 ~---~~~~---~~~~~~~---------~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 241 R---QGRL---PRIPQVL---------SQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp H---TTCC---CCCSSCC---------CHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred H---cCCC---CCCCccc---------CHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 1 1110 1111111 146778999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.65 Aligned_cols=198 Identities=22% Similarity=0.326 Sum_probs=166.2
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC-----Cc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP-----YG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 686 (943)
.++|+..+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999976 47889999997543 23456788999999999999999999999776 46
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.++||||+. |+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999985 69999997 345699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---------------------eeeeEecccceeCcccc-ccCCCCCcchhhhHHHHHHHHHhCCCCC
Q 002278 767 CIPTAMPH---------------------ASTFVLGTIGYIDPEYA-HTSRLNEKSDVYSFGIVLLEILTGKKAV 819 (943)
Q Consensus 767 ~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG~~p~ 819 (943)
........ ..+..+||+.|+|||++ .+..++.++||||+||++|||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76443211 12445799999999986 5567999999999999999999854443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.38 Aligned_cols=271 Identities=19% Similarity=0.232 Sum_probs=204.4
Q ss_pred CHHHHHHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcc-----------cHHHHHHHHHHHhcCCCCCcc
Q 002278 607 TFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH-----------NLREFETELETIGSIRHRNIV 675 (943)
Q Consensus 607 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv 675 (943)
..+++....++|+..+.||+|+||.||+|.+..++.||||++...... ..+.+.+|+++++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356677788999999999999999999999888999999998653321 136789999999999999999
Q ss_pred eeeeEEecC-----CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEE
Q 002278 676 SLHGYALSP-----YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNIL 750 (943)
Q Consensus 676 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 750 (943)
++++++... ...++||||+. |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 999998543 34699999997 688888763 344689999999999999999999999 9999999999999
Q ss_pred ECCCCceeecccccccccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHH
Q 002278 751 IDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLI 829 (943)
Q Consensus 751 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~ 829 (943)
++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999998554332 2234568999999999877 679999999999999999999999998776554443
Q ss_pred HHhcccccccc-------------ccC---cccccCc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 830 MSKADDNTVME-------------AVD---PEVSVTC---VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 830 ~~~~~~~~~~~-------------~~~---~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
......+.... ... ....... ........+.+++..|++.||++|||+.|+++|-+
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 33221111000 000 0000000 00011245779999999999999999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=356.16 Aligned_cols=267 Identities=22% Similarity=0.290 Sum_probs=187.5
Q ss_pred hcccc-ceEEeeeceEEEEEEEec---CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEec--CCcceE
Q 002278 616 ENLSE-KYIVGYGASSTVYKCALK---NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS--PYGNLL 689 (943)
Q Consensus 616 ~~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 689 (943)
+.|.. .++||+|+||+||+|+++ +++.||+|++.... ....+.+|+++++.++|||||++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44655 457999999999999976 47889999986543 23578899999999999999999999954 667899
Q ss_pred EEEEccCCChhhhccCC------CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE----CCCCceee
Q 002278 690 FYDYMVNGSLWDLLHGP------SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI----DENFDAHL 759 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl 759 (943)
||||+. |+|.+++... .....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999986 5787776421 1223589999999999999999999999 99999999999999 67889999
Q ss_pred cccccccccCCCCC--ceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcc---------HHH
Q 002278 760 SDFGIARCIPTAMP--HASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESN---------LHQ 827 (943)
Q Consensus 760 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~---------~~~ 827 (943)
+|||+|+....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+... ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987654321 223345699999999998874 589999999999999999999999975432 122
Q ss_pred HHHHhccccccccccCcccccC-----------------ccCH--------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002278 828 LIMSKADDNTVMEAVDPEVSVT-----------------CVDL--------SAVRKTFQLALLCTKRYPSERPTMQEVAR 882 (943)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~--------~~~~~l~~l~~~cl~~dP~~RPt~~el~~ 882 (943)
+..+....+......++.+... .... .....+.+++..||+.||++|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 2222211111111111111000 0000 00235678999999999999999999999
Q ss_pred HHhhcC
Q 002278 883 VLVSLL 888 (943)
Q Consensus 883 ~L~~~~ 888 (943)
|-+-..
T Consensus 334 hp~f~~ 339 (405)
T 3rgf_A 334 DPYFLE 339 (405)
T ss_dssp SGGGTS
T ss_pred Chhhcc
Confidence 977543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=343.74 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=204.3
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..++|+..+.||+|+||.||+|.++ +++.||+|++........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999987 478899999877666777889999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999998853 234689999999999999999999999 99999999999999999999999999986432111
Q ss_pred CceeeeEecccceeCcccc-----ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 773 PHASTFVLGTIGYIDPEYA-----HTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
.......||+.|+|||++ .+..++.++||||||+++|||++|+.||................... ......
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~-- 247 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-LLTPSK-- 247 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGG--
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-cCCccc--
Confidence 111234589999999988 46678999999999999999999999998766554433332222111 000111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
....+.+++..||+.||++|||+.++++|-
T Consensus 248 -------~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 248 -------WSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp -------SCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred -------cCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 124677899999999999999999998864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=360.99 Aligned_cols=244 Identities=14% Similarity=0.191 Sum_probs=190.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHH---HHHhcCCCCCcceee-------eE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETEL---ETIGSIRHRNIVSLH-------GY 680 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 680 (943)
.++|...+.||+|+||+||+|+++ +++.||||++... .....+.+.+|+ +.++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 468899999999999999999975 5899999998643 334567889999 455566899999998 66
Q ss_pred EecCCc-----------------ceEEEEEccCCChhhhccCCC----CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 002278 681 ALSPYG-----------------NLLFYDYMVNGSLWDLLHGPS----KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRI 739 (943)
Q Consensus 681 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 739 (943)
+.+++. .++||||+ +|+|.+++.... ....+++..++.++.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665532 78999999 689999986311 112344588889999999999999999 99
Q ss_pred EecCCCCccEEECCCCceeecccccccccCCCCCceeeeEecccceeCccccccC-----------CCCCcchhhhHHHH
Q 002278 740 IHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS-----------RLNEKSDVYSFGIV 808 (943)
Q Consensus 740 vH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvi 808 (943)
+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2334557 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 809 LLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 809 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
+|||+||+.||.+....... ..... ..+.+ ...+.+++..||+.||++|||+.+++++-
T Consensus 303 l~elltg~~Pf~~~~~~~~~-------~~~~~-~~~~~---------~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 361 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS-------EWIFR-SCKNI---------PQPVRALLEGFLRYPKEDRLLPLQAMETP 361 (377)
T ss_dssp HHHHHHSSCCC------CCS-------GGGGS-SCCCC---------CHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred HHHHHHCCCCCcccccccch-------hhhhh-hccCC---------CHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence 99999999999754321100 00000 01111 24677899999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=351.17 Aligned_cols=257 Identities=23% Similarity=0.264 Sum_probs=189.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEec--------C
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALS--------P 684 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--------~ 684 (943)
..+|+..+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 458999999999999999999975 68899999987666666678899999999996 9999999999942 3
Q ss_pred CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCccEEECCCCceeeccc
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR--IIHRDVKSSNILIDENFDAHLSDF 762 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~DF 762 (943)
...++||||+. |+|.+++........+++.+++.++.|++.||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 34689999995 79989886433345699999999999999999999998 8 999999999999999999999999
Q ss_pred ccccccCCCCCc-----------eeeeEecccceeCcccc---ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHH
Q 002278 763 GIARCIPTAMPH-----------ASTFVLGTIGYIDPEYA---HTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828 (943)
Q Consensus 763 Gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~ 828 (943)
|+++........ ......||+.|+|||++ .+..++.++|||||||++|||+||+.||.........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 999876543221 11134589999999998 5667889999999999999999999999764432211
Q ss_pred HHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 829 IMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
.. .. ........ ...+.+++..||+.||++|||+.|++++|+.+...
T Consensus 263 ~~----~~--~~~~~~~~---------~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 263 NG----KY--SIPPHDTQ---------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -------C--CCCTTCCS---------SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cC----cc--cCCccccc---------chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 10 00 00000111 12356899999999999999999999999887654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=353.52 Aligned_cols=259 Identities=22% Similarity=0.329 Sum_probs=205.4
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999987 57889999986543 3345678999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++. ....+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999996 3456899999999999999999999831 7999999999999999999999999999765322
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccc-ccc-------------
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADD-NTV------------- 838 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~-~~~------------- 838 (943)
......||+.|+|||++.+..++.++|||||||++|||++|+.||................ ...
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1223468999999999999999999999999999999999999998654332211110000 000
Q ss_pred ---------------------ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 839 ---------------------MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 839 ---------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.....+.... ......+.+++..||+.||++|||+.|+++|-+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPS----GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCT----TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCc----ccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0000011110 011246789999999999999999999998765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=336.70 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=198.9
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecC-CcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP-YGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 693 (943)
.++|+..+.||+|+||+||+|..+ ++.||+|.+... ...+.+.+|+++++.++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 578999999999999999999876 789999998654 3457889999999999999999999997655 468999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999998631 122388999999999999999999999 99999999999999999999999999998654321
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
....+++.|+|||++.+..++.++||||||+++|||+| |+.||.............. .. .+....
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~------~~~~~~---- 237 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GY------KMDAPD---- 237 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TC------CCCCCT----
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CC------CCCCcc----
Confidence 22347899999999999999999999999999999998 9999986543322222111 11 111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.....+.+++..||+.||++|||+.++++.|+.+.
T Consensus 238 -~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 238 -GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 11246788999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.84 Aligned_cols=260 Identities=17% Similarity=0.187 Sum_probs=205.0
Q ss_pred hhccccceEEeeeceEEEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEE-ecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCAL-KNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYA-LSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||.||+|++ .+++.||+|++..... .+.+.+|+++++.++|++++..+.++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 56899999999999999999997 4688999998865432 24688999999999988877666665 55667799999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE---CCCCceeecccccccccC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIP 769 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DFGla~~~~ 769 (943)
|+ +++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999863 234699999999999999999999999 99999999999999 488899999999998775
Q ss_pred CCCCc------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc---HHHHHHHhcccc-ccc
Q 002278 770 TAMPH------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN---LHQLIMSKADDN-TVM 839 (943)
Q Consensus 770 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~---~~~~~~~~~~~~-~~~ 839 (943)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 44321 12345699999999999999999999999999999999999999975321 111111111000 001
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
....+.+ ...+.+++..||+.||++|||+.++++.|+.+....
T Consensus 240 ~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 EVLCKGY---------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHTTTS---------CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhhC---------CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 1111111 246789999999999999999999999998775443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.60 Aligned_cols=252 Identities=22% Similarity=0.372 Sum_probs=205.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEec---------
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS--------- 683 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 683 (943)
...+|+..+.||+|+||.||+|.+. +++.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4578999999999999999999986 68999999986543 456789999999999999999998854
Q ss_pred -------CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc
Q 002278 684 -------PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756 (943)
Q Consensus 684 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 756 (943)
....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 33478999999999999999632 234689999999999999999999999 9999999999999999999
Q ss_pred eeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccc
Q 002278 757 AHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN 836 (943)
Q Consensus 757 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 836 (943)
+||+|||+++....... .....|++.|+|||++.+..++.++||||||+++|||++|..|+........ ... ..
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~-~~ 234 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT---DLR-DG 234 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH---HHH-TT
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH---Hhh-cc
Confidence 99999999987754322 2234589999999999999999999999999999999999998853222111 111 11
Q ss_pred ccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 837 TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
.. .+.+ ...+.+++..||+.||++|||+.|++++++.+.....
T Consensus 235 ~~----~~~~---------~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 235 II----SDIF---------DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp CC----CTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred cc----cccC---------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11 1111 1356789999999999999999999999998776543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=347.63 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=208.8
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcc-----------------cHHHHHHHHHHHhcCCCCCccee
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH-----------------NLREFETELETIGSIRHRNIVSL 677 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l 677 (943)
.++|+..+.||+|+||.||+|.. +++.||+|++...... ..+.+.+|+++++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998643211 11789999999999999999999
Q ss_pred eeEEecCCcceEEEEEccCCChhhh------ccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEE
Q 002278 678 HGYALSPYGNLLFYDYMVNGSLWDL------LHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNIL 750 (943)
Q Consensus 678 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nil 750 (943)
++++.+.+..++||||+++|+|.++ +... ....+++..+..++.|++.||+|||+ . +|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 5421 24679999999999999999999998 8 9999999999999
Q ss_pred ECCCCceeecccccccccCCCCCceeeeEecccceeCccccccC-CCCC-cchhhhHHHHHHHHHhCCCCCCCCccHHHH
Q 002278 751 IDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS-RLNE-KSDVYSFGIVLLEILTGKKAVDNESNLHQL 828 (943)
Q Consensus 751 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltG~~p~~~~~~~~~~ 828 (943)
++.++.+||+|||.++..... ......|++.|+|||++.+. .++. ++|||||||++|||++|+.||.........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999999999999876443 23334689999999999887 6666 999999999999999999999877653333
Q ss_pred HHHhccc-cccccccCccccc------CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 829 IMSKADD-NTVMEAVDPEVSV------TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 829 ~~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....... ...+......... ..........+.+++..||+.||++|||+.|+++|-+
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 3322222 1111110000000 0000112256789999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=353.84 Aligned_cols=264 Identities=17% Similarity=0.175 Sum_probs=205.7
Q ss_pred hhccccceEEeeeceEEEEEEEecC---------CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcce---------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN---------SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVS--------- 676 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 676 (943)
.++|+..+.||+|+||.||+|++.. ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999864 789999998654 46789999999999999887
Q ss_pred ------eeeEEec-CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccE
Q 002278 677 ------LHGYALS-PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNI 749 (943)
Q Consensus 677 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 749 (943)
+++++.. +...++||||+ +|+|.+++... ....+++.+++.++.|++.||+|||++ +|+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 6777765 66789999999 99999999732 135799999999999999999999999 999999999999
Q ss_pred EECCCC--ceeecccccccccCCCCCc------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 002278 750 LIDENF--DAHLSDFGIARCIPTAMPH------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDN 821 (943)
Q Consensus 750 ll~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~ 821 (943)
+++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999988 8999999999876432111 11233689999999999999999999999999999999999999986
Q ss_pred Cc-cHHHHHHHhcc-ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002278 822 ES-NLHQLIMSKAD-DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892 (943)
Q Consensus 822 ~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~~ 892 (943)
.. ........... .........+..... .....+.+++..||+.||++|||+.++++.|+.+.....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWI----RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEE----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccC----CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 54 22222221111 001111110000000 012567899999999999999999999999988765443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.36 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=205.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..++|+..+.||+|+||.||+|.++ +++.||+|++.... ..+.+.+|+++++.++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4678999999999999999999986 48899999986543 34778999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999852 245689999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||..................... ....
T Consensus 180 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~------- 250 (314)
T 3com_A 180 AK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR-KPEL------- 250 (314)
T ss_dssp SC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-SGGG-------
T ss_pred cc-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccC-Cccc-------
Confidence 22 22345899999999999999999999999999999999999999876654443332222111000 0011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....+.+++..||+.||++|||+.+++++-+-
T Consensus 251 --~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 251 --WSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp --SCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred --CCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 12467789999999999999999999987653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=339.14 Aligned_cols=261 Identities=18% Similarity=0.190 Sum_probs=201.1
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEE-ecCCcceEE
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYA-LSPYGNLLF 690 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv 690 (943)
...++|+..+.||+|+||+||+|++. +++.||+|++..... ...+.+|+++++.++|++++..+.++ ...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 34578999999999999999999974 678999998654332 24578899999999988877766665 566677999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE---CCCCceeecccccccc
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARC 767 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DFGla~~ 767 (943)
|||+ +|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999 99999998632 34689999999999999999999999 99999999999999 7889999999999987
Q ss_pred cCCCCCc------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccH---HHHHHHhcccc-c
Q 002278 768 IPTAMPH------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL---HQLIMSKADDN-T 837 (943)
Q Consensus 768 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~---~~~~~~~~~~~-~ 837 (943)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ........... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 7544321 123456999999999999999999999999999999999999999753221 11111110000 0
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
......+.+ ...+.+++..||+.||++|||+.++++.|+.+...
T Consensus 238 ~~~~~~~~~---------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 238 PIEVLCKGY---------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp CHHHHTTTS---------CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhhhhccC---------CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 001111111 24678999999999999999999999999887654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=345.39 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=206.8
Q ss_pred HhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
..++|+..+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4578999999999999999999842 46789999986443 3445678899999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCC----CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---CCceee
Q 002278 687 NLLFYDYMVNGSLWDLLHGPS----KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE---NFDAHL 759 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl 759 (943)
.++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999996432 124589999999999999999999999 9999999999999984 456999
Q ss_pred cccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccc
Q 002278 760 SDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNT 837 (943)
Q Consensus 760 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 837 (943)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||..................
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 99999986533221 11223347889999999999999999999999999999998 99999876543332222211110
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
...+. ....+.+++..||+.||++||++.+++++++.+...
T Consensus 265 ---~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 265 ---DPPKN---------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ---CCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCCCC---------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 01111 124677899999999999999999999999977654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=371.50 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=200.2
Q ss_pred eEEeeeceEEEEEEEec---CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALK---NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||+||+|.+. .++.||||++.... ....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999754 35789999987543 3446789999999999999999999999965 468899999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC--c
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP--H 774 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~--~ 774 (943)
|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.+..... .
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999996 345689999999999999999999999 999999999999999999999999999987754322 2
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+............... +..+..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-------~~~p~~---- 596 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------MGCPAG---- 596 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------CCCCTT----
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------CCCCCC----
Confidence 2233447889999999999999999999999999999998 9999987665443332222211 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
....+.+++..||+.||++||++.++++.|+.+.
T Consensus 597 -~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 597 -CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp -CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1256789999999999999999999999998653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=338.81 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=200.9
Q ss_pred hhccccceEEeeeceEEEEEEEecC--Cc--eEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN--SR--PIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.++|+..+.||+|+||+||+|++.. ++ .||+|++.... ....+.+.+|+++++.++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4689999999999999999998642 33 58999886542 344567899999999999999999999998764 8
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 999999999999999863 235689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce--eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 768 IPTAMPHA--STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 768 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
........ .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.................... ..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 248 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPE 248 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCT
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--CCc
Confidence 75443321 223457889999999998889999999999999999999 9999987655443333222211111 111
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
. ....+.+++..||+.||++|||+.+++++|+...+.
T Consensus 249 ~---------~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 249 D---------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp T---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred C---------cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1 125678999999999999999999999999987654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=350.48 Aligned_cols=263 Identities=19% Similarity=0.221 Sum_probs=201.0
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecC-------
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP------- 684 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 684 (943)
...++|+..+.||+|+||+||+|.+. +++.||+|++..... ...+|+++++.++|||||++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 45678999999999999999999975 689999999865422 234799999999999999999998543
Q ss_pred -------------------------------CcceEEEEEccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhh
Q 002278 685 -------------------------------YGNLLFYDYMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLH 732 (943)
Q Consensus 685 -------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH 732 (943)
...++||||++ |+|.+.+... .....+++..+..++.|++.||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 23789999997 5777666421 13456999999999999999999999
Q ss_pred hCCCCCeEecCCCCccEEEC-CCCceeecccccccccCCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHH
Q 002278 733 HDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLL 810 (943)
Q Consensus 733 ~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ 810 (943)
+. +|+||||||+||+++ .++.+||+|||+|+........ ....||+.|+|||++.+. .++.++||||+||++|
T Consensus 159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 99 999999999999998 6889999999999876543322 234589999999998875 4899999999999999
Q ss_pred HHHhCCCCCCCCccHHHHHHHhcccccccc------------ccCcccccCc----cCHHHHHHHHHHHHHccCCCCCCC
Q 002278 811 EILTGKKAVDNESNLHQLIMSKADDNTVME------------AVDPEVSVTC----VDLSAVRKTFQLALLCTKRYPSER 874 (943)
Q Consensus 811 elltG~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~R 874 (943)
||++|+.||.+......+..+....+.... ...+...... ........+.+++.+||+.||++|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999988776665554432211100 0000000000 000112457899999999999999
Q ss_pred CCHHHHHHHHh
Q 002278 875 PTMQEVARVLV 885 (943)
Q Consensus 875 Pt~~el~~~L~ 885 (943)
||+.|+++|-+
T Consensus 314 ~t~~e~l~hp~ 324 (383)
T 3eb0_A 314 INPYEAMAHPF 324 (383)
T ss_dssp CCHHHHHTSGG
T ss_pred CCHHHHhcCHH
Confidence 99999998644
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=346.36 Aligned_cols=264 Identities=22% Similarity=0.272 Sum_probs=205.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecC-----Ccc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSP-----YGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 687 (943)
.++|+..+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999976 57889999987543 23346788999999999999999999999765 357
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+. |+|.+++. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999996 58999885 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce--eeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc---
Q 002278 768 IPTAMPHA--STFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA--- 841 (943)
Q Consensus 768 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 841 (943)
........ .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..............+.....
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 64332211 233469999999998654 558999999999999999999999998766554443332211111000
Q ss_pred -------------cCcccccCc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 842 -------------VDPEVSVTC--VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 842 -------------~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....-.... ........+.+++..|++.||++|||+.|+++|-+-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 000000000 000112467899999999999999999999998653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=353.11 Aligned_cols=272 Identities=18% Similarity=0.214 Sum_probs=196.2
Q ss_pred HHHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 608 FDDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 608 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
-.......++|+..+.||+|+||+||+|.++ +++.||||++.... .......+|++.++.++||||+++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3456678899999999999999999999986 57899999886532 233456778888888999999999999965433
Q ss_pred -------ceEEEEEccCCChhhhcc-CCCCCccCCHHHHHHHHHHHHHHHHHhh--hCCCCCeEecCCCCccEEECC-CC
Q 002278 687 -------NLLFYDYMVNGSLWDLLH-GPSKKVKLDWETRLKIAVGAAQGLAYLH--HDCNPRIIHRDVKSSNILIDE-NF 755 (943)
Q Consensus 687 -------~~lv~e~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~Dlkp~Nill~~-~~ 755 (943)
.++||||++++ +.+.+. .......+++..+..++.|++.||+||| +. +|+||||||+||+++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 68999999764 443332 1124456899999999999999999999 77 9999999999999996 89
Q ss_pred ceeecccccccccCCCCCceeeeEecccceeCccccccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcc
Q 002278 756 DAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKAD 834 (943)
Q Consensus 756 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 834 (943)
.+||+|||+++........ ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.............
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEPN--VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEEECCCTTCBCCCTTSCC--CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cEEEeeCCCceecCCCCCc--ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 9999999999877544322 2345899999999987654 899999999999999999999999877665544443322
Q ss_pred ccccccc----cCccc-----------c----cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 835 DNTVMEA----VDPEV-----------S----VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 835 ~~~~~~~----~~~~~-----------~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.+..... ..+.. . ...........+.+++..||+.||++|||+.|+++|-+-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence 1111100 00000 0 000001124578899999999999999999999998653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=344.28 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=207.9
Q ss_pred HhhccccceEEeeeceEEEEEEEe-----cCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCC--c
Q 002278 614 STENLSEKYIVGYGASSTVYKCAL-----KNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPY--G 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~ 686 (943)
..++|+..+.||+|+||.||+|+. .+++.||+|++........+.+.+|+++++.++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 356789999999999999999984 357899999998766666778999999999999999999999987654 6
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 7999999999999999963 234589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc-------
Q 002278 767 CIPTAMPHA--STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT------- 837 (943)
Q Consensus 767 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~------- 837 (943)
......... .....++..|+|||++.+..++.++|||||||++|||+||+.||..... ...........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHHHHHCTTCCTHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHHHhhccccchhhhHHH
Confidence 775443221 1223467889999999998899999999999999999999999864311 11100000000
Q ss_pred ----cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 838 ----VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 838 ----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
......+.... .....+.+++..||+.||++|||+.++++.|+.+.
T Consensus 272 ~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 272 LIELLKNNGRLPRPD-----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHTTCCCCCCT-----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCC-----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00000011111 11256789999999999999999999999998754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=333.78 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=208.0
Q ss_pred HHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
...++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34678999999999999999999986 68899999986432 3456789999999999999999999999999999999
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC---Cceeeccccccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN---FDAHLSDFGIAR 766 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DFGla~ 766 (943)
||||+++++|.+++. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999886 345689999999999999999999999 99999999999999754 469999999998
Q ss_pred ccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
........ ....|++.|+|||++.+. ++.++||||||+++|+|++|+.||.+......................+.+
T Consensus 173 ~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 2wei_A 173 CFQQNTKM--KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249 (287)
T ss_dssp TBCCCSSC--SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTS
T ss_pred eecCCCcc--ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhc
Confidence 76543221 223589999999988764 899999999999999999999999876654433333222211111111111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++..|++.||++|||+.+++++-+
T Consensus 250 ---------~~~~~~li~~~l~~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 250 ---------SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (287)
T ss_dssp ---------CHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ---------CHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence 246778999999999999999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.09 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=197.6
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--------ccHHHHHHHHHHHhcCCCCCcceeeeEEecC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--------HNLREFETELETIGSIRHRNIVSLHGYALSP 684 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 684 (943)
..++|...+.||+|+||.||+|.++ +++.||||.+..... .....+.+|+++++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999976 478899999864321 2234578999999999999999999998765
Q ss_pred CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc---eeecc
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD---AHLSD 761 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~D 761 (943)
. .++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999886 345689999999999999999999999 9999999999999987654 99999
Q ss_pred cccccccCCCCCceeeeEecccceeCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHH-hccccc
Q 002278 762 FGIARCIPTAMPHASTFVLGTIGYIDPEYAH---TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMS-KADDNT 837 (943)
Q Consensus 762 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~-~~~~~~ 837 (943)
||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||............ ......
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 9999876432 1122345899999999874 467899999999999999999999999754322111111 111111
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
......+.+ ...+.+++..||+.||++|||+.+++++-
T Consensus 239 ~~~~~~~~~---------~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 239 FIPEVWAEV---------SEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp CCHHHHTTS---------CHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred cCchhhhhc---------CHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 111111111 24677999999999999999999998764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=344.57 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=203.9
Q ss_pred HHHHHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEec---
Q 002278 609 DDIMRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALS--- 683 (943)
Q Consensus 609 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 683 (943)
.++....++|+..+.||+|+||.||+|.+. +++.||+|++... ......+.+|+++++++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 334446788999999999999999999975 6889999998643 33457889999999998 79999999999976
Q ss_pred ---CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeec
Q 002278 684 ---PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLS 760 (943)
Q Consensus 684 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 760 (943)
....++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence 45789999999999999998642 235689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCceeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccc
Q 002278 761 DFGIARCIPTAMPHASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADD 835 (943)
Q Consensus 761 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 835 (943)
|||++......... .....||+.|+|||++. +..++.++|||||||++|||++|+.||................
T Consensus 172 Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 172 DFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eCcCceecCcCccc-cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 99999876433222 23346999999999987 5678999999999999999999999998766554443322211
Q ss_pred cccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 836 NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
. .....+.+ ...+.+++..||+.||++||++.+++++-+
T Consensus 251 ~--~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 251 A--PRLKSKKW---------SKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp C--CCCSCSCS---------CHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred c--ccCCcccc---------CHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 1 11111111 246778999999999999999999999755
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=354.83 Aligned_cols=261 Identities=20% Similarity=0.208 Sum_probs=205.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcC------CCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSI------RHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 687 (943)
..+|+..+.||+|+||+||+|.+. +++.||||++... ......+.+|+++++.+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999876 4789999998643 23345677788887766 578999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc--eeecccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD--AHLSDFGIA 765 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~DFGla 765 (943)
++||||+. ++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999995 6999988643 223589999999999999999999999 9999999999999999887 999999999
Q ss_pred cccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc---
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV--- 842 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 842 (943)
+...... ....||+.|+|||++.+..++.++|||||||++|||+||++||.+......+.......+......
T Consensus 250 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 250 CYEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp EETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 7654332 234689999999999999999999999999999999999999988776555443332211111000
Q ss_pred ------------Ccc-----------------------c--ccCccCHH------HHHHHHHHHHHccCCCCCCCCCHHH
Q 002278 843 ------------DPE-----------------------V--SVTCVDLS------AVRKTFQLALLCTKRYPSERPTMQE 879 (943)
Q Consensus 843 ------------~~~-----------------------~--~~~~~~~~------~~~~l~~l~~~cl~~dP~~RPt~~e 879 (943)
.+. . ........ ....+.+++.+||+.||++|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 000 0 00000000 1246789999999999999999999
Q ss_pred HHHHHh
Q 002278 880 VARVLV 885 (943)
Q Consensus 880 l~~~L~ 885 (943)
+++|-+
T Consensus 406 ~L~Hpw 411 (429)
T 3kvw_A 406 ALRHPW 411 (429)
T ss_dssp HHTSTT
T ss_pred HhCChh
Confidence 999865
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=343.29 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=192.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
..++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4678999999999999999999965 57899999886433 334567889999999999999999999999999999999
Q ss_pred EEccCCChhhhccC-----CCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 692 DYMVNGSLWDLLHG-----PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 692 e~~~~g~L~~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
||+++|+|.+++.. ......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999998852 11245689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC----ceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc
Q 002278 767 CIPTAMP----HASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA 841 (943)
Q Consensus 767 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 841 (943)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 7643221 11233468999999999876 568999999999999999999999998766544443333222211110
Q ss_pred --cCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 842 --VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 842 --~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
..+..... ....+.+++..||+.||++|||+.+++++-
T Consensus 250 ~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 250 GVQDKEMLKK-----YGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp -----CCCCC-----CCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred ccccchhhhh-----hhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 01111111 124677899999999999999999999874
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=345.86 Aligned_cols=351 Identities=19% Similarity=0.152 Sum_probs=206.9
Q ss_pred cCCCCCCCCCCCCCC-cceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEE
Q 002278 13 VLLDWDDVHNSDFCS-WRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHI 91 (943)
Q Consensus 13 ~~~~w~~~~~~~~c~-w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 91 (943)
.+++|.. +.+||. |.+..|.-...++ ............-..+.+++.|++++|.++...+..|..+++|++|
T Consensus 2 ~~~~~~~--~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L 74 (390)
T 3o6n_A 2 NVKPRQP--EYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74 (390)
T ss_dssp -----CC--EECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEE
T ss_pred CcCCCCC--ccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEE
Confidence 4788985 568885 4444443222221 2211111222233456889999999999984434447889999999
Q ss_pred eccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccC
Q 002278 92 ELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALT 171 (943)
Q Consensus 92 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 171 (943)
+|++|++++..+..|+.+++|++|+|++|++++..|..|.++++|++|+|++|+++...+..|..+++|++|+|++|+++
T Consensus 75 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~ 154 (390)
T 3o6n_A 75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154 (390)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccC
Confidence 99999998766678999999999999999999888888889999999999999888555555677777777777777777
Q ss_pred CCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccc
Q 002278 172 GMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGL 251 (943)
Q Consensus 172 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 251 (943)
++.+..+..+++|++|++++|++++. .+..+++|+.|++++|.+++. ..
T Consensus 155 ~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~----------------------------~~ 203 (390)
T 3o6n_A 155 RIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL----------------------------AI 203 (390)
T ss_dssp BCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE----------------------------EC
T ss_pred ccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc----------------------------CC
Confidence 77766677777777777777776643 245556666666666665421 11
Q ss_pred cCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEE
Q 002278 252 MQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELN 331 (943)
Q Consensus 252 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 331 (943)
..+|+.|++++|.+... |.. ..++|+.|++++|.+++. ..+..+++|++|++++|.++
T Consensus 204 ~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~----------------- 261 (390)
T 3o6n_A 204 PIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE----------------- 261 (390)
T ss_dssp CSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC-----------------
T ss_pred CCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCC-----------------
Confidence 23455555555555432 111 123444444444444432 23444444444444444444
Q ss_pred ccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCC
Q 002278 332 LADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG 411 (943)
Q Consensus 332 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 411 (943)
+..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|.|+.
T Consensus 262 -------~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~ 332 (390)
T 3o6n_A 262 -------KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT 332 (390)
T ss_dssp -------EEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC
T ss_pred -------CcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce
Confidence 4444444444444444444444442 2333444555555555555555 334444555555555555555553
Q ss_pred ccCCCcccccccceeecccccccc
Q 002278 412 SVPASIGDLEHLLTLNLSRNHLNG 435 (943)
Q Consensus 412 ~~~~~~~~l~~L~~L~Ls~N~l~~ 435 (943)
. + +..+++|+.|++++|+++.
T Consensus 333 ~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 333 L-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp C-C--CCTTCCCSEEECCSSCEEH
T ss_pred e-C--chhhccCCEEEcCCCCccc
Confidence 2 2 4555666666666666653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=345.22 Aligned_cols=264 Identities=22% Similarity=0.261 Sum_probs=203.4
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecC-----Ccc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSP-----YGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 687 (943)
.++|+..+.||+|+||.||+|.+. +++.||||++.... ......+.+|+++++.++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999976 57889999986433 23355778999999999999999999998654 567
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+. |+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999996 68999885 24689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---------eeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc
Q 002278 768 IPTAMPH---------ASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT 837 (943)
Q Consensus 768 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 837 (943)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..............+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 6432211 1122468999999998764 67899999999999999999999999877655444332211111
Q ss_pred cccccC----------------cccccCc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 838 VMEAVD----------------PEVSVTC---VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 838 ~~~~~~----------------~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...... +...... ........+.+++.+||+.||++|||+.|+++|-+-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 000000 0000000 000112467799999999999999999999998654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=348.02 Aligned_cols=266 Identities=26% Similarity=0.370 Sum_probs=198.0
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHH--HhcCCCCCcceeeeEEec-----CCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELET--IGSIRHRNIVSLHGYALS-----PYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~ 686 (943)
..++|+..+.||+|+||+||+|+. +++.||||++... ....+..|.++ +..++||||+++++++.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 357899999999999999999977 5789999998643 23444445554 445899999999986542 224
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCC------CCCeEecCCCCccEEECCCCceeec
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC------NPRIIHRDVKSSNILIDENFDAHLS 760 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dlkp~Nill~~~~~~kl~ 760 (943)
.++||||+++|+|.+++.. ...++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 5899999999999999952 34589999999999999999999762 3389999999999999999999999
Q ss_pred ccccccccCCCCC-------ceeeeEecccceeCcccccc-------CCCCCcchhhhHHHHHHHHHhCCCCCCCCccH-
Q 002278 761 DFGIARCIPTAMP-------HASTFVLGTIGYIDPEYAHT-------SRLNEKSDVYSFGIVLLEILTGKKAVDNESNL- 825 (943)
Q Consensus 761 DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltG~~p~~~~~~~- 825 (943)
|||+++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987643221 11123358999999999887 35667999999999999999997776432110
Q ss_pred ----------------HHHHHHhccccccccccCcccccCcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 826 ----------------HQLIMSKADDNTVMEAVDPEVSVTCV-DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 826 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...... .... ...+.++.... .......+.+++..||+.||++|||+.|+++.|+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVL-VSRE----KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHH-HTTS----CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhh-hccc----ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 010000 0001 11122221111 1234567899999999999999999999999998877
Q ss_pred CCCC
Q 002278 889 PAPP 892 (943)
Q Consensus 889 ~~~~ 892 (943)
....
T Consensus 318 ~~~~ 321 (336)
T 3g2f_A 318 MIWE 321 (336)
T ss_dssp HCCC
T ss_pred HHHH
Confidence 5443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=354.60 Aligned_cols=261 Identities=24% Similarity=0.283 Sum_probs=198.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCC------cc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPY------GN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 687 (943)
..+|+..+.||+|+||.||+|+++ +++.||||++.... ....+|+++++.++|||||++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346889999999999999999986 58999999986532 22347999999999999999999985421 25
Q ss_pred eEEEEEccCCChhhhccC-CCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC-Cceeecccccc
Q 002278 688 LLFYDYMVNGSLWDLLHG-PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-FDAHLSDFGIA 765 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DFGla 765 (943)
++||||+++ ++.+.+.. ......+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999976 56555431 11245689999999999999999999999 99999999999999955 56899999999
Q ss_pred cccCCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc-----
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM----- 839 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~----- 839 (943)
+.+...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+....+...
T Consensus 205 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 205 KQLVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp EECCTTCCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhcccCCCc--eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 876443222 234689999999998765 799999999999999999999999998776665554433211110
Q ss_pred -------cccCcccccCc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 -------EAVDPEVSVTC----VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 -------~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+...+.+.... ........+.+++.+||+.||++|||+.|+++|-+
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 00011110000 00011256789999999999999999999998765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=341.09 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=198.9
Q ss_pred hhccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEec----------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS---------- 683 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 683 (943)
.++|...+.||+|+||.||+|.+.. ++.||+|++........+.+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999874 88999999876666667788999999999999999999998843
Q ss_pred ----CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC-CCCcee
Q 002278 684 ----PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAH 758 (943)
Q Consensus 684 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~k 758 (943)
....++||||++ |+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 356789999997 69999985 34689999999999999999999999 999999999999997 567999
Q ss_pred ecccccccccCCCCCc--eeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccc
Q 002278 759 LSDFGIARCIPTAMPH--ASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADD 835 (943)
Q Consensus 759 l~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 835 (943)
|+|||+++........ ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+..............
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999876432111 1122347899999998865 678999999999999999999999998776554433332211
Q ss_pred ccccccc-----------------CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 836 NTVMEAV-----------------DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 836 ~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....... .+..............+.+++..|++.||++|||+.++++|-+-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 1110000 00000000000112567899999999999999999999997653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=338.53 Aligned_cols=257 Identities=19% Similarity=0.218 Sum_probs=201.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEec--CCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALS--PYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 690 (943)
.++|+..+.||+|+||+||+|.+. +++.||+|++.. ...+.+.+|+++++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 468999999999999999999875 678999999864 34578899999999997 9999999999987 5567999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC-ceeecccccccccC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-DAHLSDFGIARCIP 769 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFGla~~~~ 769 (943)
|||+.+++|.+++. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999884 388999999999999999999999 999999999999999776 89999999998765
Q ss_pred CCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcc-HHHHHHHhccccc--cc------
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESN-LHQLIMSKADDNT--VM------ 839 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~-~~~~~~~~~~~~~--~~------ 839 (943)
.... .....|++.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...........+. ..
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 4332 223468999999999887 6799999999999999999999999964332 2222211110000 00
Q ss_pred -cccCc---------------ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 -EAVDP---------------EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 -~~~~~---------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...++ .+............+.+++..|++.||++|||+.|+++|-+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 00000 00000000012356789999999999999999999999754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=349.96 Aligned_cols=254 Identities=15% Similarity=0.146 Sum_probs=204.2
Q ss_pred HhhccccceEEeeeceEEEEEEE------ecCCceEEEEEecccCcccHHHHHHHHHHHhcCC---CCCcceeeeEEecC
Q 002278 614 STENLSEKYIVGYGASSTVYKCA------LKNSRPIAVKKLYNQYPHNLREFETELETIGSIR---HRNIVSLHGYALSP 684 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 684 (943)
..++|...+.||+|+||+||+|. ...++.||+|++... ...++..|+++++.++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45789999999999999999994 345789999998653 4567888888888887 99999999999999
Q ss_pred CcceEEEEEccCCChhhhccCCC--CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---------
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPS--KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE--------- 753 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--------- 753 (943)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +||||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 99999999999999999996311 235699999999999999999999999 9999999999999998
Q ss_pred --CCceeecccccccccCCC-CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHH
Q 002278 754 --NFDAHLSDFGIARCIPTA-MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIM 830 (943)
Q Consensus 754 --~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~ 830 (943)
++.+||+|||+|+.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----- 291 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG----- 291 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence 899999999999765322 223334456999999999999999999999999999999999999999643210
Q ss_pred HhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhhcCCC
Q 002278 831 SKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSER-PTMQEVARVLVSLLPA 890 (943)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~el~~~L~~~~~~ 890 (943)
........+.. .. ...+.+++..|++.+|.+| |+++++.+.++.+...
T Consensus 292 -----~~~~~~~~~~~----~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 292 -----ECKPEGLFRRL----PH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -----EEEECSCCTTC----SS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----ceeechhcccc----Cc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00001111111 11 2455678999999999998 5788888888776543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=341.23 Aligned_cols=261 Identities=20% Similarity=0.257 Sum_probs=205.8
Q ss_pred hhccccceEEeeeceEEEEEEEe-c-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCC------CcceeeeEEecCCc
Q 002278 615 TENLSEKYIVGYGASSTVYKCAL-K-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHR------NIVSLHGYALSPYG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 686 (943)
.++|+..+.||+|+||+||+|.+ + +++.||+|++... ....+.+.+|+++++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999987 3 5788999998643 33456788899999888655 59999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-------------
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE------------- 753 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~------------- 753 (943)
.++||||+ +++|.+++... ....+++.++..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 89999998643 223689999999999999999999999 9999999999999987
Q ss_pred ------CCceeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHH
Q 002278 754 ------NFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQ 827 (943)
Q Consensus 754 ------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~ 827 (943)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 6789999999998754332 234589999999999999999999999999999999999999987665443
Q ss_pred HHHHhcccccccccc-------------------------------CcccccCccCHHHHHHHHHHHHHccCCCCCCCCC
Q 002278 828 LIMSKADDNTVMEAV-------------------------------DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT 876 (943)
Q Consensus 828 ~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 876 (943)
........+..+... .+..............+.+++..||+.||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 322221111111100 0000001112234567889999999999999999
Q ss_pred HHHHHHHHh
Q 002278 877 MQEVARVLV 885 (943)
Q Consensus 877 ~~el~~~L~ 885 (943)
+.|+++|-+
T Consensus 323 ~~ell~hp~ 331 (339)
T 1z57_A 323 LREALKHPF 331 (339)
T ss_dssp HHHHTTSGG
T ss_pred HHHHhcCHH
Confidence 999988743
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=342.96 Aligned_cols=258 Identities=22% Similarity=0.273 Sum_probs=202.2
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc----
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPYGN---- 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 687 (943)
.++|...+.||+|+||+||+|.++ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999976 578999999975432 2356788999999999999999999999877655
Q ss_pred --eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 688 --LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 688 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
++||||+. |+|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999996 68888774 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..............+........
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 865432 223458999999999887 679999999999999999999999999876655544443222111111000
Q ss_pred ccc-------------cCccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 845 EVS-------------VTCVDL-----SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 845 ~~~-------------~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.+. ...... .....+.+++..|++.||++|||+.|+++|-+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 000 000000 11256789999999999999999999999865
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.10 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=195.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEec---------
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS--------- 683 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 683 (943)
..++|+..+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+++++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4578999999999999999999975 6889999998543 3445678899999999999999999999865
Q ss_pred ----CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 684 ----PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 684 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
....++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 3456899999999999999963 234678899999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCC-------------CceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccH
Q 002278 760 SDFGIARCIPTAM-------------PHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNL 825 (943)
Q Consensus 760 ~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~ 825 (943)
+|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 9999998764321 1122345689999999998864 68999999999999999998 55433222
Q ss_pred HHHHHHhcc-ccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 826 HQLIMSKAD-DNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 826 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
......... ....+ +.+.. .....+.+++..||+.||++|||+.+++++-+
T Consensus 235 ~~~~~~~~~~~~~~~----~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 235 VNILKKLRSVSIEFP----PDFDD-----NKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp HHHHHHHHSTTCCCC----TTCCT-----TTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred HHHHHhccccccccC----ccccc-----cchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 222222211 11111 11111 11245678999999999999999999999744
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=340.56 Aligned_cols=264 Identities=23% Similarity=0.241 Sum_probs=203.7
Q ss_pred HHhhccccceEEeeeceEEEEEEEec--CCceEEEEEecccC--cccHHHHHHHHHHHhcC---CCCCcceeeeEEe---
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALK--NSRPIAVKKLYNQY--PHNLREFETELETIGSI---RHRNIVSLHGYAL--- 682 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 682 (943)
+..++|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 35678999999999999999999984 57889999886432 12223556677776655 8999999999987
Q ss_pred --cCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeec
Q 002278 683 --SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLS 760 (943)
Q Consensus 683 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 760 (943)
.....++||||+. |+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4566899999997 6999988643 223589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc
Q 002278 761 DFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME 840 (943)
Q Consensus 761 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 840 (943)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..............+....
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 999998664321 223346899999999999999999999999999999999999999877665544433321111000
Q ss_pred ccCc----------------ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 841 AVDP----------------EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 841 ~~~~----------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..++ ..... .......+.+++.+||+.||++|||+.++++|-+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKF--VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGT--CCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ccCccccccchhhhcccCcchhhhc--cccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0000 00000 0011246778999999999999999999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=366.77 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=206.5
Q ss_pred HhhccccceEEeeeceEEEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN----SRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
..++|+..+.||+|+||+||+|.+.. +..||+|++.... ....+.+.+|+.+++.++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 45788999999999999999998753 4568999886543 334467899999999999999999999985 45689
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999963 234689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
............||+.|+|||++.+..++.++|||||||++|||++ |..||.+................ ...+.+
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~- 617 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNC- 617 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---CCCTTC-
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCccc-
Confidence 5543333344557889999999999999999999999999999997 99999876654433332222111 011111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...+.+++..||+.||++|||+.++++.|+.+.
T Consensus 618 --------~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 618 --------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 246778999999999999999999999998764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=343.91 Aligned_cols=264 Identities=19% Similarity=0.192 Sum_probs=205.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC-CC-----CcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR-HR-----NIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 686 (943)
..++|+..+.||+|+||+||+|.++ +++.||||++... ......+..|+++++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999976 5788999998643 233456778888888875 44 49999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC--CCCceeeccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID--ENFDAHLSDFGI 764 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~DFGl 764 (943)
.++||||+. |+|.+++... ....+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999995 5999998643 224589999999999999999999952 23899999999999995 578899999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC-
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD- 843 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 843 (943)
++...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.........+....+.......
T Consensus 208 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 208 SCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp CEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98765432 2346899999999999999999999999999999999999999987665554443322111110000
Q ss_pred -------------------------------ccc-------------------ccCccCHHHHHHHHHHHHHccCCCCCC
Q 002278 844 -------------------------------PEV-------------------SVTCVDLSAVRKTFQLALLCTKRYPSE 873 (943)
Q Consensus 844 -------------------------------~~~-------------------~~~~~~~~~~~~l~~l~~~cl~~dP~~ 873 (943)
+.. ........+...+.+++.+||+.||++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 000 000011233457889999999999999
Q ss_pred CCCHHHHHHHHh
Q 002278 874 RPTMQEVARVLV 885 (943)
Q Consensus 874 RPt~~el~~~L~ 885 (943)
|||+.|+++|-+
T Consensus 364 Rpta~e~L~hp~ 375 (382)
T 2vx3_A 364 RIQPYYALQHSF 375 (382)
T ss_dssp SCCHHHHTTSGG
T ss_pred CCCHHHHhcCcc
Confidence 999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=332.40 Aligned_cols=257 Identities=22% Similarity=0.276 Sum_probs=188.9
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-cc-HHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-HN-LREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
..++|+..+.||+|+||+||+|.+. +++.||+|++..... .. .+.+..+...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999975 688999999865432 22 22344555568888999999999999999999999
Q ss_pred EEEccCCChhhhccCC-CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 691 YDYMVNGSLWDLLHGP-SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
|||++ |+|.+++... .....+++..++.++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99997 5887776421 12456999999999999999999999842 89999999999999999999999999998765
Q ss_pred CCCCceeeeEecccceeCcccc----ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYA----HTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
.... .....||+.|+|||++ .+..++.++||||+||++|||+||+.||.................. .......
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 238 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQLPADK 238 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-CCCCTTT
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-CCccccc
Confidence 4322 2234589999999996 5667899999999999999999999999864433322222211111 0110111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+ ...+.+++..|++.||++|||+.|+++|-+
T Consensus 239 ~---------~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 239 F---------SAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp S---------CHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred C---------CHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 1 246789999999999999999999998654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=335.65 Aligned_cols=256 Identities=22% Similarity=0.264 Sum_probs=200.7
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc-----
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSPYG----- 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 686 (943)
.++|...+.||+|+||.||+|.++ +++.||||++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357889999999999999999976 588999999865432 234678899999999999999999999987654
Q ss_pred -ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 687 -NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 687 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
.++||||+. |+|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 68888774 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccc----
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVME---- 840 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---- 840 (943)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+......+.......+....
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865432 233468999999999887 67899999999999999999999999877655443333221111000
Q ss_pred ----------------ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 841 ----------------AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 841 ----------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+... .......+.+++.+|++.||++|||+.++++|-+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQL--FPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTT--CTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHh--cCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 000011000 0012356789999999999999999999999865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=351.14 Aligned_cols=256 Identities=10% Similarity=-0.014 Sum_probs=181.6
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHH---HHHhcCCCCCcceee-------eE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETEL---ETIGSIRHRNIVSLH-------GY 680 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 680 (943)
...|...+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+ +.++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 456889999999999999999976 688999999976542 2345567774 45555 799987754 55
Q ss_pred EecCC-----------------cceEEEEEccCCChhhhccCCCCCccCCHHHH------HHHHHHHHHHHHHhhhCCCC
Q 002278 681 ALSPY-----------------GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETR------LKIAVGAAQGLAYLHHDCNP 737 (943)
Q Consensus 681 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~ 737 (943)
+..++ ..++||||++ |+|.+++... ...+++..+ ..++.|++.||+|||++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 54332 2699999998 8999999632 223455555 77889999999999999
Q ss_pred CeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeEecccceeCcccccc--CCCCCcchhhhHHHHHHHHHhC
Q 002278 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTG 815 (943)
Q Consensus 738 ~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG 815 (943)
+|+||||||+|||++.++.+||+|||+|+..... .....||+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999866432 113347799999999987 6799999999999999999999
Q ss_pred CCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 816 KKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 816 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.||......... ................... .......+.+++..||+.||++|||+.++++|-+
T Consensus 290 ~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 290 FLPFGLVTPGIKG---SWKRPSLRVPGTDSLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp SCSTTBCCTTCTT---CCCBCCTTSCCCCSCCCTT-SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred CCCCCCcCccccc---chhhhhhhhccccccchhh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 9999865321000 0000000000000000000 0011256789999999999999999999987643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=352.77 Aligned_cols=256 Identities=19% Similarity=0.227 Sum_probs=203.2
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCC-CCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRH-RNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|...+.||+|+||.||+|.+. +++.||||++..... ...+.+|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 468999999999999999999974 688999998764432 2457889999999987 566666667777788899999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE---CCCCceeecccccccccC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI---DENFDAHLSDFGIARCIP 769 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DFGla~~~~ 769 (943)
|+ +++|.+++... ...+++.+++.++.||+.||+|||++ +||||||||+|||+ +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999632 34699999999999999999999999 99999999999999 688999999999998775
Q ss_pred CCCCc------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc--HHH-HHHHhccc-cccc
Q 002278 770 TAMPH------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN--LHQ-LIMSKADD-NTVM 839 (943)
Q Consensus 770 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~--~~~-~~~~~~~~-~~~~ 839 (943)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ... +....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 44322 12245699999999999999999999999999999999999999986432 111 11111100 0011
Q ss_pred cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
+.+...+ ...+.+++..||+.||++||++.++++.|+.+
T Consensus 238 ~~l~~~~---------p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EALCRGY---------PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHTTS---------CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHhcCC---------cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111111 24678999999999999999999999988776
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=333.86 Aligned_cols=257 Identities=23% Similarity=0.286 Sum_probs=201.1
Q ss_pred HHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCC--CCCcceeeeEEecCCcce
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIR--HRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~ 688 (943)
...++|+..+.||+|+||.||+|.+++++.||+|++.... ....+.+.+|++++++++ ||||+++++++..+...+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 3467899999999999999999999889999999986443 334567889999999997 599999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||| +.+++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++ +.+||+|||+++..
T Consensus 105 lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 105 MVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999 66889999997 345689999999999999999999999 9999999999999964 89999999999876
Q ss_pred CCCCCc-eeeeEecccceeCcccccc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccc
Q 002278 769 PTAMPH-ASTFVLGTIGYIDPEYAHT-----------SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDN 836 (943)
Q Consensus 769 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 836 (943)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.................
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 443221 1233468999999999875 4688899999999999999999999986544332222221111
Q ss_pred ccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 837 TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
. ...++... ...+.+++..||+.||++||++.|++++.+-.
T Consensus 257 ~-----~~~~~~~~-----~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~ 297 (313)
T 3cek_A 257 H-----EIEFPDIP-----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297 (313)
T ss_dssp S-----CCCCCCCS-----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred c-----ccCCcccc-----hHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence 1 01111111 14677899999999999999999999987643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=358.72 Aligned_cols=349 Identities=20% Similarity=0.232 Sum_probs=214.7
Q ss_pred ccCCCCCCCCCCCCCC----cceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCC
Q 002278 12 NVLLDWDDVHNSDFCS----WRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGS 87 (943)
Q Consensus 12 ~~~~~w~~~~~~~~c~----w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~ 87 (943)
..+++|.. +.+||. |.++.|+.. ++-...... .+..--.+.+++.|++++|.++...+..|.++++
T Consensus 7 ~~l~~~~~--~~~C~~~~~~~~c~~~~~~------i~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~ 76 (597)
T 3oja_B 7 YNVKPRQP--EYKCIDSNLQYDCVFYDVH------IDMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76 (597)
T ss_dssp ----CCCS--EECCCCC--CCSEEECSCE------ECSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHCCC
T ss_pred ccccCCCC--CCcCcccCcCceeEecCce------ecccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccCCC
Confidence 36788975 567874 777766521 122111111 1112224677888888888888554455778888
Q ss_pred CcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccC
Q 002278 88 LVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRG 167 (943)
Q Consensus 88 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 167 (943)
|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.|++.++..|..+++|++|+|++
T Consensus 77 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~ 156 (597)
T 3oja_B 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSN 156 (597)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeC
Confidence 88888888888876667888888888888888888877777788888888888888888765555566677777777777
Q ss_pred CccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCc
Q 002278 168 NALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPE 247 (943)
Q Consensus 168 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 247 (943)
|.++++++..|..+++|++|+|++|.+++. .+..+++|+.|++++|.+++
T Consensus 157 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~--------------------------- 206 (597)
T 3oja_B 157 NNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST--------------------------- 206 (597)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE---------------------------
T ss_pred CcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc---------------------------
Confidence 777766666666666666666666666643 23445556666666655542
Q ss_pred cccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccc
Q 002278 248 VIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQL 327 (943)
Q Consensus 248 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 327 (943)
+....+|+.|++++|.+....+.. .++|+.|+|++|.+++ +..+..+++|
T Consensus 207 -l~~~~~L~~L~ls~n~l~~~~~~~---------------------------~~~L~~L~L~~n~l~~--~~~l~~l~~L 256 (597)
T 3oja_B 207 -LAIPIAVEELDASHNSINVVRGPV---------------------------NVELTILKLQHNNLTD--TAWLLNYPGL 256 (597)
T ss_dssp -EECCTTCSEEECCSSCCCEEECSC---------------------------CSCCCEEECCSSCCCC--CGGGGGCTTC
T ss_pred -ccCCchhheeeccCCccccccccc---------------------------CCCCCEEECCCCCCCC--ChhhccCCCC
Confidence 112234555555555554221111 1344455555555443 2344555555
Q ss_pred eEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCC
Q 002278 328 FELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVN 407 (943)
Q Consensus 328 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 407 (943)
+.|+|++|.+.+.+|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|
T Consensus 257 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N 334 (597)
T 3oja_B 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 334 (597)
T ss_dssp SEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSS
T ss_pred CEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCC
Confidence 555555555555555555555555555555555553 3444555666666666666666 45555666666667777777
Q ss_pred cCCCccCCCcccccccceeecccccccc
Q 002278 408 NFSGSVPASIGDLEHLLTLNLSRNHLNG 435 (943)
Q Consensus 408 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 435 (943)
.|++. + +..+++|+.|+|++|.+.+
T Consensus 335 ~l~~~-~--~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 335 SIVTL-K--LSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp CCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCCCc-C--hhhcCCCCEEEeeCCCCCC
Confidence 66643 2 5566778888888888764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.14 Aligned_cols=253 Identities=19% Similarity=0.239 Sum_probs=175.0
Q ss_pred Hhhccccc-eEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEec----CCcc
Q 002278 614 STENLSEK-YIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS----PYGN 687 (943)
Q Consensus 614 ~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 687 (943)
..++|... ++||+|+||+||+|.++ +++.||+|++... ..........++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 35678885 46999999999999987 5889999998643 1222223334667799999999999876 3447
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---CCceeeccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE---NFDAHLSDFGI 764 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DFGl 764 (943)
++||||+++|+|.+++... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 8999999999999999743 234699999999999999999999999 9999999999999976 45599999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHH----hcccccccc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMS----KADDNTVME 840 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~----~~~~~~~~~ 840 (943)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .........
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence 98664332 23346899999999998888999999999999999999999999754432211000 000000011
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
.... .....+.+++..|++.||++|||+.|++++-+-
T Consensus 255 ~~~~---------~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 255 PEWS---------EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp TTST---------TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred hhhc---------cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 0001 112467789999999999999999999998764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=340.29 Aligned_cols=335 Identities=19% Similarity=0.185 Sum_probs=218.2
Q ss_pred CCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEE
Q 002278 133 IPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILD 212 (943)
Q Consensus 133 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~ 212 (943)
+++|+.|++++|.++...+..|..+++|++|+|++|.++++.+..|..+++|++|+|++|++++..|..|.++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 56777777777777754444455566666666666666655555555555555555555555544444455555555555
Q ss_pred eecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCC
Q 002278 213 ISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGP 292 (943)
Q Consensus 213 Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 292 (943)
|++|+++. ..+..|..+++|++|++++|.+.+.
T Consensus 124 L~~n~l~~-----------------------l~~~~~~~l~~L~~L~L~~n~l~~~------------------------ 156 (390)
T 3o6n_A 124 LERNDLSS-----------------------LPRGIFHNTPKLTTLSMSNNNLERI------------------------ 156 (390)
T ss_dssp CCSSCCCC-----------------------CCTTTTTTCTTCCEEECCSSCCCBC------------------------
T ss_pred CCCCccCc-----------------------CCHHHhcCCCCCcEEECCCCccCcc------------------------
Confidence 55544431 1112234445555555555555444
Q ss_pred CCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCccccccccc
Q 002278 293 IPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNL 372 (943)
Q Consensus 293 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 372 (943)
.+..|..+++|++|++++|++++. .+..+++|+.|++++|.+++. ...++|+.|++++|.+... |.. ..
T Consensus 157 ~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~ 225 (390)
T 3o6n_A 157 EDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VN 225 (390)
T ss_dssp CTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CC
T ss_pred ChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--cc
Confidence 444445555555555555555432 133445555555555555421 2234566666666666643 222 23
Q ss_pred CccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecc
Q 002278 373 GSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDM 452 (943)
Q Consensus 373 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 452 (943)
++|+.|++++|.+++. ..+..+++|+.|++++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|
T Consensus 226 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L 302 (390)
T 3o6n_A 226 VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 302 (390)
T ss_dssp SSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEEC
T ss_pred ccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEEC
Confidence 6778888888887743 467788888888888888887778888889999999999999985 5666788899999999
Q ss_pred cCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCCcccCcCCCCccccCCCCCCC
Q 002278 453 SFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGN 532 (943)
Q Consensus 453 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~~~~~Np~~c~~ 532 (943)
++|+++ .+|..+..+++|+.|+|++|++++. | +..+++|+.|++++|++++.... ..+..+....+.+++..|+.
T Consensus 303 ~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCT
T ss_pred CCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecc
Confidence 999998 6788899999999999999999854 3 67889999999999999874221 23445555667888888875
Q ss_pred C
Q 002278 533 W 533 (943)
Q Consensus 533 ~ 533 (943)
+
T Consensus 378 ~ 378 (390)
T 3o6n_A 378 D 378 (390)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=338.60 Aligned_cols=260 Identities=21% Similarity=0.321 Sum_probs=202.1
Q ss_pred HHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 613 RSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 613 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
...++|+..+.||+|+||.||+|.++. .||+|++.... ....+.+.+|+++++.++||||+++++++.+....++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 346789999999999999999998764 59999886432 23345678899999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 999999999999964 234689999999999999999999999 999999999999998 67999999999876532
Q ss_pred CC----CceeeeEecccceeCcccccc---------CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc
Q 002278 771 AM----PHASTFVLGTIGYIDPEYAHT---------SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT 837 (943)
Q Consensus 771 ~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 837 (943)
.. ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 11 112223458999999998874 35788999999999999999999999876544333222221111
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
......++ ..+.+++..||+.||++|||+.++++.|+.+....
T Consensus 262 --~~~~~~~~---------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 262 --NLSQIGMG---------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp --CCCCSSCC---------TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred --CCCcCCCC---------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111111 34678999999999999999999999999877654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=346.59 Aligned_cols=262 Identities=21% Similarity=0.214 Sum_probs=200.5
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC--------CCCcceeeeEEe---
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR--------HRNIVSLHGYAL--- 682 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 682 (943)
.++|+..+.||+|+||+||+|++. +++.||||++... ....+.+.+|+++++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 468999999999999999999975 5788999998643 334567889999999885 788999999987
Q ss_pred -cCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC------
Q 002278 683 -SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF------ 755 (943)
Q Consensus 683 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~------ 755 (943)
.....++||||+ ++++.+.+... ....+++..+..++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 556789999999 66666665422 2346899999999999999999999853 899999999999999775
Q ss_pred -------------------------------------------ceeecccccccccCCCCCceeeeEecccceeCccccc
Q 002278 756 -------------------------------------------DAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH 792 (943)
Q Consensus 756 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 792 (943)
.+||+|||+++...... ....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcccCChhhc
Confidence 79999999998764332 2245899999999999
Q ss_pred cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc------HHHHHHHhccccccccc-----------cC-----ccc----
Q 002278 793 TSRLNEKSDVYSFGIVLLEILTGKKAVDNESN------LHQLIMSKADDNTVMEA-----------VD-----PEV---- 846 (943)
Q Consensus 793 ~~~~~~~~DvwSlGvil~elltG~~p~~~~~~------~~~~~~~~~~~~~~~~~-----------~~-----~~~---- 846 (943)
+..++.++|||||||++|||+||+.||..... ...........+..+.. .. ..+
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 99999999999999999999999999975431 11111111111110000 00 000
Q ss_pred ---------ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 847 ---------SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 847 ---------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
............+.+++.+||+.||++|||+.|+++|-+
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 000112345567889999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=346.61 Aligned_cols=254 Identities=24% Similarity=0.298 Sum_probs=190.1
Q ss_pred ccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEEcc
Q 002278 617 NLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
.|...+.||+|+||+||.+...+++.||||++... ..+.+.+|+++++.+ +|||||++++++.++...++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 45556889999999998776677999999998643 345678899999876 89999999999999999999999995
Q ss_pred CCChhhhccCCCCCc----cCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC-------------Ccee
Q 002278 696 NGSLWDLLHGPSKKV----KLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN-------------FDAH 758 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-------------~~~k 758 (943)
|+|.+++....... ...+..++.++.||+.||+|||+. +|+||||||+||+++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999997432211 113335678999999999999999 99999999999999754 4899
Q ss_pred ecccccccccCCCCCc---eeeeEecccceeCcccccc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHH
Q 002278 759 LSDFGIARCIPTAMPH---ASTFVLGTIGYIDPEYAHT-------SRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQ 827 (943)
Q Consensus 759 l~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~ 827 (943)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999999987543221 1224569999999999876 568999999999999999999 9999976544332
Q ss_pred HHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 828 LIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.+.. ....... . ...........+.+++..||+.||++|||+.++++|-+
T Consensus 249 ~i~~--~~~~~~~-----~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 249 NIIR--GIFSLDE-----M-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp HHHH--TCCCCCC-----C-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHhc--CCCCccc-----c-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 1111 1111100 0 01112344567889999999999999999999998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=330.69 Aligned_cols=254 Identities=22% Similarity=0.267 Sum_probs=183.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc-cH-HHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH-NL-REFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
.++|+..+.||+|+||.||+|.++ +++.||||++...... .. +.+..+..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468899999999999999999986 6889999998654322 22 23444555688889999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
||+ ++.+..+... ....+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 5556555431 23568999999999999999999998 6 899999999999999999999999999976644
Q ss_pred CCCceeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..........................
T Consensus 178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred Ccc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 322 23346899999999984 45688999999999999999999999986443333222222111110000011
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+ ...+.+++..||+.||++||++.+++++-+
T Consensus 256 ~---------~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 256 F---------SGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp C---------CHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred C---------CHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 1 246778999999999999999999988654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=356.43 Aligned_cols=335 Identities=19% Similarity=0.179 Sum_probs=221.9
Q ss_pred CCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEE
Q 002278 133 IPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILD 212 (943)
Q Consensus 133 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~ 212 (943)
+++++.|++++|.++..++..|..+++|++|+|++|.|+++++..|+.+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 45667777777776655455555555555555555555555444444444444444444444444444444444444444
Q ss_pred eecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCC
Q 002278 213 ISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGP 292 (943)
Q Consensus 213 Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 292 (943)
| ++|.+.+..+..|.++++|+.|+|++|.+++.
T Consensus 130 L-----------------------------------------------~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~ 162 (597)
T 3oja_B 130 L-----------------------------------------------ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI 162 (597)
T ss_dssp C-----------------------------------------------CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC
T ss_pred e-----------------------------------------------eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCC
Confidence 4 44444433333344445555555555555544
Q ss_pred CCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCccccccccc
Q 002278 293 IPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNL 372 (943)
Q Consensus 293 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 372 (943)
.|..|..+++|++|++++|.+++.. +..+++|+.|++++|.+.+ +...++|+.|++++|.+....+.. .
T Consensus 163 ~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~ 231 (597)
T 3oja_B 163 EDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---N 231 (597)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---C
T ss_pred ChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---C
Confidence 4445555555555555555555331 3344555556666665543 223345667777777766433222 2
Q ss_pred CccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecc
Q 002278 373 GSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDM 452 (943)
Q Consensus 373 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 452 (943)
++|+.|+|++|.+++ +..+..+++|+.|+|++|.+.+..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|
T Consensus 232 ~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L 308 (597)
T 3oja_B 232 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 308 (597)
T ss_dssp SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEEC
T ss_pred CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEEC
Confidence 578888888888875 3667888889999999999988888889999999999999999986 5777788999999999
Q ss_pred cCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCCcccCcCCCCccccCCCCCCC
Q 002278 453 SFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGN 532 (943)
Q Consensus 453 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~~~~~Np~~c~~ 532 (943)
++|+++ .+|..+..+++|+.|+|++|+|++. | +..+++|+.|++++|++++.... ..+..+....+.+++..|+.
T Consensus 309 s~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 309 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCT
T ss_pred CCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCc
Confidence 999998 7888899999999999999999855 3 67788999999999999875321 33455666678899999986
Q ss_pred C
Q 002278 533 W 533 (943)
Q Consensus 533 ~ 533 (943)
+
T Consensus 384 ~ 384 (597)
T 3oja_B 384 D 384 (597)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=333.95 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=204.3
Q ss_pred hhccccceEEeeeceEEEEEEEecC-C-ceEEEEEecccCcccHHHHHHHHHHHhcCCCCC------cceeeeEEecCCc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-S-RPIAVKKLYNQYPHNLREFETELETIGSIRHRN------IVSLHGYALSPYG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 686 (943)
.++|+..+.||+|+||+||+|.+.. + +.||+|++... ....+.+.+|+++++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4689999999999999999999753 4 68999998643 344567888999999887655 8999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE---------------
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI--------------- 751 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill--------------- 751 (943)
.++||||+ ++++.+++... ....+++.++..++.|++.||+|||++ +|+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 99999999 66777766532 224689999999999999999999999 99999999999999
Q ss_pred ----CCCCceeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHH
Q 002278 752 ----DENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQ 827 (943)
Q Consensus 752 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~ 827 (943)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 567899999999998654332 234589999999999999999999999999999999999999987665544
Q ss_pred HHHHhcccccccccc-------------------------------CcccccCccCHHHHHHHHHHHHHccCCCCCCCCC
Q 002278 828 LIMSKADDNTVMEAV-------------------------------DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPT 876 (943)
Q Consensus 828 ~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 876 (943)
........+..+... .+..............+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 333222211111100 0000001112233457889999999999999999
Q ss_pred HHHHHHHHh
Q 002278 877 MQEVARVLV 885 (943)
Q Consensus 877 ~~el~~~L~ 885 (943)
+.|+++|-+
T Consensus 328 ~~e~l~hp~ 336 (355)
T 2eu9_A 328 LAEALLHPF 336 (355)
T ss_dssp HHHHTTSGG
T ss_pred HHHHhcChh
Confidence 999988754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=333.68 Aligned_cols=247 Identities=20% Similarity=0.268 Sum_probs=193.2
Q ss_pred HHHhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc------cHHHHHHHHHHHhcC----CCCCcceeeeE
Q 002278 612 MRSTENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH------NLREFETELETIGSI----RHRNIVSLHGY 680 (943)
Q Consensus 612 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~ 680 (943)
....++|+..+.||+|+||.||+|.+. +++.||+|++...... ....+.+|+++++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 345678999999999999999999875 5789999998654321 223455788888888 89999999999
Q ss_pred EecCCcceEEEEE-ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC-CCCcee
Q 002278 681 ALSPYGNLLFYDY-MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAH 758 (943)
Q Consensus 681 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~k 758 (943)
+...+..++|||| +.+++|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYIT---EKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 78999999996 345689999999999999999999999 999999999999999 889999
Q ss_pred ecccccccccCCCCCceeeeEecccceeCccccccCCCC-CcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc
Q 002278 759 LSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLN-EKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT 837 (943)
Q Consensus 759 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 837 (943)
|+|||+++...... .....|++.|+|||++.+..+. .++|||||||++|||++|+.||...... . .....
T Consensus 181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~---~~~~~ 251 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI---L---EAELH 251 (312)
T ss_dssp ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---H---HTCCC
T ss_pred EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH---h---hhccC
Confidence 99999998765432 2234589999999998876654 5899999999999999999999754221 1 11111
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
..+.+ ...+.+++.+||+.||++|||+.|++++-+-
T Consensus 252 ----~~~~~---------~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 252 ----FPAHV---------SPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp ----CCTTS---------CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred ----CcccC---------CHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 11111 2457789999999999999999999998653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=331.72 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=179.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHH-HHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-HNLREFETELE-TIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
.++|+..+.||+|+||.||+|..+ +++.||||++..... ....++..|+. +++.++||||+++++++..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 468889999999999999999986 688999999875432 23345556666 677889999999999999999999999
Q ss_pred EEccCCChhhhccCC--CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 692 DYMVNGSLWDLLHGP--SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 692 e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||+++ +|.+++... .....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99975 777776420 12456899999999999999999999842 89999999999999999999999999998764
Q ss_pred CCCCceeeeEecccceeCcccc----ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYA----HTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
.... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||.............. ....+.
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------~~~~~~ 249 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV------KGDPPQ 249 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC------CSCCCC
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh------cCCCCC
Confidence 4322 2233689999999998 456789999999999999999999999986543222111111 111111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.... .......+.+++..||+.||++|||+.+++++.+
T Consensus 250 ~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 250 LSNSE-EREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp CCCCS-SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred CCCcc-cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 11100 0011246789999999999999999999988654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=341.26 Aligned_cols=252 Identities=20% Similarity=0.288 Sum_probs=189.8
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..+|...++||+|+||+||.....+++.||||++..... ..+.+|+++++.+ +|||||++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 457888999999999997765566789999999865432 2356799999999 799999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-----CCceeeccccccccc
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-----NFDAHLSDFGIARCI 768 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~DFGla~~~ 768 (943)
+. |+|.+++... .....+..+..++.||+.||+|||+. +|+||||||+||+++. ...+||+|||+|+..
T Consensus 100 ~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 6999998743 22345556788999999999999999 9999999999999953 235889999999876
Q ss_pred CCCCC--ceeeeEecccceeCccccc---cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhcccccccccc
Q 002278 769 PTAMP--HASTFVLGTIGYIDPEYAH---TSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAV 842 (943)
Q Consensus 769 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 842 (943)
..... .......||+.|+|||++. +..++.++||||+||++|||+| |+.||........... ..... ....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--~~~~~-~~~~ 250 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--LGACS-LDCL 250 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH--TTCCC-CTTS
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH--hccCC-cccc
Confidence 53321 1233456999999999998 4567889999999999999999 9999975543322211 11111 1111
Q ss_pred CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 843 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.+ .......+.+++..||+.||++|||+.++++|-+
T Consensus 251 ~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~ 286 (432)
T 3p23_A 251 HP-------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286 (432)
T ss_dssp CT-------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred Cc-------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence 11 1123345678999999999999999999997643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=336.45 Aligned_cols=263 Identities=16% Similarity=0.191 Sum_probs=199.6
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC-----------CCCcceeeeEEe
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR-----------HRNIVSLHGYAL 682 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 682 (943)
.++|+..+.||+|+||+||+|.+. +++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999975 6789999998643 334567888999988876 899999999997
Q ss_pred cCC----cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC------
Q 002278 683 SPY----GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID------ 752 (943)
Q Consensus 683 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~------ 752 (943)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ +|+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 654 678999999 89999998643 2345899999999999999999999843 899999999999994
Q ss_pred CCCceeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc------HH
Q 002278 753 ENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESN------LH 826 (943)
Q Consensus 753 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~------~~ 826 (943)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 44579999999998765432 223589999999999999999999999999999999999999975431 11
Q ss_pred HHHHHhccccccccc--------------------cCc-cc--------ccCccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002278 827 QLIMSKADDNTVMEA--------------------VDP-EV--------SVTCVDLSAVRKTFQLALLCTKRYPSERPTM 877 (943)
Q Consensus 827 ~~~~~~~~~~~~~~~--------------------~~~-~~--------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 877 (943)
.........+..+.. ... .. ............+.+++..||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 111111111111000 000 00 0001123456778899999999999999999
Q ss_pred HHHHHHHhh
Q 002278 878 QEVARVLVS 886 (943)
Q Consensus 878 ~el~~~L~~ 886 (943)
.|+++|-+-
T Consensus 329 ~ell~hp~f 337 (373)
T 1q8y_A 329 GGLVNHPWL 337 (373)
T ss_dssp HHHHTCGGG
T ss_pred HHHhhChhh
Confidence 999998653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=334.93 Aligned_cols=244 Identities=22% Similarity=0.326 Sum_probs=200.5
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc------cHHHHHHHHHHHhcCC--CCCcceeeeEEecC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH------NLREFETELETIGSIR--HRNIVSLHGYALSP 684 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 684 (943)
..++|+..+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.+++.++ ||||+++++++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4678999999999999999999965 5788999998654321 2245678999999986 59999999999999
Q ss_pred CcceEEEEEccC-CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC-CCCceeeccc
Q 002278 685 YGNLLFYDYMVN-GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDF 762 (943)
Q Consensus 685 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DF 762 (943)
+..++|||++.+ ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999976 89999986 345689999999999999999999999 999999999999999 7899999999
Q ss_pred ccccccCCCCCceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc
Q 002278 763 GIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA 841 (943)
Q Consensus 763 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 841 (943)
|+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... . .....
T Consensus 195 g~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~---~~~~~---- 261 (320)
T 3a99_A 195 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---I---RGQVF---- 261 (320)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---H---HCCCC----
T ss_pred cccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---h---ccccc----
Confidence 9998765432 223458999999999887665 68899999999999999999999754221 1 11111
Q ss_pred cCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 842 VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 842 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+.+ ...+.+++.+||+.||++|||+.+++++-+
T Consensus 262 ~~~~~---------~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 262 FRQRV---------SSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp CSSCC---------CHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ccccC---------CHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 11111 146778999999999999999999998754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=328.91 Aligned_cols=258 Identities=33% Similarity=0.558 Sum_probs=188.9
Q ss_pred CcceEEecCCCCCC--CCCCCcCCCCcCcEEEccc-CccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEE
Q 002278 278 YTGKLYLHGNKLTG--PIPPELGNMSKLSYLQLQN-NQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQF 354 (943)
Q Consensus 278 ~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 354 (943)
+++.|+|++|.+++ .+|..|.++++|++|++++ |.+.+.+|..|..+++|++|+|++|++++.+|..|..+++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 34455555555554 4555555566666666663 55655566666666666666666666665666666666666666
Q ss_pred EeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCC-CccEEecCCCcCCCccCCCcccccccceeecccccc
Q 002278 355 NVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRII-NLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHL 433 (943)
Q Consensus 355 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 433 (943)
++++|.+++.+|..|..+++|++|+|++|++++.+|..+..+. +|+.|++++|++++.+|..+..++ |+.|+|++|++
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 6666666666666666677777777777777666676677666 777777777777777777777776 88888888888
Q ss_pred cccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCCc
Q 002278 434 NGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIR 513 (943)
Q Consensus 434 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~ 513 (943)
++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|+|+|.+|...
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~ 288 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence 877888888888888888888888865554 7778888888888888888888888888888888888888888888877
Q ss_pred ccCcCCCCccccCCCCCCCCCCCcc
Q 002278 514 NFSRFSSNSFIGNPLLCGNWIGSIC 538 (943)
Q Consensus 514 ~~~~~~~~~~~~Np~~c~~~~~~~c 538 (943)
.+.++..+.+.+||++||.|+. .|
T Consensus 289 ~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 289 NLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cccccChHHhcCCCCccCCCCC-CC
Confidence 7888888889999999998875 46
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=358.38 Aligned_cols=261 Identities=21% Similarity=0.253 Sum_probs=199.2
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEec------CCc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALS------PYG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 686 (943)
.++|+..+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999975 58899999986542 3445678999999999999999999998765 667
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc---eeecccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD---AHLSDFG 763 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DFG 763 (943)
.++||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 799999999999999998654445689999999999999999999999 9999999999999997665 9999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccc----cc
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT----VM 839 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~----~~ 839 (943)
+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||........+......... ..
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 9987754432 23346999999999999999999999999999999999999999765443332211111000 00
Q ss_pred ccc------Cccccc-CccCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002278 840 EAV------DPEVSV-TCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880 (943)
Q Consensus 840 ~~~------~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el 880 (943)
+.. ....+. ..........+.+++..|+..||++|||+.++
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000 000000 00112245678899999999999999999774
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=320.75 Aligned_cols=241 Identities=25% Similarity=0.407 Sum_probs=155.5
Q ss_pred ccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccce
Q 002278 249 IGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLF 328 (943)
Q Consensus 249 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 328 (943)
+..+++|++|++++|.+.+..+ +..+++|+.|++++|.....+ ..+..+++|++|++++|.+.+..+ +..+++|+
T Consensus 106 ~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~ 180 (347)
T 4fmz_A 106 LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLY 180 (347)
T ss_dssp GTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCS
T ss_pred HcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCC
Confidence 3444455555555555443222 445555555555555333222 235556666666666666653332 55666666
Q ss_pred EEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCc
Q 002278 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNN 408 (943)
Q Consensus 329 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 408 (943)
+|++++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|.
T Consensus 181 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~ 254 (347)
T 4fmz_A 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQ 254 (347)
T ss_dssp EEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCc
Confidence 66666666654333 5666666777777776664433 6667777777777777764333 6677777777777777
Q ss_pred CCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCc
Q 002278 409 FSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQ 488 (943)
Q Consensus 409 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 488 (943)
+++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..|..|+.+++|+.|+|++|++++..|
T Consensus 255 l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-- 328 (347)
T 4fmz_A 255 ISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-- 328 (347)
T ss_dssp CCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--
T ss_pred cCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--
Confidence 7743 3577777888888888888754 457778888888888888887777788888888888888888886666
Q ss_pred CccccCCcccccCCcccc
Q 002278 489 LSNCFSLSNLNVSYNNLS 506 (943)
Q Consensus 489 ~~~l~~L~~L~ls~N~l~ 506 (943)
+..+++|+.|++++|+|+
T Consensus 329 ~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 329 LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGGCTTCSEESSSCC---
T ss_pred hhhhhccceeehhhhccc
Confidence 777888888888888875
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.96 Aligned_cols=152 Identities=24% Similarity=0.372 Sum_probs=87.6
Q ss_pred cCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCcc
Q 002278 321 LGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400 (943)
Q Consensus 321 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 400 (943)
+..+++|+.|++++|.+.+..+ +..+++|++|++++|++++..+ +..+++|+.|++++|.+++. ..+..+++|+
T Consensus 195 ~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~ 268 (347)
T 4fmz_A 195 LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLK 268 (347)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCC
T ss_pred ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcC
Confidence 3344444444444444443222 4444444444555544443322 45555555555555555532 3455566666
Q ss_pred EEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcc
Q 002278 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNN 480 (943)
Q Consensus 401 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 480 (943)
.|++++|.+++. ..+..+++|+.|++++|++++..|..|..+++|++|++++|++++..| +..+++|+.|++++|+
T Consensus 269 ~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 269 MLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344 (347)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC-
T ss_pred EEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhc
Confidence 666666666643 246667777777777777776667777777777777777777775444 6777777777777777
Q ss_pred cC
Q 002278 481 LQ 482 (943)
Q Consensus 481 l~ 482 (943)
|+
T Consensus 345 i~ 346 (347)
T 4fmz_A 345 IK 346 (347)
T ss_dssp --
T ss_pred cc
Confidence 65
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=314.90 Aligned_cols=230 Identities=12% Similarity=0.077 Sum_probs=183.8
Q ss_pred hccccceEEeeeceEEEEEEEecC-CceEEEEEecccCcc---cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPH---NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||.||+|.+.. ++.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 679999999999999999999864 889999999765432 3467889999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++++|.+++.. + ....++.+++.|++.||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999952 2 35567889999999999999999 99999999999999999999998554
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHH---HHhccccccccccCccccc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLI---MSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 848 (943)
|++ .++.++|||||||++|||+||+.||.+........ ..............+.+
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 232 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI-- 232 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS--
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC--
Confidence 333 36889999999999999999999998654321100 00000000011111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
...+.+++.+||+.||++| |+.|+++.|+......
T Consensus 233 -------~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 233 -------PFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -------CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -------CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 2467899999999999999 9999999998876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=311.46 Aligned_cols=235 Identities=19% Similarity=0.224 Sum_probs=180.1
Q ss_pred hhccccc-eEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHH-hcCCCCCcceeeeEEec----CCcc
Q 002278 615 TENLSEK-YIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETI-GSIRHRNIVSLHGYALS----PYGN 687 (943)
Q Consensus 615 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 687 (943)
.++|... +.||+|+||.||+|..+ +++.||+|++... ..+.+|++++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3566666 78999999999999975 5789999998542 5677888887 66689999999999876 5678
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---CCceeeccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE---NFDAHLSDFGI 764 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DFGl 764 (943)
++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999742 234689999999999999999999999 9999999999999997 78899999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
++... +..++.++||||+||++|||+||+.||.+.......... .... .....
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---~~~~-~~~~~ 219 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRI-RMGQY 219 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---CCSS-CTTCC
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---HHHH-hhccc
Confidence 86432 234678999999999999999999999765432211000 0000 00000
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
..+... .......+.+++..||+.||++|||+.|+++|.+-
T Consensus 220 ~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 220 EFPNPE-WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp SSCHHH-HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cCCchh-cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 000000 00112567899999999999999999999998664
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=351.28 Aligned_cols=238 Identities=20% Similarity=0.260 Sum_probs=192.0
Q ss_pred hhccccceEEeeeceEEEEEEEec--CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc-----
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK--NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYG----- 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 686 (943)
.++|++.+.||+|+||+||+|.+. +++.||||++.... ......+.+|+++++.++|||||++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999986 57899999886543 3345578899999999999999999999987665
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.++||||+++++|.+++.. .+++.+++.++.||+.||+|||++ +|+||||||+||+++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987752 689999999999999999999999 99999999999999986 89999999998
Q ss_pred ccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
..... ....||+.|+|||++.+.. +.++|||||||++|||++|.+||.+... .....
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~---------------~~~~~-- 286 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV---------------DGLPE-- 286 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC---------------SSCCT--
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc---------------ccccc--
Confidence 76543 2346999999999987654 8999999999999999999999874211 00000
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhh
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPT-MQEVARVLVS 886 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~el~~~L~~ 886 (943)
..........+.+++.+||+.||++||+ ++++...+..
T Consensus 287 --~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 --DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0011122356788999999999999995 5555555543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.32 Aligned_cols=288 Identities=22% Similarity=0.273 Sum_probs=181.6
Q ss_pred CCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEe
Q 002278 63 NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLA 142 (943)
Q Consensus 63 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 142 (943)
+++.+++++|+++ .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4556666666665 4554442 456666666666664445556666666666666666665556666666666666666
Q ss_pred ccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceeccc--ccCCCCcCCCcccEEEeecccccC
Q 002278 143 RNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTG--TIPDSIGNCTSFEILDISYNQITG 220 (943)
Q Consensus 143 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~l~~l~~L~~L~Ls~N~l~~ 220 (943)
+|+++ .+|..+. ++|++|++++|+++++++..|..+++|++|++++|.++. ..+..+..+ +|++|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 66666 3333332 566666666666666666666667777777777777642 556666666 77777777777763
Q ss_pred cCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCC
Q 002278 221 EIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNM 300 (943)
Q Consensus 221 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 300 (943)
+|. .+ .++|+.|++++|.+.+..+..|..+++|+.|+|++|++++..+..|..+
T Consensus 187 -l~~-----------------------~~--~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 240 (332)
T 2ft3_A 187 -IPK-----------------------DL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240 (332)
T ss_dssp -CCS-----------------------SS--CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC
T ss_pred -cCc-----------------------cc--cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC
Confidence 222 11 1456666777777766666667777777777777777776666667777
Q ss_pred CcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCC------CcCcEEEeeCCccc--Cccccccccc
Q 002278 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSC------TALNQFNVHGNRLS--GAIPSSFRNL 372 (943)
Q Consensus 301 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~--~~~~~~~~~l 372 (943)
++|++|++++|+++ .+|..+..+++|+.|++++|+|++..+..|..+ ..|+.|++++|.+. +..|.+|..+
T Consensus 241 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l 319 (332)
T 2ft3_A 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319 (332)
T ss_dssp TTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTB
T ss_pred CCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccccc
Confidence 77777777777776 566667777777777777777776666655543 45666777777665 4556666666
Q ss_pred CccceeeccCCc
Q 002278 373 GSLTYLNLSRNN 384 (943)
Q Consensus 373 ~~L~~L~L~~N~ 384 (943)
++|+.|++++|+
T Consensus 320 ~~L~~l~l~~n~ 331 (332)
T 2ft3_A 320 TDRLAIQFGNYK 331 (332)
T ss_dssp CCSTTEEC----
T ss_pred chhhhhhccccc
Confidence 666666666653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=323.49 Aligned_cols=246 Identities=15% Similarity=0.126 Sum_probs=187.9
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccC--------cccHHHHHHHHHHHhcCC---------CCCcce
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--------PHNLREFETELETIGSIR---------HRNIVS 676 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~ 676 (943)
..++|+..+.||+|+||+||+|++ +++.||||++.... ....+.+.+|+++++.++ |||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 357899999999999999999998 57999999997542 234578889999988885 777777
Q ss_pred eeeEEe-----------------c-------------CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHH
Q 002278 677 LHGYAL-----------------S-------------PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726 (943)
Q Consensus 677 l~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~ 726 (943)
+.+++. + ....++||||+++|++.+.+. ...+++.++..++.|++.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHH
Confidence 766643 2 678899999999998777764 245899999999999999
Q ss_pred HHHHhh-hCCCCCeEecCCCCccEEECCCC--------------------ceeecccccccccCCCCCceeeeEecccce
Q 002278 727 GLAYLH-HDCNPRIIHRDVKSSNILIDENF--------------------DAHLSDFGIARCIPTAMPHASTFVLGTIGY 785 (943)
Q Consensus 727 ~l~~LH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y 785 (943)
||+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999999887 8999999999876532 34699999
Q ss_pred eCccccccCCCCCcchhhhHHHH-HHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHH
Q 002278 786 IDPEYAHTSRLNEKSDVYSFGIV-LLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLAL 864 (943)
Q Consensus 786 ~aPE~~~~~~~~~~~DvwSlGvi-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 864 (943)
+|||++.+.. +.++||||+|++ .+++++|..||.+......................+. ........+.+++.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP-----AMKQIKRKIQEFHR 317 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSH-----HHHHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchh-----hhhhcCHHHHHHHH
Confidence 9999998776 899999998777 7789999999954211111111111010111110000 01234567889999
Q ss_pred HccCCCCCCCCCHHHHH-HHH
Q 002278 865 LCTKRYPSERPTMQEVA-RVL 884 (943)
Q Consensus 865 ~cl~~dP~~RPt~~el~-~~L 884 (943)
+||+.| |+.|++ +|-
T Consensus 318 ~~L~~d-----sa~e~l~~Hp 333 (336)
T 2vuw_A 318 TMLNFS-----SATDLLCQHS 333 (336)
T ss_dssp HGGGSS-----SHHHHHHHCG
T ss_pred HHhccC-----CHHHHHhcCC
Confidence 999966 999999 764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=307.61 Aligned_cols=287 Identities=23% Similarity=0.281 Sum_probs=153.5
Q ss_pred EEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCccc
Q 002278 43 LNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQL 122 (943)
Q Consensus 43 L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l 122 (943)
++++++.++ .+|..+. +.|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 36 l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (330)
T 1xku_A 36 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112 (330)
T ss_dssp EECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcC
Confidence 444455555 4555443 4667777777777755555677777777777777777765566677777777777777776
Q ss_pred ccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCC
Q 002278 123 TGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSI 202 (943)
Q Consensus 123 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l 202 (943)
+ .+|..+. ++|++|++++|++++..+..|..+++|++|++++|.++. .+..+..+
T Consensus 113 ~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~~~~~~ 167 (330)
T 1xku_A 113 K-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIENGAF 167 (330)
T ss_dssp S-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBCTTGG
T ss_pred C-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc----------------------cCcChhhc
Confidence 6 3444332 566666666666655444444444444444444444432 12445566
Q ss_pred cCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceE
Q 002278 203 GNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKL 282 (943)
Q Consensus 203 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 282 (943)
.++++|++|++++|+++. +|..+. ++|+.|++++|.+.+..+..|..+++|+.|
T Consensus 168 ~~l~~L~~L~l~~n~l~~-l~~~~~-------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 221 (330)
T 1xku_A 168 QGMKKLSYIRIADTNITT-IPQGLP-------------------------PSLTELHLDGNKITKVDAASLKGLNNLAKL 221 (330)
T ss_dssp GGCTTCCEEECCSSCCCS-CCSSCC-------------------------TTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred cCCCCcCEEECCCCcccc-CCcccc-------------------------ccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 667777777777776662 222111 234444444444444334444444444444
Q ss_pred EecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccC------CCcCcEEEe
Q 002278 283 YLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISS------CTALNQFNV 356 (943)
Q Consensus 283 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~L 356 (943)
+|++|.+++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|+|+++.+..|+. .+.|+.|++
T Consensus 222 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l 300 (330)
T 1xku_A 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 300 (330)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEEC
T ss_pred ECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEe
Confidence 44444444444444444555555555555554 44444455555555555555555444444432 245556666
Q ss_pred eCCcccC--cccccccccCccceeeccCCc
Q 002278 357 HGNRLSG--AIPSSFRNLGSLTYLNLSRNN 384 (943)
Q Consensus 357 ~~N~l~~--~~~~~~~~l~~L~~L~L~~N~ 384 (943)
++|.+.. +.|..|..+.+|+.++|++|+
T Consensus 301 ~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ecCcccccccCccccccccceeEEEecccC
Confidence 6666542 445556666666666666653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=326.32 Aligned_cols=244 Identities=14% Similarity=0.195 Sum_probs=181.1
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCC-CCcce---------eee
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRH-RNIVS---------LHG 679 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~---------l~~ 679 (943)
...+|...+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+.+++.++| ++... ...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456888899999999999999965 688999999873332 235678999999999987 32211 111
Q ss_pred E------------Eec-----CCcceEEEEEccCCChhhhccC----CCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 002278 680 Y------------ALS-----PYGNLLFYDYMVNGSLWDLLHG----PSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR 738 (943)
Q Consensus 680 ~------------~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 738 (943)
. +.. ....+++|++ .+++|.+++.. ......+++..++.++.|++.||+|||++ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 1 111 1123555554 57899998841 11345688899999999999999999999 9
Q ss_pred eEecCCCCccEEECCCCceeecccccccccCCCCCceeeeEecccceeCcccc----------ccCCCCCcchhhhHHHH
Q 002278 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYA----------HTSRLNEKSDVYSFGIV 808 (943)
Q Consensus 739 ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvi 808 (943)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999999865432 333457 999999998 55568899999999999
Q ss_pred HHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 809 LLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 809 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
+|||+||+.||......... ..... ..+.+ ...+.+++..||+.||++||++.+++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~-------~~~~~-~~~~~---------~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGS-------EWIFR-SCKNI---------PQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCS-------GGGGS-SCCCC---------CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhhH-------HHHHh-hcccC---------CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999999865432110 00000 00111 2567899999999999999998777653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=304.40 Aligned_cols=288 Identities=22% Similarity=0.283 Sum_probs=179.7
Q ss_pred cccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecC
Q 002278 207 SFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHG 286 (943)
Q Consensus 207 ~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 286 (943)
+|+.+++++|.++ .+|..+. .+++.|++++|.+++..|..|..+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~-~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS-PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC-TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred cCCEEECCCCCcc-ccCCCCC-CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 5666666666665 3343332 3455566666666555566666777777777777777766666677777777777777
Q ss_pred CCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccC--CcCcccccCCCcCcEEEeeCCcccCc
Q 002278 287 NKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLE--GPIPHNISSCTALNQFNVHGNRLSGA 364 (943)
Q Consensus 287 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~ 364 (943)
|+++ .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|.++ +..+..+..+ +|+.|++++|++++
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~- 186 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG- 186 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence 7766 3344333 56777777777776555556666777777777777664 2555566666 66666666666664
Q ss_pred ccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCC
Q 002278 365 IPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNL 444 (943)
Q Consensus 365 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 444 (943)
+|..+. ++|++|+|++|++++..+..+..+++|+.|++++|++++..+..+..+++|+.|+|++|+++ .+|..+..+
T Consensus 187 l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 263 (332)
T 2ft3_A 187 IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263 (332)
T ss_dssp CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence 333332 56666666666666665566666666666666666666655556666666666666666666 455666666
Q ss_pred CccceecccCccccccCChhhhcc------cccceecccCcccC--CCCCCcCccccCCcccccCCcc
Q 002278 445 RSIQTIDMSFNQLSGSIPAELGQL------QNIISLILNNNNLQ--GGIPDQLSNCFSLSNLNVSYNN 504 (943)
Q Consensus 445 ~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~ls~N~ 504 (943)
++|+.|++++|+|++..+..|..+ .+|+.|++++|++. +..|..+..+++|+.+++++|+
T Consensus 264 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp TTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 666666666666665444555432 45666667776665 4555666666666666666663
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=302.39 Aligned_cols=269 Identities=22% Similarity=0.282 Sum_probs=137.8
Q ss_pred cceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecC
Q 002278 159 VLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQG 238 (943)
Q Consensus 159 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 238 (943)
.|++|+|++|+++++.+..|..+++|++|+|++|++++..|..|.++++|++|++++|+++ .+|..+. .+|+.|++++
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-~~L~~L~l~~ 130 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP-KTLQELRVHE 130 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC-TTCCEEECCS
T ss_pred CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc-ccccEEECCC
Confidence 3444444444444444445556666666666666666556666777777777777777766 2332221 2333333333
Q ss_pred ccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccc
Q 002278 239 NKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIP 318 (943)
Q Consensus 239 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 318 (943)
|.+++..+..+..+++|+.|++++|.+.. .+..+..|..+++|++|++++|.++. +|
T Consensus 131 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~~~~~~~~l~~L~~L~l~~n~l~~-l~ 187 (330)
T 1xku_A 131 NEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIENGAFQGMKKLSYIRIADTNITT-IP 187 (330)
T ss_dssp SCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBCTTGGGGCTTCCEEECCSSCCCS-CC
T ss_pred CcccccCHhHhcCCccccEEECCCCcCCc----------------------cCcChhhccCCCCcCEEECCCCcccc-CC
Confidence 33333333444444444555444444432 01334445555555555555555552 33
Q ss_pred cccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCC
Q 002278 319 AELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIIN 398 (943)
Q Consensus 319 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 398 (943)
..+. ++|++|++++|++++..|..|..+++|+.|++++|++++..+..|..+++|+.|+|++|+++ .+|..+..+++
T Consensus 188 ~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~ 264 (330)
T 1xku_A 188 QGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 264 (330)
T ss_dssp SSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSS
T ss_pred cccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCC
Confidence 3222 45555566666555555555555566666666666665555555666666666666666665 45555555666
Q ss_pred ccEEecCCCcCCCccCCCcccc------cccceeecccccccc--cCCccccCCCccceecccCc
Q 002278 399 LDTLDLSVNNFSGSVPASIGDL------EHLLTLNLSRNHLNG--LLPAEFGNLRSIQTIDMSFN 455 (943)
Q Consensus 399 L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N 455 (943)
|+.|++++|+|++..+..|... ..|+.|++++|.+.. +.|..|..+.+|+.++|++|
T Consensus 265 L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 265 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp CCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred cCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence 6666666666654444444321 334444444444431 23344444444444444444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=306.01 Aligned_cols=276 Identities=17% Similarity=0.283 Sum_probs=183.2
Q ss_pred ccccccc-CccccCCCCC--CCCCCCCCCcceeEecCCCCcEEEEEcCCCCCccccCCCc--CCCCCCCEEEeeCCcccc
Q 002278 2 AIKASFS-NLANVLLDWD--DVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSI--GDLRNLQSIDFQGNKLTG 76 (943)
Q Consensus 2 ~~~~~~~-~~~~~~~~w~--~~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l--~~l~~L~~L~Ls~n~l~~ 76 (943)
+||+++. |+.+.+++|. ...+.++|.|.|+.|+.. +..+ .....+++|+|++|+|+
T Consensus 34 ~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~------------------~~~l~~~~~~~l~~L~L~~n~l~- 94 (328)
T 4fcg_A 34 QWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKAT------------------ADLLEDATQPGRVALELRSVPLP- 94 (328)
T ss_dssp HHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHH------------------HHHHHHHTSTTCCEEEEESSCCS-
T ss_pred HHHHhccCCchhhhhhhcccccccccccccCCcchhhh------------------HHHHhcccccceeEEEccCCCch-
Confidence 5788885 7778889993 113579999999999531 1111 12356677777777776
Q ss_pred cCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccc
Q 002278 77 QIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYW 156 (943)
Q Consensus 77 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 156 (943)
.+|..+.++++|++|+|++|.++ .+|..|+.+++|++|+|++|+++ .+|..|..+++|++|+|++|++.+.+|..+..
T Consensus 95 ~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~ 172 (328)
T 4fcg_A 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172 (328)
T ss_dssp SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEE
T ss_pred hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhh
Confidence 66666777777777777777777 66777777777777777777777 66777777777777777777766666655432
Q ss_pred cccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEe
Q 002278 157 NEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSL 236 (943)
Q Consensus 157 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L 236 (943)
. ..+..+..+++|++|+|++|+++ .+|..+.++++|++|+|++|+++
T Consensus 173 ~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~----------------- 219 (328)
T 4fcg_A 173 T---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS----------------- 219 (328)
T ss_dssp E---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-----------------
T ss_pred c---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-----------------
Confidence 1 01234556666777777777776 55666777777777777777665
Q ss_pred cCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccc
Q 002278 237 QGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT 316 (943)
Q Consensus 237 ~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 316 (943)
.+|..+..+++|++|+|++|.+.+.+|..|..+++|+.|+|++|++.+.+|..+..+++|++|+|++|.+.+.
T Consensus 220 -------~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~ 292 (328)
T 4fcg_A 220 -------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292 (328)
T ss_dssp -------CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC
T ss_pred -------cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh
Confidence 2334456666777777777666666666666666666666666666666666666666666666666666666
Q ss_pred cccccCCcccceEEEccccccC
Q 002278 317 IPAELGKLEQLFELNLADNNLE 338 (943)
Q Consensus 317 ~~~~~~~l~~L~~L~L~~N~l~ 338 (943)
+|..++.+++|+.+++..|.+.
T Consensus 293 iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 293 LPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCGGGGGSCTTCEEECCGGGSC
T ss_pred ccHHHhhccCceEEeCCHHHHH
Confidence 6666666666666666655444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=4.3e-36 Score=347.90 Aligned_cols=365 Identities=20% Similarity=0.196 Sum_probs=170.5
Q ss_pred CCCCEEEeeCCcccccCCCC-ccCCCCCcEEeccCCCcCC----ccchhccccccceEEEecCcccccCCCcccC-CCC-
Q 002278 62 RNLQSIDFQGNKLTGQIPDE-IGNCGSLVHIELSDNSLYG----DIPFSISKLKQLEFLNLKNNQLTGPIPSTLT-QIP- 134 (943)
Q Consensus 62 ~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~- 134 (943)
++|++|||++|+++...... +..+++|++|+|++|++++ .++..+..+++|++|+|++|.++...+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 35666666666665332222 5556666666666666653 2344455556666666666665543222221 233
Q ss_pred ---CCcEEEEecccccc----ccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCc
Q 002278 135 ---NLKTLDLARNQLTG----EIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTS 207 (943)
Q Consensus 135 ---~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~ 207 (943)
+|++|+|++|+|+. .++..+..+++|++|+|++|.+++..+..+.. ..+...++
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~-------------------~l~~~~~~ 143 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE-------------------GLLDPQCR 143 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH-------------------HHTSTTCC
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH-------------------HHhcCCCc
Confidence 45555555555552 23444444444444444444433211111110 00111233
Q ss_pred ccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccC-----CCCCcceE
Q 002278 208 FEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILG-----NLSYTGKL 282 (943)
Q Consensus 208 L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L 282 (943)
|++|++++|++++... ..++..+..+++|+.|++++|.+.+..+..+. ..++|++|
T Consensus 144 L~~L~L~~n~l~~~~~-------------------~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L 204 (461)
T 1z7x_W 144 LEKLQLEYCSLSAASC-------------------EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL 204 (461)
T ss_dssp CCEEECTTSCCBGGGH-------------------HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEE
T ss_pred ceEEECCCCCCCHHHH-------------------HHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEE
Confidence 4444444444331100 01233344455555555555555432222221 13345555
Q ss_pred EecCCCCCCC----CCCCcCCCCcCcEEEcccCcccccc-----ccccCCcccceEEEccccccCCc----CcccccCCC
Q 002278 283 YLHGNKLTGP----IPPELGNMSKLSYLQLQNNQLVGTI-----PAELGKLEQLFELNLADNNLEGP----IPHNISSCT 349 (943)
Q Consensus 283 ~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~ 349 (943)
+|++|.++.. ++..+..+++|++|++++|.+++.. +..+..+++|++|++++|+++.. ++..+..++
T Consensus 205 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~ 284 (461)
T 1z7x_W 205 KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284 (461)
T ss_dssp ECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCT
T ss_pred EccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCC
Confidence 5555554432 2334444555555666555554321 12222345555555555555432 333444445
Q ss_pred cCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCc----cCCCcccccccce
Q 002278 350 ALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGS----VPASIGDLEHLLT 425 (943)
Q Consensus 350 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~ 425 (943)
+|++|++++|.+....+..+... .....++|+.|++++|.+++. ++..+..+++|++
T Consensus 285 ~L~~L~Ls~n~i~~~~~~~l~~~-------------------l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 345 (461)
T 1z7x_W 285 SLKELSLAGNELGDEGARLLCET-------------------LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE 345 (461)
T ss_dssp TCCEEECTTCCCHHHHHHHHHHH-------------------HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCE
T ss_pred CcceEECCCCCCchHHHHHHHHH-------------------hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccE
Confidence 55555555555443222222211 000113455555555555432 2334445566666
Q ss_pred eecccccccccCCccccC-----CCccceecccCccccc----cCChhhhcccccceecccCcccCC
Q 002278 426 LNLSRNHLNGLLPAEFGN-----LRSIQTIDMSFNQLSG----SIPAELGQLQNIISLILNNNNLQG 483 (943)
Q Consensus 426 L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~ 483 (943)
|+|++|++++..+..+.. .++|++|+|++|++++ .+|..+..+++|++|+|++|++++
T Consensus 346 L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 346 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp EECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred EEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 666666665443333322 4566666666666664 556666666667777777776654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-35 Score=343.86 Aligned_cols=388 Identities=20% Similarity=0.162 Sum_probs=226.5
Q ss_pred cEEEEEcCCCCCccccCCC-cCCCCCCCEEEeeCCcccc----cCCCCccCCCCCcEEeccCCCcCCccchhcc-ccc--
Q 002278 39 SVVSLNLSSLNLGGEISPS-IGDLRNLQSIDFQGNKLTG----QIPDEIGNCGSLVHIELSDNSLYGDIPFSIS-KLK-- 110 (943)
Q Consensus 39 ~v~~L~l~~~~~~~~~~~~-l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~-- 110 (943)
+++.|||++|+++...... +..+++|++|+|++|++++ .++..+..+++|++|+|++|++.+..+..+. .++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 5789999999998654444 7889999999999999985 4577788899999999999999865555544 465
Q ss_pred --cceEEEecCccccc----CCCcccCCCCCCcEEEEeccccccccchhccc-----cccceeccccCCccCCCC----C
Q 002278 111 --QLEFLNLKNNQLTG----PIPSTLTQIPNLKTLDLARNQLTGEIPRLIYW-----NEVLQYLGLRGNALTGML----S 175 (943)
Q Consensus 111 --~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~----~ 175 (943)
+|++|+|++|+++. .++..|..+++|++|+|++|.++...+..+.. ..+|++|+|++|++++.. +
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 79999999999984 45889999999999999999998655554432 345777777777766532 2
Q ss_pred cccccccccceeeccceecccccCCCCc-----CCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCcccc
Q 002278 176 PDMCQLTGLWYFDVRGNNLTGTIPDSIG-----NCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIG 250 (943)
Q Consensus 176 ~~~~~l~~L~~L~L~~N~i~~~~~~~l~-----~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 250 (943)
..+..+++|++|++++|.++...+..+. .+++|++|++++|.+++... ..++..+.
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~-------------------~~l~~~l~ 224 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC-------------------RDLCGIVA 224 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH-------------------HHHHHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHH-------------------HHHHHHHH
Confidence 2233345555555555554432222221 12344444444444331100 01344555
Q ss_pred ccCCCcEEecCCCCCCCCC-----CcccCCCCCcceEEecCCCCCCC----CCCCcCCCCcCcEEEcccCcccccccccc
Q 002278 251 LMQALAVLDLSENELVGPI-----PPILGNLSYTGKLYLHGNKLTGP----IPPELGNMSKLSYLQLQNNQLVGTIPAEL 321 (943)
Q Consensus 251 ~l~~L~~L~Ls~N~l~~~~-----~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 321 (943)
.+++|+.|++++|.+.+.. +..+..+++|++|+|++|.++.. ++..+..+++|++|++++|.+.+..+..+
T Consensus 225 ~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l 304 (461)
T 1z7x_W 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304 (461)
T ss_dssp HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred hCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHH
Confidence 5666666666666654321 11122344455555555544421 23333344444444444444433222222
Q ss_pred CCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCc----ccccccccCccceeeccCCcCCCCCCCCCCC--
Q 002278 322 GKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGA----IPSSFRNLGSLTYLNLSRNNFKGKVPTELGR-- 395 (943)
Q Consensus 322 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-- 395 (943)
... .....++|+.|++++|.+++. ++..+..+++|++|+|++|++++..+..+..
T Consensus 305 ~~~-------------------l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l 365 (461)
T 1z7x_W 305 CET-------------------LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGL 365 (461)
T ss_dssp HHH-------------------HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHH
T ss_pred HHH-------------------hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHH
Confidence 211 001113555555555555433 3344455566666666666555332222221
Q ss_pred ---CCCccEEecCCCcCCC----ccCCCcccccccceeecccccccccCCcccc-----CCCccceecccCccccccCCh
Q 002278 396 ---IINLDTLDLSVNNFSG----SVPASIGDLEHLLTLNLSRNHLNGLLPAEFG-----NLRSIQTIDMSFNQLSGSIPA 463 (943)
Q Consensus 396 ---l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~ 463 (943)
.++|+.|++++|.+++ .+|..+..+++|++|+|++|++++.....+. ....|+.|++.++.+....+.
T Consensus 366 ~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~ 445 (461)
T 1z7x_W 366 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 445 (461)
T ss_dssp TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred cCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHH
Confidence 4567777777777764 5666677777788888888877643111111 123456666665555533333
Q ss_pred h
Q 002278 464 E 464 (943)
Q Consensus 464 ~ 464 (943)
.
T Consensus 446 ~ 446 (461)
T 1z7x_W 446 R 446 (461)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=296.78 Aligned_cols=286 Identities=21% Similarity=0.236 Sum_probs=189.4
Q ss_pred CCCCCCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCc
Q 002278 22 NSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGD 101 (943)
Q Consensus 22 ~~~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 101 (943)
...+|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|++++.
T Consensus 26 ~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 91 (353)
T 2z80_A 26 ASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI 91 (353)
T ss_dssp -CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred cCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCcc
Confidence 4578899987 64 4667777 6777665 4888999999988866666788888888888888888876
Q ss_pred cchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccc-hhccccccceeccccCC-ccCCCCCcccc
Q 002278 102 IPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIP-RLIYWNEVLQYLGLRGN-ALTGMLSPDMC 179 (943)
Q Consensus 102 ~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n-~l~~~~~~~~~ 179 (943)
.|.+|+++++|++|+|++|++++..+..|.++++|++|+|++|+++...+ ..+..+++|++|++++| .++.+.+..+.
T Consensus 92 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 171 (353)
T 2z80_A 92 EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171 (353)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT
T ss_pred CHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHcc
Confidence 67778888888888888888886555557888888888888888774333 35556666666666666 35555555555
Q ss_pred cccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEe
Q 002278 180 QLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLD 259 (943)
Q Consensus 180 ~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 259 (943)
.+++|++|++++|++++..|..+.++++|++|++++|+++ ...+..+..+++|+.|+
T Consensus 172 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-----------------------~~~~~~~~~~~~L~~L~ 228 (353)
T 2z80_A 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-----------------------LLLEIFVDVTSSVECLE 228 (353)
T ss_dssp TCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-----------------------THHHHHHHHTTTEEEEE
T ss_pred CCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-----------------------cchhhhhhhcccccEEE
Confidence 5555555555555555555555555555555555555543 22223344566777777
Q ss_pred cCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCcccc----ccccccCCcccceEEEcccc
Q 002278 260 LSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVG----TIPAELGKLEQLFELNLADN 335 (943)
Q Consensus 260 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N 335 (943)
+++|.+++..+..+.. ......++.++++++.+.+ .+|..+..+++|++|+|++|
T Consensus 229 L~~n~l~~~~~~~l~~---------------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N 287 (353)
T 2z80_A 229 LRDTDLDTFHFSELST---------------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287 (353)
T ss_dssp EESCBCTTCCCC---------------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSS
T ss_pred CCCCcccccccccccc---------------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCC
Confidence 7777776543332221 1123445555666655543 35667777888888888888
Q ss_pred ccCCcCcccccCCCcCcEEEeeCCcccCcc
Q 002278 336 NLEGPIPHNISSCTALNQFNVHGNRLSGAI 365 (943)
Q Consensus 336 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 365 (943)
+++.+.+..|..+++|++|++++|++.+..
T Consensus 288 ~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 288 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 888554445678888888888888887543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=288.01 Aligned_cols=289 Identities=22% Similarity=0.300 Sum_probs=170.4
Q ss_pred ccccccCccccCCCCCCCCCCCCCCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCc
Q 002278 3 IKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEI 82 (943)
Q Consensus 3 ~~~~~~~~~~~~~~w~~~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~ 82 (943)
-++++.|+..+|.+|+.....|+|.|.++.|...... -.-+... +.... .++..+
T Consensus 21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~-----~~~~~~~-------------------g~~~~-~~~~~l 75 (328)
T 4fcg_A 21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNN-----PQIETRT-------------------GRALK-ATADLL 75 (328)
T ss_dssp --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTC-----TTSCCSH-------------------HHHHH-HHHHHH
T ss_pred ccccCchHHHHHHHHHHhccCCchhhhhhhccccccc-----ccccccC-------------------Ccchh-hhHHHH
Confidence 3556777778899997433358999999998533210 0000111 11111 112222
Q ss_pred --cCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccc
Q 002278 83 --GNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVL 160 (943)
Q Consensus 83 --~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 160 (943)
...++++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..|..+++|++|+|++|+++ .+|..+..+++|
T Consensus 76 ~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L 152 (328)
T 4fcg_A 76 EDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL 152 (328)
T ss_dssp HHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTC
T ss_pred hcccccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCC
Confidence 23588999999999999 88989999999999999999999 88999999999999999999998 566666666666
Q ss_pred eeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCcc
Q 002278 161 QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNK 240 (943)
Q Consensus 161 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~ 240 (943)
++|+|++|.+.+..|..+... ..+..|.++++|++|+|++|+++
T Consensus 153 ~~L~L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~--------------------- 196 (328)
T 4fcg_A 153 RELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR--------------------- 196 (328)
T ss_dssp CEEEEEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC---------------------
T ss_pred CEEECCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC---------------------
Confidence 655555555444433322210 11122344555555555555554
Q ss_pred ccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccc
Q 002278 241 LTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAE 320 (943)
Q Consensus 241 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 320 (943)
.+|..+..+++|++|+|++|.+.+ +|..+..+++|++|+|++|++.+.+|..|..+++|++|+|++|.+.+.+|..
T Consensus 197 ---~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~ 272 (328)
T 4fcg_A 197 ---SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272 (328)
T ss_dssp ---CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTT
T ss_pred ---cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchh
Confidence 234445555556666666665553 3334555555555555555555555555555555555555555444444444
Q ss_pred cCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCC
Q 002278 321 LGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGN 359 (943)
Q Consensus 321 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 359 (943)
+..+++|+.|+|++|++.+.+|..+..+++|+.+++..|
T Consensus 273 ~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~ 311 (328)
T 4fcg_A 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311 (328)
T ss_dssp GGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGG
T ss_pred hhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHH
Confidence 444444444444444444444444444444444444433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-33 Score=337.26 Aligned_cols=452 Identities=15% Similarity=0.071 Sum_probs=302.9
Q ss_pred CCCCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcc---cccCCCCcc------------CCCCC
Q 002278 24 DFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKL---TGQIPDEIG------------NCGSL 88 (943)
Q Consensus 24 ~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l---~~~~p~~~~------------~l~~L 88 (943)
-|++|.++.+... ..+.+.. .+....+..+..+++|++|+|+++.. .+.+|..++ .+++|
T Consensus 40 vck~W~~~~~~~~----~~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L 114 (592)
T 3ogk_B 40 VCRRWFKIDSETR----EHVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114 (592)
T ss_dssp SCHHHHHHHHHHC----CEEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HhHHHHHhhhccc----cEEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC
Confidence 4668999854322 1233332 22323344567889999999998632 134554444 78999
Q ss_pred cEEeccCCCcCCccchhcccc--ccceEEEecCcc-ccc-CCCcccCCCCCCcEEEEeccccccc----cchhccccccc
Q 002278 89 VHIELSDNSLYGDIPFSISKL--KQLEFLNLKNNQ-LTG-PIPSTLTQIPNLKTLDLARNQLTGE----IPRLIYWNEVL 160 (943)
Q Consensus 89 ~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~n~-l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L 160 (943)
++|+|++|.+++..+..++.+ ++|++|+|++|. ++. .++.....+++|++|+|++|.+++. ++..+..+++|
T Consensus 115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L 194 (592)
T 3ogk_B 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194 (592)
T ss_dssp CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC
T ss_pred CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc
Confidence 999999999987777777774 459999999987 321 1223345789999999999998765 44556678899
Q ss_pred eeccccCCccCCCCCcc----cccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEe
Q 002278 161 QYLGLRGNALTGMLSPD----MCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSL 236 (943)
Q Consensus 161 ~~L~L~~n~l~~~~~~~----~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L 236 (943)
++|++++|.++++.... +..+++|+.|++++|.+.+ ++..+.++++|++|+++.+... .+.
T Consensus 195 ~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~--~~~------------ 259 (592)
T 3ogk_B 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNED--IGM------------ 259 (592)
T ss_dssp CEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCC--TTC------------
T ss_pred cEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccc--cch------------
Confidence 99999999998554333 4567899999999998885 5677888999999999864322 110
Q ss_pred cCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCC-CCcCCCCcCcEEEcccCcccc
Q 002278 237 QGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIP-PELGNMSKLSYLQLQNNQLVG 315 (943)
Q Consensus 237 ~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ 315 (943)
...+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|++|+++++...+
T Consensus 260 ------~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~ 332 (592)
T 3ogk_B 260 ------PEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDR 332 (592)
T ss_dssp ------TTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHH
T ss_pred ------HHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHH
Confidence 112334555667777777765433 456667777777777777777653322 234667788888888333333
Q ss_pred ccccccCCcccceEEEcc-----------ccccCCcC-cccccCCCcCcEEEeeCCcccCcccccccc-cCccceeecc-
Q 002278 316 TIPAELGKLEQLFELNLA-----------DNNLEGPI-PHNISSCTALNQFNVHGNRLSGAIPSSFRN-LGSLTYLNLS- 381 (943)
Q Consensus 316 ~~~~~~~~l~~L~~L~L~-----------~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~- 381 (943)
.++..+..+++|++|+|+ .|.++... +..+..+++|++|+++.|.+++..+..+.. +++|+.|+++
T Consensus 333 ~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~ 412 (592)
T 3ogk_B 333 GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVL 412 (592)
T ss_dssp HHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEE
T ss_pred HHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEee
Confidence 334444567778888888 35555332 222455788888888888887666666654 7888888885
Q ss_pred ---CCcCCCC-----CCCCCCCCCCccEEecCCCc--CCCccCCCcc-cccccceeecccccccc-cCCccccCCCccce
Q 002278 382 ---RNNFKGK-----VPTELGRIINLDTLDLSVNN--FSGSVPASIG-DLEHLLTLNLSRNHLNG-LLPAEFGNLRSIQT 449 (943)
Q Consensus 382 ---~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~ 449 (943)
.|.+++. ++..+..+++|+.|++++|. +++..+..+. .+++|++|+|++|++++ .++..+.++++|++
T Consensus 413 ~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~ 492 (592)
T 3ogk_B 413 LDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQK 492 (592)
T ss_dssp CSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCE
T ss_pred cCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCe
Confidence 6666643 22225567788888887543 5544444443 37788889998888875 33455677888999
Q ss_pred ecccCcccccc-CChhhhcccccceecccCcccCCCCCCcCc-cccCCcccccCC
Q 002278 450 IDMSFNQLSGS-IPAELGQLQNIISLILNNNNLQGGIPDQLS-NCFSLSNLNVSY 502 (943)
Q Consensus 450 L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~ 502 (943)
|+|++|++++. ++..+..+++|+.|+|++|+++..--..+. .++.+....+..
T Consensus 493 L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~ 547 (592)
T 3ogk_B 493 LEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPS 547 (592)
T ss_dssp EEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECC
T ss_pred eeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecC
Confidence 99999988754 344556788899999999988754333332 455554444443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=282.32 Aligned_cols=250 Identities=20% Similarity=0.269 Sum_probs=165.5
Q ss_pred CCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCc--cc
Q 002278 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGD--IP 103 (943)
Q Consensus 26 c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p 103 (943)
|.|.+|.|++. +++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|+|++|+++.. .|
T Consensus 7 C~~~~l~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 71 (306)
T 2z66_A 7 CSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71 (306)
T ss_dssp EETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEE
T ss_pred eCCCEEEcCCC------------Ccc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcc
Confidence 78988888654 344 5666553 6899999999999954445589999999999999999833 36
Q ss_pred hhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccc-hhccccccceeccccCCccCCCCCccccccc
Q 002278 104 FSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIP-RLIYWNEVLQYLGLRGNALTGMLSPDMCQLT 182 (943)
Q Consensus 104 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 182 (943)
..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+.++.+..+..++
T Consensus 72 ~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 150 (306)
T 2z66_A 72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 150 (306)
T ss_dssp HHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCT
T ss_pred cccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCc
Confidence 77888999999999999998 567778889999999999998885544 4566666666666666666665555555566
Q ss_pred ccceeeccceeccc-ccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecC
Q 002278 183 GLWYFDVRGNNLTG-TIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLS 261 (943)
Q Consensus 183 ~L~~L~L~~N~i~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls 261 (943)
+|++|++++|.+++ ..|..+..+++|++|++++|++++ ..|..+..+++|+.|+|+
T Consensus 151 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~-----------------------~~~~~~~~l~~L~~L~L~ 207 (306)
T 2z66_A 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-----------------------LSPTAFNSLSSLQVLNMS 207 (306)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE-----------------------ECTTTTTTCTTCCEEECT
T ss_pred CCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCC-----------------------cCHHHhcCCCCCCEEECC
Confidence 66666666665554 345555555555555555555442 233444455555555555
Q ss_pred CCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCC-cCcEEEcccCccc
Q 002278 262 ENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMS-KLSYLQLQNNQLV 314 (943)
Q Consensus 262 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~ 314 (943)
+|.+++..+..|..+++|+.|+|++|++++..|..+..++ +|++|++++|.+.
T Consensus 208 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~ 261 (306)
T 2z66_A 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261 (306)
T ss_dssp TSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred CCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence 5555544444455555555555555555555555555542 5555555555554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=289.51 Aligned_cols=259 Identities=19% Similarity=0.169 Sum_probs=194.4
Q ss_pred CCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEc
Q 002278 253 QALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNL 332 (943)
Q Consensus 253 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 332 (943)
++|++|++++|.+++..+..|.++++|+.|+|++|++++..|..|.++++|++|++++|++++..+..|.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 36777777777777655566777777777777777777666677777777888888888877655555777788888888
Q ss_pred cccccCCcCc-ccccCCCcCcEEEeeCC-cccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCC
Q 002278 333 ADNNLEGPIP-HNISSCTALNQFNVHGN-RLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFS 410 (943)
Q Consensus 333 ~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 410 (943)
++|++++..+ ..|..+++|++|++++| .+.+..+..|.++++|++|++++|++++..|..+..+++|++|++++|.+.
T Consensus 132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 8888875544 46777888888888887 466666777888888888888888888777888888888888888888887
Q ss_pred CccCCCcccccccceeecccccccccCCcccc---CCCccceecccCccccc----cCChhhhcccccceecccCcccCC
Q 002278 411 GSVPASIGDLEHLLTLNLSRNHLNGLLPAEFG---NLRSIQTIDMSFNQLSG----SIPAELGQLQNIISLILNNNNLQG 483 (943)
Q Consensus 411 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~ 483 (943)
...+..+..+++|+.|+|++|++++..+..+. ....++.++|++|.+++ .+|..+..+++|+.|+|++|+++.
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~ 291 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS 291 (353)
T ss_dssp THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC
T ss_pred cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc
Confidence 44333445678888888888888876555443 34567777777777765 478888999999999999999994
Q ss_pred CCCCcCccccCCcccccCCccccccCCC
Q 002278 484 GIPDQLSNCFSLSNLNVSYNNLSGIIPP 511 (943)
Q Consensus 484 ~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 511 (943)
..+..+..+++|++|++++|++++..|.
T Consensus 292 i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 292 VPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 4443458899999999999999887664
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-30 Score=279.19 Aligned_cols=250 Identities=22% Similarity=0.273 Sum_probs=178.2
Q ss_pred cEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccc--cccccCCcccceEEEcc
Q 002278 256 AVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT--IPAELGKLEQLFELNLA 333 (943)
Q Consensus 256 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~ 333 (943)
+.++++++.++. +|..+. ++|++|+|++|+++...+..|.++++|++|++++|+++.. .+..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCccc-CCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 355666666553 333222 4566666666666654444566677777777777776622 24555566777777777
Q ss_pred ccccCCcCcccccCCCcCcEEEeeCCcccCccc-ccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCC-
Q 002278 334 DNNLEGPIPHNISSCTALNQFNVHGNRLSGAIP-SSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG- 411 (943)
Q Consensus 334 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~- 411 (943)
+|.+. .+|..+..+++|++|++++|++++..+ ..|..+++|++|++++|.+++..+..+..+++|+.|++++|.+.+
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 77776 355557777777777777777775544 567777777777777777777777777777788888888887765
Q ss_pred ccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCcc
Q 002278 412 SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSN 491 (943)
Q Consensus 412 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 491 (943)
..|..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..|..+..
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 46777778888888888888888777777888888888888888887666667778888888888888888777777777
Q ss_pred cc-CCcccccCCccccccC
Q 002278 492 CF-SLSNLNVSYNNLSGII 509 (943)
Q Consensus 492 l~-~L~~L~ls~N~l~~~~ 509 (943)
++ +|+.|+|++|++++..
T Consensus 246 ~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 246 FPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp CCTTCCEEECTTCCEECSG
T ss_pred hhccCCEEEccCCCeeccc
Confidence 74 7888888888887643
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=286.25 Aligned_cols=248 Identities=22% Similarity=0.267 Sum_probs=154.3
Q ss_pred CCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEcc
Q 002278 254 ALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLA 333 (943)
Q Consensus 254 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 333 (943)
....++++++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3455666666665 3343332 456666666666666666666666666666666666666656666666666666666
Q ss_pred ccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccC-CcCCCCCCCCCCCCCCccEEecCCCcCCCc
Q 002278 334 DNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSR-NNFKGKVPTELGRIINLDTLDLSVNNFSGS 412 (943)
Q Consensus 334 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 412 (943)
+|+|+.+.+..|..+++|++|+|++|+|+...+..|..+++|+.|+|++ |.+....+..|..+++|+.|+|++|.++ .
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~ 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-S
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-c
Confidence 6666655555666666666666666666655555666666666666666 3333333445666666666666666666 3
Q ss_pred cCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccc
Q 002278 413 VPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNC 492 (943)
Q Consensus 413 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 492 (943)
+| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 33 35566666666666666666666666666666666666666666556666666666666666666665555555666
Q ss_pred cCCcccccCCcccc
Q 002278 493 FSLSNLNVSYNNLS 506 (943)
Q Consensus 493 ~~L~~L~ls~N~l~ 506 (943)
++|+.|+|++|++.
T Consensus 279 ~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 279 HHLERIHLHHNPWN 292 (440)
T ss_dssp TTCCEEECCSSCEE
T ss_pred cCCCEEEcCCCCcc
Confidence 66666665555543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=286.89 Aligned_cols=247 Identities=22% Similarity=0.242 Sum_probs=155.6
Q ss_pred CcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccc
Q 002278 255 LAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLAD 334 (943)
Q Consensus 255 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 334 (943)
...++++++.++. +|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 4455666655553 333332 4556666666666665566666666666666666666665556666666666666666
Q ss_pred cccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccC-CcCCCCCCCCCCCCCCccEEecCCCcCCCcc
Q 002278 335 NNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSR-NNFKGKVPTELGRIINLDTLDLSVNNFSGSV 413 (943)
Q Consensus 335 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 413 (943)
|+|++..+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++ |.+....+..|..+++|+.|+|++|++++ +
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~ 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-M 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-C
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-c
Confidence 666655555666666666666666666655555666666666666666 34443334456666666666666666663 3
Q ss_pred CCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCcccc
Q 002278 414 PASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCF 493 (943)
Q Consensus 414 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 493 (943)
| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 3 356666677777777777666666666677777777777777666666666667777777777777665555666666
Q ss_pred CCcccccCCcccc
Q 002278 494 SLSNLNVSYNNLS 506 (943)
Q Consensus 494 ~L~~L~ls~N~l~ 506 (943)
+|+.|+|++|++.
T Consensus 291 ~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 291 YLVELHLHHNPWN 303 (452)
T ss_dssp TCCEEECCSSCEE
T ss_pred CCCEEEccCCCcC
Confidence 6666666666554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-30 Score=300.33 Aligned_cols=292 Identities=26% Similarity=0.322 Sum_probs=161.9
Q ss_pred ccCCCCCCCCCCCCCCcceeEecC------CCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCC
Q 002278 12 NVLLDWDDVHNSDFCSWRGVFCDN------SSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNC 85 (943)
Q Consensus 12 ~~~~~w~~~~~~~~c~w~gv~c~~------~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l 85 (943)
...++|.. +.+||.|+|..|.- ....++.|++++|+++ .+|..+. ++|++|+|++|+|+ .+|. .+
T Consensus 10 ~~w~~W~~--~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l 80 (622)
T 3g06_A 10 AVWSAWRR--AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LP 80 (622)
T ss_dssp CHHHHHHH--TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CC
T ss_pred HHHHHHHh--cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cC
Confidence 35566754 46899997743210 1123567788888877 6776665 67788888888777 4554 46
Q ss_pred CCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccc
Q 002278 86 GSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGL 165 (943)
Q Consensus 86 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 165 (943)
++|++|+|++|+|+ .+|. .+++|++|+|++|++++ +|. .+++|+.|+|++|+|+. +|.. +++|++|+|
T Consensus 81 ~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~L 148 (622)
T 3g06_A 81 PELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSV 148 (622)
T ss_dssp TTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred CCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEEC
Confidence 77777777777777 4554 56777777777777774 333 45667777777777663 3332 255555555
Q ss_pred cCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccC
Q 002278 166 RGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKI 245 (943)
Q Consensus 166 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~ 245 (943)
++|++++++. .+.+|+.|++++|+|++ +| ..+++|+.|++++|+|+ + +
T Consensus 149 s~N~l~~l~~----~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~-----------------------~-l 196 (622)
T 3g06_A 149 SDNQLASLPA----LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLA-----------------------S-L 196 (622)
T ss_dssp CSSCCSCCCC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-----------------------C-C
T ss_pred cCCcCCCcCC----ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCC-----------------------C-C
Confidence 5555554422 23344445555555442 22 22344444444444444 1 1
Q ss_pred CccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcc
Q 002278 246 PEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLE 325 (943)
Q Consensus 246 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 325 (943)
|. .+++|+.|++++|.++. +|.. +++|+.|+|++|+|++ +| ..+++|++|+|++|+|+ .+|. .++
T Consensus 197 ~~---~~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~ 261 (622)
T 3g06_A 197 PT---LPSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPS 261 (622)
T ss_dssp CC---CCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCT
T ss_pred CC---ccchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccc
Confidence 11 12455555555555552 2221 2445555555555553 23 23355556666666555 2333 344
Q ss_pred cceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCccccccccc
Q 002278 326 QLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNL 372 (943)
Q Consensus 326 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 372 (943)
+|+.|+|++|+|+ .+|..+.++++|+.|+|++|++++..|..+..+
T Consensus 262 ~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 262 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred cCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 5555555555555 345555555555555555555555555444443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=286.02 Aligned_cols=252 Identities=23% Similarity=0.265 Sum_probs=228.3
Q ss_pred CcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEee
Q 002278 278 YTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVH 357 (943)
Q Consensus 278 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 357 (943)
....++..++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3567899999998 5666654 789999999999998888999999999999999999999989999999999999999
Q ss_pred CCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCC-cCCCccCCCcccccccceeeccccccccc
Q 002278 358 GNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVN-NFSGSVPASIGDLEHLLTLNLSRNHLNGL 436 (943)
Q Consensus 358 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 436 (943)
+|+|+++.+..|..+++|++|+|++|+++...+..|..+++|+.|+|++| .+....+..|.++++|+.|+|++|+++.
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~- 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE- 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-
Confidence 99999888889999999999999999999888889999999999999995 4554445579999999999999999995
Q ss_pred CCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCC-ccc
Q 002278 437 LPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPI-RNF 515 (943)
Q Consensus 437 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~ 515 (943)
+| .+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|+++++.. ..+
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 45 5899999999999999999888999999999999999999999999999999999999999999999988764 557
Q ss_pred CcCCCCccccCCCCCCCCC
Q 002278 516 SRFSSNSFIGNPLLCGNWI 534 (943)
Q Consensus 516 ~~~~~~~~~~Np~~c~~~~ 534 (943)
..+..+.+.+|||.|+|.+
T Consensus 279 ~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 279 HHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp TTCCEEECCSSCEECSSTT
T ss_pred cCCCEEEcCCCCccCCCCc
Confidence 7888889999999999743
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=286.97 Aligned_cols=251 Identities=22% Similarity=0.253 Sum_probs=227.7
Q ss_pred cceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeC
Q 002278 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHG 358 (943)
Q Consensus 279 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 358 (943)
...++.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 467899999998 4666554 6899999999999998899999999999999999999999999999999999999999
Q ss_pred CcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCC-cCCCccCCCcccccccceeecccccccccC
Q 002278 359 NRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVN-NFSGSVPASIGDLEHLLTLNLSRNHLNGLL 437 (943)
Q Consensus 359 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 437 (943)
|+|++..+..|..+++|++|+|++|+++...+..|..+++|+.|++++| .+....+..|.++++|+.|+|++|++++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM- 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-
Confidence 9999888888999999999999999999877889999999999999994 55544445799999999999999999964
Q ss_pred CccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCC-cccC
Q 002278 438 PAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPI-RNFS 516 (943)
Q Consensus 438 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~ 516 (943)
| .+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|+++++.. ..+.
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 4 5889999999999999999988999999999999999999999999999999999999999999999988764 5577
Q ss_pred cCCCCccccCCCCCCCCC
Q 002278 517 RFSSNSFIGNPLLCGNWI 534 (943)
Q Consensus 517 ~~~~~~~~~Np~~c~~~~ 534 (943)
.+..+.+.+|||.|+|.+
T Consensus 291 ~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 291 YLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TCCEEECCSSCEECSTTT
T ss_pred CCCEEEccCCCcCCCCCc
Confidence 788889999999999743
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-29 Score=267.43 Aligned_cols=236 Identities=24% Similarity=0.261 Sum_probs=123.9
Q ss_pred CCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCc-cccccccccCCcccceEEE
Q 002278 253 QALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQ-LVGTIPAELGKLEQLFELN 331 (943)
Q Consensus 253 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~ 331 (943)
++|+.|++++|.+++..+..|..+++|++|+|++|.+++..|..|..+++|++|++++|. +....|..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 355555555555554444455555555555555555554445555555555555555554 4444455555555555555
Q ss_pred ccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCC
Q 002278 332 LADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG 411 (943)
Q Consensus 332 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 411 (943)
+++|++++..|..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 55555555555555555555555555555554444445555555555555555554444445555555555555555555
Q ss_pred ccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcC
Q 002278 412 SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQL 489 (943)
Q Consensus 412 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 489 (943)
..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++....+. ..-...++.+..+.|.+....|..+
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGG
T ss_pred cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHh
Confidence 4455555555555555555555554444455555555555555555532221 1222334444444555544444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=301.27 Aligned_cols=235 Identities=23% Similarity=0.197 Sum_probs=136.8
Q ss_pred CCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEc
Q 002278 253 QALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNL 332 (943)
Q Consensus 253 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 332 (943)
++|+.|+|++|.+.+..|..|..+++|+.|+|++|.+++..| |..+++|++|+|++|.+++..+ .++|+.|++
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L 106 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence 367777777777776666677777777777777777765444 6667777777777777664322 256666666
Q ss_pred cccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCC-CCCCccEEecCCCcCCC
Q 002278 333 ADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELG-RIINLDTLDLSVNNFSG 411 (943)
Q Consensus 333 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~ 411 (943)
++|.|++..+.. +++|+.|+|++|.|++..|..|..+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|++
T Consensus 107 ~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 107 ANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp CSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred cCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 666666554432 35566666666666665565666666666666666666655555443 45556666666666553
Q ss_pred ccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccC-CCCCCcCc
Q 002278 412 SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQ-GGIPDQLS 490 (943)
Q Consensus 412 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~ 490 (943)
. |. +..+++|+.|+|++|+|++.+ ..|..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++. +.+|..+.
T Consensus 184 ~-~~-~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 184 V-KG-QVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp E-EC-CCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred c-cc-cccCCCCCEEECCCCCCCCCC-HhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 3 21 223555555555555555432 235555555555555555552 4555555555555555555555 34444444
Q ss_pred cccCCcccccC
Q 002278 491 NCFSLSNLNVS 501 (943)
Q Consensus 491 ~l~~L~~L~ls 501 (943)
.++.|+.++++
T Consensus 260 ~l~~L~~l~~~ 270 (487)
T 3oja_A 260 KNQRVQTVAKQ 270 (487)
T ss_dssp TCHHHHHHHHH
T ss_pred hCCCCcEEecc
Confidence 45555444443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-32 Score=324.07 Aligned_cols=327 Identities=12% Similarity=0.039 Sum_probs=230.9
Q ss_pred cccccceeeccceecccc----cCCCCcCCCcccEEEeecccccCc----CCCCC-CcceEeEEEecCccccccCCcccc
Q 002278 180 QLTGLWYFDVRGNNLTGT----IPDSIGNCTSFEILDISYNQITGE----IPYNI-GFLQVATLSLQGNKLTGKIPEVIG 250 (943)
Q Consensus 180 ~l~~L~~L~L~~N~i~~~----~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~~-~~~~L~~L~L~~n~l~~~~~~~l~ 250 (943)
.+++|++|+|++|.+++. ++..+.++++|++|++++|.+++. ++..+ ...+|+.|++++|.+.+ ++..+.
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~ 240 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK 240 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh
Confidence 345555555555554433 222334455666666666655421 11111 22356666666666654 567888
Q ss_pred ccCCCcEEecCCCCCC---CCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccc-cccCCccc
Q 002278 251 LMQALAVLDLSENELV---GPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIP-AELGKLEQ 326 (943)
Q Consensus 251 ~l~~L~~L~Ls~N~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~ 326 (943)
.+++|+.|+++.+... ...+..+..+++|+.|.++++... .+|..+..+++|++|++++|.+++... ..+..+++
T Consensus 241 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~ 319 (592)
T 3ogk_B 241 AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN 319 (592)
T ss_dssp HCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTT
T ss_pred hhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcC
Confidence 9999999999864332 234467788899999999986544 677788889999999999999865443 34688999
Q ss_pred ceEEEccccccCCcCcccccCCCcCcEEEee-----------CCcccCc-ccccccccCccceeeccCCcCCCCCCCCCC
Q 002278 327 LFELNLADNNLEGPIPHNISSCTALNQFNVH-----------GNRLSGA-IPSSFRNLGSLTYLNLSRNNFKGKVPTELG 394 (943)
Q Consensus 327 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 394 (943)
|++|+++++-..+.++..+..+++|++|+++ .|.++.. ++..+..+++|++|+++.|.+++..+..+.
T Consensus 320 L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~ 399 (592)
T 3ogk_B 320 LEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIG 399 (592)
T ss_dssp CCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHH
T ss_pred CCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHH
Confidence 9999999443333344455778999999999 3677643 233355689999999999999876655565
Q ss_pred C-CCCccEEecC----CCcCCCc-----cCCCcccccccceeecccc--cccccCCcccc-CCCccceecccCccccc-c
Q 002278 395 R-IINLDTLDLS----VNNFSGS-----VPASIGDLEHLLTLNLSRN--HLNGLLPAEFG-NLRSIQTIDMSFNQLSG-S 460 (943)
Q Consensus 395 ~-l~~L~~L~Ls----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~ 460 (943)
. +++|+.|+++ .|.+++. ++..+.++++|+.|+|++| .+++..+..+. .+++|++|+|++|++++ .
T Consensus 400 ~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~ 479 (592)
T 3ogk_B 400 TYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEG 479 (592)
T ss_dssp HHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHH
T ss_pred hhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHH
Confidence 5 8899999996 6777753 3334677899999999854 36655544444 48899999999999986 3
Q ss_pred CChhhhcccccceecccCcccCCC-CCCcCccccCCcccccCCcccccc
Q 002278 461 IPAELGQLQNIISLILNNNNLQGG-IPDQLSNCFSLSNLNVSYNNLSGI 508 (943)
Q Consensus 461 ~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~ 508 (943)
++..+..+++|+.|+|++|++++. ++..+..+++|+.|+|++|+++..
T Consensus 480 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 480 LMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 456668899999999999998754 344456789999999999998764
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=264.37 Aligned_cols=248 Identities=25% Similarity=0.244 Sum_probs=200.1
Q ss_pred eEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCC-CCCCCCCCcCCCCcCcEEEc
Q 002278 230 QVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNK-LTGPIPPELGNMSKLSYLQL 308 (943)
Q Consensus 230 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L 308 (943)
+++.|++++|.+++..+..|..+++|++|+|++|.+.+..|..|.++++|++|+|++|. ++...|..|..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 45555555555555666777888888888888888887778888888888999998887 77776888888899999999
Q ss_pred ccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCC
Q 002278 309 QNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK 388 (943)
Q Consensus 309 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 388 (943)
++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|+|++|++++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 99999887788888899999999999999887777888899999999999999877777888999999999999999988
Q ss_pred CCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhc-
Q 002278 389 VPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQ- 467 (943)
Q Consensus 389 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~- 467 (943)
.|..+..+++|+.|++++|.+++..+..+..+++|+.|+|++|.+....+. ..-...++.+..+.|.+....|..+.+
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~g~ 271 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGR 271 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTTC
T ss_pred CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHhCCc
Confidence 888999999999999999999977667788999999999999999754332 122345777788888888888887754
Q ss_pred -ccccceecccC
Q 002278 468 -LQNIISLILNN 478 (943)
Q Consensus 468 -l~~L~~L~L~~ 478 (943)
+..++..++.+
T Consensus 272 ~l~~l~~~~l~~ 283 (285)
T 1ozn_A 272 DLKRLAANDLQG 283 (285)
T ss_dssp BGGGSCGGGSCC
T ss_pred ChhhcCHHHhcc
Confidence 33444444433
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=282.39 Aligned_cols=265 Identities=22% Similarity=0.192 Sum_probs=192.1
Q ss_pred eEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccC
Q 002278 232 ATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNN 311 (943)
Q Consensus 232 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 311 (943)
+.++++.+.+...+...+..+++|++|+|++|.+++..|..|..+++|+.|+|++|.+++..+ |..+++|++|++++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 344555666655555556666778888888888887767777888888888888888875543 777888888888888
Q ss_pred ccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCC
Q 002278 312 QLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPT 391 (943)
Q Consensus 312 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 391 (943)
++++.. ..++|++|++++|++++..+.. +++|+.|++++|++++..+..|..+++|++|+|++|++++..+.
T Consensus 91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 162 (317)
T 3o53_A 91 YVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162 (317)
T ss_dssp EEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred cccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence 877432 2377888888888887655443 46678888888888877777777888888888888888766555
Q ss_pred CC-CCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccc
Q 002278 392 EL-GRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQN 470 (943)
Q Consensus 392 ~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 470 (943)
.+ ..+++|++|+|++|.+++. +. ...+++|++|+|++|++++. |..|..+++|+.|+|++|+|+ .+|..+..+++
T Consensus 163 ~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~ 238 (317)
T 3o53_A 163 ELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238 (317)
T ss_dssp GGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTT
T ss_pred HHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCC
Confidence 55 3677788888888887744 32 23477788888888888754 444777888888888888887 56777778888
Q ss_pred cceecccCcccC-CCCCCcCccccCCcccccC-CccccccCC
Q 002278 471 IISLILNNNNLQ-GGIPDQLSNCFSLSNLNVS-YNNLSGIIP 510 (943)
Q Consensus 471 L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls-~N~l~~~~~ 510 (943)
|+.|+|++|+++ +.+|..+..+++|+.|+++ .+.++|..|
T Consensus 239 L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp CCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred CCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 888888888887 6667777777888888887 445555544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=277.41 Aligned_cols=249 Identities=21% Similarity=0.224 Sum_probs=131.8
Q ss_pred CCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcC-Cccchhcc-------ccccceEEEecCcccccCCCccc-
Q 002278 60 DLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLY-GDIPFSIS-------KLKQLEFLNLKNNQLTGPIPSTL- 130 (943)
Q Consensus 60 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~-------~l~~L~~L~Ls~n~l~~~~~~~~- 130 (943)
..++|++|++++|.+ .+|..+... |++|+|++|++. ..+|..+. ++++|++|+|++|++++.+|..+
T Consensus 41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 116 (312)
T 1wwl_A 41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116 (312)
T ss_dssp EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence 344566666666666 455554443 666666666663 33444443 56677777777777766666655
Q ss_pred -CCCCCCcEEEEeccccccccchhcccc-----ccceeccccCCccCCCCCcccccccccceeeccceecccc--cCCCC
Q 002278 131 -TQIPNLKTLDLARNQLTGEIPRLIYWN-----EVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGT--IPDSI 202 (943)
Q Consensus 131 -~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~--~~~~l 202 (943)
..+++|++|+|++|++++. |..+..+ ++|++|+|++|+++++.+..|..+++|++|+|++|++.+. .+..+
T Consensus 117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 195 (312)
T 1wwl_A 117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195 (312)
T ss_dssp SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHS
T ss_pred HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHH
Confidence 6667777777777777654 5555555 5555555555555555555555555555555555554432 11122
Q ss_pred --cCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCC-cccCCCCCc
Q 002278 203 --GNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIP-PILGNLSYT 279 (943)
Q Consensus 203 --~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L 279 (943)
.++++|++|+|++|++++. + ......+..+++|+.|+|++|.+.+..| ..+..+++|
T Consensus 196 ~~~~l~~L~~L~L~~N~l~~~-~-------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L 255 (312)
T 1wwl_A 196 CPLKFPTLQVLALRNAGMETP-S-------------------GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255 (312)
T ss_dssp CTTSCTTCCEEECTTSCCCCH-H-------------------HHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTC
T ss_pred HhccCCCCCEEECCCCcCcch-H-------------------HHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCC
Confidence 4455555555555554410 0 1111223445566666666666655443 334444555
Q ss_pred ceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccC
Q 002278 280 GKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLE 338 (943)
Q Consensus 280 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 338 (943)
+.|+|++|+|+ .+|..+. ++|++|++++|+|++. |. +..+++|++|+|++|+++
T Consensus 256 ~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 256 NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred CEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 55555555554 3343333 4455555555555433 32 444444444444444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-30 Score=281.92 Aligned_cols=250 Identities=21% Similarity=0.211 Sum_probs=167.0
Q ss_pred ccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCC-CCCCCCcC-------CCCcCcEEEcccCccccccccc
Q 002278 249 IGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLT-GPIPPELG-------NMSKLSYLQLQNNQLVGTIPAE 320 (943)
Q Consensus 249 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~ 320 (943)
++..++|+.|++++|.+ .+|..+... |+.|+|++|.++ ..+|..+. ++++|++|++++|++++..|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34445566666666666 344433332 666666666663 23333333 4666777777777776666665
Q ss_pred c--CCcccceEEEccccccCCcCcccccCC-----CcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCC--CCC
Q 002278 321 L--GKLEQLFELNLADNNLEGPIPHNISSC-----TALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK--VPT 391 (943)
Q Consensus 321 ~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~ 391 (943)
+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|+|++..+..|..+++|++|+|++|++.+. .+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 4 6667777777777777655 5656555 6777777777777766667777777777777777776543 222
Q ss_pred CC--CCCCCccEEecCCCcCCCc---cCCCcccccccceeecccccccccCC-ccccCCCccceecccCccccccCChhh
Q 002278 392 EL--GRIINLDTLDLSVNNFSGS---VPASIGDLEHLLTLNLSRNHLNGLLP-AEFGNLRSIQTIDMSFNQLSGSIPAEL 465 (943)
Q Consensus 392 ~~--~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 465 (943)
.+ ..+++|++|+|++|+|++. ....+..+++|+.|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 22 6777778888888877731 11234566788888888888877664 45666788888888888887 677766
Q ss_pred hcccccceecccCcccCCCCCCcCccccCCcccccCCcccccc
Q 002278 466 GQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508 (943)
Q Consensus 466 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 508 (943)
. ++|+.|+|++|+|++. |. +..+++|++|++++|++++.
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 6 7888888888888855 55 77888888888888888753
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-29 Score=274.62 Aligned_cols=229 Identities=17% Similarity=0.167 Sum_probs=171.6
Q ss_pred CccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcc
Q 002278 246 PEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLE 325 (943)
Q Consensus 246 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 325 (943)
|..|..+++|++|+|++|.+.+..+ |..+++|++|+|++|++++.. ..++|++|++++|++++..+.. ++
T Consensus 51 ~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~ 120 (317)
T 3o53_A 51 AADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQ 120 (317)
T ss_dssp HHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CS
T ss_pred HHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cC
Confidence 3445555555555555555554332 555666666666666665322 2367777777777777554443 46
Q ss_pred cceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCccccccc-ccCccceeeccCCcCCCCCCCCCCCCCCccEEec
Q 002278 326 QLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFR-NLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDL 404 (943)
Q Consensus 326 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 404 (943)
+|++|++++|++++..+..+..+++|++|++++|++++..+..+. .+++|++|+|++|++++. +. ...+++|+.|+|
T Consensus 121 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~L 198 (317)
T 3o53_A 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDL 198 (317)
T ss_dssp SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEEC
T ss_pred CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEEC
Confidence 688888888888877777788888888888888888877666664 688889999999988854 32 334889999999
Q ss_pred CCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCcccc-ccCChhhhcccccceeccc-CcccC
Q 002278 405 SVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS-GSIPAELGQLQNIISLILN-NNNLQ 482 (943)
Q Consensus 405 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~-~N~l~ 482 (943)
++|++++ +|..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+++ .+.++
T Consensus 199 s~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~ 276 (317)
T 3o53_A 199 SSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLT 276 (317)
T ss_dssp CSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHH
T ss_pred CCCcCCc-chhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhcc
Confidence 9999995 55568999999999999999994 6788999999999999999998 7788999999999999999 45677
Q ss_pred CCCCCc
Q 002278 483 GGIPDQ 488 (943)
Q Consensus 483 ~~~p~~ 488 (943)
+..|..
T Consensus 277 ~~~~~~ 282 (317)
T 3o53_A 277 GQNEEE 282 (317)
T ss_dssp SSSSCC
T ss_pred CCchhc
Confidence 666543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-27 Score=277.70 Aligned_cols=267 Identities=27% Similarity=0.321 Sum_probs=136.8
Q ss_pred cceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecC
Q 002278 159 VLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQG 238 (943)
Q Consensus 159 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 238 (943)
.++.|++++|.++.++. .+. ++|++|+|++|+|+. +|. .+++|++|+|++|+|+
T Consensus 41 ~l~~L~ls~n~L~~lp~-~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~------------------- 94 (622)
T 3g06_A 41 GNAVLNVGESGLTTLPD-CLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT------------------- 94 (622)
T ss_dssp CCCEEECCSSCCSCCCS-CCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCS-------------------
T ss_pred CCcEEEecCCCcCccCh-hhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCC-------------------
Confidence 35555666665554432 221 445555555555552 222 3344555555555544
Q ss_pred ccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccc
Q 002278 239 NKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIP 318 (943)
Q Consensus 239 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 318 (943)
+ +|. .+++|++|+|++|.+++. |. .+++|+.|++++|++++ +|.. +++|++|++++|++++ +|
T Consensus 95 ----~-lp~---~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~ 157 (622)
T 3g06_A 95 ----S-LPV---LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LP 157 (622)
T ss_dssp ----C-CCC---CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CC
T ss_pred ----c-CCC---CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cC
Confidence 2 222 345555555555555532 22 34555556666665553 3322 2556666666666653 22
Q ss_pred cccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCC
Q 002278 319 AELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIIN 398 (943)
Q Consensus 319 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 398 (943)
. .+++|+.|++++|+|++ +| ..+++|+.|++++|+|++ +|.. +++|+.|++++|.++ .+|.. +++
T Consensus 158 ~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~ 222 (622)
T 3g06_A 158 A---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSG 222 (622)
T ss_dssp C---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTT
T ss_pred C---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCC
Confidence 2 23455566666666653 22 334556666666666553 2221 345666666666665 33322 245
Q ss_pred ccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccC
Q 002278 399 LDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNN 478 (943)
Q Consensus 399 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 478 (943)
|+.|+|++|.|++ +| ..+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++
T Consensus 223 L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~ 293 (622)
T 3g06_A 223 LKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293 (622)
T ss_dssp CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCS
T ss_pred CCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecC
Confidence 6666666666653 33 234556666666666653 333 3455666666666665 4555566666666666666
Q ss_pred cccCCCCCCcCccc
Q 002278 479 NNLQGGIPDQLSNC 492 (943)
Q Consensus 479 N~l~~~~p~~~~~l 492 (943)
|++++.+|..+..+
T Consensus 294 N~l~~~~~~~l~~L 307 (622)
T 3g06_A 294 NPLSERTLQALREI 307 (622)
T ss_dssp CCCCHHHHHHHHHH
T ss_pred CCCCCcCHHHHHhc
Confidence 66665555544433
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=291.14 Aligned_cols=185 Identities=17% Similarity=0.118 Sum_probs=130.5
Q ss_pred EeeeceEEEEEEEec-CCceEEEEEecccC----------cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceEEE
Q 002278 624 VGYGASSTVYKCALK-NSRPIAVKKLYNQY----------PHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 624 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 691 (943)
.+.|++|.+..++.. -|+.||+|.+.... ....+++.+|+++|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 566777777666533 47889999986432 12345689999999999 6999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||++||+|.+++.. .++++.. +|+.||+.||+|+|++ |||||||||+|||++++|++||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999973 4456654 5889999999999999 9999999999999999999999999999877544
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCC
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAV 819 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~ 819 (943)
... ....+||+.|||||++.+. +..++|+||+|++++++.+|..++
T Consensus 393 ~~~-~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 CSW-PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred Ccc-ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 332 2335699999999998764 677899999999998887665443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-31 Score=320.36 Aligned_cols=432 Identities=15% Similarity=0.133 Sum_probs=255.4
Q ss_pred CCCCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCccc---ccCCCC------------ccCCCCC
Q 002278 24 DFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLT---GQIPDE------------IGNCGSL 88 (943)
Q Consensus 24 ~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~---~~~p~~------------~~~l~~L 88 (943)
-|++|+++.. .....++++..... .....+..+++|++|+|+++... +..|.. +..+++|
T Consensus 33 vck~W~~~~~----~~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 33 VCKSWYEIER----WCRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp SCHHHHHHHH----HHCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHHhhh----hhceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 5668998822 22345666554322 12234678899999999997532 122221 3467899
Q ss_pred cEEeccCCCcCCccchhcc-ccccceEEEecCc-ccccC-CCcccCCCCCCcEEEEeccccccccchhcc----ccccce
Q 002278 89 VHIELSDNSLYGDIPFSIS-KLKQLEFLNLKNN-QLTGP-IPSTLTQIPNLKTLDLARNQLTGEIPRLIY----WNEVLQ 161 (943)
Q Consensus 89 ~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~n-~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l~~L~ 161 (943)
++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 9999999998877777775 6899999999998 55532 344555789999999999988765554444 556888
Q ss_pred eccccCCccCCCCCcccc----cccccceeeccce-ecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEe
Q 002278 162 YLGLRGNALTGMLSPDMC----QLTGLWYFDVRGN-NLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSL 236 (943)
Q Consensus 162 ~L~L~~n~l~~~~~~~~~----~l~~L~~L~L~~N-~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L 236 (943)
+|++++|. ..+....+. .+++|++|++++| .+.+ ++..+..+++|++|+++.+.. ++
T Consensus 188 ~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~----------------~~ 249 (594)
T 2p1m_B 188 SLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTA----------------EV 249 (594)
T ss_dssp EEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCC----------------CC
T ss_pred EEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccC----------------cc
Confidence 88888887 333333333 3588888888887 4443 666777788888888765532 12
Q ss_pred cCccccccCCccccccCCCcEE-ecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCC-CCcCCCCcCcEEEcccCccc
Q 002278 237 QGNKLTGKIPEVIGLMQALAVL-DLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIP-PELGNMSKLSYLQLQNNQLV 314 (943)
Q Consensus 237 ~~n~l~~~~~~~l~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 314 (943)
..+.+.+ ++..+..+++|+.| .+.+... +.++..+..+++|++|+|++|.+++... ..+..+++|+.|++++| +.
T Consensus 250 ~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~ 326 (594)
T 2p1m_B 250 RPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IE 326 (594)
T ss_dssp CHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GH
T ss_pred chhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cC
Confidence 2334443 33456677777777 3433322 1233444456677777777777553211 12446677777777777 33
Q ss_pred cc-cccccCCcccceEEEcc---------ccccCCcCccccc-CCCcCcEEEeeCCcccCccccccc-ccCccceeecc-
Q 002278 315 GT-IPAELGKLEQLFELNLA---------DNNLEGPIPHNIS-SCTALNQFNVHGNRLSGAIPSSFR-NLGSLTYLNLS- 381 (943)
Q Consensus 315 ~~-~~~~~~~l~~L~~L~L~---------~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~- 381 (943)
.. ++.....+++|++|+++ .+.+++.....+. .+++|+.|.++.|.+++.....+. .+++|+.|+|+
T Consensus 327 ~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~ 406 (594)
T 2p1m_B 327 DAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCI 406 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEE
T ss_pred HHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeec
Confidence 22 22222346677777773 3344432222222 367777777777777654444444 46777777777
Q ss_pred -C----CcCCCCCC-----CCCCCCCCccEEecCCCcCCCccCCCccc-ccccceeecccccccccCCccc-cCCCccce
Q 002278 382 -R----NNFKGKVP-----TELGRIINLDTLDLSVNNFSGSVPASIGD-LEHLLTLNLSRNHLNGLLPAEF-GNLRSIQT 449 (943)
Q Consensus 382 -~----N~l~~~~~-----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~ 449 (943)
+ |.++.... ..+..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ .++++|++
T Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~ 485 (594)
T 2p1m_B 407 IEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRK 485 (594)
T ss_dssp SSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCE
T ss_pred ccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCE
Confidence 3 34431110 1134455666666655 444333333333 5666666666666654433333 44566666
Q ss_pred ecccCccccccCCh-hhhcccccceecccCcccC
Q 002278 450 IDMSFNQLSGSIPA-ELGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 450 L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~ 482 (943)
|+|++|++++..+. .+..+++|+.|++++|+++
T Consensus 486 L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 486 LEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp EEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred EECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 66666666433322 2334566666666666653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=283.05 Aligned_cols=245 Identities=22% Similarity=0.225 Sum_probs=182.0
Q ss_pred CCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEE
Q 002278 275 NLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQF 354 (943)
Q Consensus 275 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 354 (943)
..++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.|++..+ .++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34478888888888887777788888888888888888876555 7888888888888888875433 2788888
Q ss_pred EeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcc-cccccceeecccccc
Q 002278 355 NVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIG-DLEHLLTLNLSRNHL 433 (943)
Q Consensus 355 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l 433 (943)
++++|.|++..+.. +++|+.|+|++|.+++..|..++.+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|
T Consensus 105 ~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 88888888665543 46788888888888877777888888888888888888877777775 678888888888888
Q ss_pred cccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCcccc-ccCCC-
Q 002278 434 NGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLS-GIIPP- 511 (943)
Q Consensus 434 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~~~- 511 (943)
++..+ +..+++|+.|+|++|+|++ +|..|..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++. +.+|.
T Consensus 182 ~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~ 257 (487)
T 3oja_A 182 YDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (487)
T ss_dssp CEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred ccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence 86532 3357888888888888885 55558888888888888888884 6667788888888888888887 33322
Q ss_pred CcccCcCCCCccc-------cCCCCCCCC
Q 002278 512 IRNFSRFSSNSFI-------GNPLLCGNW 533 (943)
Q Consensus 512 ~~~~~~~~~~~~~-------~Np~~c~~~ 533 (943)
+..+..+..+... +|++.|+++
T Consensus 258 ~~~l~~L~~l~~~~~~~~~~~~~~~c~~~ 286 (487)
T 3oja_A 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVP 286 (487)
T ss_dssp HTTCHHHHHHHHHHHHHHTSSSSCCCSST
T ss_pred HHhCCCCcEEeccccccccCCCcccccCC
Confidence 2223333333332 677777654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.3e-27 Score=249.86 Aligned_cols=193 Identities=27% Similarity=0.304 Sum_probs=138.0
Q ss_pred CCCCCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCcc
Q 002278 23 SDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDI 102 (943)
Q Consensus 23 ~~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 102 (943)
.|+|.|.|+.|.-.. .++.+++++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+++...
T Consensus 2 ~~~C~~~~~~C~c~~-~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCNN-NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEET-TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeCC-CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 599999999996432 3456888888888 5776654 57888888888888666667888888888888888888555
Q ss_pred chhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCccccccc
Q 002278 103 PFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLT 182 (943)
Q Consensus 103 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 182 (943)
+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++++++..|..++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 55677888888888888888876667777888888888888887766666666666666666666666666555555566
Q ss_pred ccceeeccceecccccCCCCcCCCcccEEEeeccccc
Q 002278 183 GLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQIT 219 (943)
Q Consensus 183 ~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~ 219 (943)
+|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus 158 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (270)
T 2o6q_A 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCC
Confidence 6666666666555544445555555555555555554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=243.39 Aligned_cols=210 Identities=20% Similarity=0.245 Sum_probs=131.1
Q ss_pred cCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeecc
Q 002278 302 KLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLS 381 (943)
Q Consensus 302 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 381 (943)
+|++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555554444455555555555555555555555555555666666666666655555556666666666666
Q ss_pred CCcCCCCCCCCCCCCCCccEEecCCCcCCCc-cCCCcccccccceeecccccccccCCccccCCCccc----eecccCcc
Q 002278 382 RNNFKGKVPTELGRIINLDTLDLSVNNFSGS-VPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQ----TIDMSFNQ 456 (943)
Q Consensus 382 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~ 456 (943)
+|++++..+..+..+++|++|++++|.+++. +|..|..+++|+.|+|++|++++..+..|..+++|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 6666655555566666666666666666642 466666677777777777777666666666666555 67777777
Q ss_pred ccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCC
Q 002278 457 LSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPI 512 (943)
Q Consensus 457 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~ 512 (943)
+++..+..+ ...+|+.|+|++|++++..+..+..+++|+.|++++|++++..|.+
T Consensus 189 l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 189 MNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred ccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 774433333 3346777777777777665656677777777777777777665543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=239.50 Aligned_cols=224 Identities=21% Similarity=0.230 Sum_probs=162.6
Q ss_pred EEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccc
Q 002278 257 VLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNN 336 (943)
Q Consensus 257 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 336 (943)
.++.++..+. .+|..+. ++|++|+|++|++++..+..|.++++|++|++++|++++..+..|..+++|++|+|++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 3445555554 2343332 356667777777766555567777777777777777776666677777777777777777
Q ss_pred cCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCC-CCCCCCCCCCccEEecCCCcCCCccCC
Q 002278 337 LEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK-VPTELGRIINLDTLDLSVNNFSGSVPA 415 (943)
Q Consensus 337 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 415 (943)
+++..+..|.++++|++|++++|.+.+..+..|..+++|++|++++|++++. +|..+..+++|+.|++++|++++..+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 7766667777777777777777777766666777777888888888887753 477788888888888888888876667
Q ss_pred Ccccccccc----eeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCC
Q 002278 416 SIGDLEHLL----TLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGG 484 (943)
Q Consensus 416 ~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 484 (943)
.+..+++|+ .|++++|++++..+..+.. .+|+.|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp GGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred HhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 777777776 7888888888766655554 4788899999988866566678888899999999988753
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-29 Score=300.61 Aligned_cols=414 Identities=14% Similarity=0.142 Sum_probs=283.1
Q ss_pred cEEEEEcCCCCCccccC---C------------CcCCCCCCCEEEeeCCcccccCCCCcc-CCCCCcEEeccCC-CcCCc
Q 002278 39 SVVSLNLSSLNLGGEIS---P------------SIGDLRNLQSIDFQGNKLTGQIPDEIG-NCGSLVHIELSDN-SLYGD 101 (943)
Q Consensus 39 ~v~~L~l~~~~~~~~~~---~------------~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~ 101 (943)
+++.|+|+++.....+. . ....+++|++|+|++|.+++..+..+. .+++|++|+|++| .++..
T Consensus 67 ~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~ 146 (594)
T 2p1m_B 67 KVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTD 146 (594)
T ss_dssp TCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHH
T ss_pred CceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHH
Confidence 46789999876432221 1 134688999999999999877776665 6999999999999 55532
Q ss_pred -cchhccccccceEEEecCcccccCCCcccC----CCCCCcEEEEeccc--ccc-ccchhccccccceeccccCC-ccCC
Q 002278 102 -IPFSISKLKQLEFLNLKNNQLTGPIPSTLT----QIPNLKTLDLARNQ--LTG-EIPRLIYWNEVLQYLGLRGN-ALTG 172 (943)
Q Consensus 102 -~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~----~l~~L~~L~Ls~N~--l~~-~~~~~~~~l~~L~~L~L~~n-~l~~ 172 (943)
++..+..+++|++|+|++|.+++..+..+. .+++|++|+|++|. ++. .++..+..+++|++|+|++| .+.+
T Consensus 147 ~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~ 226 (594)
T 2p1m_B 147 GLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK 226 (594)
T ss_dssp HHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH
T ss_pred HHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH
Confidence 445556899999999999998876555444 67799999999997 321 22333455699999999999 4544
Q ss_pred CCCcccccccccceeeccc-------eecccccCCCCcCCCcccEE-EeecccccCcCCCCCCcceEeEEEecCcccccc
Q 002278 173 MLSPDMCQLTGLWYFDVRG-------NNLTGTIPDSIGNCTSFEIL-DISYNQITGEIPYNIGFLQVATLSLQGNKLTGK 244 (943)
Q Consensus 173 ~~~~~~~~l~~L~~L~L~~-------N~i~~~~~~~l~~l~~L~~L-~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~ 244 (943)
.+..+..+++|++|+++. |.+.+ ++..+.++++|+.| .+.+... ..
T Consensus 227 -l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~------------------------~~ 280 (594)
T 2p1m_B 227 -LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP------------------------AY 280 (594)
T ss_dssp -HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG------------------------GG
T ss_pred -HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch------------------------hh
Confidence 556677889999999544 44554 33467888999888 3332211 12
Q ss_pred CCccccccCCCcEEecCCCCCCCCC-CcccCCCCCcceEEecCCCCCCC-CCCCcCCCCcCcEEEcc---------cCcc
Q 002278 245 IPEVIGLMQALAVLDLSENELVGPI-PPILGNLSYTGKLYLHGNKLTGP-IPPELGNMSKLSYLQLQ---------NNQL 313 (943)
Q Consensus 245 ~~~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~---------~N~l 313 (943)
++..+..+++|+.|+|++|.+.+.. ...+..+++|++|++++| ++.. ++.....+++|++|+++ .+.+
T Consensus 281 l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l 359 (594)
T 2p1m_B 281 LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVAL 359 (594)
T ss_dssp GGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCC
T ss_pred HHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCC
Confidence 3444556777888888887765322 223556778888888877 3321 11122346788888883 3455
Q ss_pred ccccccccC-CcccceEEEccccccCCcCccccc-CCCcCcEEEee--C----CcccCc-----ccccccccCccceeec
Q 002278 314 VGTIPAELG-KLEQLFELNLADNNLEGPIPHNIS-SCTALNQFNVH--G----NRLSGA-----IPSSFRNLGSLTYLNL 380 (943)
Q Consensus 314 ~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~~-----~~~~~~~l~~L~~L~L 380 (943)
++.....+. .+++|+.|.++.|.+++.....+. .+++|+.|+++ + |.++.. ++..+..+++|+.|+|
T Consensus 360 ~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L 439 (594)
T 2p1m_B 360 TEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL 439 (594)
T ss_dssp CHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEEC
T ss_pred CHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEee
Confidence 433333333 378888888888888766555554 57889999998 4 556522 2223667889999999
Q ss_pred cCCcCCCCCCCCCCC-CCCccEEecCCCcCCCccCCCc-ccccccceeecccccccccCCc-cccCCCccceecccCccc
Q 002278 381 SRNNFKGKVPTELGR-IINLDTLDLSVNNFSGSVPASI-GDLEHLLTLNLSRNHLNGLLPA-EFGNLRSIQTIDMSFNQL 457 (943)
Q Consensus 381 ~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l 457 (943)
++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++.... .+..+++|+.|++++|++
T Consensus 440 ~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 440 SG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp CS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred cC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 77 555444444444 7889999999999875544444 6689999999999999654443 445689999999999998
Q ss_pred cccCChhh-hcccccceecccCcc
Q 002278 458 SGSIPAEL-GQLQNIISLILNNNN 480 (943)
Q Consensus 458 ~~~~p~~~-~~l~~L~~L~L~~N~ 480 (943)
+......+ ..+++|+...+..+.
T Consensus 519 ~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 519 SFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp BHHHHHHHHHHCTTEEEEEECSSS
T ss_pred CHHHHHHHHHhCCCCEEEEecCCC
Confidence 64333334 456666665555543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=240.22 Aligned_cols=206 Identities=22% Similarity=0.249 Sum_probs=113.4
Q ss_pred cCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccc
Q 002278 297 LGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLT 376 (943)
Q Consensus 297 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 376 (943)
+.++++|+.+++++|.++ .+|..+. ++++.|+|++|+|++..+..|..+++|++|+|++|.|++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 455666777777777776 3444333 4566667777766666666666666666666666666543222 4555555
Q ss_pred eeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCcc
Q 002278 377 YLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQ 456 (943)
Q Consensus 377 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 456 (943)
+|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 5555555555 444455555555555555555554444445555555555555555554444445555555555555555
Q ss_pred ccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCCcccCcCCCCccccCCCCCCC
Q 002278 457 LSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGN 532 (943)
Q Consensus 457 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~~~~~Np~~c~~ 532 (943)
|+ +..+..+..+++|+.|+|++|+|+.+++.......+..+.+.||||.|+|
T Consensus 160 l~------------------------~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 160 LT------------------------ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CS------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CC------------------------ccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 55 33333344444444444444444444443333344445556677777764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-24 Score=228.31 Aligned_cols=204 Identities=25% Similarity=0.327 Sum_probs=133.4
Q ss_pred CCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEc
Q 002278 253 QALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNL 332 (943)
Q Consensus 253 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 332 (943)
.+.+.++++++.++. +|..+. ++++.|+|++|++++..+..|..+++|++|++++|+++...+..|..+++|++|+|
T Consensus 16 ~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 16 NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 456777888777774 444333 46777777777777666667777777777777777777555555667777777777
Q ss_pred cccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCc
Q 002278 333 ADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGS 412 (943)
Q Consensus 333 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 412 (943)
++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|.+++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 77777766666666666777777777766666666666666666666666666655455566666666666666666655
Q ss_pred cCCCcccccccceeecccccccccCCccccCCCccceecccCccccc
Q 002278 413 VPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459 (943)
Q Consensus 413 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 459 (943)
.+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 55556666666666666666665555556666666666666666553
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=235.38 Aligned_cols=160 Identities=23% Similarity=0.322 Sum_probs=80.5
Q ss_pred ccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccc
Q 002278 345 ISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLL 424 (943)
Q Consensus 345 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 424 (943)
+..+++|++|++++|.+++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|++++..+..|..+++|+
T Consensus 81 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 160 (272)
T 3rfs_A 81 LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLT 160 (272)
T ss_dssp GTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCC
Confidence 33444444444444444434444444444444444444444444444444445555555555555544444445555555
Q ss_pred eeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCcc
Q 002278 425 TLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNN 504 (943)
Q Consensus 425 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 504 (943)
.|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++.+. +++|+.|+++.|.
T Consensus 161 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~ 233 (272)
T 3rfs_A 161 ELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINK 233 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHH
T ss_pred EEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHh
Confidence 555555555544444455555555555555555544444455555555555555555432 3345566666666
Q ss_pred ccccCCC
Q 002278 505 LSGIIPP 511 (943)
Q Consensus 505 l~~~~~~ 511 (943)
++|.+|.
T Consensus 234 ~~g~ip~ 240 (272)
T 3rfs_A 234 HSGVVRN 240 (272)
T ss_dssp TGGGBBC
T ss_pred CCCcccC
Confidence 6665553
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=233.36 Aligned_cols=205 Identities=22% Similarity=0.243 Sum_probs=186.9
Q ss_pred ccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcC
Q 002278 272 ILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTAL 351 (943)
Q Consensus 272 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 351 (943)
.+.++++++++++++|.++. +|..+. ++|+.|+|++|.+++..+..|..+++|+.|+|++|.|++..+. ..+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred cccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 36788999999999999994 565554 6899999999999988899999999999999999999965443 789999
Q ss_pred cEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccc
Q 002278 352 NQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRN 431 (943)
Q Consensus 352 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 431 (943)
++|++++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 99999999998 67888999999999999999999888889999999999999999999888888999999999999999
Q ss_pred cccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCC
Q 002278 432 HLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG 483 (943)
Q Consensus 432 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 483 (943)
+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++..
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 999877788899999999999999999 789888889999999999999863
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=231.45 Aligned_cols=193 Identities=19% Similarity=0.202 Sum_probs=175.6
Q ss_pred CCCCCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCcc
Q 002278 23 SDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDI 102 (943)
Q Consensus 23 ~~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 102 (943)
.+||.|.|..|... ...+++++++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|++++..
T Consensus 2 ~~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 75 (251)
T 3m19_A 2 KTCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS 75 (251)
T ss_dssp --CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC
T ss_pred ccCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccC
Confidence 37999999999543 236899999999 7887776 68999999999999888889999999999999999999888
Q ss_pred chhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCccccccc
Q 002278 103 PFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLT 182 (943)
Q Consensus 103 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 182 (943)
|..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+++++..|..++
T Consensus 76 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 155 (251)
T 3m19_A 76 AGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155 (251)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred HhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCc
Confidence 88899999999999999999988888999999999999999999988888889999999999999999999998999999
Q ss_pred ccceeeccceecccccCCCCcCCCcccEEEeecccccCc
Q 002278 183 GLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGE 221 (943)
Q Consensus 183 ~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 221 (943)
+|++|+|++|++++..+..|..+++|++|+|++|+++..
T Consensus 156 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999999999999988888999999999999999999754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=228.98 Aligned_cols=209 Identities=23% Similarity=0.285 Sum_probs=143.2
Q ss_pred CCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEE
Q 002278 275 NLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQF 354 (943)
Q Consensus 275 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 354 (943)
.+++|+.|++++|.++.. ..+..+++|++|++++|.+++. ..+..+++|++|+|++|.+++..+..|..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 114 (272)
T 3rfs_A 39 ELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL 114 (272)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred cccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEE
Confidence 344444555555544421 2355556666666666666532 255666666666666666666666666666677777
Q ss_pred EeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeeccccccc
Q 002278 355 NVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLN 434 (943)
Q Consensus 355 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 434 (943)
++++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|+++
T Consensus 115 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 77777776666666777777777777777777666666677777777777777777666666777788888888888888
Q ss_pred ccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccC
Q 002278 435 GLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFS 494 (943)
Q Consensus 435 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 494 (943)
+..|..|..+++|+.|+|++|++.+. +++|+.|++..|+++|.+|..++.++.
T Consensus 195 ~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 195 SVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred ccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 77777778888888888888877754 346778888888888888887776654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-25 Score=259.74 Aligned_cols=185 Identities=16% Similarity=0.187 Sum_probs=146.6
Q ss_pred ccceEEeeeceEEEEEEEecCCceEEEEEecccCcc--------cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 619 SEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPH--------NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 619 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
...+.||+|+||+||+|.. .++.+|+|+....... ..+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4456899999999999954 4778899987543211 134578999999999999999777777778888999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999963 568999999999999999 9999999999999999 999999999998754
Q ss_pred CCCce------eeeEecccceeCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCCC
Q 002278 771 AMPHA------STFVLGTIGYIDPEYAHT--SRLNEKSDVYSFGIVLLEILTGKKAVD 820 (943)
Q Consensus 771 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~p~~ 820 (943)
..... .....||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211 124569999999999987 668888999999999888888777663
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-25 Score=246.88 Aligned_cols=257 Identities=20% Similarity=0.209 Sum_probs=172.7
Q ss_pred EEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCC----CCccCCC-CCcEEeccCCCcCCccchhcccc-----ccc
Q 002278 43 LNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIP----DEIGNCG-SLVHIELSDNSLYGDIPFSISKL-----KQL 112 (943)
Q Consensus 43 L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L 112 (943)
++|+.|++++.+|..+...++|++|||++|+|++..+ +.|..++ +|++|+|++|++++..+..|..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 6788888888888777777779999999998886655 6677888 89999999998887777777775 888
Q ss_pred eEEEecCcccccCCCcccC----CC-CCCcEEEEeccccccccchhccc-----cccceeccccCCccCCCCCccc----
Q 002278 113 EFLNLKNNQLTGPIPSTLT----QI-PNLKTLDLARNQLTGEIPRLIYW-----NEVLQYLGLRGNALTGMLSPDM---- 178 (943)
Q Consensus 113 ~~L~Ls~n~l~~~~~~~~~----~l-~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~~~~~---- 178 (943)
++|+|++|++++..+..+. .+ ++|++|+|++|+|++..+..+.. .++|++|+|++|.+++.....+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 8888888888876665443 34 78888888888888666655443 2577777777777775433332
Q ss_pred cccc-ccceeeccceecccccCCCC----cCC-CcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccc-
Q 002278 179 CQLT-GLWYFDVRGNNLTGTIPDSI----GNC-TSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGL- 251 (943)
Q Consensus 179 ~~l~-~L~~L~L~~N~i~~~~~~~l----~~l-~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~- 251 (943)
..++ +|++|+|++|++++..+..+ ..+ ++|++|+|++|+|++... ..++..+..
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~-------------------~~l~~~l~~~ 223 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSY-------------------AELAYIFSSI 223 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH-------------------HHHHHHHHHS
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHH-------------------HHHHHHHhcC
Confidence 2333 66666666666665444322 233 466666666666552100 023444544
Q ss_pred cCCCcEEecCCCCCCCCCC----cccCCCCCcceEEecCCCCCCCC-------CCCcCCCCcCcEEEcccCccccccc
Q 002278 252 MQALAVLDLSENELVGPIP----PILGNLSYTGKLYLHGNKLTGPI-------PPELGNMSKLSYLQLQNNQLVGTIP 318 (943)
Q Consensus 252 l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~~-------~~~~~~l~~L~~L~L~~N~l~~~~~ 318 (943)
.++|+.|+|++|.+.+..+ ..+..+++|+.|+|++|.+.+.. +..+..+++|+.||+++|++....+
T Consensus 224 ~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp CTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred CCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 3478888888888876544 33456677777777777754332 2345666777777777777765433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=219.59 Aligned_cols=196 Identities=15% Similarity=0.216 Sum_probs=104.6
Q ss_pred cCcEEEcccCccccccccccCCcccceEEEccccc-cCCcCcccccCCCcCcEEEeeC-CcccCcccccccccCccceee
Q 002278 302 KLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNN-LEGPIPHNISSCTALNQFNVHG-NRLSGAIPSSFRNLGSLTYLN 379 (943)
Q Consensus 302 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ 379 (943)
+|++|++++|++++..+..|.++++|++|++++|+ ++++.+..|.++++|++|++++ |+++++.+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555554444455555555555555554 5444444555555555555555 555544445555555555555
Q ss_pred ccCCcCCCCCCCCCCCCCCcc---EEecCCC-cCCCccCCCcccccccc-eeecccccccccCCccccCCCccceecccC
Q 002278 380 LSRNNFKGKVPTELGRIINLD---TLDLSVN-NFSGSVPASIGDLEHLL-TLNLSRNHLNGLLPAEFGNLRSIQTIDMSF 454 (943)
Q Consensus 380 L~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (943)
+++|++++ +|. +..+.+|+ .|++++| .+++..+..|.++++|+ .|++++|+++.+.+..|.. ++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 55555553 333 45555555 5666666 55544444555566666 6666666665333333433 5666666666
Q ss_pred cc-ccccCChhhhcc-cccceecccCcccCCCCCCcCccccCCcccccCCc
Q 002278 455 NQ-LSGSIPAELGQL-QNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYN 503 (943)
Q Consensus 455 N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 503 (943)
|+ +++..+..|..+ ++|+.|+|++|++++. |.. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 63 654444555556 6666666666666533 322 3445555555544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=218.56 Aligned_cols=206 Identities=18% Similarity=0.195 Sum_probs=137.1
Q ss_pred ccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCC-cCCccchhccccccceEEEecC-cccccCCCccc
Q 002278 53 EISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNS-LYGDIPFSISKLKQLEFLNLKN-NQLTGPIPSTL 130 (943)
Q Consensus 53 ~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-n~l~~~~~~~~ 130 (943)
.+|. +. ++|++|+|++|+|++..+..|.++++|++|+|++|+ ++...+.+|+++++|++|+|++ |++++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 5666 43 389999999999997777789999999999999997 8855566899999999999998 89987777888
Q ss_pred CCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccce-ecccccCCCCcCCCccc
Q 002278 131 TQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGN-NLTGTIPDSIGNCTSFE 209 (943)
Q Consensus 131 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~~~~l~~l~~L~ 209 (943)
..+++|++|+|++|++++ +|. |..+.+|+ .|++|++++| ++++..+..|.++++|+
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~---------------------~L~~L~l~~N~~l~~i~~~~~~~l~~L~ 158 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTD---------------------IFFILEITDNPYMTSIPVNAFQGLCNET 158 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCC---------------------SEEEEEEESCTTCCEECTTTTTTTBSSE
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccc---------------------cccEEECCCCcchhhcCcccccchhcce
Confidence 999999999999998885 443 44444443 1225555555 55544455566666666
Q ss_pred -EEEeecccccCcCCCCCCcceEeEEEecCcc-ccccCCcccccc-CCCcEEecCCCCCCCCCCcccCCCCCcceEEecC
Q 002278 210 -ILDISYNQITGEIPYNIGFLQVATLSLQGNK-LTGKIPEVIGLM-QALAVLDLSENELVGPIPPILGNLSYTGKLYLHG 286 (943)
Q Consensus 210 -~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~-l~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 286 (943)
+|++++|+++...+..+...+|+.|++++|+ ++...+..|..+ ++|+.|++++|++++..+. .+++|+.|++++
T Consensus 159 ~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~ 235 (239)
T 2xwt_C 159 LTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARN 235 (239)
T ss_dssp EEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTT
T ss_pred eEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccC
Confidence 6666666666322222333445555555552 554445555666 6666666666666643222 344455555544
Q ss_pred C
Q 002278 287 N 287 (943)
Q Consensus 287 n 287 (943)
+
T Consensus 236 ~ 236 (239)
T 2xwt_C 236 T 236 (239)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=217.90 Aligned_cols=178 Identities=22% Similarity=0.291 Sum_probs=92.7
Q ss_pred cCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeecc
Q 002278 302 KLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLS 381 (943)
Q Consensus 302 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 381 (943)
..+.++++++.++ .+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3556666666665 3444333 355666666666665555555555555555555555555555555555555555555
Q ss_pred CCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccC
Q 002278 382 RNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSI 461 (943)
Q Consensus 382 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 461 (943)
+|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 55555444444555555555555555555444444444555555555555555444444444555555555555554433
Q ss_pred ChhhhcccccceecccCcccC
Q 002278 462 PAELGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 462 p~~~~~l~~L~~L~L~~N~l~ 482 (943)
+..|..+++|+.|+|++|+++
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBC
T ss_pred HHHHhCCCCCCEEEeeCCcee
Confidence 334444444444444444444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-25 Score=246.52 Aligned_cols=270 Identities=20% Similarity=0.217 Sum_probs=170.4
Q ss_pred CCCCCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCC--CCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCC
Q 002278 23 SDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDL--RNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYG 100 (943)
Q Consensus 23 ~~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l--~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 100 (943)
..|.+|+++.|+.. .++.+|++++++.+ ..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++
T Consensus 34 ~vc~~W~~~~~~~~--~~~~l~l~~~~~~~---~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 34 GVCKRWYRLASDES--LWQTLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp SSCHHHHHHHTCST--TSSEEECTTCBCCH---HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred HHHHHHHHHhcCch--hheeeccccccCCH---HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence 46668999988643 46689999988873 446666 7899999999999976655 5678999999999999886
Q ss_pred c-cchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEecc-cccc-ccchhccccccceeccccCC-ccCCCCCc
Q 002278 101 D-IPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARN-QLTG-EIPRLIYWNEVLQYLGLRGN-ALTGMLSP 176 (943)
Q Consensus 101 ~-~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~-~~~~~~~~l~~L~~L~L~~n-~l~~~~~~ 176 (943)
. +|..+..+++|++|+|++|.+++..+..+..+++|++|+|++| .+++ .++..+..+++|++|++++| .+++..
T Consensus 108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~-- 185 (336)
T 2ast_B 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKH-- 185 (336)
T ss_dssp HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHH--
T ss_pred HHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHH--
Confidence 5 7788889999999999999988888888889999999999999 6764 25666666777777777776 665320
Q ss_pred ccccccccceeeccceecccccCCCCcCCC-cccEEEeeccc--ccCcCCCCCCcceEeEEEecCccccccCCccccccC
Q 002278 177 DMCQLTGLWYFDVRGNNLTGTIPDSIGNCT-SFEILDISYNQ--ITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQ 253 (943)
Q Consensus 177 ~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~-~L~~L~Ls~N~--l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~ 253 (943)
++..+..++ +|++|++++|. ++. +.++..+..++
T Consensus 186 ---------------------~~~~~~~l~~~L~~L~l~~~~~~~~~----------------------~~l~~~~~~~~ 222 (336)
T 2ast_B 186 ---------------------VQVAVAHVSETITQLNLSGYRKNLQK----------------------SDLSTLVRRCP 222 (336)
T ss_dssp ---------------------HHHHHHHSCTTCCEEECCSCGGGSCH----------------------HHHHHHHHHCT
T ss_pred ---------------------HHHHHHhcccCCCEEEeCCCcccCCH----------------------HHHHHHHhhCC
Confidence 222334444 55555555542 210 01223333444
Q ss_pred CCcEEecCCCC-CCCCCCcccCCCCCcceEEecCCC-CCCCCCCCcCCCCcCcEEEcccCccccccccccCCc-ccceEE
Q 002278 254 ALAVLDLSENE-LVGPIPPILGNLSYTGKLYLHGNK-LTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKL-EQLFEL 330 (943)
Q Consensus 254 ~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L 330 (943)
+|+.|++++|. +++..+..+..+++|+.|++++|. ++......+..+++|+.|++++| ++ ...+..+ .+|..|
T Consensus 223 ~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L 298 (336)
T 2ast_B 223 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHL 298 (336)
T ss_dssp TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTS
T ss_pred CCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcce
Confidence 44444444444 333334444444555555555553 11111113455566666666666 22 1223333 235555
Q ss_pred EccccccCCcCcccccC
Q 002278 331 NLADNNLEGPIPHNISS 347 (943)
Q Consensus 331 ~L~~N~l~~~~p~~~~~ 347 (943)
++++|++++..|..+..
T Consensus 299 ~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 299 QINCSHFTTIARPTIGN 315 (336)
T ss_dssp EESCCCSCCTTCSSCSS
T ss_pred EEecccCccccCCcccc
Confidence 56666666666655543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-25 Score=247.01 Aligned_cols=176 Identities=22% Similarity=0.233 Sum_probs=76.4
Q ss_pred EEeecccccCcCCCCCCcce-EeEEEecCccccccCC----ccccccC-CCcEEecCCCCCCCCCCcccCCC-----CCc
Q 002278 211 LDISYNQITGEIPYNIGFLQ-VATLSLQGNKLTGKIP----EVIGLMQ-ALAVLDLSENELVGPIPPILGNL-----SYT 279 (943)
Q Consensus 211 L~Ls~N~l~~~~~~~~~~~~-L~~L~L~~n~l~~~~~----~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~l-----~~L 279 (943)
+++++|.+++.+|......+ |++|+|++|.+++..+ +.+..++ +|++|+|++|.+.+..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 44555555554444443333 5555555555544433 4444444 45555555555544444434332 445
Q ss_pred ceEEecCCCCCCCCCCCcCC----C-CcCcEEEcccCccccccccccCC-----cccceEEEccccccCCcCc----ccc
Q 002278 280 GKLYLHGNKLTGPIPPELGN----M-SKLSYLQLQNNQLVGTIPAELGK-----LEQLFELNLADNNLEGPIP----HNI 345 (943)
Q Consensus 280 ~~L~L~~n~l~~~~~~~~~~----l-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~p----~~~ 345 (943)
++|+|++|.+++..+..+.. + ++|++|+|++|++++..+..+.. .++|++|+|++|+++...+ ..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 55555555544433332222 2 44555555555544333322221 1344555555554443222 122
Q ss_pred cCCC-cCcEEEeeCCcccCcccccccc----c-CccceeeccCCcCC
Q 002278 346 SSCT-ALNQFNVHGNRLSGAIPSSFRN----L-GSLTYLNLSRNNFK 386 (943)
Q Consensus 346 ~~l~-~L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~L~~N~l~ 386 (943)
..++ +|++|+|++|+|++..+..+.. + ++|+.|+|++|.++
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~ 209 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLG 209 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCC
Confidence 2232 4444444444444333332222 1 34444444444444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=227.44 Aligned_cols=200 Identities=20% Similarity=0.226 Sum_probs=106.0
Q ss_pred cCCCcEEecCCCCCCCCCCccc--CCCCCcceEEecCCCCCCCCC----CCcCCCCcCcEEEcccCccccccccccCCcc
Q 002278 252 MQALAVLDLSENELVGPIPPIL--GNLSYTGKLYLHGNKLTGPIP----PELGNMSKLSYLQLQNNQLVGTIPAELGKLE 325 (943)
Q Consensus 252 l~~L~~L~Ls~N~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 325 (943)
+++|++|++++|.+.+..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++.+..+..|..++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 4557777777777776666665 666777777777777665433 2234566666666666666655556666666
Q ss_pred cceEEEccccccCCc--C--cccccCCCcCcEEEeeCCcccCcccc----cccccCccceeeccCCcCCCCCCCCCCCC-
Q 002278 326 QLFELNLADNNLEGP--I--PHNISSCTALNQFNVHGNRLSGAIPS----SFRNLGSLTYLNLSRNNFKGKVPTELGRI- 396 (943)
Q Consensus 326 ~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l- 396 (943)
+|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++. .+..+++|++|+|++|++++..|..+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 666666666665431 1 1223455556666666665542 121 23445555555555555554444444443
Q ss_pred --CCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccc
Q 002278 397 --INLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457 (943)
Q Consensus 397 --~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 457 (943)
++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|
T Consensus 249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l 306 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPF 306 (310)
T ss_dssp CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTT
T ss_pred CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCC
Confidence 34445555555444 3333332 3444444444444432 11 33344444444444444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=227.62 Aligned_cols=199 Identities=19% Similarity=0.193 Sum_probs=115.3
Q ss_pred CcEEEcccCcccccccccc--CCcccceEEEccccccCCcCc----ccccCCCcCcEEEeeCCcccCcccccccccCccc
Q 002278 303 LSYLQLQNNQLVGTIPAEL--GKLEQLFELNLADNNLEGPIP----HNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLT 376 (943)
Q Consensus 303 L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 376 (943)
|++|++++|.+.+..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|++.+..+..|..+++|+
T Consensus 93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 172 (310)
T 4glp_A 93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT 172 (310)
T ss_dssp CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence 4444444444444444443 444444444444444443222 2233455555555555555555555555566666
Q ss_pred eeeccCCcCCCC----CCCCCCCCCCccEEecCCCcCCCccCC----CcccccccceeecccccccccCCccccCC---C
Q 002278 377 YLNLSRNNFKGK----VPTELGRIINLDTLDLSVNNFSGSVPA----SIGDLEHLLTLNLSRNHLNGLLPAEFGNL---R 445 (943)
Q Consensus 377 ~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~ 445 (943)
+|+|++|++.+. .+..+..+++|++|+|++|+++. ++. .+..+++|++|+|++|++++..|..+..+ +
T Consensus 173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~ 251 (310)
T 4glp_A 173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSS 251 (310)
T ss_dssp EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCT
T ss_pred EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcC
Confidence 666666655421 12223556666666666666652 222 24566777777777777776666666665 5
Q ss_pred ccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccc
Q 002278 446 SIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSG 507 (943)
Q Consensus 446 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 507 (943)
+|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 252 ~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 252 ALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp TCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 7777777777777 5666553 6777777777777743 33 5667777777777777753
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=225.40 Aligned_cols=244 Identities=22% Similarity=0.179 Sum_probs=159.2
Q ss_pred CCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccc-h
Q 002278 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIP-F 104 (943)
Q Consensus 26 c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~ 104 (943)
|+|+.|.|++ ++++ .+|..+ .+++++|+|++|+|+...+++|.++++|++|+|++|++.+.+| .
T Consensus 9 C~~~~v~C~~------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~ 73 (350)
T 4ay9_X 9 CSNRVFLCQE------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73 (350)
T ss_dssp EETTEEEEES------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred eeCCEEEecC------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence 6788888864 4455 677766 3689999999999995555679999999999999999876665 4
Q ss_pred hccccccceE-EEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccc
Q 002278 105 SISKLKQLEF-LNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTG 183 (943)
Q Consensus 105 ~~~~l~~L~~-L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 183 (943)
+|.++++|++ +.+++|+++...|..|..+++|++|++++|+|+...+..+....++..|++.+
T Consensus 74 ~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~---------------- 137 (350)
T 4ay9_X 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD---------------- 137 (350)
T ss_dssp SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEES----------------
T ss_pred HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcc----------------
Confidence 6888888765 66677889888888899999999999999988865554444444444444432
Q ss_pred cceeeccceecccccCCCCcCCC-cccEEEeecccccCcCCCCCCcceEeEEEecC-ccccccCCccccccCCCcEEecC
Q 002278 184 LWYFDVRGNNLTGTIPDSIGNCT-SFEILDISYNQITGEIPYNIGFLQVATLSLQG-NKLTGKIPEVIGLMQALAVLDLS 261 (943)
Q Consensus 184 L~~L~L~~N~i~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~Ls 261 (943)
.|++....+..|..+. .+++|+|++|+|+...+..+...+++.|++.+ |.++.+.++.|..+++|++|||+
T Consensus 138 -------~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs 210 (350)
T 4ay9_X 138 -------NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210 (350)
T ss_dssp -------CTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECT
T ss_pred -------ccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcC
Confidence 1334433344455543 46677777777765444555555666666653 45554445566777777777777
Q ss_pred CCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccC
Q 002278 262 ENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNN 311 (943)
Q Consensus 262 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 311 (943)
+|+|+...+..|.++.+|+.+++ +.++ .+| .+..+++|+.+++.++
T Consensus 211 ~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 211 RTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp TSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred CCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCC
Confidence 77777554444444333332222 2222 333 3555556666665543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=223.54 Aligned_cols=240 Identities=18% Similarity=0.152 Sum_probs=132.4
Q ss_pred cEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccc-cccCCcccceE-EEcc
Q 002278 256 AVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIP-AELGKLEQLFE-LNLA 333 (943)
Q Consensus 256 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~-L~L~ 333 (943)
++++.++++++ .+|..+ .+++++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| .+|.++++|.+ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 34555555555 334333 2355666666666665444556666666666666666544333 34556655443 4445
Q ss_pred ccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccC-CcCCCCCCCCCCCCC-CccEEecCCCcCCC
Q 002278 334 DNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSR-NNFKGKVPTELGRII-NLDTLDLSVNNFSG 411 (943)
Q Consensus 334 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~ 411 (943)
.|+|+.+.|..|..+++|++|++++|+|++..+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 5666655566666666666666666666655555555555566666643 445544444455443 45666666666663
Q ss_pred ccCCCcccccccceeeccc-ccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCc
Q 002278 412 SVPASIGDLEHLLTLNLSR-NHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLS 490 (943)
Q Consensus 412 ~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 490 (943)
+|.......+|+.|++++ |.++.+.+..|.++++|++|||++|+|+...+..|.+|++|+.+++ ++++ .+| .+.
T Consensus 169 -i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~ 243 (350)
T 4ay9_X 169 -IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLE 243 (350)
T ss_dssp -ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTT
T ss_pred -CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cch
Confidence 343333445666666653 5555444455666666666666666666333334444444444333 2333 444 255
Q ss_pred cccCCcccccCCc
Q 002278 491 NCFSLSNLNVSYN 503 (943)
Q Consensus 491 ~l~~L~~L~ls~N 503 (943)
++++|+.++++++
T Consensus 244 ~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 244 KLVALMEASLTYP 256 (350)
T ss_dssp TCCSCCEEECSCH
T ss_pred hCcChhhCcCCCC
Confidence 6666666666654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=6.7e-23 Score=222.80 Aligned_cols=194 Identities=24% Similarity=0.404 Sum_probs=97.8
Q ss_pred CCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcE
Q 002278 274 GNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQ 353 (943)
Q Consensus 274 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 353 (943)
..+++|++|++++|.++. ++ .+..+++|++|++++|++++..+ +..+++|++|+|++|++++. ..+..+++|+.
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence 345556666666666553 22 45555666666666666553332 55555555555555555532 23445555555
Q ss_pred EEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccc
Q 002278 354 FNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHL 433 (943)
Q Consensus 354 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 433 (943)
|++++|++++.. .+..+++ |+.|++++|.+++..+ +..+++|+.|+|++|++
T Consensus 112 L~l~~n~l~~~~--~l~~l~~------------------------L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l 163 (308)
T 1h6u_A 112 LDLTSTQITDVT--PLAGLSN------------------------LQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV 163 (308)
T ss_dssp EECTTSCCCCCG--GGTTCTT------------------------CCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred EECCCCCCCCch--hhcCCCC------------------------CCEEECCCCccCcCcc--ccCCCCccEEEccCCcC
Confidence 555555554321 1444444 4455555554443222 44455555555555555
Q ss_pred cccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccc
Q 002278 434 NGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSG 507 (943)
Q Consensus 434 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 507 (943)
++..+ +..+++|+.|+|++|++++. +. +..+++|+.|+|++|++++..| +..+++|+.|++++|++++
T Consensus 164 ~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 164 SDLTP--LANLSKLTTLKADDNKISDI-SP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CCChh--hcCCCCCCEEECCCCccCcC-hh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 43222 45555555555555555432 22 4555555555555555553332 4555555555555555554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-25 Score=251.79 Aligned_cols=249 Identities=17% Similarity=0.183 Sum_probs=143.0
Q ss_pred cCCccccccCCCcEEecCCCCCCCCCC----cccCCCCCcceEEecCCCCC---CCCCCCcCCCCcCcEEEcccCccccc
Q 002278 244 KIPEVIGLMQALAVLDLSENELVGPIP----PILGNLSYTGKLYLHGNKLT---GPIPPELGNMSKLSYLQLQNNQLVGT 316 (943)
Q Consensus 244 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~ 316 (943)
.++..+..+++|+.|+|++|.+.+..+ ..|..+++|+.|+|++|.+. +.+|..+. .
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~-----------------~ 85 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR-----------------L 85 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH-----------------H
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHH-----------------H
Confidence 345566666777777777776664322 22445555555555554322 22222220 0
Q ss_pred cccccCCcccceEEEccccccCC----cCcccccCCCcCcEEEeeCCcccCcccccc----ccc---------Cccceee
Q 002278 317 IPAELGKLEQLFELNLADNNLEG----PIPHNISSCTALNQFNVHGNRLSGAIPSSF----RNL---------GSLTYLN 379 (943)
Q Consensus 317 ~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l---------~~L~~L~ 379 (943)
+...+..+++|++|+|++|.+.. .+|..+..+++|++|+|++|.|+...+..+ ..+ ++|++|+
T Consensus 86 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~ 165 (386)
T 2ca6_A 86 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165 (386)
T ss_dssp HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred HHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEE
Confidence 00112445555555555555554 244455555555556665555543322222 222 5666666
Q ss_pred ccCCcCC-CCCC---CCCCCCCCccEEecCCCcCC--C---ccCCCcccccccceeeccccccc----ccCCccccCCCc
Q 002278 380 LSRNNFK-GKVP---TELGRIINLDTLDLSVNNFS--G---SVPASIGDLEHLLTLNLSRNHLN----GLLPAEFGNLRS 446 (943)
Q Consensus 380 L~~N~l~-~~~~---~~~~~l~~L~~L~Ls~N~l~--~---~~~~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~ 446 (943)
|++|+++ +.++ ..+..+++|+.|+|++|.|+ + ..|..+..+++|+.|+|++|.++ +.+|..+..+++
T Consensus 166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~ 245 (386)
T 2ca6_A 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245 (386)
T ss_dssp CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence 6666665 2222 24445566777777777665 2 34446667777777777777775 456666777777
Q ss_pred cceecccCcccccc----CChhhhc--ccccceecccCcccCC----CCCCcC-ccccCCcccccCCccccccC
Q 002278 447 IQTIDMSFNQLSGS----IPAELGQ--LQNIISLILNNNNLQG----GIPDQL-SNCFSLSNLNVSYNNLSGII 509 (943)
Q Consensus 447 L~~L~Ls~N~l~~~----~p~~~~~--l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~ls~N~l~~~~ 509 (943)
|+.|+|++|+|++. +|..+.. +++|+.|+|++|++++ .+|..+ .++++|+.|++++|++++..
T Consensus 246 L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred cCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 77777777777654 4555533 7777777777777775 366665 45777888888877776553
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.2e-25 Score=248.20 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=156.1
Q ss_pred cceEeEEEecCccccccCC----ccccccCCCcEEecCCCCCC---CCCCccc-------CCCCCcceEEecCCCCCC--
Q 002278 228 FLQVATLSLQGNKLTGKIP----EVIGLMQALAVLDLSENELV---GPIPPIL-------GNLSYTGKLYLHGNKLTG-- 291 (943)
Q Consensus 228 ~~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~Ls~N~l~---~~~~~~~-------~~l~~L~~L~L~~n~l~~-- 291 (943)
..+|+.|+|++|.+....+ ..+..+++|++|+|++|.+. +.+|..+ ..+++|++|+|++|.++.
T Consensus 31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 110 (386)
T 2ca6_A 31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 110 (386)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHH
Confidence 4579999999999987644 44778999999999997554 3445444 566667777777776665
Q ss_pred --CCCCCcCCCCcCcEEEcccCccccccccccCCc-ccceEEEccccccCCcCcccccCCCcCcEEEeeCCccc-Cccc-
Q 002278 292 --PIPPELGNMSKLSYLQLQNNQLVGTIPAELGKL-EQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLS-GAIP- 366 (943)
Q Consensus 292 --~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~- 366 (943)
.+|..+..+++|++|+|++|.++...+..+... ..+ ..|++.+ ..++|++|++++|+++ +.++
T Consensus 111 ~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l-----~~~~~~~-------~~~~L~~L~L~~n~l~~~~~~~ 178 (386)
T 2ca6_A 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL-----AVNKKAK-------NAPPLRSIICGRNRLENGSMKE 178 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHH-----HHHHHHH-------TCCCCCEEECCSSCCTGGGHHH
T ss_pred HHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHH-----hhhhhcc-------cCCCCcEEECCCCCCCcHHHHH
Confidence 244455566666666666666653333322221 000 0000000 0045555555555554 2222
Q ss_pred --ccccccCccceeeccCCcCCC-----CCCCCCCCCCCccEEecCCCcCC----CccCCCcccccccceeecccccccc
Q 002278 367 --SSFRNLGSLTYLNLSRNNFKG-----KVPTELGRIINLDTLDLSVNNFS----GSVPASIGDLEHLLTLNLSRNHLNG 435 (943)
Q Consensus 367 --~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~ 435 (943)
..+..+++|+.|+|++|+++. ..+..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++
T Consensus 179 l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~ 258 (386)
T 2ca6_A 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 258 (386)
T ss_dssp HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred HHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCch
Confidence 345556666666666666651 23335666677777777777774 3566677777788888888888775
Q ss_pred c----CCccc--cCCCccceecccCccccc----cCChhh-hcccccceecccCcccCCCCC
Q 002278 436 L----LPAEF--GNLRSIQTIDMSFNQLSG----SIPAEL-GQLQNIISLILNNNNLQGGIP 486 (943)
Q Consensus 436 ~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~~p 486 (943)
. ++..+ +.+++|+.|+|++|++++ .+|..+ .++++|+.|+|++|++++..|
T Consensus 259 ~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 259 RGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred hhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 4 45555 347888888888888886 477776 667888888888888886553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-24 Score=237.42 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=168.3
Q ss_pred CcEEecCCCCCCCCCCcccCCC--CCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccc-cccccCCcccceEEE
Q 002278 255 LAVLDLSENELVGPIPPILGNL--SYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT-IPAELGKLEQLFELN 331 (943)
Q Consensus 255 L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ 331 (943)
++.+++++|.+. +..+..+ ++++.|++++|.+++..+. +..+++|++|++++|.+++. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 445555555443 3334444 5555566666665544433 44567777777777776644 566667777777777
Q ss_pred ccccccCCcCcccccCCCcCcEEEeeCC-cccC-cccccccccCccceeeccCC-cCCCC-CCCCCCCCC-CccEEecCC
Q 002278 332 LADNNLEGPIPHNISSCTALNQFNVHGN-RLSG-AIPSSFRNLGSLTYLNLSRN-NFKGK-VPTELGRII-NLDTLDLSV 406 (943)
Q Consensus 332 L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~-~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~Ls~ 406 (943)
|++|.+++..+..+..+++|++|++++| .+++ .++..+..+++|++|++++| .+++. ++..+..++ +|+.|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 7777777666667777777777777777 5654 25555677777777777777 77643 455566677 788888888
Q ss_pred C--cCC-CccCCCcccccccceeeccccc-ccccCCccccCCCccceecccCcc-ccccCChhhhcccccceecccCccc
Q 002278 407 N--NFS-GSVPASIGDLEHLLTLNLSRNH-LNGLLPAEFGNLRSIQTIDMSFNQ-LSGSIPAELGQLQNIISLILNNNNL 481 (943)
Q Consensus 407 N--~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l 481 (943)
| .++ +.+|..+..+++|+.|+|++|. +++..+..+..+++|++|++++|. ++......+..+++|+.|++++| +
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i 283 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V 283 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c
Confidence 7 444 3456667778888888888888 666777788888888888888885 32222235788888999999888 3
Q ss_pred CCCCCCcCccc-cCCcccccCCccccccCCC
Q 002278 482 QGGIPDQLSNC-FSLSNLNVSYNNLSGIIPP 511 (943)
Q Consensus 482 ~~~~p~~~~~l-~~L~~L~ls~N~l~~~~~~ 511 (943)
+ ...+..+ ..|..|++++|++++..|.
T Consensus 284 ~---~~~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 284 P---DGTLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp C---TTCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred C---HHHHHHHHhhCcceEEecccCccccCC
Confidence 3 2234444 3478888999999988775
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=5.4e-22 Score=215.65 Aligned_cols=194 Identities=20% Similarity=0.338 Sum_probs=145.8
Q ss_pred ccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccce
Q 002278 249 IGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLF 328 (943)
Q Consensus 249 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 328 (943)
+..+++|+.|++++|.+.. ++ .+..+++|+.|+|++|.+++..+ +..+++|++|++++|++++. ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence 3457788888888888875 33 57778888888888888886544 88888888999998888753 3688888999
Q ss_pred EEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCc
Q 002278 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNN 408 (943)
Q Consensus 329 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 408 (943)
+|+|++|++++.. .+..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|.
T Consensus 111 ~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence 9999999988643 38888999999999999886544 7788888888888888875333 7777777777777777
Q ss_pred CCCccCCCcccccccceeecccccccccCCccccCCCccceecccCcccc
Q 002278 409 FSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS 458 (943)
Q Consensus 409 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 458 (943)
+++..+ +..+++|+.|+|++|++++.. .+..+++|+.|+|++|+++
T Consensus 185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 185 ISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred cCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 775433 666777777777777776543 2666667777777777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=216.12 Aligned_cols=152 Identities=16% Similarity=0.164 Sum_probs=122.2
Q ss_pred HHHHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCc------------------ccHHHHHHHHHHHhcCCC
Q 002278 610 DIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYP------------------HNLREFETELETIGSIRH 671 (943)
Q Consensus 610 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 671 (943)
.+......|...+.||+|+||.||+|.+.+++.||+|.+..... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34445566777899999999999999997789999999864321 12456889999999999
Q ss_pred CCcceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE
Q 002278 672 RNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI 751 (943)
Q Consensus 672 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 751 (943)
| +++.+++.. +..++||||++||+|.+ +.. .....++.|++.||+|||+. +|+||||||+|||+
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence 4 666665543 56799999999999998 531 12447999999999999999 99999999999999
Q ss_pred CCCCceeecccccccccCCCCCceeeeEecccceeCcccccc
Q 002278 752 DENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793 (943)
Q Consensus 752 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 793 (943)
+ ++.+||+|||+|+ .+..|+|||++.+
T Consensus 227 ~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence 9 9999999999986 3455788998753
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.8e-23 Score=239.97 Aligned_cols=221 Identities=25% Similarity=0.343 Sum_probs=134.7
Q ss_pred CccccCCCCCCCCCCCCC-----Cccee-EecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCc
Q 002278 9 NLANVLLDWDDVHNSDFC-----SWRGV-FCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEI 82 (943)
Q Consensus 9 ~~~~~~~~w~~~~~~~~c-----~w~gv-~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~ 82 (943)
+.-..+.+|.. +.++| .|.|+ .|... +++.|+|++|++++ +|..+. ++|++|+|++|+|+ .+|
T Consensus 28 ~~~~~l~~W~~--~~~~~~~~~~~~~~l~~C~~~--~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip--- 96 (571)
T 3cvr_A 28 DYFSAWDKWEK--QALPGENRNEAVSLLKECLIN--QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP--- 96 (571)
T ss_dssp HHHHHHHHHHT--TCCTTCCHHHHHHHHHHHHHT--TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---
T ss_pred hHHHHHHHHhc--cCCccccccchhhhccccccC--CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---
Confidence 33346778864 46778 79999 78642 56778888888875 776663 67888888888887 566
Q ss_pred cCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhcccccccee
Q 002278 83 GNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQY 162 (943)
Q Consensus 83 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 162 (943)
..+++|++|+|++|+|++ +|. |.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|.
T Consensus 97 ~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---------- 157 (571)
T 3cvr_A 97 ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---------- 157 (571)
T ss_dssp CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC----------
T ss_pred cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC----------
Confidence 446778888888887775 565 554 77777777777775 444 46667777777776664 332
Q ss_pred ccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCcccc
Q 002278 163 LGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLT 242 (943)
Q Consensus 163 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~ 242 (943)
.+++|++|+|++|+|++ +|. |. ++|++|+|++|+|+ .+|. +.. +|
T Consensus 158 -----------------~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~-~L----------- 202 (571)
T 3cvr_A 158 -----------------LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV-RN----------- 202 (571)
T ss_dssp -----------------CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC---------------
T ss_pred -----------------cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH-hh-----------
Confidence 23455555555555554 343 44 66777777777766 3443 221 22
Q ss_pred ccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCC
Q 002278 243 GKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMS 301 (943)
Q Consensus 243 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 301 (943)
+.....|+.|+|++|.|+ .+|..+..+++|+.|+|++|.+++.+|..|..+.
T Consensus 203 ------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 203 ------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp -----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred ------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 011223455555555555 3444455566666666666666655555554443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.2e-21 Score=195.34 Aligned_cols=161 Identities=26% Similarity=0.286 Sum_probs=89.0
Q ss_pred cceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecC
Q 002278 326 QLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLS 405 (943)
Q Consensus 326 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 405 (943)
+|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44555555555554444444555555555555555554444445555555555555555554444445555556666666
Q ss_pred CCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCC
Q 002278 406 VNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGI 485 (943)
Q Consensus 406 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 485 (943)
+|+|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.+. +++|+.|+++.|+++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCcee
Confidence 6665554444455566666666666666655555556666666666666655532 335566666666666666
Q ss_pred CCcCcccc
Q 002278 486 PDQLSNCF 493 (943)
Q Consensus 486 p~~~~~l~ 493 (943)
|..++.++
T Consensus 182 p~~~~~l~ 189 (208)
T 2o6s_A 182 RNSAGSVA 189 (208)
T ss_dssp BCTTSSBC
T ss_pred eccCcccc
Confidence 65555443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.4e-21 Score=224.40 Aligned_cols=188 Identities=27% Similarity=0.359 Sum_probs=114.4
Q ss_pred CCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEcc
Q 002278 254 ALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLA 333 (943)
Q Consensus 254 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 333 (943)
+|+.|+|++|.+++ +|..+ .++|+.|+|++|+|+ .+| ..+++|++|++++|+|++ +|. +.. +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78888888888876 45444 266778888888777 445 345777777777777775 554 544 67777777
Q ss_pred ccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCcc
Q 002278 334 DNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSV 413 (943)
Q Consensus 334 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 413 (943)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|++++ +|. +. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 777775 333 45667777777777664 333 35666666666666664 444 44 56666666666666 44
Q ss_pred CCCccccccc-------ceeecccccccccCCccccCCCccceecccCccccccCChhhhccc
Q 002278 414 PASIGDLEHL-------LTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQ 469 (943)
Q Consensus 414 ~~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 469 (943)
|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..|..+.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 44 433 44 55555555555 3444444455555555555555555555554443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=9e-21 Score=193.55 Aligned_cols=162 Identities=22% Similarity=0.268 Sum_probs=89.0
Q ss_pred cCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeecc
Q 002278 302 KLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLS 381 (943)
Q Consensus 302 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 381 (943)
+|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44444444444444444444445555555555555554444444555555555555555554444445555555555555
Q ss_pred CCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccC
Q 002278 382 RNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSI 461 (943)
Q Consensus 382 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 461 (943)
+|++++..+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|.+.+ .+++|+.|+++.|+++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCcee
Confidence 555554444445556666666666666665444445666666666666665543 2345666666666666666
Q ss_pred Chhhhcccc
Q 002278 462 PAELGQLQN 470 (943)
Q Consensus 462 p~~~~~l~~ 470 (943)
|..++.++.
T Consensus 182 p~~~~~l~~ 190 (208)
T 2o6s_A 182 RNSAGSVAP 190 (208)
T ss_dssp BCTTSSBCT
T ss_pred eccCccccC
Confidence 666655543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-20 Score=194.83 Aligned_cols=158 Identities=27% Similarity=0.246 Sum_probs=128.6
Q ss_pred CCCCCCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCc
Q 002278 22 NSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGD 101 (943)
Q Consensus 22 ~~~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 101 (943)
+++.|+|.+|.|.+.. ++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+..
T Consensus 15 ~~~~Cs~~~v~c~~~~------------l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i 79 (229)
T 3e6j_A 15 SQCSCSGTTVDCRSKR------------HA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL 79 (229)
T ss_dssp TTCEEETTEEECTTSC------------CS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCEEeCCEeEccCCC------------cC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc
Confidence 5799999999997543 33 5666554 8899999999999988889999999999999999999866
Q ss_pred cchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccc
Q 002278 102 IPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQL 181 (943)
Q Consensus 102 ~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 181 (943)
.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+++++..|..+
T Consensus 80 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 158 (229)
T 3e6j_A 80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158 (229)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTC
T ss_pred ChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCC
Confidence 6677899999999999999999777778899999999999999998 667777777777777777777777666666666
Q ss_pred cccceeeccceecc
Q 002278 182 TGLWYFDVRGNNLT 195 (943)
Q Consensus 182 ~~L~~L~L~~N~i~ 195 (943)
++|+.|+|++|.+.
T Consensus 159 ~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 159 SSLTHAYLFGNPWD 172 (229)
T ss_dssp TTCCEEECTTSCBC
T ss_pred CCCCEEEeeCCCcc
Confidence 66666666666655
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=8e-20 Score=187.90 Aligned_cols=150 Identities=20% Similarity=0.209 Sum_probs=113.7
Q ss_pred EEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCccc
Q 002278 43 LNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQL 122 (943)
Q Consensus 43 L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l 122 (943)
+++++++++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|.+|.++++|++|+|++|+|
T Consensus 16 v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 16 VDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 344455666 5676664 6889999999999877777888899999999999999877788888888888888888888
Q ss_pred ccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecc
Q 002278 123 TGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLT 195 (943)
Q Consensus 123 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~ 195 (943)
+...+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|.+.
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 8666667788888888888888888776777777777777777777766666555555555555555555554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.4e-20 Score=190.73 Aligned_cols=133 Identities=20% Similarity=0.228 Sum_probs=67.2
Q ss_pred ceeeccCCcCCCCCC-CCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccC
Q 002278 376 TYLNLSRNNFKGKVP-TELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSF 454 (943)
Q Consensus 376 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (943)
+.|+|++|++++..+ ..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 114 (220)
T 2v70_A 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114 (220)
T ss_dssp SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence 344444444443322 2234444444444444444444444455555555555555555544444455555555555555
Q ss_pred ccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCcccccc
Q 002278 455 NQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508 (943)
Q Consensus 455 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 508 (943)
|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++.
T Consensus 115 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 555544455555555555555555555555555555555555555555555543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=201.90 Aligned_cols=127 Identities=24% Similarity=0.224 Sum_probs=62.1
Q ss_pred eEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccC-CcccceEEEccccccCCcCcccccCCCcCcEEEeeCC
Q 002278 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELG-KLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGN 359 (943)
Q Consensus 281 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 359 (943)
.+++++|.++. +|..+. ..++.|+|++|+|++..+..|. .+++|+.|+|++|+|+++.+..|..+++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 45555555553 333332 2355555555555544444444 5555555555555555444444555555555555555
Q ss_pred cccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCC
Q 002278 360 RLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFS 410 (943)
Q Consensus 360 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 410 (943)
+|+++.+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|+
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence 554444444444444444444444444444444444444444444444444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=8.9e-20 Score=196.28 Aligned_cols=169 Identities=22% Similarity=0.337 Sum_probs=76.3
Q ss_pred CCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceee
Q 002278 300 MSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLN 379 (943)
Q Consensus 300 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 379 (943)
+++|+.|++++|.+... + .+..+++|++|+|++|++++..+ +..+++|+.|++++|++++. + .+..+++|+.|+
T Consensus 45 l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~ 118 (291)
T 1h6t_A 45 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLS 118 (291)
T ss_dssp HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEE
T ss_pred cCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC-h-hhccCCCCCEEE
Confidence 34444444444444322 1 23344444444444444443222 44444444444444444421 1 244444444444
Q ss_pred ccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccc
Q 002278 380 LSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459 (943)
Q Consensus 380 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 459 (943)
|++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..| +..+++|+.|+|++|+|++
T Consensus 119 L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 119 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred CCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 444444422 2344444455555555554432 234455555555555555554332 5555555555555555552
Q ss_pred cCChhhhcccccceecccCcccC
Q 002278 460 SIPAELGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 460 ~~p~~~~~l~~L~~L~L~~N~l~ 482 (943)
+| .+..+++|+.|++++|+++
T Consensus 193 -l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 193 -LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp -CG-GGTTCTTCSEEEEEEEEEE
T ss_pred -Ch-hhccCCCCCEEECcCCccc
Confidence 22 2455555555555555554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.2e-22 Score=232.78 Aligned_cols=204 Identities=22% Similarity=0.206 Sum_probs=149.0
Q ss_pred cCCCCCcEEeccCCCcCCccchhccccccceEEEecCcc-------------cccCCCcccCCCCCCcEEE-Eecccccc
Q 002278 83 GNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ-------------LTGPIPSTLTQIPNLKTLD-LARNQLTG 148 (943)
Q Consensus 83 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l~~ 148 (943)
..+++|+.|+|++|+++ .+|.+++.+++|+.|++++|. +.+..|..++.+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 45777888888888887 678888888888888887665 3445566666666676666 5555432
Q ss_pred ccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCc
Q 002278 149 EIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGF 228 (943)
Q Consensus 149 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 228 (943)
.|+.+.+++|.++.+.+ ..|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~--------- 476 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR--------- 476 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC---------
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc---------
Confidence 34555566666655432 247888888888885 565 888888888888888877
Q ss_pred ceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCC-CCCcCCCCcCcEEE
Q 002278 229 LQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI-PPELGNMSKLSYLQ 307 (943)
Q Consensus 229 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~ 307 (943)
.+|..++.+++|+.|+|++|.|++ +| .|+.+++|+.|+|++|+|++.. |..|..+++|+.|+
T Consensus 477 ---------------~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 477 ---------------ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp ---------------CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred ---------------ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 355667778888888888888886 45 7888888888888888888776 88888888888888
Q ss_pred cccCccccccccc---cCCcccceEEEc
Q 002278 308 LQNNQLVGTIPAE---LGKLEQLFELNL 332 (943)
Q Consensus 308 L~~N~l~~~~~~~---~~~l~~L~~L~L 332 (943)
|++|++++.+|.. +..+++|+.|++
T Consensus 540 L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 540 LQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred ecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 8888888654432 234678888764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.1e-20 Score=202.89 Aligned_cols=176 Identities=24% Similarity=0.266 Sum_probs=110.9
Q ss_pred cEEEcccCccccccccccCCcccceEEEccccccCCcCccccc-CCCcCcEEEeeCCcccCcccccccccCccceeeccC
Q 002278 304 SYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNIS-SCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSR 382 (943)
Q Consensus 304 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 382 (943)
+.+++++|.++ .+|..+. +.++.|+|++|+|++..+..|. .+++|+.|+|++|+|+++.+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 56777777777 4554443 3466777777777766666665 677777777777777766666677777777777777
Q ss_pred CcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccc---cCCCccceecccCccccc
Q 002278 383 NNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEF---GNLRSIQTIDMSFNQLSG 459 (943)
Q Consensus 383 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~ 459 (943)
|+|++..+..|..+.+|+.|+|++|+|++..|..|.++++|+.|+|++|+|+++.+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 77665555566666666666666666665556666666666666666666665444444 446666666666666664
Q ss_pred cCChhhhccccc--ceecccCcccC
Q 002278 460 SIPAELGQLQNI--ISLILNNNNLQ 482 (943)
Q Consensus 460 ~~p~~~~~l~~L--~~L~L~~N~l~ 482 (943)
..+..|..++.+ +.|+|++|++.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 333455555542 55555555554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.2e-19 Score=184.68 Aligned_cols=151 Identities=17% Similarity=0.175 Sum_probs=96.0
Q ss_pred EEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCC-CCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCc
Q 002278 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIP-DEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120 (943)
Q Consensus 42 ~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n 120 (943)
.+++++|.++ .+|..+. ..+++|+|++|+|++..| ..|..+++|++|+|++|+|++..+.+|+++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4666777776 4666553 345778888888875544 34677777777777777777555556777777777777777
Q ss_pred ccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCC
Q 002278 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPD 200 (943)
Q Consensus 121 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~ 200 (943)
++++..+..|..+++|++|+|++|+|++..|..|..+ ++|++|+|++|+|++..|.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------------------------~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGL------------------------SSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTC------------------------TTCSEEECTTSCCCCBCTT
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCC------------------------ccCCEEECCCCcCCEECHH
Confidence 7776666666666666666666666665555555444 4455555555555544455
Q ss_pred CCcCCCcccEEEeeccccc
Q 002278 201 SIGNCTSFEILDISYNQIT 219 (943)
Q Consensus 201 ~l~~l~~L~~L~Ls~N~l~ 219 (943)
.|..+++|++|+|++|.+.
T Consensus 148 ~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 148 AFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp TTTTCTTCCEEECCSCCEE
T ss_pred HhcCCCCCCEEEecCcCCc
Confidence 5555556666666666554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.3e-19 Score=182.43 Aligned_cols=152 Identities=26% Similarity=0.365 Sum_probs=93.3
Q ss_pred cEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCC
Q 002278 304 SYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383 (943)
Q Consensus 304 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 383 (943)
+.+++++|.++ .+|..+. ++|+.|+|++|+|+++.+..|..+++|+.|+|++|+|+++.|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 34555555555 3343332 45556666666666555555666666666666666666555666666666666666666
Q ss_pred cCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCcccc
Q 002278 384 NFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS 458 (943)
Q Consensus 384 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 458 (943)
+++...+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 666444445566666666666666666655666666666666666666666665566666666666666666665
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-19 Score=209.27 Aligned_cols=172 Identities=28% Similarity=0.439 Sum_probs=86.9
Q ss_pred cccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceE
Q 002278 250 GLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFE 329 (943)
Q Consensus 250 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 329 (943)
..+.+|+.|++++|.+... + .+..+++|+.|+|++|.+++..+ +..+++|+.|+|++|++.+ ++ .+..+++|+.
T Consensus 40 ~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~ 113 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKS 113 (605)
T ss_dssp HHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCE
T ss_pred hcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCE
Confidence 4455566666666665532 2 34555555555555555554332 5555555555555555542 11 3444455555
Q ss_pred EEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcC
Q 002278 330 LNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNF 409 (943)
Q Consensus 330 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 409 (943)
|+|++|+|.+. . .+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.|
T Consensus 114 L~Ls~N~l~~l--~------------------------~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l 165 (605)
T 1m9s_A 114 LSLEHNGISDI--N------------------------GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 165 (605)
T ss_dssp EECTTSCCCCC--G------------------------GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCC
T ss_pred EEecCCCCCCC--c------------------------cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcC
Confidence 55555554432 2 244444455555555554432 3444555555555555555
Q ss_pred CCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccc
Q 002278 410 SGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459 (943)
Q Consensus 410 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 459 (943)
.+..| +..+++|+.|+|++|+|++. ..|..+++|+.|+|++|++++
T Consensus 166 ~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 166 SDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 54433 55555555555555555542 235555555555555555553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=8e-20 Score=215.42 Aligned_cols=181 Identities=22% Similarity=0.330 Sum_probs=121.4
Q ss_pred CCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccce
Q 002278 298 GNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTY 377 (943)
Q Consensus 298 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 377 (943)
..+++|+.|++++|.+.. ++ .+..+++|+.|+|++|+|.+..+ +..+++|+.|+|++|.|++. ..+..+++|+.
T Consensus 40 ~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~ 113 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKS 113 (605)
T ss_dssp HHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCE
T ss_pred hcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCE
Confidence 344555555555555542 22 35555555566666665554433 55666666666666666532 25677778888
Q ss_pred eeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccc
Q 002278 378 LNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457 (943)
Q Consensus 378 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 457 (943)
|+|++|++++. ..+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|
T Consensus 114 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 114 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp EECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence 88888887743 3577788888888888888754 567788888888888888886655 77888888888888888
Q ss_pred cccCChhhhcccccceecccCcccCCCCCCcCccc
Q 002278 458 SGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNC 492 (943)
Q Consensus 458 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 492 (943)
++ + +.+..+++|+.|+|++|++++.....+..+
T Consensus 188 ~~-l-~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l 220 (605)
T 1m9s_A 188 SD-L-RALAGLKNLDVLELFSQECLNKPINHQSNL 220 (605)
T ss_dssp CB-C-GGGTTCTTCSEEECCSEEEECCCCCCCSSC
T ss_pred CC-C-hHHccCCCCCEEEccCCcCcCCcccccccE
Confidence 75 3 357788888888888888875444333333
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-19 Score=191.01 Aligned_cols=172 Identities=28% Similarity=0.439 Sum_probs=90.7
Q ss_pred cccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceE
Q 002278 250 GLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFE 329 (943)
Q Consensus 250 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 329 (943)
..+++|+.|++++|.+... + .+..+++|+.|+|++|++++..+ +..+++|++|++++|++++ ++ .+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 3455666666666665533 2 24555555555555555554322 5555555555555555543 11 2444445555
Q ss_pred EEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcC
Q 002278 330 LNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNF 409 (943)
Q Consensus 330 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 409 (943)
|+|++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++
T Consensus 117 L~L~~n~i~~~--------------------------~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l 168 (291)
T 1h6t_A 117 LSLEHNGISDI--------------------------NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 168 (291)
T ss_dssp EECTTSCCCCC--------------------------GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred EECCCCcCCCC--------------------------hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcc
Confidence 55555544432 2344455555555555555432 3455555555666666655
Q ss_pred CCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccc
Q 002278 410 SGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459 (943)
Q Consensus 410 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 459 (943)
++..+ +..+++|+.|+|++|++++. | .+..+++|+.|++++|+++.
T Consensus 169 ~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 169 SDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred ccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 54333 55566666666666666542 2 35666666666666666653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=7.4e-19 Score=181.95 Aligned_cols=154 Identities=22% Similarity=0.295 Sum_probs=97.4
Q ss_pred EEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeeccccc
Q 002278 353 QFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNH 432 (943)
Q Consensus 353 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 432 (943)
.++.+++.+. .+|..+. ++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 23 ~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 23 TVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 4444444444 2232221 556666666666665556666666666666666666665444556666667777777777
Q ss_pred ccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCC
Q 002278 433 LNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIP 510 (943)
Q Consensus 433 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 510 (943)
|+++.+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|++++|++++..+
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 76665666667777777777777776 566667777777777777777776555666677777777777776665443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-21 Score=228.49 Aligned_cols=204 Identities=22% Similarity=0.187 Sum_probs=153.0
Q ss_pred cccccceEEEecCcccccCCCcccCCCCCCcEEEEeccc-------------cccccchhccccccceecc-ccCCccCC
Q 002278 107 SKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQ-------------LTGEIPRLIYWNEVLQYLG-LRGNALTG 172 (943)
Q Consensus 107 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~-------------l~~~~~~~~~~l~~L~~L~-L~~n~l~~ 172 (943)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|. +.+.+|..+..+++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 56889999999999998 789999999999999998775 3334445555555555555 343332
Q ss_pred CCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCcccccc
Q 002278 173 MLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLM 252 (943)
Q Consensus 173 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l 252 (943)
.+|..+.+++|.|+...+ ..|+. |+|++|.|++ +|. ++.+
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~------~~L~~-----------------------L~Ls~n~l~~-lp~-~~~l 462 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEY------ADVRV-----------------------LHLAHKDLTV-LCH-LEQL 462 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHH------TTCSE-----------------------EECTTSCCSS-CCC-GGGG
T ss_pred ---------chhhhhhhhcccccccCc------cCceE-----------------------EEecCCCCCC-CcC-cccc
Confidence 234444455555443221 12444 4455555544 455 8889
Q ss_pred CCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCcccccc-ccccCCcccceEEE
Q 002278 253 QALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI-PAELGKLEQLFELN 331 (943)
Q Consensus 253 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~ 331 (943)
++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|+|++ +| .|..+++|+.|+|++|+|++.. |..++.+++|+.|+
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 99999999999999 678899999999999999999996 56 8999999999999999999776 89999999999999
Q ss_pred ccccccCCcCccc---ccCCCcCcEEEe
Q 002278 332 LADNNLEGPIPHN---ISSCTALNQFNV 356 (943)
Q Consensus 332 L~~N~l~~~~p~~---~~~l~~L~~L~L 356 (943)
|++|++++.+|.. +..+++|+.|++
T Consensus 540 L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 540 LQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred ecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 9999998765532 344788888864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=6e-19 Score=178.19 Aligned_cols=155 Identities=16% Similarity=0.198 Sum_probs=135.3
Q ss_pred CcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCC
Q 002278 57 SIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNL 136 (943)
Q Consensus 57 ~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 136 (943)
+...+++|++|++++|+|+ .+| .+..+++|++|++++|.++ .+ ..+..+++|++|++++|++++..+..|..+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3467889999999999998 666 6999999999999999876 33 478899999999999999998889999999999
Q ss_pred cEEEEeccccccccchhccccccceeccccCCc-cCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeec
Q 002278 137 KTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNA-LTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISY 215 (943)
Q Consensus 137 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~ 215 (943)
++|+|++|++++..+..+..+++|++|+|++|+ ++.+. .+..+++|++|++++|++++. + .+..+++|++|++++
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~--~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM--PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG--GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECB
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH--hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeC
Confidence 999999999998888999999999999999998 87763 688999999999999999864 3 788999999999999
Q ss_pred cccc
Q 002278 216 NQIT 219 (943)
Q Consensus 216 N~l~ 219 (943)
|+|.
T Consensus 191 N~i~ 194 (197)
T 4ezg_A 191 QTIG 194 (197)
T ss_dssp C---
T ss_pred cccC
Confidence 9986
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.4e-19 Score=188.55 Aligned_cols=81 Identities=20% Similarity=0.279 Sum_probs=36.7
Q ss_pred cCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEE
Q 002278 252 MQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELN 331 (943)
Q Consensus 252 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 331 (943)
+.++..+++++|.+++.. .+..+++|+.|++++|.++. ++ .+..+++|++|++++|++++..+ +..+++|+.|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 344455555555554321 34444445555555554442 22 34444444444444444443222 44444444444
Q ss_pred ccccccC
Q 002278 332 LADNNLE 338 (943)
Q Consensus 332 L~~N~l~ 338 (943)
|++|+++
T Consensus 92 L~~N~l~ 98 (263)
T 1xeu_A 92 VNRNRLK 98 (263)
T ss_dssp CCSSCCS
T ss_pred CCCCccC
Confidence 4444444
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-19 Score=196.92 Aligned_cols=289 Identities=10% Similarity=0.057 Sum_probs=135.9
Q ss_pred CCCCCEEEeeCCcccccCCCCccC-CCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCC-------
Q 002278 61 LRNLQSIDFQGNKLTGQIPDEIGN-CGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQ------- 132 (943)
Q Consensus 61 l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~------- 132 (943)
+.+|++|.++++ +...--..+.. +++|+.|||++|+|. .....-+.++.+..+.+..|.| .+.+|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~-~~~~~~~~~~~~~~~~~~~~~I---~~~aF~~~~~~~~~ 98 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIK-MYSGKAGTYPNGKFYIYMANFV---PAYAFSNVVNGVTK 98 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEEC-CEEESSSSSGGGCCEEECTTEE---CTTTTEEEETTEEE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeE-EecCcccccccccccccccccc---CHHHhccccccccc
Confidence 556677777653 22111112222 556666666666665 1111111222234444444432 2344444
Q ss_pred -CCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceec----ccccCCCCcCCCc
Q 002278 133 -IPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNL----TGTIPDSIGNCTS 207 (943)
Q Consensus 133 -l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i----~~~~~~~l~~l~~ 207 (943)
+++|+.|+|.+ .++...+.+|.++.+|+.|++++|.+..+.+..|....++..+.+..+.. .......|.++..
T Consensus 99 g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 99 GKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp ECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred ccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence 55555555555 55544445555555555555555555555555555554444444443211 1122233444444
Q ss_pred cc-EEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecC
Q 002278 208 FE-ILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHG 286 (943)
Q Consensus 208 L~-~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 286 (943)
|+ .+.+....- ++. ..........++..+.+.++-...........+++|+.|+|++
T Consensus 178 L~~~i~~~~~~~---l~~-------------------~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~ 235 (329)
T 3sb4_A 178 LETTIQVGAMGK---LED-------------------EIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISK 235 (329)
T ss_dssp CEEEEEECTTCC---HHH-------------------HHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTT
T ss_pred cceeEEecCCCc---HHH-------------------HHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCC
Confidence 44 333322110 000 0000000122333343333211100000001244555555555
Q ss_pred CCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccce-EEEccccccCCcCcccccCCCcCcEEEeeCCcccCcc
Q 002278 287 NKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLF-ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAI 365 (943)
Q Consensus 287 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 365 (943)
|+++.+.+.+|.++++|+.|++.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.+|++|+.+++++|.++.+.
T Consensus 236 n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~ 313 (329)
T 3sb4_A 236 TNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLG 313 (329)
T ss_dssp BCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEEC
T ss_pred CCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccc
Confidence 5555555555666666666666665 5545555666666666 666665 555555666666666666666666666666
Q ss_pred cccccccCccceee
Q 002278 366 PSSFRNLGSLTYLN 379 (943)
Q Consensus 366 ~~~~~~l~~L~~L~ 379 (943)
+.+|.++++|+.++
T Consensus 314 ~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 314 DELFGNGVPSKLIY 327 (329)
T ss_dssp TTTTCTTCCCCEEE
T ss_pred hhhhcCCcchhhhc
Confidence 66666666666664
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=9.2e-20 Score=220.56 Aligned_cols=202 Identities=19% Similarity=0.184 Sum_probs=104.9
Q ss_pred CCCCCCCCCCCCCCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCC-----EEEeeCCcccccCCCCccCCCCC
Q 002278 14 LLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQ-----SIDFQGNKLTGQIPDEIGNCGSL 88 (943)
Q Consensus 14 ~~~w~~~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~-----~L~Ls~n~l~~~~p~~~~~l~~L 88 (943)
-..|... .+..+.|.++.++. .+++.|+|++|++.. ++..+.....|. .++++.|.+. ..|+.|..+++|
T Consensus 152 ~~~~~~~-~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L 226 (727)
T 4b8c_D 152 KQQPTGD-STPSGTATNSAVST--PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLW 226 (727)
T ss_dssp ---------------------------------------------------------------------------CCCCC
T ss_pred cCCCcCC-CCccccCCCceecC--CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCC
Confidence 3456542 45778899988876 468999999999885 344433322222 2333344444 557778888888
Q ss_pred cEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCC
Q 002278 89 VHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGN 168 (943)
Q Consensus 89 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n 168 (943)
+.|+|++|++. .+|..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+ .+|..|..+.+|++|+|++|
T Consensus 227 ~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N 303 (727)
T 4b8c_D 227 HALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDN 303 (727)
T ss_dssp CEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSS
T ss_pred cEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCC
Confidence 88888888888 67777778888888888888888 77888888888888888888888 66777888888888888888
Q ss_pred ccCCCCCcccccccccceeeccceecccccCCCCcCCCc-ccEEEeecccccCcCCC
Q 002278 169 ALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTS-FEILDISYNQITGEIPY 224 (943)
Q Consensus 169 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~~~ 224 (943)
.|+.++ ..|+.+++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus 304 ~l~~lp-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 304 MVTTLP-WEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CCCCCC-SSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CCCccC-hhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 887653 44777777888888887777777766654432 23466777777766654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.1e-19 Score=187.25 Aligned_cols=165 Identities=21% Similarity=0.302 Sum_probs=73.1
Q ss_pred cceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeC
Q 002278 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHG 358 (943)
Q Consensus 279 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 358 (943)
+..+++++|.+++.. .+..+++|++|++++|.++. ++ .+..+++|++|+|++|+|++..+ +..+++|+.|++++
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 344444444444221 34444444444444444442 22 34444444444444444443322 44444444444444
Q ss_pred CcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCC
Q 002278 359 NRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLP 438 (943)
Q Consensus 359 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 438 (943)
|++++..+ +.. ++|+.|+|++|++++. ..+..+++|+.|++++|+|++. + .+..+++|+.|+|++|++++.
T Consensus 95 N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-- 165 (263)
T 1xeu_A 95 NRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-- 165 (263)
T ss_dssp SCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--
T ss_pred CccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--
Confidence 44443211 111 4444444444444432 1244444445555555544432 2 344445555555555555433
Q ss_pred ccccCCCccceecccCcccc
Q 002278 439 AEFGNLRSIQTIDMSFNQLS 458 (943)
Q Consensus 439 ~~~~~l~~L~~L~Ls~N~l~ 458 (943)
..+..+++|+.|++++|+++
T Consensus 166 ~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 166 GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp TTSTTCCCCCEEEEEEEEEE
T ss_pred HHhccCCCCCEEeCCCCccc
Confidence 34444555555555555554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.75 E-value=3e-19 Score=196.12 Aligned_cols=290 Identities=12% Similarity=0.075 Sum_probs=145.4
Q ss_pred CCCCcEEeccCCCcCCccchhccc-cccceEEEecCcccc--cCCCcccCCCCCCcEEEEeccccccccchhccc-----
Q 002278 85 CGSLVHIELSDNSLYGDIPFSISK-LKQLEFLNLKNNQLT--GPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYW----- 156 (943)
Q Consensus 85 l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~n~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~----- 156 (943)
+.+|+.|.++++ +...-...+.. +++|+.|||++|++. ...+.. ++.++.+.+..|.| .+..|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~I---~~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANFV---PAYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTEE---CTTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccc---cccccccccccccc---CHHHhccccccc
Confidence 556777777654 22111122333 566777777777766 222222 22345555555533 2445555
Q ss_pred ---cccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeE
Q 002278 157 ---NEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVAT 233 (943)
Q Consensus 157 ---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~ 233 (943)
+.+|+.|.|.+ .++.+.+..|.++++|+.+++++|.+..+.+..|.++.++..+.+..+...
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~-------------- 161 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAY-------------- 161 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHH--------------
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhh--------------
Confidence 66666666666 666666666666666666666666665555555555555554444332210
Q ss_pred EEecCccccccCCccccccCCCc-EEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCc
Q 002278 234 LSLQGNKLTGKIPEVIGLMQALA-VLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQ 312 (943)
Q Consensus 234 L~L~~n~l~~~~~~~l~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 312 (943)
..........|..+..|+ .+++.... .++..+. ..-....+++.+.+.++-
T Consensus 162 -----~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~--------------------~~~~~~~~~~~l~~~~~l 213 (329)
T 3sb4_A 162 -----RFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIM--------------------KAGLQPRDINFLTIEGKL 213 (329)
T ss_dssp -----HTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHH--------------------HTTCCGGGCSEEEEEECC
T ss_pred -----hccccccccccccccccceeEEecCCC---cHHHHHh--------------------hcccCccccceEEEeeee
Confidence 000111122333344444 33332211 0111000 000123344455554442
Q ss_pred ccccccccc-CCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccc-eeeccCCcCCCCCC
Q 002278 313 LVGTIPAEL-GKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLT-YLNLSRNNFKGKVP 390 (943)
Q Consensus 313 l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~ 390 (943)
.. .....+ ..+++|+.|+|++|+++.+.+..|.+|++|+.|+|.+| +..+.+.+|.++++|+ .+++.+ .++.+.+
T Consensus 214 ~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~ 290 (329)
T 3sb4_A 214 DN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEF 290 (329)
T ss_dssp CH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECT
T ss_pred cH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEch
Confidence 21 111111 12455666666666666555556666666666666665 5555556666666666 666665 5554555
Q ss_pred CCCCCCCCccEEecCCCcCCCccCCCcccccccceee
Q 002278 391 TELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLN 427 (943)
Q Consensus 391 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 427 (943)
..|.++.+|+.|++++|.++...+..|.++++|+.|+
T Consensus 291 ~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 291 GAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred hhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 6666666666666666666655555666666666654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.6e-18 Score=180.13 Aligned_cols=139 Identities=17% Similarity=0.193 Sum_probs=107.6
Q ss_pred hhccccceEEeeeceEEEEEEEe-cCCce--EEEEEecccCcc------------------------cHHHHHHHHHHHh
Q 002278 615 TENLSEKYIVGYGASSTVYKCAL-KNSRP--IAVKKLYNQYPH------------------------NLREFETELETIG 667 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~ 667 (943)
..-|+..+.||+|+||.||+|.+ .+|+. ||||++...... ....+.+|++.++
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 33467788999999999999998 67888 999986433111 1135788999999
Q ss_pred cCCCCCc--ceeeeEEecCCcceEEEEEccC-C----ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhh-hCCCCCe
Q 002278 668 SIRHRNI--VSLHGYALSPYGNLLFYDYMVN-G----SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH-HDCNPRI 739 (943)
Q Consensus 668 ~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i 739 (943)
.+.|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.|++||| +. +|
T Consensus 126 ~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---gi 192 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---EL 192 (258)
T ss_dssp HHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CE
T ss_pred HHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CE
Confidence 9988764 333332 367999999943 4 66665431 234567889999999999999 88 99
Q ss_pred EecCCCCccEEECCCCceeeccccccccc
Q 002278 740 IHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 740 vH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999999754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.5e-18 Score=173.62 Aligned_cols=153 Identities=14% Similarity=0.253 Sum_probs=89.7
Q ss_pred CCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCccccccccee
Q 002278 347 SCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTL 426 (943)
Q Consensus 347 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 426 (943)
.+++|+.|++++|.|+ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|.+++..+..+..+++|++|
T Consensus 42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 3444555555555554 223 3555555555555555443 12345556666666666666665556666666666666
Q ss_pred ecccccccccCCccccCCCccceecccCcc-ccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccc
Q 002278 427 NLSRNHLNGLLPAEFGNLRSIQTIDMSFNQ-LSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNL 505 (943)
Q Consensus 427 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 505 (943)
+|++|++++..|..|..+++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|++
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence 666666666566666666677777777776 44 444 56667777777777777764 33 566677777777777766
Q ss_pred cc
Q 002278 506 SG 507 (943)
Q Consensus 506 ~~ 507 (943)
.+
T Consensus 194 ~~ 195 (197)
T 4ezg_A 194 GG 195 (197)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.5e-19 Score=213.78 Aligned_cols=143 Identities=24% Similarity=0.314 Sum_probs=69.3
Q ss_pred CcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccc
Q 002278 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDL 420 (943)
Q Consensus 341 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 420 (943)
.+..|..++.|+.|+|++|.|. .+|..+..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|+ .+|..|+.|
T Consensus 216 ~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 292 (727)
T 4b8c_D 216 PKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSC 292 (727)
T ss_dssp ------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGG
T ss_pred ChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCC
Confidence 3444444444555555555544 23333334555555555555555 44555555555555555555555 445555555
Q ss_pred cccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccc-cceecccCcccCCCCCC
Q 002278 421 EHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQN-IISLILNNNNLQGGIPD 487 (943)
Q Consensus 421 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~ 487 (943)
++|++|+|++|.|+ .+|..|++|++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus 293 ~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 293 FQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp TTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 55555555555554 34444555555555555555555555555443322 12245555555555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-18 Score=173.91 Aligned_cols=131 Identities=24% Similarity=0.371 Sum_probs=84.2
Q ss_pred cEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCC-CCCCCCCccEEecCCCcCCCccCCCcccccccceeeccc
Q 002278 352 NQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPT-ELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSR 430 (943)
Q Consensus 352 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 430 (943)
+.+++++|.++ .+|..+.. +|+.|+|++|++++..+. .+..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56677777765 34443322 666677777766655443 366666666666666666666666666666666666666
Q ss_pred ccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCC
Q 002278 431 NHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGI 485 (943)
Q Consensus 431 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 485 (943)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 6666666666666666666666666666666666666666666666666666543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=9.1e-18 Score=168.59 Aligned_cols=132 Identities=23% Similarity=0.362 Sum_probs=112.0
Q ss_pred eEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccc-cccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCC
Q 002278 328 FELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPS-SFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSV 406 (943)
Q Consensus 328 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 406 (943)
+.+++++|+++ .+|..+.. +|++|++++|+|++..+. .|..+++|++|+|++|++++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67889999987 45554433 888999999999877664 588899999999999999988888899999999999999
Q ss_pred CcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCC
Q 002278 407 NNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIP 462 (943)
Q Consensus 407 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 462 (943)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99998778888889999999999999998888889999999999999999986554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=156.51 Aligned_cols=132 Identities=24% Similarity=0.260 Sum_probs=78.9
Q ss_pred CCCcEEeccCCCcC-CccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceecc
Q 002278 86 GSLVHIELSDNSLY-GDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLG 164 (943)
Q Consensus 86 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 164 (943)
++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..|..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 44455555555555555555555533 4555556666666666666554555555566666666
Q ss_pred ccCCccCCCCC-cccccccccceeeccceecccccC---CCCcCCCcccEEEeeccccc
Q 002278 165 LRGNALTGMLS-PDMCQLTGLWYFDVRGNNLTGTIP---DSIGNCTSFEILDISYNQIT 219 (943)
Q Consensus 165 L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~---~~l~~l~~L~~L~Ls~N~l~ 219 (943)
|++|+++++.. ..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 66666665532 456666777777777777764433 36677777777777777765
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.66 E-value=7.2e-16 Score=172.70 Aligned_cols=250 Identities=12% Similarity=0.084 Sum_probs=145.9
Q ss_pred CCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCc
Q 002278 245 IPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKL 324 (943)
Q Consensus 245 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 324 (943)
...+|... +|+.+++..| ++.+....|.+ .+|+.+.+.+ .++.+...+|.++++|+.+++++|.++.+...+|. .
T Consensus 128 ~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~ 202 (401)
T 4fdw_A 128 PKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-Y 202 (401)
T ss_dssp CTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-T
T ss_pred hHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-e
Confidence 33444442 4555655544 44444455555 3466666654 44445555666666666666666666644444554 3
Q ss_pred ccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEec
Q 002278 325 EQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDL 404 (943)
Q Consensus 325 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 404 (943)
.+|+.+.|.++ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.| .+.++.+....|.++.+|+.+++
T Consensus 203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l 278 (401)
T 4fdw_A 203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTT 278 (401)
T ss_dssp CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEE
T ss_pred cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEe
Confidence 56666666533 55555566666666666666654 44455556665 56666666 33444455556666666666666
Q ss_pred CCCcCC-----CccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCc
Q 002278 405 SVNNFS-----GSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNN 479 (943)
Q Consensus 405 s~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 479 (943)
.+|.+. ...+..|.++++|+.++|. |.++.+....|.++++|+.++|..| ++..-+..|.++ +|+.|++++|
T Consensus 279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n 355 (401)
T 4fdw_A 279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGT 355 (401)
T ss_dssp ESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCS
T ss_pred CCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCC
Confidence 665543 2445566677777777776 3466566666777777777777544 554455666666 7777777777
Q ss_pred ccCCCCCCcCcccc-CCcccccCCcccc
Q 002278 480 NLQGGIPDQLSNCF-SLSNLNVSYNNLS 506 (943)
Q Consensus 480 ~l~~~~p~~~~~l~-~L~~L~ls~N~l~ 506 (943)
.+....+..|.+++ .++.|.+..|.+.
T Consensus 356 ~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 356 TPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp SCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CCcccccccccCCCCCccEEEeCHHHHH
Confidence 66655555566653 5566666555443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.3e-15 Score=170.52 Aligned_cols=248 Identities=10% Similarity=0.103 Sum_probs=149.2
Q ss_pred CCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCC
Q 002278 199 PDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSY 278 (943)
Q Consensus 199 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 278 (943)
..+|.++ +|+.+.+..| ++......|...+|+.+.+.+ .++.+...+|..+.+|+.++|++|.+..+....|. .++
T Consensus 129 ~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~ 204 (401)
T 4fdw_A 129 KDAFRNS-QIAKVVLNEG-LKSIGDMAFFNSTVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAG 204 (401)
T ss_dssp TTTTTTC-CCSEEECCTT-CCEECTTTTTTCCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCC
T ss_pred HhhcccC-CccEEEeCCC-ccEECHHhcCCCCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecc
Confidence 3344442 4555554443 332222223223344444443 34445556677777777777777777765556665 467
Q ss_pred cceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeC
Q 002278 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHG 358 (943)
Q Consensus 279 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 358 (943)
|+.+.|.++ ++.+...+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.| .+.++.+...+|.+|++|+.+.+.+
T Consensus 205 L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~ 280 (401)
T 4fdw_A 205 IEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYG 280 (401)
T ss_dssp CSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEES
T ss_pred cCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCC
Confidence 777777643 66566667777777777777764 44455566666 66777777 4556656667777777777777777
Q ss_pred Cccc-----CcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccc
Q 002278 359 NRLS-----GAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHL 433 (943)
Q Consensus 359 N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 433 (943)
|.+. .+.+.+|.++++|+.+.|. +.++.+....|.++.+|+.++|..| ++.....+|.++ +|+.|++++|.+
T Consensus 281 ~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 281 STFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp SCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred ccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 6654 3555666667777777666 3355455566666666666666444 444445566666 666666666666
Q ss_pred cccCCccccCCC-ccceecccCccc
Q 002278 434 NGLLPAEFGNLR-SIQTIDMSFNQL 457 (943)
Q Consensus 434 ~~~~p~~~~~l~-~L~~L~Ls~N~l 457 (943)
....+..|.+++ .++.|++..|.+
T Consensus 358 ~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 358 PQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp CBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred cccccccccCCCCCccEEEeCHHHH
Confidence 655555566553 555665555544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-16 Score=154.77 Aligned_cols=132 Identities=20% Similarity=0.260 Sum_probs=74.5
Q ss_pred CcCcEEEeeCCccc-CcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceee
Q 002278 349 TALNQFNVHGNRLS-GAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLN 427 (943)
Q Consensus 349 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 427 (943)
++|+.|++++|.++ +.+|..+..+++|+.|+|++|.+++. ..+..+++|+.|++++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 34455555555555555555555533 4555555666666666666544555555566666666
Q ss_pred cccccccccCC-ccccCCCccceecccCccccccCC---hhhhcccccceecccCcccC
Q 002278 428 LSRNHLNGLLP-AEFGNLRSIQTIDMSFNQLSGSIP---AELGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 428 Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~ 482 (943)
|++|++++..+ ..|..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 66666654321 456666666666666666663333 25556666666666666655
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.8e-16 Score=157.60 Aligned_cols=127 Identities=25% Similarity=0.386 Sum_probs=90.8
Q ss_pred ceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCc
Q 002278 376 TYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFN 455 (943)
Q Consensus 376 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 455 (943)
+.+++++|.++ .+|..+. .+|+.|+|++|.|+ .+|..|..+++|+.|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45667777776 4555443 46777777777777 56667777777777777777777777777777777777777777
Q ss_pred cccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCcccc
Q 002278 456 QLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLS 506 (943)
Q Consensus 456 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 506 (943)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 777666667777777777777777777665556777777777776666554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.4e-15 Score=168.04 Aligned_cols=67 Identities=15% Similarity=0.195 Sum_probs=33.8
Q ss_pred ccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEe
Q 002278 74 LTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLA 142 (943)
Q Consensus 74 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 142 (943)
++.....+|.++.+|+.+.|..+ ++.....+|.++++|+.++|.++ ++.+...+|.++++|+.+.+.
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p 125 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLP 125 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhccc
Confidence 44333445666666666666532 44333445555566665555433 333444455555555554443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.6e-16 Score=156.03 Aligned_cols=126 Identities=26% Similarity=0.301 Sum_probs=80.8
Q ss_pred EEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcc
Q 002278 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ 121 (943)
Q Consensus 42 ~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~ 121 (943)
.+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+.+|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 3555666666 5565543 46777777777776 566667777777777777777776555667777777777777777
Q ss_pred cccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccC
Q 002278 122 LTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALT 171 (943)
Q Consensus 122 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 171 (943)
|++..+..|..+++|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 77666666666677777766666666444444555555555555555443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.5e-16 Score=153.45 Aligned_cols=134 Identities=20% Similarity=0.254 Sum_probs=94.9
Q ss_pred cceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccC
Q 002278 375 LTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSF 454 (943)
Q Consensus 375 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (943)
.+.+++++|+++ .+|..+. ++|+.|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 456666666666 3443332 4677777777777765556667777777777777777766666677777777777777
Q ss_pred ccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCC
Q 002278 455 NQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPP 511 (943)
Q Consensus 455 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 511 (943)
|+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++++.+|.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 777765556677777888888888888766565567778888888888887776553
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=7.6e-16 Score=152.44 Aligned_cols=132 Identities=23% Similarity=0.279 Sum_probs=101.3
Q ss_pred CCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchh
Q 002278 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFS 105 (943)
Q Consensus 26 c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 105 (943)
|+|.+|.|++. +++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|++++..+..
T Consensus 7 C~~~~l~~~~~------------~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 71 (177)
T 2o6r_A 7 CSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV 71 (177)
T ss_dssp EETTEEECCSS------------CCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred eCCCEEEecCC------------CCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence 57887777543 444 4554443 68899999999998666667888899999999999988666666
Q ss_pred ccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCC
Q 002278 106 ISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTG 172 (943)
Q Consensus 106 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 172 (943)
|+.+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|.+.+
T Consensus 72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 7888888888888888887777778888888888888888886665556667777777777777664
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.8e-16 Score=152.16 Aligned_cols=110 Identities=19% Similarity=0.279 Sum_probs=51.3
Q ss_pred CCCCEEEeeCCccc-ccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEE
Q 002278 62 RNLQSIDFQGNKLT-GQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLD 140 (943)
Q Consensus 62 ~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 140 (943)
++|++|++++|+++ +.+|..+..+++|++|+|++|++++. ..|+.+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34555555555554 44444445555555555555555432 3444455555555555555443444444444555555
Q ss_pred Eeccccccc-cchhccccccceeccccCCccCCC
Q 002278 141 LARNQLTGE-IPRLIYWNEVLQYLGLRGNALTGM 173 (943)
Q Consensus 141 Ls~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~ 173 (943)
|++|++++. .+..+..+++|++|++++|.++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 128 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNL 128 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGS
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccch
Confidence 555544431 123344444444444444444433
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.62 E-value=5.7e-15 Score=166.24 Aligned_cols=335 Identities=11% Similarity=0.033 Sum_probs=211.7
Q ss_pred ccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCC
Q 002278 121 QLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPD 200 (943)
Q Consensus 121 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~ 200 (943)
.++.+...+|.++++|+.+.|..+ ++.....+|.++.+|+.++|.++ ++.+....|.++.+|+.+.+..+ +..+...
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 355566677888888888888644 66555667777777777777654 66666666777777766665543 3323444
Q ss_pred CCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcc
Q 002278 201 SIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTG 280 (943)
Q Consensus 201 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 280 (943)
+|.++..++..... .+......+|..+++|+.+.+.++. ..+....|.+..+|+
T Consensus 135 aF~~~~~~~~~~~~-------------------------~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~ 188 (394)
T 4fs7_A 135 AFKGCDFKEITIPE-------------------------GVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLK 188 (394)
T ss_dssp TTTTCCCSEEECCT-------------------------TCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCC
T ss_pred eeecccccccccCc-------------------------cccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCce
Confidence 55544332222111 1111334566777778888876553 335556777777788
Q ss_pred eEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCc
Q 002278 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNR 360 (943)
Q Consensus 281 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 360 (943)
.+.+..| ++.+....|.++..|+.+.+.++... +...+....+|+.+.+..+ ++.+....|.++..|+.+.+..+.
T Consensus 189 ~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~ 264 (394)
T 4fs7_A 189 SIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNK 264 (394)
T ss_dssp BCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTT
T ss_pred EEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCc
Confidence 7777665 44455567777777877777766543 2333344466777777543 344556677777888888777765
Q ss_pred ccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCcc
Q 002278 361 LSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAE 440 (943)
Q Consensus 361 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 440 (943)
.. +....|..+..++.+.+..+.+. ...|....+|+.+.+..+ ++.+...+|.++.+|+.++|.++ ++.+....
T Consensus 265 ~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a 338 (394)
T 4fs7_A 265 LR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS 338 (394)
T ss_dssp CE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred ce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence 54 56667777777777777665432 345667777777777654 44445566777777777777644 66566677
Q ss_pred ccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcc
Q 002278 441 FGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSN 497 (943)
Q Consensus 441 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 497 (943)
|.++++|+.+++..| ++..-...|.++.+|+.+++..| ++ .+...|.++++|+.
T Consensus 339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 777777777777766 55455567777777777777654 33 23445666666654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.7e-16 Score=149.13 Aligned_cols=127 Identities=18% Similarity=0.254 Sum_probs=62.3
Q ss_pred CcCcEEEeeCCccc-CcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceee
Q 002278 349 TALNQFNVHGNRLS-GAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLN 427 (943)
Q Consensus 349 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 427 (943)
++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34444444444444 34444444445555555555555433 3444555555555555555544444444455555555
Q ss_pred ccccccccc-CCccccCCCccceecccCccccccCC---hhhhcccccceeccc
Q 002278 428 LSRNHLNGL-LPAEFGNLRSIQTIDMSFNQLSGSIP---AELGQLQNIISLILN 477 (943)
Q Consensus 428 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~ 477 (943)
+++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555542 22445555555555555555553333 245555555555544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-16 Score=173.25 Aligned_cols=140 Identities=13% Similarity=0.062 Sum_probs=102.9
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCc--------------ccHH--------HHHHHHHHHhcCCCC
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYP--------------HNLR--------EFETELETIGSIRHR 672 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~ 672 (943)
..-|++...||+|+||.||+|...+|+.||||+++.... .... ...+|...+.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 334888999999999999999999999999998643210 0011 123567777777555
Q ss_pred CcceeeeEEecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC
Q 002278 673 NIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID 752 (943)
Q Consensus 673 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 752 (943)
++.....+.. ...++||||++|++|.++... +....++.|++.+|.|||+. |||||||||.|||++
T Consensus 174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp TCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 4432222222 245899999999888776431 12356889999999999998 999999999999998
Q ss_pred CCC----------ceeeccccccccc
Q 002278 753 ENF----------DAHLSDFGIARCI 768 (943)
Q Consensus 753 ~~~----------~~kl~DFGla~~~ 768 (943)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 3899999987643
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.5e-17 Score=166.45 Aligned_cols=155 Identities=21% Similarity=0.249 Sum_probs=117.6
Q ss_pred cCCCCCCCEEEeeCCcccccCCC------CccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccC
Q 002278 58 IGDLRNLQSIDFQGNKLTGQIPD------EIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLT 131 (943)
Q Consensus 58 l~~l~~L~~L~Ls~n~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 131 (943)
+.....++.++++.+.+++.+|. .|..+++|++|+|++|++++ +| .+..+++|++|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34455677777777777776666 78888888888888888874 66 7888888888888888887 5677777
Q ss_pred CCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCC-cccccccccceeeccceecccccCCC---------
Q 002278 132 QIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLS-PDMCQLTGLWYFDVRGNNLTGTIPDS--------- 201 (943)
Q Consensus 132 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~--------- 201 (943)
.+++|++|+|++|++++ +| .+..+++|++|+|++|+++++.+ ..+..+++|++|++++|.+++..|..
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 77888888888888875 44 57777888888888888877644 46778888888888888887665553
Q ss_pred -CcCCCcccEEEeeccccc
Q 002278 202 -IGNCTSFEILDISYNQIT 219 (943)
Q Consensus 202 -l~~l~~L~~L~Ls~N~l~ 219 (943)
+..+++|+.|| +|.++
T Consensus 169 ~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHCSSCSEEC--CGGGT
T ss_pred HHHhCCCcEEEC--CcccC
Confidence 77788888887 66665
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=1.6e-15 Score=149.89 Aligned_cols=133 Identities=17% Similarity=0.186 Sum_probs=76.6
Q ss_pred ccccCccceeeccCCcCCCCCCCCCCCCC-CccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCcc
Q 002278 369 FRNLGSLTYLNLSRNNFKGKVPTELGRII-NLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSI 447 (943)
Q Consensus 369 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 447 (943)
+.++.+|+.|++++|+++. +|. +..+. +|+.|++++|.|++. ..|..+++|++|+|++|+|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 3444555555555555552 232 33333 566666666665532 455566666666666666665444445666666
Q ss_pred ceecccCccccccCCh--hhhcccccceecccCcccCCCCCCc----CccccCCcccccCCccccc
Q 002278 448 QTIDMSFNQLSGSIPA--ELGQLQNIISLILNNNNLQGGIPDQ----LSNCFSLSNLNVSYNNLSG 507 (943)
Q Consensus 448 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~ls~N~l~~ 507 (943)
+.|+|++|+|+ .+|. .+..+++|+.|++++|+++ .+|.. +..+++|+.||+++|.+..
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 66666666664 4444 5666666666666666665 34443 5666777777777776653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=6.3e-15 Score=145.58 Aligned_cols=132 Identities=14% Similarity=0.158 Sum_probs=91.4
Q ss_pred ccCCCcCcEEEeeCCcccCcccccccccC-ccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCccccccc
Q 002278 345 ISSCTALNQFNVHGNRLSGAIPSSFRNLG-SLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHL 423 (943)
Q Consensus 345 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 423 (943)
+.++.+|+.|++++|+++.. +. +..+. +|+.|+|++|.+++. ..+..+++|+.|++++|.|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 44555666666666666532 33 33333 777777777777654 567777778888888888775444445778888
Q ss_pred ceeecccccccccCCc--cccCCCccceecccCccccccCChh----hhcccccceecccCcccC
Q 002278 424 LTLNLSRNHLNGLLPA--EFGNLRSIQTIDMSFNQLSGSIPAE----LGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 424 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 482 (943)
++|+|++|+|+. +|. .+..+++|+.|++++|+++ .+|.. +..+++|+.|++++|.+.
T Consensus 91 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 888888888863 444 6778888888888888887 55654 788888888888888765
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=7.7e-17 Score=162.80 Aligned_cols=111 Identities=23% Similarity=0.294 Sum_probs=46.0
Q ss_pred cccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCccccccc
Q 002278 344 NISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHL 423 (943)
Q Consensus 344 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 423 (943)
.+..+++|++|++++|.+++ +| .+..+++|+.|++++|+++ .+|..+..+++|+.|++++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 34444444444444444443 22 3444444444444444444 233333333344444444444442 22 24444444
Q ss_pred ceeecccccccccCC-ccccCCCccceecccCccccc
Q 002278 424 LTLNLSRNHLNGLLP-AEFGNLRSIQTIDMSFNQLSG 459 (943)
Q Consensus 424 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 459 (943)
+.|+|++|++++..+ ..+..+++|++|++++|++++
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence 444444444443211 234444444444444444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=5e-14 Score=138.06 Aligned_cols=105 Identities=24% Similarity=0.306 Sum_probs=55.2
Q ss_pred cceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccC
Q 002278 375 LTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSF 454 (943)
Q Consensus 375 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (943)
.+.+++++|+++ .+|..+. .+|+.|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 345666666665 3444332 4555555555555555455555555555555555555554444455555555555555
Q ss_pred ccccccCChhhhcccccceecccCcccC
Q 002278 455 NQLSGSIPAELGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 455 N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 482 (943)
|+|++..+..|..+++|+.|+|++|+++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 5555433334555555555555555444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=134.95 Aligned_cols=107 Identities=26% Similarity=0.313 Sum_probs=53.6
Q ss_pred cEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCc
Q 002278 400 DTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNN 479 (943)
Q Consensus 400 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 479 (943)
+.+++++|.++ .+|..+. ++|+.|+|++|+|+++.|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 44555555554 2343332 44555555555555544555555555555555555555433344455555555555555
Q ss_pred ccCCCCCCcCccccCCcccccCCccccccC
Q 002278 480 NLQGGIPDQLSNCFSLSNLNVSYNNLSGII 509 (943)
Q Consensus 480 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 509 (943)
+|++..+..|..+++|+.|+|++|++++..
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 555444444555555555555555554443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=9.8e-14 Score=136.39 Aligned_cols=104 Identities=21% Similarity=0.319 Sum_probs=57.0
Q ss_pred ceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCc
Q 002278 376 TYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFN 455 (943)
Q Consensus 376 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 455 (943)
+.+++++|+++ .+|..+. .+|+.|+|++|+|++..|..|.++++|+.|+|++|+|+++.+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666665 4454443 45566666666665555555555555555555555555544444555555555555555
Q ss_pred cccccCChhhhcccccceecccCcccC
Q 002278 456 QLSGSIPAELGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 456 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 482 (943)
+|++..+..|..+++|+.|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555333333555555555555555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.4e-13 Score=133.64 Aligned_cols=105 Identities=20% Similarity=0.237 Sum_probs=91.9
Q ss_pred EEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCc
Q 002278 41 VSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNN 120 (943)
Q Consensus 41 ~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n 120 (943)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 36899999997 7888775 88999999999999888889999999999999999999665666889999999999999
Q ss_pred ccccCCCcccCCCCCCcEEEEecccccc
Q 002278 121 QLTGPIPSTLTQIPNLKTLDLARNQLTG 148 (943)
Q Consensus 121 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 148 (943)
+|++..+..|..+++|++|+|++|.+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 9997766679999999999999999884
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.4e-12 Score=144.67 Aligned_cols=132 Identities=14% Similarity=0.243 Sum_probs=60.3
Q ss_pred ccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccc
Q 002278 343 HNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEH 422 (943)
Q Consensus 343 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 422 (943)
.+|.++..|+.+.+..+..+ +...+|.++++|+.+.+. +.++.+....|.++.+|+.++|..+ ++.+...+|.++.+
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~ 335 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ 335 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence 34444444444444433322 334444555555555543 2233333444555555555555433 33233445666666
Q ss_pred cceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCccc
Q 002278 423 LLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNL 481 (943)
Q Consensus 423 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 481 (943)
|+.+.|..+ ++.+....|.++++|+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 666666433 444445566666666666666654431 3445555566665555543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.6e-12 Score=146.21 Aligned_cols=157 Identities=13% Similarity=0.150 Sum_probs=105.8
Q ss_pred CCcCCCC-CCCEEEeeCCcccccCCCCccCCCCCcEEeccCCC---cCCccchhccccccceEEEecCcccccCCCcccC
Q 002278 56 PSIGDLR-NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNS---LYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLT 131 (943)
Q Consensus 56 ~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 131 (943)
.+|.++. .|+.+.|..+ ++.....+|.++++|+.+.++.|. ++.....+|.++.+|+.+.+..+ ++.+....|.
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence 3577764 5888888754 665566778888888888887764 55444567888888887777655 4446667788
Q ss_pred CCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEE
Q 002278 132 QIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEIL 211 (943)
Q Consensus 132 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L 211 (943)
.+.+|+.+.+..+. .......|..+..|+.+.+.++ ++.+....|.. .+|+.+.+..+-.. .....|.++.+|+..
T Consensus 135 ~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 135 HCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTI 210 (394)
T ss_dssp TCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEE
T ss_pred hhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcccccee
Confidence 88888888886543 3355667777778888877654 55566666654 56777777654332 445667777777777
Q ss_pred Eeecccc
Q 002278 212 DISYNQI 218 (943)
Q Consensus 212 ~Ls~N~l 218 (943)
....+..
T Consensus 211 ~~~~~~~ 217 (394)
T 4gt6_A 211 TSDSESY 217 (394)
T ss_dssp EECCSSS
T ss_pred ccccccc
Confidence 6665544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=9e-13 Score=145.63 Aligned_cols=112 Identities=20% Similarity=0.203 Sum_probs=96.8
Q ss_pred CCC--CCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeC-CcccccCCCCccCCCCCcEEeccCCCcC
Q 002278 23 SDF--CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQG-NKLTGQIPDEIGNCGSLVHIELSDNSLY 99 (943)
Q Consensus 23 ~~~--c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 99 (943)
..| |.|.+|.|.+. |+++ .+|. |..+++|++|+|++ |+|++..|..|.+|++|++|+|++|+|+
T Consensus 3 ~~c~~C~~~~v~~~~~-----------n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 69 (347)
T 2ifg_A 3 DACCPHGSSGLRCTRD-----------GALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69 (347)
T ss_dssp SSSCCSSSSCEECCSS-----------CCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC
T ss_pred CcCccccCCEEEcCCC-----------CCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccc
Confidence 356 88888877542 1566 5888 99999999999996 9999777788999999999999999999
Q ss_pred CccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEecccccc
Q 002278 100 GDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTG 148 (943)
Q Consensus 100 ~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 148 (943)
+..|..|++|++|++|+|++|+|++..+..|..++ |+.|+|++|.+..
T Consensus 70 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 70 FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp EECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred eeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 88888999999999999999999977777777776 9999999999874
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=5.3e-14 Score=155.97 Aligned_cols=158 Identities=18% Similarity=0.174 Sum_probs=83.3
Q ss_pred CCCCEEEeeCCcccccCCCCccC-----CCCCcEEeccCCCcCCccchhcc-ccccceEEEecCcccccCCCccc-----
Q 002278 62 RNLQSIDFQGNKLTGQIPDEIGN-----CGSLVHIELSDNSLYGDIPFSIS-KLKQLEFLNLKNNQLTGPIPSTL----- 130 (943)
Q Consensus 62 ~~L~~L~Ls~n~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~~~~~----- 130 (943)
+.|++|+|++|+|+......|.. ..+|++|+|++|.++......+. .+++|++|+|++|.++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 45667777777766432222222 25677777777776543333332 45667777777776664333333
Q ss_pred CCCCCCcEEEEeccccccc----cchhccccccceeccccCCccCCCC----Ccccccccccceeeccceecccc----c
Q 002278 131 TQIPNLKTLDLARNQLTGE----IPRLIYWNEVLQYLGLRGNALTGML----SPDMCQLTGLWYFDVRGNNLTGT----I 198 (943)
Q Consensus 131 ~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~i~~~----~ 198 (943)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++.. ...+...++|+.|+|++|.|+.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 2356677777777766532 3333445556666666666655321 22333444555555555555432 2
Q ss_pred CCCCcCCCcccEEEeeccccc
Q 002278 199 PDSIGNCTSFEILDISYNQIT 219 (943)
Q Consensus 199 ~~~l~~l~~L~~L~Ls~N~l~ 219 (943)
+..+...++|++|+|++|.|+
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCC
T ss_pred HHHHHhCCCCCEEeccCCCCC
Confidence 222333455555555555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=1.9e-12 Score=143.02 Aligned_cols=104 Identities=20% Similarity=0.256 Sum_probs=69.8
Q ss_pred eeeccCC-cCCCCCCCCCCCCCCccEEecCC-CcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccC
Q 002278 377 YLNLSRN-NFKGKVPTELGRIINLDTLDLSV-NNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSF 454 (943)
Q Consensus 377 ~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (943)
.++++++ +++ .+|. +..+++|+.|+|++ |.|++..+..|.++++|+.|+|++|+|+++.|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 666 4565 77777777777775 777765556677777777777777777776666777777777777777
Q ss_pred ccccccCChhhhcccccceecccCcccCC
Q 002278 455 NQLSGSIPAELGQLQNIISLILNNNNLQG 483 (943)
Q Consensus 455 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 483 (943)
|+|++..+..|..++ |+.|+|.+|+|..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 777754444454444 7777777776663
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=6.4e-14 Score=155.32 Aligned_cols=111 Identities=17% Similarity=0.188 Sum_probs=54.6
Q ss_pred CCccEEecCCCcCCC----ccCCCcccccccceeeccccccccc----CCccccCCCccceecccCcccccc----CChh
Q 002278 397 INLDTLDLSVNNFSG----SVPASIGDLEHLLTLNLSRNHLNGL----LPAEFGNLRSIQTIDMSFNQLSGS----IPAE 464 (943)
Q Consensus 397 ~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 464 (943)
.+|+.|+|++|.|+. .++..+..+++|++|+|++|.|+.. ++..+...++|++|+|++|.|+.. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 345555555555432 1222334455566666666665532 234445556666677777666542 2333
Q ss_pred hhcccccceecccCcccCCCCCCcCccc---c--CCcccc--cCCccccc
Q 002278 465 LGQLQNIISLILNNNNLQGGIPDQLSNC---F--SLSNLN--VSYNNLSG 507 (943)
Q Consensus 465 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l---~--~L~~L~--ls~N~l~~ 507 (943)
+...++|++|+|++|+|+..-...+..+ . .|+.+. +..|.++.
T Consensus 235 L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~~ 284 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSE 284 (372)
T ss_dssp HHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CHH
T ss_pred HHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccCH
Confidence 4455667777777777664333222221 1 156666 66666653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=2.7e-11 Score=127.96 Aligned_cols=146 Identities=14% Similarity=0.045 Sum_probs=113.1
Q ss_pred HHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEE
Q 002278 612 MRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 612 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 690 (943)
......|+.....|.|+++.||++... ++.+++|............+.+|+++++.+. +..+.++++++...+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567877778888899999999755 6789999986532223346888999999885 67788899999888889999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCC-----------------------------------
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC----------------------------------- 735 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 735 (943)
|||++|.++.+.+.. ......++.+++++++.||+..
T Consensus 89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999876421 1223467889999999999810
Q ss_pred ---------------------CCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 736 ---------------------NPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 736 ---------------------~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876566799998764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.2e-09 Score=121.96 Aligned_cols=316 Identities=12% Similarity=0.033 Sum_probs=160.4
Q ss_pred hhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccc
Q 002278 104 FSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTG 183 (943)
Q Consensus 104 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 183 (943)
.++....+|+.+.+.. .++.+...+|.++++|+.++|..+ ++.....+|.++ +|+.+.+..+ ++.+....|.. .+
T Consensus 40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~ 114 (379)
T 4h09_A 40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TD 114 (379)
T ss_dssp TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CC
T ss_pred cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CC
Confidence 3566778888888864 466577788888999999988754 554555666555 4555554322 44343344433 24
Q ss_pred cceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCC
Q 002278 184 LWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSEN 263 (943)
Q Consensus 184 L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N 263 (943)
|+.+.+..+ ++.+....|.+ .+++.+.+..+ ++.+....|.....++.+.+..+
T Consensus 115 L~~i~lp~~-~~~i~~~~F~~------------------------~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~ 168 (379)
T 4h09_A 115 LDDFEFPGA-TTEIGNYIFYN------------------------SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSN 168 (379)
T ss_dssp CSEEECCTT-CCEECTTTTTT------------------------CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTT
T ss_pred cccccCCCc-ccccccccccc------------------------ceeeeeeccce-eeccccchhcccccccccccccc
Confidence 444444332 11122222322 22333332221 22233444555555665555544
Q ss_pred CCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcc
Q 002278 264 ELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPH 343 (943)
Q Consensus 264 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 343 (943)
.........+ ....+ . .....+.....+..+.+..+... .....+....+|+.+.+..+ +..+...
T Consensus 169 ~~~~~~~~~~---------~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~ 234 (379)
T 4h09_A 169 NKNYVAENYV---------LYNKN--K-TILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDG 234 (379)
T ss_dssp CSSEEEETTE---------EEETT--S-SEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTT
T ss_pred cceeecccce---------ecccc--c-ceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccc
Confidence 3221000000 00000 0 11112233334444444433222 33444555555555555433 3334455
Q ss_pred cccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCccccccc
Q 002278 344 NISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHL 423 (943)
Q Consensus 344 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 423 (943)
.|.++..|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++......|..+.+|+.+.+.++.++.....+|.++.+|
T Consensus 235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L 312 (379)
T 4h09_A 235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL 312 (379)
T ss_dssp TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC
T ss_pred cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCC
Confidence 5666666666666554 44455556666666666666443 333444556666666666666666654445566666677
Q ss_pred ceeecccccccccCCccccCCCccceecccCccccccCChhhhcc
Q 002278 424 LTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQL 468 (943)
Q Consensus 424 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 468 (943)
+.++|..+ ++.+....|.++++|+.+.+..+ ++..-...|.+.
T Consensus 313 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 313 SSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred CEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 77766543 55455566777777777766544 443334455544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.6e-09 Score=120.91 Aligned_cols=171 Identities=9% Similarity=0.072 Sum_probs=135.1
Q ss_pred cccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCC
Q 002278 319 AELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIIN 398 (943)
Q Consensus 319 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 398 (943)
..+.....+..+.+..+. .......+..+.+|+.+.+..+ +..+...+|.++.+|+.+.+..+ ++.+....|....+
T Consensus 188 ~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~ 264 (379)
T 4h09_A 188 ESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTA 264 (379)
T ss_dssp EECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTT
T ss_pred ccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeeh
Confidence 345555566666665443 3366678888999999998766 44477788999999999999876 66567788999999
Q ss_pred ccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccC
Q 002278 399 LDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNN 478 (943)
Q Consensus 399 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 478 (943)
|+.+.+..+ +.......|.++.+|+.+.+.++.++.+....|.++.+|+.++|..+ ++..-...|.++.+|+.+.+..
T Consensus 265 l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 265 LKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred hcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 999999765 55455678999999999999999999888899999999999999865 7655567899999999999976
Q ss_pred cccCCCCCCcCccccCC
Q 002278 479 NNLQGGIPDQLSNCFSL 495 (943)
Q Consensus 479 N~l~~~~p~~~~~l~~L 495 (943)
+ ++..-...|.++..+
T Consensus 343 ~-v~~I~~~aF~~c~~~ 358 (379)
T 4h09_A 343 S-ITLIESGAFEGSSIT 358 (379)
T ss_dssp T-CCEECTTTTTTSSCC
T ss_pred c-cCEEchhHhhCCCCC
Confidence 5 765556677777533
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=1.6e-10 Score=121.93 Aligned_cols=128 Identities=14% Similarity=0.107 Sum_probs=96.6
Q ss_pred eeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCC--cceeeeEEecCCcceEEEEEccCCChhhh
Q 002278 625 GYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRN--IVSLHGYALSPYGNLLFYDYMVNGSLWDL 702 (943)
Q Consensus 625 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 702 (943)
+.|..+.||++...+++.+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998777788999987543 2245778999988886444 456888888877889999999998884
Q ss_pred ccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCC-----------------------------------------------
Q 002278 703 LHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC----------------------------------------------- 735 (943)
Q Consensus 703 l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------------- 735 (943)
... .+ ...++.++++.++.||+..
T Consensus 104 ~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 211 11 2356778888888888741
Q ss_pred --------CCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 736 --------NPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 736 --------~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.+.++|+|++|.||++++++.+.|+|||.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=3.3e-09 Score=117.42 Aligned_cols=142 Identities=12% Similarity=0.145 Sum_probs=106.3
Q ss_pred cceEEeeeceEEEEEEEecCCceEEEEEec--ccC-cccHHHHHHHHHHHhcCC--CCCcceeeeEEecC---CcceEEE
Q 002278 620 EKYIVGYGASSTVYKCALKNSRPIAVKKLY--NQY-PHNLREFETELETIGSIR--HRNIVSLHGYALSP---YGNLLFY 691 (943)
Q Consensus 620 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 691 (943)
..+.++.|.++.||++...+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45678999999999988764 678888775 322 123457888999999887 45678888888766 4479999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCC------------------------------------
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC------------------------------------ 735 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 735 (943)
||++|..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999988775422 123678888999999999999999731
Q ss_pred -------------------CCCeEecCCCCccEEECCCCc--eeecccccccc
Q 002278 736 -------------------NPRIIHRDVKSSNILIDENFD--AHLSDFGIARC 767 (943)
Q Consensus 736 -------------------~~~ivH~Dlkp~Nill~~~~~--~kl~DFGla~~ 767 (943)
.+.++|||+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997653 68999998863
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.87 E-value=6e-10 Score=122.24 Aligned_cols=59 Identities=19% Similarity=0.203 Sum_probs=30.7
Q ss_pred ccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCccccccc--ccCccceeecc
Q 002278 320 ELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFR--NLGSLTYLNLS 381 (943)
Q Consensus 320 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~ 381 (943)
.+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.+.......+. .+++|+.|+|+
T Consensus 167 ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 167 VLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred HHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 3445566666666665211 1122 22 56677777766666433222332 46666666664
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.86 E-value=5.4e-10 Score=122.59 Aligned_cols=60 Identities=25% Similarity=0.261 Sum_probs=31.7
Q ss_pred chhccccccceEEEecCcc-cccCCCcccCCCCCCcEEEEeccccccccchhcc--ccccceecccc
Q 002278 103 PFSISKLKQLEFLNLKNNQ-LTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIY--WNEVLQYLGLR 166 (943)
Q Consensus 103 p~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~ 166 (943)
+..+..+++|+.|+|++|. +. ++. +. +++|++|+|..|.+.......+. .+++|++|+|+
T Consensus 165 ~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 165 SPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred HHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 3445556677777776662 21 222 32 66777777776666533333332 34555555553
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.3e-09 Score=117.72 Aligned_cols=187 Identities=21% Similarity=0.173 Sum_probs=122.1
Q ss_pred ceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCC-CCC--cceeeeEEecCC---cceEEEEEc
Q 002278 621 KYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRN--IVSLHGYALSPY---GNLLFYDYM 694 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 694 (943)
.+.++.|.+..||++. ..+++|+.... .....+.+|+++++.+. +.. +.+++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 56888886432 34567889999998873 333 334444433332 348899999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhC----------------------------------------
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD---------------------------------------- 734 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------- 734 (943)
+|.++.+... ..++..++..++.+++..++.||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865332 2467778888888898888888861
Q ss_pred ---------------CCCCeEecCCCCccEEECC--CCceeecccccccccCCCCCceeee-------------Eecccc
Q 002278 735 ---------------CNPRIIHRDVKSSNILIDE--NFDAHLSDFGIARCIPTAMPHASTF-------------VLGTIG 784 (943)
Q Consensus 735 ---------------~~~~ivH~Dlkp~Nill~~--~~~~kl~DFGla~~~~~~~~~~~~~-------------~~gt~~ 784 (943)
..+.++|+|++|.||++++ +..+.++||+.+..-.....-.... .....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1135899999999999998 4568899999886532210000000 000001
Q ss_pred eeC-ccccccCCCCCcchhhhHHHHHHHHHhCCCCCC
Q 002278 785 YID-PEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVD 820 (943)
Q Consensus 785 y~a-PE~~~~~~~~~~~DvwSlGvil~elltG~~p~~ 820 (943)
+.. |+.... .....+.|++|.++|.+.+|..+|.
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111 111111 1123689999999999999988773
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.75 E-value=2.9e-10 Score=118.07 Aligned_cols=160 Identities=23% Similarity=0.219 Sum_probs=73.6
Q ss_pred CCCCcceeEecCCCCcEEEEEcCC---CCCccccCC-CcCCCCCCCEEEeeCCcccccCCC-CccCCCCCcE--EeccCC
Q 002278 24 DFCSWRGVFCDNSSLSVVSLNLSS---LNLGGEISP-SIGDLRNLQSIDFQGNKLTGQIPD-EIGNCGSLVH--IELSDN 96 (943)
Q Consensus 24 ~~c~w~gv~c~~~~~~v~~L~l~~---~~~~~~~~~-~l~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~--L~Ls~N 96 (943)
+.|+|.|+.|+..+.+|..+...+ ..+.+.+++ .+..++. .|...+|.-++.+.- .|...+.|+. ++++.|
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 568999999987776776555543 112222211 1111111 112222222211111 1333333433 445555
Q ss_pred CcCCccchh----ccccccceEEEecCccccc--CCCcccCCCCCCcEEEEeccccccccchhccccc--cceeccccCC
Q 002278 97 SLYGDIPFS----ISKLKQLEFLNLKNNQLTG--PIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNE--VLQYLGLRGN 168 (943)
Q Consensus 97 ~l~~~~p~~----~~~l~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~n 168 (943)
+.. ..+.. ..++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|
T Consensus 154 ~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~N 230 (267)
T 3rw6_A 154 RRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGN 230 (267)
T ss_dssp SHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTS
T ss_pred HHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCC
Confidence 433 22221 1345556666666666554 2234445556666666666665533 2222233 5666666666
Q ss_pred ccCCCCC-------cccccccccceee
Q 002278 169 ALTGMLS-------PDMCQLTGLWYFD 188 (943)
Q Consensus 169 ~l~~~~~-------~~~~~l~~L~~L~ 188 (943)
.+.+-.+ ..+..+++|+.||
T Consensus 231 pl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 231 SLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp TTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred cCccccCcchhHHHHHHHHCcccCeEC
Confidence 6553222 1245566666655
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.62 E-value=2.5e-09 Score=105.90 Aligned_cols=119 Identities=12% Similarity=0.168 Sum_probs=77.6
Q ss_pred ccCCCcCCCCCCCEEEeeCC-ccccc----CCCCccCCCCCcEEeccCCCcCCcc----chhccccccceEEEecCcccc
Q 002278 53 EISPSIGDLRNLQSIDFQGN-KLTGQ----IPDEIGNCGSLVHIELSDNSLYGDI----PFSISKLKQLEFLNLKNNQLT 123 (943)
Q Consensus 53 ~~~~~l~~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~n~l~ 123 (943)
.+...+...+.|++|+|++| .|+.. +...+...++|++|+|++|.|.... ...+...++|++|+|++|.|+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34456677788888888888 77642 4445566778888888888887433 334455577888888888877
Q ss_pred cC----CCcccCCCCCCcEEEE--eccccccc----cchhccccccceeccccCCccC
Q 002278 124 GP----IPSTLTQIPNLKTLDL--ARNQLTGE----IPRLIYWNEVLQYLGLRGNALT 171 (943)
Q Consensus 124 ~~----~~~~~~~l~~L~~L~L--s~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~ 171 (943)
.. +...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 43 3455666777888888 67777643 2333334455555555555543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.38 E-value=3.1e-08 Score=97.95 Aligned_cols=123 Identities=14% Similarity=0.180 Sum_probs=74.4
Q ss_pred cCCCCccCCCCCcEEeccCC-CcCCc----cchhccccccceEEEecCcccccC----CCcccCCCCCCcEEEEeccccc
Q 002278 77 QIPDEIGNCGSLVHIELSDN-SLYGD----IPFSISKLKQLEFLNLKNNQLTGP----IPSTLTQIPNLKTLDLARNQLT 147 (943)
Q Consensus 77 ~~p~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 147 (943)
.+...+...++|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34445667788889999888 88743 334455667888888888887642 2334555577888888888776
Q ss_pred cc----cchhccccccceeccc--cCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeeccccc
Q 002278 148 GE----IPRLIYWNEVLQYLGL--RGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQIT 219 (943)
Q Consensus 148 ~~----~~~~~~~l~~L~~L~L--~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~ 219 (943)
.. +...+...++|++|+| ++|.|+..... .+...+...++|++|+|++|.+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~--------------------~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM--------------------EIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH--------------------HHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHH--------------------HHHHHHHhCCCcCEEeccCCCCC
Confidence 43 3344444455555555 44555422111 12233445566777777777664
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.37 E-value=3.6e-08 Score=102.32 Aligned_cols=64 Identities=23% Similarity=0.311 Sum_probs=28.6
Q ss_pred CCccEEecCCCcCCC--ccCCCcccccccceeecccccccccCCccccCCC--ccceecccCccccccCC
Q 002278 397 INLDTLDLSVNNFSG--SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLR--SIQTIDMSFNQLSGSIP 462 (943)
Q Consensus 397 ~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p 462 (943)
++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|++|+|++|.+.+.+|
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 344444444444443 2233344455555555555555433 2222222 55555555555554443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.2e-06 Score=90.81 Aligned_cols=135 Identities=17% Similarity=0.111 Sum_probs=94.8
Q ss_pred ceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCC---CcceeeeEEe-cCCcceEEEEEccC
Q 002278 621 KYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHR---NIVSLHGYAL-SPYGNLLFYDYMVN 696 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 696 (943)
...++.|....||+. ++.+++|+-. .......+.+|+++++.+.+. .|.+++.++. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456899999999988 5678888742 223456788999999998753 2556666664 44567899999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhC------------------------------------------
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD------------------------------------------ 734 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 734 (943)
..+.+... ..++..+...++.++++.|+.||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88866321 1234455555556666665555542
Q ss_pred ---------------CCCCeEecCCCCccEEECC---CCc-eeeccccccc
Q 002278 735 ---------------CNPRIIHRDVKSSNILIDE---NFD-AHLSDFGIAR 766 (943)
Q Consensus 735 ---------------~~~~ivH~Dlkp~Nill~~---~~~-~kl~DFGla~ 766 (943)
..+.++|+|++|.||+++. ++. +.|+||+.+.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1235699999999999987 455 4899999875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.2e-06 Score=90.46 Aligned_cols=134 Identities=17% Similarity=0.164 Sum_probs=96.4
Q ss_pred EEeeeceE-EEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 623 IVGYGASS-TVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 623 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
.+..|..| .||+.... ++..+++|+-.. .....+.+|.+.++.+. +--|.++++++.+++..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45667666 68988765 456788887543 23467888999988774 33367788899888899999999999887
Q ss_pred hhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhC---------------------------------------------
Q 002278 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD--------------------------------------------- 734 (943)
Q Consensus 700 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------- 734 (943)
.+.... .......++.+++..++.||+.
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 765421 1122344566666777777643
Q ss_pred ----------CCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 735 ----------CNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 735 ----------~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
..+.++|+|+.+.||++++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01247999999999999987777899999774
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.15 E-value=9e-07 Score=85.02 Aligned_cols=92 Identities=18% Similarity=0.104 Sum_probs=69.0
Q ss_pred cCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCC-cCCccchhcccc----ccceEEEecCcc-cccCCC
Q 002278 54 ISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNS-LYGDIPFSISKL----KQLEFLNLKNNQ-LTGPIP 127 (943)
Q Consensus 54 ~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~n~-l~~~~~ 127 (943)
+|.....-..|++|||+++.|+...-..+.++++|++|+|++|. |++..-..++.+ ++|++|+|++|. ++...-
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 44433333468999999998887666678889999999999985 775444556654 479999999884 876555
Q ss_pred cccCCCCCCcEEEEeccc
Q 002278 128 STLTQIPNLKTLDLARNQ 145 (943)
Q Consensus 128 ~~~~~l~~L~~L~Ls~N~ 145 (943)
..+.++++|++|+|+++.
T Consensus 133 ~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHGGGCTTCCEEEEESCT
T ss_pred HHHhcCCCCCEEECCCCC
Confidence 677888999999999885
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=5.4e-06 Score=91.29 Aligned_cols=81 Identities=11% Similarity=0.030 Sum_probs=55.6
Q ss_pred ceEE-eeeceEEEEEEEec-------CCceEEEEEecccC---cccHHHHHHHHHHHhcCC-C--CCcceeeeEEecC--
Q 002278 621 KYIV-GYGASSTVYKCALK-------NSRPIAVKKLYNQY---PHNLREFETELETIGSIR-H--RNIVSLHGYALSP-- 684 (943)
Q Consensus 621 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 684 (943)
.+.| +.|....+|+.... +++.+++|...... ......+.+|+++++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88999999998764 25678888764322 101245778888888774 3 3466788877655
Q ss_pred -CcceEEEEEccCCChhh
Q 002278 685 -YGNLLFYDYMVNGSLWD 701 (943)
Q Consensus 685 -~~~~lv~e~~~~g~L~~ 701 (943)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.93 E-value=2.6e-06 Score=81.82 Aligned_cols=90 Identities=14% Similarity=0.090 Sum_probs=56.1
Q ss_pred CCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcc-cccCCCcccCCC----CCCcEEEEeccc-cccccch
Q 002278 79 PDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ-LTGPIPSTLTQI----PNLKTLDLARNQ-LTGEIPR 152 (943)
Q Consensus 79 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~~~ 152 (943)
|.....--+|++|||+++.|+...-..+.++++|++|+|++|. ++...-..++.+ ++|++|+|++|. |+..--.
T Consensus 54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~ 133 (176)
T 3e4g_A 54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII 133 (176)
T ss_dssp CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence 4333233467888888888776555667777888888888774 665444455554 367777777764 6644344
Q ss_pred hccccccceeccccCC
Q 002278 153 LIYWNEVLQYLGLRGN 168 (943)
Q Consensus 153 ~~~~l~~L~~L~L~~n 168 (943)
.+..+++|++|+|+++
T Consensus 134 ~L~~~~~L~~L~L~~c 149 (176)
T 3e4g_A 134 ALHHFRNLKYLFLSDL 149 (176)
T ss_dssp HGGGCTTCCEEEEESC
T ss_pred HHhcCCCCCEEECCCC
Confidence 4455555666665555
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.84 E-value=6.4e-05 Score=79.82 Aligned_cols=79 Identities=15% Similarity=0.214 Sum_probs=58.2
Q ss_pred ccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCC---CCcceeeeEEecCCcceEEEEE
Q 002278 617 NLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRH---RNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.......+|.|..+.||+.+..+|+.|++|+-..........+.+|++.|+.+.. --+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3455677899999999999999999999998765544444568889999888742 1344555442 45899999
Q ss_pred ccCCCh
Q 002278 694 MVNGSL 699 (943)
Q Consensus 694 ~~~g~L 699 (943)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=9.8e-05 Score=82.42 Aligned_cols=75 Identities=8% Similarity=0.012 Sum_probs=49.0
Q ss_pred ceEEeeeceEEEEEEEec-CCceEEEEEecccCc-------ccHHHHHHHHHHHhcCCC--CC-cceeeeEEecCCcceE
Q 002278 621 KYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP-------HNLREFETELETIGSIRH--RN-IVSLHGYALSPYGNLL 689 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 689 (943)
.+.+|.|.++.||++... +++.++||....... .....+..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999764 467899997643211 123456778888887642 33 3455543 3456789
Q ss_pred EEEEccCC
Q 002278 690 FYDYMVNG 697 (943)
Q Consensus 690 v~e~~~~g 697 (943)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00026 Score=75.55 Aligned_cols=139 Identities=14% Similarity=0.123 Sum_probs=91.7
Q ss_pred cceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCC---CCCcceeeeEEecCCcceEEEEEccC
Q 002278 620 EKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR---HRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 620 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
..+.|+.|.+..+|+... +++.+++|..... ....+.+|++.++.+. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 345689999999999876 4678888876532 3567889999888874 35678888888888889999999998
Q ss_pred CChhh-----------hccCCCC---Cc----------------cCCHHHHH---HHH----------------HHHHH-
Q 002278 697 GSLWD-----------LLHGPSK---KV----------------KLDWETRL---KIA----------------VGAAQ- 726 (943)
Q Consensus 697 g~L~~-----------~l~~~~~---~~----------------~l~~~~~~---~i~----------------~~i~~- 726 (943)
..+.. .++.... .+ .-+|.+.. ++. ..++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76521 1221111 00 12454321 111 11111
Q ss_pred HHHHhhh-CCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 727 GLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 727 ~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
....|.. ...+.+||+|+.+.|++++.++ +.|.||+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1223421 2256899999999999999887 8899974
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.62 E-value=7.2e-05 Score=81.65 Aligned_cols=140 Identities=14% Similarity=0.158 Sum_probs=78.5
Q ss_pred eEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCC-----CCCcceee-e--EEecCCcceEEEEE
Q 002278 622 YIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR-----HRNIVSLH-G--YALSPYGNLLFYDY 693 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~ 693 (943)
..|+.|..+.||++...++ .+++|+.... ...+..|.++++.+. .|.++... | +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466678899999987644 5889988642 234445555555443 24443311 1 12235567899999
Q ss_pred ccCCChh--------------hhccC----CCCC-------ccCCHHHH-------------------------------
Q 002278 694 MVNGSLW--------------DLLHG----PSKK-------VKLDWETR------------------------------- 717 (943)
Q Consensus 694 ~~~g~L~--------------~~l~~----~~~~-------~~l~~~~~------------------------------- 717 (943)
++|..+. ..++. .... ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 00110 0000 01122211
Q ss_pred HHHHHHHHHHHHHhhh----------CCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 718 LKIAVGAAQGLAYLHH----------DCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 718 ~~i~~~i~~~l~~LH~----------~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
..+...+..++++|++ ...+.++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666653 023489999999999999888889999999764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.42 E-value=2.3e-05 Score=76.70 Aligned_cols=114 Identities=15% Similarity=0.170 Sum_probs=67.1
Q ss_pred CCcCCCCCCCEEEeeCC-cccc----cCCCCccCCCCCcEEeccCCCcCCccch----hccccccceEEEecCcccccC-
Q 002278 56 PSIGDLRNLQSIDFQGN-KLTG----QIPDEIGNCGSLVHIELSDNSLYGDIPF----SISKLKQLEFLNLKNNQLTGP- 125 (943)
Q Consensus 56 ~~l~~l~~L~~L~Ls~n-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~n~l~~~- 125 (943)
..+.+-+.|++|+|++| +|.. .+-+.+..-+.|+.|+|++|+|.+.... .+..-+.|++|+|++|+|...
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 34455667888888775 6653 2344455567788888888887744333 333456777777777777632
Q ss_pred ---CCcccCCCCCCcEEEEecc---cccc----ccchhccccccceeccccCCc
Q 002278 126 ---IPSTLTQIPNLKTLDLARN---QLTG----EIPRLIYWNEVLQYLGLRGNA 169 (943)
Q Consensus 126 ---~~~~~~~l~~L~~L~Ls~N---~l~~----~~~~~~~~l~~L~~L~L~~n~ 169 (943)
+...+..-+.|++|+|++| .+.. .+...+...+.|+.|+++.|.
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 2234555566777777654 3331 233444455556666665544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00062 Score=76.44 Aligned_cols=78 Identities=9% Similarity=0.096 Sum_probs=46.9
Q ss_pred CCeEecCCCCccEEECCCCceeecccccccccCCCCCceeeeEecccceeCccccccCC---CCCcchhhhHHHHHHHHH
Q 002278 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR---LNEKSDVYSFGIVLLEIL 813 (943)
Q Consensus 737 ~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell 813 (943)
+.++|||++|.|||++.++ ++++||+.+..-.....-......-...|++|+...... .....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4899999999999999876 999999988643211000000000013466666554211 122355567788888776
Q ss_pred hC
Q 002278 814 TG 815 (943)
Q Consensus 814 tG 815 (943)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00011 Score=71.95 Aligned_cols=88 Identities=15% Similarity=0.191 Sum_probs=58.4
Q ss_pred CccCCCCCcEEeccCC-CcCCc----cchhccccccceEEEecCcccccCC----CcccCCCCCCcEEEEeccccccc--
Q 002278 81 EIGNCGSLVHIELSDN-SLYGD----IPFSISKLKQLEFLNLKNNQLTGPI----PSTLTQIPNLKTLDLARNQLTGE-- 149 (943)
Q Consensus 81 ~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~-- 149 (943)
.+.+-+.|++|+|++| +|... +..++..-+.|+.|+|++|+|.... ...+..-+.|++|+|++|+|...
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3455678999999985 77643 3445666688888999988887433 33444567888888888888743
Q ss_pred --cchhccccccceeccccCC
Q 002278 150 --IPRLIYWNEVLQYLGLRGN 168 (943)
Q Consensus 150 --~~~~~~~l~~L~~L~L~~n 168 (943)
+...+...+.|++|+|++|
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHhhCCceeEEECCCC
Confidence 3334444555666666554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0015 Score=69.66 Aligned_cols=73 Identities=7% Similarity=0.055 Sum_probs=45.0
Q ss_pred ccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCc-ceeeeEEecCCcceEEEEEc-cC
Q 002278 619 SEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNI-VSLHGYALSPYGNLLFYDYM-VN 696 (943)
Q Consensus 619 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~ 696 (943)
.-.+.|+.|....+|++ +.+++|........ .....+|+++++.+...++ .+++++ +.+..++++||+ +|
T Consensus 21 ~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 21 TGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred cceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 33678999999999998 56888877543211 1123567777776643333 344443 344568899999 55
Q ss_pred CCh
Q 002278 697 GSL 699 (943)
Q Consensus 697 g~L 699 (943)
.++
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.008 Score=64.71 Aligned_cols=157 Identities=13% Similarity=0.085 Sum_probs=87.9
Q ss_pred cCHHHHHHHhhccc-----cceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCC--cceee
Q 002278 606 HTFDDIMRSTENLS-----EKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRN--IVSLH 678 (943)
Q Consensus 606 ~~~~~~~~~~~~~~-----~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 678 (943)
.+.+++....+.|. ....++ |....||++...+|+.+++|...... .....+..|.++++.+.... +++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 44555555545443 234577 88889999877777789999875321 23466777888877764222 34444
Q ss_pred eE-----EecCCcceEEEEEccCCChhh----h----------cc----CCC--CCccCCHHHH----------------
Q 002278 679 GY-----ALSPYGNLLFYDYMVNGSLWD----L----------LH----GPS--KKVKLDWETR---------------- 717 (943)
Q Consensus 679 ~~-----~~~~~~~~lv~e~~~~g~L~~----~----------l~----~~~--~~~~l~~~~~---------------- 717 (943)
.. ....+..+++|++++|..+.. . ++ ... .....++...
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 43 112345578999998754321 0 11 000 0111222211
Q ss_pred ------HHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 718 ------LKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 718 ------~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
...+..++..++-.-. .....++|||+++.||+++ + .+.++||+.+.
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 0111122222222111 1233689999999999999 4 89999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0039 Score=67.45 Aligned_cols=31 Identities=26% Similarity=0.312 Sum_probs=27.0
Q ss_pred CCeEecCCCCccEEECCC----Cceeecccccccc
Q 002278 737 PRIIHRDVKSSNILIDEN----FDAHLSDFGIARC 767 (943)
Q Consensus 737 ~~ivH~Dlkp~Nill~~~----~~~kl~DFGla~~ 767 (943)
+.++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6799999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0086 Score=64.29 Aligned_cols=157 Identities=13% Similarity=0.099 Sum_probs=84.5
Q ss_pred CHHHHHHHhhcccc-----ceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCC--cceeee
Q 002278 607 TFDDIMRSTENLSE-----KYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRN--IVSLHG 679 (943)
Q Consensus 607 ~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 679 (943)
+.+++.....+|.. .+.|+.|....+|+....++ .+++|...... ....+..|+++++.+...+ +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 44555555555544 34567788899999987655 68888876421 1234556777776663212 233332
Q ss_pred E------EecCCcceEEEEEccCCChhhh--------------cc----CCCCC--cc---CCHHHHHH-----------
Q 002278 680 Y------ALSPYGNLLFYDYMVNGSLWDL--------------LH----GPSKK--VK---LDWETRLK----------- 719 (943)
Q Consensus 680 ~------~~~~~~~~lv~e~~~~g~L~~~--------------l~----~~~~~--~~---l~~~~~~~----------- 719 (943)
. ....+..+++|+|++|..+... ++ ..... .. ..|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1223456899999988654210 11 00000 00 11222110
Q ss_pred -HHHHHHHHHHHhhhC----CCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 720 -IAVGAAQGLAYLHHD----CNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 720 -i~~~i~~~l~~LH~~----~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
+...+...++++++. ...+++|+|+.+.||++++++.+.++||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011134445555431 13478999999999999887666899998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0026 Score=71.31 Aligned_cols=73 Identities=15% Similarity=0.239 Sum_probs=49.2
Q ss_pred ceEEeeeceEEEEEEEecC--------CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCc-ceeeeEEecCCcceEEE
Q 002278 621 KYIVGYGASSTVYKCALKN--------SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNI-VSLHGYALSPYGNLLFY 691 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 691 (943)
.+.|+.|....||++...+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568889999999998653 467888877432 122455679988888753333 566665532 3899
Q ss_pred EEccCCCh
Q 002278 692 DYMVNGSL 699 (943)
Q Consensus 692 e~~~~g~L 699 (943)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0092 Score=67.14 Aligned_cols=74 Identities=12% Similarity=0.048 Sum_probs=47.2
Q ss_pred ceEEeeeceEEEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHhcCCCCCc-ceeeeEEecCCcceEEEEEccCCC
Q 002278 621 KYIVGYGASSTVYKCALKN-SRPIAVKKLYNQYPHNLREFETELETIGSIRHRNI-VSLHGYALSPYGNLLFYDYMVNGS 698 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 698 (943)
.+.|+.|-...+|++...+ ++.+++|+...... ......+|..+++.+...++ .++++++. + ..||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568889999999998765 46788887643221 11123578888888864444 56676662 2 35999998755
Q ss_pred h
Q 002278 699 L 699 (943)
Q Consensus 699 L 699 (943)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0018 Score=59.03 Aligned_cols=56 Identities=21% Similarity=0.326 Sum_probs=28.3
Q ss_pred EEecCCCcCC-CccCCCcccccccceeecccccccccCCccccCCCccceecccCcccc
Q 002278 401 TLDLSVNNFS-GSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLS 458 (943)
Q Consensus 401 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 458 (943)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555554 12343221 23555555555555554555555555555555555553
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.55 E-value=0.014 Score=57.26 Aligned_cols=101 Identities=17% Similarity=0.130 Sum_probs=66.3
Q ss_pred ChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCceee
Q 002278 698 SLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777 (943)
Q Consensus 698 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 777 (943)
+|.++|.. ...++++++++.++.|.+.+|.-+-...++ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 78888873 456899999999999999998776221111 1334467999999999988764 1110
Q ss_pred eEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCC
Q 002278 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK 817 (943)
Q Consensus 778 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~ 817 (943)
.....+.|||... ...+.+.=|||+|+++|..+--..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0123567888764 345678899999999999886333
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0072 Score=66.16 Aligned_cols=140 Identities=17% Similarity=0.187 Sum_probs=82.0
Q ss_pred eEEeeeceEEEEEEEecC--------CceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEEE
Q 002278 622 YIVGYGASSTVYKCALKN--------SRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 692 (943)
+.+..|....+|++...+ ++.+++|+.-. .......+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 457778889999988642 46788887532 2234566778999988875 3223566666543 28999
Q ss_pred EccCCChhhh-----------------ccCCC--CCccC--CHHHHHHHHHHHHH-------------------HHHHhh
Q 002278 693 YMVNGSLWDL-----------------LHGPS--KKVKL--DWETRLKIAVGAAQ-------------------GLAYLH 732 (943)
Q Consensus 693 ~~~~g~L~~~-----------------l~~~~--~~~~l--~~~~~~~i~~~i~~-------------------~l~~LH 732 (943)
|++|..+..- ++... ..... -+.++.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655321 11111 01112 24455555544322 223332
Q ss_pred ----hC-CCCCeEecCCCCccEEECCC----Cceeeccccccc
Q 002278 733 ----HD-CNPRIIHRDVKSSNILIDEN----FDAHLSDFGIAR 766 (943)
Q Consensus 733 ----~~-~~~~ivH~Dlkp~Nill~~~----~~~kl~DFGla~ 766 (943)
.. ....++|+|+.+.||+++.+ +.+.++||..|.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 11 13368999999999999876 789999998774
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0062 Score=55.49 Aligned_cols=57 Identities=25% Similarity=0.366 Sum_probs=42.3
Q ss_pred ceeeccCCcCC-CCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeeccccccc
Q 002278 376 TYLNLSRNNFK-GKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLN 434 (943)
Q Consensus 376 ~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 434 (943)
..++.+++.++ ..+|..+. .+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36777777775 24555443 36888888888888766777888888888999888775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0067 Score=66.61 Aligned_cols=73 Identities=11% Similarity=0.132 Sum_probs=42.7
Q ss_pred eEEeeeceEEEEEEEecC---------CceEEEEEecccCcccHHHHHHHHHHHhcCCCCC-cceeeeEEecCCcceEEE
Q 002278 622 YIVGYGASSTVYKCALKN---------SRPIAVKKLYNQYPHNLREFETELETIGSIRHRN-IVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 691 (943)
..++.|....+|++...+ ++.+++|..... .........|.++++.+...+ +.++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-VDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-ccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 457788888999988653 257777775432 111123467888877775333 34566544 237899
Q ss_pred EEccCCCh
Q 002278 692 DYMVNGSL 699 (943)
Q Consensus 692 e~~~~g~L 699 (943)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.94 E-value=0.04 Score=59.48 Aligned_cols=30 Identities=17% Similarity=0.303 Sum_probs=26.9
Q ss_pred CCeEecCCCCccEEECCCCceeeccccccc
Q 002278 737 PRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 737 ~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
..++|+|+.+.||++++++.+.++||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 478999999999999988889999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.04 E-value=0.14 Score=56.73 Aligned_cols=74 Identities=8% Similarity=0.054 Sum_probs=47.5
Q ss_pred ceEEeeeceEEEEEEEecC--------CceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEE
Q 002278 621 KYIVGYGASSTVYKCALKN--------SRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 691 (943)
.+.+..|....+|++...+ ++.+++++..... .......+|.++++.+. +.-..++++.+ ..+.||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 3467778899999998753 5778888754322 22223457888887774 22234555533 237899
Q ss_pred EEccCCCh
Q 002278 692 DYMVNGSL 699 (943)
Q Consensus 692 e~~~~g~L 699 (943)
||++|..+
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.56 E-value=0.43 Score=52.61 Aligned_cols=29 Identities=31% Similarity=0.452 Sum_probs=24.5
Q ss_pred CeEecCCCCccEEE------CCCCceeeccccccc
Q 002278 738 RIIHRDVKSSNILI------DENFDAHLSDFGIAR 766 (943)
Q Consensus 738 ~ivH~Dlkp~Nill------~~~~~~kl~DFGla~ 766 (943)
.++|+|+.+.||++ +++..++++||-.|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 456779999998874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 943 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-31 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-05 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-11 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-26 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-24 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 7e-09 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-06 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-06 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 7e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-62
Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 17/288 (5%)
Query: 609 DDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGS 668
DD ++ +G G+ TVYK + + + P L+ F+ E+ +
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
RH NI+ GY+ +P + + SL+ LH + K + + IA AQG+
Sbjct: 61 TRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGM 117
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP-HASTFVLGTIGYID 787
YLH IIHRD+KS+NI + E+ + DFG+A H + G+I ++
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 788 PEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP 844
PE + + +SDVY+FGIVL E++TG+ N +N Q+I + P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY-----LSP 229
Query: 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892
++S + + +L C K+ ERP ++ + L + P
Sbjct: 230 DLSKVRSNCP--KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-59
Identities = 74/279 (26%), Positives = 117/279 (41%), Gaps = 17/279 (6%)
Query: 606 HTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELET 665
D+ E L +G G V+ +AVK L Q + F E
Sbjct: 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANL 61
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA 725
+ ++H+ +V L+ + +YM NGSL D L P +KL L +A A
Sbjct: 62 MKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIA 119
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY 785
+G+A++ IHRD++++NIL+ + ++DFG+AR I A I +
Sbjct: 120 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845
PE + KSDV+SFGI+L EI+T + ++I + +
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN------LERGYRMV 230
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
C + + +QL LC K P +RPT + VL
Sbjct: 231 RPDNCPE-----ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 7e-57
Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 17/273 (6%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIV 675
L+ +G G V+ N +A+K + + + +F E E + + H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
L+G L L +++M +G L D L +++ ET L + + +G+ +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGM---AYLE 118
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR 795
+IHRD+ + N L+ EN +SDFG+ R + +ST + + PE SR
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 796 LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855
+ KSDV+SFG+++ E+ + K + +++ D +T P ++ T V
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---DISTGFRLYKPRLASTHV---- 231
Query: 856 VRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+Q+ C K P +RP + R L +
Sbjct: 232 ----YQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 5e-56
Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 24/293 (8%)
Query: 614 STENLSEKYIVGYGASSTVYKCALKNS-----RPIAVKKLYNQY-PHNLREFETELETIG 667
++ + ++G G VYK LK S P+A+K L Y +F E +G
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 668 SIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
H NI+ L G ++ +YM NG+L L K + + + G A G
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAG 122
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV--LGTIGY 785
+ + N +HRD+ + NIL++ N +SDFG++R + T I +
Sbjct: 123 M---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845
PE + SDV+SFGIV+ E++T + E + H+++ + +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM------KAINDGFRLP 233
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLA 898
+ C +QL + C ++ + RP ++ +L L+ AP + +LA
Sbjct: 234 TPMDCPS-----AIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-56
Identities = 66/292 (22%), Positives = 113/292 (38%), Gaps = 33/292 (11%)
Query: 624 VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS 683
+G G V++ + +AVK ++ E E+ +RH NI+
Sbjct: 11 IGKGRFGEVWRGKWRG-EEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 684 PYGNL----LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC---- 735
G L DY +GSL+D L+ + + E +K+A+ A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 736 -NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA---MPHASTFVLGTIGYIDPEYA 791
P I HRD+KS NIL+ +N ++D G+A +A + A +GT Y+ PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 792 HTS------RLNEKSDVYSFGIVLLEILTGKKAVDNES---------NLHQLIMSKADDN 836
S +++D+Y+ G+V EI + +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 837 TVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ + P + A+R ++ C + R T + + L L
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-55
Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 17/284 (5%)
Query: 609 DDIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGS 668
D E+L + +G G V+ + +A+K L + F E + +
Sbjct: 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKK 68
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
+RH +V L+ +S + +YM GSL D L G + K + +A A G+
Sbjct: 69 LRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGM 126
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDP 788
AY+ +HRD++++NIL+ EN ++DFG+AR I A I + P
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848
E A R KSDV+SFGI+L E+ T + + ++ + + M PE
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMP-CPPECPE 241
Query: 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPP 892
+ D L C ++ P ERPT + + L +
Sbjct: 242 SLHD---------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (484), Expect = 4e-55
Identities = 68/289 (23%), Positives = 127/289 (43%), Gaps = 17/289 (5%)
Query: 601 MDMAIHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREF 659
MD + +D +++ K+ +G G VY+ K +AVK L + + EF
Sbjct: 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEF 60
Query: 660 ETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLK 719
E + I+H N+V L G + ++M G+L D L +++ ++ L
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLY 119
Query: 720 IAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFV 779
+A + + YL IHRD+ + N L+ EN ++DFG++R + A
Sbjct: 120 MATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
Query: 780 LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM 839
I + PE ++ + KSDV++FG++L EI T + +L Q+
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------Y 226
Query: 840 EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
E ++ + + + K ++L C + PS+RP+ E+ + ++
Sbjct: 227 ELLEKDYRMERPE-GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (485), Expect = 4e-55
Identities = 65/304 (21%), Positives = 119/304 (39%), Gaps = 34/304 (11%)
Query: 606 HTFDDIMRSTENLSEKY---------IVGYGASSTVYKCALKNS----RPIAVKKLYNQY 652
TF+D + +++ ++G G V LK +A+K L + Y
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 653 -PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVK 711
R+F +E +G H N++ L G ++ ++M NGSL L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 712 LDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771
+ + G A G+ YL +HRD+ + NIL++ N +SDFG++R +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 772 MPHASTF----VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQ 827
+ I + PE + SDV+S+GIV+ E+++ + +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 828 LIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887
+I N + + + C QL L C ++ + RP ++ L +
Sbjct: 242 VI------NAIEQDYRLPPPMDCPS-----ALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
Query: 888 LPAP 891
+ P
Sbjct: 291 IRNP 294
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-55
Identities = 61/263 (23%), Positives = 107/263 (40%), Gaps = 23/263 (8%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G G V + +AVK + N + F E + +RH N+V L G +
Sbjct: 14 TIGKGEFGDVMLGDYRG-NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 683 SPYGNL-LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIH 741
G L + +YM GSL D L + V L + LK ++ + + YL +H
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNFVH 126
Query: 742 RDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSD 801
RD+ + N+L+ E+ A +SDFG+ + + + + PE + + KSD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSD 182
Query: 802 VYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQ 861
V+SFGI+L EI + + L ++ V + + C ++
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPR------VEKGYKMDAPDGCPP-----AVYE 231
Query: 862 LALLCTKRYPSERPTMQEVARVL 884
+ C + RP+ ++ L
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-54
Identities = 50/270 (18%), Positives = 110/270 (40%), Gaps = 17/270 (6%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIV 675
++L+ +G G V + +A+K + + + EF E + + ++ H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 676 SLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
L+G + +YM NG L + L + + + L++ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSR 795
+ +HRD+ + N L+++ +SDFG++R + +S + + PE S+
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 796 LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSA 855
+ KSD+++FG+++ EI + K + + + + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH------IAQGLRLYRPHLASE--- 228
Query: 856 VRKTFQLALLCTKRYPSERPTMQEVARVLV 885
K + + C ERPT + + ++
Sbjct: 229 --KVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 1e-52
Identities = 70/302 (23%), Positives = 119/302 (39%), Gaps = 43/302 (14%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNS------RPIAVKKLYNQYPHNLR-EFETELETIGS 668
N+ +G GA V++ +AVK L + +++ +F+ E +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSK-------------------- 708
+ NIV L G L ++YM G L + L S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 709 -KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767
L +L IA A G+AYL + +HRD+ + N L+ EN ++DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 768 IPTA-MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLH 826
I +A A I ++ PE +R +SDV+++G+VL EI +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 827 QLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886
++I D N + A + + L LC + P++RP+ + R+L
Sbjct: 250 EVIYYVRDGN--ILACPENCPLELYN---------LMRLCWSKLPADRPSFCSIHRILQR 298
Query: 887 LL 888
+
Sbjct: 299 MC 300
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-52
Identities = 56/279 (20%), Positives = 105/279 (37%), Gaps = 26/279 (9%)
Query: 613 RSTENLSEKYIVGYGASSTVYKCALKNS---RPIAVKKLYNQY--PHNLREFETELETIG 667
R L +K + G G TV K + + +AVK L N+ P E E +
Sbjct: 5 RKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 668 SIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQG 727
+ + IV + G + +L + G L L + + + +++ + G
Sbjct: 64 QLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMG 119
Query: 728 LAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH--ASTFVLGTIGY 785
+ YL +HRD+ + N+L+ A +SDFG+++ + + A T + +
Sbjct: 120 MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 786 IDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845
PE + + + KSDV+SFG+++ E + + ++ + +
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------AMLEKGERMG 230
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
C + + L LC RP V L
Sbjct: 231 CPAGCPR-----EMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 5e-52
Identities = 59/273 (21%), Positives = 107/273 (39%), Gaps = 21/273 (7%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKLY--NQYPHNLREFETELETIGSIRHR 672
E+ Y +G G+ K K+ + + K+L + + +E+ + ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 673 NIVSLHGYALSPYGNLLF--YDYMVNGSLWDLLHGPSKKVK-LDWETRLKIAVGAAQGLA 729
NIV + + L+ +Y G L ++ +K+ + LD E L++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 730 YLH--HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYID 787
H D ++HRD+K +N+ +D + L DFG+AR + A FV GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMS 182
Query: 788 PEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847
PE + NEKSD++S G +L E+ S + + S
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---FRRIPYRYS 239
Query: 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ + RP+++E+
Sbjct: 240 DELNE---------IITRMLNLKDYHRPSVEEI 263
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 5e-52
Identities = 61/299 (20%), Positives = 117/299 (39%), Gaps = 41/299 (13%)
Query: 615 TENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKLYNQY-PHNLREFETELETIGSIRHR 672
++ + +G G V+K + K S +A K ++ + P + EL+ +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 673 NIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH 732
IV +G S + ++M GSL +L K ++ + K+++ +GL YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH 792
+I+HRDVK SNIL++ + L DFG++ + +M + +GT Y+ PE
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQ 176
Query: 793 TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852
+ + +SD++S G+ L+E+ G+ + +M P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 853 LSAVRKTFQ-------------------------------LALLCTKRYPSERPTMQEV 880
LS+ + C + P+ER ++++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-52
Identities = 53/277 (19%), Positives = 106/277 (38%), Gaps = 24/277 (8%)
Query: 615 TENLS-EKYIVGYGASSTVYKCALKNS---RPIAVKKLYNQY-PHNLREFETELETIGSI 669
+NL +G G +V + + +A+K L + E E + + +
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66
Query: 670 RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLA 729
+ IV L G +L + G L L G K+ ++ ++ + G+
Sbjct: 67 DNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMK 123
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH--ASTFVLGTIGYID 787
YL +HRD+ + N+L+ A +SDFG+++ + + A + + +
Sbjct: 124 YLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 788 PEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847
PE + + + +SDV+S+G+ + E L+ + + + +M+ + ME PE
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRME-CPPECP 238
Query: 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
L C +RP V + +
Sbjct: 239 PELYA---------LMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-51
Identities = 60/266 (22%), Positives = 107/266 (40%), Gaps = 26/266 (9%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHG 679
+G G+ TVYK + +A +L ++ + F+ E E + ++H NIV +
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 680 YALSPYGN----LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
S +L + M +G+L L + + + +GL +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 736 NPRIIHRDVKSSNILI-DENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
P IIHRD+K NI I + D G+A + A V+GT ++ PE
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMY-EE 187
Query: 795 RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854
+ +E DVY+FG+ +LE+ T + N Q I + + D +
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTSGVKPASFDKVAIPEVKE-- 244
Query: 855 AVRKTFQLALLCTKRYPSERPTMQEV 880
+ C ++ ER +++++
Sbjct: 245 -------IIEGCIRQNKDERYSIKDL 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 6e-51
Identities = 61/283 (21%), Positives = 113/283 (39%), Gaps = 27/283 (9%)
Query: 608 FDDIMRSTENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETE 662
++ + R N + + + G GA VYK K + A K + + L ++ E
Sbjct: 1 YEHVTRDL-NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722
++ + S H NIV L + ++ G++ ++ + L +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCK 117
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT 782
L YLH + +IIHRD+K+ NIL + D L+DFG++ + +F+ GT
Sbjct: 118 QTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GT 173
Query: 783 IGYIDPEYAHTSRL-----NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT 837
++ PE + K+DV+S GI L+E+ + N ++++ A
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEP 232
Query: 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
A S D ++K C ++ R T ++
Sbjct: 233 PTLAQPSRWSSNFKDF--LKK-------CLEKNVDARWTTSQL 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-50
Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 31/293 (10%)
Query: 614 STENLSEKYIV----GYGASSTVYKC-ALKNSRPIAVKKLYNQYPHNLREFETELETIGS 668
S + +KY G GAS TVY + + +A++++ Q E+ +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
++ NIV+ L + +Y+ GSL D++ + +D + Q L
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQAL 129
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDP 788
+LH + ++IHRD+KS NIL+ + L+DFG I ST V GT ++ P
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 185
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848
E K D++S GI+ +E++ G+ NE+ L L + A + T ++S
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPELQNPEKLSA 244
Query: 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEV--------ARVLVSLLPAPPA 893
D + + C +R + +E+ A+ L SL P A
Sbjct: 245 IFRDF--LNR-------CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-50
Identities = 63/307 (20%), Positives = 126/307 (41%), Gaps = 33/307 (10%)
Query: 599 LHMDMA------IHTFDDIMRSTENLSEKY--IVGYGASSTVYKCALKNSR----PIAVK 646
+H+D++ + ++ +L + ++G G VY L ++ AVK
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61
Query: 647 KL-YNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLH 704
L + +F TE + H N++SL G L G+ L YM +G L + +
Sbjct: 62 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 705 GPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764
++ + + + A+G+ + + +HRD+ + N ++DE F ++DFG+
Sbjct: 122 --NETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 176
Query: 765 ARCIP---TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDN 821
AR + H T + ++ E T + KSDV+SFG++L E++T
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 822 ESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVA 881
+ N + + +++ C D +++ L C RP+ E+
Sbjct: 237 DVNTFDITVY------LLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELV 285
Query: 882 RVLVSLL 888
+ ++
Sbjct: 286 SRISAIF 292
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-50
Identities = 69/308 (22%), Positives = 123/308 (39%), Gaps = 34/308 (11%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNS---RPIAVKKLYNQY-PHNLREFETELETIGSI-R 670
++ + ++G G V K +K A+K++ + R+F ELE + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHG-------------PSKKVKLDWETR 717
H NI++L G L +Y +G+L D L S L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 718 LKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHAST 777
L A A+G+ YL + IHRD+ + NIL+ EN+ A ++DFG++R T
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKT 184
Query: 778 FVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNT 837
+ ++ E + S SDV+S+G++L EI++ +L
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------ 238
Query: 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSL 897
+ + E + C D + + L C + P ERP+ ++ L +L ++
Sbjct: 239 LPQGYRLEKPLNCDD-----EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 293
Query: 898 AAPKPIDY 905
+ Y
Sbjct: 294 TLYEKFTY 301
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 7e-50
Identities = 65/322 (20%), Positives = 121/322 (37%), Gaps = 25/322 (7%)
Query: 611 IMRSTENLSEKYIVGYGASSTVYKCALKNS-----RPIAVKKLY-NQYPHNLREFETELE 664
I++ TE + ++G GA TVYK P+A+K+L P +E E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 665 TIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ S+ + ++ L G L+ L M G L D + K + + L V
Sbjct: 64 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQI 120
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF-VLGTI 783
A+G+ YL R++HRD+ + N+L+ ++DFG+A+ + I
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 784 GYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843
++ E +SDV+S+G+ + E++T + + I S + +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQ-P 235
Query: 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAPPAKLSLAAPKPI 903
P ++ + + C RP +E+ + P L + + +
Sbjct: 236 PICTIDVYM---------IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286
Query: 904 DYYTKFVVNRERQQRVEHDDNS 925
+ N R E D +
Sbjct: 287 HLPSPTDSNFYRALMDEEDMDD 308
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 9e-50
Identities = 60/298 (20%), Positives = 101/298 (33%), Gaps = 42/298 (14%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNSR------PIAVKKLYNQY-PHNLREFETELETIGS 668
ENL ++G GA V +AVK L + +EL+ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 669 I-RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVK---------------- 711
+ H NIV+L G L ++Y G L + L +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 712 ----LDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767
L +E L A A+G+ +L +HRD+ + N+L+ + DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 768 IPTAMPHAS-TFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLH 826
I + + + ++ PE KSDV+S+GI+L EI + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 827 QLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884
+ M+ + + C +RP+ + L
Sbjct: 274 ANFYKLIQNGFKMD-QPFYATEEIYI---------IMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-49
Identities = 61/262 (23%), Positives = 103/262 (39%), Gaps = 20/262 (7%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKL-YNQYPHNLREFETELETIGSIRHRNIVSLHGY 680
+G GA V + + +AVK + + + E+ + H N+V +G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 681 ALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRII 740
LF +Y G L+D + + + + G+ YLH I
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 125
Query: 741 HRDVKSSNILIDENFDAHLSDFGIARCI-PTAMPHASTFVLGTIGYIDPEYAHTSRLN-E 798
HRD+K N+L+DE + +SDFG+A + GT+ Y+ PE + E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 799 KSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRK 858
DV+S GIVL +L G+ D S+ Q + T + ++ + L + K
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKKIDSAPLAL--LHK 242
Query: 859 TFQLALLCTKRYPSERPTMQEV 880
PS R T+ ++
Sbjct: 243 -------ILVENPSARITIPDI 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-49
Identities = 63/271 (23%), Positives = 107/271 (39%), Gaps = 22/271 (8%)
Query: 623 IVGYGASSTVYKCALKNS----RPIAVKKLYNQYPHNLRE-FETELETIGSIRHRNIVSL 677
+G G V++ + +A+K N ++RE F E T+ H +IV L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 678 HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
G ++ + + G L L +K LD + + A + LAYL
Sbjct: 74 IGV-ITENPVWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLES---K 127
Query: 738 RIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLN 797
R +HRD+ + N+L+ N L DFG++R + + + ++ I ++ PE + R
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 798 EKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVR 857
SDV+ FG+ + EIL + +I + + + P T
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--PMPPNCPPTLYS----- 240
Query: 858 KTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
L C PS RP E+ L ++L
Sbjct: 241 ----LMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-49
Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 26/271 (9%)
Query: 614 STENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKLYNQY---PHNLREFETELETIGSI 669
+ E+ +G G VY K S +A+K L+ + E+E +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 670 RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLA 729
RH NI+ L+GY L +Y G+++ L K K D + A L+
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 120
Query: 730 YLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
Y H + R+IHRD+K N+L+ + ++DFG + P++ + GT+ Y+ PE
Sbjct: 121 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPE 174
Query: 790 YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849
+EK D++S G++ E L GK + + + T + V
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA--- 231
Query: 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
L K PS+RP ++EV
Sbjct: 232 ----------RDLISRLLKHNPSQRPMLREV 252
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-49
Identities = 61/297 (20%), Positives = 107/297 (36%), Gaps = 37/297 (12%)
Query: 616 ENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLY-NQYPHNLREFETELETIGS 668
LS +G GA V + + +AVK L + + +EL+ +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 669 I-RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHG---------------PSKKVKL 712
+ H NIV+L G L+ +Y G L + L ++ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 713 DWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772
D E L + A+G+A+L IHRD+ + NIL+ + DFG+AR I
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 773 PHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMS 831
+ + ++ PE +SDV+S+GI L E+ + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 832 KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ M D + C P +RPT +++ +++ +
Sbjct: 260 MIKEGFRML-SPEHAPAEMYD---------IMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 4e-49
Identities = 66/278 (23%), Positives = 111/278 (39%), Gaps = 33/278 (11%)
Query: 614 STENLSEKY----IVGYGASSTVYKC-ALKNSRPIAVKKL---YNQYPHNLREFETELET 665
++ + + +G+G+ VY ++NS +A+KK+ Q ++ E+
Sbjct: 9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAA 725
+ +RH N + G L + L +Y + + L K L + GA
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGAL 125
Query: 726 QGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGY 785
QGLAYLH +IHRDVK+ NIL+ E L DFG A + + +GT +
Sbjct: 126 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYW 177
Query: 786 IDPEYAHTS---RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842
+ PE + + K DV+S GI +E+ K + N + + L N
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNESPALQ 235
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
S + C ++ P +RPT + +
Sbjct: 236 SGHWSEYFRN---------FVDSCLQKIPQDRPTSEVL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-48
Identities = 60/273 (21%), Positives = 104/273 (38%), Gaps = 25/273 (9%)
Query: 624 VGYGASSTVYKCALK----NSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVS 676
+G G+ V + + +AVK L P + +F E+ + S+ HRN++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 677 LHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCN 736
L+G L+P + + GSL D + T + AV A+G+ YL
Sbjct: 76 LYGVVLTPP-MKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYLES--- 129
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH--ASTFVLGTIGYIDPEYAHTS 794
R IHRD+ + N+L+ + DFG+ R +P H + PE T
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 795 RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854
+ SD + FG+ L E+ T + N Q++ + + + +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYN-- 246
Query: 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887
+ + C P +RPT + L+
Sbjct: 247 -------VMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (436), Expect = 6e-48
Identities = 55/311 (17%), Positives = 120/311 (38%), Gaps = 24/311 (7%)
Query: 616 ENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIR 670
+++ + Y + G GA V++ + + A K + + + E++T+ +R
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 81
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
H +V+LH ++ Y++M G L++ + + K+ + ++ +GL +
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLGTIGYIDP 788
+H + +H D+K NI+ L DFG+ + T GT + P
Sbjct: 140 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAP 194
Query: 789 EYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848
E A + +D++S G++ +L+G E++ L K+ D + ++ +S
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVAR-VLVSLLPAPPAKLSLAAPKPIDYYT 907
D +RK P+ R T+ + ++ AP + + +
Sbjct: 255 DGKDF--IRK-------LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD 305
Query: 908 KFVVNRERQQR 918
+
Sbjct: 306 SIKTKYDAWPE 316
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (428), Expect = 1e-46
Identities = 54/274 (19%), Positives = 109/274 (39%), Gaps = 23/274 (8%)
Query: 614 STENLSEKY----IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGS 668
++ + Y +G GA V++C K + R K + YP + + E+ +
Sbjct: 23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ 82
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
+ H +++LH Y +L +++ G L+D + ++ K+ + A +GL
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGL 140
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLGTIGYI 786
++H I+H D+K NI+ + + + DFG+A + T +
Sbjct: 141 KHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFA 195
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846
PE + +D+++ G++ +L+G E +L L K D E V
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
S D ++ ++ P +R T+ +
Sbjct: 256 SPEAKDF--IKN-------LLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (411), Expect = 2e-45
Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 30/287 (10%)
Query: 617 NLSEKY----IVGYGASSTVYKC-ALKNSRPIAVKKL---YNQYPHNLREFETELETIGS 668
+LS++Y I+G+G S V+ L+ R +AVK L + P F E + +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 669 IRHRNIVSLHGY--ALSPYGNLLF--YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ H IV+++ A +P G L + +Y+ +L D++H + + + +++ A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADA 120
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA--STFVLGT 782
Q L + H IIHRDVK +NI+I + DFGIAR I + + V+GT
Sbjct: 121 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 783 IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842
Y+ PE A ++ +SDVYS G VL E+LTG+ +S + +D A
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP-TMQEVARVLVSLL 888
+S + V K + P R T E+ LV +
Sbjct: 238 HEGLSADLDAV--VLK-------ALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-45
Identities = 52/271 (19%), Positives = 107/271 (39%), Gaps = 22/271 (8%)
Query: 616 ENLSEKYIV----GYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRH 671
+ L EKY++ G G V++C +S+ + K + + E+ + RH
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 672 RNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYL 731
RNI+ LH S ++ ++++ +++ ++ + +L+ + + L +L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFL 118
Query: 732 HHDCNPRIIHRDVKSSNILIDENFDAH--LSDFGIARCIPTAMPHASTFVLGTIGYIDPE 789
H + I H D++ NI+ + + +FG AR + F Y PE
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPE 173
Query: 790 YAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849
++ +D++S G ++ +L+G E+N + + T E E+S+
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+D V + + R T E
Sbjct: 234 AMDF--VDR-------LLVKERKSRMTASEA 255
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-44
Identities = 65/307 (21%), Positives = 116/307 (37%), Gaps = 29/307 (9%)
Query: 605 IHTFDDIMRSTENLSEKYIVGYGASSTVYKCALKNS------RPIAVKKLYNQY-PHNLR 657
++ D+ + E ++ +G G+ VY+ K +A+K +
Sbjct: 9 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 68
Query: 658 EFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKK-------V 710
EF E + ++V L G L+ + M G L L
Sbjct: 69 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128
Query: 711 KLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770
+++A A G+AYL+ + +HRD+ + N ++ E+F + DFG+ R I
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185
Query: 771 AMPHASTF-VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLI 829
+ L + ++ PE SDV+SFG+VL EI T + + Q++
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245
Query: 830 MSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889
VME + C D F+L +C + P RP+ E+ + +
Sbjct: 246 RF------VMEGGLLDKPDNCPD-----MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
Query: 890 APPAKLS 896
++S
Sbjct: 295 PGFREVS 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 38/297 (12%)
Query: 616 ENLSEKYIVGYGASSTVYKCALK--------NSRPIAVKKLYNQY-PHNLREFETELETI 666
+ L +G GA V +AVK L + +L + +E+E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 667 GSI-RHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLH-------------GPSKKVKL 712
I +H+NI++L G + +Y G+L + L + + +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 713 DWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772
+ + A A+G+ YL + IHRD+ + N+L+ E+ ++DFG+AR I
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 773 PHASTFV-LGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMS 831
+ T + ++ PE +SDV+SFG++L EI T + + +L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-- 247
Query: 832 KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ E + C + + + + C PS+RPT +++ L ++
Sbjct: 248 ----KLLKEGHRMDKPSNCTN-----ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 74/298 (24%), Positives = 117/298 (39%), Gaps = 36/298 (12%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNS------RPIAVKKLYNQYPH-NLREFETELETIGS 668
+ L +G GA V + R +AVK L H R +EL+ +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 669 IRHR-NIVSLHGYALSPYGNLLF-YDYMVNGSLWDLLHG-------------PSKKVKLD 713
I H N+V+L G P G L+ ++ G+L L K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 714 WETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773
E + + A+G+ +L + IHRD+ + NIL+ E + DFG+AR I
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 774 HA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSK 832
+ + ++ PE +SDV+SFG++L EI + + + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 833 ADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890
+ T M A D + +Q L C PS+RPT E+ L +LL A
Sbjct: 250 LKEGTRMRAPD----------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-43
Identities = 57/273 (20%), Positives = 102/273 (37%), Gaps = 24/273 (8%)
Query: 613 RSTENLSEKYIVGYGASSTVYKC-ALKNSRPIAVKKLYNQY---PHNLREFETELETIGS 668
+ E+ I+G G+ STV L SR A+K L ++ + + E + +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 669 IRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGL 728
+ H V L+ Y NG L + K D A+ +
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYT---AEIV 118
Query: 729 AYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR-CIPTAMPHASTFVLGTIGYID 787
+ L + IIHRD+K NIL++E+ ++DFG A+ P + + +GT Y+
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 788 PEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847
PE + SD+++ G ++ +++ G + + E P+
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK-- 236
Query: 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
DL V K ++R +E+
Sbjct: 237 --ARDL--VEK-------LLVLDATKRLGCEEM 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 2e-41
Identities = 51/274 (18%), Positives = 102/274 (37%), Gaps = 20/274 (7%)
Query: 613 RSTENLSEKY----IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLRE-FETELETI 666
+ E++ + Y ++G GA S V K + + +A+K + + E E+ +
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 667 GSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
I+H NIV+L S L + G L+D + +K ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLD 118
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
+ YLH + +DE+ +SDFG+++ + GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYV 176
Query: 787 DPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846
PE ++ D +S G++ +L G +E++ + ++
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
S + D +R ++ P +R T ++
Sbjct: 237 SDSAKDF--IRH-------LMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (375), Expect = 1e-40
Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 34/282 (12%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKL---------YNQYPHNLREFETELET 665
EN K I+G G SS V +C K + + AVK + + E++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 666 IGSIR-HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ + H NI+ L + L +D M G L+D L +KV L + KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIG 784
+ + LH I+HRD+K NIL+D++ + L+DFG + + V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPS 174
Query: 785 YIDPEYAHTSRL------NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838
Y+ PE S ++ D++S G+++ +L G + + L M + +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ S T DL V + P +R T +E
Sbjct: 235 GSPEWDDYSDTVKDL--VSR-------FLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 8e-40
Identities = 56/269 (20%), Positives = 101/269 (37%), Gaps = 25/269 (9%)
Query: 616 ENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKLYNQY---PHNLREFETELETIG-SIR 670
E+ ++G G+ V+ K + + A+K L ++ E + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
H + + + +Y+ G L + K D A GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEY 790
LH I++RD+K NIL+D++ ++DFG+ + +TF GT YI PE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 791 AHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850
+ N D +SFG++L E+L G+ + + D+ ++ E
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE----A 230
Query: 851 VDLSAVRKTFQLALLCTKRYPSERPTMQE 879
DL + K R P +R ++
Sbjct: 231 KDL--LVK-------LFVREPEKRLGVRG 250
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 9e-40
Identities = 53/283 (18%), Positives = 101/283 (35%), Gaps = 28/283 (9%)
Query: 620 EKYIV----GYGASSTVYKCALKNSRPIAVKKLY--NQYPHNLREFETELETIGSIRHRN 673
EKY G G VYK A+KK+ + E+ + ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
IV L+ + +L ++++ L + L+ T Q L + +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFL---LQLLNGIAY 115
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
+ R++HRD+K N+LI+ + ++DFG+AR + + ++ +
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS------ 847
+ + D++S G + E++ G S QL+ T P V+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 848 -----VTCVDLSAVRKTF-----QLALLCTKRYPSERPTMQEV 880
+ + K L K P++R T ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (368), Expect = 4e-39
Identities = 56/262 (21%), Positives = 102/262 (38%), Gaps = 22/262 (8%)
Query: 623 IVGYGASSTVYKC-ALKNSRPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLH 678
+G G+ V+ + N R A+K L + + E + + H I+ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR 738
G + DY+ G L+ LL AA+ L + +
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE 798
II+RD+K NIL+D+N ++DFG A+ +P + GT YI PE T N+
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNK 180
Query: 799 KSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRK 858
D +SFGI++ E+L G + + + + + + DL + +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED----VKDL--LSR 234
Query: 859 TFQLALLCTKRYPSERPTMQEV 880
+ ++R + + ++V
Sbjct: 235 L--ITRDLSQRLGNLQNGTEDV 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 5e-39
Identities = 60/292 (20%), Positives = 104/292 (35%), Gaps = 29/292 (9%)
Query: 613 RSTENLSEKYIVGYGASSTVYKC--ALKNSRPIAVKKLYNQ-----YPHNLREFETELET 665
R+ + +G GA V+K R +A+K++ Q P + L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 666 IGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLW---DLLHGPSKKVKLDWETRLKIAV 722
+ + H N+V L + +V + + + ET +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT 782
+GL +LH ++HRD+K NIL+ + L+DFG+AR M T V+ T
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178
Query: 783 IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL------IMSKADDN 836
+ Y PE S D++S G + E+ K S++ QL I +++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 837 TVMEAVDPEVSVTCVDLSAVRKTF--------QLALLCTKRYPSERPTMQEV 880
+ P + + K L L C P++R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 9e-39
Identities = 58/282 (20%), Positives = 115/282 (40%), Gaps = 32/282 (11%)
Query: 614 STENLSEKYIV----GYGASSTVYKCALKNS-RPIAVKKL------YNQYPHNLREFETE 662
EN+ + Y G G + V KC K++ A K + ++ + + E E
Sbjct: 4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722
+ + I+H N+++LH + +L + + G L+D L +K L E +
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFL- 119
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDA----HLSDFGIARCIPTAMPHASTF 778
Q L +++ + +I H D+K NI++ + + DFG+A I +
Sbjct: 120 --KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKN 175
Query: 779 VLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838
+ GT ++ PE + L ++D++S G++ +L+G ++ L A +
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ S D +R+ + P +R T+Q+
Sbjct: 236 EDEYFSNTSALAKDF--IRR-------LLVKDPKKRMTIQDS 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (360), Expect = 2e-38
Identities = 46/275 (16%), Positives = 92/275 (33%), Gaps = 22/275 (8%)
Query: 624 VGYGASSTVYKCA-LKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYAL 682
+G G+ +Y + +A+K + H + E + ++ + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 683 SPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHR 742
+ + ++ SL DL + S+K +T L +A + Y+H + IHR
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIHR 127
Query: 743 DVKSSNILI---DENFDAHLSDFGIARCIPTAMPHA------STFVLGTIGYIDPEYAHT 793
DVK N L+ + ++ DFG+A+ A H + + GT Y
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 794 SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853
+ + D+ S G VL+ G + + M + C
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL---CKGY 244
Query: 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ C ++P + ++ +L
Sbjct: 245 PSEFA--TYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (361), Expect = 1e-37
Identities = 55/274 (20%), Positives = 95/274 (34%), Gaps = 27/274 (9%)
Query: 614 STENLSEKYIVGYGASSTVYKCALKNS-RPIAVKKL------YNQYPHNLREFETELETI 666
+ + S I+G G VY C ++ + A+K L Q L +
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 667 GSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQ 726
+ IV + +P D M G L L + A
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIIL 118
Query: 727 GLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYI 786
GL ++H+ +++RD+K +NIL+DE+ +SD G+A PH +GT GY+
Sbjct: 119 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYM 172
Query: 787 DPEYAHTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845
PE + +D +S G +L ++L G + + + +E +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDS 231
Query: 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQE 879
S L + +R + R
Sbjct: 232 FSPELRSL--LEG-------LLQRDVNRRLGCLG 256
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-37
Identities = 69/314 (21%), Positives = 118/314 (37%), Gaps = 54/314 (17%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHN-----LREFETELETIGSIRHRNIVS 676
+G G +TVYK KN+ + +A+KK+ + R E++ + + H NI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 677 LHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCN 736
L L +D+M + + L + QGL YLH
Sbjct: 65 LLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 737 PRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL 796
I+HRD+K +N+L+DEN L+DFG+A+ + A T + T Y PE +R+
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARM 177
Query: 797 -NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL------------------------IMS 831
D+++ G +L E+L + +S+L QL +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 832 KADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVAR---VLVSLL 888
K+ + + +DL ++ P R T + +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDL--IQG-------LFLFNPCARITATQALKMKYFSNRPG 288
Query: 889 PAPPAKLSLAAPKP 902
P P +L P+P
Sbjct: 289 PTPGCQL----PRP 298
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-36
Identities = 61/291 (20%), Positives = 113/291 (38%), Gaps = 30/291 (10%)
Query: 617 NLSEKY----IVGYGASSTVYKC-ALKNSRPIAVKKL-YNQYPHNLREFETELETIGSIR 670
++ +Y +G GA V N +A+KK+ ++ + E++ + R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 671 HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAY 730
H NI+ ++ +P + Y+V + L+ K L + +GL Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 731 LHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTF--VLGTIGYIDP 788
+H + ++HRD+K SN+L++ D + DFG+AR H + T Y P
Sbjct: 125 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 789 EYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQL------------------I 829
E S+ + D++S G +L E+L+ + + L QL I
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 830 MSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
KA + + +V + +A K L P +R +++
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-36
Identities = 61/282 (21%), Positives = 100/282 (35%), Gaps = 32/282 (11%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYA 681
++G G+ VY+ L +S +A+KK+ + R EL+ + + H NIV L +
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 682 LSPYGN------LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
S L DY+ H K L + LAY+H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 736 NPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
I HRD+K N+L+D + L DFG A+ + P+ +++ +
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGAT 198
Query: 795 RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854
DV+S G VL E+L G+ +S + QL+ T E++ +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 855 AVRKT----------------FQLALLCTKRYPSERPTMQEV 880
+ L + P+ R T E
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 5e-36
Identities = 58/284 (20%), Positives = 97/284 (34%), Gaps = 24/284 (8%)
Query: 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLY--NQYPHNLREFETELETIGSIRHR 672
EN + +G G VYK K +A+KK+ + E+ + + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 673 NIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH 732
NIV L + L ++ L + S + QGLA+ H
Sbjct: 62 NIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH 792
++HRD+K N+LI+ L+DFG+AR + + V+
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 793 TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS----- 847
+ D++S G + E++T + +S + QL T E V P V+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 848 ------VTCVDLSAVRKTF-----QLALLCTKRYPSERPTMQEV 880
D S V L P++R + +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-35
Identities = 55/270 (20%), Positives = 96/270 (35%), Gaps = 31/270 (11%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYA 681
++G G + V + K + A+K L P RE E + + +IV +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWR---ASQCPHIVRIVDVY 74
Query: 682 LSPYGN----LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNP 737
+ Y L+ + + G L+ + + +I + + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLH---SI 130
Query: 738 RIIHRDVKSSNILIDENFD---AHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTS 794
I HRDVK N+L L+DFG A+ + + T Y+ PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPE 188
Query: 795 RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKA----DDNTVMEAVDPEVSVTC 850
+ ++ D++S G+++ +L G + L K EVS
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248
Query: 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
L +R K P++R T+ E
Sbjct: 249 KML--IRN-------LLKTEPTQRMTITEF 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (336), Expect = 3e-35
Identities = 40/287 (13%), Positives = 82/287 (28%), Gaps = 28/287 (9%)
Query: 618 LSEKYIV----GYGASSTVYKC-ALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHR 672
+ Y V G G+ +++ L N++ +A+K + + + E T +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGC 60
Query: 673 NIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH 732
+ Y + + ++ SL DLL K +T A + +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAH-----LSDFGIARCIP------TAMPHASTFVLG 781
+++RD+K N LI + + DFG+ + + G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 782 TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA 841
T Y+ + + D+ + G V + L G +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-- 233
Query: 842 VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ C + P + + +L
Sbjct: 234 -STPLRELCAGFPEEFY--KYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 2e-34
Identities = 45/262 (17%), Positives = 94/262 (35%), Gaps = 22/262 (8%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLH 678
+G G+ V K S A+K L Q + E + ++ +V L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR 738
+ +Y+ G ++ L + + A YLH +
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SLD 161
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE 798
+I+RD+K N+LID+ ++DFG A+ + + + GT + PE + N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 799 KSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRK 858
D ++ G+++ E+ G + + + ++ +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL----- 272
Query: 859 TFQLALLCTKRYPSERPTMQEV 880
L + TKR+ + + + ++
Sbjct: 273 ---LQVDLTKRFGNLKNGVNDI 291
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 56/278 (20%), Positives = 103/278 (37%), Gaps = 42/278 (15%)
Query: 618 LSEKY----IVGYGASSTVYKC-ALKNSRPIAVKKLYNQY------PHNLREFETELETI 666
L +Y ++G G +VY + ++ P+A+K + N E+ +
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 667 GSIR--HRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGA 724
+ ++ L + P +L + +++ L E
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQV 119
Query: 725 AQGLAYLHHDCNPRIIHRDVKSSNILIDEN-FDAHLSDFGIARCIPTAMPHASTFVLGTI 783
+ + + N ++HRD+K NILID N + L DFG + + T GT
Sbjct: 120 LEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTR 173
Query: 784 GYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV 842
Y PE+ R + V+S GI+L +++ G +++ + + +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF----------F 223
Query: 843 DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
VS C L +R C PS+RPT +E+
Sbjct: 224 RQRVSSECQHL--IRW-------CLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 49/265 (18%), Positives = 100/265 (37%), Gaps = 25/265 (9%)
Query: 623 IVGYGASSTVYKCALKNS-RPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLH 678
++G G V K + R A+K L + + TE + + RH + +L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 679 GYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR 738
+ +Y G L+ L ++ E A+ ++ L + +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYG---AEIVSALEYLHSRD 125
Query: 739 IIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNE 798
+++RD+K N+++D++ ++DFG+ + + TF GT Y+ PE +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGR 184
Query: 799 KSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRK 858
D + G+V+ E++ G+ N+ + + ++ + PE L +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE----AKSL--LAG 238
Query: 859 TFQLALLC---TKRYPSERPTMQEV 880
LL +R +EV
Sbjct: 239 -----LLKKDPKQRLGGGPSDAKEV 258
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 5e-34
Identities = 53/285 (18%), Positives = 99/285 (34%), Gaps = 30/285 (10%)
Query: 620 EKY----IVGYGASSTVYKCALKNS-RPIAVKKLY--NQYPHNLREFETELETIGSIRHR 672
+KY +G G TV+K + + +A+K++ + E+ + ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 673 NIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH 732
NIV LH S L +++ LD E Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFL---FQLLKGLG 115
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH 792
+ ++HRD+K N+LI+ N + L++FG+AR + S V+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 793 TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLI-----------------MSKADD 835
+ D++S G + E+ + + +++ + M+K D
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 836 NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
S+ V L K P +R + +E
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-33
Identities = 58/288 (20%), Positives = 106/288 (36%), Gaps = 34/288 (11%)
Query: 624 VGYGASSTVYKCALKNS-RPIAVKKLY--NQYPHNLREFETELETIGSIRHRNIVSLHGY 680
+G G V+K + + + +A+KK+ N+ E++ + ++H N+V+L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 681 ---ALSPYGNLLFYDYMVNGSLWDLLHG--PSKKVKLDWETRLKIAVGAAQGLAYLHHDC 735
SPY Y+V L G + VK ++ L L++
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM---QMLLNGLYYIH 134
Query: 736 NPRIIHRDVKSSNILIDENFDAHLSDFGIARCI---PTAMPHASTFVLGTIGYIDPEYAH 792
+I+HRD+K++N+LI + L+DFG+AR + P+ T + T+ Y PE
Sbjct: 135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194
Query: 793 TSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS---- 847
R D++ G ++ E+ T + + HQL + ++ V P V
Sbjct: 195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254
Query: 848 ---------------VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
L P++R +
Sbjct: 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-32
Identities = 58/297 (19%), Positives = 110/297 (37%), Gaps = 32/297 (10%)
Query: 610 DIMRSTENLSEKY----IVGYGASSTVYKCA-LKNSRPIAVKKLYNQY--PHNLREFETE 662
++ ++ + Y VG GA V + +A+KKLY + + E
Sbjct: 8 EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYD-YMVNGSLWDLLHGPSKKVKLDWETRLKIA 721
L + +RH N++ L F D Y+V + L K KL + +
Sbjct: 68 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV 127
Query: 722 VGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG 781
+GL Y+H IIHRD+K N+ ++E+ + + DFG+AR + M + +V+
Sbjct: 128 YQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVT 181
Query: 782 TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKK--AVDNESNLHQLIM--------- 830
+ R + D++S G ++ E++TGK + + + IM
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 831 --SKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALL-----CTKRYPSERPTMQEV 880
+ + + + D +++ + +R T E
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-31
Identities = 57/269 (21%), Positives = 100/269 (37%), Gaps = 21/269 (7%)
Query: 623 IVGYGASSTVYKC----ALKNSRPIAVKKL----YNQYPHNLREFETELETIGSIRHR-N 673
++G GA V+ + A+K L Q TE + + IR
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 674 IVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH 733
+V+LH + L DY+ G L+ L ++ + + + + + L H
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHE---VQIYVGEIVLALEH 144
Query: 734 DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHT 793
II+RD+K NIL+D N L+DFG+++ + GTI Y+ P+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 794 SR--LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851
++ D +S G+++ E+LTG + + E+S
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264
Query: 852 DLSAVRKTFQLALLCTKRYPSERPTMQEV 880
DL +++ L KR E+
Sbjct: 265 DL--IQRL--LMKDPKKRLGCGPRDADEI 289
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 122 bits (307), Expect = 3e-31
Identities = 79/304 (25%), Positives = 131/304 (43%), Gaps = 13/304 (4%)
Query: 1 MAIKASFSNLANVLLDWDDVHNSDFC--SWRGVFCDNSS--LSVVSLNLSSLNLGG--EI 54
+ IK N L W +D C +W GV CD + V +L+LS LNL I
Sbjct: 12 LQIKKDLGN-PTTLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPI 68
Query: 55 SPSIGDLRNLQSIDFQGN-KLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLE 113
S+ +L L + G L G IP I L ++ ++ ++ G IP +S++K L
Sbjct: 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128
Query: 114 FLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGM 173
L+ N L+G +P +++ +PNL + N+++G IP L
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 174 LSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVAT 233
P L + D+ N L G G+ + + + ++ N + ++ +
Sbjct: 189 KIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNG 248
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNK-LTG- 291
L L+ N++ G +P+ + ++ L L++S N L G IP GNL NK L G
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307
Query: 292 PIPP 295
P+P
Sbjct: 308 PLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 100 bits (250), Expect = 9e-24
Identities = 76/254 (29%), Positives = 106/254 (41%), Gaps = 4/254 (1%)
Query: 281 KLYLHGNKLTG--PIPPELGNMSKLSYLQLQNN-QLVGTIPAELGKLEQLFELNLADNNL 337
L L G L PIP L N+ L++L + LVG IP + KL QL L + N+
Sbjct: 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113
Query: 338 EGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRII 397
G IP +S L + N LSG +P S +L +L + N G +P G
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173
Query: 398 NLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457
L T N +L ++LSRN L G +
Sbjct: 174 KLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD-ASVLFGSDKNTQKIHLAKNS 232
Query: 458 SGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSR 517
++G +N+ L L NN + G +P L+ L +LNVS+NNL G IP N R
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292
Query: 518 FSSNSFIGNPLLCG 531
F +++ N LCG
Sbjct: 293 FDVSAYANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 93.7 bits (231), Expect = 3e-21
Identities = 80/264 (30%), Positives = 113/264 (42%), Gaps = 29/264 (10%)
Query: 255 LAVLDLSENELVG--PIPPILGNLSYTGKLYLHGN-KLTGPIPPELGNMSKLSYLQLQNN 311
+ LDLS L PIP L NL Y LY+ G L GPIPP + +++L YL + +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 312 QLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRN 371
+ G IP L +++ L L+ + N L G +P +ISS L GNR+SGAIP S+ +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 372 LGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNF---------------------- 409
L N +NL +DLS N
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 410 -SGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQL 468
+G ++L L+L N + G LP L+ + ++++SFN L G IP + G L
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNL 290
Query: 469 QNIISLILNNNNLQGGIPDQLSNC 492
Q NN G P L C
Sbjct: 291 QRFDVSAYANNKCLCGSP--LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 34/141 (24%), Positives = 65/141 (46%), Gaps = 3/141 (2%)
Query: 367 SSFRNLGSLTYLNLSRNNFKGK--VPTELGRIINLDTLDLSVN-NFSGSVPASIGDLEHL 423
+ + L+LS N +P+ L + L+ L + N G +P +I L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 424 LTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG 483
L ++ +++G +P ++++ T+D S+N LSG++P + L N++ + + N + G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 484 GIPDQLSNCFSLSNLNVSYNN 504
IPD + L N
Sbjct: 164 AIPDSYGSFSKLFTSMTISRN 184
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 1e-27
Identities = 59/297 (19%), Positives = 109/297 (36%), Gaps = 32/297 (10%)
Query: 610 DIMRSTENLSEKY----IVGYGASSTVYKC-ALKNSRPIAVKKLYNQY--PHNLREFETE 662
++ ++ + E+Y VG GA +V K +AVKKL + + + E
Sbjct: 8 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWD-LLHGPSKKVKLDWETRLKIA 721
L + ++H N++ L F D + L L+ K KL + +
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 722 VGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLG 781
+GL Y+H HRD+K SN+ ++E+ + + DFG+AR + +V
Sbjct: 128 YQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVAT 181
Query: 782 TIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA 841
+ N+ D++S G ++ E+LTG+ ++ QL + T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 842 VD------------------PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEV 880
+ P+++ V + A L +R T +
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 113 bits (283), Expect = 2e-27
Identities = 76/396 (19%), Positives = 128/396 (32%), Gaps = 32/396 (8%)
Query: 60 DLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKN 119
L +T + + + ++ + I + L L +N N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 120 NQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMC 179
NQLT P L + L + + NQ+ P N L L
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 180 QLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGN 239
++ N + I + L + L +
Sbjct: 134 L----NRLELSSNTI-----SDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 184
Query: 240 KLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGN 299
I + L L + N++ P L+ +L L+GN+L L +
Sbjct: 185 NKVSDISVLAKLTNL-ESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLAS 239
Query: 300 MSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGN 359
++ L+ L L NNQ+ P L L +L EL L N + P + + N +
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297
Query: 360 RLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGD 419
S NL +LTYL L NN P + + L L + N S +S+ +
Sbjct: 298 E----DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 420 LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFN 455
L ++ L+ N ++ L P NL I + ++
Sbjct: 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 107 bits (267), Expect = 2e-25
Identities = 79/426 (18%), Positives = 141/426 (33%), Gaps = 58/426 (13%)
Query: 78 IPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLK 137
D + L ++ + S + L Q+ L + + + NL
Sbjct: 16 FTDT--ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLT 69
Query: 138 TLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGT 197
++ + NQLT P + L + + N + +
Sbjct: 70 QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT---- 123
Query: 198 IPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAV 257
D + N T+ L++S N I+ + Q ++ ++ L +
Sbjct: 124 DIDPLKNLTNLNRLELSSNTISDISALSGLTSL------QQLSFGNQVTDLKPLANLTTL 177
Query: 258 LDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI 317
L + +L L+ L N+++ P ++ L L L NQL
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD-- 233
Query: 318 PAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTY 377
L L L +L+LA+N + P +S T L + + N++S P L +LT
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 289
Query: 378 LNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLL 437
L L+ N + P + NL L L NN S P + L L L + N ++
Sbjct: 290 LELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343
Query: 438 PAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSN 497
+ NL +I + NQ+S P L+N ++
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--------------------------LANLTRITQ 377
Query: 498 LNVSYN 503
L ++
Sbjct: 378 LGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.8 bits (237), Expect = 1e-21
Identities = 76/414 (18%), Positives = 140/414 (33%), Gaps = 55/414 (13%)
Query: 104 FSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYL 163
F+ + L + L +T + + T + + TL R +
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK---------------- 57
Query: 164 GLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIP 223
++ G+ L L + N LT P + N T + ++ NQI P
Sbjct: 58 -----SIDGV-----EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 105
Query: 224 YNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLY 283
+ + + L + + +++ G
Sbjct: 106 LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV 165
Query: 284 LHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPH 343
L E ++S + KL L L +N + P
Sbjct: 166 TDLKPLANLTTLERLDISSNKVSDISVL----------AKLTNLESLIATNNQISDITPL 215
Query: 344 NISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLD 403
I T L++ +++GN+L + +L +LT L+L+ N P L + L L
Sbjct: 216 GI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 269
Query: 404 LSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPA 463
L N S P + L L L L+ N L + NL+++ + + FN +S P
Sbjct: 270 LGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP- 324
Query: 464 ELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSR 517
+ L + L NN + L+N +++ L+ +N +S + P+ N +R
Sbjct: 325 -VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT-PLANLTR 374
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.5 bits (231), Expect = 8e-21
Identities = 60/354 (16%), Positives = 119/354 (33%), Gaps = 48/354 (13%)
Query: 39 SVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSL 98
V +L L + + + L NL I+F N+LT P + N LV I +++N +
Sbjct: 45 QVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
Query: 99 YGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIP------NLKTLDLARNQLTGEIPR 152
P + L P+ + + + + +
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 153 LIYWNEVLQYLGL-------RGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNC 205
L+ L ++ + +LT L N ++ P I
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--L 218
Query: 206 TSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENEL 265
T+ + L ++ NQ+ I + L L N+++ P + + L L L N++
Sbjct: 219 TNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 275
Query: 266 VGPIP--------------------PILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSY 305
P + NL L L+ N ++ P + +++KL
Sbjct: 276 SNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 333
Query: 306 LQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGN 359
L NN++ + + L L + L+ N + P +++ T + Q ++
Sbjct: 334 LFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 82.4 bits (202), Expect = 4e-17
Identities = 53/234 (22%), Positives = 88/234 (37%), Gaps = 22/234 (9%)
Query: 7 FSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQS 66
+NL + + S + SL + +S + +G L NL
Sbjct: 171 LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDI-------TPLGILTNLDE 223
Query: 67 IDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPI 126
+ GN+L + + +L ++L++N + P S L +L L L NQ++
Sbjct: 224 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNIS 279
Query: 127 PSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWY 186
P L + L L+L NQ E I + L YL L N ++ + LT L
Sbjct: 280 P--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQR 333
Query: 187 FDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPY-NIGFLQVATLSLQGN 239
N ++ S+ N T+ L +NQI+ P N+ + L L
Sbjct: 334 LFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRIT--QLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.4 bits (158), Expect = 1e-11
Identities = 30/127 (23%), Positives = 52/127 (40%), Gaps = 7/127 (5%)
Query: 44 NLSSLNLGGEISPSIGDLRNLQSIDFQGNKL-TGQIPDEIGNCGSLVHIELSDNSLYGDI 102
L+ L LG +I L L ++ + I N +L ++ L N++
Sbjct: 264 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS 323
Query: 103 PFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQY 162
P S L +L+ L NN+++ S+L + N+ L NQ++ P + +
Sbjct: 324 PVS--SLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQ 377
Query: 163 LGLRGNA 169
LGL A
Sbjct: 378 LGLNDQA 384
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 111 bits (278), Expect = 3e-27
Identities = 46/275 (16%), Positives = 96/275 (34%), Gaps = 23/275 (8%)
Query: 623 IVGYGASSTVYKC-ALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGY 680
+G G S V++ + N+ + VK L P ++ + E++ + ++R NI++L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADI 98
Query: 681 ALSPYGNLLF--YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPR 738
P ++++ N L L + L Y H
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--- 149
Query: 739 IIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL- 796
I+HRDVK N++ID E+ L D+G+A + + + + PE ++
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMY 207
Query: 797 NEKSDVYSFGIVLLEILTGK---KAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853
+ D++S G +L ++ K + + I + + +D
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888
+ + + + + A + L
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-26
Identities = 55/226 (24%), Positives = 91/226 (40%), Gaps = 12/226 (5%)
Query: 610 DIMRSTENLSEKY----IVGYGASSTVYKC-ALKNSRPIAVKKLYNQY--PHNLREFETE 662
++ ST + ++Y +G GA V R +A+KKL + + + E
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 663 LETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722
L + + H+NI+SL F D + L D +++LD E +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGT 782
G+ +LH IHRD+K SNI++ + + DFG+AR T T + T
Sbjct: 127 QMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVT 181
Query: 783 IGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQL 828
Y PE E D++S G ++ E++ K + Q
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (264), Expect = 1e-25
Identities = 64/295 (21%), Positives = 110/295 (37%), Gaps = 27/295 (9%)
Query: 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNC 85
C R V C + L V +L + +D Q NK+T + N
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPP---------------DTALLDLQNNKITEIKDGDFKNL 54
Query: 86 GSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQ 145
+L + L +N + P + + L +LE L L NQL + L+ + +
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 146 LTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNC 205
+ + + V+ LG +G+ + + L Y + N+T TIP +
Sbjct: 115 VRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--P 170
Query: 206 TSFEILDISYNQITGEIPYNIGFLQV-ATLSLQGNKLTGKIPEVIGLMQALAVLDLSENE 264
S L + N+IT ++ L A L L N ++ + L L L+ N+
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 265 LVGPIPPILGNLSYTGKLYLHGNKLTG------PIPPELGNMSKLSYLQLQNNQL 313
LV +P L + Y +YLH N ++ P + S + L +N +
Sbjct: 231 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.7 bits (247), Expect = 2e-23
Identities = 59/287 (20%), Positives = 107/287 (37%), Gaps = 14/287 (4%)
Query: 102 IPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQ 161
+P + L+L+NN++T + NL TL L N+++ P L+
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 162 YLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGE 221
L L N L + L L + + ++ + + E+ E
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 222 IPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGK 281
G +++ + + +T IP+ GL +L L L N++ L L+ K
Sbjct: 143 NGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 282 LYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEG-- 339
L L N ++ L N L L L NN+LV +P L + + + L +NN+
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIG 258
Query: 340 ----PIPHNISSCTALNQFNVHGNRLS--GAIPSSFRNLGSLTYLNL 380
P + + + ++ N + PS+FR + + L
Sbjct: 259 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.6 bits (239), Expect = 2e-22
Identities = 54/271 (19%), Positives = 100/271 (36%), Gaps = 14/271 (5%)
Query: 269 IPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLF 328
+P L T L L NK+T + N+ L L L NN++ P L +L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK 388
L L+ N L+ + L ++ ++ + + + L + G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGI 141
Query: 389 VPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQ 448
+ L + ++ N + ++P + L L+L N + + A L ++
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 449 TIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGI 508
+ +SFN +S L ++ L LNNN L +P L++ + + + NN+S I
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAI 257
Query: 509 IP-------PIRNFSRFSSNSFIGNPLLCGN 532
+ +S S NP+
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.1 bits (235), Expect = 7e-22
Identities = 57/287 (19%), Positives = 107/287 (37%), Gaps = 18/287 (6%)
Query: 179 CQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFL-QVATLSLQ 237
C L + L +P + +LD+ N+IT + L + TL L
Sbjct: 10 CHLRVV---QCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILI 63
Query: 238 GNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPEL 297
NK++ P + L L LS+N+L + L K+ + L
Sbjct: 64 NNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL 123
Query: 298 GNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVH 357
M + L + G +++L + +AD N+ IP + +L + ++
Sbjct: 124 NQMIVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLD 179
Query: 358 GNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASI 417
GN+++ +S + L +L L LS N+ L +L L L+ N VP +
Sbjct: 180 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 238
Query: 418 GDLEHLLTLNLSRNHLNGL------LPAEFGNLRSIQTIDMSFNQLS 458
D +++ + L N+++ + P S + + N +
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.1 bits (178), Expect = 2e-14
Identities = 33/203 (16%), Positives = 72/203 (35%), Gaps = 10/203 (4%)
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
+P ++ TAL ++ N+++ F+NL +L L L N P ++ L+
Sbjct: 25 VPKDLPPDTAL--LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL--S 458
L LS N L+ L N + + + F L + +++ N L S
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHE---NEITKVRKSVFNGLNQMIVVELGTNPLKSS 139
Query: 459 GSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRF 518
G ++ + + + + N+ + L+ L++ N ++ +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQGLPPS---LTELHLDGNKITKVDAASLKGLNN 196
Query: 519 SSNSFIGNPLLCGNWIGSICGPS 541
+ + + GS+
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTP 219
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 65.8 bits (159), Expect = 5e-12
Identities = 27/155 (17%), Positives = 53/155 (34%), Gaps = 3/155 (1%)
Query: 374 SLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHL 433
L + S + KVP +L + LDL N + +L++L TL L N +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 434 NGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCF 493
+ + P F L ++ + +S NQL LQ + ++ + + L+
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 494 SLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPL 528
+ + + + S +
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.9 bits (141), Expect = 8e-10
Identities = 41/199 (20%), Positives = 73/199 (36%), Gaps = 22/199 (11%)
Query: 21 HNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPD 80
N + VF + + VV L + L G + + ++ L I +T IP
Sbjct: 109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 167
Query: 81 EIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLD 140
G SL + L N + S+ L L L L N ++ +L P+L+ L
Sbjct: 168 --GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225
Query: 141 LARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPD 200
L N+L ++P + ++ +Q + L N ++ + S D C P
Sbjct: 226 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP------------------PG 266
Query: 201 SIGNCTSFEILDISYNQIT 219
S+ + + N +
Sbjct: 267 YNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.1 bits (126), Expect = 6e-08
Identities = 29/166 (17%), Positives = 58/166 (34%), Gaps = 12/166 (7%)
Query: 12 NVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQG 71
++++ G F LS + + +++ I + +L + G
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGL--PPSLTELHLDG 180
Query: 72 NKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLT 131
NK+T + +L + LS NS+ S++ L L+L NN+L +P L
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 239
Query: 132 QIPNLKTLDLARNQLTG------EIPRLIYWNEVLQYLGLRGNALT 171
++ + L N ++ P + L N +
Sbjct: 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 20/117 (17%), Positives = 41/117 (35%), Gaps = 3/117 (2%)
Query: 422 HLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNL 481
HL + S L + P + +D+ N+++ + L+N+ +LIL NN +
Sbjct: 11 HLRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 482 QGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSIC 538
P + L L +S N L + + + + + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (255), Expect = 4e-24
Identities = 44/216 (20%), Positives = 80/216 (37%), Gaps = 23/216 (10%)
Query: 621 KYIV----GYGASSTVYKC-ALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIV 675
+YI+ G+G STV+ + N+ +A+K + E E++ + + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNT 72
Query: 676 SL-------------HGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAV 722
H P G + + V G L + + +I+
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 723 GAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPTAMPHAS-TFVL 780
GL Y+H C IIH D+K N+L++ + +L IA T +
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 781 GTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK 816
T Y PE + +D++S ++ E++TG
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (234), Expect = 6e-22
Identities = 63/276 (22%), Positives = 105/276 (38%), Gaps = 8/276 (2%)
Query: 233 TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGP 292
T S L +P G+ A + L N + L+LH N L
Sbjct: 15 TTSCPQQGLQ-AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 293 IPPELGNMSKLSYLQLQNNQLVGTI-PAELGKLEQLFELNLADNNLEGPIPHNISSCTAL 351
++ L L L +N + ++ PA L +L L+L L+ P AL
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 352 NQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG 411
+ N L +FR+LG+LT+L L N + +LD L L N +
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 412 SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNI 471
P + DL L+TL L N+L+ L LR++Q + ++ N A +
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWL 250
Query: 472 ISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSG 507
+++ + +P +L+ ++ N+L G
Sbjct: 251 QKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (218), Expect = 7e-20
Identities = 61/283 (21%), Positives = 95/283 (33%), Gaps = 9/283 (3%)
Query: 179 CQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFL-QVATLSLQ 237
C L +P I + + + + N+I+ + + L L
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 238 GNKLTGKIPEVIGLMQALAVLDLSENELVGPIPP-ILGNLSYTGKLYLHGNKLTGPIPPE 296
N L + L LDLS+N + + P L L+L L P
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 297 LGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNV 356
++ L YL LQ+N L L L L L N + +L++ +
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 357 HGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPAS 416
H NR++ P +FR+LG L L L NN L + L L L+ N + +
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRA 243
Query: 417 IGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459
L S + + LP L ++ N L G
Sbjct: 244 RPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (212), Expect = 5e-19
Identities = 65/274 (23%), Positives = 93/274 (33%), Gaps = 7/274 (2%)
Query: 211 LDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIP 270
+ +P I + L GN+++ + L +L L N L
Sbjct: 16 TSCPQQGLQ-AVPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 271 PILGNLSYTGKLYLHGNKLTGPIPP-ELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFE 329
L+ +L L N + P + +L L L L P L L
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 330 LNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKV 389
L L DN L+ L +HGNR+S +FR L SL L L +N
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 390 PTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQT 449
P + L TL L NN S ++ L L L L+ N A +Q
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQK 252
Query: 450 IDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG 483
S +++ S+P L L N+LQG
Sbjct: 253 FRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (203), Expect = 7e-18
Identities = 48/250 (19%), Positives = 87/250 (34%), Gaps = 4/250 (1%)
Query: 282 LYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPI 341
L +P + + + L N++ A L L L N L
Sbjct: 16 TSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 342 PHNISSCTALNQFNVHGNRLSGAI-PSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
+ L Q ++ N ++ P++F LG L L+L R + P + L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460
L L N + DL +L L L N ++ + F L S+ + + N+++
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 461 IPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSS 520
P L +++L L NNL + L+ +L L ++ N ++
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQK 252
Query: 521 NSFIGNPLLC 530
+ + C
Sbjct: 253 FRGSSSEVPC 262
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (195), Expect = 7e-17
Identities = 60/261 (22%), Positives = 99/261 (37%), Gaps = 7/261 (2%)
Query: 269 IPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLF 328
+P + + + +++LHGN+++ L+ L L +N L A L L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 329 ELNLADNNLEGPI-PHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKG 387
+L+L+DN + P L+ ++ L P FR L +L YL L N +
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 388 KVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSI 447
+ NL L L N S + L L L L +N + + P F +L +
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 448 QTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSG 507
T+ + N LS L L+ + L LN+N L S + +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPC 262
Query: 508 IIPPI---RNFSRFSSNSFIG 525
+P R+ R ++N G
Sbjct: 263 SLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (190), Expect = 3e-16
Identities = 44/279 (15%), Positives = 80/279 (28%), Gaps = 40/279 (14%)
Query: 26 CSWRG---VFCDNSSLSVV---------SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNK 73
C C L V + L + + S RNL + N
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 74 LTGQIPDEIGNCGSLVHIELSDNSLYGDI-PFSISKLKQLEFLNLKNNQLTGPIPSTLTQ 132
L L ++LSDN+ + P + L +L L+L L P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 133 IPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGN 192
+ L+ L L N L L +L L GN ++ + L L + N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 193 NLTGTIPDSI------------------------GNCTSFEILDISYNQITGEIPYNIGF 228
+ P + + + L ++ N + +
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247
Query: 229 LQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVG 267
+ +++ +P+ + + L+ N+L G
Sbjct: 248 AWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (182), Expect = 3e-15
Identities = 40/241 (16%), Positives = 73/241 (30%), Gaps = 5/241 (2%)
Query: 3 IKASFSNLANVLLDWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLR 62
ASF N+ + W + + L + L
Sbjct: 48 PAASFRACRNLTILWLHSNVLARIDAAAFTGLALL--EQLDLSDNAQLRSVDPATFHGLG 105
Query: 63 NLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQL 122
L ++ L P +L ++ L DN+L + L L L L N++
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165
Query: 123 TGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLT 182
+ + +L L L +N++ P L L L N L+ + + + L
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225
Query: 183 GLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLT 242
L Y + N + + S +++ +P + + L N L
Sbjct: 226 ALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAGRDL--KRLAANDLQ 282
Query: 243 G 243
G
Sbjct: 283 G 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 4e-05
Identities = 37/163 (22%), Positives = 58/163 (35%), Gaps = 9/163 (5%)
Query: 376 TYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNG 435
+ + + VP + + L N S AS +L L L N L
Sbjct: 14 VTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 436 LLPAEFGNLRSIQTIDMSFNQLSGSI-PAELGQLQNIISLILNNNNLQGGIPDQLSNCFS 494
+ A F L ++ +D+S N S+ PA L + +L L+ LQ P +
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130
Query: 495 LSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSI 537
L L + N L + F + + L GN I S+
Sbjct: 131 LQYLYLQDNALQALPDDT-----FRDLGNLTHLFLHGNRISSV 168
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.4 bits (208), Expect = 3e-19
Identities = 30/199 (15%), Positives = 60/199 (30%), Gaps = 24/199 (12%)
Query: 623 IVGYGASSTVYKCALKNSRPIAVK----------KLYNQYPHNLREFETELETIGSIRHR 672
++G G S V+ C + VK K+ + + F R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 673 NIVSLHGYALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLH 732
+ L G Y + N L +L+ ++ + +A +
Sbjct: 67 ALQKLQGL-----AVPKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFY 120
Query: 733 HDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAH 792
H I+H D+ N+L+ E + DF + + + I ++
Sbjct: 121 HRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSV--EVGEEGWREILERDVRNIITYFS- 173
Query: 793 TSRLNEKSDVYSFGIVLLE 811
+ D+ S +L+
Sbjct: 174 -RTYRTEKDINSAIDRILQ 191
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (160), Expect = 2e-12
Identities = 48/211 (22%), Positives = 73/211 (34%), Gaps = 6/211 (2%)
Query: 320 ELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLN 379
E+ K+ E+N NL +P ++ ++ N L ++ LT LN
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 380 LSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPA 439
L R + + +N S+P L L L++S N L L
Sbjct: 62 LDRAELTKLQVD---GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 440 EFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLN 499
L +Q + + N+L P L + L L NNNL L+ +L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 500 VSYNNLSGIIPPIRNFSRFSSNSFIGNPLLC 530
+ N+L I GNP LC
Sbjct: 179 LQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (148), Expect = 8e-11
Identities = 39/210 (18%), Positives = 67/210 (31%), Gaps = 8/210 (3%)
Query: 201 SIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDL 260
+ S ++ +T +P ++ L L N L + L L+L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP-KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 261 SENE-LVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPA 319
E + L L + +P + L+ L + N+L
Sbjct: 63 DRAELTKLQVDGTLPVLGT----LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 320 ELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLN 379
L L +L EL L N L+ P ++ L + ++ N L+ L +L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 380 LSRNNFKGKVPTELGRIINLDTLDLSVNNF 409
L N+ +P L L N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 3e-10
Identities = 39/206 (18%), Positives = 68/206 (33%), Gaps = 24/206 (11%)
Query: 57 SIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLN 116
+ + + ++ LT +P ++ + LS+N LY ++ +L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 117 LKNNQLTGPIP---------------------STLTQIPNLKTLDLARNQLTGEIPRLIY 155
L +LT +P L LD++ N+LT +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 156 WNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISY 215
LQ L L+GN L + + L + NNLT + + + L +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 216 NQITGEIPYNIGFLQVATLSLQGNKL 241
N + G + L GN
Sbjct: 182 NSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 7e-10
Identities = 50/200 (25%), Positives = 74/200 (37%), Gaps = 7/200 (3%)
Query: 258 LDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI 317
++ + L +PP L T L+L N L L ++L+ L L +L
Sbjct: 15 VNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ 71
Query: 318 PAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTY 377
L L L+L+ N L+ + +V NRL+ + R LG L
Sbjct: 72 VDG--TLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQE 128
Query: 378 LNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLL 437
L L N K P L L+ L L+ NN + + LE+L TL L N L +
Sbjct: 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-I 187
Query: 438 PAEFGNLRSIQTIDMSFNQL 457
P F + + N
Sbjct: 188 PKGFFGSHLLPFAFLHGNPW 207
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.0 bits (129), Expect = 2e-09
Identities = 21/111 (18%), Positives = 40/111 (36%), Gaps = 6/111 (5%)
Query: 115 LNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGML 174
L+L + LT + L Q+ + LDL+ N+L P L + + +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVL---QASDNALEN 57
Query: 175 SPDMCQLTGLWYFDVRGNNLTGT-IPDSIGNCTSFEILDISYNQITGEIPY 224
+ L L + N L + + +C +L++ N + E
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 108
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.8 bits (126), Expect = 6e-09
Identities = 27/108 (25%), Positives = 45/108 (41%), Gaps = 6/108 (5%)
Query: 43 LNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDI 102
L+L+ +L + + L + +D N+L P + L ++ SDN +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALEN 57
Query: 103 PFSISKLKQLEFLNLKNNQLTG-PIPSTLTQIPNLKTLDLARNQLTGE 149
++ L +L+ L L NN+L L P L L+L N L E
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.4 bits (125), Expect = 8e-09
Identities = 29/109 (26%), Positives = 44/109 (40%), Gaps = 6/109 (5%)
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460
L L+ + + V + L + L+LS N L L P LR ++ + S N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LE 56
Query: 461 IPAELGQLQNIISLILNNNNLQGG-IPDQLSNCFSLSNLNVSYNNLSGI 508
+ L + L+L NN LQ L +C L LN+ N+L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.9 bits (121), Expect = 3e-08
Identities = 20/119 (16%), Positives = 43/119 (36%), Gaps = 7/119 (5%)
Query: 355 NVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVP 414
++ L+ + L +T+L+LS N + P L + L+ L ++ +
Sbjct: 4 HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALENV 58
Query: 415 ASIGDLEHLLTLNLSRNHLNGL-LPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNII 472
+ +L L L L N L + + +++ N L +L ++
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 4e-08
Identities = 26/128 (20%), Positives = 42/128 (32%), Gaps = 12/128 (9%)
Query: 305 YLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGA 364
L L + L T+ L +L + L+L+ N L P +++ L N
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LE 56
Query: 365 IPSSFRNLGSLTYLNLSRNNFKG-KVPTELGRIINLDTLDLSVNNFSG------SVPASI 417
NL L L L N + L L L+L N+ + +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 418 GDLEHLLT 425
+ +LT
Sbjct: 117 PSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 3e-07
Identities = 33/126 (26%), Positives = 46/126 (36%), Gaps = 9/126 (7%)
Query: 257 VLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT 316
VL L+ +L + L L L L N+L PP L + L LQ +N L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENV 58
Query: 317 IPAELGKLEQLFELNLADNNLEG-PIPHNISSCTALNQFNVHGNRLSGA---IPSSFRNL 372
Q EL L +N L+ + SC L N+ GN L L
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 373 GSLTYL 378
S++ +
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 8e-06
Identities = 20/105 (19%), Positives = 35/105 (33%), Gaps = 5/105 (4%)
Query: 188 DVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPE 247
+ +LT + + LD+S+N++ P + L+ + + +
Sbjct: 4 HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDG 60
Query: 248 VIGLMQALAVLDLSENELVG-PIPPILGNLSYTGKLYLHGNKLTG 291
V L + L L N L L + L L GN L
Sbjct: 61 VANLPRLQ-ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 24/129 (18%), Positives = 49/129 (37%), Gaps = 14/129 (10%)
Query: 137 KTLDLARNQLTG--EIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNL 194
+ L LA LT + +L+ + +L L N L + P + L L N
Sbjct: 1 RVLHLAHKDLTVLCHLEQLLL----VTHLDLSHNRLRAL-PPALAALRCLEVLQASDNA- 54
Query: 195 TGTIPDSIGNCTSFEILDISYNQITG-EIPYNIGFL-QVATLSLQGNKLTGK---IPEVI 249
D + N + L + N++ + ++ L+LQGN L + +
Sbjct: 55 -LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113
Query: 250 GLMQALAVL 258
++ +++ +
Sbjct: 114 EMLPSVSSI 122
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 3e-09
Identities = 42/231 (18%), Positives = 67/231 (29%), Gaps = 17/231 (7%)
Query: 104 FSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYL 163
F L + + +T + T + + TL +T I + Y N L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEGVQYLNN-LIGL 68
Query: 164 GLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIP 223
L+ N +T + I T +
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 224 YNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLY 283
N+ L +I + L + LS L NLS L
Sbjct: 129 SNLQVL---------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLK 179
Query: 284 LHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLAD 334
NK++ P L ++ L + L+NNQ+ P L LF + L +
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.0 bits (123), Expect = 8e-08
Identities = 28/231 (12%), Positives = 69/231 (29%), Gaps = 17/231 (7%)
Query: 31 VFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVH 90
+F D + + + + N+ ++ + DL + ++ G +T + + +L+
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIG 67
Query: 91 IELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEI 150
+EL DN + P NL + L + + L +
Sbjct: 68 LELKDNQITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST 117
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEI 210
++ + N + + N +
Sbjct: 118 QITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTT 177
Query: 211 LDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLS 261
L N+I+ P + + L+ N+++ P + L ++ L+
Sbjct: 178 LKADDNKISDISPLA-SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 19/67 (28%), Positives = 29/67 (43%), Gaps = 5/67 (7%)
Query: 79 PDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKT 138
+ N L ++ DN + P + L L ++LKNNQ++ P L NL
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 139 LDLARNQ 145
+ L NQ
Sbjct: 222 VTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 28/217 (12%), Positives = 66/217 (30%), Gaps = 22/217 (10%)
Query: 299 NMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHG 358
++ + + + T+ L+ + L+ + + L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 359 NRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIG 418
N+++ P + L+ + + T + + +++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 419 DLEHLLTLNLSRNHL--------------NGLLPAEFGNLRSIQTIDMSFNQLSGSIPAE 464
L L + + L NL + T+ N++S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 465 LGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVS 501
L L N+I + L NN + P L+N +L + ++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 4e-06
Identities = 38/213 (17%), Positives = 72/213 (33%), Gaps = 23/213 (10%)
Query: 258 LDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI 317
+ ++ + + +L L G +T + ++ L L+L++NQ+
Sbjct: 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA 79
Query: 318 PAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNL----- 372
P + EL+ I S T + A S+ + L
Sbjct: 80 PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
Query: 373 ---------GSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHL 423
G LS N + T L + L TL N S P + L +L
Sbjct: 140 QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNL 197
Query: 424 LTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQ 456
+ ++L N ++ + P N ++ + ++ NQ
Sbjct: 198 IEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 5e-06
Identities = 34/218 (15%), Positives = 68/218 (31%), Gaps = 22/218 (10%)
Query: 275 NLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLAD 334
L+ K+ + +T + ++ ++ L + TI + L L L L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 335 NNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSR------------ 382
N + P + + + + + AI
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 383 --NNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAE 440
++ + LS+ N S + +L L TL N ++ + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 441 FGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNN 478
+L ++ + + NQ+S P L N+ + L N
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 26/201 (12%), Positives = 59/201 (29%), Gaps = 20/201 (9%)
Query: 324 LEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383
L ++ +N+ + + + + G ++ + L +L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 384 NFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGN 443
P + I L + ++ LT + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 444 LRSIQTIDMSFNQL--------------SGSIPAELGQLQNIISLILNNNNLQGGIPDQL 489
L + + L S L L + +L ++N + P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 490 SNCFSLSNLNVSYNNLSGIIP 510
++ +L +++ N +S + P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 39/219 (17%), Positives = 66/219 (30%), Gaps = 17/219 (7%)
Query: 211 LDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIP 270
+ + +T + + TLS G +T E + + L L+L +N++
Sbjct: 24 IAAGKSNVTDTVTQA-DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI--TDL 78
Query: 271 PILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFEL 330
L NL + G S + T A L L+ L+
Sbjct: 79 APLKNL-TKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137
Query: 331 NLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP 390
I + N + + + NL LT L N P
Sbjct: 138 L-------NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190
Query: 391 TELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLS 429
L + NL + L N S P + + +L + L+
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 54.4 bits (129), Expect = 7e-09
Identities = 40/188 (21%), Positives = 74/188 (39%), Gaps = 14/188 (7%)
Query: 26 CSWRGVFCDNSSLSVV----SLNLSSLNLGG------EISPSIGDLRNLQSIDFQGNKLT 75
C V C L + L+ + L L G L +L ++ + N+LT
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 76 GQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPN 135
G P+ + ++L +N + L QL+ LNL +NQ++ +P + + +
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 136 LKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLT 195
L +L+LA N L ++ E L+ L G A ++ + D+ +
Sbjct: 128 LTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFK 183
Query: 196 GTIPDSIG 203
+ +S G
Sbjct: 184 CSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.7 bits (109), Expect = 3e-06
Identities = 41/186 (22%), Positives = 73/186 (39%), Gaps = 8/186 (4%)
Query: 282 LYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNLEGP 340
+ G L IP ++ + L L +N+L L G+L L +L L N L G
Sbjct: 13 VDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 341 IPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLD 400
P+ + + + + N++ F L L LNL N +P + +L
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 401 TLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460
+L+L+ N F+ + E L +L+ P++ +R +Q D+ ++ S
Sbjct: 130 SLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCS 185
Query: 461 IPAELG 466
G
Sbjct: 186 SENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.6 bits (106), Expect = 6e-06
Identities = 32/178 (17%), Positives = 65/178 (36%), Gaps = 8/178 (4%)
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGS-LTYLNLSRNNFKG 387
++ L+ IP +I + ++ N L L L L RN G
Sbjct: 12 TVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68
Query: 388 KVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSI 447
P ++ L L N L L TLNL N ++ ++P F +L S+
Sbjct: 69 IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128
Query: 448 QTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNL 505
+++++ N + + + + LN + G P ++ + + ++ ++
Sbjct: 129 TSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.9 bits (99), Expect = 5e-05
Identities = 41/213 (19%), Positives = 71/213 (33%), Gaps = 34/213 (15%)
Query: 176 PDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI--GFLQVAT 233
P MC G D G L IP I L ++ N++ + +
Sbjct: 3 PAMCHCEGT-TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVK 58
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI 293
L L+ N+LTG P + L L EN++ + L L L+ N+++ +
Sbjct: 59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118
Query: 294 PPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQ 353
P +++ L+ L L +N H L +
Sbjct: 119 PGSFEHLNSLTSLNLASNPFNC-------------------------NCHLAWFAEWLRK 153
Query: 354 FNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFK 386
+++G PS R+ + +L + FK
Sbjct: 154 KSLNGGAARCGAPSKVRD---VQIKDLPHSEFK 183
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 2e-08
Identities = 54/347 (15%), Positives = 107/347 (30%), Gaps = 29/347 (8%)
Query: 33 CDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIE 92
C + L L++L L + +L+S+ N LT ++P+ + L +
Sbjct: 35 CLDRQAHE--LELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQS---LKSLL 84
Query: 93 LSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPR 152
+ +N+L + L+ L N + +L S+ +I ++ L +
Sbjct: 85 VDNNNLKA-LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE 143
Query: 153 LIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILD 212
I L + + + D+ + + ++I
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203
Query: 213 ISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPI 272
I + + N + ++ L Q + I
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQ--------SLTFLDVSENI 255
Query: 273 LGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNL 332
LS + N + I L L + NN+L+ +PA +LE L
Sbjct: 256 FSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIA 311
Query: 333 ADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLN 379
+ N+L +P + L +V N L P ++ L +N
Sbjct: 312 SFNHLAE-VPELPQNLKQL---HVEYNPLRE-FPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 7e-08
Identities = 22/96 (22%), Positives = 40/96 (41%), Gaps = 8/96 (8%)
Query: 427 NLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIP 486
N + + + S++ +++S N+L +PA +L+ LI + N+L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLAE-VP 320
Query: 487 DQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNS 522
+ N L L+V YN L + NS
Sbjct: 321 ELPQN---LKQLHVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 8e-08
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 10/95 (10%)
Query: 353 QFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGS 412
+ N S I S SL LN+S N ++P L+ L S N+ +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-E 318
Query: 413 VPASIGDLEHLLTLNLSRNHLNGL--LPAEFGNLR 445
VP +L+ L++ N L +P +LR
Sbjct: 319 VPELPQNLKQ---LHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 22/122 (18%), Positives = 41/122 (33%), Gaps = 9/122 (7%)
Query: 16 DWDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLT 75
D ++ S + + EI +L+ ++ NKL
Sbjct: 238 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 297
Query: 76 GQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPN 135
++P L + S N L ++P LKQ L+++ N L P + +
Sbjct: 298 -ELPALPPR---LERLIASFNHL-AEVPELPQNLKQ---LHVEYNPLRE-FPDIPESVED 348
Query: 136 LK 137
L+
Sbjct: 349 LR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 9/93 (9%)
Query: 307 QLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIP 366
N I + L ELN+++N L +P L + N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVP 320
Query: 367 SSFRNLGSLTYLNLSRNNFKGKVPTELGRIINL 399
+L L++ N + + P + +L
Sbjct: 321 EL---PQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.003
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 5/65 (7%)
Query: 398 NLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457
L+L+ S S+P LE L S N L LP +L+S+ + + L
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESL---VASCNSLTE-LPELPQSLKSLLVDNNNLKAL 93
Query: 458 SGSIP 462
S P
Sbjct: 94 SDLPP 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 5e-08
Identities = 12/92 (13%), Positives = 32/92 (34%), Gaps = 5/92 (5%)
Query: 397 INLDTLDLSVNNFSGS-VPASIGDLEHLLTLNLSRNHLNG----LLPAEFGNLRSIQTID 451
+++ +LD+ S + + L+ + L L + + ++ ++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 452 MSFNQLSGSIPAELGQLQNIISLILNNNNLQG 483
+ N+L + Q S + +LQ
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 22/118 (18%), Positives = 41/118 (34%), Gaps = 12/118 (10%)
Query: 87 SLVHIELSDNSLYGDIPFS--ISKLKQLEFLNLKNNQLTG----PIPSTLTQIPNLKTLD 140
+ +++ L D ++ + L+Q + + L + LT I S L P L L+
Sbjct: 3 DIQSLDIQCEEL-SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 141 LARNQLTGEIPRLI-----YWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNN 193
L N+L + + +Q L L+ LTG + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 119
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 5e-07
Identities = 18/140 (12%), Positives = 40/140 (28%), Gaps = 5/140 (3%)
Query: 423 LLTLNLSRNHLNGLLPAE-FGNLRSIQTIDMSFNQLSG----SIPAELGQLQNIISLILN 477
+ +L++ L+ AE L+ Q + + L+ I + L + L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 478 NNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWIGSI 537
+N L + + + +L SS L + ++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123
Query: 538 CGPSVTKARVMFSRTAVVCM 557
G + + +
Sbjct: 124 LGDAGLQLLCEGLLDPQCRL 143
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 16/93 (17%), Positives = 30/93 (32%), Gaps = 5/93 (5%)
Query: 37 SLSVVSLNLSSLNLGGE-ISPSIGDLRNLQSIDFQGNKLTGQ----IPDEIGNCGSLVHI 91
SL + SL++ L + + L+ Q + LT I + +L +
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 92 ELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTG 124
L N L + + Q ++ L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 16/97 (16%), Positives = 31/97 (31%), Gaps = 9/97 (9%)
Query: 334 DNNLEGPIPHNISSCTALNQFNVHGNRLSG----AIPSSFRNLGSLTYLNLSRNNFKGKV 389
D + + L + +S ++ ++ SL L+LS N
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 390 PTELGRII-----NLDTLDLSVNNFSGSVPASIGDLE 421
+L + L+ L L +S + + LE
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 6e-06
Identities = 10/90 (11%), Positives = 22/90 (24%), Gaps = 5/90 (5%)
Query: 351 LNQFNVHGNRLSGA-IPSSFRNLGSLTYLNLSRNNFKGKVPTELGRII----NLDTLDLS 405
+ ++ LS A L + L ++ + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 406 VNNFSGSVPASIGDLEHLLTLNLSRNHLNG 435
N + + + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 14/80 (17%), Positives = 26/80 (32%), Gaps = 9/80 (11%)
Query: 84 NCGSLVHIELSDNSL----YGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQI-----P 134
L + L+D + + ++ L L+L NN L L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 135 NLKTLDLARNQLTGEIPRLI 154
L+ L L + E+ +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 12/116 (10%), Positives = 32/116 (27%), Gaps = 15/116 (12%)
Query: 17 WDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGE----ISPSIGDLRNLQSIDFQGN 72
++ + L L+ ++ ++ ++ +L+ +D N
Sbjct: 348 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 407
Query: 73 KLTGQIPDEIG-----NCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLT 123
L ++ L + L D ++ +L+ L L
Sbjct: 408 CLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 14/105 (13%), Positives = 35/105 (33%), Gaps = 22/105 (20%)
Query: 135 NLKTLDLARNQLTGE-IPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNN 193
++++LD+ +L+ L+ + Q + L LT
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT--------------------EA 42
Query: 194 LTGTIPDSIGNCTSFEILDISYNQITGEIPYNIG-FLQVATLSLQ 237
I ++ + L++ N++ + + LQ + +Q
Sbjct: 43 RCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 21/113 (18%), Positives = 32/113 (28%), Gaps = 26/113 (23%)
Query: 303 LSYLQLQNNQLVGTIPAEL-GKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRL 361
+ L +Q +L AEL L+Q + L D L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL--------------------TEAR 43
Query: 362 SGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRII-----NLDTLDLSVNNF 409
I S+ R +L LNL N + + + + L L
Sbjct: 44 CKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 14/72 (19%), Positives = 26/72 (36%), Gaps = 9/72 (12%)
Query: 110 KQLEFLNLKNNQLTG----PIPSTLTQIPNLKTLDLARNQLTGEIPR-----LIYWNEVL 160
L L L + ++ + +TL +L+ LDL+ N L + +L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 161 QYLGLRGNALTG 172
+ L L +
Sbjct: 429 EQLVLYDIYWSE 440
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 5e-05
Identities = 18/95 (18%), Positives = 31/95 (32%), Gaps = 5/95 (5%)
Query: 255 LAVLDLSENELV-GPIPPILGNLSYTGKLYLHGNKLTG----PIPPELGNMSKLSYLQLQ 309
+ LD+ EL +L L + L LT I L L+ L L+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 310 NNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHN 344
+N+L + + Q + +L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 15/77 (19%), Positives = 30/77 (38%), Gaps = 9/77 (11%)
Query: 422 HLLTLNLSRNHLNGL----LPAEFGNLRSIQTIDMSFNQLSGSIPAELGQ-----LQNII 472
L L L+ ++ L A S++ +D+S N L + +L + +
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 473 SLILNNNNLQGGIPDQL 489
L+L + + D+L
Sbjct: 430 QLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 14/93 (15%), Positives = 24/93 (25%), Gaps = 10/93 (10%)
Query: 374 SLTYLNLSRNNFKGKVPTEL-GRIINLDTLDLSVNNFSGSVPASIGD----LEHLLTLNL 428
+ L++ EL + + L + + I L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 429 SRNHLNG-----LLPAEFGNLRSIQTIDMSFNQ 456
N L +L IQ + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 14/82 (17%), Positives = 26/82 (31%), Gaps = 9/82 (10%)
Query: 438 PAEFGNLRSIQTIDMSFNQLSG----SIPAELGQLQNIISLILNNNNLQGGIPDQLS--- 490
++ + ++ +S S+ A L ++ L L+NN L QL
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 491 --NCFSLSNLNVSYNNLSGIIP 510
L L + S +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 14/89 (15%), Positives = 26/89 (29%), Gaps = 9/89 (10%)
Query: 366 PSSFRNLGSLTYLNLSRNNFKGKVPTELGRII----NLDTLDLSVNNFSGSVPASIGD-- 419
+ L L L+ + + L + +L LDLS N + + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 420 ---LEHLLTLNLSRNHLNGLLPAEFGNLR 445
L L L + + + L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 16/84 (19%), Positives = 26/84 (30%), Gaps = 9/84 (10%)
Query: 252 MQALAVLDLSENEL----VGPIPPILGNLSYTGKLYLHGNKLTGPIPPELG-----NMSK 302
L VL L++ ++ + L +L L N L +L
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 303 LSYLQLQNNQLVGTIPAELGKLEQ 326
L L L + + L LE+
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 8/80 (10%), Positives = 27/80 (33%), Gaps = 10/80 (12%)
Query: 184 LWYFDVRGNNLTGT----IPDSIGNCTSFEILDISYNQITGEIPYNIG------FLQVAT 233
L + +++ + + ++ S LD+S N + + +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 234 LSLQGNKLTGKIPEVIGLMQ 253
L L + ++ + + ++
Sbjct: 431 LVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 16/83 (19%), Positives = 28/83 (33%), Gaps = 9/83 (10%)
Query: 299 NMSKLSYLQLQNNQL----VGTIPAELGKLEQLFELNLADNNLEGPIPHNISS-----CT 349
S L L L + + ++ A L L EL+L++N L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 350 ALNQFNVHGNRLSGAIPSSFRNL 372
L Q ++ S + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 16/74 (21%), Positives = 26/74 (35%), Gaps = 6/74 (8%)
Query: 209 EILDISYNQITGEIPYNI--GFLQVATLSLQGNKLTGK----IPEVIGLMQALAVLDLSE 262
+ LDI +++ + Q + L LT I + + ALA L+L
Sbjct: 5 QSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRS 64
Query: 263 NELVGPIPPILGNL 276
NEL +
Sbjct: 65 NELGDVGVHCVLQG 78
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.0 bits (120), Expect = 3e-07
Identities = 39/336 (11%), Positives = 88/336 (26%), Gaps = 35/336 (10%)
Query: 37 SLSVVSLNLSSLNLGG--EISPSIGDLRNLQSIDFQGNKLTGQ----IPDEIGNCGSLVH 90
S+ SL L ++ + + + +++ I GN + + + + I + L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 91 IELSDNSLY---GDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLT 147
E SD +IP ++ L Q K + + + L+++
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 148 GEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTS 207
+ + ++ L N L
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 208 FEILDISYNQITGEIPYNIGFLQVATLSLQGNKL--------------TGKIPEVIGLMQ 253
L + + I + +L + + +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 254 ALAVLDLSENELVGPIPPILGNLSYTGK------LYLHGNKLTGPIPPEL-----GNMSK 302
L L L++ L + + + L L N++ L M
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 303 LSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLE 338
L +L+L N+ + ++ ++F E
Sbjct: 304 LLFLELNGNRF-SEEDDVVDEIREVFSTRGRGELDE 338
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 47/340 (13%), Positives = 85/340 (25%), Gaps = 42/340 (12%)
Query: 104 FSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGE----IPRLIYWNEV 159
FSI K L+ + + + L + ++K + L+ N + E + I +
Sbjct: 3 FSIEG-KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 160 LQYLGLRGNAL----------TGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFE 209
L+ +L + + L + N T + + + S
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 210 ILDISYN-QITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGP 268
G P + A L NK P + ++ L+ +
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 269 IPPILGNLSYTGKLYLHGNKLTGPIPPELGNMS------KLSYLQLQNNQLVGTIPAELG 322
L + G + + L
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 323 KLEQLFELNLADNNLEGPIPHNISSC------TALNQFNVHGNRLSGAIPSS-----FRN 371
L EL L D L + L + N + +
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 372 LGSLTYLNLSRNNFK--GKVPTELGRII------NLDTLD 403
+ L +L L+ N F V E+ + LD LD
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 36/325 (11%), Positives = 78/325 (24%), Gaps = 33/325 (10%)
Query: 187 FDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFL-----QVATLSLQGNKL 241
D ++ + S + + +S N I E + +
Sbjct: 12 LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
Query: 242 TGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLS----------------YTGKLYLH 285
E+ ++ L L +L L+ +
Sbjct: 72 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131
Query: 286 GNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNI 345
G + +N + +I +LE A + H +
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191
Query: 346 SSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLS 405
+ + L + N + + L NL L L+
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251
Query: 406 VNNFSGSVPASIGD------LEHLLTLNLSRNHLNG-----LLPAEFGNLRSIQTIDMSF 454
S A++ D L TL L N + L + + ++++
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311
Query: 455 NQLSGSIPAELGQLQNIISLILNNN 479
N+ + +++ + S
Sbjct: 312 NRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 7e-07
Identities = 46/278 (16%), Positives = 96/278 (34%), Gaps = 24/278 (8%)
Query: 281 KLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEG- 339
L L G L + L + + + + + + E ++ ++L+++ +E
Sbjct: 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61
Query: 340 PIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTE------- 392
+ +S C+ L ++ G RLS I ++ +L LNLS + + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 393 -LGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTID 451
L + D + + +V + L +N L ++ +D
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 452 MSFNQL-SGSIPAELGQLQNIISLILNN-NNLQGGIPDQLSNCFSLSNLNVSYNNLSGII 509
+S + + E QL + L L+ ++ +L +L L V G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 510 PPIR--------NFSRFSSNSFIGNPLLCGNWIGSICG 539
++ N S F++ I P + I G
Sbjct: 242 QLLKEALPHLQINCSHFTT---IARPTIGNKKNQEIWG 276
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 30/226 (13%), Positives = 66/226 (29%), Gaps = 13/226 (5%)
Query: 36 SSLSVVSLNLSSLNLGGEISPSI-GDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELS 94
S V ++LS+ + I LQ++ +G +L+ I + + +LV + LS
Sbjct: 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103
Query: 95 DNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTG------ 148
S + + L + + + + + L+G
Sbjct: 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQ 163
Query: 149 ---EIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRG-NNLTGTIPDSIGN 204
+ ++ L + QL L + + ++ +G
Sbjct: 164 KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 223
Query: 205 CTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIG 250
+ + L + G + L L + + T IG
Sbjct: 224 IPTLKTLQVFGIVPDGTLQLLKEALP--HLQINCSHFTTIARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 7e-06
Identities = 49/290 (16%), Positives = 95/290 (32%), Gaps = 25/290 (8%)
Query: 161 QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITG 220
Q L L G L ++ + G+ F + + + + + + +D+S + I
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60
Query: 221 EIPYNI--GFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSY 278
+ I ++ LSL+G +L+ I + L L NLS
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL----------------NLSG 104
Query: 279 TGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLE 338
+ L ++ + + + QL N +
Sbjct: 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK 164
Query: 339 GPIPHNISSCTALNQFNVHGNRL-SGAIPSSFRNLGSLTYLNLSR-NNFKGKVPTELGRI 396
+ + C L ++ + + F L L +L+LSR + + ELG I
Sbjct: 165 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224
Query: 397 INLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRS 446
L TL + G++ L H L ++ +H + GN ++
Sbjct: 225 PTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKN 271
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 33/190 (17%), Positives = 62/190 (32%), Gaps = 14/190 (7%)
Query: 31 VFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVH 90
+F D + + L N+ +S + DL + ++ + D + +L
Sbjct: 11 IFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQ 66
Query: 91 IELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEI 150
I S+N L P +N P+ + +I
Sbjct: 67 INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL--------TLFNNQI 118
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEI 210
+ + L ++ T + LT L + N +T P + N T+ E
Sbjct: 119 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLER 176
Query: 211 LDISYNQITG 220
LDIS N+++
Sbjct: 177 LDISSNKVSD 186
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (105), Expect = 6e-06
Identities = 20/111 (18%), Positives = 36/111 (32%), Gaps = 2/111 (1%)
Query: 425 TLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAEL-GQLQNIISLILNNNNLQG 483
L +R+ ++ + + Q + L + +L + + L+
Sbjct: 12 GLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70
Query: 484 GIPDQLSNCFSLSNLNVSYNNLSGIIPPIRNFSRFSSNSFIGNPLLCGNWI 534
PD LS LN+S+N L + GNPL C +
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 7e-05
Identities = 25/149 (16%), Positives = 42/149 (28%), Gaps = 5/149 (3%)
Query: 176 PDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI--GFLQVAT 233
PD C G + + + L I Q + G ++
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 234 LSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI 293
L++ + L P+ L+ L+LS N L + +L L GN L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 294 PPE-LGNMSKLSYLQLQNNQLVGTIPAEL 321
L + + +L L
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 3e-04
Identities = 21/139 (15%), Positives = 37/139 (26%), Gaps = 2/139 (1%)
Query: 374 SLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASI-GDLEHLLTLNLSRNH 432
+ L +R+ L NL L + + L L L + ++
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 433 LNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNC 492
L + P F + +++SFN L + L ++ N L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127
Query: 493 FSLSNLNVSYNNLSGIIPP 511
V L
Sbjct: 128 EEEGLGGVPEQKLQCHGQG 146
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.003
Identities = 24/144 (16%), Positives = 41/144 (28%), Gaps = 4/144 (2%)
Query: 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPS-SFRNLGSLTYLNLSRNNFKG 387
L + H++ L + + + + R LG L L + ++ +
Sbjct: 12 GLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70
Query: 388 KVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLN-GLLPAEFGNLRS 446
P L L+LS N S+ L L LS N L+
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEE 129
Query: 447 IQTIDMSFNQLSGSIPAELGQLQN 470
+ +L L + N
Sbjct: 130 EGLGGVPEQKLQCHGQGPLAHMPN 153
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.003
Identities = 18/135 (13%), Positives = 38/135 (28%), Gaps = 5/135 (3%)
Query: 111 QLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWN-EVLQYLGLRGNA 169
L + L NL L + Q + L+ L + +
Sbjct: 9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 170 LTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQI--TGEIPYNIG 227
L + L ++ N L ++ S + L +S N + + + +
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 228 FLQVATLSLQGNKLT 242
+ + + KL
Sbjct: 127 WEEEGLGGVPEQKLQ 141
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (105), Expect = 1e-05
Identities = 34/239 (14%), Positives = 67/239 (28%), Gaps = 9/239 (3%)
Query: 79 PDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKT 138
I +C S ++ + +IP + + L +L + +L+
Sbjct: 2 HHRICHC-SNRVFLCQESKV-TEIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 139 LDLARNQLTGEIPRLIYWNEVLQYLGLRGNAL--TGMLSPDMCQLTGLWYFDVRGNNLTG 196
+++++N + I ++ N + A + L L Y + +
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 197 TIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVAT---LSLQGNKLTGKIPEVIGLMQ 253
+ +LDI N I N L L N + Q
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 254 ALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQ 312
+ N L + S L + ++ L N+ KL N +
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 3e-05
Identities = 31/229 (13%), Positives = 58/229 (25%), Gaps = 10/229 (4%)
Query: 115 LNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLI--YWNEVLQYLGLRGNALTG 172
+ +++T IPS L N L +L + + +
Sbjct: 13 FLCQESKVTE-IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 173 MLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVA 232
+ NNL P++ N + + L IS I +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 233 TLSLQGNKLTGKIPEVIGLMQALAV---LDLSENELVGPIPPILGNLSYTGKLYLHGNKL 289
L + + E + L L++N + N L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 290 TGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLE 338
S L + ++ L L++L + NL+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 3e-05
Identities = 28/225 (12%), Positives = 59/225 (26%), Gaps = 7/225 (3%)
Query: 233 TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGP 292
Q +K+T +IP L + L +L K+ + N +
Sbjct: 12 VFLCQESKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 293 IPPELGNMSKLSYLQL----QNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSC 348
I ++ + + N + + Q ++ + S
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 349 TALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNN 408
L + N + S L L++N + + NN
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 409 FSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMS 453
+ L++SR ++ L NL+ ++
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 6e-05
Identities = 29/254 (11%), Positives = 64/254 (25%), Gaps = 27/254 (10%)
Query: 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNC 85
CS R C S ++ + +L RN + F KL
Sbjct: 8 CSNRVFLCQESKVTEIPSDLP---------------RNAIELRFVLTKLRVIQKGAFSGF 52
Query: 86 GSLVHIELSDNSLYGDI-------PFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKT 138
G L IE+S N + I + +++ + NL Q +
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 139 LDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTI 198
+ +I L +Q + LW +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 199 PDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVL 258
+ + + ++ ++ + L + ++ + ++ L
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPV--ILDISRTRIHSLPSYGLENLKKLRAR 230
Query: 259 DLSENELVGPIPPI 272
+ +P +
Sbjct: 231 STYNLK---KLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 31/230 (13%), Positives = 65/230 (28%), Gaps = 9/230 (3%)
Query: 257 VLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGT 316
V E+++ + N L KL L +++ N ++
Sbjct: 12 VFLCQESKVTEIPSDLPRNAIE---LRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 317 IPAELGKLEQLFELNLAD--NNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGS 374
I A++ + NNL P + L + + +
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 375 LTYLNLSR--NNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNH 432
L++ N + + +G L L+ N + + N+
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 433 LNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQ 482
L L F +D+S ++ L L+ + + + NL+
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 29/233 (12%), Positives = 58/233 (24%), Gaps = 9/233 (3%)
Query: 178 MCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVAT---L 234
+C + F + + +T IP + + L ++ +
Sbjct: 5 ICHCSNR-VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI 60
Query: 235 SLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIP 294
S + L + + N L+ P NL L + +
Sbjct: 61 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120
Query: 295 PELGNMSKLSYLQLQN--NQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALN 352
+ + L +Q+ N + +G + L L N ++ +
Sbjct: 121 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDE 180
Query: 353 QFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLS 405
N L F L++SR L + L
Sbjct: 181 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 30/235 (12%), Positives = 66/235 (28%), Gaps = 10/235 (4%)
Query: 282 LYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPI 341
+K+T IP +L L+ +L L ++ ++ N++ I
Sbjct: 13 FLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 342 PHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFK----GKVPTELGRII 397
++ S + + L +N V
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 398 NLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457
L + ++N + + +G + L L++N + + F + + N L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 458 SGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPI 512
+ L ++ + L N L + NL +P +
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK-LPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 18/121 (14%), Positives = 38/121 (31%), Gaps = 10/121 (8%)
Query: 17 WDDVHNSDFCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTG 76
D N + + S V L L+ + + + + + N L
Sbjct: 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191
Query: 77 QIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNL 136
D V +++S ++ + + LK+L + N L ++P L
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN----------LKKLPTL 241
Query: 137 K 137
+
Sbjct: 242 E 242
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 3e-05
Identities = 26/140 (18%), Positives = 51/140 (36%), Gaps = 8/140 (5%)
Query: 27 SWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCG 86
+ + S +L+L L P + ++ + + + + N
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR----SDPDLVAQNIDVVLN-RRSSMAATLRIIEENIP 65
Query: 87 SLVHIELSDNSLYG--DIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARN 144
L+ + LS+N LY D+ + K L+ LNL N+L + L+ L L N
Sbjct: 66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 125
Query: 145 QLTGEIP-RLIYWNEVLQYL 163
L+ + Y + + +
Sbjct: 126 SLSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 5e-05
Identities = 26/155 (16%), Positives = 48/155 (30%), Gaps = 6/155 (3%)
Query: 331 NLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP 390
L +E + +S +Q + L LN ++ +
Sbjct: 3 ELKPEQVEQ-LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLR 58
Query: 391 TELGRIINLDTLDLSVNNFSG--SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQ 448
I L +L+LS N + + + +L LNLS N L + ++
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 449 TIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQG 483
+ + N LS + + + I L G
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 3e-04
Identities = 24/97 (24%), Positives = 42/97 (43%), Gaps = 3/97 (3%)
Query: 77 QIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTG--PIPSTLTQIP 134
+ ++ V + + + + +L LNL NN+L + S + + P
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91
Query: 135 NLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALT 171
NLK L+L+ N+L E L+ L L GN+L+
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 9e-05
Identities = 31/164 (18%), Positives = 64/164 (39%), Gaps = 12/164 (7%)
Query: 174 LSPDMCQ-------LTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNI 226
L+ ++ + D+RG + I + F+ +D S N+I ++
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFP 60
Query: 227 GFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVG-PIPPILGNLSYTGKLYLH 285
++ TL + N++ + + L L L+ N LV L +L L +
Sbjct: 61 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL 120
Query: 286 GNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFE 329
N +T L + K+ +++ + Q V E + E++F+
Sbjct: 121 RNPVTNKKHYRLYVIYKVPQVRVLDFQKVK--LKERQEAEKMFK 162
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 28/156 (17%), Positives = 53/156 (33%), Gaps = 12/156 (7%)
Query: 73 KLTGQIPDEIG---NCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPST 129
KLT ++ ++ N ++L + I + L Q + ++ +N++
Sbjct: 2 KLTAELIEQAAQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI--RKLDG 58
Query: 130 LTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMC----QLTGLW 185
+ LKTL + N++ L L L L N+L + D LT L
Sbjct: 59 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 118
Query: 186 YFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGE 221
N I +LD + ++ +
Sbjct: 119 ILRNPVTNKKHYRLYVIYKVPQVRVLD--FQKVKLK 152
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 8e-04
Identities = 25/140 (17%), Positives = 45/140 (32%), Gaps = 7/140 (5%)
Query: 295 PELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQF 354
+ N + L L+ ++ I L+Q ++ +DN + L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 355 NVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKG----KVPTELGRIINLDTLDLSVNNFS 410
V+ NR+ + L LT L L+ N+ L + L L V N
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 411 GSVPASIGDLEHLLTLNLSR 430
I + + L+ +
Sbjct: 129 HYRLYVIYKVPQVRVLDFQK 148
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 33/192 (17%), Positives = 58/192 (30%), Gaps = 28/192 (14%)
Query: 78 IPDEIGNC---GSLVHIELSDNSLYGDIP------FSISKLKQLEFLNLKNNQLTGPIPS 128
I D I S+V E L+G IP ++S LK + L L N +
Sbjct: 7 IKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE----- 61
Query: 129 TLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFD 188
++ + ++ L + L + + +L L
Sbjct: 62 KISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLY 121
Query: 189 VRGNNLTGTI-PDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPE 247
+ N +T D + E L ++ N + + N N + E
Sbjct: 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN-------------NATSEYRIE 168
Query: 248 VIGLMQALAVLD 259
V+ + L LD
Sbjct: 169 VVKRLPNLKKLD 180
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 10/84 (11%)
Query: 406 VNNFSGSVPASIGD------LEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSG 459
+ + + +VP I + NL + + + L SI I + + +
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60
Query: 460 SIPAELGQLQNIISLILNNNNLQG 483
+ L N+ L LN N L
Sbjct: 61 VQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 36/204 (17%), Positives = 74/204 (36%), Gaps = 16/204 (7%)
Query: 275 NLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLAD 334
+ T K L +T + ++ + + N+ + + L + +L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 335 NNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELG 394
N L P + + + ++ + +LS + L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKK------LKSLSLEHNGISDINGLV 131
Query: 395 RIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSF 454
+ L++L L N + + L L TL+L N ++ ++P L +Q + +S
Sbjct: 132 HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 455 NQLSGSIPAELGQLQNIISLILNN 478
N +S + A L L+N+ L L +
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 2e-04
Identities = 29/231 (12%), Positives = 66/231 (28%), Gaps = 39/231 (16%)
Query: 31 VFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVH 90
+F D++ + NL ++ ++ + +L ++ I + +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG----------- 63
Query: 91 IELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEI 150
I L + L L N+LT + NLK L
Sbjct: 64 ---------------IQYLPNVTKLFLNGNKLTDIK-----PLANLKNLGWLFLDENKVK 103
Query: 151 PRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEI 210
+ + ++ + + T+ + + +
Sbjct: 104 DLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSL 163
Query: 211 LDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLS 261
+ +I G ++ L L N ++ + + GL + L VL+L
Sbjct: 164 ----EDNQISDIVPLAGLTKLQNLYLSKNHISD-LRALAGL-KNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 35/221 (15%), Positives = 64/221 (28%), Gaps = 22/221 (9%)
Query: 191 GNNLTGTIPDSIG------NCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGK 244
G+ T+P I ++ +T + N + + + +
Sbjct: 4 GSETI-TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN-ELNSIDQIIANNSDIKSV 61
Query: 245 IPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLS 304
I + + L L+ N+L P L NL G L+L NK+ + K
Sbjct: 62 QG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSL 117
Query: 305 YLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGA 364
L+ + + N + + + + +
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD------- 170
Query: 365 IPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLS 405
L L L LS+N+ L + NLD L+L
Sbjct: 171 -IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 943 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.56 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.32 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.58 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.56 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.78 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.7 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.11 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.38 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.39 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=418.05 Aligned_cols=248 Identities=27% Similarity=0.384 Sum_probs=212.4
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+|+++ +++.||+|++.+. .....+.+.+|+++++.++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999986 5789999998643 2345677899999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999996 445799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
. .....||+.|||||++.+..++.++||||+||++|||+||+.||.+......+..........++. +
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~----~----- 227 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----V----- 227 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT----S-----
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCcc----C-----
Confidence 2 234569999999999999999999999999999999999999998776555444433332222211 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++.+||++||++|||++|+++|-+
T Consensus 228 ----s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 228 ----TEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred ----CHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence 145678999999999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=417.47 Aligned_cols=255 Identities=26% Similarity=0.375 Sum_probs=202.1
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
++|+..+.||+|+||+||+|++++++.||||++... ....+++.+|++++++++|||||+++|++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 568889999999999999999988889999998753 4456789999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+|+|.+++.. ....+++..+..++.|||.||+|||++ +|+||||||+||++++++.+||+|||+|+.........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999864 345689999999999999999999999 99999999999999999999999999998876554444
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhC-CCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG-KKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.....||+.|+|||++.+..++.++|||||||++|||+|+ ++||.... ............. +..+..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~~~~------~~~p~~----- 226 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFR------LYKPRL----- 226 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-HHHHHHHHHHTCC------CCCCTT-----
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-HHHHHHHHHhcCC------CCCccc-----
Confidence 4456799999999999999999999999999999999995 55555443 3333332222111 111111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
....+.+++..||+.||++|||++|++++|+.+.
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1246789999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=420.69 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=214.9
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
++|+..+.||+|+||+||+|+++ +++.||||++........+.+.+|+++++.++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999975 58999999997666666788999999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++|+|.+++. ...+++.++..++.||+.||+|||++ +||||||||+|||++.++++||+|||+|+.+......
T Consensus 100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 9999999875 34699999999999999999999999 9999999999999999999999999999987544332
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
....+||+.|+|||++.+..++.++||||+||++|||+||+.||.+.................. ..++.+
T Consensus 173 -~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~-------- 242 (293)
T d1yhwa1 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKL-------- 242 (293)
T ss_dssp -BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSGGGS--------
T ss_pred -ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCcccC--------
Confidence 2345699999999999999999999999999999999999999987776555444332221111 111112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++.+||+.||++|||+.|+++|-+
T Consensus 243 -s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 243 -SAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp -CHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred -CHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 145678999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=417.98 Aligned_cols=259 Identities=29% Similarity=0.438 Sum_probs=208.0
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEeccc--CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQ--YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||+||+|+++ ..||||++... .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467899999999999999999865 36999998643 34456789999999999999999999998754 56899999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++.. ....+++.++..++.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999963 345699999999999999999999999 99999999999999999999999999998765432
Q ss_pred C-ceeeeEecccceeCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc--cccCccc
Q 002278 773 P-HASTFVLGTIGYIDPEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM--EAVDPEV 846 (943)
Q Consensus 773 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 846 (943)
. .......||+.|||||++.+ ..++.++|||||||++|||+||+.||.+.................+ ....+.+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 2 22334569999999999864 3588999999999999999999999987766555444333222111 1111111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
...+.+++.+||+.||++|||++|++++|+.+...
T Consensus 239 ---------~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 239 ---------PKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---------hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 25678999999999999999999999999876543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=416.41 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=207.0
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999986 58899999986543 3344678999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999997 445799999999999999999999999 99999999999999999999999999998764332
Q ss_pred C-ceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 773 P-HASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 773 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
. ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||..................... ..+.+
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~---- 232 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKKI---- 232 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTST-TGGGS----
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-ccccC----
Confidence 2 22334579999999999988775 57899999999999999999999765443333222222211111 11111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++.+||+.||++|||++|+++|-|
T Consensus 233 -----s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 233 -----DSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp -----CHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred -----CHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 145668999999999999999999988744
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-49 Score=420.50 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=219.4
Q ss_pred HhhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
..++|+..+.||+|+||+||+|.++ +++.||||++... ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 4568889999999999999999987 4788999998654 4456789999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+++|+|.+++... ....+++..+..++.|||.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998632 345789999999999999999999999 99999999999999999999999999999876655
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
........|++.|+|||++.+..++.++|||||||++|||++|..||....+............ .+..+...
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~------~~~~~~~~-- 241 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------RMERPEGC-- 241 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC------CCCCCTTC--
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC------CCCCCccc--
Confidence 5555556689999999999999999999999999999999997777665555554444332221 11111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
...+.+++..||+.||++|||++|+++.|+.+...
T Consensus 242 ---~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 242 ---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 24678999999999999999999999999876543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=412.97 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=211.6
Q ss_pred HhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..++|+..+.||+|+||+||+|.+++++.||||++... ....+.+.+|++++++++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 34688899999999999999999998889999998654 3456789999999999999999999998754 567999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++... ....+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 89 ~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999987632 233589999999999999999999999 999999999999999999999999999998765443
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
.......||+.|+|||++.+..++.++|||||||++|||+||..|+................. .+..+...
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~------~~~~p~~~--- 235 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------RMVRPDNC--- 235 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------CCCCCTTC---
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------CCCCcccC---
Confidence 334445689999999999999999999999999999999996555544444433333332211 11111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...+.+++.+||+.||++|||++++++.|+.+.
T Consensus 236 --~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 236 --PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 246788999999999999999999999988654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-48 Score=418.60 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=200.5
Q ss_pred hccccceEEeeeceEEEEEEEecC-C---ceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-S---RPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
++|+..+.||+|+||+||+|.++. + ..||||++.... ....+.|.+|++++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456667899999999999999763 2 258889886543 33456799999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++.. ....+++.++..++.|||+||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998873 345699999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCc----eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 771 AMPH----ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 771 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
.... ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+............. .. +.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~-~~------~~ 253 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-YR------LP 253 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CC------CC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC------CC
Confidence 3222 1223457999999999999999999999999999999998 89999876654433322221 11 11
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 846 VSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 846 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.+.. ....+.+++..||+.||++|||+.|+++.|+.+..
T Consensus 254 ~~~~-----~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 PPMD-----CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCTT-----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCcc-----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1111 12567889999999999999999999999987754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=406.13 Aligned_cols=253 Identities=21% Similarity=0.348 Sum_probs=215.4
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEcc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMV 695 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 695 (943)
++|+..+.||+|+||+||+|++++++.||||++... ....+++.+|++++++++|||||+++|++.++...++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 578899999999999999999988889999998754 3456789999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce
Q 002278 696 NGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA 775 (943)
Q Consensus 696 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 775 (943)
+|++.+++.. ....+++..+.+++.|+++||+|||++ +|+||||||+||++++++.+||+|||+|+.........
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999998763 345689999999999999999999999 99999999999999999999999999998776554444
Q ss_pred eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 776 STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 776 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+.......... . ..|. .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~---~~p~---~----- 225 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-L---YRPH---L----- 225 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-C---CCCT---T-----
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC-C---CCcc---c-----
Confidence 444568999999999999999999999999999999998 8999987765443322222111 1 1111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
....+.+++.+||+.||++|||+++++++|..
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 12467899999999999999999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=417.10 Aligned_cols=254 Identities=21% Similarity=0.278 Sum_probs=211.8
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
+.|++.+.||+|+||+||+|+++ +++.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46889999999999999999986 57889999997766667788999999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++|+|.+++.. ....+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.......
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence 99999998752 234699999999999999999999999 999999999999999999999999999976532211
Q ss_pred eeeeEecccceeCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 775 ASTFVLGTIGYIDPEYAH-----TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
......||+.|+|||++. +..|+.++||||+||++|||+||+.||.+...............+... .++.+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~--- 241 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRW--- 241 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGGGS---
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-ccccC---
Confidence 122356999999999874 456899999999999999999999999877666555444433221111 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...+.+++.+||+.||++|||+.|+++|-+
T Consensus 242 ------s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 242 ------SSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp ------CHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred ------CHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 246778999999999999999999988744
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=411.86 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=197.2
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEec--CCcceEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALS--PYGNLLF 690 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 690 (943)
++|+..+.||+|+||+||+|+.+ +++.||||++.... ....+.+.+|++++++++|||||++++++.+ +...++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999976 57899999986543 2345668899999999999999999999865 4457899
Q ss_pred EEEccCCChhhhccCCC-CCccCCHHHHHHHHHHHHHHHHHhhhCC--CCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 691 YDYMVNGSLWDLLHGPS-KKVKLDWETRLKIAVGAAQGLAYLHHDC--NPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||++. ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999985321 2356999999999999999999999871 11499999999999999999999999999998
Q ss_pred cCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
....... .....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+.......+...... ..+..+
T Consensus 164 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~- 238 (269)
T d2java1 164 LNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---RIPYRY- 238 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTS-
T ss_pred cccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC---CCCccc-
Confidence 7544322 23456999999999999999999999999999999999999999876654433332221111 111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
...+.+++.+||+.||++|||++|+++|-
T Consensus 239 --------s~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 239 --------SDELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred --------CHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence 14577899999999999999999998863
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-47 Score=418.86 Aligned_cols=255 Identities=19% Similarity=0.293 Sum_probs=218.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999976 5889999999776656667889999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC--CCCceeecccccccccCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID--ENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~DFGla~~~~~~ 771 (943)
+++|+|.+++.. ....+++..+..++.||+.||+|||++ +||||||||+|||++ .++.+||+|||+|+.....
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999853 345699999999999999999999999 999999999999996 4678999999999987544
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
. ......||+.|||||++.+..++.++||||+||++|||+||+.||.+.+....+..+............+.++
T Consensus 180 ~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s---- 253 (350)
T d1koaa2 180 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS---- 253 (350)
T ss_dssp S--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCC----
T ss_pred c--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC----
Confidence 3 3344679999999999999999999999999999999999999998877665555544443333332222222
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+.+++.+||+.||++|||++|+++|-+
T Consensus 254 -----~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 254 -----EDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp -----HHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred -----HHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 45678999999999999999999999854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=415.45 Aligned_cols=249 Identities=22% Similarity=0.261 Sum_probs=209.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|+..+.||+|+||+||+|+++ +++.||||++.+. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999986 5889999998643 2345677999999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999886 456799999999999999999999999 9999999999999999999999999999987543
Q ss_pred CC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 772 MP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 772 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
.. ......+||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+.......+......+++. ++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~----~s--- 234 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK----FF--- 234 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTT----CC---
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCcc----CC---
Confidence 22 22334569999999999999999999999999999999999999999876655544443333222221 11
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARV 883 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~ 883 (943)
..+.+++.+||+.||++|||++|+.++
T Consensus 235 ------~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 235 ------PKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ------HHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ------HHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 356789999999999999999987554
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-48 Score=415.95 Aligned_cols=254 Identities=21% Similarity=0.269 Sum_probs=199.4
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.+.|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|+++++.++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456999999999999999999986 57899999986543 2334567899999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC---CCCceeecccccccccC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID---ENFDAHLSDFGIARCIP 769 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DFGla~~~~ 769 (943)
|++||+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999997 345799999999999999999999999 999999999999995 57899999999998764
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccC
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVT 849 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (943)
... .....+||+.|||||++.+..++.++||||+||++|||+||+.||.+.........+............+.++
T Consensus 162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s-- 237 (307)
T d1a06a_ 162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS-- 237 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC--
T ss_pred CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC--
Confidence 432 2234569999999999999999999999999999999999999998877665555444443333333333332
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 850 CVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 850 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+.+++.+||+.||++|||+.|+++|-+
T Consensus 238 -------~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 238 -------DSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp -------HHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred -------HHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 45778999999999999999999999843
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-47 Score=418.33 Aligned_cols=254 Identities=20% Similarity=0.323 Sum_probs=218.8
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
+.|++.+.||+|+||+||+|+++ +++.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 68999999997665555677889999999999999999999999999999999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC--CCCceeecccccccccCCCC
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID--ENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~DFGla~~~~~~~ 772 (943)
++|+|.+++.. ...++++.+++.++.||+.||+|||++ +||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999988753 344699999999999999999999999 999999999999998 67899999999999876542
Q ss_pred CceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.........+......+.....+.++
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s----- 256 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS----- 256 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC-----
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC-----
Confidence 3344679999999999999999999999999999999999999999877766655554444444433333333
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+.+++..||+.||++|||+.|+++|-+
T Consensus 257 ----~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 257 ----PEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 45678999999999999999999999743
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=402.53 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=201.4
Q ss_pred ccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEec----CCcceEEE
Q 002278 619 SEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALS----PYGNLLFY 691 (943)
Q Consensus 619 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 691 (943)
+..+.||+|+||+||+|+++ +++.||+|++.... ....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999986 57889999986543 3345678999999999999999999999865 33468999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC-CCCceeecccccccccCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID-ENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DFGla~~~~~ 770 (943)
||+++|+|.+++. ....+++.++..++.||+.||+|||++ .++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999996 445799999999999999999999998 12299999999999997 578999999999986543
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
. .....+||+.|||||++.+ .++.++||||+||++|||+||+.||.+................ +...+...
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~~---- 238 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKVA---- 238 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGCC----
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC-CcccCccC----
Confidence 3 2234579999999999875 5999999999999999999999999877666555444333221 11111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
...+.+++.+||++||++|||+.|+++|-
T Consensus 239 -----~~~~~~li~~~l~~dp~~R~s~~ell~Hp 267 (270)
T d1t4ha_ 239 -----IPEVKEIIEGCIRQNKDERYSIKDLLNHA 267 (270)
T ss_dssp -----CHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred -----CHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence 13567899999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=405.29 Aligned_cols=260 Identities=27% Similarity=0.383 Sum_probs=207.8
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYM 694 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 694 (943)
.++|+..+.||+|+||+||+|+++++++||||++... ....+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 4679999999999999999999998889999998644 4456789999999999999999999999854 5689999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++|+|.+++... ....++|.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+........
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999888632 234589999999999999999999999 9999999999999999999999999999877555444
Q ss_pred eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCccCHH
Q 002278 775 ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDLS 854 (943)
Q Consensus 775 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (943)
......||+.|+|||++.++.++.++|||||||++|||+||..|+................... ..++.+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~--~~~~~~-------- 239 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--PCPPEC-------- 239 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CCCTTS--------
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--CCCccc--------
Confidence 4455679999999999999999999999999999999999766665444444444333222111 112222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 855 AVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 855 ~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
..++.+++.+||+.||++|||+++|++.|+.+....
T Consensus 240 -~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 240 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 246789999999999999999999999999877543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=407.07 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=214.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC------cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY------PHNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.++|+..+.||+|+||+||+|+++ +++.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999985 68899999986432 23467899999999999999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC----ceeecccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF----DAHLSDFG 763 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DFG 763 (943)
++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +||||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999996 345799999999999999999999999 999999999999998776 49999999
Q ss_pred cccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 764 IARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 764 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
+|+....... .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+......+..+............
T Consensus 163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 9987754322 23346899999999999999999999999999999999999999987766655554444333332222
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.++ ..+.+++++||+.||++|||++|+++|-+
T Consensus 241 ~~~s---------~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 241 SNTS---------ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp TTSC---------HHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCCC---------HHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 2222 45678999999999999999999998743
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=404.17 Aligned_cols=255 Identities=20% Similarity=0.327 Sum_probs=207.6
Q ss_pred hhccccceE-EeeeceEEEEEEEec---CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYI-VGYGASSTVYKCALK---NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.++|..... ||+|+||+||+|.++ ++..||||++.... ....++|.+|++++++++|||||+++|++.+ +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 345666664 999999999999865 34579999987543 3445789999999999999999999999875 46899
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++|+|.+++.. ....+++.++..++.|+|.||+|||++ +|+||||||+||+++.++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998753 345699999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCce--eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 770 TAMPHA--STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 770 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+......... .+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-------~~~~ 233 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-------RMEC 233 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-------CCCC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------CCCC
Confidence 443222 223458999999999999999999999999999999998 999998766544333222211 1111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
+... +..+.+++..||+.||++|||+.++.+.|+..
T Consensus 234 p~~~-----~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 234 PPEC-----PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CTTC-----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcC-----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 24677999999999999999999999988754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=412.05 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=209.2
Q ss_pred hhccccceEEeeeceEEEEEEEecCC------ceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNS------RPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPYG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 686 (943)
.++|+..+.||+|+||+||+|+++.. ..||+|++.... ......+.+|+++++++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 46899999999999999999997632 368999886543 34456788999999988 89999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCC--------------------CccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCC
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSK--------------------KVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKS 746 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 746 (943)
.++||||+++|+|.++++.... ...+++..++.++.||+.||+|||++ +||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999964321 23589999999999999999999999 999999999
Q ss_pred ccEEECCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcc
Q 002278 747 SNILIDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESN 824 (943)
Q Consensus 747 ~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~ 824 (943)
+||+++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876544332 2334568999999999999999999999999999999998 8999987655
Q ss_pred HHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 825 LHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
............. +..+... ...+.+++..||+.||++|||++||+++|..
T Consensus 273 ~~~~~~~~~~~~~------~~~p~~~-----~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DANFYKLIQNGFK------MDQPFYA-----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SHHHHHHHHTTCC------CCCCTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhcCCC------CCCCCcC-----CHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 4444433332211 1111111 2467899999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=417.85 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=206.8
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
.++|+..+.||+|+||+||+|+++ +++.||+|++.... ......+.+|++++++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 568999999999999999999976 57889999986543 3445678999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
|+++|+|.+++. ....+++..+..++.|++.||+|||+ + +|+||||||+|||+++++++||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999996 44579999999999999999999997 5 8999999999999999999999999999876432
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHH-hccccccc-----------
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMS-KADDNTVM----------- 839 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~-~~~~~~~~----------- 839 (943)
. ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+........ ....+...
T Consensus 159 ~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp T---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred c---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2 23357999999999999999999999999999999999999999765432211110 00000000
Q ss_pred -----------------------cccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 -----------------------EAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 -----------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
....+..+.. .....+.+++.+||..||++|||++|+++|-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG----VFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBT----TBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence 0000111100 01245778999999999999999999998743
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-47 Score=408.67 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=209.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.+.|+..+.||+|+||+||+|+++ +++.||||++..... ...+.+.+|++++++++|||||++++++.+++..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 356999999999999999999976 578899999865432 2345688999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|++..++. ....+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999977664 345799999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeeEecccceeCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHT---SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
. ....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+......+........+... .+.+
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~- 239 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHW- 239 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTS-
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCC-
Confidence 3 23469999999999864 45899999999999999999999999887766555544433222111 1111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVS 886 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~ 886 (943)
...+.+++.+||+.||++|||++|+++|-+-
T Consensus 240 --------s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 240 --------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred --------CHHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 1467789999999999999999999987553
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=404.46 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=204.6
Q ss_pred hhccccceEEeeeceEEEEEEEecCC-----ceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNS-----RPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 688 (943)
.+.|+..++||+|+||+||+|.++.+ ..||||++.... .....+|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688889999999999999997643 369999986543 334457899999999999999999999999999999
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
+||||+.+|++.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999998753 335699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccc
Q 002278 769 PTAMP--HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEV 846 (943)
Q Consensus 769 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (943)
..... .......||+.|+|||++.+..++.++|||||||++|||+||..|+................. .+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------~~~~ 234 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------RLPT 234 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------CCCC
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC------CCCC
Confidence 54322 222334589999999999999999999999999999999997666654444444443332221 1112
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 847 SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 847 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
+.. ....+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 235 ~~~-----~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 235 PMD-----CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CTT-----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred chh-----hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 111 124678999999999999999999999999876643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=400.24 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=200.3
Q ss_pred eEEeeeceEEEEEEEecC---CceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEEccC
Q 002278 622 YIVGYGASSTVYKCALKN---SRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDYMVN 696 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 696 (943)
+.||+|+||+||+|.++. ++.||||++.... +...+++.+|++++++++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998753 4679999986533 3345679999999999999999999999865 467899999999
Q ss_pred CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCce-
Q 002278 697 GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPHA- 775 (943)
Q Consensus 697 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~- 775 (943)
|+|.+++. ....+++.++..++.||+.||+|||++ +||||||||+||+++.++.+||+|||+|+.+.......
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999987 445699999999999999999999999 99999999999999999999999999998775443322
Q ss_pred -eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccCH
Q 002278 776 -STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVDL 853 (943)
Q Consensus 776 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (943)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.............. .+..+..+
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-------~~~~p~~~--- 235 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------RMGCPAGC--- 235 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------CCCCCTTC---
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-------CCCCCccc---
Confidence 233568999999999999999999999999999999998 899998766543322222211 11111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 854 SAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 854 ~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
+..+.+++.+||+.||++|||++++.+.|+..
T Consensus 236 --~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 236 --PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp --CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 24677899999999999999999998887653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=408.68 Aligned_cols=251 Identities=19% Similarity=0.246 Sum_probs=213.7
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 690 (943)
.++|+..+.||+|+||+||+|+.+ +++.||+|++.+. .....+.+.+|+.+++.++|||||++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999975 6899999998643 234567789999999999999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++++|++||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999987 456789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
.... ....+||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+.......+......++.. ++
T Consensus 158 ~~~~-~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~----~s--- 229 (337)
T d1o6la_ 158 DGAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LS--- 229 (337)
T ss_dssp TTCC-BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----SC---
T ss_pred CCcc-cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCcc----CC---
Confidence 3322 334579999999999999999999999999999999999999999877654444443333322222 11
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPT-----MQEVARVLV 885 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L~ 885 (943)
..+.+++..||++||++||+ ++|+++|-+
T Consensus 230 ------~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 230 ------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp ------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ------HHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 34568999999999999994 899998743
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-46 Score=401.88 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=212.3
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|++.+.||+|+||+||+|+++ +++.||||++.+. .....+.+.+|+.+++.++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999986 5889999998643 2345678899999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||++||++.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999886 455688999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
. ...+||+.|||||++.+..++.++||||+||++|||+||+.||.+.+.......+.......+.. ++
T Consensus 158 ~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~----~s---- 225 (316)
T d1fota_ 158 T----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF----FN---- 225 (316)
T ss_dssp B----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTT----SC----
T ss_pred c----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCC----CC----
Confidence 2 23569999999999999999999999999999999999999999877655554444433322222 21
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
..+.+++.+|+..||++|| |++++++|-+
T Consensus 226 -----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 226 -----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp -----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -----HHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 3566899999999999996 8999998744
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.8e-46 Score=395.19 Aligned_cols=258 Identities=27% Similarity=0.384 Sum_probs=209.9
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc----
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP---HNLREFETELETIGSIRHRNIVSLHGYALSPYG---- 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 686 (943)
.++|++.+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+++++.++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 357999999999999999999975 688999999965432 334578999999999999999999999976543
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.|+||||++||+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.++++|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 689999999999999886 455799999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCC--ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 767 CIPTAMP--HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 767 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
....... .......||+.|+|||++.+..+++++||||+||++|||+||+.||.+......................+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 6543322 23344579999999999999999999999999999999999999999877766655555544444333334
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhc
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERP-TMQEVARVLVSL 887 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~el~~~L~~~ 887 (943)
.++ ..+.+++.+|+++||++|| |++++.+.|.++
T Consensus 240 ~~s---------~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 240 GLS---------ADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp SCC---------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCC---------HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 333 4677899999999999999 899998888764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=395.36 Aligned_cols=256 Identities=25% Similarity=0.345 Sum_probs=199.3
Q ss_pred hhccccceEEeeeceEEEEEEEecC----CceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN----SRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
.++|+..+.||+|+||+||+|++.. +..||||++..... ...+.+.+|++++++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998753 34688998865433 33567899999999999999999999996 467899
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
||||+++|++.+++.. ....+++.+++.++.||++||+|||++ +|+||||||+||++++++.+||+|||+|+...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998753 345689999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCccccc
Q 002278 770 TAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV 848 (943)
Q Consensus 770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (943)
...........||+.|+|||++.+..++.++|||||||++|||+| |++||.+................ ..++.+
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~-- 234 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNC-- 234 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTC--
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC--
Confidence 554444555678999999999999999999999999999999998 89999876654433332222111 112222
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 849 TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 849 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...+.+++..||+.||++|||+.|++++|+.+.
T Consensus 235 -------~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 235 -------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 246789999999999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-45 Score=400.74 Aligned_cols=247 Identities=17% Similarity=0.190 Sum_probs=212.3
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 691 (943)
++|++.+.||+|+||+||+|+++ +++.||||++.+. .....+.+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999986 6899999998543 2345677899999999999999999999999999999999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTA 771 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~ 771 (943)
||+.+|+|.+++. ....+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999986 445799999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
. ....||+.|||||++.+..++.++||||+||++|||+||+.||.+.........+.......+.. ++
T Consensus 195 ~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~----~s---- 262 (350)
T d1rdqe_ 195 T----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FS---- 262 (350)
T ss_dssp B----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----CC----
T ss_pred c----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCcc----CC----
Confidence 2 23569999999999999999999999999999999999999998876655554444433322221 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
..+.++++.||+.||++|+ |++++++|-+
T Consensus 263 -----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 263 -----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp -----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -----HHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence 3567899999999999994 8999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=402.39 Aligned_cols=254 Identities=18% Similarity=0.239 Sum_probs=215.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
.++|++.+.||+|+||+||+|.++ +++.||||++.... .....+.+|+++++.++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367999999999999999999986 57889999986543 3345688999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCC--CceeecccccccccCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDEN--FDAHLSDFGIARCIPTA 771 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~DFGla~~~~~~ 771 (943)
++||+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999963 234699999999999999999999999 99999999999999854 57999999999876543
Q ss_pred CCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 772 MPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
.......||+.|+|||...+..++.++||||+||++|||++|+.||.+......+..+......+.....+.++
T Consensus 158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s---- 231 (321)
T d1tkia_ 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS---- 231 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSC----
T ss_pred --CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCC----
Confidence 23344679999999999999999999999999999999999999999877665555554444443333333332
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+.+++..|+..||++|||++|+++|-+
T Consensus 232 -----~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 232 -----IEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp -----HHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -----HHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 35678999999999999999999999754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.8e-46 Score=391.94 Aligned_cols=252 Identities=26% Similarity=0.329 Sum_probs=210.7
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcc---------cHHHHHHHHHHHhcCC-CCCcceeeeEEecC
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH---------NLREFETELETIGSIR-HRNIVSLHGYALSP 684 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 684 (943)
++|+..+.||+|+||+||+|+.+ +++.||||++...... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 67999999999999999999975 6889999998654321 1235789999999997 99999999999999
Q ss_pred CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
+..|+||||+++|+|.+++. ..+.+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997 456799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeEecccceeCcccccc------CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHT------SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTV 838 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 838 (943)
++....... .....||+.|+|||++.+ ..++.++||||+||++|||+||+.||.+.........+.......
T Consensus 157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 998765432 233569999999998763 346889999999999999999999999877655544444333322
Q ss_pred ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
.....+.++ ..+.+++.+||++||++|||+.|+++|-
T Consensus 235 ~~~~~~~~s---------~~~~~li~~~L~~~p~~R~s~~eil~h~ 271 (277)
T d1phka_ 235 GSPEWDDYS---------DTVKDLVSRFLVVQPQKRYTAEEALAHP 271 (277)
T ss_dssp CTTTGGGSC---------HHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred CCcccccCC---------HHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 222222222 4677899999999999999999998874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=395.42 Aligned_cols=259 Identities=25% Similarity=0.259 Sum_probs=203.4
Q ss_pred cceEEeeeceEEEEEEEec-CCceEEEEEecccCcc-----cHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 620 EKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPH-----NLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 620 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
..++||+|+||+||+|+++ +++.||||++...... ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999976 5889999998643321 124688999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+.++++..+.. ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99988877764 445689999999999999999999999 999999999999999999999999999987755433
Q ss_pred ceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCccccc----
Q 002278 774 HASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSV---- 848 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 848 (943)
.. ...+||+.|+|||++.+. .++.++||||+||++|||+||++||.+..+.+....+....+.......+....
T Consensus 156 ~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AY-THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CC-CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cc-cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 22 234699999999988754 579999999999999999999999998877666554433222111111100000
Q ss_pred ------CccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 849 ------TCVDL-----SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 849 ------~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..... .....+.+++.+|++.||++|||++|+++|-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 00000 11246789999999999999999999999854
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-45 Score=394.35 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=210.9
Q ss_pred HhhccccceEEeeeceEEEEEEEecC------CceEEEEEecccCc-ccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQYP-HNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
..++|+..+.||+|+||+||+|++++ ++.||||++..... ...+++.+|++++++++||||+++++++.+...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 45689999999999999999999752 46899999865433 335679999999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCC---------------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 002278 687 NLLFYDYMVNGSLWDLLHGPS---------------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVK 745 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 745 (943)
.+++|||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 999999999999999985321 123489999999999999999999999 99999999
Q ss_pred CccEEECCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCC-CCCCCCc
Q 002278 746 SSNILIDENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK-KAVDNES 823 (943)
Q Consensus 746 p~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~p~~~~~ 823 (943)
|+||+++.++.+||+|||+|+........ ..+...||+.|+|||.+.+..++.++|||||||++|||++|. +||.+..
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 99999999999999999999876443222 223456889999999999999999999999999999999985 6777665
Q ss_pred cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 824 NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
..+......... . +..+... +..+.+++..||+.||++||||.||++.|+.+.
T Consensus 248 ~~e~~~~v~~~~--~-----~~~p~~~-----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEVIYYVRDGN--I-----LACPENC-----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHTTC--C-----CCCCTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCC--C-----CCCCccc-----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 544333322211 1 1111111 146779999999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=399.72 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=203.7
Q ss_pred hccccceEEeeeceEEEEEEEecC-Cc----eEEEEEeccc-CcccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKN-SR----PIAVKKLYNQ-YPHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 689 (943)
++|+..+.||+|+||+||+|.+.. ++ +||+|++... .....+++.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999753 33 6899988643 345677899999999999999999999999875 5678
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccC
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIP 769 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~ 769 (943)
++||+.+|+|.+++.. ....+++..++.++.|||.||+|||++ +||||||||+||+++.++.+||+|||+|+...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999998763 345799999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccc
Q 002278 770 TAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS 847 (943)
Q Consensus 770 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (943)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |++||.+.............. .+..+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-------~~~~p 235 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------RLPQP 235 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-------CCCCC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------CCCCC
Confidence 443322 233468999999999999999999999999999999999 889998654433222211111 11111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 848 VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 848 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
.. ....+.+++.+||+.||++|||+.|++++++.+.
T Consensus 236 ~~-----~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 236 PI-----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp TT-----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc-----cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 11 1246778999999999999999999999988764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=399.98 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=208.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHh-cCCCCCcceeeeEEecCCcceEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQ---YPHNLREFETELETIG-SIRHRNIVSLHGYALSPYGNLLF 690 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 690 (943)
++|...+.||+|+||+||+|+++ +++.||||++.+. .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999986 5889999999643 2344566677777665 68999999999999999999999
Q ss_pred EEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCC
Q 002278 691 YDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 691 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~ 770 (943)
|||+++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997 456789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCc
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTC 850 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (943)
.... .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+....+..+.......+.. +
T Consensus 156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~----~---- 226 (320)
T d1xjda_ 156 GDAK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----L---- 226 (320)
T ss_dssp TTCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----S----
T ss_pred cccc-ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc----C----
Confidence 3332 334569999999999999999999999999999999999999998876655444443332222211 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 002278 851 VDLSAVRKTFQLALLCTKRYPSERPTMQ-EVARV 883 (943)
Q Consensus 851 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~-el~~~ 883 (943)
...+.+++.+||..||++||++. ++++|
T Consensus 227 -----s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 227 -----EKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp -----CHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -----CHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 14567899999999999999995 78765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=385.74 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=199.5
Q ss_pred hhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecC-CcceEEEEE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP-YGNLLFYDY 693 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 693 (943)
.++|+..+.||+|+||.||+|+++ +++||||+++.. ...+.+.+|++++++++|||||+++|++.++ +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 457888899999999999999986 778999999653 3457899999999999999999999999654 567999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+++|+|.+++... ....+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 9999999998631 223589999999999999999999999 99999999999999999999999999998654322
Q ss_pred ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCcccccCccC
Q 002278 774 HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCVD 852 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (943)
....+|+.|+|||++.+..+++++|||||||++|||+| |++||....... ....... ...+.++...
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-~~~~i~~------~~~~~~~~~~-- 225 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVEK------GYKMDAPDGC-- 225 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HHHHHTT------TCCCCCCTTC--
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHc------CCCCCCCccC--
Confidence 23458999999999999999999999999999999998 788887654332 2222211 1122222211
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 853 LSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 853 ~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
...+.+++.+||+.||++|||+.+++++|+.+.
T Consensus 226 ---~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 226 ---PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 146779999999999999999999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=387.11 Aligned_cols=256 Identities=24% Similarity=0.374 Sum_probs=200.6
Q ss_pred hhccccceEEeeeceEEEEEEEecC--C--ceEEEEEecccC---cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN--S--RPIAVKKLYNQY---PHNLREFETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.++|+..+.||+|+||+||+|+... + ..||||++.... ....++|.+|++++++++|||||+++|++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3678999999999999999998653 2 368999886532 3345689999999999999999999999976 467
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
++||||+++|++.+++.. ....+++..++.++.|+|.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999998763 345699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCce--eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 768 IPTAMPHA--STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 768 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
........ .....|+..|+|||++.+..++.++|||||||++|||+| |+.||.+................. ...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~ 238 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPE 238 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--CCCT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--CCcc
Confidence 75543322 233457889999999999999999999999999999998 899998776655443333222111 1111
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
.+ ...+.+++..||+.||++|||+.++.+.|++.
T Consensus 239 ~~---------~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 239 DC---------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc---------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 14677999999999999999999999988753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=391.83 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=207.7
Q ss_pred hhccccceEEeeeceEEEEEEEecC-Cc--eEEEEEeccc-CcccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcceE
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN-SR--PIAVKKLYNQ-YPHNLREFETELETIGSI-RHRNIVSLHGYALSPYGNLL 689 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 689 (943)
.++|+..+.||+|+||+||+|++++ +. .||||++... .....+.+.+|+++++++ +|||||++++++.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 3688889999999999999999864 33 5788887543 334556799999999998 79999999999999999999
Q ss_pred EEEEccCCChhhhccCC-------------CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCc
Q 002278 690 FYDYMVNGSLWDLLHGP-------------SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFD 756 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 756 (943)
||||+++|+|.++++.. .....+++..+..++.|||.||+|+|+. +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 99999999999999643 2345799999999999999999999999 9999999999999999999
Q ss_pred eeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCC-CCCCCCccHHHHHHHhccc
Q 002278 757 AHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK-KAVDNESNLHQLIMSKADD 835 (943)
Q Consensus 757 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~ 835 (943)
+||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|. +||.+.... .........
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-~~~~~i~~~ 242 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLPQG 242 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHGGGT
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-HHHHHHHhc
Confidence 99999999986543322 22345899999999999999999999999999999999976 566655433 333322221
Q ss_pred cccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 002278 836 NTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPAP 891 (943)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~~ 891 (943)
..+..+... ...+.+++.+||+.||++||||.|++++|+.+....
T Consensus 243 ------~~~~~~~~~-----~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 243 ------YRLEKPLNC-----DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ------CCCCCCTTB-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ------CCCCCCccC-----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 112222111 246779999999999999999999999998876543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=393.07 Aligned_cols=261 Identities=25% Similarity=0.314 Sum_probs=199.3
Q ss_pred HhhccccceEEeeeceEEEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCC
Q 002278 614 STENLSEKYIVGYGASSTVYKCALKN------SRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPY 685 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 685 (943)
..++|+..+.||+|+||+||+|.+.. ++.||||++.... ....+.+.+|...+.++ +|+|||.+++++.+++
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 45789999999999999999998653 3579999986543 33455677888887776 6899999999987654
Q ss_pred -cceEEEEEccCCChhhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE
Q 002278 686 -GNLLFYDYMVNGSLWDLLHGPS-------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI 751 (943)
Q Consensus 686 -~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 751 (943)
..++||||+++|+|.++++... ....+++.++..++.||+.||+|||++ +||||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeE
Confidence 5799999999999999986322 123589999999999999999999999 99999999999999
Q ss_pred CCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhC-CCCCCCCccHHHHH
Q 002278 752 DENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTG-KKAVDNESNLHQLI 829 (943)
Q Consensus 752 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~p~~~~~~~~~~~ 829 (943)
++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+|| .+||.+........
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999876443322 23345699999999999999999999999999999999996 56787655444333
Q ss_pred HHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 830 MSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
....... .+..+... ...+.+++.+||+.||++|||+.|++++|+.++
T Consensus 248 ~~~~~~~------~~~~~~~~-----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 248 RRLKEGT------RMRAPDYT-----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHTC------CCCCCTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCC------CCCCCccC-----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 3322211 11111111 246779999999999999999999999998764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-44 Score=398.10 Aligned_cols=250 Identities=22% Similarity=0.256 Sum_probs=202.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC---cccHHHH---HHHHHHHhcCCCCCcceeeeEEecCCcc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY---PHNLREF---ETELETIGSIRHRNIVSLHGYALSPYGN 687 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 687 (943)
.++|++.+.||+|+||+||+|+++ +++.||||++.+.. ......+ ..|+++++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 357999999999999999999986 58999999985322 1222233 3457778888999999999999999999
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARC 767 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~ 767 (943)
|+||||+++|+|.+++. ....+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999996 456789999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcc--HHHHHHHhccccccccccCc
Q 002278 768 IPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESN--LHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 768 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 844 (943)
+..... ....||+.|+|||++.+ ..++.++||||+||++|||+||+.||.+... ........... ....++
T Consensus 157 ~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~ 230 (364)
T d1omwa3 157 FSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---AVELPD 230 (364)
T ss_dssp CSSSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC---CCCCCS
T ss_pred cCCCcc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---CCCCCC
Confidence 754432 23469999999999875 5689999999999999999999999975432 22222211111 111111
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPT-----MQEVARVLV 885 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~el~~~L~ 885 (943)
.++ ..+.+++.+||+.||++||| ++|+++|-+
T Consensus 231 ~~s---------~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 231 SFS---------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp SSC---------HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred CCC---------HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 121 45678999999999999999 799998754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=388.99 Aligned_cols=264 Identities=22% Similarity=0.257 Sum_probs=206.5
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999975 68899999986433 2335678999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
|+.++.+...... ....+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9976544433332 345699999999999999999999999 99999999999999999999999999998775433
Q ss_pred CceeeeEecccceeCccccccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc----
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS---- 847 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 847 (943)
. ......||+.|+|||+..... ++.++||||+||++|+|++|+.||.+.+....+.......+...+...+...
T Consensus 157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 2 223346999999999877765 5789999999999999999999999877666555443322221111111110
Q ss_pred ------cC-ccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 848 ------VT-CVDL-----SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 848 ------~~-~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.. .... .....+.+++.+|++.||++|||++|+++|-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f 285 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence 00 0000 11246778999999999999999999999833
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=386.41 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=202.3
Q ss_pred ceEEeeeceEEEEEEEecCC----ceEEEEEeccc-CcccHHHHHHHHHHHhcCCCCCcceeeeEEec-CCcceEEEEEc
Q 002278 621 KYIVGYGASSTVYKCALKNS----RPIAVKKLYNQ-YPHNLREFETELETIGSIRHRNIVSLHGYALS-PYGNLLFYDYM 694 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 694 (943)
.++||+|+||+||+|++..+ ..||||++... .....++|.+|++++++++|||||+++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997542 35899998653 34455789999999999999999999999875 45789999999
Q ss_pred cCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCCc
Q 002278 695 VNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMPH 774 (943)
Q Consensus 695 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 774 (943)
++|+|.+++.. .....++..+++++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999874 344578899999999999999999999 9999999999999999999999999999876443221
Q ss_pred ---eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccccCcc
Q 002278 775 ---ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVSVTCV 851 (943)
Q Consensus 775 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (943)
......||+.|+|||++.+..++.++||||||+++|||+||+.||.......++......... +..+...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~------~~~p~~~- 259 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------LLQPEYC- 259 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC------CCCCTTC-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------CCCcccC-
Confidence 222346899999999999999999999999999999999988887654433333322222111 1111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 852 DLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 852 ~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
...+.+++.+||+.||++||++.||+++|+.+...
T Consensus 260 ----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 260 ----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 24677999999999999999999999999988654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=393.31 Aligned_cols=255 Identities=20% Similarity=0.205 Sum_probs=198.9
Q ss_pred hhccccce-EEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhc-CCCCCcceeeeEEec----CCcc
Q 002278 615 TENLSEKY-IVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGS-IRHRNIVSLHGYALS----PYGN 687 (943)
Q Consensus 615 ~~~~~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 687 (943)
.++|.+.. +||+|+||+||+|+++ +++.||||++... ..+.+|++++.+ .+|||||+++++|.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788764 6999999999999975 6889999998643 567889998654 589999999999865 3557
Q ss_pred eEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC---CCceeeccccc
Q 002278 688 LLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE---NFDAHLSDFGI 764 (943)
Q Consensus 688 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DFGl 764 (943)
|+|||||+||+|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 9999999999999999742 234699999999999999999999999 9999999999999985 56799999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCc
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDP 844 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (943)
|+....... .....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+................ ...
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~----~~~ 234 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQY 234 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS----CSS
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc----CCC
Confidence 987755432 23356999999999999999999999999999999999999999765433221111110000 000
Q ss_pred ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 845 EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 845 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.++.. ........+.+++.+|++.||++|||+.|+++|-+
T Consensus 235 ~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 235 EFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp SCCTT-HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred CCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 00000 00112356789999999999999999999999754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=392.35 Aligned_cols=262 Identities=25% Similarity=0.341 Sum_probs=201.1
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHH--HHHHHhcCCCCCcceeeeEEecCC----cceE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFET--ELETIGSIRHRNIVSLHGYALSPY----GNLL 689 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~l 689 (943)
+.|...+.||+|+||+||+|+++ |+.||||++... ..+.+.+ |+..+..++|||||++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 56778889999999999999874 789999998543 2334444 455556789999999999997654 4689
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhC-----CCCCeEecCCCCccEEECCCCceeeccccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD-----CNPRIIHRDVKSSNILIDENFDAHLSDFGI 764 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~kl~DFGl 764 (943)
||||+++|+|.++++. ..++|.++.+++.|+|.||+|+|+. ..++||||||||+|||+++++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999963 3689999999999999999999973 134999999999999999999999999999
Q ss_pred ccccCCCCCc---eeeeEecccceeCccccccCC------CCCcchhhhHHHHHHHHHhCCCCCCCCc------------
Q 002278 765 ARCIPTAMPH---ASTFVLGTIGYIDPEYAHTSR------LNEKSDVYSFGIVLLEILTGKKAVDNES------------ 823 (943)
Q Consensus 765 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG~~p~~~~~------------ 823 (943)
++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9877543322 223456999999999987643 5678999999999999999998874211
Q ss_pred --cHHHHHHHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 824 --NLHQLIMSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 824 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
......... .....+|.++...........+.+++.+||+.||++|||+.||+++|+.+...
T Consensus 235 ~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 235 DPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 111111111 11122333333333334567788999999999999999999999999876543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.9e-44 Score=383.84 Aligned_cols=262 Identities=21% Similarity=0.233 Sum_probs=207.0
Q ss_pred hccccceEEeeeceEEEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 693 (943)
++|+..+.||+|+||+||+|++++++.||||++.... ....+.+.+|+.++++++|||||++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999999999999996543 33457899999999999999999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAMP 773 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 773 (943)
+.++.+..+.. ....+++..+..++.||+.||+|||+. +||||||||+|||++.++.+|++|||.|........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98887777765 456799999999999999999999999 999999999999999999999999999987754432
Q ss_pred ceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcccc-----
Q 002278 774 HASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPEVS----- 847 (943)
Q Consensus 774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 847 (943)
......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+..............+.......+...
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 2334468999999999876 457899999999999999999999998776655544432211111100000000
Q ss_pred -----------cCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 848 -----------VTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 848 -----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
...........+.+++++|++.||++|||++|+++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp 282 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 0000001124677999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-44 Score=382.90 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=206.1
Q ss_pred hhccccceEEeeeceEEEEEEEecC--------CceEEEEEecccCc-ccHHHHHHHHHHHhcC-CCCCcceeeeEEecC
Q 002278 615 TENLSEKYIVGYGASSTVYKCALKN--------SRPIAVKKLYNQYP-HNLREFETELETIGSI-RHRNIVSLHGYALSP 684 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 684 (943)
.++|+..+.||+|+||.||+|+... +..||||++..... ....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999998643 24699999876543 3456788899988887 799999999999999
Q ss_pred CcceEEEEEccCCChhhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE
Q 002278 685 YGNLLFYDYMVNGSLWDLLHGPS-------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI 751 (943)
Q Consensus 685 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 751 (943)
+..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 99999999999999999996432 124689999999999999999999999 99999999999999
Q ss_pred CCCCceeecccccccccCCCCCc-eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHH
Q 002278 752 DENFDAHLSDFGIARCIPTAMPH-ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLI 829 (943)
Q Consensus 752 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~ 829 (943)
+.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||++ |++||.+.... ...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-HHH
Confidence 99999999999999877543322 2333568999999999999999999999999999999998 78888765543 333
Q ss_pred HHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 830 MSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
....... .+..+... ...+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 248 ~~i~~~~------~~~~p~~~-----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 248 KLLKEGH------RMDKPSNC-----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHTTC------CCCCCSSC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCC------CCCCCccc-----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 2222211 11111111 146789999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-44 Score=385.20 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=211.1
Q ss_pred hhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcC-CCCCcceeeeEEecCCc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSI-RHRNIVSLHGYALSPYG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 686 (943)
.++|+..+.||+|+||.||+|+++ .++.||||++.... ......+.+|+.+++++ +|||||++++++.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 468889999999999999999863 34689999997543 33455788999999998 69999999999999999
Q ss_pred ceEEEEEccCCChhhhccCCC---------------CCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEE
Q 002278 687 NLLFYDYMVNGSLWDLLHGPS---------------KKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILI 751 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 751 (943)
.++||||+++|+|.++++... ....+++..+..++.||+.|++|||++ +||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999986322 223589999999999999999999999 99999999999999
Q ss_pred CCCCceeecccccccccCCCCC-ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccHHHHH
Q 002278 752 DENFDAHLSDFGIARCIPTAMP-HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILT-GKKAVDNESNLHQLI 829 (943)
Q Consensus 752 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p~~~~~~~~~~~ 829 (943)
+.++.+|++|||.++....... .......||+.|+|||++.+..++.++|||||||++|||+| |++||........+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999998765433 23334578999999999999999999999999999999999 666666554433333
Q ss_pred HHhccccccccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002278 830 MSKADDNTVMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLL 888 (943)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~ 888 (943)
....... .+..+.. ....+.+++.+||+.||++|||+.++++.|++..
T Consensus 259 ~~i~~~~------~~~~~~~-----~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 259 KMIKEGF------RMLSPEH-----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHTC------CCCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCC------CCCCccc-----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 3222111 1111111 1246789999999999999999999999998653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=382.23 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=212.0
Q ss_pred HhhccccceEEeeeceEEEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK------NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPYG 686 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 686 (943)
..++|+..+.||+|+||+||+|.++ .++.||||++.... ......+.+|++++++++|||||++++++..+..
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3578999999999999999999874 25789999996543 2334568899999999999999999999999999
Q ss_pred ceEEEEEccCCChhhhccCC-------CCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceee
Q 002278 687 NLLFYDYMVNGSLWDLLHGP-------SKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHL 759 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 759 (943)
.++||||+++|+|.+++... .....+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEE
Confidence 99999999999999987521 1223578999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCce-eeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCC-CCCCCCccHHHHHHHhccccc
Q 002278 760 SDFGIARCIPTAMPHA-STFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGK-KAVDNESNLHQLIMSKADDNT 837 (943)
Q Consensus 760 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~ 837 (943)
+|||+|+......... .....||+.|+|||.+.+..++.++|||||||++|||+||. +||.+........... ....
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-~~~~ 253 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-EGGL 253 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-TTCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hCCC
Confidence 9999998764432221 22335899999999999999999999999999999999985 6776655443333222 2111
Q ss_pred cccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002278 838 VMEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLPA 890 (943)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~~ 890 (943)
+..+... ...+.+++.+||+.+|++|||+.+|+++|+....+
T Consensus 254 ------~~~p~~~-----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 254 ------LDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ------CCCCTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ------CCCcccc-----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1111111 24688999999999999999999999999876553
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=380.14 Aligned_cols=242 Identities=22% Similarity=0.322 Sum_probs=198.3
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc------ccHHHHHHHHHHHhcCC--CCCcceeeeEEecCCc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP------HNLREFETELETIGSIR--HRNIVSLHGYALSPYG 686 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 686 (943)
++|++.+.||+|+||+||+|++. +++.||||++..... ....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999976 689999999864321 11234678999999886 8999999999999999
Q ss_pred ceEEEEEccC-CChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-CCceeeccccc
Q 002278 687 NLLFYDYMVN-GSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-NFDAHLSDFGI 764 (943)
Q Consensus 687 ~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DFGl 764 (943)
.++||||+.+ +++.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 67888876 456799999999999999999999999 9999999999999985 57999999999
Q ss_pred ccccCCCCCceeeeEecccceeCccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccC
Q 002278 765 ARCIPTAMPHASTFVLGTIGYIDPEYAHTSRL-NEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVD 843 (943)
Q Consensus 765 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (943)
|+...... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||...... ...... .+
T Consensus 158 a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------~~~~~~----~~ 224 (273)
T d1xwsa_ 158 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF----FR 224 (273)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HHCCCC----CS
T ss_pred ceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------hhcccC----CC
Confidence 98764432 233569999999999987665 57799999999999999999999764321 111111 11
Q ss_pred cccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 844 PEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 844 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
+.++ ..+.+++.+||+.||++|||++|+++|-+
T Consensus 225 ~~~s---------~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 225 QRVS---------SECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp SCCC---------HHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CCCC---------HHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 2222 45678999999999999999999998743
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=379.80 Aligned_cols=263 Identities=23% Similarity=0.219 Sum_probs=201.7
Q ss_pred HhhccccceEEeeeceEEEEEEEec-C-CceEEEEEecccC--cccHHHHHHHHHHHhcC---CCCCcceeeeEEec---
Q 002278 614 STENLSEKYIVGYGASSTVYKCALK-N-SRPIAVKKLYNQY--PHNLREFETELETIGSI---RHRNIVSLHGYALS--- 683 (943)
Q Consensus 614 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--- 683 (943)
+.++|++.+.||+|+||+||+|++. + ++.||||++.... ......+.+|+++++.+ +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 4578999999999999999999974 4 5678999985432 22233456677776655 89999999999853
Q ss_pred --CCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecc
Q 002278 684 --PYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSD 761 (943)
Q Consensus 684 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 761 (943)
....+++|||+.+|.+...... ....+++..+..++.|++.||+|||++ +||||||||+|||+++++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 2357899999988877554432 345689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc
Q 002278 762 FGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA 841 (943)
Q Consensus 762 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 841 (943)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+......+..+....+.....
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9999865433 22334569999999999999999999999999999999999999999877666554443221111110
Q ss_pred cCc----------------ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 842 VDP----------------EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 842 ~~~----------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..+ ...... ......+.+++.+||+.||++|||+.|+++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFV--TDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTC--CSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cccccccchhhhhccccccchhhcc--ccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 000 000000 011245678999999999999999999998743
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=373.88 Aligned_cols=265 Identities=20% Similarity=0.246 Sum_probs=205.3
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC-------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP------- 684 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 684 (943)
.++|++.+.||+|+||+||+|+++ +++.||||++.... .....++.+|++++++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999975 68999999985432 34456788999999999999999999998653
Q ss_pred -CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccc
Q 002278 685 -YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFG 763 (943)
Q Consensus 685 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFG 763 (943)
...++||||+.++.+..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+|++|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 35789999998887766554 445689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC---ceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc
Q 002278 764 IARCIPTAMP---HASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM 839 (943)
Q Consensus 764 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 839 (943)
+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..+...........+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9987653321 122234699999999998765 689999999999999999999999988776655544433322222
Q ss_pred cccCcccc------------cCccCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 EAVDPEVS------------VTCVDL-------SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 ~~~~~~~~------------~~~~~~-------~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
........ ...... .....+.+++.+||++||++|||++|+++|-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 21111110 000000 11235568999999999999999999999965
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=376.81 Aligned_cols=259 Identities=24% Similarity=0.270 Sum_probs=197.8
Q ss_pred ccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcceeeeEEecC------CcceE
Q 002278 617 NLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP------YGNLL 689 (943)
Q Consensus 617 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 689 (943)
.|+..++||+|+||+||+|+++ +++.||||++..... ...+|++++++++|||||+++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999986 588999999865432 234799999999999999999998543 23589
Q ss_pred EEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC-ceeeccccccccc
Q 002278 690 FYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-DAHLSDFGIARCI 768 (943)
Q Consensus 690 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFGla~~~ 768 (943)
||||+++|.+..+.........+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998765444433222455799999999999999999999999 999999999999999775 8999999999877
Q ss_pred CCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc--------
Q 002278 769 PTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM-------- 839 (943)
Q Consensus 769 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------- 839 (943)
...... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+....+...
T Consensus 174 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 544332 23469999999998765 5789999999999999999999999987766555444322111100
Q ss_pred ----cccCccccc----CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002278 840 ----EAVDPEVSV----TCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVL 884 (943)
Q Consensus 840 ----~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L 884 (943)
....+.... ..........+.+++.+|+..||++|||+.|+++|-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 304 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 000000000 000001224677899999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=372.99 Aligned_cols=264 Identities=21% Similarity=0.266 Sum_probs=201.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC----cce
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY-PHNLREFETELETIGSIRHRNIVSLHGYALSPY----GNL 688 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 688 (943)
.++|+..+.||+|+||+||+|.++ +++.||||++.... ....+.+.+|++++++++||||+++++++..+. ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999975 68999999996543 334567889999999999999999999997654 346
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccccc
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCI 768 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~ 768 (943)
++++|+.+|+|.+++. ...+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 6677888999999995 34699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--ceeeeEecccceeCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhcccccccccc---
Q 002278 769 PTAMP--HASTFVLGTIGYIDPEYAH-TSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAV--- 842 (943)
Q Consensus 769 ~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 842 (943)
..... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||.+.....................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 43322 1223456999999999985 45678999999999999999999999987765444333221111100000
Q ss_pred ------------Cccc-ccCc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 843 ------------DPEV-SVTC--VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 843 ------------~~~~-~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
.+.. .... ........+.+++..|++.||++|||++|+++|-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 0000 0000 00001135678999999999999999999999844
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=376.30 Aligned_cols=257 Identities=24% Similarity=0.286 Sum_probs=198.6
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCC------
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPY------ 685 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 685 (943)
.++|++.+.||+|+||+||+|.++ +++.||||++.... ....+.+.+|+++++.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999976 58899999997543 233557889999999999999999999997654
Q ss_pred cceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccc
Q 002278 686 GNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIA 765 (943)
Q Consensus 686 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla 765 (943)
..++||||+ +++|..+.+ ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 469999999 667877764 35699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeEecccceeCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccc---
Q 002278 766 RCIPTAMPHASTFVLGTIGYIDPEYAHT-SRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEA--- 841 (943)
Q Consensus 766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 841 (943)
+...... +...||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+....+.......+.....
T Consensus 169 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 169 RQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp EECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 8765432 23469999999999876 457899999999999999999999998876655543333222111110
Q ss_pred -----------------cCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 842 -----------------VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 842 -----------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
......... ......+.+++.+|+..||++|||++|+++|-+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASIL--TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTC--TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hhcchhhhhhhccCCcccccchHHhc--cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 000000000 011235678999999999999999999999843
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-41 Score=361.43 Aligned_cols=263 Identities=20% Similarity=0.220 Sum_probs=207.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecCCcceEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 692 (943)
++|++.+.||+|+||+||+|+++ +++.||||++.... .....++.+|+.+++.++|||||++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999976 67889999986443 3446788999999999999999999999999999999999
Q ss_pred EccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeecccccccccCCCC
Q 002278 693 YMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIARCIPTAM 772 (943)
Q Consensus 693 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~~~~~~~ 772 (943)
++.++++..++. ....+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988876 455789999999999999999999999 99999999999999999999999999998875443
Q ss_pred CceeeeEecccceeCccccccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHh-ccccccccccCc------
Q 002278 773 PHASTFVLGTIGYIDPEYAHTSR-LNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSK-ADDNTVMEAVDP------ 844 (943)
Q Consensus 773 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~------ 844 (943)
.. .....+++.|+|||++.+.. ++.++||||+||++|||++|+.||....+........ .......+...+
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp SC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 22 22345788999999988765 6899999999999999999999976544443333221 111111000000
Q ss_pred ----------ccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 845 ----------EVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 845 ----------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
..............+.+++.+|++.||++|||++|+++|-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 00000000111245678999999999999999999998743
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=373.47 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=203.2
Q ss_pred hccccceEEeeeceEEEEEEEec----CCceEEEEEecccC----cccHHHHHHHHHHHhcCCC-CCcceeeeEEecCCc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK----NSRPIAVKKLYNQY----PHNLREFETELETIGSIRH-RNIVSLHGYALSPYG 686 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 686 (943)
++|+..+.||+|+||+||+|+.. +|+.||||.+.... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999863 37889999986432 2334668899999999976 899999999999999
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.+++|||+.+|+|.+++. ....+++..+..++.|++.|++|+|+. +||||||||+||+++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999986 445678899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeEecccceeCccccccC--CCCCcchhhhHHHHHHHHHhCCCCCCCCccH---HHHHHHhccccccccc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHTS--RLNEKSDVYSFGIVLLEILTGKKAVDNESNL---HQLIMSKADDNTVMEA 841 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~ 841 (943)
.+............|++.|+|||.+.+. .++.++||||+||++|||+||+.||.+.... ........... ..
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~---~~ 254 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---PP 254 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC---CC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC---CC
Confidence 7754434334445699999999998764 4788999999999999999999999755322 22222111111 11
Q ss_pred cCcccccCccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 002278 842 VDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERP-----TMQEVARVLV 885 (943)
Q Consensus 842 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~el~~~L~ 885 (943)
..+.+ ...+.+++.+||++||++|| |++|+++|-+
T Consensus 255 ~~~~~---------s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 255 YPQEM---------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp CCTTS---------CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CcccC---------CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 11111 24677899999999999999 5899988744
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-41 Score=363.17 Aligned_cols=255 Identities=18% Similarity=0.187 Sum_probs=195.4
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCcc-eeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNIV-SLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 693 (943)
++|+..+.||+|+||+||+|++. +++.||||.+..... ..++..|+++++.++|+++| .+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999975 578999998765432 24578899999999877655 455556777788899999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEEC---CCCceeecccccccccCC
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILID---ENFDAHLSDFGIARCIPT 770 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DFGla~~~~~ 770 (943)
+ +|++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|++|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 8 5666666542 345699999999999999999999999 999999999999986 456799999999998754
Q ss_pred CCCc------eeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccc----ccccc
Q 002278 771 AMPH------ASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADD----NTVME 840 (943)
Q Consensus 771 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~----~~~~~ 840 (943)
.... ......||+.|||||++.+..++.++|||||||++|||+||+.||................ ....+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3321 2234569999999999999999999999999999999999999997544322211111000 01111
Q ss_pred ccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002278 841 AVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSL 887 (943)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~ 887 (943)
...+.+ +..+.+++..||+.+|++||+++++.+.|+.+
T Consensus 239 ~~~~~~---------p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 VLCKGY---------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHTTTS---------CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HhccCC---------CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 111112 24677899999999999999999988877654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-41 Score=359.05 Aligned_cols=257 Identities=16% Similarity=0.180 Sum_probs=204.3
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCCC-CCcceeeeEEecCCcceEEEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIRH-RNIVSLHGYALSPYGNLLFYDY 693 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 693 (943)
++|++.+.||+|+||+||+|++. +++.||||.+..... ...+.+|++.++.+.| +|++.+++++..+...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57999999999999999999976 578999998754332 2457788999999975 8999999999999999999999
Q ss_pred ccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECC-----CCceeeccccccccc
Q 002278 694 MVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDE-----NFDAHLSDFGIARCI 768 (943)
Q Consensus 694 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~DFGla~~~ 768 (943)
+ +|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+|+.+
T Consensus 83 ~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 8 7899998863 234689999999999999999999999 9999999999999974 578999999999987
Q ss_pred CCCCC------ceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccH---HHHHHHhcc-cccc
Q 002278 769 PTAMP------HASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL---HQLIMSKAD-DNTV 838 (943)
Q Consensus 769 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~---~~~~~~~~~-~~~~ 838 (943)
..... .......||+.|||||++.+..++.++|||||||++|||+||+.||.+.... ......... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 54321 1223456999999999999999999999999999999999999999754321 111111111 1111
Q ss_pred ccccCcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002278 839 MEAVDPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLVSLLP 889 (943)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~~~~~ 889 (943)
.....+.+ +.++.+++..|++.+|++||+++.+.+.++.+..
T Consensus 237 ~~~l~~~~---------p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 237 LRELCAGF---------PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHHTTTS---------CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hHHhcCCC---------CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 11111222 1467789999999999999999999888876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-40 Score=361.41 Aligned_cols=256 Identities=18% Similarity=0.194 Sum_probs=198.0
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecC--CcceEEE
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALSP--YGNLLFY 691 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 691 (943)
++|++.+.||+|+||+||+|+++ +++.||||++... ..+.+.+|+++++.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999985 5889999998643 3567899999999995 99999999999754 4578999
Q ss_pred EEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCC-ceeecccccccccCC
Q 002278 692 DYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENF-DAHLSDFGIARCIPT 770 (943)
Q Consensus 692 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DFGla~~~~~ 770 (943)
||+.+|+|..+.+ .+++..+..++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999987642 589999999999999999999999 999999999999998654 699999999987754
Q ss_pred CCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHH-HHHHHhcccc------------
Q 002278 771 AMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLH-QLIMSKADDN------------ 836 (943)
Q Consensus 771 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~------------ 836 (943)
... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||....... .........+
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 432 2334689999999998765 47999999999999999999999997554322 2111111000
Q ss_pred -----cccccc-------CcccccCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 837 -----TVMEAV-------DPEVSVTCVDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 837 -----~~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
...... ................+.+++++|++.||++|||++|+++|-+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 000000 0000000000111245778999999999999999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=366.26 Aligned_cols=259 Identities=21% Similarity=0.225 Sum_probs=194.1
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHhcCCCCCcceeeeEEecC------Cc
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQY--PHNLREFETELETIGSIRHRNIVSLHGYALSP------YG 686 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 686 (943)
++|++.+.||+|+||+||+|.++ +++.||||++.... .....++.+|+.++++++|||||+++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999987 58999999996543 23345688999999999999999999999643 56
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.|+||||+.++.+. .+. ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 79999999765554 443 3589999999999999999999999 99999999999999999999999999988
Q ss_pred ccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccc-------
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVM------- 839 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~------- 839 (943)
..... .......||+.|+|||++.+..+++++||||+||++|||++|+.||.+.+................
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred ccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 66443 223445699999999999999999999999999999999999999987765544433221111000
Q ss_pred --------------------cccCcccccCc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 840 --------------------EAVDPEVSVTC--VDLSAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 840 --------------------~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
........... ........+.+++++|++.||++|||++|+++|-+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 00000000000 01123456788999999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=366.27 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=201.1
Q ss_pred hhccccceEEeeeceEEEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHhcCCCCCcceeeeEEecC-----Cc
Q 002278 615 TENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYP--HNLREFETELETIGSIRHRNIVSLHGYALSP-----YG 686 (943)
Q Consensus 615 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 686 (943)
.++|++.+.||+|+||+||+|+++ +++.||||++..... ...+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999975 689999999975432 3345788999999999999999999999643 34
Q ss_pred ceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 687 NLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 687 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.+++++|+.+|+|.+++. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 577888899999999985 34699999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCceeeeEecccceeCccccccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCccHHHHHHHhccccccccccCcc
Q 002278 767 CIPTAMPHASTFVLGTIGYIDPEYAHTS-RLNEKSDVYSFGIVLLEILTGKKAVDNESNLHQLIMSKADDNTVMEAVDPE 845 (943)
Q Consensus 767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (943)
..... .....|++.|+|||+..+. .++.++||||+||++|+|++|+.||.+.+.......+..............
T Consensus 170 ~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 65332 2334589999999987765 468999999999999999999999987766554444332222111100000
Q ss_pred c-------------ccCccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002278 846 V-------------SVTCVDL-----SAVRKTFQLALLCTKRYPSERPTMQEVARVLV 885 (943)
Q Consensus 846 ~-------------~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~el~~~L~ 885 (943)
. ....... .....+.+++.+|++.||++|||+.|+++|-+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 0 0000000 11245678999999999999999999999854
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=9e-40 Score=355.27 Aligned_cols=283 Identities=29% Similarity=0.504 Sum_probs=234.8
Q ss_pred CcccccccCccccCCCCCCCCCCCCC--CcceeEecCCC--CcEEEEEcCCCCCcc--ccCCCcCCCCCCCEEEeeC-Cc
Q 002278 1 MAIKASFSNLANVLLDWDDVHNSDFC--SWRGVFCDNSS--LSVVSLNLSSLNLGG--EISPSIGDLRNLQSIDFQG-NK 73 (943)
Q Consensus 1 ~~~~~~~~~~~~~~~~w~~~~~~~~c--~w~gv~c~~~~--~~v~~L~l~~~~~~~--~~~~~l~~l~~L~~L~Ls~-n~ 73 (943)
++||++++||. .+++|.. ++||| +|.||.|++.+ .||+.|||++++++| .+|+++++|++|++|||++ |+
T Consensus 12 l~~k~~~~~~~-~l~sW~~--~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~ 88 (313)
T d1ogqa_ 12 LQIKKDLGNPT-TLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88 (313)
T ss_dssp HHHHHHTTCCG-GGTTCCT--TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETT
T ss_pred HHHHHHCCCCC-cCCCCCC--CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccc
Confidence 47999999975 7999975 68999 59999998764 489999999999998 5789999999999999997 89
Q ss_pred ccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchh
Q 002278 74 LTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRL 153 (943)
Q Consensus 74 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 153 (943)
++|.+|..|+++++|++|+|++|++.+..|..+..+.+|+.+++++|.+.+.+|..|.++++|+.+++++|.+++.+|..
T Consensus 89 l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~ 168 (313)
T d1ogqa_ 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168 (313)
T ss_dssp EESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGG
T ss_pred cccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccc
Confidence 99999999999999999999999999888899999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-eeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEe
Q 002278 154 IYWNEVL-QYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVA 232 (943)
Q Consensus 154 ~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~ 232 (943)
+..+..+ +.+.+++|++++..+..+..+..+ .+++++|...+.+|..+..+++|+.|++++|.+++.+|.
T Consensus 169 ~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~-------- 239 (313)
T d1ogqa_ 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-------- 239 (313)
T ss_dssp GGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG--------
T ss_pred cccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc--------
Confidence 9888775 889999999998888888877655 688888888888888888889999999888888755443
Q ss_pred EEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCc
Q 002278 233 TLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQ 312 (943)
Q Consensus 233 ~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 312 (943)
+..+++|+.|+|++|++++.+|..|+++++|++|+|++|+|+|.+| .+.++++|+.+++++|+
T Consensus 240 ----------------~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 240 ----------------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302 (313)
T ss_dssp ----------------CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CSTTGGGSCGGGTCSSS
T ss_pred ----------------cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-CcccCCCCCHHHhCCCc
Confidence 3445555666666666655556566666666666666666665555 34556666666666665
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-35 Score=326.65 Aligned_cols=262 Identities=16% Similarity=0.153 Sum_probs=190.6
Q ss_pred hccccceEEeeeceEEEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHhcCC-----------CCCcceeeeEEec
Q 002278 616 ENLSEKYIVGYGASSTVYKCALK-NSRPIAVKKLYNQYPHNLREFETELETIGSIR-----------HRNIVSLHGYALS 683 (943)
Q Consensus 616 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 683 (943)
++|++.+.||+|+||+||+|+++ +++.||||++... ....+.+.+|+++++.++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999975 6899999998643 223456788998888764 5789999998864
Q ss_pred C--CcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCC-----
Q 002278 684 P--YGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENF----- 755 (943)
Q Consensus 684 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~----- 755 (943)
. ...+++|+++..+..............+++..+..++.||+.|++|||+ . +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 3 4556677776555433332222345678999999999999999999998 6 999999999999998654
Q ss_pred -ceeecccccccccCCCCCceeeeEecccceeCccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCccH------HHH
Q 002278 756 -DAHLSDFGIARCIPTAMPHASTFVLGTIGYIDPEYAHTSRLNEKSDVYSFGIVLLEILTGKKAVDNESNL------HQL 828 (943)
Q Consensus 756 -~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p~~~~~~~------~~~ 828 (943)
.++++|||.|+...... ....||+.|+|||++.+..++.++||||+||+++||++|+.||...... ...
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 39999999998654322 2346999999999999999999999999999999999999999743211 111
Q ss_pred HHHhccccc--------------------cccccCccc---------ccCccCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002278 829 IMSKADDNT--------------------VMEAVDPEV---------SVTCVDLSAVRKTFQLALLCTKRYPSERPTMQE 879 (943)
Q Consensus 829 ~~~~~~~~~--------------------~~~~~~~~~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 879 (943)
.......+. ......... ............+.+++.+|++.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111000000 000000000 000112345677889999999999999999999
Q ss_pred HHHHHh
Q 002278 880 VARVLV 885 (943)
Q Consensus 880 l~~~L~ 885 (943)
+++|-+
T Consensus 325 ~L~Hp~ 330 (362)
T d1q8ya_ 325 LVNHPW 330 (362)
T ss_dssp HHTCGG
T ss_pred HhcCcc
Confidence 999843
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=9.8e-33 Score=299.33 Aligned_cols=258 Identities=33% Similarity=0.564 Sum_probs=186.4
Q ss_pred cceEEecCCCCCC--CCCCCcCCCCcCcEEEccc-CccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEE
Q 002278 279 TGKLYLHGNKLTG--PIPPELGNMSKLSYLQLQN-NQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFN 355 (943)
Q Consensus 279 L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 355 (943)
++.|+|++|.+++ .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+..|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 4445555555544 2455666666666666664 566666666666666666666666666666666666666666666
Q ss_pred eeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCc-cEEecCCCcCCCccCCCcccccccceeeccccccc
Q 002278 356 VHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINL-DTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLN 434 (943)
Q Consensus 356 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 434 (943)
+++|.+.+.+|..|..++.|+.+++++|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|...
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 66666666666677777777777777777776667666666665 677777777777777777666544 5788888888
Q ss_pred ccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccCCCCcc
Q 002278 435 GLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGIIPPIRN 514 (943)
Q Consensus 435 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 514 (943)
+.+|..+..+++|+.+++++|.+++.+ ..++.+++|+.|+|++|+|+|.+|..++++++|++|||++|+|+|.+|.+..
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~ 289 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred ccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence 888888888888888888888887654 4677788888888888888888888888888888888888888888887777
Q ss_pred cCcCCCCccccCCCCCCCCCCCccC
Q 002278 515 FSRFSSNSFIGNPLLCGNWIGSICG 539 (943)
Q Consensus 515 ~~~~~~~~~~~Np~~c~~~~~~~c~ 539 (943)
+..+..+.+.||+.+||.|+. .|+
T Consensus 290 L~~L~~l~l~~N~~l~g~plp-~c~ 313 (313)
T d1ogqa_ 290 LQRFDVSAYANNKCLCGSPLP-ACT 313 (313)
T ss_dssp GGGSCGGGTCSSSEEESTTSS-CCC
T ss_pred CCCCCHHHhCCCccccCCCCC-CCC
Confidence 788888888899999998873 663
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=5.4e-30 Score=286.30 Aligned_cols=356 Identities=27% Similarity=0.377 Sum_probs=183.2
Q ss_pred EcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccc
Q 002278 44 NLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLT 123 (943)
Q Consensus 44 ~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~ 123 (943)
+++.+++++.++ ..++.+|++|++++|+|+. + +.|+.+++|++|+|++|+|++ +| .|+++++|++|++++|++.
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCcccccccccccccc
Confidence 344444444332 2455567777777777663 3 346667777777777777763 33 2666677777777777666
Q ss_pred cCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCCCCc
Q 002278 124 GPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIG 203 (943)
Q Consensus 124 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~ 203 (943)
+.. .++.+++|+.|++++|.+++..+ ......+..+....|.+....+....
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~l~~~~~~~~~ 153 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQITDIDP--------------------------LKNLTNLNRLELSSNTISDISALSGL 153 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCCGG--------------------------GTTCTTCSEEEEEEEEECCCGGGTTC
T ss_pred ccc--ccccccccccccccccccccccc--------------------------cccccccccccccccccccccccccc
Confidence 432 26666666666666666653222 12223344444444544432222222
Q ss_pred CCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEE
Q 002278 204 NCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLY 283 (943)
Q Consensus 204 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 283 (943)
..............+. .+.............|... ....+..+++++.++
T Consensus 154 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~ 203 (384)
T d2omza2 154 TSLQQLSFGNQVTDLK----------------------------PLANLTTLERLDISSNKVS--DISVLAKLTNLESLI 203 (384)
T ss_dssp TTCSEEEEEESCCCCG----------------------------GGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEE
T ss_pred ccccccccccccchhh----------------------------hhccccccccccccccccc--cccccccccccceee
Confidence 1122221111111111 1111222222222222222 122233344444444
Q ss_pred ecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccC
Q 002278 284 LHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSG 363 (943)
Q Consensus 284 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 363 (943)
+++|.+++..| +..+++|+.|++++|+++. + ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|++++
T Consensus 204 l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~ 277 (384)
T d2omza2 204 ATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 277 (384)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC
T ss_pred ccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCC
Confidence 44444443322 2334455555555555542 1 234455555555555555554322 4555556666666665553
Q ss_pred cccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccC
Q 002278 364 AIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGN 443 (943)
Q Consensus 364 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 443 (943)
.. .+..++.++.+.++.|.+++. ..+..+.+++.|++++|++++..+ +..+++|++|+|++|+|++ ++ .|.+
T Consensus 278 ~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~ 349 (384)
T d2omza2 278 IS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLAN 349 (384)
T ss_dssp CG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGG
T ss_pred CC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcC
Confidence 32 245556666666666666532 235556666666666666665332 6666777777777777764 22 4667
Q ss_pred CCccceecccCccccccCChhhhcccccceecccCc
Q 002278 444 LRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNN 479 (943)
Q Consensus 444 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 479 (943)
+++|++|++++|+|++..| +.++++|+.|+|++|
T Consensus 350 l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 7777777777777764433 667777777777766
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=1.1e-29 Score=283.79 Aligned_cols=356 Identities=24% Similarity=0.305 Sum_probs=262.2
Q ss_pred eccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccC
Q 002278 92 ELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALT 171 (943)
Q Consensus 92 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 171 (943)
.++.+.+++.+. ...+.+|++|++++|.|+.. +.+..+++|++|+|++|+|++..+ +..+++|++|++++|+++
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccccc
Confidence 445555554332 23555666666666666532 345666666666666666664322 666667777777777776
Q ss_pred CCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccc
Q 002278 172 GMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGL 251 (943)
Q Consensus 172 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 251 (943)
++. .++.+++|+.|++++|.+++..+ ......+..+....|.+....+.. ...
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~-----------------------~~~ 154 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS-----------------------GLT 154 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGT-----------------------TCT
T ss_pred ccc--ccccccccccccccccccccccc--cccccccccccccccccccccccc-----------------------ccc
Confidence 653 37788889999999888875533 445677888888888876322111 011
Q ss_pred cCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEE
Q 002278 252 MQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELN 331 (943)
Q Consensus 252 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 331 (943)
............. ...+.............|... ....+..+++++.|++++|.+++..| +...++|++|+
T Consensus 155 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~ 225 (384)
T d2omza2 155 SLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELS 225 (384)
T ss_dssp TCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred cccccccccccch-----hhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEE
Confidence 1111222222211 233445555566666666654 34667889999999999999997654 46678999999
Q ss_pred ccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCC
Q 002278 332 LADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG 411 (943)
Q Consensus 332 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 411 (943)
+++|+++.. +.+..+++|+.|++++|.+++..+ +..+++|+.|++++|++++.. .+..+..++.++++.|.+.+
T Consensus 226 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~ 299 (384)
T d2omza2 226 LNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED 299 (384)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC
T ss_pred CCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc
Confidence 999999853 468899999999999999996543 888999999999999998543 47788999999999999985
Q ss_pred ccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCcc
Q 002278 412 SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSN 491 (943)
Q Consensus 412 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 491 (943)
. ..+..+++++.|++++|++++.. .+..+++|++|++++|+|++ +| .|.++++|++|++++|+|++..| +.+
T Consensus 300 ~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~ 371 (384)
T d2omza2 300 I--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LAN 371 (384)
T ss_dssp C--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTT
T ss_pred c--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hcc
Confidence 3 35888999999999999999764 38899999999999999984 54 69999999999999999997665 899
Q ss_pred ccCCcccccCCc
Q 002278 492 CFSLSNLNVSYN 503 (943)
Q Consensus 492 l~~L~~L~ls~N 503 (943)
+++|+.|+|++|
T Consensus 372 l~~L~~L~L~~N 383 (384)
T d2omza2 372 LTRITQLGLNDQ 383 (384)
T ss_dssp CTTCSEEECCCE
T ss_pred CCCCCEeeCCCC
Confidence 999999999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=5.8e-27 Score=252.55 Aligned_cols=246 Identities=25% Similarity=0.311 Sum_probs=156.1
Q ss_pred CCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchh
Q 002278 26 CSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFS 105 (943)
Q Consensus 26 c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 105 (943)
|.|++|.|++. +++ ++|..+. +++++|+|++|+|+...+.+|.++++|++|++++|++....|.+
T Consensus 10 c~~~~~~C~~~------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~ 74 (305)
T d1xkua_ 10 CHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74 (305)
T ss_dssp EETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred ecCCEEEecCC------------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence 68999999764 344 6777764 68999999999998554557999999999999999999777888
Q ss_pred ccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceeccccCCccCCCCCcccccccccc
Q 002278 106 ISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLW 185 (943)
Q Consensus 106 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 185 (943)
|.++++|++|++++|+++. +|..+ .+.|+.|++++|.+.+..+..+.....+..+....|....
T Consensus 75 f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~------------- 138 (305)
T d1xkua_ 75 FAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS------------- 138 (305)
T ss_dssp TTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG-------------
T ss_pred hhCCCccCEecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccc-------------
Confidence 9999999999999999884 45433 3577888888888876555555555555555554443321
Q ss_pred eeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCccccccCCccccccCCCcEEecCCCCC
Q 002278 186 YFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENEL 265 (943)
Q Consensus 186 ~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l 265 (943)
....+..+..+++|+++++++|.++. +|... ..+++.|++++|.+.+..+..|..++.+++|++++|.+
T Consensus 139 ---------~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~-~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l 207 (305)
T d1xkua_ 139 ---------SGIENGAFQGMKKLSYIRIADTNITT-IPQGL-PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207 (305)
T ss_dssp ---------GGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC-CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCC
T ss_pred ---------cCCCccccccccccCccccccCCccc-cCccc-CCccCEEECCCCcCCCCChhHhhccccccccccccccc
Confidence 12233456666777777777776652 22211 22344444444444444555555555555555555555
Q ss_pred CCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccc
Q 002278 266 VGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLV 314 (943)
Q Consensus 266 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 314 (943)
.+..+..|.++++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+
T Consensus 208 ~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp CEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred cccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 5554555555555555555555555 23445555555555555555554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=5.2e-26 Score=244.97 Aligned_cols=247 Identities=23% Similarity=0.289 Sum_probs=129.2
Q ss_pred cceeccccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecC
Q 002278 159 VLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQG 238 (943)
Q Consensus 159 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~ 238 (943)
++++|+|++|+|+.+++..|.++++|++|++++|.+....|..|.++++|++|++++|+++. +|... ...+..|.+.+
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~-~~~l~~L~~~~ 109 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM-PKTLQELRVHE 109 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC-CTTCCEEECCS
T ss_pred CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccch-hhhhhhhhccc
Confidence 45555555555555555556666666666666666665556666677777777777776662 33221 12344455555
Q ss_pred ccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccc
Q 002278 239 NKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIP 318 (943)
Q Consensus 239 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 318 (943)
|.+....+..+.....+..++...|..... ...+..|..+++|+++++++|.+. .+|
T Consensus 110 n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~----------------------~~~~~~~~~l~~L~~l~l~~n~l~-~l~ 166 (305)
T d1xkua_ 110 NEITKVRKSVFNGLNQMIVVELGTNPLKSS----------------------GIENGAFQGMKKLSYIRIADTNIT-TIP 166 (305)
T ss_dssp SCCCBBCHHHHTTCTTCCEEECCSSCCCGG----------------------GBCTTGGGGCTTCCEEECCSSCCC-SCC
T ss_pred cchhhhhhhhhhcccccccccccccccccc----------------------CCCccccccccccCccccccCCcc-ccC
Confidence 555544444455555566666655543211 112233444455555555555554 222
Q ss_pred cccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCC
Q 002278 319 AELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIIN 398 (943)
Q Consensus 319 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 398 (943)
..+ +++|+.|++++|.+.+..+..|..++.++.|++++|.+.+..+.+|.++++|++|+|++|+|+ .+|..+..+++
T Consensus 167 ~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~ 243 (305)
T d1xkua_ 167 QGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243 (305)
T ss_dssp SSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSS
T ss_pred ccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccC
Confidence 221 344555555555555555555555555555555555555555555555555666666655555 34555555555
Q ss_pred ccEEecCCCcCCCccCCCc------ccccccceeecccccc
Q 002278 399 LDTLDLSVNNFSGSVPASI------GDLEHLLTLNLSRNHL 433 (943)
Q Consensus 399 L~~L~Ls~N~l~~~~~~~~------~~l~~L~~L~Ls~N~l 433 (943)
|++|+|++|+|+......| ..+.+|+.|+|++|.+
T Consensus 244 L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~ 284 (305)
T d1xkua_ 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284 (305)
T ss_dssp CCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred CCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcC
Confidence 5555555555553222222 2334445555555544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.1e-26 Score=242.87 Aligned_cols=251 Identities=24% Similarity=0.259 Sum_probs=165.4
Q ss_pred CCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcc-cCccccccccccCCcccceEEE
Q 002278 253 QALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQ-NNQLVGTIPAELGKLEQLFELN 331 (943)
Q Consensus 253 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~ 331 (943)
+++++|+|++|+|+...+..|.++++|+.|++++|++....+..+..+..++.++.. .|.++...+..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 345666666666665555556666666666666666665555566666666666543 4555555566666666677777
Q ss_pred ccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCC
Q 002278 332 LADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSG 411 (943)
Q Consensus 332 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 411 (943)
+++|.+....+..+..+++|+.+++++|+|+++.+.+|..+++|+.|++++|++++..+..|.++++|+.+++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 77776666666666666777777777777766666667777777777777777776666777777777777777777776
Q ss_pred ccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCcc
Q 002278 412 SVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSN 491 (943)
Q Consensus 412 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 491 (943)
..|..|.++++|++|++++|++++..+..|+++++|++|+|++|++...-+ ..+-...++.+....++++...|..+.
T Consensus 192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~- 269 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLA- 269 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGT-
T ss_pred cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHc-
Confidence 667777777777777777777777777777777777777777777775332 222233456666666666666665544
Q ss_pred ccCCcccccCCccccc
Q 002278 492 CFSLSNLNVSYNNLSG 507 (943)
Q Consensus 492 l~~L~~L~ls~N~l~~ 507 (943)
.+...+++.+.|+|
T Consensus 270 --g~~l~~l~~~~l~g 283 (284)
T d1ozna_ 270 --GRDLKRLAANDLQG 283 (284)
T ss_dssp --TCBGGGSCGGGSCC
T ss_pred --CCccccCCHHHCCC
Confidence 34555666666655
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.3e-25 Score=239.06 Aligned_cols=250 Identities=25% Similarity=0.240 Sum_probs=207.8
Q ss_pred eEeEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEec-CCCCCCCCCCCcCCCCcCcEEEc
Q 002278 230 QVATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLH-GNKLTGPIPPELGNMSKLSYLQL 308 (943)
Q Consensus 230 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~-~n~l~~~~~~~~~~l~~L~~L~L 308 (943)
.+++|+|++|+|+...+..|..+++|++|++++|++..+.+..+..+..+..+... .|.++...+..|.++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 34556666666665666778889999999999999998888888888888888764 66777777888999999999999
Q ss_pred ccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCC
Q 002278 309 QNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGK 388 (943)
Q Consensus 309 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 388 (943)
++|.+....+..+...++|+.+++++|+|+++.+..|..+++|+.|++++|+|+++.+.+|.++++|+.+++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 99999877788888899999999999999988888899999999999999999988889999999999999999999988
Q ss_pred CCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcc
Q 002278 389 VPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQL 468 (943)
Q Consensus 389 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 468 (943)
.|..|..+++|++|++++|++.+..+..|..+++|++|+|++|.+...-+ .-.-...++.+....+++....|..+.+
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g- 270 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG- 270 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT-
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC-
Confidence 89999999999999999999998888889999999999999999985432 1112245778888888888778887754
Q ss_pred cccceecccCcccCC
Q 002278 469 QNIISLILNNNNLQG 483 (943)
Q Consensus 469 ~~L~~L~L~~N~l~~ 483 (943)
+..++++.+.|+|
T Consensus 271 --~~l~~l~~~~l~g 283 (284)
T d1ozna_ 271 --RDLKRLAANDLQG 283 (284)
T ss_dssp --CBGGGSCGGGSCC
T ss_pred --CccccCCHHHCCC
Confidence 3445566666654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.3e-24 Score=228.62 Aligned_cols=197 Identities=22% Similarity=0.268 Sum_probs=128.6
Q ss_pred CCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccce
Q 002278 298 GNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTY 377 (943)
Q Consensus 298 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 377 (943)
.+...+...+.+++.++ .+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+ + .+..+++|+.
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence 34455666788888877 4565443 4677777777777766667777777777777777777633 2 3456677777
Q ss_pred eeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccc
Q 002278 378 LNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQL 457 (943)
Q Consensus 378 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 457 (943)
|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred ccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 777777776 3455666666777777777776665666666666666666666666666666666666666666666666
Q ss_pred cccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccC
Q 002278 458 SGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVS 501 (943)
Q Consensus 458 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 501 (943)
++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|+
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~ 203 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECC
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEec
Confidence 6555555666666666666666666 455555555555544433
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.2e-23 Score=220.98 Aligned_cols=201 Identities=23% Similarity=0.246 Sum_probs=128.9
Q ss_pred CCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEE
Q 002278 275 NLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQF 354 (943)
Q Consensus 275 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 354 (943)
+.+.+.+++.+++.++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+.+ | .++.+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccc
Confidence 34445556666666663 454442 4566667777766655556666666677777766666633 2 24566666677
Q ss_pred EeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeeccccccc
Q 002278 355 NVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLN 434 (943)
Q Consensus 355 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 434 (943)
+|++|++++ .+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.+....+..+..+++|+.|++++|+|+
T Consensus 83 ~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred ccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 777666663 3555666666667777666666666666666666666777666666555555666666666777777666
Q ss_pred ccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccC
Q 002278 435 GLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 435 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 482 (943)
+..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 666666666666777777776666 56666666666666777666654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.86 E-value=4.6e-20 Score=202.14 Aligned_cols=58 Identities=28% Similarity=0.421 Sum_probs=28.0
Q ss_pred CCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCCh
Q 002278 397 INLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPA 463 (943)
Q Consensus 397 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 463 (943)
++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.
T Consensus 284 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 284 PSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 34555555555554 33332 344555555555555 23322 234555566666655 4443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.86 E-value=3.4e-20 Score=203.19 Aligned_cols=77 Identities=32% Similarity=0.366 Sum_probs=49.6
Q ss_pred ccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccC
Q 002278 399 LDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNN 478 (943)
Q Consensus 399 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 478 (943)
....++..|.+.+ ++ ..+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++
T Consensus 266 ~~~~~~~~~~~~~-~~---~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~ 333 (353)
T d1jl5a_ 266 LYYLNASSNEIRS-LC---DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEY 333 (353)
T ss_dssp CCEEECCSSCCSE-EC---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCS
T ss_pred hcccccccCcccc-cc---ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcC
Confidence 3455666666552 22 23567788888888877 34543 456777888888887 56643 45677788888
Q ss_pred cccCCCCCCc
Q 002278 479 NNLQGGIPDQ 488 (943)
Q Consensus 479 N~l~~~~p~~ 488 (943)
|+|+ .+|+.
T Consensus 334 N~L~-~lp~~ 342 (353)
T d1jl5a_ 334 NPLR-EFPDI 342 (353)
T ss_dssp SCCS-SCCCC
T ss_pred CcCC-CCCcc
Confidence 8877 55553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.1e-22 Score=199.86 Aligned_cols=163 Identities=16% Similarity=0.218 Sum_probs=120.9
Q ss_pred ccceEEeeeceEEEEEEEecCCceEEEEEecccCc------------------ccHHHHHHHHHHHhcCCCCCcceeeeE
Q 002278 619 SEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYP------------------HNLREFETELETIGSIRHRNIVSLHGY 680 (943)
Q Consensus 619 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 680 (943)
.+.+.||+|+||+||+|.+.+|+.||||++..... .......+|.+.+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45788999999999999998899999998642210 011234568889999999999988765
Q ss_pred EecCCcceEEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCccEEECCCCceeec
Q 002278 681 ALSPYGNLLFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHDCNPRIIHRDVKSSNILIDENFDAHLS 760 (943)
Q Consensus 681 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 760 (943)
. ..+++|||++++.+.+ ++......++.|++.+++|||++ +|+||||||+|||++++ .++++
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 3 3489999998765543 23344567999999999999999 99999999999999965 48999
Q ss_pred ccccccccCCCCCceeeeEecccceeCc------cccccCCCCCcchhhhHHHHH
Q 002278 761 DFGIARCIPTAMPHASTFVLGTIGYIDP------EYAHTSRLNEKSDVYSFGIVL 809 (943)
Q Consensus 761 DFGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwSlGvil 809 (943)
|||.|+........ .|... +. ....|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 99999765433211 11111 11 235678899999976443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=5.1e-19 Score=182.74 Aligned_cols=220 Identities=17% Similarity=0.139 Sum_probs=107.7
Q ss_pred cEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCcccccc-ccccCCcccceEEEccc
Q 002278 256 AVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTI-PAELGKLEQLFELNLAD 334 (943)
Q Consensus 256 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~ 334 (943)
++++++++.++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+...+ +..|.++++++++.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 45556655555 3333221 24455555555555433444555555555555555544322 23344444444444432
Q ss_pred cccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCC-CCCCCCCCccEEecCCCcCCCcc
Q 002278 335 NNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVP-TELGRIINLDTLDLSVNNFSGSV 413 (943)
Q Consensus 335 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~ 413 (943)
.|.+....+..|.++++|+.|++++|+++...+ ..+..+..+..+..+++.+....
T Consensus 88 -----------------------~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~ 144 (242)
T d1xwdc1 88 -----------------------ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 144 (242)
T ss_dssp -----------------------CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEEC
T ss_pred -----------------------cccccccccccccccccccccccchhhhccccccccccccccccccccccccccccc
Confidence 234443444444455555555555554442211 12233344444445555555444
Q ss_pred CCCccccc-ccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccc
Q 002278 414 PASIGDLE-HLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNC 492 (943)
Q Consensus 414 ~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 492 (943)
+..|.+++ .++.|++++|+++.+.+..|.....++.+++++|+|+...+..|.++++|+.|+|++|+|+...+..|.++
T Consensus 145 ~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 224 (242)
T d1xwdc1 145 RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224 (242)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred ccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence 44444443 45566666666664444444332223333456666663333446666666666666666665445556666
Q ss_pred cCCcccccC
Q 002278 493 FSLSNLNVS 501 (943)
Q Consensus 493 ~~L~~L~ls 501 (943)
++|+.+++.
T Consensus 225 ~~L~~l~~~ 233 (242)
T d1xwdc1 225 KKLRARSTY 233 (242)
T ss_dssp CEEESSSEE
T ss_pred cccccCcCC
Confidence 666666554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1e-18 Score=180.31 Aligned_cols=217 Identities=17% Similarity=0.150 Sum_probs=147.5
Q ss_pred eEEEecCccccccCCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCC-CCCcCCCCcCcEEEccc
Q 002278 232 ATLSLQGNKLTGKIPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPI-PPELGNMSKLSYLQLQN 310 (943)
Q Consensus 232 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~ 310 (943)
+.++.+++.++. +|+.+ .+++++|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~~-iP~~l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCSS-CCSCS--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCCC-cCCCC--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 578888888884 55544 258999999999999777778999999999999999988644 55789999999999864
Q ss_pred -CccccccccccCCcccceEEEccccccCCcCcc-cccCCCcCcEEEeeCCcccCcccccccccC-ccceeeccCCcCCC
Q 002278 311 -NQLVGTIPAELGKLEQLFELNLADNNLEGPIPH-NISSCTALNQFNVHGNRLSGAIPSSFRNLG-SLTYLNLSRNNFKG 387 (943)
Q Consensus 311 -N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~ 387 (943)
|.+....+..|.++++|+.|++++|++....+. .+..+..+..+...++.+..+.+..|.+++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 788878888899999999999999998754332 234455666666666677655566666554 56666666666663
Q ss_pred CCCCCCCCCCCccE-EecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecc
Q 002278 388 KVPTELGRIINLDT-LDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDM 452 (943)
Q Consensus 388 ~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 452 (943)
..+..+ ...+++. +++++|+++...+..|.++++|++|+|++|+|+.+.+..|.++++|+.|++
T Consensus 168 i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 168 IHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp ECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 333332 3333333 344555555433344555555555555555555444444555555555444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=2.2e-19 Score=183.43 Aligned_cols=207 Identities=22% Similarity=0.311 Sum_probs=101.1
Q ss_pred CCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccceecc
Q 002278 85 CGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVLQYLG 164 (943)
Q Consensus 85 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 164 (943)
+.++..++++.+++++.. .++.+++|+.|++++|.|+. + +.+..+++|++|++++|++++..| +..+++|++++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 344445566666666433 34566677777777777663 3 346667777777777776664322 45555555555
Q ss_pred ccCCccCCCCCcccccccccceeeccceecccccCCCCcCCCcccEEEeecccccCcCCCCCCcceEeEEEecCcccccc
Q 002278 165 LRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNKLTGK 244 (943)
Q Consensus 165 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~n~l~~~ 244 (943)
+++|.++.+ ..+..+++|+.+++++|...+. ..+...+.++.+.++.+.+. .
T Consensus 92 ~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~-----------------------~- 143 (227)
T d1h6ua2 92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQIT-----------------------N- 143 (227)
T ss_dssp CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCC-----------------------C-
T ss_pred ccccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhc-----------------------h-
Confidence 555555543 2344444444444444444322 12333344444444444432 1
Q ss_pred CCccccccCCCcEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCc
Q 002278 245 IPEVIGLMQALAVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKL 324 (943)
Q Consensus 245 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 324 (943)
...+..+++|+.|++++|.+.+.. .++++++|++|+|++|++++. ..|.++++|++|+|++|++++.. .+.++
T Consensus 144 -~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l 216 (227)
T d1h6ua2 144 -ISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVS--PLANT 216 (227)
T ss_dssp -CGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECTTSCCCBCG--GGTTC
T ss_pred -hhhhccccccccccccccccccch--hhcccccceecccCCCccCCC--hhhcCCCCCCEEECcCCcCCCCc--ccccC
Confidence 112334455555555555554221 244444444444444444432 12444444444444444444221 13444
Q ss_pred ccceEEEc
Q 002278 325 EQLFELNL 332 (943)
Q Consensus 325 ~~L~~L~L 332 (943)
++|+.|++
T Consensus 217 ~~L~~L~l 224 (227)
T d1h6ua2 217 SNLFIVTL 224 (227)
T ss_dssp TTCCEEEE
T ss_pred CCCCEEEe
Confidence 44444444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.8e-19 Score=184.01 Aligned_cols=204 Identities=25% Similarity=0.369 Sum_probs=107.8
Q ss_pred cEEecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEcccc
Q 002278 256 AVLDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADN 335 (943)
Q Consensus 256 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 335 (943)
..++++.+++.+.. .+..+.+|+.|++.+|.|+.. ..+..+++|++|++++|++++..| +..+++|+.+++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 34455555555322 334445555555555555532 234555555555555555543222 444444555555544
Q ss_pred ccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCC
Q 002278 336 NLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPA 415 (943)
Q Consensus 336 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 415 (943)
.++.+ ..+.++++|+.+++++|...+. ..+.....+..+.++.+.+....
T Consensus 96 ~~~~i--------------------------~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~-- 145 (227)
T d1h6ua2 96 PLKNV--------------------------SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS-- 145 (227)
T ss_dssp CCSCC--------------------------GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--
T ss_pred ccccc--------------------------cccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--
Confidence 44421 1344455555555555554422 22344455566666666555322
Q ss_pred CcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCC
Q 002278 416 SIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSL 495 (943)
Q Consensus 416 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 495 (943)
.+..+++|+.|++++|.++.. ..|.++++|++|+|++|++++ +| .++.+++|++|+|++|+|++..| +.++++|
T Consensus 146 ~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L 219 (227)
T d1h6ua2 146 PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNL 219 (227)
T ss_dssp GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTC
T ss_pred hhccccccccccccccccccc--hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCC
Confidence 245556666666666666532 235666666666666666663 33 26666677777777777664332 5666677
Q ss_pred cccccC
Q 002278 496 SNLNVS 501 (943)
Q Consensus 496 ~~L~ls 501 (943)
+.|+++
T Consensus 220 ~~L~ls 225 (227)
T d1h6ua2 220 FIVTLT 225 (227)
T ss_dssp CEEEEE
T ss_pred CEEEee
Confidence 777665
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=8.9e-19 Score=173.50 Aligned_cols=174 Identities=20% Similarity=0.283 Sum_probs=128.5
Q ss_pred EEEccccccCCcCcccccCCCcCcEEEeeCCcccC-cccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCC
Q 002278 329 ELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSG-AIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVN 407 (943)
Q Consensus 329 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 407 (943)
.++.++++++ .+|..+. +++++|+|++|+|++ ..+..|.++++|+.|+|++|++.+..+..+..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4566666666 3343331 466777777777764 44566788888888888888888778888888888888888888
Q ss_pred cCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCC
Q 002278 408 NFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPD 487 (943)
Q Consensus 408 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 487 (943)
+|+...|..|.++++|++|+|++|+|+++.|..|..+++|++|+|++|.+.... ....-...++.+.+..|.++...|.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~-~~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC-HLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG-GGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc-chHHHhhhhhhhcccCCCeEeCCCh
Confidence 888777778888888999999999998888888888999999999999887433 2223334577778888888776665
Q ss_pred cCccccCCcccccCCccccccC
Q 002278 488 QLSNCFSLSNLNVSYNNLSGII 509 (943)
Q Consensus 488 ~~~~l~~L~~L~ls~N~l~~~~ 509 (943)
. +..++.++|+.|.|....
T Consensus 168 ~---l~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 168 K---VRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp T---TTTSBGGGSCTTTCCCCC
T ss_pred h---hcCCEeeecCHhhCcCCC
Confidence 4 445667788888776443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=4e-22 Score=227.16 Aligned_cols=110 Identities=25% Similarity=0.301 Sum_probs=74.8
Q ss_pred cEEEEEcCCCCCccc-cCCCcCCCCCCCEEEeeCCcccc----cCCCCccCCCCCcEEeccCCCcCCcc----chhcc-c
Q 002278 39 SVVSLNLSSLNLGGE-ISPSIGDLRNLQSIDFQGNKLTG----QIPDEIGNCGSLVHIELSDNSLYGDI----PFSIS-K 108 (943)
Q Consensus 39 ~v~~L~l~~~~~~~~-~~~~l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~-~ 108 (943)
.++.||+++|++++. +..-+..+++++.|+|++|+|+. .++..+..+++|++|||++|+|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 577888888888763 23345667778888888888773 34455677888888888888876322 22222 2
Q ss_pred cccceEEEecCcccccC----CCcccCCCCCCcEEEEecccccc
Q 002278 109 LKQLEFLNLKNNQLTGP----IPSTLTQIPNLKTLDLARNQLTG 148 (943)
Q Consensus 109 l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~ 148 (943)
..+|++|+|++|+++.. ++..+..+++|++|+|++|.|+.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 24688888888887643 34566777888888888887763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.3e-21 Score=222.89 Aligned_cols=109 Identities=26% Similarity=0.271 Sum_probs=60.8
Q ss_pred CCCEEEeeCCcccccC-CCCccCCCCCcEEeccCCCcCC----ccchhccccccceEEEecCcccccC----CCcccCC-
Q 002278 63 NLQSIDFQGNKLTGQI-PDEIGNCGSLVHIELSDNSLYG----DIPFSISKLKQLEFLNLKNNQLTGP----IPSTLTQ- 132 (943)
Q Consensus 63 ~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~- 132 (943)
+|++||+++|+|++.. .+.+..+++|+.|+|++|.|+. .++..+..+++|++|+|++|.|+.. +...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5677777777776421 2335556777777777777663 2234455667777777777766521 1122222
Q ss_pred CCCCcEEEEeccccccc----cchhccccccceeccccCCccC
Q 002278 133 IPNLKTLDLARNQLTGE----IPRLIYWNEVLQYLGLRGNALT 171 (943)
Q Consensus 133 l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~ 171 (943)
.++|++|+|++|+|+.. ++..+..+++|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 24566666666666532 2333444445555555555443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=2.8e-18 Score=169.82 Aligned_cols=178 Identities=20% Similarity=0.237 Sum_probs=144.1
Q ss_pred CcEEEeeCCcccCcccccccccCccceeeccCCcCCC-CCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecc
Q 002278 351 LNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKG-KVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLS 429 (943)
Q Consensus 351 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 429 (943)
.+.++.++|+++ .+|..+. +++++|+|++|+|++ ..+..|..+++|+.|+|++|.+.+..+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 467899999998 4555442 689999999999976 446678899999999999999998889999999999999999
Q ss_pred cccccccCCccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCcCccccCCcccccCCccccccC
Q 002278 430 RNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSYNNLSGII 509 (943)
Q Consensus 430 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 509 (943)
+|+|+.+.|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++....+. ..-...++.+.+..|.++...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCC
Confidence 9999998899999999999999999999987888899999999999999999854332 222334677888889888655
Q ss_pred CCCcccCcCCCCccccCCCCCCCCC
Q 002278 510 PPIRNFSRFSSNSFIGNPLLCGNWI 534 (943)
Q Consensus 510 ~~~~~~~~~~~~~~~~Np~~c~~~~ 534 (943)
|. .+....-..+..|.+.|.++-
T Consensus 166 p~--~l~~~~l~~L~~n~l~C~~~~ 188 (192)
T d1w8aa_ 166 PS--KVRDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp ST--TTTTSBGGGSCTTTCCCCCC-
T ss_pred Ch--hhcCCEeeecCHhhCcCCCCC
Confidence 53 234444456777888886543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=6e-18 Score=169.98 Aligned_cols=163 Identities=21% Similarity=0.329 Sum_probs=72.5
Q ss_pred CcCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeec
Q 002278 301 SKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNL 380 (943)
Q Consensus 301 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 380 (943)
.+|++|++++|.++.. + .+..+++|++|+|++|+|++.. .++.+++|++|++++|+|++ ++ .+.++++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 3444444444444421 1 2334444444444444444322 13344444444444444442 12 2444455555555
Q ss_pred cCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCcccccc
Q 002278 381 SRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGS 460 (943)
Q Consensus 381 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 460 (943)
++|.+.. + ..+..++.++.+++++|.+++ +..+..+++|+.+++++|++++.. .|.++++|++|+|++|+|+ .
T Consensus 120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~-~ 192 (210)
T d1h6ta2 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHIS-D 192 (210)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-B
T ss_pred ccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCC-C
Confidence 5554431 1 234444445555555555442 122344455555555555554321 2445555555555555554 2
Q ss_pred CChhhhcccccceeccc
Q 002278 461 IPAELGQLQNIISLILN 477 (943)
Q Consensus 461 ~p~~~~~l~~L~~L~L~ 477 (943)
+| .|..+++|+.|+|+
T Consensus 193 l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 193 LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CG-GGTTCTTCSEEEEE
T ss_pred Ch-hhcCCCCCCEEEcc
Confidence 33 34455555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=4.4e-18 Score=169.45 Aligned_cols=177 Identities=27% Similarity=0.400 Sum_probs=84.2
Q ss_pred EecCCCCCCCCCCcccCCCCCcceEEecCCCCCCCCCCCcCCCCcCcEEEcccCccccccccccCCcccceEEEcccccc
Q 002278 258 LDLSENELVGPIPPILGNLSYTGKLYLHGNKLTGPIPPELGNMSKLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNL 337 (943)
Q Consensus 258 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 337 (943)
+.++.+.+++..+ ...+.++++|++++|.++.. +.+..+++|++|++++|++++..+ ++++++|+.|++++|.+
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence 3444444443221 12344455555555555432 234445555555555555543222 44455555555555544
Q ss_pred CCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCc
Q 002278 338 EGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASI 417 (943)
Q Consensus 338 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 417 (943)
.... .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. ++ .+
T Consensus 97 ~~~~--------------------------~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l 146 (199)
T d2omxa2 97 ADIT--------------------------PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-AL 146 (199)
T ss_dssp CCCG--------------------------GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GG
T ss_pred cccc--------------------------ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cc
Confidence 4221 234444444444444444321 224444555555555555542 22 34
Q ss_pred ccccccceeecccccccccCCccccCCCccceecccCccccccCChhhhccccccee
Q 002278 418 GDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISL 474 (943)
Q Consensus 418 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 474 (943)
..+++|+.|++++|++++.. .|+++++|++|++++|+++. +| .++.+++|++|
T Consensus 147 ~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 147 SGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp TTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 55555555666666555432 25566666666666666652 33 35556655544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=8.1e-18 Score=169.00 Aligned_cols=185 Identities=21% Similarity=0.327 Sum_probs=150.5
Q ss_pred cCcEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeecc
Q 002278 302 KLSYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLS 381 (943)
Q Consensus 302 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 381 (943)
++....++.+.+++.++. ..+.+|+.|++++|.++... .+..+++|++|++++|+|++.. .+..+++|+.|+++
T Consensus 25 ~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~ 98 (210)
T d1h6ta2 25 ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLD 98 (210)
T ss_dssp HHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred HHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccc
Confidence 333445666766654432 45788999999999998543 4788999999999999998654 36789999999999
Q ss_pred CCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccC
Q 002278 382 RNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSI 461 (943)
Q Consensus 382 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 461 (943)
+|++++ ++ .+..+++|+.|++++|.+.. + ..+..++.|+.+++++|.+++ +..+..+++|+.+++++|++++ +
T Consensus 99 ~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i 171 (210)
T d1h6ta2 99 ENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-I 171 (210)
T ss_dssp SSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-C
T ss_pred cccccc-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccc-c
Confidence 999984 44 58889999999999999873 3 358889999999999999974 3467889999999999999985 4
Q ss_pred ChhhhcccccceecccCcccCCCCCCcCccccCCcccccCC
Q 002278 462 PAELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNLNVSY 502 (943)
Q Consensus 462 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 502 (943)
+ .+.++++|+.|+|++|+|+. +| .+.++++|++|+|++
T Consensus 172 ~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 172 V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 4 38899999999999999984 55 588999999999874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.1e-17 Score=164.46 Aligned_cols=179 Identities=23% Similarity=0.359 Sum_probs=139.8
Q ss_pred cEEEcccCccccccccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCCcccCcccccccccCccceeeccCC
Q 002278 304 SYLQLQNNQLVGTIPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN 383 (943)
Q Consensus 304 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 383 (943)
..+.++.+.+++..+ ...+.+|++|++++|.|+.. +.+..+++|++|++++|+|++..+ +.++++|++|++++|
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccc
Confidence 334455555554332 23566677777777777643 346778888888888888886543 888999999999999
Q ss_pred cCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCccceecccCccccccCCh
Q 002278 384 NFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRSIQTIDMSFNQLSGSIPA 463 (943)
Q Consensus 384 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 463 (943)
.+.. ++ .+..++.|+.|++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|+.|++++|++++ ++
T Consensus 95 ~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~-l~- 166 (199)
T d2omxa2 95 QIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTD-LK- 166 (199)
T ss_dssp CCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCC-CG-
T ss_pred cccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccC-Cc-
Confidence 9874 33 488999999999999999853 348889999999999999984 3 468899999999999999985 43
Q ss_pred hhhcccccceecccCcccCCCCCCcCccccCCccc
Q 002278 464 ELGQLQNIISLILNNNNLQGGIPDQLSNCFSLSNL 498 (943)
Q Consensus 464 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 498 (943)
.++++++|+.|++++|+++. +| .++++++|+.|
T Consensus 167 ~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 167 PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 48999999999999999985 44 47888888765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.1e-15 Score=145.62 Aligned_cols=112 Identities=21% Similarity=0.248 Sum_probs=62.7
Q ss_pred CcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCC
Q 002278 57 SIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNL 136 (943)
Q Consensus 57 ~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 136 (943)
.+.++..+++|||++|+|+ .+|..+..+++|++|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 3455556666666666666 44555556666666666666666 332 35666666666666666664444445556666
Q ss_pred cEEEEeccccccccc-hhccccccceeccccCCccC
Q 002278 137 KTLDLARNQLTGEIP-RLIYWNEVLQYLGLRGNALT 171 (943)
Q Consensus 137 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~ 171 (943)
++|+|++|+|+.... ..+..+++|++|++++|.++
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc
Confidence 666666666653211 23344444444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=6.1e-15 Score=133.36 Aligned_cols=100 Identities=26% Similarity=0.393 Sum_probs=47.5
Q ss_pred EEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccc
Q 002278 66 SIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQ 145 (943)
Q Consensus 66 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 145 (943)
.|||++|+|+ .++ .++++++|++|++++|+|+ .+|..|+.+++|+.|++++|+|+. +| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4555555555 333 2455555555555555555 344445555555555555555552 22 35555555555555555
Q ss_pred ccccc-chhccccccceeccccCCcc
Q 002278 146 LTGEI-PRLIYWNEVLQYLGLRGNAL 170 (943)
Q Consensus 146 l~~~~-~~~~~~l~~L~~L~L~~n~l 170 (943)
|+... ...+..+++|++|++++|.+
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcC
Confidence 54221 12333334444444444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=2.5e-15 Score=143.14 Aligned_cols=128 Identities=20% Similarity=0.169 Sum_probs=108.4
Q ss_pred CccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccccccchhccccccc
Q 002278 81 EIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLTGEIPRLIYWNEVL 160 (943)
Q Consensus 81 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 160 (943)
.|.++.+|++|+|++|+|+ .++..+..+++|++|+|++|+|+.. +.|..+++|++|+|++|+|+...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 4678889999999999999 5677778899999999999999954 458999999999999999997666677789999
Q ss_pred eeccccCCccCCCCC-cccccccccceeeccceecccccCC----CCcCCCcccEEE
Q 002278 161 QYLGLRGNALTGMLS-PDMCQLTGLWYFDVRGNNLTGTIPD----SIGNCTSFEILD 212 (943)
Q Consensus 161 ~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~----~l~~l~~L~~L~ 212 (943)
++|++++|+|+.+.. ..+..+++|++|++++|.++.. |. .+..+++|++||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~-~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccc-cchHHHHHHHCCCcCeeC
Confidence 999999999988754 5678889999999999988743 32 467788888887
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=1.4e-14 Score=130.88 Aligned_cols=102 Identities=26% Similarity=0.378 Sum_probs=91.3
Q ss_pred EEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcc
Q 002278 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQ 121 (943)
Q Consensus 42 ~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~ 121 (943)
.|||++|+++ .++ .+..+++|++|||++|+|+ .+|..|+.+++|+.|++++|+|+. +| .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 5899999999 554 5999999999999999999 778889999999999999999994 55 59999999999999999
Q ss_pred cccCC-CcccCCCCCCcEEEEecccccc
Q 002278 122 LTGPI-PSTLTQIPNLKTLDLARNQLTG 148 (943)
Q Consensus 122 l~~~~-~~~~~~l~~L~~L~Ls~N~l~~ 148 (943)
++... ...+..+++|+.|++++|+++.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 99553 3678999999999999999973
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.3e-15 Score=160.20 Aligned_cols=125 Identities=20% Similarity=0.208 Sum_probs=79.0
Q ss_pred EEEcCCCCCccccCCCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCc-cchhccccccceEEEecCc
Q 002278 42 SLNLSSLNLGGEISPSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGD-IPFSISKLKQLEFLNLKNN 120 (943)
Q Consensus 42 ~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~n 120 (943)
.+||+++.+.+.....+.. ..+..+.+++..+... ........+|++|||+++.++.. ++..+..+++|++|+|++|
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 5788887776543333221 2355667776666532 23344566888888888887643 3445677888888888888
Q ss_pred ccccCCCcccCCCCCCcEEEEecc-ccccc-cchhccccccceeccccCC
Q 002278 121 QLTGPIPSTLTQIPNLKTLDLARN-QLTGE-IPRLIYWNEVLQYLGLRGN 168 (943)
Q Consensus 121 ~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~~L~~L~L~~n 168 (943)
.+++..+..+..+++|++|+|++| .++.. +...+..+++|++|+++++
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 887777777888888888888875 45421 1222234455555555543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=1.4e-15 Score=165.44 Aligned_cols=188 Identities=19% Similarity=0.156 Sum_probs=83.3
Q ss_pred ccccccCCCcEEecCCCCCCCC----CCcccCCCCCcceEEecCCCCCCCC----------CCCcCCCCcCcEEEcccCc
Q 002278 247 EVIGLMQALAVLDLSENELVGP----IPPILGNLSYTGKLYLHGNKLTGPI----------PPELGNMSKLSYLQLQNNQ 312 (943)
Q Consensus 247 ~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~----------~~~~~~l~~L~~L~L~~N~ 312 (943)
..+....+|+.|+|++|.+... +...+...++|+.|+++++...... ...+...++|+.|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 3444555666666666655421 1223444555555555554433111 1113334556666666665
Q ss_pred cccc----cccccCCcccceEEEccccccCCcCccc-------------ccCCCcCcEEEeeCCcccCc----ccccccc
Q 002278 313 LVGT----IPAELGKLEQLFELNLADNNLEGPIPHN-------------ISSCTALNQFNVHGNRLSGA----IPSSFRN 371 (943)
Q Consensus 313 l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~~----~~~~~~~ 371 (943)
+... +...+...++|+.|++++|.+....... ....+.|+.|++++|++... +...+..
T Consensus 105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~ 184 (344)
T d2ca6a1 105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184 (344)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred cccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhh
Confidence 5432 1222333455566666555543111000 12334555555555555321 1222334
Q ss_pred cCccceeeccCCcCCCC-----CCCCCCCCCCccEEecCCCcCCCc----cCCCcccccccceeeccccccc
Q 002278 372 LGSLTYLNLSRNNFKGK-----VPTELGRIINLDTLDLSVNNFSGS----VPASIGDLEHLLTLNLSRNHLN 434 (943)
Q Consensus 372 l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 434 (943)
.+.|+.|+|++|.++.. +...+...++|+.|+|++|.++.. +...+..+++|++|+|++|.|+
T Consensus 185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 44555555555554321 122344444555555555544311 1223334445555555555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=5.7e-15 Score=155.31 Aligned_cols=206 Identities=21% Similarity=0.271 Sum_probs=110.3
Q ss_pred CcCcEEEcccCccccc-cccccCCcccceEEEccccccCCcCcccccCCCcCcEEEeeCC-cccCc-ccccccccCccce
Q 002278 301 SKLSYLQLQNNQLVGT-IPAELGKLEQLFELNLADNNLEGPIPHNISSCTALNQFNVHGN-RLSGA-IPSSFRNLGSLTY 377 (943)
Q Consensus 301 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~ 377 (943)
.+|++||+++|.+... +...+..+++|++|+|++|.+....+..+..+++|++|+++++ .++.. +...+..+++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 3455555555544322 2233444555555555555555444445555555555555552 33311 1112334556666
Q ss_pred eeccCCc-CCCC-CCCCCCC-CCCccEEecCCC--cCCCc-cCCCcccccccceeecccc-cccccCCccccCCCcccee
Q 002278 378 LNLSRNN-FKGK-VPTELGR-IINLDTLDLSVN--NFSGS-VPASIGDLEHLLTLNLSRN-HLNGLLPAEFGNLRSIQTI 450 (943)
Q Consensus 378 L~L~~N~-l~~~-~~~~~~~-l~~L~~L~Ls~N--~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L 450 (943)
|+++++. ++.. +...+.. .++|+.|+++++ .++.. +...+..+++|++|+|++| .+++.....+..+++|++|
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 6666542 2211 0111111 245667777654 23211 2222345677888888775 4666666677778888888
Q ss_pred cccCc-cccccCChhhhcccccceecccCcccCCCCCCcCccc-cCCcccccCCccccccCC
Q 002278 451 DMSFN-QLSGSIPAELGQLQNIISLILNNNNLQGGIPDQLSNC-FSLSNLNVSYNNLSGIIP 510 (943)
Q Consensus 451 ~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~~ 510 (943)
+|+++ .++......++++++|+.|+++++ ++ +..+..+ ..+..|++..++++++.+
T Consensus 206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~---d~~l~~l~~~lp~L~i~~~~ls~~~~ 263 (284)
T d2astb2 206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIAR 263 (284)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTC
T ss_pred ECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC---HHHHHHHHHhCccccccCccCCCCCC
Confidence 88884 676666667778888888888776 32 1122221 234445567778877644
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.42 E-value=2.7e-15 Score=163.12 Aligned_cols=94 Identities=21% Similarity=0.216 Sum_probs=54.2
Q ss_pred cCCCCccCCCCCcEEeccCCCcCCcc----chhccccccceEEEecCcccccC----------CCcccCCCCCCcEEEEe
Q 002278 77 QIPDEIGNCGSLVHIELSDNSLYGDI----PFSISKLKQLEFLNLKNNQLTGP----------IPSTLTQIPNLKTLDLA 142 (943)
Q Consensus 77 ~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~n~l~~~----------~~~~~~~l~~L~~L~Ls 142 (943)
.+...+....+|+.|+|++|.|.... ...+...++|+.|+++++..... +...+...++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 34455667788888888888876433 23355667788888877654321 11234455667777777
Q ss_pred ccccccc----cchhccccccceeccccCCcc
Q 002278 143 RNQLTGE----IPRLIYWNEVLQYLGLRGNAL 170 (943)
Q Consensus 143 ~N~l~~~----~~~~~~~l~~L~~L~L~~n~l 170 (943)
+|.++.. +...+..+++|++|++++|.+
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l 133 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 133 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred ccccccccccchhhhhcccccchheecccccc
Confidence 7666532 222233344555555555544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.42 E-value=1.7e-15 Score=149.57 Aligned_cols=87 Identities=21% Similarity=0.310 Sum_probs=38.9
Q ss_pred CCcCCCCCCCEEEeeCCcccccCCCCccCCCCCcEEeccCCCcCCccchhccccccceEEEecCcccccCCCcccCCCCC
Q 002278 56 PSIGDLRNLQSIDFQGNKLTGQIPDEIGNCGSLVHIELSDNSLYGDIPFSISKLKQLEFLNLKNNQLTGPIPSTLTQIPN 135 (943)
Q Consensus 56 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 135 (943)
.++..+++|++|+|++|+|+ .++ .|..+++|++|+|++|+|+ .+|..+..+++|++|++++|+++.. ..+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccc
Confidence 34444555555555555554 222 2444445555555555444 3333333344444444444444421 22444444
Q ss_pred CcEEEEeccccc
Q 002278 136 LKTLDLARNQLT 147 (943)
Q Consensus 136 L~~L~Ls~N~l~ 147 (943)
|+.|+|++|+|+
T Consensus 117 L~~L~L~~N~i~ 128 (198)
T d1m9la_ 117 LRVLYMSNNKIT 128 (198)
T ss_dssp SSEEEESEEECC
T ss_pred ccccccccchhc
Confidence 444444444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.35 E-value=7.8e-15 Score=144.81 Aligned_cols=110 Identities=25% Similarity=0.318 Sum_probs=51.2
Q ss_pred ccccccCccceeeccCCcCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccccccccCCccccCCCc
Q 002278 367 SSFRNLGSLTYLNLSRNNFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRNHLNGLLPAEFGNLRS 446 (943)
Q Consensus 367 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 446 (943)
..+..+++|+.|+|++|+|+. ++ .+..+++|+.|+|++|.|+ .+|..+..+++|+.|++++|+|+.+ ..+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccc
Confidence 344444455555555555442 22 2444445555555555444 2333333344455555555555432 22444555
Q ss_pred cceecccCccccccCC--hhhhcccccceecccCcccC
Q 002278 447 IQTIDMSFNQLSGSIP--AELGQLQNIISLILNNNNLQ 482 (943)
Q Consensus 447 L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~ 482 (943)
|+.|+|++|+|+. ++ ..+..+++|+.|+|++|+++
T Consensus 117 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 117 LRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccchhcc-ccccccccCCCccceeecCCCccc
Confidence 5555555555542 22 23445555555555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=1.2e-12 Score=123.22 Aligned_cols=109 Identities=19% Similarity=0.180 Sum_probs=88.2
Q ss_pred CCCcceeEecCCCCcEEEEEcCCCCCccccCCCcCCCCCCCEEEeeCC-cccccCCCCccCCCCCcEEeccCCCcCCccc
Q 002278 25 FCSWRGVFCDNSSLSVVSLNLSSLNLGGEISPSIGDLRNLQSIDFQGN-KLTGQIPDEIGNCGSLVHIELSDNSLYGDIP 103 (943)
Q Consensus 25 ~c~w~gv~c~~~~~~v~~L~l~~~~~~~~~~~~l~~l~~L~~L~Ls~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 103 (943)
|+.+.+|.|.+. ++. .+|..+..+++|++|+|++| .|+...++.|.++++|+.|+|++|+|+...|
T Consensus 7 c~~~~~l~c~~~------------~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~ 73 (156)
T d2ifga3 7 PHGSSGLRCTRD------------GAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (156)
T ss_dssp CSSSSCEECCSS------------CCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred cCCCCeEEecCC------------CCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccc
Confidence 445777777543 344 56778888999999999876 5886666779999999999999999997778
Q ss_pred hhccccccceEEEecCcccccCCCcccCCCCCCcEEEEeccccc
Q 002278 104 FSISKLKQLEFLNLKNNQLTGPIPSTLTQIPNLKTLDLARNQLT 147 (943)
Q Consensus 104 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 147 (943)
.+|..+++|++|+|++|+|+...++.|..+ +|+.|+|++|.+.
T Consensus 74 ~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp TGGGSCSCCCEEECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ccccccccccceeccCCCCcccChhhhccc-cccccccCCCccc
Confidence 889999999999999999996555556544 7999999999885
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=3e-12 Score=120.57 Aligned_cols=103 Identities=20% Similarity=0.157 Sum_probs=46.6
Q ss_pred EEEeeCCcccCcccccccccCccceeeccCC-cCCCCCCCCCCCCCCccEEecCCCcCCCccCCCcccccccceeecccc
Q 002278 353 QFNVHGNRLSGAIPSSFRNLGSLTYLNLSRN-NFKGKVPTELGRIINLDTLDLSVNNFSGSVPASIGDLEHLLTLNLSRN 431 (943)
Q Consensus 353 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 431 (943)
.++.+++.+. ..|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3444444443 22333444444444444433 244333344444445555555555554444444555555555555555
Q ss_pred cccccCCccccCCCccceecccCccc
Q 002278 432 HLNGLLPAEFGNLRSIQTIDMSFNQL 457 (943)
Q Consensus 432 ~l~~~~p~~~~~l~~L~~L~Ls~N~l 457 (943)
+|+.+.+..|..+ +|+.|+|++|.+
T Consensus 91 ~l~~l~~~~~~~~-~l~~L~L~~Np~ 115 (156)
T d2ifga3 91 ALESLSWKTVQGL-SLQELVLSGNPL 115 (156)
T ss_dssp CCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred CCcccChhhhccc-cccccccCCCcc
Confidence 5553333333333 355555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=2e-09 Score=101.60 Aligned_cols=83 Identities=24% Similarity=0.252 Sum_probs=43.4
Q ss_pred cccccccceeecccccccccC--CccccCCCccceecccCccccccCChhhhcccccceecccCcccCCCCCCc------
Q 002278 417 IGDLEHLLTLNLSRNHLNGLL--PAEFGNLRSIQTIDMSFNQLSGSIPAELGQLQNIISLILNNNNLQGGIPDQ------ 488 (943)
Q Consensus 417 ~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~------ 488 (943)
+..+++|++|+|++|+|+.+. +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|+++....+.
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 345566666666666665432 233455666666666666666322223333345666666666665433321
Q ss_pred -CccccCCcccc
Q 002278 489 -LSNCFSLSNLN 499 (943)
Q Consensus 489 -~~~l~~L~~L~ 499 (943)
+..+|+|+.||
T Consensus 141 i~~~~P~L~~LD 152 (162)
T d1koha1 141 IRERFPKLLRLD 152 (162)
T ss_dssp HHTTSTTCCEET
T ss_pred HHHHCCCCCEEC
Confidence 33455666554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=1.8e-09 Score=101.84 Aligned_cols=81 Identities=27% Similarity=0.291 Sum_probs=37.0
Q ss_pred CCCCCcEEEEeccccccc--cchhccccccceeccccCCccCCCCCcccccccccceeeccceecccccCC-------CC
Q 002278 132 QIPNLKTLDLARNQLTGE--IPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTGTIPD-------SI 202 (943)
Q Consensus 132 ~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~-------~l 202 (943)
.+++|++|+|++|+|+.. ++..+..+++|++|+|++|+|+.+.+-.+....+|+.|++++|.+...... .+
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~ 142 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR 142 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHH
Confidence 344444444444444422 123334444455555555555444333333334455555555555433221 24
Q ss_pred cCCCcccEEE
Q 002278 203 GNCTSFEILD 212 (943)
Q Consensus 203 ~~l~~L~~L~ 212 (943)
..+++|+.||
T Consensus 143 ~~~P~L~~LD 152 (162)
T d1koha1 143 ERFPKLLRLD 152 (162)
T ss_dssp TTSTTCCEET
T ss_pred HHCCCCCEEC
Confidence 4567777665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.35 E-value=4e-07 Score=93.13 Aligned_cols=148 Identities=14% Similarity=0.065 Sum_probs=100.5
Q ss_pred HHHHHhhccccceEEeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcce
Q 002278 610 DIMRSTENLSEKYIVGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNL 688 (943)
Q Consensus 610 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 688 (943)
++..-.+.|+..+..+.++.+.||+... +++.+++|+...........+.+|.++++.+. +--+.+++++..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4455556665544434444568998864 45667888876554444556778888877664 333567788888888889
Q ss_pred EEEEEccCCChhhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhC----------------------------------
Q 002278 689 LFYDYMVNGSLWDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD---------------------------------- 734 (943)
Q Consensus 689 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------- 734 (943)
+||++++|..+.+..... .....++.++++.++.||+.
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998886654211 11233455666666666643
Q ss_pred ----------------------CCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 735 ----------------------CNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 735 ----------------------~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
..+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01247999999999999987667799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=2.6e-05 Score=78.69 Aligned_cols=130 Identities=15% Similarity=0.116 Sum_probs=86.3
Q ss_pred EEeeece-EEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCC--CCcceeeeEEecCCcceEEEEEccCCCh
Q 002278 623 IVGYGAS-STVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRH--RNIVSLHGYALSPYGNLLFYDYMVNGSL 699 (943)
Q Consensus 623 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L 699 (943)
.+..|.. +.||+....++..+++|...... ...+..|++.++.+.. -.+.+++++..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455554 67899988878888888765432 2346677777776642 3356778888888888999999988765
Q ss_pred hhhccCCCCCccCCHHHHHHHHHHHHHHHHHhhhC---------------------------------------------
Q 002278 700 WDLLHGPSKKVKLDWETRLKIAVGAAQGLAYLHHD--------------------------------------------- 734 (943)
Q Consensus 700 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------- 734 (943)
.+.. ... ...+.++++.++-||+.
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 111 11223344444444431
Q ss_pred ----------CCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 735 ----------CNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 735 ----------~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
..+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 12247999999999999987667899998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.78 E-value=3.6e-06 Score=79.00 Aligned_cols=88 Identities=13% Similarity=0.193 Sum_probs=49.2
Q ss_pred CCCCCCEEEeeCC-ccccc----CCCCccCCCCCcEEeccCCCcCCcc----chhccccccceEEEecCcccccC----C
Q 002278 60 DLRNLQSIDFQGN-KLTGQ----IPDEIGNCGSLVHIELSDNSLYGDI----PFSISKLKQLEFLNLKNNQLTGP----I 126 (943)
Q Consensus 60 ~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~n~l~~~----~ 126 (943)
+.+.|++|+|+++ .|+.. +-..+...++|++|+|++|.+.... ...+...+.|++|+|++|.++.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3466777777653 45421 2334555566777777777665322 22344456677777777766532 1
Q ss_pred CcccCCCCCCcEEEEeccccc
Q 002278 127 PSTLTQIPNLKTLDLARNQLT 147 (943)
Q Consensus 127 ~~~~~~l~~L~~L~Ls~N~l~ 147 (943)
...+...++|++|+|++|.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 234555566666666666543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.70 E-value=4.6e-06 Score=78.27 Aligned_cols=91 Identities=14% Similarity=0.219 Sum_probs=63.6
Q ss_pred cCCCCCcEEeccCC-CcCCc----cchhccccccceEEEecCcccccC----CCcccCCCCCCcEEEEeccccccc----
Q 002278 83 GNCGSLVHIELSDN-SLYGD----IPFSISKLKQLEFLNLKNNQLTGP----IPSTLTQIPNLKTLDLARNQLTGE---- 149 (943)
Q Consensus 83 ~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~---- 149 (943)
.+.++|++|+|+++ .++.. +...+...++|++|+|++|.+... +...+...+.|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 35688999999974 56532 334566778899999999988732 234455678899999999988743
Q ss_pred cchhccccccceeccccCCccCCC
Q 002278 150 IPRLIYWNEVLQYLGLRGNALTGM 173 (943)
Q Consensus 150 ~~~~~~~l~~L~~L~L~~n~l~~~ 173 (943)
+...+...++|++|+|++|++..+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~ 115 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVL 115 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCc
Confidence 233455556677777777766544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00031 Score=75.27 Aligned_cols=76 Identities=11% Similarity=0.080 Sum_probs=48.1
Q ss_pred ceEEeeeceEEEEEEEecC-CceEEEEEeccc-------CcccHHHHHHHHHHHhcCC-C-C-CcceeeeEEecCCcceE
Q 002278 621 KYIVGYGASSTVYKCALKN-SRPIAVKKLYNQ-------YPHNLREFETELETIGSIR-H-R-NIVSLHGYALSPYGNLL 689 (943)
Q Consensus 621 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~l 689 (943)
.+.||.|....||++...+ ++.|+||.-... .+....+...|.++++.+. + | .+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999998654 578888864321 1223344566888777653 2 2 34555544 4556789
Q ss_pred EEEEccCCC
Q 002278 690 FYDYMVNGS 698 (943)
Q Consensus 690 v~e~~~~g~ 698 (943)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.11 E-value=3.3e-05 Score=72.13 Aligned_cols=111 Identities=14% Similarity=0.198 Sum_probs=62.3
Q ss_pred cCCCCCCCEEEeeC-Cccccc----CCCCccCCCCCcEEeccCCCcCCcc----chhccccccceEEEecCcccccC---
Q 002278 58 IGDLRNLQSIDFQG-NKLTGQ----IPDEIGNCGSLVHIELSDNSLYGDI----PFSISKLKQLEFLNLKNNQLTGP--- 125 (943)
Q Consensus 58 l~~l~~L~~L~Ls~-n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~n~l~~~--- 125 (943)
..+.+.|++|+|++ +.|+.. +-.++...++|++|+|++|.++... ...+...+.++.|++++|.++..
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34556777777776 456532 3334556677777777777776432 23345567777777777776532
Q ss_pred -CCcccCCCCCCcEEEE--ecccccc----ccchhccccccceeccccCC
Q 002278 126 -IPSTLTQIPNLKTLDL--ARNQLTG----EIPRLIYWNEVLQYLGLRGN 168 (943)
Q Consensus 126 -~~~~~~~l~~L~~L~L--s~N~l~~----~~~~~~~~l~~L~~L~L~~n 168 (943)
+...+...++|+.++| ++|.+.. .+...+..+++|+.|+++.+
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 2245556667766444 3455542 23333444455555555443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.85 E-value=7.9e-05 Score=69.45 Aligned_cols=115 Identities=16% Similarity=0.210 Sum_probs=68.3
Q ss_pred ccCCCCCcEEeccC-CCcCCc----cchhccccccceEEEecCcccccC----CCcccCCCCCCcEEEEeccccccc---
Q 002278 82 IGNCGSLVHIELSD-NSLYGD----IPFSISKLKQLEFLNLKNNQLTGP----IPSTLTQIPNLKTLDLARNQLTGE--- 149 (943)
Q Consensus 82 ~~~l~~L~~L~Ls~-N~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~--- 149 (943)
..+.++|++|+|++ +.++.. +..++...++|++|+|++|.++.. +...+...+.|+.|++++|.++..
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 45668899999987 456532 234455678888888888887643 223455567888888888877632
Q ss_pred -cchhccccccceeccccCCccCCCCCcccccccccceeeccceeccc----ccCCCCcCCCcccEEEeecccc
Q 002278 150 -IPRLIYWNEVLQYLGLRGNALTGMLSPDMCQLTGLWYFDVRGNNLTG----TIPDSIGNCTSFEILDISYNQI 218 (943)
Q Consensus 150 -~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~----~~~~~l~~l~~L~~L~Ls~N~l 218 (943)
+...+...++|+.++| ++++|.+.. .+...+...++|+.|+++.+..
T Consensus 93 ~l~~~l~~~~~L~~l~L----------------------~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRI----------------------DNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHGGGGCSSCCEEEC----------------------CCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCccccEEee----------------------ccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2233334444443222 223333321 2333455667777777776654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.38 E-value=0.0045 Score=64.00 Aligned_cols=135 Identities=13% Similarity=0.105 Sum_probs=76.2
Q ss_pred eEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCc--ceeee-----EEecCCcceEEEEEccCCChhh
Q 002278 629 SSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNI--VSLHG-----YALSPYGNLLFYDYMVNGSLWD 701 (943)
Q Consensus 629 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g~L~~ 701 (943)
--.||++...+|+.|++|..... ....+++..|.+.+..+....+ +.... .+...+..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 34799999999999999987543 3356778889888877742222 11111 1233455678899987643311
Q ss_pred ----hc----------c----CC--CCCccCCHH----------------------HHHHHHHHHHHHHHHh-hhCCCCC
Q 002278 702 ----LL----------H----GP--SKKVKLDWE----------------------TRLKIAVGAAQGLAYL-HHDCNPR 738 (943)
Q Consensus 702 ----~l----------~----~~--~~~~~l~~~----------------------~~~~i~~~i~~~l~~L-H~~~~~~ 738 (943)
.. + .. ......++. .....+..+...+.-. .+....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 0 00 001111111 1122222333222222 1222347
Q ss_pred eEecCCCCccEEECCCCceeeccccccc
Q 002278 739 IIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 739 ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
+||+|+.+.|||++++ ..++||+-+.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 8999999999999754 4589999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.93 E-value=0.011 Score=62.83 Aligned_cols=72 Identities=14% Similarity=0.196 Sum_probs=48.5
Q ss_pred eEEeeeceEEEEEEEecCC--------ceEEEEEecccCcccHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcceEEEE
Q 002278 622 YIVGYGASSTVYKCALKNS--------RPIAVKKLYNQYPHNLREFETELETIGSIR-HRNIVSLHGYALSPYGNLLFYD 692 (943)
Q Consensus 622 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 692 (943)
..|+.|-.-.+|++...++ +.|.++..- . ........+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5688899999999986532 345555543 2 334456678998888875 4334577777642 68999
Q ss_pred EccCCCh
Q 002278 693 YMVNGSL 699 (943)
Q Consensus 693 ~~~~g~L 699 (943)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.39 E-value=0.052 Score=55.26 Aligned_cols=157 Identities=13% Similarity=0.053 Sum_probs=80.0
Q ss_pred CHHHHHHHhhccccceE-----EeeeceEEEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHhcCCCCCc--ceeee
Q 002278 607 TFDDIMRSTENLSEKYI-----VGYGASSTVYKCALKNSRPIAVKKLYNQYPHNLREFETELETIGSIRHRNI--VSLHG 679 (943)
Q Consensus 607 ~~~~~~~~~~~~~~~~~-----lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~ 679 (943)
+.+++.....+|..... |..|---+.|.....++ ++++|+..... ..+++..|++++..+...++ .....
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 45677777777876543 44666688899887655 58889875432 22445556666666632221 11111
Q ss_pred ------EEecCCcceEEEEEccCCChhhhc--------------c----CCC--CCccC------------------CHH
Q 002278 680 ------YALSPYGNLLFYDYMVNGSLWDLL--------------H----GPS--KKVKL------------------DWE 715 (943)
Q Consensus 680 ------~~~~~~~~~lv~e~~~~g~L~~~l--------------~----~~~--~~~~l------------------~~~ 715 (943)
+.........++.++.+......- + ... ..... ...
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 011223445566666554332110 0 000 00000 001
Q ss_pred HHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCccEEECCCCceeeccccccc
Q 002278 716 TRLKIAVGAAQGLAYLHH-DCNPRIIHRDVKSSNILIDENFDAHLSDFGIAR 766 (943)
Q Consensus 716 ~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DFGla~ 766 (943)
.....+......+...+. ....++||+|+.+.||+++.+...-|+||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122222222222221 123489999999999999988777899999874
|